nonylphenol	O
diethoxylate	O
inhibits	O
apoptosis	O
induced	B-T169
in	O
pc12	O
cells	O
nonylphenol	O
and	O
short-chain	O
nonylphenol	O
ethoxylates	O
such	O
as	O
np2	O
eo	O
are	O
present	B-T033
in	O
aquatic	O
environment	O
as	O
wastewater	O
contaminants	O
,	O
and	O
their	O
toxic	O
effects	O
on	O
aquatic	O
species	O
have	O
been	O
reported	O
.	O
	
apoptosis	O
has	O
been	O
shown	O
to	O
be	O
induced	B-T169
by	O
serum	O
deprivation	B-T080
or	O
copper	O
treatment	B-T169
.	O
	
to	O
understand	O
the	O
toxicity	B-T080
of	O
nonylphenol	O
diethoxylate	O
,	O
we	O
investigated	O
the	O
effects	B-T080
of	I-T080
np2	O
eo	O
on	O
apoptosis	O
induced	B-T169
by	O
serum	O
deprivation	B-T080
and	O
copper	O
by	O
using	O
pc12	O
cell	O
system	O
.	O
	
nonylphenol	O
diethoxylate	O
itself	O
showed	O
no	O
toxicity	O
and	O
recovered	O
cell	O
viability	O
from	O
apoptosis	O
.	O
	
in	O
addition	O
,	O
nonylphenol	O
diethoxylate	O
decreased	B-T081
dna	O
fragmentation	O
caused	O
by	O
apoptosis	O
in	O
pc12	O
cells	O
.	O
	
this	O
phenomenon	O
was	O
confirmed	O
after	O
treating	B-T169
apoptotic	B-T080
pc12	O
cells	O
with	O
nonylphenol	O
diethoxylate	O
,	O
whereas	O
the	O
cytochrome	B-T116
c	I-T116
release	O
into	O
the	O
cytosol	O
decreased	B-T081
as	O
compared	O
to	O
that	O
in	O
apoptotic	O
cells	O
not	O
treated	B-T169
with	O
nonylphenol	O
diethoxylate	O
s	O
.	O
	
furthermore	O
,	O
bax	B-T116
contents	O
in	O
apoptotic	O
cells	O
were	O
reduced	B-T080
after	O
exposure	B-T080
to	I-T080
nonylphenol	O
diethoxylate	O
.	O
	
thus	O
,	O
nonylphenol	O
diethoxylate	O
has	O
the	O
opposite	B-T080
effect	I-T080
on	O
apoptosis	O
in	O
pc12	O
cells	O
compared	O
to	O
nonylphenol	O
,	O
which	O
enhances	O
apoptosis	O
induced	B-T169
by	O
serum	O
deprivation	B-T080
.	O
	
the	O
difference	B-T080
in	O
structure	O
of	O
the	O
two	O
compounds	O
is	O
hypothesized	B-T078
to	O
be	O
responsible	O
for	O
this	O
phenomenon	O
.	O
	
these	O
results	B-T033
indicated	O
that	O
nonylphenol	O
diethoxylate	O
has	O
capability	B-T080
to	O
affect	O
cell	O
differentiation	O
and	O
development	O
and	O
has	O
potentially	B-T080
harmful	O
effect	O
on	O
organisms	O
because	O
of	O
its	O
unexpected	O
impact	B-T080
on	O
apoptosis	O
.	O
	
ezh2	O
and	O
zfx	O
oncogenes	O
in	O
malignant	B-T080
behaviour	I-T080
of	O
parathyroid	O
neoplasms	O
several	O
studies	O
reported	O
somatic	O
mutations	O
of	O
many	O
genes	O
men1	O
,	O
ctnnb1	O
,	O
cdkis	O
and	O
others	O
in	O
parathyroid	O
adenoma	O
,	O
although	O
with	O
different	B-T080
prevalence	B-T081
.	O
	
recently	O
,	O
activating	O
mutations	O
of	O
the	O
ezh2	O
and	O
zfx	O
oncogenes	O
were	O
identified	O
in	O
benign	B-T080
parathyroid	O
adenoma	O
by	O
whole	O
exome	O
sequencing	O
.	O
	
the	O
same	O
mutations	O
had	O
been	O
found	O
in	O
blood	O
and	O
ovary	O
malignant	O
tumours	O
.	O
	
on	O
one	O
hand	O
,	O
this	O
result	O
raised	O
the	O
hypothesis	B-T078
that	O
these	O
oncogenes	O
may	O
play	O
a	O
role	O
in	O
the	O
onset	B-T080
of	O
parathyroid	O
tumour	O
,	O
but	O
it	O
would	O
also	O
suggest	O
they	O
may	O
be	O
involved	O
in	O
malignant	B-T080
,	O
rather	O
benign	B-T080
,	O
parathyroid	O
neoplasm	O
.	O
	
our	O
aim	B-T078
was	O
to	O
verify	O
the	O
occurrence	B-T079
of	O
selected	O
mutations	O
of	O
the	O
ezh2	O
and	O
zfx	O
genes	O
in	O
an	O
italian	O
cohort	O
of	O
23	O
sporadic	B-T079
parathyroid	O
carcinomas	O
,	O
12	O
atypical	B-T080
and	O
45	O
typical	B-T080
adenomas	O
.	O
	
dna	O
was	O
extracted	B-T061
from	O
paraffin-embedded	O
tissues	O
,	O
pcr	O
amplified	O
and	O
directly	O
sequenced	B-T169
.	O
	
no	B-T033
mutations	O
were	O
detected	B-T033
in	O
the	O
coding	O
sequence	O
and	O
boundaries	O
of	O
both	O
genes	O
in	O
any	O
of	O
the	O
samples	O
.	O
	
two	O
polymorphisms	O
of	O
the	O
ezh2	O
gene	O
were	O
identified	B-T080
with	O
different	B-T080
prevalence	B-T081
the	O
rs2072407	O
variant	O
was	O
present	B-T033
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	B-T080
frequency	B-T079
in	O
larger	B-T081
populations	B-T081
,	O
while	O
the	O
rs78589034	O
variant	O
,	O
located	O
close	O
to	O
the	O
5'	O
end	O
of	O
the	O
exon	O
16	O
,	O
was	O
detected	B-T033
in	O
only	O
one	O
proband	O
with	O
familial	B-T169
isolated	B-T169
hyperparathyroidism	B-T047
we	O
investigated	B-T169
the	O
possible	O
outcome	B-T169
on	O
the	O
splicing	O
process	O
.	O
	
ezh2	O
and	O
zfx	O
genes	O
do	O
not	O
seem	O
to	O
have	O
an	O
impact	B-T080
on	O
the	O
onset	B-T080
of	O
most	O
parathyroid	O
tumours	O
,	O
both	O
benign	B-T080
and	O
malignant	B-T080
,	O
though	O
further	O
studies	O
on	O
larger	B-T081
cohorts	O
of	O
different	B-T080
ethnicity	B-T080
patient	O
-	O
physician	O
discordance	B-T080
in	O
global	O
assessment	O
in	O
rheumatoid	B-T047
arthritis	I-T047
a	O
systematic	B-T169
literature	O
review	O
with	O
meta-analysis	O
the	O
integration	O
of	O
the	O
patient	O
in	O
therapeutic	B-T169
decision-making	O
is	O
important	O
in	O
the	O
management	O
of	O
rheumatoid	B-T047
arthritis	I-T047
ra	B-T047
,	O
but	O
the	O
patient	O
opinion	O
regarding	O
disease	B-T047
status	B-T080
may	O
differ	O
from	O
the	O
physician's	O
opinion	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
in	O
the	O
published	O
literature	O
the	O
frequency	B-T079
and	O
drivers	O
of	O
patient	O
-	O
physician	O
discordance	B-T080
in	O
global	O
assessment	O
in	O
ra	B-T047
.	O
	
a	O
systematic	B-T169
literature	O
review	O
of	O
all	O
articles	O
published	O
up	O
to	O
january	O
2015	O
in	O
medline	O
or	O
embase	O
,	O
reporting	O
discordance	B-T080
in	O
ra	B-T047
,	O
was	O
conducted	O
by	O
2	O
investigators	O
.	O
	
discordance	B-T080
was	O
defined	O
based	O
on	O
the	O
absolute	B-T080
difference	I-T080
of	O
patient	O
global	O
pga	O
and	O
physician	O
global	O
assessments	O
phga	O
on	O
0-10-cm	O
scales	O
.	O
	
the	O
frequency	B-T079
of	O
discordance	B-T080
and	O
its	O
predictors	B-T033
were	O
collected	O
in	O
each	O
study	O
.	O
	
frequencies	B-T079
of	O
discordance	B-T080
were	O
pooled	B-T169
by	O
meta-analysis	O
using	O
random	B-T080
effect	B-T080
.	O
	
in	O
all	O
,	O
12	O
studies	O
were	O
selected	O
i.e	O
,	O
11	O
patients	O
weighted	B-T081
mean	I-T081
sd	O
age	O
was	O
55.1	O
13.9	O
years	B-T079
,	O
weighted	B-T081
mean	I-T081
sd	O
disease	B-T079
duration	I-T079
was	O
10.4	O
9.3	O
years	B-T079
,	O
and	O
80.7	O
were	O
women	O
.	O
	
the	O
value	B-T081
of	O
the	O
difference	B-T081
|	O
pga	O
-	O
phga	O
|	O
defining	O
discordance	B-T080
varied	O
between	O
0.5	O
cm	O
n	O
=	O
2	O
studies	O
to	O
3	O
cm	O
n	O
=	O
5	O
studies	O
the	O
weighted	B-T081
mean	I-T081
value	I-T081
was	O
2.7	O
cm	O
.	O
	
the	O
pooled	B-T169
percentage	B-T081
of	O
patients	O
with	O
discordance	B-T080
was	O
43%	O
95%	O
confidence	B-T081
interval	I-T081
36%-51%	O
range	B-T081
25%-76%	O
.	O
	
pga	O
was	O
usually	O
higher	B-T080
than	O
phga	O
.	O
	
the	O
drivers	O
of	O
pga	O
were	O
pain	O
and	O
functional	B-T169
incapacity	O
,	O
whereas	O
drivers	O
of	O
phga	O
were	O
joint	O
counts	O
and	O
acute-phase	B-T116
reactants	I-T116
.	O
	
discordance	B-T080
in	O
global	O
assessment	O
was	O
most	O
frequently	B-T079
defined	O
as	O
a	O
difference	B-T080
of	O
3	O
points	O
or	O
more	O
even	O
with	O
such	O
a	O
stringent	O
definition	O
,	O
up	O
to	O
half	B-T081
the	O
patients	O
were	O
found	O
to	O
be	O
discordant	B-T080
.	O
	
the	O
long-term	B-T079
consequences	B-T169
of	O
this	O
discordance	B-T080
a	O
randomized	O
controlled	O
noninferiority	O
trial	O
of	O
single	B-T081
dose	I-T081
of	O
oral	O
dexamethasone	O
versus	O
5	O
days	B-T079
of	O
oral	O
prednisone	O
in	O
acute	O
adult	O
asthma	B-T047
oral	O
dexamethasone	O
demonstrates	O
bioavailability	B-T081
similar	B-T080
to	O
that	O
of	O
oral	O
prednisone	O
but	O
has	O
a	O
longer	O
half-life	B-T079
.	O
	
we	O
evaluate	O
whether	O
a	O
single	B-T081
dose	I-T081
of	O
oral	O
dexamethasone	O
plus	B-T169
4	O
days	B-T079
of	O
placebo	O
is	O
not	O
inferior	O
to	O
5	O
days	B-T079
of	O
oral	O
prednisone	O
in	O
treatment	B-T169
of	O
adults	O
with	O
mild	B-T033
to	O
moderate	B-T033
asthma	B-T033
exacerbations	I-T033
to	O
prevent	B-T169
relapse	O
defined	O
as	O
an	O
unscheduled	B-T079
return	O
visit	O
for	O
additional	B-T033
treatment	I-T033
for	O
persistent	B-T047
or	O
worsening	B-T080
asthma	B-T047
within	O
14	O
days	B-T079
.	O
	
adult	O
emergency	O
department	O
patients	O
aged	O
18	O
to	O
55	O
years	B-T079
were	O
randomized	O
to	O
receive	B-T080
either	O
a	O
single	B-T081
dose	I-T081
of	O
12	O
mg	O
of	O
oral	O
dexamethasone	O
with	O
4	O
days	B-T079
of	O
placebo	O
or	O
a	O
5-	O
day	B-T079
course	B-T079
of	O
oral	O
prednisone	O
60	O
mg	O
a	O
day	B-T079
.	O
	
outcomes	B-T169
including	B-T169
relapse	O
were	O
assessed	O
by	O
a	O
follow-up	O
telephone	O
interview	O
at	O
2	O
weeks	B-T079
.	O
	
one	O
hundred	B-T081
seventy-three	I-T081
dexamethasone	B-T109
and	O
203	O
prednisone	B-T109
subjects	O
completed	B-T080
the	O
study	O
regimen	O
and	O
telephone	O
follow-up	O
.	O
	
the	O
dexamethasone	B-T109
group	O
by	O
a	O
small	O
margin	O
surpassed	O
the	O
preset	O
8%	O
difference	B-T080
between	O
groups	O
for	O
noninferiority	B-T080
in	O
relapse	O
rates	B-T081
within	O
14	O
days	B-T079
12.1	O
versus	O
9.8	O
difference	B-T080
2.3	O
95%	O
confidence	B-T081
interval	I-T081
-4	O
to	O
8.6	O
.	O
	
subjects	O
in	O
the	O
2	O
groups	O
had	O
similar	O
rates	B-T081
of	O
hospitalization	O
for	O
their	O
relapse	O
visit	O
dexamethasone	B-T109
3.4	O
versus	O
prednisone	B-T109
2.9	O
difference	B-T080
0.5	O
95%	O
confidence	B-T081
interval	I-T081
-4	O
to	O
3.1	O
.	O
	
adverse	B-T080
effect	I-T080
rates	B-T081
were	O
generally	O
the	O
same	O
in	O
the	O
2	O
groups	O
.	O
	
a	O
single	B-T081
dose	I-T081
of	O
oral	O
dexamethasone	O
did	O
not	O
demonstrate	O
noninferiority	B-T080
to	O
prednisone	B-T109
for	O
5	O
days	B-T079
by	O
a	O
very	O
small	O
margin	O
for	O
treatment	B-T169
of	O
adults	O
with	O
mild	B-T033
to	O
moderate	B-T033
asthma	B-T033
exacerbations	I-T033
.	O
	
enhanced	O
compliance	B-T033
and	O
convenience	B-T080
may	O
support	O
the	O
use	B-T169
of	O
dexamethasone	B-T109
malignancy	O
is	O
associated	B-T080
with	I-T080
microcalcification	O
and	O
higher	B-T081
ap/t	I-T081
ratio	I-T081
in	O
ultrasonography	O
,	O
but	O
not	O
with	O
hashimoto's	B-T047
thyroiditis	I-T047
in	O
histopathology	O
in	O
patients	O
with	O
thyroid	O
nodules	O
evaluated	O
as	O
bethesda	O
category	O
iii	O
aus	O
/	O
flus	B-T033
in	O
cytology	O
the	O
predictors	O
of	O
malignancy	O
are	O
important	O
for	O
the	O
decision	O
of	O
appropriate	O
management	O
in	O
nodules	O
with	O
atypia	O
of	O
undetermined	O
significance	O
/	O
follicular	B-T033
lesion	I-T033
of	I-T033
undetermined	I-T033
significance	I-T033
aus	O
/	O
flus	B-T033
.	O
	
our	O
aim	O
was	O
to	O
determine	O
the	O
ultrasonographical	O
,	O
clinical	O
,	O
and	O
biochemical	O
predictors	O
of	O
malignancy	O
in	O
these	O
patients	O
.	O
	
a	O
total	O
of	O
427	O
patients	O
with	O
cytologically	O
bethesda	O
category	O
iii	O
aus	O
/	O
flus	B-T033
thyroid	O
nodules	O
were	O
included	O
in	O
this	O
retrospective	O
study	O
.	O
	
we	O
divided	O
the	O
nodules	O
into	O
two	O
subgroups	O
according	O
to	O
the	O
histopathology	O
as	O
benign	B-T080
and	O
malignant	B-T080
,	O
and	O
compared	O
the	O
preoperative	B-T079
ultrasonographical	O
,	O
clinical	O
,	O
and	O
biochemical	B-T033
findings	I-T033
.	O
	
in	O
overall	O
,	O
427	O
patients	O
with	O
449	O
aus	O
/	O
flus	B-T033
nodules	O
who	O
had	O
undergone	O
surgery	B-T061
,	O
the	O
rate	O
of	O
malignancy	O
was	O
23.4	O
%	O
105/449	O
.	O
	
when	O
evaluated	O
separately	O
,	O
the	O
rate	O
of	O
malignancy	O
was	O
25.8	O
%	O
in	O
nodules	O
with	O
aus	O
82/318	O
and	O
17.6	O
%	O
in	O
nodules	O
with	O
flus	B-T033
23/131	O
p	O
=	O
0.061	O
.	O
	
the	O
vast	O
majority	O
of	O
malignant	O
specimens	O
in	O
histopathology	O
consisted	O
of	O
papillary	O
thyroid	O
carcinoma	O
ptc	O
n	O
=	O
91	O
,	O
86.7	O
%	O
.	O
	
preoperative	B-T079
ultrasonographic	O
features	O
of	O
105	O
malignant	O
nodules	O
in	O
histopathology	O
were	O
compared	O
with	O
the	O
344	O
benign	O
nodules	O
in	O
histopathology	O
.	O
	
anteroposterior/transverse	B-T081
ap/t	I-T081
ratio	I-T081
was	O
significantly	O
higher	O
in	O
malignant	O
group	O
compared	O
to	O
benign	O
group	O
p	O
=	O
0.013	O
.	O
	
in	O
multiple	O
logistic	O
analysis	O
,	O
we	O
found	O
that	O
higher	B-T081
ap/t	I-T081
ratio	I-T081
and	O
microcalcification	O
were	O
independently	O
associated	B-T080
with	I-T080
malignancy	O
p	O
<	O
0.05	O
.	O
	
the	O
malignancy	O
-associated	O
cut-off	O
value	O
of	O
ap/t	B-T081
ratio	I-T081
at	O
maximum	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
was	O
0.81	O
.	O
	
we	O
did	O
not	O
find	O
any	O
correlation	B-T080
between	O
malignancy	O
and	O
hashimoto's	B-T047
thyroiditis	I-T047
in	O
histopathology	O
in	O
multivariate	B-T081
analysis	I-T081
p	O
>	O
0.05	O
.	O
	
in	O
bethesda	O
category	O
iii	O
nodules	O
with	O
higher	B-T081
ap/t	I-T081
ratio	I-T081
and	O
microcalcification	O
,	O
surgery	B-T061
might	O
be	O
considered	O
as	O
a	O
first	O
therapeutic	O
option	O
instead	O
of	O
repeat	O
fine-needle	O
aspiration	O
biopsy	O
or	O
impact	B-T080
of	O
cofactor	O
-	O
binding	O
loop	O
mutations	O
on	O
thermotolerance	O
and	O
activity	O
of	O
e	O
.	O
	
coli	O
transketolase	B-T116
improvement	O
of	O
thermostability	O
in	O
engineered	B-T116
enzymes	I-T116
can	O
allow	O
biocatalysis	O
on	O
substrates	O
with	O
poor	O
aqueous	B-T080
solubility	B-T080
.	O
	
denaturation	O
of	O
the	O
cofactor	O
-	O
binding	O
loops	O
of	O
escherichia	O
coli	O
transketolase	B-T116
tk	B-T116
was	O
previously	O
linked	O
to	O
the	O
loss	B-T081
of	O
enzyme	O
activity	O
under	O
conditions	B-T080
of	O
high	B-T080
ph	B-T081
or	O
urea	B-T109
.	O
	
incubation	O
at	O
temperatures	B-T081
just	O
below	O
the	O
thermal	O
melting	O
transition	O
,	O
above	O
which	O
the	O
protein	B-T116
aggregates	B-T169
,	O
was	O
also	O
found	O
to	O
anneal	B-T169
the	O
enzyme	B-T116
to	O
give	O
an	O
increased	B-T081
specific	O
activity	O
.	O
	
the	O
potential	O
role	O
of	O
cofactor	O
-	O
binding	O
loop	O
instability	B-T033
in	O
this	O
process	O
remained	O
unclear	O
.	O
	
in	O
this	O
work	O
,	O
the	O
two	O
cofactor	O
-	O
binding	O
loops	O
residues	O
185-192	O
and	O
382-392	O
were	O
progressively	O
mutated	O
towards	O
the	O
equivalent	O
sequence	O
from	O
the	O
thermostable	B-T080
thermus	O
thermophilus	O
tk	B-T116
and	O
variants	O
assessed	O
for	O
their	O
impact	B-T080
on	O
both	O
thermostability	O
and	O
activity	O
.	O
	
cofactor-binding	O
loop	O
2	O
variants	O
had	O
detrimental	B-T080
effects	I-T080
on	O
specific	O
activity	O
at	O
elevated	B-T080
temperatures	B-T081
,	O
whereas	O
the	O
h192p	O
mutation	O
in	O
cofactor-binding	O
loop	O
1	O
resulted	O
in	O
a	O
two-fold	O
improved	O
stability	O
to	O
inactivation	B-T169
at	O
elevated	B-T080
temperatures	B-T081
,	O
and	O
increased	B-T081
the	O
critical	B-T081
onset	I-T081
temperature	I-T081
for	O
aggregation	B-T169
.	O
	
the	O
specific	O
activity	O
of	O
h192p	O
was	O
3-fold	O
and	O
19-fold	O
higher	B-T080
than	O
that	O
for	O
wild-type	O
at	O
60	O
and	O
65	O
respectively	O
,	O
and	O
also	O
remained	O
2.7	O
fold	O
higher	B-T080
after	O
re-cooling	O
from	O
pre-incubations	O
at	O
either	O
55	O
or	O
60	O
for	O
1h	O
.	O
	
interestingly	O
,	O
h192p	O
was	O
also	O
2-times	O
more	O
active	B-T169
than	O
wild-type	O
tk	B-T116
at	O
25	O
.	O
	
optimal	B-T080
activity	O
was	O
achieved	O
at	O
60	O
for	O
h192p	O
compared	O
to	O
55	O
for	O
wild	O
type	O
.	O
	
these	O
results	O
show	O
that	O
cofactor-binding	O
loop	O
1	O
,	O
plays	O
a	O
pivotal	O
role	O
in	O
partial	B-T081
denaturation	O
and	O
aggregation	B-T169
at	O
elevated	B-T080
temperatures	B-T081
.	O
	
furthermore	O
,	O
a	O
single	O
rigidifying	O
mutation	O
within	O
this	O
loop	O
can	O
significantly	O
improve	O
the	O
enzyme	O
specific	O
activity	O
,	O
as	O
well	O
as	O
the	O
stability	O
to	O
thermal	O
denaturation	O
and	O
aggregation	B-T169
,	O
to	O
give	O
an	O
increased	B-T081
temperature	B-T081
optimum	B-T080
for	O
safety	O
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	O
anticoagulant	B-T061
therapy	I-T061
cardiac	O
catheterization	O
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	B-T169
after	O
the	O
anticoagulation	B-T061
has	O
been	O
withdrawn	B-T061
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	B-T061
therapy	I-T061
with	I-T061
heparin	I-T061
is	O
used	O
.	O
	
a	O
prospective	O
observational	O
study	O
including	O
489	O
patients	O
undergoing	O
transradial	O
catheterization	O
was	O
conducted	O
.	O
	
a	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	B-T109
group	O
a	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	B-T080
group	O
b	O
for	O
complications	O
after	O
the	O
procedure	O
bleeding	O
and	O
vascular	O
access	O
complications	O
.	O
	
patients	O
in	O
group	O
a	O
were	O
older	O
74	O
years	O
vs	O
.	O
	
68	O
years	O
,	O
p<0	O
and	O
the	O
main	O
indication	B-T078
for	O
anticoagulation	B-T061
was	O
atrial	B-T047
fibrillation	I-T047
58.6	O
.	O
	
no	B-T033
complications	O
occurred	O
during	O
the	O
procedures	O
.	O
	
there	O
were	O
no	B-T033
acute	O
bleedings	O
just	O
after	B-T079
the	O
bandage	O
removal	O
.	O
	
during	O
the	O
first	O
24h	O
,	O
only	O
3	O
2.1	O
radial	O
occlusions	O
in	O
group	O
a	O
and	O
2	O
0.6	O
in	O
group	O
b	O
p=0	O
were	O
recorded	B-T080
.	O
	
hematomas	O
between	O
5	O
and	O
10cm	O
appeared	O
in	O
5%	O
of	O
the	O
group	O
a	O
vs	O
.	O
	
4.6	O
in	O
group	O
b	O
.	O
	
during	O
the	O
1-month	B-T079
follow-up	O
period	B-T079
,	O
one	O
more	O
radial	O
occlusion	O
in	O
each	O
group	B-T078
was	O
recorded	B-T080
and	O
there	O
were	O
4	O
1.1	O
additional	O
mild	B-T080
hematomas	O
in	O
group	O
b	O
and	O
none	O
in	O
group	O
a	O
p=0	O
.	O
	
performing	B-T169
a	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
without	B-T080
removal	O
of	O
the	O
oral	O
chronic	O
anticoagulation	O
appears	O
safe	B-T033
in	O
patients	O
under	O
acenocumarol	B-T109
therapy	B-T061
.	O
	
does	O
infrared	O
visualization	B-T169
improve	O
selection	O
of	O
venipuncture	O
sites	O
for	O
indwelling	B-T169
needle	O
at	O
the	O
forearm	O
in	O
second-year	O
nursing	O
students	O
to	O
evaluate	O
the	O
effectiveness	B-T080
of	O
a	O
vein	O
visualization	O
display	O
system	O
using	O
near-infrared	O
light	O
""""	O
vein	O
display	O
""""	O
for	O
the	O
safe	O
and	O
proper	O
selection	O
of	O
venipuncture	O
sites	O
for	O
indwelling	B-T169
needle	O
placement	O
in	O
the	O
forearm	O
.	O
	
ten	O
second	O
year	O
nursing	O
students	O
were	O
recruited	O
to	O
apply	O
an	O
indwelling	B-T169
needle	O
line	O
with	O
and	O
without	O
vein	O
display	B-T169
.	O
	
another	O
ten	O
participants	O
were	O
recruited	O
from	O
various	O
faculty	O
to	O
serve	O
as	O
patients	O
.	O
	
the	O
quality	O
of	O
the	O
venipuncture	O
procedure	O
at	O
various	O
selected	O
sites	O
was	O
evaluated	O
according	O
to	O
a	O
scale	O
developed	O
by	O
the	O
authors	O
.	O
	
time	B-T079
,	O
scores	B-T081
and	O
patterns	B-T080
of	O
puncture	O
-	O
site	O
selection	O
were	O
compared	O
with	O
respect	O
to	O
three	O
different	O
methods	O
1	O
attempt	O
1	O
tourniquet	O
only	O
,	O
2	O
attempt	O
2	O
vein	O
display	O
only	O
and	O
3	O
attempt	O
3	O
both	O
.	O
	
to	O
validate	O
the	O
effectiveness	B-T080
of	O
vein	O
display	B-T169
,	O
52	O
trials	O
were	O
conducted	O
in	O
total	O
.	O
	
we	O
found	O
that	O
venipuncture	O
site	O
selection	O
time	O
was	O
significantly	O
improved	O
with	O
the	O
vein	O
display	O
,	O
particularly	O
in	O
the	O
case	O
of	O
difficult	O
to	O
administer	B-T169
venipuncture	O
sites	O
.	O
	
overall	O
,	O
we	O
found	O
no	O
significant	O
difference	O
with	O
respect	O
to	O
venipuncture	O
quality	B-T080
,	O
as	O
determined	O
by	O
our	O
scale	O
.	O
	
these	O
results	O
suggest	O
that	O
equipment	O
such	O
as	O
the	O
vein	O
display	O
can	O
contribute	O
immensely	O
to	O
the	O
improvement	O
of	O
practical	B-T080
skills	I-T080
,	O
such	O
as	O
venipuncture	O
,	O
especially	O
in	O
the	O
context	O
of	O
elderly	O
patients	O
.	O
	
elective	B-T061
nephron	B-T061
sparing	I-T061
surgery	I-T061
decreases	B-T081
other	B-T033
cause	I-T033
mortality	I-T033
relative	B-T080
to	O
radical	B-T061
nephrectomy	I-T061
only	O
in	O
specific	B-T080
subgroups	O
of	O
patients	O
with	O
renal	O
cell	O
carcinoma	O
there	O
is	O
no	O
consensus	O
regarding	O
a	O
protective	B-T033
effect	I-T033
on	O
mortality	B-T081
due	O
to	O
a	O
cause	O
other	O
than	O
cancer	O
in	O
patients	O
treated	B-T061
with	I-T061
elective	B-T061
nephron	B-T061
sparing	I-T061
surgery	I-T061
relative	B-T080
to	O
their	O
radical	B-T061
nephrectomy	I-T061
counterparts	O
.	O
	
we	O
test	B-T169
whether	O
the	O
protective	B-T033
effect	I-T033
of	O
nephron	B-T061
sparing	I-T061
surgery	I-T061
relative	B-T080
to	O
radical	B-T061
nephrectomy	I-T061
is	O
universal	B-T080
or	O
present	O
in	O
specific	B-T080
subgroups	O
of	O
patients	O
.	O
	
a	O
collaborative	B-T081
database	O
of	O
5	O
institutions	B-T078
was	O
queried	O
to	O
evaluate	O
1	O
patients	O
without	O
chronic	B-T047
kidney	I-T047
disease	I-T047
diagnosed	B-T033
with	O
a	O
clinical	B-T080
t1	O
renal	O
mass	O
that	O
was	O
treated	B-T061
with	I-T061
nephron	B-T061
sparing	I-T061
surgery	I-T061
or	O
radical	B-T061
nephrectomy	I-T061
.	O
	
multivariable	O
cox	O
regression	O
analysis	O
was	O
done	O
to	O
assess	O
the	O
impact	B-T080
of	O
surgery	B-T061
type	O
nephron	B-T061
sparing	I-T061
surgery	I-T061
vs	O
radical	B-T061
nephrectomy	I-T061
on	O
other	B-T033
cause	I-T033
mortality	I-T033
after	O
adjustment	O
for	O
patient	O
and	O
cancer	O
characteristics	B-T080
.	O
	
interaction	B-T169
terms	O
were	O
used	O
to	O
test	B-T169
the	O
hypothesis	O
that	O
the	O
impact	B-T080
of	O
surgery	B-T061
type	O
varies	O
according	O
to	O
specific	B-T080
subcohorts	O
of	O
patients	O
.	O
	
ten-year	B-T079
other	B-T033
cause	I-T033
mortality	I-T033
-free	O
survival	B-T081
rates	I-T081
were	O
90%	O
and	O
88%	O
after	O
nephron	B-T061
sparing	I-T061
surgery	I-T061
and	O
radical	B-T061
nephrectomy	I-T061
,	O
respectively	O
.	O
	
in	O
the	O
overall	B-T080
population	O
radical	B-T061
nephrectomy	I-T061
was	O
not	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
of	O
other	B-T033
cause	I-T033
mortality	I-T033
on	O
multivariable	B-T081
analysis	I-T081
compared	O
to	O
nephron	B-T061
sparing	I-T061
surgery	I-T061
hr	B-T081
0.91	O
,	O
95%	O
ci	B-T081
0.6	O
,	O
p	O
=	O
0.6	O
.	O
	
however	O
,	O
radical	B-T061
nephrectomy	I-T061
increased	B-T081
the	O
risk	B-T078
of	O
other	B-T033
cause	I-T033
mortality	I-T033
according	O
to	O
the	O
increasing	B-T081
baseline	B-T081
charlson	O
comorbidity	O
index	O
interaction	B-T169
test	B-T169
p	O
=	O
0.0008	O
.	O
	
for	O
example	O
,	O
in	O
a	O
patient	O
with	O
a	O
charlson	O
comorbidity	O
index	O
of	O
4	O
the	O
probability	B-T081
of	O
10-year	B-T079
other	B-T033
cause	I-T033
mortality	I-T033
-free	O
survival	O
was	O
86%	O
after	O
nephron	B-T061
sparing	I-T061
surgery	I-T061
and	O
60%	O
after	O
radical	B-T061
nephrectomy	I-T061
.	O
	
elective	B-T061
nephron	B-T061
sparing	I-T061
surgery	I-T061
does	O
not	O
improve	B-T033
other	O
cause	O
survival	O
relative	B-T080
to	O
radical	B-T061
nephrectomy	I-T061
consistently	O
in	O
all	O
patients	O
with	O
kidney	O
cancer	O
.	O
	
patients	O
who	O
are	O
more	O
ill	O
with	O
relevant	B-T080
comorbidities	B-T078
are	O
those	O
who	O
benefit	B-T081
the	O
most	O
from	O
nephron	B-T061
sparing	I-T061
surgery	I-T061
in	O
terms	O
of	O
other	B-T033
cause	I-T033
mortality	I-T033
.	O
	
prospective	O
study	O
of	O
dietary	O
non	O
enzymatic	O
antioxidant	O
capacity	O
on	O
the	O
risk	B-T078
of	O
hip	O
fracture	O
in	O
the	O
elderly	O
dietary	O
antioxidants	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
prevention	O
of	O
bone	B-T047
loss	I-T047
and	O
associated	O
fractures	O
by	O
reducing	O
levels	O
of	O
oxidative	O
stress	O
.	O
	
we	O
prospectively	O
investigated	O
the	O
association	O
between	O
dietary	O
non	O
enzymatic	O
antioxidant	O
capacity	O
neac	O
and	O
the	O
risk	B-T078
of	O
hip	O
fracture	O
and	O
whether	O
this	O
effect	O
was	O
modified	O
by	O
smoking	O
.	O
	
in	O
the	O
swedish	O
national	O
march	O
cohort	O
13	O
men	O
and	O
women	O
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	O
,	O
cardiovascular	B-T047
disease	I-T047
or	O
hip	O
fracture	O
,	O
were	O
followed	O
through	O
record-linkages	O
from	O
1997	O
through	O
2010	O
.	O
	
neac	O
was	O
assessed	O
by	O
a	O
validated	O
food	O
frequency	O
questionnaire	O
collected	O
at	O
baseline	B-T081
.	O
	
we	O
categorized	O
the	O
distribution	O
of	O
neac	O
into	O
sex	O
-	O
specific	B-T080
quartiles	B-T080
and	O
used	O
multivariable	B-T081
adjusted	I-T081
cox	I-T081
proportional	I-T081
hazards	I-T081
regression	I-T081
models	I-T081
to	O
estimate	O
hazard	B-T081
ratios	I-T081
hrs	B-T081
with	O
95%	O
confidence	B-T081
intervals	I-T081
95%	O
ci	B-T081
.	O
	
during	O
a	O
mean	O
follow-up	O
time	B-T079
of	O
12.4years	O
,	O
we	O
identified	O
491	O
incident	O
cases	O
of	O
first	O
hip	O
fracture	O
.	O
	
subjects	O
in	O
the	O
highest	O
quartile	B-T080
of	O
dietary	O
neac	O
had	O
a	O
39%	O
lower	B-T033
risk	I-T033
of	O
incident	O
hip	O
fracture	O
compared	O
to	O
those	O
in	O
the	O
lowest	O
quartile	B-T080
hr	B-T081
0.61	O
95%	O
ci	B-T081
0.44	O
.	O
	
the	O
association	O
was	O
non-linear	O
p	O
for	O
non-linearity	O
0.004	O
with	O
a	O
potential	O
threshold	O
between	O
the	O
first	O
and	O
the	O
second	O
quartile	B-T080
and	O
no	O
further	O
risk	O
reduction	O
at	O
higher	O
levels	O
of	O
dietary	O
neac	O
.	O
	
due	O
to	O
a	O
low	O
smoking	O
prevalence	O
in	O
our	O
study	O
population	O
,	O
we	O
had	O
limited	O
power	O
to	O
detect	O
effect	O
modification	O
between	O
dietary	O
neac	O
and	O
smoking	O
on	O
a	O
multiplicative	B-T081
or	O
additive	B-T081
scale	I-T081
.	O
	
higher	O
dietary	O
neac	O
intake	O
is	O
associated	O
with	O
lower	O
risk	B-T078
of	O
hip	O
fracture	O
function	O
and	O
clinical	B-T080
meaningfulness	B-T080
of	O
treatments	B-T061
for	O
mild	B-T080
alzheimer's	B-T047
disease	I-T047
effectiveness	B-T080
of	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
treatments	B-T061
is	O
commonly	O
evaluated	O
with	O
coprimary	B-T169
outcomes	I-T169
cognition	O
with	O
function	O
to	O
ensure	O
clinical	B-T080
meaningfulness	B-T080
of	O
a	O
cognitive	O
effect	B-T080
.	O
	
we	O
reviewed	B-T080
the	O
literature	O
for	O
functional	O
outcomes	B-T169
in	O
mild	B-T080
ad	B-T047
or	O
mild	O
cognitive	O
impairment	O
mci	O
patients	O
distinct	O
from	O
combined	O
mild-moderate	B-T080
/	O
severe	B-T080
ad	B-T047
treated	B-T061
with	I-T061
approved	O
ad	B-T047
drugs	O
.	O
	
cognitive	B-T061
and	O
functional	O
treatment	B-T061
differences	O
in	O
mild	B-T080
ad	B-T047
patients	O
in	O
solanezumab	B-T116
expedition	O
/	O
expedition2	O
studies	O
were	O
compared	O
across	O
time	B-T079
.	O
	
seven	O
publications	O
provided	O
mci	O
/	O
mild	B-T080
ad	B-T047
functional	O
outcomes	B-T169
,	O
one	O
of	O
which	O
reported	O
a	O
significant	O
functional	O
treatment	B-T033
effect	I-T033
.	O
	
secondary	O
analyses	O
of	O
expedition	O
studies	O
suggested	O
a	O
smaller	O
functional	O
effect	B-T080
of	O
solanezumab	B-T116
relative	O
to	O
cognition	O
.	O
	
an	O
increasing	B-T169
effect	B-T080
of	O
solanezumab	B-T116
over	O
18	O
months	B-T079
was	O
shown	O
for	O
cognition	O
and	O
function	O
.	O
	
function	O
as	O
the	O
sole	O
measure	B-T081
to	O
demonstrate	O
clinical	B-T080
meaningfulness	B-T080
of	O
cognitive	O
effects	B-T080
in	O
mild	B-T080
ad	B-T047
may	O
have	O
limitations	B-T169
.	O
	
for	O
disease	B-T047
-	O
modifying	B-T169
treatments	B-T061
,	O
point	O
differences	O
on	O
cognitive	O
and	O
functional	O
scales	O
should	O
be	O
qualified	O
with	O
duration	B-T079
of	I-T079
treatment	I-T079
.	O
	
in	O
search	O
of	O
the	O
e	O
.	O
	
coli	O
compounds	O
that	O
change	O
the	O
antibiotic	O
production	B-T169
pattern	O
of	O
streptomyces	O
coelicolor	O
during	O
inter-species	O
interaction	O
the	O
aim	O
of	O
this	O
work	O
was	O
to	O
investigate	B-T169
the	O
interaction	B-T169
between	O
e.coli	O
and	O
streptomyces	O
coelicolor	O
a3	O
2	O
for	O
the	O
increased	B-T081
production	B-T169
of	O
undecylprodigiosin	B-T109
and	O
identify	O
the	O
e	O
.	O
	
coli	O
actives	B-T169
mediating	O
this	O
inter-species	O
interaction	O
.	O
	
the	O
antibiotics	O
of	O
interest	O
were	O
the	O
red-pigmented	B-T109
undecylprodigiosin	I-T109
and	O
blue-pigmented	B-T080
actinorhodin	B-T109
.	O
	
pure	O
cultures	O
of	O
s	O
.	O
	
coelicolor	O
in	O
a	O
defined	O
medium	O
produced	O
higher	O
concentrations	B-T081
of	O
actinorhodin	B-T109
compared	O
to	O
those	O
of	O
undecylprodigiosin	B-T109
.	O
	
the	O
latter	O
however	O
,	O
is	O
more	O
important	O
due	O
to	O
its	O
immunosuppressive	O
and	O
antitumor	O
properties	O
.	O
	
as	O
a	O
strategy	O
to	O
increase	B-T169
undecylprodigiosin	B-T109
production	B-T169
,	O
we	O
added	O
separately	O
,	O
live	O
cells	O
and	O
heat-killed	O
cells	O
of	O
e	O
.	O
	
coli	O
c600	O
,	O
and	O
the	O
cell-free	O
supernatant	O
of	O
e	O
.	O
	
coli	O
culture	O
to	O
s	O
.	O
	
coelicolor	O
cultures	O
in	O
shake	O
flasks	O
.	O
	
the	O
interaction	B-T169
with	O
live	O
cells	O
of	O
e	O
.	O
	
coli	O
altered	O
the	O
antibiotic	O
production	B-T169
pattern	O
and	O
undecylprodigiosin	B-T109
production	B-T169
was	O
enhanced	O
by	O
3.5	O
compared	O
to	O
the	O
pure	O
cultures	O
of	O
s	O
.	O
	
coelicolor	O
and	O
actinorhodin	B-T109
decreased	B-T081
by	O
15-fold	O
.	O
	
the	O
heat-killed	O
cells	O
of	O
e	O
.	O
	
coli	O
however	O
,	O
had	O
no	B-T080
effect	I-T080
on	O
antibiotic	O
production	B-T169
.	O
	
in	O
all	O
cases	O
,	O
growth	O
and	O
glucose	B-T033
consumption	I-T033
of	O
s	O
.	O
	
coelicolor	O
remained	O
almost	O
the	O
same	B-T080
as	O
those	O
observed	B-T169
in	O
the	O
pure	O
culture	O
indicating	O
that	O
the	O
changes	B-T169
in	O
antibiotic	O
production	B-T169
were	O
not	O
due	O
to	O
nutritional	O
stress	B-T033
.	O
	
results	B-T169
with	O
cell-free	O
supernatant	O
of	O
e	O
.	O
	
coli	O
culture	O
indicated	O
that	O
the	O
interaction	B-T169
between	O
s	O
.	O
	
coelicolor	O
and	O
e	O
.	O
	
coli	O
was	O
mediated	O
via	O
diffusible	O
molecule	O
.	O
	
using	O
a	O
set	O
of	O
extraction	O
procedures	O
and	O
agar-well	O
diffusion	O
bioassays	O
,	O
we	O
isolated	B-T169
and	O
preliminarily	O
identified	B-T080
a	O
class	O
of	O
compounds	O
.	O
	
for	O
the	O
preliminary	O
verification	B-T169
,	O
we	O
added	O
the	O
compound	O
which	O
was	O
the	O
common	O
chemical	O
structural	O
moiety	O
in	O
this	O
class	O
of	O
compounds	O
to	O
the	O
pure	O
s	O
.	O
	
coelicolor	O
cultures	O
.	O
	
we	O
observed	O
similar	O
effects	B-T080
on	O
antibiotic	O
production	B-T169
as	O
with	O
the	O
live	O
e	O
.	O
	
coli	O
cells	O
and	O
their	O
supernatant	O
indicating	O
that	O
this	O
class	O
of	O
compounds	O
secreted	O
by	O
e	O
.	O
	
coli	O
indeed	O
could	O
act	O
as	O
actives	B-T169
during	O
interspecies	O
interaction	O
and	O
increase	B-T169
the	O
production	B-T169
of	O
group	O
iii/iv	O
muscle	O
afferents	O
limit	B-T169
the	O
intramuscular	O
metabolic	B-T169
perturbation	B-T169
during	O
whole	O
body	O
exercise	O
in	O
humans	O
the	O
purpose	B-T169
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
iii/iv	O
muscle	O
afferents	O
in	O
limiting	B-T169
the	O
endurance	B-T033
exercise	O
-	O
induced	B-T169
metabolic	B-T169
perturbation	B-T169
assayed	O
in	O
muscle	O
biopsy	O
samples	O
taken	O
from	O
locomotor	O
muscle	O
.	O
	
lumbar	O
intrathecal	O
fentanyl	B-T109
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ-opioid	B-T116
receptor	I-T116
-	O
sensitive	B-T169
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	B-T079
time	B-T079
trial	O
.	O
	
the	O
findings	B-T033
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
iii/iv	O
muscle	O
afferent	O
feedback	O
constrains	O
voluntary	O
neural	B-T169
'	O
drive	O
'	O
to	O
working	B-T169
locomotor	O
muscle	O
and	O
limits	B-T169
the	O
exercise	O
-	O
induced	B-T169
intramuscular	O
metabolic	B-T169
perturbation	B-T169
.	O
	
therefore	O
,	O
the	O
cns	O
might	O
regulate	O
the	O
degree	B-T081
of	O
metabolic	B-T169
perturbation	B-T169
within	O
locomotor	O
muscle	O
and	O
thereby	O
limit	B-T169
peripheral	O
fatigue	O
.	O
	
it	O
appears	B-T080
that	O
the	O
group	O
iii/iv	O
muscle	O
afferents	O
are	O
an	O
important	B-T080
neural	B-T169
link	O
in	O
this	O
regulatory	O
mechanism	B-T169
,	O
which	O
probably	B-T078
serves	O
to	O
protect	B-T033
locomotor	O
muscle	O
from	O
the	O
potentially	B-T080
severe	B-T080
functional	B-T033
impairment	I-T033
as	O
a	O
consequence	B-T169
of	O
severe	B-T080
intramuscular	O
metabolic	B-T169
disturbance	B-T080
.	O
	
to	O
investigate	B-T169
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	B-T080
group	O
iii/iv	O
muscle	O
afferents	O
in	O
limiting	B-T169
the	O
intramuscular	O
metabolic	B-T169
perturbation	B-T169
during	O
whole	O
body	O
endurance	B-T033
exercise	O
,	O
eight	O
subjects	O
performed	B-T169
5	O
km	O
cycling	B-T079
time	B-T079
trials	O
under	B-T033
control	I-T033
conditions	I-T033
ctrl	B-T033
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	B-T109
impairing	B-T169
lower	O
limb	O
muscle	O
afferent	O
feedback	O
fent	O
.	O
	
vastus	O
lateralis	O
muscle	O
biopsies	O
were	O
obtained	B-T169
before	B-T079
and	O
immediately	B-T079
after	B-T079
exercise	O
.	O
	
motoneuronal	O
output	O
was	O
estimated	O
through	O
vastus	O
lateralis	O
surface	O
electromyography	O
emg	O
.	O
	
exercise	O
-	O
induced	B-T169
changes	B-T169
in	O
intramuscular	O
metabolites	O
were	O
determine	O
d	O
using	O
liquid	O
and	O
gas	O
chromatography-mass	O
spectrometry	O
.	O
	
quadriceps	O
fatigue	O
was	O
quantified	B-T081
by	O
pre	B-T079
-	O
to	O
post	B-T079
-	O
exercise	O
changes	B-T169
in	O
potentiated	O
quadriceps	O
twitch	O
torque	O
δqtsingle	O
evoked	B-T080
by	O
electrical	B-T169
femoral	O
nerve	O
stimulation	B-T061
.	O
	
although	O
motoneuronal	O
output	O
was	O
21	O
12%	O
higher	B-T080
during	O
fent	O
compared	O
to	O
ctrl	B-T033
p	O
<	O
0.05	O
,	O
time	B-T079
to	O
complete	B-T080
the	O
time	B-T079
trial	O
was	O
similar	B-T080
8.8	O
min	O
.	O
	
compared	O
to	O
ctrl	B-T033
,	O
power	O
output	O
during	O
fent	O
was	O
10	O
4%	O
higher	B-T080
in	O
the	O
first	B-T033
half	I-T033
of	O
the	O
time	B-T079
trial	O
,	O
but	O
11	O
5%	O
lower	B-T080
in	O
the	O
second	B-T033
half	I-T033
both	O
p	O
<	O
0.01	O
.	O
	
the	O
exercise	O
-	O
induced	B-T169
increase	B-T169
in	O
intramuscular	O
inorganic	O
phosphate	O
,	O
h	O
,	O
adenosine	O
diphosphate	O
,	O
lactate	B-T109
and	O
phosphocreatine	B-T116
depletion	B-T169
was	O
55	O
30	O
,	O
62	O
18	O
,	O
129	O
63	O
,	O
47	O
14	O
p	O
<	O
0.001	O
and	O
27	O
14%	O
p	O
<	O
0.01	O
greater	B-T081
in	O
fent	O
than	O
ctrl	B-T033
.	O
	
δqtsingle	O
was	O
greater	B-T081
following	O
fent	O
than	O
ctrl	B-T033
-52	O
2	O
vs	O
-31	O
1%	O
,	O
p	O
<	O
0.001	O
and	O
this	O
difference	B-T081
was	O
positively	B-T033
correlated	B-T080
with	O
the	O
difference	B-T081
in	O
inorganic	O
phosphate	O
r	O
=	O
0.79	O
p	O
<	O
0.01	O
and	O
h	O
r	O
=	O
0.92	O
p	O
<	O
0.01	O
.	O
	
in	O
conclusion	B-T078
,	O
during	O
whole	O
body	O
exercise	O
,	O
group	O
iii/iv	O
muscle	O
afferents	O
provide	O
feedback	O
to	O
the	O
cns	O
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	O
output	O
to	O
the	O
active	B-T169
skeletal	O
muscle	O
.	O
	
this	O
regulatory	O
mechanism	B-T169
limits	B-T169
the	O
exercise	O
-	O
induced	B-T169
intramuscular	O
metabolic	B-T169
perturbation	B-T169
,	O
preventing	O
an	O
abnormal	B-T033
homeostatic	I-T033
challenge	O
and	O
excessive	B-T080
peripheral	O
fatigue	O
.	O
	
the	O
effects	B-T080
of	I-T080
paternal	B-T080
high-fat	O
diet	O
exposure	B-T080
on	O
offspring	O
metabolism	O
with	O
epigenetic	O
changes	O
in	O
the	O
mouse	O
adiponectin	O
and	O
leptin	O
gene	O
promoters	O
recent	O
studies	O
have	O
demonstrated	O
that	O
epigenetic	O
changes	O
resulting	O
from	O
malnutrition	B-T047
might	O
play	O
important	O
roles	O
in	O
transgenerational	O
links	O
with	O
metabolic	B-T047
diseases	I-T047
.	O
	
previously	O
,	O
we	O
observed	B-T169
that	O
exposure	B-T080
to	O
a	O
high-fat	O
diet	O
hfd	O
in	O
utero	O
caused	B-T169
a	O
metabolic	B-T169
syndrome	B-T047
-like	O
phenomenon	O
through	B-T169
epigenetic	O
modifications	O
of	O
the	O
adiponectin	O
and	O
leptin	O
genes	O
that	O
persisted	O
for	O
multiple	B-T081
generations	B-T079
.	O
	
recent	O
etiological	B-T169
studies	O
indicated	B-T033
that	O
paternal	B-T080
bmi	O
had	O
effects	B-T080
on	O
offspring	O
bmi	O
that	O
were	O
independent	B-T169
of	I-T169
but	O
additive	B-T080
to	O
maternal	B-T033
bmi	O
effects	B-T080
.	O
	
thus	O
,	O
we	O
examined	O
whether	O
paternal	B-T080
hfd	O
-	O
induced	B-T169
obesity	B-T047
affected	B-T080
the	O
metabolic	B-T169
status	B-T080
of	O
offspring	O
through	B-T169
epigenetic	O
changes	O
in	O
the	O
adiponectin	O
and	O
leptin	O
genes	O
.	O
	
additionally	O
,	O
we	O
investigated	B-T169
whether	O
a	O
normal	O
diet	O
during	B-T079
subsequent	B-T078
generations	I-T078
abolished	O
the	O
epigenetic	O
changes	O
associated	B-T080
with	I-T080
paternal	B-T080
hfd	O
exposure	B-T080
before	B-T079
conception	O
.	O
	
we	O
observed	B-T169
the	O
effects	B-T080
of	I-T080
paternal	B-T080
hfd	O
exposure	B-T080
before	B-T079
conception	O
over	O
multiple	B-T081
generations	B-T079
on	O
offspring	O
metabolic	B-T169
traits	O
,	O
including	B-T169
weight	B-T033
and	O
fat	B-T109
gain	B-T081
,	O
glucose	B-T047
intolerance	I-T047
,	O
hypertriglyceridemia	B-T047
,	O
abnormal	B-T116
adipocytokine	I-T116
levels	B-T080
,	O
hypertension	B-T047
,	O
and	O
adiponectin	O
and	O
leptin	O
gene	O
expression	O
and	O
epigenetic	O
changes	O
.	O
	
normal	O
diet	O
consumption	O
by	O
male	O
offspring	O
during	O
the	O
subsequent	O
generation	O
following	O
paternal	B-T080
hfd	O
exposure	B-T080
diminished	B-T081
whereas	O
consumption	O
for	O
two	O
generations	B-T079
completely	O
abolished	O
the	O
effect	B-T080
of	O
paternal	B-T080
hfd	O
exposure	B-T080
on	O
metabolic	B-T169
traits	O
and	O
adipocytokine	B-T116
promoter	O
epigenetic	O
changes	O
in	O
the	O
offspring	O
.	O
	
the	O
effects	B-T080
of	I-T080
paternal	B-T080
hfd	O
exposure	B-T080
on	O
offspring	O
were	O
relatively	O
weaker	B-T080
than	O
those	O
following	B-T079
hfd	O
exposure	B-T080
in	O
utero	O
.	O
	
however	O
,	O
paternal	B-T080
hfd	O
exposure	B-T080
had	O
an	O
additive	B-T080
metabolic	B-T169
effect	B-T080
for	O
two	O
generations	B-T079
,	O
suggesting	O
that	O
both	O
paternal	B-T080
and	O
maternal	B-T033
nutrition	O
might	O
affect	B-T080
offspring	O
metabolism	O
through	B-T169
epigenetic	O
modifications	O
of	O
adipocytokine	O
genes	O
for	O
multiple	B-T081
generations	B-T079
.	O
	
study	O
of	O
the	O
microfocus	O
x-ray	O
tube	O
based	O
on	O
a	O
point-like	B-T169
target	I-T169
used	O
for	O
micro-computed	O
tomography	O
for	O
a	O
micro-computed	O
tomography	O
micro-ct	O
system	O
,	O
the	O
microfocus	O
x-ray	O
tube	O
is	O
an	O
essential	B-T080
component	O
because	O
the	O
spatial	O
resolution	B-T081
of	O
ct	O
images	O
,	O
in	O
theory	B-T078
,	O
is	O
mainly	O
determined	O
by	O
the	O
size	O
and	O
stability	B-T080
of	O
the	O
x-ray	O
focal	O
spot	O
of	O
the	O
microfocus	O
x-ray	O
tube	O
.	O
	
however	O
,	O
many	O
factors	B-T169
,	O
including	O
voltage	B-T081
fluctuations	B-T079
,	O
mechanical	O
vibrations	O
,	O
and	O
temperature	B-T080
changes	I-T080
,	O
can	O
cause	B-T078
the	O
size	O
and	O
the	O
stability	B-T080
of	O
the	O
x-ray	O
focal	O
spot	O
to	O
degrade	O
.	O
	
a	O
new	O
microfocus	O
x-ray	O
tube	O
based	O
on	O
a	O
point-like	B-T169
micro-target	I-T169
in	O
which	O
the	O
x-ray	O
target	B-T169
is	O
irradiated	O
with	O
an	O
unfocused	O
electron	O
beam	O
was	O
investigated	B-T169
.	O
	
egs4	B-T081
monte	I-T081
carlo	I-T081
simulation	I-T081
code	I-T081
was	O
employed	O
for	O
the	O
calculation	O
of	O
the	O
x-ray	O
intensity	O
produced	O
from	O
the	O
point-like	B-T169
micro-target	I-T169
and	O
the	O
substrate	O
.	O
	
the	O
effects	B-T080
of	I-T080
several	O
arrangements	O
of	O
the	O
target	B-T169
material	O
,	O
target	B-T169
and	O
beam	O
size	O
were	O
studied	O
.	O
	
the	O
simulation	O
results	B-T169
demonstrated	O
that	O
if	O
the	O
intensity	O
of	O
x-rays	O
generated	B-T080
at	O
the	O
point-like	B-T169
target	I-T169
is	O
greater	B-T081
than	I-T081
half	O
of	O
the	O
x-ray	O
intensity	O
produced	O
on	O
the	O
substrate	O
,	O
the	O
x-ray	O
focal	O
spot	O
is	O
determined	O
in	O
part	O
by	O
the	O
point-like	B-T169
target	I-T169
rather	O
than	O
by	O
the	O
electron	O
beam	O
in	O
the	O
conventional	B-T080
x-ray	O
tube	O
.	O
	
in	O
theory	B-T078
,	O
since	O
it	O
is	O
able	O
to	O
reduce	B-T080
those	O
unfavorable	O
effects	B-T080
such	O
as	O
the	O
electron	B-T033
beam	I-T033
trajectory	I-T033
swinging	I-T033
and	O
the	O
beam	O
size	O
changing	B-T169
for	O
the	O
microfocus	O
x-ray	O
tube	O
,	O
it	O
could	O
alleviate	B-T080
ct	O
image	O
artifacts	O
caused	B-T078
by	O
the	O
x-ray	O
focal	O
spot	O
shift	B-T033
and	O
size	B-T081
change	I-T081
.	O
	
early	B-T079
assessment	O
of	O
bilateral	B-T061
inguinal	I-T061
hernia	I-T061
repair	I-T061
a	O
comparison	O
between	O
the	O
laparoscopic	B-T061
total	I-T061
extraperitoneal	I-T061
and	O
stoppa	B-T061
approaches	I-T061
the	O
present	B-T079
clinical	O
trial	O
was	O
designed	O
to	O
compare	O
the	O
results	B-T169
of	O
bilateral	B-T061
inguinal	I-T061
hernia	I-T061
repair	I-T061
between	O
patients	O
who	O
underwent	O
the	O
conventional	B-T169
stoppa	B-T061
technique	I-T061
and	O
laparoscopic	B-T061
total	I-T061
extraperitoneal	I-T061
repair	I-T061
lte	B-T061
with	O
a	O
single	O
mesh	O
and	O
without	O
staple	B-T061
fixation	I-T061
.	O
	
this	O
controlled	O
,	O
randomised	O
clinical	O
trial	O
was	O
conducted	O
at	O
general	O
surgery	O
and	O
trauma	O
of	O
the	O
clinics	O
hospital	O
,	O
medical	O
school	O
,	O
the	O
university	O
of	O
sγo	O
paulo	O
between	O
september	O
2010	O
and	O
february	O
2011	O
.	O
	
totally	O
,	O
50	O
male	O
patients	O
,	O
with	O
a	O
bilateral	O
inguinal	O
hernia	O
,	O
older	O
than	O
25	O
years	B-T079
were	O
considered	O
eligible	B-T080
for	O
the	O
study	O
.	O
	
the	O
following	O
parameters	O
were	O
analysed	O
during	O
the	O
early	B-T079
post-operative	B-T079
period	I-T079
1	O
the	O
intensity	B-T080
of	O
surgical	B-T033
trauma	I-T033
,	O
operation	B-T079
time	I-T079
,	O
c-reactive	B-T116
protein	I-T116
crp	B-T116
levels	B-T080
,	O
white	O
blood	O
cell	O
count	O
,	O
bleeding	O
and	O
pain	O
intensity	O
2	O
quality	B-T078
of	I-T078
life	I-T078
assessment	O
and	O
3	O
post-operative	O
complications	O
.	O
	
lte	B-T061
procedure	I-T061
was	O
longer	B-T080
than	O
the	O
stoppa	B-T061
procedure	I-T061
134.6	O
min	O
38.3	O
vs	O
.	O
	
90.6	O
min	O
41.3	O
p	O
<	O
0.05	O
.	O
	
the	O
levels	B-T080
of	O
crp	B-T116
were	O
higher	B-T080
in	O
the	O
stoppa	B-T061
group	B-T078
p	O
<	O
0.05	O
but	O
the	O
number	O
of	O
leucocytes	O
,	O
haematocrit	B-T033
,	O
and	O
haemoglobin	B-T116
were	O
similar	B-T080
between	O
the	O
groups	B-T078
p	O
>	O
0.05	O
.	O
	
there	O
was	O
no	B-T033
difference	I-T033
in	O
pain	O
during	O
the	O
1	O
st	O
and	O
7	O
th	O
post-operative	B-T033
,	O
physical	B-T033
functioning	I-T033
,	O
physical	B-T169
limitation	I-T169
,	O
the	O
impact	B-T080
of	O
pain	O
on	O
daily	O
activities	O
,	O
and	O
the	O
carolinas	O
comfort	O
scale	O
during	O
the	O
7	O
th	O
and	O
15	O
th	O
post-operative	B-T033
p	O
>	O
0.05	O
.	O
	
complications	O
occurred	O
in	O
88%	O
of	O
stoppa	B-T061
group	B-T078
22	O
patients	O
and	O
64%	O
in	O
lte	B-T061
group	B-T078
16	O
patients	O
p	O
<	O
0.05	O
.	O
	
the	O
comparative	O
study	O
between	O
the	O
stoppa	B-T061
and	O
lte	B-T061
approaches	O
for	O
the	O
bilateral	B-T061
inguinal	I-T061
hernia	I-T061
repair	I-T061
demonstrated	O
that	O
1	O
the	O
lte	B-T061
approach	O
showed	O
less	O
surgical	B-T033
trauma	I-T033
despite	O
the	O
longer	B-T080
operation	B-T079
time	I-T079
2	O
quality	B-T078
of	I-T078
life	I-T078
during	O
the	O
early	B-T079
post-operative	B-T079
period	I-T079
were	O
similar	B-T080
and	O
3	O
complication	O
rates	B-T081
were	O
higher	B-T080
in	O
the	O
stoppa	B-T061
group	B-T078
.	O
	
morphological	O
characteristics	B-T080
regulating	O
phallic	O
glans	O
engorgement	B-T047
in	O
the	O
american	O
alligator	O
the	O
distal	O
part	O
of	O
the	O
crocodilian	O
phallus	O
consists	O
of	O
a	O
bulbous	O
glans	O
containing	O
well-developed	O
vascular	O
tissues	O
that	O
can	O
inflate	O
before	O
or	O
during	O
sexual	O
activity	O
,	O
enlarging	B-T080
and	O
elaborating	O
the	O
glans	O
into	O
a	O
complex	B-T080
,	O
though	O
still	O
functionally	B-T169
undefined	B-T078
,	O
copulatory	O
structure	O
.	O
	
an	O
enlarged	B-T080
glans	O
putatively	O
interacts	B-T169
with	O
the	O
female	O
cloaca	O
and	O
may	O
change	B-T169
the	O
shape	O
of	O
her	O
reproductive	O
tract	O
to	O
facilitate	O
insemination	O
and	O
increase	B-T169
the	O
probability	B-T081
of	O
fertilization	O
.	O
	
here	O
,	O
we	O
investigated	O
the	O
cellular-level	O
properties	O
of	O
the	O
glans	O
and	O
other	O
inflatable	O
phallic	O
tissues	O
associated	O
with	O
the	O
sperm	O
-conducting	O
sulcus	O
spermaticus	O
in	O
the	O
american	O
alligator	O
alligator	O
mississippiensis	O
.	O
	
using	O
histochemical	O
staining	O
,	O
we	O
visualized	O
and	O
defined	O
collagen	B-T116
and	O
elastin	O
fiber	O
densities	B-T081
and	O
orientations	O
in	O
these	O
tissues	O
.	O
	
extracellular	O
matrix	O
architectures	O
provided	O
insights	O
about	O
phallic	O
glans	O
material	O
properties	O
and	O
how	O
they	O
may	O
affect	B-T169
tissue	O
strength	B-T081
and	O
flexibility	B-T080
during	O
inflation	O
and	O
in	O
response	O
to	O
copulatory	O
forces	O
.	O
	
we	O
also	O
investigated	O
the	O
potential	B-T080
sources	O
of	O
fluids	O
that	O
induce	B-T169
inflation	O
in	O
alligator	O
phalli	O
.	O
	
combining	O
serial	O
sectioning	O
and	O
three-dimensional	O
reconstruction	O
,	O
we	O
identified	O
a	O
pair	O
of	O
supracrucal	O
plexus	O
vascular	O
bodies	O
at	O
the	O
proximal	O
end	O
of	O
the	O
alligator	O
phallus	O
that	O
extend	O
distally	O
adjacent	O
to	O
ventro-medial	O
sulcus	O
tissues	O
.	O
	
together	O
,	O
our	O
gross	B-T080
and	O
histological	B-T033
examination	I-T033
of	O
the	O
american	O
alligator	O
phallic	O
glans	O
suggests	O
that	O
its	O
tissues	O
are	O
arranged	O
in	O
a	O
manner	O
that	O
would	O
allow	O
vascular	O
inflation	O
to	O
expand	O
the	O
glans	O
to	O
a	O
specific	O
and	O
repeatable	O
shape	O
,	O
and	O
potentially	B-T080
release	O
secretory	O
products	O
into	O
the	O
female	O
reproductive	O
tract	O
.	O
	
both	O
elements	O
could	O
play	O
roles	O
in	O
postcopulatory	O
sexual	O
selection	O
,	O
by	O
mechanically	B-T169
and/or	O
chemically	O
affecting	O
female	O
reproductive	O
physiology	O
.	O
	
a	O
novel	O
role	O
for	O
poly	B-T116
binding	I-T116
proteins	I-T116
in	O
programmed	O
ribosomal	O
frameshifting	O
translational	O
control	B-T080
through	O
programmed	O
ribosomal	O
frameshifting	O
prf	O
is	O
exploited	O
widely	O
by	O
viruses	O
and	O
increasingly	O
documented	O
in	O
cellular	O
genes	O
.	O
	
frameshifting	O
is	O
induced	B-T169
by	O
mrna	O
secondary	O
structures	O
that	O
compromise	O
ribosome	O
fidelity	O
during	O
decoding	B-T169
of	O
a	O
heptanucleotide	O
'slippery'	O
sequence	O
.	O
	
the	O
nsp2	B-T116
prf	O
signal	O
of	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
is	O
distinctive	O
in	O
directing	O
both	O
-2	O
and	O
-1	O
prf	O
and	O
in	O
its	O
requirement	B-T169
for	O
a	O
trans-acting	B-T116
protein	I-T116
factor	I-T116
,	O
the	O
viral	O
replicase	B-T116
subunit	I-T116
nsp1β	I-T116
.	O
	
here	O
we	O
show	O
that	O
the	O
the	O
trans-activation	O
of	O
frameshifting	O
is	O
carried	O
out	O
by	O
a	O
protein	B-T116
complex	I-T116
composed	O
of	O
nsp1β	B-T116
and	O
a	O
cellular	O
poly	B-T116
binding	I-T116
protein	I-T116
pcbp	B-T116
.	O
	
from	O
the	O
results	O
of	O
in	B-T080
vitro	I-T080
translation	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
demonstrate	O
that	O
a	O
pcbp	B-T116
/	O
nsp1β	B-T116
complex	B-T116
binds	O
to	O
a	O
c-rich	O
sequence	O
downstream	O
of	O
the	O
slippery	O
sequence	O
and	O
here	O
mimics	O
the	O
activity	O
of	O
a	O
structured	O
mrna	O
stimulator	O
of	O
prf	O
.	O
	
this	O
is	O
the	O
first	O
description	O
of	O
a	O
role	O
for	O
a	O
trans-acting	B-T116
cellular	I-T116
protein	I-T116
in	O
prf	O
.	O
	
the	O
discovery	O
broadens	O
the	O
repertoire	O
of	O
activities	O
associated	B-T080
with	I-T080
poly	B-T116
binding	I-T116
proteins	I-T116
and	O
prototypes	B-T080
a	O
new	O
class	O
of	O
virus	O
-	O
host	O
interactions	B-T169
.	O
	
production	O
of	O
bioactive	O
conjugated	B-T109
linoleic	I-T109
acid	I-T109
by	O
the	O
multifunctional	B-T116
enolase	B-T116
from	O
lactobacillus	O
plantarum	O
lactobacillus	O
plantarum	O
α-enolase	B-T116
,	O
a	O
multifunctional	B-T116
-anchorless-	O
surface	B-T116
protein	I-T116
belonging	O
to	O
the	O
conserved	O
family	O
of	O
enolases	B-T116
with	O
a	O
central	O
role	O
in	O
glycolytic	O
metabolism	O
,	O
was	O
characterized	O
to	O
have	O
a	O
side	O
role	O
in	O
the	O
intricate	O
metabolism	O
of	O
biohydrogenation	O
of	O
linoleic	B-T109
acid	I-T109
,	O
catalyzing	O
the	O
formation	B-T169
of	O
bioactive	O
9-cis-11-trans-cla	B-T109
through	O
dehydration	O
and	O
isomerization	O
of	O
10-hydroxy-12-cis-octadecenoic	B-T109
acid	I-T109
.	O
	
the	O
identity	O
of	O
the	O
enolase	B-T116
was	O
confirmed	O
through	O
mass	O
spectrometric	O
analysis	O
that	O
showed	O
the	O
characteristic	O
442	O
amino	O
acid	O
sequence	O
with	O
a	O
molecular	B-T081
mass	I-T081
of	O
48.03	O
kda	B-T081
.	O
	
the	O
enolase	B-T116
was	O
not	O
capable	O
of	O
using	O
linoleic	B-T109
acid	I-T109
directly	O
as	O
a	O
substrate	O
but	O
instead	O
uses	O
its	O
hydroxyl	O
derivative	B-T169
10-hydroxi-12-cis-octadecenoic	B-T109
acid	I-T109
to	O
finally	O
form	O
bioactive	O
conjugated	B-T109
linoleic	I-T109
acid	I-T109
.	O
	
biochemical	B-T169
optimization	O
studies	O
were	O
carried	O
out	O
to	O
elucidate	O
the	O
conditions	O
for	O
maximum	O
production	O
of	O
9-cis-11-trans-cla	B-T109
and	O
maximum	O
stability	O
of	O
α-enolase	B-T116
when	O
catalyzing	O
this	O
reaction	O
.	O
	
furthermore	O
,	O
through	O
structural	B-T061
analysis	I-T061
of	O
the	O
protein	B-T116
,	O
we	O
propose	O
the	O
binding	O
sites	O
of	O
substrate	O
and	O
product	O
molecules	O
that	O
were	O
characterized	O
as	O
two	O
hydrophobic	B-T080
superficial	O
pockets	O
located	O
at	O
opposite	O
ends	O
of	O
the	O
enolase	B-T116
connected	O
through	O
a	O
channel	B-T116
where	O
the	O
catalysis	O
of	O
dehydration	O
and	O
isomerization	O
might	O
occur	O
.	O
	
these	O
results	O
prove	O
that	O
multifunctional	B-T116
α-enolase	B-T116
also	O
plays	O
a	O
role	O
in	O
cell	O
detoxification	O
from	O
polyunsaturated	B-T109
fatty	I-T109
acids	I-T109
such	O
as	O
linoleic	B-T109
acid	I-T109
,	O
along	O
with	O
the	O
linoleate	B-T116
isomerase	I-T116
complex	O
.	O
	
associations	B-T080
of	O
body	O
mass	O
index	O
and	O
physical	O
activity	O
with	O
sexual	B-T047
dysfunction	I-T047
in	O
breast	O
cancer	O
survivors	O
sexual	B-T047
dysfunction	I-T047
is	O
a	O
common	O
and	O
distressing	B-T033
consequence	B-T169
of	I-T169
breast	O
cancer	O
bc	O
treatment	B-T061
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
sexual	O
functioning	O
of	O
bc	O
patients	O
and	O
its	O
association	O
with	O
women's	O
personal	O
characteristics	B-T080
and	O
cancer	B-T061
treatments	I-T061
.	O
	
in	O
this	O
cross-sectional	O
study	O
,	O
sexual	O
function	O
was	O
assessed	O
using	O
the	O
female	O
sexual	O
function	O
index	O
fsfi	O
.	O
	
the	O
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
hrqol	B-T078
was	O
measured	O
using	O
the	O
european	O
organization	O
for	O
research	O
and	O
treatment	O
of	O
cancer	O
eortc	O
qlq-c30	O
and	O
its	O
breast	O
module	O
br-23	O
.	O
	
of	O
the	O
235	O
participants	O
approached	O
,	O
216	O
participants	O
were	O
included	O
in	O
the	O
study	O
.	O
	
of	O
these	O
,	O
63	O
patients	O
reported	O
no	B-T033
sexual	I-T033
activity	I-T033
in	O
the	O
last	O
month	B-T079
and	O
thus	O
were	O
analyzed	O
only	O
in	O
relation	O
to	O
the	O
sexual	O
desire	O
domain	B-T169
of	O
fsfi	O
.	O
	
a	O
total	O
of	O
154	O
71.3	O
%	O
patients	O
were	O
classified	O
with	O
hypoactive	O
sexual	O
desire	O
disorder	O
hsdd	O
.	O
	
from	O
those	O
patients	O
reporting	O
sexual	O
activity	O
in	O
the	O
last	O
month	B-T079
,	O
63.3	O
%	O
97	O
out	O
of	O
153	O
were	O
classified	O
with	O
sexual	B-T047
dysfunction	I-T047
.	O
	
using	O
hierarchical	O
logistic	O
regression	O
,	O
the	O
variance	O
explained	O
change	O
in	O
r	O
2	O
by	O
the	O
addition	O
of	O
body	O
mass	O
index	O
bmi	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	B-T078
models	O
of	O
sexual	B-T047
dysfunction	I-T047
and	O
hsdd	O
were	O
6.8	O
and	O
7.2	O
%	O
,	O
respectively	O
.	O
	
age	O
,	O
bmi	O
,	O
and	O
physical	O
activity	O
were	O
independently	O
associated	O
with	O
sexual	B-T047
dysfunction	I-T047
and	O
hsdd	O
.	O
	
additionally	O
,	O
bc	O
patients	O
with	O
sexual	B-T047
dysfunction	I-T047
reported	O
lower	B-T081
scores	B-T081
on	O
global	O
hrqol	B-T078
,	O
role	O
functioning	B-T169
,	O
and	O
fatigue	O
.	O
	
based	O
on	O
our	O
findings	B-T033
,	O
bc	O
survivors	O
should	O
be	O
encouraged	O
to	O
practice	O
regular	O
physical	O
activity	O
and	O
to	O
lose	O
weight	O
in	O
order	O
to	O
avoid	O
sexual	B-T047
dysfunction	I-T047
.	O
	
however	O
,	O
future	O
clinical	O
trials	O
are	O
needed	O
to	O
confirm	O
these	O
combination	O
of	O
telmisartan	B-T109
with	O
sildenafil	B-T109
ameliorate	B-T080
progression	O
of	O
diabetic	B-T047
nephropathy	I-T047
in	O
streptozotocin	B-T109
-	O
induced	B-T169
diabetic	B-T033
model	O
diabetic	B-T047
nephropathy	I-T047
dn	B-T047
is	O
a	O
leading	O
cause	O
of	O
end-stage	B-T047
renal	I-T047
disease	I-T047
in	O
the	O
world	O
.	O
	
several	O
signaling	O
pathways	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
dn	B-T047
including	O
elevation	O
in	O
level	O
of	O
angiotensin	B-T116
ii	I-T116
,	O
formation	B-T169
of	O
advanced	B-T109
glycation	I-T109
end	I-T109
products	I-T109
age	B-T109
,	O
activation	O
of	O
protein	B-T116
kinase	I-T116
c	I-T116
pkc	B-T116
,	O
and	O
lipid	B-T033
accumulation	I-T033
.	O
	
these	O
pathways	O
activate	O
one	O
another	O
mutually	O
leading	O
to	O
oxidative	O
stress	O
,	O
increasing	O
expression	O
of	O
transforming	B-T116
growth	I-T116
factor	I-T116
beta-1	I-T116
tgf-β	B-T116
1	I-T116
and	O
release	B-T169
of	O
interleukins	B-T116
and	O
adhesion	B-T116
molecules	I-T116
,	O
so	O
the	O
aim	O
of	O
this	O
study	O
is	O
to	O
interrupt	O
more	O
than	O
pathogenic	B-T033
pathway	O
to	O
ameliorate	B-T080
the	O
progression	O
of	O
dn	B-T047
.	O
	
in	O
the	O
present	O
study	O
,	O
white	O
male	O
rats	O
n=48	O
were	O
divided	O
into	O
six	O
groups	O
8	O
rats	O
each	O
,	O
the	O
first	O
two	O
groups	O
served	O
as	O
normal	O
control	O
and	O
a	O
control	O
vehicle	O
group	O
while	O
the	O
remaining	O
four	O
groups	O
were	O
rendered	O
diabetic	B-T033
by	O
a	O
single	O
intraperitoneal	B-T061
injection	I-T061
of	O
streptozotocin	B-T109
stz	B-T109
and	O
being	O
left	O
for	O
4	O
weeks	O
to	O
develop	O
dn	B-T047
.	O
	
thereafter	O
,	O
the	O
rats	O
were	O
divided	O
into	O
dn	B-T047
group	O
,	O
dn	B-T047
group	O
receiving	O
telmisartan	B-T109
or	O
sildenafil	B-T109
or	O
telmisartan	B-T109
sildenafil	B-T109
combination	O
.	O
	
after	O
the	O
specified	B-T080
treatment	B-T169
period	B-T079
,	O
urine	O
samples	O
were	O
collected	B-T078
using	O
metabolic	O
cages	O
to	O
measure	O
proteinuria	B-T033
,	O
animals	O
were	O
then	O
euthanized	O
,	O
blood	O
and	O
tissue	O
samples	O
were	O
collected	B-T078
for	O
measurement	O
of	O
blood	O
glucose	O
,	O
bun	O
,	O
s.cr	O
,	O
ldl	O
,	O
no	O
,	O
tgf-β1	O
,	O
il-1β	O
,	O
ageps	O
,	O
and	O
sod	O
.	O
	
the	O
combination	B-T061
therapy	I-T061
showed	O
significant	O
decrease	O
in	O
bun	O
,	O
s.cr	B-T109
,	O
ldl	B-T109
,	O
tgf-β1	B-T116
,	O
il-1β	B-T116
,	O
proteinuria	B-T033
and	O
ageps	B-T109
and	O
significant	O
increase	O
in	O
sod	B-T116
and	O
no	O
.	O
	
the	O
findings	O
showed	O
that	O
combination	B-T061
therapy	I-T061
was	O
able	O
to	O
ameliorate	B-T080
dn	B-T047
and	O
that	O
the	O
effects	O
were	O
superior	B-T080
to	O
the	O
single	O
drugs	O
analysis	O
of	O
low-biomass	B-T081
microbial	O
communities	O
in	O
the	O
deep	O
biosphere	O
over	O
the	O
past	O
few	B-T081
decades	I-T081
,	O
the	O
subseafloor	O
biosphere	O
has	O
been	O
explored	O
by	O
scientific	B-T169
ocean	I-T169
drilling	I-T169
to	O
depths	O
of	O
about	O
2.5km	O
below	O
the	O
seafloor	O
.	O
	
although	O
organic-rich	O
anaerobic	O
sedimentary	O
habitats	O
in	O
the	O
ocean	O
margins	O
harbor	O
large	O
numbers	O
of	O
microbial	O
cells	O
,	O
microbial	O
populations	O
in	O
ultraoligotrophic	O
aerobic	O
sedimentary	O
habitats	O
in	O
the	O
open	O
ocean	B-T169
gyres	I-T169
are	O
several	O
orders	O
of	O
magnitude	B-T081
less	O
abundant	B-T080
.	O
	
despite	O
advances	O
in	O
cultivation-independent	B-T169
molecular	I-T169
ecological	I-T169
techniques	I-T169
,	O
exploring	O
the	O
low-biomass	B-T081
environment	O
remains	O
technologically	B-T080
challenging	I-T080
,	O
especially	O
in	O
the	O
deep	O
subseafloor	O
biosphere	O
.	O
	
reviewing	B-T080
the	O
historical	O
background	O
of	O
deep-biosphere	O
analytical	O
methods	O
,	O
the	O
importance	B-T080
of	O
obtaining	O
clean	O
samples	O
and	O
tracing	B-T033
contamination	B-T078
,	O
as	O
well	O
as	O
methods	O
for	O
detecting	B-T033
microbial	O
life	B-T078
,	O
technological	O
aspects	O
of	O
molecular	O
microbiology	O
,	O
and	O
detecting	B-T033
subseafloor	O
metabolic	O
activity	O
the	O
sensitivity	B-T081
and	I-T081
specifity	I-T081
of	O
dr-70	O
immunoassay	O
as	O
a	O
tumor	O
marker	O
for	O
non-small	O
cell	O
lung	O
cancer	O
lung	O
cancer	O
is	O
the	O
most	O
important	O
causes	O
of	O
the	O
cancer	B-T081
related	I-T081
mortality	I-T081
.	O
	
patients	O
with	O
lung	O
cancer	O
are	O
usually	O
diagnosed	O
at	O
advanced	O
or	O
locally	O
advanced	O
stage	O
,	O
for	O
this	O
reason	O
early	O
diagnosis	O
of	O
lung	O
cancer	O
is	O
very	O
important	O
.	O
	
for	O
early	O
detection	O
of	O
lung	O
cancer	O
some	O
methods	O
are	O
emphasized	O
such	O
as	O
low-dose	O
computed	O
tomography	O
or	O
tumor	O
biomarkers	O
.	O
	
in	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
dr-70	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
as	O
a	O
tumor	O
marker	O
in	O
detection	B-T061
of	O
non-small	O
cell	O
lung	O
cancers	O
.	O
	
between	O
may	B-T079
2013	O
and	O
april	B-T079
2014	O
,	O
the	O
serum	O
samples	O
from	O
88	O
non	O
lung	O
cancer	O
patients	O
,	O
86	O
patients	O
with	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disesase	I-T047
were	O
obtained	O
.	O
	
blood	O
samples	O
from	O
each	O
participant	O
were	O
analyzed	O
for	O
dr-70	O
level	B-T080
.	O
	
totally	O
174	O
patients	O
were	O
enrolled	O
to	O
the	O
study	O
152	O
male	O
,	O
22	O
female	O
.	O
	
histopathologically	B-T169
47	O
patients	O
were	O
diagnosed	O
with	O
squamous	O
cell	O
lung	O
cancer	O
,	O
34	O
38.6	O
with	O
adenocarcinoma	O
,	O
and	O
7	O
8%	O
with	O
non-small	O
cell	O
lung	O
cancer	O
.	O
	
the	O
mean	O
serum	O
dr-70	O
levels	B-T080
in	O
lung	O
cancer	O
patients	O
2.43	O
1.82	O
µg/ml	O
was	O
significantly	B-T033
higher	I-T033
compared	O
to	O
the	O
86	O
non-cancerous	B-T033
subjects	O
1.15	O
0.70	O
µg/ml	O
p<	O
0.01	O
.	O
	
dr-70	O
exhibited	O
clinical	B-T080
sensitivity	B-T081
and	I-T081
specificity	I-T081
of	O
54.5	O
and	O
83.7	O
,	O
respectively	O
,	O
at	O
an	O
optimal	B-T080
cut	B-T169
off	I-T169
at	O
1.98	O
µg/ml	O
.	O
	
it	O
could	O
be	O
said	O
that	O
the	O
risk	O
of	O
the	O
presence	O
of	O
the	O
disease	B-T047
is	O
6.171	O
times	O
higher	O
in	O
the	O
cases	O
where	O
dr-70	O
level	B-T080
is	O
1.98	O
µg/ml	O
and	O
higher	O
.	O
	
dr-70	O
,	O
a	O
marker	O
used	O
to	O
measure	B-T081
fibrin	B-T116
degradation	I-T116
products	I-T116
,	O
generated	O
by	O
all	O
major	O
cancers	O
,	O
may	O
helps	O
to	O
find	O
high	B-T033
risk	I-T033
lung	O
cancer	O
patients	O
.	O
	
catastrophic	B-T081
expenditure	I-T081
and	O
impoverishment	B-T081
of	O
patients	O
affected	O
by	O
7	O
rare	B-T047
diseases	I-T047
in	O
china	O
china	O
is	O
actively	O
promoting	O
regulation	O
of	O
rare	B-T047
diseases	I-T047
,	O
rare	B-T047
disease	I-T047
and	O
orphan	O
drugs	O
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O
	
however	O
,	O
few	O
studies	O
have	O
been	O
done	O
to	O
evaluate	O
the	O
affordability	B-T081
of	O
rare	B-T047
disease	I-T047
patients	O
in	O
china	O
.	O
	
this	O
study	O
aims	O
to	O
provide	O
policy	O
recommendations	B-T078
for	O
the	O
establishment	B-T080
of	O
social	O
security	O
mechanism	O
for	O
rare	B-T047
diseases	I-T047
in	O
china	O
,	O
so	O
as	O
to	O
address	O
the	O
problem	O
of	O
poverty	O
caused	O
by	O
these	O
diseases	B-T047
.	O
	
a	O
total	O
of	O
7	O
rare	B-T047
diseases	I-T047
were	O
selected	O
by	O
delphi	O
method	O
.	O
	
affordability	B-T081
of	O
treatment	B-T061
for	O
the	O
7	O
rare	B-T047
diseases	I-T047
was	O
assessed	O
through	O
annual	B-T081
per	I-T081
capital	I-T081
income	I-T081
,	O
catastrophic	B-T081
expenditure	I-T081
and	O
impoverishment	B-T081
expenditure	B-T081
among	O
urban	O
and	O
rural	O
residents	O
in	O
china	O
.	O
	
assessed	O
through	O
annual	B-T081
per	I-T081
capital	I-T081
income	I-T081
,	O
health	B-T081
expenditure	I-T081
for	O
the	O
7	O
rare	B-T047
diseases	I-T047
are	O
all	O
rather	O
high	O
.	O
	
the	O
highest	O
health	B-T081
expenditure	I-T081
is	O
equivalent	O
to	O
income	B-T081
of	O
69.34	O
years	B-T079
of	O
one	O
urban	O
resident	O
,	O
and	O
the	O
burden	O
is	O
heavier	O
for	O
rural	O
residents	O
.	O
	
through	O
catastrophic	B-T081
expenditure	I-T081
assessment	O
,	O
proportions	B-T081
of	O
the	O
population	O
experiencing	O
catastrophic	B-T081
expenditure	I-T081
caused	O
by	O
the	O
7	O
rare	B-T047
diseases	I-T047
are	O
all	O
under	O
0.167	O
however	O
,	O
once	O
one	O
is	O
ill	O
and	O
taking	O
medications	O
,	O
he	O
will	O
suffer	O
from	O
catastrophic	B-T081
health	I-T081
expenditure	I-T081
.	O
	
through	O
impoverishment	B-T081
expenditure	B-T081
assessment	O
,	O
the	O
proportions	B-T081
of	O
impoverishment	B-T081
payment	B-T081
are	O
low	O
among	O
both	O
urban	O
and	O
rural	O
residents	O
,	O
but	O
the	O
7	O
rare	B-T047
diseases	I-T047
could	O
lead	O
nearly	O
4.6	O
million	O
people	O
into	O
poverty	O
on	O
a	O
national	O
scale	O
.	O
	
the	O
affordability	B-T081
of	O
treatment	B-T061
for	O
rare	B-T047
disease	I-T047
as	O
well	O
as	O
orphan	O
drugs	O
is	O
rather	O
poor	B-T080
.	O
	
residents	O
of	O
different	O
income	B-T080
levels	I-T080
all	O
have	O
difficulties	O
to	O
afford	O
the	O
treatment	B-T061
for	O
rare	B-T047
diseases	I-T047
,	O
so	O
poverty	O
caused	O
by	O
rare	B-T047
diseases	I-T047
is	O
quite	O
widespread	O
.	O
	
therefore	O
,	O
social	O
security	O
mechanism	O
for	O
rare	B-T047
disease	I-T047
patients	O
should	O
be	O
established	O
and	O
specific	O
payment	B-T081
pattern	O
for	O
orphan	O
drugs	O
experimental	O
study	O
in	O
pulmonary	O
artery	O
sealing	B-T061
with	O
a	O
vessel-sealing	O
device	O
the	O
development	O
of	O
vessel-sealing	O
devices	O
will	O
facilitate	O
safety	O
in	O
video-assisted	B-T061
thoracoscopic	I-T061
surgery	I-T061
.	O
	
our	O
objective	O
was	O
to	O
evaluate	O
the	O
feasibility	B-T080
and	O
safety	O
of	O
sealing	B-T061
pulmonary	O
arteries	O
with	O
the	O
enseal	O
tissue-sealing	O
device	O
.	O
	
pulmonary	O
arteries	O
from	O
beagle	O
dogs	O
mean	O
body	O
weight	O
13.1	O
kg	O
,	O
range	O
10.5	O
kg	O
were	O
divided	O
into	O
3	O
groups	O
according	O
to	O
the	O
in-vivo	O
sealing	O
method	O
used	O
enseal	O
,	O
ligation	B-T061
,	O
and	O
proximal	O
ligation	B-T061
plus	O
distal	O
enseal	O
and	O
extracted	O
to	O
evaluate	O
the	O
pressure	O
tolerance	B-T080
up	O
to	O
75	O
mm	O
hg	O
at	O
the	O
sealed	B-T169
end	O
.	O
	
a	O
left	O
lower	O
lobectomy	B-T061
was	O
performed	O
to	O
evaluate	O
chronic-phase	B-T079
durability	O
of	O
the	O
sealed	O
stumps	O
in	O
a	O
survival	O
model	O
.	O
	
two	O
or	O
three	O
branches	O
of	O
the	O
pulmonary	O
arteries	O
in	O
each	O
dog	O
were	O
allocated	O
to	O
each	O
of	O
the	O
3	O
groups	O
.	O
	
after	O
the	O
scheduled	O
survival	O
period	B-T079
,	O
the	O
pulmonary	O
arteries	O
were	O
sampled	O
.	O
	
pressure	O
tolerance	B-T080
at	O
the	O
sealed	B-T169
end	O
was	O
evaluated	O
in	O
91	O
pulmonary	O
artery	O
sections	O
.	O
	
all	O
sealed	B-T169
ends	O
showed	O
pressure	O
tolerance	B-T080
>75	O
mm	O
hg	O
.	O
	
a	O
left	O
lower	O
lobectomy	B-T061
was	O
performed	O
in	O
13	O
dogs	O
in	O
which	O
35	O
pulmonary	O
artery	O
sections	O
had	O
been	O
allocated	O
into	O
the	O
3	O
groups	O
.	O
	
no	B-T033
sealing	B-T061
failure	B-T169
was	O
found	O
,	O
and	O
pathological	B-T169
findings	B-T033
showed	O
healing	O
and	O
persistent	B-T079
hemostasis	O
at	O
all	O
sealed	B-T169
ends	O
of	O
the	O
pulmonary	O
arteries	O
after	O
2	O
and	O
4	O
weeks	B-T079
of	O
the	O
survival	O
period	B-T079
.	O
	
pulmonary	O
arteries	O
sealed	B-T169
in	O
vivo	O
with	O
the	O
enseal	O
device	O
showed	O
pressure	O
tolerance	B-T080
>75	O
mm	O
hg	O
in	O
the	O
acute	B-T079
phase	I-T079
,	O
and	O
persistent	B-T079
hemostasis	O
after	O
2	O
or	O
4	O
weeks	B-T079
.	O
	
pulmonary	O
artery	O
sealing	B-T061
with	O
the	O
enseal	O
device	O
is	O
feasible	B-T080
and	O
safe	O
in	O
thoracic	B-T061
surgery	I-T061
pathophysiology	B-T169
,	O
treatment	B-T061
and	O
prevention	B-T061
of	O
ovarian	B-T047
hyperstimulation	I-T047
syndrome	I-T047
severe	B-T080
ovarian	B-T047
hyperstimulation	I-T047
syndrome	I-T047
ohss	B-T047
is	O
an	O
iatrogenic	B-T080
condition	B-T080
that	O
affects	O
1%	O
of	O
women	O
that	O
undergo	O
treatment	B-T061
with	O
assisted	B-T061
reproductive	I-T061
technology	I-T061
.	O
	
the	O
review	O
aims	B-T078
to	O
summarize	O
recent	B-T079
evidence	B-T078
on	O
pathophysiology	B-T169
,	O
treatment	B-T061
,	O
and	O
prevention	B-T061
of	O
ohss	B-T047
.	O
	
the	O
pathophysiology	B-T169
is	O
still	O
not	O
completely	B-T080
understood	O
however	O
,	O
vascular	B-T116
endothelial	I-T116
growth	I-T116
factor	I-T116
is	O
likely	O
to	O
be	O
an	O
important	B-T080
mediator	O
.	O
	
human	B-T116
chorionic	I-T116
gonadotropin	I-T116
was	O
previously	O
thought	O
to	O
be	O
necessary	O
for	O
ohss	B-T047
to	O
occur	O
however	O
,	O
recent	O
case	O
reports	O
have	O
proven	B-T080
otherwise	O
.	O
	
the	O
contribution	O
of	O
an	O
attenuated	O
anti-mullerian	B-T116
hormone	I-T116
signalling	O
pathway	O
and	O
cd11c	B-T116
+	O
hla-dr	B-T116
+	O
dendritic	O
cells	O
and	O
associated	B-T080
interleukins	B-T116
has	O
been	O
explored	O
recently	B-T079
as	O
contributors	O
to	O
pathogenesis	O
.	O
	
treatment	B-T061
is	O
largely	O
supportive	B-T061
and	O
is	O
based	B-T078
mainly	O
on	O
consensus	O
statements	B-T078
rather	O
than	O
evidence	B-T078
.	O
	
therefore	O
,	O
it	O
is	O
important	B-T080
to	O
prevent	B-T169
this	O
condition	B-T080
by	O
identifying	O
women	O
at	B-T080
risk	I-T080
,	O
allowing	O
the	O
clinician	O
to	O
implement	O
preventive	O
strategies	O
,	O
including	B-T169
the	O
use	O
of	O
gnrh	O
antagonist	O
cycles	B-T079
with	O
agonist	O
triggers	O
.	O
	
more	O
research	O
is	O
required	B-T169
to	O
elucidate	O
the	O
pathophysiology	B-T169
behind	O
the	O
condition	B-T080
.	O
	
clinicians	O
should	O
employ	B-T169
strategies	O
to	O
prevent	B-T061
ohss	B-T047
.	O
	
eosinophilic	B-T047
gastroenteritis	I-T047
as	O
a	O
rare	B-T080
cause	B-T169
of	O
recurrent	O
epigastric	O
pain	O
eosinophilic	B-T047
gastroenteritis	I-T047
ege	B-T047
is	O
a	O
rare	O
inflammatory	B-T047
disorder	I-T047
of	O
gastrointestinal	O
tract	O
characterized	O
by	O
eosinophilic	O
infiltration	O
of	O
the	O
bowel	O
wall	O
.	O
	
it	O
can	O
mimic	O
many	O
gastrointestinal	B-T047
disorders	I-T047
due	O
to	O
its	O
wide	B-T033
spectrum	I-T033
of	I-T033
presentations	I-T033
.	O
	
diagnose	B-T033
is	O
mostly	O
based	O
on	O
excluding	B-T169
other	B-T080
disorders	B-T047
and	O
a	O
high	B-T080
suspicion	O
.	O
	
here	O
we	O
report	O
a	O
case	O
of	O
26	O
year	B-T079
old	B-T079
man	O
with	O
a	O
history	B-T033
of	O
sever	O
epigastric	O
pain	O
followed	O
by	O
nausea	O
,	O
vomiting	O
since	O
a	O
few	B-T081
days	B-T079
before	B-T079
admission	O
with	O
final	O
diagnosis	B-T033
of	O
comparison	O
of	O
sonoelastography	O
with	O
sonourethrography	O
and	O
retrograde	O
urethrography	O
in	O
the	O
evaluation	O
of	O
male	O
anterior	O
urethral	O
strictures	O
retrograde	O
urethrography	O
rug	O
is	O
the	O
most	O
common	O
and	O
preferred	O
imaging	B-T169
modality	I-T169
for	O
imaging	O
of	O
the	O
anterior	O
urethral	O
strictures	O
despite	O
its	O
well-known	O
limitations	B-T169
and	O
disadvantages	O
.	O
	
sonourethrography	O
sug	O
was	O
introduced	O
in	O
1988	O
to	O
overcome	O
the	O
limitations	B-T169
of	O
rug	O
and	O
to	O
provide	O
more	O
accurate	B-T080
results	I-T080
.	O
	
as	O
proper	O
selection	O
of	O
imaging	B-T169
modality	I-T169
is	O
very	O
important	O
for	O
planning	O
the	O
treatment	O
,	O
various	O
advances	O
in	O
this	O
area	O
are	O
required	O
.	O
	
one	O
of	O
the	O
major	O
factors	O
for	O
recurrence	O
of	O
stricture	B-T047
disease	I-T047
is	O
spongiofibrosis	O
.	O
	
sonoelastography	O
se	O
is	O
a	O
newer	O
technique	O
,	O
tried	O
in	O
various	O
other	O
pathologies	O
.	O
	
in	O
this	O
study	O
,	O
we	O
have	O
used	O
this	O
technique	O
for	O
the	O
first	O
time	O
to	O
assess	O
its	O
efficacy	B-T080
in	O
the	O
evaluation	O
of	O
anterior	O
urethral	O
stricture	O
disease	O
by	O
comparison	O
with	O
rug	O
and	O
sug	O
.	O
	
between	O
august	O
2014	O
and	O
may	O
2015	O
,	O
77	O
patients	O
with	O
clinical	O
features	O
of	O
anterior	O
urethral	O
stricture	O
disease	O
were	O
included	O
in	O
the	O
study	O
and	O
evaluated	O
by	O
rug	O
followed	O
by	O
sug	O
and	O
se	O
for	O
stricture	B-T047
location	O
,	O
length	B-T081
,	O
depth	O
of	O
spongiofibrosis	O
and	O
periurethral	O
pathologies	O
.	O
	
the	O
results	O
were	O
then	O
correlated	O
with	O
operative	O
and	O
histopathological	B-T169
findings	I-T169
.	O
	
overall	O
diagnostic	B-T080
accuracy	I-T080
of	O
se	O
,	O
sug	O
,	O
and	O
rgu	O
for	O
the	O
estimation	O
of	O
stricture	B-T047
location	O
,	O
and	O
length	B-T081
were	O
estimated	O
92.68	O
vs	O
.	O
	
91.54	O
,	O
79%	O
vs	O
.	O
	
78.87	O
and	O
80.48	O
vs	O
.	O
	
43.66	O
,	O
respectively	O
,	O
while	O
for	O
depth	O
of	O
spongiofibrosis	O
se	O
,	O
and	O
sug	O
had	O
accuracy	B-T080
rates	I-T080
of	O
87.3	O
,	O
48%	O
,	O
respectively	O
.	O
	
the	O
mean	O
length	O
measured	O
on	O
se	O
was	O
nearest	O
to	O
the	O
mean	O
intra-operative	B-T079
stricture	B-T047
length	B-T081
21.34	O
mm	O
.	O
	
se	O
findings	O
significantly	O
correlated	O
with	O
the	O
colour	B-T033
of	I-T033
bladder	I-T033
mucosa	I-T033
on	O
cystoscopic	O
examination	O
p=0	O
whereas	O
the	O
association	O
was	O
non-significant	O
p=0	O
for	O
difficulty	O
in	O
incision	B-T061
.	O
	
while	O
a	O
nonsignificant	O
correlation	O
existed	O
between	O
sug	O
findings	O
related	O
both	O
to	O
the	O
colour	B-T033
of	I-T033
the	I-T033
bladder	I-T033
mucosa	I-T033
and	O
difficulty	O
in	O
incision	B-T061
on	O
cystoscopy	O
,	O
se	O
findings	O
had	O
a	O
significant	O
association	O
p<0	O
with	O
histopathology	B-T169
findings	I-T169
for	O
severe	O
degree	O
of	O
fibrosis	O
.	O
	
sonoelastography	O
estimates	O
stricture	O
site	O
and	O
length	O
better	O
in	O
comparison	O
with	O
rug	O
and	O
sug	O
.	O
	
it	O
estimates	O
degree	O
of	O
spongiofibrosis	O
which	O
serves	O
as	O
an	O
important	O
prognostic	O
factor	O
for	O
stricture	O
recurrence	O
more	O
accurately	B-T080
than	O
changes	B-T169
in	O
risk	B-T033
factors	I-T033
for	O
young	B-T079
male	O
suicide	B-T033
in	O
newcastle	O
upon	O
tyne	O
,	O
1961-2009	O
aims	B-T078
and	O
method	O
to	O
ascertain	O
differences	B-T080
in	O
patterns	B-T033
of	I-T033
suicide	I-T033
in	O
young	B-T079
men	O
over	O
three	O
decades	B-T081
1960s	O
,	O
1990s	O
and	O
2000s	O
and	O
discuss	O
implications	B-T080
for	O
suicide	B-T033
prevention	B-T080
.	O
	
data	B-T078
on	O
suicides	B-T033
and	O
open	O
verdicts	O
in	O
men	O
aged	O
15-34	O
were	O
obtained	O
from	O
coroner's	O
records	O
in	O
newcastle	O
upon	O
tyne	O
and	O
analysed	O
using	O
spss	O
software	O
.	O
	
results	B-T169
an	O
increase	B-T169
in	O
suicide	B-T033
rates	I-T033
from	O
the	O
first	O
to	O
the	O
second	O
decade	B-T081
was	O
followed	O
by	O
a	O
fall	O
in	O
the	O
third	O
decade	B-T081
.	O
	
this	O
was	O
associated	B-T080
with	I-T080
an	O
increasing	B-T169
proportion	B-T081
of	O
single	B-T081
men	O
,	O
those	O
living	B-T033
alone	I-T033
,	O
unemployment	B-T033
,	O
consumption	O
of	O
alcohol	O
,	O
use	O
of	O
hanging	O
,	O
previous	B-T079
suicide	B-T033
attempt	I-T033
and	O
history	O
of	O
treatment	O
for	O
mental	O
illness	O
.	O
	
clinical	B-T080
implications	B-T080
this	O
study	O
highlights	O
the	O
need	O
for	O
more	O
interventions	B-T061
and	O
focus	O
to	O
be	O
given	O
to	O
young	B-T079
males	O
in	O
the	O
suicide	B-T033
prevention	B-T080
area	I-T080
and	O
is	O
of	O
high	O
importance	O
in	O
the	O
field	O
of	O
public	O
health	O
.	O
	
areas	O
that	O
could	O
be	O
tackled	O
include	O
reducing	B-T080
access	O
to	O
means	O
of	O
suicide	B-T033
,	O
reducing	B-T080
alcohol	O
use	O
,	O
support	O
for	O
relationship	B-T080
difficulties	B-T080
,	O
engagement	O
with	O
mental	O
health	O
services	O
and	O
management	O
of	O
chronic	B-T047
illness	I-T047
.	O
	
social	O
cognition	O
in	O
schizophrenia	O
factor	B-T081
structure	I-T081
of	O
emotion	O
processing	O
and	O
theory	B-T078
of	I-T078
mind	I-T078
factor	B-T081
analytic	I-T081
studies	I-T081
examining	O
social	O
cognition	O
in	O
schizophrenia	O
have	O
yielded	O
inconsistent	O
results	B-T169
most	O
likely	O
due	O
to	O
the	O
varying	O
number	O
and	O
quality	O
of	O
measures	O
.	O
	
with	O
the	O
recent	O
conclusion	O
of	O
phase	B-T079
3	I-T079
of	O
the	O
social	O
cognition	O
psychometric	O
evaluation	O
scope	O
study	O
,	O
the	O
most	O
psychometrically	O
sound	O
measures	O
of	O
social	O
cognition	O
have	O
been	O
identified	O
.	O
	
therefore	O
,	O
the	O
aims	O
of	O
the	O
present	O
study	O
were	O
to	O
1	O
examine	B-T033
the	O
factor	B-T081
structure	I-T081
of	O
social	O
cognition	O
in	O
schizophrenia	O
through	O
the	O
utilization	O
of	O
psychometrically	O
sound	O
measures	O
,	O
2	O
examine	B-T033
the	O
stability	B-T080
of	O
the	O
factor	B-T081
structure	I-T081
across	O
two	O
study	O
visits	O
,	O
3	O
compare	O
the	O
factor	B-T081
structure	I-T081
of	O
social	O
cognition	O
in	O
schizophrenia	O
to	O
that	O
in	O
healthy	B-T080
controls	I-T080
,	O
and	O
4	O
examine	B-T033
the	O
relationship	O
between	O
the	O
factors	B-T081
and	O
relevant	O
outcome	B-T081
measures	I-T081
including	O
social	O
functioning	O
and	O
symptoms	O
.	O
	
results	B-T169
supported	O
a	O
one-factor	O
model	O
for	O
the	O
patient	O
and	O
healthy	B-T080
control	I-T080
samples	O
at	O
both	O
visits	O
.	O
	
this	O
single	O
factor	O
was	O
significantly	O
associated	O
with	O
negative	O
symptoms	O
in	O
the	O
schizophrenia	O
sample	O
and	O
with	O
social	O
functioning	O
in	O
both	O
groups	O
at	O
both	O
study	O
visits	O
assessment	O
of	O
residual	O
disease	O
with	O
molecular	O
breast	O
imaging	O
in	O
patients	O
undergoing	O
neoadjuvant	B-T061
therapy	I-T061
association	O
with	O
molecular	B-T080
subtypes	O
assessment	O
of	O
residual	O
disease	O
after	O
neoadjuvant	B-T061
therapy	I-T061
for	O
breast	O
cancer	O
is	O
an	O
ongoing	O
challenge	O
of	O
breast	O
imaging	O
.	O
	
this	O
study	O
evaluates	O
the	O
accuracy	B-T080
of	O
a	O
novel	O
dedicated	O
system	O
for	O
molecular	O
breast	O
imaging	O
mbi	O
composed	O
of	O
the	O
new	O
generation	O
of	O
cadmium	O
zinc	O
telluride	O
detectors	O
in	O
assessing	O
residual	O
disease	O
after	O
neoadjuvant	B-T061
therapy	I-T061
in	O
patients	O
with	O
breast	O
cancer	O
.	O
	
clinical	O
data	O
,	O
imaging	O
,	O
surgical	B-T169
,	O
and	O
pathological	B-T169
findings	B-T033
of	O
51	O
women	O
with	O
breast	O
cancer	O
undergoing	O
neoadjuvant	B-T061
therapy	I-T061
were	O
recorded	O
.	O
	
mbi	O
findings	B-T033
were	O
correlated	B-T080
with	O
surgical	O
pathology	O
results	O
.	O
	
accuracy	B-T080
of	O
mbi	O
in	O
predicting	O
complete	B-T033
pathological	I-T033
response	I-T033
and	O
size	O
of	O
residual	O
disease	O
was	O
assessed	O
according	O
to	O
molecular	B-T080
subtypes	O
.	O
	
the	O
size	O
of	O
the	O
largest	O
focus	O
of	O
uptake	O
on	O
mbi	O
correlated	B-T080
with	O
the	O
largest	O
dimension	O
measured	O
on	O
pathology	B-T169
r	O
=	O
0.55	O
p	O
<	O
001	O
.	O
	
this	O
correlation	B-T080
was	O
stronger	O
for	O
triple	O
negative	O
and	O
her2/neu	O
positive	O
subtypes	O
r	O
=	O
0.92	O
and	O
0.62	O
,	O
respectively	O
.	O
	
sixteen	O
patients	O
31%	O
had	O
complete	B-T033
pathological	I-T033
response	I-T033
.	O
	
the	O
sensitivity	B-T081
and	O
specificity	B-T081
of	O
mbi	O
for	O
detecting	O
residual	O
disease	O
were	O
83%	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
,	O
66-93	O
and	O
69%	O
95%	O
ci	B-T081
,	O
42-88	O
,	O
respectively	O
.	O
	
for	O
triple	O
negative	O
or	O
her2/neu	O
positive	O
disease	O
the	O
sensitivity	B-T081
and	O
specificity	B-T081
were	O
88%	O
95%	O
ci	B-T081
,	O
62-98	O
and	O
75%	O
95%	O
ci	B-T081
,	O
43-93	O
,	O
respectively	O
.	O
	
the	O
accuracy	B-T080
of	O
mbi	O
in	O
assessing	O
residual	O
disease	O
after	O
neoadjuvant	B-T061
treatment	I-T061
might	O
be	O
related	O
to	O
the	O
molecular	B-T080
subtype	O
.	O
	
accuracy	B-T080
is	O
highest	O
in	O
the	O
triple	O
negative	O
and	O
her2/neu	O
positive	O
subtypes	O
.	O
	
the	O
relationship	B-T080
between	O
histological	B-T169
prostatitis	B-T047
and	O
lower	O
urinary	O
tract	O
symptoms	O
and	O
sexual	O
function	O
this	O
prospective	O
analysis	O
assessed	O
the	O
effect	B-T080
of	O
histological	B-T169
prostatitis	B-T047
on	O
lower	O
urinary	O
tract	O
functions	B-T169
and	O
sexual	O
function	O
.	O
	
the	O
patients	O
were	O
separated	B-T080
into	O
two	O
groups	B-T078
as	O
histologically	B-T169
observed	B-T169
prostatitis	B-T047
group	B-T078
a	I-T078
and	O
no	B-T033
prostatitis	I-T033
group	B-T078
b	I-T078
according	O
to	O
the	O
biopsy	O
outcomes	B-T169
.	O
	
international	O
prostate	O
symptom	O
score	O
,	O
international	O
index	O
of	O
erectile	O
function-5	O
scores	O
,	O
maximal	B-T033
and	O
average	B-T033
flow	I-T033
rate	I-T033
,	O
and	O
residual	B-T033
urine	I-T033
volumes	I-T033
were	O
compared	O
statistically	O
between	O
groups	B-T078
.	O
	
there	O
was	O
no	O
significant	B-T081
difference	B-T080
p>0	O
in	O
baseline	B-T081
age	O
t=0	O
,	O
body	O
mass	O
index	O
value	O
t=0	O
,	O
prostate	B-T081
volume	I-T081
t=0	O
,	O
prostate-specific	O
antigen	O
levels	O
t=0	O
,	O
maximal	B-T033
t=0	O
and	O
average	B-T033
flow	I-T033
rate	I-T033
t=0	O
,	O
and	O
post-void	B-T079
residual	B-T033
urine	I-T033
volume	I-T033
t=0	O
.	O
	
mean	B-T081
international	O
prostate	O
symptom	O
score	O
in	O
patients	O
with	O
prostatitis	B-T047
was	O
numerically	B-T081
but	O
not	O
significantly	B-T081
higher	I-T081
than	O
that	O
in	O
those	O
without	B-T080
prostatitis	B-T047
t=0	O
,	O
p=0	O
.	O
	
mean	B-T081
international	O
index	O
of	O
erectile	O
function-5	O
score	O
in	O
the	O
prostatitis	B-T047
group	B-T078
was	O
significantly	B-T081
lower	I-T081
than	O
that	O
in	O
those	O
without	B-T080
prostatitis	B-T047
t=1	O
,	O
p=0	O
.	O
	
histological	B-T169
prostatitis	B-T047
notably	O
affected	B-T169
sexual	O
function	O
of	O
patients	O
and	O
may	O
serve	O
as	O
a	O
major	B-T080
risk	B-T033
factor	I-T033
for	O
sexual	B-T047
dysfunction	I-T047
while	O
having	O
little	O
effect	B-T080
on	O
lower	O
urinary	O
tract	O
symptoms	O
.	O
	
beyond	O
""""	O
median	B-T081
waiting	B-T079
time	I-T079
""""	O
development	B-T169
and	O
validation	O
of	O
a	O
competing	O
risk	O
model	O
to	O
predict	B-T078
outcomes	B-T169
on	O
the	O
kidney	O
transplant	O
waiting	O
list	O
median	B-T081
historical	B-T079
time	B-T079
to	O
kidney	B-T061
transplant	I-T061
is	O
misleading	O
because	O
it	O
does	O
not	O
convey	O
the	O
competing	O
risks	B-T078
of	O
death	O
or	O
removal	B-T033
from	I-T033
the	I-T033
waiting	I-T033
list	I-T033
.	O
	
we	O
developed	O
and	O
validated	O
a	O
competing	O
risk	O
model	O
to	O
calculate	O
likelihood	O
of	O
outcomes	B-T080
for	O
kidney	B-T061
transplant	I-T061
candidates	O
and	O
demonstrate	O
how	O
this	O
information	B-T078
differs	B-T080
from	O
median	B-T081
time	B-T079
to	O
transplant	B-T061
.	O
	
data	B-T078
were	O
obtained	B-T169
from	O
the	O
us	O
scientific	O
registry	O
of	O
transplant	O
recipients	O
.	O
	
the	O
retrospective	O
cohort	O
included	O
163	O
636	O
adults	O
listed	O
for	O
kidney	B-T061
transplant	I-T061
before	O
december	O
31	O
,	O
2011	O
.	O
	
predictors	B-T033
were	O
age	O
,	O
sex	O
,	O
blood	O
type	O
,	O
calculated	O
panel-reactive	O
antibodies	O
,	O
donation	B-T061
service	O
area	O
,	O
dialysis	B-T061
duration	B-T079
,	O
comorbid	B-T033
conditions	I-T033
,	O
and	O
body	O
mass	O
index	O
.	O
	
outcomes	B-T080
were	O
deceased	O
or	O
living	O
donor	O
transplant	B-T061
,	O
death	O
or	O
removal	B-T033
from	I-T033
the	I-T033
list	I-T033
due	B-T169
to	I-T169
deteriorating	B-T080
medical	B-T169
condition	B-T080
,	O
or	O
removal	B-T033
due	B-T169
to	I-T169
other	B-T033
reasons	I-T033
.	O
	
we	O
calculated	B-T169
hazards	B-T080
for	O
the	O
possible	B-T033
outcomes	B-T080
,	O
then	O
the	O
cumulative	B-T080
incidence	B-T081
function	O
for	O
a	O
given	O
candidate	O
using	O
competing	O
risk	B-T078
methodology	B-T078
.	O
	
discrimination	O
and	O
calibration	B-T081
were	O
assessed	O
through	B-T169
c	O
statistics	O
and	O
calibration	B-T081
plots	B-T169
for	O
each	B-T081
cause	B-T169
-	O
specific	B-T080
cox	B-T081
proportional	I-T081
hazard	I-T081
model	I-T081
.	O
	
c	O
statistics	O
ranged	O
from	O
0.64	O
to	O
0.73	O
.	O
	
calibration	B-T081
plots	B-T169
showed	O
good	B-T080
calibration	B-T081
.	O
	
the	O
competing	O
risk	O
model	O
shows	O
probability	B-T081
of	O
all	O
possible	B-T033
outcomes	B-T080
for	O
up	O
to	O
12	B-T079
years	I-T079
given	O
a	O
candidate's	O
characteristics	B-T080
,	O
contrasted	O
with	O
the	O
median	B-T081
waiting	B-T079
time	I-T079
for	O
that	O
candidate's	O
donation	B-T061
service	O
area	O
.	O
	
a	O
competing	O
risk	O
model	O
conveys	O
more	O
relevant	B-T080
information	B-T078
than	O
the	O
median	B-T081
waiting	B-T079
time	I-T079
for	O
a	O
given	O
transplant	O
center	O
.	O
	
this	O
model	B-T081
will	O
be	O
updated	B-T079
to	O
create	O
a	O
calculator	O
reflecting	O
the	O
most	O
recent	B-T079
outcomes	B-T080
and	O
changes	B-T169
in	O
allocation	O
policy	O
.	O
	
it	O
illustrates	O
the	O
conversations	O
that	O
should	O
be	O
initiated	B-T169
with	O
transplant	B-T061
candidates	O
.	O
	
tead1	O
regulates	O
the	O
expression	O
of	O
peripheral	O
myelin	O
protein	O
22	O
during	O
schwann	O
cell	O
development	O
schwann	O
cells	O
are	O
myelinating	O
glia	O
in	O
the	O
peripheral	O
nervous	O
system	O
that	O
form	O
the	O
myelin	O
sheath	O
.	O
	
a	O
major	O
cause	O
of	O
peripheral	B-T047
neuropathy	I-T047
is	O
a	O
copy	O
number	O
variant	O
involving	O
the	O
peripheral	O
myelin	O
protein	O
22	O
pmp22	O
gene	O
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
duplication	O
on	O
chromosome	O
17	O
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
charcot-marie-tooth	B-T047
disease	I-T047
cmt1a	B-T047
.	O
	
rodent	O
models	O
of	O
cmt1a	B-T047
have	O
been	O
used	O
to	O
show	O
that	O
reducing	O
pmp22	O
overexpression	O
mitigates	O
several	O
aspects	O
of	O
a	O
cmt1a	B-T047
-related	O
phenotype	O
.	O
	
mechanistic	B-T169
studies	O
of	O
pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sox10	B-T116
sry	B-T116
sex	I-T116
determining	I-T116
region	I-T116
y-box	I-T116
10	I-T116
and	O
egr2	B-T116
/	O
krox20	B-T116
early	B-T116
growth	I-T116
response	I-T116
protein	I-T116
2	I-T116
transcription	B-T116
factors	I-T116
in	O
myelinated	O
nerves	O
.	O
	
however	O
,	O
relatively	O
little	O
is	O
known	O
regarding	O
how	O
other	O
transcription	B-T116
factors	I-T116
induce	B-T169
pmp22	O
expression	O
during	O
schwann	O
cell	O
development	O
and	O
myelination	O
.	O
	
here	O
,	O
we	O
examined	O
pmp22	O
enhancers	O
as	O
a	O
function	O
of	O
cell	O
type-specificity	O
,	O
nerve	O
injury	O
and	O
development	B-T169
.	O
	
while	O
pmp22	O
enhancers	O
marked	O
by	O
active	B-T169
histone	O
modifications	O
were	O
lost	B-T169
or	O
remodeled	O
after	O
injury	O
,	O
we	O
found	O
that	O
these	O
enhancers	O
were	O
permissive	O
in	O
early	O
development	B-T169
prior	O
to	O
pmp22	O
upregulation	O
.	O
	
pmp22	O
enhancers	O
contain	O
binding	B-T116
motifs	I-T116
for	O
tea	B-T116
domain	I-T116
tead	B-T116
transcription	B-T116
factors	I-T116
of	O
the	O
hippo	O
signaling	O
pathway	O
.	O
	
we	O
discovered	O
that	O
tead1	O
and	O
co-activators	O
yap	O
and	O
taz	O
are	O
required	O
for	O
pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
egr2	O
tead1	O
directly	O
binds	O
pmp22	O
and	O
egr2	O
enhancers	O
early	O
in	O
development	B-T169
and	O
tead1	O
binding	O
is	O
induced	B-T169
during	O
myelination	O
,	O
correlating	O
with	O
pmp22	O
expression	O
.	O
	
the	O
data	B-T078
identify	O
tead1	O
as	O
a	O
novel	O
regulator	O
of	O
pmp22	O
expression	O
during	O
development	B-T169
in	O
concert	O
with	O
sox10	O
and	O
neutrophil	B-T116
gelatinase-associated	I-T116
lipocalin	I-T116
in	O
a	O
triphasic	B-T079
rat	O
model	O
of	O
adenine	O
-	O
induced	B-T169
kidney	O
injury	O
the	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
whether	O
ngal	B-T116
,	O
given	O
its	O
advantages	O
over	O
traditional	O
biomarkers	O
,	O
can	O
be	O
used	O
to	O
describe	O
the	O
dynamic	O
characteristics	O
of	O
the	O
renal	B-T047
tubulointerstitial	I-T047
insult	I-T047
caused	O
by	O
adenine	O
.	O
	
subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
ngal	B-T116
as	O
a	O
biomarker	O
of	O
any	O
acute	O
kidney	O
injury	O
,	O
on	O
top	O
of	O
chronic	B-T047
interstitial	I-T047
disease	I-T047
,	O
if	O
ngal	B-T116
levels	B-T080
are	O
stable	B-T080
through	B-T169
the	O
chronic	B-T079
phase	I-T079
of	O
our	O
adenine	O
model	O
.	O
	
study	O
group	O
rats	O
were	O
fed	O
an	O
adenine	O
diet	O
,	O
and	O
control	O
group	O
rats	O
were	O
fed	O
a	O
regular	O
diet	O
only	O
.	O
	
blood	O
and	O
urine	O
samples	O
for	O
urea	B-T109
,	O
creatinine	B-T109
and	O
ngal	B-T116
were	O
drawn	O
from	O
each	O
rat	O
at	O
the	O
beginning	B-T079
of	O
the	O
study	O
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O
	
kidney	O
slices	O
from	O
these	O
rats	O
were	O
stained	O
with	O
hematoxylin-eosin	O
he	O
and	O
β-actin	B-T116
stainings	O
.	O
	
serum	O
urea	O
,	O
creatinine	O
and	O
ngal	B-T116
levels	B-T080
and	O
urinary	O
ngal/creatinine	O
ratio	O
in	O
the	O
study	O
group	O
were	O
higher	O
than	O
baseline	B-T081
and	O
than	O
in	O
the	O
control	O
group	O
these	O
differences	O
were	O
statistically	B-T081
significant	I-T081
in	O
some	O
of	O
the	O
intervals	B-T079
.	O
	
tubulointerstitial	B-T047
changes	O
and	O
adenine	O
crystals	O
were	O
evident	O
in	O
the	O
study	O
group	O
rats	O
.	O
	
in	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	O
,	O
creatinine	O
and	O
ngal	B-T116
levels	B-T080
and	O
urinary	O
ngal/creatinine	O
ratio	O
followed	O
a	O
triphasic	B-T033
pattern	I-T033
of	O
kidney	O
injury	O
an	O
acute	B-T079
phase	I-T079
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	B-T081
recovery	O
phase	B-T079
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	B-T047
kidney	I-T047
disease	I-T047
phase	B-T079
after	O
stabilization	O
of	O
renal	O
function	O
.	O
	
ngal	B-T116
can	O
serve	O
a	O
biomarker	O
for	O
acute	O
kidney	O
injury	O
and	O
possibly	O
for	O
chronic	B-T047
kidney	I-T047
disease	I-T047
in	O
the	O
tubulointerstitial	B-T047
rat	O
model	O
.	O
	
talking	O
or	O
keeping	B-T080
silent	I-T080
about	O
parental	O
mental	B-T033
health	I-T033
problems	I-T033
-a	O
grounded	O
theory	O
of	O
parents	O
'	O
decision	O
making	O
and	O
experiences	O
with	O
their	O
children	O
this	O
grounded	O
theory	O
study	O
explored	O
parents	O
'	O
experiences	O
of	O
responding	O
to	O
their	O
children's	O
need	O
for	O
understanding	O
parental	O
mental	O
health	O
concerns	B-T078
.	O
	
fifteen	O
parents	O
with	O
severe	B-T080
and	O
enduring	O
mental	B-T033
health	I-T033
difficulties	I-T033
participated	O
in	O
the	O
study	O
.	O
	
the	O
findings	B-T033
suggest	O
four	O
main	O
social	O
processes	O
that	O
influence	O
parents	O
'	O
talk	O
with	O
their	O
children	O
about	O
parental	O
mental	B-T033
health	I-T033
issues	I-T033
,	O
namely	O
""""	O
protecting	O
and	O
being	O
protected	O
""""	O
""""	O
responding	O
to	O
children's	O
search	O
for	O
understanding	O
""""	O
""""	O
prioritizing	B-T079
family	O
life	O
""""	O
and	O
""""	O
relating	O
to	O
others	O
""""	O
implications	O
of	O
the	O
findings	B-T033
for	O
clinical	O
practice	O
and	O
future	O
research	O
are	O
considered	O
.	O
	
in	O
particular	O
,	O
the	O
need	O
for	O
more	O
family-orientated	O
services	O
where	O
parents	O
experience	O
parental	O
mental	B-T033
health	I-T033
problems	I-T033
a	O
case	O
of	O
bilateral	O
pneumothoraces	B-T047
resulting	O
from	O
tracheostomy	B-T061
for	O
advanced	O
laryngeal	O
cancer	O
pneumothorax	B-T047
is	O
a	O
possible	O
complication	O
of	O
tracheostomy	B-T061
.	O
	
we	O
report	O
a	O
rare	O
case	O
of	O
bilateral	O
pneumothoraces	B-T047
resulting	O
from	O
tracheostomy	B-T061
in	O
an	O
advanced	O
laryngeal	O
cancer	O
patient	O
.	O
	
a	O
59-year-old	O
man	O
was	O
referred	O
to	O
our	O
clinic	O
for	O
evaluation	O
and	O
treatment	B-T061
of	O
laryngeal	O
tumor	O
.	O
	
laryngeal	O
endoscopy	O
showed	O
limited	B-T033
movement	I-T033
of	O
bilateral	O
vocal	O
cords	O
,	O
and	O
computed	O
tomography	O
revealed	O
a	O
tumor	O
lesion	B-T033
extending	O
from	O
the	O
vocal	O
cords	O
to	O
the	O
subglottic	O
area	O
.	O
	
three	O
days	B-T079
after	O
the	O
first	B-T033
visit	I-T033
,	O
the	O
patient	O
developed	O
respiratory	O
difficulty	O
,	O
and	O
we	O
elected	O
to	O
perform	O
emergency	B-T061
tracheostomy	I-T061
for	O
airway	B-T061
management	I-T061
.	O
	
immediately	O
after	O
the	O
start	O
of	O
the	O
procedure	B-T061
,	O
he	O
began	O
hyperventilating	B-T033
,	O
and	O
complained	O
of	O
respiratory	B-T033
discomfort	I-T033
and	O
chest	O
pain	O
.	O
	
we	O
then	O
recognized	O
a	O
mediastinal	O
air	B-T047
leak	I-T047
,	O
and	O
we	O
suspected	B-T080
pneumothorax	B-T047
resulting	O
from	O
the	O
tracheostomy	B-T061
.	O
	
chest	O
x-ray	O
showed	O
bilateral	O
pneumothoraces	B-T047
therefore	O
,	O
we	O
inserted	O
bilateral	O
chest	O
drainage	O
tubes	O
,	O
which	O
stabilized	B-T033
his	O
respiratory	B-T033
condition	I-T033
.	O
	
we	O
speculated	O
that	O
the	O
pathogenesis	O
of	O
the	O
bilateral	O
pneumothoraces	B-T047
was	O
weakened	B-T080
alveolar	O
walls	O
secondary	O
to	O
long-term	B-T079
smoking	O
,	O
and	O
a	O
significant	O
rise	B-T169
in	O
airway	O
pressure	O
because	O
of	O
airway	O
constriction	O
by	O
the	O
neck-extended	O
position	O
and	O
hyperventilation	B-T033
,	O
during	O
arsenic	B-T116
triglutathione	I-T116
as	B-T116
transport	O
by	O
multidrug	B-T116
resistance	I-T116
protein	I-T116
1	I-T116
mrp1	B-T116
/	O
abcc1	B-T116
is	O
selectively	O
modified	B-T169
by	O
phosphorylation	O
of	O
tyr920/ser921	O
and	O
glycosylation	O
of	O
asn19/asn23	O
the	O
atp-binding	B-T116
cassette	I-T116
abc	I-T116
transporter	I-T116
multidrug	B-T116
resistance	I-T116
protein	I-T116
1	I-T116
mrp1	B-T116
/	O
abcc1	B-T116
is	O
responsible	O
for	O
the	O
cellular	O
export	O
of	O
a	O
chemically	O
diverse	B-T080
array	O
of	O
xenobiotics	O
and	O
endogenous	B-T169
compounds	O
.	O
	
arsenic	O
,	O
a	O
human	O
carcinogen	O
,	O
is	O
a	O
high-affinity	B-T080
mrp1	B-T116
substrate	O
as	O
arsenic	B-T116
triglutathione	I-T116
as	B-T116
.	O
	
in	O
this	O
study	O
,	O
marked	O
differences	O
in	O
as	B-T116
transport	O
kinetics	O
were	O
observed	O
between	O
mrp1	B-T116
-enriched	O
membrane	O
vesicles	O
prepared	O
from	O
human	O
embryonic	O
kidney	O
293	O
hek	O
km	B-T081
3.8	O
µm	O
and	O
vmax	O
307	O
pmol/mg	O
per	O
minute	O
and	O
hela	O
km	B-T081
0.32	O
µm	O
and	O
vmax	O
42	O
pmol/mg	O
per	O
minute	O
cells	O
.	O
	
mutant	B-T116
mrp1	B-T116
lacking	O
n-linked	O
glycosylation	O
asn19/23/1006gln	O
sugar-free	O
sf	B-T116
expressed	O
in	O
either	O
hek293	O
or	O
hela	O
cells	O
had	O
low	O
km	B-T081
and	O
vmax	O
values	O
for	O
as	B-T116
,	O
similar	B-T080
to	O
hela	O
wild-type	O
wt	O
mrp1	B-T116
.	O
	
when	O
prepared	O
in	O
the	O
presence	B-T033
of	O
phosphatase	O
inhibitors	O
,	O
both	O
wt-	B-T116
and	O
sf-mrp1	B-T116
-enriched	O
membrane	O
vesicles	O
had	O
a	O
high	O
km	B-T081
value	O
for	O
as	B-T116
3-6	O
µm	O
,	O
regardless	O
of	O
the	O
cell	O
line	O
.	O
	
kinetic	B-T033
parameters	I-T033
of	O
as	B-T116
for	O
hek	O
-	O
asn19/23gln-mrp1	B-T116
were	O
similar	B-T080
to	O
those	O
of	O
hela	O
/	O
hek	O
-	O
sf-mrp1	B-T116
and	O
hela-wt	O
-	O
mrp1	B-T116
,	O
whereas	O
those	O
of	O
single	B-T081
glycosylation	O
mutants	B-T116
were	O
like	O
those	O
of	O
hek-wt	O
-mrp1	O
.	O
	
mutation	O
of	O
19	O
potential	B-T080
mrp1	O
phosphorylation	O
sites	O
revealed	O
that	O
hek	O
-	O
tyr920phe/ser921ala-mrp1	B-T116
transported	O
as	B-T116
like	O
hela-wt	O
-	O
mrp1	B-T116
,	O
whereas	O
individual	O
hek	O
-	O
tyr920phe-	B-T116
and	O
-	O
ser921ala-mrp1	B-T116
mutants	B-T116
were	O
similar	B-T080
to	O
hek-wt	O
-	O
mrp1	B-T116
.	O
	
together	O
,	O
these	O
results	B-T033
suggest	O
that	O
asn19/asn23	O
glycosylation	O
and	O
tyr920/ser921	O
phosphorylation	O
are	O
responsible	O
for	O
altering	B-T169
the	O
kinetics	O
of	O
mrp1	B-T116
-mediated	O
as	B-T116
transport	O
.	O
	
the	O
kinetics	O
of	O
as	B-T116
transport	O
by	O
hek	O
-	O
asn19/23gln/tyr920glu/ser921glu	O
were	O
similar	B-T080
to	O
hek-wt	O
-	O
mrp1	B-T116
,	O
indicating	O
that	O
the	O
phosphorylation	O
-mimicking	O
substitutions	O
abrogated	O
the	O
influence	O
of	O
asn19/23gln	O
glycosylation	O
.	O
	
overall	O
,	O
these	O
data	O
suggest	O
that	O
cross-talk	O
between	O
mrp1	B-T116
glycosylation	O
and	O
phosphorylation	O
occurs	O
and	O
that	O
phosphorylation	O
of	O
tyr920	O
and	O
ser921	O
can	O
switch	O
mrp1	B-T116
to	O
a	O
lower-affinity	B-T080
,	O
higher-capacity	B-T080
as	B-T116
transporter	B-T116
,	O
allowing	O
arsenic	O
detoxification	O
over	O
a	O
broad	O
concentration	B-T081
range	B-T081
.	O
	
naphthohydroquinones	O
,	O
naphthoquinones	B-T109
,	O
anthraquinones	B-T109
,	O
and	O
a	O
naphthohydroquinone	O
dimer	O
isolated	B-T169
from	O
the	O
aerial	O
parts	O
of	O
morinda	O
parvifolia	O
and	O
their	O
cytotoxic	O
effects	O
through	O
up-regulation	O
of	O
p53	O
five	O
unknown	B-T080
compounds	O
,	O
morindaparvins	O
c-g	O
,	O
consisting	O
of	O
naphthohydroquinones	O
,	O
a	O
naphthoquinone	B-T109
,	O
an	O
anthraquinone	B-T109
,	O
and	O
a	O
naphthohydroquinone	O
dimer	O
,	O
together	O
with	O
three	O
known	O
quinones	B-T109
and	O
seven	O
other	O
known	O
compounds	O
,	O
were	O
isolated	B-T169
from	O
the	O
aerial	O
parts	O
of	O
morinda	O
parvifolia	O
.	O
	
the	O
structures	O
of	O
morindaparvins	O
c	O
,	O
d	O
,	O
e	O
,	O
f	O
,	O
and	O
g	O
were	O
elucidated	O
on	O
the	O
basis	O
of	O
spectroscopic	O
or	O
x-ray	O
diffraction	O
analysis	O
as	O
methyl	O
4-hydroxy-1	O
,	O
methyl	O
4	O
,	O
3-amino-6-methoxy-2-methoxycarbonyl-1	O
,	O
1	O
,	O
and	O
dimethyl	O
1	O
,	O
respectively	O
.	O
	
naphthoquinones	B-T109
and	O
naphthohydroquinone	O
dimers	O
were	O
previously	O
unknown	B-T080
in	O
the	O
genus	O
morinda	O
.	O
	
in	O
addition	O
,	O
the	O
compounds	O
were	O
tested	B-T169
for	O
cytotoxicity	O
against	O
four	O
human	O
cancer	O
cell	O
lines	O
hela	O
,	O
a2780	O
,	O
ketr3	O
and	O
mcf-7	O
and	O
their	O
effects	B-T080
on	O
p53	O
-	O
activated	O
transcription	O
.	O
	
three	O
naphthoquinones	B-T109
had	O
moderate	B-T080
cytotoxic	O
effects	O
with	O
ic50	B-T081
values	O
ranging	B-T081
from	O
1.51	O
to	O
9.56	O
μm	O
,	O
through	O
up-regulation	O
of	O
p53	O
transcriptional	O
activity	O
.	O
	
identification	O
and	O
sar	B-T080
evaluation	O
of	O
hemozoin	B-T109
-	O
inhibiting	O
benzamides	B-T109
active	B-T169
against	O
plasmodium	O
falciparum	O
quinoline	B-T109
antimalarials	O
target	B-T169
hemozoin	B-T109
formation	B-T169
causing	O
a	O
cytotoxic	B-T169
accumulation	B-T033
of	O
ferriprotoporphyrin	B-T109
ix	I-T109
fe	B-T109
.	O
	
well-developed	O
sar	B-T080
models	O
exist	O
for	O
β-hematin	B-T109
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	O
mechanisms	O
for	O
this	O
compound	O
class	O
,	O
but	O
no	O
comparably	O
detailed	O
investigations	B-T033
exist	O
for	O
other	O
hemozoin	B-T109
inhibiting	O
chemotypes	O
.	O
	
here	O
,	O
benzamide	B-T109
analogues	O
based	O
on	O
previous	O
hts	O
hits	O
have	O
been	O
purchased	O
or	O
synthesized	O
.	O
	
only	O
derivatives	O
containing	O
an	O
electron	O
deficient	O
aromatic	O
ring	O
and	O
capable	O
of	O
adopting	O
flat	O
conformations	O
,	O
optimal	O
for	O
π-π	B-T169
interactions	I-T169
with	O
fe	B-T109
,	O
inhibited	B-T080
β-hematin	B-T109
formation	B-T169
.	O
	
the	O
two	O
most	O
potent	O
analogues	O
showed	O
nanomolar	B-T081
parasite	O
activity	O
,	O
with	O
little	O
cq	B-T109
cross-resistance	O
,	O
low	O
cytotoxicity	O
,	O
and	O
high	O
in	B-T080
vitro	I-T080
microsomal	B-T080
stability	B-T080
.	O
	
selected	O
analogues	O
inhibited	B-T080
hemozoin	B-T109
formation	B-T169
in	O
plasmodium	O
falciparum	O
causing	O
high	O
levels	B-T080
of	O
free	O
heme	B-T109
.	O
	
in	O
contrast	O
to	O
quinolines	B-T109
,	O
introduction	B-T169
of	O
amine	O
side	O
chains	O
did	O
not	O
lead	O
to	O
benzamide	B-T109
accumulation	B-T033
in	O
the	O
parasite	O
.	O
	
these	O
data	B-T078
reveal	O
complex	O
relationships	B-T080
between	O
heme	O
binding	O
,	O
free	O
heme	B-T109
levels	B-T080
,	O
cellular	O
accumulation	O
,	O
and	O
in	B-T080
vitro	I-T080
activity	O
of	O
potential	O
novel	B-T080
antimalarials	O
.	O
	
shear	B-T081
modulus	I-T081
of	O
structured	O
electrorheological	O
fluid	O
mixtures	O
some	O
immiscible	O
blends	O
under	O
a	O
strong	O
electric	O
field	O
often	O
exhibit	O
periodic	B-T079
structures	O
,	O
bridging	O
the	O
gap	O
between	O
two	O
electrodes	O
.	O
	
upon	O
shear	O
,	O
the	O
structures	O
tilt	B-T080
,	O
and	O
exhibit	O
an	O
elastic	B-T169
response	O
which	O
is	O
mostly	O
governed	O
by	O
the	O
electric	O
energy	O
.	O
	
assuming	O
a	O
two-dimensional	B-T081
stripe	O
structure	O
,	O
we	O
calculate	O
the	O
maxwell	O
stress	O
,	O
and	O
derive	O
an	O
expression	B-T078
for	O
the	O
shear	B-T081
modulus	I-T081
,	O
demonstrating	O
how	O
it	O
depends	O
on	O
the	O
external	O
electric	O
field	O
,	O
the	O
composition	O
,	O
and	O
the	O
dielectric	B-T081
properties	I-T081
of	O
the	O
blend	O
.	O
	
we	O
also	O
suggest	O
the	O
notion	O
of	O
effective	O
interfacial	O
tension	O
,	O
which	O
renormalizes	O
the	O
effect	B-T080
of	I-T080
the	O
electric	O
field	O
.	O
	
this	O
leads	O
to	O
a	O
simple	O
derivation	B-T080
of	O
the	O
scaling	O
law	O
for	O
the	O
selection	O
of	O
the	O
wavelength	B-T081
of	O
the	O
structure	O
formed	O
under	O
an	O
electric	O
field	O
.	O
	
sequence-specific	O
dna	O
binding	O
by	O
long	O
hairpin	O
pyrrole-imidazole	B-T109
polyamides	I-T109
containing	O
an	O
8-amino-3	B-T109
acid	I-T109
unit	O
with	O
the	O
aim	O
of	O
improving	O
aqueous	B-T081
solubility	I-T081
,	O
we	O
designed	O
and	O
synthesized	O
five	O
n-methylpyrrole	B-T109
py	I-T109
im	I-T109
polyamides	I-T109
capable	O
of	O
recognizing	O
9-bp	O
sequences	O
.	O
	
their	O
dna-binding	O
affinities	O
and	O
sequence	O
specificities	B-T081
were	O
evaluated	O
by	O
spr	O
and	O
bind-n-seq	O
analyses	O
.	O
	
the	O
design	O
of	O
polyamide	B-T109
1	I-T109
was	O
based	O
on	O
a	O
conventional	O
model	O
,	O
with	O
three	O
consecutive	O
py	B-T109
or	O
im	B-T109
rings	O
separated	O
by	O
a	O
β-alanine	B-T116
to	O
match	O
the	O
curvature	O
and	O
twist	O
of	O
long	O
dna	O
helices	O
.	O
	
polyamides	B-T109
2	I-T109
and	I-T109
3	I-T109
contained	O
an	O
8-amino-3	B-T109
acid	I-T109
ao	B-T109
unit	O
,	O
which	O
has	O
previously	O
only	O
been	O
used	O
as	O
a	O
linker	B-T109
within	O
linear	O
py-im	B-T109
polyamides	I-T109
or	O
between	O
py	B-T109
-	O
im	O
hairpin	O
motifs	O
for	O
tandem	O
hairpin	O
.	O
	
it	O
is	O
demonstrated	O
herein	O
that	O
ao	O
also	O
functions	O
as	O
a	O
linker	O
element	O
that	O
can	O
extend	O
to	O
2-bp	O
in	O
hairpin	O
motifs	O
.	O
	
notably	O
,	O
although	O
the	O
ao	O
-containing	O
unit	O
can	O
fail	O
to	O
bind	O
the	O
expected	O
sequence	O
,	O
polyamide	O
4	O
,	O
which	O
has	O
two	O
ao	O
units	O
facing	O
each	O
other	O
in	O
a	O
hairpin	O
form	O
,	O
successfully	O
showed	O
the	O
expected	O
motif	O
and	O
a	O
kd	O
value	O
of	O
16nm	O
was	O
recorded	O
.	O
	
polyamide	O
5	O
,	O
containing	O
a	O
β-alanine-β-alanine	O
unit	O
instead	O
of	O
the	O
ao	O
of	O
polyamide	O
2	O
,	O
was	O
synthesized	O
for	O
comparison	O
.	O
	
the	O
aqueous	O
solubilities	O
and	O
nuclear	O
localization	O
of	O
three	O
of	O
the	O
polyamides	O
were	O
also	O
examined	O
.	O
	
the	O
results	O
suggest	O
the	O
possibility	O
of	O
applying	O
the	O
ao	O
unit	O
in	O
the	O
core	O
of	O
py-im	O
polyamide	O
compounds	I-T109
causes	B-T033
of	I-T033
death	I-T033
among	O
children	O
aged	O
5	O
to	O
14	O
years	B-T079
old	B-T079
from	O
2008	O
to	O
2013	O
in	O
kersa	O
health	O
and	O
demographic	O
surveillance	O
system	O
kersa	O
hdss	O
,	O
ethiopia	O
the	O
global	O
burden	O
of	O
mortality	B-T081
among	I-T081
children	I-T081
is	O
still	O
very	O
huge	O
though	O
its	O
trend	B-T079
has	O
started	O
declining	O
following	O
the	O
improvements	O
in	O
the	O
living	B-T081
standard	I-T081
.	O
	
it	O
presents	O
serious	O
challenges	O
to	O
the	O
well-being	O
of	O
children	O
in	O
many	O
african	O
countries	O
.	O
	
today	O
,	O
sub-saharan	O
africa	O
alone	O
accounts	O
for	O
about	O
50%	O
of	O
global	B-T080
child	B-T081
mortality	I-T081
.	O
	
the	O
overall	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
magnitude	B-T081
and	O
distribution	B-T169
of	O
causes	B-T033
of	I-T033
death	I-T033
among	O
children	O
aged	O
5	O
to	O
14	O
year	O
olds	O
in	O
the	O
population	O
of	O
kersa	O
hdss	O
using	O
verbal	B-T080
autopsy	O
method	O
for	O
the	O
period	B-T079
2008	O
to	O
2013	O
.	O
	
kersa	O
health	O
and	O
demographic	O
surveillance	O
system	O
kersa	O
hdss	O
was	O
established	O
in	O
september	B-T079
2007	O
.	O
	
the	O
center	O
consists	O
of	O
10	O
rural	O
and	O
2	O
urban	O
kebeles	O
which	O
were	O
selected	O
randomly	O
from	O
38	O
kebeles	O
in	O
the	O
district	O
.	O
	
thus	O
this	O
study	O
was	O
conducted	O
in	O
kersa	O
hdss	O
and	O
data	B-T078
was	O
taken	O
from	O
kersa	O
hdss	O
database	O
.	O
	
the	O
study	O
population	O
included	O
all	O
children	O
aged	O
5	O
to	O
14	O
years	O
registered	O
during	O
the	O
period	B-T079
of	O
2008	O
to	O
2013	O
in	O
kersa	O
hdss	O
using	O
age	O
specific	O
va	O
questionnaires	O
.	O
	
data	B-T078
were	O
extracted	O
from	O
spss	O
database	O
and	O
analyzed	O
using	O
stata	O
.	O
	
a	O
total	O
of	O
229	O
deaths	B-T033
were	O
recorded	O
over	O
the	O
period	B-T079
of	O
six	O
years	O
with	O
a	O
crude	O
death	B-T081
rate	I-T081
of	O
219.6	O
per	O
100	O
population	O
of	O
this	O
age	O
group	O
over	O
the	O
study	O
period	B-T079
.	O
	
this	O
death	B-T081
rate	I-T081
was	O
217.5	O
and	O
221.5	O
per	O
100	O
populations	O
for	O
females	O
and	O
males	O
,	O
respectively	O
.	O
	
75%	O
of	O
deaths	B-T033
took	O
place	O
at	O
home	O
.	O
	
the	O
study	O
identified	O
severe	O
malnutrition	B-T047
33.9	O
,	O
intestinal	B-T047
infectious	I-T047
diseases	I-T047
13.8	O
and	O
acute	B-T047
lower	I-T047
respiratory	I-T047
infections	I-T047
9.2	O
to	O
be	O
the	O
three	O
most	O
leading	O
causes	B-T033
of	I-T033
death	I-T033
.	O
	
in	O
broad	O
causes	B-T033
of	I-T033
death	I-T033
classification	O
,	O
injuries	O
have	O
been	O
found	O
to	O
be	O
the	O
second	O
most	O
cause	B-T033
of	I-T033
death	I-T033
next	O
to	O
communicable	B-T047
diseases	I-T047
56.3	O
attributing	O
to	O
13.1	O
of	O
the	O
total	O
deaths	B-T033
.	O
	
in	O
specific	O
causes	B-T033
of	I-T033
death	I-T033
classification	O
severe	O
malnutrition	B-T047
,	O
intestinal	B-T047
infectious	I-T047
diseases	I-T047
and	O
acute	B-T047
lower	I-T047
respiratory	I-T047
infections	I-T047
were	O
the	O
three	O
leading	O
causes	B-T033
of	I-T033
death	I-T033
where	O
,	O
in	O
broad	O
causes	B-T033
of	I-T033
death	I-T033
communicable	B-T047
diseases	I-T047
and	O
injuries	O
were	O
among	O
the	O
leading	O
causes	B-T033
of	I-T033
death	I-T033
.	O
	
hence	O
,	O
concerned	O
bodies	O
should	O
take	O
measures	O
to	O
avert	O
the	O
situation	O
of	O
mortality	B-T081
from	O
these	O
causes	B-T033
of	I-T033
death	I-T033
and	O
further	O
inferential	O
analysis	O
into	O
the	O
prevention	B-T061
and	O
management	O
of	O
infectious	B-T047
diseases	I-T047
naïve	O
cd8	O
t	O
cell	O
derived	O
tumor	O
-	O
specific	B-T080
cytotoxic	O
effectors	O
as	O
a	O
potential	O
remedy	O
for	O
overcoming	O
tgf-β	B-T116
immunosuppression	B-T047
in	O
the	O
tumor	O
microenvironment	O
despite	O
of	O
the	O
potential	O
implications	O
for	O
cancer	B-T061
immunotherapy	I-T061
,	O
conventional	B-T080
approaches	B-T169
using	O
in	B-T080
vitro	I-T080
expanded	O
cd8	O
t	O
cells	O
have	O
suboptimal	B-T080
outcomes	B-T080
,	O
mostly	O
due	O
to	O
loss	B-T081
of	O
functionality	B-T169
from	O
cellular	O
exhaustion	O
.	O
	
we	O
therefore	O
investigated	O
the	O
phenotypic	O
and	O
functional	B-T169
differences	B-T080
among	O
in	B-T080
vitro	I-T080
activated	O
cd8	O
t	O
cells	O
of	O
three	O
different	O
sources	B-T033
,	O
namely	O
naïve	O
nteff	O
,	O
memory	O
mteff	O
and	O
tumor-infiltrating	O
lymphocytes	O
tileff	O
from	O
human	O
and	O
mice	O
,	O
to	O
better	O
understand	O
mechanisms	B-T169
behind	O
potent	O
effector	O
functions	B-T169
and	O
potential	O
for	O
overcoming	O
current	O
limitations	B-T169
.	O
	
in	O
line	O
with	O
the	O
greater	O
proliferation	O
activity	O
and	O
longer	O
telomere	O
lengths	B-T081
of	O
nteff	O
populations	O
,	O
cells	O
of	O
naïve	B-T079
origin	I-T079
exhibited	O
significantly	O
less	O
amounts	O
of	O
t	O
cell	O
exhaustion	O
markers	O
than	O
those	O
of	O
mteff	O
and	O
tileff	O
,	O
and	O
moreover	O
,	O
acquired	O
distinct	O
expression	O
patterns	O
of	O
memory-promoting	B-T116
transcription	I-T116
factors	I-T116
,	O
t-bet	B-T116
and	O
eomes	B-T116
,	O
induced	B-T169
in	O
a	O
rapid	B-T080
and	O
sustainable	B-T169
manner	B-T169
.	O
	
nteff	O
cells	O
appeared	O
to	O
have	O
lower	O
expression	O
of	O
foxp1	B-T116
and	O
were	O
refractory	O
to	O
apoptosis	O
upon	O
tgf-β	B-T116
conditioning	B-T169
,	O
implying	O
better	O
survival	O
potential	B-T080
and	O
resistance	B-T169
to	O
tumor	O
-	O
induced	B-T169
immune	B-T047
suppression	I-T047
.	O
	
of	O
cd8	O
t	O
cell	O
pools	O
activated	O
to	O
tumor	O
-	O
specific	B-T080
ctls	O
,	O
naïve	O
cell	O
generated	O
effectors	O
possessed	O
the	O
most	O
potent	O
cytotoxic	B-T033
activity	I-T033
,	O
validating	O
implications	O
for	O
use	O
in	O
rational	O
design	O
of	O
adoptive	B-T061
immunotherapy	I-T061
.	O
	
antiadipogenic	B-T033
activity	I-T033
of	O
γ-oryzanol	B-T109
and	O
its	O
stability	B-T080
in	O
pigmented	B-T080
rice	O
γ-oryzanol	B-T109
,	O
a	O
prevalent	O
compound	O
in	O
pigmented	B-T080
rice	O
varieties	B-T080
,	O
has	O
been	O
reported	O
to	O
ameliorate	O
obesity-associated	B-T047
metabolic	I-T047
disorders	I-T047
.	O
	
antiadipogenic	B-T033
activities	I-T033
of	O
γ-oryzanol	B-T109
were	O
determined	O
in	O
human	O
adipose	O
-	O
derived	B-T078
mesenchymal	O
stem	O
cells	O
and	O
mouse	O
-	O
derived	B-T078
3t3-l1	O
cells	O
.	O
	
γ-oryzanol	B-T109
significantly	O
decreased	B-T081
lipid	B-T033
accumulation	I-T033
and	O
reduced	B-T080
glycerol-3-phosphate	O
dehydrogenase	O
activities	O
in	O
both	O
adipocytes	O
.	O
	
in	O
addition	O
,	O
γ-oryzanol	B-T109
in	O
four	O
pigmented	B-T080
rice	O
varieties	B-T080
black	O
with	O
giant	O
embryo	O
,	O
brown	O
,	O
sugary	O
brown	O
,	O
and	O
red	O
was	O
stable	B-T080
when	O
stored	B-T169
at	O
4	O
and	O
also	O
at	O
room	B-T080
temperature	I-T080
for	O
22	O
weeks	O
,	O
whereas	O
other	O
bioactives	O
such	O
as	O
lutein	B-T109
and	O
β-carotene	B-T109
were	O
stable	B-T080
only	O
at	O
-80	O
.	O
	
furthermore	O
,	O
the	O
yield	B-T081
of	O
γ-oryzanol	B-T109
from	O
these	O
rice	O
varieties	B-T080
was	O
significantly	O
increased	O
through	O
steaming	O
and	O
roasting	O
processes	O
.	O
	
therefore	O
,	O
γ-oryzanol	B-T109
exerts	O
antiadipogenic	B-T033
activity	I-T033
by	O
suppressing	B-T169
adipocyte	O
differentiations	O
and	O
is	O
stable	B-T080
in	O
pigmented	B-T080
rice	O
for	O
an	O
extended	B-T169
period	B-T079
of	I-T079
time	I-T079
during	O
storage	B-T169
and	O
after	B-T079
cooking	O
.	O
	
thus	O
,	O
the	O
intake	B-T169
of	O
pigmented	B-T080
rice	O
may	O
be	O
a	O
useful	O
strategy	O
for	O
preventing	B-T169
obesity	B-T047
.	O
	
impact	B-T080
of	O
chemotherapy	B-T061
on	O
diet	O
and	O
nutritional	B-T033
status	I-T033
of	O
women	O
with	O
breast	O
cancer	O
a	O
prospective	O
study	O
certain	O
food	O
groups	O
are	O
often	O
rejected	B-T080
during	O
chemotherapy	B-T061
ct	B-T061
due	O
to	O
the	O
side	O
effects	O
of	O
treatment	O
,	O
which	O
may	O
interfere	B-T169
with	I-T169
adequate	O
diet	O
and	O
nutritional	B-T033
status	I-T033
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
treatment	B-T169
impact	B-T080
on	O
the	O
diet	O
and	O
nutritional	B-T033
status	I-T033
of	O
women	O
with	O
breast	O
cancer	O
bc	O
.	O
	
in	O
this	O
prospective	O
longitudinal	O
study	O
,	O
conducted	O
in	O
2014-2015	O
,	O
55	O
women	O
diagnosed	O
with	O
bc	O
,	O
with	O
a	O
mean	O
age	O
51.5	O
years	B-T079
,	O
were	O
followed	O
and	O
data	B-T078
were	O
collected	O
at	O
three	O
different	O
times	O
.	O
	
anthropometric	B-T081
and	O
dietary	O
assessments	O
were	O
performed	O
,	O
the	O
latter	O
by	O
applying	O
nine	O
24h	O
dietary	B-T061
recall	I-T061
s	O
,	O
by	O
using	O
the	O
brazilian	O
healthy	O
eating	O
index	O
revised	O
bhei-r	O
,	O
and	O
calculating	O
the	O
prevalence	B-T081
of	O
inadequacy	B-T080
by	O
the	O
ear	O
cut-off	O
point	O
method	O
.	O
	
regarding	O
the	O
bhei-r	O
analysis	O
,	O
the	O
majority	O
of	O
women	O
had	O
a	O
""""	O
diet	O
requires	O
modification	B-T033
'	O
,	O
both	O
at	O
the	O
beginning	B-T079
t0	O
,	O
58.2	O
,	O
n	O
=	O
32	O
and	O
during	B-T079
treatment	I-T079
t1	O
,	O
54.5	O
,	O
n	O
=	O
30	O
.	O
	
however	O
,	O
after	O
the	O
end	O
of	O
the	O
ct	B-T061
,	O
the	O
greater	B-T081
percentage	I-T081
of	O
patients	O
t2	O
,	O
49.1	O
,	O
n	O
=	O
27	O
were	O
classified	O
as	O
having	O
an	O
""""	O
inadequate	B-T033
diet	I-T033
""""	O
,	O
since	O
the	O
total	B-T080
fruit	O
consumption	O
as	O
well	O
as	O
the	O
dark	O
green	O
and	O
orange	O
vegetable	O
and	O
legume	O
consumption	O
decreased	B-T081
significantly	I-T081
during	B-T079
treatment	I-T079
p	O
=	O
0.043	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
.	O
	
there	O
was	O
a	O
significant	B-T080
reduction	I-T080
in	O
the	O
intake	B-T169
of	O
macro	O
and	O
micronutrients	O
,	O
with	O
a	O
high	O
prevalence	B-T081
of	O
inadequacy	B-T080
,	O
of	O
up	O
to	O
100%	O
,	O
for	O
calcium	O
,	O
iron	O
,	O
phosphorus	O
,	O
magnesium	O
,	O
niacin	B-T109
,	O
riboflavin	B-T109
,	O
thiamin	B-T109
,	O
vitamin	B-T109
b6	I-T109
,	O
vitamin	B-T109
c	I-T109
and	O
zinc	O
.	O
	
assessment	O
of	O
the	O
nutritional	B-T033
status	I-T033
indicated	O
that	O
56%	O
n	O
=	O
31	O
of	O
patients	O
were	O
overweight	O
at	O
these	O
three	O
different	O
times	O
.	O
	
weight	O
,	O
bmi	O
and	O
waist	O
circumference	O
increased	B-T081
significantly	I-T081
,	O
indicating	O
a	O
worse	B-T033
nutritional	B-T033
status	I-T033
,	O
and	O
there	O
was	O
a	O
correlation	B-T080
between	O
poor	B-T080
diet	I-T080
quality	I-T080
and	O
higher	B-T080
values	I-T080
for	O
bmi	O
,	O
waist-hip	O
ratio	O
and	O
waist-to-height	B-T033
ratio	I-T033
.	O
	
chemotherapy	B-T061
interferes	B-T169
in	O
the	O
patients	O
'	O
diet	O
generating	O
a	O
negative	B-T080
impact	I-T080
on	O
the	O
quality	B-T080
and	O
intake	B-T169
of	O
micro	O
and	O
macronutrients	O
,	O
as	O
well	O
as	O
an	O
impact	B-T080
on	O
their	O
nutritional	B-T033
status	I-T033
,	O
with	O
an	O
increase	O
in	O
anthropometric	B-T081
measurements	I-T081
.	O
	
benefit	O
and	O
risk	O
in	O
short	O
term	O
after	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
by	O
direct	O
anterior	O
approach	O
combined	O
with	O
dual	O
mobility	O
cup	O
no	O
previous	O
reports	O
have	O
described	O
the	O
benefits	O
and	O
risks	O
associated	O
with	O
the	O
dual	O
mobility	O
cup	O
dmc	O
in	O
primary	O
tha	B-T061
via	O
direct	O
anterior	O
approach	O
daa	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
safety	O
and	O
rate	O
of	O
early	O
postoperative	O
complication	O
of	O
the	O
daa	O
with	O
the	O
dmc	O
for	O
tha	B-T061
with	O
those	O
of	O
the	O
daa	O
with	O
a	O
single	O
standard	O
cup	O
,	O
and	O
to	O
investigate	O
the	O
influence	O
of	O
the	O
learning	O
curve	O
of	O
the	O
use	O
of	O
dmc	O
on	O
intra	B-T079
-	O
and	O
perioperative	B-T079
outcomes	B-T169
.	O
	
we	O
retrospectively	O
investigated	O
60	O
hips	O
treated	B-T061
in	O
the	O
single-	O
daa	O
group	B-T078
and	O
60	O
hips	O
treated	B-T061
in	O
the	O
dual-	O
daa	O
group	B-T078
.	O
	
a	O
primary	B-T080
/	O
secondary	B-T081
outcome	B-T169
variable	O
was	O
the	O
presence	O
of	O
any	O
intra	O
-	O
or	O
perioperative	B-T079
complication	O
within	O
the	O
first	O
6	O
months	B-T079
/the	O
operative	B-T079
time	I-T079
and	O
hip	O
function	O
at	O
6	O
months	B-T079
postoperatively	B-T079
.	O
	
we	O
also	O
analyzed	O
influence	O
of	O
the	O
learning	O
curve	O
of	O
the	O
use	O
of	O
dmc	O
on	O
intra	B-T079
-	O
and	O
perioperative	B-T079
outcomes	B-T169
.	O
	
no	B-T033
intraoperative	O
complications	O
were	O
observed	O
in	O
either	O
group	B-T078
.	O
	
one	O
anterior	O
dislocation	O
and	O
one	O
periprosthetic	O
hip	O
fracture	O
were	O
occurred	O
in	O
the	O
single-	O
daa	O
group	B-T078
.	O
	
the	O
surgical	B-T079
times	I-T079
in	O
the	O
single-	O
daa	O
and	O
dual-	O
daa	O
groups	B-T078
were	O
112.0	O
20.9	O
and	O
121.0	O
26.9	O
min	O
p	O
<	O
0.001	O
.	O
	
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
6-	O
month	B-T079
postoperative	B-T079
hip	B-T081
function	I-T081
scores	I-T081
between	O
the	O
two	O
groups	B-T078
.	O
	
there	O
was	O
no	O
influence	O
of	O
the	O
learning	O
curve	O
of	O
the	O
use	O
of	O
dmc	O
on	O
intra	B-T079
-	O
and	O
perioperative	B-T079
outcomes	B-T169
.	O
	
we	O
have	O
demonstrated	O
the	O
short-term	O
safety	O
and	O
lack	O
of	O
inferiority	O
of	O
using	O
the	O
dmc	O
in	O
the	O
daa	O
compared	O
with	O
the	O
standard	O
single	O
mobility	O
cup	O
.	O
	
diffuse	O
traumatic	O
brain	O
injury	O
affects	O
chronic	B-T079
corticosterone	B-T109
function	B-T169
in	O
the	O
rat	O
as	O
many	O
as	O
20-55%	O
of	O
patients	O
with	O
a	O
history	B-T033
of	O
traumatic	O
brain	O
injury	O
tbi	O
experience	O
chronic	B-T079
endocrine	B-T047
dysfunction	I-T047
,	O
leading	O
to	O
impaired	O
quality	O
of	O
life	O
,	O
impaired	B-T169
rehabilitation	B-T169
efforts	O
and	O
lowered	B-T033
life	I-T033
expectancy	I-T033
.	O
	
endocrine	B-T047
dysfunction	I-T047
after	O
tbi	O
is	O
thought	O
to	O
result	B-T169
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-pituitary	O
endocrine	O
hpe	O
dysfunction	O
.	O
	
these	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
tbi	O
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	O
cort	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	O
.	O
	
we	O
used	O
a	O
rodent	O
model	O
of	O
diffuse	O
tbi	O
induced	O
by	O
midline	O
fluid	O
percussion	O
injury	O
mfpi	O
.	O
	
at	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	O
animals	O
,	O
circulating	O
levels	O
of	O
cort	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	O
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	O
glucocorticoid	O
commonly	O
used	O
to	O
test	O
hpe	O
axis	O
regulation	O
.	O
	
testosterone	O
was	O
evaluated	O
at	O
rest	O
.	O
	
further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
golgi	O
stain	O
,	O
neuropathology	O
silver	O
stain	O
and	O
activated	O
astrocytes	O
gfap	O
in	O
the	O
paraventricular	O
nucleus	O
pvn	O
of	O
the	O
hypothalamus	O
.	O
	
resting	O
plasma	O
cort	O
levels	O
were	O
decreased	O
at	O
2	O
months	O
postinjury	O
and	O
there	O
was	O
a	O
blunted	O
cort	O
increase	O
in	O
response	O
to	O
restraint	O
induced	O
stress	O
.	O
	
no	O
changes	O
in	O
testosterone	O
were	O
measured	O
.	O
	
these	O
changes	O
in	O
cort	O
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	O
processes	O
in	O
the	O
pvn	O
over	O
time	O
,	O
devoid	O
of	O
neuropathology	O
or	O
astrocytosis	O
.	O
	
results	O
provide	O
evidence	O
that	O
a	O
single	O
moderate	O
diffuse	O
tbi	O
leads	O
to	O
changes	O
in	O
cort	O
function	O
,	O
which	O
can	O
contribute	O
to	O
the	O
persistence	O
of	O
symptoms	O
related	O
to	O
endocrine	O
dysfunction	O
.	O
	
future	O
experiments	O
aim	O
to	O
evaluate	O
additional	O
hp-related	O
hormones	O
and	O
endocrine	O
circuit	O
pathology	O
following	O
diffuse	O
tbi	O
methamphetamine	B-T109
,	O
3	B-T109
mdma	B-T109
and	O
3	B-T109
mdpv	B-T109
induce	B-T169
differential	B-T080
cytotoxic	O
effects	O
in	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	O
designer	O
drugs	O
such	O
as	O
synthetic	O
psychostimulants	O
are	O
indicative	O
of	O
a	O
worldwide	O
problem	B-T033
of	O
drug	O
abuse	O
and	O
addiction	O
.	O
	
in	O
addition	O
to	O
methamphetamine	B-T109
meth	B-T109
,	O
these	O
drugs	O
include	O
3	B-T109
mdma	B-T109
and	O
commercial	O
preparations	O
of	O
synthetic	B-T109
cathinones	I-T109
including	O
3	B-T109
mdpv	B-T109
,	O
typically	O
referred	O
to	O
as	O
""""	O
bath	B-T109
salts	I-T109
""""	O
these	O
psychostimulants	O
exert	O
neurotoxic	O
effects	O
by	O
altering	B-T078
monoamine	O
systems	O
in	O
the	O
brain	O
.	O
	
additionally	O
,	O
meth	B-T109
and	O
mdma	B-T109
adversely	O
affect	O
the	O
integrity	B-T080
of	O
the	O
blood-brain	O
barrier	O
bbb	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	B-T080
of	I-T080
mdpv	B-T109
on	O
the	O
bbb	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	B-T080
of	I-T080
meth	B-T109
,	O
mdma	B-T109
and	O
mdpv	B-T109
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	O
bbmvecs	O
,	O
an	O
accepted	O
in	O
vitro	O
model	O
of	O
the	O
bbb	O
.	O
	
confluent	B-T080
bbmvec	O
monolayers	O
were	O
treated	B-T169
with	O
meth	B-T109
,	O
mdma	B-T109
and	O
mdpv	B-T109
0.5mm	O
for	O
24h	O
.	O
	
meth	B-T109
and	O
mdma	B-T109
increased	B-T081
lactate	B-T116
dehydrogenase	I-T116
release	B-T169
only	O
at	O
the	O
highest	B-T080
concentration	B-T081
2.5mm	O
,	O
whereas	O
mdpv	B-T109
induced	B-T169
cytotoxicity	O
at	O
all	O
concentration	B-T081
s	O
.	O
	
mdma	B-T109
and	O
meth	B-T109
decreased	B-T081
cellular	O
proliferation	O
only	O
at	O
2.5mm	O
,	O
with	O
similar	O
effects	B-T080
observed	O
after	O
mdpv	B-T109
exposures	B-T080
starting	O
at	O
1mm	O
.	O
	
only	O
mdpv	B-T109
increased	B-T081
reactive	O
oxygen	O
species	O
production	O
at	O
all	O
concentrations	B-T081
tested	B-T169
whereas	O
all	O
3	O
drugs	O
increased	B-T081
nitric	O
oxide	O
production	O
.	O
	
morphological	O
analysis	O
revealed	O
different	B-T080
patterns	O
of	O
compound	O
-	O
induced	B-T169
cell	O
damage	O
.	O
	
meth	B-T109
induced	B-T169
vacuole	O
formatio	B-T169
n	O
at	O
1mm	O
and	O
disruption	B-T169
of	O
the	O
monolayer	O
at	O
2.5mm	O
.	O
	
mdma	B-T109
induced	B-T169
disruption	B-T169
of	O
the	O
endothelial	O
monolayer	O
from	O
1mm	O
without	O
vacuolization	B-T033
.	O
	
on	O
the	O
other	O
hand	O
,	O
mdpv	B-T109
induced	B-T169
monolayer	O
disruption	B-T169
at	O
doses	B-T081
0.5mm	O
without	O
vacuole	O
formation	B-T169
at	O
2.5mm	O
,	O
the	O
few	O
remaining	O
cells	O
lacked	O
endothelial	B-T080
morphology	I-T080
.	O
	
these	O
data	B-T078
suggest	O
that	O
even	O
though	O
these	O
synthetic	O
psychostimulants	O
alter	O
monoaminergic	O
systems	O
,	O
they	O
each	O
induce	B-T169
bbb	O
toxicity	O
by	O
different	B-T080
mechanisms	B-T169
with	O
mdpv	B-T109
being	O
the	O
most	O
alleviation	B-T080
of	O
hepatic	O
fat	B-T033
accumulation	I-T033
by	O
betaine	B-T109
involves	O
reduction	B-T080
of	O
homocysteine	B-T116
via	O
up-regulation	O
of	O
betaine-homocysteine	B-T116
methyltransferase	I-T116
bhmt	B-T116
we	O
investigated	B-T169
the	O
anti-lipogenic	B-T169
effect	I-T169
of	O
betaine	B-T109
in	O
rats	O
fed	O
methionine	B-T116
and	O
choline	B-T109
-	O
deficient	B-T080
diet	O
mcd	O
.	O
	
intake	O
of	O
mcd	O
for	O
3	O
wk	O
resulted	O
in	O
a	O
significant	B-T078
accumulation	B-T033
of	O
hepatic	O
lipids	B-T109
,	O
which	O
was	O
prevented	B-T080
by	O
betaine	B-T109
supplementation	B-T061
in	O
drinking	O
water	O
1%	O
.	O
	
phosphorylation	O
of	O
amp-activated	B-T116
protein	I-T116
kinase	I-T116
ampk	B-T116
,	O
acetyl-coa	B-T116
carboxylase	I-T116
acc	B-T116
,	O
sterol	B-T116
regulatory	I-T116
element-binding	I-T116
protein	I-T116
1c	I-T116
srebp-1c	B-T116
,	O
and	O
liver	B-T116
kinase	I-T116
b1	I-T116
lkb1	B-T116
was	O
inhibited	B-T080
by	O
mcd	O
intake	B-T169
,	O
and	O
these	O
changes	O
were	O
all	O
inhibited	B-T080
by	O
betaine	B-T109
feeding	O
.	O
	
meanwhile	O
,	O
betaine	B-T109
supplementation	B-T061
reversed	B-T169
the	O
reduction	B-T080
of	O
methionine	O
and	O
s-adenosylmethionine	O
sam	O
,	O
and	O
the	O
elevation	B-T080
of	O
homocysteine	O
levels	O
in	O
the	O
liver	O
,	O
which	O
could	O
be	O
attributable	O
to	O
the	O
induction	O
of	O
betaine-homocysteine	B-T116
methyltransfease	I-T116
bhmt	B-T116
and	O
methionine	B-T116
adenosyltransferase	I-T116
mat	B-T116
.	O
	
different	B-T080
cell	O
lines	O
were	O
used	O
to	O
clarify	O
the	O
role	O
of	O
homocysteine	B-T116
on	O
activation	O
of	O
the	O
ampk	B-T116
pathway	O
.	O
	
homocysteine	B-T116
treatment	B-T169
decreased	B-T081
pampk	B-T116
,	O
pacc	B-T116
,	O
psrebp-1c	B-T116
and	O
plkb1	B-T116
in	O
hepg2	O
cells	O
.	O
	
metformin	B-T109
-	O
induced	B-T169
activation	O
of	O
ampk	B-T116
was	O
also	O
inhibited	B-T080
by	O
homocysteine	B-T116
.	O
	
treatment	B-T169
with	O
hydroxylamine	O
,	O
a	O
cystathionine	B-T116
β-synthase	I-T116
inhibitor	O
,	O
resulted	O
in	O
a	O
reduction	B-T080
of	O
pampk	B-T116
,	O
pacc	B-T116
and	O
psrebp-1c	B-T116
,	O
accompanied	O
by	O
an	O
elevation	B-T080
of	O
intracellular	O
homocysteine	B-T116
.	O
	
betaine	B-T109
treatment	B-T061
prevented	B-T080
the	O
homocysteine	B-T116
-	O
induced	B-T169
reduction	B-T080
of	O
pampk	B-T116
,	O
pacc	B-T116
,	O
psrebp-1c	B-T116
and	O
plkb1	B-T116
in	O
h4iie	O
cells	O
,	O
but	O
not	O
in	O
hepg2	O
cells	O
.	O
	
also	O
the	O
elevation	B-T080
of	O
cellular	O
homocysteine	B-T116
and	O
inhibition	O
of	O
protein	O
expression	O
of	O
bhmt	B-T116
were	O
prevented	B-T080
by	O
betaine	B-T109
only	O
in	O
h4iie	O
cells	O
which	O
express	O
bhmt	B-T116
.	O
	
the	O
results	O
suggest	O
that	O
the	O
beneficial	O
effect	O
of	O
betaine	B-T109
against	O
hepatic	O
lipid	B-T109
accumulation	B-T033
may	O
be	O
attributed	B-T078
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
depletion	B-T169
of	O
homocysteine	B-T116
via	O
up-regulation	O
of	O
bhmt	B-T116
in	O
dual-color	O
sted	O
microscopy	O
reveals	O
a	O
sandwich	O
structure	O
of	O
bassoon	B-T116
and	O
piccolo	B-T116
in	O
active	O
zones	O
of	O
adult	O
and	O
aged	O
mice	O
presynaptic	O
active	O
zones	O
play	O
a	O
pivotal	O
role	O
as	O
synaptic	O
vesicle	O
release	O
sites	O
for	O
synaptic	O
transmission	O
,	O
but	O
the	O
molecular	O
architecture	O
of	O
active	O
zones	O
in	O
mammalian	O
neuromuscular	O
junctions	O
nmjs	O
at	O
sub-diffraction	O
limited	O
resolution	O
remains	O
unknown	O
.	O
	
bassoon	B-T116
and	O
piccolo	B-T116
are	O
active	O
zone	O
specific	O
cytosolic	O
proteins	B-T116
essential	O
for	O
active	O
zone	O
assembly	O
in	O
nmjs	O
,	O
ribbon	O
synapses	O
,	O
and	O
brain	O
synapses	O
.	O
	
these	O
proteins	B-T116
are	O
thought	O
to	O
colocalize	O
and	O
share	O
some	O
functions	O
at	O
active	O
zones	O
.	O
	
here	O
,	O
we	O
report	O
an	O
unexpected	O
finding	O
of	O
non-overlapping	O
localization	O
of	O
these	O
two	O
proteins	B-T116
in	O
mouse	O
nmjs	O
revealed	O
using	O
dual-color	O
stimulated	O
emission	O
depletion	O
sted	O
super	O
resolution	O
microscopy	O
.	O
	
piccolo	B-T116
puncta	B-T033
sandwiched	O
bassoon	B-T116
puncta	B-T033
and	O
aligned	B-T081
in	O
a	O
piccolo	B-T116
-	O
bassoon	B-T116
-	O
piccolo	B-T116
structure	O
in	O
adult	O
nmjs	O
.	O
	
p/q-type	B-T116
voltage-gated	I-T116
calcium	I-T116
channel	I-T116
vgcc	B-T116
puncta	B-T033
colocalized	O
with	O
bassoon	B-T116
puncta	B-T033
.	O
	
the	O
p/q-type	B-T116
vgcc	I-T116
and	O
bassoon	B-T116
protein	O
levels	O
decreased	B-T081
significantly	O
in	O
nmjs	O
from	O
aged	O
mouse	O
.	O
	
in	O
contrast	O
,	O
the	O
piccolo	B-T116
levels	O
in	O
nmjs	O
from	O
aged	O
mice	O
were	O
comparable	O
to	O
levels	O
in	O
adult	O
mice	O
.	O
	
this	O
study	O
revealed	O
the	O
molecular	O
architecture	O
of	O
active	O
zones	O
in	O
mouse	O
nmjs	O
at	O
sub-diffraction	O
limited	O
resolution	O
,	O
and	O
described	O
the	O
selective	O
degeneration	O
mechanism	O
of	O
active	O
zone	O
proteins	B-T116
in	O
nmjs	O
from	O
aged	O
mice	O
.	O
	
interestingly	O
,	O
the	O
localization	O
pattern	O
of	O
active	O
zone	O
proteins	B-T116
described	O
herein	O
is	O
similar	O
to	O
active	O
zone	O
structures	O
described	O
using	O
electron	O
microscope	O
tomography	O
.	O
	
molecular	B-T080
serum	O
signature	O
of	O
treatment	O
resistant	O
depression	O
a	O
substantial	O
number	O
of	O
patients	O
suffering	O
from	O
major	O
depressive	O
disorder	O
mdd	O
do	O
not	O
respond	O
to	O
multiple	B-T081
trials	O
of	O
anti-depressants	O
,	O
develop	O
a	O
chronic	B-T079
course	O
of	O
disease	O
and	O
become	O
treatment	B-T061
resistant	O
.	O
	
most	O
of	O
the	O
studies	O
investigating	O
molecular	B-T080
changes	B-T169
in	O
treatment-resistant	O
depression	O
trd	O
have	O
only	O
examined	O
a	O
limited	O
number	O
of	O
molecules	O
and	O
genes	O
.	O
	
consequently	O
,	O
biomarkers	O
associated	O
with	O
trd	O
are	O
still	O
lacking	O
.	O
	
this	O
study	O
aimed	O
to	O
use	O
recently	O
advanced	O
high-throughput	O
proteomic	O
platforms	O
to	O
identify	O
peripheral	O
biomarkers	O
of	O
trd	O
defined	O
by	O
two	O
staging	O
models	O
,	O
the	O
thase	O
and	O
rush	O
staging	O
model	O
trm	O
and	O
the	O
maudsley	O
staging	O
model	O
msm	O
.	O
	
serum	O
collected	O
from	O
an	O
inpatient	O
cohort	O
of	O
65	O
individuals	O
suffering	O
from	O
mdd	O
was	O
analysed	O
using	O
two	O
different	O
mass	O
spectrometric-based	O
platforms	O
,	O
label-free	O
liquid	O
chromatography	O
mass	O
spectrometry	O
lc-ms	O
and	O
selective	B-T169
reaction	I-T169
monitoring	I-T169
srm	B-T169
,	O
as	O
well	O
as	O
a	O
multiplex	O
bead	O
based	O
assay	O
.	O
	
in	O
the	O
lc-ms	O
analysis	O
,	O
proteins	B-T116
involved	O
in	O
the	O
acute	O
phase	O
response	O
and	O
complement	O
activation	O
and	O
coagulation	O
were	O
significantly	O
different	O
between	O
the	O
staging	O
groups	O
in	O
both	O
models	O
.	O
	
in	O
the	O
multiplex	O
bead-based	O
assay	O
analysis	O
tnf-α	O
levels	O
log	B-T081
=	O
-4	O
,	O
p	O
=	O
0.045	O
were	O
significantly	B-T081
different	B-T080
in	O
the	O
trm	O
comparison	O
.	O
	
using	O
srm	B-T169
,	O
significant	B-T081
changes	B-T169
of	O
three	O
apolipoproteins	B-T116
a-i	I-T116
β	O
=	O
0.029	O
,	O
p	O
=	O
0.035	O
,	O
m	B-T116
β	O
=	O
-0	O
,	O
p	O
=	O
0.009	O
and	O
f	B-T116
β	O
=	O
-0	O
,	O
p	O
=	O
0.024	O
were	O
associated	O
with	O
the	O
trm	O
but	O
not	O
the	O
msm	O
.	O
	
overall	O
,	O
our	O
findings	B-T033
suggest	O
that	O
proteins	B-T116
,	O
which	O
are	O
involved	O
in	O
immune	O
and	O
complement	O
activation	O
,	O
may	O
represent	O
potential	O
biomarkers	O
that	O
could	O
be	O
used	O
by	O
clinicians	O
to	O
identify	O
high-risk	B-T033
patients	O
.	O
	
nevertheless	O
,	O
given	O
that	O
the	O
molecular	B-T080
changes	B-T169
between	O
the	O
staging	O
groups	O
were	O
subtle	O
,	O
the	O
results	O
need	O
to	O
be	O
interpreted	B-T169
benchmark	O
study	O
on	O
fine-mode	O
aerosol	O
in	O
a	O
big	O
urban	O
area	O
and	O
relevant	B-T081
doses	I-T081
deposited	B-T169
in	O
the	O
human	O
respiratory	O
tract	O
it	O
is	O
well-known	O
that	O
the	O
health	B-T078
effects	B-T080
of	O
pm	O
increase	O
as	O
particle	B-T081
size	I-T081
decreases	O
particularly	O
,	O
great	O
concern	O
has	O
risen	O
on	O
the	O
role	O
of	O
ultrafine	O
particles	O
ufps	O
.	O
	
starting	O
from	O
the	O
knowledge	O
that	O
the	O
main	O
fraction	B-T081
of	I-T081
atmospheric	O
aerosol	O
in	O
rome	O
is	O
characterized	O
by	O
significant	O
levels	B-T080
of	O
pm2.5	O
almost	O
75%	O
of	O
pm10	O
fraction	O
is	O
pm2.5	O
,	O
the	O
paper	O
is	O
focused	O
on	O
submicron	O
particles	O
in	O
such	O
great	O
urban	O
area	O
.	O
	
the	O
daytime	B-T079
/	O
nighttime	B-T079
,	O
work-	B-T079
/	O
weekdays	B-T079
and	O
cold	O
/	O
hot	O
seasonal	B-T079
trends	I-T079
of	O
submicron	O
particles	O
will	O
be	O
investigated	O
and	O
discussed	O
along	O
with	O
nox	O
and	O
total	O
pah	B-T109
drifts	O
demonstrating	O
the	O
primary	O
origin	O
of	O
ufps	O
from	O
combustion	O
processes	O
.	O
	
furthermore	O
,	O
moving	O
from	O
these	O
data	O
,	O
the	O
total	O
dose	B-T081
of	O
submicron	O
particles	O
deposited	B-T169
in	O
the	O
respiratory	O
system	O
i.e	O
,	O
head	O
,	O
tracheobronchial	O
and	O
alveolar	O
regions	O
in	O
different	O
lung	O
lobes	O
has	O
been	O
estimated	O
.	O
	
dosimeter	O
estimates	B-T081
were	O
performed	O
with	O
the	O
multiple-path	O
particle	O
dosimetry	O
model	O
mppd	O
v.2	O
.	O
	
the	O
paper	O
discusses	O
the	O
aerosol	O
doses	B-T081
deposited	B-T169
in	O
the	O
respiratory	O
system	O
of	O
individuals	O
exposed	B-T080
in	O
proximity	O
of	O
traffic	B-T033
.	O
	
during	O
traffic	B-T033
peak	O
hours	B-T079
,	O
about	O
6.6	O
10	O
particles	O
are	O
deposited	B-T169
into	O
the	O
respiratory	O
system	O
.	O
	
such	O
dose	B-T081
is	O
almost	O
entirely	O
made	O
of	O
ufps	O
.	O
	
according	O
to	O
the	O
greater	O
dose	B-T081
estimated	B-T081
,	O
right	O
lung	O
lobes	O
are	O
expected	O
to	O
be	O
more	O
susceptible	B-T169
to	O
respiratory	B-T169
pathologies	O
than	O
left	O
lobes	O
.	O
	
international	O
liver	O
transplant	O
society	O
practice	O
guidelines	O
diagnosis	B-T033
and	O
management	O
of	O
hepatopulmonary	B-T047
syndrome	I-T047
and	O
portopulmonary	B-T047
hypertension	I-T047
two	O
distinct	O
pulmonary	B-T047
vascular	I-T047
disorders	I-T047
,	O
hepatopulmonary	B-T047
syndrome	I-T047
hps	B-T047
and	O
portopulmonary	B-T047
hypertension	I-T047
poph	B-T047
may	O
occur	O
as	O
a	O
consequence	B-T169
of	I-T169
hepatic	O
parenchymal	O
or	O
vascular	B-T033
abnormalities	I-T033
.	O
	
hps	B-T047
and	O
poph	B-T047
have	O
major	O
clinical	B-T080
implications	B-T033
for	O
liver	B-T061
transplantation	I-T061
.	O
	
a	O
european	O
respiratory	O
society	O
task	O
force	O
on	O
pulmonary-hepatic	B-T047
disorders	I-T047
convened	O
in	O
2002	O
to	O
standardize	O
the	O
diagnosis	B-T033
and	O
guide	O
management	O
of	O
these	O
disorders	B-T047
.	O
	
these	O
international	O
liver	O
transplant	O
society	O
diagnostic	O
and	O
management	O
guidelines	O
are	O
based	O
on	O
that	O
task	O
force	O
consensus	O
and	O
should	O
continue	O
to	O
evolve	O
as	O
clinical	B-T080
experience	O
dictates	O
.	O
	
based	O
on	O
a	O
review	O
of	O
over	O
1000	O
published	O
hps	B-T047
and	O
poph	B-T047
articles	O
identified	O
via	O
a	O
medline	O
search	O
1985-2015	O
,	O
clinical	O
guidelines	O
were	O
based	O
on	O
,	O
selected	O
single	O
care	O
reports	O
,	O
small	B-T081
series	I-T081
,	O
registries	O
,	O
databases	O
,	O
and	O
expert	O
opinion	O
.	O
	
the	O
paucity	O
of	O
randomized	O
,	O
controlled	O
trials	O
in	O
either	O
of	O
these	O
disorders	B-T047
was	O
noted	O
.	O
	
guidelines	O
are	O
presented	O
in	O
5	O
parts	O
i	O
.	O
	
definitions	O
/	O
diagnostic	O
criteria	O
ii	O
.	O
	
hepatopulmonary	B-T047
syndrome	I-T047
iii	O
.	O
	
portopulmonary	B-T047
hypertension	I-T047
iv	O
.	O
	
implications	B-T033
for	O
liver	B-T061
transplantation	I-T061
and	O
v	O
.	O
	
suggestions	B-T078
for	O
future	O
clinical	O
research	O
.	O
	
uveitis	B-T047
in	O
children	O
the	O
review	O
provides	O
updates	O
on	O
novel	B-T080
risk	B-T080
markers	I-T080
for	O
the	O
development	B-T169
of	O
pediatric	B-T080
inflammatory	B-T047
uveitis	I-T047
and	O
a	O
severe	O
disease	O
course	O
,	O
on	O
treatment	B-T061
of	O
refractory	B-T033
disease	I-T033
,	O
and	O
on	O
the	O
measurement	B-T169
of	O
visual	B-T169
outcomes	I-T169
.	O
	
there	O
are	O
several	O
new	O
genetic	O
markers	O
,	O
biomarkers	O
,	O
and	O
clinical	B-T080
factors	B-T169
that	O
may	O
influence	O
a	O
child's	O
uveitis	B-T047
disease	O
course	O
.	O
	
it	O
is	O
important	O
to	O
identify	O
children	O
at	O
risk	B-T078
for	O
poor	B-T169
visual	I-T169
outcomes	I-T169
and	O
who	O
are	O
refractory	B-T169
to	O
traditional	B-T061
therapy	I-T061
.	O
	
racial	B-T033
disparities	I-T033
have	O
recently	O
been	O
reported	O
.	O
	
we	O
describe	O
agents	O
of	O
potential	B-T081
benefit	I-T081
.	O
	
in	O
addition	O
,	O
we	O
discuss	O
the	O
importance	O
of	O
patient	O
reported	O
outcomes	O
in	O
this	O
population	O
.	O
	
uveitis	B-T047
can	O
lead	O
to	O
vision-threatening	O
complications	O
.	O
	
timely	B-T061
and	I-T061
aggressive	I-T061
treatment	I-T061
of	O
children	O
identified	O
to	O
be	O
at	O
risk	B-T078
for	O
a	O
severe	O
uveitis	O
course	O
may	O
lead	O
to	O
improved	B-T169
outcomes	I-T169
.	O
	
utility	B-T169
of	O
a	O
mhealth	O
app	O
for	O
self-management	O
and	O
education	O
of	O
cardiac	B-T047
diseases	I-T047
in	O
spanish	O
urban	O
and	O
rural	O
areas	O
analyze	O
the	O
utility	B-T169
of	O
a	O
mobile	O
health	O
app	O
named	O
heartkeeper	O
in	O
several	O
groups	O
of	O
population	O
and	O
obtain	B-T169
conclusions	B-T078
to	O
be	O
applied	B-T169
to	O
other	O
similar	O
apps	O
.	O
	
a	O
questionnaire	O
has	O
been	O
designed	O
to	O
evaluate	O
the	O
usage	B-T169
and	O
utility	B-T169
of	O
the	O
heartkeeper	O
app	O
.	O
	
the	O
questionnaire	O
information	B-T078
was	O
collected	B-T169
by	O
collaborating	O
cardiologists	O
from	O
32	O
patients	O
before	O
and	O
after	O
they	O
used	B-T169
the	O
app	O
.	O
	
patients	O
were	O
randomly	O
selected	O
with	O
established	O
quotas	O
within	O
interest	O
groups	O
,	O
so	O
that	O
men	O
and	O
women	O
,	O
patients	O
older	O
or	O
younger	B-T079
than	O
60	O
years	B-T079
old	I-T079
and	O
patients	O
living	O
in	O
urban	O
or	O
rural	O
areas	O
were	O
equally	O
represented	O
.	O
	
using	O
the	O
appropriate	O
statistical	O
techniques	O
we	O
see	O
that	O
the	O
heartkeeper	O
app	O
was	O
useful	O
for	O
patients	O
as	O
they	O
qualify	B-T080
with	O
70	O
points	O
out	O
of	O
100	O
the	O
overall	B-T033
opinion	I-T033
of	O
the	O
app	O
,	O
it	O
helps	O
them	O
remember	O
more	O
easily	O
taking	O
their	O
pills	O
with	O
a	O
mean	O
improvement	O
of	O
20.94	O
points	O
p	O
<	O
0.001	O
and	O
they	O
perceive	O
a	O
global	O
improvement	O
of	O
their	O
health	O
8.28	O
points	O
,	O
p	O
<	O
0.001	O
.	O
	
we	O
also	O
observe	B-T169
that	O
these	O
improvements	O
do	O
not	O
depend	O
,	O
in	O
general	O
,	O
on	O
the	O
area	O
urban	O
or	O
rural	O
where	O
the	O
patient	O
comes	O
from	O
or	O
on	O
their	O
sex	O
.	O
	
although	O
older	O
patients	O
needed	B-T080
more	O
help	O
to	O
use	B-T169
the	O
app	O
and	O
used	B-T169
it	O
slightly	O
less	B-T079
frequently	I-T079
,	O
the	O
improvements	O
on	O
several	B-T081
measures	I-T081
considered	O
,	O
such	O
as	O
remembering	O
taking	O
pills	O
,	O
breathing	O
problems	O
or	O
trouble	O
developing	O
activities	O
,	O
depend	O
significantly	O
p	O
<	O
0.05	O
on	O
age	O
with	O
older	O
patients	O
reporting	O
higher	B-T080
improvements	O
than	O
younger	O
ones	O
.	O
	
the	O
results	B-T169
obtained	O
with	O
the	O
sample	B-T081
of	O
patients	O
considered	O
in	O
this	O
research	O
prove	O
the	O
utility	B-T169
of	O
the	O
heartkeeper	O
app	O
.	O
	
this	O
utility	B-T169
is	O
similar	O
in	O
urban	O
and	O
rural	O
areas	O
and	O
for	O
patients	O
of	O
both	O
sexes	O
and	O
,	O
to	B-T080
some	I-T080
extent	I-T080
,	O
depends	O
on	O
the	O
age	O
of	O
the	O
patient	O
with	O
older	O
patients	O
reporting	O
slightly	B-T079
lower	I-T079
frequency	I-T079
of	O
use	B-T169
but	O
higher	B-T080
health	O
improvements	O
than	O
younger	O
ones	O
.	O
	
a	O
holistic	B-T078
approach	I-T078
to	O
age	O
estimation	O
in	O
refugee	O
children	O
many	O
refugee	O
children	O
arriving	O
in	O
australia	O
have	O
an	O
inaccurately	B-T080
documented	O
date	O
of	O
birth	O
dob	O
.	O
	
a	O
medical	O
assessment	O
of	O
a	O
child's	O
age	O
is	O
often	O
requested	O
when	O
there	O
is	O
a	O
concern	B-T078
that	O
their	O
documented	O
dob	O
is	O
incorrect	B-T080
.	O
	
this	O
study's	O
aim	O
was	O
to	O
assess	O
the	O
accuracy	B-T080
a	O
holistic	O
age	O
assessment	O
tool	O
aat	O
in	O
estimating	O
the	O
age	O
of	O
refugee	O
children	O
newly	O
settled	O
in	O
australia	O
.	O
	
a	O
holistic	O
aat	O
that	O
combines	O
medical	O
and	O
non-medical	B-T078
approaches	I-T078
was	O
used	O
to	O
estimate	O
the	O
ages	O
of	O
60	O
refugee	O
children	O
with	O
a	O
known	O
dob	O
.	O
	
the	O
tool	O
used	O
four	O
components	O
to	O
assess	O
age	O
an	O
oral	O
narrative	O
,	O
developmental	B-T080
assessment	O
,	O
anthropometric	O
measures	O
and	O
pubertal	B-T033
assessment	O
.	O
	
assessors	O
were	O
blinded	O
to	O
the	O
true	B-T080
age	O
of	O
the	O
child	O
.	O
	
correlation	B-T081
coefficients	I-T081
for	O
the	O
actual	B-T080
and	O
estimated	O
age	O
were	O
calculated	O
for	O
the	O
tool	O
overall	O
and	O
individual	O
components	O
.	O
	
the	O
correlation	B-T081
coefficient	I-T081
between	O
the	O
actual	B-T080
and	O
estimated	O
age	O
from	O
the	O
aat	O
was	O
very	O
strong	O
at	O
0.9802	O
boys	O
0.9748	O
,	O
girls	O
0.9876	O
.	O
	
the	O
oral	O
narrative	O
component	O
of	O
the	O
tool	O
performed	O
best	O
r	O
=	O
0.9603	O
.	O
	
overall	O
,	O
86.7	O
of	O
age	O
estimates	O
were	O
within	O
1	O
year	B-T079
of	O
the	O
true	B-T080
age	O
.	O
	
the	O
range	O
of	O
differences	O
was	O
-1	O
to	O
3.92	O
years	B-T079
with	O
a	O
standard	B-T081
deviation	I-T081
of	O
0.77	O
years	B-T079
9.24	O
months	B-T079
.	O
	
the	O
aat	O
is	O
a	O
holistic	B-T078
,	O
simple	B-T080
and	O
safe	O
instrument	O
that	O
can	O
be	O
used	O
to	O
estimate	O
age	O
in	O
refugee	O
children	O
with	O
results	O
comparable	O
with	O
radiological	O
methods	O
caged-opossum	O
motif	O
enrichment	O
analysis	O
from	O
cage	O
-derived	O
tsss	O
with	O
the	O
emergence	O
of	O
large-scale	O
cap	O
analysis	O
of	O
gene	O
expression	O
cage	O
datasets	O
from	O
individual	O
labs	O
and	O
the	O
fantom	O
consortium	O
,	O
one	O
can	O
now	O
analyze	O
the	O
cis-regulatory	O
regions	O
associated	O
with	O
gene	O
transcription	O
at	O
an	O
unprecedented	B-T080
level	I-T080
of	I-T080
refinement	I-T080
.	O
	
by	O
coupling	O
transcription	O
factor	O
binding	O
site	O
tfbs	O
enrichment	O
analysis	O
with	O
cage	O
-derived	O
genomic	O
regions	O
,	O
caged-opossum	O
can	O
identify	B-T080
tfs	B-T116
that	O
act	O
as	O
key	O
regulators	O
of	O
genes	O
involved	O
in	O
specific	B-T080
mammalian	O
cell	O
and	O
tissue	O
types	O
.	O
	
the	O
webtool	O
allows	O
for	O
the	O
analysis	O
of	O
cage	O
-derived	O
transcription	O
start	O
sites	O
tsss	O
either	O
provided	O
by	O
the	O
user	O
or	O
selected	O
from	O
1300	O
mammalian	O
samples	O
from	O
the	O
fantom5	O
project	O
with	O
pre-computed	O
tfbs	O
predicted	O
with	O
jaspar	O
tf	O
binding	O
profiles	O
.	O
	
the	O
tool	O
helps	O
power	O
insights	O
into	O
the	O
regulation	O
of	O
genes	O
through	O
the	O
study	O
of	O
the	O
specific	B-T080
usage	B-T169
of	O
tsss	O
within	O
specific	B-T080
cell	O
types	O
and/or	O
under	O
specific	B-T080
conditions	I-T080
.	O
	
the	O
caged-oposum	O
web	O
tool	O
is	O
implemented	O
in	O
perl	O
,	O
mysql	O
and	O
apache	O
and	O
is	O
available	O
at	O
http	O
contacts	O
anthony.mathelier	O
or	O
wyeth	O
supplementary	O
information	O
supplementary	O
data	O
are	O
available	O
at	O
bioinformatics	O
online	O
.	O
	
self-assembled	O
polymeric	O
vectors	O
mixtures	O
characterization	O
of	O
the	O
polymorphism	B-T080
and	O
existence	O
of	O
synergistic	B-T080
effects	B-T080
in	O
photodynamic	B-T061
therapy	I-T061
the	O
objective	O
of	O
this	O
work	O
was	O
to	O
assess	O
the	O
relation	O
between	O
the	O
purity	B-T081
of	O
polymeric	O
self-assemblies	O
vectors	O
solution	O
and	O
their	O
photodynamic	B-T061
therapeutic	I-T061
efficiency	B-T081
.	O
	
for	O
this	O
,	O
several	O
amphiphilic	O
block	O
copolymers	O
of	O
poly	B-T109
have	O
been	O
used	O
to	O
form	O
self-assemblies	O
with	O
different	O
morphologies	B-T080
micelles	B-T109
,	O
worm-like	B-T109
micelles	I-T109
or	O
vesicles	B-T080
.	O
	
in	O
a	O
first	O
step	O
,	O
controlled	O
mixtures	O
of	O
preformed	O
micelles	B-T109
and	O
vesicles	B-T080
have	O
been	O
characterized	O
both	O
by	O
dynamic	O
light	O
scattering	O
and	O
asymmetrical	O
flow	O
field	O
flow	O
fractionation	O
asflfff	O
.	O
	
for	O
this	O
,	O
a	O
custom-made	O
program	O
,	O
storms	O
,	O
was	O
developed	O
to	O
analyze	O
dls	O
data	B-T078
in	O
a	O
thorough	O
manner	O
by	O
providing	O
a	O
large	O
set	O
of	O
fitting	O
parameters	O
.	O
	
this	O
showed	O
that	O
dls	O
only	O
sensed	O
the	O
larger	B-T081
vesicles	B-T080
when	O
the	O
micelles	B-T109
/	O
vesicles	B-T080
ratio	B-T081
was	O
80/20	O
w/w	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
asflfff	O
allowed	O
clear	O
detection	B-T033
of	O
the	O
presence	O
of	O
micelles	B-T109
when	O
this	O
same	O
ratio	B-T081
was	O
as	O
low	O
as	O
10/90	O
.	O
	
subsequently	O
,	O
the	O
photodynamic	B-T061
therapy	I-T061
efficiency	B-T081
of	O
various	O
controlled	O
mixtures	O
was	O
assessed	O
using	O
multicellular	O
spheroids	B-T033
when	O
a	O
photosensitizer	O
,	O
pheophorbide	B-T109
a	I-T109
,	O
was	O
encapsulated	B-T080
in	O
the	O
polymer	O
self-assemblies	O
.	O
	
some	O
mixtures	O
were	O
shown	O
to	O
be	O
as	O
efficient	B-T080
as	O
monomorphous	B-T033
systems	I-T033
.	O
	
in	O
some	O
cases	O
,	O
mixtures	O
were	O
found	O
to	O
exhibit	O
a	O
higher	O
pdt	B-T061
efficiency	B-T081
compared	O
to	O
the	O
individual	O
nano	B-T081
-	O
objects	O
,	O
revealing	O
a	O
synergistic	B-T080
effect	B-T080
for	O
the	O
efficient	O
delivery	O
of	O
the	O
photosensitizer	O
.	O
	
polymorphous	B-T080
vectors	O
can	O
therefore	O
be	O
superior	O
in	O
therapeutic	B-T169
applications	I-T169
.	O
	
fuzheng	O
qingjie	O
granules	O
inhibit	O
growth	O
of	O
hepatoma	O
cells	O
via	O
inducing	B-T169
mitochondria	O
-mediated	O
apoptosis	O
and	O
enhancing	O
immune	O
function	O
fuzheng	O
qingjie	O
fzqj	O
granules	O
,	O
a	O
compound	O
chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	B-T061
therapy	I-T061
for	O
alimentary	O
tract	O
cancers	O
.	O
	
however	O
,	O
the	O
underlying	O
anticancer	B-T033
mechanisms	B-T169
are	O
still	O
not	O
well	O
understood	O
.	O
	
in	O
the	O
present	B-T079
study	O
,	O
hepg2	O
cells	O
were	O
treated	B-T169
with	O
fzqj	O
-	O
containing	O
serum	O
.	O
	
cell	O
proliferation	O
was	O
evaluated	O
using	O
mtt	O
assay	O
.	O
	
apoptosis	O
was	O
analyzed	O
using	O
a	O
flow	O
cytometer	O
.	O
	
cell	O
ultrastructure	O
was	O
observed	B-T169
under	O
a	O
transmission	O
electron	O
microscope	O
.	O
	
the	O
mitochondrial	O
membrane	O
potential	O
δψ	O
was	O
examined	B-T033
with	O
jc-1	O
dye	O
.	O
	
in	O
h22	O
tumor-bearing	O
mice	O
,	O
cd4	O
t	O
cells	O
,	O
cd8	O
t	O
cells	O
,	O
cd3	O
t	O
cells	O
,	O
and	O
natural	O
killer	O
cells	O
nk	O
in	O
peripheral	O
blood	O
were	O
evaluated	O
cytometrically	O
.	O
	
interleukin	B-T116
il	I-T116
and	O
tumor	B-T116
necrosis	I-T116
factor	I-T116
tnf	B-T116
levels	B-T080
were	O
measured	B-T080
using	O
radioimmunoassay	O
the	O
mrna	O
levels	B-T080
of	O
bax	O
and	O
bcl-2	O
were	O
examined	B-T033
by	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
.	O
	
the	O
protein	B-T116
levels	B-T080
of	O
bax	B-T116
,	O
bcl-2	B-T116
,	O
cytochrome	B-T116
c	I-T116
,	O
caspase	B-T116
3	I-T116
and	O
9	B-T116
,	O
parp	B-T116
,	O
and	O
cd69	B-T116
were	O
examined	B-T033
by	O
western	O
blotting	O
.	O
	
the	O
apoptotic	B-T080
cells	O
in	O
tissues	O
were	O
observed	B-T169
using	O
tunel	O
method	O
.	O
	
alanine	B-T116
transaminase	I-T116
alt	B-T116
,	O
aspartate	B-T116
transaminase	I-T116
ast	B-T116
,	O
blood	O
urea	O
nitrogen	O
bun	O
,	O
and	O
creatinine	B-T109
cre	B-T109
were	O
detected	B-T033
by	O
an	O
automatic	B-T169
biochemical	B-T169
analyzer	O
.	O
	
the	O
results	B-T169
showed	O
that	O
fzqj	O
-	O
containing	O
serum	O
remarkably	O
inhibited	O
proliferation	O
of	O
hepg2	O
cells	O
in	O
dose	B-T081
-	O
and	O
time	B-T079
-	O
dependent	B-T080
manners	O
,	O
induced	B-T169
hepg2	O
cell	O
apoptosis	O
and	O
caused	O
a	O
decrease	B-T081
of	O
δψ	O
.	O
	
analysis	O
of	O
tumor	O
tissue	O
showed	O
that	O
fzqj	O
-	O
induced	B-T169
apoptosis	O
was	O
accompanied	O
by	O
downregulation	O
of	O
bcl-2	B-T116
and	O
upregulation	O
of	O
bax	B-T116
,	O
release	B-T169
of	O
cytochrome	B-T116
c	I-T116
,	O
activation	O
of	O
caspase	B-T116
3	I-T116
and	O
9	B-T116
,	O
and	O
cleavage	O
of	O
parp	B-T116
.	O
	
in	O
addition	O
,	O
fzqj	O
increased	B-T081
the	O
percentages	B-T081
of	O
cd4	O
t	O
and	O
nk	O
cells	O
,	O
the	O
ratio	B-T081
of	O
cd4	O
/	O
cd8	O
t	O
cells	O
as	O
well	O
as	O
the	O
levels	B-T080
of	O
serum	O
tnf-α	B-T116
.	O
	
fzqj	O
also	O
increased	B-T081
cd69	B-T116
expression	O
in	O
tumor	O
tissue	O
.	O
	
no	B-T033
hepatorenal	I-T033
toxicity	I-T033
was	O
observed	B-T169
in	O
h22	O
tumor-bearing	O
mice	O
.	O
	
these	O
results	B-T169
indicated	B-T033
that	O
fzqj	O
could	O
inhibit	O
the	O
growth	O
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	O
function	O
and	O
inducing	B-T169
mitochondria	O
mediated	O
professional	O
reinventions	O
swedish	O
psychologists	O
,	O
1990-2010	O
since	O
the	O
early	O
20th	B-T079
century	I-T079
,	O
the	O
swedish	O
psychology	O
profession	O
has	O
undergone	O
several	O
changes	B-T169
in	O
its	O
essential	O
tasks	O
,	O
epistemological	O
foundations	O
,	O
and	O
social	O
roles	O
.	O
	
these	O
changes	B-T169
occurred	O
through	O
an	O
ongoing	O
"""tuning"""	O
with	O
swedish	O
society	O
,	O
in	O
which	O
the	O
profession	O
strove	O
to	O
appear	O
relevant	O
to	O
society's	O
concerns	B-T078
and	O
problems	B-T033
as	O
well	O
as	O
enroll	O
others	O
to	O
share	O
the	O
profession's	O
goals	O
and	O
aims	B-T078
.	O
	
studying	O
the	O
history	B-T169
of	O
the	O
profession	O
can	O
thus	O
shed	O
light	O
on	O
the	O
changing	B-T169
definitions	O
and	O
contours	O
of	O
the	O
psychology	O
profession	O
itself	O
as	O
well	O
as	O
on	O
the	O
organization	B-T169
of	O
the	O
society	O
in	O
which	O
it	O
acts	O
.	O
	
this	O
article	O
examines	O
the	O
history	B-T169
of	O
the	O
swedish	O
psychology	O
profession	O
from	O
1990	O
to	O
2010	O
,	O
through	O
an	O
analysis	O
of	O
the	O
discussions	O
and	O
debates	O
taking	O
place	O
in	O
the	O
swedish	O
psychological	O
association's	O
journal	O
.	O
	
the	O
analytical	O
framework	O
used	O
draws	O
on	O
work	O
done	O
within	O
actor-network	O
theory	O
and	O
science	O
studies	O
.	O
	
we	O
argue	O
that	O
the	O
profession's	O
institutional	B-T080
connections	I-T080
,	O
defining	O
tasks	O
,	O
epistemological	O
underpinnings	B-T078
,	O
and	O
social	O
position	O
have	O
changed	B-T169
in	O
major	O
ways	O
during	O
these	O
2	O
decades	B-T081
.	O
	
overall	O
,	O
as	O
a	O
result	O
of	O
an	O
increasingly	O
felt	O
insecurity	O
,	O
the	O
profession	O
has	O
turned	O
outward	O
and	O
tried	O
to	O
find	O
new	O
ways	O
to	O
legitimize	B-T169
itself	O
to	O
politicians	O
,	O
the	O
media	O
,	O
patients	O
,	O
and	O
customers	O
through	O
means	O
such	O
as	O
a	O
more	O
economized	B-T169
vocabulary	O
and	O
novel	B-T080
forms	O
of	O
empirical	O
research	O
.	O
	
these	O
changes	B-T169
have	O
led	O
to	O
a	O
more	O
socialized	O
profession	O
,	O
now	O
more	O
closely	O
tuned	O
to	O
other	O
actors	O
in	O
swedish	O
society	O
,	O
leading	O
to	O
conflicts	B-T080
within	O
the	O
profession	O
over	O
whether	O
this	O
is	O
an	O
opportunity	O
to	O
better	O
control	B-T080
their	O
own	O
destiny	O
or	O
if	O
it	O
will	O
lead	O
to	O
a	O
loss	B-T033
of	I-T033
autonomy	I-T033
.	O
	
psycinfo	O
database	O
record	O
personally	O
meaningful	O
rituals	O
a	O
way	O
to	O
increase	B-T169
compassion	O
and	O
decrease	B-T081
burnout	B-T033
among	O
hospice	O
staff	O
and	O
volunteers	O
rituals	O
can	O
increase	B-T169
a	O
sense	O
of	O
connectedness	O
,	O
meaning	B-T078
,	O
and	O
support	O
,	O
especially	O
after	O
the	O
death	O
of	O
those	O
for	O
whom	O
we	O
care	O
.	O
	
hospice	O
staff	O
may	O
benefit	O
from	O
the	O
use	O
of	O
personal	O
rituals	O
as	O
they	O
cope	O
with	O
the	O
frequent	B-T081
deaths	I-T081
of	O
their	O
patients	O
,	O
ultimately	O
aiming	O
to	O
provide	O
compassionate	O
care	O
while	O
minimizing	O
burnout	B-T033
.	O
	
this	O
study	O
investigated	O
the	O
role	O
of	O
personally	O
meaningful	O
rituals	O
in	O
increasing	B-T169
compassion	O
and	O
decreasing	B-T080
burnout	B-T033
among	O
hospice	O
staff	O
and	O
volunteers	O
.	O
	
an	O
online	O
survey	O
was	O
completed	O
by	O
members	O
of	O
the	O
national	O
hospice	O
and	O
palliative	O
care	O
organization	O
nhpco	O
which	O
inquired	O
about	O
personal	O
ritual	O
practices	O
,	O
and	O
included	O
the	O
professional	O
quality	O
of	O
life	O
proqol	O
scale	O
to	O
measure	O
current	O
levels	O
of	O
compassion	O
satisfaction	O
,	O
burnout	O
,	O
and	O
secondary	O
traumatic	O
stress	O
.	O
	
three	O
hundred	O
ninety	O
hospice	O
staff	O
and	O
volunteers	O
from	O
across	O
38	O
states	O
completed	O
the	O
online	O
survey	O
.	O
	
the	O
majority	O
of	O
participants	O
were	O
caucasian	O
and	O
female	O
,	O
with	O
an	O
average	O
of	O
nine	O
years	O
of	O
experience	O
in	O
hospice	O
and	O
palliative	O
care	O
.	O
	
the	O
majority	O
of	O
hospice	O
staff	O
and	O
volunteers	O
used	O
personally	O
meaningful	O
rituals	O
after	O
the	O
death	O
of	O
their	O
patients	O
to	O
help	O
them	O
cope	O
71%	O
.	O
	
those	O
who	O
used	O
rituals	O
demonstrated	O
significantly	O
higher	O
compassion	O
satisfaction	O
and	O
significantly	O
lower	O
burnout	O
as	O
measured	O
by	O
the	O
proqol	O
,	O
with	O
professional	O
support	O
,	O
social	O
support	O
,	O
and	O
age	O
playing	O
significant	O
roles	O
as	O
well	O
.	O
	
rituals	O
may	O
be	O
an	O
important	O
way	O
to	O
increase	O
compassion	O
and	O
decrease	O
burnout	O
among	O
hospice	O
staff	O
and	O
volunteers	O
.	O
	
organizations	O
may	O
benefit	O
from	O
providing	O
training	O
and	O
support	O
for	O
personalized	O
rituals	O
among	O
team	O
members	O
,	O
especially	O
new	O
staff	O
who	O
may	O
be	O
at	O
greater	O
risk	O
for	O
burnout	B-T033
activation	O
of	O
the	O
orphan	B-T116
receptor	I-T116
gpr55	I-T116
by	O
lysophosphatidylinositol	B-T109
promotes	O
metastasis	O
in	O
triple-negative	O
breast	O
cancer	O
the	O
orphan	B-T116
g	I-T116
protein-coupled	I-T116
receptor	I-T116
gpr55	B-T116
has	O
been	O
directly	B-T080
or	O
indirectly	B-T080
related	B-T080
to	O
basic	O
alterations	B-T078
that	O
drive	O
malignant	B-T080
growth	O
uncontrolled	B-T080
cancer	O
cell	O
proliferation	O
,	O
sustained	O
angiogenesis	O
,	O
and	O
cancer	O
cell	O
adhesion	O
and	O
migration	O
.	O
	
however	O
,	O
little	B-T081
is	O
known	B-T080
about	O
the	O
involvement	B-T169
of	O
this	O
receptor	B-T116
in	O
metastasis	O
.	O
	
here	O
,	O
we	O
show	O
that	O
elevated	B-T080
gpr55	O
expression	O
in	O
human	O
tumors	O
is	O
associated	B-T080
with	I-T080
the	O
aggressive	O
basal	O
/	O
triple-negative	O
breast	O
cancer	O
population	O
,	O
higher	B-T081
probability	I-T081
to	O
develop	O
metastases	O
,	O
and	O
therefore	O
poor	B-T080
patient	O
prognosis	O
.	O
	
activation	O
of	O
gpr55	B-T116
by	O
its	O
proposed	O
endogenous	B-T169
ligand	O
lysophosphatidylinositol	B-T109
confers	O
pro-invasive	B-T080
features	B-T080
on	O
breast	O
cancer	O
cells	O
both	O
in	B-T080
vitro	I-T080
and	O
in	O
vivo	O
.	O
	
specifically	O
,	O
this	O
effect	B-T080
is	O
elicited	B-T080
by	I-T080
coupling	B-T169
to	O
gq/11	B-T116
heterotrimeric	I-T116
proteins	I-T116
and	O
the	O
subsequent	B-T079
activation	O
,	O
through	O
erk	B-T116
,	O
of	O
the	O
transcription	B-T116
factor	I-T116
etv4	I-T116
/	O
pea3	B-T116
.	O
	
together	B-T080
,	O
these	O
data	B-T078
show	O
that	O
gpr55	B-T116
promotes	O
breast	O
cancer	O
metastasis	O
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	B-T116
receptor	I-T116
may	O
constitute	O
a	O
new	B-T080
therapeutic	B-T169
target	B-T169
and	O
potential	B-T080
biomarker	O
in	O
the	O
highly	O
aggressive	O
triple-negative	O
subtype	O
.	O
	
effect	B-T080
of	O
ultrasonic	B-T169
processing	O
on	O
the	O
changes	O
in	O
activity	O
,	O
aggregation	B-T169
and	O
the	O
secondary	O
and	O
tertiary	O
structure	O
of	O
polyphenol	B-T116
oxidase	I-T116
in	O
oriental	O
sweet	O
melon	O
cucumis	O
melo	O
var	O
.	O
	
makuwa	O
makino	O
polyphenol	B-T116
oxidase	I-T116
ppo	B-T116
mainly	O
contributes	O
to	O
the	O
browning	O
reaction	O
of	O
fruits	O
and	O
vegetables	O
and	O
causes	O
serious	B-T080
damage	B-T169
to	O
the	O
quality	B-T080
of	O
sweet	O
melon	O
products	O
.	O
	
however	O
,	O
traditional	B-T169
methods	B-T169
to	O
inactivate	B-T169
browning	O
may	O
induce	B-T169
more	O
unexpected	O
risks	B-T078
than	O
ultrasonic	B-T169
processing	O
.	O
	
meanwhile	O
,	O
there	O
are	O
no	O
reports	O
on	O
the	O
effect	B-T080
of	O
ultrasound	O
on	O
ppo	B-T116
directly	O
purified	B-T169
from	O
sweet	O
melon	O
.	O
	
the	O
ppo	B-T116
in	O
the	O
original	B-T078
juice	O
was	O
less	O
inactivated	B-T169
than	O
the	O
purified	B-T169
form	O
when	O
treated	B-T061
with	I-T061
ultrasound	O
.	O
	
as	O
for	O
purified	B-T169
ppo	B-T116
,	O
superior	O
to	O
thermal	B-T061
treatment	I-T061
,	O
less	O
heat	O
was	O
needed	O
to	O
inactivate	B-T169
the	O
ppo	B-T116
with	O
ultrasonic	B-T169
treatment	B-T061
.	O
	
at	O
intensity	B-T033
lower	I-T033
than	O
200	O
w	O
,	O
ultrasound	O
did	O
not	O
significantly	B-T078
affect	O
the	O
structure	O
and	O
activity	B-T078
of	O
ppo	B-T116
p	O
>	O
0.05	O
,	O
and	O
latent	B-T080
ppo	B-T116
was	O
activated	O
.	O
	
at	O
intensity	B-T033
higher	I-T033
than	O
200	O
w	O
,	O
ultrasound	O
inactivated	B-T169
ppo	B-T116
,	O
induced	B-T169
aggregation	B-T169
and	O
dissociation	O
of	O
ppo	B-T116
particles	O
and	O
significantly	B-T081
decreased	I-T081
the	O
α-helix	O
structure	O
content	O
.	O
	
low-frequency	B-T079
high-intensity	O
ultrasound	O
caused	O
an	O
inactivation	B-T169
effect	B-T080
and	O
conformational	O
changes	O
of	O
purified	B-T169
ppo	B-T116
from	O
oriental	O
sweet	O
melons	O
.	O
	
changes	B-T169
in	O
the	O
ppo	B-T116
structure	O
induced	B-T169
by	O
ultrasound	O
eventually	O
inactivated	B-T169
the	O
enzyme	B-T116
.	O
	
ultrasound	O
may	O
be	O
a	O
potential	B-T080
method	B-T169
to	O
inactivate	B-T169
ppo	B-T116
in	O
oriental	O
sweet	O
melons	O
.	O
	
phylogeography	O
of	O
the	O
spanish	O
moon	O
moth	O
graellsia	O
isabellae	O
lepidoptera	O
,	O
saturniidae	O
geographic	O
and	O
demographic	B-T078
factors	I-T078
as	O
well	O
as	O
specialisation	O
to	O
a	O
new	O
host-plant	O
may	O
lead	O
to	O
host	O
-	O
associated	B-T080
differentiation	B-T169
in	O
plant	O
-feeding	O
insects	O
.	O
	
we	O
explored	O
the	O
phylogeography	O
of	O
a	O
protected	B-T169
moth	O
,	O
graellsia	O
isabellae	O
,	O
and	O
its	O
two	O
recognised	O
host-plant	O
species	O
pinus	O
sylvestris	O
and	O
p	O
.	O
	
nigra	O
in	O
order	O
to	O
seek	O
for	O
any	O
concordance	O
useful	O
to	O
disentangle	O
the	O
evolutionary	B-T169
history	I-T169
of	O
this	O
iconic	O
lepidopteran	O
.	O
	
dna	O
variation	O
in	O
one	O
mitochondrial	O
marker	O
and	O
nine	O
nuclear	O
microsatellite	O
loci	O
revealed	O
a	O
strong	O
phylogeographic	B-T033
pattern	I-T033
across	O
28	O
populations	O
of	O
g	O
.	O
	
isabellae	O
studied	O
in	O
spain	O
and	O
france	O
comprising	O
six	O
groups	B-T078
mostly	O
distributed	B-T169
along	O
different	B-T080
mountain	O
ranges	O
.	O
	
reanalysis	O
of	O
a	O
previously	O
published	O
chloroplast	O
microsatellite	O
dataset	O
revealed	B-T080
a	O
three	O
and	O
two-	O
group	O
structure	O
for	O
spanish	O
p	O
.	O
	
sylvestris	O
and	O
p	O
.	O
	
nigra	O
,	O
respectively	O
.	O
	
overall	O
,	O
the	O
population	O
groupings	O
of	O
this	O
protected	B-T169
moth	O
did	O
not	O
match	B-T080
the	O
ones	O
of	O
p	O
.	O
	
sylvestris	O
and	O
p	O
.	O
	
nigra	O
.	O
	
there	O
was	O
no	B-T080
evidence	I-T080
of	I-T080
host	O
-	O
associated	B-T080
differentiation	B-T169
between	O
populations	O
using	O
p	O
.	O
	
sylvestris	O
and	O
the	O
ones	O
inhabiting	B-T169
p	O
.	O
	
nigra	O
.	O
	
the	O
two	O
major	B-T080
mitochondrial	O
clades	B-T078
of	O
g	O
.	O
	
isabellae	O
likely	O
diverged	O
before	O
the	O
last	B-T079
glacial	I-T079
maximum	I-T079
and	O
geographically	O
separated	B-T080
the	O
species	O
into	O
a	O
""""	O
southern	O
""""	O
central	B-T081
and	I-T081
southern	I-T081
iberian	I-T081
clusters	I-T081
and	O
a	O
""""	O
northern	O
""""	O
lineage	O
eastern	B-T081
iberian	I-T081
,	O
pyrenean	B-T081
and	O
french	B-T081
alpine	I-T081
clusters	I-T081
.	O
	
the	O
eastern	B-T081
iberian	I-T081
system	I-T081
,	O
where	O
this	O
insect	O
uses	O
both	O
host-plants	O
,	O
harboured	O
the	O
highest	B-T080
level	B-T080
of	O
genetic	B-T169
diversity	B-T080
.	O
	
such	O
a	O
group	B-T078
independently	O
colonised	B-T033
the	O
west	O
and	O
east	O
parts	O
of	O
the	O
pyrenees	O
.	O
	
our	O
results	O
point	O
to	O
a	O
native	B-T169
origin	B-T079
for	O
the	O
french	B-T081
populations	I-T081
occurring	B-T079
in	O
the	O
alps	O
,	O
genetically	B-T169
related	O
to	O
the	O
eastern	O
iberian	O
and	O
pyrenean	O
sites	O
.	O
	
the	O
central	B-T078
iberian	I-T078
group	I-T078
derived	O
from	O
southern	O
iberian	O
ancestors	O
.	O
	
secondary	B-T081
contacts	B-T080
were	O
inferred	O
between	O
the	O
southern/central	B-T081
iberian	I-T081
populations	I-T081
and	O
eastern	B-T081
iberian	I-T081
cluster	I-T081
as	O
well	O
as	O
between	O
the	O
two	O
pyrenean	B-T081
ones	I-T081
.	O
	
the	O
mito-nuclear	B-T081
discordance	I-T081
observed	O
with	O
regard	O
to	O
the	O
eastern	B-T081
iberian	I-T081
cluster	I-T081
is	O
congruent	B-T080
with	O
a	O
secondary	B-T081
contact	B-T080
after	O
the	O
evolution	O
of	O
mito-nuclear	B-T080
incompatibilities	I-T080
in	O
geographically	O
isolated	O
areas	O
.	O
	
prevalence	B-T081
of	O
physical	O
activity	O
and	O
sitting	O
time	B-T079
among	O
south	O
korean	O
adolescents	O
results	B-T033
from	O
the	O
korean	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
,	O
2013	O
this	O
study	O
aimed	O
to	O
describe	O
physical	O
activity	O
pa	O
and	O
sitting	O
time	B-T079
,	O
and	O
to	O
examine	O
associations	B-T080
between	O
sociodemographic	B-T078
factors	I-T078
,	O
weight	O
status	B-T080
,	O
pa	O
,	O
and	O
sitting	O
time	B-T079
among	O
south	O
korean	O
adolescents	O
12-18	O
years	B-T079
.	O
	
findings	B-T169
are	O
based	O
on	O
self-report	O
data	O
from	O
638	O
participants	O
in	O
the	O
2013	O
korea	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
.	O
	
only	O
4.9	O
of	O
adolescents	O
accumulated	O
60	O
minutes	B-T079
of	O
moderate-to-vigorous	O
pa	O
daily	B-T079
.	O
	
adolescents	O
spent	O
532.4	O
9.3	O
mins/d	B-T079
sitting	O
.	O
	
after	O
controlling	O
for	O
age	O
and	O
sex	O
,	O
individuals	O
in	O
higher	O
income	O
groups	O
compared	O
with	O
the	O
lowest	O
income	O
group	O
,	O
living	O
in	O
nonmetro	O
seoul	O
compared	O
with	O
metro	O
seoul	O
,	O
and	O
who	O
were	O
overweight	O
compared	O
with	O
nonoverweight	O
were	O
more	O
likely	O
to	O
meet	O
pa	O
guidelines	O
.	O
	
participants	O
in	O
the	O
highest	O
income	O
group	O
compared	O
with	O
lowest	O
income	O
group	O
,	O
and	O
residing	O
in	O
nonmetro	O
seoul	O
compared	O
with	O
metro	O
seoul	O
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
high	O
sitting	O
time	B-T079
group	B-T078
>720	O
min/d	B-T079
p	O
<	O
05	O
.	O
	
increasing	B-T169
pa	O
and	O
reducing	B-T080
sitting	O
should	O
be	O
a	O
public	O
health	O
priority	B-T079
in	O
south	O
korea	O
.	O
	
graphene	O
/	O
nafion	B-T109
composite	O
film	O
modified	O
glassy	B-T080
carbon	O
electrode	O
for	O
simultaneous	B-T079
determination	O
of	O
paracetamol	B-T109
,	O
aspirin	B-T109
and	O
caffeine	B-T109
in	O
pharmaceutical	O
formulations	O
a	O
graphene	O
-	O
nafion	B-T109
composite	O
film	O
was	O
fabricated	O
on	O
the	O
glassy	B-T080
carbon	O
electrode	O
gr-nf/gce	O
,	O
and	O
used	O
for	O
simultaneous	B-T079
determination	O
of	O
paracetamol	B-T109
par	B-T109
,	O
aspirin	B-T109
asa	B-T109
and	O
caffeine	B-T109
caf	B-T109
.	O
	
the	O
electrochemical	B-T080
behaviors	I-T080
of	O
par	B-T109
,	O
asa	B-T109
and	O
caf	B-T109
were	O
investigated	B-T169
by	O
cyclic	O
voltammetry	O
and	O
square-wave	O
adsorptive	O
anodic	O
stripping	O
voltammetry	O
.	O
	
by	O
using	O
stripping	O
one	O
for	O
simultaneous	B-T079
determination	O
of	O
par	B-T109
,	O
asa	B-T109
and	O
caf	B-T109
,	O
their	O
electrochemical	B-T080
oxidation	I-T080
peaks	I-T080
appeared	B-T080
at	O
+0	O
,	O
1.04	O
and	O
1.44v	O
,	O
and	O
good	B-T080
linear	B-T080
current	I-T080
responses	I-T080
were	O
obtained	B-T169
with	O
the	O
detection	B-T081
limits	I-T081
of	O
18ngml	O
1.2	O
,	O
11.7ngml	O
6.5	O
and	O
7.3ngml	O
3.8	O
,	O
respectively	O
.	O
	
finally	O
,	O
the	O
proposed	B-T078
electrochemical	O
sensor	O
was	O
successfully	B-T080
applied	B-T169
for	O
quantifying	B-T081
par	B-T109
,	O
asa	B-T109
and	O
caf	B-T109
in	O
commercial	O
tablet	O
formulations	O
.	O
	
long-term	B-T079
antibiofilm	O
activity	O
of	O
carboxymethyl	B-T109
chitosan	I-T109
on	O
mixed	O
biofilm	O
on	O
silicone	B-T109
silicone	B-T109
voice	O
prostheses	O
are	O
most	O
frequently	B-T079
used	O
in	O
voice	B-T061
rehabilitation	I-T061
of	O
laryngectomized	B-T061
patients	O
.	O
	
however	O
,	O
the	O
functional	B-T033
device	I-T033
lifetimes	B-T079
are	O
limited	B-T169
due	B-T169
to	I-T169
formation	B-T169
of	O
mixed	O
biofilms	O
.	O
	
existing	O
in	O
vitro	O
models	O
simulating	O
biofilm	O
formation	O
are	O
restricted	B-T169
to	O
only	O
short-term	B-T079
periods	B-T079
.	O
	
the	O
goal	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
effect	B-T080
of	O
carboxymethyl	B-T109
chitosan	I-T109
on	O
mixed	O
biofilm	O
formation	O
of	O
fungi	O
and	O
bacteria	O
on	O
silicone	B-T109
over	O
a	O
long-term	B-T079
period	B-T079
.	O
	
mixed	O
species	O
biofilms	O
of	O
candida	O
albicans	O
,	O
candida	O
tropicalis	O
,	O
lactobacillus	O
gasseri	O
,	O
streptococcus	O
salivarius	O
,	O
rothia	O
dentocariosa	O
,	O
and	O
staphylococcus	O
epidermidis	O
were	O
cultivated	O
on	O
the	O
surfaces	O
of	O
medical-grade	B-T109
silicone	I-T109
with	O
and	O
without	O
addition	O
of	O
carboxymethyl	B-T109
chitosan	I-T109
.	O
	
biofilm	O
kinetics	O
was	O
monitored	O
using	O
specially	O
designed	O
image	O
analysis	O
software	O
to	O
calculate	O
the	O
percentual	B-T169
surface	I-T169
covering	I-T169
of	O
each	O
platelet	O
.	O
	
biofilm	O
architecture	O
was	O
investigated	B-T169
by	O
scanning	O
electron	O
microscopy	O
.	O
	
a	O
cover	B-T169
of	O
living	B-T078
mixed	O
biofilm	O
could	O
be	O
generated	O
over	O
22	O
days	B-T079
on	O
silicone	B-T109
and	O
the	O
maximum	B-T081
of	O
22%	O
biofilm	O
surface	B-T169
covering	I-T169
at	O
day	B-T079
22	O
.	O
	
however	O
,	O
less	B-T081
than	I-T081
4%	O
surface	B-T169
coverage	I-T169
was	O
observed	B-T169
on	O
the	O
carboxymethyl	B-T109
chitosan	I-T109
-	O
treated	B-T169
plates	O
in	O
the	O
testing	B-T169
period	B-T079
.	O
	
scanning	O
electron	O
microscopy	O
confirms	B-T033
that	O
,	O
on	O
surfaces	O
treated	B-T169
by	O
carboxymethyl	B-T109
chitosan	I-T109
,	O
the	O
biofilm	O
was	O
less	B-T080
dense	B-T080
.	O
	
in	O
addition	O
,	O
there	O
were	O
fewer	B-T081
layers	O
of	O
cells	O
and	O
profuse	B-T033
cellular	I-T033
debris	I-T033
,	O
together	B-T080
with	O
degrading	O
and	O
morphologically	O
altered	O
yeast	O
cells	O
.	O
	
carboxymethyl	O
chitosan	O
may	O
serve	O
as	O
a	O
possible	O
antibiofilm	O
agent	O
to	O
limit	O
biofilm	O
formation	O
on	O
voice	O
prostheses	O
.	O
	
na	O
laryngoscope	O
,	O
126	O
,	O
spectral	O
fingerprints	O
of	O
large-scale	O
cortical	O
dynamics	O
during	B-T079
ambiguous	B-T080
motion	O
perception	O
ambiguous	B-T169
stimuli	O
have	O
been	O
widely	O
used	O
to	O
study	O
the	O
neuronal	O
correlates	B-T080
of	O
consciousness	O
.	O
	
recently	O
,	O
it	O
has	O
been	O
suggested	O
that	O
conscious	O
perception	O
might	O
arise	O
from	O
the	O
dynamic	B-T169
interplay	O
of	O
functionally	O
specialized	O
but	O
widely	O
distributed	O
cortical	O
areas	O
.	O
	
while	O
previous	O
research	O
mainly	O
focused	O
on	O
phase	O
coupling	O
as	O
a	O
correlate	B-T080
of	O
cortical	O
communication	O
,	O
more	O
recent	O
findings	O
indicated	O
that	O
additional	O
coupling	O
modes	O
might	O
coexist	O
and	O
possibly	O
subserve	O
distinct	O
cortical	O
functions	O
.	O
	
here	O
,	O
we	O
studied	O
two	O
coupling	O
modes	O
,	O
namely	O
phase	O
and	O
envelope	O
coupling	O
,	O
which	O
might	O
differ	O
in	O
their	O
origins	O
,	O
putative	O
functions	O
and	O
dynamics	O
.	O
	
therefore	O
,	O
we	O
recorded	O
128-channel	O
eeg	O
while	O
participants	O
performed	O
a	O
bistable	O
motion	O
task	O
and	O
utilized	O
state-of-the-art	O
source-space	O
connectivity	B-T169
analysis	O
techniques	B-T169
to	O
study	O
the	O
functional	O
relevance	O
of	O
different	O
coupling	O
modes	O
for	O
cortical	O
communication	O
.	O
	
our	O
results	O
indicate	O
that	O
gamma-band	O
phase	O
coupling	O
in	O
extrastriate	O
visual	O
cortex	O
might	O
mediate	O
the	O
integration	O
of	O
visual	O
tokens	O
into	O
a	O
moving	O
stimulus	O
during	O
ambiguous	B-T080
visual	O
stimulation	O
.	O
	
furthermore	O
,	O
our	O
results	O
suggest	O
that	O
long-range	O
fronto-occipital	O
gamma-band	O
envelope	O
coupling	O
sustains	O
the	O
horizontal	O
percept	O
during	O
ambiguous	B-T080
motion	O
perception	O
.	O
	
additionally	O
,	O
our	O
results	O
support	O
the	O
idea	O
that	O
local	O
parieto-occipital	O
alpha-band	O
phase	O
coupling	O
controls	O
the	O
inter-	O
hemispheric	O
information	B-T169
transfer	I-T169
.	O
	
these	O
findings	O
provide	O
correlative	B-T080
evidence	B-T078
for	O
the	O
notion	O
that	O
synchronized	B-T079
oscillatory	O
brain	O
activity	O
reflects	O
the	O
processing	O
of	O
sensory	O
input	O
as	O
well	O
as	O
the	O
information	O
integration	O
across	O
several	O
spatiotemporal	O
scales	O
.	O
	
the	O
results	O
indicate	O
that	O
distinct	B-T081
coupling	I-T081
modes	I-T081
are	O
involved	O
in	O
different	O
cortical	O
computations	O
and	O
that	O
the	O
rich	O
spatiotemporal	O
correlation	O
structure	O
of	O
the	O
brain	O
might	O
constitute	O
the	O
functional	B-T169
architecture	O
for	O
cortical	O
beneficial	O
effects	O
of	O
voglibose	B-T109
administration	B-T061
on	O
body	O
weight	O
and	O
lipid	O
metabolism	O
via	O
gastrointestinal	O
bile	B-T109
acid	I-T109
modification	O
this	O
study	O
was	O
designed	O
with	O
the	O
goal	O
of	O
examining	O
the	O
effects	B-T169
of	O
voglibose	B-T109
administration	B-T061
on	O
body	O
weight	O
and	O
lipid	O
metabolism	O
and	O
underlying	O
mechanism	B-T169
high	B-T061
fat	I-T061
diet	I-T061
-induced	O
obese	O
mice	O
.	O
	
male	O
c57bl/6	O
mice	O
were	O
randomly	O
assigned	O
to	O
one	O
of	O
four	O
groups	O
a	O
control	O
diet	O
ctl	O
,	O
high-fat	O
diet	O
hf	O
,	O
high-fat	O
diet	O
supplemented	O
with	O
voglibose	O
vo	O
,	O
and	O
high	O
fat	O
diet	O
pair-fed	O
group	O
pf	O
.	O
	
after	O
12	O
weeks	B-T079
,	O
the	O
following	O
characteristics	B-T080
were	O
investigated	O
serum	O
lipid	O
and	O
glucose	O
levels	O
,	O
serum	O
polar	O
metabolite	O
profiles	O
,	O
and	O
expression	B-T081
levels	I-T081
of	O
genes	O
involved	O
in	O
lipid	O
and	O
bile	O
acid	O
metabolism	O
.	O
	
in	O
addition	O
,	O
pyrosequencing	O
was	O
used	O
to	O
analyze	O
the	O
composition	O
of	O
gut	O
microbiota	O
found	O
in	O
feces	O
.	O
	
total	B-T033
body	I-T033
weight	I-T033
gain	I-T033
was	O
significantly	B-T081
lower	I-T081
in	O
the	O
vo	O
group	O
than	O
in	O
the	O
ctl	O
,	O
hf	O
,	O
and	O
pf	O
groups	O
.	O
	
the	O
vo	O
group	O
exhibited	O
improved	O
metabolic	O
profiles	O
including	O
those	O
of	O
blood	O
glucose	O
,	O
triglyceride	O
,	O
and	O
total	O
cholesterol	O
levels	O
.	O
	
the	O
12-	O
week	B-T079
voglibose	B-T109
administration	B-T061
decreased	O
the	O
ratio	O
of	O
firmicutes	O
to	O
bacteroidetes	O
found	O
in	O
feces	O
.	O
	
circulating	O
levels	B-T080
of	O
taurocholic	B-T109
and	O
cholic	B-T109
acid	I-T109
were	O
significantly	B-T081
higher	I-T081
in	O
the	O
vo	O
group	O
than	O
in	O
the	O
hf	O
and	O
ctl	O
groups	O
.	O
	
deoxycholic	B-T109
acid	I-T109
levels	B-T080
tended	O
to	O
be	O
higher	O
in	O
the	O
vo	O
group	O
than	O
in	O
the	O
hf	O
group	O
.	O
	
voglibose	B-T109
administration	B-T061
downregulated	O
expression	B-T081
levels	I-T081
of	O
cyp8b1	O
and	O
hnf4α	O
genes	O
and	O
upregulated	O
those	O
of	O
pgc1α	O
,	O
whereas	O
fxrα	O
was	O
not	O
affected	O
.	O
	
voglibose	B-T109
administration	B-T061
elicits	O
changes	O
in	O
the	O
composition	O
of	O
the	O
intestinal	O
microbiota	O
and	O
circulating	O
metabolites	O
,	O
which	O
ultimately	O
has	O
systemic	O
effects	O
on	O
body	O
weight	O
and	O
lipid	O
metabolism	O
in	O
supramolecular	O
recognition	O
of	O
amino	B-T116
acids	I-T116
by	O
twisted	B-T109
cucurbit	I-T109
binding	O
interactions	B-T169
between	O
twisted	B-T109
cucurbit	I-T109
tq	B-T109
and	O
twenty	O
standard	B-T080
amino	B-T116
acids	I-T116
aas	B-T116
have	O
been	O
investigated	B-T169
by	O
nmr	O
spectroscopy	O
and	O
isothermal	O
titration	O
calorimetry	O
itc	O
in	O
aqueous	O
hcl	O
solutions	O
and	O
in	O
dmso	B-T109
.	O
	
the	O
results	B-T169
showed	O
that	O
tq	B-T109
displays	B-T169
clear	O
binding	O
affinity	O
for	O
aas	B-T116
with	O
a	O
positively	O
charged	O
side	O
chain	O
or	O
containing	B-T169
an	O
aromatic	B-T109
ring	I-T109
,	O
but	O
weaker	B-T080
binding	O
affinity	O
for	O
aas	B-T116
with	O
hydrophobic	O
or	O
polar	O
side	O
chains	O
,	O
with	O
the	O
binding	O
mode	B-T169
depending	O
on	O
the	O
type	O
of	O
side	O
chain	O
present	O
in	O
the	O
comparison	O
of	O
alkaline	O
phosphatase	O
activity	O
of	O
mc3t3-e1	O
cells	O
cultured	O
on	O
different	O
ti	O
surfaces	O
modified	O
sandblasted	O
with	O
large	O
grit	O
and	O
acid-etched	O
msla	O
,	O
laser-treated	O
,	O
and	O
laser	O
and	O
acid-treated	O
ti	O
surfaces	O
in	O
this	O
study	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
implant	O
surface	O
treatment	O
on	O
cell	O
differentiation	O
of	O
osteoblast	O
cells	O
.	O
	
for	O
this	O
purpose	O
,	O
three	O
surfaces	O
were	O
compared	O
1	O
a	O
modified	O
sla	O
msla	O
sand-blasted	O
with	O
large	O
grit	O
,	O
acid-etched	O
,	O
and	O
immersed	O
in	O
0.9	O
nacl	O
,	O
2	O
a	O
laser	O
treatment	O
lt	O
laser	O
treatment	O
titanium	O
surface	O
and	O
3	O
a	O
laser	O
and	O
acid-treated	O
lat	O
laser	O
treatment	O
,	O
acid-etched	O
titanium	O
surface	O
.	O
	
the	O
msla	O
surfaces	O
were	O
considered	O
as	O
the	O
control	O
group	O
,	O
and	O
lt	O
and	O
lat	O
surfaces	O
as	O
test	B-T078
groups	I-T078
.	O
	
alkaline	B-T116
phosphatase	I-T116
expression	O
alp	B-T116
was	O
used	O
to	O
quantify	O
osteoblastic	O
differentiation	O
of	O
mc3t3-e1	O
cell	O
.	O
	
surface	O
roughness	B-T080
was	O
evaluated	O
by	O
a	O
contact	O
profilometer	O
urfpak-sv	O
mitutoyo	O
,	O
kawasaki	O
,	O
japan	O
and	O
characterized	O
by	O
two	O
parameters	O
mean	B-T080
roughness	I-T080
ra	B-T080
and	O
maximum	B-T081
peak-to-valley	I-T081
height	I-T081
rt	B-T081
.	O
	
scanning	O
electron	O
microscope	O
revealed	O
that	O
msla	O
control	O
group	O
surface	O
was	O
not	O
as	O
rough	B-T080
as	O
lt	O
,	O
lat	O
surface	O
test	B-T078
groups	I-T078
.	O
	
alkaline	B-T116
phosphatase	I-T116
expression	O
,	O
the	O
measure	O
of	O
osteoblastic	O
differentiation	O
,	O
and	O
total	O
alp	B-T116
expression	O
by	O
surface-adherent	O
cells	O
were	O
found	O
to	O
be	O
highest	O
at	O
21	O
days	B-T079
for	O
all	O
three	O
surfaces	O
tested	O
p<	O
.	O
	
furthermore	O
,	O
alp	B-T116
expression	O
levels	B-T080
of	O
msla	O
and	O
lat	O
surfaces	O
were	O
significantly	O
higher	O
than	O
expression	O
levels	B-T080
of	O
lt	O
surface-adherent	O
cells	O
at	O
7	O
,	O
14	O
,	O
and	O
21	O
days	B-T079
,	O
respectively	O
p<	O
.	O
	
however	O
,	O
alp	B-T116
expression	O
levels	B-T080
between	O
msla	O
and	O
lat	O
surface	O
were	O
equal	O
at	O
7	O
,	O
14	O
,	O
and	O
21	O
days	B-T079
p>	O
.	O
	
this	O
study	O
suggested	O
that	O
msla	O
and	O
lat	O
surfaces	O
exhibited	O
more	O
favorable	B-T080
environment	O
for	O
osteoblast	O
differentiation	O
when	O
compared	O
with	O
lt	O
surface	O
,	O
the	O
results	O
that	O
are	O
important	O
for	O
implant	O
surface	O
modification	B-T169
studies	O
.	O
	
overcoming	O
structural	O
inequalities	B-T080
in	O
oral	O
health	O
the	O
role	O
of	O
dental	O
curricula	O
to	O
date	O
the	O
role	O
of	O
health	O
professional	O
schools	O
in	O
addressing	O
oral	O
health	O
inequalities	B-T080
have	O
been	O
minimal	O
,	O
as	O
attempts	O
have	O
focused	B-T169
principally	O
upon	O
systemic	B-T169
reform	B-T078
and	O
broader	O
societal	B-T078
obligations	I-T078
.	O
	
professionalism	B-T078
is	O
a	O
broad	O
competency	B-T080
that	O
is	O
taught	O
throughout	O
dental	O
schools	O
and	O
encompasses	O
a	O
range	B-T081
of	O
attributes	O
.	O
	
professionalism	B-T078
as	O
a	O
competency	B-T080
draws	O
some	O
debate	O
and	O
appears	O
to	O
be	O
a	O
shifting	B-T169
phenomenon	I-T169
.	O
	
we	O
may	O
ask	O
if	O
professionalism	B-T078
in	O
the	O
dental	O
curricula	O
may	O
be	O
better	O
addressed	O
by	O
social	B-T078
accountability	I-T078
social	B-T078
accountability	I-T078
directs	O
oral	O
health	O
professional	O
curricula	O
education	O
,	O
research	O
,	O
and	O
service	O
activities	O
towards	O
addressing	O
the	O
priority	B-T079
health	B-T078
concerns	B-T078
of	O
the	O
community	O
,	O
in	O
our	O
case	O
oral	O
health	O
inequalities	B-T080
.	O
	
although	O
working	O
toward	O
dental	O
schools	O
becoming	O
more	O
socially	B-T078
accountable	I-T078
seems	O
like	O
a	O
sensible	O
way	O
to	O
address	O
oral	O
health	O
inequalities	B-T080
,	O
it	O
might	O
have	O
limitations	O
.	O
	
we	O
will	O
consider	O
some	O
of	O
the	O
challenges	O
in	O
the	O
dental	O
curricula	O
by	O
considering	O
some	O
of	O
the	O
political	O
,	O
structural	O
,	O
social	O
and	O
ethical	B-T078
factors	B-T169
that	O
influence	O
our	O
institutions	O
and	O
our	O
function	B-T169
analysis	O
of	O
mef2c	O
promoter	O
in	O
muscle	O
differentiation	O
regeneration	O
of	O
adult	O
skeletal	O
muscle	O
following	O
injury	O
occurs	O
through	O
the	O
activation	O
of	O
satellite	O
cells	O
,	O
that	O
proliferates	O
,	O
differentiates	O
,	O
and	O
fuses	O
with	O
injured	B-T169
myofibers	O
.	O
	
myocyte	B-T116
enhancer	I-T116
factor	I-T116
2	I-T116
mef2	I-T116
proteins	I-T116
are	O
reported	O
that	O
they	O
have	O
the	O
potential	O
contributions	O
to	O
adult	O
muscle	B-T033
regeneration	I-T033
.	O
	
in	O
order	O
to	O
further	O
understand	O
mef2c	O
gene	O
,	O
the	O
promoter	O
of	O
pig	O
mef2c	O
gene	O
was	O
analyzed	O
in	O
this	O
paper	O
.	O
	
quantitative	O
real-time	O
pcr	O
qrt-pcr	O
revealed	O
the	O
expression	O
pattern	O
of	O
mef2c	O
gene	O
in	O
muscle	O
of	O
eight	O
tissues	O
.	O
	
the	O
mef2c	O
promoter	O
had	O
the	O
higher	O
transcriptional	O
activity	O
in	O
differentiated	O
c2c12	O
cells	O
than	O
that	O
in	O
proliferating	O
c2c12	O
cells	O
,	O
which	O
was	O
accompanied	O
by	O
the	O
up-regulation	O
of	O
mrna	O
expression	O
of	O
mef2c	O
gene	O
.	O
	
function	B-T169
deletion	O
and	O
mutation	O
analyses	O
showed	O
that	O
myod	B-T116
and	O
mef2	B-T116
binding	O
sites	O
within	O
the	O
mef2c	O
promoter	O
were	O
responsible	O
for	O
the	O
regulation	O
of	O
mef2c	O
transcription	O
.	O
	
mef2c	O
could	O
up-regulate	O
the	O
transcriptional	O
activities	O
of	O
mef2c	O
promoter	O
constructs	O
which	O
contained	O
a	O
3'-end	O
nucleotide	O
sequence	O
with	O
p300	B-T116
binding	O
site	O
.	O
	
the	O
electrophoretic	O
mobility	O
shift	O
assays	O
emsa	O
and	O
chromatin	O
immunoprecipitation	O
chip	O
assays	O
determined	O
the	O
myod	B-T116
binding	O
site	O
in	O
mef2c	O
promoter	O
.	O
	
these	O
results	O
advanced	O
our	O
knowledge	O
of	O
the	O
promoter	O
of	O
the	O
pig	O
mef2c	O
gene	O
.	O
	
and	O
the	O
study	O
of	O
mef2c	O
promoter	O
regulator	O
elements	O
helped	O
to	O
elucidating	O
the	O
regulation	O
mechanisms	O
of	O
mef2c	O
in	O
muscle	O
differentiation	O
or	O
muscle	B-T061
repair	I-T061
and	O
regeneration	B-T033
.	O
	
novel	O
insights	O
into	O
development	O
of	O
diabetic	B-T033
bladder	B-T047
disorder	I-T047
provided	O
by	O
metabolomic	O
analysis	O
of	O
the	O
rat	O
nondiabetic	O
and	O
diabetic	B-T033
detrusor	O
and	O
urothelial	O
layer	O
there	O
are	O
at	O
present	O
no	O
published	O
studies	O
providing	O
a	O
global	O
overview	O
of	O
changes	B-T169
in	O
bladder	O
metabolism	O
resulting	O
from	O
diabetes	B-T047
.	O
	
such	O
studies	O
have	O
the	O
potential	O
to	O
provide	O
mechanistic	O
insight	O
into	O
the	O
development	O
of	O
diabetic	B-T033
bladder	B-T047
disorder	I-T047
dbd	I-T047
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
compared	O
the	O
metabolome	O
of	O
detrusor	O
and	O
urothelial	O
layer	O
in	O
a	O
1-mo	O
streptozotocin	B-T109
-induced	O
rat	O
model	O
of	O
type	B-T047
1	I-T047
diabetes	I-T047
with	O
nondiabetic	O
controls	O
.	O
	
our	O
studies	O
revealed	O
that	O
diabetes	B-T047
caused	O
both	O
common	O
and	O
differential	O
changes	B-T169
in	O
the	O
detrusor	O
and	O
urothelial	O
layer's	O
metabolome	O
.	O
	
diabetes	B-T047
resulted	O
in	O
similar	O
changes	B-T169
in	O
the	O
levels	O
of	O
previously	O
described	O
diabetic	B-T047
markers	O
in	O
both	O
tissues	O
,	O
such	O
as	O
glucose	B-T109
,	O
lactate	B-T109
,	O
2-hydroxybutyrate	B-T109
,	O
branched-chain	B-T116
amino	I-T116
acid	I-T116
degradation	I-T116
products	I-T116
,	O
bile	B-T109
acids	I-T109
,	O
and	O
1	B-T109
,	O
as	O
well	O
as	O
markers	O
of	O
oxidative	O
stress	O
.	O
	
in	O
the	O
detrusor	O
but	O
not	O
the	O
urothelial	O
layer	O
,	O
diabetes	B-T047
caused	O
activation	O
of	O
the	O
pentose-phosphate	B-T109
and	O
polyol	B-T109
pathways	O
,	O
concomitant	O
with	O
a	O
reduction	O
in	O
the	O
tca	O
cycle	O
and	O
β-oxidation	O
.	O
	
changes	B-T169
in	O
detrusor	O
energy-generating	O
pathways	O
resulted	O
in	O
an	O
accumulation	O
of	O
sorbitol	B-T109
that	O
,	O
through	O
generation	O
of	O
advanced	B-T109
glycation	I-T109
end	I-T109
products	I-T109
,	O
is	O
likely	O
to	O
play	O
a	O
central	O
role	O
in	O
the	O
development	O
of	O
dbd	B-T047
.	O
	
in	O
the	O
diabetic	B-T033
urothelial	O
layer	O
there	O
was	O
decreased	O
flux	O
of	O
glucose	B-T109
via	O
glycolysis	O
and	O
changes	B-T169
in	O
lipid	O
metabolism	O
,	O
particularly	O
prostaglandin	O
synthesis	O
,	O
which	O
also	O
potentially	O
contributes	O
to	O
detrusor	O
dysfunction	O
proximal	O
soil	O
sensing	O
-	O
a	O
contribution	O
for	O
species	O
habitat	O
distribution	B-T169
modelling	O
of	O
earthworms	O
in	O
agricultural	O
soils	O
earthworms	O
are	O
important	O
for	O
maintaining	O
soil	O
ecosystem	O
functioning	B-T169
and	O
serve	O
as	O
indicators	O
of	O
soil	O
fertility	B-T080
.	O
	
however	O
,	O
detection	O
of	O
earthworms	O
is	O
time-consuming	B-T080
,	O
which	O
hinders	O
the	O
assessment	O
of	O
earthworm	O
abundances	B-T080
with	O
high	O
sampling	B-T078
density	B-T081
over	O
entire	O
fields	O
.	O
	
recent	O
developments	O
of	O
mobile	O
terrestrial	O
sensor	O
platforms	O
for	O
proximal	O
soil	O
sensing	O
pss	O
provided	O
new	O
tools	O
for	O
collecting	O
dense	O
spatial	O
information	B-T078
of	O
soils	O
using	O
various	O
sensing	O
principles	O
.	O
	
yet	O
,	O
the	O
potential	O
of	O
pss	O
for	O
assessing	O
earthworm	O
habitats	O
is	O
largely	O
unexplored	O
.	O
	
this	O
study	O
investigates	B-T169
whether	O
pss	O
data	B-T078
contribute	O
to	O
the	O
spatial	O
prediction	B-T078
of	O
earthworm	O
abundances	B-T080
in	O
species	O
distribution	B-T169
models	O
of	O
agricultural	O
soils	O
.	O
	
proximal	O
soil	O
sensing	O
data	B-T078
,	O
e.g	O
,	O
soil	O
electrical	B-T081
conductivity	I-T081
ec	B-T081
,	O
ph	B-T081
,	O
and	O
near	O
infrared	O
absorbance	O
nir	O
,	O
were	O
collected	B-T078
in	O
real-time	B-T079
in	O
a	O
field	O
with	O
two	O
management	O
strategies	O
reduced	B-T080
tillage	O
/	O
conventional	O
tillage	O
and	O
sandy	O
to	O
loam	O
soils	O
.	O
	
pss	O
was	O
related	O
to	O
observations	O
from	O
a	O
long-term	B-T079
11	O
years	B-T079
earthworm	O
observation	B-T033
study	I-T033
conducted	O
at	O
42	O
plots	O
.	O
	
earthworms	O
were	O
sampled	B-T078
from	O
0.5	O
x	O
0.5	O
x	O
0.2	O
m³	O
soil	O
blocks	O
and	O
identified	B-T080
to	O
species	O
level	B-T080
.	O
	
sensor	O
data	B-T078
were	O
highly	O
correlated	O
with	O
earthworm	O
abundances	B-T080
observed	B-T169
in	O
reduced	B-T080
tillage	O
but	O
less	O
correlated	B-T080
with	O
earthworm	O
abundances	B-T080
observed	B-T169
in	O
conventional	O
tillage	O
.	O
	
this	O
may	O
indicate	O
that	O
management	O
influences	O
the	O
sensor	O
-	O
earthworm	O
relationship	O
.	O
	
generalized	O
additive	O
models	O
and	O
state-space	O
models	O
showed	O
that	O
modelling	O
based	O
on	O
data	B-T078
fusion	O
from	O
ec	B-T081
,	O
ph	B-T081
,	O
and	O
nir	O
sensors	O
produced	O
better	O
results	B-T033
than	O
modelling	O
without	O
sensor	O
data	B-T078
or	O
data	B-T078
from	O
just	O
a	O
single	O
sensor	O
.	O
	
regarding	O
the	O
individual	O
earthworm	O
species	O
,	O
particular	O
sensor	O
combinations	O
were	O
more	O
appropriate	O
than	O
others	O
due	O
to	O
the	O
different	O
habitat	O
requirements	B-T169
of	O
the	O
earthworms	O
.	O
	
earthworm	O
species	O
with	O
soil	O
-specific	O
habitat	O
preferences	B-T078
were	O
spatially	O
predicted	O
with	O
higher	O
accuracy	B-T080
by	O
pss	O
than	O
more	O
ubiquitous	B-T080
species	O
.	O
	
our	O
findings	B-T033
suggest	O
that	O
pss	O
contributes	O
to	O
the	O
spatial	O
modelling	O
of	O
earthworm	O
abundances	B-T080
at	O
field	O
scale	O
and	O
that	O
it	O
will	O
support	O
species	O
distribution	B-T169
modelling	O
in	O
the	O
attempt	O
to	O
understand	O
the	O
soil	O
-	O
earthworm	O
relationships	O
in	O
size	B-T081
matters	O
to	O
function	O
brain	B-T081
volume	I-T081
correlates	B-T080
with	O
intrinsic	O
brain	O
activity	O
across	O
healthy	B-T080
individuals	O
a	O
fundamental	O
issue	O
in	O
neuroscience	O
is	O
to	O
understand	O
the	O
structural	O
substrates	B-T169
of	O
neural	O
activities	O
.	O
	
intrinsic	O
brain	O
activity	O
has	O
been	O
increasingly	O
recognized	O
as	O
an	O
important	O
functional	O
activity	O
mode	O
and	O
is	O
tightly	O
linked	O
with	O
various	O
cognitive	O
functions	O
.	O
	
structurally	O
,	O
cognitive	O
functions	O
have	O
also	O
shown	O
a	O
relation	O
with	O
brain	B-T081
volume	I-T081
/	O
size	B-T081
.	O
	
therefore	O
,	O
an	O
association	B-T080
between	O
intrinsic	O
brain	O
activities	O
and	O
brain	B-T081
volume	I-T081
/	O
size	B-T081
can	O
be	O
hypothesized	O
,	O
and	O
brain	B-T081
volume	I-T081
/	O
size	B-T081
may	O
impact	B-T080
intrinsic	O
brain	O
activity	O
in	O
human	O
brains	O
.	O
	
the	O
present	O
study	O
aimed	O
to	O
explicitly	O
investigate	B-T169
this	O
brain	O
structure	O
-	O
function	O
relationship	B-T080
using	O
two	O
large	O
independent	O
cohorts	O
of	O
176	O
and	O
236	O
young	O
adults	O
.	O
	
structural	O
-	O
mri	O
was	O
performed	B-T169
to	O
estimate	B-T081
the	O
brain	B-T081
volume	I-T081
,	O
and	O
resting-state	O
functional-mri	O
was	O
applied	O
to	O
extract	O
the	O
amplitude	B-T081
of	I-T081
low-frequency	I-T081
fluctuations	I-T081
alff	B-T081
,	O
an	O
imaging	O
measure	O
of	O
intrinsic	O
brain	O
activity	O
.	O
	
intriguingly	O
,	O
our	O
results	O
revealed	O
a	O
robust	O
linear	O
correlation	B-T080
between	O
whole-brain	B-T081
size	I-T081
and	O
alff	B-T081
.	O
	
moreover	O
,	O
specific	B-T080
brain	O
lobes	O
/	O
regions	O
,	O
including	O
the	O
frontal	O
lobe	O
,	O
the	O
left	O
middle	O
frontal	O
gyrus	O
,	O
anterior	O
cingulate	O
gyrus	O
,	O
rolandic	O
operculum	O
,	O
and	O
insula	O
,	O
also	O
showed	O
a	O
reliable	B-T080
,	O
positive	B-T033
volume	B-T081
-	O
alff	B-T081
correlation	B-T080
in	O
the	O
two	O
cohorts	O
.	O
	
these	O
findings	O
offer	O
direct	B-T080
,	O
empirical	B-T080
evidence	B-T169
of	I-T169
a	O
strong	B-T080
association	B-T080
between	O
brain	B-T081
size	I-T081
/	O
volume	B-T081
and	O
intrinsic	O
brain	O
activity	O
,	O
as	O
well	O
as	O
provide	O
novel	O
insight	O
into	O
the	O
structural	O
substrates	B-T169
of	O
the	O
intrinsic	O
brain	O
activity	O
of	O
the	O
human	O
brain	O
.	O
	
on	O
the	O
control	B-T169
of	O
social	B-T169
approach-avoidance	B-T033
behavior	I-T033
neural	B-T169
and	O
endocrine	B-T169
mechanisms	B-T169
the	O
ability	O
to	O
control	B-T169
our	O
automatic	B-T169
action	O
tendencies	B-T078
is	O
crucial	B-T080
for	O
adequate	B-T080
social	B-T033
interactions	I-T033
.	O
	
emotional	B-T033
events	O
trigger	B-T080
automatic	B-T169
approach	B-T033
and	I-T033
avoidance	I-T033
tendencies	B-T078
.	O
	
although	O
these	O
actions	O
may	O
be	O
generally	O
adaptive	B-T169
,	O
the	O
capacity	B-T081
to	O
override	O
these	O
emotional	B-T033
reactions	I-T033
may	O
be	O
key	O
to	O
flexible	B-T080
behavior	O
during	O
social	B-T033
interaction	I-T033
.	O
	
the	O
present	B-T079
chapter	B-T078
provides	O
a	O
review	B-T078
of	O
the	O
neuroendocrine	O
mechanisms	B-T169
underlying	O
this	O
ability	O
and	O
their	O
relation	B-T080
to	O
social	B-T169
psychopathologies	O
.	O
	
aberrant	B-T080
social	O
behavior	O
,	O
such	O
as	O
observed	B-T169
in	O
social	O
anxiety	O
or	O
psychopathy	O
,	O
is	O
marked	B-T080
by	O
abnormalities	B-T033
in	O
approach-avoidance	B-T033
tendencies	B-T078
and	O
the	O
ability	O
to	O
control	B-T169
them	O
.	O
	
key	O
neural	B-T169
regions	O
involved	B-T169
in	O
the	O
regulation	O
of	O
approach-avoidance	B-T033
behavior	I-T033
are	O
the	O
amygdala	O
,	O
widely	O
implicated	B-T080
in	O
automatic	B-T169
emotional	B-T033
processing	O
,	O
and	O
the	O
anterior	O
prefrontal	O
cortex	O
,	O
which	O
exerts	O
control	B-T169
over	O
the	O
amygdala	O
.	O
	
hormones	O
,	O
especially	O
testosterone	B-T109
and	O
cortisol	B-T109
,	O
have	O
been	O
shown	O
to	O
affect	O
approach-avoidance	B-T033
behavior	I-T033
and	O
the	O
associated	B-T080
neural	B-T169
mechanisms	B-T169
.	O
	
the	O
present	B-T079
chapter	B-T078
also	O
discusses	O
ways	O
to	O
directly	B-T080
influence	O
social	B-T169
approach	B-T033
and	I-T033
avoidance	I-T033
behavior	I-T033
and	O
will	O
end	O
with	O
a	O
research	O
agenda	O
to	O
further	O
advance	B-T169
this	O
important	B-T080
research	O
field	O
.	O
	
control	B-T169
over	O
approach-avoidance	B-T033
tendencies	B-T078
may	O
serve	O
as	O
an	O
exemplar	O
of	O
emotional	B-T033
action	O
regulation	O
and	O
might	O
have	O
a	O
great	B-T081
value	B-T080
in	O
understanding	O
the	O
underlying	O
mechanisms	B-T169
of	O
the	O
development	B-T169
of	O
affective	O
disorders	O
.	O
	
high	O
occurrence	O
of	O
non-clear	O
cell	O
renal	O
cell	O
carcinoma	O
in	O
oman	O
it	O
is	O
conventionally	O
accepted	O
that	O
renal	O
cell	O
carcinoma	O
rcc	O
occurs	O
in	O
older	O
patients	O
and	O
the	O
clear	O
cell	O
type	O
is	O
the	O
most	O
common	O
histology	O
.	O
	
however	O
,	O
ethnic	B-T080
variations	I-T080
exist	O
and	O
this	O
study	O
was	O
carried	O
out	O
to	O
determine	O
the	O
epidemiological	O
pattern	O
of	O
rcc	O
in	O
oman	O
.	O
	
ninety	O
rcc	O
patients	O
who	O
presented	B-T078
to	O
a	O
tertiary	O
care	O
center	O
in	O
the	O
sultanate	O
of	O
oman	O
from	O
2010	O
to	O
2014	O
were	O
studied	O
.	O
	
the	O
main	B-T033
findings	I-T033
were	O
that	O
the	O
median	O
age	O
of	O
presentation	B-T078
was	O
low	B-T080
,	O
more	O
patients	O
presented	B-T078
with	O
localized	O
stage	B-T079
,	O
and	O
there	O
was	O
a	O
higher	O
incidence	O
of	O
non-clear	O
especially	O
papillary	O
histology	O
.	O
	
data	B-T078
from	O
other	O
gulf	O
countries	O
patient	B-T061
mobility	I-T061
for	O
elective	O
secondary	O
health	O
care	O
services	O
in	O
response	O
to	O
patient	O
choice	O
policies	O
a	O
systematic	O
review	O
our	O
review	O
establishes	O
the	O
empirical	B-T080
evidence	B-T078
for	O
patient	B-T061
mobility	I-T061
for	O
elective	O
secondary	O
care	O
services	O
in	O
countries	O
that	O
allow	O
patients	O
to	O
choose	O
their	O
health	O
care	O
provider	O
.	O
	
pubmed	O
and	O
embase	O
were	O
searched	O
for	O
relevant	O
articles	O
between	O
1990	O
and	O
2015	O
.	O
	
of	O
5	O
titles	O
/	O
abstracts	O
reviewed	B-T080
,	O
26	O
studies	O
were	O
included	O
.	O
	
the	O
studies	O
used	O
three	O
main	O
methodological	O
models	O
to	O
establish	O
mobility	B-T033
.	O
	
variation	B-T080
in	O
the	O
extent	O
of	O
patient	B-T061
mobility	I-T061
was	O
observed	O
across	O
the	O
studies	O
.	O
	
mobility	B-T033
was	O
positively	O
associated	B-T080
with	I-T080
lower	B-T079
waiting	I-T079
times	I-T079
,	O
indicators	B-T169
of	O
better	O
service	O
quality	O
,	O
and	O
access	O
to	O
advanced	O
technology	O
.	O
	
it	O
was	O
negatively	O
associated	O
with	O
advanced	O
age	O
or	O
lower	O
socioeconomic	O
backgrounds	O
.	O
	
from	O
a	O
policy	O
perspective	O
we	O
demonstrate	O
that	O
a	O
significant	O
proportion	B-T081
of	O
patients	O
are	O
prepared	O
to	O
travel	O
beyond	O
their	O
nearest	O
provider	O
for	O
elective	O
services	O
.	O
	
as	O
a	O
consequence	O
,	O
some	O
providers	O
are	O
likely	O
to	O
be	O
""""	O
winners	O
""""	O
and	O
others	O
""""	O
losers	B-T033
""""	O
which	O
could	O
result	O
in	O
overall	O
decreased	B-T081
provider	O
capacity	B-T081
or	O
inefficient	B-T169
utilization	O
of	O
existing	O
services	O
.	O
	
equity	B-T080
new	B-T080
breast	O
pain	O
chart	O
for	O
objective	O
record	O
of	O
mastalgia	O
mastalgia	O
is	O
the	O
commonest	B-T081
affliction	O
of	O
mammary	O
gland	O
among	O
ladies	O
of	O
the	O
reproductive	B-T079
age	O
group	O
.	O
	
since	O
etiopathogenesis	B-T169
and	O
therapy	B-T061
are	O
different	B-T080
for	O
cyclical	O
and	O
noncyclical	O
pain	O
,	O
it	O
is	O
imperative	O
to	O
ascertain	O
the	O
exact	O
type	O
correctly	O
.	O
	
this	O
is	O
usually	O
done	O
in	O
the	O
breast	O
clinics	O
by	O
advising	O
the	O
patient	O
to	O
fill	O
a	O
pain	O
diary	O
over	O
a	O
period	B-T079
of	O
2	O
months	B-T079
over	O
two	O
menstrual	O
cycles	O
.	O
	
the	O
cardiff	O
pain	O
chart	O
records	O
the	O
severity	B-T080
of	O
pain	O
in	O
the	O
form	O
of	O
a	O
triangle	O
for	O
mild	B-T080
to	O
moderate	O
pain	O
and	O
a	O
square	O
for	O
severe	B-T033
pain	I-T033
.	O
	
moreover	O
,	O
cardiff	O
pain	O
chart	O
does	O
not	O
allow	O
a	O
patient	O
to	O
record	B-T080
the	O
severity	B-T080
of	O
pain	O
on	O
days	B-T079
of	O
menses	O
,	O
as	O
she	O
has	O
to	O
put	O
the	O
letter	O
"""p"""	O
in	O
the	O
box	O
.	O
	
these	O
problems	B-T033
have	O
been	O
resolved	O
in	O
the	O
new	B-T080
breast	O
pain	O
chart	O
.	O
	
in	O
the	O
new	B-T080
pain	O
chart	O
,	O
the	O
lady	O
records	B-T080
pain	O
severity	B-T080
in	O
the	O
form	O
of	O
visual	O
linear	O
analogue	O
scale	O
score	O
on	O
every	B-T079
day	I-T079
of	O
menstrual	O
cycle	O
.	O
	
she	O
enters	O
her	O
menstrual	O
experience	O
on	O
a	O
separate	O
part	O
of	O
chart	O
,	O
which	O
allows	O
us	O
to	O
visualize	O
the	O
full	O
month's	B-T079
pain	O
severity	B-T080
the	O
demand	O
for	O
cigarettes	O
in	O
tanzania	O
and	O
implications	O
for	O
tobacco	B-T109
taxation	O
policy	O
the	O
study	O
attempts	O
to	O
estimate	O
the	O
demand	O
for	O
cigarettes	O
in	O
tanzania	O
and	O
presents	O
simulation	O
results	B-T169
on	O
the	O
effect	B-T080
of	O
the	O
cigarette	O
excise	O
tax	O
on	O
smoking	O
participation	B-T169
,	O
government	O
revenue	O
,	O
and	O
related	O
topics	O
.	O
	
after	O
briefly	O
summarizing	O
the	O
magnitude	B-T081
and	O
spread	O
of	O
cigarette	B-T033
consumption	I-T033
in	O
the	O
country	O
,	O
the	O
paper	O
reviews	O
some	O
empirical	O
estimates	O
from	O
african	O
and	O
other	O
countries	O
.	O
	
the	O
2008	O
tanzanian	O
household	O
budget	O
survey	O
was	O
used	O
to	O
estimate	O
the	O
demand	O
for	O
cigarettes	O
in	O
tanzania	O
.	O
	
the	O
descriptive	O
statistics	O
suggest	O
that	O
the	O
smoking	O
prevalence	O
for	O
tanzania	O
is	O
15.35	O
percent	O
with	O
low	O
variability	O
across	O
expenditure	O
income	O
groups	O
.	O
	
smoking	O
intensity	O
and	O
per	O
capita	O
consumption	O
were	O
estimated	O
at	O
7.08	O
cigarettes	O
and	O
1.33	O
cigarettes	O
,	O
respectively	O
,	O
a	O
relatively	O
low	O
value	O
.	O
	
a	O
two-part	O
demand	O
equation	O
model	O
was	O
used	O
to	O
estimate	O
various	O
elasticities	O
.	O
	
for	O
the	O
overall	O
equation	O
,	O
the	O
price	O
elasticities	O
of	O
smoking	O
participation	B-T169
,	O
smoking	O
intensity	O
,	O
and	O
total	O
elasticity	O
were	O
estimated	O
at	O
-0	O
,	O
-0	O
,	O
and	O
-1	O
,	O
respectively	O
.	O
	
compared	O
to	O
similar	O
results	O
in	O
other	O
developing	B-T080
countries	I-T080
,	O
the	O
estimates	O
appear	O
quite	O
high	O
.	O
	
when	O
estimated	O
by	O
expenditure	O
income	O
groups	O
,	O
the	O
magnitude	B-T081
of	O
the	O
elasticity	O
appears	O
higher	O
among	O
high	O
expenditure	O
groups	O
than	O
among	O
low	O
expenditure	O
groups	O
.	O
	
two	O
simulation	O
exercises	O
were	O
undertaken	O
.	O
	
first	O
,	O
the	O
effect	B-T080
of	O
different	O
excise	O
rates	B-T081
on	O
smoking	O
participation	B-T081
rate	I-T081
,	O
cigarette	B-T033
consumption	I-T033
,	O
tax	O
revenue	O
,	O
and	O
related	O
responses	O
was	O
estimated	O
and	O
highlighted	O
.	O
	
second	O
,	O
the	O
same	O
exercise	O
was	O
undertaken	O
to	O
determine	O
the	O
effect	B-T080
of	O
a	O
given	O
increase	B-T169
in	O
the	O
cigarette	O
excise	O
tax	O
on	O
various	O
expenditure	O
groups	O
.	O
	
the	O
overall	O
results	B-T169
suggest	O
that	O
an	O
increase	B-T169
in	O
the	O
excise	O
tax	O
on	O
cigarettes	O
in	O
tanzania	O
would	O
reduce	O
cigarette	B-T033
consumption	I-T033
and	O
increase	B-T169
government	O
tax	O
revenue	O
.	O
	
physicians'	O
knowledge	O
on	O
the	O
work-related	B-T047
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
copd	B-T047
may	O
be	O
induced	O
by	O
the	O
work	O
environment	O
conditions	B-T080
.	O
	
according	O
to	O
the	O
estimates	B-T081
,	O
10-20%	O
of	O
all	O
copd	B-T047
cases	B-T169
are	O
associated	B-T080
with	I-T080
occupational	O
exposure	O
to	O
dusts	O
and	O
irritant	O
gases	O
.	O
	
however	O
,	O
in	O
2014	O
,	O
only	O
11	O
cases	B-T169
of	O
work-related	B-T047
copd	B-T047
were	O
recognized	O
in	O
poland	O
.	O
	
the	O
aim	O
of	O
the	O
study	O
was	O
to	O
analyze	O
the	O
reasons	O
for	O
the	O
low	B-T080
incidence	B-T081
of	O
work-related	B-T047
copd	B-T047
in	O
the	O
context	B-T078
of	O
pulmonologists	O
'	O
knowledge	O
about	O
occupational	B-T169
risk	B-T033
factors	I-T033
and	O
procedures	B-T169
on	O
reporting	O
suspected	B-T047
occupational	B-T047
diseases	I-T047
.	O
	
a	O
survey	O
included	O
94	O
pulmonologists	O
randomly	B-T080
selected	O
out	O
of	O
225	O
specialists	O
registered	O
at	O
the	O
local	O
physicians	O
chamber	O
in	O
łódź	O
.	O
	
the	O
study	O
was	O
performed	B-T169
anonymously	B-T080
with	O
the	O
use	O
of	O
original	O
questionnaire	O
.	O
	
more	O
than	O
a	O
half	O
of	O
the	O
surveyed	O
pulmonologists	O
identified	B-T080
environmental	O
risk	B-T033
factors	I-T033
for	O
copd	B-T047
correctly	O
,	O
while	O
only	O
23.4	O
properly	O
identified	B-T080
the	O
main	O
occupational	B-T169
risk	B-T033
factors	I-T033
as	O
the	O
cause	B-T078
of	O
copd	B-T047
.	O
	
only	O
58.5	O
of	O
the	O
pulmonologists	O
always	O
asked	O
their	O
patients	O
suffering	B-T033
from	O
copd	B-T047
about	O
their	O
job	O
/	O
profession	O
and	O
60.6	O
of	O
them	O
did	O
not	O
have	O
any	O
knowledge	O
about	O
procedures	B-T169
on	O
reporting	O
suspected	B-T047
occupational	B-T047
diseases	I-T047
.	O
	
the	O
physicians	O
rarely	B-T080
ask	O
patients	O
suffering	B-T033
from	O
copd	B-T047
about	O
their	O
job	O
/	O
profession	O
and	O
the	O
relationship	B-T080
between	O
their	O
ailments	O
and	O
occupational	O
exposure	O
.	O
	
what	O
is	O
more	O
,	O
they	O
do	O
not	O
know	O
legal	O
regulations	O
on	O
proper	O
referral	O
of	O
a	O
patient	O
with	O
a	O
suspected	B-T047
case	B-T169
of	O
occupational	B-T047
disease	I-T047
.	O
	
the	O
results	B-T169
of	O
the	O
study	O
clearly	O
indicate	B-T078
that	O
there	O
is	O
an	O
urgent	O
need	O
for	O
increasing	B-T169
pulmonologists	O
'	O
knowledge	O
on	O
work-related	B-T047
copd	B-T047
.	O
	
case	O
report	O
of	O
necrotizing	B-T047
fasciitis	I-T047
associated	B-T080
with	I-T080
streptococcus	O
pneumoniae	O
necrotizing	B-T047
fasciitis	I-T047
,	O
caused	O
by	O
streptococcus	O
pneumoniae	O
,	O
is	O
an	O
extremely	B-T080
rare	I-T080
and	O
life-threatening	B-T033
bacterial	O
soft	B-T047
tissue	I-T047
infection	I-T047
.	O
	
we	O
report	O
a	O
case	B-T169
of	O
early	O
necrotizing	B-T047
fasciitis	I-T047
associated	B-T080
with	I-T080
streptococcus	O
pneumoniae	O
infection	O
in	O
a	O
26-	O
year	B-T079
-old	O
man	O
who	O
was	O
immunocompromised	B-T033
with	O
mixed	B-T047
connective	I-T047
tissue	I-T047
disease	I-T047
.	O
	
the	O
patient	O
presented	O
with	O
acute	B-T079
,	O
painful	O
,	O
erythematous	B-T169
,	O
and	O
edematous	O
skin	O
lesions	B-T033
of	O
his	O
right	O
lower	O
back	O
,	O
which	O
rapidly	O
progressed	B-T169
to	O
the	O
right	O
knee	O
.	O
	
the	O
patient	O
underwent	O
surgical	O
exploration	O
,	O
and	O
a	O
diagnosis	B-T033
of	O
necrotizing	B-T047
fasciitis	I-T047
was	O
confirmed	O
by	O
pathological	B-T169
evidence	B-T078
of	O
necrosis	O
of	O
the	O
fascia	O
and	O
neutrophil	O
infiltration	O
in	O
tissue	O
biopsies	O
.	O
	
cultures	O
of	O
fascial	O
tissue	O
biopsies	O
and	O
blood	O
samples	O
were	O
positive	B-T033
for	O
streptococcus	O
pneumoniae	O
.	O
	
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
of	O
necrotizing	B-T047
fasciitis	I-T047
resulting	O
from	O
streptococcus	O
pneumoniae	O
diagnosed	B-T033
at	O
early	O
phase	B-T079
the	O
patient	O
recovered	O
well	O
without	O
surgical	B-T061
debridement	I-T061
.	O
	
a	O
comparative	O
study	O
of	O
the	O
efficacy	B-T080
of	O
iv	O
dexketoprofen	B-T109
,	O
lornoxicam	B-T109
,	O
and	O
diclophenac	O
sodium	O
on	O
postoperative	B-T061
analgesia	I-T061
and	O
tramadol	B-T109
consumption	O
in	O
patients	O
receiving	O
patient-controlled	B-T061
tramadol	B-T109
this	O
study	O
was	O
designed	O
to	O
compare	O
the	O
effects	B-T080
of	I-T080
dexketoprofen	B-T109
,	O
lornoxicam	B-T109
,	O
and	O
diclophenac	O
sodium	O
on	O
postoperative	B-T061
analgesia	I-T061
and	O
tramadol	B-T109
consumption	O
in	O
patients	O
receiving	O
postoperative	B-T079
patient-controlled	B-T061
tramadol	B-T109
after	O
a	O
major	B-T080
abdominal	B-T061
surgery	I-T061
.	O
	
eighty	O
patients	O
were	O
randomized	B-T033
to	O
receive	O
one	O
of	O
the	O
four	O
study	O
drugs	O
.	O
	
patients	O
in	O
group	B-T078
dexketoprofen	B-T109
dt	B-T109
received	O
iv	O
50	O
mg	O
dexketoprofen	B-T109
,	O
group	B-T078
lornoxicam	B-T109
lr	B-T109
received	O
iv	O
8	O
mg	O
lornoxicam	B-T109
,	O
group	B-T078
diclophenac	O
sodium	O
ds	O
received	O
75	O
mg	O
iv	O
diclophenac	O
sodium	O
and	O
group	B-T078
saline	O
s	O
received	O
0.9	O
saline	O
in	O
2	O
ml	O
syringes	O
,	O
20	O
min	B-T079
before	O
the	O
end	O
of	O
anaesthesia	B-T061
.	O
	
a	O
standardized	B-T080
1	O
mg	O
kg	O
dose	B-T081
of	O
tramadol	B-T109
was	O
routinely	B-T080
administered	B-T169
to	O
all	O
patients	O
as	O
the	O
loading	B-T081
dose	I-T081
at	O
the	O
end	O
of	O
surgery	B-T061
.	O
	
postoperatively	B-T079
,	O
whenever	O
patients	O
requested	O
,	O
they	O
were	O
allowed	O
to	O
use	O
a	O
tramadol	B-T109
patient-controlled	B-T033
analgesia	I-T033
device	I-T033
giving	O
a	O
bolus	B-T061
dose	I-T061
0.2	O
mg	O
kg	O
of	O
tramadol	B-T109
.	O
	
pain	O
,	O
discomfort	O
,	O
and	O
sedation	B-T033
scores	B-T081
,	O
cumulative	B-T080
tramadol	B-T109
consumption	O
,	O
supplemental	B-T169
meperidine	B-T109
requirement	B-T169
,	O
and	O
side	O
effects	O
were	O
recorded	O
.	O
	
visual	B-T081
rating	I-T081
scale	I-T081
and	O
patient	O
discomfort	O
scores	B-T081
were	O
significantly	B-T078
lower	O
in	O
dt	B-T109
,	O
lr	B-T109
and	O
ds	O
groups	B-T078
compared	O
to	O
those	O
in	O
in	O
group	B-T078
s	O
p<0	O
.	O
	
cumulative	B-T080
tramadol	B-T109
consumption	O
was	O
significantly	B-T078
lower	O
in	O
non-steroidal	O
anti-inflammatory	O
drug	O
nsaid	O
treated	B-T169
groups	B-T078
at	O
each	O
study	O
period	O
after	O
the	O
second	O
postoperative	B-T079
hour	B-T079
than	O
in	O
group	B-T078
s	O
p<0	O
.	O
	
supplemental	B-T169
meperidine	B-T109
requirement	B-T169
was	O
significantly	B-T078
higher	O
in	O
group	B-T078
s	O
at	O
each	O
study	O
period	O
after	O
postoperative	B-T079
30	O
min	B-T079
than	O
in	O
nsaid	O
-	O
treated	B-T169
groups	B-T078
p<0	O
.	O
	
after	O
major	B-T080
abdominal	B-T061
surgery	I-T061
,	O
adding	O
iv	O
diclophenac	B-T109
,	O
lornoxicam	B-T109
or	O
dexketoprofen	B-T109
to	O
patient-controlled	B-T061
tramadol	B-T109
resulted	O
in	O
lower	O
pain	O
scores	B-T081
,	O
smaller	B-T080
tramadol	B-T109
consumption	O
,	O
less	O
rescue	O
supplemental	B-T169
analgesic	B-T109
requirement	B-T169
,	O
and	O
fewer	O
side	O
effects	O
compared	O
with	O
the	O
tramadol	B-T109
alone	O
perioperative	O
management	O
of	O
severe	B-T033
hypertension	I-T033
during	O
laparoscopic	B-T061
surgery	I-T061
for	O
pheochromocytoma	O
phaeochromocytoma	O
is	O
a	O
catecholamine-secreting	O
vascular	O
tumour	O
that	O
is	O
derived	O
from	O
chromaffin	O
cell	O
.	O
	
lethal	B-T033
cardiovascular	O
complications	O
,	O
such	O
as	O
serious	O
hypertension	B-T047
,	O
myocardial	B-T047
infarction	I-T047
and	O
aortic	B-T047
dissection	I-T047
,	O
may	O
occur	O
because	O
of	O
uncontrolled	O
catecholamine	O
release	O
.	O
	
each	O
stage	B-T079
of	O
anaesthesia	B-T061
management	I-T061
has	O
vital	O
importance	O
because	O
of	O
this	O
destructive	O
catecholamine	O
secretion	O
that	O
may	O
occur	O
during	O
induction	B-T061
,	O
perioperative	B-T079
stage	I-T079
and	O
surgical	B-T061
manipulation	I-T061
.	O
	
in	O
this	O
study	O
,	O
we	O
report	O
regarding	O
the	O
preoperative	O
preparation	O
and	O
severe	O
,	O
persistent	O
hypertension	O
attack	O
management	O
with	O
a	O
combination	O
of	O
α-adrenergic	O
blockade	O
,	O
β-adrenergic	O
blockade	O
,	O
sodium	B-T109
nitroprusside	I-T109
and	O
remifentanil	B-T109
in	O
a	O
patient	O
who	O
underwent	O
laparoscopic	B-T061
surgery	I-T061
for	O
a	O
case	B-T169
based	O
reflection	B-T033
on	O
communicating	B-T169
end	I-T169
of	O
life	B-T078
information	B-T078
in	O
non-english	B-T033
speaking	I-T033
patients	O
mr	O
x	O
was	O
a	O
56	O
year	B-T079
old	I-T079
chinese	O
man	O
non-english	B-T033
speaking	I-T033
,	O
who	O
presented	O
to	O
the	O
emergency	O
department	O
with	O
a	O
range	O
of	O
non-specific	B-T080
symptoms	O
.	O
	
on	O
full	O
workup	O
,	O
he	O
was	O
diagnosed	B-T033
with	O
an	O
advanced	O
cancer	O
of	O
the	O
pancreas	O
.	O
	
it	O
was	O
an	O
aggressive	O
,	O
highly	O
treatment	B-T047
resistant	I-T047
cancer	I-T047
,	O
with	O
an	O
alarmingly	O
poor	B-T033
prognosis	I-T033
.	O
	
before	O
the	O
diagnosis	B-T033
had	O
been	O
made	O
,	O
the	O
family	O
had	O
informed	O
our	O
team	O
that	O
we	O
were	O
not	O
to	O
discuss	O
medical	B-T169
issues	B-T033
with	O
mr	O
x	O
directly	O
,	O
and	O
that	O
upon	O
arriving	O
on	O
a	O
diagnosis	B-T033
we	O
were	O
to	O
come	O
to	O
them	O
first	O
and	O
they	O
would	O
subsequently	O
inform	O
him	O
.	O
	
they	O
reported	O
that	O
mr	O
x	O
was	O
in	O
support	O
of	O
this	O
arrangement	O
.	O
	
eventually	O
we	O
told	O
the	O
family	O
about	O
mr	O
x's	O
diagnosis	B-T033
,	O
and	O
they	O
asserted	O
their	O
collective	O
will	O
to	O
keep	O
this	O
information	B-T078
from	O
him	O
,	O
reaffirming	O
that	O
all	O
medical	B-T169
discussion	B-T061
go	O
through	O
them	O
.	O
	
however	O
,	O
the	O
doctor	O
in	O
charge	O
explained	O
the	O
diagnosis	B-T033
to	O
mr	O
x	O
using	O
an	O
interpreter	O
while	O
his	O
family	O
were	O
away	O
from	O
his	O
bed	O
.	O
	
in	O
this	O
discussion	O
,	O
i	O
consider	O
this	O
case	B-T169
from	O
the	O
perspective	O
of	O
respecting	B-T061
patients'	I-T061
and	I-T061
families'	I-T061
preferences	I-T061
around	O
medical	O
treatment	O
and	O
care	O
.	O
	
difference-in-differences	O
method	O
in	O
comparative	O
effectiveness	O
research	O
utility	O
with	O
unbalanced	O
groups	O
comparative	O
effectiveness	O
research	O
cer	O
often	O
includes	O
observational	O
studies	O
utilizing	O
administrative	B-T033
data	I-T033
.	O
	
multiple	O
conditioning	O
methods	O
can	O
be	O
used	O
for	O
cer	O
to	O
adjust	O
for	O
group	O
differences	B-T080
,	O
including	O
difference-in-differences	O
did	O
estimation	O
.	O
	
this	O
study	O
presents	O
did	O
and	O
demonstrates	O
how	O
to	O
apply	O
this	O
conditioning	O
method	O
to	O
estimate	O
treatment	B-T080
outcomes	I-T080
in	O
the	O
cer	O
setting	O
by	O
utilizing	O
the	O
marketscan	O
databases	O
for	O
multiple	B-T047
sclerosis	I-T047
ms	B-T047
patients	O
receiving	O
different	O
therapies	B-T061
.	O
	
the	O
sample	O
included	O
6762	O
patients	O
,	O
with	O
363	O
in	O
the	O
test	O
cohort	O
glatiramer	B-T116
acetate	I-T116
ga	B-T116
switched	O
to	O
fingolimod	B-T109
fty	B-T109
and	O
6399	O
in	O
the	O
control	O
cohort	O
ga	B-T116
only	O
,	O
no	B-T033
switch	I-T033
from	O
a	O
us	O
administrative	O
claims	O
database	O
.	O
	
a	O
trend	O
analysis	O
was	O
conducted	O
to	O
rule	O
out	O
concerns	O
regarding	O
regression	O
to	O
the	O
mean	B-T081
and	O
to	O
compare	O
relapse	O
rates	O
among	O
treatment	O
cohorts	O
.	O
	
did	O
analysis	O
was	O
used	O
to	O
enable	O
comparisons	O
among	O
the	O
test	O
and	O
control	O
cohorts	O
.	O
	
logistic	O
regression	O
was	O
used	O
to	O
estimate	O
the	O
probability	B-T081
of	O
relapse	O
after	O
switching	O
from	O
ga	B-T116
to	O
fty	B-T109
,	O
and	O
to	O
compare	O
group	O
differences	B-T080
in	O
the	O
pre	B-T079
-	O
and	O
post	B-T079
-	O
index	B-T079
periods	I-T079
.	O
	
crude	O
did	O
analysis	O
showed	O
that	O
in	O
the	O
pre	B-T079
-	O
index	B-T079
period	I-T079
more	O
patients	O
in	O
the	O
test	O
cohort	O
experienced	O
an	O
ms	B-T047
relapse	O
and	O
had	O
a	O
higher	O
mean	B-T081
number	I-T081
of	O
relapses	O
than	O
in	O
the	O
control	O
cohort	O
.	O
	
during	O
the	O
pre	B-T079
-	O
index	B-T079
period	I-T079
,	O
numeric	B-T080
and	O
relative	O
data	O
for	O
ms	B-T047
relapses	O
in	O
patients	O
in	O
the	O
test	O
cohort	O
were	O
significantly	O
higher	O
than	O
in	O
the	O
control	O
cohort	O
,	O
while	O
no	B-T033
significant	I-T033
between-	O
group	O
differences	B-T080
emerged	O
during	O
the	O
post	B-T079
-	O
index	B-T079
period	I-T079
.	O
	
generalized	O
linear	B-T081
modeling	I-T081
with	O
did	O
regression	O
estimation	O
showed	O
that	O
the	O
mean	O
number	O
of	O
ms	B-T047
relapses	O
decreased	O
significantly	O
in	O
the	O
post	B-T079
-	O
index	B-T079
period	I-T079
among	O
patients	O
in	O
the	O
test	O
cohort	O
compared	O
with	O
patients	O
in	O
the	O
control	O
cohort	O
.	O
	
in	O
this	O
study	O
,	O
an	O
ms	B-T047
population	O
was	O
utilized	O
to	O
demonstrate	O
how	O
did	O
can	O
be	O
applied	O
to	O
estimate	O
treatment	B-T033
effects	I-T033
in	O
a	O
heterogeneous	B-T080
population	O
,	O
where	O
the	O
test	O
and	O
control	O
cohorts	O
varied	O
greatly	O
.	O
	
the	O
results	O
show	O
that	O
did	O
offers	O
a	O
robust	O
method	O
for	O
comparing	O
diverse	B-T080
cohorts	O
when	O
other	O
risk-adjustment	B-T081
methods	I-T081
metabolomic	O
analysis	B-T169
of	O
glycerophospholipid	B-T109
signatures	O
of	O
inflammation	O
treated	B-T061
with	I-T061
non-steroidal	O
anti-inflammatory	O
drugs	O
-induced-	O
raw264.7	O
cells	O
using	O
1	O
nmr	O
and	O
u-hplc	O
/	O
q-tof-ms	O
non-destructive	O
proton	O
nuclear	O
magnetic	O
resonance	O
1	O
nmr	O
spectroscopy	O
and	O
highly	B-T080
sensitive	I-T080
ultra-performance	O
liquid	O
chromatography	O
quadrupole	O
time-of-flight	O
mass	O
spectrometry	O
u-hplc	O
/	O
q-tof-ms	O
coupled	O
to	O
data	O
processing	O
methods	O
were	O
applied	O
to	O
analyze	O
the	O
metabolic	O
profiling	O
changes	O
of	O
glycerophospholipids	B-T109
gpls	B-T109
in	O
raw264.7	O
cells	O
from	O
inflammation	O
to	O
prognosis	O
.	O
	
analysis	O
of	O
1	O
nmr	O
was	O
shown	O
that	O
the	O
models	O
were	O
grouped	B-T169
successfully	O
,	O
illustrating	O
that	O
all	O
of	O
them	O
had	O
significant	O
differences	B-T080
.	O
	
based	O
on	O
the	O
highly	B-T080
simple	I-T080
,	O
accurate	B-T080
,	O
non-targeted	O
and	O
non-destructively	O
advantages	O
of	O
1	O
nmr	O
,	O
it	O
could	O
be	O
used	O
as	O
a	O
new	O
screening	O
tool	O
of	O
anti-inflammatory	O
drugs	O
in	O
the	O
metabolic	O
profiling	O
of	O
gpls	B-T109
.	O
	
58	O
gpls	B-T109
were	O
identified	B-T080
by	O
u-hplc	O
/	O
q-tof-ms	O
,	O
and	O
19	O
components	O
were	O
firstly	O
identified	B-T080
in	O
this	O
study	O
compared	O
with	O
our	O
previous	O
results	O
.	O
	
in	O
addition	O
,	O
ten	O
potential	B-T080
biomarkers	O
were	O
proved	O
,	O
of	O
which	O
phosphatidylcholine	B-T109
pc	B-T109
16	O
and	O
18	O
changed	B-T081
consistently	O
in	O
three	O
drug-induced	B-T169
groups	B-T078
and	O
might	O
be	O
the	O
important	O
biomarkers	O
.	O
	
compared	O
with	O
1	O
nmr	O
,	O
u-hplc	O
/	O
q-tof-ms	O
showed	O
higher	B-T080
sensitivity	B-T081
and	I-T081
specificity	I-T081
and	O
was	O
more	O
suitable	O
for	O
the	O
determination	O
of	O
biomarkers	O
apart	O
from	O
the	O
deficiency	B-T080
of	O
time-consuming	B-T080
sample	O
preparation	O
steps	O
and	O
unambiguous	O
metabolite	O
identification	B-T080
.	O
	
therefore	O
,	O
it	O
is	O
feasible	O
to	O
analyze	O
the	O
changes	B-T081
of	O
gpls	B-T109
during	O
inflammation	O
by	O
combining	O
1	O
nmr	O
spectroscopy	O
with	O
u-hplc	O
/	O
q-tof-ms	O
.	O
	
the	O
metabolic	O
profiling	O
of	O
gpls	B-T109
provides	O
valuable	O
evidence	B-T078
for	O
inflammation	O
diagnosis	B-T033
and	O
prognosis	O
,	O
and	O
might	O
unravel	O
the	O
mechanisms	B-T169
involved	O
in	O
inflammation	O
progression	O
.	O
	
characterization	O
of	O
novel	B-T080
deor-family	B-T116
member	O
from	O
the	O
streptomyces	O
ahygroscopicus	O
strain	O
ck-15	O
that	O
acts	O
as	O
a	O
repressor	B-T116
of	O
morphological	O
development	B-T169
wuyiencin	O
is	O
produced	O
by	O
streptomyces	O
ahygroscopicus	O
var	O
.	O
	
wuyiensis	O
,	O
which	O
has	O
been	O
widely	O
used	O
in	O
china	O
as	O
an	O
industrially	O
produced	O
biopesticide	O
to	O
control	B-T080
various	O
fungal	B-T047
diseases	I-T047
.	O
	
although	O
its	O
mechanism	B-T169
of	O
action	O
,	O
breeding	O
,	O
and	O
fermentation	O
had	O
been	O
extensively	O
characterized	O
,	O
less	O
is	O
known	O
about	O
the	O
regulatory	O
functions	O
that	O
affect	O
its	O
biosynthesis	B-T169
or	O
morphological	O
development	B-T169
.	O
	
the	O
wysr3	O
gene	O
of	O
s	O
.	O
	
ahygroscopicus	O
strain	O
ck-15	O
,	O
a	O
novel	B-T080
member	O
of	O
the	O
deor	B-T116
family	I-T116
of	O
regulatory	O
genes	O
,	O
was	O
assessed	O
to	O
determine	O
its	O
function	B-T169
by	O
gene	O
knockdown	O
.	O
	
herein	O
,	O
we	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
deor	B-T116
family	I-T116
proteins	I-T116
derived	O
from	O
the	O
same	O
source	B-T033
are	O
likely	O
to	O
be	O
a	O
single	B-T081
branch	O
in	O
a	O
phylogenetic	B-T080
tree	I-T080
and	O
show	O
that	O
wysr3	O
acts	O
as	O
a	O
repressor	B-T116
for	O
its	O
morphological	O
development	B-T169
without	O
effecting	O
wuyiencin	O
production	O
.	O
	
we	O
found	O
that	O
the	O
δwysr3	O
strain	O
can	O
grow	O
quickly	O
to	O
reach	O
a	O
plateau	B-T081
stage	B-T079
of	O
maximum	O
biomass	B-T081
at	O
60	O
h	O
,	O
which	O
is	O
12	O
h	O
faster	B-T080
than	O
the	O
wild-type	O
strain	O
.	O
	
in	O
the	O
industrial	O
fermentation	O
production	O
process	O
,	O
the	O
δwysr3	O
strain	O
can	O
reduce	B-T080
consumption	O
and	O
save	O
both	O
time	B-T079
and	O
targeting	B-T169
the	O
ecology	O
within	O
the	O
role	O
of	O
the	O
gut-brain	O
axis	O
and	O
human	O
microbiota	O
in	O
drug	O
addiction	O
despite	O
major	B-T079
advances	I-T079
in	O
our	O
understanding	O
of	O
the	O
brain	O
using	B-T169
traditional	O
neuroscience	O
,	O
reliable	O
and	O
efficacious	B-T080
treatments	B-T061
for	O
drug	O
addiction	O
have	O
remained	B-T033
elusive	I-T033
.	O
	
hence	O
,	O
the	O
time	B-T079
has	O
come	O
to	O
utilize	B-T169
novel	B-T080
approaches	O
,	O
particularly	O
those	O
drawing	B-T080
upon	O
contemporary	B-T079
advances	B-T079
in	O
fields	O
outside	O
of	O
established	B-T080
neuroscienc	O
e	O
and	O
psychiatry	O
.	O
	
put	O
another	O
way	O
,	O
the	O
time	B-T079
has	O
come	O
for	O
a	O
paradigm	O
shift	O
in	O
the	O
addiction	O
sciences	O
.	O
	
apropos	B-T080
,	O
a	O
revolution	B-T169
in	O
the	O
area	O
of	O
human	O
health	B-T078
is	O
underway	B-T169
,	O
which	O
is	O
occurring	O
at	O
the	O
nexus	B-T080
between	O
enteric	O
microbiology	O
and	O
neuroscience	O
.	O
	
it	O
has	O
become	O
increasingly	B-T169
clear	B-T080
that	O
the	O
human	O
microbiota	O
the	O
vast	O
ecology	O
of	O
bacteria	O
residing	O
within	O
the	O
human	O
organism	O
,	O
plays	O
an	O
important	B-T080
role	O
in	O
health	B-T078
and	O
disease	B-T047
.	O
	
this	O
is	O
not	O
surprising	O
,	O
as	O
it	O
has	O
been	O
estimated	B-T081
that	O
bacteria	O
living	O
in	O
the	O
human	O
body	O
approximately	B-T080
1kg	O
of	O
mass	B-T081
,	O
roughly	O
equivalent	B-T080
to	O
that	O
of	O
the	O
human	O
brain	O
outnumber	O
human	O
cells	O
10	O
to	O
1	O
.	O
	
while	O
advances	O
in	O
the	O
understanding	O
of	O
the	O
role	O
of	O
microbiota	O
in	O
other	O
areas	O
of	O
human	O
health	B-T078
have	O
yielded	B-T081
intriguing	B-T080
results	B-T169
e.g	O
,	O
clostridium	B-T047
difficile	I-T047
,	O
irritable	B-T047
bowel	I-T047
syndrome	I-T047
,	O
autism	O
,	O
etc	O
,	O
to	O
date	B-T079
,	O
no	O
systematic	B-T169
programs	B-T169
of	O
research	O
have	O
examined	B-T033
the	O
role	O
of	O
microbiota	O
in	O
drug	O
addiction	O
.	O
	
the	O
current	B-T079
hypothesis	B-T078
,	O
therefore	O
,	O
is	O
that	O
gut	O
dysbiosis	O
plays	O
a	O
key	O
role	O
in	O
addictive	O
disorders	B-T047
.	O
	
in	O
the	O
context	B-T078
of	O
this	O
hypothesis	B-T078
,	O
this	O
paper	O
provides	O
a	O
rationale	B-T078
for	O
future	B-T079
research	O
to	O
target	B-T169
the	O
""""	O
gut	O
-	O
brain	O
axis	O
""""	O
in	O
addiction	O
.	O
	
a	O
brief	O
background	O
of	O
the	O
gut	O
-	O
brain	O
axis	O
is	O
provided	O
,	O
along	O
with	O
a	O
series	B-T081
of	O
hypothesis-driven	B-T078
ideas	B-T078
outlining	O
potential	B-T080
treatments	B-T061
for	O
addiction	O
via	O
manipulations	B-T033
of	O
the	O
""""	O
ecology	O
homogeneous	B-T080
synthesis	O
of	O
ag	O
nanoparticles	O
-doped	O
water-soluble	B-T109
cellulose	I-T109
acetate	I-T109
for	O
versatile	B-T080
applications	B-T169
we	O
report	O
a	O
facile	B-T080
and	O
efficient	B-T080
approach	O
for	O
synthesis	O
of	O
well-dispersed	O
and	O
stable	B-T080
silver	O
nanoparticles	O
ag	O
nps	O
using	O
water-soluble	B-T109
cellulose	I-T109
acetate	I-T109
ca	B-T109
as	O
both	O
reductant	O
and	O
stabilizer	O
.	O
	
partially	B-T081
substituted	O
ca	B-T109
with	O
highly	B-T080
active	B-T169
hydroxyl	O
groups	O
and	O
excellent	B-T080
water-solubility	B-T081
is	O
able	B-T033
to	O
reduce	O
silver	O
ions	O
in	O
homogeneous	B-T080
aqueous	B-T080
medium	O
effectively	B-T080
.	O
	
the	O
synthesized	O
ag	O
nps	O
were	O
characterized	O
by	O
uv-vis	O
spectroscopy	O
,	O
x-ray	O
diffraction	O
,	O
x-ray	O
photoelectron	O
spectroscopy	O
,	O
transmission	O
electron	O
microscopy	O
and	O
energy	O
dispersive	O
x-ray	O
spectroscope	O
analysis	O
.	O
	
the	O
as-	O
prepared	B-T033
ag	O
nps	O
were	O
well-dispersed	O
,	O
showing	O
a	O
surface	O
plasmon	O
resonance	O
peak	B-T080
at	O
426	O
nm	B-T081
.	O
	
the	O
resulted	O
ag	O
nps	O
ca	B-T109
nanohybrids	O
exhibit	O
high	B-T080
catalytic	B-T169
activity	I-T169
for	O
the	O
reduction	O
of	O
4-nitrophenol	B-T109
to	O
4-aminophenol	B-T109
in	O
the	O
presence	O
of	O
nabh4	O
.	O
	
meanwhile	O
,	O
the	O
nanohybrids	O
are	O
also	O
effective	B-T080
in	O
inhibiting	O
the	O
growth	O
of	O
bacterial	O
.	O
	
this	O
environmentally	O
friendly	O
method	O
promotes	O
the	O
use	B-T169
of	I-T169
renewable	B-T078
natural	I-T078
resources	I-T078
to	O
prepare	O
a	O
variety	O
of	O
inorganic-organic	O
materials	O
for	O
catalysis	O
,	O
antibacterial	O
,	O
sensors	O
and	O
other	O
isx-9	B-T109
can	O
potentiate	O
cell	O
proliferation	O
and	O
neuronal	O
commitment	O
in	O
the	O
rat	O
dentate	O
gyrus	O
adult	O
hippocampal	O
neurogenesis	O
can	O
be	O
modulated	O
by	O
various	O
physiological	O
and	O
pathological	O
conditions	O
,	O
including	O
stress	B-T033
,	O
affective	O
disorders	O
,	O
and	O
several	O
neurological	B-T080
conditions	B-T080
.	O
	
given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	O
of	O
the	O
hippocampus	O
namely	O
learning	O
and	O
memory	O
and	O
affective	B-T078
behaviors	O
,	O
it	O
is	O
believed	O
that	O
alterations	B-T078
in	O
hippocampal	O
neurogenesis	O
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	B-T080
associated	B-T080
with	I-T080
these	O
psychiatric	B-T169
and	O
neurological	B-T080
conditions	B-T080
.	O
	
thus	O
,	O
the	O
search	O
for	O
compounds	O
that	O
can	O
reverse	B-T169
these	O
deficits	B-T080
with	O
minimal	B-T080
side	O
effects	O
has	O
become	O
a	O
recognized	O
priority	O
.	O
	
in	O
the	O
present	O
study	O
we	O
tested	B-T169
the	O
pro-neurogenic	B-T080
effects	B-T080
of	O
isoxazole	B-T109
9	I-T109
isx-9	B-T109
,	O
a	O
small	O
synthetic	O
molecule	O
that	O
has	O
been	O
recently	O
identified	B-T080
through	O
the	O
screening	O
of	O
chemical	O
libraries	O
in	O
stem	O
cell-based	O
assays	O
.	O
	
we	O
found	O
that	O
administration	B-T061
of	O
isx-9	B-T109
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	O
proliferation	O
and	O
increase	B-T169
the	O
number	B-T081
of	O
immature	B-T080
neurons	O
in	O
the	O
hippocampal	O
dg	O
of	O
adult	O
rats	O
.	O
	
in	B-T169
addition	I-T169
,	O
isx-9	B-T109
treatment	B-T061
was	O
able	O
to	O
completely	B-T080
reverse	B-T169
the	O
marked	B-T080
reduction	B-T080
in	O
these	O
initial	B-T079
stages	B-T079
of	O
the	O
neurogenic	O
process	O
observed	B-T169
in	O
vehicle	O
-	O
treated	B-T169
animals	O
which	O
were	O
submitted	O
to	O
repeated	B-T169
handling	O
and	O
exposure	B-T080
to	I-T080
daily	B-T079
intraperitoneal	B-T061
injections	I-T061
.	O
	
based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	B-T169
handling	O
and	O
manipulation	B-T061
of	O
animals	O
should	O
include	O
a	O
naïve	O
non-manipulated	O
control	B-T080
to	O
determine	O
the	O
baseline	B-T081
levels	B-T080
of	O
hippocampal	O
cell	O
proliferation	O
and	O
neuronal	O
differentiation	O
.	O
	
overall	O
,	O
these	O
findings	B-T033
demonstrate	O
that	O
isx-9	B-T109
is	O
a	O
promising	O
synthetic	O
compound	O
for	O
the	O
mitigation	O
of	O
stress	B-T033
-	O
induced	B-T169
deficits	B-T080
in	O
adult	O
hippocampal	O
neurogenesis	O
.	O
	
future	O
studies	O
are	O
thus	O
warranted	O
to	O
evaluate	O
the	O
pro-neurogenic	B-T080
properties	B-T080
of	O
isx-9	B-T109
in	O
animal	O
models	O
of	O
affective	O
and	O
neurological	B-T047
disorders	I-T047
associated	B-T080
with	I-T080
impaired	B-T169
hippocampal	O
structural	O
plasticity	O
.	O
	
changes	B-T169
in	O
parenting	O
strategies	O
after	O
a	O
young	B-T079
person's	O
self-harm	O
a	O
qualitative	O
study	O
when	O
faced	O
with	O
the	O
discovery	O
of	O
their	O
child's	O
self-harm	O
,	O
mothers	O
and	O
fathers	O
may	O
re-evaluate	O
their	O
parenting	O
strategies	O
.	O
	
this	O
can	O
include	O
changes	B-T169
to	O
the	O
amount	O
of	O
support	O
they	O
provide	O
their	O
child	O
and	O
changes	B-T169
to	O
the	O
degree	B-T081
to	O
which	O
they	O
control	B-T080
and	O
monitor	O
their	O
child	O
.	O
	
we	O
conducted	O
an	O
in-depth	O
qualitative	O
study	O
with	O
37	O
parents	O
of	O
young	B-T079
people	O
who	O
had	O
self-harmed	O
in	O
which	O
we	O
explored	O
how	O
and	O
why	O
their	O
parenting	O
changed	B-T169
after	O
the	O
discovery	O
of	O
self-harm	O
.	O
	
early	B-T079
on	O
,	O
parents	O
often	O
found	O
themselves	O
"""walking"	O
on	O
"eggshells"""	O
so	O
as	O
not	O
to	O
upset	O
their	O
child	O
,	O
but	O
later	O
they	O
felt	O
more	O
able	O
to	O
take	O
some	O
control	B-T080
.	O
	
parents	O
'	O
reactions	B-T169
to	O
the	O
self-harm	O
often	O
depended	O
on	O
how	O
they	O
conceptualised	O
it	O
as	O
part	O
of	O
adolescence	B-T079
,	O
as	O
a	O
mental	O
health	O
issue	O
or	O
as	O
""""	O
naughty	O
behaviour	O
""""	O
.	O
	
parenting	O
of	O
other	O
children	O
in	O
the	O
family	O
could	O
also	O
be	O
affected	O
,	O
with	O
parents	O
worrying	O
about	O
less	O
of	O
their	O
time	B-T079
being	O
available	O
for	O
siblings	O
.	O
	
many	O
parents	O
developed	O
specific	O
strategies	O
they	O
felt	O
helped	O
them	O
to	O
be	O
more	O
effective	O
parents	O
,	O
such	O
as	O
learning	O
to	O
avoid	O
blaming	O
themselves	O
or	O
their	O
child	O
for	O
the	O
self-harm	O
and	O
developing	O
new	O
ways	O
to	O
communicate	B-T033
with	O
their	O
child	O
.	O
	
parents	O
were	O
generally	O
eager	O
to	O
pass	O
their	O
knowledge	O
on	O
to	O
other	O
people	O
in	O
the	O
same	O
situation	B-T169
.	O
	
parents	O
reported	O
changes	B-T169
in	O
their	O
parenting	O
behaviours	O
after	O
the	O
discovery	O
of	O
a	O
child	O
's	O
self-harm	O
.	O
	
professionals	O
involved	O
in	O
the	O
care	O
of	O
young	B-T079
people	O
who	O
self-harm	O
might	O
use	O
this	O
information	B-T078
in	O
supporting	O
and	O
advising	O
parents	O
.	O
	
optimizing	O
survival	B-T169
of	O
patients	O
with	O
marginally	B-T080
operable	I-T080
stage	O
iiia	O
non-small-cell	O
lung	O
cancer	O
receiving	O
chemoradiotherapy	B-T061
with	B-T169
or	O
without	B-T080
surgery	B-T169
for	O
marginally	B-T080
operable	I-T080
stage	O
iiia	O
non-small-cell	O
lung	O
cancer	O
nsclc	O
,	O
surgery	B-T169
might	O
not	O
be	O
done	O
as	O
planned	O
after	O
neoadjuvant	B-T061
concurrent	B-T061
chemoradiotherapy	I-T061
ccrt	B-T061
for	O
reasons	O
unresectable	O
or	O
medically	B-T080
inoperable	I-T080
conditions	B-T080
,	O
or	O
patient	O
refusal	O
.	O
	
this	O
study	O
aims	O
to	O
investigate	B-T169
the	O
outcomes	B-T169
of	O
a	O
phased	B-T061
ccrt	I-T061
protocol	I-T061
established	O
to	O
maximize	O
the	O
operability	B-T169
of	O
marginally	B-T080
operable	I-T080
stage	O
iiia	O
nsclc	O
and	O
to	O
care	O
for	O
reassessed	O
inoperable	O
patients	O
,	O
in	O
comparison	O
with	O
continuous-course	B-T061
definitive	I-T061
ccrt	I-T061
.	O
	
forty-seven	O
patients	O
with	O
marginally	B-T080
operable	I-T080
stage	O
iiia	O
nsclc	O
receiving	O
ccrt	B-T061
were	O
included	O
.	O
	
twenty-eight	O
patients	O
were	O
treated	B-T169
with	O
our	O
phased	B-T061
ccrt	I-T061
protocol	I-T061
,	O
including	O
neoadjuvant	B-T061
ccrt	B-T061
followed	O
by	O
surgery	B-T169
group	B-T078
a	I-T078
,	O
n	O
=	O
16	O
or	O
,	O
for	O
reassessed	O
inoperable	O
patients	O
,	O
maintenance	O
chemotherapy	O
and	O
split-course	O
ccrt	O
boost	O
group	O
b	O
,	O
n	O
=	O
12	O
.	O
	
the	O
other	O
19	O
were	O
treated	O
with	O
continuous-course	O
definitive	O
ccrt	O
group	O
c	O
.	O
	
overall	O
survival	O
os	O
and	O
progression-free	O
survival	O
pfs	O
were	O
analyzed	O
.	O
	
among	O
all	O
,	O
median	O
os	O
and	O
pfs	O
were	O
35.6	O
and	O
12.8	O
months	O
,	O
respectively	O
median	O
follow-up	O
,	O
22.3	O
months	O
.	O
	
the	O
median	O
os	O
of	O
group	O
a	O
not	O
reached	O
was	O
better	O
than	O
that	O
of	O
group	O
b	O
34.4	O
months	O
and	O
group	O
c	O
15.2	O
months	O
p	O
=	O
009	O
.	O
	
on	O
multivariate	O
analysis	O
,	O
performance	O
status	O
0	O
to	O
1	O
hazard	O
ratio	O
hr	O
,	O
0.026	O
p	O
<	O
001	O
,	O
adenocarcinoma	O
hr	O
,	O
0.156	O
p	O
=	O
003	O
,	O
and	O
group	O
a	O
hr	O
,	O
0.199	O
p	O
=	O
033	O
were	O
independent	O
prognostic	O
factors	O
.	O
	
the	O
os	O
of	O
group	O
b	O
hr	O
,	O
0.450	O
95%	O
confidence	O
interval	O
,	O
0.118	O
p	O
=	O
243	O
was	O
not	O
statistically	O
different	O
from	O
that	O
of	O
group	O
c	O
.	O
	
for	O
marginally	O
operable	O
stage	O
iiia	O
nsclc	O
,	O
our	O
phased	O
ccrt	O
strategy	O
may	O
optimize	O
survival	O
by	O
maximizing	O
operability	O
and	O
maintain	O
an	O
acceptable	O
survival	O
for	O
reassessed	O
inoperable	O
patients	O
by	O
split-course	O
ccrt	O
boost	O
following	O
maintenance	B-T033
chemotherapy	I-T033
.	O
	
evaluation	O
of	O
three	B-T081
protein-extraction	O
methods	O
for	O
proteome	B-T116
analysis	O
of	O
maize	O
leaf	O
midrib	O
,	O
a	O
compound	O
tissue	O
rich	O
in	O
sclerenchyma	O
cells	O
leaf	O
morphology	B-T080
is	O
closely	O
related	O
to	O
the	O
growth	O
and	O
development	O
of	O
maize	O
zea	O
mays	O
l	O
plants	O
and	O
final	O
kernel	O
production	O
.	O
	
as	O
an	O
important	O
part	O
of	O
the	O
maize	O
leaf	O
,	O
the	O
midrib	O
holds	O
leaf	O
blades	O
in	O
the	O
aerial	O
position	O
for	O
maximum	O
sunlight	O
capture	O
.	O
	
leaf	O
midrib	O
s	O
of	O
adult	B-T079
plants	O
contain	O
substantial	O
sclerenchyma	O
cells	O
with	O
heavily	B-T080
thickened	I-T080
and	O
lignified	B-T109
secondary	O
walls	O
and	O
have	O
a	O
high	O
amount	O
of	O
phenolics	B-T109
,	O
making	O
protein	O
extraction	O
and	O
proteome	B-T116
analysis	O
difficult	O
in	O
leaf	O
midrib	O
tissue	O
.	O
	
in	O
the	O
present	O
study	O
,	O
three	O
protein-extraction	O
methods	O
that	O
are	O
commonly	O
used	O
in	O
plant	O
proteomics	O
,	O
i.e	O
,	O
phenol	B-T109
extraction	O
,	O
tca	B-T109
/	O
acetone	B-T109
extraction	O
,	O
and	O
tca	B-T109
/	O
acetone	B-T109
/	O
phenol	B-T109
extraction	O
,	O
were	O
qualitatively	B-T080
and	O
quantitatively	B-T081
evaluated	I-T081
based	O
on	O
2de	O
maps	O
and	O
ms/ms	O
analysis	O
using	O
the	O
midribs	O
of	O
the	O
10th	O
newly	O
expanded	O
leaves	O
of	O
maize	O
plants	O
.	O
	
microscopy	O
revealed	O
the	O
existence	O
of	O
substantial	O
amounts	O
of	O
sclerenchyma	O
underneath	O
maize	O
midrib	O
epidermises	O
particularly	O
abaxial	O
epidermises	O
.	O
	
the	O
spot-number	O
order	O
obtained	O
via	O
2de	O
mapping	O
was	O
as	O
follows	O
phenol	B-T109
extraction	O
655	O
>	O
tca	B-T109
/	O
acetone	B-T109
extraction	O
589	O
>	O
tca	B-T109
/	O
acetone	B-T109
/	O
phenol	B-T109
extraction	O
545	O
.	O
	
ms/ms	O
analysis	O
identified	O
a	O
total	O
of	O
17	O
spots	O
that	O
exhibited	O
2-fold	O
changes	O
in	O
abundance	O
among	O
the	O
three	B-T081
methods	O
using	O
phenol	B-T109
extraction	O
as	O
a	O
control	O
.	O
	
sixteen	O
of	O
the	O
proteins	B-T116
identified	O
were	O
hydrophilic	B-T080
,	O
with	O
gravy	B-T081
values	I-T081
ranging	O
from	O
-0	O
to	O
-0	O
.	O
	
for	O
all	O
three	B-T081
methods	O
,	O
we	O
were	O
able	O
to	O
obtain	O
high-quality	O
protein	B-T116
samples	O
and	O
good	O
2de	O
maps	O
for	O
the	O
maize	O
leaf	O
midrib	O
.	O
	
however	O
,	O
phenol	B-T109
extraction	O
produced	O
a	O
better	O
2de	O
map	O
with	O
greater	O
resolution	O
between	O
spots	O
,	O
and	O
tca	B-T109
/	O
acetone	B-T109
extraction	O
produced	O
higher	O
protein	B-T116
yields	B-T081
.	O
	
thus	O
,	O
this	O
paper	O
includes	O
a	O
discussion	O
regarding	O
the	O
possible	O
reasons	O
for	O
differential	B-T080
protein	O
extraction	O
among	O
the	O
three	B-T081
methods	O
.	O
	
this	O
study	O
provides	O
useful	O
information	O
that	O
can	O
be	O
used	O
to	O
select	O
suitable	O
protein	O
extraction	O
methods	O
for	O
the	O
proteome	B-T116
analysis	O
of	O
recalcitrant	O
plant	O
tissues	O
that	O
are	O
rich	O
in	O
sclerenchyma	O
cells	O
.	O
	
dominant	B-T033
and	O
non-	O
dominant	B-T033
frequency	B-T079
structure	O
of	O
evoked	B-T080
ventricular	B-T047
fibrillation	I-T047
in	O
dogs	O
with	O
myocardial	B-T047
ischemia	I-T047
the	O
first	O
10	O
min	O
of	O
electrically	B-T061
provoked	I-T061
ventricular	B-T047
fibrillation	I-T047
in	O
dogs	O
with	O
ischemic	B-T047
heart	I-T047
disease	I-T047
were	O
characterized	O
by	O
organized	B-T169
myocardial	O
activity	O
evidenced	O
by	O
the	O
dominant	B-T033
ecg	I-T033
frequency	I-T033
structure	O
.	O
	
during	O
the	O
first	O
2	O
min	O
of	O
ventricular	B-T047
fibrillation	I-T047
,	O
low-frequency	B-T080
oscillations	I-T080
4-7	O
hz	O
dominated	O
,	O
while	O
on	O
min	O
3	O
to	O
10	O
after	O
the	O
onset	O
of	O
fibrillation	B-T047
,	O
the	O
dominant	B-T033
frequencies	I-T033
were	O
low	B-T080
and	O
medium	B-T081
4-12	O
hz	O
.	O
	
after	O
10-min	O
fibrillation	B-T047
,	O
the	O
oscillations	B-T061
became	O
non-	O
dominant	B-T033
.	O
	
thus	O
,	O
ischemic	B-T033
myocardium	I-T033
maintains	O
the	O
organized	B-T079
structure	I-T079
of	O
ventricular	B-T047
fibrillation	I-T047
for	O
the	O
first	O
10	O
min	O
,	O
which	O
is	O
important	O
for	O
the	O
development	B-T169
of	O
automatic	O
diagnostics	O
of	O
abnormal	B-T033
cardiac	I-T033
activity	I-T033
in	O
adverse	O
events	O
risk	B-T078
associated	B-T080
with	I-T080
angiogenesis	O
inhibitors	O
addition	O
to	O
therapy	B-T061
in	O
ovarian	O
cancer	O
a	O
meta-analysis	O
of	O
randomized	O
controlled	O
trials	O
inhibition	O
of	O
angiogenesis	O
has	O
been	O
regarded	O
as	O
an	O
attractive	O
treatment	B-T061
strategy	I-T061
for	O
advanced	O
or	O
recurrent	O
ovarian	O
cancer	O
.	O
	
we	O
conduct	O
this	O
meta-analysis	O
to	O
investigate	B-T169
the	O
risk	B-T078
of	O
adverse	O
events	O
of	O
special	O
interest	O
related	O
to	O
angiogenesis	O
inhibitors	O
ais	O
in	O
ovarian	O
cancer	O
.	O
	
databases	O
from	O
pubmed	O
,	O
web	O
of	O
science	O
and	O
cochrane	O
library	O
up	O
to	O
december	O
2015	O
were	O
searched	O
to	O
identify	O
relevant	B-T080
studies	O
.	O
	
eligible	O
studies	O
included	O
prospective	O
randomized	O
controlled	O
phase	O
ii/iii	O
clinical	O
trials	O
evaluating	O
therapy	B-T061
with	O
or	O
without	O
ais	O
for	O
ovarian	O
cancer	O
.	O
	
summary	O
relative	B-T081
risk	I-T081
rr	B-T081
and	O
95%	O
confidence	B-T081
intervals	I-T081
cis	B-T081
were	O
calculated	O
using	O
random-effects	B-T080
or	O
fixed-effects	B-T080
according	O
to	O
the	O
heterogeneity	B-T080
among	O
included	O
trials	O
.	O
	
a	O
total	O
of	O
7	O
patients	O
from	O
ten	O
clinical	O
trials	O
were	O
included	O
in	O
the	O
meta-analysis	O
.	O
	
pooled	B-T169
rr	B-T081
showed	O
that	O
the	O
use	B-T169
of	I-T169
ais	O
was	O
associated	B-T080
with	I-T080
a	O
statistically	O
increased	B-T081
risk	B-T078
in	O
four	O
of	O
the	O
adverse	B-T169
outcomes	B-T080
studied	O
arterial	O
thromboembolic	O
events	O
rr	B-T081
=	O
2.0	O
,	O
gastrointestinal	B-T047
gi	I-T047
perforation	I-T047
rr	B-T081
=	O
3.86	O
,	O
proteinuria	B-T033
rr	B-T081
=	O
2.44	O
,	O
and	O
hypertension	B-T047
rr	B-T081
=	O
5.39	O
.	O
	
no	B-T033
statistically	I-T033
significant	I-T033
differences	B-T080
were	O
found	O
for	O
hemorrhagic	O
events	O
p	O
=	O
0.07	O
,	O
venous	B-T047
thromboembolic	I-T047
events	O
p	O
=	O
0.13	O
,	O
or	O
fatal	B-T080
adverse	O
events	O
p	O
=	O
0.26	O
.	O
	
the	O
addition	O
of	O
ais	O
to	O
therapy	B-T061
in	O
ovarian	O
cancer	O
did	O
significantly	O
increase	B-T169
the	O
risk	B-T078
of	O
arterial	O
thromboembolic	O
events	O
,	O
gi	B-T047
perforation	I-T047
,	O
proteinuria	B-T033
and	O
hypertension	B-T047
,	O
but	O
not	O
for	O
venous	B-T047
thromboembolic	I-T047
events	O
,	O
hemorrhagic	O
events	O
,	O
or	O
fatal	B-T080
adverse	O
events	O
.	O
	
relationship	B-T080
between	O
lrrk2	O
r1628p	O
polymorphism	O
and	O
parkinson's	B-T047
disease	I-T047
in	O
asian	O
populations	O
although	O
the	O
leucine-rich	O
repeat	O
kinase	O
2	O
lrrk2	O
r1628p	O
polymorphism	O
has	O
been	O
associated	B-T080
with	I-T080
the	O
risk	B-T078
of	O
parkinson's	B-T047
disease	I-T047
pd	B-T047
in	O
taiwan	O
,	O
china	O
,	O
and	O
singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	B-T080
.	O
	
thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta-analysis	O
was	O
to	O
evaluate	O
the	O
associations	B-T080
between	O
the	O
lrrk2	O
r1628p	O
polymorphism	O
rs33949390	O
and	O
pd	B-T047
in	O
asian	O
populations	O
.	O
	
a	O
search	O
for	O
eligible	O
studies	O
was	O
performed	O
in	O
pubmed	O
,	O
embase	O
,	O
sinomed	O
,	O
and	O
the	O
china	O
knowledge	O
resource	O
integrated	O
database	O
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95%	O
confidence	B-T081
intervals	I-T081
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	B-T080
between	O
the	O
r1628p	O
polymorphism	O
and	O
pd	B-T047
.	O
	
this	O
meta-analysis	O
assessed	O
19	O
studies	O
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9	O
pd	B-T047
patients	O
and	O
8	O
controls	O
and	O
found	O
that	O
the	O
r1628p	O
polymorphism	O
was	O
significantly	O
associated	B-T080
with	I-T080
the	O
risk	B-T078
of	O
pd	B-T047
in	O
asian	O
populations	O
.	O
	
moreover	O
,	O
stratification	O
analyses	O
indicated	O
that	O
the	O
r1628p	O
polymorphism	O
was	O
significantly	O
associated	B-T080
with	I-T080
an	O
increased	O
risk	B-T078
of	O
pd	B-T047
among	O
chinese	O
as	O
well	O
as	O
non-chinese	O
asian	O
populations	O
and	O
an	O
increased	O
risk	B-T078
of	O
pd	B-T047
in	O
chinese	O
patients	O
from	O
china	O
,	O
taiwan	O
,	O
and	O
singapore	O
.	O
	
in	O
a	O
stratified	O
analysis	O
conducted	O
according	O
to	O
age	O
,	O
significant	O
associations	B-T080
were	O
found	O
for	O
both	O
late-onset	O
pd	B-T047
and	O
early-onset	O
pd	B-T047
.	O
	
the	O
present	O
data	O
indicate	O
that	O
the	O
r1628p	O
polymorphism	O
of	O
the	O
lrrk2	O
gene	O
contributes	O
to	O
pd	B-T047
susceptibility	O
in	O
asian	O
,	O
especially	O
chinese	O
,	O
populations	O
.	O
	
efficacy	B-T080
and	O
safety	B-T080
of	O
cisplatin	O
,	O
dexamethasone	B-T109
,	O
gemcitabine	O
and	O
pegaspargase	B-T116
ddgp	O
regimen	B-T061
in	O
newly	B-T080
diagnosed	I-T080
,	O
advanced-stage	B-T080
extranodal	O
natural	O
killer/t-cell	O
lymphoma	O
interim	B-T079
analysis	O
of	O
a	O
phase	B-T079
4	I-T079
study	O
nct01501149	O
to	O
explore	O
a	O
more	O
effective	B-T080
treatment	B-T169
for	O
newly	B-T080
diagnosed	I-T080
,	O
advanced-stage	B-T080
extranodal	O
natural	O
killer/t-cell	O
lymphoma	O
,	O
nasal	O
type	O
enktl	O
,	O
we	O
conducted	O
a	O
phase	B-T079
4	I-T079
study	O
of	O
the	O
cisplatin	O
,	O
dexamethasone	B-T109
,	O
gemcitabine	O
,	O
pegaspargase	B-T116
ddgp	O
regimen	B-T061
.	O
	
the	O
primary	O
end	B-T080
point	I-T080
was	O
the	O
2-year	O
progression-free	B-T081
survival	I-T081
pfs	B-T081
after	O
the	O
protocol	B-T061
treatment	I-T061
.	O
	
secondary	O
endpoints	B-T080
included	O
response	B-T079
rate	I-T079
rr	B-T079
,	O
overall	B-T081
survival	I-T081
os	B-T081
and	O
median	B-T079
survival	I-T079
time	I-T079
mst	B-T079
.	O
	
the	O
interim	B-T079
analysis	O
included	O
data	B-T078
only	O
from	O
march	O
2011	O
to	O
september	O
2013	O
,	O
who	O
received	B-T080
six	O
cycles	O
of	O
ddgp	O
chemotherapy	B-T061
.	O
	
a	O
total	O
of	O
25	O
eligible	B-T080
patients	O
were	O
enrolled	O
.	O
	
seventeen	O
patients	O
17/24	O
,	O
70.83	O
achieved	O
complete	B-T033
response	I-T033
cr	B-T033
and	O
four	O
4/24	O
,	O
16.67	O
achieved	O
partial	B-T033
response	I-T033
pr	B-T033
,	O
three	O
3/24	O
,	O
12.50	O
had	O
progressive	B-T047
disease	I-T047
pd	B-T047
.	O
	
the	O
rr	B-T079
after	O
treatment	B-T169
was	O
87.50	O
.	O
	
after	O
a	O
median	B-T081
follow-up	O
duration	B-T079
of	O
24.67	O
months	B-T079
range	O
4-48	O
months	B-T079
.	O
	
the	O
2-year	O
pfs	B-T081
and	O
os	B-T081
rate	I-T081
were	O
61.80	O
95%	O
ci	B-T081
,	O
42.00	O
to	O
81.60	O
and	O
68.50	O
%	O
95%	O
ci	B-T081
,	O
48.70	O
to	O
88.30	O
,	O
respectively	O
.	O
	
the	O
mst	B-T079
was	O
36.55	O
months	B-T079
95%	O
ci	B-T081
,	O
29.41	O
months	B-T079
to	O
43.70	O
months	B-T079
.	O
	
grade	O
3/4	O
leukopenia	B-T047
occurred	B-T079
in	O
fourteen	O
patients	O
58.33	O
and	O
grade	O
3/4	O
thrombocytopenia	B-T047
occurred	B-T079
in	O
eleven	O
patients	O
45.83	O
.	O
	
twelve	O
patients	O
50.00	O
experienced	O
activated	O
partial	O
phromboplastin	O
ptime	O
aptt	O
elongation	B-T033
and	O
fourteen	O
patients	O
58.33	O
experienced	O
hypofibrinogenemia	B-T047
.	O
	
in	O
conclusion	O
,	O
ddgp	O
regimen	B-T061
is	O
an	O
effective	B-T080
and	O
tolerated	B-T033
treatment	B-T169
for	O
newly	B-T080
diagnosed	I-T080
,	O
advanced-stage	B-T080
enktl	O
.	O
	
this	O
trial	O
was	O
registered	O
at	O
www.clinicaltrials	O
effect	B-T080
of	O
hepatitis	B-T047
c	I-T047
virus	I-T047
coinfection	I-T047
on	O
the	O
content	O
of	O
cd4	O
and	O
cd8	O
t	O
cell	O
subpopulations	O
in	O
hiv	O
-	O
infected	B-T033
patients	O
receiving	B-T080
antiretroviral	B-T061
therapy	I-T061
we	O
studied	O
the	O
effect	B-T080
of	O
hepatitis	B-T047
c	I-T047
virus	I-T047
coinfection	I-T047
on	O
t	O
cell	O
subpopulations	O
in	O
hiv	O
-	O
infected	B-T033
patients	O
receiving	O
antiretroviral	B-T061
therapy	I-T061
.	O
	
coinfection	B-T047
with	O
hepatitis	O
c	O
virus	O
was	O
followed	O
by	O
a	O
decrease	B-T081
in	O
the	O
number	O
of	O
naive	O
cd4	O
t	O
cells	O
and	O
an	O
increase	B-T169
in	O
the	O
count	B-T081
of	O
central	O
cd8	O
memory	O
t	O
cells	O
in	O
these	O
patients	O
.	O
	
hepatitis	O
c	O
virus	O
had	O
no	B-T080
effect	I-T080
on	O
the	O
number	O
of	O
cd4	O
memory	O
t	O
cells	O
main	O
target	O
for	O
hiv	O
.	O
	
this	O
can	O
explain	O
the	O
absence	O
of	O
strong	O
negative	B-T033
effect	B-T080
of	O
hepatitis	O
c	O
virus	O
on	O
the	O
course	B-T079
of	O
hiv	O
infection	O
.	O
	
examining	B-T169
the	O
contribution	O
of	O
motor	B-T169
movement	I-T169
and	O
language	O
dominance	B-T078
to	O
increased	B-T081
left	O
lateralization	O
during	O
sign	O
generation	O
in	O
native	B-T169
signers	O
the	O
neural	O
systems	O
supporting	O
speech	O
and	O
sign	B-T078
processing	O
are	O
very	O
similar	B-T080
,	O
although	O
not	O
identical	O
.	O
	
in	O
a	O
previous	O
ftcd	O
study	O
of	O
hearing	O
native	B-T169
signers	O
gutierrez-sigut	O
,	O
daws	O
,	O
et	O
al	O
,	O
2015	O
we	O
found	O
stronger	O
left	O
lateralization	O
for	O
sign	B-T078
than	O
speech	O
.	O
	
given	O
that	O
this	O
increased	B-T081
lateralization	O
could	O
not	O
be	O
explained	O
by	O
hand	O
movement	O
alone	O
,	O
the	O
contribution	O
of	O
motor	B-T169
movement	I-T169
versus	O
'	O
linguistic	O
'	O
processes	O
to	O
the	O
strength	B-T078
of	O
hemispheric	O
lateralization	O
during	O
sign	B-T078
production	O
remains	O
unclear	O
.	O
	
here	O
we	O
directly	O
contrast	B-T080
lateralization	O
strength	B-T078
of	O
covert	B-T078
versus	O
overt	B-T080
signing	B-T078
during	O
phonological	B-T169
and	O
semantic	B-T078
fluency	B-T080
tasks	B-T169
.	O
	
to	O
address	O
the	O
possibility	O
that	O
hearing	O
native	B-T169
signers	O
'	O
elevated	B-T080
lateralization	B-T081
indices	I-T081
lis	B-T081
were	O
due	O
to	O
performing	O
a	O
task	B-T169
in	O
their	O
less	O
dominant	B-T169
language	O
,	O
here	O
we	O
test	O
deaf	O
native	B-T169
signers	O
,	O
whose	O
dominant	B-T169
language	O
is	O
british	O
sign	O
language	O
bsl	O
.	O
	
signers	O
were	O
more	O
strongly	O
left	O
lateralized	O
for	O
overt	B-T080
than	O
covert	B-T078
sign	B-T078
generation	O
.	O
	
however	O
,	O
the	O
strength	B-T078
of	O
lateralization	O
was	O
not	O
correlated	B-T080
with	O
the	O
amount	O
of	O
time	O
producing	O
movements	O
of	O
the	O
right	O
hand	O
.	O
	
comparisons	O
with	O
previous	O
data	B-T078
from	O
hearing	O
native	B-T169
english	O
speakers	O
suggest	O
stronger	O
laterality	B-T081
indices	I-T081
for	O
sign	B-T078
than	O
speech	O
in	O
both	O
covert	B-T078
and	O
overt	B-T080
tasks	B-T169
.	O
	
this	O
increased	B-T081
left	O
lateralization	O
may	O
be	O
driven	O
by	O
specific	O
properties	B-T080
of	O
sign	B-T078
production	O
such	O
as	O
the	O
increased	B-T081
use	B-T169
of	O
self-monitoring	O
mechanisms	B-T169
or	O
the	O
nature	B-T078
of	O
phonological	O
encoding	O
of	O
hard	O
ticks	O
acari	O
ixodidae	O
of	O
livestock	O
in	O
nicaragua	O
,	O
with	O
notes	O
about	O
distribution	B-T169
we	O
document	O
the	O
species	O
of	O
ticks	O
that	O
parasitize	B-T047
livestock	O
in	O
nicaragua	O
.	O
	
the	O
study	O
was	O
based	O
on	O
tick	O
collection	B-T169
on	O
cattle	O
and	O
horses	O
from	O
437	O
farms	O
in	O
nine	O
departments	O
.	O
	
of	O
4841	O
animals	O
examined	O
4481	O
cows	O
and	O
360	O
horses	O
,	O
3299	O
were	O
parasitized	B-T047
,	O
which	O
represent	O
68	O
%	O
of	O
the	O
bovines	O
and	O
67	O
%	O
of	O
the	O
equines	O
in	O
study	O
59	O
cows	O
and	O
25	O
horses	O
were	O
parasitized	B-T047
by	O
more	O
than	O
one	O
species	O
.	O
	
in	O
addition	O
,	O
280	O
specimens	O
of	O
the	O
entomological	O
museum	O
in	O
león	O
were	O
examined	O
.	O
	
the	O
ticks	O
found	O
on	O
cattle	O
were	O
rhipicephalus	O
microplus	O
75.2	O
%	O
of	O
the	O
ticks	O
collected	B-T169
,	O
amblyomma	O
mixtum	O
20.8	O
%	O
,	O
a	O
.	O
	
parvum	O
2.6	O
%	O
,	O
a	O
.	O
	
tenellum	O
0.7	O
%	O
,	O
a	O
.	O
	
maculatum	O
0.7	O
%	O
.	O
	
while	O
the	O
ticks	O
collected	B-T169
from	O
the	O
horses	O
were	O
dermacentor	O
nitens	O
41.5	O
%	O
,	O
a	O
.	O
	
mixtum	O
31.7	O
%	O
,	O
r	O
.	O
	
microplus	O
13.8	O
%	O
,	O
a	O
.	O
	
parvum	O
6.5	O
%	O
,	O
a	O
.	O
	
tenellum	O
3.3	O
%	O
,	O
d	O
.	O
	
dissimilis	O
2.4	O
%	O
and	O
a	O
.	O
	
maculatum	O
assessment	O
the	O
exposure	B-T080
level	B-T080
of	O
rare	O
earth	O
elements	O
in	O
workers	O
producing	O
cerium	B-T109
,	O
lanthanum	O
oxide	O
ultrafine	B-T109
and	O
nanoparticles	O
in	O
order	O
to	O
assess	O
occupational	B-T169
exposure	B-T080
level	B-T080
of	O
15	O
rare	O
earth	O
elements	O
rees	O
and	O
identify	B-T080
the	O
associated	B-T080
influence	O
,	O
we	O
used	O
inductively	O
coupled	O
plasma	O
mass	O
spectrometry	O
icp-ms	O
based	B-T169
on	O
closed	B-T169
-	O
vessel	O
microwave	O
-	O
assisted	B-T080
wet	B-T169
digestion	I-T169
procedure	I-T169
to	O
determinate	O
the	O
concentration	B-T081
of	O
y	O
,	O
la	O
,	O
ce	B-T109
,	O
pr	O
,	O
nd	O
,	O
sm	O
,	O
eu	O
,	O
gd	O
,	O
tb	O
,	O
dy	O
,	O
ho	O
,	O
er	O
,	O
tm	O
,	O
yb	O
and	O
lu	O
in	O
urinary	O
samples	O
obtained	B-T169
from	O
workers	O
producing	O
ultrafine	B-T109
and	O
nanoparticles	O
containing	O
cerium	B-T109
and	O
lanthanum	O
oxide	O
.	O
	
the	O
results	O
suggest	B-T078
that	O
la	O
and	O
ce	B-T109
were	O
the	O
primary	B-T080
component	O
,	O
together	O
accounting	O
for	O
97	O
%	O
of	O
total	O
rees	O
in	O
workers	O
.	O
	
the	O
urinary	O
levels	B-T080
of	O
la	O
,	O
and	O
ce	B-T109
among	O
the	O
workers	O
6.36	O
,	O
15.32	O
μg.g	O
creatinine	B-T109
,	O
respectively	O
were	O
significantly	B-T078
enriched	B-T080
compared	O
to	O
those	O
levels	B-T080
measured	B-T080
in	O
the	O
control	O
subjects	O
1.52	O
,	O
4.04	O
μg.g	O
creatinine	B-T109
,	O
respectively	O
p	O
<	O
0.05	O
.	O
	
this	O
study	O
simultaneously	B-T079
identified	B-T080
the	O
associated	B-T080
individual	O
factors	B-T169
,	O
the	O
results	O
indicate	B-T078
that	O
the	O
concentrations	B-T081
in	O
over	O
5	O
years	O
group	B-T078
11.64	O
10.93	O
for	O
la	O
,	O
27.83	O
24.38	O
for	O
ce	B-T109
were	O
significantly	B-T078
elevated	B-T080
compared	O
to	O
1-5	O
years	O
group	B-T078
2.58	O
1.51	O
for	O
la	O
,	O
6.87	O
3.90	O
for	O
ce	B-T109
p	O
<	O
0.05	O
.	O
	
compared	O
the	O
urinary	O
levels	B-T080
of	O
la	O
and	O
ce	B-T109
at	O
the	O
separation	B-T169
and	O
packaging	O
locations	O
9.10	O
9.51	O
for	O
la	O
,	O
22.29	O
21.01	O
for	O
ce	B-T109
with	O
the	O
other	O
locations	O
2.85	O
0.98	O
for	O
la	O
,	O
6.37	O
2.12	O
for	O
ce	B-T109
,	O
the	O
results	O
show	O
urinary	O
concentrations	B-T081
were	O
significantly	B-T078
higher	B-T080
in	O
workers	O
at	O
separation	B-T169
and	O
packaging	O
locations	O
p	O
<	O
0.01	O
.	O
	
inter	B-T079
-	O
individual	O
variation	B-T080
in	O
levels	B-T080
of	O
la	O
and	O
ce	B-T109
in	O
urine	O
is	O
the	O
result	B-T169
of	O
multi-factorial	B-T081
comprehensive	B-T080
action	O
.	O
	
further	O
researches	O
should	O
focus	B-T169
on	O
the	O
multiple	B-T081
factors	B-T169
contributing	O
to	O
the	O
rees	O
levels	B-T080
of	O
the	O
occupationally	B-T169
exposed	B-T080
workers	O
.	O
	
two	O
known	B-T080
and	O
one	O
new	B-T080
species	O
of	O
draconematidae	O
and	O
epsilonematida	O
nematoda	O
,	O
desmodorida	O
from	O
the	O
white	O
sea	O
,	O
north	O
russia	O
morphological	O
descriptions	O
of	O
three	O
""""	O
walking	O
nematode	O
""""	O
species	O
found	O
for	O
the	O
first	O
time	O
in	O
the	O
white	O
sea	O
are	O
presented	O
.	O
	
draconema	O
ophicephalum	O
claparède	O
,	O
1863	O
draconematidae	O
and	O
epsilonema	O
steineri	O
chitwood	O
,	O
1935	O
epsilonematidae	O
,	O
both	O
known	O
from	O
insufficient	B-T080
material	O
and	O
females	O
only	O
,	O
are	O
re-described	O
and	O
problems	B-T033
of	O
their	O
taxonomic	B-T169
identification	B-T080
as	O
well	O
as	O
species	O
compositions	O
of	O
respective	O
genera	O
are	O
discussed	O
.	O
	
the	O
new	B-T080
species	O
prochaetosoma	O
marisalbi	O
sp	O
.	O
	
n	O
.	O
	
draconematidae	O
differs	O
from	O
other	O
prochaetosoma	O
species	O
except	O
p	O
.	O
	
longicapitatum	O
allgén	O
,	O
1935	O
in	O
that	O
the	O
pharyngeal	O
bulb	O
lumen	O
is	O
not	B-T033
cuticularised	I-T033
,	O
from	O
p	O
.	O
	
longicapitatum	O
by	O
shape	O
of	O
body	O
and	O
rostrum	O
,	O
greater	B-T081
number	O
of	O
cephalic	O
adhesive	O
tubes	O
,	O
and	O
from	O
p	O
.	O
	
maertensi	O
decraemer	O
,	O
1989	O
by	O
having	O
a	O
relatively	O
longer	B-T080
tail	O
,	O
fewer	O
anterior	O
adhesive	O
tubes	O
and	O
longer	B-T080
spicules	O
,	O
besides	O
lacking	O
cuticular	O
thickening	O
in	O
the	O
pharyngeal	O
bulb	O
.	O
	
draconema	O
hoonsooi	O
,	O
d	O
.	O
	
youngeouni	O
,	O
p.rochaetosoma	O
beomseomense	O
,	O
p	O
.	O
	
brevicaudatum	O
,	O
p	O
.	O
	
byungilli	O
,	O
p	O
.	O
	
cracense	O
,	O
p	O
.	O
	
saheungi	O
,	O
p	O
.	O
	
sujungi	O
,	O
p	O
.	O
	
supseomense	O
erected	B-T080
by	O
rho	O
min	O
2011	O
are	O
considered	O
as	O
invalid	B-T080
species	O
while	O
prochaetosoma	O
arcticum	O
,	O
p	O
.	O
	
lugubre	O
and	O
epsilonema	O
cygnoides	O
are	O
assumed	O
as	O
species	O
inquirenda	O
.	O
	
from	O
a	O
phylogenetic	O
tree	O
based	O
on	O
the	O
18s	O
rrna	O
gene	O
,	O
all	O
three	O
white	O
sea	O
species	O
adjoin	O
to	O
unidentified	B-T080
species	O
of	O
their	O
respective	O
differential	B-T080
effects	B-T080
of	I-T080
crude	B-T109
oil	I-T109
on	O
denitrification	O
and	O
anammox	O
,	O
and	O
the	O
impact	B-T080
on	O
n2o	O
production	O
denitrification	O
and	O
anammox	O
are	O
key	O
processes	O
for	O
reducing	B-T080
the	O
external	O
nitrogen	O
loads	O
delivered	B-T169
to	O
coastal	O
ecosystems	O
,	O
and	O
these	O
processes	O
can	O
be	O
affected	B-T169
by	O
pollutants	O
.	O
	
in	O
this	O
study	O
,	O
we	O
investigated	B-T169
the	O
effect	B-T080
of	I-T080
crude	B-T109
oil	I-T109
on	O
denitrification	O
and	O
anammox	O
.	O
	
controlled	O
laboratory	O
experiments	O
were	O
performed	O
using	O
sediment	O
slurries	O
from	O
the	O
lima	O
estuary	O
nw	O
portugal	O
.	O
	
anammox	O
and	O
denitrification	O
rates	B-T081
were	O
measured	O
using	O
15	O
no3	O
,	O
and	O
the	O
production	O
of	O
29	O
and	O
30	O
quantified	O
by	O
membrane	O
inlet	O
mass	O
spectrometry	O
.	O
	
results	O
revealed	O
that	O
while	O
denitrification	O
rates	B-T081
were	O
stimulated	O
between	O
10	O
and	O
25	O
000	O
times	O
after	O
crude	B-T109
oil	I-T109
amendment	O
,	O
anammox	O
activity	O
was	O
partially	O
between	O
2	O
and	O
5	O
times	O
or	O
completely	B-T080
inhibited	B-T080
by	O
the	O
addition	B-T169
of	O
crude	B-T109
oil	I-T109
when	O
comparing	O
to	O
rates	B-T081
in	O
unamended	O
controls	O
.	O
	
similar	O
results	O
were	O
observed	O
across	O
four	O
estuarine	O
sediment	O
types	B-T080
,	O
despite	O
their	O
different	O
physical-chemical	B-T080
characteristics	I-T080
.	O
	
moreover	O
,	O
n2o	O
production	O
was	O
reduced	B-T080
by	O
2-36	O
times	O
following	O
crude	B-T109
oil	I-T109
addition	B-T169
.	O
	
further	O
work	O
is	O
required	O
to	O
fully	O
understand	O
the	O
mechanism	B-T169
of	O
the	O
observed	B-T169
reduction	B-T080
in	O
n2o	O
production	O
.	O
	
this	O
study	O
represents	O
one	O
of	O
the	O
first	O
contributions	O
to	O
the	O
understanding	O
of	O
the	O
impact	B-T080
of	O
crude	B-T109
oil	I-T109
pollution	O
on	O
denitrification	O
and	O
anammox	O
,	O
with	O
profound	O
implications	O
for	O
the	O
management	O
of	O
aquatic	O
ecosystems	O
regarding	O
eutrophication	O
n-removal	O
.	O
	
shining	O
the	O
light	O
on	O
the	O
dark	O
side	O
of	O
medical	B-T169
leadership	O
-	O
a	O
qualitative	O
study	O
in	O
australia	O
purpose	O
the	O
paper	O
aims	B-T078
to	O
explore	O
the	O
beliefs	B-T078
of	O
doctors	O
in	O
leadership	O
roles	O
of	O
the	O
concept	B-T078
of	O
"""the"	O
dark	O
"side"""	O
,	O
using	O
data	B-T078
collected	O
from	O
interviews	O
carried	O
out	O
with	O
45	O
doctors	O
in	O
medical	B-T169
leadership	O
roles	O
across	O
australia	O
.	O
	
the	O
paper	O
looks	O
at	O
the	O
beliefs	B-T078
from	O
the	O
perspectives	B-T078
of	O
doctors	O
who	O
are	O
already	O
in	O
leadership	O
roles	O
themselves	O
to	O
identify	O
potential	O
barriers	B-T033
they	O
might	O
have	O
encountered	O
and	O
to	O
arrive	O
at	O
better-informed	O
strategies	O
to	O
engage	O
more	O
doctors	O
in	O
the	O
leadership	O
of	O
the	O
australian	O
health	O
system	O
.	O
	
the	O
research	O
question	O
is	O
"""what"	O
are	O
the	O
beliefs	B-T078
of	O
medical	B-T169
leaders	O
that	O
form	O
the	O
key	O
themes	O
or	O
dimensions	B-T081
of	O
the	O
negative	O
perception	O
of	O
the	O
'dark	O
side'	O
.	O
	
design/methodology/approach	O
the	O
paper	O
analysed	O
data	B-T078
from	O
two	O
similar	O
qualitative	O
studies	O
examining	O
medical	B-T169
leadership	O
and	O
engagement	O
in	O
australia	O
by	O
the	O
same	O
author	O
,	O
in	O
collaboration	O
with	O
other	O
researchers	O
,	O
which	O
used	O
in-depth	O
semi-structured	O
interviews	O
with	O
45	O
purposively	O
sampled	O
senior	O
medical	B-T169
leaders	O
in	O
leadership	O
roles	O
across	O
australia	O
in	O
health	O
services	O
,	O
private	O
and	O
public	O
hospitals	O
,	O
professional	O
associations	O
and	O
health	O
departments	O
.	O
	
the	O
data	B-T078
were	O
analysed	O
using	O
deductive	O
and	O
inductive	O
approaches	O
through	O
a	O
coding	O
framework	O
based	O
on	O
the	O
interview	O
data	B-T078
and	O
literature	O
review	O
,	O
with	O
all	O
sections	O
of	O
coded	O
data	B-T078
grouped	B-T078
into	O
themes	O
.	O
	
findings	O
medical	B-T169
leaders	O
had	O
four	O
key	O
beliefs	B-T078
about	O
the	O
"""dark"	O
"side"""	O
as	O
perceived	O
through	O
the	O
eyes	O
of	O
their	O
own	O
past	O
clinical	B-T080
experience	I-T080
and/or	O
their	O
clinical	B-T080
colleagues	O
.	O
	
these	O
four	O
beliefs	B-T078
or	O
dimensions	B-T081
of	O
the	O
negative	O
perception	O
colloquially	O
known	O
as	O
"""the"	O
dark	O
"side"""	O
are	O
the	O
belief	B-T078
that	O
they	O
lack	O
both	O
managerial	O
and	O
clinical	B-T080
credibility	B-T080
,	O
they	O
have	O
confused	O
identities	O
,	O
they	O
may	O
be	O
in	O
conflict	B-T078
with	O
clinicians	O
,	O
their	O
clinical	B-T080
colleagues	O
lack	O
insight	O
into	O
the	O
complexities	O
of	O
medical	B-T169
leadership	O
and	O
,	O
as	O
a	O
result	O
,	O
doctors	O
are	O
actively	O
discouraged	O
from	O
making	O
the	O
transition	O
from	O
clinical	B-T080
practice	I-T080
to	O
medical	B-T169
leadership	O
roles	O
in	O
the	O
first	O
place	O
.	O
	
research	O
limitations/implications	O
this	O
research	O
was	O
conducted	O
within	O
the	O
western	O
developed-nation	B-T080
setting	O
of	O
australia	O
and	O
only	O
involved	O
interviews	O
with	O
doctors	O
in	O
medical	B-T169
leadership	O
roles	O
.	O
	
the	O
findings	O
are	O
therefore	O
limited	O
to	O
the	O
doctors	O
'	O
own	O
perceptions	O
of	O
themselves	O
based	O
on	O
their	O
past	O
experiences	O
and	O
beliefs	B-T078
.	O
	
future	O
research	O
involving	O
doctors	O
who	O
have	O
not	O
chosen	O
to	O
transition	O
to	O
leadership	O
roles	O
,	O
or	O
other	O
health	O
practitioners	O
in	O
other	O
settings	O
,	O
may	O
provide	O
a	O
broader	O
perspective	B-T078
.	O
	
also	O
,	O
this	O
research	O
was	O
exploratory	O
and	O
descriptive	B-T033
in	O
nature	O
using	O
qualitative	O
methods	O
,	O
and	O
quantitative	O
research	O
can	O
be	O
carried	O
out	O
in	O
the	O
future	O
to	O
extend	O
this	O
research	O
for	O
statistical	O
generalisation	O
.	O
	
practical	O
implications	O
the	O
paper	O
includes	O
implications	O
for	O
health	O
organisations	O
,	O
training	O
providers	O
,	O
medical	B-T169
employers	O
and	O
health	O
departments	O
and	O
describes	O
a	O
multi-prong	O
strategy	O
to	O
address	O
this	O
important	O
issue	O
.	O
	
originality/value	O
this	O
paper	O
fulfils	O
an	O
identified	O
need	O
to	O
study	O
the	O
concept	B-T078
of	O
"""moving"	O
to	O
the	O
dark	O
"side"""	O
as	O
a	O
negative	O
perception	O
of	O
medical	B-T169
leadership	O
and	O
contributes	O
to	O
the	O
evidence	B-T078
in	O
this	O
under-	O
researched	O
area	O
.	O
	
this	O
paper	O
has	O
used	O
data	B-T078
from	O
two	O
similar	O
studies	O
,	O
combined	O
together	O
for	O
the	O
first	O
time	O
,	O
with	O
new	O
analysis	O
and	O
coding	O
,	O
looking	O
at	O
the	O
concept	B-T078
erlotinib	B-T109
plus	O
gemcitabine	O
versus	O
gemcitabine	O
for	O
pancreatic	O
cancer	O
real	B-T080
-	O
world	O
analysis	O
of	O
korean	O
national	O
database	O
a	O
randomized	O
clinical	O
trial	O
has	O
found	O
that	O
the	O
addition	O
of	O
erlotinib	B-T109
to	O
gemcitabine	O
gem	O
-	O
e	B-T109
for	O
pancreatic	O
cancer	O
led	O
to	O
a	O
modest	B-T080
increase	B-T169
in	O
survival	O
.	O
	
the	O
aim	B-T078
of	O
this	O
national	O
population	O
-	O
based	B-T169
retrospective	O
study	O
was	O
to	O
compare	O
the	O
effectiveness	B-T080
of	O
gem	O
-	O
e	B-T109
to	O
gem	O
alone	O
for	O
pancreatic	O
cancer	O
patients	O
in	O
real	O
clinical	O
practice	O
.	O
	
patients	O
with	O
pancreatic	O
cancer	O
icd-10	O
c25	O
with	O
prescription	O
claims	O
of	O
gemcitabine	O
or	O
erlotinib	B-T109
between	O
jan	O
1	O
,	O
2007	O
and	O
dec	O
31	O
,	O
2012	O
were	O
retrospectively	B-T080
identified	B-T080
from	O
the	O
korean	O
health	O
insurance	O
claims	O
database	O
.	O
	
to	O
be	O
included	O
in	O
the	O
study	O
population	O
,	O
patients	O
were	O
required	B-T169
to	O
have	O
had	O
a	O
histological	O
or	O
cytological	B-T033
diagnosis	I-T033
within	O
one	O
year	O
before	O
chemotherapy	B-T061
.	O
	
patients	O
treated	B-T033
with	I-T033
prior	O
radiotherapy	B-T061
,	O
surgery	O
,	O
or	O
chemotherapy	B-T061
were	O
excluded	B-T078
to	O
reduce	B-T061
heterogeneity	B-T080
.	O
	
overall	O
survival	O
from	O
the	O
initiation	B-T169
of	O
therapy	B-T061
and	O
the	O
medical	B-T081
costs	I-T081
of	O
gem	O
-	O
e	B-T109
and	O
gem	O
were	O
compared	O
.	O
	
a	O
total	O
of	O
4	O
patients	O
were	O
included	O
in	O
the	O
analysis	O
.	O
	
overall	O
survival	O
was	O
not	O
significantly	B-T078
longer	B-T080
in	O
patients	O
treated	B-T033
with	O
gem	O
-	O
e	B-T109
median	B-T081
6.77	O
months	O
for	O
gem	O
-	O
e	B-T109
vs	O
.	O
	
6.68	O
months	O
for	O
gem	O
,	O
p	O
=	O
0.0977	O
.	O
	
there	O
was	O
also	O
no	B-T033
significant	I-T033
difference	B-T081
in	O
the	O
respective	O
one-year	O
survival	B-T081
rates	I-T081
27.0	O
%	O
vs	O
.	O
	
27.3	O
%	O
p	O
=	O
0.5988	O
.	O
	
multivariate	B-T081
analysis	I-T081
using	O
age	O
,	O
gender	O
,	O
and	O
comorbidities	B-T078
as	O
covariates	O
did	O
not	O
reveal	B-T080
any	O
significant	B-T078
differences	B-T081
in	O
survival	O
.	O
	
based	B-T169
on	O
this	O
relative	B-T081
effectiveness	I-T081
,	O
the	O
incremental	B-T081
cost	B-T081
per	O
life	B-T078
year	B-T079
gained	B-T081
over	O
gem	O
was	O
estimated	B-T081
at	O
usd	B-T081
70	O
for	O
gem	O
-	O
e	B-T109
.	O
	
gem	O
-	O
e	B-T109
for	O
pancreatic	O
cancer	O
is	O
not	O
more	O
effective	B-T080
than	O
gem	O
in	O
a	O
real	B-T080
-	O
world	O
setting	B-T078
,	O
and	O
it	O
does	O
not	O
provide	O
reasonable	B-T033
cost-effectiveness	B-T081
over	O
development	O
of	O
a	O
novel	O
quantitative	B-T081
structure-activity	I-T081
relationship	I-T081
model	O
to	O
accurately	O
predict	O
pulmonary	O
absorption	O
and	O
replace	O
routine	O
use	O
of	O
the	O
isolated	B-T169
perfused	B-T169
respiring	O
rat	O
lung	O
model	O
we	O
developed	O
and	O
tested	O
a	O
novel	O
quantitative	B-T081
structure-activity	I-T081
relationship	I-T081
qsar	B-T081
model	O
to	O
better	O
understand	O
the	O
physicochemical	O
drivers	O
of	O
pulmonary	O
absorption	O
,	O
and	O
to	O
facilitate	O
compound	O
design	O
through	O
improved	O
prediction	B-T078
of	O
absorption	O
.	O
	
the	O
model	O
was	O
tested	O
using	O
a	O
large	O
array	O
of	O
both	O
existing	O
and	O
newly	O
designed	O
compounds	O
.	O
	
pulmonary	O
absorption	O
data	O
was	O
generated	O
using	O
the	O
isolated	B-T169
perfused	B-T169
respiring	O
rat	O
lung	O
iprlu	O
model	O
for	O
82	O
drug	O
discovery	O
compounds	O
and	O
17	O
marketed	O
drugs	O
.	O
	
this	O
dataset	O
was	O
used	O
to	O
build	O
a	O
novel	O
qsar	B-T081
model	O
based	O
on	O
calculated	O
physicochemical	O
properties	O
.	O
	
a	O
further	O
9	O
compounds	O
were	O
used	O
to	O
test	O
the	O
model's	O
predictive	O
capability	B-T080
.	O
	
the	O
qsar	B-T081
model	O
performed	O
well	O
on	O
the	O
9	O
compounds	O
in	O
the	O
""""	O
test	O
set	O
""""	O
with	O
a	O
predicted	O
versus	O
observed	O
correlation	B-T081
of	O
r	O
=	O
0.85	O
,	O
and	O
>65%	O
of	O
compounds	O
correctly	O
categorised	O
.	O
	
calculated	O
descriptors	O
associated	O
with	O
permeability	O
and	O
hydrophobicity	B-T080
positively	O
correlated	O
with	O
pulmonary	O
absorption	O
,	O
whereas	O
those	O
associated	O
with	O
charge	B-T080
,	O
ionisation	O
and	O
size	O
negatively	O
correlated	O
.	O
	
the	O
novel	O
qsar	B-T081
model	O
described	O
here	O
can	O
replace	O
routine	O
generation	O
of	O
iprlu	O
model	O
data	O
for	O
ranking	O
and	O
classifying	O
compounds	O
prior	O
to	O
synthesis	O
.	O
	
it	O
will	O
also	O
provide	O
scientists	O
working	O
in	O
the	O
field	O
of	O
inhaled	O
drug	O
discovery	O
with	O
a	O
deeper	O
understanding	O
of	O
the	O
physicochemical	O
drivers	O
of	O
pulmonary	O
absorption	O
based	O
on	O
a	O
relevant	O
respiratory	O
compound	O
dataset	O
.	O
	
the	O
epiderm	O
3d	O
human	O
reconstructed	O
skin	O
micronucleus	O
rsmn	O
assay	O
historical	O
control	O
data	B-T078
and	O
proof	B-T033
of	O
principle	O
studies	O
for	O
mechanistic	O
assay	O
adaptations	O
the	O
in	O
vitro	O
human	O
reconstructed	O
skin	O
micronucleus	O
rsmn	O
assay	O
in	O
epiderm	O
is	O
a	O
promising	O
novel	O
animal	O
alternative	O
for	O
evaluating	O
genotoxicity	O
of	O
topically	B-T061
applied	I-T061
chemicals	O
.	O
	
it	O
is	O
particularly	O
useful	O
for	O
assessing	O
cosmetic	O
ingredients	O
that	O
can	O
no	O
longer	O
be	O
tested	B-T169
using	O
in	O
vivo	O
assays	O
.	O
	
to	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision-making	O
,	O
we	O
have	O
established	O
the	O
rsmn	O
assay	O
in	O
our	O
laboratory	O
according	O
to	O
good	O
laboratory	O
practice	O
and	O
following	O
the	O
principles	O
of	O
the	O
oecd	O
test	O
guideline	O
487	O
in	B-T080
vitro	I-T080
mammalian	O
cell	O
micronucleus	O
test	O
.	O
	
proficiency	O
with	O
the	O
assay	O
was	O
established	O
by	O
correctly	O
identifying	O
direct-acting	O
genotoxins	O
and	O
genotoxins	O
requiring	O
metabolism	O
,	O
as	O
well	O
as	O
non-genotoxic	B-T033
/	O
non-carcinogenic	B-T033
chemicals	O
.	O
	
we	O
also	O
report	O
the	O
analysis	O
of	O
our	O
historical	O
control	O
data	B-T078
that	O
demonstrate	O
vehicle	O
control	O
and	O
positive	O
control	O
values	B-T081
for	O
%	O
micronuclei	O
in	O
binucleated	O
cells	O
are	O
in	O
the	O
ranges	O
reported	O
previously	O
.	O
	
technical	O
issues	O
including	O
evaluating	O
various	O
solvents	O
with	O
both	O
48h	O
and	O
72h	O
treatment	B-T061
regimens	I-T061
were	O
investigated	B-T169
.	O
	
for	O
the	O
first	O
time	O
,	O
mechanistic	O
studies	O
using	O
crest	O
analysis	O
revealed	O
that	O
the	O
rsmn	O
assay	O
is	O
suitable	O
for	O
distinguishing	O
aneugens	O
and	O
clastogens	O
.	O
	
moreover	O
,	O
the	O
assay	O
is	O
also	O
suitable	O
for	O
measuring	O
cytokines	B-T116
as	O
markers	B-T080
for	O
proliferative	O
and	O
toxic	O
effects	O
of	O
wnt-5a	B-T116
/	O
frizzled9	B-T116
receptor	O
signaling	O
through	O
the	O
gαo	B-T116
/	O
gβγ	B-T116
complex	I-T116
regulates	O
dendritic	O
spine	O
formation	O
wnt	B-T116
ligands	I-T116
play	O
crucial	O
roles	O
in	O
the	O
development	O
and	O
regulation	O
of	O
synapse	O
structure	O
and	O
function	O
.	O
	
specifically	O
,	O
wnt-5a	B-T116
acts	O
as	O
a	O
secreted	B-T116
growth	I-T116
factor	I-T116
that	O
regulates	O
dendritic	O
spine	O
formation	O
in	O
rodent	O
hippocampal	O
neurons	O
,	O
resulting	O
in	O
postsynaptic	O
development	O
that	O
promotes	O
the	O
clustering	O
of	O
the	O
postsynaptic	O
density	O
protein-95	O
psd-95	O
.	O
	
here	O
,	O
we	O
focused	O
on	O
the	O
early	B-T079
events	O
occurring	O
after	O
the	O
interaction	O
between	O
wnt-5a	B-T116
and	O
its	O
frizzled	B-T116
receptor	I-T116
at	O
the	O
neuronal	O
cell	O
surface	O
.	O
	
additionally	O
,	O
we	O
studied	O
the	O
role	O
of	O
heterotrimeric	B-T116
g	I-T116
proteins	I-T116
in	O
wnt-5a	B-T116
-dependent	O
synaptic	O
development	O
.	O
	
we	O
report	O
that	O
frizzled9	B-T116
fzd9	B-T116
,	O
a	O
wnt	B-T116
receptor	B-T116
related	O
to	O
williams'	B-T047
syndrome	I-T047
,	O
is	O
localized	O
in	O
the	O
postsynaptic	O
region	O
,	O
where	O
it	O
interacts	O
with	O
wnt-5a	B-T116
.	O
	
functionally	O
,	O
fzd9	B-T116
is	O
required	O
for	O
the	O
wnt-5a	B-T116
-mediated	O
increase	B-T169
in	O
dendritic	O
spine	O
density	O
.	O
	
fzd9	B-T116
forms	O
a	O
pre-coupled	O
complex	O
with	O
gαo	B-T116
under	O
basal	O
conditions	O
that	O
dissociates	O
after	O
wnt-5a	B-T116
stimulation	O
.	O
	
accordingly	O
,	O
we	O
found	O
that	O
g-protein	O
inhibition	O
abrogates	O
wnt-5a	B-T116
-dependent	O
pathway	O
in	O
hippocampal	O
neurons	O
.	O
	
in	O
particular	O
,	O
the	O
activation	O
of	O
gαo	B-T116
appears	O
to	O
be	O
a	O
key	O
factor	O
controlling	O
the	O
wnt-5a	B-T116
-	O
induced	B-T169
dendritic	O
spine	O
density	O
.	O
	
in	O
addition	O
,	O
we	O
found	O
that	O
gβγ	B-T116
is	O
required	O
for	O
the	O
wnt-5a	B-T116
-mediated	O
increase	B-T169
in	O
cytosolic	O
calcium	O
levels	B-T080
and	O
spinogenesis	O
.	O
	
our	O
findings	B-T169
reveal	O
that	O
fzd9	B-T116
and	O
heterotrimeric	B-T116
g	I-T116
proteins	I-T116
regulate	O
wnt-5a	B-T116
signaling	O
and	O
dendritic	O
spines	O
in	O
cultured	O
hippocampal	O
neurons	O
.	O
	
a	O
delayed	B-T079
diagnosis	B-T033
of	O
chronic	B-T047
mesenteric	I-T047
ischaemia	I-T047
the	O
role	O
of	O
clinicians	O
'	O
cognitive	B-T169
errors	B-T080
chronic	B-T079
diarrhoeal	B-T047
illnesses	I-T047
with	O
nausea	O
and	O
weight	B-T033
loss	I-T033
are	O
a	O
common	B-T081
indication	B-T078
for	O
gastroenterology	O
review	B-T078
.	O
	
while	O
many	O
such	O
cases	O
have	O
intra-luminal	O
aetiologies	B-T169
,	O
such	O
as	O
inflammatory	B-T047
bowel	I-T047
disease	I-T047
,	O
coeliac	B-T047
disease	I-T047
or	O
other	O
malabsorptive	B-T033
conditions	I-T033
,	O
with	O
many	O
other	O
cases	O
due	O
to	O
functional	B-T169
gut	O
disorders	B-T047
or	O
systemic	B-T169
malignancy	O
,	O
clinicians	O
must	O
also	O
keep	O
vascular	B-T047
disorders	I-T047
in	O
mind	O
.	O
	
here	O
we	O
report	O
a	O
patient	O
with	O
a	O
delayed	B-T079
diagnosis	B-T033
of	O
chronic	B-T047
mesenteric	I-T047
ischaemia	I-T047
after	O
6	O
months	B-T079
of	O
gastrointestinal	O
symptoms	O
strongly	O
mimicking	O
an	O
alternative	O
diagnosis	B-T033
such	O
as	O
inflammatory	B-T047
bowel	I-T047
disease	I-T047
due	O
an	O
atypical	B-T080
predominance	B-T169
of	O
nausea	O
and	O
diarrhoea	O
rather	O
than	O
pain	O
.	O
	
we	O
briefly	O
review	B-T078
the	O
literature	O
on	O
treatment	B-T169
of	O
this	O
condition	B-T047
but	O
also	O
discuss	O
with	O
particular	O
attention	O
the	O
sequence	B-T169
of	O
cognitive	B-T169
errors	B-T080
made	O
by	O
clinicians	O
that	O
led	O
to	O
a	O
diagnostic	B-T033
delay	B-T079
,	O
inviting	O
readers	O
to	O
thus	O
reflect	O
on	O
how	O
such	O
errors	B-T080
can	O
be	O
minimised	B-T080
in	O
their	O
evaluation	O
of	O
choroidal	O
thickness	B-T080
in	O
patients	O
with	O
pseudoexfoliation	B-T047
syndrome	I-T047
and	O
pseudoexfoliation	B-T047
glaucoma	I-T047
purpose	B-T169
.	O
	
to	O
compare	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	B-T080
in	O
eyes	O
with	O
pseudoexfoliation	B-T047
pex	I-T047
syndrome	I-T047
and	O
pex	B-T047
glaucoma	I-T047
with	O
the	O
normal	B-T080
eyes	O
of	O
healthy	B-T080
controls	O
.	O
	
materials	O
and	O
methods	O
.	O
	
in	O
this	O
prospective	O
study	O
,	O
30	O
eyes	O
of	O
30	O
patients	O
with	O
pex	B-T047
syndrome	I-T047
,	O
28	O
eyes	O
of	O
28	O
patients	O
with	O
pex	B-T047
glaucoma	I-T047
,	O
and	O
30	O
eyes	O
of	O
30	O
age	O
-matched	O
healthy	B-T080
subjects	O
were	O
enrolled	O
.	O
	
choroidal	O
thicknesses	B-T080
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
were	O
measured	B-T080
by	O
using	O
spectral	O
domain	O
optical	O
coherence	O
tomography	O
.	O
	
results	O
.	O
	
gender	O
,	O
age	O
,	O
and	O
axial	B-T081
length	I-T081
did	O
not	B-T033
significantly	I-T033
differ	O
between	O
the	O
groups	O
all	O
,	O
p	O
>	O
0.05	O
.	O
	
the	O
mean	B-T081
values	I-T081
of	O
choroidal	O
thickness	B-T080
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
except	B-T169
the	O
superior	O
quadrant	O
in	O
the	O
patients	O
with	O
pex	B-T047
syndrome	I-T047
and	O
pex	B-T047
glaucoma	I-T047
were	O
lower	O
compared	O
with	O
controls	O
all	O
p	O
<	O
0.05	O
.	O
	
the	O
mean	B-T081
values	I-T081
of	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	B-T080
in	O
the	O
pex	B-T047
glaucoma	I-T047
group	O
were	O
lower	O
compared	O
with	O
pex	B-T047
syndrome	I-T047
group	O
however	O
this	O
difference	B-T080
was	O
not	B-T033
significant	I-T033
.	O
	
conclusions	O
.	O
	
the	O
findings	B-T033
of	O
this	O
study	O
revealed	B-T080
that	O
macular	O
and	O
peripapillary	O
choroidal	O
thicknesses	B-T080
were	O
decreased	B-T081
in	O
pex	B-T047
syndrome	I-T047
and	O
pex	B-T047
glaucoma	I-T047
cases	B-T169
.	O
	
the	O
role	O
of	O
choroid	O
in	O
the	O
development	B-T169
of	O
glaucomatous	B-T047
damage	B-T169
in	O
patients	O
with	O
pex	B-T047
syndrome	I-T047
remains	O
clinical	O
features	O
and	O
complications	O
of	O
the	O
hla-b27	B-T116
-associated	O
acute	B-T047
anterior	I-T047
uveitis	I-T047
a	O
metanalysis	O
in	O
this	O
article	O
,	O
we	O
report	O
a	O
literature-based	O
metanalysis	O
we	O
have	O
conducted	O
to	O
outline	O
the	O
clinical	O
features	O
of	O
the	O
hla-b27	B-T116
acute	B-T047
anterior	I-T047
uveitis	I-T047
aau	B-T047
.	O
	
the	O
examined	B-T033
material	O
was	O
based	O
on	O
observational	O
studies	O
in	O
which	O
participants	O
were	O
affected	O
by	O
acute	B-T047
anterior	I-T047
uveitis	I-T047
and	O
divided	O
into	O
hla	O
b27+	O
and	O
hla	O
b27-	O
.	O
	
we	O
performed	O
a	O
search	O
on	O
articles	O
with	O
the	O
words	O
""""	O
hla	B-T047
b27	I-T047
uveitis	I-T047
""""	O
dated	O
before	O
may	O
2014	O
.	O
	
among	O
these	O
,	O
29	O
articles	O
were	O
selected	O
for	O
a	O
second	O
review	B-T078
.	O
	
after	O
a	O
further	O
evaluation	O
,	O
22	O
articles	O
were	O
analyzed	O
.	O
	
the	O
clinical	O
characteristics	O
studied	O
in	O
the	O
metanalysis	O
were	O
1	O
systemic	B-T047
disease	I-T047
2	O
sex	B-T081
distribution	I-T081
3	O
laterality	O
4	O
visual	O
acuity	O
5	O
hypopion	B-T047
6	O
anterior	B-T116
chamber's	I-T116
fibrin	I-T116
7	O
elevated	B-T033
intraocular	I-T033
pressure	I-T033
iop	O
during	O
inflammation	O
8	O
glaucoma	B-T047
9	O
posterior	B-T047
synechiae	I-T047
10	O
cataract	O
11	O
cystoid	B-T047
macular	I-T047
edema	I-T047
12	O
papillitis	B-T047
.	O
	
we	O
have	O
calculated	O
a	O
relative	B-T081
risk	I-T081
rr	B-T081
for	O
each	O
outcome	B-T081
measured	I-T081
.	O
	
the	O
results	B-T169
obtained	O
remark	O
some	O
of	O
the	O
peculiar	O
features	O
linked	O
to	O
the	O
hla	B-T116
b27	I-T116
acute	B-T047
anterior	I-T047
uveitis	I-T047
,	O
such	O
as	O
strong	O
association	B-T080
with	I-T080
ankylosing	B-T047
spondylitis	I-T047
rr	B-T081
=	O
6.80	O
and	O
systemic	B-T047
diseases	I-T047
rr	B-T081
=	O
9.9	O
,	O
male	O
prevalence	B-T081
rr	B-T081
=	O
1.2	O
,	O
unilateral	O
rr	B-T081
=	O
1.1	O
or	O
alternating	O
bilateral	O
rr	B-T081
=	O
2.2	O
involvement	B-T169
,	O
hypopion	B-T047
rr	B-T081
=	O
5.5	O
,	O
fibrinous	B-T116
reaction	B-T169
and	O
even	O
papillitis	B-T047
r	O
=	O
7.7	O
.	O
	
simultaneous	O
bilateral	O
rr	B-T081
=	O
0.3	O
aau	B-T047
is	O
more	O
frequent	B-T079
in	O
hla-b27	B-T116
negative	B-T033
form	O
.	O
	
we	O
report	O
higher	O
risk	B-T078
of	O
elevated	B-T033
iop	I-T033
and	O
glaucoma	B-T047
rr	B-T081
=	O
0.6	O
in	O
b27-	B-T047
acute	I-T047
anterior	I-T047
uveitis	I-T047
.	O
	
no	O
significant	O
difference	O
between	O
hla	B-T033
b	I-T033
27	I-T033
positive	I-T033
and	O
negative	B-T033
aau	B-T047
was	O
observed	B-T169
according	O
to	O
final	O
visual	O
acuity	O
and	O
complications	O
such	O
as	O
posterior	B-T047
synechiae	I-T047
,	O
cataract	O
,	O
and	O
maculare	B-T047
edema	I-T047
.	O
	
we	O
trust	O
that	O
this	O
will	O
inform	O
on	O
the	O
clinical	O
evaluation	O
and	O
therapeutic	B-T169
decision	O
in	O
addressing	O
a	O
still	O
ill-defined	O
ophthalmologic	B-T169
condition	B-T080
.	O
	
a	O
case	O
presenting	O
with	O
splenic	B-T047
infarct	I-T047
diagnosed	B-T033
as	O
primary	O
bone	O
marrow	O
cd5	O
positive	O
dlbcl	O
a	O
clinicopathological	B-T080
correlation	I-T080
de	B-T078
novo	I-T078
cd5+	O
diffuse	B-T033
large	I-T033
b	I-T033
cell	I-T033
lymphoma	I-T033
dlbcl	O
is	O
a	O
rare	B-T080
and	O
aggressive	B-T033
subtype	I-T033
of	O
dlbcl	O
.	O
	
it	O
is	O
a	O
distinct	O
clinicopathologic	B-T033
entity	O
with	O
complex	B-T169
molecular	I-T169
profile	I-T169
and	O
poor	B-T033
prognosis	I-T033
.	O
	
a	O
59	O
year	B-T079
old	O
female	O
presented	B-T033
with	I-T033
pyrexia	O
of	O
unknown	O
origin	O
since	O
1	O
month	B-T079
.	O
	
on	O
examination	O
,	O
there	O
was	O
severe	B-T033
pallor	I-T033
,	O
hepatosplenomegaly	O
and	O
no	B-T080
palpable	I-T080
lymphadenopathy	B-T047
.	O
	
complete	O
blood	O
count	O
revealed	B-T080
bicytopenia	O
with	O
normal	B-T033
total	I-T033
leucocyte	I-T033
count	I-T033
.	O
	
liver	O
and	O
renal	O
function	O
tests	O
were	O
normal	B-T080
.	O
	
ultrasonography	O
abdomen	O
revealed	B-T080
splenic	B-T033
enlargement	I-T033
with	O
two	B-T033
focal	I-T033
lesions	I-T033
attributed	O
to	O
either	O
splenic	B-T047
abscess	I-T047
or	O
infarcts	B-T047
.	O
	
patient	O
was	O
being	O
managed	O
as	O
splenic	B-T047
infarct	I-T047
but	O
continued	O
to	O
have	O
bicytopenia	O
.	O
	
further	O
investigation	O
showed	O
elevated	B-T033
serum	I-T033
ferritin	I-T033
,	O
triglycerides	B-T033
and	O
ldh	O
.	O
	
with	O
a	O
clinical	B-T080
suspicion	O
of	O
infection	O
and	O
haemophagocytic	B-T047
lymphohistiocytosis	I-T047
bone	O
marrow	O
aspiration	O
bma	O
and	O
biopsy	O
bmbx	O
was	O
done	O
.	O
	
bma	O
showed	O
extensive	O
haemophagocytosis	O
and	O
7.4	O
%	O
large	O
lymphoma-like	O
cells	O
.	O
	
on	O
this	O
basis	O
pet-ct	O
was	O
suggested	O
which	O
showed	O
enlarged	O
spleen	O
with	O
diffuse	O
uptake	O
.	O
	
bmbx	O
showed	O
nodular	O
and	O
intrasinusoidal	O
collection	O
of	O
abnormal	O
lymphoid	O
cells	O
.	O
	
on	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	O
for	O
cd20	O
,	O
cd5	O
,	O
mum1	O
,	O
bcl-2	O
,	O
bcl-6	O
and	O
negative	O
for	O
cd3	O
,	O
cd10	O
and	O
cd23	O
.	O
	
cd34	O
highlighted	O
focal	O
intrasinusoidal	O
pattern	O
.	O
	
the	O
complete	O
clinicopathological	O
profile	O
suggested	O
the	O
diagnosis	O
of	O
de	O
novo	O
cd5+	O
dlbcl	O
,	O
with	O
primary	O
hepatosplenic	O
pattern	O
of	O
involvement	O
.	O
	
cd5+	O
dlbcl	O
presenting	O
as	O
splenic	O
infarct	O
is	O
very	O
rare	O
.	O
	
this	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	O
of	O
a	O
primary	O
aggressive	O
lymphoma	O
with	O
haemophagocytosis	O
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	O
and	O
splenic	O
infarct	O
without	O
lymphadenopathy	O
.	O
	
this	O
indicates	O
the	O
importance	O
of	O
good	O
morphological	O
assessment	O
of	O
a	O
bone	O
marrow	O
aspirate	O
and	O
biopsy	O
to	O
make	O
a	O
correct	O
diagnosis	B-T033
the	O
cost-effectiveness	B-T081
of	O
family	O
/	O
family-based	B-T061
therapy	I-T061
for	O
treatment	B-T169
of	O
externalizing	O
disorders	O
,	O
substance	O
use	O
disorders	O
and	O
delinquency	O
a	O
systematic	O
review	O
family	B-T061
therapy	I-T061
and	O
family-based	B-T169
treatment	I-T169
has	O
been	O
commonly	O
applied	O
in	O
children	O
and	O
adolescents	O
in	O
mental	B-T061
health	I-T061
care	I-T061
and	O
has	O
been	O
proven	O
to	O
be	O
effective	O
.	O
	
there	O
is	O
an	O
increased	O
interest	O
in	O
economic	O
evaluations	O
of	O
these	O
,	O
often	O
expensive	O
,	O
interventions	B-T061
.	O
	
the	O
aim	O
of	O
this	O
systematic	O
review	O
is	O
to	O
summarize	O
and	O
evaluate	O
the	O
evidence	O
on	O
cost-effectiveness	B-T081
of	O
family	O
/	O
family-based	B-T061
therapy	I-T061
for	O
externalizing	O
disorders	O
,	O
substance	O
use	O
disorders	O
and	O
delinquency	O
.	O
	
a	O
systematic	O
literature	O
search	O
was	O
performed	O
in	O
pubmed	O
,	O
education	O
resource	O
information	O
centre	O
eric	O
,	O
psycinfo	O
and	O
cochrane	O
reviews	O
including	O
studies	O
conducted	O
after	O
1990	O
and	O
before	O
the	O
first	O
of	O
august	O
of	O
2013	O
.	O
	
full	O
economic	O
evaluations	O
investigating	O
family	O
/	O
family-based	B-T061
interventions	I-T061
for	O
adolescents	O
between	O
10	O
and	O
20	O
years	B-T079
treated	B-T169
for	O
substance	O
use	O
disorders	O
,	O
delinquency	O
or	O
externalizing	O
disorders	O
were	O
included	O
.	O
	
seven	O
hundred	O
thirty-one	O
articles	O
met	O
the	O
search	O
criteria	O
and	O
51	O
studies	O
were	O
initially	O
selected	O
.	O
	
the	O
final	O
selection	O
resulted	O
in	O
the	O
inclusion	O
of	O
11	O
studies	O
.	O
	
the	O
quality	B-T080
of	O
these	O
studies	O
was	O
assessed	O
.	O
	
within	O
the	O
identified	O
studies	O
,	O
there	O
was	O
great	O
variation	O
in	O
the	O
specific	O
type	O
of	O
family	O
/	O
family-based	B-T061
interventions	I-T061
and	O
disorders	B-T047
.	O
	
according	O
to	O
the	O
outcomes	O
of	O
the	O
checklists	O
,	O
the	O
overall	O
quality	B-T080
of	O
the	O
economic	O
evaluations	O
was	O
low	O
.	O
	
results	O
varied	O
by	O
study	O
.	O
	
due	O
to	O
the	O
variations	O
in	O
setting	O
,	O
design	O
and	O
outcome	O
it	O
was	O
not	O
feasible	O
to	O
pool	O
results	O
using	O
a	O
meta-analysis	O
.	O
	
the	O
quality	B-T080
of	O
the	O
identified	O
economic	O
evaluations	O
of	O
family	O
/	O
family-based	B-T061
therapy	I-T061
for	O
treatment	B-T169
of	O
externalizing	O
disorders	O
,	O
adolescent	O
substance	O
use	O
disorders	O
and	O
delinquency	O
was	O
insufficient	O
to	O
determine	O
the	O
cost-effectiveness	B-T081
.	O
	
although	O
commonly	O
applied	O
,	O
family	O
/	O
family-based	B-T061
therapy	I-T061
is	O
costly	O
and	O
more	O
research	O
of	O
higher	O
quality	B-T080
regulation	O
of	O
abca1	O
and	O
abcg1	O
gene	O
expression	O
in	O
the	O
intraabdominal	O
adipose	O
tissue	O
tissue	O
specific	O
expression	O
of	O
genes	O
encoding	O
cholesterol	B-T109
transporters	B-T116
abca1	B-T116
and	O
abcg1	B-T116
as	O
well	O
as	O
genes	O
encoding	O
the	O
most	O
important	O
transcriptional	O
regulators	B-T116
of	O
adipogenesis	O
-	O
lxra	B-T116
,	O
lxrb	B-T116
,	O
pparg	B-T116
and	O
rora	B-T116
has	O
been	O
investigated	B-T169
in	O
intraabdominal	O
adipose	O
tissue	O
iat	O
samples	O
a	O
direct	O
correlation	B-T080
between	O
the	O
content	O
of	O
abca1	B-T116
and	O
abcg1	B-T116
proteins	I-T116
with	O
rora	B-T116
protein	I-T116
level	B-T080
r=0	O
,	O
p<0	O
r=0	O
,	O
p<0	O
,	O
respectively	O
suggests	B-T078
the	O
role	O
of	O
the	O
transcription	B-T116
factor	I-T116
rora	B-T116
in	O
the	O
regulation	O
of	O
iat	O
abca1	B-T116
and	O
abcg1	B-T116
protein	I-T116
levels	B-T080
.	O
	
abca1	O
and	O
abcg1	O
gene	O
expression	O
positively	O
correlated	B-T080
with	O
obesity	B-T047
indicators	O
such	O
as	O
body	O
mass	O
index	O
bmi	O
r=0	O
,	O
p=0	O
r=0	O
,	O
p=0	O
,	O
respectively	O
and	O
waist	O
circumference	O
r=0	O
,	O
p=0	O
r=0	O
,	O
p=0	O
,	O
respectively	O
.	O
	
the	O
development	B-T169
of	O
obesity	B-T047
is	O
associated	B-T080
with	I-T080
decreased	B-T081
iat	O
levels	B-T080
of	O
rora	O
and	O
lxrb	O
mrna	O
p=0	O
and	O
p=0	O
,	O
respectively	O
.	O
	
these	O
data	B-T078
suggest	B-T078
that	O
the	O
nuclear	B-T116
factor	I-T116
rora	I-T116
can	O
play	O
a	O
significant	B-T078
role	O
in	O
the	O
regulation	O
of	O
cholesterol	O
metabolism	O
and	O
control	B-T080
iat	O
expression	O
of	O
abca1	B-T116
and	O
abcg1	B-T116
,	O
while	O
the	O
level	B-T080
of	O
iat	O
lxrb	O
gene	O
expression	O
may	O
be	O
an	O
important	O
factor	O
associated	B-T080
with	I-T080
the	O
development	B-T169
of	O
triterpenoids	B-T109
from	O
the	O
stems	O
of	O
tripterygium	O
regelii	O
three	O
new	O
triterpenoids	B-T109
,	O
triregelolides	B-T109
a	O
,	O
b	O
1	O
,	O
2	O
,	O
and	O
triregeloic	B-T109
acid	I-T109
3	O
,	O
were	O
isolated	B-T169
from	O
the	O
stems	O
of	O
tripterygium	O
regelii	O
along	O
with	O
twenty	O
known	O
triterpene	B-T109
analogues	O
4-23	O
.	O
	
the	O
structures	O
of	O
three	O
new	O
compounds	B-T109
were	O
identified	O
by	O
analyzing	O
their	O
nmr	O
spectroscopic	O
and	O
hresims	O
data	O
.	O
	
compounds	B-T109
4	B-T109
,	O
7	B-T109
,	O
8	B-T109
,	O
10	B-T109
,	O
13	B-T109
,	O
14	B-T109
,	O
17	B-T109
,	O
21-23	B-T109
were	O
isolated	B-T169
from	O
t	O
.	O
	
regelii	O
for	O
the	O
first	O
time	O
.	O
	
compounds	B-T109
3	B-T109
,	O
5	B-T109
,	O
6	B-T109
,	O
8	B-T109
,	O
9	B-T109
,	O
10	B-T109
,	O
14	B-T109
and	O
16	B-T109
showed	O
inhibitory	O
effects	O
on	O
the	O
proliferation	O
of	O
human	O
breast	O
cancer	O
cells	O
mcf-7	O
by	O
24.1	O
,	O
69.6	O
,	O
72.8	O
,	O
21.6	O
,	O
23.1	O
,	O
43.3	O
,	O
25.5	O
and	O
23.5	O
p<0	O
at	O
a	O
concentration	B-T081
biochemical	B-T169
evidence	O
for	O
a	O
mitochondrial	O
genetic	B-T169
modifier	O
in	O
the	O
phenotypic	O
manifestation	B-T169
of	O
leber's	B-T047
hereditary	I-T047
optic	I-T047
neuropathy	I-T047
-associated	O
mitochondrial	O
dna	O
mutation	O
leber's	B-T047
hereditary	I-T047
optic	I-T047
neuropathy	I-T047
lhon	B-T047
is	O
the	O
most	O
common	O
mitochondrial	B-T047
disease	I-T047
.	O
	
mitochondrial	O
modifiers	O
are	O
proposed	O
to	O
modify	O
the	O
phenotypic	O
expression	O
of	O
primary	O
lhon	B-T047
-associated	O
mitochondrial	O
dna	O
mtdna	O
mutations	O
.	O
	
in	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
the	O
lhon	B-T047
susceptibility	O
allele	O
m.14502t	O
>	O
c	O
,	O
p	O
.	O
	
58i	O
>	O
v	O
in	O
the	O
nd6	O
gene	O
modulated	O
the	O
phenotypic	O
expression	O
of	O
primary	O
lhon	B-T047
-associated	O
m.11778g	O
>	O
a	O
mutation	O
.	O
	
twenty-two	O
han	O
chinese	O
pedigrees	O
carrying	O
m.14502t	O
>	O
c	O
and	O
m.11778g	O
>	O
a	O
mutations	O
exhibited	O
significantly	O
higher	O
penetrance	B-T081
of	O
optic	B-T047
neuropathy	I-T047
than	O
those	O
carrying	O
only	O
m.11778g	O
>	O
a	O
mutation	O
.	O
	
we	O
performed	O
functional	B-T169
assays	O
using	O
the	O
cybrid	O
cell	O
models	O
,	O
generated	O
by	O
fusing	O
mtdna-less	O
ρ	O
cells	O
with	O
enucleated	O
cells	O
from	O
lhon	B-T047
patients	O
carrying	O
both	O
m.11778g	O
>	O
a	O
and	O
m.14502t	O
>	O
c	O
mutations	O
,	O
only	O
m.14502t	O
>	O
c	O
or	O
m.11778g	O
>	O
a	O
mutation	O
and	O
a	O
control	O
belonging	O
to	O
the	O
same	O
mtdna	O
haplogroup	O
.	O
	
these	O
cybrids	O
cell	O
lines	O
bearing	O
m.14502t	O
>	O
c	O
mutation	O
exhibited	O
mild	O
effects	B-T080
on	O
mitochondrial	O
functions	B-T169
compared	O
with	O
those	O
carrying	O
only	O
m.11778g	O
>	O
a	O
mutation	O
.	O
	
however	O
,	O
more	O
severe	O
mitochondrial	O
dysfunctions	O
were	O
observed	O
in	O
cell	O
lines	O
bearing	O
both	O
m.14502t	O
>	O
c	O
and	O
m.11778g	O
>	O
a	O
mutations	O
than	O
those	O
carrying	O
only	O
m.11778g	O
>	O
a	O
or	O
m.14502t	O
>	O
c	O
mutation	O
.	O
	
in	O
particular	O
,	O
the	O
m.14502t	O
>	O
c	O
mutation	O
altered	O
assemble	O
of	O
complex	B-T116
i	I-T116
,	O
thereby	O
aggravating	O
the	O
respiratory	B-T169
phenotypes	O
associated	O
with	O
m.11778g	O
>	O
a	O
mutation	O
,	O
resulted	O
in	O
a	O
more	O
defective	B-T169
complex	B-T116
i	I-T116
.	O
	
furthermore	O
,	O
more	O
reductions	O
in	O
the	O
levels	O
of	O
mitochondrial	O
atp	O
and	O
increasing	O
production	O
of	O
reactive	O
oxygen	O
species	O
were	O
also	O
observed	O
in	O
mutant	O
cells	O
bearing	O
both	O
m.14502t	O
>	O
c	O
and	O
m.11778g	O
>	O
a	O
mutation	O
than	O
those	O
carrying	O
only	O
11778g	O
>	O
a	O
mutation	O
.	O
	
our	O
findings	O
provided	O
new	O
insights	O
into	O
the	O
pathophysiology	B-T169
of	O
lhon	B-T047
that	O
were	O
manifested	B-T080
by	I-T080
interaction	O
between	O
primary	O
and	O
secondary	O
mtdna	O
mutations	O
.	O
	
improving	B-T080
care	O
transitions	O
across	O
healthcare	O
settings	O
through	O
a	O
human	B-T033
factors	I-T033
approach	O
after	O
more	O
than	O
two	O
decades	B-T081
of	O
research	O
focused	O
on	O
care	O
transition	O
improvement	O
and	O
intervention	B-T061
development	B-T169
,	O
unfavorable	B-T033
outcome	I-T033
measures	B-T169
associated	B-T080
with	I-T080
care	O
transitions	O
across	O
healthcare	O
settings	O
persist	O
.	O
	
readmissions	O
rates	B-T081
remain	O
an	O
important	O
outcome	B-T169
to	O
target	B-T169
for	O
intervention	B-T061
,	O
adverse	O
events	O
associated	B-T080
with	I-T080
care	O
transitions	O
continue	O
to	O
be	O
an	O
issue	B-T033
,	O
and	O
patients	O
are	O
often	O
dissatisfied	O
with	O
the	O
quality	B-T080
of	O
their	O
care	O
.	O
	
currently	O
,	O
interventions	B-T061
to	O
improve	O
care	O
transitions	O
are	O
disease	B-T047
specific	B-T080
,	O
require	O
substantial	B-T080
financial	O
investments	O
in	O
training	O
allied	O
healthcare	O
professionals	O
,	O
or	O
focus	O
primarily	O
on	O
hospital-based	O
discharge	O
planning	O
with	O
mixed	O
results	O
.	O
	
this	O
complex	B-T080
situation	I-T080
requires	O
a	O
method	O
of	O
evaluation	O
that	O
can	O
provide	O
a	O
comprehensive	B-T080
,	O
in-depth	O
,	O
and	O
context-driven	B-T078
investigation	O
of	O
potential	B-T033
risks	I-T033
to	O
safe	O
care	O
transitions	O
across	O
healthcare	O
settings	O
,	O
which	O
can	O
lead	O
to	O
the	O
creation	O
of	O
effective	B-T080
,	O
usable	B-T080
,	O
and	O
sustainable	B-T169
interventions	B-T061
.	O
	
a	O
systems'	O
approach	O
known	O
as	O
human	O
factors	O
and	O
ergonomics	O
hfe	O
evaluates	O
the	O
factors	B-T169
in	O
a	O
system	O
that	O
affect	O
human	O
performance	O
.	O
	
this	O
article	O
describes	O
how	O
hfe	O
can	O
complement	O
and	O
further	O
strengthen	O
efforts	O
to	O
improve	B-T080
care	O
transitions	O
.	O
	
adenosine	O
and	O
the	O
adenosine	O
a2a	O
receptor	O
agonist	O
,	O
cgs21680	B-T109
,	O
upregulate	O
cd39	O
and	O
cd73	B-T116
expression	O
through	O
e2f-1	B-T116
and	O
creb	B-T116
in	O
regulatory	O
t	O
cells	O
isolated	B-T169
from	O
septic	B-T169
mice	O
the	O
number	O
of	O
regulatory	O
t	O
cells	O
treg	O
cells	O
and	O
the	O
expression	O
of	O
ectonucleoside	O
triphosphate	O
diphosphohydrolase	O
1	O
entpd1	O
also	O
known	O
as	O
cd39	O
and	O
5'-ectonucleotidase	B-T116
nt5e	B-T116
also	O
known	O
as	O
cd73	B-T116
on	O
the	O
treg	O
cell	O
surface	O
are	O
increased	B-T081
during	O
sepsis	B-T047
.	O
	
in	O
this	O
study	O
,	O
to	O
determine	O
the	O
factors	O
leading	O
to	O
the	O
high	B-T080
expression	O
of	O
cd39	O
and	O
cd73	B-T116
,	O
and	O
the	O
regulation	O
of	O
the	O
cd39	O
/	O
cd73	B-T116
/	O
adenosine	O
pathway	O
in	O
treg	O
cells	O
under	O
septic	B-T169
conditions	O
,	O
we	O
constructed	O
a	O
mouse	O
model	O
of	O
sepsis	B-T047
and	O
separated	O
the	O
treg	O
cells	O
using	O
a	O
flow	O
cytometer	O
.	O
	
the	O
treg	O
cells	O
isolated	B-T169
from	O
the	O
peritoneal	O
lavage	O
and	O
splenocytes	O
of	O
the	O
mice	O
were	O
treated	B-T061
with	I-T061
adenosine	O
or	O
the	O
specific	O
adenosine	O
a2a	O
receptor	O
agonist	O
,	O
cgs21680	B-T109
,	O
and	O
were	O
transfected	O
with	O
specific	O
sirna	O
targeting	B-T169
e2f	B-T116
transcription	I-T116
factor	I-T116
1	I-T116
e2f-1	B-T116
or	O
cyclic	B-T116
adenosine	I-T116
monophosphate	I-T116
camp	I-T116
response	I-T116
element-binding	I-T116
protein	I-T116
creb	B-T116
,	O
which	O
are	O
predicted	O
transcription	B-T116
regulatory	I-T116
factors	I-T116
of	O
cd39	O
or	O
cd73	B-T116
.	O
	
the	O
regulatory	O
relationships	O
among	O
these	O
factors	O
were	O
then	O
determined	O
by	O
western	O
blot	O
analysis	O
and	O
dual-luciferase	O
reporter	O
assay	O
.	O
	
in	O
addition	O
,	O
changes	B-T169
in	O
adenosine	O
metabolism	O
were	O
measured	O
in	O
the	O
treated	B-T169
cells	O
.	O
	
the	O
results	O
revealed	O
that	O
adenosine	O
and	O
cgs21680	B-T109
significantly	O
upregulated	O
cd39	O
and	O
cd73	B-T116
expression	O
p<0	O
.	O
	
e2f-1	B-T116
and	O
creb	B-T116
induced	O
cd39	O
and	O
cd73	B-T116
expression	O
,	O
and	O
were	O
upregulated	O
by	O
adenosine	O
and	O
cgs21680	B-T109
.	O
	
adenosine	O
triphosphate	O
atp	O
hydrolysis	O
and	O
adenosine	O
generation	O
were	O
inhibited	O
by	O
the	O
knockdown	B-T080
of	O
e2f-1	B-T116
or	O
creb	B-T116
,	O
and	O
were	O
accelerated	B-T169
in	O
the	O
presence	O
of	O
cgs21680	B-T109
.	O
	
based	O
on	O
these	O
results	O
,	O
it	O
can	O
be	O
inferred	O
that	O
adenosine	O
,	O
the	O
adenosine	O
a2a	O
receptor	O
agonist	O
,	O
e2f-1	B-T116
and	O
creb	B-T116
are	O
the	O
possible	O
factors	O
contributing	O
to	O
the	O
high	B-T080
expression	O
of	O
cd39	O
and	O
cd73	B-T116
on	O
the	O
treg	O
cell	O
surface	O
during	O
sepsis	B-T047
.	O
	
adenosine	O
and	O
its	O
a2a	O
receptor	O
agonist	O
served	O
as	O
the	O
signal	O
transducer	O
factors	O
of	O
the	O
cd39	O
/	O
cd73	B-T116
/	O
adenosine	O
pathway	O
,	O
accelerating	B-T169
adenosine	O
generation	O
.	O
	
our	O
study	O
may	O
benefit	O
further	O
research	O
on	O
adenosine	O
metabolism	O
for	O
the	O
treatment	B-T061
of	O
exploring	O
consumer	O
and	O
patient	O
knowledge	O
,	O
behavior	O
,	O
and	O
attitude	O
toward	B-T078
medicinal	O
and	O
lifestyle	O
products	O
purchased	O
from	O
the	O
internet	O
a	O
web	O
-	O
based	B-T169
survey	O
in	O
recent	O
years	O
,	O
lifestyle	O
products	O
have	O
emerged	O
to	O
help	O
improve	B-T033
people's	O
physical	O
and	O
mental	O
performance	O
.	O
	
the	O
internet	O
plays	O
a	O
major	B-T080
role	O
in	O
the	O
spread	B-T080
of	O
these	O
products	O
.	O
	
however	O
,	O
the	O
literature	O
has	O
reported	O
issues	O
regarding	O
the	O
authenticity	B-T080
of	O
medicines	O
purchased	O
from	O
the	O
internet	O
and	O
the	O
impact	B-T080
of	O
counterfeit	O
medicines	O
on	O
public	O
health	B-T078
.	O
	
little	O
or	O
no	B-T080
data	I-T080
are	I-T080
available	I-T080
on	O
the	O
authenticity	B-T080
of	O
lifestyle	O
products	O
and	O
actual	O
toxicity	B-T080
associated	B-T080
with	I-T080
their	O
use	B-T169
and	O
misuse	B-T033
.	O
	
our	O
aim	O
was	O
to	O
investigate	B-T169
consumer	B-T080
and	O
patient	O
attitudes	O
toward	B-T078
the	O
purchase	O
of	O
lifestyle	O
products	O
from	O
the	O
internet	O
,	O
their	O
knowledge	O
of	O
product	O
authenticity	B-T080
and	O
toxicity	B-T080
,	O
and	O
their	O
experiences	O
with	O
counterfeit	B-T080
lifestyle	O
products	O
.	O
	
a	O
web	O
-	O
based	B-T169
study	O
was	O
performed	B-T169
between	O
may	O
2014	O
and	O
may	O
2015	O
.	O
	
uniform	B-T080
collection	O
of	O
data	O
was	O
performed	B-T169
through	B-T169
an	O
anonymous	B-T080
online	O
questionnaire	O
.	O
	
participants	O
were	O
invited	O
worldwide	O
via	O
email	O
,	O
social	O
media	O
,	O
or	O
personal	O
communication	O
to	O
complete	B-T080
the	O
online	O
questionnaire	O
.	O
	
a	O
total	B-T080
of	O
320	O
participants	O
completed	B-T080
the	O
questionnaire	O
.	O
	
the	O
results	B-T169
of	O
the	O
questionnaire	O
showed	O
that	O
208	O
65.0	O
participants	O
purchased	O
lifestyle	O
products	O
from	O
the	O
internet	O
mainly	B-T080
due	B-T169
to	I-T169
convenience	B-T080
and	O
reduced	B-T080
cost	B-T081
.	O
	
more	B-T081
than	I-T081
half	B-T081
55.6	O
,	O
178/320	O
of	O
participants	O
purchased	O
cosmetic	O
products	O
,	O
whereas	O
only	O
a	O
minority	B-T080
purchased	O
medicinal	O
products	O
.	O
	
yet	O
,	O
62.8	O
201/320	O
of	O
participants	O
were	O
aware	O
of	O
the	O
presence	B-T033
of	O
counterfeit	B-T080
lifestyle	O
products	O
from	O
the	O
internet	O
,	O
and	O
11.9	O
38/320	O
experienced	O
counterfeit	B-T080
products	O
.	O
	
in	O
only	O
0.9	O
3/320	O
of	O
those	O
cases	B-T169
were	O
counterfeit	B-T080
lifestyle	O
products	O
reported	O
to	O
authorities	O
.	O
	
moreover	O
,	O
7.2	O
23/320	O
of	O
the	O
participants	O
experienced	O
adverse	O
effects	O
due	O
to	O
counterfeit	B-T080
lifestyle	O
products	O
.	O
	
in	O
summary	O
,	O
patients	O
experienced	O
counterfeit	B-T080
lifestyle	O
products	O
that	O
resulted	B-T169
in	I-T169
adverse	O
effects	O
on	O
their	O
health	B-T078
.	O
	
although	O
certain	O
adverse	O
effects	O
were	O
reported	O
in	O
this	O
study	O
,	O
counterfeit	B-T080
products	O
were	O
underreported	O
to	O
authorities	O
.	O
	
further	O
public	O
awareness	O
campaigns	O
and	O
patient	O
education	O
are	O
it's	O
not	O
all	O
doom	O
and	O
gloom	O
prune	B-T047
belly	I-T047
syndrome	I-T047
associated	O
with	O
vacterl	O
prune	B-T047
belly	I-T047
syndrome	I-T047
is	O
a	O
rare	B-T080
abnormality	B-T033
its	O
association	O
with	O
vacterl	O
is	O
even	O
rarer	B-T080
.	O
	
this	O
association	O
has	O
been	O
reported	O
in	O
literature	O
a	O
few	O
times	O
since	O
first	O
reported	O
in	O
1993	O
and	O
so	O
far	O
the	O
majority	O
have	O
either	O
been	O
stillbirths	B-T033
or	I-T033
died	I-T033
shortly	I-T033
after	I-T033
birth	I-T033
.	O
	
we	O
present	O
a	O
case	O
of	O
prune	B-T047
belly	I-T047
syndrome	I-T047
associated	O
with	O
vacterl	O
changes	B-T169
in	O
cardiovascular	O
health	B-T080
status	I-T080
and	O
the	O
risk	B-T078
of	I-T078
new-onset	O
hypertension	O
in	O
kailuan	O
cohort	B-T081
study	I-T081
american	O
heart	O
association	O
cardiovascular	O
health	O
metrics	O
are	O
intimately	O
related	O
to	O
cardiovascular	B-T047
diseases	I-T047
.	O
	
acting	O
as	O
a	O
key	B-T080
independent	O
risk	B-T033
factor	I-T033
for	O
high	B-T080
morbidity	B-T081
and	O
mortality	B-T081
of	O
cardiovascular	B-T047
diseases	I-T047
,	O
hypertension	B-T047
and	O
its	O
relationship	B-T080
between	O
health	B-T080
status	I-T080
get	O
urgent	O
attention	O
.	O
	
while	O
the	O
influence	O
of	O
individual	O
health	B-T080
status	I-T080
changes	B-T169
and	O
the	O
future	O
risk	B-T078
of	I-T078
new-onset	O
hypertension	O
is	O
rarely	O
understood	O
,	O
the	O
present	O
study	O
applied	O
this	O
construct	O
to	O
assess	O
the	O
changes	B-T169
of	O
cardiovascular	O
health	B-T080
status	I-T080
and	O
the	O
morbidity	B-T081
of	O
hypertension	B-T047
in	O
kailuan	O
cohort	B-T081
study	I-T081
in	O
north	O
china	O
.	O
	
the	O
cardiovascular	O
health	B-T081
score	I-T081
chs	B-T081
was	O
evaluated	O
by	O
the	O
follow-ups	O
of	O
2006-2007	O
,	O
2008-2009	O
,	O
2010-2011	O
and	O
2012-2013	O
.	O
	
the	O
study	O
population	O
n	O
=	O
19381	O
was	O
divided	B-T169
into	O
5	O
groups	B-T078
based	O
on	O
the	O
changes	B-T169
in	O
their	O
chs	B-T081
score	I-T081
between	O
the	O
first	O
two	O
follow-ups	O
chs	O
of	O
2006-2007	O
and	O
2008-2009	O
-2	O
,	O
-1	O
,	O
0	O
,	O
1	O
,	O
2	O
.	O
	
the	O
morbidity	B-T081
of	O
hypertension	B-T047
was	O
collected	B-T169
during	B-T079
2010-2011	O
and	O
2012-2013	O
follow-ups	O
.	O
	
data	O
analysis	O
showed	O
that	O
during	B-T079
a	O
median	B-T081
follow-up	O
of	O
3.79	O
years	O
,	O
morbidity	B-T081
of	O
hypertension	B-T047
had	O
a	O
graded	O
relationship	B-T080
with	O
chs	O
.	O
	
as	O
chs	O
scored	O
from	O
low	O
to	O
high	O
,	O
the	O
standardized	O
morbidity	B-T081
of	O
hypertension	B-T047
for	O
all	O
participants	O
were	O
81.40	O
,	O
75.47	O
,	O
68.37	O
,	O
71.43	O
and	O
83.13	O
per	O
1000	O
person-year	O
,	O
respectively	O
.	O
	
an	O
increased	B-T081
chs	O
score	O
of	O
1	O
was	O
associated	O
with	O
a	O
10%	O
decrease	B-T081
in	O
the	O
future	B-T079
risk	B-T078
of	I-T078
new-onset	O
hypertension	O
hr	O
0.90	O
,	O
95%	O
ci	B-T081
0.88	O
.	O
	
in	O
conclusion	O
,	O
there	O
was	O
a	O
strong	O
inverse	O
relationship	B-T080
between	O
the	O
incidence	O
of	O
new-onset	O
hypertension	O
and	O
elevation	B-T080
of	O
cardiovascular	O
health	O
metrics	O
.	O
	
population	O
-wide	O
prevention	B-T080
,	O
especially	O
the	O
promotion	O
of	O
lifestyle	O
improvements	O
,	O
is	O
critical	B-T080
to	O
reducing	B-T080
the	O
morbidity	B-T081
of	O
new-onset	O
hypertension	O
.	O
	
an	O
hiv	O
-	O
tailored	O
quit	O
-	O
smoking	O
counselling	O
pilot	O
intervention	B-T061
targeting	B-T169
depressive	O
symptoms	O
plus	O
nicotine	B-T061
replacement	I-T061
therapy	I-T061
cardiovascular	B-T047
disease	I-T047
cvd	B-T047
rates	B-T081
among	O
people	O
living	O
with	O
hiv/aids	O
phas	O
are	O
high	B-T080
.	O
	
rates	B-T081
of	O
cigarette	O
smoking	O
,	O
a	O
leading	B-T169
contributor	O
to	O
cvd	B-T047
among	O
phas	O
,	O
are	O
40-70%	O
2-3	O
times	O
higher	B-T080
than	O
the	O
general	O
population	O
.	O
	
furthermore	O
,	O
phas	O
have	O
high	B-T080
rates	B-T081
of	O
depression	O
40-60%	O
,	O
a	O
risk	B-T033
factor	I-T033
for	O
smoking	O
cessation	O
relapse	O
.	O
	
the	O
current	O
pilot	O
study	O
examined	B-T033
the	O
effectiveness	B-T080
of	O
a	O
specifically	O
tailored	O
5-	O
session	O
smoking	O
cessation	O
counselling	O
programme	O
for	O
phas	O
,	O
which	O
addressed	O
depression	O
,	O
in	O
combination	O
with	O
nicotine	B-T061
replacement	I-T061
therapy	I-T061
nrt	B-T061
in	O
a	O
cohort	O
of	O
pha	O
smokers	B-T033
n	O
=	O
50	O
.	O
	
at	O
6-	O
month	B-T079
follow-up	O
,	O
28%	O
of	O
participants	O
demonstrated	O
biochemically	B-T169
verified	B-T169
abstinence	B-T061
from	O
smoking	O
.	O
	
this	O
result	B-T033
compares	O
favourably	O
to	O
other	O
quit	O
-	O
smoking	O
intervention	B-T061
studies	O
,	O
particularly	O
given	O
the	O
high	B-T080
percentage	B-T081
of	O
hiv+	O
smokers	B-T033
with	O
depression	O
.	O
	
at	O
study	O
baseline	B-T081
,	O
52%	O
of	O
hiv+	O
smokers	B-T033
scored	O
above	O
the	O
clinical	B-T080
cut-off	B-T169
for	O
depression	O
on	O
the	O
centre	O
for	O
epidemiological	O
studies	O
-	O
depression	O
ces-d	O
scale	O
.	O
	
hiv+	O
smokers	B-T033
with	O
depression	O
at	O
study	O
baseline	B-T081
demonstrated	O
quantitatively	B-T081
lower	O
depression	O
at	O
6-	O
month	B-T079
follow-up	O
with	O
a	O
large	B-T081
effect	B-T081
size	I-T081
d	O
=	O
1	O
,	O
though	O
it	O
did	O
not	O
reach	O
statistical	B-T081
significance	I-T081
p	O
=	O
058	O
.	O
	
furthermore	O
,	O
those	O
with	O
depression	O
were	O
no	O
more	O
likely	O
to	O
relapse	O
than	O
those	O
without	O
depression	O
p	O
=	O
33	O
,	O
suggesting	O
that	O
our	O
counselling	O
programme	O
adequately	B-T080
addressed	O
this	O
significant	B-T078
barrier	B-T080
to	O
smoking	O
cessation	O
among	O
phas	O
.	O
	
our	O
pilot	O
study	O
indicates	O
the	O
importance	B-T080
of	O
tailored	O
programmes	O
to	O
help	O
phas	O
quit	O
smoking	O
,	O
the	O
significance	B-T078
of	O
addressing	O
depressive	O
symptoms	O
,	O
and	O
the	O
need	O
for	O
tailored	O
counselling	O
programmes	O
to	O
enhance	O
quit	O
rates	B-T081
among	O
effects	B-T080
of	I-T080
complex	B-T080
life	B-T079
cycles	I-T079
on	O
genetic	O
diversity	O
cyclical	O
parthenogenesis	O
neutral	O
patterns	O
of	O
population	O
genetic	O
diversity	O
in	O
species	O
with	O
complex	B-T080
life	B-T079
cycles	I-T079
are	O
difficult	O
to	O
anticipate	B-T078
.	O
	
cyclical	O
parthenogenesis	O
cp	O
,	O
in	O
which	O
organisms	O
undergo	O
several	O
rounds	O
of	O
clonal	O
reproduction	O
followed	O
by	O
a	O
sexual	O
event	O
,	O
is	O
one	O
such	O
life	B-T079
cycle	I-T079
.	O
	
many	O
species	O
,	O
including	O
crop	O
pests	O
aphids	O
,	O
human	O
parasites	O
trematodes	O
or	O
models	O
used	O
in	O
evolutionary	O
science	O
daphnia	O
,	O
are	O
cyclical	O
parthenogens	O
.	O
	
it	O
is	O
therefore	O
crucial	O
to	O
understand	O
the	O
impact	O
of	O
such	O
a	O
life	B-T079
cycle	I-T079
on	O
neutral	O
genetic	O
diversity	O
.	O
	
in	O
this	O
paper	O
,	O
we	O
describe	O
distributions	B-T169
of	O
genetic	O
diversity	O
under	O
conditions	B-T080
of	O
cp	O
with	O
various	O
clonal	O
phase	B-T079
lengths	B-T081
.	O
	
using	O
a	O
markov	B-T081
chain	I-T081
model	I-T081
of	O
cp	O
for	O
a	O
single	B-T081
locus	O
and	O
individual-based	O
simulations	O
for	O
two	B-T081
loci	O
,	O
our	O
analysis	O
first	O
demonstrates	O
that	O
strong	O
departures	O
from	O
full	O
sexuality	O
are	O
observed	O
after	O
only	O
a	O
few	O
generations	B-T079
of	O
clonality	B-T080
.	O
	
the	O
convergence	O
towards	O
predictions	B-T078
made	O
under	O
conditions	O
of	O
full	O
clonality	B-T080
during	O
the	O
clonal	O
phase	B-T079
depends	O
on	O
the	O
balance	O
between	O
mutations	O
and	O
genetic	O
drift	O
.	O
	
second	O
,	O
the	O
sexual	O
event	O
of	O
cp	O
usually	O
resets	O
the	O
genetic	O
diversity	O
at	O
a	O
single	B-T081
locus	O
towards	O
predictions	B-T078
made	O
under	O
full	O
sexuality	O
.	O
	
however	O
,	O
this	O
single	O
recombination	O
event	O
is	O
insufficient	O
to	O
reshuffle	O
gametic	O
phases	O
towards	O
full-sexuality	O
predictions	B-T078
.	O
	
finally	O
,	O
for	O
similar	O
levels	O
of	O
clonality	B-T080
,	O
cp	O
and	O
acyclic	O
partial	B-T081
clonality	B-T080
wherein	O
a	O
fixed	O
proportion	O
of	O
individuals	O
are	O
clonally	B-T080
produced	O
within	O
each	O
generation	B-T079
differentially	O
affect	O
the	O
distribution	B-T169
of	O
genetic	O
diversity	O
.	O
	
overall	O
,	O
this	O
work	O
provides	O
solid	O
predictions	B-T078
of	O
neutral	O
genetic	O
diversity	O
that	O
may	O
serve	O
as	O
a	O
null	O
model	O
in	O
detecting	O
the	O
action	O
of	O
common	O
evolutionary	O
or	O
demographic	O
processes	O
in	O
cyclical	O
parthenogens	O
recent	B-T079
advances	B-T078
in	O
chitosan	B-T109
-based	O
nanoparticulate	O
pulmonary	O
drug	O
delivery	O
the	O
advent	O
of	O
biodegradable	B-T109
polymer	I-T109
-	O
encapsulated	B-T080
drug	O
nanoparticles	O
has	O
made	O
the	O
pulmonary	O
route	B-T169
of	I-T169
administration	I-T169
an	O
exciting	O
area	O
of	O
drug	O
delivery	O
research	O
.	O
	
chitosan	B-T109
,	O
a	O
natural	B-T169
biodegradable	B-T109
and	O
biocompatible	O
polysaccharide	B-T109
has	O
received	B-T080
enormous	O
attention	O
as	O
a	O
carrier	O
for	O
drug	O
delivery	O
.	O
	
recently	O
,	O
nanoparticles	O
of	O
chitosan	B-T109
cs	B-T109
and	O
its	O
synthetic	B-T109
derivatives	I-T109
have	O
been	O
investigated	B-T169
for	O
the	O
encapsulation	O
and	O
delivery	B-T169
of	O
many	O
drugs	O
with	O
improved	B-T033
targeting	B-T169
and	O
controlled	B-T079
release	I-T079
.	O
	
herein	O
,	O
recent	B-T079
advances	B-T078
in	O
the	O
preparation	O
and	O
use	B-T169
of	I-T169
micro-	O
/	O
nanoparticles	O
of	O
chitosan	B-T109
and	O
its	O
derivatives	B-T109
for	O
pulmonary	O
delivery	B-T169
of	O
various	O
therapeutic	O
agents	O
drugs	O
,	O
genes	O
,	O
vaccines	O
are	O
reviewed	B-T080
.	O
	
although	O
chitosan	B-T109
has	O
wide	O
applications	B-T169
in	O
terms	O
of	O
formulations	O
and	O
routes	B-T169
of	I-T169
drug	I-T169
delivery	I-T169
,	O
this	O
review	O
is	O
focused	O
on	O
pulmonary	O
delivery	O
of	O
drug-encapsulated	O
nanoparticles	O
of	O
chitosan	B-T109
and	O
its	O
derivatives	B-T109
.	O
	
in	O
addition	O
,	O
the	O
controversial	B-T078
toxicological	O
effects	O
of	O
chitosan	B-T109
nanoparticles	O
for	O
lung	O
delivery	B-T169
form	B-T080
and	O
function	B-T169
in	O
gene	O
regulatory	O
networks	O
the	O
structure	O
of	O
network	B-T080
motifs	I-T080
determines	O
fundamental	B-T080
properties	I-T080
of	O
their	O
dynamical	O
state	O
space	O
network	B-T080
motifs	I-T080
have	O
been	O
studied	O
extensively	O
over	O
the	O
past	O
decade	O
,	O
and	O
certain	O
motifs	B-T080
,	O
such	O
as	O
the	O
feed-forward	B-T080
loop	I-T080
,	O
play	O
an	O
important	O
role	O
in	O
regulatory	O
networks	O
.	O
	
recent	B-T079
studies	O
have	O
used	O
boolean	O
network	B-T169
motifs	B-T080
to	O
explore	O
the	O
link	O
between	O
form	B-T080
and	O
function	B-T169
in	O
gene	O
regulatory	O
networks	O
and	O
have	O
found	O
that	O
the	O
structure	O
of	O
a	O
motif	B-T080
does	O
not	O
strongly	O
determine	O
its	O
function	B-T169
,	O
if	O
this	O
is	O
defined	O
in	O
terms	O
of	O
the	O
gene	O
expression	O
patterns	O
the	O
motif	B-T080
can	O
produce	O
.	O
	
here	O
,	O
we	O
offer	O
a	O
different	O
,	O
higher	B-T080
-	O
level	B-T080
definition	O
of	O
the	O
'	O
function	B-T169
'	O
of	O
a	O
motif	B-T080
,	O
in	O
terms	O
of	O
two	O
fundamental	B-T080
properties	I-T080
of	O
its	O
dynamical	O
state	O
space	O
as	O
a	O
boolean	O
network	B-T169
.	O
	
one	O
is	O
the	O
basin	B-T081
entropy	I-T081
,	O
which	O
is	O
a	O
complexity	B-T169
measure	B-T081
of	O
the	O
dynamics	O
of	O
boolean	O
networks	B-T169
.	O
	
the	O
other	O
is	O
the	O
diversity	B-T080
of	O
cyclic	B-T081
attractor	I-T081
lengths	I-T081
that	O
a	O
given	O
motif	B-T080
can	O
produce	O
.	O
	
using	O
these	O
two	O
measures	B-T081
,	O
we	O
examine	O
all	O
104	O
topologically	O
distinct	O
three-node	O
motifs	B-T080
and	O
show	O
that	O
the	O
structural	O
properties	B-T080
of	O
a	O
motif	B-T080
,	O
such	O
as	O
the	O
presence	O
of	O
feedback	B-T080
loops	I-T080
and	O
feed-forward	B-T080
loops	I-T080
,	O
predict	O
fundamental	B-T080
characteristics	I-T080
of	O
its	O
dynamical	O
state	O
space	O
,	O
which	O
in	O
turn	O
determine	O
aspects	O
of	O
its	O
functional	B-T169
versatility	I-T169
.	O
	
we	O
also	O
show	O
that	O
these	O
higher	B-T080
-	O
level	B-T080
properties	B-T080
have	O
a	O
direct	O
bearing	O
on	O
real	O
regulatory	O
networks	O
,	O
as	O
both	O
basin	B-T081
entropy	I-T081
and	O
cycle	B-T081
length	I-T081
diversity	B-T080
show	O
a	O
close	O
correspondence	O
with	O
the	O
prevalence	B-T081
,	O
in	O
neural	O
and	O
genetic	O
regulatory	O
networks	O
,	O
of	O
the	O
13	O
connected	O
motifs	B-T080
without	O
self-interactions	B-T169
that	O
have	O
been	O
studied	O
extensively	O
in	O
the	O
jak1	B-T116
-	O
stat3	B-T116
signals	O
are	O
essential	B-T080
effectors	B-T116
of	O
the	O
usp6	B-T116
/	O
tre17	B-T116
oncogene	I-T116
in	O
tumorigenesis	O
bone	O
and	O
soft	O
tissue	O
tumors	O
bstt	O
are	O
relatively	O
poorly	O
understood	O
,	O
hampering	O
the	O
development	B-T169
of	O
effective	B-T080
therapies	B-T061
.	O
	
here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin-specific	B-T116
protease	I-T116
6	I-T116
usp6	B-T116
tre17	B-T116
oncogene	I-T116
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	O
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	B-T047
bone	I-T047
cyst	I-T047
abc	B-T047
,	O
and	O
the	O
related	O
benign	B-T080
lesion	B-T033
nodular	B-T047
fasciitis	I-T047
.	O
	
ectopic	O
expression	O
of	O
usp6	B-T116
is	O
known	O
to	O
drive	O
formation	B-T169
of	O
tumors	O
,	O
which	O
recapitulate	O
key	B-T080
features	I-T080
of	O
abc	B-T047
and	O
nodular	B-T047
fasciitis	I-T047
however	O
,	O
the	O
identity	B-T078
of	O
usp6's	B-T116
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O
	
here	O
we	O
report	O
that	O
the	O
jak1	B-T116
-	O
stat3	B-T116
signaling	O
pathway	O
serves	O
as	O
an	O
essential	B-T080
effector	B-T116
of	O
usp6	B-T116
in	O
bstt	O
formation	B-T169
.	O
	
we	O
found	O
that	O
usp6	B-T116
directly	O
deubiquitinated	O
jak1	B-T116
,	O
leading	B-T169
to	O
its	O
stabilization	B-T033
and	O
activation	O
of	O
stat3	B-T116
.	O
	
the	O
tumorigenic	O
potential	B-T080
of	O
usp6	B-T116
was	O
attenuated	B-T080
significantly	I-T080
by	I-T080
crispr	O
-mediated	O
deletion	O
of	O
jak1	O
or	O
stat3	O
,	O
or	O
by	O
administration	B-T169
of	O
a	O
jak	B-T116
family	I-T116
inhibitor	B-T080
.	O
	
analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	B-T047
fasciitis	I-T047
confirmed	B-T033
the	O
activation	O
of	O
a	O
jak1	B-T116
-	O
stat3	B-T116
gene	B-T169
signature	I-T169
in	O
vivo	O
together	O
,	O
our	O
studies	O
highlight	O
jak1	B-T116
as	O
the	O
first	O
identified	O
substrate	O
for	O
usp6	B-T116
,	O
and	O
they	O
offer	O
a	O
mechanistic	B-T078
rationale	I-T078
for	O
the	O
clinical	O
investigation	O
of	O
jak	B-T116
and	O
stat3	B-T116
inhibitors	B-T080
as	O
therapeutics	B-T169
for	O
the	O
treatment	B-T061
of	O
bone	O
and	O
soft	O
tissue	O
tumors	O
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
usp6	B-T116
overexpression	O
.	O
	
the	O
evidence	B-T078
behind	O
integrating	O
palliative	O
care	O
into	O
oncology	O
practice	O
palliative	O
care	O
services	O
provided	O
alongside	O
traditional	B-T169
oncology	O
care	O
have	O
been	O
shown	O
to	O
be	O
beneficial	B-T080
to	O
patients	O
and	O
families	O
.	O
	
this	O
article	O
provides	O
a	O
brief	B-T079
history	O
of	O
palliative	O
care	O
,	O
a	O
pathway	O
to	O
implementing	O
these	O
services	O
into	O
currently	B-T079
established	B-T080
oncology	O
programs	O
,	O
and	O
a	O
brief	O
discussion	O
of	O
common	B-T080
barriers	I-T080
.	O
	
secondary	O
ossification	O
center	O
appearance	B-T080
and	O
closure	B-T061
in	I-T061
the	I-T061
pelvis	I-T061
and	O
proximal	O
femur	O
variable	O
ossification	O
patterns	O
of	O
the	O
pelvis	O
in	O
skeletally	O
immature	B-T080
patients	O
can	O
make	O
the	O
interpretation	O
of	O
pelvic	O
radiographs	O
challenging	O
.	O
	
inconsistencies	O
among	O
prior	O
studies	O
and	O
lack	O
of	O
sex	O
comparisons	O
underscore	O
the	O
need	O
for	O
a	O
more	O
comprehensive	O
characterization	O
of	O
the	O
secondary	O
ossification	O
centers	O
.	O
	
this	O
study	O
evaluates	O
the	O
chronology	O
and	O
sex	O
differences	O
for	O
appearance	B-T080
and	O
closure	B-T061
of	I-T061
pelvic	I-T061
and	O
proximal	O
femoral	O
secondary	O
ossification	O
centers	O
using	O
computed	O
tomography	O
ct	O
.	O
	
patients	O
who	O
underwent	O
abdominal	O
and	O
pelvic	O
ct	O
scans	O
between	O
january	O
2009	O
and	O
december	O
2014	O
at	O
2	O
tertiary	O
level	O
1	O
trauma	O
centers	O
were	O
retrospectively	B-T080
reviewed	B-T080
.	O
	
patients	O
between	O
the	O
ages	O
of	O
2	O
and	O
32	O
years	O
with	O
adequate	O
imaging	O
of	O
the	O
pelvis	O
and	O
proximal	O
femurs	O
were	O
included	O
.	O
	
patients	O
with	O
a	O
history	O
of	O
orthopaedic	O
trauma	O
or	O
pathology	O
affecting	B-T169
ossification	O
were	O
excluded	O
.	O
	
ct	O
scans	O
were	O
assessed	O
for	O
the	O
appearance	B-T080
and	O
closure	B-T061
of	O
the	O
following	O
secondary	O
ossification	O
centers	O
anterior	O
inferior	O
iliac	O
spine	O
aiis	O
,	O
anterior	O
superior	O
iliac	O
spine	O
asis	O
,	O
femoral	O
head	O
fh	O
,	O
greater	O
trochanter	O
gt	O
,	O
iliac	O
crest	O
ic	O
,	O
ischial	O
tuberosity	O
it	O
,	O
lesser	O
trochanter	O
lt	O
,	O
posterior	O
superior	O
iliac	O
spine	O
psis	O
,	O
symphysis	O
pubis	O
sp	O
,	O
and	O
triradiate	O
cartilage	O
trc	O
.	O
	
basic	O
descriptive	O
statistics	O
are	O
reported	O
.	O
	
a	O
total	O
of	O
496	O
ct	O
scans	O
met	O
inclusion	B-T080
criteria	I-T080
240	O
males	O
and	O
256	O
females	O
.	O
	
the	O
order	O
of	O
appearance	B-T080
of	O
the	O
secondary	O
ossification	O
centers	O
was	O
male	O
gt	O
,	O
lt	O
,	O
aiis	O
,	O
it	O
,	O
asis	O
,	O
psis	O
,	O
ic	O
,	O
and	O
sp	O
female	O
gt	O
,	O
lt	O
,	O
it	O
,	O
aiis	O
,	O
psis	O
,	O
ic	O
,	O
asis	O
,	O
and	O
sp	O
.	O
	
the	O
order	O
of	O
closure	B-T061
was	O
similar	O
male	O
trc	O
,	O
lt	O
,	O
fh	O
,	O
aiis	O
,	O
gt	O
,	O
asis	O
,	O
psis	O
,	O
it	O
,	O
ic	O
,	O
and	O
sp	O
female	O
lt	O
,	O
trc	O
,	O
aiis	O
,	O
fh	O
,	O
gt	O
,	O
asis	O
,	O
psis	O
,	O
it	O
,	O
ic	O
,	O
and	O
sp	O
.	O
	
female	O
ossification	O
centers	O
appeared	O
1	O
to	O
2	O
years	O
before	O
males	O
in	O
all	O
locations	O
.	O
	
female	O
ossification	O
centers	O
closed	O
1	O
to	O
2	O
years	O
before	O
males	O
in	O
all	O
locations	O
except	O
trc	O
,	O
ic	O
,	O
and	O
sp	O
.	O
	
the	O
appearance	B-T080
and	O
closure	B-T061
of	I-T061
the	I-T061
pelvis	I-T061
and	O
proximal	O
femur	O
secondary	O
ossification	O
centers	O
follow	O
a	O
predictable	O
pattern	O
of	O
development	O
,	O
occurring	O
slightly	O
earlier	O
in	O
females	O
than	O
males	O
.	O
	
knowledge	O
of	O
more	O
precise	O
ages	B-T033
of	I-T033
developmen	I-T033
t	O
and	O
sex	O
differences	O
better	O
characterize	O
this	O
complex	O
skeletal	O
development	O
.	O
	
future	O
studies	O
may	O
use	O
secondary	O
ossification	O
centers	O
to	O
further	O
evaluate	O
skeletal	O
maturity	O
,	O
assess	O
pediatric	O
pathology	O
,	O
and	O
aid	O
surgical	O
management	O
.	O
	
pediatric	O
orthopaedic	O
trauma	O
and	O
associated	O
injuries	O
of	O
snowmobile	B-T033
,	O
atv	O
,	O
and	O
dirtbike	O
accidents	O
a	O
19-year	B-T079
experience	O
at	O
a	O
level	O
1	O
pediatric	O
trauma	O
center	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
type	B-T080
and	O
severity	B-T080
of	O
orthopaedic	O
and	O
associated	O
injuries	O
for	O
snowmobile	B-T033
,	O
all-terrain	O
vehicles	O
atv	O
and	O
motorized	O
dirtbike	O
accidents	O
in	O
a	O
pediatric	O
patient	O
population	O
.	O
	
a	O
total	O
of	O
758	O
patients	O
who	O
presented	O
following	O
either	O
snowmobile	O
n=87	O
,	O
atv-related	O
n=308	O
or	O
dirtbike	O
n=363	O
trauma	O
at	O
our	O
institution	O
between	O
1996	O
and	O
2015	O
were	O
retrospectively	O
reviewed	B-T080
.	O
	
a	O
total	O
of	O
441	O
axial	O
and	O
appendicular	O
fractures	O
occurred	O
requiring	O
533	O
procedures	B-T169
.	O
	
snowmobile	B-T033
and	O
dirtbike	O
accidents	O
were	O
associated	B-T080
with	I-T080
a	O
higher	O
rate	O
of	O
fractures	O
63%	O
,	O
64%	O
than	O
the	O
atv	O
group	O
50%	O
p=0	O
.	O
	
snowmobile	O
injuries	O
had	O
the	O
highest	O
rate	O
of	O
spinal	O
23%	O
and	O
lower	O
extremity	O
fractures	O
53%	O
p=0	O
.	O
	
snowmobile	O
and	O
dirtbike	O
cohorts	O
had	O
higher	O
rate	O
of	O
femur	O
fractures	O
22%	O
,	O
17%	O
,	O
p=0	O
whereas	O
the	O
atv	O
cohort	O
had	O
higher	O
rates	O
of	O
upper	O
extremity	O
18%	O
,	O
hand	O
11%	O
,	O
scapula	O
4.6	O
,	O
and	O
open	O
fractures	O
28.6	O
p<0	O
.	O
	
head	O
trauma	O
was	O
the	O
most	O
commonly	O
associated	O
injury	O
in	O
275	O
patients	O
with	O
the	O
highest	O
rate	O
in	O
the	O
atv	O
group	O
44%	O
who	O
also	O
had	O
the	O
highest	O
rate	O
of	O
no	O
helmet	O
use	O
76%	O
.	O
	
snowmobile	O
and	O
atv	O
patients	O
had	O
higher	O
injury	O
severity	O
score	O
11.3	O
,	O
9.6	O
than	O
dirtbike	O
patients	O
7.8	O
p=0	O
.	O
	
atv	O
patients	O
were	O
found	O
to	O
be	O
younger	B-T079
11.8	O
y	O
compared	O
with	O
snowmobile	O
13.2	O
y	O
and	O
dirtbike	O
13.5	O
y	O
p<0	O
.	O
	
pediatric	O
snowmobile	B-T033
,	O
atv	O
and	O
dirtbike	O
accidents	O
result	O
in	O
severe	B-T080
orthopaedic	O
and	O
associated	O
injuries	O
with	O
each	O
vehicle	O
demonstrating	O
significantly	O
different	O
injury	O
patterns	O
.	O
	
injury	B-T061
prevention	I-T061
should	O
focus	O
on	O
improved	O
safety	O
mechanisms	O
,	O
protective	O
gear	O
,	O
safe	O
areas	O
for	O
off-road	O
vehicle	O
use	O
and	O
strict	O
laws	O
with	O
minimum	O
age	O
hospitalist	O
co-management	O
of	O
pediatric	B-T080
orthopaedic	B-T061
surgical	O
patients	O
at	O
a	O
community	O
hospital	O
the	O
benefits	O
of	O
hospitalist	O
co-management	O
of	O
pediatric	B-T080
surgical	O
patients	O
include	O
bettering	B-T080
patient	O
safety	O
,	O
decreasing	B-T033
negative	B-T080
patient	B-T078
outcomes	I-T078
,	O
providing	O
comprehensive	O
medical	O
care	O
,	O
and	O
establishing	O
a	O
dedicated	B-T078
resource	I-T078
to	O
patients	O
for	O
postoperative	O
care	O
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
characterize	O
the	O
nature	B-T078
of	O
patients	O
co-managed	O
by	O
a	O
pediatric	B-T080
hospitalist	O
.	O
	
the	O
authors	O
hypothesize	B-T078
that	O
hospitalist	O
co-management	O
is	O
safe	B-T033
and	O
efficacious	B-T080
in	O
pediatric	B-T080
orthopaedic	B-T061
surgical	O
patients	O
who	O
are	O
admitted	O
to	O
a	O
community	O
hospital	O
.	O
	
a	O
retrospective	O
review	O
was	O
performed	O
of	O
all	O
pediatric	B-T080
orthopaedic	B-T061
surgical	O
patients	O
admitted	O
to	O
a	O
community	O
hospital	O
who	O
were	O
co-managed	O
by	O
a	O
pediatric	B-T080
hospitalist	O
.	O
	
indications	O
for	O
hospitalization	O
included	O
pain	B-T061
control	I-T061
,	O
antibiotic	B-T061
infusion	I-T061
,	O
and	O
need	O
for	O
neurovascular	O
monitoring	O
.	O
	
parameters	O
of	O
postoperative	O
care	O
and	O
co-management	O
were	O
assessed	O
,	O
including	O
presence	B-T033
of	O
complications	B-T078
,	O
medication	B-T061
introduction	I-T061
or	O
adjustment	O
by	O
the	O
hospitalist	O
,	O
follow-up	O
adherence	B-T169
,	O
and	O
readmission	O
/	O
complication	B-T078
rates	B-T081
after	O
discharge	O
.	O
	
thirty-two	O
patients	O
were	O
assessed	O
with	O
an	O
average	O
age	O
of	O
8.8	O
years	B-T079
.	O
	
twenty-five	O
percent	B-T081
of	O
patients	O
had	O
an	O
associated	B-T078
comorbidity	I-T078
,	O
including	O
asthma	B-T047
,	O
attention	O
deficit	O
disorder	O
,	O
and/or	O
autism	O
.	O
	
the	O
pediatric	B-T080
hospitalist	O
added	O
pain	B-T061
medication	I-T061
to	O
the	O
original	O
postoperative	O
orders	O
placed	O
by	O
the	O
orthopaedics	O
team	O
in	O
44	O
percent	B-T081
of	O
patients	O
14	O
of	O
the	O
32	O
either	O
for	O
breakthrough	O
pain	O
or	O
better	O
long-term	O
coverage	O
.	O
	
additionally	O
,	O
25	O
percent	B-T081
of	O
patients	O
had	O
pain	B-T061
medication	I-T061
adjusted	O
from	O
the	O
original	O
dosing	B-T081
and	O
schedule	O
.	O
	
the	O
hospitalist	O
team	O
contacted	O
the	O
surgeon	O
about	O
the	O
four	O
patients	O
12.5	O
percent	B-T081
.	O
	
in	O
three	O
of	O
the	O
cases	O
,	O
the	O
surgeon	O
was	O
contacted	O
to	O
discuss	O
pain	B-T061
medication	I-T061
,	O
and	O
one	O
patient	O
woke	O
up	O
agitated	O
from	O
anesthesia	B-T061
,	O
necessitating	O
a	O
visit	O
from	O
the	O
surgeon	O
on	O
the	O
pediatrics	O
floor	O
.	O
	
the	O
length	O
of	O
stay	O
was	O
one	O
day	O
for	O
all	O
patients	O
.	O
	
the	O
hospitalists	O
rounded	O
on	O
and	O
discharged	O
patients	O
the	O
subsequent	O
morning	O
.	O
	
all	O
patients	O
were	O
given	O
a	O
follow-up	O
appointment	O
and	O
schedule	O
by	O
the	O
hospitalist	O
team	O
,	O
and	O
every	O
patient	O
followed	O
up	O
accordingly	O
within	O
ten	O
days	B-T079
of	O
discharge	O
.	O
	
no	O
complications	B-T078
or	O
hospital	O
readmissions	O
occurred	O
within	O
thirty	O
days	B-T079
of	O
discharge	O
.	O
	
hospitalist	O
co-management	O
of	O
pediatric	B-T080
orthopaedic	B-T061
surgical	O
patients	O
in	O
a	O
community	O
hospital	O
allows	O
for	O
better	O
medical	O
comorbidity	O
and	O
medication	O
management	O
.	O
	
hospitalist	O
s	O
can	O
provide	O
closer	O
observation	O
during	O
the	O
inpatient	O
stay	O
and	O
help	O
streamline	O
communication	O
between	O
providers	O
and	O
patients	O
while	O
allowing	O
the	O
surgeon	O
the	O
ability	O
to	O
be	O
more	O
mobile	O
.	O
	
co-management	O
is	O
safe	O
and	O
efficacious	O
in	O
pediatric	O
orthopaedic	O
surgical	O
patients	O
who	O
are	O
admitted	O
to	O
a	O
community	O
hospital	O
.	O
	
extra	O
carbohydrate	B-T116
binding	I-T116
module	I-T116
contributes	O
to	O
the	O
processivity	B-T080
and	O
catalytic	O
activity	O
of	O
a	O
non-modular	B-T116
hydrolase	I-T116
family	O
5	B-T116
endoglucanase	I-T116
from	O
fomitiporia	O
mediterranea	O
mf3/22	O
fmeg	B-T116
from	O
fomitiporia	O
mediterranea	O
is	O
a	O
non-modular	B-T116
endoglucanase	I-T116
composed	O
of	O
a	O
24-amino	B-T116
acids	I-T116
extension	B-T169
and	O
13-amino	B-T116
acids	I-T116
linker-like	B-T116
peptide	I-T116
at	O
the	O
n-terminus	O
and	O
a	O
312-amino	B-T116
acids	I-T116
gh5	O
catalytic	O
domain	O
cd	O
at	O
the	O
c-terminus	O
.	O
	
in	O
this	O
study	O
,	O
six	O
fmeg	B-T116
derivatives	O
with	O
deletion	O
of	O
n-terminal	B-T116
fragments	I-T116
or	O
fusion	B-T116
with	O
an	O
extra	O
family	B-T116
1	I-T116
carbohydrate-binding	I-T116
module	I-T116
cbm1	B-T116
was	O
constructed	O
in	O
order	O
to	O
evaluate	O
the	O
contribution	O
of	O
cbm1	B-T116
to	O
fmeg	B-T116
processivity	B-T080
and	O
catalytic	O
activity	O
.	O
	
fmeg	B-T116
showed	O
a	O
weak	O
processivity	B-T080
and	O
released	O
cellobiose	B-T109
g2	B-T109
and	O
cellotriose	B-T109
g3	B-T109
as	O
main	O
end	O
products	O
,	O
and	O
cellotriose	B-T109
g4	B-T109
as	O
minor	O
end	O
product	O
from	O
filter	O
paper	O
fp	O
,	O
but	O
more	O
amount	O
of	O
g4	B-T109
was	O
released	O
from	O
regenerated	B-T109
amorphous	I-T109
cellulose	I-T109
rac	B-T109
.	O
	
all	O
derivatives	B-T109
had	O
similar	O
activity	O
on	O
carboxymethylcellulose	B-T109
cmc	B-T109
with	O
the	O
same	B-T080
optimal	I-T080
ph	B-T081
7.0	O
and	O
temperature	B-T081
50	O
.	O
	
however	O
,	O
fusing	O
an	O
extra	O
cbm1	B-T116
to	O
fmeg	B-T116
or	O
fmeg	B-T116
with	O
flexible	B-T116
peptide	I-T116
significantly	O
improved	O
its	O
processivity	B-T080
and	O
catalytic	B-T169
activity	I-T169
to	O
fp	O
and	O
rac	B-T109
.	O
	
overall	O
,	O
1.79	O
and	O
1.84	O
increases	O
in	O
the	O
soluble	B-T080
/insoluble	O
product	O
ratio	B-T081
on	O
fp	O
,	O
and	O
1.38	O
and	O
1.39	O
increases	O
on	O
rac	B-T109
,	O
compared	O
to	O
fmeg	B-T116
,	O
were	O
recorded	O
for	O
cbm1	B-T116
-	O
fmeg	B-T116
and	O
cbm1	B-T116
-linker-	O
fmeg	B-T116
,	O
respectively	O
.	O
	
meanwhile	O
,	O
they	O
displayed	O
2.64	O
and	O
2.67	B-T033
more	I-T033
activity	I-T033
on	O
rac	B-T109
,	O
and	O
1.68	O
and	O
1.77	O
on	O
fp	O
,	O
respectively	O
.	O
	
similar	O
improvement	O
was	O
also	O
obtained	O
for	O
cbm1	B-T116
-linker-	O
fmeg	B-T116
as	O
compared	O
with	O
fmeg	B-T116
.	O
	
interestingly	O
,	O
fusion	O
of	O
an	O
extra	O
cbm1	B-T116
with	O
fmeg	B-T116
also	O
caused	O
an	O
alteration	B-T078
of	O
cleavage	O
pattern	O
on	O
insoluble	B-T109
celluloses	I-T109
.	O
	
our	O
results	O
suggest	O
that	O
such	O
improvements	O
in	O
processivity	B-T080
and	O
catalytic	B-T169
activity	I-T169
may	O
arise	O
from	O
cbm1	B-T116
binding	O
affinity	O
.	O
	
the	O
n-terminal	B-T116
24-	I-T116
or	I-T116
37-amino	I-T116
acids	I-T116
may	O
serve	O
as	O
linker	O
for	O
sufficient	O
spatial	O
separation	O
of	O
the	O
two	O
domains	O
required	O
for	O
processivity	B-T080
and	O
catalytic	B-T169
activity	I-T169
.	O
	
in	O
addition	O
,	O
deletion	O
of	O
the	O
n-terminal	B-T116
24-	I-T116
or	I-T116
37-amino	I-T116
acids	I-T116
led	O
to	O
significant	B-T080
reduction	I-T080
in	O
thermostability	O
but	O
not	O
the	O
enzymatic	O
activity	O
.	O
	
overnight	B-T079
switching	O
from	O
oxcarbazepine	B-T109
to	O
eslicarbazepine	B-T109
acetate	I-T109
an	O
observational	O
study	O
there	O
are	O
clinical	O
situations	O
where	O
it	O
might	O
be	O
appropriate	B-T080
to	O
switch	O
patients	O
from	O
immediate-release	O
oxcarbazepine	B-T109
oxc	B-T109
to	O
eslicarbazepine	B-T109
acetate	I-T109
esl	B-T109
.	O
	
we	O
investigated	B-T169
the	O
effects	B-T080
of	I-T080
transitioning	O
patients	O
overnight	B-T079
from	O
oxc	B-T109
to	O
esl	B-T109
.	O
	
a	O
retrospective	O
,	O
single-center	O
study	O
was	O
conducted	O
in	O
which	O
patients	O
with	O
drug-resistant	O
focal	B-T047
epilepsy	I-T047
on	O
a	O
stable	O
dose	B-T081
of	O
immediate-release	O
oxc	B-T109
for	O
at	O
least	O
4	B-T079
weeks	I-T079
were	O
switched	O
overnight	B-T079
to	O
esl	B-T109
.	O
	
patients	O
were	O
switched	O
because	O
they	O
experienced	O
persistent	B-T079
seizures	O
with	O
oxc	B-T109
but	O
were	O
unable	B-T033
to	O
tolerate	B-T080
increased	O
oxc	B-T109
dosing	B-T081
due	O
to	O
adverse	O
events	O
.	O
	
tolerability	B-T080
was	O
assessed	O
using	O
the	O
adverse	O
events	O
profile	O
aep	O
,	O
quality	B-T078
of	I-T078
life	I-T078
was	O
assessed	O
using	O
the	O
quality	O
of	O
life	O
in	O
epilepsy	O
inventory	O
10	O
qolie-10	O
,	O
and	O
alertness	O
was	O
assessed	O
as	O
reaction	B-T079
time	I-T079
using	O
a	O
subtest	O
of	O
the	O
test	O
battery	O
for	O
attention	O
performance	O
version	O
2.3	O
.	O
	
assessments	O
were	O
performed	B-T169
immediately	B-T079
prior	B-T079
to	I-T079
and	O
5	B-T079
days	I-T079
after	O
switching	O
from	O
oxc	B-T109
to	O
esl	B-T109
days	B-T079
0	O
and	O
5	O
,	O
respectively	O
.	O
	
the	O
analysis	O
included	O
21	O
patients	O
12	O
women	O
,	O
9	O
men	O
mean	B-T033
age	I-T033
36	I-T033
years	I-T033
.	O
	
after	O
switching	O
from	O
oxc	B-T109
to	O
esl	B-T109
,	O
there	O
were	O
significant	O
improvements	O
in	O
mean	B-T081
scores	I-T081
for	O
aep	O
p<	O
,	O
qolie-10	O
p=	O
,	O
and	O
alertness	O
p<	O
.	O
	
adverse	O
events	O
profile	O
total	B-T081
scores	I-T081
improved	B-T033
for	O
21/21	O
100.0	O
patients	O
,	O
qolie-10	O
total	B-T081
scores	I-T081
improved	B-T033
for	O
17/21	O
81.0	O
patients	O
,	O
and	O
alertness	O
scores	B-T081
improved	B-T033
for	O
16/21	O
76.2	O
patients	O
.	O
	
in	O
this	O
short-term	B-T079
,	O
single-center	O
study	O
,	O
an	O
overnight	B-T079
switch	O
from	O
twice-daily	B-T079
oxc	B-T109
to	O
once-daily	B-T079
esl	B-T109
in	O
patients	O
with	O
drug-resistant	O
focal	B-T047
epilepsies	I-T047
resulted	B-T033
in	O
improvements	O
in	O
side	O
effects	O
,	O
quality	B-T078
of	I-T078
life	I-T078
,	O
and	O
complete	B-T080
genome	O
sequences	O
of	O
three	O
outbreak	O
-associated	O
legionella	O
pneumophila	O
isolates	O
we	O
report	O
here	O
the	O
complete	B-T080
genome	O
sequences	O
of	O
three	O
legionella	O
pneumophila	O
isolates	O
that	O
are	O
associated	B-T080
with	I-T080
a	O
legionnaires'	B-T047
disease	I-T047
outbreak	O
in	O
new	O
york	O
in	O
2012	O
.	O
	
two	O
clinical	B-T080
isolates	O
d7630	O
and	O
d7632	O
and	O
one	O
environmental	O
isolate	O
d7631	O
were	O
recovered	B-T080
from	O
this	O
outbreak	O
.	O
	
a	O
single	O
isolate-specific	O
virulence	O
gene	O
was	O
found	O
in	O
d7632	O
.	O
	
these	O
isolates	O
were	O
included	O
in	O
a	O
large	O
study	O
evaluating	O
the	O
genomic	O
resolution	O
of	O
various	O
bioinformatics	O
approaches	B-T169
for	O
l	O
.	O
	
pneumophila	O
serogroup	O
1	O
isolates	O
.	O
	
complete	O
genome	O
sequence	O
analysis	O
of	O
a	O
naturally	O
reassorted	O
infectious	O
bursal	O
disease	O
virus	O
from	O
india	O
the	O
novel	O
infectious	O
bursal	O
disease	O
virus	O
ibdv	O
isolate	O
bge14/abt1/mvc/india	O
is	O
a	O
very	O
virulent	B-T080
ibdv	O
that	O
was	O
isolated	O
from	O
broiler	O
flocks	O
in	O
southern	O
parts	O
of	O
india	O
during	O
2014	O
.	O
	
here	O
,	O
we	O
report	O
,	O
for	O
the	O
first	O
time	O
in	O
india	O
,	O
the	O
complete	O
genome	O
sequence	O
of	O
bge14/abt1/mvc/india	O
,	O
a	O
reassortment	O
strain	O
with	O
segments	O
a	O
and	O
b	O
derived	O
from	O
a	O
very	O
virulent	B-T080
ibdv	O
strain	O
and	O
an	O
attenuated	O
ibdv	O
,	O
respectively	O
.	O
	
the	O
findings	O
from	O
this	O
study	O
provide	O
additional	O
insight	O
into	O
the	O
genetic	O
exchange	O
between	O
attenuated	O
and	O
very	O
virulent	B-T080
strains	O
of	O
ibdv	O
circulating	B-T169
in	O
the	O
field	O
.	O
	
patient	B-T080
satisfaction	I-T080
with	O
postpartum	B-T079
teaching	O
methods	O
postpartum	B-T079
discharge	O
instructions	O
are	O
a	O
crucial	O
part	O
of	O
a	O
mother's	O
birth	O
experience	O
.	O
	
finding	B-T033
the	O
method	O
to	O
provide	O
those	O
discharge	O
instructions	O
in	O
a	O
manner	O
that	O
increases	B-T169
the	O
mother's	O
satisfaction	O
with	O
her	O
hospital	O
experience	O
is	O
important	O
.	O
	
this	O
quasi-experimental	O
study	O
examined	B-T033
the	O
relationship	B-T080
between	O
new	B-T080
mothers'	O
interaction	B-T033
with	O
nurses	O
providing	O
postpartum	B-T079
instructions	O
by	O
the	O
traditional	B-T169
and	O
class	O
methods	O
and	O
their	O
satisfaction	O
with	O
discharge	O
teaching	O
.	O
	
the	O
results	O
indicated	O
new	B-T080
mothers	O
were	O
satisfied	O
with	O
both	O
methods	O
of	O
discharge	O
teaching	O
however	O
,	O
they	O
were	O
more	O
likely	O
to	O
report	O
stronger	O
agreement	O
with	O
overall	O
satisfaction	O
with	O
the	O
traditional	B-T169
method	O
of	O
discharge	O
teaching	O
than	O
with	O
attending	B-T169
the	O
discharge	O
class	O
.	O
	
splicing	O
variants	O
of	O
adar2	B-T116
and	O
adar2	B-T116
-mediated	O
rna	O
editing	O
in	O
glioma	O
the	O
roles	O
of	O
alternative	O
splicing	O
and	O
rna	O
editing	O
in	O
gene	O
regulation	O
and	O
transcriptome	O
diversity	O
are	O
well	O
documented	O
.	O
	
adenosine	B-T116
deaminases	I-T116
acting	O
on	O
rna	O
adars	B-T116
are	O
responsible	O
for	O
adenosine-to-inosine	O
a-to-i	O
editing	O
and	O
exemplify	O
the	O
complex	O
association	O
between	O
rna	O
editing	O
and	O
alternative	O
splicing	O
.	O
	
the	O
self-editing	O
activity	O
of	O
adar2	B-T116
,	O
which	O
acts	O
on	O
its	O
own	O
pre-mrna	O
,	O
leads	O
to	O
its	O
alternative	O
splicing	O
.	O
	
alternative	O
splicing	O
occurs	O
independently	O
at	O
nine	O
splicing	O
sites	O
on	O
adar2	B-T116
pre-mrna	O
,	O
generating	O
numerous	O
alternative	O
splicing	O
variants	O
with	O
various	O
catalytic	O
activities	O
.	O
	
a-to-i	O
rna	O
editing	O
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	O
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	B-T047
,	O
including	O
amyotrophic	B-T047
lateral	I-T047
sclerosis	I-T047
,	O
mood	O
disorders	O
,	O
epilepsy	B-T047
and	O
glioma	O
.	O
	
reduced	O
editing	O
at	O
the	O
glutamine	B-T116
/	O
arginine	B-T116
site	O
of	O
the	O
ampa	B-T116
receptor	I-T116
subunit	I-T116
glua2	I-T116
in	O
glioma	O
,	O
without	O
any	O
alteration	O
in	O
adar2	B-T116
expression	O
,	O
is	O
a	O
notable	O
phenomenon	O
.	O
	
several	O
studies	O
have	O
tried	O
to	O
explain	O
this	O
alteration	B-T078
in	O
the	O
catalytic	O
activity	O
of	O
adar2	B-T116
however	O
,	O
the	O
underlying	O
mechanism	O
remains	O
unclear	O
.	O
	
the	O
present	O
review	O
summarizes	O
the	O
relevant	O
literature	O
and	O
shares	O
experimental	B-T033
results	I-T033
concerning	O
adar2	B-T116
alternative	O
splicing	O
.	O
	
in	O
particular	O
,	O
the	O
present	O
review	O
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	O
variants	O
of	O
adar2	B-T116
may	O
reduce	O
the	O
adar2	B-T116
editing	O
activity	O
in	O
glioma	O
.	O
	
dominant	O
expression	O
of	O
adar2	B-T116
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	O
causes	O
reduced	O
rna	O
editing	O
of	O
glua2	B-T116
subunit	I-T116
at	O
the	O
glutamine	B-T116
/	O
arginine	B-T116
site	O
in	O
heat-shock	B-T116
protein	I-T116
60	I-T116
of	O
porphyromonas	O
gingivalis	O
may	O
induce	O
dysfunction	O
of	O
human	O
umbilical	O
endothelial	O
cells	O
via	O
regulation	O
of	O
endothelial-nitric	B-T116
oxide	I-T116
synthase	I-T116
and	O
vascular	B-T116
endothelial-cadherin	I-T116
accumulating	O
evidence	O
has	O
established	O
that	O
periodontitis	B-T047
was	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
coronary	B-T047
heart	I-T047
disease	I-T047
cad	B-T047
.	O
	
porphyromonus	O
gingivalis	O
p	O
.	O
	
gingivalis	O
,	O
a	O
major	O
periodontal	B-T080
pathogen	O
,	O
has	O
already	O
been	O
shown	O
to	O
have	O
a	O
significant	O
role	O
in	O
the	O
inflammatory	O
response	O
of	O
cad	B-T047
in	O
vivo	O
.	O
	
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
identify	O
whether	O
p	O
.	O
	
gingivalis	O
heat-shock	B-T116
protein	I-T116
60	I-T116
hsp60	B-T116
induced	O
the	O
dysfunction	O
of	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
huvecs	O
in	B-T080
vitro	I-T080
.	O
	
huvecs	O
were	O
stimulated	O
with	O
a	O
range	O
of	O
p	O
.	O
	
gingivalis	O
hsp60	B-T116
concentrations	B-T081
1	O
,	O
10	O
and	O
100	O
ng/l	O
at	O
different	O
time-points	B-T079
.	O
	
the	O
levels	B-T080
of	O
vascular	B-T116
endothelial	I-T116
ve	I-T116
,	O
endothelial	B-T116
nitric	I-T116
oxide	I-T116
synthase	I-T116
enos	B-T116
and	O
cysteinyl	B-T116
aspartate-specific	I-T116
protease-3	I-T116
caspase-3	B-T116
were	O
measured	O
using	O
western	O
blot	O
analysis	O
.	O
	
the	O
apoptotic	O
rate	B-T081
of	O
huvecs	O
was	O
detected	O
using	O
flow	O
cytometry	O
.	O
	
p	O
.	O
	
gingivalis	O
hsp60	B-T116
at	O
a	O
concentration	B-T081
of	O
10	O
ng/l	O
significantly	O
decreased	O
the	O
expression	O
levels	B-T080
of	O
ve-cadherin	B-T116
and	O
enos	B-T116
protein	I-T116
at	O
24	O
h	B-T079
stimulation	O
,	O
whereas	O
no	O
difference	O
in	O
these	O
proteins	B-T116
was	O
identified	O
following	O
a	O
low	B-T081
dose	I-T081
of	O
p	O
.	O
	
gingivalis	O
hsp60	B-T116
1	O
ng/l	O
.	O
	
p	O
.	O
	
gingivalis	O
hsp60	B-T116
at	O
100	O
ng/l	O
significantly	O
downregulated	O
the	O
expression	O
levels	B-T080
of	O
ve-cadherin	B-T116
and	O
enos	B-T116
protein	I-T116
at	O
12	O
h	O
in	O
huvecs	O
.	O
	
however	O
,	O
the	O
cleavage	O
of	O
caspase-3	B-T116
showed	O
an	O
opposing	O
change	O
at	O
different	O
concentrations	B-T081
.	O
	
consistently	O
,	O
p	O
.	O
	
gingivalis	O
hsp60	B-T116
induced	O
apoptosis	O
of	O
huvecs	O
in	O
a	O
concentration	B-T081
-	O
dependent	B-T169
manner	O
.	O
	
these	O
results	B-T169
indicated	O
that	O
p	O
.	O
	
gingivalis	O
hsp60	B-T116
may	O
induce	O
dysfunction	O
and	O
apoptosis	O
in	O
huvecs	O
via	O
downregulating	O
the	O
expression	O
levels	B-T080
of	O
ve-cadherin	B-T116
and	O
enos	B-T116
,	O
and	O
promoting	O
the	O
cleavage	O
of	O
estradiol	B-T109
prodrugs	O
ep	O
for	O
efficient	O
oral	B-T061
estrogen	B-T169
treatment	I-T169
and	O
abolished	O
effects	O
on	O
estrogen	B-T109
modulated	O
liver	O
functions	O
oral	B-T061
compared	O
to	O
parenteral	B-T061
estrogen	B-T169
administration	I-T169
is	O
characterized	O
by	O
reduced	O
systemic	B-T169
but	O
prominent	O
hepatic	O
estrogenic	B-T033
effects	I-T033
on	O
lipids	B-T109
,	O
hemostatic	O
factors	O
,	O
gh	B-T116
-/	O
igf	B-T116
i	I-T116
axis	O
,	O
angiotensinogen	B-T116
.	O
	
in	O
order	O
to	O
avoid	O
such	O
adverse	O
metabolic	O
effects	O
of	O
oral	B-T061
treatment	I-T061
,	O
estradiol	B-T109
e2	B-T109
prodrugs	O
ep	O
were	O
designed	O
which	O
bypass	O
the	O
liver	O
tissue	O
as	O
inactive	O
molecules	O
.	O
	
carbone17-oh	O
sulfonamide	O
-o2-nh2	O
substituted	O
esters	O
of	O
e2	B-T109
ec508	B-T109
,	O
others	O
were	O
synthesized	O
and	O
tested	O
for	O
carbonic	B-T116
anhydrase	I-T116
ii	I-T116
ca-ii	B-T116
binding	O
.	O
	
ca	B-T116
ii	I-T116
in	O
erythrocytes	O
is	O
thought	O
to	O
oppose	O
extraction	O
of	O
ep	O
from	O
portal	O
vein	O
blood	O
during	O
liver	O
passage	O
.	O
	
ovariectomized	B-T033
ovx	B-T033
,	O
day	O
minus	O
14	O
rats	O
were	O
orally	B-T061
treated	I-T061
once	O
daily	O
from	O
day	O
1-3	O
.	O
	
sacrifice	O
day	O
4	O
.	O
	
uteri	O
were	O
dissected	B-T169
and	O
weighed	O
.	O
	
cholesterol	O
fractions	O
and	O
angiotensinogen	O
were	O
determined	O
in	O
plasma	O
.	O
	
oral	O
e2	O
and	O
ethinyl	B-T109
estradiol	I-T109
ee	B-T109
generated	O
dose	O
related	O
uterine	O
growth	O
and	O
important	O
hepatic	O
estrogenic	B-T033
effects	I-T033
.	O
	
ep	O
induced	O
uterine	O
growth	O
at	O
about	O
hundred-fold	O
lower	O
doses	O
.	O
	
this	O
was	O
possible	O
with	O
almost	O
absent	O
effects	O
on	O
plasma	O
cholesterol	B-T109
or	O
angiotensinogen	B-T116
.	O
	
preliminary	O
pharmacokinetic	O
studies	O
with	O
ec508	B-T109
used	O
intravenous	O
and	O
oral	B-T061
administration	I-T061
in	O
male	O
rats	O
.	O
	
resulting	O
blood	O
levels	O
revealed	O
complete	O
oral	B-T061
bioavailability	B-T081
.	O
	
further	O
high	O
blood	O
-	O
but	O
low	O
plasma	O
concentrations	O
indicated	O
erythrocyte	O
binding	O
of	O
ec508	B-T109
in	O
vivo	O
as	O
potential	O
mechanism	O
of	O
low	O
extraction	O
at	O
liver	O
passage	O
.	O
	
very	O
high	O
systemic	B-T169
estrogenicity	B-T109
combined	O
with	O
markedly	O
lower	O
or	O
absent	O
adverse	O
hepatic	O
estrogenic	B-T033
effects	I-T033
is	O
evidence	O
for	O
a	O
systemic	B-T169
release	O
of	O
e2	B-T109
from	O
sulfonamide	O
ep	O
.	O
	
in	O
conclusion	O
,	O
tested	O
oral	B-T061
ep	O
bypass	O
the	O
liver	O
in	O
erythrocytes	O
furnishing	O
systemic	B-T169
estradiol	B-T109
at	O
hydrolysis	O
.	O
	
this	O
mechanism	O
avoids	O
the	O
hepatic	O
estrogenic	O
impact	O
of	O
conventional	O
oral	B-T061
estrogen	B-T061
therapy	I-T061
.	O
	
differences	B-T080
in	O
pain	O
experience	O
and	O
cooperation	O
between	O
consecutive	B-T061
surgeries	I-T061
in	O
patients	O
undergoing	O
phacoemulsification	B-T061
the	O
purpose	O
of	O
this	O
study	O
is	O
to	O
compare	O
pain	O
experience	O
and	O
cooperation	O
between	O
consecutive	B-T061
surgeries	I-T061
in	O
patients	O
undergoing	O
phacoemulsification	B-T061
in	O
both	O
eyes	O
,	O
using	O
sub-tenon's	B-T061
local	I-T061
anesthesia	I-T061
without	O
sedation	B-T061
.	O
	
in	O
this	O
study	O
,	O
268	O
patients	O
with	O
bilateral	B-T047
senile	I-T047
cataracts	I-T047
were	O
recruited	O
.	O
	
all	O
operations	B-T061
were	O
performed	O
without	O
sedation	B-T061
,	O
using	O
a	O
clear	O
corneal	O
phacoemulsification	B-T061
technique	I-T061
and	O
sub-tenon's	B-T061
local	I-T061
anesthesia	I-T061
,	O
by	O
one	O
of	O
four	O
surgeons	O
.	O
	
the	O
first	O
surgery	B-T061
was	O
performed	O
on	O
the	O
eye	O
with	O
the	O
higher	O
grade	O
cataract	O
.	O
	
the	O
other	O
eye	O
was	O
operated	O
on	O
within	O
3	B-T079
months	I-T079
by	O
the	O
same	O
surgeon	O
mean	O
interval	O
1.9	O
1.1	O
months	B-T079
.	O
	
all	O
patients	O
were	O
asked	O
to	O
grade	O
their	O
pain	O
experience	O
during	O
induction	B-T061
and	O
maintenance	O
of	O
anesthesia	B-T061
and	O
also	O
during	O
the	O
phacoemulsification	B-T061
surgery	I-T061
,	O
using	O
a	O
visual	O
analogue	O
scale	O
vas	O
from	O
0	O
no	B-T033
pain	I-T033
to	O
10	O
unbearable	O
pain	O
administered	O
after	O
the	O
surgery	B-T061
.	O
	
the	O
cooperation	O
of	O
the	O
patient	O
was	O
graded	O
from	O
0	O
no	O
event	O
to	O
3	O
markedeye	O
and	O
head	O
movement	O
and	O
lid	O
squeezing	O
by	O
the	O
attending	O
surgeon	O
.	O
	
the	O
vas	B-T081
scores	I-T081
and	O
cooperation	O
scores	B-T081
of	O
the	O
patients	O
were	O
the	O
outcome	B-T081
measurements	I-T081
.	O
	
the	O
mean	B-T033
pain	I-T033
score	I-T033
was	O
2.11	O
0.79	O
in	O
the	O
first	O
eye	O
and	O
3.33	O
0.80	O
in	O
the	O
second	O
eye	O
during	O
the	O
administration	B-T061
of	O
sub-tenon's	B-T061
anesthesia	I-T061
,	O
and	O
1.50	O
0.60	O
in	O
the	O
first	O
eye	O
and	O
2.10	O
0.57	O
in	O
the	O
second	O
eye	O
during	O
the	O
phacoemulsification	B-T061
surgery	I-T061
.	O
	
the	O
patient	O
cooperation	O
score	B-T081
was	O
1.60	O
0.75	O
in	O
the	O
first	O
surgery	B-T061
and	O
2.08	O
0.72	O
in	O
the	O
second	O
surgery	B-T061
.	O
	
the	O
differences	B-T080
between	O
the	O
first	O
and	O
second	O
surgeries	B-T061
were	O
statistically	O
significant	O
for	O
all	O
outcome	B-T081
measures	I-T081
p	O
<	O
0.01	O
.	O
	
patients	O
who	O
previously	O
underwent	O
phaco	B-T061
surgery	I-T061
in	O
one	O
eye	O
experienced	O
more	O
pain	O
and	O
showed	O
worse	B-T033
cooperation	O
during	O
the	O
phaco	B-T061
surgery	I-T061
in	O
the	O
second	O
eye	O
,	O
especially	O
if	O
there	O
was	O
a	O
short	O
time	O
between	O
the	O
surgeries	B-T061
,	O
viz	O
,	O
less	O
than	O
3	O
months	B-T079
.	O
	
therefore	O
,	O
if	O
the	O
surgeon	O
has	O
difficulty	B-T080
in	O
the	O
first	O
operation	B-T061
gaining	O
the	O
patient's	O
cooperation	O
,	O
the	O
surgeon	O
must	O
be	O
careful	O
if	O
contralateral	B-T061
eye	I-T061
surgery	I-T061
is	O
required	O
,	O
the	O
addition	O
of	O
sedation	B-T061
/	O
analgesia	B-T061
should	O
be	O
considered	O
or	O
the	O
surgery	B-T061
postponed	O
for	O
a	O
while	O
to	O
abolish	O
the	O
influence	O
of	O
recent	O
memory	O
on	O
the	O
patient's	O
subsequent	O
pain	O
experience	O
.	O
	
co-chip	O
enables	O
genome-wide	O
mapping	O
of	O
histone	O
mark	O
co-occurrence	B-T079
at	O
single-molecule	O
resolution	O
histone	O
modifications	O
play	O
an	O
important	B-T080
role	O
in	O
chromatin	O
organization	O
and	O
transcriptional	O
regulation	O
,	O
but	O
despite	O
the	O
large	B-T081
amount	I-T081
of	O
genome-wide	O
histone	O
modification	O
data	B-T078
collected	B-T078
in	O
different	B-T080
cells	O
and	O
tissues	O
,	O
little	O
is	O
known	O
about	O
co-occurrence	B-T079
of	O
modifications	O
on	O
the	O
same	O
nucleosome	B-T116
.	O
	
here	O
we	O
present	B-T078
a	O
genome-wide	O
quantitative	O
method	O
for	O
combinatorial	O
indexed	O
chromatin	O
immunoprecipitation	O
co-chip	O
to	O
characterize	O
co-occurrence	B-T079
of	O
histone	O
modifications	O
on	O
nucleosomes	B-T116
.	O
	
using	O
co-chip	O
,	O
we	O
study	O
the	O
genome-wide	O
co-occurrence	B-T079
of	O
14	O
chromatin	O
marks	O
70	O
pairwise	B-T080
combinations	I-T080
,	O
and	O
find	O
previously	O
undescribed	O
co-occurrence	B-T079
patterns	O
,	O
including	O
the	O
co-occurrence	B-T079
of	O
h3k9me1	O
and	O
h3k27ac	O
in	O
super-enhancers	O
.	O
	
finally	O
,	O
we	O
apply	B-T169
co-chip	O
to	O
measure	B-T081
the	O
distribution	B-T169
of	O
the	O
bivalent	B-T081
h3k4me3	O
-	O
h3k27me3	O
domains	O
in	O
two	O
distinct	O
mouse	O
embryonic	O
stem	O
cell	O
mesc	O
states	O
and	O
in	O
four	O
adult	O
tissues	O
.	O
	
we	O
observe	B-T169
dynamic	B-T169
changes	B-T081
in	O
5	O
regions	O
and	O
discover	O
both	O
loss	B-T081
and	O
de	B-T078
novo	I-T078
gain	B-T081
of	O
bivalency	B-T081
in	O
key	O
tissue-specific	O
regulatory	O
genes	O
,	O
suggesting	B-T078
a	O
functional	O
role	O
for	O
bivalent	B-T081
domains	O
during	O
different	O
stages	B-T079
of	O
development	B-T169
.	O
	
these	O
results	B-T033
show	O
that	O
co-chip	O
can	O
reveal	B-T080
the	O
complex	B-T169
interactions	I-T169
between	O
histone	O
modifications	O
.	O
	
hand-assisted	B-T061
laparoscopic	I-T061
versus	O
standard	B-T061
laparoscopic	I-T061
colectomy	I-T061
are	O
outcomes	B-T080
and	O
operative	B-T079
time	I-T079
different	O
hal	B-T061
colectomy	B-T061
is	O
a	O
technique	B-T169
perceived	O
to	O
provide	O
the	O
benefits	O
of	O
laparoscopic	B-T061
surgery	I-T061
while	O
improving	O
tactile	O
feedback	O
and	O
operative	B-T079
time	I-T079
.	O
	
published	O
data	B-T078
are	O
largely	O
limited	O
to	O
small	O
,	O
single-institution	O
studies	O
.	O
	
the	O
2012-2013	O
national	O
surgical	O
quality	O
improvement	O
program	O
participant	O
data	O
use	O
file	O
was	O
queried	O
for	O
patients	O
undergoing	O
elective	O
sl	B-T061
or	O
hal	B-T061
colectomy	B-T061
.	O
	
patients	O
underwent	O
1	O
propensity	O
matching	O
and	O
had	O
outcomes	B-T080
compared	O
.	O
	
an	O
additional	O
subgroup	O
analysis	O
was	O
performed	O
for	O
patients	O
undergoing	O
segmental	O
resections	B-T061
only	O
.	O
	
13	O
patients	O
were	O
identified	O
,	O
of	O
whom	O
6084	O
43.6	O
%	O
underwent	O
hal	B-T061
colectomy	B-T061
.	O
	
patients	O
undergoing	O
hal	B-T061
versus	O
sl	B-T061
colectomy	I-T061
had	O
higher	O
rates	B-T081
of	O
postoperative	B-T047
ileus	I-T047
8.7	O
vs	O
.	O
	
6.3	O
%	O
,	O
p	O
<	O
0.001	O
,	O
wound	O
complication	O
8.8	O
vs	O
.	O
	
6.8	O
%	O
,	O
p	O
=	O
0.006	O
,	O
and	O
30-	O
day	B-T079
readmission	O
7.5	O
vs	O
.	O
	
6.0	O
%	O
,	O
p	O
=	O
0.002	O
,	O
without	O
any	O
differences	O
in	O
operative	B-T079
time	I-T079
156	O
vs	O
.	O
	
157	O
min	O
,	O
p	O
=	O
0.713	O
.	O
	
amongst	O
segmental	O
colectomies	B-T061
,	O
hal	B-T061
remained	O
associated	O
with	O
higher	O
rates	B-T081
of	O
wound	O
complications	O
8.6	O
vs	O
.	O
	
6.5	O
%	O
,	O
p	O
=	O
0.016	O
,	O
postoperative	B-T047
ileus	I-T047
8.9	O
vs	O
.	O
	
6.3	O
%	O
,	O
p	O
<	O
0.001	O
,	O
and	O
30-	O
day	B-T079
readmission	O
7.1	O
vs	O
.	O
	
5.9	O
%	O
,	O
p	O
=	O
0.041	O
with	O
no	O
difference	O
in	O
operative	B-T079
time	I-T079
between	O
hal	B-T061
and	O
sl	O
145	O
vs	O
.	O
	
145	O
min	O
,	O
p	O
=	O
0.334	O
.	O
	
use	O
of	O
hal	B-T061
colectomy	B-T061
is	O
associated	O
with	O
increased	O
risk	O
of	O
wound	O
complications	O
,	O
postoperative	B-T047
ileus	I-T047
,	O
and	O
readmissions	O
.	O
	
importantly	O
,	O
this	O
technique	B-T169
is	O
not	O
associated	O
with	O
any	O
decrease	O
in	O
operative	B-T079
time	I-T079
.	O
	
safety	O
and	O
immunogenecity	O
of	O
a	O
live	O
attenuated	O
rift	O
valley	O
fever	O
vaccine	O
cl13t	O
in	O
camels	O
rift	B-T047
valley	I-T047
fever	I-T047
is	O
an	O
emerging	O
zoonotic	O
viral	B-T047
disease	I-T047
,	O
enzootic	B-T047
and	O
endemic	B-T047
in	O
africa	O
and	O
the	O
arabian	O
peninsula	O
,	O
which	O
poses	O
a	O
significant	B-T078
threat	B-T078
to	O
both	O
human	O
and	O
animal	O
health	B-T047
.	O
	
the	O
disease	B-T047
is	O
most	O
severe	B-T080
in	O
ruminants	O
causing	B-T169
abortions	O
in	O
pregnant	O
animals	O
,	O
especially	O
sheep	O
animals	O
and	O
high	O
mortality	B-T081
in	O
young	B-T079
populations	O
.	O
	
high	O
mortality	B-T081
rates	I-T081
and	O
severe	B-T080
clinical	B-T080
manifestation	B-T080
have	O
also	O
been	O
reported	O
among	O
camel	O
populations	O
in	O
africa	O
,	O
to	O
attend	O
however	O
none	O
of	O
the	O
currently	B-T079
available	B-T169
live	O
vaccines	O
against	O
rvf	B-T047
have	O
been	O
tested	B-T169
for	O
safety	O
and	O
efficacy	B-T080
in	O
this	O
species	O
.	O
	
in	O
this	O
study	O
,	O
the	O
safety	O
and	O
efficacy	B-T080
through	O
a	O
neutralizing	B-T116
antibody	I-T116
response	O
of	O
the	O
thermostable	O
live	O
attenuated	O
rvf	O
cl13t	O
vaccine	O
were	O
evaluated	O
in	O
camels	O
in	O
two	O
different	B-T080
preliminary	B-T079
experiments	O
involving	O
16	O
camels	O
,	O
that	O
12	O
camels	O
and	O
4	O
pregnant	O
camels	O
.	O
	
the	O
study	O
revealed	B-T080
that	O
the	O
cl13t	O
vaccine	O
was	O
safe	O
to	O
use	B-T169
in	O
camels	O
and	O
no	O
abortions	O
or	O
teratogenic	O
effects	O
were	O
observed	B-T169
.	O
	
the	O
single	O
dose	B-T081
of	O
the	O
vaccine	O
stimulated	O
a	O
strong	B-T080
and	O
long-lasting	O
neutralizing	B-T116
antibody	I-T116
response	O
for	O
up	O
to	O
12	O
months	B-T079
.	O
	
the	O
presence	B-T033
of	O
neutralization	B-T116
antibodies	I-T116
is	O
likely	O
to	O
correlate	B-T080
with	I-T080
protection	B-T033
however	O
protection	B-T033
would	O
need	O
to	O
be	O
confirmed	B-T080
by	I-T080
challenge	O
experiments	O
using	O
the	O
virulent	B-T080
rvf	O
virus	O
.	O
	
autoantibodies	B-T116
to	O
mog	B-T116
in	O
a	O
distinct	O
subgroup	O
of	O
adult	O
multiple	B-T047
sclerosis	I-T047
to	O
evaluate	O
the	O
presence	O
of	O
antibodies	B-T116
to	O
conformation	O
-intact	O
myelin	B-T116
oligodendrocyte	I-T116
glycoprotein	I-T116
mog	B-T116
in	O
a	O
subgroup	O
of	O
adult	O
patients	O
with	O
clinically	B-T080
definite	O
multiple	B-T047
sclerosis	I-T047
ms	B-T047
preselected	O
for	O
a	O
specific	O
clinical	B-T080
phenotype	O
including	O
severe	B-T080
spinal	O
cord	O
,	O
optic	O
nerve	O
,	O
and	O
brainstem	O
involvement	O
.	O
	
antibodies	B-T116
to	O
mog	B-T116
were	O
investigated	B-T169
using	O
a	O
cell-based	O
assay	O
in	O
3	O
groups	O
of	O
patients	O
104	O
preselected	O
patients	O
with	O
ms	B-T047
group	O
1	O
,	O
55	O
age	O
-	O
and	O
sex	O
-matched	O
,	O
otherwise	O
unselected	O
patients	O
with	O
ms	B-T047
group	O
2	O
,	O
and	O
in	O
22	O
brain-biopsied	O
patients	O
with	O
demyelinating	B-T047
diseases	I-T047
of	O
the	O
cns	O
n	O
=	O
19	O
with	O
ms	B-T047
,	O
4	O
of	O
whom	O
classified	O
as	O
ms	B-T047
type	I-T047
ii	I-T047
group	O
3	O
.	O
	
recognized	O
epitopes	O
were	O
identified	O
with	O
mutated	O
variants	O
of	O
mog	O
.	O
	
antibodies	B-T116
to	O
mog	B-T116
were	O
found	O
in	O
about	O
5%	O
5/104	O
of	O
preselected	O
adult	O
patients	O
with	O
ms	B-T047
.	O
	
in	O
contrast	O
,	O
in	O
groups	O
2	O
and	O
3	O
,	O
none	O
of	O
the	O
patients	O
tested	B-T169
positive	O
for	O
mog	B-T116
antibodies	B-T116
.	O
	
patients	O
with	O
ms	B-T047
with	O
antibodies	B-T116
to	O
mog	B-T116
predominantly	O
manifested	B-T169
with	O
concomitant	B-T079
severe	B-T080
brainstem	O
and	O
spinal	O
cord	O
involvement	O
and	O
had	O
a	O
severe	B-T080
disease	O
course	O
with	O
high	O
relapse	O
rates	B-T081
and	O
failure	B-T033
to	O
several	O
disease-modifying	B-T061
therapies	I-T061
.	O
	
three	O
of	O
them	O
had	O
been	O
treated	B-T061
with	I-T061
plasma	B-T061
exchange	I-T061
with	O
a	O
favorable	O
response	O
.	O
	
all	O
anti-mog	O
-positive	O
patients	O
with	O
ms	B-T047
showed	O
typical	O
ms	B-T047
lesions	B-T033
on	O
brain	O
mri	O
.	O
	
longitudinal	O
analysis	O
up	O
to	O
9	O
years	B-T079
revealed	O
fluctuations	O
and	O
reappearance	O
of	O
anti-mog	O
reactivity	O
.	O
	
epitope	O
mapping	O
indicated	O
interindividual	B-T080
heterogeneity	I-T080
,	O
yet	O
intraindividual	B-T080
stability	I-T080
of	O
the	O
antibody	O
response	O
.	O
	
antibodies	B-T116
to	O
mog	B-T116
can	O
be	O
found	O
in	O
a	O
distinct	O
subgroup	O
of	O
adult	O
ms	B-T047
with	O
a	O
specific	O
clinical	B-T080
phenotype	O
and	O
may	O
indicate	O
disease	B-T047
heterogeneity	B-T080
.	O
	
acute	O
ph-negative	O
lymphoblastic	O
leukemias	O
in	O
adults	O
risk	B-T033
factors	I-T033
in	O
the	O
use	O
of	O
the	O
all-2009	O
protocol	O
to	O
analyze	O
well-known	O
risk	B-T033
factors	I-T033
rfs	B-T033
,	O
such	O
as	O
age	O
,	O
immunophenotype	O
,	O
baseline	B-T081
leukocytosis	O
,	O
enhanced	O
lactate	B-T116
dehydrogenase	I-T116
ldh	B-T116
activity	O
,	O
time	O
to	O
achieve	O
complete	O
remission	B-T033
,	O
a	O
risk	O
group	O
,	O
and	O
cytogenetic	O
abnormalities	O
in	O
patients	O
with	O
acute	O
lymphoblastic	O
leukemia	O
all	O
in	O
the	O
use	O
of	O
the	O
all-2009	O
protocol	O
.	O
	
the	O
protocol	O
covered	O
298	O
patients	O
137	O
women	O
including	B-T169
13	O
pregnant	O
women	O
and	O
161	O
men	O
aged	O
15	O
to	O
55	O
years	O
median	O
age	O
28	O
years	O
with	O
ph-negative	O
all	O
.	O
	
the	O
phenotype	O
was	O
unknown	O
in	O
6	O
patients	O
.	O
	
three	O
1%	O
were	O
ascertained	O
to	O
have	O
a	O
biphenotypic	O
variant	O
.	O
	
182	O
62.4	O
patients	O
were	O
found	O
to	O
have	O
b-cell	O
all	O
early	O
pre-b	O
all	O
n=51	O
common	O
all	O
n=92	O
,	O
and	O
pre-b	O
all	O
n=39	O
107	O
36.6	O
patients	O
had	O
t-cell	O
all	O
early	O
t-all	O
n=56	O
thymic	O
t-all	O
n=41	O
,	O
and	O
mature	B-T079
t-all	O
n=10	O
.	O
	
according	O
to	O
the	O
baseline	B-T081
clinical	B-T080
and	O
laboratory	O
parameters	B-T033
leukocytosis	O
of	O
30	O
and	O
more	O
for	O
b-all	O
and	O
that	O
of	O
100	O
and	O
more	O
for	O
t-all	O
phenotype	O
в-i	O
for	O
b-all	O
,	O
phenotype	O
т-i-ii-iv	O
for	O
t-all	O
ldh	B-T116
activity	O
was	O
more	O
than	O
twice	O
the	O
normal	O
values	O
the	O
presence	B-T033
of	O
translocation	O
t	O
,	O
the	O
high-risk	O
group	O
included	B-T169
most	O
patients	O
with	O
b-all	O
n=110	O
72.8	O
and	O
t-all	O
n=76	O
76%	O
.	O
	
thirty-five	O
patients	O
with	O
t-all	O
underwent	O
autologous	B-T061
bone	I-T061
marrow	I-T061
transplantation	I-T061
bmt	B-T061
.	O
	
allogeneic	B-T061
bmt	I-T061
was	O
performed	B-T169
in	O
18	O
7%	O
of	O
the	O
258	O
patients	O
who	O
had	O
undergone	O
an	O
induction	O
phase	O
.	O
	
five-year	O
overall	B-T081
survival	I-T081
for	O
all	O
the	O
patients	O
included	B-T169
in	O
the	O
investigation	O
was	O
59%	O
relapse-free	B-T061
survival	O
was	O
65%	O
,	O
which	O
was	O
significantly	O
different	O
in	O
the	O
patients	O
with	O
b-all	O
and	O
in	O
those	O
with	O
t-all	O
the	O
overall	B-T081
survival	I-T081
rates	I-T081
were	O
53.3	O
and	O
67.5	O
p=0	O
the	O
relapse-free	O
survival	O
was	O
56	O
and	O
79%	O
p=0	O
,	O
respectively	O
.	O
	
multivariate	B-T081
analysis	I-T081
including	B-T169
the	O
well-known	O
rfs	B-T033
demonstrated	O
that	O
the	O
latter	O
for	O
t-all	O
were	O
of	O
no	O
independent	O
prognostic	O
value	O
and	O
only	O
the	O
patient's	O
age	O
was	O
identified	O
for	O
b-all	O
p=0	O
.	O
	
a	O
lower	O
chemotherapeutic	O
load	O
and	O
a	O
small	O
number	O
of	O
allogeneic	B-T061
bmts	I-T061
did	O
not	O
affect	O
total	O
positive	O
treatment	B-T061
results	O
in	O
adult	O
patients	O
with	O
all	O
,	O
by	O
complying	O
with	O
the	O
principle	O
achieving	O
the	O
continuity	O
of	O
cytostatic	O
effects	B-T080
and	O
by	O
preserving	B-T169
the	O
total	O
cytostatic	O
loading	B-T081
dose	I-T081
.	O
	
the	O
results	O
of	O
the	O
russian	O
investigation	O
casts	O
some	O
doubt	O
on	O
the	O
necessity	O
of	O
using	O
very	O
intensive	O
consolidation	O
cycles	O
and	O
performing	O
a	O
large	O
number	O
of	O
allogeneic	B-T061
bmts	I-T061
in	O
adult	O
patients	O
with	O
multidetector	O
ct	O
of	O
expected	O
findings	B-T033
and	O
complications	O
after	O
contemporary	B-T079
inguinal	B-T061
hernia	I-T061
repair	I-T061
surgery	B-T061
inguinal	B-T061
hernia	I-T061
repair	I-T061
ihr	B-T061
with	O
prosthetic	O
mesh	O
implantation	B-T061
is	O
the	O
most	O
common	O
procedure	B-T061
in	O
general	B-T061
surgery	I-T061
,	O
and	O
may	O
be	O
performed	B-T169
using	O
either	O
an	O
open	O
or	O
laparoscopic	O
approach	O
.	O
	
this	O
paper	O
provides	O
an	O
overview	O
of	O
contemporary	B-T079
tension-free	O
ihr	B-T061
techniques	B-T169
and	O
materials	O
,	O
and	O
illustrates	O
the	O
expected	O
postoperative	B-T033
imaging	O
findings	O
and	O
iatrogenic	O
injuries	O
.	O
	
emphasis	O
is	O
placed	O
on	O
multidetector	O
ct	O
,	O
which	O
represents	O
the	O
ideal	B-T080
modality	B-T078
to	O
comprehensively	O
visualize	O
the	O
operated	B-T169
groin	O
region	O
and	O
deeper	O
intra-abdominal	O
structures	O
.	O
	
ct	O
consistently	O
depicts	O
seroma	O
,	O
mesh	O
infections	O
,	O
hemorrhages	O
,	O
bowel	O
complications	O
and	O
urinary	O
bladder	O
injuries	O
,	O
and	O
thus	O
generally	O
provides	O
a	O
consistent	B-T078
basis	O
for	O
therapeutic	B-T169
choice	O
.	O
	
since	O
radiologists	O
are	O
increasingly	B-T169
requested	O
to	O
investigate	B-T169
suspected	B-T078
iatrogenic	B-T080
complications	O
,	O
this	O
paper	O
aims	O
to	O
provide	O
an	O
increased	B-T081
familiarity	O
with	O
early	B-T079
ct	O
studies	O
after	O
ihr	B-T061
,	O
including	O
complications	O
and	O
normal	B-T080
postoperative	B-T033
appearances	B-T080
such	O
as	O
focal	O
pseudolesions	O
,	O
in	O
order	O
to	O
avoid	O
misinterpretation	O
and	O
inappropriate	B-T080
management	O
.	O
	
the	O
transcription	B-T116
factors	I-T116
ms188	B-T116
and	O
ams	B-T116
form	O
a	O
complex	B-T080
to	O
activate	B-T169
the	O
expression	O
of	O
cyp703a2	B-T116
for	O
sporopollenin	O
biosynthesis	O
in	O
arabidopsis	O
thaliana	O
the	O
sexine	O
layer	O
of	O
pollen	O
grain	O
is	O
mainly	O
composed	O
of	O
sporopollenins	B-T109
.	O
	
the	O
sporophytic	O
secretory	O
tapetum	O
is	O
required	B-T169
for	O
the	O
biosynthesis	O
of	O
sporopollenin	O
.	O
	
although	O
several	O
enzymes	B-T116
involved	B-T169
in	O
sporopollenin	O
biosynthesis	O
have	O
been	O
reported	O
,	O
the	O
regulatory	O
mechanism	O
of	O
these	O
enzymes	B-T116
in	O
tapetal	O
layer	O
remains	O
elusive	O
.	O
	
aborted	B-T116
microspores	I-T116
ams	B-T116
and	O
male	B-T116
sterile	I-T116
188	I-T116
/	O
myb103	B-T116
/	O
myb80	B-T116
ms188	B-T116
/	O
myb103	B-T116
/	O
myb80	B-T116
are	O
two	O
tapetal	O
cell	O
-specific	O
transcription	B-T116
factors	I-T116
required	B-T169
for	O
pollen	O
wall	O
formation	O
.	O
	
ams	B-T116
functions	B-T169
upstream	O
of	O
ms188	B-T116
.	O
	
here	O
we	O
report	O
that	O
ams	B-T116
and	O
ms188	B-T116
target	B-T169
the	O
cyp703a2	O
gene	O
,	O
which	O
is	O
involved	B-T169
in	O
sporopollenin	O
biosynthesis	O
.	O
	
we	O
found	O
that	O
ams	B-T116
and	O
ms188	B-T116
were	O
localized	O
in	O
tapetum	O
while	O
cyp703a2	B-T116
was	O
localized	O
in	O
both	O
tapetum	O
and	O
locule	O
.	O
	
chromatin	O
immunoprecipitation	O
chip	O
showed	O
that	O
ms188	B-T116
directly	O
bound	O
to	O
the	O
promoter	O
of	O
cyp703a2	O
and	O
luciferase-inducible	B-T116
assay	O
showed	O
that	O
ms188	B-T116
activated	O
the	O
expression	O
of	O
cyp703a2	B-T116
.	O
	
yeast	O
two-hybrid	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
emsas	O
further	O
demonstrated	O
that	O
ms188	B-T116
complexed	B-T080
with	O
ams	B-T116
.	O
	
the	O
expression	O
of	O
cyp703a2	O
could	O
be	O
partially	O
restored	O
by	O
the	O
elevated	B-T080
levels	I-T080
of	O
ms188	B-T116
in	O
the	O
ams	B-T116
mutant	O
.	O
	
therefore	O
,	O
our	O
data	B-T078
reveal	B-T080
that	O
ms188	B-T116
coordinates	B-T169
with	O
ams	B-T116
to	O
activate	B-T169
cyp703a2	B-T116
in	O
sporopollenin	O
biosynthesis	O
of	O
plant	O
tapetum	O
.	O
	
activation	O
of	O
ephrinb-ephb	B-T169
receptor	I-T169
signalling	I-T169
in	O
rat	O
spinal	O
cord	O
contributes	O
to	O
maintenance	O
of	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
dnp	B-T033
is	O
severe	B-T080
and	O
intractable	B-T169
in	O
clinic	O
.	O
	
the	O
specific	B-T080
cellular	O
and	O
molecular	O
mechanisms	B-T169
underlying	O
dnp	B-T033
remain	O
elusive	O
and	O
its	O
treatment	B-T169
are	O
limited	B-T169
.	O
	
we	O
investigated	B-T169
roles	O
of	O
ephb1	B-T116
receptor	I-T116
in	O
the	O
development	O
of	O
dnp	B-T033
.	O
	
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
sprague-dawley	O
rats	O
by	O
a	O
single	O
i.p	O
.	O
	
streptozotocin	B-T109
stz	B-T109
or	O
alloxan	B-T109
.	O
	
western	O
blot	O
analysis	O
and	O
immunohistochemistry	O
were	O
used	O
to	O
analyse	O
expression	O
of	O
ephb1	B-T116
receptor	I-T116
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	O
cells	O
and	O
the	O
pro-inflammatory	B-T116
cytokines	I-T116
in	O
the	O
spinal	O
cord	O
.	O
	
dnp	B-T033
manifested	B-T169
as	O
mechanical	O
allodynia	O
,	O
which	O
was	O
determined	O
by	O
measuring	B-T080
incidence	B-T081
of	O
foot	O
withdrawal	O
in	O
response	O
to	O
mechanical	O
indentation	O
of	O
the	O
hind	O
paw	O
by	O
an	O
electro	O
von	O
frey	O
filament	O
.	O
	
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
and	O
high	B-T033
blood	I-T033
glucose	I-T033
were	O
exhibited	O
simultaneously	B-T079
in	O
around	O
70%	O
of	O
animals	O
that	O
received	O
i.p	O
.	O
	
stz	B-T109
or	O
alloxan	B-T109
.	O
	
phosphorylation	O
of	O
ephb1	B-T116
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	O
,	O
and	O
level	B-T080
of	O
tumour	B-T116
necrosis	I-T116
factor	I-T116
tnf	B-T116
and	O
interleukin	B-T116
il	I-T116
in	O
the	O
spinal	O
cord	O
were	O
significantly	O
increased	O
in	O
rats	O
with	O
dnp	B-T033
.	O
	
spinal	O
blocking	B-T169
ephb1	B-T116
receptor	I-T116
activation	O
in	O
the	O
late	O
phase	O
after	O
stz	B-T109
injection	B-T061
significantly	O
suppressed	B-T169
the	O
established	O
mechanical	O
allodynia	O
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	O
and	O
activity	O
of	O
tnf-α	B-T116
and	O
il-1β	B-T116
.	O
	
however	O
,	O
spinal	O
treatment	B-T169
of	O
ephb1	B-T116
-	O
fc	B-T116
in	O
the	O
early	O
phase	O
after	O
stz	B-T109
injection	B-T061
did	O
not	O
prevent	O
the	O
induction	B-T169
of	O
dnp	B-T033
.	O
	
ephb1	B-T116
receptor	I-T116
activation	O
in	O
the	O
spinal	O
cord	O
is	O
critical	B-T080
to	O
the	O
maintenance	O
,	O
but	O
not	O
induction	B-T169
of	O
diabetic	B-T033
pain	O
.	O
	
ephb1	B-T116
receptor	I-T116
may	O
be	O
a	O
potential	B-T080
target	B-T169
for	O
relieving	B-T061
the	O
established	O
diabetic	B-T033
pain	O
.	O
	
activation	O
of	O
ephb1	B-T116
receptor	I-T116
in	O
the	O
spinal	O
cord	O
is	O
critical	B-T080
to	O
maintaining	B-T169
the	O
established	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
,	O
but	O
not	O
to	O
diabetic	B-T033
pain	O
induction	B-T169
.	O
	
spinal	O
blocking	B-T169
ephb1	B-T116
receptor	I-T116
activation	O
suppresses	B-T169
ongoing	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
.	O
	
conservation	B-T080
of	O
the	O
red	O
kite	O
milvus	O
milvus	O
aves	O
accipitriformes	O
is	O
not	O
affected	B-T169
by	O
the	O
establishment	O
of	O
a	O
broad	O
hybrid	O
zone	O
with	O
the	O
black	O
kite	O
milvus	O
migrans	O
migrans	O
in	O
central	O
europe	O
among	O
accipitriformes	O
sensu	O
stricto	O
,	O
only	O
a	O
few	O
species	O
have	O
been	O
reported	O
to	O
form	O
hybrid	O
zones	O
these	O
include	O
the	O
red	O
kite	O
milvus	O
milvus	O
and	O
black	O
kite	O
milvus	O
migrans	O
migrans	O
.	O
	
m	O
.	O
	
milvus	O
is	O
endemic	B-T169
to	O
the	O
western	O
palearctic	O
and	O
has	O
an	O
estimated	O
total	O
population	B-T081
of	O
20-24	O
breeding	O
pairs	B-T080
.	O
	
the	O
species	O
was	O
in	O
decline	O
until	O
the	O
1970s	O
due	O
to	O
persecution	O
and	O
has	O
declined	O
again	O
since	O
the	O
1990s	O
due	O
to	O
ingestion	O
of	O
rodenticide-treated	O
baits	O
,	O
illegal	B-T078
poisoning	O
and	O
changes	O
in	O
agricultural	O
practices	O
,	O
particularly	O
in	O
its	O
core	O
range	B-T081
.	O
	
whereas	O
f1	O
m	O
.	O
	
milvus	O
m	O
.	O
	
migr	O
.	O
	
migrans	O
hybrid	O
offspring	O
have	O
been	O
found	O
,	O
f2	O
and	O
f3	O
hybrids	O
have	O
only	O
rarely	O
been	O
reported	O
,	O
with	O
low	O
nesting	O
success	O
rates	B-T081
of	O
f1	O
hybrids	O
and	O
partial	B-T081
hybrid	O
sterility	O
likely	O
playing	O
a	O
role	O
.	O
	
here	O
,	O
we	O
analyzed	O
the	O
mitochondrial	O
co1	O
and	O
cytb	O
and	O
nuclear	O
myc	O
dna	O
loci	O
of	O
184	O
m	O
.	O
	
milvus	O
,	O
124	O
m	O
.	O
	
migr	O
.	O
	
migrans	O
and	O
3	O
f1	O
hybrid	O
individuals	O
collected	O
across	O
central	O
europe	O
.	O
	
in	O
agreement	O
with	O
previous	O
studies	O
,	O
we	O
found	O
low	O
heterozygosity	O
in	O
m	O
.	O
	
milvus	O
regardless	O
of	O
locus	O
.	O
	
we	O
found	O
that	O
populations	B-T081
of	O
both	O
examined	B-T033
species	O
were	O
characterized	O
by	O
a	O
high	O
gene	O
flow	O
within	O
populations	B-T081
,	O
with	O
all	O
of	O
the	O
major	O
haplotypes	O
distributed	O
across	O
the	O
entire	O
examined	B-T033
area	O
.	O
	
few	O
haplotypes	O
displayed	O
statistically	B-T081
significant	I-T081
aggregation	B-T169
in	O
one	O
region	O
over	O
another	O
.	O
	
we	O
did	O
not	O
find	O
mitochondrial	O
dna	O
of	O
one	O
species	O
in	O
individuals	O
with	O
the	O
plumage	O
of	O
the	O
other	O
species	O
,	O
except	O
in	O
f1	O
hybrids	O
,	O
which	O
agrees	O
with	O
haldane	O
rule	O
.	O
	
it	O
remains	O
to	O
be	O
investigated	B-T169
by	O
genomic	O
methods	B-T169
whether	O
occasional	O
gene	O
flow	O
occurs	O
through	O
the	O
paternal	B-T080
line	O
,	O
as	O
the	O
examined	B-T033
myc	O
gene	O
displayed	O
only	O
marginal	O
divergence	O
between	O
m	O
.	O
	
milvus	O
and	O
m	O
.	O
	
migr	O
.	O
	
migrans	O
.	O
	
the	O
central	O
europe	O
an	O
population	B-T081
of	O
m	O
.	O
	
milvus	O
is	O
clearly	O
subject	O
to	O
free	O
intraspecific	O
gene	O
flow	O
,	O
which	O
has	O
direct	O
implications	O
when	O
considering	O
the	O
origin	B-T079
of	O
individuals	O
in	O
m	O
.	O
	
milvus	O
extracellular	O
potassium	O
and	O
seizures	O
excitation	O
,	O
inhibition	O
and	O
the	O
role	O
of	O
ih	B-T116
seizure	O
activity	O
leads	O
to	O
increases	O
in	O
extracellular	O
potassium	O
concentration	B-T081
k	O
formula	O
see	O
text	O
,	O
which	O
can	O
result	O
in	O
changes	O
in	O
neuronal	O
passive	B-T080
and	O
active	B-T169
membrane	O
properties	O
as	O
well	O
as	O
in	O
population	O
activities	O
.	O
	
in	O
this	O
study	O
,	O
we	O
examined	O
how	O
extracellular	O
potassium	O
modulates	O
seizure	O
activities	O
using	O
an	O
acute	O
4-ap	B-T109
induced	O
seizure	O
model	O
in	O
the	O
neocortex	O
,	O
both	O
in	O
vivo	O
and	O
in	B-T080
vitro	I-T080
.	O
	
moderately	O
elevated	O
k	O
formula	O
see	O
text	O
up	O
to	O
9	O
see	O
text	O
prolonged	B-T079
seizure	O
durations	B-T079
and	O
shortened	B-T079
interictal	I-T079
intervals	I-T079
as	O
well	O
as	O
depolarized	O
the	O
neuronal	O
resting	O
membrane	O
potential	O
rmp	O
.	O
	
however	O
,	O
when	O
k	O
formula	O
see	O
text	O
reached	O
higher	O
than	O
9	O
see	O
text	O
,	O
seizure	O
like	O
events	O
sles	O
were	O
blocked	B-T169
and	O
neurons	O
went	O
into	O
a	O
depolarization	O
-	O
blocked	B-T169
state	O
.	O
	
spreading	B-T080
depression	O
was	O
never	O
observed	O
as	O
the	O
blockade	O
of	O
ictal	O
events	O
could	O
be	O
reversed	O
within	O
1-2	O
see	O
text	O
after	O
the	O
raised	O
k	O
formula	O
see	O
text	O
was	O
changed	O
back	O
to	O
control	O
levels	O
.	O
	
this	O
concentration	B-T081
-dependent	O
dual	O
effect	O
of	O
k	O
formula	O
see	O
text	O
was	O
observed	O
using	O
in	O
vivo	O
and	O
in	B-T080
vitro	I-T080
mouse	O
brain	O
preparations	O
as	O
well	O
as	O
in	O
human	O
neocortical	O
tissue	O
resected	O
during	O
epilepsy	B-T047
surgery	B-T061
.	O
	
blocking	B-T169
the	O
ih	O
current	O
,	O
mediated	O
by	O
hyperpolarization-activated	B-T116
cyclic	I-T116
nucleotide-gated	I-T116
hcn	I-T116
channels	I-T116
,	O
modulated	O
the	O
elevated	O
k	O
formula	O
see	O
text	O
influence	O
on	O
sles	O
by	O
promoting	O
the	O
high	O
k	O
formula	O
see	O
text	O
inhibitory	O
actions	O
.	O
	
these	O
results	O
demonstrate	O
biphasic	O
actions	O
of	O
raised	O
k	O
formula	O
see	O
text	O
on	O
neuronal	O
excitability	O
and	O
seizure	O
activity	O
.	O
	
activation	O
of	O
general	B-T116
control	I-T116
nonderepressible	I-T116
2	I-T116
kinase	I-T116
protects	B-T033
human	O
glomerular	O
endothelial	O
cells	O
from	O
harmful	O
high-glucose	B-T033
-	O
induced	B-T169
molecular	O
pathways	O
considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	B-T116
restriction	B-T169
on	O
diabetic	B-T047
nephropathy	I-T047
dn	B-T047
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	B-T116
control	I-T116
nonderepressible	I-T116
2	I-T116
gcn2	I-T116
kinase	I-T116
activation	O
,	O
a	O
sensor	O
of	O
amino	B-T116
acid	I-T116
deprivation	B-T080
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	O
in	O
primary	O
human	O
glomerular	O
endothelial	O
cells	O
genc	O
.	O
	
genc	O
were	O
cultured	O
under	O
normal	O
or	O
high	B-T080
-glucose	O
conditions	O
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
gcn2	O
kinase	O
activator	O
,	O
tryptophanol	O
.	O
	
glucose	O
transporter	O
1	O
glut1	O
expression	O
was	O
assessed	O
by	O
western	O
blotting	O
and	O
reactive	O
oxygen	O
species	O
ros	O
using	O
a	O
fluorogenic	O
probe	O
.	O
	
activities	O
of	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
gapdh	O
and	O
protein	O
kinase	O
c	O
pkc	O
were	O
assessed	O
by	O
commercial	O
activity	O
assays	O
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
elisa	O
and	O
o-linked	O
β-n-acetyl	O
glucosamine	O
o-glcnac	O
proteins	O
by	O
western	O
blotting	O
.	O
	
high	O
glucose	O
induced	O
glut1	O
expression	O
,	O
increased	O
ros	O
and	O
inhibited	O
gapdh	O
.	O
	
also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
pkc	O
activity	O
,	O
the	O
level	O
of	O
the	O
o-glcnac-modified	O
proteins	O
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	O
endproducts'	O
precursor	O
methylglyoxal	O
.	O
	
co-treatment	O
of	O
genc	O
with	O
tryptophanol	O
restored	O
the	O
above	O
high-glucose	O
-	O
induced	O
alterations	O
.	O
	
activation	O
of	O
gcn2	O
kinase	O
protects	O
genc	O
from	O
high-glucose	O
-	O
induced	O
harmful	O
molecular	O
pathways	O
.	O
	
by	O
inhibiting	O
concurrently	O
many	O
pathways	O
involved	O
in	O
dn	O
pathogenesis	O
,	O
gcn2	O
kinase	O
may	O
serve	O
as	O
a	O
pharmaceutical	O
target	O
for	O
the	O
treatment	O
of	O
dn	B-T047
juicer	O
provides	O
a	O
one-click	O
system	O
for	O
analyzing	O
loop-resolution	O
hi-c	O
experiments	O
hi-c	O
experiments	O
explore	O
the	O
3d	O
structure	O
of	O
the	O
genome	O
,	O
generating	O
terabases	O
of	O
data	O
to	O
create	O
high-resolution	O
contact	O
maps	O
.	O
	
here	O
,	O
we	O
introduce	O
juicer	O
,	O
an	O
open-source	O
tool	O
for	O
analyzing	O
terabase-scale	B-T081
hi-c	O
datasets	O
.	O
	
juicer	O
allows	O
users	O
without	B-T080
a	O
computational	O
background	O
to	O
transform	O
raw	O
sequence	O
data	O
into	O
normalized	O
contact	O
maps	O
with	O
one	O
click	O
.	O
	
juicer	O
produces	O
a	O
hic	O
file	O
containing	O
compressed	B-T169
contact	O
matrices	O
at	O
many	O
resolutions	B-T081
,	O
facilitating	O
visualization	O
and	O
analysis	O
at	O
multiple	B-T081
scales	I-T081
.	O
	
structural	O
features	O
,	O
such	O
as	O
loops	O
and	O
domains	O
,	O
are	O
automatically	O
annotated	B-T080
.	O
	
juicer	O
is	O
available	O
as	O
open	B-T080
source	B-T081
software	O
bjn	O
awards	O
2016	O
iv	B-T061
therapy	I-T061
claire	O
rickard	O
professor	O
of	O
nursing	O
,	O
national	O
health	O
and	O
medical	O
research	O
council	O
nhmrc	O
centre	O
of	O
research	O
excellence	O
in	O
nursing	O
,	O
griffith	O
university	O
,	O
was	O
awarded	O
second	O
place	O
in	O
the	O
bjn	O
awards	O
2016	O
for	O
iv	B-T061
therapy	I-T061
nurse	O
of	O
the	O
year	B-T079
.	O
	
here	O
she	O
talks	O
about	O
the	O
she	O
has	O
done	O
to	O
be	O
recognised	O
in	O
this	O
stressful	B-T169
life	O
events	O
and	O
leucocyte	B-T047
telomere	I-T047
length	I-T047
do	O
lifestyle	O
factors	O
,	O
somatic	B-T080
and	O
mental	O
health	O
,	O
or	O
low	O
grade	O
inflammation	O
mediate	O
this	O
relationship	B-T080
results	O
from	O
a	O
cohort	O
of	O
danish	O
men	O
born	O
in	O
1953	O
exposure	B-T080
to	I-T080
psychosocial	B-T169
stress	B-T033
is	O
associated	B-T080
with	I-T080
increased	O
risk	B-T078
of	O
a	O
number	O
of	O
somatic	B-T080
and	O
mental	O
disorders	O
with	O
relation	B-T080
to	O
immune	O
system	O
functioning	O
.	O
	
we	O
aimed	O
to	O
explore	O
whether	O
stressful	O
events	O
in	O
early	O
and	O
recent	O
life	O
was	O
associated	O
with	O
leucocyte	O
telomere	O
length	O
tl	O
,	O
which	O
is	O
assumed	O
to	O
reflect	O
the	O
accumulated	O
burden	O
of	O
inflammation	O
and	O
oxidative	O
stress	O
occurring	O
during	O
the	O
life	O
course	O
.	O
	
we	O
specifically	O
aimed	O
to	O
address	O
whether	O
childhood	O
constitutes	O
a	O
sensitive	O
period	O
and	O
how	O
much	O
of	O
the	O
relation	B-T080
between	O
stressful	O
life	O
events	O
and	O
tl	O
is	O
mediated	O
through	O
somatic	O
and	O
mental	O
health	O
,	O
lifestyle	O
,	O
and	O
markers	O
of	O
low-grade	O
inflammation	O
.	O
	
a	O
cohort	O
of	O
danish	O
men	O
born	O
in	O
1953	O
has	O
been	O
followed	O
since	O
birth	O
in	O
the	O
metropolit	O
cohort	O
.	O
	
these	O
men	O
underwent	O
a	O
health	O
examination	O
including	O
blood	O
sampling	O
in	O
2010	O
and	O
a	O
subset	O
of	O
324	O
also	O
had	O
a	O
quantitative	O
pcr-based	O
measurement	O
of	O
tl	O
.	O
	
the	O
relation	O
between	O
stressful	O
life	O
events	O
and	O
tl	O
was	O
analysed	O
using	O
structural	O
equation	O
modelling	O
,	O
which	O
also	O
provided	O
an	O
estimate	O
of	O
the	O
proportion	O
of	O
the	O
total	O
effect	O
mediated	O
by	O
somatic	O
and	O
mental	O
health	O
cardiovascular	O
disease	O
,	O
body	O
mass	O
and	O
depressive	O
mood	O
,	O
lifestyle	O
factors	O
,	O
and	O
low	O
grade	O
inflammation	O
c-reactive	O
protein	O
crp	O
,	O
interleukin	O
il	O
and	O
il-10	O
.	O
	
total	O
number	O
of	O
stressful	O
events	O
experienced	O
during	O
the	O
life	O
course	O
was	O
not	O
associated	O
with	O
tl	O
.	O
	
in	O
terms	O
of	O
sensitive	O
periods	O
,	O
we	O
found	O
that	O
number	O
of	O
stressful	O
events	O
in	O
childhood	O
was	O
associated	O
with	O
shorter	O
tl	O
βper	O
number	O
stressful	O
events	O
in	O
childhood	O
=-0	O
p=0	O
.	O
	
this	O
relation	O
was	O
particularly	O
strong	O
for	O
being	O
placed	O
away	O
from	O
home	O
β=-0	O
p<0	O
.	O
	
thirty	O
percent	O
of	O
the	O
total	O
effect	O
of	O
stressful	O
events	O
in	O
childhood	O
on	O
tl	O
was	O
mediated	O
by	O
the	O
included	O
variables	O
,	O
with	O
the	O
largest	O
proportion	O
being	O
mediated	O
through	O
depressive	O
mood	O
16%	O
and	O
crp	O
9%	O
.	O
	
this	O
study	O
suggests	O
that	O
stressful	O
events	O
in	O
childhood	O
are	O
associated	O
with	O
shorter	O
tl	O
in	O
middle-aged	O
men	O
and	O
that	O
part	O
of	O
this	O
relation	O
is	O
explained	O
by	O
depressive	O
mood	O
and	O
low	O
grade	O
inflammation	O
description	O
of	O
ancylomarina	O
subtilis	O
gen	O
.	O
	
nov	O
,	O
sp	O
.	O
	
nov	O
,	O
isolated	B-T169
from	O
coastal	O
sediment	O
,	O
proposal	B-T078
of	O
marinilabiliales	O
ord	O
.	O
	
nov	O
.	O
	
and	O
transfer	B-T078
of	O
marinilabiliaceae	O
,	O
prolixibacteraceae	O
and	O
marinifilaceae	O
to	O
the	O
order	O
marinilabiliales	O
a	O
gram-stain-negative	O
,	O
facultatively	O
anaerobic	O
,	O
moderately	O
halophilic	O
,	O
filamentous	B-T080
,	O
non-motile	O
bacterium	O
,	O
designated	B-T169
fa102t	O
,	O
was	O
isolated	B-T169
from	O
marine	O
sediment	O
of	O
the	O
coast	O
of	O
weihai	O
,	O
china	O
.	O
	
phylogenetic	O
analysis	O
based	B-T169
on	O
16s	O
rrna	O
gene	O
sequences	O
showed	B-T169
that	O
strain	B-T080
fa102t	O
formed	O
a	O
distinct	B-T080
evolutionary	O
lineage	O
within	O
the	O
family	O
marinifilaceae	O
and	O
its	O
closest	B-T033
relative	I-T033
was	O
marinifilum	O
fragile	O
jcm	O
15579t	O
93.2	O
sequence	B-T081
similarity	I-T081
.	O
	
the	O
dna	O
g+c	B-T081
content	I-T081
of	O
the	O
novel	B-T080
strain	B-T080
was	O
36.5	O
mol%	O
.	O
	
the	O
predominant	B-T080
cellular	O
fatty	B-T109
acids	I-T109
and	O
respiratory	B-T169
quinone	B-T109
were	O
iso-c15	B-T109
and	O
iso-c15	B-T116
3-oh	I-T116
,	O
and	O
mk-7	B-T109
,	O
respectively	B-T080
.	O
	
on	O
the	O
basis	B-T169
of	O
the	O
phylogenetic	O
,	O
phenotypic	O
and	O
physiological	B-T169
data	B-T078
,	O
strain	B-T080
fa102t	O
represents	O
a	O
novel	B-T080
genus	O
and	O
species	O
,	O
for	O
which	O
the	O
name	O
ancylomarina	O
subtilis	O
gen	O
.	O
	
nov	O
,	O
sp	O
.	O
	
nov	O
.	O
	
is	O
proposed	B-T080
.	O
	
the	O
type	B-T080
strain	B-T080
of	O
ancylomarina	O
subtilis	O
is	O
fa102t	O
=	O
kctc	O
42257t	O
=	O
dsm	O
28825t	O
=	O
cicc	O
10902t	O
.	O
	
furthermore	O
,	O
a	O
new	B-T080
order	O
named	O
marinilabiliales	O
is	O
proposed	B-T080
to	O
accommodate	B-T033
three	O
families	O
previously	B-T079
classified	O
in	O
the	O
order	O
bacteroidales	O
.	O
	
marinilabiliales	O
ord	O
.	O
	
nov	O
.	O
	
encompasses	O
the	O
families	O
marinilabiliaceae	O
,	O
prolixibacteraceae	O
and	O
treatment	B-T061
for	O
rheumatoid	B-T047
arthritis	I-T047
and	O
risk	B-T033
of	O
alzheimer's	B-T047
disease	I-T047
a	O
nested	O
case-control	O
analysis	O
it	O
is	O
increasingly	B-T169
becoming	O
accepted	B-T080
that	O
inflammation	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
,	O
as	O
several	B-T081
immune	O
-related	O
genes	O
have	O
been	O
associated	B-T080
with	I-T080
ad	B-T047
.	O
	
among	O
these	O
is	O
tumor	B-T116
necrosis	I-T116
factor	I-T116
tnf	I-T116
,	O
a	O
proinflammatory	B-T116
cytokine	I-T116
known	O
to	O
play	O
an	O
important	O
role	O
in	O
autoimmune	B-T047
disorders	I-T047
,	O
including	O
rheumatoid	B-T047
arthritis	I-T047
ra	B-T047
.	O
	
although	O
ad	B-T047
and	O
ra	B-T047
appear	O
to	O
involve	O
similar	B-T080
pathological	O
mechanisms	O
through	O
the	O
production	O
of	O
tnf-α	B-T116
,	O
the	O
relationship	B-T080
between	O
ad	B-T047
and	O
ra	B-T047
remains	O
unknown	B-T080
.	O
	
to	O
determine	O
the	O
relative	B-T081
risk	I-T081
of	O
ad	B-T047
among	O
ra	B-T047
patients	O
and	O
non-	O
ra	B-T047
patients	O
,	O
and	O
whether	O
anti-tnf	B-T061
therapy	I-T061
for	O
ra	B-T047
was	O
associated	B-T080
with	I-T080
a	O
lower	B-T080
risk	B-T033
of	O
ad	B-T047
in	O
ra	B-T047
patients	O
.	O
	
we	O
performed	O
a	O
nested	O
case-control	O
study	O
of	O
more	O
than	O
8.5	O
million	O
commercially	O
insured	O
adults	O
aged	O
18	O
years	O
in	O
all	O
50	O
us	O
states	O
,	O
puerto	O
rico	O
,	O
and	O
us	O
virgin	O
islands	O
in	O
the	O
verisk	O
health	O
claims	O
database	O
.	O
	
we	O
derived	O
a	O
sub-cohort	O
of	O
subjects	O
with	O
a	O
diagnosis	B-T033
of	O
ra	B-T047
controls	O
,	O
or	O
ra	B-T047
and	O
ad	B-T047
cases	O
,	O
matching	O
cases	O
and	O
controls	O
based	O
on	O
age	O
,	O
sex	O
,	O
exposure	O
assessment	O
period	O
,	O
and	O
methotrexate	B-T061
treatment	I-T061
.	O
	
we	O
also	O
assessed	O
relative	O
risk	O
of	O
ad	B-T047
following	O
exposure	B-T080
to	I-T080
standard	B-T080
ra	B-T047
therapies	B-T061
,	O
including	O
anti-tnf	O
agents	O
infliximab	B-T116
,	O
adalimumab	B-T116
,	O
etanercept	B-T116
,	O
methotrexate	B-T109
,	O
prednisone	B-T109
,	O
sulfasalazine	B-T109
,	O
and	O
rituximab	B-T116
.	O
	
odds	B-T081
ratios	I-T081
were	O
adjusted	O
for	O
comorbidities	B-T078
,	O
including	O
coronary	B-T047
artery	I-T047
disease	I-T047
,	O
diabetes	B-T047
mellitus	I-T047
,	O
and	O
peripheral	B-T047
vascular	I-T047
disease	I-T047
.	O
	
ad	B-T047
was	O
more	O
prevalent	B-T080
p	O
<	O
0.0001	O
among	O
ra	B-T047
patients	O
0.79	O
%	O
than	O
among	O
those	O
without	B-T080
ra	B-T047
0.11	O
%	O
.	O
	
chronic	B-T033
conditions	I-T033
such	O
as	O
coronary	B-T047
artery	I-T047
disease	I-T047
odds	B-T081
ratio	I-T081
or	B-T081
1.48	O
95	O
%	O
confidence	B-T081
interval	I-T081
ci	B-T081
1.04	O
p	O
=	O
0.03	O
,	O
diabetes	B-T047
or	B-T081
1.86	O
95	O
%	O
ci	B-T081
1.32	O
p	O
=	O
0.0004	O
,	O
and	O
peripheral	B-T047
vascular	I-T047
disease	I-T047
or	B-T081
1.61	O
95	O
%	O
ci	B-T081
1.06	O
p	O
=	O
0.02	O
significantly	O
increased	O
the	O
relative	B-T081
risk	I-T081
of	O
ad	B-T047
among	O
ra	B-T047
patients	O
.	O
	
exposure	B-T080
to	I-T080
anti-tnf	O
agents	O
as	O
a	O
class	B-T081
,	O
but	O
not	O
other	O
immunosuppressive	O
drugs	O
studied	O
,	O
was	O
associated	B-T080
with	I-T080
lowered	B-T081
risk	B-T033
of	O
ad	B-T047
among	O
ra	B-T047
patients	O
unadjusted	O
or	B-T081
0.44	O
95	O
%	O
ci	B-T081
0.22	O
p	O
=	O
0.02	O
adjusted	O
or	B-T081
0.45	O
95	O
%	O
ci	B-T081
0.23	O
p	O
=	O
0.02	O
.	O
	
sub-group	B-T081
analysis	I-T081
demonstrated	O
that	O
of	O
the	O
three	O
anti-tnf	O
agents	O
studied	O
,	O
only	O
etanercept	B-T116
unadjusted	O
or	B-T081
,	O
0.33	O
95	O
%	O
ci	B-T081
0.08	O
p	O
=	O
0.03	O
adjusted	O
or	B-T081
0.30	O
95	O
%	O
ci	B-T081
0.08	O
p	O
=	O
0.02	O
was	O
associated	B-T080
with	I-T080
a	O
decreased	B-T081
risk	B-T033
of	O
ad	B-T047
in	O
ra	B-T047
patients	O
.	O
	
there	O
is	O
an	O
increased	B-T081
risk	B-T033
of	O
ad	B-T047
in	O
the	O
studied	O
ra	B-T047
population	B-T081
.	O
	
the	O
relative	B-T081
risk	I-T081
of	O
ad	B-T047
among	O
ra	B-T047
subjects	O
was	O
lowered	B-T081
in	O
those	O
exposed	B-T080
to	I-T080
etanercept	B-T116
.	O
	
anti-tnf	B-T061
therapy	I-T061
with	O
etanercept	B-T116
shows	O
promise	B-T078
as	O
a	O
potential	B-T080
treatment	B-T061
for	O
dimerization	O
of	O
egfr	B-T116
and	O
her2	B-T116
induces	O
breast	O
cancer	O
cell	O
motility	O
through	O
stat1	B-T116
-dependent	O
acta2	B-T116
induction	B-T169
the	O
dimerization	O
of	O
egfr	B-T116
and	O
her2	B-T116
is	O
associated	O
with	O
poor	O
prognosis	O
such	O
as	O
induction	B-T169
of	O
tumor	O
growth	O
and	O
cell	O
invasion	O
compared	O
to	O
when	O
egfr	B-T116
remains	O
as	O
a	O
homodimer	O
.	O
	
however	O
,	O
the	O
mechanism	B-T169
for	O
events	O
after	O
dimerization	O
in	O
breast	O
cancer	O
models	O
is	O
not	O
clear	O
.	O
	
we	O
found	O
that	O
expressions	O
of	O
alpha-smooth	B-T116
muscle	I-T116
actin	I-T116
acta2	B-T116
and	O
signal	B-T116
transducer	I-T116
and	I-T116
activator	I-T116
of	I-T116
transcription	I-T116
1	I-T116
stat1	B-T116
significantly	O
increased	B-T081
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
her2	B-T116
in	O
egfr	B-T116
-	O
positive	B-T033
breast	O
cancer	O
cells	O
.	O
	
acta2	B-T116
and	O
stat1	B-T116
expression	O
was	O
also	O
increased	B-T081
in	O
her2	B-T116
-	O
positive	B-T033
breast	O
cancer	O
patients	O
.	O
	
in	O
contrast	O
,	O
acta2	B-T116
expression	O
was	O
decreased	B-T081
by	O
her2	O
sirna	O
.	O
	
next	O
,	O
we	O
investigated	O
the	O
co-relation	O
between	O
stat1	B-T116
and	O
acta2	B-T116
expression	O
.	O
	
basal	O
acta2	B-T116
expression	O
was	O
significantly	O
decreased	B-T081
by	O
treatment	B-T061
with	O
the	O
stat1	O
inhibitor	O
fludarabine	O
or	O
the	O
jak2	O
inhibitor	O
ag490	B-T109
.	O
	
in	O
contrast	O
,	O
acta2	B-T116
expression	O
was	O
increased	B-T081
by	O
stat1	B-T116
overexpression	O
.	O
	
levels	O
of	O
acta2	B-T116
,	O
stat1	B-T116
,	O
and	O
her2	B-T116
were	O
increased	B-T081
and	O
relapse	O
free	B-T081
survival	I-T081
was	O
decreased	B-T081
in	O
high-risk	B-T033
breast	O
cancer	O
patients	O
.	O
	
we	O
also	O
investigated	B-T169
the	O
effect	O
of	O
acta2	B-T116
on	O
cell	O
motility	O
,	O
which	O
was	O
suppressed	B-T169
by	O
acta2	O
shrna	O
overexpression	O
in	O
mda-mb231	O
her2	B-T116
and	O
4t1	O
mammary	O
carcinoma	O
cells	O
.	O
	
the	O
number	O
of	O
lung	B-T033
metastatic	I-T033
nodules	I-T033
was	O
significantly	O
decreased	B-T081
in	O
acta2	B-T116
knockdown	O
mice	O
.	O
	
taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	B-T169
of	O
acta2	B-T116
by	O
egfr	B-T116
and	O
her2	B-T116
dimerization	O
was	O
regulated	O
through	O
a	O
jak2	B-T116
/	O
stat1	B-T116
signaling	O
pathway	O
,	O
and	O
aberrant	O
acta2	B-T116
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	O
cells	O
intensive	O
social	B-T169
cognitive	B-T061
treatment	I-T061
can	O
do	O
treatment	B-T169
with	O
participation	B-T169
of	O
support	O
partners	O
in	O
persons	O
with	O
relapsing	B-T047
remitting	I-T047
multiple	I-T047
sclerosis	I-T047
observation	O
of	O
improved	B-T033
self-efficacy	O
,	O
quality	B-T078
of	I-T078
life	I-T078
,	O
anxiety	B-T033
and	O
depression	O
1	O
year	B-T079
later	O
in	O
persons	O
with	O
multiple	B-T047
sclerosis	I-T047
ms	B-T047
self-efficacy	O
positively	B-T033
affects	O
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
hrqol	B-T078
and	O
physical	O
activity	O
.	O
	
in	O
a	O
previous	O
study	O
we	O
observed	B-T169
that	O
6	O
months	B-T079
after	O
an	O
intensive	O
3-	O
day	B-T079
social	B-T169
cognitive	B-T061
treatment	I-T061
can	O
do	O
treatment	B-T169
with	O
the	O
participation	B-T169
of	O
support	O
partners	O
,	O
self-efficacy	O
and	O
hrqol	B-T078
had	O
improved	B-T033
in	O
persons	O
with	O
relapsing	B-T047
remitting	I-T047
ms	I-T047
rrms	B-T047
.	O
	
given	O
the	O
chronic	B-T079
nature	B-T080
of	I-T080
the	I-T080
disease	I-T080
,	O
it	O
is	O
important	O
to	O
know	O
whether	O
these	O
beneficial	B-T081
changes	B-T169
may	O
last	O
.	O
	
can	O
do	O
treatment	B-T169
was	O
given	O
to	O
60	O
persons	O
with	O
ms	B-T047
and	O
their	O
support	O
partners	O
.	O
	
at	O
baseline	B-T081
and	O
12	O
months	B-T079
after	O
treatment	B-T061
self-efficacy	O
control	B-T169
,	O
self-efficacy	O
function	B-T169
,	O
physical	B-T169
and	O
mental	O
hrqol	B-T078
,	O
anxiety	B-T033
,	O
depression	O
and	O
fatigue	O
were	O
assessed	O
via	O
self-report	O
questionnaires	O
.	O
	
differences	B-T080
were	O
tested	B-T169
via	O
a	O
paired	O
t	O
test	O
.	O
	
of	O
the	O
57	O
persons	O
with	O
ms	B-T047
that	O
completed	B-T080
the	O
baseline	B-T081
assessment	O
and	O
the	O
3-	O
day	B-T079
treatment	B-T169
,	O
38	O
filled	O
in	O
the	O
12th	O
month	B-T079
questionnaires	O
response	B-T033
rate	B-T081
66.7	O
%	O
,	O
22	O
with	O
rrms	B-T047
and	O
14	O
with	O
progressive	B-T169
ms	B-T047
.	O
	
in	O
the	O
rr	B-T047
group	B-T078
self-efficacy	O
control	B-T169
had	O
increased	B-T081
by	O
20.2	O
%	O
and	O
physical	B-T169
hrqol	B-T078
by	O
15.0	O
%	O
,	O
and	O
depression	O
and	O
anxiety	B-T033
had	O
decreased	B-T081
by	O
29.8	O
and	O
25.9	O
%	O
,	O
respectively	O
all	O
p	O
<	O
0.05	O
the	O
changes	B-T169
in	O
mental	O
hrqol	B-T078
+17	O
%	O
and	O
fatigue	O
-20	O
%	O
failed	B-T169
to	O
be	O
statistically	B-T081
significant	I-T081
p	O
=	O
0.087	O
,	O
p	O
=	O
0.080	O
,	O
respectively	O
.	O
	
in	O
the	O
progressive	B-T169
group	B-T078
no	O
changes	B-T169
suggestive	B-T169
of	I-T169
improvement	O
were	O
seen	O
.	O
	
the	O
findings	B-T169
suggest	B-T078
that	O
a	O
3-	O
day	B-T079
intensive	O
social	B-T169
cognitive	B-T061
treatment	I-T061
can	O
do	O
treatment	B-T169
with	O
the	O
participation	B-T169
of	O
support	O
partners	O
may	O
have	O
long	B-T079
lasting	I-T079
beneficial	B-T081
effects	B-T080
on	O
the	O
self-efficacy	O
and	O
hrqol	B-T078
in	O
persons	O
with	O
rrms	B-T047
and	O
that	O
improvements	O
in	O
anxiety	B-T033
and	O
depression	O
,	O
not	O
seen	O
in	O
the	O
6-	O
month	B-T079
study	O
,	O
may	O
yet	O
develop	B-T169
at	O
12	O
perineal	O
injuries	O
and	O
birth	B-T033
positions	I-T033
among	O
2992	O
women	O
with	O
a	O
low	B-T033
risk	I-T033
pregnancy	I-T033
who	O
opted	O
for	O
a	O
homebirth	B-T033
whether	O
certain	O
birth	B-T033
positions	I-T033
are	O
associated	B-T080
with	I-T080
perineal	O
injuries	O
and	O
severe	O
perineal	O
trauma	O
spt	O
is	O
still	O
unclear	B-T033
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
prevalence	B-T081
of	O
perineal	O
injuries	O
of	O
different	O
severity	B-T080
in	O
a	O
low-risk	B-T081
population	O
of	O
women	O
who	O
planned	O
to	O
give	O
birth	B-T033
at	I-T033
home	I-T033
and	O
to	O
compare	O
the	O
prevalence	B-T081
of	O
perineal	O
injuries	O
,	O
spt	O
and	O
episiotomy	B-T061
in	O
different	O
birth	B-T033
positions	I-T033
in	O
four	O
nordic	O
countries	O
.	O
	
a	O
population	O
-based	O
prospective	O
cohort	O
study	O
of	O
planned	O
home	B-T033
births	I-T033
in	O
four	O
nordic	O
countries	O
.	O
	
to	O
assess	O
medical	O
outcomes	O
a	O
questionnaire	O
completed	O
after	O
birth	O
by	O
the	O
attending	O
midwife	O
was	O
used	O
.	O
	
descriptive	O
statistics	O
,	O
bivariate	O
analysis	O
and	O
logistic	O
regression	O
were	O
used	O
to	O
analyze	O
the	O
data	B-T078
.	O
	
two	O
thousand	O
nine	O
hundred	O
ninety-two	O
women	O
with	O
planned	O
home	B-T033
births	I-T033
,	O
who	O
birthed	O
spontaneously	O
at	O
home	O
or	O
after	O
transfer	O
to	O
hospital	O
,	O
between	O
2008	O
and	O
2013	O
were	O
included	O
.	O
	
the	O
prevalence	B-T081
of	O
spt	O
was	O
0.7	O
%	O
and	O
the	O
prevalence	B-T081
of	O
episiotomy	B-T061
was	O
1.0	O
%	O
.	O
	
there	O
were	O
differences	O
between	O
the	O
countries	O
regarding	O
all	O
maternal	B-T033
characteristics	B-T080
.	O
	
no	O
association	O
between	O
flexible	B-T080
sacrum	O
positions	O
and	O
sutured	B-T169
perineal	O
injuries	O
was	O
found	O
or	B-T081
1.02	O
95	O
%	O
ci	B-T081
0.86	O
or	O
spt	O
or	B-T081
0.68	O
ci	B-T081
95	O
%	O
0.26	O
.	O
	
flexible	B-T080
sacrum	O
positions	O
were	O
associated	B-T080
with	I-T080
fewer	O
episiotomies	B-T061
or	B-T081
0.20	O
ci	B-T081
95	O
%	O
0.10	O
.	O
	
a	O
low	O
prevalence	B-T081
of	O
spt	O
and	O
episiotomy	B-T061
was	O
found	O
among	O
women	O
opting	O
for	O
a	O
home	B-T033
birth	I-T033
in	O
four	O
nordic	O
countries	O
.	O
	
women	O
used	O
a	O
variety	O
of	O
birth	B-T033
positions	I-T033
and	O
a	O
majority	O
gave	O
birth	O
in	O
flexible	B-T080
sacrum	O
positions	O
.	O
	
no	O
associations	O
were	O
found	O
between	O
flexible	B-T080
sacrum	O
positions	O
and	O
spt	O
.	O
	
flexible	B-T080
sacrum	O
positions	O
were	O
associated	B-T080
with	I-T080
fewer	O
parallel-processing	O
continuous-flow	O
device	O
for	O
optimization	O
-	O
free	B-T169
polymerase	O
chain	O
reaction	O
a	O
parallel-processing	O
four-station	O
polymerase	O
chain	O
reaction	O
pcr	O
device	O
has	O
been	O
developed	O
,	O
which	O
performs	B-T169
continuous-flow	O
pcr	O
without	O
optimization	O
of	O
the	O
annealing	O
temperature	B-T081
.	O
	
since	O
the	O
annealing	O
temperature	B-T081
of	O
each	O
station	O
can	O
be	O
controlled	B-T169
independently	B-T169
,	O
the	O
device	O
covers	B-T169
an	O
annealing	O
temperature	B-T081
range	B-T081
of	O
50-68	O
c	O
,	O
which	O
is	O
wide	O
enough	O
to	O
perform	B-T169
pcr	O
for	O
any	O
dna	O
fragment	O
regardless	O
of	O
its	O
optimum	B-T080
annealing	O
condition	B-T080
.	O
	
this	O
arrangement	B-T169
lets	O
us	O
continuously	B-T078
obtain	B-T169
an	O
amplified	O
amount	B-T081
of	O
a	O
dna	O
fragment	O
at	O
least	O
from	O
one	O
of	O
the	O
stations	O
.	O
	
the	O
device	O
consists	O
of	O
four	O
identical	B-T080
cylindrical	O
stations	O
diameter	B-T081
20	O
mm	O
,	O
height	O
55	O
mm	O
.	O
	
a	O
polytetrafluoroethylene	B-T109
capillary	O
reactor	O
length	B-T081
2	O
m	O
,	O
i.d	O
.	O
	
100	O
μm	O
,	O
o.d	O
.	O
	
400	O
μm	O
is	O
wound	O
helically	O
up	O
around	B-T078
each	O
station	O
.	O
	
the	O
whole	O
assembly	O
is	O
designed	O
to	O
minimize	B-T080
the	O
number	B-T081
of	O
heating	O
blocks	O
for	O
providing	O
temperatures	B-T081
of	O
denaturation	O
,	O
annealing	O
,	O
and	O
extension	B-T169
to	O
be	O
seven	O
and	O
to	O
shape	O
a	O
compact	B-T033
cube	O
height	O
55	O
mm	O
,	O
base	B-T081
60	O
mm	O
60	O
mm	O
.	O
	
the	O
reproducibility	B-T080
for	O
continuous-flow	O
pcr	O
is	O
reasonably	O
high	B-T080
run	B-T169
-to-	O
run	B-T169
and	O
station	O
-to-	O
station	O
relative	O
standard	B-T081
deviation	I-T081
of	O
their	O
amplification	O
is	O
lower	O
than	O
6	O
%	O
and	O
about	O
4	O
%	O
,	O
respectively	O
.	O
	
performance	O
on	O
the	O
optimization	O
-	O
free	B-T169
dna	O
amplification	O
has	O
been	O
evaluated	O
with	O
four	O
dna	O
samples	O
with	O
different	B-T080
annealing	O
conditions	B-T080
and	O
product	O
sizes	O
323	O
,	O
608	O
,	O
828	O
,	O
and	O
1101	O
bp	O
,	O
which	O
has	O
demonstrated	B-T080
that	O
in	O
all	O
cases	B-T169
,	O
pcr	O
is	O
successful	B-T080
at	O
least	O
on	O
one	O
station	O
.	O
	
in	O
addition	B-T169
,	O
three	O
dna	O
fragment	O
s	O
with	O
different	B-T080
lengths	B-T081
323	O
,	O
1101	O
,	O
and	O
2836	O
bp	O
have	O
been	O
successfully	B-T080
amplified	O
in	O
a	O
segmented	O
-	O
flow	O
mode	B-T169
without	O
the	O
carry-over	O
contamination	B-T078
between	O
segments	O
.	O
	
this	O
result	B-T169
suggests	O
that	O
this	O
device	O
could	O
serve	O
as	O
the	O
pcr	O
module	O
of	O
a	O
continuous-flow	O
high-throughput	O
on-line	O
total	O
dna	O
analysis	O
system	B-T169
integrating	B-T080
all	O
necessary	O
modules	O
from	O
cell	O
lysis	O
/	O
dna	O
extraction	O
to	O
pcr	O
product	O
analysis	O
.	O
	
assessing	O
sex-differences	O
and	O
the	O
effect	B-T080
of	O
timing	B-T079
of	O
vaccination	B-T061
on	O
immunogenicity	O
,	O
reactogenicity	B-T033
and	O
efficacy	B-T033
of	I-T033
vaccines	I-T033
in	O
young	B-T079
children	O
study	O
protocol	O
for	O
an	O
individual	O
participant	O
data	B-T078
meta-analysis	O
of	O
randomised	O
controlled	O
trials	O
disease	B-T047
incidence	B-T081
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	B-T047
or	O
inflammatory	B-T047
diseases	I-T047
.	O
	
sex-differences	O
in	O
immune	O
responses	O
to	O
some	O
vaccines	O
have	O
also	O
been	O
observed	O
,	O
mostly	O
to	O
viral	O
vaccines	O
in	O
adults	O
.	O
	
little	O
evidence	B-T078
is	O
available	B-T169
on	O
whether	O
sex-differences	O
occur	O
in	O
response	B-T033
to	O
immunisation	B-T061
in	O
infancy	B-T079
even	O
though	O
this	O
is	O
the	O
age	O
group	O
in	O
which	O
most	O
vaccines	O
are	O
administered	B-T169
.	O
	
factors	B-T169
other	O
than	O
sex	O
,	O
such	O
as	O
timing	B-T079
or	O
coadministration	B-T061
of	O
other	O
vaccines	O
,	O
can	O
also	O
influence	O
the	O
immune	O
response	O
to	O
vaccination	B-T061
.	O
	
individual	O
participant	O
data	B-T078
meta-analysis	O
of	O
randomised	O
controlled	O
trials	O
of	O
vaccines	O
in	O
healthy	O
infants	O
and	O
young	B-T079
children	O
will	O
be	O
conducted	O
.	O
	
fully	O
anonymised	O
data	B-T078
from	O
170	O
randomised	O
controlled	O
trials	O
of	O
v	O
accines	O
for	O
diphtheria	B-T047
,	O
tetanus	B-T047
,	O
bordetella	O
pertussis	O
,	O
polio	B-T047
,	O
haemophilus	O
influenzae	O
type	O
b	O
,	O
hepatitis	B-T047
b	I-T047
,	O
streptococcus	O
pneumoniae	O
,	O
neisseria	O
meningitidis	O
,	O
measles	B-T047
,	O
mumps	B-T047
,	O
rubella	B-T047
,	O
varicella	B-T047
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O
	
outcomes	B-T169
include	O
measures	B-T169
of	O
immunogenicity	O
immunoglobulins	B-T116
,	O
reactogenicity	B-T033
,	O
safety	O
and	O
disease	B-T047
-specific	O
clinical	B-T080
efficacy	I-T080
.	O
	
data	B-T078
from	O
trials	O
of	O
vaccines	O
containing	O
similar	O
components	O
will	O
be	O
combined	O
in	O
hierarchical	B-T169
models	O
and	O
the	O
effect	B-T080
of	O
sex	O
and	O
timing	B-T079
of	O
vaccinations	B-T061
estimated	O
for	O
each	O
outcome	B-T169
separately	O
.	O
	
systematic	O
reviews	O
of	O
published	O
estimates	O
of	O
sex-differences	O
cannot	O
adequately	O
answer	B-T061
questions	I-T061
in	O
this	O
field	O
since	O
such	O
comparisons	O
are	O
never	O
the	O
main	O
purpose	B-T169
of	O
a	O
clinical	O
trial	O
,	O
thus	O
a	O
large	B-T081
degree	B-T081
of	O
reporting	O
bias	B-T078
exists	O
in	O
the	O
published	O
literature	O
.	O
	
recent	O
improvements	O
in	O
the	O
widespread	O
availability	B-T169
of	I-T169
individual	O
participant	O
data	B-T078
from	O
randomised	O
controlled	O
trials	O
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	B-T080
individual	O
participant	O
data	B-T078
meta-analyses	O
which	O
were	O
previously	B-T079
impossible	B-T033
,	O
thereby	O
reducing	B-T080
the	O
effect	B-T080
of	O
publication	O
or	O
reporting	O
bias	B-T078
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	O
.	O
	
preliminary	B-T078
results	I-T078
will	O
be	O
available	B-T169
in	O
2016	O
with	O
final	O
results	B-T169
available	B-T169
in	O
2019	O
.	O
	
no	B-T169
ethics	B-T078
review	O
is	O
required	O
for	O
secondary	O
analyses	O
of	O
anonymised	O
an	O
ultrasensitive	B-T169
electrochemiluminescence	O
sensor	O
based	O
on	O
reduced	O
graphene	O
oxide	O
-	O
copper	O
sulfide	O
composite	B-T080
coupled	O
with	O
capillary	O
electrophoresis	O
for	O
determination	O
of	O
amlodipine	B-T109
besylate	I-T109
in	O
mice	O
plasma	O
a	O
new	O
electrochemiluminescence	O
ecl	O
sensor	O
based	O
on	O
reduced	O
graphene	O
oxide	O
-	O
copper	O
sulfide	O
rgo	O
-	O
cus	O
composite	B-T080
coupled	O
with	O
capillary	O
electrophoresis	O
ce	O
was	O
constructed	O
for	O
the	O
ultrasensitive	B-T169
detection	B-T061
of	O
amlodipine	B-T109
besylate	I-T109
aml	B-T109
for	O
the	O
first	O
time	O
.	O
	
in	O
this	O
work	O
,	O
rgo	O
-	O
cus	O
composite	B-T080
was	O
synthesized	O
by	O
one-pot	O
hydrothermal	B-T169
method	I-T169
and	O
used	O
for	O
electrode	O
modification	B-T033
.	O
	
the	O
electrochemical	O
and	O
ecl	O
behaviors	O
of	O
the	O
sensor	O
were	O
investigated	B-T169
.	O
	
more	O
than	O
5-fold	O
enhance	O
in	O
ecl	O
intensity	B-T081
was	O
observed	B-T169
after	O
modified	O
with	O
rgo	O
-	O
cus	O
composite	B-T080
.	O
	
the	O
results	O
can	O
be	O
ascribed	O
to	O
the	O
presence	B-T080
of	O
rgo	O
-	O
cus	O
composite	B-T080
on	O
the	O
electrode	O
surface	O
that	O
facilitates	O
the	O
electron	B-T081
transfer	I-T081
rate	I-T081
between	O
the	O
electroactive	B-T169
center	O
of	O
ru	O
and	O
the	O
electrode	O
.	O
	
the	O
ecl	O
sensor	O
was	O
coupled	B-T169
with	O
ce	O
to	O
improve	O
the	O
selectivity	O
and	O
the	O
ce	O
-	O
ecl	O
parameters	B-T033
that	O
affect	O
separation	O
and	O
detection	B-T061
were	O
optimized	O
.	O
	
under	O
the	O
optimum	B-T080
conditions	O
,	O
the	O
linear	B-T081
ranges	I-T081
for	O
aml	B-T109
was	O
0.008	O
with	O
a	O
detection	B-T081
limit	I-T081
of	O
2.8ng	O
s/n=3	O
.	O
	
the	O
method	O
displayed	O
the	O
advantages	O
of	O
high	O
sensitivity	O
,	O
good	O
selectivity	O
,	O
wide	O
linear	B-T081
range	I-T081
,	O
low	O
detection	B-T081
limit	I-T081
and	O
fine	B-T080
reproducibility	I-T080
,	O
and	O
was	O
used	O
to	O
analyze	O
aml	B-T109
in	O
mice	O
plasma	O
with	O
a	O
satisfactory	O
result	O
,	O
which	O
holds	O
a	O
great	O
potential	B-T080
in	O
the	O
field	O
of	O
pharmaceutical	O
analysis	O
.	O
	
estrogen	B-T109
and	O
progesterone	B-T109
hormone	O
receptor	O
expression	O
in	O
oral	O
cavity	O
cancer	O
recent	O
studies	O
have	O
shown	O
an	O
increase	B-T169
in	O
the	O
incidence	B-T081
of	O
oral	O
squamous	O
cell	O
carcinoma	O
oscc	O
in	O
younger	B-T079
patients	O
.	O
	
the	O
hypothesis	B-T078
that	O
tumors	O
could	O
be	O
hormonally	O
induced	B-T169
during	O
pregnancy	O
or	O
in	O
young	B-T079
female	O
patients	O
without	O
the	O
well-known	O
risk	B-T033
factors	I-T033
alcohol	O
or	O
tobacco	O
abuse	O
seems	O
to	O
be	O
plausible	O
.	O
	
estrogen	B-T116
receptor	I-T116
alpha	I-T116
erα	B-T116
and	O
progesterone	B-T116
receptor	I-T116
pr	B-T116
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	O
n=5	O
,	O
oral	B-T033
precursor	I-T033
lesions	I-T033
simple	B-T047
hyperplasia	I-T047
,	O
n=11	O
squamous	O
intraepithelial	O
neoplasia	O
,	O
sin	O
i-iii	O
,	O
n=35	O
,	O
and	O
oscc	O
specimen	O
.	O
	
osccs	O
were	O
stratified	B-T080
in	O
a	O
young	B-T079
female	O
n=7	O
study	O
cohort	O
and	O
older	O
patients	O
n=46	O
.	O
	
in	O
the	O
young	B-T079
female	O
study	O
cohort	O
three	O
patients	O
n=3/7	O
developed	O
oscc	O
during	O
or	O
shortly	O
after	O
pregnancy	O
.	O
	
breast	O
cancer	O
tissues	O
were	O
used	O
as	O
positive	O
control	O
for	O
erα	B-T116
and	O
pr	B-T116
expression	O
.	O
	
erα	B-T116
expression	O
was	O
found	O
in	O
four	O
oral	B-T033
precursor	I-T033
lesions	I-T033
squamous	O
intraepithelial	O
neoplasia	O
,	O
sin	O
i-iii	O
,	O
n=4/35	O
,	O
11%	O
and	O
in	O
five	O
oscc	O
specimen	O
n=5/46	O
,	O
11%	O
.	O
	
the	O
five	O
erα	B-T116
positive	B-T033
oscc	O
samples	O
were	O
older	O
male	O
patients	O
.	O
	
all	O
patients	O
within	O
the	O
young	B-T079
female	O
study	O
cohort	O
were	O
negatively	B-T033
stained	O
for	O
both	O
erα	B-T116
and	O
pr	B-T116
.	O
	
er	B-T116
expression	O
could	O
be	O
regarded	O
as	O
a	O
seldom	B-T080
risk	B-T033
factor	I-T033
for	O
oscc	O
.	O
	
pr	B-T116
expression	O
seems	O
to	O
be	O
not	O
relevant	B-T080
for	O
the	O
development	B-T169
of	O
studying	O
neuroprotective	B-T169
effect	I-T169
of	O
atorvastatin	B-T109
as	O
a	O
small	B-T109
molecule	I-T109
drug	O
on	O
high	B-T033
glucose	I-T033
-	O
induced	B-T169
neurotoxicity	O
in	O
undifferentiated	B-T080
pc12	O
cells	O
role	O
of	O
nadph	B-T116
oxidase	I-T116
overproduction	B-T080
of	O
reactive	O
oxygen	O
species	O
ros	O
by	O
nadph	B-T116
oxidase	I-T116
nox	B-T116
activation	O
has	O
been	O
considered	B-T078
the	O
essential	B-T080
mechanism	B-T169
induced	B-T169
by	O
hyperglycemia	B-T047
in	O
various	O
tissues	O
.	O
	
however	O
,	O
there	O
is	O
no	B-T080
comprehensive	I-T080
study	O
on	O
the	O
role	O
of	O
noxs	B-T116
in	O
high	B-T033
glucose	I-T033
hg	B-T033
induced	B-T169
toxic	O
effect	O
in	O
neural	O
tissues	O
.	O
	
recently	O
,	O
a	O
therapeutic	B-T169
strategy	O
in	O
oxidative	B-T169
related	B-T080
pathologies	O
has	O
been	O
introduced	B-T169
by	O
blocking	B-T169
the	O
undesirable	O
actions	O
of	O
nox	B-T116
enzymes	I-T116
by	O
small	B-T109
molecules	I-T109
.	O
	
the	O
protective	B-T033
roles	O
of	O
statins	B-T109
in	O
ameliorating	B-T080
oxidative	O
stress	O
by	O
nox	B-T116
inhibition	O
have	O
been	O
shown	O
in	O
some	O
tissues	O
except	O
neural	O
.	O
	
we	O
hypothesized	B-T078
then	O
,	O
that	O
different	B-T080
noxs	B-T116
may	O
have	O
role	O
in	O
hg	B-T033
-	O
induced	B-T169
neural	O
cell	O
injury	O
.	O
	
furthermore	O
,	O
we	O
postulate	B-T078
that	O
atorvastatin	B-T109
as	O
a	O
small	B-T109
molecule	I-T109
may	O
modulate	O
this	O
noxs	O
activity	O
to	O
protect	B-T033
neural	O
cells	O
.	O
	
undifferentiated	B-T080
pc12	O
cells	O
were	O
treated	B-T061
with	I-T061
hg	B-T033
140	O
mm/	O
24	B-T079
h	I-T079
in	O
the	O
presence	B-T033
and	O
absence	B-T169
of	O
atorvastatin	B-T109
1	O
μm/	O
96	B-T079
h	I-T079
.	O
	
the	O
cell	O
viability	O
was	O
measured	B-T080
by	O
mtt	O
assay	O
and	O
the	O
gene	B-T081
and	O
protein	O
expressions	O
profile	O
of	O
nox	B-T116
1-4	O
were	O
determined	B-T080
by	I-T080
rt-pcr	O
and	O
western	O
blotting	O
,	O
respectively	O
.	O
	
levels	B-T080
of	O
ros	O
and	O
malondialdehyde	B-T109
mda	B-T109
were	O
also	O
evaluated	O
.	O
	
gene	O
and	O
protein	O
expression	O
levels	B-T080
of	O
nox	B-T116
1-4	O
and	O
consequently	B-T033
ros	O
and	O
mda	B-T109
levels	B-T080
were	O
elevated	B-T080
in	O
hg	B-T033
-	O
treated	B-T169
pc12	O
cells	O
.	O
	
atorvastatin	B-T109
could	O
significantly	B-T078
decrease	B-T081
hg	B-T033
-	O
induced	B-T169
noxs	B-T116
,	O
ros	O
and	O
mda	B-T109
elevation	O
and	O
improve	B-T033
impaired	B-T169
cell	O
viability	O
.	O
	
it	O
can	O
be	O
concluded	B-T078
that	O
hg	B-T033
could	O
elevate	B-T080
noxs	O
activity	O
,	O
ros	O
and	O
mda	B-T109
levels	B-T080
in	O
neural	O
tissues	O
and	O
atorvastatin	B-T109
as	O
a	O
small	B-T109
molecule	I-T109
nox	O
inhibitor	O
drug	O
may	O
prevent	B-T080
and	O
delay	B-T079
diabetic	B-T047
complications	I-T047
,	O
particularly	O
intravascular	O
inflammation	O
triggers	B-T080
intracerebral	O
activated	O
microglia	O
and	O
contributes	O
to	O
secondary	O
brain	O
injury	O
after	O
experimental	B-T080
subarachnoid	B-T047
hemorrhage	I-T047
esah	B-T047
activation	O
of	O
innate	O
immunity	O
contributes	O
to	O
secondary	O
brain	O
injury	O
after	O
experimental	B-T080
subarachnoid	B-T047
hemorrhage	I-T047
esah	B-T047
.	O
	
microglia	O
accumulation	B-T033
and	O
activation	O
within	O
the	O
brain	O
has	O
recently	O
been	O
shown	O
to	O
induce	O
neuronal	O
cell	O
death	O
after	O
esah	B-T047
.	O
	
in	O
isolated	B-T169
mouse	O
brain	O
capillaries	O
after	O
esah	B-T047
,	O
we	O
show	O
a	O
significantly	O
increased	O
gene	O
expression	O
for	O
intercellular	O
adhesion	O
molecule-1	O
icam-1	O
and	O
p-selectin	O
.	O
	
hence	O
,	O
we	O
hypothesized	B-T078
that	O
extracerebral	O
intravascular	O
inflammatory	O
processes	O
might	O
initiate	O
the	O
previously	O
reported	O
microglia	O
accumulation	B-T033
within	O
the	O
brain	O
tissue	O
.	O
	
we	O
therefore	O
induced	O
esah	B-T047
in	O
knockout	O
mice	O
for	O
icam-1	O
icam-1	O
and	O
p-selectin	O
glycoprotein	O
ligand-1	O
psgl-1	O
to	O
find	O
a	O
significant	O
decrease	O
in	O
neutrophil	O
-	O
endothelial	O
interaction	O
within	O
the	O
first	O
7	O
days	O
after	O
the	O
bleeding	O
in	O
a	O
chronic	B-T079
cranial	O
window	O
model	O
.	O
	
this	O
inhibition	O
of	O
neutrophil	O
recruitment	O
to	O
the	O
endothelium	O
results	O
in	O
significantly	O
ameliorated	B-T033
microglia	O
accumulation	B-T033
and	O
neuronal	O
cell	O
death	O
in	O
knockout	O
animals	O
in	O
comparison	O
to	O
controls	O
.	O
	
our	O
results	O
suggest	O
an	O
outside-in	O
activation	O
of	O
the	O
cns	O
innate	O
immune	O
system	O
at	O
the	O
vessel	O
/	O
brain	O
interface	O
following	O
esah	B-T047
.	O
	
microglia	O
cells	O
,	O
as	O
part	O
of	O
the	O
brain's	O
innate	O
immune	O
system	O
,	O
are	O
triggered	B-T080
by	O
an	O
inflammatory	O
reaction	O
in	O
the	O
microvasculature	O
after	O
esah	B-T047
,	O
thus	O
contributing	O
to	O
neuronal	O
cell	O
death	O
.	O
	
this	O
finding	O
offers	O
a	O
whole	O
range	O
of	O
new	O
research	O
targets	B-T169
,	O
as	O
well	O
as	O
possible	O
therapy	B-T169
options	O
for	O
patients	O
suffering	O
from	O
amphetamine	O
withdrawal	O
differentially	O
increases	O
the	O
expression	O
of	O
organic	B-T116
cation	I-T116
transporter	I-T116
3	I-T116
and	O
serotonin	B-T116
transporter	I-T116
in	O
limbic	O
brain	O
regions	O
amphetamine	O
withdrawal	O
increases	O
anxiety	B-T033
and	O
stress	B-T033
sensitivity	O
related	O
to	O
blunted	B-T080
ventral	O
hippocampus	O
vhipp	O
and	O
enhances	O
the	O
central	O
nucleus	O
of	O
the	O
amygdala	O
cea	O
serotonin	B-T109
responses	O
.	O
	
extracellular	O
serotonin	B-T109
levels	B-T080
are	O
regulated	O
by	O
the	O
serotonin	B-T116
transporter	I-T116
sert	B-T116
and	O
organic	B-T116
cation	I-T116
transporter	I-T116
3	I-T116
oct3	B-T116
,	O
and	O
vhipp	O
oct3	B-T116
expression	O
is	O
enhanced	O
during	O
24	B-T079
hours	I-T079
of	O
amphetamine	O
withdrawal	O
,	O
while	O
sert	B-T116
expression	O
is	O
unaltered	O
.	O
	
here	O
,	O
we	O
tested	O
whether	O
oct3	B-T116
and	O
sert	B-T116
expression	O
in	O
the	O
cea	O
is	O
also	O
affected	O
during	O
acute	O
withdrawal	O
to	O
explain	O
opposing	O
regional	O
alterations	O
in	O
limbic	O
serotonergic	O
neurotransmission	O
and	O
if	O
respective	O
changes	O
continued	O
with	O
two	B-T079
weeks	I-T079
of	O
withdrawal	O
.	O
	
we	O
also	O
determined	O
whether	O
changes	O
in	O
transporter	B-T116
expression	O
were	O
confined	O
to	O
these	O
regions	O
.	O
	
male	O
rats	O
received	O
amphetamine	B-T109
or	O
saline	O
for	O
two	B-T079
weeks	I-T079
followed	O
by	O
24	B-T079
hours	I-T079
or	O
two	B-T079
weeks	I-T079
of	O
withdrawal	O
,	O
with	O
transporter	B-T116
expression	O
measured	O
using	O
western	O
immunoblot	O
.	O
	
oct3	B-T116
and	O
sert	B-T116
expression	O
increased	O
in	O
the	O
cea	O
at	O
both	O
withdrawal	O
timepoints	O
.	O
	
in	O
the	O
vhipp	O
,	O
oct3	B-T116
expression	O
increased	O
only	O
at	O
24	B-T079
hours	I-T079
of	O
withdrawal	O
,	O
with	O
an	O
equivalent	O
pattern	O
seen	O
in	O
the	O
dorsomedial	O
hypothalamus	O
.	O
	
no	B-T033
changes	I-T033
were	O
evident	O
in	O
any	O
other	O
regions	O
sampled	O
.	O
	
these	O
regionally	O
specific	O
changes	O
in	O
limbic	O
oct3	B-T116
and	O
sert	B-T116
expression	O
may	O
partially	O
contribute	O
to	O
the	O
serotonergic	B-T109
imbalance	O
and	O
negative	B-T033
affect	I-T033
during	O
amphetamine	O
withdrawal	O
.	O
	
nutritional	B-T169
aspects	I-T169
of	O
night	B-T079
eating	O
and	O
its	O
association	B-T080
with	I-T080
weight	O
status	B-T080
among	O
korean	O
adolescents	O
a	O
growing	B-T169
body	O
of	O
research	O
has	O
indicated	O
that	O
night	B-T079
eating	O
could	O
be	O
associated	B-T080
with	I-T080
poor	B-T033
diet	I-T033
quality	B-T080
and	O
negative	B-T033
health	O
outcomes	O
.	O
	
this	O
study	O
examined	O
the	O
nutritional	B-T169
aspects	I-T169
of	O
night	B-T079
eating	O
,	O
its	O
related	O
factors	B-T169
,	O
and	O
the	O
association	B-T080
between	O
night	B-T079
eating	O
and	O
body	O
weight	O
among	O
korean	O
adolescents	O
.	O
	
this	O
study	O
analysed	O
the	O
data	B-T078
from	O
a	O
one	O
day	B-T079
24-hour	O
dietary	O
recall	O
as	O
well	O
as	O
a	O
demographic	O
survey	O
of	O
1	O
korean	O
adolescents	O
aged	O
12	O
to	O
18-	O
years	B-T079
-old	O
obtained	O
from	O
the	O
2010-2012	O
korea	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
.	O
	
'	O
night	B-T079
eating	O
'	O
was	O
defined	O
as	O
consuming	O
25%	O
or	O
more	O
of	O
one's	O
daily	B-T081
energy	I-T081
intake	I-T081
between	O
21	O
and	O
06	O
.	O
	
subjects	O
complying	O
with	O
the	O
preceding	O
condition	B-T080
were	O
classified	O
as	O
'	O
night	B-T079
eaters	O
'	O
,	O
whereas	O
the	O
rest	O
were	O
considered	O
'	O
non-night	O
eaters	O
'	O
.	O
	
logistic	O
regression	O
analysis	O
examined	O
factors	B-T169
related	O
to	O
night	B-T079
eating	O
.	O
	
multiple	B-T081
linear	I-T081
regression	I-T081
analyses	I-T081
were	O
used	O
to	O
examine	O
the	O
relationship	B-T080
between	O
night	B-T079
eating	O
and	O
bmi	O
z-scores	B-T081
,	O
whereas	O
multinomial	O
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
examine	O
the	O
relationship	B-T080
between	O
night	B-T079
eating	O
and	O
weight	O
status	B-T080
.	O
	
about	O
21%	O
of	O
korean	O
adolescents	O
appeared	O
to	O
be	O
night	B-T079
eaters	O
.	O
	
night	B-T079
eaters	O
showed	O
increased	B-T081
breakfast	O
skipping	B-T033
p	O
=	O
0.001	O
,	O
higher	O
energy	B-T081
intake	I-T081
from	O
snacks	O
p	O
<	O
0.001	O
,	O
greater	O
proportion	B-T081
of	I-T081
energy	I-T081
intake	I-T081
from	I-T081
fat	I-T081
p	O
=	O
0.029	O
,	O
and	O
lower	B-T081
dietary	I-T081
diversity	I-T081
scores	I-T081
p	O
=	O
0.008	O
than	O
non-night	O
eaters	O
.	O
	
male	O
adolescents	O
presented	O
1.9	O
times	B-T081
higher	O
odds	O
of	O
being	O
night	B-T079
eaters	O
than	O
females	O
.	O
	
adolescents	O
whose	O
both	O
parents	O
were	O
night	B-T079
eaters	O
were	O
4.4	O
times	B-T081
as	O
likely	O
to	O
be	O
night	B-T079
eaters	O
as	O
those	O
whose	O
neither	O
parents	O
were	O
.	O
	
female	O
adolescents	O
showed	O
a	O
significant	O
relationship	B-T080
between	O
night	B-T079
eating	O
and	O
bmi	O
z-scores	B-T081
β	O
=	O
0.28	O
,	O
p	O
=	O
0.004	O
.	O
	
however	O
,	O
night	B-T079
eating	O
did	O
not	O
increase	B-T169
odds	O
of	O
being	O
overweight	O
or	O
obese	B-T047
in	O
adolescents	O
.	O
	
night	B-T079
eating	O
in	O
korean	O
adolescents	O
was	O
related	O
to	O
undesirable	B-T033
dietary	I-T033
behaviours	I-T033
and	O
low	B-T033
diet	I-T033
quality	I-T033
in	O
general	O
as	O
well	O
as	O
higher	O
bmi	O
z-scores	B-T081
in	O
females	O
.	O
	
male	O
gender	O
and	O
parental	O
night	B-T079
eating	O
appeared	O
to	O
be	O
the	O
factors	B-T169
that	O
significantly	O
increased	B-T081
odds	O
of	O
night	B-T079
eating	O
.	O
	
these	O
results	O
suggest	O
that	O
night	B-T079
eating	O
should	O
be	O
considered	O
when	O
designing	O
nutrition	O
education	O
or	O
intervention	B-T061
programs	I-T061
targeting	O
a	O
randomized	O
trial	O
of	O
plasma-lyte	O
a	O
and	O
0.9	O
%	O
sodium	O
chloride	O
in	O
acute	B-T047
pediatric	I-T047
gastroenteritis	I-T047
compare	O
the	O
efficacy	B-T080
and	O
safety	O
of	O
plasma-lyte	O
a	O
pla	O
versus	O
0.9	O
%	O
sodium	O
chloride	O
nacl	O
intravenous	B-T061
iv	I-T061
fluid	I-T061
replacement	I-T061
in	O
children	O
with	O
moderate	O
to	O
severe	B-T047
dehydration	I-T047
secondary	O
to	O
acute	B-T047
gastroenteritis	I-T047
age	B-T047
.	O
	
prospective	O
,	O
randomized	O
,	O
double-blind	O
study	O
conducted	O
at	O
eight	O
pediatric	B-T080
emergency	O
departments	O
eds	O
in	O
the	O
us	O
and	O
canada	O
nct	O
.	O
	
the	O
primary	B-T080
outcome	I-T080
measure	I-T080
was	O
serum	O
bicarbonate	O
level	O
at	O
4	O
h	O
.	O
	
secondary	B-T080
outcomes	I-T080
included	O
safety	O
and	O
tolerability	O
.	O
	
the	O
hypothesis	B-T078
was	O
that	O
pla	O
would	O
be	O
superior	O
to	O
0.9	O
%	O
nacl	O
in	O
improvement	O
of	O
4-h	O
bicarbonate	O
.	O
	
patients	O
n	O
=	O
100	O
aged	O
6	O
months	O
to	O
<11	O
years	O
with	O
age	B-T047
-induced	O
moderate-to-	O
severe	B-T047
dehydration	I-T047
were	O
enrolled	O
.	O
	
patients	O
with	O
a	O
baseline	B-T081
bicarbonate	O
level	O
22	O
meq/l	O
formed	B-T169
the	O
modified	B-T169
intent	B-T169
to	I-T169
treat	I-T169
mitt	B-T169
group	O
.	O
	
at	O
baseline	B-T081
,	O
the	O
treatment	B-T061
groups	O
were	O
comparable	O
except	O
that	O
the	O
pla	O
group	O
was	O
older	O
.	O
	
at	O
hour	O
4	O
,	O
the	O
pla	O
group	O
had	O
greater	O
increases	B-T033
in	I-T033
serum	I-T033
bicarbonate	I-T033
from	O
baseline	B-T081
than	O
did	O
the	O
0.9	O
%	O
nacl	O
group	O
mean	O
sd	O
at	O
4	O
h	O
18	O
3.74	O
vs	O
18.0	O
3.67	O
change	O
from	O
baseline	B-T081
of	O
1.6	O
and	O
0.0	O
,	O
respectively	O
p	O
=	O
004	O
.	O
	
both	O
treatment	B-T061
groups	O
received	O
similar	O
fluid	B-T081
volumes	I-T081
.	O
	
the	O
pla	O
group	O
had	O
less	O
abdominal	O
pain	O
and	O
better	O
dehydration	B-T047
scores	O
at	O
hour	O
2	O
both	O
p	O
=	O
03	O
but	O
not	O
at	O
hour	O
4	O
p	O
=	O
0.15	O
and	O
0.08	O
,	O
respectively	O
.	O
	
no	O
patient	O
experienced	O
clinically	B-T078
relevant	I-T078
worsening	I-T078
of	O
laboratory	O
findings	O
or	O
physical	O
examination	O
,	O
and	O
hospital	B-T081
admission	I-T081
rates	I-T081
were	O
similar	B-T080
.	O
	
one	O
patient	O
in	O
each	O
treatment	B-T061
group	O
developed	O
hyponatremia	B-T047
.	O
	
four	O
patients	O
developed	O
hyperkalemia	B-T033
pla	O
1	O
,	O
0.9	O
%	O
nacl	O
3	O
.	O
	
in	O
comparison	O
with	O
0.9	O
%	O
nacl	O
,	O
pla	O
for	O
rehydration	B-T061
in	O
children	O
with	O
age	B-T047
was	O
well	O
tolerated	O
and	O
led	O
to	O
more	O
rapid	O
improvement	O
in	O
serum	O
bicarbonate	O
and	O
dehydration	B-T047
the	O
relationships	B-T080
between	O
symptoms	O
and	O
quality	B-T078
of	I-T078
life	I-T078
over	O
the	O
course	B-T079
of	O
cognitive-behavioral	B-T061
therapy	I-T061
for	O
panic	O
disorder	O
in	O
japan	O
this	O
study	O
examined	B-T033
the	O
relationships	B-T080
between	O
changes	B-T169
in	O
symptoms	O
and	O
changes	B-T169
in	O
quality	B-T078
of	I-T078
life	I-T078
qol	B-T078
during	O
cognitive-behavioral	B-T061
therapy	I-T061
cbt	B-T061
for	O
panic	O
disorder	O
pd	O
.	O
	
we	O
treated	B-T169
198	O
pd	O
patients	O
with	O
group	O
cbt	B-T061
in	O
japan	O
.	O
	
using	O
multiple	O
regression	O
analysis	O
,	O
we	O
examined	B-T033
the	O
associations	B-T080
between	O
changes	B-T169
in	O
qol	B-T078
and	O
changes	B-T169
in	O
pd	O
symptoms	O
or	O
comorbid	O
psychological	O
symptoms	O
during	O
cbt	B-T061
.	O
	
changes	B-T169
in	O
anticipatory	B-T033
anxiety	I-T033
,	O
agoraphobic	O
fear	O
/	O
avoidance	O
,	O
and	O
somatization	O
were	O
significant	O
predictors	B-T078
of	O
changes	B-T169
in	O
some	O
aspects	O
of	O
qol	B-T078
.	O
	
it	O
might	O
be	O
useful	O
to	O
decrease	O
somatization	O
,	O
anticipatory	B-T033
anxiety	I-T033
,	O
and	O
agoraphobic	O
fear	O
to	O
improve	O
qol	B-T078
in	O
cbt	B-T061
for	O
coupling	B-T169
of	O
trpv6	B-T116
and	O
tmem16a	B-T116
in	O
epithelial	O
principal	O
cells	O
of	O
the	O
rat	O
epididymis	O
the	O
epididymis	O
establishes	O
a	O
congenial	B-T080
environment	O
for	O
sperm	O
maturation	O
and	O
protection	B-T033
.	O
	
its	O
fluid	O
is	O
acidic	B-T081
,	O
and	O
the	O
calcium	O
concentration	B-T081
is	O
low	B-T080
and	O
declines	O
along	O
the	O
length	B-T081
of	O
the	O
epididymal	O
tubule	O
.	O
	
however	O
,	O
our	O
knowledge	O
of	O
ionic	O
currents	O
and	O
mechanisms	B-T169
of	O
calcium	O
homeostasis	O
in	O
rat	O
epididymal	O
epithelial	O
cells	O
remains	O
enigmatic	O
.	O
	
in	O
this	O
study	O
,	O
to	O
better	O
understand	O
calcium	O
regulation	O
in	O
the	O
epididymis	O
,	O
we	O
use	O
the	O
patch-clamp	O
method	O
to	O
record	O
from	O
single	O
rat	O
cauda	O
epididymal	O
principal	O
cells	O
.	O
	
we	O
detect	B-T033
a	O
constitutively	O
active	B-T169
ca	O
current	O
with	O
characteristics	B-T080
that	O
match	O
the	O
epithelial	O
calcium	B-T116
channel	I-T116
trpv6	B-T116
.	O
	
electrophysiological	O
and	O
pharmacological	O
data	O
also	O
reveal	O
a	O
constitutively	O
active	B-T116
calcium-activated	I-T116
chloride	I-T116
conductance	I-T116
cacc	B-T116
.	O
	
removal	O
of	O
extracellular	O
calcium	O
attenuates	O
not	O
only	O
the	O
trpv6	B-T116
-like	O
conductance	O
,	O
but	O
also	O
the	O
cacc	B-T116
.	O
	
lanthanide	O
block	B-T169
is	O
time	B-T079
dependent	B-T080
such	O
that	O
the	O
trpv6	B-T116
-like	O
component	O
is	O
inhibited	O
first	O
,	O
followed	O
by	O
the	O
cacc	B-T116
.	O
	
the	O
putative	O
cacc	B-T116
blocker	O
niflumic	B-T109
acid	I-T109
partially	O
inhibits	O
whole-cell	O
currents	O
,	O
whereas	O
la	O
almost	O
abolishes	O
whole-cell	O
currents	O
in	O
principal	O
cells	O
.	O
	
membrane	O
potential	O
measurements	B-T169
reveal	O
an	O
interplay	O
between	O
la	O
-	O
sensitive	B-T116
ion	I-T116
channels	I-T116
and	O
those	O
that	O
are	O
sensitive	B-T169
to	O
the	O
specific	O
tmem16a	B-T116
inhibitor	O
tannic	B-T109
acid	I-T109
.	O
	
in	O
vivo	O
perfusion	B-T061
of	O
the	O
cauda	O
epididymal	O
tubule	O
shows	O
a	O
substantial	O
rate	O
of	O
ca	O
reabsorption	O
from	O
the	O
luminal	O
side	O
,	O
which	O
is	O
dose-dependently	O
suppressed	B-T169
by	O
ruthenium	O
red	O
,	O
a	O
putative	O
blocker	O
of	O
epithelial	O
ca	B-T116
channels	I-T116
and	O
cacc	B-T116
.	O
	
finally	O
,	O
we	O
discover	O
messenger	O
rna	O
for	O
both	O
trpv6	B-T116
and	O
tmem16a	B-T116
in	O
the	O
rat	O
epididymis	O
and	O
show	O
that	O
their	O
proteins	B-T116
colocalize	O
in	O
the	O
apical	O
membrane	O
of	O
principal	O
cells	O
.	O
	
collectively	O
,	O
these	O
data	B-T078
provide	O
evidence	B-T078
for	O
a	O
coupling	B-T169
mechanism	B-T169
between	O
trpv6	B-T116
and	O
tmem16a	B-T116
in	O
principal	O
cells	O
that	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
calcium	O
homeostasis	O
in	O
the	O
voices	O
a	O
conversation	O
with	O
allen	O
j	O
.	O
	
wilcox	O
allen	O
james	O
wilcox	O
was	O
born	O
on	O
30	O
september	O
1946	O
in	O
columbus	O
,	O
oh	O
.	O
	
he	O
studied	O
medicine	O
at	O
the	O
university	O
of	O
michigan	O
,	O
graduated	O
in	O
1973	O
,	O
and	O
after	O
a	O
rotating	O
internship	O
,	O
he	O
completed	B-T033
a	I-T033
master's	I-T033
degree	I-T033
in	O
maternal	O
and	O
child	O
health	O
1976	O
and	O
a	O
phd	O
in	O
epidemiology	O
1979	O
at	O
the	O
university	O
of	O
north	O
carolina	O
in	O
chapel	O
hill	O
.	O
	
after	O
graduation	O
,	O
he	O
went	O
to	O
work	O
at	O
the	O
national	O
institute	O
of	O
environmental	O
health	O
sciences	O
niehs	O
,	O
one	O
of	O
the	O
us	O
national	O
institutes	O
of	O
health	O
in	O
durham	O
,	O
nc	O
,	O
where	O
he	O
has	O
spent	O
his	O
career	O
.	O
	
he	O
developed	O
a	O
research	O
program	O
in	O
reproductive	O
and	O
perinatal	O
epidemiology	O
,	O
a	O
relatively	O
unexplored	O
area	O
at	O
the	O
time	O
.	O
	
his	O
studies	O
include	O
the	O
early	B-T047
pregnancy	I-T047
study	O
,	O
which	O
documented	O
the	O
extent	O
of	O
subclinical	B-T080
pregnancy	O
loss	O
in	O
humans	O
and	O
established	B-T080
the	O
fertile	B-T079
days	I-T079
of	O
a	O
woman's	O
menstrual	O
cycle	O
.	O
	
he	O
served	O
as	O
the	O
chief	O
of	O
the	O
epidemiology	O
branch	O
from	O
1991	O
to	O
2001	O
,	O
and	O
as	O
editor-in-chief	O
of	O
the	O
journal	O
epidemiology	O
from	O
2001	O
to	O
2014	O
.	O
	
his	O
textbook	O
,	O
fertility	O
and	O
pregnancy-an	O
epidemiologic	O
perspective	O
,	O
was	O
published	O
by	O
oxford	O
university	O
press	O
in	O
2010	O
.	O
	
he	O
was	O
elected	O
to	O
the	O
american	O
epidemiological	O
society	O
in	O
1989	O
,	O
and	O
served	O
as	O
its	O
president	O
in	O
2003	O
.	O
	
he	O
also	O
served	O
as	O
president	O
of	O
the	O
society	O
of	O
pediatric	O
and	O
perinatal	O
epidemiological	O
research	O
1996	O
and	O
the	O
president	O
of	O
the	O
society	O
of	O
epidemiological	O
research	O
1998	O
.	O
	
he	O
holds	O
adjunct	O
teaching	O
appointments	B-T079
at	O
the	O
university	O
of	O
north	O
carolina	O
,	O
harvard	O
university	O
,	O
and	O
the	O
university	O
of	O
bergen	O
norway	O
,	O
which	O
awarded	O
him	O
an	O
honorary	B-T080
doctoral	O
degree	O
evaluation	O
of	O
spontaneous	B-T169
bone	O
regeneration	O
after	O
enucleation	B-T061
of	O
large	B-T081
cysts	B-T047
of	O
the	O
jaws	O
using	O
radiographic	O
computed	O
software	O
spontaneous	B-T169
regeneration	O
of	O
bone	O
is	O
commonly	B-T081
seen	O
in	O
the	O
small	B-T081
surgical	B-T061
defects	B-T169
caused	O
by	O
enucleation	B-T061
of	O
cysts	B-T047
.	O
	
however	O
,	O
in	O
case	O
of	O
large	B-T081
surgical	B-T061
defects	B-T169
caused	O
by	O
the	O
enucleation	B-T061
,	O
spontaneous	B-T169
regeneration	O
of	O
bone	O
is	O
a	O
rare	B-T080
phenomenon	O
and	O
it	O
depends	B-T080
on	O
factors	B-T169
,	O
such	O
as	O
age	O
of	O
the	O
patient	O
,	O
intact	B-T080
periosteum	O
,	O
and	O
proper	O
stabilization	B-T061
.	O
	
the	O
study	O
included	B-T169
16	O
patients	O
,	O
who	O
reported	O
to	O
the	O
department	O
of	O
oral	O
and	O
maxillofacial	O
surgery	O
with	O
the	O
complaint	B-T047
of	O
pain	O
and	O
swelling	B-T033
in	O
the	O
jaws	O
diagnosed	B-T033
as	O
cyst	B-T047
.	O
	
the	O
sample	O
included	B-T169
equal	O
numbers	B-T081
of	O
male	O
and	O
female	O
subjects	O
aged	O
between	O
15	O
and	O
40	O
years	O
.	O
	
panoramic	O
radiographs	O
were	O
taken	O
pre-	B-T079
and	O
postoperatively	B-T079
on	O
day	O
2	O
of	O
the	O
enucleation	B-T061
.	O
	
the	O
dimensions	B-T081
of	O
the	O
cyst	B-T047
were	O
evaluated	O
on	O
the	O
radiograph	O
according	O
to	O
the	O
proforma	B-T169
.	O
	
subsequent	B-T079
radiographs	O
were	O
taken	O
at	O
regular	B-T080
intervals	B-T079
of	O
1.5	O
,	O
3	O
,	O
and	O
6	O
months	O
using	O
standard	B-T081
parameters	O
and	O
were	O
analyzed	O
using	O
mcid	O
analysis	O
software	O
of	O
imaging	O
research	O
.	O
	
mean	B-T081
reduction	B-T061
was	O
seen	O
in	O
up	O
to	O
39	O
and	O
60%	O
in	O
the	O
cystic	B-T080
cavity	O
size	O
and	O
increase	B-T169
in	O
the	O
mean	B-T081
density	B-T081
up	O
to	O
59	O
and	O
90.2	O
at	O
3	O
and	O
6	O
months	O
intervals	B-T079
respectively	O
.	O
	
spontaneous	B-T169
bone	O
regeneration	O
was	O
seen	O
even	O
after	O
primary	B-T080
closure	B-T061
of	O
the	O
large	B-T081
cystic	B-T080
defect	B-T169
without	O
the	O
need	B-T080
for	O
placement	O
of	O
foreign	O
substances	O
or	O
grafts	O
and	O
it	O
also	O
eliminated	B-T080
the	O
complications	O
resulting	B-T169
from	I-T169
placement	O
of	O
foreign	O
substance	O
.	O
	
further	O
studies	O
are	O
required	B-T169
in	O
a	O
larger	B-T081
sample	O
with	O
longer	B-T080
follow-up	O
durations	B-T079
to	O
confirm	B-T080
the	O
outcome	B-T080
of	I-T080
the	I-T080
present	I-T080
work	I-T080
for	O
the	O
benefit	B-T081
of	O
patients	O
.	O
	
the	O
present	B-T079
study	O
depicted	O
that	O
spontaneous	B-T169
bone	O
regeneration	O
can	O
occur	O
with	O
accepted	B-T080
results	B-T033
after	O
simple	B-T080
enucleation	B-T061
of	O
jaw	O
cyst	B-T047
without	O
the	O
aid	B-T080
of	O
any	O
graft	O
material	O
.	O
	
hence	O
,	O
simple	B-T080
enucleation	B-T061
may	O
be	O
considered	B-T078
as	O
a	O
first	B-T061
line	I-T061
of	I-T061
treatment	I-T061
modality	B-T078
for	O
cystic	B-T080
lesion	B-T033
of	O
the	O
jaws	O
.	O
	
this	O
simplifies	O
the	O
surgical	B-T061
procedure	I-T061
,	O
decreases	B-T081
the	O
economic	B-T169
and	O
biologic	B-T080
costs	B-T081
,	O
and	O
reduces	B-T061
the	O
risk	B-T078
of	O
postoperative	O
complications	O
.	O
	
follow-up	O
is	O
necessary	O
along	O
with	O
patient's	O
compliance	O
for	O
the	O
success	B-T080
of	I-T080
treatment	I-T080
.	O
	
membrane	O
protein	O
solubilization	O
and	O
composition	O
of	O
protein	B-T116
detergent	O
complexes	O
membrane	B-T116
proteins	I-T116
are	O
typically	O
expressed	O
in	O
heterologous	B-T080
systems	B-T169
with	O
a	O
view	O
to	O
in	O
vitro	O
characterization	O
.	O
	
a	O
critical	O
step	O
in	O
the	O
preparation	O
of	O
membrane	B-T116
proteins	I-T116
after	O
expression	O
in	O
any	O
system	B-T169
is	O
the	O
solubilization	O
of	O
the	O
protein	O
in	O
aqueous	O
solution	O
,	O
typically	O
using	O
detergents	O
and	O
lipids	B-T109
,	O
to	O
obtain	O
the	O
protein	B-T116
in	O
a	O
form	O
suitable	B-T080
for	O
purification	B-T169
,	O
structural	B-T061
or	O
functional	B-T169
analysis	O
.	O
	
this	O
process	O
is	O
particularly	O
difficult	O
as	O
the	O
objective	O
is	O
to	O
prepare	O
the	O
protein	B-T116
in	O
an	O
unnatural	B-T080
environment	O
,	O
a	O
protein	B-T116
detergent	O
complex	O
,	O
separating	O
it	O
from	O
its	O
natural	B-T169
lipid	B-T109
partners	O
while	O
causing	O
the	O
minimum	B-T080
destabilization	O
or	O
modification	B-T033
of	O
the	O
structure	O
.	O
	
although	O
the	O
process	O
is	O
difficult	B-T080
,	O
and	O
relatively	O
hard	O
to	O
master	O
,	O
an	O
increasing	B-T169
number	O
of	O
membrane	B-T116
proteins	I-T116
have	O
been	O
successfully	B-T169
isolated	I-T169
after	O
expression	O
in	O
a	O
wide	O
variety	O
of	O
systems	B-T169
.	O
	
in	O
this	O
chapter	O
we	O
give	O
a	O
general	O
protocol	O
for	O
preparing	O
protein	B-T116
detergent	O
complexes	O
that	O
is	O
aimed	O
at	O
guiding	O
the	O
reader	O
through	O
the	O
different	O
critical	O
steps	O
.	O
	
in	O
the	O
second	O
part	O
of	O
the	O
chapter	O
we	O
illustrate	O
how	O
to	O
analyze	O
the	O
composition	O
of	O
protein	B-T116
detergent	O
complexes	O
this	O
analysis	O
is	O
important	O
as	O
it	O
has	O
been	O
found	O
that	O
compositional	O
variation	B-T080
can	O
we	O
predict	B-T078
burnout	O
among	O
student	O
nurses	O
an	O
exploration	O
of	O
the	O
icwr-1	O
model	O
of	O
individual	O
psychological	O
resilience	O
the	O
nature	O
of	O
nursing	O
work	O
is	O
demanding	B-T061
and	O
can	O
be	O
stressful	B-T169
.	O
	
previous	O
studies	O
have	O
shown	O
a	O
high	B-T080
rate	B-T081
of	O
burnout	O
among	O
employed	B-T033
nurses	O
.	O
	
recently	O
,	O
efforts	O
have	O
been	O
made	O
to	O
understand	O
the	O
role	O
of	O
resilience	O
in	O
determining	O
the	O
psychological	O
adjustment	O
of	O
employed	B-T033
nurses	O
.	O
	
a	O
theoretical	O
model	O
of	O
resilience	O
was	O
proposed	O
recently	O
that	O
includes	B-T169
several	B-T081
constructs	O
identified	O
in	O
the	O
literature	O
related	O
to	O
resilience	O
and	O
to	O
psychological	O
functioning	O
.	O
	
as	O
nursing	O
students	O
are	O
the	O
future	B-T079
of	O
the	O
nursing	O
workforce	O
it	O
is	O
important	B-T080
to	O
advance	B-T079
our	O
understanding	O
of	O
the	O
determinants	B-T169
of	O
resilience	O
in	O
this	O
population	O
.	O
	
student	O
nurses	O
who	O
had	O
completed	B-T078
their	O
final	B-T079
practicum	O
were	O
invited	O
to	O
participate	O
in	O
an	O
online	O
survey	O
measuring	B-T080
the	O
key	O
constructs	O
of	O
the	O
icwr-1	O
model	O
.	O
	
422	O
students	O
from	O
across	O
australia	O
and	O
canada	O
completed	B-T078
the	O
survey	O
between	O
july	O
2014	O
and	O
july	O
2015	O
.	O
	
as	O
well	O
as	O
several	B-T081
key	O
demographics	B-T078
,	O
trait	B-T033
negative	I-T033
affect	I-T033
,	O
mindfulness	O
,	O
self-efficacy	O
,	O
coping	O
,	O
resilience	O
,	O
and	O
burnout	O
were	O
measured	B-T080
.	O
	
we	O
used	O
structural	O
equation	O
modeling	O
and	O
found	O
support	O
for	O
the	O
major	B-T080
pathways	O
of	O
the	O
model	O
namely	O
that	O
resilience	O
had	O
a	O
significant	B-T078
influence	O
on	O
the	O
relationship	B-T080
between	O
mindfulness	O
,	O
self-efficacy	O
and	O
coping	O
,	O
and	O
psychological	O
adjustment	O
burnout	O
scores	B-T081
.	O
	
furthermore	O
,	O
as	O
predicted	B-T078
,	O
neuroticism	O
moderated	O
the	O
relationship	B-T080
between	O
coping	O
and	O
burnout	O
.	O
	
results	O
are	O
discussed	O
in	O
terms	O
of	O
potential	B-T080
approaches	B-T169
to	O
supporting	O
nursing	O
students	O
who	O
may	O
be	O
at	B-T080
risk	I-T080
of	O
medication	B-T061
intervention	I-T061
for	O
chronic	B-T047
kidney	I-T047
disease	I-T047
patients	O
transitioning	O
from	O
hospital	O
to	O
home	O
study	O
design	O
and	O
baseline	B-T081
characteristics	B-T080
the	O
hospital	O
readmission	O
rate	B-T081
in	O
the	O
population	O
with	O
chronic	B-T047
kidney	I-T047
disease	I-T047
ckd	B-T047
is	O
high	O
and	O
strategies	O
to	O
reduce	O
this	O
risk	B-T078
are	O
urgently	O
needed	B-T080
.	O
	
the	O
ckd	B-T047
-	O
medication	B-T061
intervention	I-T061
trial	I-T061
ckd	B-T047
-	O
mit	B-T061
www.clinicaltrials	O
ncto1459770	O
is	O
a	O
single-blind	O
investigators	O
,	O
randomized	O
,	O
clinical	O
trial	O
conducted	O
at	O
providence	O
health	O
care	O
in	O
spokane	O
,	O
washington	O
.	O
	
study	O
participants	O
are	O
hospitalized	O
patients	O
with	O
ckd	B-T047
stages	B-T079
3-5	O
not	O
treated	B-T061
with	I-T061
kidney	B-T061
replacement	I-T061
therapy	I-T061
and	O
acute	O
illness	O
.	O
	
the	O
study	O
intervention	O
is	O
a	O
pharmacist-led	O
,	O
home-based	O
,	O
medication	O
management	O
intervention	B-T061
delivered	B-T169
within	O
7	O
days	B-T079
after	O
hospital	O
discharge	O
.	O
	
the	O
primary	B-T169
outcome	I-T169
is	O
a	O
composite	O
of	O
hospital	O
readmissions	O
and	O
visits	O
to	O
emergency	O
departments	O
and	O
urgent	O
care	O
centers	O
for	O
90	O
days	B-T079
following	O
hospital	O
discharge	O
.	O
	
secondary	B-T169
outcomes	I-T169
are	O
achievements	O
of	O
guideline-based	O
targets	B-T169
for	O
ckd	B-T047
risk	B-T033
factors	I-T033
and	O
complications	O
.	O
	
enrollment	O
began	O
in	O
february	B-T080
2012	O
and	O
ended	O
in	O
may	B-T079
2015	O
.	O
	
at	O
baseline	B-T081
,	O
the	O
age	O
of	O
participants	O
was	O
69	O
11	O
years	B-T079
mean	O
sd	O
,	O
50%	O
77	O
of	O
155	O
were	O
women	O
,	O
83%	O
117	O
of	O
141	O
had	O
hypertension	B-T047
and	O
56%	O
79	O
of	O
141	O
had	O
diabetes	B-T047
.	O
	
at	O
baseline	B-T081
,	O
the	O
estimated	O
glomerular	O
filtration	O
rate	B-T081
was	O
41	O
14	O
ml/min/1	O
m2	O
and	O
urine	O
albumin-to-creatinine	O
ratio	O
was	O
43	O
mg/g	O
interquartile	B-T081
range	I-T081
8-528	O
mg/g	O
.	O
	
the	O
most	O
frequent	O
diagnosis	O
category	O
for	O
the	O
index	O
hospital	O
admission	O
was	O
cardiovascular	B-T047
diseases	I-T047
at	O
34%	O
53	O
of	O
155	O
,	O
but	O
the	O
most	O
common	O
single	B-T033
diagnosis	I-T033
for	O
admission	O
was	O
community-acquired	B-T080
acute	B-T047
kidney	I-T047
injury	I-T047
at	O
10%	O
16	O
of	O
155	O
.	O
	
participants	O
in	O
ckd	B-T047
-	O
mit	B-T061
are	O
typical	O
of	O
acutely	O
ill	O
hospitalized	O
patients	O
with	O
ckd	B-T047
.	O
	
a	O
medication	O
management	O
intervention	B-T061
after	O
hospital	O
discharge	O
is	O
under	O
study	O
to	O
reduce	B-T080
post	B-T079
-	O
hospitalization	O
acute	O
care	O
utilization	B-T169
and	O
to	O
improve	O
ckd	B-T047
management	O
.	O
	
direct	B-T080
repair	O
of	O
lumbar	O
pars	O
interarticularis	O
defects	B-T169
by	O
utilizing	B-T169
intraoperative	O
o-arm-based	O
navigation	O
and	O
microendoscopic	O
techniques	O
a	O
retrospective	O
analysis	O
of	O
the	O
clinical	B-T033
outcomes	I-T033
of	O
eight	O
patients	O
with	O
the	O
lumbar	O
pars	O
interarticulars	O
defects	B-T169
treated	B-T033
by	O
direct	B-T080
repair	O
with	O
the	O
aid	B-T080
of	O
intraoperative	O
o-arm	O
based	O
navigation	O
and	O
microendoscopic	O
techniques	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
investigate	B-T169
the	O
efficacy	B-T080
and	O
safety	O
of	O
direct	B-T080
screw	O
repair	O
by	O
using	B-T169
minimally	B-T061
invasive	I-T061
surgery	I-T061
for	O
the	O
lumbar	O
pars	O
interarticulars	O
defects	B-T169
in	O
a	O
pilot	O
study	O
.	O
	
direct	B-T080
repair	O
of	O
pars	O
interarticulars	O
defects	B-T169
has	O
been	O
used	B-T169
to	O
treat	B-T061
young	O
adult	O
patients	O
.	O
	
reports	O
concerning	B-T078
direct	B-T080
repair	O
by	O
minimally	B-T061
invasive	I-T061
techniques	I-T061
for	O
pars	O
interarticulars	O
defects	B-T169
are	O
quite	O
rare	B-T080
.	O
	
review	B-T078
of	O
medical	O
records	O
identified	B-T080
eight	O
consecutive	B-T080
patients	O
treated	B-T033
with	O
intraoperative	O
o-arm	O
based	O
navigation	O
and	O
microendoscopic	O
techniques	O
.	O
	
debridement	B-T061
and	O
autograft	B-T061
of	O
pars	O
interarticularis	O
defects	B-T169
was	O
performed	B-T169
under	O
microendoscopic	O
procedure	O
.	O
	
then	O
,	O
percutaneous	O
bilateral	O
intralaminar	O
screws	O
were	O
inserted	O
by	O
utilizing	B-T169
intraoperative	O
navigation	O
.	O
	
the	O
clinical	O
and	O
radiological	O
data	B-T078
were	O
collected	B-T078
and	O
analyzed	O
retrospectively	B-T080
.	O
	
eight	O
patients	O
had	O
a	O
mean	B-T081
age	O
of	O
28.4	O
years	O
,	O
and	O
five	O
were	O
30	O
years	O
or	O
younger	B-T079
at	O
the	O
time	B-T079
of	O
treatment	B-T061
.	O
	
symptoms	O
included	O
axial	O
back	O
pain	O
in	O
100%	O
of	O
patients	O
without	O
concomitant	B-T079
radiculopathy	B-T047
.	O
	
autograft	B-T061
was	O
used	B-T169
in	O
all	O
cases	O
.	O
	
the	O
average	B-T081
follow-up	O
duration	B-T079
was	O
27.4	O
months	O
with	O
a	O
range	B-T081
of	O
20	O
to	O
33	O
months	O
.	O
	
symptoms	O
resolved	B-T033
completely	B-T080
or	O
partially	B-T081
in	O
all	O
patients	O
.	O
	
low	O
back	O
pain	O
visual	O
analog	O
scores	O
decrease	B-T081
from	O
preoperative	B-T079
6.8	O
to	O
postoperative	B-T079
1.4	O
of	O
eight	O
cases	O
.	O
	
of	O
16	O
pars	O
defects	B-T169
,	O
healing	O
was	O
observed	B-T169
in	O
13	O
81.3	O
at	O
last	O
radiological	O
follow-up	O
.	O
	
one	O
patient	O
with	O
bilateral	O
fusion	O
failure	O
refused	O
revision	B-T061
surgery	I-T061
because	O
of	O
mild	B-T033
complaint	I-T033
.	O
	
no	B-T033
complications	I-T033
such	O
as	O
dural	O
tear	O
,	O
nerve	O
root	O
injury	O
,	O
and	O
infection	O
occurred	O
.	O
	
minimally	B-T061
invasive	I-T061
direct	B-T080
repair	O
of	O
the	O
pars	O
interarticularis	O
defects	B-T169
with	O
intralaminar	O
screws	O
by	O
using	B-T169
microendoscopic	O
system	O
and	O
navigation	O
procedure	O
can	O
provide	O
safe	O
and	O
effective	B-T080
treatment	B-T061
of	O
spondylolysis	B-T047
with	O
satisfactory	B-T080
clinical	B-T080
and	O
radiological	O
outcomes	B-T169
,	O
which	O
need	B-T080
some	O
special	O
tools	O
with	O
steep	B-T080
learning	O
curve	O
.	O
	
evidence	B-T078
-based	O
review	O
and	O
survey	O
of	O
expert	O
opinion	O
of	O
reconstruction	B-T061
of	O
metastatic	O
spine	O
tumors	O
systematic	B-T169
review	O
and	O
consensus	O
expert	O
opinion	O
.	O
	
to	O
provide	O
surgeons	O
and	O
other	O
health	O
care	O
professionals	O
with	O
guidelines	O
for	O
surgical	B-T061
reconstruction	I-T061
of	O
metastatic	O
spine	B-T047
disease	I-T047
based	O
on	O
evidence	B-T078
and	O
expert	O
opinion	O
.	O
	
the	O
surgical	B-T061
treatment	I-T061
of	O
spinal	O
metastases	O
is	O
controversial	O
.	O
	
specifically	O
two	O
aspects	O
of	O
surgical	B-T061
reconstruction	I-T061
are	O
addressed	O
in	O
this	O
study	O
i	O
choice	O
of	O
bone	B-T061
graft	I-T061
used	O
during	B-T079
surgery	B-T061
for	O
metastatic	O
spine	O
tumors	O
and	O
ii	O
the	O
design	O
of	O
reconstruction	B-T061
or	O
construct	O
to	O
stabilize	B-T033
.	O
	
a	O
systematic	B-T169
review	O
of	O
the	O
available	B-T169
medical	B-T169
literature	O
from	O
1980	O
to	O
2015	O
was	O
conducted	O
,	O
and	O
combined	B-T080
with	O
consensus	O
expert	O
opinion	O
from	O
a	O
recent	O
survey	O
of	O
spine	O
surgeons	O
who	O
treat	B-T061
metastatic	O
spine	O
tumors	O
.	O
	
there	O
is	O
very	O
little	O
evidence	B-T078
in	O
the	O
literature	O
to	O
provide	O
guidance	O
on	O
the	O
use	B-T169
of	I-T169
bone	B-T061
graft	I-T061
in	O
metastatic	O
tumor	O
reconstruction	B-T061
.	O
	
there	O
is	O
little	O
evidence	B-T078
in	O
the	O
literature	O
to	O
support	O
the	O
preferential	O
use	B-T169
of	I-T169
one	O
graft	O
type	O
over	O
the	O
other	O
.	O
	
approximately	O
,	O
41%	O
of	O
respondents	O
said	O
they	O
used	O
bone	B-T061
graft	I-T061
or	O
bone	B-T061
graft	I-T061
substitutes	O
to	O
accomplish	O
fusion	B-T061
.	O
	
there	O
were	O
17	O
studies	O
that	O
described	O
the	O
use	B-T169
of	I-T169
a	O
prefabricated	O
prosthetic	O
,	O
10	O
studies	O
describing	O
the	O
use	B-T169
of	I-T169
polymethyl	B-T109
methacrylate	I-T109
pmma	B-T109
bone	O
cement	O
,	O
and	O
only	O
three	O
studies	O
describing	O
the	O
use	B-T169
of	I-T169
bone	B-T061
graft	I-T061
for	O
anterior	O
column	O
reconstruction	B-T061
.	O
	
the	O
use	B-T169
of	I-T169
structural	B-T061
allograft	I-T061
was	O
most	O
popular	O
among	O
the	O
experts	O
for	O
anterior	O
reconstruction	B-T061
,	O
followed	B-T079
by	I-T079
cage	O
reconstruction	B-T061
,	O
and	O
pmma	B-T109
bone	O
cement	O
.	O
	
achieving	O
bony	O
union	O
may	O
be	O
of	O
importance	B-T080
for	O
the	O
maintenance	O
of	O
spinal	O
stability	B-T080
in	O
the	O
long	B-T079
term	I-T079
after	O
reconstruction	B-T061
.	O
	
whether	O
bony	O
union	O
is	O
required	B-T169
for	O
patients	O
with	O
shorter	B-T081
life	O
expectancies	O
is	O
debatable	O
.	O
	
the	O
literature	O
supports	O
the	O
use	B-T169
of	I-T169
anterior	O
reconstruction	B-T061
with	O
either	O
a	O
prefabricated	O
prosthetic	O
or	O
pmma	B-T109
bone	O
cement	O
.	O
	
it	O
also	O
supports	O
the	O
use	B-T169
of	I-T169
an	O
anterior	O
construct	O
reinforced	O
with	O
bilateral	O
posterior	O
instrumentation	B-T080
when	O
performing	B-T061
a	O
three-column	B-T061
reconstruction	I-T061
.	O
	
the	O
value	O
of	O
transesophageal	O
echocardiography	O
for	O
embolic	B-T047
strokes	I-T047
of	I-T047
undetermined	I-T047
source	I-T047
our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	O
of	O
transesophageal	O
echocardiography	O
tee	O
in	O
consecutive	O
patients	O
with	O
ischemic	B-T047
stroke	I-T047
is	B-T047
fulfilling	O
the	O
diagnostic	O
criteria	O
of	O
embolic	B-T047
strokes	I-T047
of	I-T047
undetermined	I-T047
source	I-T047
esus	B-T047
.	O
	
we	O
prospectively	O
evaluated	O
consecutive	O
patients	O
with	O
acute	O
is	B-T047
satisfying	O
esus	B-T047
criteria	O
who	O
underwent	O
in-	O
hospital	O
tee	O
examination	O
in	O
3	O
tertiary	O
care	O
stroke	O
centers	O
during	B-T079
a	I-T079
12-month	I-T079
period	I-T079
.	O
	
we	O
also	O
performed	O
a	O
systematic	O
review	O
and	O
meta-analysis	O
estimating	O
the	O
cumulative	O
effect	O
of	O
tee	O
findings	B-T033
on	O
therapeutic	B-T169
management	I-T169
for	O
secondary	B-T061
stroke	I-T061
prevention	I-T061
among	O
different	O
is	B-T047
subgroups	O
.	O
	
we	O
identified	O
61	O
patients	O
with	O
esus	B-T047
who	O
underwent	O
investigation	O
with	O
tee	O
mean	O
age	O
44	O
12	O
years	O
,	O
49%	O
men	O
,	O
median	O
nih	O
stroke	O
scale	O
score	O
=	O
5	O
points	O
interquartile	B-T081
range	I-T081
3-8	O
.	O
	
tee	O
revealed	O
additional	O
findings	B-T033
in	O
52%	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
40%-65%	O
of	O
the	O
study	O
population	O
.	O
	
tee	O
findings	B-T033
changed	O
management	O
initiation	B-T169
of	O
anticoagulation	B-T061
therapy	I-T061
,	O
administration	B-T061
of	O
iv	B-T061
antibiotic	I-T061
therapy	I-T061
,	O
and	O
patent	B-T061
foramen	I-T061
ovale	I-T061
closure	I-T061
in	O
10	O
16%	O
95%	O
ci	B-T081
9%-28%	O
patients	O
.	O
	
the	O
pooled	B-T081
rate	I-T081
of	O
reported	O
anticoagulation	B-T061
therapy	I-T061
attributed	O
to	O
abnormal	B-T033
tee	O
findings	B-T033
among	O
3	O
acute	O
is	B-T047
patients	O
included	O
in	O
the	O
meta-analysis	O
12	O
studies	O
was	O
8.7	O
95%	O
ci	B-T081
7.3	O
.	O
	
in	O
subgroup	O
analysis	O
,	O
the	O
rates	O
of	O
initiation	B-T169
of	O
anticoagulation	B-T061
therapy	I-T061
on	O
the	O
basis	O
of	O
tee	O
investigation	O
did	O
not	O
differ	O
p	O
=	O
0.315	O
among	O
patients	O
with	O
cryptogenic	B-T169
stroke	I-T169
6.9	O
95%	O
ci	B-T081
4.9	O
,	O
esus	B-T047
8.1	O
95%	O
ci	B-T081
3.4	O
,	O
and	O
is	B-T047
9.4	O
95%	O
ci	B-T081
7.5	O
.	O
	
abnormal	O
tee	O
findings	B-T033
may	O
decisively	O
affect	O
the	O
selection	O
of	O
appropriate	B-T080
therapeutic	B-T061
strategy	I-T061
in	O
approximately	O
1	O
of	O
7	O
patients	O
with	O
simultaneous	B-T079
thrombosis	O
of	O
multiple	O
coronary	O
arteries	O
in	O
a	O
patient	O
with	O
rheumatoid	B-T047
arthritis	I-T047
we	O
present	O
a	O
case	B-T169
of	O
simultaneous	B-T079
coronary	B-T047
thrombosis	I-T047
of	I-T047
the	I-T047
left	I-T047
main	I-T047
,	O
the	O
left	O
anterior	O
descending	O
artery	O
and	O
the	O
right	O
coronary	O
artery	O
in	O
a	O
patient	O
,	O
recently	O
diagnosed	O
with	O
rheumatoid	B-T047
arthritis	I-T047
.	O
	
unintentional	O
injuries	O
in	O
children	O
up	O
to	O
six	O
years	B-T079
of	O
age	O
and	O
related	O
parental	O
knowledge	O
,	O
attitudes	O
,	O
and	O
behaviors	O
in	O
italy	O
to	O
describe	O
risk	B-T033
factors	I-T033
associated	B-T080
with	I-T080
unintentional	O
injuries	O
among	O
children	O
aged	O
<6	O
years	B-T079
and	O
to	O
examine	O
parents	O
'	O
level	O
of	O
knowledge	O
,	O
attitudes	O
,	O
and	O
behaviors	O
about	O
pediatric	B-T080
injuries	O
and	O
related	O
preventive	O
measures	O
.	O
	
a	O
cross-sectional	O
survey	O
was	O
conducted	O
between	O
may	B-T079
and	O
july	B-T080
2015	O
on	O
a	O
random	O
sample	O
of	O
794	O
parents	O
of	O
3-	O
to	O
6-year-old	O
children	O
through	O
a	O
self-administered	B-T169
anonymous	O
questionnaire	O
.	O
	
a	O
total	O
of	O
409	O
parents	O
participated	O
.	O
	
two-thirds	O
of	O
the	O
children	O
had	O
experienced	O
at	O
least	O
1	O
unintentional	O
injury	O
in	O
the	O
previous	O
12	O
months	B-T079
.	O
	
more	O
than	O
one-half	O
of	O
these	O
children	O
were	O
boys	O
.	O
	
the	O
leading	B-T033
cause	I-T033
was	O
falls	O
the	O
injuries	O
occurred	O
mainly	O
at	O
home	O
,	O
and	O
only	O
9.2	O
were	O
brought	O
for	O
attention	O
to	O
an	O
emergency	O
department	O
.	O
	
parents	O
who	O
did	O
not	O
believe	O
that	O
it	O
is	O
possible	O
to	O
prevent	O
unintentional	O
injuries	O
were	O
more	O
likely	O
to	O
have	O
had	O
a	O
child	O
injured	B-T169
.	O
	
approximately	O
70%	O
of	O
respondents	O
were	O
aware	O
of	O
security	O
measures	O
to	O
prevent	O
pediatric	B-T080
injuries	O
,	O
and	O
this	O
knowledge	O
was	O
more	O
prevalent	O
in	O
older	O
parents	O
and	O
in	O
those	O
with	O
at	O
least	O
a	O
college	O
level	O
of	O
education	O
compared	O
with	O
those	O
with	O
a	O
middle	O
school	O
education	O
.	O
	
the	O
perceived	O
utility	O
of	O
education	O
about	O
preventive	O
measures	O
of	O
pediatric	B-T080
injuries	O
had	O
a	O
mean	B-T081
value	I-T081
of	O
8.9	O
on	O
a	O
likert	O
scale	O
of	O
1-10	O
1	O
,	O
not	O
useful	O
,	O
to	O
10	O
,	O
very	O
useful	O
and	O
was	O
significantly	O
higher	O
in	O
mothers	O
.	O
	
this	O
study	O
highlights	O
a	O
clear	O
need	O
for	O
public	O
health	O
educational	O
programs	O
for	O
parents	O
regarding	O
prevention	O
of	O
unintentional	O
injuries	O
in	O
children	O
as	O
a	O
valuable	O
tool	O
to	O
increase	O
safety	O
and	O
injury	B-T061
prevention	I-T061
and	O
to	O
reduce	B-T081
risks	B-T078
,	O
because	O
the	O
majority	O
of	O
such	O
injuries	O
occur	O
at	O
truncated	O
bovine	O
integrin	B-T116
alpha-v/beta-6	I-T116
as	O
a	O
universal	O
capture	O
ligand	O
for	O
fmd	B-T047
diagnosis	B-T033
foot-and-mouth	B-T047
disease	I-T047
fmd	B-T047
is	O
endemic	B-T047
in	O
many	O
regions	O
of	O
the	O
world	O
and	O
is	O
one	O
of	O
the	O
most	O
prevalent	O
epizootic	O
animal	B-T047
diseases	I-T047
.	O
	
fmd	B-T047
affects	O
livestock	O
,	O
such	O
as	O
cattle	O
,	O
sheep	O
,	O
goats	O
and	O
pigs	O
,	O
and	O
causes	O
enormous	B-T081
economic	I-T081
losses	I-T081
due	O
to	O
reduced	O
productivity	B-T081
and	O
trade	B-T169
restrictions	I-T169
.	O
	
preparedness	B-T033
and	O
early	O
diagnosis	O
are	O
essential	B-T080
for	O
effective	O
control	O
of	O
fmd	B-T047
.	O
	
many	O
diagnostic	O
assays	O
are	O
dependent	B-T080
on	O
raising	O
high-affinity	B-T080
,	O
anti-fmd	O
virus	O
fmdv	O
serotype-specific	B-T116
antibodies	I-T116
in	O
small	O
animals	O
rabbits	O
and	O
guinea	O
pigs	O
that	O
give	O
broad	O
virus	O
coverage	O
.	O
	
here	O
we	O
show	O
that	O
soluble	B-T080
,	O
truncated	B-T080
forms	I-T080
of	O
bovine	O
αvβ6	B-T116
bind	O
fmdv	O
in	O
an	O
authentic	O
rgd	B-T116
and	O
divalent	O
cation	O
dependent	O
interaction	O
and	O
can	O
be	O
used	O
as	O
the	O
trapping	O
reagent	O
in	O
a	O
fmdv	O
sandwich	O
elisa	O
.	O
	
in	O
addition	O
,	O
inclusion	B-T080
of	O
flag	B-T116
or	O
his	B-T116
tags	I-T116
facilitates	O
simple	O
purification	O
without	O
the	O
loss	B-T081
of	O
virus	O
binding	O
.	O
	
we	O
also	O
provide	O
evidence	B-T078
that	O
when	O
combined	B-T080
with	O
a	O
guinea	O
pig	O
polyclonal	O
serum	O
,	O
or	O
serotype-specific	B-T116
monoclonal	I-T116
antibodies	I-T116
,	O
the	O
integrin	B-T116
can	O
be	O
used	O
to	O
detect	B-T033
viruses	O
representative	O
of	O
all	O
fmdv	O
serotypes	O
.	O
	
we	O
also	O
show	O
that	O
recombinant	O
fmdv	O
empty	O
capsids	O
,	O
with	O
stabilising	O
disulphide	O
bonds	O
,	O
can	O
serve	O
as	O
an	O
antigen	O
in	O
the	O
elisa	O
and	O
can	O
therefore	O
replace	O
inactivated	O
virus	O
antigen	O
as	O
a	O
positive	O
control	O
for	O
the	O
assay	O
.	O
	
our	O
results	O
demonstrate	O
the	O
potential	B-T080
use	O
of	O
bovine	O
αvβ6	B-T116
and	O
fmdv	O
empty	O
capsids	O
in	O
fmd	B-T047
diagnostic	O
assays	O
.	O
	
stress	O
and	O
binge	O
drinking	O
a	O
toxic	O
combination	O
for	O
the	O
teenage	B-T079
brain	O
young	O
adult	O
university	B-T080
students	I-T080
frequently	O
binge	O
on	O
alcohol	O
and	O
have	O
high	B-T080
stress	B-T033
levels	I-T033
.	O
	
based	O
on	O
findings	O
in	O
rodents	O
,	O
we	O
predicted	O
that	O
heavy	B-T033
current	I-T033
alcohol	I-T033
use	I-T033
and	O
elevated	B-T080
stress	O
and	O
depression	B-T033
scores	I-T033
would	O
be	O
associated	B-T080
with	I-T080
deficits	B-T080
on	O
high	B-T080
interference	B-T169
memory	O
tasks	O
,	O
while	O
early	B-T033
onset	I-T033
,	O
prolonged	O
binge	O
patterns	O
would	O
lead	O
to	O
broader	O
cognitive	O
deficits	O
on	O
tests	O
of	O
associative	O
encoding	O
and	O
executive	O
functions	O
.	O
	
we	O
developed	O
the	O
concentration	O
memory	O
task	O
,	O
a	O
novel	O
computerized	O
version	O
of	O
the	O
concentration	O
card	O
game	O
with	O
a	O
high	B-T080
degree	O
of	O
interference	B-T169
.	O
	
we	O
found	O
that	O
young	O
adults	O
with	O
elevated	B-T080
stress	B-T033
,	O
depression	B-T033
,	O
and	O
alcohol	B-T081
consumption	I-T081
scores	I-T081
were	O
impaired	B-T169
in	O
the	O
concentration	O
memory	O
task	O
.	O
	
we	O
also	O
analyzed	O
data	O
from	O
a	O
previous	O
study	O
,	O
and	O
found	O
that	O
higher	B-T080
alcohol	B-T081
consumption	I-T081
scores	I-T081
were	O
associated	B-T080
with	I-T080
impaired	B-T169
performance	O
on	O
another	O
high	B-T080
interference	B-T169
memory	O
task	O
,	O
based	O
on	O
kirwan	O
and	O
stark's	O
mnemonic	O
similarity	O
test	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
adolescent	O
onset	B-T081
of	O
binge	O
drinking	O
predicted	O
poorer	B-T080
performance	O
on	O
broader	O
range	O
of	O
memory	O
tests	O
,	O
including	O
a	O
more	O
systematic	O
test	O
of	O
spatial	O
recognition	O
memory	O
,	O
and	O
an	O
associative	O
learning	O
task	O
.	O
	
our	O
results	B-T033
are	O
broadly	O
consistent	B-T078
with	I-T078
findings	O
in	O
rodents	O
that	O
acute	O
alcohol	O
and	O
stress	O
exposure	O
suppress	B-T169
neurogenesis	O
in	O
the	O
adult	O
hippocampus	O
,	O
which	O
in	O
turn	O
impairs	B-T169
performance	O
in	O
high	B-T080
interference	B-T169
memory	O
tasks	O
,	O
while	O
adolescent	O
onset	B-T081
binge	O
drinking	O
causes	O
more	O
extensive	B-T080
brain	O
damage	O
and	O
cognitive	O
deficits	O
.	O
	
of	O
kindlins	B-T116
and	O
cancer	O
kindlins	B-T116
are	O
4.1	O
ferm	O
domain	O
containing	O
proteins	B-T116
.	O
	
there	O
are	O
three	O
kindlins	B-T116
in	O
mammals	O
,	O
which	O
share	O
high	B-T080
sequence	O
identity	O
.	O
	
kindlin-1	B-T116
is	O
expressed	O
primarily	O
in	O
epithelial	O
cells	O
,	O
kindlin-2	B-T116
is	O
widely	O
distributed	B-T169
and	O
is	O
particularly	O
abundant	B-T080
in	O
adherent	O
cells	O
,	O
and	O
kindlin-3	B-T116
is	O
expressed	O
primarily	O
in	O
hematopoietic	O
cells	O
.	O
	
these	O
distributions	B-T169
are	O
not	O
exclusive	B-T078
some	O
cells	O
express	O
multiple	B-T081
kindlins	B-T116
,	O
and	O
transformed	O
cells	O
often	B-T079
exhibit	O
aberrant	B-T080
expression	O
,	O
both	O
in	O
the	O
isoforms	B-T116
and	O
the	O
levels	B-T080
of	O
kindlins	B-T116
.	O
	
great	O
interest	O
in	O
the	O
kindlins	B-T116
has	O
emerged	O
from	O
the	O
recognition	O
that	O
they	O
play	O
major	B-T080
roles	O
in	O
controlling	O
integrin	B-T116
function	O
.	O
	
in	O
vitro	O
studies	O
,	O
in	O
vivo	O
studies	O
of	O
mice	O
deficient	B-T169
in	O
kindlins	B-T116
,	O
and	O
studies	O
of	O
patients	O
with	O
genetic	B-T169
deficiencies	B-T169
of	O
kindlins	B-T116
have	O
clearly	O
established	B-T080
that	O
they	O
regulate	O
the	O
capacity	B-T081
of	O
integrins	B-T116
to	O
mediate	B-T080
their	O
functions	B-T169
.	O
	
kindlins	B-T116
are	O
adaptor	B-T116
proteins	I-T116
their	O
function	B-T169
emanate	B-T080
from	O
their	O
interaction	B-T169
with	O
binding	O
partners	O
,	O
including	O
the	O
cytoplasmic	O
tails	O
of	O
integrins	B-T116
and	O
components	O
of	O
the	O
actin	O
cytoskeleton	O
.	O
	
the	O
purpose	B-T169
of	O
this	O
review	O
is	O
to	O
provide	O
a	O
brief	B-T079
overview	O
of	O
kindlin	B-T116
structure	B-T116
and	O
function	O
,	O
a	O
consideration	B-T033
of	O
their	O
binding	O
partners	O
,	O
and	O
then	O
to	O
focus	O
on	O
the	O
relationship	B-T080
of	O
each	O
kindlin	B-T116
family	B-T116
member	O
with	O
cancer	O
.	O
	
in	O
view	O
of	O
many	O
correlations	B-T080
of	O
kindlin	B-T116
expression	O
levels	B-T080
and	O
neoplasia	O
and	O
the	O
known	O
association	B-T080
of	O
integrins	B-T116
with	O
tumor	O
progression	O
and	O
metastasis	O
,	O
we	O
consider	B-T078
whether	O
regulation	O
of	O
kindlins	B-T116
or	O
their	O
function	B-T169
would	O
be	O
attractive	B-T080
targets	B-T169
for	O
treatment	B-T061
of	I-T061
cancer	I-T061
.	O
	
preclinical	B-T080
fibrinolysis	O
in	O
patients	O
with	O
st-segment	B-T047
elevation	I-T047
myocardial	I-T047
infarction	I-T047
in	O
a	O
rural	O
region	O
in	O
the	O
current	O
guidelines	O
for	O
the	O
treatment	B-T061
of	O
patients	O
with	O
st-segment	B-T047
elevation	I-T047
myocardial	I-T047
infarction	I-T047
stemi	B-T047
,	O
the	O
european	O
society	O
of	O
cardiology	O
esc	O
recommends	B-T078
preclinical	B-T080
fibrinolysis	O
as	O
a	O
reperfusion	B-T061
therapy	I-T061
if	O
,	O
due	O
to	O
long	O
transportation	B-T078
times	B-T079
,	O
no	O
cardiac	O
catheterisation	O
is	O
available	B-T169
within	O
90-120	O
min	B-T079
.	O
	
however	O
,	O
there	O
is	O
little	O
remaining	B-T080
in-depth	O
expertise	B-T080
in	O
this	O
method	B-T169
because	O
fibrinolysis	O
is	O
presently	B-T078
only	O
rarely	B-T080
indicated	B-T033
.	O
	
in	O
a	O
rural	O
area	O
in	O
southwestern	O
germany	O
,	O
where	O
an	O
emergency	B-T061
primary	I-T061
percutaneous	I-T061
coronary	I-T061
intervention	I-T061
was	O
not	O
routinely	B-T080
available	B-T169
within	O
90-120	O
min	B-T079
,	O
156	O
stemi	B-T047
patients	O
underwent	O
fibrinolysis	O
with	O
the	O
plasminogen	B-T116
activator	I-T116
reteplase	I-T116
,	O
performed	B-T080
by	I-T080
trained	O
emergency	O
physicians	O
.	O
	
the	O
practicality	B-T080
of	O
the	O
treatment	B-T061
,	O
as	O
well	O
as	O
complications	O
and	O
the	O
mortality	B-T081
of	O
the	O
patients	O
in	O
the	O
preclinical	B-T080
phase	B-T079
until	O
arrival	O
at	O
the	O
hospital	O
,	O
were	O
retrospectively	O
studied	O
.	O
	
the	O
mean	B-T079
time	I-T079
from	O
onset	B-T080
of	I-T080
the	O
symptoms	O
to	O
first	O
medical	O
contact	O
was	O
114	O
116	O
min	B-T079
.	O
	
the	O
mean	B-T079
interval	I-T079
to	O
the	O
start	B-T079
of	O
fibrinolysis	O
of	O
13.5	O
6.4	O
min	B-T079
was	O
within	O
the	O
30	O
min	B-T079
mandated	O
by	O
the	O
esc	O
.	O
	
patients	O
with	O
inferior	B-T047
stemi	I-T047
represented	O
the	O
largest	B-T081
subgroup	O
.	O
	
occurring	O
in	O
39	O
cases	O
25	O
%	O
,	O
complications	O
due	O
to	O
infarction	O
were	O
relatively	O
common	B-T081
during	O
the	O
prehospital	O
phase	B-T079
,	O
including	O
15	O
cases	O
9.6	O
%	O
of	O
cardiogenic	O
shock	O
,	O
but	O
in	O
all	O
cases	O
the	O
complications	O
were	O
manageable	B-T033
.	O
	
no	O
patient	O
died	B-T033
before	O
arrival	O
at	O
the	O
hospital	O
.	O
	
as	O
lysis	O
-	O
associated	B-T080
adverse	O
effects	O
,	O
merely	O
two	O
uncomplicated	B-T080
mucosal	O
haemorrhages	O
and	O
one	O
case	O
of	O
mild	B-T047
allergic	I-T047
skin	I-T047
reactions	I-T047
were	O
seen	B-T080
.	O
	
in	O
emergency	O
situations	O
with	O
long	O
transportation	B-T078
times	B-T079
to	O
the	O
nearest	O
suitable	B-T080
cardiac	O
catheterisation	O
laboratory	O
,	O
preclinical	B-T080
fibrinolysis	O
in	O
stemi	B-T047
still	O
represents	O
a	O
workable	B-T169
method	I-T169
.	O
	
success	O
of	O
this	O
strategy	O
requires	O
particularly	O
strong	O
training	O
of	O
the	O
emergency	O
physicians	O
in	O
ecg	O
and	O
lysis	O
therapy	B-T061
,	O
and	O
co-operation	O
with	O
nearby	O
cardiac	O
centres	O
.	O
	
a	O
method	B-T169
of	O
providing	O
engaging	O
formative	O
feedback	O
to	O
large	B-T081
cohort	O
first-year	B-T079
physiology	O
and	O
anatomy	O
students	O
a	O
growing	O
body	O
of	O
evidence	B-T078
demonstrates	O
a	O
critical	B-T080
role	O
for	O
effective	B-T080
,	O
meaningful	B-T080
feedback	O
to	O
enhance	O
student	O
learning	O
.	O
	
effective	B-T080
feedback	O
can	O
become	O
part	O
of	O
the	O
learning	O
cycle	B-T079
that	O
is	O
not	O
only	O
a	O
learning	O
opportunity	O
for	O
the	O
student	O
but	O
can	O
also	O
be	O
used	O
to	O
inform	O
the	O
teacher	O
and	O
ongoing	B-T078
curriculum	O
development	O
.	O
	
feedback	O
is	O
considered	B-T078
particularly	O
important	B-T080
during	B-T079
the	O
first	B-T079
year	I-T079
of	O
university	O
and	O
can	O
even	O
be	O
viewed	O
as	O
a	O
retention	B-T169
strategy	O
that	O
can	O
help	O
attenuate	O
student	O
performance	O
anxieties	O
and	O
solidify	B-T080
perceptions	O
of	O
academic	O
support	O
.	O
	
unfortunately	O
,	O
the	O
provision	O
of	O
individualized	B-T080
,	O
timely	B-T080
feedback	O
can	O
be	O
particularly	O
challenging	O
in	O
first-year	B-T079
courses	O
as	O
they	O
tend	O
to	O
be	O
large	B-T081
and	O
diverse	B-T080
cohort	O
classes	O
that	O
pose	O
challenges	O
of	O
time	B-T079
and	O
logistics	O
.	O
	
various	O
forms	O
of	O
generic	O
feedback	O
can	O
provide	O
rapid	B-T080
and	O
cost-effect	B-T081
feedback	O
to	O
large	B-T081
cohorts	O
but	O
may	O
be	O
of	O
limited	B-T169
benefit	B-T081
to	O
students	O
other	O
than	O
signaling	O
weaknesses	B-T033
in	O
knowledge	O
.	O
	
the	O
present	B-T033
study	O
describes	B-T078
a	O
method	B-T169
that	O
was	O
used	O
to	O
provide	O
formative	O
task-related	O
feedback	O
to	O
a	O
large	B-T081
cohort	O
of	O
first-year	B-T079
physiology	O
and	O
anatomy	O
students	O
.	O
	
based	O
on	O
student	O
evaluations	O
presented	B-T078
in	O
this	O
study	O
,	O
this	O
method	B-T169
provided	O
feedback	O
in	O
a	O
manner	O
that	O
engaged	O
students	O
,	O
uncovered	B-T169
underlying	B-T033
misconceptions	I-T033
,	O
facilitated	O
peer	O
discussion	O
,	O
and	O
provided	O
opportunity	O
for	O
new	B-T080
instruction	O
while	O
allowing	O
the	O
lecturer	O
to	O
recognize	O
common	B-T081
gaps	O
in	O
knowledge	O
and	O
inform	O
ongoing	B-T078
curriculum	O
development	O
.	O
	
sirt2	B-T116
deacetylates	O
and	O
inhibits	O
the	O
peroxidase	O
activity	O
of	O
peroxiredoxin-1	B-T116
to	O
sensitize	O
breast	O
cancer	O
cells	O
to	O
oxidant	O
stress	O
-	O
inducing	B-T169
agents	O
sirt2	B-T116
is	O
a	O
protein	O
deacetylase	O
with	O
tumor	O
suppressor	O
activity	O
in	O
breast	O
and	O
liver	O
tumors	O
where	O
it	O
is	O
mutated	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	B-T033
activity	I-T033
are	O
not	O
fully	O
defined	O
.	O
	
here	O
we	O
demonstrate	O
that	O
sirt2	B-T116
binds	O
,	O
deacetylates	O
,	O
and	O
inhibits	O
the	O
peroxidase	O
activity	O
of	O
the	O
antioxidant	B-T116
protein	I-T116
peroxiredoxin	I-T116
prdx-1	B-T116
in	O
breast	O
cancer	O
cells	O
.	O
	
ectopic	O
overexpression	O
of	O
sirt2	B-T116
,	O
but	O
not	O
its	O
catalytically	O
dead	O
mutant	O
,	O
increased	B-T081
intracellular	O
levels	O
of	O
reactive	O
oxygen	O
species	O
ros	O
induced	O
by	O
hydrogen	O
peroxide	O
,	O
which	O
led	O
to	O
increased	B-T081
levels	B-T080
of	O
an	O
overoxidized	B-T116
and	I-T116
multimeric	I-T116
form	I-T116
of	I-T116
prdx-1	I-T116
with	O
activity	B-T116
as	I-T116
a	I-T116
molecular	I-T116
chaperone	I-T116
.	O
	
elevated	B-T080
levels	B-T080
of	O
sirt2	O
sensitized	O
breast	O
cancer	O
cells	O
to	O
intracellular	O
dna	O
damage	O
and	O
cell	O
death	O
induced	O
by	O
oxidative	O
stress	O
,	O
as	O
associated	O
with	O
increased	B-T081
levels	B-T080
of	O
nuclear	B-T116
foxo3a	I-T116
and	O
the	O
proapoptotic	B-T116
bim	I-T116
protein	I-T116
.	O
	
in	O
addition	O
,	O
elevated	B-T080
levels	B-T080
of	O
sirt2	B-T116
sensitized	O
breast	O
cancer	O
cells	O
to	O
arsenic	O
trioxide	O
,	O
an	O
approved	O
therapeutic	O
agent	O
,	O
along	O
with	O
other	O
intracellular	O
ros	O
-	O
inducing	O
agents	O
.	O
	
conversely	O
,	O
antisense	O
rna	O
-	O
mediated	O
attenuation	O
of	O
sirt2	B-T116
reversed	B-T169
ros	O
-	O
induced	O
toxicity	O
as	O
demonstrated	O
in	O
a	O
zebrafish	O
embryo	O
model	O
system	O
.	O
	
collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	O
activity	O
of	O
sirt2	B-T116
requires	O
its	O
ability	O
to	O
restrict	B-T169
the	O
antioxidant	O
activity	O
of	O
prdx-1	B-T116
,	O
thereby	O
sensitizing	O
breast	O
cancer	O
cells	O
to	O
ros	O
-	O
induced	O
dna	O
damage	O
and	O
cell	O
cytotoxicity	O
.	O
	
on	O
the	O
development	B-T169
of	O
conjunctival	B-T047
hyperemia	I-T047
computer-assisted	O
diagnosis	O
tools	O
influence	O
of	O
feature	B-T080
selection	O
and	O
class	O
imbalance	O
in	O
automatic	O
gradings	O
the	O
sudden	O
increase	O
of	O
blood	O
flow	O
in	O
the	O
bulbar	O
conjunctiva	O
,	O
known	O
as	O
hyperemia	B-T047
,	O
is	O
associated	O
to	O
a	O
red	O
hue	O
of	O
variable	B-T080
intensity	B-T080
.	O
	
experts	O
measure	O
hyperemia	B-T047
using	O
levels	O
in	O
a	O
grading	O
scale	O
,	O
a	O
procedure	O
that	O
is	O
subjective	O
,	O
non-repeatable	O
and	O
time	B-T080
consuming	I-T080
,	O
thus	O
creating	O
a	O
need	O
for	O
its	O
automatisation	O
.	O
	
however	O
,	O
the	O
task	O
is	O
far	O
from	O
straightforward	B-T080
due	O
to	O
data	O
issues	O
such	O
as	O
class	O
imbalance	O
or	O
correlated	B-T080
features	B-T080
.	O
	
in	O
this	O
paper	O
,	O
we	O
study	O
the	O
specific	O
features	B-T080
of	O
hyperemia	B-T047
and	O
propose	O
various	O
approaches	O
to	O
address	O
these	O
problems	O
in	O
the	O
context	O
of	O
an	O
automatic	O
framework	O
for	O
hyperemia	B-T047
grading	B-T033
.	O
	
oversampling	O
,	O
undersampling	O
and	O
smote	O
approaches	O
were	O
applied	O
in	O
order	O
to	O
tackle	O
the	O
problem	O
of	O
class	O
imbalance	O
.	O
	
25	O
features	O
were	O
computed	O
for	O
each	O
image	O
and	O
regression	O
methods	O
were	O
then	O
used	O
to	O
transform	O
them	O
into	O
a	O
value	O
on	O
the	O
grading	O
scale	O
.	O
	
the	O
values	O
and	O
relationships	O
among	O
features	B-T080
and	O
experts'	B-T033
values	I-T033
were	O
analysed	O
,	O
and	O
five	O
feature	B-T080
selection	O
techniques	O
were	O
subsequently	O
studied	O
.	O
	
the	O
lowest	B-T081
mean	I-T081
square	I-T081
error	I-T081
mse	B-T081
for	O
the	O
regression	O
systems	O
trained	O
with	O
individual	O
features	O
is	O
below	O
0.1	O
for	O
both	O
scales	O
.	O
	
multi-layer	O
perceptron	O
mlp	O
obtains	O
the	O
best	O
values	O
,	O
but	O
is	O
less	O
consistent	O
than	O
the	O
random	O
forest	O
rf	O
method	O
.	O
	
when	O
all	O
features	O
are	O
combined	O
,	O
the	O
best	O
results	O
for	O
both	O
scales	O
are	O
achieved	O
with	O
mlp	O
.	O
	
correlation	O
based	O
feature	O
selection	O
cfs	O
and	O
m5	O
provide	O
the	O
best	O
results	O
,	O
mse	B-T081
=0	O
and	O
mse	B-T081
=0	O
respectively	O
.	O
	
finally	O
,	O
the	O
class	O
imbalance	O
problem	O
is	O
minimised	O
with	O
the	O
smote	O
approach	O
for	O
both	O
scales	O
mse	B-T081
<0	O
.	O
	
machine	O
learning	O
methods	O
are	O
able	O
to	O
perform	O
an	O
objective	O
assessment	O
of	O
hyperemia	B-T047
grading	B-T033
,	O
removing	O
both	O
intra-	B-T080
and	I-T080
inter-expert	I-T080
subjectivity	I-T080
while	O
providing	O
a	O
gain	O
in	O
computation	O
time	B-T079
.	O
	
smote	O
and	O
oversampling	O
approaches	O
minimise	O
the	O
class	O
imbalance	O
problem	O
,	O
while	O
feature	B-T080
selection	O
reduces	O
the	O
number	O
of	O
features	B-T080
from	O
25	O
to	O
3-5	O
without	O
worsening	O
the	O
mse	B-T081
.	O
	
as	O
the	O
differences	O
between	O
the	O
system	O
and	O
a	O
human	O
expert	O
are	O
similar	O
to	O
the	O
differences	O
between	O
experts	O
,	O
we	O
can	O
therefore	O
conclude	O
that	O
the	O
system	O
behaves	O
like	O
an	O
medication	O
,	O
rehabilitation	B-T169
and	O
health	O
care	O
consumption	O
in	O
adults	O
with	O
cerebral	B-T047
palsy	I-T047
a	O
population	O
based	O
study	O
to	O
evaluate	O
medication	O
,	O
rehabilitation	B-T169
and	O
healthcare	O
consumption	O
in	O
adults	O
with	O
cp	B-T047
as	O
a	O
function	B-T169
of	O
gross	O
motor	O
function	O
classification	O
system	O
gmfcs	O
level	O
.	O
	
questionnaire	O
-based	O
cross-sectional	O
study	O
.	O
	
brittany	O
,	O
a	O
french	O
county	O
.	O
	
adults	O
with	O
cerebral	B-T047
palsy	I-T047
.	O
	
questionnaires	O
relating	O
to	O
drugs	O
,	O
orthotic	O
devices	O
,	O
mobility	O
aids	O
,	O
rehabilitation	B-T169
and	O
medical	B-T033
input	I-T033
were	O
sent	B-T169
to	O
435	O
members	O
of	O
a	O
unique	B-T080
regional	O
french	O
network	B-T169
dedicated	O
to	O
adults	O
with	O
cerebral	B-T047
palsy	I-T047
.	O
	
the	O
questionnaire	O
was	O
completed	B-T080
by	O
the	O
participant	O
or	O
a	O
helper	O
if	O
necessary	O
.	O
	
of	O
the	O
282	O
responders	B-T033
,	O
7.8	O
had	O
a	O
gmfcs	O
level	O
of	O
i	O
,	O
14.2	O
ii	O
,	O
17.7	O
iii	O
,	O
29.1	O
iv	O
and	O
31.2	O
v	O
.	O
	
participants	O
consumed	O
a	O
large	O
amount	O
of	O
healthcare	O
.	O
	
almost	B-T081
three-quarters	I-T081
took	O
orally	O
administered	O
drugs	O
,	O
of	O
which	O
antispastic	O
and	O
antiepileptic	O
drugs	O
were	O
among	O
the	O
most	B-T079
frequent	I-T079
.	O
	
nearly	O
all	O
patients	O
had	O
at	O
least	O
one	O
type	O
of	O
rehabilitation	B-T169
,	O
87.2	O
had	O
physiotherapy	B-T061
,	O
78%	O
used	O
at	O
least	O
one	O
mobility	O
aid	O
and	O
69.5	O
used	O
at	O
least	O
one	O
orthotic	O
device	O
.	O
	
the	O
frequency	B-T079
of	O
numerous	O
inputs	O
increased	O
with	O
gmfcs	O
level	O
.	O
	
specificities	B-T081
were	O
found	B-T033
for	O
each	O
gmfcs	O
level	O
,	O
e.g	O
.	O
	
participants	O
with	O
gmfcs	O
level	O
iv	O
and	O
v	O
had	O
a	O
high	B-T080
level	I-T080
of	O
medical	B-T033
input	I-T033
and	O
a	O
greater	B-T169
use	I-T169
of	I-T169
trunk-supporting	O
devices	O
,	O
antireflux	B-T061
and	O
laxative	O
.	O
	
profiles	B-T081
could	O
be	O
established	O
based	O
on	O
gmfcs	O
levels	O
.	O
	
adults	O
with	O
cerebral	B-T047
palsy	I-T047
use	O
a	O
large	B-T081
amount	I-T081
of	O
drugs	O
,	O
mobility	O
aids	O
,	O
orthotic	O
devices	O
,	O
rehabilitation	B-T169
and	O
medical	B-T033
input	I-T033
.	O
	
healthcare	O
is	O
targeted	B-T169
at	O
cerebral	B-T047
palsy	I-T047
-related	O
issues	O
.	O
	
gmfcs	O
is	O
a	O
determinant	O
of	O
healthcare	O
consumption	O
and	O
thus	O
a	O
useful	O
tool	O
for	O
clinical	O
practice	O
to	O
target	O
care	O
appropriately	B-T080
transcriptome	O
sequencing	O
and	O
de	B-T078
novo	I-T078
characterization	O
of	O
korean	O
endemic	O
land	O
snail	O
,	O
koreanohadra	O
kurodana	O
for	O
functional	O
transcripts	O
and	O
ssr	O
markers	O
the	O
korean	O
endemic	O
land	O
snail	O
koreanohadra	O
kurodana	O
gastropoda	O
bradybaenidae	O
found	O
in	O
humid	O
areas	O
of	O
broadleaf	O
forests	O
and	O
shrubs	O
have	O
been	O
considered	O
vulnerable	O
as	O
the	O
number	O
of	O
individuals	O
are	O
declining	O
in	O
recent	O
years	B-T079
.	O
	
the	O
species	O
is	O
poorly	O
characterized	O
at	O
the	O
genomic	O
level	O
that	O
limits	O
the	O
understanding	O
of	O
functions	B-T169
at	O
the	O
molecular	B-T080
and	O
genetics	B-T169
level	I-T169
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
performed	O
de	B-T078
novo	I-T078
transcriptome	O
sequencing	O
to	O
produce	O
a	O
comprehensive	O
transcript	O
dataset	O
of	O
visceral	O
mass	O
tissue	O
of	O
k	O
.	O
	
kurodana	O
by	O
the	O
illumina	O
paired-end	O
sequencing	O
technology	O
.	O
	
over	O
234	O
million	O
quality	O
reads	O
were	O
assembled	O
to	O
a	O
total	O
of	O
315	O
contigs	O
and	O
191	O
unigenes	O
,	O
with	O
an	O
average	O
and	O
n50	O
length	B-T081
of	O
585.6	O
and	O
715	O
bp	O
and	O
678	O
and	O
927	O
bp	O
,	O
respectively	O
.	O
	
overall	O
,	O
36.32	O
%	O
of	O
the	O
unigenes	O
found	O
matches	O
to	O
known	O
protein	O
/	O
nucleotide	O
sequences	O
in	O
the	O
public	O
databases	O
.	O
	
the	O
direction	O
of	O
the	O
unigenes	O
to	O
functional	O
categories	O
was	O
determined	O
using	O
cog	O
,	O
go	O
,	O
kegg	O
,	O
and	O
interproscan	O
protein	O
domain	O
search	O
.	O
	
the	O
go	O
analysis	O
search	O
resulted	O
in	O
22	O
unigenes	O
12.02	O
%	O
being	O
categorized	O
into	O
40	O
functional	O
groups	O
.	O
	
the	O
kegg	O
annotation	O
revealed	O
that	O
metabolism	B-T169
pathway	I-T169
genes	O
were	O
enriched	O
.	O
	
the	O
most	O
prominent	O
protein	O
motifs	O
include	O
the	O
zinc	O
finger	O
,	O
ribonuclease	B-T116
h	I-T116
,	O
reverse	B-T116
transcriptase	I-T116
,	O
and	O
ankyrin	O
repeat	O
domains	O
.	O
	
the	O
simple	O
sequence	O
repeats	O
ssrs	O
identified	O
from	O
>1	O
kb	O
length	B-T081
of	O
unigenes	O
show	O
a	O
dominancy	O
of	O
dinucleotide	O
repeat	O
motifs	O
followed	O
with	O
tri-	O
and	O
tetranucleotide	O
motifs	O
.	O
	
a	O
number	O
of	O
unigenes	O
were	O
putatively	O
assessed	O
to	O
belong	O
to	O
adaptation	O
and	O
defense	O
mechanisms	O
including	O
heat	B-T116
shock	I-T116
proteins	I-T116
70	I-T116
,	O
toll-like	B-T116
receptor	I-T116
4	I-T116
,	O
amp-activated	B-T116
protein	I-T116
kinase	I-T116
,	O
aquaporin-2	B-T116
,	O
etc	O
.	O
	
our	O
data	O
provide	O
a	O
rich	O
source	O
for	O
the	O
identification	B-T080
and	O
functional	O
characterization	O
of	O
new	O
genes	O
and	O
candidate	O
polymorphic	B-T080
ssr	O
markers	O
in	O
k	O
.	O
	
kurodana	O
.	O
	
the	O
availability	O
of	O
transcriptome	O
information	O
http	O
would	O
promote	O
the	O
utilization	O
of	O
the	O
resources	O
for	O
phylogenetics	O
study	O
and	O
genetic	O
diversity	O
assessment	O
.	O
	
prediction	B-T078
of	O
estrogenic	B-T109
bioactivity	O
of	O
environmental	O
chemical	O
metabolites	O
the	O
us	O
environmental	O
protection	O
agency's	O
epa	O
endocrine	O
disruptor	O
screening	O
program	O
edsp	O
is	O
using	O
in	B-T078
vitro	I-T078
data	I-T078
generated	O
from	O
toxcast	O
/	O
tox21	O
high-throughput	O
screening	O
assays	O
to	O
assess	O
the	O
endocrine	O
activity	O
of	O
environmental	O
chemicals	O
.	O
	
considering	O
that	O
in	O
vitro	O
assays	O
may	O
have	O
limited	O
metabolic	B-T169
capacity	I-T169
,	O
inactive	O
chemicals	O
that	O
are	O
biotransformed	O
into	O
metabolites	O
with	O
endocrine	O
bioactivity	O
may	O
be	O
missed	O
for	O
further	O
screening	B-T169
and	O
testing	B-T169
.	O
	
therefore	O
,	O
there	O
is	O
a	O
value	O
in	O
developing	O
novel	O
approaches	O
to	O
account	O
for	O
metabolism	O
and	O
endocrine	O
activity	O
of	O
both	O
parent	O
chemicals	O
and	O
their	O
associated	O
metabolites	O
.	O
	
we	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	O
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	B-T109
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	B-T109
activity	O
.	O
	
three	O
er	B-T116
qsar	B-T081
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	B-T109
bioactivity	O
of	O
the	O
parent	O
compounds	O
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	B-T169
of	O
the	O
parent	O
chemical	O
and	O
metabolites	O
.	O
	
the	O
metabolite	O
prediction	O
software	O
correctly	O
identified	O
known	O
estrogenic	B-T109
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	O
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	B-T109
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	O
.	O
	
the	O
qsar	B-T081
models	O
estimated	O
stronger	O
estrogenic	B-T109
activity	O
for	O
the	O
majority	O
of	O
the	O
known	O
estrogenic	B-T109
metabolites	O
compared	O
to	O
their	O
parent	O
chemicals	O
.	O
	
finally	O
,	O
the	O
three	O
models	O
identified	O
a	O
similar	O
set	O
of	O
parent	O
compounds	O
as	O
top	O
ranked	O
chemicals	O
based	O
on	O
the	O
estrogenicity	B-T169
of	O
putative	O
metabolites	O
.	O
	
this	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	B-T033
of	O
chemicals	O
with	O
estrogenic	B-T109
metabolites	O
and	O
may	O
reduce	O
potential	O
false	O
negative	O
results	O
from	O
in	O
vitro	O
assays	O
.	O
	
effects	B-T080
of	I-T080
application	B-T169
of	O
social	O
marketing	O
theory	B-T078
and	O
the	O
health	O
belief	O
model	O
in	O
promoting	O
cervical	B-T061
cancer	I-T061
screening	I-T061
among	O
targeted	B-T169
women	O
in	O
sisaket	O
province	O
,	O
thailand	O
cervical	O
cancer	O
is	O
a	O
major	B-T080
public	B-T033
health	I-T033
problem	I-T033
in	O
thailand	O
,	O
being	O
ranked	O
second	O
only	O
to	O
breast	O
cancer	O
.	O
	
thai	O
women	O
have	O
been	O
reported	O
to	O
have	O
a	O
low	B-T080
rate	B-T081
of	O
cervical	B-T061
cancer	I-T061
screening	I-T061
27.7	O
of	O
the	O
80%	O
goal	O
of	O
who	O
.	O
	
we	O
therefore	O
aimed	B-T078
to	O
apply	B-T169
the	O
social	O
marketing	O
theory	B-T078
and	O
health	O
belief	O
model	O
in	O
promoting	O
cervical	B-T061
cancer	I-T061
screening	I-T061
in	O
kanthararom	O
district	O
,	O
sisaket	O
province	O
.	O
	
a	O
total	B-T080
of	O
92	O
from	O
974	O
targeted	B-T169
women	O
aged	O
3060	O
years	B-T079
were	O
randomly	O
divided	B-T169
into	O
two	O
groups	B-T078
.	O
	
the	O
experimental	O
group	O
underwent	O
application	B-T169
of	O
social	O
marketing	O
theory	B-T078
and	O
a	O
health	O
belief	O
model	O
program	B-T169
promoting	O
cervical	B-T061
cancer	I-T061
screening	I-T061
while	O
the	O
control	O
group	O
received	B-T080
normal	O
services	O
.	O
	
two	O
research	O
tools	O
were	O
used	O
1	O
application	B-T169
of	O
social	O
marketing	O
theory	B-T078
and	O
health	O
belief	O
model	O
program	B-T169
and	O
2	O
questionnaire	O
used	O
to	O
evaluate	O
perceptions	O
of	O
cervical	O
cancer	O
.	O
	
descriptive	O
and	O
inferential	B-T081
statistics	I-T081
including	B-T169
paired	B-T080
sample	O
ttest	O
and	O
independent	B-T169
ttest	O
were	O
used	O
to	O
analyze	O
the	O
data	O
.	O
	
after	O
the	O
program	B-T169
had	O
been	O
used	O
,	O
the	O
mean	B-T033
score	I-T033
of	O
perception	O
of	O
cervical	O
cancer	O
of	O
experimental	O
group	O
was	O
at	O
a	O
higher	B-T080
level	B-T080
x=4	O
s.d	B-T081
.	O
	
=0	O
,	O
than	O
in	O
the	O
control	O
group	O
x=3	O
s.d	B-T081
.	O
	
=0	O
with	O
statistical	B-T081
significance	I-T081
p<0	O
.	O
	
this	O
research	O
demonstrated	O
an	O
appropriate	B-T080
communication	O
process	O
in	O
behavioral	O
modification	B-T169
to	O
prevent	O
cervical	O
cancer	O
.	O
	
it	O
can	O
be	O
recommended	B-T078
that	O
this	O
program	B-T169
featuring	B-T080
social	O
marketing	O
and	O
the	O
health	O
belief	O
model	O
be	O
used	O
to	O
promote	O
cervical	B-T061
cancer	I-T061
screening	I-T061
in	O
targeted	B-T169
women	O
and	O
it	O
can	O
be	O
promoted	O
as	O
a	O
guideline	O
for	O
other	O
health	O
services	O
,	O
especially	O
in	O
health	O
promotion	O
and	O
disease	B-T061
prevention	I-T061
.	O
	
visualization	O
of	O
the	O
intimal	O
flap	O
in	O
intracranial	O
arterial	O
dissection	O
using	O
high-resolution	O
3t	O
mri	O
presence	B-T033
of	O
an	O
intimal	O
flap	O
is	O
a	O
critical	B-T080
imaging	O
finding	O
in	O
diagnosing	B-T033
intracranial	O
artery	O
dissection	O
icad	O
.	O
	
recent	O
reports	O
showed	O
that	O
high-resolution	O
magnetic	O
resonance	O
imaging	O
mri	O
was	O
better	B-T080
at	O
identifying	O
intimal	O
flaps	O
as	O
compared	O
with	O
routine	O
mri	O
techniques	O
used	O
in	O
clinical	O
settings	O
.	O
	
however	O
,	O
no	O
current	O
standardized	O
sequence	B-T169
for	O
high-resolution	O
mri	O
without	O
gadolinium	O
enhancement	O
produces	O
images	B-T078
of	O
satisfactory	O
quality	B-T080
with	O
clinically	O
tolerable	O
scanning	O
times	B-T079
.	O
	
this	O
study	O
evaluated	O
a	O
nonenhanced	O
high-resolution	O
fast	O
spin	O
echo	O
hr-fse	O
mri	O
sequence	B-T169
for	O
visualizing	O
intimal	O
flaps	O
in	O
patients	O
with	O
icad	O
.	O
	
three	O
patients	O
with	O
icad	O
underwent	O
plain	O
mri	O
examination	O
using	O
a	O
2-dimensional	O
t2-weighted	O
fse	O
imaging	O
sequence	B-T169
optimized	O
for	O
our	O
3t	B-T169
system	I-T169
in-plane	O
pixel	O
size	O
,	O
23	O
mm	O
23	O
mm	O
slice	O
thickness	O
3	O
mm	O
with	O
no	O
interslice	O
gap	O
,	O
as	O
well	O
as	O
scanning	O
with	O
conventional	B-T080
modalities	B-T078
,	O
including	O
ct	O
angiography	O
,	O
magnetic	O
resonance	O
angiography	O
,	O
and	O
digital	O
subtraction	O
angiography	O
.	O
	
we	O
assessed	O
whether	O
these	O
imaging	B-T169
methods	I-T169
could	O
visualize	O
an	O
intimal	O
flap	O
and/or	O
double	B-T033
lumen	I-T033
sign	I-T033
in	O
the	O
participants	O
and	O
compared	O
the	O
results	B-T033
between	O
hr-fse	O
and	O
the	O
other	O
modalities	B-T078
.	O
	
hr-fse	O
images	B-T078
clearly	O
showed	O
intimal	O
flaps	O
and	O
double	B-T033
lumen	I-T033
signs	I-T033
in	O
all	O
3	O
patients	O
,	O
whereas	O
the	O
conventional	B-T080
modalities	B-T078
identified	B-T080
a	O
double	B-T033
lumen	I-T033
sign	I-T033
in	O
only	O
2	O
of	O
the	O
3	O
patients	O
.	O
	
the	O
present	O
method	O
of	O
optimized	O
hr-fse	O
imaging	O
with	O
a	O
3t	B-T169
system	I-T169
improved	B-T033
visualization	O
of	O
intimal	O
flaps	O
and	O
should	O
thus	O
be	O
considered	O
for	O
assessing	O
patients	O
with	O
suspected	B-T078
icad	O
that	O
cannot	O
be	O
definitively	O
diagnosed	B-T033
by	O
conventional	B-T080
imaging	B-T169
modalities	I-T169
.	O
	
quantification	B-T081
of	O
intact	B-T080
plasma	O
agt	B-T116
consisting	O
of	O
oxidized	O
and	O
reduced	O
conformations	O
using	O
a	O
modified	O
elisa	O
the	O
pleiotropic	O
actions	O
of	O
the	O
renin-angiotensin	O
system	O
ras	O
depend	O
on	O
the	O
availability	B-T169
of	I-T169
angiotensinogen	B-T116
agt	B-T116
which	O
generates	O
angiotensin	B-T116
i	I-T116
ang	B-T116
i	I-T116
when	O
cleaved	O
by	O
renin	B-T116
.	O
	
thus	O
,	O
quantification	B-T081
of	O
the	O
intact	B-T080
agt	B-T116
iagt	B-T116
concentrations	B-T081
is	O
important	B-T080
to	O
evaluate	O
the	O
actual	B-T080
renin	B-T116
substrate	I-T116
available	B-T169
.	O
	
the	O
iagt	B-T116
conformation	O
exists	O
as	O
oxidized	B-T116
agt	I-T116
oxi-agt	B-T116
and	O
reduced	B-T116
agt	I-T116
red-agt	B-T116
in	O
a	O
disulfide	O
bond	O
,	O
and	O
oxi-agt	B-T116
has	O
a	O
higher	B-T080
affinity	O
for	O
renin	B-T116
,	O
which	O
may	O
exacerbate	O
ras	O
-	O
associated	O
diseases	O
.	O
	
accordingly	O
,	O
we	O
determined	B-T080
iagt	B-T116
,	O
oxi-agt	B-T116
,	O
and	O
red-agt	B-T116
levels	B-T080
in	O
plasma	O
from	O
rats	O
and	O
mice	O
.	O
	
blood	O
samples	O
were	O
obtained	B-T169
by	O
cardiac	O
puncture	O
and	O
then	O
immediately	B-T079
mixed	B-T169
with	O
an	O
inhibitor	O
solution	O
containing	B-T169
a	O
renin	O
inhibitor	O
.	O
	
total	B-T080
agt	B-T116
tagt	B-T116
levels	B-T080
were	O
measured	B-T080
by	O
tagt	B-T116
elisa	O
which	O
detects	B-T033
both	O
cleaved	O
and	O
iagt	B-T116
.	O
	
iagt	B-T116
levels	B-T080
were	O
determined	B-T080
by	I-T080
iagt	B-T116
elisa	O
which	O
was	O
found	O
to	O
only	O
detect	B-T033
red-agt	B-T116
.	O
	
thus	O
,	O
it	O
was	O
necessary	O
to	O
treat	O
samples	O
with	O
dithiothreitol	B-T109
,	O
a	O
reducing	O
agent	O
,	O
to	O
quantify	B-T081
total	B-T080
iagt	B-T116
concentration	B-T081
.	O
	
tagt	B-T116
levels	B-T080
in	O
rat	O
and	O
mouse	O
plasma	O
were	O
1	O
139	O
and	O
1	O
77	O
ng/ml	O
,	O
respectively	O
.	O
	
iagt	B-T116
levels	B-T080
were	O
53%	O
of	O
tagt	B-T116
in	O
rat	O
plasma	O
but	O
only	O
22%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	B-T081
plasma	O
renin	B-T116
activity	O
in	O
mice	O
.	O
	
the	O
ratios	B-T081
of	O
oxi-agt	B-T116
and	O
red-agt	B-T116
were	O
4	O
rat	O
and	O
16	O
mouse	O
.	O
	
plasma	O
iagt	B-T116
consists	O
of	O
oxi-agt	B-T116
and	O
red-agt	B-T116
,	O
suggesting	B-T078
that	O
oxidative	O
stress	O
can	O
influence	O
ang	B-T116
i	I-T116
generation	O
by	O
the	O
agt	B-T116
conformation	O
switch	O
.	O
	
furthermore	O
,	O
the	O
lower	O
availability	B-T169
of	I-T169
plasma	O
iagt	B-T116
in	O
mice	O
suggests	B-T078
that	O
it	O
may	O
serve	O
as	O
a	O
limiting	B-T169
factor	B-T169
in	O
ang	B-T116
i	I-T116
formation	B-T169
in	O
this	O
carbon	O
monoxide	O
improves	B-T033
efficacy	B-T080
of	O
mesenchymal	O
stromal	O
cells	O
during	B-T079
sepsis	B-T047
by	O
production	O
of	O
specialized	O
proresolving	B-T033
lipid	O
mediators	O
mesenchymal	O
stromal	O
cells	O
are	O
being	O
investigated	B-T169
as	O
a	O
cell-based	B-T061
therapy	I-T061
for	O
a	O
number	O
of	O
disease	O
processes	O
,	O
with	O
promising	O
results	B-T033
in	O
animal	O
models	O
of	O
systemic	B-T047
inflammation	I-T047
and	O
sepsis	B-T047
.	O
	
studies	O
are	O
ongoing	O
to	O
determine	O
ways	O
to	O
further	O
improve	B-T033
the	O
therapeutic	B-T169
potential	B-T080
of	O
mesenchymal	O
stromal	O
cells	O
.	O
	
a	O
gas	O
molecule	O
that	O
improves	B-T033
outcome	B-T169
in	O
experimental	B-T080
sepsis	B-T047
is	O
carbon	O
monoxide	O
.	O
	
we	O
hypothesized	O
that	O
preconditioning	B-T169
of	O
mesenchymal	O
stromal	O
cells	O
with	O
carbon	O
monoxide	O
ex	B-T169
vivo	I-T169
would	O
promote	O
further	O
therapeutic	B-T169
benefit	B-T081
when	O
cells	O
are	O
administered	B-T169
in	O
vivo	O
after	O
the	O
onset	B-T080
of	I-T080
polymicrobial	B-T047
sepsis	B-T047
in	O
mice	O
.	O
	
animal	O
study	O
and	O
primary	O
cell	O
culture	O
.	O
	
laboratory	O
investigation	O
.	O
	
balb/c	O
mice	O
.	O
	
polymicrobial	B-T047
sepsis	B-T047
was	O
induced	B-T169
by	O
cecal	O
ligation	B-T061
and	O
puncture	O
.	O
	
mesenchymal	O
stromal	O
cells	O
,	O
mesenchymal	O
stromal	O
cells	O
-	O
conditioned	B-T080
with	O
carbon	O
monoxide	O
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	B-T080
with	O
carbon	O
monoxide	O
were	O
delivered	B-T169
by	O
tail	O
vein	O
injections	B-T061
to	O
septic	B-T169
mice	O
.	O
	
the	O
mice	O
were	O
assessed	O
for	O
survival	O
,	O
bacterial	B-T080
clearance	B-T080
,	O
and	O
the	O
inflammatory	O
response	O
during	B-T079
sepsis	B-T047
in	O
each	O
of	O
the	O
groups	B-T078
.	O
	
mesenchymal	O
stromal	O
cells	O
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	B-T080
phagocytosis	O
by	O
neutrophils	O
,	O
the	O
production	O
of	O
specialized	O
proresolving	B-T033
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	O
stromal	O
cells	O
function	O
using	O
gene	O
silencing	O
.	O
	
ex	B-T169
vivo	I-T169
preconditioning	B-T169
with	O
carbon	O
monoxide	O
allowed	O
mesenchymal	O
stromal	O
cells	O
to	O
be	O
administered	B-T169
later	O
after	O
the	O
onset	B-T080
of	I-T080
sepsis	B-T047
6	O
hr	O
,	O
and	O
yet	O
maintain	O
their	O
therapeutic	O
effect	O
with	O
increased	B-T081
survival	O
.	O
	
carbon	O
monoxide	O
preconditioned	B-T081
mesenchymal	O
stromal	O
cells	O
were	O
also	O
able	O
to	O
alleviate	O
organ	O
injury	O
,	O
improve	B-T033
bacterial	B-T080
clearance	B-T080
,	O
and	O
promote	O
the	O
resolution	O
of	O
inflammation	O
.	O
	
mesenchymal	O
stromal	O
cells	O
exposed	B-T080
to	I-T080
carbon	O
monoxide	O
,	O
with	O
docosahexaenoic	B-T109
acid	I-T109
substrate	O
,	O
produced	O
specialized	O
proresolving	B-T033
lipid	O
mediators	O
,	O
particularly	O
d-series	B-T080
resolvins	B-T109
,	O
which	O
promoted	O
survival	O
.	O
	
silencing	O
of	O
lipoxygenase	O
pathways	O
5-lipoxygenase	O
and	O
12	O
/	O
15-lipoxygenase	O
,	O
which	O
are	O
important	B-T080
enzymes	B-T116
for	O
specialized	O
proresolving	B-T033
lipid	O
mediator	O
biosynthesis	B-T169
,	O
resulted	B-T169
in	O
a	O
loss	O
of	O
therapeutic	B-T169
benefit	B-T081
bestowed	O
on	O
mesenchymal	O
stromal	O
cells	O
by	O
carbon	O
monoxide	O
.	O
	
taken	O
together	O
,	O
these	O
data	B-T078
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	B-T033
lipid	O
mediators	O
contribute	O
to	O
improved	B-T033
mesenchymal	O
stromal	O
cell	O
efficacy	B-T080
when	O
exposed	B-T080
to	I-T080
carbon	O
monoxide	O
,	O
resulting	O
in	O
an	O
improved	B-T033
therapeutic	O
response	O
during	B-T079
sepsis	B-T047
.	O
	
effect	B-T080
of	O
primary	O
health	O
care	O
reforms	O
in	O
turkey	O
on	O
health	O
service	O
utilization	O
and	O
user	B-T033
satisfaction	I-T033
strengthening	B-T080
primary	O
health	O
care	O
phc	O
is	O
considered	O
a	O
priority	O
for	O
efficient	B-T080
and	O
responsive	B-T169
health	O
systems	O
,	O
but	O
empirical	B-T080
evidence	B-T078
from	O
low-	O
and	O
middle-	O
income	B-T081
countries	O
is	O
limited	B-T169
.	O
	
the	O
stepwise	B-T061
introduction	I-T061
of	O
family	O
medicine	O
across	O
all	O
81	O
provinces	O
of	O
turkey	O
a	O
middle-income	B-T080
country	O
between	O
2005	O
and	O
2010	O
,	O
aimed	O
at	O
phc	O
strengthening	B-T080
,	O
presents	O
a	O
natural	O
experiment	O
for	O
assessing	O
the	O
effect	B-T080
of	O
family	O
medicine	O
on	O
health	O
service	O
utilization	O
and	O
user	B-T033
satisfaction	I-T033
the	O
effect	B-T080
of	O
health	O
system	O
reforms	O
,	O
that	O
introduced	O
family	O
medicine	O
,	O
on	O
utilization	B-T169
was	O
assessed	O
using	O
longitudinal	O
,	O
province-level	O
data	O
for	O
12	O
years	B-T079
and	O
multivariate	O
regression	O
models	O
adjusting	O
for	O
supply-side	B-T080
variables	I-T080
,	O
demographics	O
,	O
socio-economic	B-T080
development	I-T080
and	O
underlying	O
yearly	B-T079
trends	B-T079
.	O
	
user	B-T033
satisfaction	I-T033
with	O
primary	O
and	O
secondary	O
care	O
services	O
was	O
explored	O
using	O
data	B-T078
from	O
annual	O
life	O
satisfaction	O
surveys	O
.	O
	
trends	B-T079
in	O
preferred	O
first	O
point	O
of	O
contact	B-T169
primary	O
vs	O
secondary	O
,	O
public	O
vs	O
.	O
	
private	O
,	O
reason	O
for	O
choice	O
and	O
health	O
services	O
issues	O
,	O
were	O
described	B-T078
and	O
stratified	B-T080
by	O
patient	O
characteristics	O
,	O
provider	O
type	O
,	O
and	O
rural/urban	O
settings	O
between	O
2002	O
and	O
2013	O
,	O
the	O
average	B-T081
number	I-T081
of	O
phc	O
consultations	O
increased	B-T081
from	O
1.75	O
to	O
2.83	O
per	O
person	O
per	O
year	B-T079
.	O
	
in	O
multivariate	O
models	O
,	O
family	O
medicine	O
introduction	B-T061
was	O
associated	B-T080
with	I-T080
an	O
increase	B-T169
of	O
0.37	O
phc	O
consultations	O
per	O
person	O
p	O
<	O
0.001	O
,	O
and	O
slower	B-T080
annual	O
growth	O
in	O
phc	O
and	O
secondary	O
care	O
consultations	O
.	O
	
following	O
family	O
medicine	O
introduction	B-T061
,	O
the	O
growth	O
of	O
phc	O
and	O
secondary	O
care	O
consultations	O
per	O
person	O
was	O
0.08	O
and	O
0.30	O
,	O
respectively	O
,	O
a	O
year	B-T079
.	O
	
phc	O
increased	B-T081
as	O
preferred	O
provider	O
by	O
9.5	O
over	O
7	O
years	B-T079
with	O
the	O
reasons	O
of	O
proximity	O
and	O
service	B-T033
satisfaction	I-T033
,	O
which	O
increased	B-T081
by	O
14.9	O
and	O
11.8	O
,	O
respectively	O
.	O
	
reporting	O
of	O
poor	B-T033
facility	I-T033
hygiene	I-T033
,	O
difficulty	B-T033
getting	I-T033
an	I-T033
appointment	I-T033
,	O
poor	B-T080
physician	O
behaviour	O
and	O
high	B-T080
costs	B-T081
of	I-T081
health	I-T081
care	I-T081
all	O
declined	B-T080
p	O
<	O
0.001	O
in	O
phc	O
settings	O
,	O
but	O
remained	O
higher	B-T080
among	O
urban	B-T080
,	O
low-income	B-T033
and	O
working-age	O
populations	O
.	O
	
laparoscopic	O
radical	B-T061
lymph	I-T061
node	I-T061
dissection	I-T061
for	O
advanced	O
colon	O
cancer	O
close	O
to	O
the	O
hepatic	O
flexure	O
complete	B-T061
mesocolic	I-T061
excision	I-T061
is	O
currently	O
recognized	O
as	O
a	O
standard	B-T061
procedure	I-T061
for	O
colon	O
cancer	O
.	O
	
gastroepiploic	O
,	O
infrapyloric	O
,	O
and	O
superficial	O
pancreatic	O
head	O
lymph	O
node	O
metastases	O
in	O
the	O
gastrocolic	O
ligament	O
have	O
been	O
reported	O
for	O
colon	O
cancer	O
close	O
to	O
the	O
hepatic	O
flexure	O
.	O
	
we	O
sought	O
to	O
investigate	O
metastases	O
in	O
the	O
gastrocolic	O
ligament	O
in	O
colon	O
cancer	O
close	O
to	O
the	O
hepatic	O
flexure	O
.	O
	
this	O
was	O
a	O
single-center	O
retrospective	O
study	O
.	O
	
all	O
patients	O
with	O
t2	B-T033
or	O
deeper	O
invasive	B-T080
colon	O
cancer	O
in	O
the	O
relevant	O
tumor	O
location	O
who	O
underwent	O
laparoscopic	B-T061
right	I-T061
hemicolectomy	I-T061
or	O
extended	B-T061
right	I-T061
hemicolectomy	I-T061
at	O
our	O
institution	O
between	O
1	O
april	B-T079
2011	O
and	O
31	O
march	B-T079
2015	O
were	O
included	O
.	O
	
lymph	B-T061
node	I-T061
dissection	I-T061
in	O
the	O
gastrocolic	O
ligament	O
was	O
performed	O
in	O
35	O
cases	O
.	O
	
complications	O
occurred	O
in	O
11	O
patients	O
31%	O
and	O
were	O
grades	O
i	O
and	O
ii	O
according	O
to	O
the	O
clavien-dindo	O
classification	O
.	O
	
lymph	O
node	O
metastases	O
in	O
the	O
gastrocolic	O
ligament	O
were	O
found	O
in	O
only	O
three	O
patients	O
9%	O
.	O
	
each	O
metastasis	O
was	O
larger	O
than	O
9	O
mm	B-T081
.	O
	
metastases	O
in	O
the	O
gastrocolic	O
ligament	O
occurred	O
in	O
9%	O
of	O
patients	O
with	O
t2	B-T033
or	O
deeper	O
invasive	B-T080
colon	O
cancer	O
close	O
to	O
the	O
hepatic	O
flexure	O
.	O
	
laparoscopy	B-T061
was	O
feasible	O
and	O
useful	O
during	O
gastrocolic	B-T061
ligament	I-T061
resection	I-T061
.	O
	
this	O
study	O
included	O
a	O
small	O
sample	O
and	O
lacked	O
an	O
extended	O
follow-up	O
.	O
	
further	O
studies	O
are	O
needed	O
to	O
determine	O
the	O
clinical	B-T080
relevance	I-T080
of	O
this	O
finding	B-T033
,	O
particularly	O
in	O
terms	O
of	O
recurrence	O
and	O
long-term	B-T079
survival	O
.	O
	
smartphone	O
-based	O
psychotherapeutic	B-T061
micro-interventions	B-T061
to	O
improve	O
mood	O
in	O
a	O
real-world	B-T079
setting	I-T079
using	O
mobile	O
communication	O
technology	O
as	O
new	O
personalized	O
approach	O
to	O
treat	B-T061
mental	O
disorders	O
or	O
to	O
more	O
generally	O
improve	O
quality	B-T078
of	I-T078
life	I-T078
is	O
highly	O
promising	O
.	O
	
knowledge	O
about	O
intervention	B-T061
components	O
that	O
target	O
key	O
psychopathological	O
processes	O
in	O
terms	O
of	O
transdiagnostic	O
psychotherapy	B-T061
approaches	O
is	O
urgently	O
needed	O
.	O
	
we	O
explored	O
the	O
use	O
of	O
smartphone	O
-based	O
micro-interventions	B-T061
based	O
on	O
psychotherapeutic	O
techniques	O
,	O
guided	O
by	O
short	O
video-clips	O
,	O
to	O
elicit	O
mood	O
changes	O
.	O
	
as	O
part	O
of	O
a	O
larger	O
neurofeedback	B-T061
study	O
,	O
all	O
subjects	O
-after	O
being	O
randomly	O
assigned	O
to	O
an	O
experimental	O
or	O
control	O
neurofeedback	B-T061
condition	B-T080
-underwent	O
daily	B-T079
smartphone	O
-based	O
micro-interventions	B-T061
for	O
13	O
consecutive	O
days	B-T079
.	O
	
they	O
were	O
free	O
to	O
choose	O
out	O
of	O
provided	O
techniques	B-T169
,	O
including	O
viscerosensory	B-T080
attention	O
,	O
emotional	B-T033
imagery	O
,	O
facial	B-T033
expression	I-T033
,	O
and	O
contemplative	B-T080
repetition	B-T169
.	O
	
changes	B-T169
in	O
mood	O
were	O
assessed	O
in	O
real	O
world	O
using	O
the	O
multidimensional	O
mood	O
state	O
questionnaire	O
scales	O
good	B-T080
-	O
bad	B-T080
,	O
gb	O
awake	B-T033
-	O
tired	O
,	O
at	O
and	O
calm	O
-	O
nervous	O
,	O
cn	O
.	O
	
twenty-seven	O
men	O
participated	O
on	O
at	O
least	O
11	O
days	B-T079
and	O
were	O
thus	O
included	O
in	O
the	O
analyses	O
.	O
	
altogether	O
,	O
they	O
underwent	O
335	O
,	O
generally	O
well-tolerated	O
,	O
micro-intervention	O
sessions	O
,	O
with	O
viscerosensory	B-T080
attention	O
178	O
sessions	O
,	O
53.13	O
and	O
contemplative	B-T080
repetition	B-T169
68	O
sessions	O
,	O
20.30	O
being	O
the	O
most	O
frequently	O
applied	O
techniques	B-T169
.	O
	
mixed	O
models	O
indicated	O
that	O
subjects	O
showed	O
better	O
mood	O
gb	O
b	O
=	O
0.464	O
,	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
0.068	O
,	O
0.860	O
,	O
t	O
613.3	O
=	O
2.298	O
,	O
p	O
=	O
0.022	O
and	O
became	O
more	O
awake	B-T033
at	O
b	O
=	O
0.514	O
,	O
95%	O
ci	B-T081
0.103	O
,	O
0.925	O
,	O
t	O
612.4	O
=	O
2.456	O
,	O
p	O
=	O
0.014	O
and	O
calmer	O
cn	O
b	O
=	O
0.685	O
,	O
95%	O
ci	B-T081
0.360	O
,	O
1.010	O
,	O
t	O
612.3	O
=	O
4.137	O
,	O
p	O
<	O
0.001	O
from	O
pre	B-T079
-	O
to	O
post-micro-intervention	B-T079
.	O
	
these	O
mood	O
improvements	O
from	O
pre	B-T079
-	O
to	O
post-micro-intervention	B-T079
were	O
associated	O
with	O
changes	O
in	O
mood	O
from	O
the	O
1st	O
day	B-T079
until	O
the	O
last	O
day	B-T079
with	O
regard	O
to	O
gb	O
mood	O
r	O
=	O
0.614	O
,	O
95%	O
ci	B-T081
0.297	O
,	O
0.809	O
,	O
p	O
<	O
0.001	O
,	O
but	O
not	O
at	O
mood	O
r	O
=	O
0.279	O
,	O
95%	O
ci	B-T081
-0	O
,	O
0.602	O
,	O
p	O
=	O
0.167	O
and	O
cn	O
mood	O
r	O
=	O
0.277	O
,	O
95%	O
ci	B-T081
0.124	O
,	O
0.601	O
,	O
p	O
=	O
0.170	O
.	O
	
our	O
findings	B-T033
provide	O
evidence	O
for	O
the	O
applicability	O
of	O
smartphone	O
-based	O
micro-interventions	B-T061
eliciting	O
short-term	B-T079
mood	O
changes	O
,	O
based	O
on	O
techniques	B-T169
used	O
in	O
psychotherapeutic	B-T061
approaches	O
,	O
such	O
as	O
mindfulness	O
-based	O
psychotherapy	B-T061
,	O
transcendental	O
meditation	O
,	O
and	O
other	O
contemplative	B-T080
therapies	B-T061
.	O
	
the	O
results	O
encourage	O
exploring	O
these	O
techniques	B-T169
'	O
capability	B-T080
to	O
improve	O
mood	O
in	O
randomized	O
controlled	O
studies	O
and	O
patients	O
.	O
	
smartphone	O
-based	O
micro-interventions	B-T061
are	O
promising	O
to	O
modify	O
mood	O
in	O
real-world	B-T079
settings	I-T079
,	O
complementing	O
other	O
psychotherapeutic	B-T061
interventions	I-T061
,	O
in	O
line	O
with	O
the	O
precision	B-T079
medicine	O
approach	O
.	O
	
the	O
here	O
presented	O
data	B-T078
were	O
collected	O
within	O
a	O
randomized	O
trial	O
,	O
primary	B-T080
pituitary	O
diffuse	O
large	O
b-cell	O
lymphoma	O
with	O
somatotroph	O
hyperplasia	O
and	O
acromegaly	B-T047
case	O
report	O
diffuse	O
large	O
b-cell	O
lymphoma	O
dlbcl	O
is	O
the	O
most	O
common	B-T081
type	B-T080
of	O
non-hodgkin	O
lymphoma	O
and	O
comprises	O
approximately	O
30%	O
of	O
all	O
lymphomas	O
.	O
	
patients	O
typically	O
present	B-T033
with	O
a	O
nonpainful	B-T169
mass	B-T033
in	O
the	O
neck	O
,	O
groin	O
,	O
or	O
abdomen	O
associated	B-T080
with	I-T080
constitutional	O
symptoms	O
.	O
	
in	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	B-T080
case	B-T169
of	O
a	O
61-	O
year	B-T079
-old	O
woman	O
with	O
hyperprolactinemia	B-T047
,	O
hypothyroidism	B-T047
,	O
and	O
acromegaly	B-T047
elevation	B-T080
of	O
insulin-like	B-T116
growth	I-T116
factor-1	I-T116
igf-1	B-T116
with	O
elevated	B-T080
growth	B-T116
hormone-releasing	I-T116
hormone	I-T116
ghrh	B-T116
in	O
whom	O
an	O
mri	O
demonstrated	B-T080
diffuse	O
enlargement	O
of	O
the	O
pituitary	O
gland	O
.	O
	
despite	O
medical	B-T061
treatment	I-T061
,	O
the	O
patient	O
had	O
persistent	B-T079
elevation	B-T080
of	O
igf-1	B-T116
.	O
	
she	O
underwent	O
a	O
transsphenoidal	O
biopsy	O
,	O
which	O
yielded	O
a	O
diagnosis	B-T033
of	O
dlbcl	O
with	O
an	O
activated	O
b-cell	O
immunophenotype	O
with	O
somatotroph	O
hyperplasia	O
.	O
	
after	O
stereo-tactic	B-T061
radiation	I-T061
therapy	I-T061
in	O
combination	B-T080
with	O
chemotherapy	B-T061
,	O
she	O
is	O
currently	B-T079
in	O
remission	O
from	O
her	O
lymphoma	O
and	O
has	O
normalized	O
igf-1	B-T116
levels	B-T080
without	O
medical	B-T061
therapy	I-T061
,	O
8	O
months	B-T079
after	O
her	O
histopathological	B-T169
diagnosis	B-T033
.	O
	
this	O
is	O
the	O
only	O
reported	O
case	B-T169
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	O
diagnosis	O
,	O
multidisciplinary	O
evaluation	O
,	O
and	O
critical	B-T080
intraoperative	B-T079
decision-making	O
when	O
treating	B-T169
atypical	O
sellar	O
lesions	B-T033
.	O
	
doctor	O
competence	B-T080
and	O
the	O
demand	B-T061
for	O
healthcare	O
evidence	B-T078
from	O
rural	O
china	O
the	O
agency	O
problem	B-T033
between	O
patients	O
and	O
doctors	O
has	O
long	O
been	O
emphasised	O
in	O
the	O
health	O
economics	O
literature	O
,	O
but	O
the	O
empirical	B-T080
evidence	B-T078
on	O
whether	O
patients	O
can	O
evaluate	O
and	O
respond	O
to	O
better	B-T080
quality	O
care	O
remains	O
mixed	B-T169
and	O
inconclusive	B-T080
.	O
	
using	O
household	O
data	B-T078
linked	O
to	O
an	O
assessment	O
of	O
village	O
doctors'	O
clinical	B-T080
competence	I-T080
in	O
rural	O
china	O
,	O
we	O
show	O
that	O
there	O
is	O
no	B-T080
correlation	I-T080
between	O
doctor	O
competence	B-T080
and	O
patients'	O
healthcare	O
utilisation	B-T169
,	O
with	O
confidence	B-T081
intervals	I-T081
reasonably	O
tight	O
around	O
zero	O
.	O
	
household	O
perceptions	O
of	O
quality	B-T080
are	O
an	O
important	B-T080
determinant	B-T169
of	O
care-seeking	O
behaviour	O
,	O
yet	O
patients	O
appear	B-T080
unable	B-T033
to	O
recognise	B-T080
more	O
competent	B-T080
doctors	O
-	O
there	O
is	O
no	O
relationship	B-T080
between	O
doctor	O
competence	B-T080
and	O
perceptions	O
of	O
quality	B-T080
.	O
	
unintentional	B-T169
insecticide	O
poisoning	O
by	O
age	O
an	O
analysis	O
of	O
queensland	O
poisons	O
information	O
centre	O
calls	O
data	B-T078
from	O
the	O
queensland	O
poisons	O
information	O
centre	O
qpic	O
was	O
assessed	O
to	O
determine	B-T078
mechanisms	B-T169
of	O
acute	O
insecticide	O
poisoning	O
in	O
young	O
children	O
<5	B-T079
years	I-T079
and	O
whether	O
age	O
affects	O
insecticide-poisoning	O
patterns	O
.	O
	
records	O
of	O
all	O
insecticide-related	O
calls	O
placed	O
to	O
qpic	O
in	O
2014	O
were	O
obtained	B-T169
.	O
	
a	O
stratified	B-T080
analysis	O
of	O
call	O
patterns	O
by	O
age	O
was	O
conducted	B-T169
.	O
	
of	O
743	O
insecticide-related	O
calls	O
received	B-T080
by	I-T080
qpic	O
364	O
49.0	O
were	O
for	O
young	O
children	O
.	O
	
the	O
number	O
of	O
calls	O
peaked	B-T080
in	O
children	O
aged	B-T079
one	I-T079
.	O
	
ant	O
and	O
cockroach	O
baits	O
accounted	B-T081
for	O
39.0	O
of	O
calls	O
.	O
	
sprays	O
,	O
which	O
were	O
found	B-T033
to	O
contain	O
not	O
only	O
pyrethroids	B-T109
,	O
pyrethrins	B-T109
and/or	O
piperonly	B-T109
butoxide	I-T109
but	O
also	O
the	O
organophosphate	B-T109
diazinon	I-T109
,	O
accounted	B-T081
for	O
25.8	O
of	O
calls	O
.	O
	
mouthing	O
or	O
ingesting	O
a	O
pest-control	O
product	O
and	O
consuming	O
an	O
item/insect	O
after	O
treatment	B-T169
were	O
common	O
mechanisms	B-T169
for	O
children	O
under	O
the	O
age	B-T079
of	I-T079
two	I-T079
.	O
	
topical	O
exposure	B-T080
to	I-T080
sprays	O
,	O
via	O
direct	B-T080
application	B-T169
,	O
typically	O
by	O
the	O
child	O
or	O
an	O
older	O
sibling	O
,	O
peaked	B-T080
in	O
children	O
aged	B-T079
two	I-T079
.	O
	
in	O
12.3	O
of	O
calls	O
medical	O
attention	O
for	O
the	O
child	O
was	O
already	O
sought	O
or	O
advised	O
by	O
qpic	O
.	O
	
normal	O
behaviours	O
associated	B-T080
with	I-T080
child	O
development	O
,	O
particularly	O
mouthing	O
behaviours	O
,	O
explained	O
the	O
peak	B-T080
of	I-T080
exposure	I-T080
in	O
one-year	B-T079
-	O
olds	O
.	O
	
this	O
finding	B-T033
should	O
guide	O
strategies	O
to	O
minimise	B-T080
poisonings	O
in	O
this	O
vulnerable	O
population	O
.	O
	
investigating	O
synthetic	O
oligonucleotide	O
targeting	O
of	O
mir31	O
in	O
duchenne	B-T047
muscular	I-T047
dystrophy	I-T047
exon-skipping	O
via	O
synthetic	O
antisense	O
oligonucleotides	O
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	B-T061
for	O
duchenne	B-T047
muscular	I-T047
dystrophy	I-T047
dmd	B-T047
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence-specific	O
and	O
thus	O
each	O
oligonucleotide	O
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O
	
the	O
discovery	O
that	O
dystrophin	B-T116
mrna	O
is	O
subject	O
to	O
translational	O
suppression	O
by	O
the	O
microrna	O
mir31	O
,	O
and	O
that	O
mir31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
dmd	B-T047
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	O
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	O
.	O
	
this	O
approach	O
would	O
act	O
synergistically	B-T080
with	O
exon	O
skipping	O
where	O
possible	O
,	O
but	O
by	O
targeting	O
the	O
3'utr	O
it	O
would	O
further	O
be	O
of	O
benefit	O
to	O
the	O
many	O
dmd	B-T047
patients	O
who	O
express	O
low	O
levels	O
of	O
in-frame	O
transcript	O
.	O
	
we	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	O
with	O
several	O
different	O
strategies	O
for	O
mir31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	O
models	O
and	O
the	O
mdx	O
mouse	O
the	O
classical	O
animal	O
model	O
of	O
dmd	B-T047
,	O
and	O
monitoring	O
effects	B-T080
on	O
dystrophin	B-T116
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O
	
we	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	O
culture	O
model	O
,	O
our	O
in	O
vivo	O
data	B-T078
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	B-T116
translation	O
,	O
suggesting	O
that	O
mir31	O
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	O
approaches	O
.	O
	
possible	O
explanations	O
for	O
this	O
disappointing	O
outcome	B-T080
are	O
discussed	O
,	O
along	O
with	O
suggestions	O
for	O
future	O
undisclosed	B-T080
hiv	B-T047
infection	I-T047
and	O
art	B-T061
use	B-T169
in	O
the	O
kenya	O
aids	O
indicator	O
survey	O
2012	O
relevance	B-T080
to	O
targets	B-T169
for	O
hiv	O
diagnosis	O
and	O
treatment	B-T061
in	O
kenya	O
to	O
assess	O
the	O
impact	B-T080
of	O
undisclosed	B-T080
hiv	B-T047
infection	I-T047
and	O
antiretroviral	B-T061
arv	I-T061
therapy	I-T061
art	B-T061
on	O
national	O
estimates	B-T081
of	O
diagnosed	B-T033
hiv	I-T033
and	O
art	B-T061
coverage	B-T169
in	O
kenya	O
.	O
	
hiv-positive	B-T033
dried	O
blood	O
spot	O
samples	O
from	O
kenya's	O
second	O
aids	O
indicator	O
survey	O
were	O
tested	B-T169
for	O
an	O
arv	O
biomarker	O
by	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
.	O
	
estimates	B-T081
of	O
diagnosed	B-T033
hiv	I-T033
and	O
art	B-T061
use	B-T169
based	O
on	O
self-report	O
were	O
compared	O
with	O
those	O
corrected	O
for	O
undisclosed	B-T080
hiv	B-T047
infection	I-T047
and	O
art	B-T061
use	B-T169
based	O
on	O
arv	O
testing	O
.	O
	
multivariate	B-T081
analysis	I-T081
determined	B-T080
factors	B-T169
associated	B-T080
with	I-T080
undisclosed	B-T080
hiv	B-T047
infection	I-T047
and	O
art	B-T061
use	B-T169
among	O
persons	O
on	O
art	B-T061
.	O
	
among	O
559	O
hiv-positive	B-T033
samples	O
,	O
the	O
arv	O
biomarker	O
was	O
detected	B-T033
in	O
42.5	O
ci	O
37.4	O
.	O
	
arv	O
drugs	O
were	O
present	O
in	O
90.7	O
ci	O
86.1	O
reporting	B-T033
hiv-positive	I-T033
status	O
and	O
receiving	B-T080
art	B-T061
,	O
66.7	O
ci	O
59.9	O
reporting	B-T033
hiv-positive	I-T033
status	O
irrespective	O
of	O
art	B-T061
use	B-T169
,	O
21.0	O
ci	O
13.4	O
reporting	O
hiv-negative	O
status	O
,	O
and	O
19.3	O
ci	O
9.0	O
reporting	O
no	B-T033
previous	B-T079
hiv	O
test	O
.	O
	
after	O
correcting	O
for	O
undisclosed	B-T080
hiv	B-T047
infection	I-T047
and	O
art	B-T061
use	B-T169
,	O
diagnosed	B-T033
hiv	I-T033
increased	B-T081
from	O
46.9	O
to	O
57.2	O
and	O
art	B-T061
coverage	B-T169
increased	B-T081
from	O
31.8	O
to	O
42.8	O
.	O
	
undisclosed	B-T080
hiv	B-T047
infection	I-T047
on	O
art	B-T061
was	O
associated	B-T080
with	I-T080
being	O
aged	O
25-39	O
years	O
and	O
not	O
visiting	O
a	O
health	O
provider	O
in	O
the	O
past	O
year	O
,	O
while	O
younger	B-T033
age	I-T033
and	O
higher	B-T080
wealth	I-T080
was	O
associated	B-T080
with	I-T080
undisclosed	B-T080
art	B-T061
use	B-T169
.	O
	
substantial	B-T078
levels	B-T080
of	O
undisclosed	B-T080
hiv	B-T047
infection	I-T047
and	O
art	B-T061
use	B-T169
while	O
on	O
art	B-T061
were	O
observed	B-T169
,	O
resulting	B-T169
in	I-T169
diagnosed	B-T033
hiv	I-T033
underestimated	O
by	O
112	O
persons	O
and	O
art	B-T061
coverage	B-T169
by	O
131	O
persons	O
.	O
	
supplementing	O
self-reported	O
art	B-T061
status	B-T080
with	O
objective	O
measures	O
of	O
art	B-T061
use	B-T169
in	O
national	O
population	O
-based	O
sero-surveys	O
can	O
improve	B-T033
monitoring	O
of	O
treatment	B-T061
targets	B-T169
in	O
differential	O
control	B-T080
and	O
function	B-T169
of	O
arabidopsis	O
prodh1	O
and	O
prodh2	O
genes	O
on	O
infection	O
with	O
biotrophic	B-T033
and	O
necrotrophic	B-T033
pathogens	O
arabidopsis	O
contains	O
two	O
proline	O
dehydrogenase	O
prodh	O
genes	O
,	O
prodh1	O
and	O
prodh2	O
,	O
encoding	O
for	O
homologous	B-T116
and	O
functional	B-T169
isoenzymes	B-T116
.	O
	
although	O
prodh1	O
has	O
been	O
studied	O
extensively	O
,	O
especially	O
under	O
abiotic	O
stress	O
,	O
prodh2	O
has	O
only	O
started	O
to	O
be	O
analysed	O
in	O
recent	O
years	B-T079
.	O
	
these	O
genes	O
display	O
distinctive	O
expression	O
patterns	O
and	O
show	O
weak	B-T080
transcriptional	O
co-regulation	O
,	O
but	O
are	O
both	O
activated	O
in	O
pathogen	O
-	O
infected	B-T033
tissues	O
.	O
	
we	O
have	O
demonstrated	O
previously	O
that	O
arabidopsis	O
plants	O
with	O
silenced	O
prodh1	O
/	O
2	O
expression	O
fail	B-T169
to	O
trigger	O
defences	O
against	O
the	O
hemibiotrophic	B-T033
bacterial	O
pathogen	O
pseudomonas	O
syringae	O
pv	O
.	O
	
tomato	O
avrrpm1	O
pst-avrrpm1	O
,	O
and	O
that	O
prodh1	O
and	O
prodh2	O
are	O
differentially	O
regulated	O
by	O
salicylic	B-T109
acid	I-T109
sa	B-T109
.	O
	
in	O
the	O
current	O
work	O
,	O
we	O
used	O
prodh1	O
and	O
prodh2	O
single-	O
mutant	O
plants	O
to	O
assess	O
the	O
particular	O
contribution	O
of	O
each	O
gene	O
to	O
resistance	B-T169
against	O
pst-avrrpm1	O
and	O
the	O
necrotrophic	B-T033
fungal	O
pathogen	O
botrytis	O
cinerea	O
.	O
	
in	O
addition	O
,	O
we	O
studied	O
the	O
sensitivity	B-T169
of	O
prodh1	O
and	O
prodh2	O
to	O
the	O
jasmonic	B-T109
acid	I-T109
ja	B-T109
defence	O
pathway	O
.	O
	
we	O
found	O
that	O
prodh1	B-T116
and	O
prodh2	B-T116
are	O
both	O
necessary	O
to	O
achieve	O
maximum	O
resistance	B-T169
against	O
pst-avrrpm1	O
and	O
b	O
.	O
	
cinerea	O
.	O
	
however	O
,	O
prodh2	B-T116
has	O
a	O
major	O
effect	O
on	O
early	O
restriction	B-T169
of	O
b	O
.	O
	
cinerea	O
growth	O
.	O
	
interestingly	O
,	O
prodh1	O
is	O
up-regulated	O
by	O
sa	B-T109
and	O
ja	B-T109
,	O
whereas	O
prodh2	O
is	O
only	O
activated	O
by	O
ja	B-T109
,	O
and	O
both	O
genes	O
display	O
transcriptional	O
inter-regulation	O
at	O
basal	O
and	O
infection	O
conditions	B-T080
.	O
	
these	O
studies	O
provide	O
the	O
first	O
evidence	O
of	O
the	O
contribution	O
of	O
prodh2	O
to	O
disease	O
resistance	O
,	O
and	O
describe	O
the	O
differential	O
regulation	O
and	O
non-redundant	O
but	O
complementary	B-T169
function	I-T169
of	O
both	O
enzyme	B-T116
isoforms	I-T116
in	O
infected	B-T033
tissues	O
,	O
providing	O
support	O
for	O
a	O
fundamental	O
role	O
of	O
prodh	O
in	O
the	O
control	O
of	O
biotrophic	B-T033
and	O
necrotrophic	B-T033
pathogens	O
.	O
	
effect	B-T080
of	O
protein	B-T116
repetitiveness	B-T169
on	O
protein-protein	O
interaction	O
prediction	B-T078
results	B-T169
using	O
support	B-T081
vector	I-T081
machines	I-T081
there	O
are	O
many	O
computational	O
approaches	O
to	O
predict	O
the	O
protein-protein	O
interactions	O
using	O
support	B-T081
vector	I-T081
machines	I-T081
svms	B-T081
with	O
high	O
performance	O
.	O
	
in	O
fact	O
,	O
performance	O
of	O
currently	O
reported	O
methods	O
are	O
significantly	O
over-estimated	O
and	O
affected	O
by	O
the	O
object	O
repetitiveness	B-T169
in	O
the	O
datasets	O
used	O
.	O
	
to	O
study	O
the	O
effect	O
of	O
object	O
repetitiveness	B-T169
of	O
datasets	O
on	O
predicting	B-T078
results	B-T169
.	O
	
we	O
present	O
novel	O
methods	O
to	O
construct	O
different	O
positive	B-T033
datasets	O
with	O
or	O
without	O
repeating	O
proteins	B-T116
using	O
graph	O
maximum	O
matching	O
in	O
the	O
protein-protein	O
interaction	O
datasets	O
and	O
corresponding	O
series	O
of	O
negative	B-T033
datasets	O
with	O
different	O
proteins	B-T116
repetitiveness	B-T169
are	O
constructed	O
using	O
graph	O
adjacency	O
matrix	O
.	O
	
the	O
relationship	B-T080
between	O
the	O
svm	B-T081
prediction	B-T078
results	B-T169
and	O
the	O
repeated	B-T169
proteins	B-T116
repeat	O
numbers	O
and	O
repeat	O
rates	O
and	O
the	O
distributions	B-T169
of	O
repeated	B-T169
proteins	B-T116
in	O
the	O
datasets	O
are	O
analyzed	O
.	O
	
protein	B-T116
repetitiveness	B-T169
of	O
positive	B-T033
and	O
negative	B-T033
datasets	O
can	O
affect	O
the	O
prediction	B-T078
result	B-T169
high	O
protein	B-T116
repetitiveness	B-T169
of	O
positive	B-T033
or	O
negative	B-T033
datasets	O
yield	O
high	O
performance	O
prediction	O
result	B-T169
.	O
	
this	O
indicate	O
that	O
dealing	O
with	O
object	O
repetitiveness	B-T169
of	O
datasets	O
is	O
a	O
key	O
issue	O
in	O
protein-protein	O
interactions	O
prediction	B-T078
using	O
svms	B-T081
since	O
real	O
world	O
data	B-T078
contain	O
certain	O
degrees	O
of	O
repeat	B-T169
proteins	B-T116
.	O
	
from	O
'	O
sense	O
of	O
number	O
'	O
to	O
'	O
sense	O
of	O
magnitude	B-T081
'	O
-	O
the	O
role	O
of	O
continuous	B-T078
magnitudes	B-T081
in	O
numerical	B-T081
cognition	O
in	O
this	O
review	O
,	O
we	O
are	O
pitting	B-T169
two	O
theories	B-T078
against	O
each	O
other	O
the	O
more	O
accepted	O
theory	B-T078
-the	O
'	O
number	O
sense	O
'	O
theory	B-T078
-suggesting	O
that	O
a	O
sense	O
of	O
number	O
is	O
innate	O
and	O
non-symbolic	O
numerosity	O
is	O
being	O
processed	O
independently	O
of	O
continuous	B-T078
magnitudes	B-T081
e.g	O
,	O
size	O
,	O
area	O
,	O
density	B-T081
and	O
the	O
newly	O
emerging	O
theory	B-T078
suggesting	O
that	O
1	O
both	O
numerosities	O
and	O
continuous	B-T078
magnitudes	B-T081
are	O
processed	O
holistically	O
when	O
comparing	O
numerosities	O
,	O
and	O
2	O
a	O
sense	O
of	O
number	O
might	O
not	O
be	O
innate	O
.	O
	
in	O
the	O
first	O
part	O
of	O
this	O
review	O
,	O
we	O
discuss	O
the	O
'	O
number	O
sense	O
'	O
theory	B-T078
.	O
	
against	O
this	O
background	O
,	O
we	O
demonstrate	O
how	O
the	O
natural	O
correlation	B-T080
between	O
numerosities	O
and	O
continuous	B-T078
magnitudes	B-T081
makes	O
it	O
nearly	O
impossible	O
to	O
study	O
non-symbolic	O
numerosity	O
processing	O
in	O
isolation	O
from	O
continuous	B-T078
magnitudes	B-T081
,	O
and	O
therefore	O
the	O
results	O
of	O
behavioral	O
and	O
imaging	O
studies	O
with	O
infants	O
,	O
adults	O
and	O
animals	O
can	O
be	O
explained	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
relying	O
on	O
continuous	B-T078
magnitudes	B-T081
.	O
	
in	O
the	O
second	O
part	O
,	O
we	O
explain	O
the	O
'	O
sense	O
of	O
magnitude	B-T081
'	O
theory	B-T078
and	O
review	O
studies	O
that	O
directly	O
demonstrate	O
that	O
continuous	O
magnitudes	O
are	O
more	O
automatic	O
and	O
basic	O
than	O
numerosities	O
.	O
	
finally	O
,	O
we	O
present	O
outstanding	O
questions	O
.	O
	
our	O
conclusion	O
is	O
that	O
there	O
is	O
not	O
enough	O
convincing	O
evidence	O
to	O
support	O
the	O
number	O
sense	O
theory	B-T078
anymore	O
.	O
	
therefore	O
,	O
we	O
encourage	O
researchers	O
not	O
to	O
assume	O
that	O
number	O
sense	O
is	O
simply	O
innate	O
,	O
but	O
to	O
put	O
this	O
hypothesis	O
to	O
the	O
test	O
,	O
and	O
to	O
consider	O
if	O
such	O
an	O
assumption	O
is	O
even	O
testable	O
in	O
light	O
of	O
the	O
correlation	O
of	O
numerosity	O
and	O
continuous	B-T078
magnitudes	B-T081
.	O
	
how	O
integrated	O
management	O
strategies	O
promote	O
protein	B-T116
quality	B-T080
of	O
cotton	O
embryos	O
high	B-T080
levels	B-T080
of	O
soil	O
available	B-T169
n	O
,	O
n	O
assimilation	O
and	O
protein	B-T116
accumulation	B-T033
rate	B-T081
cottonseed	O
is	O
widely	O
used	O
as	O
a	O
source	B-T033
of	O
ruminant	O
feed	O
and	O
for	O
industrial	O
purposes	B-T169
.	O
	
therefore	O
,	O
there	O
is	O
a	O
tremendous	O
need	O
to	O
improve	B-T033
the	O
nutritional	B-T080
value	I-T080
of	O
cotton	O
embryos	O
.	O
	
in	O
this	O
study	O
,	O
a	O
conventional	O
management	O
cm	O
and	O
two	O
integrated	O
cotton	O
management	O
strategies	O
ims1	O
,	O
ims2	O
were	O
performed	B-T169
at	O
two	O
soil	O
fertility	B-T033
levels	B-T080
to	O
study	O
the	O
relationships	B-T080
among	O
soil	O
n	O
,	O
n	O
assimilation	O
,	O
embryonic	O
protein	B-T116
accumulation	B-T033
and	O
protein	B-T116
quality	B-T080
.	O
	
the	O
levels	O
of	O
proteins	O
,	O
essential	O
amino	O
acids	O
,	O
and	O
semi-essential	O
amino	O
acids	O
,	O
especially	O
those	O
of	O
glutamate	O
,	O
lysine	O
,	O
and	O
methionine	O
,	O
were	O
higher	B-T080
in	O
ims1	O
and	O
ims2	O
embryos	O
than	O
in	O
cm	O
embryos	O
.	O
	
these	O
changes	B-T169
were	O
significantly	O
positively	B-T033
correlated	B-T080
with	O
the	O
soil	O
-	O
available	B-T169
n	O
content	O
,	O
glutamine	O
synthetase	O
activity	O
and	O
peak	B-T080
value	O
of	O
protein	B-T116
accumulation	B-T033
rate	B-T081
and	O
were	O
negatively	B-T033
correlated	B-T080
with	O
the	O
free	B-T080
amino	O
acid	O
level	O
.	O
	
these	O
results	B-T033
illustrated	O
that	O
integrated	O
management	O
strategies	O
,	O
especially	O
the	O
rates	B-T081
and	O
timing	B-T079
of	O
n	O
application	B-T169
,	O
raise	B-T169
the	O
level	B-T080
of	O
soil	O
available	B-T169
n	O
,	O
which	O
is	O
beneficial	O
for	O
n	O
assimilation	O
in	O
developing	O
cotton	O
embryos	O
.	O
	
the	O
protein	O
content	O
was	O
limited	B-T169
by	O
the	O
rate	B-T081
of	O
protein	B-T116
accumulation	B-T033
rather	O
than	O
by	O
the	O
free	B-T080
amino	O
acid	O
content	O
.	O
	
the	O
combination	B-T080
of	O
target	B-T081
yield	I-T081
fertilization	O
,	O
a	O
growth	O
-driven	O
n	O
application	B-T169
schedule	O
,	O
a	O
high	B-T080
plant	O
density	B-T081
and	O
the	O
seedling	O
raising	O
with	O
bio-organic	O
fertilizer	O
can	O
substantially	O
improve	B-T033
protein	B-T116
quality	B-T080
in	O
cotton	O
embryos	O
,	O
especially	O
at	O
a	O
soil	O
with	O
low	O
soil	O
organic	B-T109
matter	I-T109
and	O
total	B-T080
nitrogen	O
.	O
	
help	O
end	O
the	O
hiv	O
epidemic	O
after	O
many	O
delays	O
,	O
the	O
public	B-T061
consultation	I-T061
on	O
hiv	B-T061
prevention	I-T061
tool	O
prep	B-T061
pre-exposure	B-T061
prophylaxis	I-T061
is	O
finally	O
here	O
.	O
	
now	O
is	O
the	O
time	O
to	O
mobilise	O
-	O
help	O
end	O
the	O
hiv	O
epidemic	O
by	O
responding	O
to	O
this	O
nhs	O
england	O
consultation	O
before	O
23	O
osseointegration	O
behavior	O
of	O
novel	B-T080
ti-nb-zr-ta-si	O
alloy	O
for	O
dental	O
implants	O
an	O
in	O
vivo	O
study	O
this	O
study	O
aimed	O
to	O
evaluate	O
the	O
effects	B-T080
of	I-T080
ti-nb-zr-ta-si	O
alloy	O
implants	O
on	O
mineral	B-T081
apposition	I-T081
rate	I-T081
and	O
new	O
bic	B-T081
contact	I-T081
in	O
rabbits	O
.	O
	
twelve	O
ti-nb-zr-ta-si	O
alloy	O
implants	O
were	O
fabricated	B-T169
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O
	
tetracycline	B-T109
and	O
alizarin	B-T109
red	I-T109
were	O
administered	O
3	O
weeks	B-T079
and	O
1	O
week	B-T079
before	O
euthanization	O
,	O
respectively	O
.	O
	
at	O
4	O
weeks	B-T079
and	O
8	O
weeks	B-T079
after	O
implantation	B-T061
,	O
animals	O
were	O
euthanized	O
,	O
respectively	O
.	O
	
surface	O
characterization	O
and	O
implant-bone	B-T081
contact	I-T081
surface	O
analysis	O
were	O
performed	B-T169
by	O
using	O
a	O
scanning	O
electron	O
microscope	O
and	O
an	O
energy	O
dispersive	O
x-ray	O
detector	O
.	O
	
mineral	B-T081
apposition	I-T081
rate	I-T081
was	O
evaluated	O
using	O
a	O
confocal	O
laser	O
scanning	O
microscope	O
.	O
	
toluidine	O
blue	O
staining	O
was	O
performed	B-T169
on	O
undecalcified	B-T033
sections	O
for	O
histology	O
and	O
histomorphology	B-T080
evaluation	O
.	O
	
scanning	O
electron	O
microscope	O
and	O
histomorphology	B-T080
observation	B-T078
revealed	B-T080
a	O
direct	B-T169
contact	I-T169
between	O
implants	O
and	O
bone	O
of	O
all	O
groups	B-T078
.	O
	
after	O
a	O
healing	O
period	B-T079
of	O
4	O
weeks	B-T079
,	O
ti-nb-zr-ta-si	O
alloy	O
implants	O
showed	O
significantly	O
higher	O
mineral	B-T081
apposition	I-T081
rate	I-T081
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
p	O
<	O
0.05	O
,	O
whereas	O
there	O
was	O
no	B-T033
significant	I-T033
difference	O
between	O
ti-nb-zr-ta-si	O
alloy	O
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
p	O
>	O
0.05	O
at	O
8	O
weeks	B-T079
.	O
	
no	B-T033
significant	I-T033
difference	O
of	O
bone-to-implant	B-T081
contact	I-T081
was	O
observed	B-T169
between	O
ti-nb-zr-ta-si	O
alloy	O
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
after	O
a	O
healing	O
period	B-T079
of	O
4	O
weeks	B-T079
and	O
8	O
weeks	B-T079
.	O
	
this	O
study	O
showed	O
that	O
ti-nb-zr-ta-si	O
alloy	O
implants	O
could	O
establish	O
a	O
close	B-T169
direct	I-T169
contact	I-T169
comparedto	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
,	O
improved	B-T033
mineral	B-T081
matrix	I-T081
apposition	I-T081
rate	I-T081
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	O
implants	O
.	O
	
simultaneous	B-T079
edited	O
mrs	O
of	O
gaba	B-T116
and	O
glutathione	B-T116
edited	O
mrs	O
allows	O
the	O
detection	B-T061
of	O
low	B-T080
-	O
concentration	B-T081
metabolites	O
,	O
whose	O
signals	O
are	O
not	B-T169
resolved	O
in	O
the	O
mr	O
spectrum	O
.	O
	
tailored	O
acquisitions	O
can	O
be	O
designed	O
to	O
detect	B-T061
,	O
for	O
example	O
,	O
the	O
inhibitory	O
neurotransmitter	O
γ-aminobutyric	B-T116
acid	I-T116
gaba	B-T116
,	O
or	O
the	O
reduction-oxidation	O
redox	O
compound	O
glutathione	B-T116
gsh	B-T116
,	O
and	O
single	B-T081
-	O
voxel	O
edited	O
experiments	O
are	O
generally	O
acquired	O
at	O
a	O
rate	B-T081
of	O
one	B-T081
metabolite	O
-	O
per-experiment	O
.	O
	
we	O
demonstrate	O
that	O
simultaneous	B-T079
detection	B-T061
of	O
the	O
overlapping	B-T079
signals	O
of	O
gaba	B-T116
and	O
gsh	B-T116
is	O
possible	O
using	B-T169
hadamard	O
encoding	O
and	O
reconstruction	O
of	O
mega-edited	O
spectroscopy	O
hermes	O
.	O
	
hermes	O
applies	B-T169
orthogonal	O
editing	O
encoding	O
following	B-T079
a	O
hadamard	O
scheme	O
,	O
such	O
that	O
gsh-	B-T116
and	O
gaba	B-T116
-	O
edited	O
difference	B-T080
spectra	O
can	O
be	O
reconstructed	O
from	O
a	O
single	O
multiplexed	O
experiment	O
.	O
	
at	O
a	O
te	B-T079
of	O
80ms	O
,	O
20-ms	O
editing	O
pulses	O
are	O
applied	B-T169
at	O
4.56ppm	O
on	O
gsh	B-T116
on	O
gaba	B-T116
,	O
both	B-T080
offsets	B-T081
using	O
a	O
dual-lobe	O
cosine-modulated	O
pulse	O
or	O
neither	O
.	O
	
hadamard	O
combinations	O
of	O
the	O
four	O
sub-experiments	O
yield	O
gaba	B-T116
and	O
gsh	B-T116
difference	B-T080
spectra	O
.	O
	
it	O
is	O
shown	O
that	O
hermes	O
gives	O
excellent	B-T080
separation	B-T080
of	O
the	O
edited	O
gaba	B-T116
and	O
gsh	B-T116
signals	O
in	O
phantoms	O
,	O
and	O
resulting	O
edited	O
lineshapes	B-T080
agree	B-T033
well	B-T080
with	O
separate	B-T080
mescher-garwood	O
point-resolved	O
spectroscopy	O
mega-press	O
acquisitions	O
.	O
	
in	O
vivo	O
,	O
the	O
quality	B-T080
and	O
signal-to-noise	B-T081
ratio	I-T081
snr	B-T081
of	O
hermes	O
spectra	O
are	O
similar	B-T080
to	O
those	O
of	O
sequentially	B-T080
acquired	B-T080
mega-press	O
spectra	O
,	O
with	O
the	O
benefit	B-T081
of	O
saving	O
half	O
the	O
acquisition	O
time	B-T079
.	O
	
chitosan	B-T109
-functionalised	O
poly	B-T109
methacrylate	I-T109
core-shell	O
microgels	O
as	O
drug	O
delivery	O
carriers	O
salicylic	B-T109
acid	I-T109
loading	B-T169
and	I-T169
release	I-T169
this	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	B-T109
-functionalised	O
poly	B-T109
methacrylate	I-T109
cs	B-T109
/	O
phema	B-T109
core-shell	O
microgels	O
as	O
drug	O
delivery	O
carriers	O
.	O
	
cs	B-T109
/	O
phema	B-T109
microgels	O
were	O
prepared	O
by	O
emulsifier-free	O
emulsion	O
polymerisation	O
with	O
n	B-T109
'-methylenebisacrylamide	I-T109
mba	B-T109
as	O
a	O
crosslinker	B-T109
.	O
	
the	O
study	O
on	O
drug	O
loading	O
,	O
using	O
salicylic	B-T109
acid	I-T109
sa	B-T109
as	O
a	O
model	O
drug	O
,	O
was	O
performed	O
.	O
	
the	O
results	O
showed	O
that	O
the	O
encapsulation	O
efficiency	O
ee	O
increased	O
as	O
drug	O
-to-	O
microgel	O
ratio	B-T081
was	O
increased	O
.	O
	
higher	O
ee	O
can	O
be	O
achieved	O
with	O
the	O
increase	O
in	O
degree	O
of	O
crosslinking	O
,	O
by	O
increasing	O
the	O
amount	O
of	O
mba	B-T109
from	O
0.01	O
g	O
to	O
0.03	O
g	O
.	O
	
in	O
addition	O
,	O
the	O
highest	O
ee	O
61.1	O
was	O
observed	O
at	O
ph	B-T081
3	O
.	O
	
the	O
highest	O
release	O
of	O
sa	O
60%	O
was	O
noticed	O
at	O
ph	B-T081
2.4	O
,	O
while	O
the	O
lowest	O
one	O
49.4	O
was	O
obtained	O
at	O
ph	B-T081
7.4	O
.	O
	
moreover	O
,	O
the	O
highest	O
release	O
of	O
sa	O
was	O
enhanced	O
by	O
the	O
presence	O
of	O
0.2	O
m	O
nacl	O
.	O
	
the	O
ph	B-T081
-	O
and	O
ionic-sensitivity	B-T080
of	O
cs	B-T109
/	O
phema	B-T109
could	O
be	O
useful	O
as	O
a	O
sustained	O
release	O
delivery	O
device	O
,	O
especially	O
for	O
oral	O
delivery	O
.	O
	
breast	B-T061
augmentation	I-T061
after	O
conservation	B-T061
surgery	I-T061
and	O
radiation	B-T061
therapy	I-T061
there	O
is	O
a	O
paucity	O
of	O
data	O
regarding	O
outcomes	O
for	O
patients	O
undergoing	O
breast	B-T061
augmentation	I-T061
with	O
implants	O
after	O
breast	B-T061
conservation	I-T061
surgery	I-T061
bcs	B-T061
and	O
radiotherapy	B-T061
.	O
	
this	O
retrospective	O
study	O
examined	O
outcomes	O
for	O
patients	O
with	O
breast	O
implant	O
-only	O
augmentation	B-T061
after	O
bcs	B-T061
and	O
radiotherapy	B-T061
.	O
	
between	O
june	O
1998	O
and	O
december	O
2010	O
,	O
671	O
women	O
underwent	O
prosthetic	O
breast	B-T061
reconstruction	I-T061
.	O
	
nineteen	O
patients	O
2.8	O
underwent	O
an	O
augmentation	B-T061
after	O
bcs	B-T061
and	O
radiotherapy	B-T061
.	O
	
the	O
mean	B-T081
age	O
was	O
55.8	O
years	B-T079
range	B-T081
,	O
40-69	O
years	B-T079
.	O
	
sixteen	O
of	O
these	O
patients	O
underwent	O
one-stage	B-T061
implant	I-T061
-only	O
breast	B-T061
augmentation	I-T061
,	O
whereas	O
3	O
patients	O
underwent	O
two-stage	B-T061
expander	I-T061
and	O
then	O
implant	B-T061
augmentation	I-T061
.	O
	
all	O
surgeries	B-T061
were	O
successful	O
.	O
	
the	O
average	O
size	O
of	O
breast	O
implant	O
used	O
was	O
258.7	O
.	O
	
seven	O
patients	O
also	O
received	O
contralateral	O
augmentation	B-T061
with	O
an	O
average	O
implant	O
size	O
of	O
232.2	O
.	O
	
one	O
patient	O
received	O
oral	B-T169
antibiotics	O
for	O
minor	O
wound	O
infection	O
.	O
	
patients	O
were	O
judged	O
to	O
have	O
an	O
excellent	O
14/19	O
73.7	O
,	O
good	O
3/19	O
15.8	O
,	O
or	O
fair	O
2/19	O
10.5	O
cosmetic	B-T033
result	B-T169
.	O
	
the	O
breasts	O
of	O
selected	O
patients	O
with	O
breast	O
cancer	O
after	O
bcs	B-T061
and	O
radiotherapy	B-T061
.	O
	
with	O
asymmetry	O
can	O
be	O
adequately	O
augmented	B-T081
with	O
breast	O
implants	O
mitochondrial	O
pyruvate	O
dehydrogenase	O
phosphatase	O
1	O
regulates	O
the	O
early	O
differentiation	O
of	O
cardiomyocytes	O
from	O
mouse	O
embryonic	O
stem	O
cells	O
mitochondria	O
are	O
crucial	O
for	O
maintaining	O
the	O
properties	O
of	O
embryonic	O
stem	O
cells	O
escs	O
and	O
for	O
regulating	O
their	O
subsequent	O
differentiation	O
into	O
diverse	O
cell	B-T078
lineages	I-T078
,	O
including	O
cardiomyocytes	O
.	O
	
however	O
,	O
mitochondrial	O
regulators	O
that	O
manage	O
the	O
rate	B-T081
of	I-T081
differentiation	I-T081
or	O
cell	O
fate	O
have	O
been	O
rarely	O
identified	O
.	O
	
this	O
study	O
aimed	O
to	O
determine	O
the	O
potential	O
mitochondrial	B-T116
factor	I-T116
that	O
controls	O
the	O
differentiation	O
of	O
escs	O
into	O
cardiac	O
myocytes	O
.	O
	
we	O
induced	O
cardiomyocyte	O
differentiation	O
from	O
mouse	O
escs	O
mescs	O
and	O
performed	O
microarray	O
assays	O
to	O
assess	O
messenger	O
rna	O
mrna	O
expression	O
changes	O
at	O
differentiation	B-T033
day	I-T033
8	I-T033
d8	B-T033
compared	O
with	O
undifferentiated	B-T080
mescs	O
d0	O
.	O
	
among	O
the	O
differentially	O
expressed	O
genes	O
,	O
pdp1	O
expression	O
was	O
significantly	O
decreased	O
27-fold	O
on	O
d8	B-T033
compared	O
to	O
d0	B-T080
,	O
which	O
was	O
accompanied	O
by	O
suppressed	B-T169
mitochondrial	O
indices	O
,	O
including	O
atp	O
levels	O
,	O
membrane	O
potential	O
,	O
ros	O
and	O
mitochondrial	O
ca	O
.	O
	
notably	O
,	O
pdp1	O
overexpression	O
significantly	O
enhanced	O
the	O
mitochondrial	O
indices	O
and	O
pyruvate	O
dehydrogenase	O
activity	O
and	O
reduced	O
the	O
expression	O
of	O
cardiac	O
differentiation	O
marker	O
mrna	O
and	O
the	O
cardiac	O
differentiation	O
rate	B-T081
compared	O
to	O
a	O
mock	O
control	O
.	O
	
in	O
confirmation	O
of	O
this	O
,	O
a	O
knockdown	O
of	O
the	O
pdp1	O
gene	O
promoted	O
the	O
expression	O
of	O
cardiac	O
differentiation	O
marker	O
mrna	O
and	O
the	O
cardiac	O
differentiation	O
rate	B-T081
.	O
	
in	O
conclusion	O
,	O
our	O
results	O
suggest	O
that	O
mitochondrial	O
pdp1	O
is	O
a	O
potential	O
regulator	O
that	O
controls	O
cardiac	O
differentiation	O
at	O
an	O
early	O
differentiation	B-T079
stage	I-T079
in	O
thermo-reversible	O
capture	O
and	O
release	O
of	O
dna	O
by	O
zwitterionic	O
surfactants	O
the	O
thermo-reversible	O
capture	O
and	O
release	O
of	O
dna	O
were	O
studied	O
by	O
the	O
protonation	O
and	O
deprotonation	O
of	O
alkyldimethylamine	B-T109
oxide	I-T109
cndmao	B-T109
,	O
n	O
=	O
10	O
,	O
12	O
and	O
14	O
in	O
tris-hcl	O
buffer	O
solution	O
.	O
	
dna	O
/	O
c14dmao	B-T109
in	O
tris-hcl	O
buffer	O
solution	O
with	O
ph	B-T081
=	O
7.2	O
is	O
transparent	B-T080
at	O
25	O
c	O
,	O
indicating	O
that	O
dna	O
molecules	O
exist	O
mainly	O
in	O
individuals	O
and	O
the	O
binding	O
of	O
c14dmao	B-T109
is	O
weak	B-T080
.	O
	
with	O
the	O
increase	B-T169
of	O
temperature	B-T081
,	O
the	O
ph	B-T081
of	O
the	O
buffer	O
solution	O
continuously	O
decreases	B-T081
,	O
which	O
leads	O
to	O
protonation	O
of	O
c14dmao	B-T109
c14dmao	B-T109
+	O
h	O
c14dmaoh	B-T109
and	O
an	O
obvious	O
increase	B-T033
of	I-T033
the	I-T033
turbidity	I-T033
of	O
the	O
samples	O
.	O
	
this	O
indicates	O
a	O
stronger	O
binding	O
of	O
the	O
protonated	O
c14dmaoh	B-T109
to	O
dna	O
.	O
	
further	O
investigations	O
demonstrated	O
the	O
formation	B-T169
of	O
dna	O
/	O
c14dmaoh	B-T109
complexes	O
,	O
in	O
which	O
the	O
stretched	O
dna	O
molecules	O
are	O
effectively	O
compacted	B-T033
as	O
evidenced	O
from	O
uv-vis	O
absorptions	O
,	O
circular	O
dichroism	O
cd	O
measurements	O
,	O
atomic	O
force	O
microscopy	O
afm	O
observations	O
,	O
dynamic	O
light	O
scattering	O
dls	O
measurements	O
and	O
agarose	O
gel	O
electrophoresis	O
age	O
.	O
	
interestingly	O
,	O
when	O
the	O
temperature	O
is	O
turned	O
back	O
to	O
25	O
c	O
,	O
the	O
compacted	O
dna	O
molecules	O
can	O
fully	O
recover	O
to	O
the	O
stretched	O
conformation	O
.	O
	
this	O
cycle	O
can	O
be	O
repeated	O
several	O
times	O
without	O
obvious	O
loss	O
of	O
efficiency	O
.	O
	
the	O
effect	O
of	O
the	O
chain	O
length	O
of	O
cndmao	O
has	O
also	O
been	O
investigated	O
.	O
	
when	O
c14dmao	O
was	O
replaced	O
by	O
c12dmao	O
,	O
similar	O
phenomena	O
can	O
be	O
observed	O
with	O
a	O
slightly	O
higher	O
critical	O
surfactant	O
concentration	O
for	O
dna	O
compaction	O
and	O
a	O
slightly	O
lower	O
ph	O
of	O
tris-hcl	O
buffer	O
solution	O
with	O
ph	O
=	O
6.8	O
.	O
	
for	O
the	O
dna	O
/	O
c10dmao	O
system	O
,	O
however	O
,	O
no	O
dna	O
compaction	O
was	O
observed	O
even	O
in	O
tris-hcl	O
buffer	O
solution	O
with	O
a	O
much	O
lower	O
ph	O
and	O
a	O
much	O
higher	O
c10dmao	O
concentration	O
.	O
	
the	O
negative	O
charges	O
of	O
dna	O
molecules	O
can	O
easily	O
be	O
neutralized	O
by	O
positive	O
charges	O
of	O
cationic	O
cndmaoh	O
n	O
=	O
12	O
and	O
14	O
micelles	O
.	O
	
dna	O
was	O
compacted	O
and	O
then	O
insoluble	O
dna	O
/	O
cndmaoh	O
complexes	O
were	O
formed	O
.	O
	
because	O
of	O
the	O
much	O
higher	O
critical	O
micelle	O
concentration	O
cmc	O
of	O
the	O
shorter	O
chain	O
length	O
c10dmaoh	O
,	O
cationic	O
c10dmaoh	O
micelles	O
cannot	O
form	O
under	O
the	O
studied	O
condition	O
to	O
compact	O
dna	O
.	O
	
the	O
strategy	O
may	O
provide	O
an	O
efficient	O
and	O
alternative	O
approach	O
for	O
stimuli-responsive	O
gene	O
therapy	O
and	O
drug	O
release	O
collaborating	O
for	O
systems	B-T169
change	B-T169
a	O
social	O
science	O
framework	O
for	O
academic	O
roles	O
in	O
community	O
partnerships	O
environmental	O
health	O
researchers	O
,	O
government	O
agencies	O
,	O
and	O
community	O
groups	O
have	O
endorsed	O
long-term	O
community	O
-	O
academic	O
partnerships	O
as	O
an	O
effective	O
strategy	O
to	O
support	O
science	O
-based	O
improvements	O
in	O
environmental	O
health	O
.	O
	
social	O
sciences	O
concepts	B-T078
,	O
approaches	B-T078
,	O
and	O
methods	O
are	O
fundamental	O
to	O
these	O
translational	O
partnerships	O
.	O
	
however	O
,	O
appropriate	B-T080
roles	B-T078
for	O
academic	O
partners	O
vary	O
throughout	O
the	O
process	O
of	O
changing	B-T169
systems	B-T169
policies	O
,	O
practices	O
,	O
programs	B-T169
,	O
etc	O
.	O
	
this	O
can	O
complicate	O
planning	O
,	O
evaluating	B-T078
,	O
and	O
sustaining	B-T169
such	O
partnerships	O
.	O
	
we	O
set	O
forth	O
a	O
conceptual	B-T078
framework	I-T078
for	O
academic	O
partners	O
'	O
roles	O
at	O
different	B-T079
stages	I-T079
of	O
systems	B-T169
change	B-T169
.	O
	
we	O
apply	O
this	O
framework	B-T078
to	O
three	O
longstanding	O
academic	O
-	O
community	O
partnerships	O
involving	O
national	O
institute	O
of	O
environmental	O
health	O
sciences	O
community	O
outreach	O
and	O
engagement	O
cores	O
.	O
	
we	O
conclude	O
by	O
discussing	O
how	O
the	O
framework	B-T078
can	O
help	O
academic	O
partners	O
tap	O
appropriate	B-T080
expertise	B-T080
,	O
redefine	O
their	O
roles	O
,	O
and	O
evaluate	O
their	O
contributions	O
to	O
community	O
efforts	O
to	O
improve	B-T033
environmental	O
health	O
.	O
	
a	O
novel	B-T080
mechanical	O
simulator	O
for	O
cannulation	B-T061
and	O
sphincterotomy	B-T061
after	O
billroth	B-T061
ii	I-T061
or	O
roux-en-y	B-T061
reconstruction	I-T061
in	O
patients	O
with	O
billroth	B-T061
ii	I-T061
b	B-T061
ii	I-T061
or	O
roux-en-y	B-T061
anatomy	O
,	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
ercp	O
is	O
demanding	O
.	O
	
here	O
,	O
we	O
describe	O
a	O
novel	B-T080
simulator	O
with	O
simulated	O
fluoroscopy	O
for	O
cannulation	B-T061
and	O
sphincterotomy	B-T061
training	O
in	O
such	O
situations	O
.	O
	
a	O
custom-made	O
simulation	O
system	O
was	O
built	O
based	O
upon	O
a	O
common	B-T081
chassis	O
of	O
a	O
series	B-T081
of	O
previously	B-T079
described	O
ercp	O
simulators	O
.	O
	
the	O
papilla	O
is	O
made	O
out	O
of	O
organic	B-T080
material	O
and	O
can	O
be	O
cut	O
by	O
high	B-T079
frequency	I-T079
current	O
.	O
	
the	O
advancement	B-T169
of	O
guidewires	O
and	O
other	O
instruments	O
within	O
transparent	B-T080
mock	O
bile	O
ducts	O
can	O
be	O
viewed	O
in	O
the	O
window	O
of	O
the	O
simulator	O
without	O
the	O
need	O
for	O
fluoroscopy	O
.	O
	
the	O
ercp	O
b	B-T061
ii	I-T061
/	O
roux-en-y	B-T061
simulation	O
system	O
was	O
first	O
evaluated	O
during	O
an	O
ercp	O
course	B-T079
.	O
	
there	O
were	O
no	O
technical	O
problems	O
related	O
to	O
the	O
novel	B-T080
simulator	O
during	O
the	O
course	B-T079
.	O
	
after	O
sphincterotomy	B-T061
,	O
the	O
organic	B-T080
papillae	O
could	O
easily	O
be	O
exchanged	B-T169
within	O
a	O
few	O
seconds	B-T079
.	O
	
overall	O
,	O
the	O
novel	B-T080
b	B-T061
ii	I-T061
/	O
roux-en-y	B-T061
simulator	O
achieved	O
favorable	B-T080
results	B-T169
by	O
trainees	O
and	O
expert	O
endoscopists	O
in	O
all	O
categories	O
assessed	O
.	O
	
the	O
new	O
b	B-T061
ii	I-T061
/	O
roux-en-y	B-T061
mechanical	O
simulator	O
is	O
simple	B-T080
and	O
practicable	B-T080
.	O
	
a	O
first	O
evaluation	O
during	O
an	O
ercp	O
course	B-T079
showed	O
promising	O
a	O
thermophilic	O
-like	O
ene-reductase	B-T116
originating	O
from	O
an	O
acidophilic	B-T169
iron	O
oxidizer	O
ene-reductases	B-T116
originating	O
from	O
extremophiles	O
are	O
gaining	O
importance	O
in	O
the	O
field	O
of	O
biocatalysis	O
due	O
to	O
higher	B-T080
-	O
stability	B-T080
properties	B-T080
.	O
	
the	O
genome	O
of	O
the	O
acidophilic	B-T169
iron-oxidizing	O
bacterium	O
""""	O
"ferrovum"""	O
sp	O
.	O
	
ja12	O
was	O
found	O
to	O
harbor	O
a	O
thermophilic	O
-like	O
ene-reductase	B-T116
foye-1	B-T116
.	O
	
the	O
foye-1	O
gene	O
was	O
ligated	O
into	O
a	O
pet16bp	O
expression	O
vector	O
system	O
,	O
and	O
the	O
enzyme	B-T116
was	O
produced	O
in	O
escherichia	O
coli	O
bl21	O
de3	O
plyss	O
cells	O
in	O
yields	O
of	O
10	O
mg	O
l	O
.	O
	
foye-1	B-T116
showed	O
remarkable	O
activity	O
and	O
rates	B-T081
on	O
n-phenylmaleimide	B-T109
and	O
n-phenyl-2-methylmaleimide	B-T109
up	O
to	O
89	O
u	O
mg	O
,	O
>97	O
%	O
conversion	B-T169
,	O
95	O
%	O
r	O
with	O
both	O
nicotinamide	B-T109
cofactors	I-T109
,	O
nadph	O
and	O
nadh	O
.	O
	
the	O
catalytic	O
efficiency	B-T081
with	O
nadph	O
was	O
27	O
times	O
higher	B-T080
compared	O
to	O
nadh	O
.	O
	
at	O
the	O
temperature	B-T081
maximum	B-T081
50	O
c	O
and	O
ph	B-T081
optimum	I-T081
6.5	O
,	O
activity	O
was	O
almost	O
doubled	O
to	O
160	O
u	O
mg	O
.	O
	
these	O
findings	B-T033
accomplish	O
foye-1	B-T116
for	O
a	O
valuable	O
biocatalyst	O
in	O
the	O
synthesis	O
of	O
succinimides	B-T109
.	O
	
the	O
appearance	O
of	O
a	O
thermophilic	O
-like	O
ene-reductase	B-T116
in	O
an	O
acidic	O
habitat	O
is	O
discussed	O
with	O
respect	O
to	O
its	O
phylogenetic	O
placement	O
and	O
to	O
the	O
genomic	O
neighborhood	O
of	O
the	O
encoding	O
gene	O
,	O
awarding	O
foye-1	B-T116
a	O
putative	O
involvement	O
in	O
a	O
quorum-sensing	O
a	O
tanshinone	B-T109
i	I-T109
derivative	B-T169
enhances	O
the	O
activities	O
of	O
antibiotics	O
against	O
staphylococcus	O
aureus	O
in	B-T080
vitro	I-T080
and	O
in	O
vivo	O
infections	O
caused	O
by	O
staphylococcus	O
aureus	O
are	O
prevalent	O
.	O
	
the	O
dramatically	O
reduced	O
discovery	O
of	O
new	O
antibiotics	O
,	O
as	O
well	O
as	O
the	O
persistent	O
emergence	O
of	O
resistant	O
bacteria	O
,	O
represents	O
a	O
major	O
health	B-T078
problem	B-T033
in	O
both	O
hospital	O
and	O
community	O
settings	O
.	O
	
using	O
antibiotic	O
enhancers	O
to	O
rescue	O
existing	O
classes	O
of	O
antibiotics	O
is	O
an	O
attractive	O
strategy	O
.	O
	
in	O
this	O
study	O
,	O
16-aldehyde	O
tanshinone	O
i	O
alt	O
was	O
synthesized	O
and	O
bacteriostatic	O
activity	O
was	O
explored	O
.	O
	
in	O
addition	O
,	O
synergistic	B-T080
or	O
additive	B-T080
activity	O
between	O
alt	O
and	O
aminoglycoside	B-T109
antibiotics	I-T109
or	O
β-lactam	B-T109
antibiotics	I-T109
in	B-T080
vitro	I-T080
was	O
identified	O
.	O
	
moreover	O
,	O
alt	O
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	B-T109
str	B-T109
and	O
ampicillin	B-T109
amp	B-T109
against	O
s	O
.	O
	
aureus	O
in	O
a	O
murine	O
infection	O
model	O
.	O
	
primary	O
mechanistic	O
insight	O
indicated	O
that	O
alt	O
could	O
damage	B-T169
the	O
bacterial	O
cell	O
membrane	O
,	O
leading	O
to	O
accumulation	B-T033
of	O
antibiotics	O
inside	O
bacterial	O
cells	O
.	O
	
this	O
finding	O
might	O
be	O
useful	O
for	O
treating	B-T169
infections	O
caused	O
by	O
s	O
.	O
	
aureus	O
and	O
expand	O
the	O
scope	O
of	O
application	B-T169
of	O
investigation	O
of	O
argyrophilic	O
nucleolar	O
organizing	O
region	O
ischemia/reperfusion	O
i/r	O
injury	O
is	O
a	O
complex	O
event	O
frequently	O
observed	B-T169
in	O
vascular	B-T061
surgery	I-T061
and	O
can	O
cause	O
functional	O
and	O
structural	O
cell	O
damage	O
.	O
	
nucleolar-organizing	O
regions	O
nors	O
are	O
sites	O
of	O
the	O
ribosomal	O
genes	O
located	O
on	O
chromosomes	O
and	O
can	O
be	O
stained	O
with	O
silver	O
when	O
they	O
are	O
active	B-T169
.	O
	
thus	O
these	O
proteins	B-T116
are	O
named	O
as	O
argyrophilic-nor	B-T116
agnor	I-T116
proteins	I-T116
.	O
	
we	O
aimed	O
to	O
investigate	O
any	O
possible	O
effects	B-T080
of	I-T080
renal	O
i/r	O
injury	O
on	O
the	O
nor	B-T116
protein	I-T116
synthesis	O
and	O
association	O
between	O
the	O
agnor	B-T116
proteins	I-T116
amount	B-T081
and	O
histopathological	B-T033
injuring	I-T033
score	I-T033
.	O
	
nine	O
female	O
wistar-albino	O
rats	O
with	O
weight	O
of	O
200-250g	O
were	O
included	O
into	O
the	O
study	O
.	O
	
the	O
animals	O
were	O
randomly	B-T080
divided	B-T169
in	O
two	O
groups	B-T078
,	O
a	O
control	O
group	O
and	O
an	O
i/r	O
group	B-T078
.	O
	
in	O
i/r	O
group	B-T078
,	O
rats	O
were	O
subjected	O
to	O
45	O
minutes	O
of	O
renal	O
pedicle	O
occlusion	O
followed	O
by	O
24	O
hours	O
of	O
reperfusion	O
.	O
	
in	O
the	O
control	O
group	O
no	O
drug	B-T061
injections	I-T061
or	O
ischemia	O
reperfusion	O
were	O
performed	B-T169
in	O
animals	O
.	O
	
then	O
histopathological	B-T033
injury	I-T033
score	I-T033
,	O
mean	B-T033
agnor	I-T033
number	I-T033
and	O
total	B-T033
agnor	I-T033
area	I-T033
/	O
nuclear	B-T033
area	I-T033
taa	B-T033
/	O
na	B-T033
were	O
detected	B-T033
for	O
each	O
rat	O
.	O
	
the	O
differences	O
between	O
control	O
and	O
i/r	O
groups	B-T078
were	O
significant	B-T078
for	O
histopathological	B-T033
injury	I-T033
scores	I-T033
p	O
=	O
0.016	O
.	O
	
also	O
the	O
differences	O
between	O
control	O
group	O
and	O
i/r	O
group	B-T078
were	O
significant	B-T078
for	O
mean	B-T033
agnor	I-T033
number	I-T033
p	O
=	O
0.000	O
and	O
taa/na	B-T081
ratio	I-T081
p	O
=	O
0.000	O
.	O
	
additionally	O
,	O
there	O
was	O
a	O
positive	B-T080
correlation	I-T080
between	O
taa/na	B-T081
ratio	I-T081
and	O
histopathological	B-T033
injury	I-T033
score	I-T033
r	O
=	O
0.728	O
p	O
=	O
0.026	O
and	O
between	O
mean	B-T033
agnor	I-T033
number	I-T033
and	O
histopathological	B-T033
injury	I-T033
score	I-T033
r	O
=	O
0.670	O
p	O
=	O
0.048	O
.	O
	
the	O
detection	B-T061
of	O
agnor	B-T116
proteins	I-T116
amount	B-T081
may	O
be	O
used	O
as	O
an	O
indicator	B-T169
to	O
obtain	O
information	B-T078
about	O
the	O
cellular	O
behaviour	O
self-protective	O
mechanism	O
of	O
tubular	O
epithelial	O
cells	O
against	O
i/r	O
injury	O
and	O
cellular	O
damage	O
levels	B-T080
when	O
emotion	O
and	O
expression	B-T033
diverge	O
the	O
social	O
costs	O
of	O
parkinson's	B-T047
disease	I-T047
patients	O
with	O
parkinson's	B-T047
disease	I-T047
pd	B-T047
are	O
perceived	O
more	O
negatively	B-T033
than	O
their	O
healthy	B-T080
peers	O
,	O
yet	O
it	O
remains	O
unclear	O
what	O
factors	B-T169
contribute	O
to	O
this	O
negative	B-T033
social	O
perception	O
.	O
	
based	O
on	O
a	O
cohort	O
of	O
17	O
pd	B-T047
patients	O
and	O
20	O
healthy	B-T080
controls	I-T080
,	O
we	O
assessed	O
how	O
naïve	O
raters	O
judge	O
the	O
emotion	O
and	O
emotional	B-T033
intensity	B-T080
displayed	B-T169
in	O
dynamic	B-T169
facial	B-T033
expressions	I-T033
as	O
adults	O
with	O
and	O
without	O
pd	B-T047
watched	O
emotionally	O
evocative	O
films	O
experiment	O
1	O
,	O
and	O
how	O
age	O
-matched	O
peers	O
naïve	O
to	O
patients	O
'	O
disease	B-T047
status	O
judge	O
their	O
social	O
desirability	O
along	O
various	O
dimensions	B-T081
from	O
audiovisual	O
stimuli	O
interview	O
excerpts	O
recorded	O
after	O
certain	O
films	O
experiment	O
2	O
.	O
	
in	O
experiment	O
1	O
,	O
participants	O
with	O
pd	B-T047
were	O
rated	O
as	O
significantly	B-T081
more	I-T081
facially	B-T033
expressive	I-T033
than	O
healthy	B-T080
controls	I-T080
moreover	O
,	O
ratings	O
demonstrated	O
that	O
pd	B-T047
patients	O
were	O
routinely	O
mistaken	O
for	O
experiencing	O
a	O
negative	B-T033
emotion	O
,	O
whereas	O
controls	B-T080
were	O
rated	O
as	O
displaying	B-T169
a	O
more	O
positive	B-T033
emotion	O
than	O
they	O
reported	O
feeling	O
.	O
	
in	O
experiment	O
2	O
,	O
results	O
showed	O
that	O
age-peers	O
rated	O
pd	B-T047
patients	O
as	O
significantly	B-T081
less	I-T081
socially	O
desirable	O
than	O
control	B-T080
participants	O
.	O
	
specifically	O
,	O
pd	B-T047
patients	O
were	O
rated	O
as	O
less	O
involved	B-T169
,	O
interested	O
,	O
friendly	B-T080
,	O
intelligent	O
,	O
optimistic	B-T033
,	O
attentive	O
,	O
and	O
physically	B-T080
attractive	I-T080
than	O
healthy	B-T080
controls	I-T080
.	O
	
taken	O
together	O
,	O
our	O
results	O
point	O
to	O
a	O
disconnect	O
between	O
how	O
pd	B-T047
patients	O
report	O
feeling	O
and	O
attributions	O
that	O
others	O
make	O
about	O
their	O
emotions	O
and	O
social	O
characteristics	O
,	O
underlining	O
significant	B-T078
social	B-T080
challenges	I-T080
of	O
the	O
disease	B-T047
.	O
	
in	O
particular	O
,	O
changes	B-T169
in	O
the	O
ability	O
to	O
modulate	O
the	O
expression	B-T033
of	O
negative	B-T033
emotions	O
may	O
contribute	O
to	O
the	O
negative	B-T033
social	B-T169
impressions	O
that	O
many	O
pd	B-T047
patients	O
establishing	O
in-	O
hospital	O
geriatrics	O
services	O
in	O
africa	O
insights	O
from	O
the	O
university	O
of	O
benin	O
teaching	O
hospital	O
geriatrics	O
project	O
unawareness	O
of	O
the	O
peculiar	O
healthcare	O
needs	B-T080
of	O
the	O
elderly	O
and	O
resource	B-T078
constraints	B-T169
may	O
be	O
some	O
reasons	O
why	O
until	O
recently	O
,	O
nigerian	O
hospitals	O
have	O
not	O
been	O
equipped	O
with	O
the	O
human	B-T081
and	O
infrastructural	B-T081
resources	I-T081
required	O
to	O
meet	O
older	O
adults	O
'	O
special	O
healthcare	O
needs	B-T080
.	O
	
there	O
is	O
paucity	O
of	O
specialized	O
health	O
services	O
for	O
the	O
elderly	O
in	O
africa	O
.	O
	
nigeria	O
,	O
with	O
a	O
population	O
of	O
over	O
170	O
million	O
,	O
did	O
not	O
have	O
any	O
healthcare	O
facility	O
with	O
dedicated	O
services	O
for	O
the	O
elderly	O
until	O
2012	O
.	O
	
the	O
university	O
of	O
benin	O
teaching	O
hospital	O
ubth	O
in	O
nigeria	O
was	O
established	O
in	O
1973	O
and	O
created	O
its	O
geriatrics	O
unit	O
in	O
october	O
2013	O
.	O
	
a	O
prepared	O
environment	O
and	O
trained	O
interdisciplinary	O
teams	O
are	O
pivotal	O
in	O
providing	O
effective	O
healthcare	O
services	O
for	O
the	O
elderly	O
.	O
	
the	O
ongoing	O
ubth	O
geriatrics	O
project	O
aims	O
to	O
provide	O
specialized	O
interdisciplinary	O
health	O
services	O
to	O
older	O
adults	O
and	O
to	O
provide	O
training	O
and	O
continuing	O
professional	O
development	O
in	O
geriatrics	O
for	O
healthcare	O
staff	O
.	O
	
in	O
developing	O
our	O
inpatient	O
services	O
,	O
we	O
adopted	O
the	O
acute	O
care	O
for	O
elders	O
ace	O
model	O
and	O
worked	O
in	O
tandem	O
with	O
the	O
"""abcs"""	O
of	O
implementing	O
ace	O
units	O
.	O
	
in	O
the	O
face	O
of	O
limited	O
resources	B-T078
,	O
it	O
was	O
possible	O
to	O
establish	O
a	O
functional	O
geriatrics	O
unit	O
with	O
a	O
trained	O
interdisciplinary	O
team	O
.	O
	
family	O
participation	B-T169
is	O
central	O
in	O
our	O
practice	O
.	O
	
since	O
october	O
2013	O
,	O
residents	O
and	O
house	O
officers	O
in	O
internal	O
medicine	O
have	O
been	O
undertaking	O
4-	O
and	O
12-	O
weekly	B-T079
rotations	B-T169
,	O
respectively	O
.	O
	
there	O
is	O
also	O
a	O
robust	O
academic	B-T033
program	I-T033
,	O
which	O
includes	O
once-	O
weekly	B-T079
geriatric	B-T080
pharmacotherapy	B-T061
seminars	O
,	O
once-	O
weekly	B-T079
interdisciplinary	O
seminars	O
,	O
and	O
2-	O
weekly	B-T079
journal	O
club	O
meetings	O
alternating	O
with	O
seminars	O
on	O
geriatric	O
assessment	O
tools	O
.	O
	
it	O
is	O
possible	O
to	O
establish	O
geriatric	O
services	O
and	O
achieve	O
best	O
practices	O
in	O
resource-limited	O
settings	O
by	O
investing	O
on	O
improving	O
available	O
human	B-T081
resources	I-T081
and	O
infrastructure	O
.	O
	
we	O
also	O
make	O
recommendations	O
for	O
setting	O
up	O
similar	O
services	O
in	O
other	O
parts	O
of	O
engaging	B-T033
adolescent	O
girls	O
in	O
transactional	O
sex	O
through	B-T169
compensated	B-T080
dating	O
transactional	O
sex	O
through	B-T169
so-called	O
compensated	B-T080
dating	O
in	O
adolescent	O
girls	O
is	O
a	O
problem	B-T033
in	O
need	B-T080
of	O
public	O
concern	B-T078
.	O
	
compensated	B-T080
dating	O
typically	O
involves	O
the	O
use	B-T169
of	I-T169
information	O
communication	O
technology	O
to	O
advertise	O
,	O
search	O
,	O
bargain	O
,	O
and	O
eventually	O
arrange	O
for	O
transactional	O
sex	O
.	O
	
the	O
technology	O
enables	O
the	O
sexual	O
partners	O
to	O
maintain	O
privacy	B-T078
and	O
secrecy	B-T078
in	O
transactional	O
sex	O
.	O
	
such	O
secrecy	B-T078
necessitates	B-T080
the	O
girls	O
'	O
disclosure	O
about	O
their	O
life	O
experiences	O
in	O
order	B-T080
to	O
address	O
the	O
concern	B-T078
.	O
	
the	O
disclosure	O
is	O
the	O
focus	B-T169
of	O
the	O
present	O
qualitative	O
study	O
of	O
27	O
girls	O
practicing	O
the	O
dating	O
in	O
hong	O
kong	O
,	O
china	O
.	O
	
based	B-T169
on	O
the	O
disclosure	O
,	O
the	O
study	O
presents	O
a	O
grounded	O
theory	O
that	O
epitomizes	O
engagement	B-T033
in	O
compensated	B-T080
dating	O
by	O
referential	O
choice	O
.	O
	
such	O
a	O
referential	B-T078
choice	I-T078
theory	I-T078
unravels	O
that	O
choice	O
with	O
reference	B-T169
to	O
the	O
family	O
push	O
and	O
social	B-T078
norms	I-T078
sustains	B-T169
the	O
engagement	B-T033
.	O
	
meanwhile	O
,	O
the	O
choice	O
rests	O
on	O
expectancy	B-T078
and	O
reinforcement	B-T169
from	O
experiential	O
learning	O
about	O
compensated	B-T080
dating	O
.	O
	
the	O
theory	B-T078
thus	O
implies	O
ways	O
to	O
undercut	O
the	O
engagement	B-T033
through	B-T169
diverting	B-T080
the	O
referential	O
choice	O
of	O
the	O
numerical	O
simulation	O
of	O
emitted	O
particle	O
characteristics	B-T080
and	O
airway	O
deposition	B-T169
distribution	O
of	O
symbicort	B-T109
turbuhaler	I-T109
dry	O
powder	O
fixed	O
combination	O
aerosol	O
drug	O
one	O
of	O
the	O
most	O
widespread	O
dry	O
powder	O
fixed	O
combinations	O
used	O
in	O
asthma	B-T047
and	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
copd	B-T047
management	O
is	O
symbicort	B-T109
turbuhaler	I-T109
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
simulate	O
the	O
deposition	B-T169
distribution	O
of	O
both	O
components	O
of	O
this	O
drug	O
within	O
the	O
airways	O
based	O
on	O
realistic	O
airflow	O
measurements	O
.	O
	
breathing	O
parameters	O
of	O
25	O
healthy	B-T033
adults	I-T033
11	O
females	O
and	O
14	O
males	O
were	O
acquired	B-T080
while	O
inhaling	O
through	O
turbuhaler	O
.	O
	
individual	O
specific	O
emitted	B-T081
doses	I-T081
and	O
particle	B-T081
size	I-T081
distributions	O
of	O
symbicort	B-T109
turbuhaler	I-T109
were	O
determined	B-T080
.	O
	
a	O
self-developed	O
particle	O
deposition	B-T169
model	O
was	O
adapted	B-T169
and	O
validated	B-T169
to	O
simulate	O
the	O
deposition	B-T169
of	O
budesonide	B-T109
inhaled	B-T109
corticosteroid	I-T109
ics	B-T109
and	O
formoterol	B-T109
long	O
acting	O
β2	O
agonist	O
laba	O
in	O
the	O
upper	O
airways	O
and	O
lungs	O
of	O
the	O
healthy	O
volunteers	O
.	O
	
based	O
on	O
current	B-T079
simulations	O
the	O
emitted	B-T081
doses	I-T081
varied	O
between	O
50.4	O
and	O
92.5	O
of	O
the	O
metered	O
dose	B-T081
for	O
the	O
ics	B-T109
,	O
and	O
between	O
38%	O
and	O
96.1	O
in	O
case	O
of	O
laba	O
component	O
depending	O
on	O
the	O
individual	O
inhalation	O
flow	O
rate	O
.	O
	
this	O
variability	O
induced	B-T169
a	O
notable	O
inter-	O
individual	O
spread	B-T080
of	O
the	O
deposited	B-T169
lung	O
doses	B-T081
mean	O
33.6	O
,	O
range	B-T081
20.4	O
for	O
budesonide	B-T109
and	O
mean	O
29.8	O
,	O
range	B-T081
16.4	O
for	O
formoterol	B-T109
.	O
	
significant	B-T078
inter-gender	O
differences	B-T080
were	O
also	O
observed	B-T169
.	O
	
average	O
lung	O
dose	B-T081
of	O
budesonide	B-T109
was	O
29.2	O
of	O
the	O
metered	O
dose	B-T081
for	O
females	O
and	O
37%	O
for	O
males	O
,	O
while	O
formoterol	B-T109
deposited	B-T169
with	O
26.4	O
efficiency	B-T081
for	O
females	O
and	O
32.5	O
for	O
males	O
.	O
	
present	O
results	B-T169
also	O
highlighted	O
the	O
importance	B-T080
of	O
breath-holding	B-T033
after	O
inhalation	O
of	O
the	O
drug	O
.	O
	
about	O
a	O
half	O
of	O
the	O
total	O
lung	O
deposition	B-T169
occurred	O
during	O
breath-hold	B-T033
at	O
9.6s	O
average	O
breath-hold	B-T033
time	B-T079
.	O
	
calculated	O
depositions	B-T169
confirmed	B-T080
appropriate	B-T080
lung	O
deposition	B-T169
of	O
symbicort	B-T109
turbuhaler	I-T109
for	O
both	O
genders	O
,	O
however	O
more	O
effort	O
for	O
optimal	B-T061
inhalation	I-T061
technique	I-T061
is	O
advised	B-T078
for	O
persons	O
with	O
low	B-T033
vital	I-T033
capacity	I-T033
.	O
	
this	O
study	O
demonstrated	O
the	O
possibility	O
of	O
personalized	B-T080
prediction	B-T078
of	O
airway	O
deposition	B-T169
of	O
aerosol	O
drugs	O
by	O
numerical	O
simulations	O
.	O
	
the	O
methodology	B-T078
developed	O
in	O
this	O
study	O
will	O
be	O
applicable	B-T080
also	O
to	O
other	O
marketed	B-T080
drugs	O
in	O
the	O
nutrient	O
intake	O
of	O
infants	O
and	O
toddlers	O
in	O
the	O
united	O
arab	O
emirates	O
the	O
feeding	O
infants	O
and	O
toddlers	O
study	O
this	O
descriptive	O
study	O
evaluated	O
the	O
nutrient	B-T081
adequacy	I-T081
of	O
the	O
diet	O
of	O
infants	O
aged	O
6-11	O
months	O
and	O
toddlers	O
aged	O
12-24	O
months	O
in	O
the	O
united	O
arab	O
emirates	O
.	O
	
a	O
random	O
sample	O
of	O
1000	O
infants	O
and	O
toddlers	O
was	O
recruited	O
from	O
2	O
cities	O
al	O
ain	O
and	O
dubai	O
from	O
march	B-T079
2011	O
to	O
february	B-T080
2012	O
and	O
their	O
usual	O
nutrient	O
intake	O
was	O
determined	O
using	O
24-hour	O
recall	O
.	O
	
in	O
all	O
,	O
54.2	O
of	O
infants	O
and	O
25.2	O
of	O
toddlers	O
were	O
breastfeeding	O
.	O
	
mean	O
energy	B-T081
intake	I-T081
of	O
infant	O
girls	O
in	O
al	O
ain	O
and	O
dubai	O
was	O
747	O
sd	O
189	O
kcal	B-T081
and	O
773	O
sd	O
215	O
kcal	B-T081
respectively	O
and	O
810.5	O
sd	O
232.2	O
kcal	B-T081
and	O
821.9	O
sd	O
262	O
kcal	B-T081
for	O
boys	O
.	O
	
in	O
toddlers	O
,	O
mean	O
energy	B-T081
intake	I-T081
for	O
girls	O
in	O
al	O
ain	O
and	O
dubai	O
was	O
1032.8	O
sd	O
252	O
kcal	B-T081
and	O
1013	O
sd	O
339.1	O
kcal	B-T081
respectively	O
and	O
1057.2	O
sd	O
201.8	O
kcal	B-T081
and	O
1030.3	O
sd	O
341.7	O
kcal	B-T081
for	O
boys	O
.	O
	
iron	B-T033
intake	I-T033
was	O
low	B-T080
in	O
both	O
groups	O
.	O
	
mean	O
body	O
mass	O
index	O
and	O
body	O
weight	O
and	O
height	O
were	O
similar	O
to	O
world	O
health	O
organization	O
figures	O
but	O
significant	O
numbers	O
of	O
infants	O
and	O
toddlers	O
of	O
both	O
sexes	O
were	O
over	O
-	O
or	O
underweight	B-T033
.	O
	
although	O
mean	O
energy	O
and	O
macronutrient	O
intakes	O
were	O
comparable	O
to	O
the	O
rda	O
,	O
significant	O
numbers	O
were	O
over	B-T047
-	O
or	O
estimation	O
of	O
the	O
hiv-1	O
backward	O
mutation	B-T080
rate	I-T080
from	O
transmitted	O
drug-resistant	O
strains	O
one	O
of	O
the	O
serious	O
threats	B-T078
facing	O
the	O
administration	O
of	O
antiretroviral	B-T061
therapy	I-T061
to	O
human	O
immunodeficiency	O
virus	O
hiv-1	O
infected	B-T047
patients	O
is	O
the	O
reported	O
increasing	B-T081
prevalence	I-T081
of	O
transmitted	O
drug	O
resistance	O
.	O
	
however	O
,	O
given	O
that	O
hiv-1	O
drug-resistant	O
strains	O
are	O
often	O
less	O
fit	O
than	O
the	O
wild-type	O
strains	O
,	O
it	O
is	O
expected	O
that	O
drug-resistant	O
strains	O
that	O
are	O
present	O
during	O
the	O
primary	B-T080
phase	B-T079
of	O
the	O
hiv-1	B-T047
infection	I-T047
are	O
replaced	B-T169
by	O
the	O
fitter	O
wild-type	O
strains	O
.	O
	
this	O
replacement	B-T169
of	O
hiv-1	B-T033
resistant	I-T033
mutations	O
involves	O
the	O
emergence	O
of	O
wild-type	O
strains	O
by	O
a	O
process	O
of	O
backward	O
mutation	O
.	O
	
how	O
quickly	O
the	O
replacement	B-T169
happens	O
is	O
dependent	B-T169
on	O
the	O
class	O
of	O
hiv-1	O
mutation	O
group	B-T078
.	O
	
we	O
estimate	O
the	O
backward	O
mutation	B-T080
rates	I-T080
and	O
relative	O
fitness	O
of	O
various	O
mutational	O
groups	B-T078
known	O
to	O
confer	O
hiv-1	O
drug	O
resistance	O
.	O
	
we	O
do	O
this	O
by	O
fitting	O
a	O
stochastic	O
model	O
to	O
data	B-T078
for	O
individuals	O
who	O
were	O
originally	O
infected	B-T033
by	O
an	O
hiv-1	O
strain	O
carrying	O
any	O
one	O
of	O
the	O
known	O
drug	O
resistance	O
-conferring	O
mutations	O
and	O
observed	O
over	O
a	O
period	O
of	O
time	O
to	O
see	O
whether	O
the	O
resistant	B-T169
strain	O
is	O
replaced	B-T169
.	O
	
to	O
do	O
this	O
,	O
we	O
seek	O
a	O
distribution	B-T169
,	O
generated	O
from	O
simulations	O
of	O
the	O
stochastic	O
model	O
,	O
that	O
best	O
describes	O
the	O
observed	B-T169
clinical	O
data	O
replacement	B-T169
times	B-T081
of	O
a	O
given	O
mutation	O
.	O
	
we	O
found	O
that	O
lamivudine/emtricitabine	B-T109
-associated	O
mutations	O
have	O
a	O
distinctly	O
higher	O
,	O
backward	O
mutation	B-T080
rate	I-T080
and	O
low	O
relative	B-T080
fitness	O
compared	O
to	O
the	O
other	O
classes	O
as	O
has	O
been	O
reported	O
before	O
while	O
protease	O
inhibitors	O
-associated	O
mutations	O
have	O
a	O
slower	O
backward	O
mutation	B-T080
rate	I-T080
and	O
high	O
relative	B-T080
fitness	O
.	O
	
for	O
the	O
other	O
mutation	O
classes	O
,	O
we	O
found	O
more	O
uncertainty	O
in	O
their	O
modeling	O
the	O
hospital	O
safety	O
partnership	O
preferences	B-T080
of	I-T080
patients	I-T080
and	O
their	O
families	O
a	O
discrete	B-T080
choice	O
conjoint	O
experiment	O
patients	O
and	O
their	O
families	O
play	O
an	O
important	O
role	O
in	O
efforts	O
to	O
improve	O
health	O
service	O
safety	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
is	O
to	O
understand	O
the	O
safety	O
partnership	O
preferences	B-T080
of	I-T080
patients	I-T080
and	O
their	O
families	O
.	O
	
we	O
used	O
a	O
discrete	B-T080
choice	O
conjoint	O
experiment	O
to	O
model	O
the	O
safety	O
partnership	O
preferences	B-T080
of	O
1	O
patients	O
or	O
those	O
such	O
as	O
parents	O
acting	O
on	O
their	O
behalf	O
.	O
	
participants	O
made	O
choices	O
between	O
hypothetical	O
safety	O
partnerships	O
composed	O
by	O
experimentally	O
varying	O
15	O
four-level	O
partnership	O
design	O
attributes	O
.	O
	
participants	O
preferred	B-T078
an	O
approach	O
to	O
safety	O
based	O
on	O
partnerships	O
between	O
patients	O
and	O
staff	O
rather	O
than	O
a	O
model	O
delegating	O
responsibility	O
for	O
safety	O
to	O
hospital	O
staff	O
.	O
	
they	O
valued	O
the	O
opportunity	O
to	O
participate	O
in	O
point	O
of	O
service	O
safety	O
partnerships	O
,	O
such	O
as	O
identity	O
and	O
medication	O
double	O
checks	O
,	O
that	O
might	O
afford	O
an	O
immediate	B-T079
risk	O
reduction	O
.	O
	
latent	O
class	O
analysis	O
yielded	O
two	O
segments	O
.	O
	
actively	O
engaged	O
participants	O
73.3	O
comprised	O
outpatients	O
with	O
higher	O
education	O
,	O
who	O
anticipated	B-T033
more	O
benefits	B-T081
to	O
safety	O
partnerships	O
,	O
were	O
more	B-T033
confident	I-T033
in	O
their	O
ability	O
to	O
contribute	O
,	O
and	O
were	O
more	O
intent	B-T080
on	O
participating	B-T169
.	O
	
they	O
were	O
more	O
likely	O
to	O
prefer	B-T080
a	O
personal	O
engagement	O
strategy	O
,	O
valued	O
scientific	B-T078
evidence	I-T078
,	O
preferred	B-T078
a	O
more	O
active	O
approach	O
to	O
safety	O
education	O
,	O
and	O
advocated	O
disclosure	B-T080
of	I-T080
errors	I-T080
.	O
	
the	O
passively	O
engaged	O
segment	O
26.7	O
anticipated	B-T033
fewer	B-T081
benefits	B-T081
,	O
were	O
less	O
confident	O
in	O
their	O
ability	O
to	O
contribute	O
,	O
and	O
were	O
less	O
intent	O
on	O
participating	B-T169
.	O
	
they	O
were	O
more	O
likely	O
to	O
prefer	O
an	O
engagement	O
strategy	O
based	O
on	O
signage	O
.	O
	
they	O
preferred	B-T078
that	O
staff	O
explain	O
why	O
they	O
thought	O
patients	O
should	O
help	O
make	O
care	O
safer	O
and	O
decide	O
whether	O
errors	B-T080
were	O
disclosed	O
.	O
	
inpatients	O
,	O
those	O
with	O
immigrant	B-T033
backgrounds	I-T033
,	O
and	O
those	O
with	O
less	B-T033
education	I-T033
were	O
more	O
likely	O
to	O
be	O
in	O
this	O
segment	O
.	O
	
health	O
services	O
need	O
to	O
communicate	O
information	B-T078
regarding	O
risks	B-T078
,	O
ask	O
about	O
partnership	O
preferences	B-T080
,	O
create	O
opportunities	O
respecting	O
individual	O
differences	O
,	O
and	O
ensure	O
a	O
positive	B-T033
response	I-T033
when	O
patients	O
raise	O
safety	O
concerns	B-T078
.	O
	
influence	O
of	O
ozone	O
and	O
paracetic	B-T109
acid	I-T109
disinfection	B-T061
on	O
adhesion	O
of	O
resilient	O
liners	O
to	O
acrylic	O
resin	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
paracetic	B-T109
acid	I-T109
paa	B-T109
and	O
ozone	O
disinfection	B-T061
on	O
the	O
tensile	B-T081
bond	I-T081
strength	I-T081
tbs	B-T081
of	O
silicone-based	B-T109
resilient	O
liners	O
to	O
acrylic	O
resins	O
.	O
	
one	O
hundred	O
and	O
twenty	O
dumbbell	O
shaped	O
heat-polymerized	O
acrylic	O
resins	O
were	O
prepared	O
.	O
	
from	O
the	O
mid	O
segment	O
of	O
the	O
specimens	O
,	O
3	O
mm	O
of	O
acrylic	O
were	O
grinded	O
off	O
and	O
separated	O
parts	O
were	O
reattached	O
by	O
resilient	O
liners	O
.	O
	
the	O
specimens	O
were	O
divided	O
into	O
2	O
control	O
control1	O
,	O
control7	O
and	O
4	O
test	O
groups	O
of	O
paa	B-T109
and	O
ozone	O
disinfection	B-T061
paa1	B-T109
,	O
paa7	B-T109
,	O
ozone1	O
and	O
ozone7	O
n=10	O
.	O
	
while	O
control	O
groups	O
were	O
immersed	O
in	O
distilled	O
water	O
for	O
10	O
min	O
control1	O
and	O
7	O
days	O
control7	O
,	O
test	O
groups	O
were	O
subjected	O
to	O
paa	B-T109
16	O
g/l	O
or	O
ozone	O
rich	O
water	O
4	O
mg/l	O
for	O
1	O
cycle	O
10	O
min	O
for	O
paa	B-T109
and	O
60	O
min	O
for	O
ozone	O
per	O
day	O
for	O
7	O
days	O
prior	O
to	O
tensile	B-T081
tests	O
.	O
	
measurements	O
of	O
the	O
tbs	B-T081
were	O
analyzed	O
using	O
3-way	O
anova	B-T081
and	O
tukey's	O
hsd	O
test	O
.	O
	
adhesive	O
strength	B-T078
of	O
mollosil	B-T109
decreased	O
significantly	O
by	O
application	O
of	O
ozone	O
disinfection	B-T061
.	O
	
paa	B-T109
disinfection	B-T061
had	O
no	O
negative	O
effect	O
on	O
the	O
tbs	B-T081
values	O
of	O
mollosil	B-T109
and	O
molloplast	B-T109
b	I-T109
to	O
acrylic	O
resin	O
.	O
	
single	O
application	O
of	O
ozone	O
disinfection	B-T061
did	O
not	O
have	O
any	O
negative	O
effect	O
on	O
tbs	B-T081
values	O
of	O
molloplast	B-T109
b	I-T109
,	O
but	O
prolonged	B-T079
exposure	B-T033
to	I-T033
ozone	I-T033
decreased	O
its	O
adhesive	O
strength	B-T078
.	O
	
the	O
adhesion	O
of	O
resilient	O
liners	O
to	O
acrylic	O
was	O
not	O
adversely	O
affected	O
by	O
paa	B-T109
disinfection	B-T061
.	O
	
immersion	O
in	O
ozonated	O
water	O
significantly	O
decreased	O
tbs	B-T081
of	O
mollosil	B-T109
.	O
	
prolonged	O
exposure	O
to	O
ozone	O
negatively	O
affects	O
adhesion	O
of	O
molloplast	B-T109
b	I-T109
to	O
denture	O
base	O
materials	O
.	O
	
the	O
construction	O
of	O
three-dimensional	O
composite	O
fibrous	B-T080
macrostructures	O
with	B-T080
nanotextures	I-T080
for	O
biomedical	O
applications	B-T169
the	O
development	O
of	O
modern	O
biomedical	O
nanotechnology	O
requires	O
three-dimensional	O
macrostructures	O
with	B-T080
nanotextures	I-T080
to	O
meet	O
the	O
requirements	O
for	O
practical	O
applications	B-T169
in	O
intricate	O
biological	O
systems	O
.	O
	
additionally	O
,	O
the	O
restoration	O
and	O
regeneration	O
of	O
some	O
specific	O
body	O
tissues	O
and	O
organs	O
rely	O
on	O
the	O
function	O
of	O
conductive	O
polymers	O
,	O
which	O
can	O
provide	O
electrical	B-T169
cues	B-T078
for	O
cells	O
.	O
	
in	O
this	O
study	O
,	O
we	O
fabricated	O
three-dimensional	O
composite	O
nanofibre	O
macrostructures	O
of	O
polycaprolactone	B-T109
pcl	B-T109
with	O
different	O
concentrations	B-T081
of	O
polyaniline	B-T109
pani	B-T109
by	O
employing	O
an	O
improved	O
electrospinning	B-T169
technology	I-T169
with	O
a	O
specially	O
designed	O
collector	O
.	O
	
the	O
3d	O
structures	O
possessed	O
cap-like	O
macrostructures	O
with	O
centimetre-scale	B-T081
thickness	B-T080
and	O
interconnected	O
pore	B-T080
nanotextures	I-T080
with	O
nanometre-scale	B-T081
nanofibres	O
.	O
	
to	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3d	O
pcl	B-T109
/	O
pani	B-T109
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
c2c12	O
cells	O
were	O
cultured	O
as	O
model	O
cells	O
.	O
	
the	O
initial	O
responses	O
of	O
c2c12	O
cells	O
to	O
the	O
3d	O
pcl	B-T109
/	O
pani	B-T109
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
pcl	B-T109
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast-like	B-T080
morphologies	I-T080
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
less	O
than	O
2.0	O
wt%	O
of	O
conductive	O
pani	B-T109
facilitated	O
cell	O
proliferation	O
,	O
which	O
indicated	O
that	O
pani	B-T109
has	O
appreciable	O
cell	O
affinity	O
.	O
	
moreover	O
,	O
the	O
addition	O
of	O
conductive	B-T080
pani	B-T109
to	O
the	O
3d	O
composite	O
nanofibre	O
macrostructures	O
considerably	O
enhanced	O
myoblast	O
differentiation	O
and	O
myotube	O
maturation	O
.	O
	
these	O
results	O
suggest	O
that	O
electrospun	B-T080
3d	O
pcl	B-T109
/	O
pani	B-T109
composite	O
nanofibre	O
macrostructures	O
would	O
have	O
promising	O
applications	O
in	O
tissue	O
engineering	I-T061
mechanisms	B-T169
of	O
replacement	B-T169
of	O
circulating	B-T169
viruses	O
by	O
seasonal	B-T047
and	O
pandemic	O
influenza	O
a	O
viruses	O
seasonal	B-T047
influenza	I-T047
causes	O
annual	O
epidemics	O
by	O
the	O
accumulation	B-T033
of	O
antigenic	O
changes	O
.	O
	
pandemic	B-T047
influenza	I-T047
occurs	O
through	O
a	O
major	O
antigenic	O
change	O
of	O
the	O
influenza	O
a	O
virus	O
,	O
which	O
can	O
originate	B-T079
from	O
other	O
hosts	O
.	O
	
although	O
new	O
antigenic	O
variants	O
of	O
the	O
influenza	O
a	O
virus	O
replace	O
formerly	O
circulating	B-T169
seasonal	O
and	O
pandemic	O
viruses	O
,	O
replacement	B-T169
mechanisms	B-T169
remain	O
poorly	O
understood	O
.	O
	
a	O
stochastic	O
individual-based	O
seir	O
susceptible-exposed-infectious-recovered	O
model	O
with	O
two	O
viral	O
strains	O
formerly	O
circulating	B-T169
old	O
strain	O
and	O
newly	O
emerged	O
strain	O
was	O
developed	O
for	O
simulations	O
to	O
elucidate	O
the	O
replacement	B-T169
mechanisms	B-T169
.	O
	
factors	B-T169
and	O
conditions	B-T080
of	O
virus	O
and	O
host	O
populations	O
affecting	O
the	O
replacement	B-T169
were	O
identified	O
.	O
	
replacement	O
is	O
more	O
likely	O
to	O
occur	O
in	O
tropical	O
regions	O
than	O
temperate	O
regions	O
.	O
	
the	O
magnitude	B-T081
of	O
the	O
ongoing	O
epidemic	O
by	O
the	O
old	O
strain	O
,	O
herd	O
immunity	O
against	O
the	O
old	O
strain	O
,	O
and	O
timing	B-T079
of	O
appearance	B-T080
of	O
the	O
new	O
strain	O
are	O
not	O
that	O
important	O
for	O
replacement	B-T169
.	O
	
it	O
is	O
probable	O
that	O
the	O
frequency	O
of	O
replacement	B-T169
by	O
a	O
pandemic	O
virus	O
is	O
higher	O
than	O
a	O
seasonal	O
virus	O
because	O
of	O
the	O
high	O
initial	O
susceptibility	B-T169
and	O
high	O
basic	O
reproductive	O
number	O
of	O
the	O
pandemic	O
virus	O
.	O
	
the	O
findings	O
of	O
this	O
study	O
on	O
replacement	B-T169
mechanisms	B-T169
could	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
virus	O
transmission	O
dynamics	O
and	O
may	O
possibly	O
be	O
helpful	O
in	O
establishing	O
an	O
effective	B-T080
strategy	O
to	O
mitigate	O
the	O
impact	O
of	O
seasonal	B-T047
and	O
pandemic	B-T047
influenza	I-T047
.	O
	
request	O
and	O
fulfillment	B-T169
of	O
postpartum	B-T079
tubal	B-T061
ligation	I-T061
in	O
patients	O
after	O
high-risk	O
pregnancy	O
female	B-T061
sterilization	I-T061
is	O
one	O
of	O
the	O
most	O
prevalent	O
methods	O
of	O
contraception	B-T061
in	O
the	O
united	O
states	O
.	O
	
prior	O
studies	O
have	O
shown	O
that	O
nearly	O
half	O
of	O
postpartum	B-T079
tubal	B-T061
ligation	I-T061
pptl	B-T061
requests	O
go	O
unfulfilled	B-T169
.	O
	
this	O
study	O
seeks	O
to	O
establish	O
whether	O
obstetric	B-T169
or	O
medical	B-T078
risk	I-T078
status	B-T080
influences	O
patients	O
'	O
request	O
for	O
or	O
subsequent	O
completion	B-T080
of	O
pptl	B-T061
.	O
	
this	O
study	O
was	O
a	O
retrospective	O
cohort	O
study	O
of	O
women	O
delivering	O
at	O
a	O
university	O
hospital	O
in	O
2009-2010	O
who	O
received	O
prenatal	O
care	O
in	O
the	O
faculty	O
and	O
resident	O
clinics	O
.	O
	
high-risk	B-T033
status	B-T080
was	O
defined	O
by	O
society	O
for	O
maternal-fetal	O
medicine	O
guidelines	O
.	O
	
documentation	O
of	O
contraceptive	O
plan	O
and	O
administration	B-T061
of	O
contraceptive	B-T061
methods	I-T061
was	O
abstracted	B-T079
from	O
patient	O
records	O
.	O
	
subsequent	O
pregnancies	O
through	O
march	O
1	O
,	O
2013	O
,	O
were	O
abstracted	B-T079
.	O
	
of	O
3063	O
participants	O
2048	O
low	B-T081
risk	I-T081
and	O
1015	O
high	B-T033
risk	I-T033
,	O
231	O
requested	O
pptl	B-T061
7.5	O
.	O
	
this	O
was	O
more	O
likely	O
among	O
high-risk	B-T033
patients	O
than	O
low-risk	B-T081
patients	O
10.0	O
vs	O
.	O
	
6.3	O
,	O
p<	O
,	O
those	O
with	O
public	B-T078
insurance	I-T078
13.8	O
vs	O
.	O
	
3.2	O
,	O
p<	O
and	O
those	O
with	O
an	O
unintended	B-T033
index	I-T033
pregnancy	I-T033
13.8	O
vs	O
.	O
	
4.1	O
,	O
p<	O
.	O
	
of	O
the	O
patients	O
requesting	O
pptl	B-T061
,	O
118	O
51.1	O
underwent	O
the	O
procedure	B-T061
immediately	O
postpartum	B-T079
.	O
	
completion	B-T080
was	O
not	O
associated	O
with	O
high-risk	B-T033
status	B-T080
54.0	O
,	O
or	O
with	O
race	O
,	O
insurance	B-T078
status	I-T078
or	O
parity	B-T033
.	O
	
among	O
113	O
women	O
with	O
an	O
unfulfilled	B-T169
pptl	B-T061
request	O
,	O
there	O
were	O
17	O
subsequent	O
pregnancies	O
15.0	O
during	O
the	O
27	O
months	B-T079
of	O
follow-up	O
.	O
	
though	O
women	O
with	O
high-risk	O
pregnancies	O
were	O
more	O
likely	O
to	O
request	O
pptl	B-T061
,	O
they	O
were	O
not	O
more	O
likely	O
to	O
complete	B-T080
the	O
procedure	B-T061
.	O
	
over	O
one	O
third	O
of	O
high-risk	B-T033
patients	O
'	O
requests	O
were	O
unfulfilled	B-T169
,	O
indicating	O
that	O
significant	O
barriers	O
may	O
remain	O
.	O
	
though	O
women	O
with	O
high-risk	O
pregnancies	O
were	O
more	O
likely	O
to	O
request	O
pptl	B-T061
,	O
they	O
were	O
not	O
more	O
likely	O
to	O
complete	B-T080
the	O
procedure	B-T061
.	O
	
providers	O
should	O
consider	O
these	O
procedures	B-T061
urgent	B-T079
,	O
especially	O
in	O
high-risk	B-T033
women	O
,	O
and	O
advocate	O
for	O
their	O
patients	O
'	O
access	O
to	O
this	O
gut	O
microbiota	O
after	O
roux-en-y	B-T061
gastric	I-T061
bypass	I-T061
and	O
sleeve	B-T061
gastrectomy	I-T061
in	O
a	O
diabetic	B-T047
rat	O
model	O
increased	O
diversity	B-T080
and	O
associations	O
of	O
discriminant	B-T080
genera	O
with	O
metabolic	O
changes	B-T169
recent	O
work	O
with	O
gut	O
microbiota	O
after	O
bariatric	B-T061
surgery	I-T061
is	O
limited	O
,	O
and	O
the	O
results	O
have	O
not	O
been	O
in	O
agreement	O
.	O
	
given	O
the	O
role	O
of	O
the	O
gut	O
microbiota	O
in	O
regulating	O
host	O
metabolism	O
,	O
we	O
explored	O
the	O
effect	O
of	O
roux-en-y	B-T061
gastric	I-T061
bypass	I-T061
rygb	B-T061
and	O
sleeve	B-T061
gastrectomy	I-T061
sg	B-T061
on	O
the	O
modifications	O
of	O
gut	O
microbiota	O
with	O
regard	O
to	O
the	O
potential	O
influence	O
of	O
food	O
intake	B-T169
and/or	O
weight	O
loss	B-T081
and	O
examined	O
their	O
links	O
with	O
host	O
metabolism	O
.	O
	
zucker	O
diabetic	O
fatty	O
rats	O
were	O
divided	O
into	O
the	O
following	O
groups	O
rygb	O
sham-operated	O
with	O
pair-fed	O
as	O
rygb	O
sham-operated	O
fed	O
ad	O
libitum	O
and	O
sg	O
.	O
	
the	O
metabolic	O
effects	O
and	O
gut	O
microbiota	O
profile	O
were	O
analyzed	O
10	O
weeks	O
postoperatively	O
.	O
	
associations	O
between	O
discriminating	O
genera	O
and	O
metabolic	O
markers	O
after	O
rygb	O
were	O
explored	O
.	O
	
the	O
2	O
procedures	O
induced	O
similar	O
glucose	O
improvement	O
and	O
increased	O
flora	O
diversity	O
after	O
10	O
weeks	O
compared	O
with	O
sham-operated	O
groups	O
.	O
	
rygb	O
induced	O
a	O
marked	O
higher	O
relative	O
abundance	O
of	O
proteobacteria	O
/	O
gammaproteobacteria	O
and	O
betaproteobacteria	O
and	O
increased	O
emergence	O
of	O
fusobacteria	O
and	O
clostridium	O
,	O
whereas	O
sg	O
resulted	O
in	O
more	O
abundant	O
actinobacteria	O
compared	O
with	O
other	O
groups	O
.	O
	
most	O
of	O
the	O
12	O
discriminant	O
genera	O
correlated	O
with	O
changes	O
in	O
metabolic	O
phenotype	O
,	O
but	O
only	O
28.6	O
of	O
these	O
correlations	O
were	O
independent	O
of	O
weight	O
,	O
and	O
4	O
discriminant	O
genera	O
still	O
negatively	O
correlated	O
with	O
serum	O
insulin	O
level	O
independent	O
of	O
food	O
intake	O
and	O
weight	O
loss	B-T081
after	O
rygb	O
.	O
	
these	O
data	O
demonstrate	O
that	O
rygb	O
and	O
sg	O
surgery	O
produced	O
similar	O
diversity	O
but	O
different	O
microbiota	O
compositions	O
changes	O
in	O
zucker	O
diabetic	O
fatty	O
rats	O
.	O
	
these	O
findings	O
stimulate	O
deeper	O
explorations	O
of	O
functions	O
of	O
the	O
discriminate	O
microbiota	O
and	O
the	O
mechanisms	O
linking	O
postsurgical	O
modulation	O
of	O
gut	O
microbiota	O
and	O
improvements	O
in	O
insulin	O
resistance	O
ocular	O
toxicity	O
of	O
auy922	B-T109
in	O
pigmented	O
and	O
albino	O
rats	O
auy922	B-T109
,	O
a	O
heat	B-T116
shock	I-T116
protein	I-T116
90	I-T116
inhibitor	B-T080
is	O
associated	O
with	O
ocular	O
adverse	O
events	O
aes	O
.	O
	
to	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
aes	O
in	O
patients	O
,	O
4	O
investigative	O
studies	O
were	O
performed	O
in	O
a	O
step-wise	O
approach	O
to	O
assess	O
retinal	O
structure	O
and	O
function	O
in	O
pigmented	O
brown	O
norway	O
and	O
albino	O
wistar	O
rats	O
.	O
	
in	O
rats	O
administered	O
30mg/kg	O
of	O
auy922	O
,	O
the	O
auc	O
0-24	O
h	O
and	O
cmax	O
are	O
comparable	O
to	O
that	O
in	O
patients	O
at	O
70mg/m	O
.	O
	
auy922	O
at	O
30mg/kg	O
was	O
poorly	O
tolerated	O
by	O
rats	O
with	O
morbidity	O
or	O
mortality	O
generally	O
after	O
the	O
third	O
weekly	O
treatment	O
.	O
	
electroretinography	O
erg	O
changes	O
were	O
observed	O
at	O
doses	O
30mg/kg	O
.	O
	
the	O
erg	O
changes	O
were	O
dose	O
dependent	O
,	O
consistent	O
with	O
an	O
effect	O
on	O
the	O
photoreceptors	O
,	O
and	O
fully	O
reversible	O
.	O
	
the	O
erg	O
effects	O
could	O
not	O
be	O
minimized	O
by	O
decreasing	O
the	O
cmax	O
while	O
maintaining	O
auc	O
.	O
	
histopathological	O
changes	O
were	O
seen	O
mainly	O
when	O
rats	O
were	O
administered	O
auy922	O
at	O
100mg/kg	O
.	O
	
the	O
2-	O
hour	O
infusion	O
of	O
auy922	O
at	O
100mg/kg	O
caused	O
disorganization	O
of	O
the	O
outer	O
segment	O
photoreceptor	O
morphology	O
in	O
male	O
brown	O
norway	O
rats	O
the	O
severity	O
of	O
the	O
disorganization	O
increased	O
with	O
the	O
number	O
of	O
administrations	O
,	O
but	O
was	O
reversible	O
during	O
a	O
4-	O
week	O
posttreatment	O
period	O
.	O
	
there	O
was	O
no	O
major	O
difference	O
in	O
ocular	O
response	O
between	O
brown	O
norway	O
and	O
wistar	O
rats	O
.	O
	
no	O
changes	O
in	O
serum	O
iron	O
levels	O
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
pde6α	O
,	O
β-transducin	O
concentrations	O
,	O
or	O
retinal	O
pigment	O
epithelium-specific	O
protein	O
rpe65	O
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
auy922	O
at	O
100mg/kg	O
compared	O
to	O
vehicle-treated	O
controls	O
.	O
	
auy922	O
retinal	O
toxicity	O
in	O
rats	O
recapitulates	O
and	O
further	O
characterizes	O
that	O
reported	O
in	O
patients	O
and	O
is	O
shown	O
to	O
be	O
reversible	O
,	O
while	O
a	O
precise	O
molecular	O
mechanism	O
for	O
the	O
effect	O
was	O
not	O
assessment	O
of	O
cerebral	O
blood	O
perfusion	O
reserve	O
with	O
acetazolamide	B-T109
using	O
3d	O
spiral	O
asl	O
mri	O
preliminary	O
experience	O
in	O
pediatric	B-T080
patients	O
to	O
demonstrate	O
the	O
clinical	O
feasibility	O
of	O
a	O
new	O
non-cartesian	O
cylindrically-distributed	O
spiral	O
3d	O
pseudo-continuous	O
arterial	O
spin	O
labeling	O
pcasl	O
magnetic	O
resonance	O
imaging	O
mri	O
pulse	O
sequence	O
in	O
pediatric	B-T080
patients	O
in	O
quantifying	B-T081
cerebral	B-T033
blood	I-T033
flow	I-T033
cbf	B-T033
response	O
to	O
an	O
acetazolamide	O
acz	O
vasodilator	O
challenge	O
.	O
	
mri	O
exams	O
were	O
performed	O
on	O
two	O
3	O
tesla	O
philips	O
ingenia	O
systems	O
using	O
32	O
channel	O
head	O
coil	O
arrays	O
.	O
	
after	O
local	O
institutional	O
review	O
board	O
approval	O
,	O
the	O
3d	O
spiral-based	O
pcasl	O
technique	O
was	O
added	O
to	O
a	O
standard	O
brain	O
mri	O
exam	O
and	O
evaluated	O
in	O
13	O
pediatric	B-T080
patients	O
average	O
age	O
11.7	O
,	O
range	O
1.4	O
.	O
	
all	O
patients	O
were	O
administered	O
acz	B-T109
for	O
clinically	B-T033
indicated	I-T033
reasons	O
.	O
	
quantitative	O
whole-brain	O
cbf	O
measurements	O
were	O
computed	O
pre	B-T079
-	O
and	O
post	B-T079
-	O
acz	B-T109
to	O
assess	O
cerebrovascular	O
reserve	O
.	O
	
3d	O
spiral	O
pcasl	O
data	B-T078
were	O
successfully	O
reconstructed	O
in	O
all	O
13	O
cases	O
.	O
	
in	O
11	O
patients	O
,	O
cbf	B-T033
increased	O
2.8	O
to	O
93.2	O
after	O
administration	O
of	O
acz	B-T109
.	O
	
in	O
the	O
two	O
remaining	O
patients	O
,	O
cbf	B-T033
decreased	O
by	O
2.4	O
to	O
6.0	O
after	O
acz	B-T109
.	O
	
the	O
group	O
average	O
change	O
in	O
cbf	B-T033
due	O
to	O
acz	B-T109
was	O
approximately	O
25.0	O
and	O
individual	O
changes	O
were	O
statistically	B-T081
significant	I-T081
p<0	O
in	O
all	O
patients	O
using	O
a	O
paired	O
t-test	O
analysis	O
.	O
	
cbf	B-T033
perfusion	O
data	O
were	O
diagnostically	O
useful	O
in	O
supporting	O
conventional	O
mr	O
angiography	O
and	O
clinical	O
findings	O
.	O
	
3d	O
cylindrically-distributed	O
spiral	O
pcasl	O
mri	O
provides	O
a	O
robust	O
approach	O
to	O
assess	O
cerebral	B-T033
blood	I-T033
flow	I-T033
and	O
reserve	O
in	O
pediatric	B-T080
patients	O
.	O
	
assessing	O
the	O
learning	O
potential	B-T080
of	O
an	O
interactive	O
digital	O
game	O
versus	O
an	O
interactive-style	O
didactic	B-T080
lecture	O
the	O
continued	O
importance	O
of	O
didactic	B-T080
teaching	O
in	O
medical	O
student	O
education	O
games	O
with	O
educational	O
intent	O
offer	O
a	O
possible	B-T033
advantage	O
of	O
being	O
more	O
interactive	O
and	O
increasing	B-T081
learner	O
satisfaction	O
.	O
	
we	O
conducted	O
a	O
two-armed	O
experiment	O
to	O
evaluate	O
student	O
satisfaction	O
and	O
content	O
mastery	O
for	O
an	O
introductory	O
pediatric	O
radiology	O
topic	O
,	O
taught	B-T080
by	O
either	O
an	O
interactive	O
digital	O
game	O
or	O
with	O
a	O
traditional	B-T169
didactic	B-T080
lecture	O
.	O
	
medical	O
students	O
participating	B-T169
in	O
a	O
fourth-year	O
radiology	O
elective	B-T079
were	O
invited	O
to	O
participate	B-T169
.	O
	
student	O
cohorts	O
were	O
alternatively	O
given	O
a	O
faculty	O
-	O
supervised	O
1h	O
session	O
playing	O
a	O
simple	O
interactive	O
digital	B-T080
tic-tac-toe	O
quiz	O
module	O
on	O
pediatric	O
gastrointestinal	O
radiology	O
or	O
a	O
1h	O
didactic	B-T080
introductory	O
lecture	O
on	O
the	O
same	O
topic	O
.	O
	
survey	O
questions	O
assessed	O
the	O
learners'	O
perceived	O
ability	O
to	O
recall	O
the	O
material	O
as	O
well	O
as	O
their	O
satisfaction	O
with	O
the	O
educational	O
experience	O
.	O
	
results	O
of	O
an	O
end-of-rotation	B-T079
exam	B-T169
were	O
reviewed	B-T080
to	O
evaluate	O
a	O
quantitative	B-T081
measure	I-T081
of	O
learning	O
between	O
groups	B-T078
.	O
	
survey	O
responses	O
were	O
analyzed	O
with	O
a	O
chi-squared	O
test	O
.	O
	
exam	B-T169
results	O
for	O
both	O
groups	B-T078
were	O
analyzed	O
with	O
a	O
paired	O
student's	B-T081
t-test	I-T081
.	O
	
students	O
in	O
the	O
lecture	O
group	B-T078
had	O
higher	B-T080
test	B-T080
scores	I-T080
compared	O
to	O
students	O
in	O
the	O
game	O
group	B-T078
4.0	O
versus	O
3.6	O
,	O
p	O
=	O
0.045	O
.	O
	
students	O
in	O
the	O
lecture	O
group	B-T078
reported	O
greater	B-T081
understanding	O
and	O
recall	O
of	O
the	O
material	O
than	O
students	O
in	O
the	O
game	O
group	B-T078
p	O
<	O
0.001	O
and	O
p	O
=	O
0.004	O
,	O
respectively	O
.	O
	
students	O
in	O
the	O
lecture	O
group	B-T078
perceived	O
the	O
lecture	O
to	O
be	O
more	O
enjoyable	B-T033
and	O
a	O
better	O
use	O
of	O
their	O
time	B-T079
compared	O
to	O
those	O
in	O
the	O
game	O
group	B-T078
p	O
=	O
0.04	O
and	O
p	O
<	O
0.001	O
,	O
respectively	O
.	O
	
there	O
was	O
no	O
statistically	B-T081
significant	I-T081
difference	B-T033
between	O
the	O
lecture	O
and	O
game	O
group	B-T078
in	O
ability	O
to	O
maintain	O
interest	O
p	O
=	O
0.187	O
.	O
	
in	O
comparison	O
to	O
pre-survey	B-T079
results	O
,	O
there	O
was	O
a	O
statistically	B-T081
significant	I-T081
decrease	B-T081
in	O
interest	O
for	O
further	O
digital	B-T080
interactive	O
materials	O
reported	O
by	O
students	O
in	O
the	O
game	O
group	B-T078
p	O
=	O
0.146	O
.	O
	
our	O
experience	O
supported	O
the	O
use	O
of	O
a	O
traditional	B-T169
lecture	O
over	O
a	O
digital	O
game	O
module	O
.	O
	
while	O
these	O
results	O
might	O
be	O
affected	B-T169
by	O
the	O
specific	B-T080
lecture	O
and	O
digital	B-T080
content	O
in	O
any	O
given	O
comparison	O
,	O
a	O
digital	B-T080
module	O
predictors	B-T078
of	O
30-	O
day	B-T079
mortality	B-T081
in	O
patients	O
with	O
spontaneous	B-T169
primary	B-T080
intracerebral	B-T033
hemorrhage	I-T033
intracerebral	B-T033
hemorrhage	I-T033
ich	B-T033
is	O
a	O
life	B-T033
threatening	I-T033
entity	O
,	O
and	O
an	O
early	O
outcome	O
assessment	O
is	O
mandatory	O
for	O
optimizing	O
therapeutic	B-T061
efforts	I-T061
.	O
	
we	O
retrospectively	B-T080
analyzed	O
data	B-T078
from	O
342	O
patients	O
with	O
spontaneous	B-T169
primary	B-T080
ich	B-T033
to	O
evaluate	O
possible	O
predictors	B-T078
of	O
30-	O
day	B-T079
mortality	B-T081
considering	O
clinical	B-T080
,	O
radiological	B-T169
,	O
and	O
therapeutical	B-T169
parameters	O
.	O
	
we	O
also	O
applied	O
three	O
widely	O
accepted	O
outcome	O
grading	O
scoring	O
systems	O
ich	B-T081
score	I-T081
,	O
func	B-T081
score	I-T081
and	O
intracerebral	O
hemorrhage	O
grading	O
scale	O
ich-gs	O
on	O
our	O
population	O
to	O
evaluate	O
the	O
correlation	B-T080
of	O
these	O
scores	B-T081
with	O
the	O
30-	O
day	B-T079
mortality	B-T081
in	O
our	O
study	O
.	O
	
we	O
also	O
applied	O
three	O
widely	O
accepted	O
outcome	O
grading	O
scoring	O
systems	O
ich	B-T081
score	I-T081
,	O
func	B-T081
score	I-T081
and	O
intracerebral	O
hemorrhage	O
grading	O
scale	O
ich-gs	O
on	O
our	O
population	O
to	O
evaluate	O
the	O
correlation	B-T080
of	O
these	O
scores	B-T081
with	O
the	O
30-	O
day	B-T079
mortality	B-T081
in	O
our	O
study	O
.	O
	
from	O
342	O
patients	O
mean	O
age	O
67	O
years	B-T079
,	O
mean	O
glasgow	O
coma	O
scale	O
gcs	O
on	O
admission	O
9	O
,	O
mean	O
ich	B-T033
volume	B-T081
62.19	O
ml	O
,	O
most	O
common	O
hematoma	O
location	O
basal	O
ganglia	O
43.9	O
,	O
102	O
received	O
surgical	B-T061
and	O
240	O
conservative	B-T061
treatment	I-T061
.	O
	
the	O
30-	O
day	B-T079
mortality	B-T081
was	O
25.15	O
.	O
	
in	O
a	O
multivariate	B-T081
analysis	I-T081
,	O
gcs	O
odds	B-T081
ratio	I-T081
or	B-T081
=0	O
,	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
=0	O
,	O
p	O
<	O
0.001	O
,	O
bleeding	O
volume	B-T081
or	B-T081
=	O
1.012	O
per	O
ml	O
,	O
95%	O
ci	B-T081
=	O
1.007	O
-	O
1.017	O
,	O
p	O
<	O
0.001	O
,	O
and	O
infratentorial	O
hematoma	O
location	O
or	B-T081
=	O
5.381	O
,	O
95%	O
ci	B-T081
=	O
2.166	O
,	O
p	O
=	O
0.009	O
were	O
significant	O
predictors	B-T078
for	O
the	O
30-	O
day	B-T079
mortality	B-T081
.	O
	
after	O
receiver	B-T081
operating	I-T081
characteristics	I-T081
analysis	O
,	O
we	O
defined	O
a	O
""""	O
high-risk	O
group	O
""""	O
for	O
an	O
unfavorable	O
short-term	B-T079
outcome	B-T169
with	O
gcs	O
<11	O
and	O
ich	B-T033
volume	B-T081
>32	O
ml	O
supratentorially	O
or	O
21	O
ml	O
infratentorially	O
.	O
	
using	O
pearson	O
correlation	O
,	O
we	O
found	O
a	O
correlation	B-T080
of	O
0.986	O
between	O
ich	B-T081
score	I-T081
and	O
30-	O
day	B-T079
mortality	B-T081
p	O
<	O
0.001	O
,	O
0.853	O
between	O
func	B-T081
score	I-T081
and	O
30-	O
day	B-T079
mortality	B-T081
p	O
=	O
0.001	O
,	O
and	O
0.924	O
between	O
ich-gs	O
and	O
30-	O
day	B-T079
mortality	B-T081
p	O
=	O
0.001	O
.	O
	
gcs	O
score	B-T081
on	O
admission	O
together	O
with	O
the	O
baseline	B-T081
volume	B-T081
and	O
localization	B-T169
of	O
the	O
hemorrhage	O
are	O
strong	O
predictors	B-T078
for	O
30-	O
day	B-T079
mortality	B-T081
in	O
patients	O
with	O
spontaneous	B-T169
primary	B-T080
intracerebral	B-T033
hemorrhage	I-T033
,	O
and	O
by	O
relying	O
on	O
them	O
it	O
is	O
possible	O
to	O
identify	O
high-risk	B-T033
patients	O
with	O
poor	O
short-term	B-T079
outcome	B-T169
.	O
	
the	O
ich	B-T081
score	I-T081
and	O
the	O
ich-gs	O
accurately	B-T080
predict	B-T078
the	O
30-	O
day	B-T079
mortality	B-T081
.	O
	
gga-mir-21	O
inhibits	B-T080
chicken	O
pre-adipocyte	O
proliferation	O
in	O
part	O
by	O
down-regulating	O
kruppel-like	O
factor	O
5	O
gga-mir-21	O
is	O
abundantly	O
expressed	O
in	O
chicken	O
pre-adipocytes	O
,	O
but	O
its	O
role	O
is	O
unclear	O
.	O
	
the	O
present	O
study	O
investigated	B-T169
the	O
role	O
of	O
gga-mir-21	O
in	O
chicken	O
pre-adipocyte	O
proliferation	O
.	O
	
cell	O
proliferation	O
assay	O
and	O
gene	O
expression	O
analysis	O
of	O
proliferating	O
cell	O
nuclear	O
antigen	O
pcna	O
showed	O
that	O
the	O
gga-mir-21	O
mimic	O
inhibited	B-T080
pre-adipocyte	O
proliferation	O
.	O
	
in	O
contrast	O
,	O
the	O
gga-mir-21	O
inhibitor	B-T080
enhanced	O
pre-adipocyte	O
proliferation	O
.	O
	
the	O
subsequent	O
investigation	B-T169
identified	O
kruppel-like	O
factor	O
5	O
klf5	O
mrna	O
as	O
a	O
target	B-T169
of	O
gga-mir-21	O
.	O
	
the	O
gga-mir-21	O
mimic	O
inhibited	B-T080
klf5	O
3	O
reporter	O
activity	O
and	O
decreased	B-T081
endogenous	B-T169
klf5	O
expression	O
in	O
primary	B-T080
pre-adipocytes	O
.	O
	
klf5	O
knockdown	O
using	O
rnai	O
had	O
a	O
similar	O
effect	B-T080
to	O
that	O
of	O
the	O
gga-mir-21	O
mimic	O
on	O
cell	O
proliferation	O
.	O
	
the	O
promoting	O
effect	B-T080
of	O
the	O
gga-mir-21	O
inhibitor	B-T080
on	O
pre-adipocyte	O
proliferation	O
was	O
partially	O
attenuated	B-T080
by	O
klf5	O
knockdown	O
.	O
	
taken	O
together	O
,	O
our	O
results	O
demonstrated	O
that	O
mir-21	O
inhibits	O
chicken	O
pre-adipocyte	O
proliferation	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
targeting	O
klf5	O
.	O
	
the	O
application	B-T169
of	O
heterogeneous	B-T081
cluster	I-T081
grouping	I-T081
to	O
reflective	O
writing	O
for	O
medical	O
humanities	O
literature	O
study	O
to	O
enhance	O
students'	O
empathy	O
,	O
critical	O
thinking	O
,	O
and	O
reflective	O
writing	O
to	O
facilitate	O
interdisciplinary	O
collaboration	O
and	O
to	O
make	O
connections	O
between	O
patients'	O
diseases	B-T047
and	O
their	O
social	B-T169
/	O
cultural	B-T169
contexts	I-T169
,	O
the	O
study	O
examined	B-T033
whether	O
the	O
use	O
of	O
heterogeneous	B-T081
cluster	I-T081
grouping	I-T081
in	O
reflective	O
writing	O
for	O
medical	O
humanities	O
literature	O
acquisition	O
could	O
have	O
positive	B-T080
effects	I-T080
on	O
medical	O
university	O
students	O
in	O
terms	O
of	O
empathy	O
,	O
critical	O
thinking	O
,	O
and	O
reflective	O
writing	O
.	O
	
a	O
15-week	B-T079
quasi-experimental	O
design	O
was	O
conducted	O
to	O
investigate	B-T169
the	O
learning	B-T169
outcomes	I-T169
.	O
	
after	O
conducting	O
cluster	O
algorithms	O
,	O
heterogeneous	B-T081
learning	I-T081
clusters	I-T081
experimental	O
group	O
n	O
=	O
43	O
and	O
non-heterogeneous	B-T081
learning	I-T081
clusters	I-T081
control	O
group	O
n	O
=	O
43	O
were	O
derived	O
for	O
a	O
medical	O
humanities	O
literature	O
study	O
.	O
	
before	O
and	O
after	O
the	O
intervention	B-T061
,	O
an	O
empathy	O
scale	O
in	O
patient	O
care	O
es	O
-	O
pc	O
,	O
a	O
critical	O
thinking	O
disposition	O
assessment	O
ctda-r	O
,	O
and	O
a	O
reflective	O
writing	O
test	O
were	O
administered	B-T169
to	O
both	O
groups	B-T078
.	O
	
the	O
findings	O
showed	O
that	O
on	O
the	O
empathy	O
scale	O
,	O
significant	O
differences	O
in	O
the	O
""""	O
behavioral	O
empathy	O
""""	O
""""	O
affective	O
empathy	O
""""	O
and	O
overall	O
sections	O
existed	O
between	O
the	O
post-test	B-T033
mean	I-T033
scores	I-T033
of	O
the	O
experimental	O
group	O
and	O
those	O
of	O
the	O
control	O
group	O
,	O
but	O
such	O
differences	O
did	O
not	O
exist	O
in	O
""""	O
intelligent	O
empathy	O
""""	O
regarding	O
critical	O
thinking	O
,	O
there	O
were	O
significant	O
differences	O
in	O
""""	O
systematicity	B-T169
and	O
analyticity	O
""""	O
""""	O
skepticism	O
and	O
well-informed	O
""""	O
""""	O
maturity	B-T080
and	O
skepticism	O
""""	O
and	O
overall	O
sections	O
.	O
	
as	O
for	O
reflective	O
writing	O
,	O
significant	O
differences	O
existed	O
in	O
""""	O
ideas	B-T078
""""	O
""""	O
voice	O
and	O
point	B-T078
of	I-T078
view	I-T078
""""	O
""""	O
critical	O
thinking	O
and	O
representation	O
""""	O
""""	O
depth	O
of	O
reflection	O
on	O
personal	O
growth	O
""""	O
and	O
overall	O
sections	O
,	O
but	O
not	O
in	O
""""	O
focus	B-T169
and	O
context	B-T078
structure	I-T078
""""	O
and	O
""""	O
language	O
and	O
conventions	O
""""	O
this	O
study	O
outlined	O
an	O
alternative	O
for	O
using	O
heterogeneous	B-T081
cluster	I-T081
grouping	I-T081
in	O
reflective	O
writing	O
about	O
medical	O
humanities	O
literature	O
to	O
facilitate	O
interdisciplinary	O
cooperation	O
to	O
provide	O
more	O
humanizing	O
medical	B-T033
care	I-T033
.	O
	
the	O
usefulness	O
of	O
employing	B-T033
an	O
electronic	O
traction	O
table	O
to	O
determine	O
flexibility	B-T080
in	O
adolescent	O
idiopathic	O
scoliosis	O
the	O
aim	O
of	O
the	O
study	O
was	O
to	O
develop	B-T169
new	O
equipment	O
for	O
the	O
assessment	O
of	O
the	O
flexibility	B-T080
of	O
the	O
spine	O
with	O
different	O
forces	O
.	O
	
this	O
new	O
system	B-T169
should	O
provide	O
a	O
different	O
perspective	O
to	O
adolescent	O
idiopathic	O
scoliosis	O
ais	O
for	O
the	O
selection	O
of	O
fusion	B-T080
levels	I-T080
and	O
surgical	B-T061
success	B-T080
.	O
	
eighteen	O
patients	O
suffering	O
from	O
ais	O
who	O
were	O
scheduled	O
to	O
undergo	O
posterior	O
instrumented	B-T061
spinal	I-T061
fusion	I-T061
in	O
our	O
clinic	O
were	O
recruited	O
in	O
this	O
study	O
.	O
	
the	O
electronic	O
traction	O
table	O
ett	O
that	O
was	O
designed	O
in	O
our	O
clinic	O
was	O
used	O
to	O
evaluate	O
the	O
radiogical	O
and	O
clinical	B-T080
parameters	O
of	O
the	O
spine	O
.	O
	
the	O
significant	O
prescriptive	B-T080
angle	I-T080
of	O
major	O
cobb	B-T033
angles	I-T033
between	O
postoperative	B-T080
angles	I-T080
were	O
longitudinal	O
traction	B-T061
and	O
lateral	B-T033
pushing	I-T033
cobb	I-T033
angles	I-T033
.	O
	
longitudinal	O
traction	B-T061
and	O
lateral	B-T033
pushing	I-T033
angles	I-T033
were	O
more	O
correlated	O
with	O
correction	B-T081
ratios	I-T081
.	O
	
there	O
was	O
a	O
significant	B-T078
difference	O
between	O
longitudinal	O
traction	B-T061
minor	O
cobb	B-T033
angle	I-T033
,	O
longitudinal	O
traction	B-T061
lateral	B-T033
pushing	I-T033
minor	I-T033
cobb	I-T033
angle	I-T033
and	O
postoperative	B-T033
minor	I-T033
cobb	I-T033
angles	I-T033
.	O
	
the	O
deformity	O
is	O
needed	O
to	O
balance	O
both	O
tractional	B-T061
and	O
rotational	B-T169
forces	O
and	O
useful	O
technique	O
to	O
evaluate	O
curve	O
flexibility	O
before	O
the	O
operation	O
.	O
	
electronic	O
traction	O
table	O
is	O
a	O
new	O
device	O
for	O
determining	O
preoperative	O
flexibility	O
with	O
longitudinal	O
traction	O
and	O
lateral	O
pushing	O
radiographs	O
.	O
	
it	O
can	O
be	O
useful	O
for	O
choosing	O
selective	O
fusion	O
levels	O
at	O
the	O
proximal	O
and	O
distal	O
end	O
of	O
the	O
vertebral	O
column	O
the	O
messaging	O
for	O
diabetes	O
intervention	B-T061
reduced	O
barriers	B-T080
to	O
medication	B-T033
adherence	I-T033
among	O
low-income	B-T033
,	O
diverse	O
adults	O
with	O
type	B-T047
2	I-T047
nonadherence	B-T033
to	O
diabetes	B-T047
medication	O
is	O
prevalent	O
and	O
costly	O
.	O
	
messaging	O
for	O
diabetes	O
med	O
,	O
a	O
mobile	O
health	O
mhealth	O
intervention	B-T061
,	O
identified	O
and	O
addressed	O
user	O
-specific	O
barriers	B-T080
to	O
medication	B-T033
adherence	I-T033
.	O
	
we	O
assessed	O
whether	O
med	O
reduced	O
users	O
'	O
targeted	O
barriers	B-T080
and	O
if	O
barrier	B-T080
reductions	O
were	O
associated	O
with	O
within-participant	O
improvements	O
in	O
adherence	B-T169
or	O
glycemic	B-T080
control	I-T080
hba1c	B-T116
.	O
	
adults	O
n	O
=	O
80	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
completed	O
self-report	O
measures	O
identifying	O
barriers	B-T080
to	O
adherence	B-T169
at	O
baseline	O
and	O
monthly	B-T079
for	O
3	O
months	B-T079
.	O
	
at	O
each	O
assessment	O
,	O
17	O
barriers	B-T080
were	O
assessed	O
and	O
ranked	O
for	O
each	O
user	O
.	O
	
each	O
subsequent	O
month	B-T079
,	O
users	O
received	O
daily	O
text	O
messages	O
addressing	O
their	O
3	O
highest	O
ranked	O
barriers	B-T080
.	O
	
targeted	O
barriers	B-T080
were	O
different	O
for	O
each	O
participant	O
and	O
could	O
change	O
monthly	B-T079
.	O
	
paired	O
t-tests	O
assessed	O
within-participant	O
improvement	O
in	O
targeted	O
barriers	B-T080
each	O
month	B-T079
,	O
and	O
nested	O
regression	O
models	O
assessed	O
if	O
changes	O
in	O
a	O
participant's	O
barrier	O
scores	O
were	O
associated	O
with	O
improvements	O
in	O
adherence	B-T169
and	O
hba1c	B-T116
.	O
	
participants	O
were	O
69%	O
non-white	O
and	O
82%	O
had	O
incomes	O
<	O
.	O
	
average	O
hba1c	B-T116
was	O
8.2	O
2.0	O
.	O
	
assessment	O
completion	O
rates	O
were	O
100%	O
at	O
baseline	O
,	O
59%	O
at	O
1	O
month	B-T079
,	O
30%	O
at	O
2	O
months	B-T079
,	O
and	O
65%	O
at	O
3	O
months	B-T079
.	O
	
the	O
most	O
commonly	O
reported	O
barriers	B-T080
were	O
the	O
cost	B-T081
of	O
medications	O
76%	O
,	O
believing	O
medications	O
are	O
harmful	O
58%	O
,	O
and	O
lacking	O
information	O
about	O
medications	O
53%	O
.	O
	
participants	O
'	O
barrier	B-T080
scores	O
improved	O
each	O
month	B-T079
and	O
barrier	B-T080
improvement	O
predicted	O
adherence	B-T169
assessed	O
via	O
nightly	O
adherence	B-T169
assessment	O
text	O
messages	O
p	O
<	O
001	O
.	O
	
among	O
participants	O
who	O
completed	O
assessments	O
each	O
month	B-T079
,	O
barrier	B-T080
improvement	O
in	O
months	B-T079
2	O
and	O
3	O
p	O
<	O
05	O
predicted	O
hba1c	B-T116
improvement	O
.	O
	
iterative	O
,	O
individual	O
tailoring	O
may	O
overcome	O
users	O
'	O
barriers	B-T080
to	O
adherence	B-T169
.	O
	
attrition	O
is	O
a	O
challenge	O
for	O
mhealth	O
interventions	B-T061
among	O
low-income	B-T033
patients	O
.	O
	
macular	O
ganglion	O
cell	O
-	O
inner	O
plexiform	O
layer	O
thickness	B-T080
is	O
associated	B-T080
with	I-T080
clinical	O
progression	O
in	O
mild	B-T047
cognitive	I-T047
impairment	I-T047
and	O
alzheimers	B-T047
disease	I-T047
we	O
investigated	O
the	O
association	O
of	O
the	O
macular	O
ganglion	O
cell	O
-	O
inner	O
plexiform	O
layer	O
gcipl	O
and	O
peripapillary	O
retinal	O
nerve	O
fiber	O
layer	O
rnfl	O
thicknesses	B-T080
with	O
disease	O
progression	O
in	O
mild	B-T047
cognitive	I-T047
impairment	I-T047
mci	B-T047
and	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
.	O
	
we	O
recruited	O
42	O
patients	O
with	O
ad	B-T047
,	O
26	O
with	O
mci	B-T047
,	O
and	O
66	O
normal	O
elderly	O
controls	O
.	O
	
the	O
thicknesses	B-T080
of	O
the	O
rnfl	O
and	O
gcipl	O
were	O
measured	O
via	O
spectral-domain	O
optic	O
coherent	O
tomography	O
in	O
all	O
participants	O
at	O
baseline	B-T081
.	O
	
the	O
patients	O
with	O
mci	B-T047
or	O
ad	B-T047
underwent	O
clinical	B-T080
and	O
neuropsychological	O
tests	O
at	O
baseline	B-T081
and	O
once	B-T079
every	I-T079
year	I-T079
thereafter	I-T079
for	I-T079
2	I-T079
years	I-T079
.	O
	
the	O
clinical	O
dementia	O
rating	O
scale-sum	O
of	O
boxes	O
cdr-sb	O
score	B-T081
exhibited	O
significant	O
negative	B-T033
relationships	B-T080
with	O
the	O
average	O
gcipl	O
thickness	B-T080
β	O
=	O
-0	O
,	O
p	O
<	O
0.05	O
and	O
the	O
gcipl	O
thickness	B-T080
in	O
the	O
superotemporal	O
,	O
superonasal	O
,	O
and	O
inferonasal	O
sectors	O
.	O
	
the	O
composite	B-T081
memory	I-T081
score	I-T081
exhibited	O
significant	O
positive	B-T033
associations	B-T080
with	O
the	O
average	O
gcipl	O
thickness	B-T080
and	O
the	O
gcipl	O
thickness	B-T080
in	O
the	O
superotemporal	O
,	O
inferonasal	O
,	O
and	O
inferotemporal	O
sectors	O
.	O
	
the	O
temporal	O
rnfl	O
thickness	B-T080
,	O
the	O
average	O
and	O
minimum	O
gcipl	O
thicknesses	B-T080
,	O
and	O
the	O
gcipl	O
thickness	B-T080
in	O
the	O
inferonasal	O
,	O
inferior	O
,	O
and	O
inferotemporal	O
sectors	O
at	O
baseline	B-T081
were	O
significantly	O
reduced	B-T080
in	O
mci	B-T047
patients	O
who	O
were	O
converted	O
to	O
ad	B-T047
compared	O
to	O
stable	O
mci	B-T047
patients	O
.	O
	
the	O
change	O
of	O
cdr-sb	O
from	O
baseline	B-T081
to	O
2	O
years	B-T079
exhibited	O
significant	O
negative	B-T033
associations	B-T080
with	O
the	O
average	O
β	O
=	O
-0	O
,	O
p	O
=	O
0.006	O
and	O
minimum	O
gcipl	O
thicknesses	B-T080
as	O
well	O
as	O
gcipl	O
thickness	B-T080
in	O
the	O
superotemporal	O
,	O
superior	O
,	O
superonasal	O
,	O
and	O
inferonasal	O
sectors	O
at	O
baseline	B-T081
.	O
	
our	O
data	O
suggest	O
that	O
macular	O
gcipl	O
thickness	B-T080
represents	O
a	O
promising	O
biomarker	O
for	O
monitoring	O
the	O
progression	O
of	O
mci	B-T047
and	O
green	O
and	O
rapid	B-T080
synthesis	O
of	O
silver	O
nanoparticles	O
using	O
borago	O
officinalis	O
leaf	O
extract	O
anticancer	B-T033
and	O
antibacterial	B-T033
activities	I-T033
this	O
study	O
highlights	O
the	O
facile	O
,	O
reliable	O
,	O
cost	B-T081
effective	B-T080
,	O
and	O
ecofriendly	O
synthesis	O
of	O
silver	O
nanoparticles	O
agnps	O
using	O
borago	O
officinalis	O
leaves	O
extract	O
efficiently	B-T080
.	O
	
the	O
biosynthesis	O
of	O
agnps	O
was	O
verified	B-T078
by	O
uv-vis	O
spectrum	O
which	O
showed	O
the	O
surface	O
plasmon	O
resonance	O
spr	O
band	O
at	O
422	O
nm	O
.	O
	
transmission	O
electron	O
microscope	O
tem	O
analysis	O
revealed	O
that	O
the	O
particles	O
were	O
spherical	O
,	O
hexagonal	O
,	O
and	O
irregular	B-T080
in	O
shape	O
and	O
had	O
size	B-T081
ranging	B-T081
from	O
30	O
to	O
80	O
nm	O
.	O
	
the	O
energy	O
dispersive	O
x-ray	O
spectroscopy	O
edx	O
and	O
elemental	O
mapping	O
have	O
displayed	O
the	O
purity	B-T081
and	O
maximum	B-T081
distribution	B-T169
of	O
silver	O
in	O
the	O
agnps	O
.	O
	
the	O
crystalline	O
nature	O
of	O
agnps	O
had	O
been	O
identified	B-T080
using	O
x-ray	O
diffraction	O
xrd	O
and	O
selected	O
area	O
diffraction	O
pattern	O
saed	O
.	O
	
the	O
particle	B-T081
size	I-T081
analysis	B-T169
revealed	O
that	O
the	O
z-average	B-T081
diameter	B-T081
of	O
the	O
agnps	O
was	O
50.86	O
nm	O
with	O
polydispersity	O
index	O
pdi	O
0.136	O
.	O
	
zeta	O
potential	O
analysis	B-T169
displayed	O
the	O
colloidal	B-T080
stability	I-T080
of	O
agnps	O
.	O
	
this	O
work	O
also	O
showed	O
the	O
efficacy	B-T080
of	O
agnps	O
against	O
lung	O
cancer	O
cell	O
lines	O
a549	O
and	O
cervical	O
cancer	O
cell	O
line	O
hela	O
,	O
in	B-T080
vitro	I-T080
.	O
	
the	O
agnps	O
showed	O
cytotoxicity	O
to	O
the	O
a549	O
and	O
hela	O
cancer	O
cell	O
line	O
at	O
the	O
concentrations	B-T081
5	O
and	O
2	O
μg/ml	O
.	O
	
the	O
agnps	O
were	O
also	O
explored	O
for	O
the	O
antibacterial	B-T033
activity	I-T033
including	O
biofilm	O
inhibition	O
against	O
pathogenic	B-T033
bacteria	O
.	O
	
the	O
b	O
.	O
	
officinalis	O
leaves	O
extract	O
can	O
be	O
used	O
efficiently	B-T080
for	O
green	O
synthesis	O
agnps	O
.	O
	
the	O
biosynthesized	O
agnps	O
demonstrated	O
potentials	B-T080
as	O
anticancer	B-T109
and	O
antibacterial	O
agents	O
.	O
	
this	O
work	O
provides	O
helpful	O
insight	O
into	O
the	O
development	B-T169
of	O
new	O
anticancer	B-T109
and	O
antimicrobial	O
agents	O
.	O
	
genotyping	O
of	O
staphylococcus	O
aureus	O
in	O
bovine	B-T047
mastitis	I-T047
and	O
correlation	O
to	O
phenotypic	O
characteristics	B-T080
reducing	O
the	O
prevalence	O
of	O
mastitis	B-T047
caused	O
by	O
staphylococcus	O
aureus	O
s	O
.	O
	
aureus	O
is	O
essential	O
to	O
improve	O
animal	O
health	B-T078
and	O
reduce	O
economic	O
losses	O
for	O
farmers	O
.	O
	
the	O
clinical	O
outcome	O
of	O
acute	B-T047
mastitis	I-T047
and	O
risk	B-T078
of	O
progression	O
to	O
persistent	B-T079
mastitis	B-T047
can	O
,	O
at	O
least	O
to	O
some	O
extent	O
,	O
be	O
related	O
to	O
genetic	O
variants	O
of	O
the	O
strain	O
causing	O
the	O
infection	O
.	O
	
in	O
the	O
present	O
study	O
we	O
have	O
used	O
microarrays	O
to	O
investigate	O
the	O
presence	O
of	O
virulence	O
genes	O
in	O
s	O
.	O
	
aureus	O
isolates	O
from	O
dairy	O
cows	O
with	O
acute	B-T047
clinical	I-T047
mastitis	I-T047
n=70	O
and	O
correlated	O
the	O
findings	B-T033
to	O
other	O
genotypic	O
and	O
phenotypic	O
characteristics	B-T080
.	O
	
among	O
the	O
most	O
commonly	O
found	O
virulence	B-T109
factors	I-T109
were	O
genes	O
encoding	O
several	O
hemolysin	O
types	B-T080
,	O
leukocidins	B-T116
d	I-T116
and	O
lukm	B-T116
/	O
lukf-p83	B-T116
,	O
clumping	B-T116
factors	I-T116
a	I-T116
and	O
b	B-T116
,	O
fibrinogen	B-T116
binding	I-T116
protein	I-T116
and	O
fibronectin-binding	B-T116
protein	I-T116
a	I-T116
.	O
	
some	O
virulence	B-T109
factors	I-T109
e.g	O
.	O
	
fibronectin-binding	B-T116
protein	I-T116
b	I-T116
and	O
staphylococcus	O
aureus	O
surface	B-T116
protein	I-T116
g	I-T116
were	O
less	O
common	O
.	O
	
genes	O
coding	O
for	O
several	O
staphylococcal	O
enterotoxins	O
and	O
toxic	B-T116
shock	I-T116
syndrome	I-T116
toxin-1	I-T116
tsst-1	B-T116
were	O
commonly	O
found	O
,	O
especially	O
in	O
one	O
major	O
pulsotype	O
.	O
	
no	B-T033
beta-lactamase	O
genes	O
were	O
found	O
in	O
any	O
common	O
pulsotype	O
,	O
while	O
present	O
in	O
some	O
rare	O
pulsotypes	O
,	O
indicated	O
to	O
be	O
of	O
human	O
origin	O
.	O
	
production	O
of	O
tsst-1	B-T116
,	O
enterotoxins	B-T116
,	O
hemolysins	O
and	O
beta-lactamase	B-T116
could	O
all	O
be	O
positively	O
correlated	O
to	O
presence	O
of	O
the	O
corresponding	O
genes	O
.	O
	
this	O
study	O
reveals	O
a	O
number	O
of	O
genotypic	O
differences	B-T080
and	O
similarities	B-T080
among	O
common	O
and	O
rare	O
pulsotypes	O
of	O
s	O
.	O
	
aureus	O
from	O
cases	O
of	O
mastitis	B-T047
in	O
sweden	O
.	O
	
the	O
results	O
could	O
help	O
the	O
design	O
of	O
diagnostic	O
tools	O
to	O
guide	O
on-farm	O
interventions	O
according	O
to	O
the	O
expected	O
impact	O
on	O
udder	O
health	B-T078
from	O
a	O
specific	O
s	O
.	O
	
aureus	O
genotype	O
.	O
	
uveitis	B-T047
in	O
spondyloarthritis	B-T047
patients	O
and	O
its	O
association	B-T080
with	I-T080
hla-b27	B-T116
histocompatibility	I-T116
antigen	I-T116
prospective	O
study	O
t	O
o	O
perform	O
a	O
prospective	O
study	O
of	O
clinical	O
presentation	O
and	O
course	B-T079
of	O
uveitis	B-T047
in	O
spondyloarthritis	B-T047
spa	B-T047
patients	O
as	O
well	O
as	O
its	O
association	B-T080
with	I-T080
the	O
hla-b27	B-T116
histocompatibility	I-T116
antigen	I-T116
.	O
	
the	O
study	O
included	O
219	O
patients	O
with	O
uveitis	B-T047
,	O
all	O
tested	B-T169
for	O
hla-b27	B-T116
antigen	I-T116
and	O
various	O
infections	O
viral	B-T047
,	O
bacterial	B-T047
,	O
and	O
parasitic	B-T047
as	O
well	O
as	O
examined	B-T033
for	O
locomotive	O
system	O
involvement	B-T169
.	O
	
the	O
presence	B-T033
of	O
the	O
hla-b27	B-T116
antigen	I-T116
was	O
determined	B-T080
in	O
142	O
64.8	O
out	O
of	O
219	O
patients	O
,	O
of	O
them	O
87	O
were	O
diagnosed	B-T033
with	O
an	O
entity	O
of	O
the	O
spa	B-T047
group	B-T078
.	O
	
the	O
remaining	B-T080
77	O
35.2	O
patients	O
appeared	O
to	O
be	O
hla-b27	B-T116
-	O
negative	B-T033
,	O
but	O
13	O
were	O
still	O
diagnosed	B-T033
with	O
an	O
entity	O
of	O
the	O
spa	B-T047
group	B-T078
.	O
	
there	O
were	O
10	O
4.6	O
patients	O
with	O
2	O
or	O
more	O
diseases	B-T047
from	O
the	O
spa	B-T047
group	B-T078
clinical	O
decussation	O
.	O
	
when	O
comparing	O
the	O
two	O
groups	B-T078
of	O
hla-b27-positive	O
and	O
negative	B-T033
patients	O
having	O
both	O
spa	B-T047
and	O
uveitis	B-T047
,	O
no	O
statistically	B-T081
significant	I-T081
difference	B-T080
was	O
found	O
as	O
to	O
the	O
age	B-T081
of	I-T081
onset	I-T081
,	O
site	O
,	O
frequency	B-T079
of	I-T079
attacks	I-T079
,	O
and	O
uni	O
-	O
or	O
bilateral	O
involvement	B-T169
p>0	O
.	O
	
we	O
also	O
performed	B-T169
a	O
comparison	O
of	O
hla-b27-positive	O
and	O
negative	B-T033
patients	O
with	O
no	O
account	O
to	O
their	O
spa	B-T047
status	B-T080
and	O
revealed	B-T080
a	O
higher	B-T080
complication	O
rate	B-T081
in	O
those	O
that	O
were	O
negative	B-T033
p<0	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
hla-b27	B-T116
-	O
negative	B-T033
patients	O
often	O
have	O
autoimmune	B-T047
or	O
infectious	B-T047
uveitis	I-T047
of	O
different	B-T080
origin	O
notable	O
for	O
long	B-T080
attacks	O
and	O
short	B-T081
remissions	B-T033
.	O
	
assessing	O
the	O
site	O
and	O
course	B-T079
of	O
uveitis	B-T047
as	O
well	O
as	O
hla-b27	B-T116
testing	B-T169
of	O
uveitis	B-T047
patients	O
has	O
proved	O
important	B-T080
for	O
etiological	B-T169
diagnosis	B-T033
.	O
	
diseases	B-T047
of	O
the	O
spa	B-T047
group	B-T078
have	O
been	O
shown	O
to	O
be	O
6.7	O
times	B-T081
more	O
common	O
in	O
hla-b27-positive	O
patients	O
as	O
compared	O
to	O
hla-b27	B-T116
-	O
negative	B-T033
ones	O
.	O
	
clinical	O
presentation	O
of	O
uveitis	B-T047
in	O
the	O
presence	B-T033
of	O
spa	B-T047
in	O
both	O
hla-b27-positive	O
and	O
negative	B-T033
patients	O
resembles	O
that	O
of	O
idiopathic	B-T047
uveitis	I-T047
-	O
an	O
independent	O
hla-b27	B-T116
-	O
associated	B-T080
syndrome	B-T047
р>0	O
.	O
	
cases	O
of	O
decussation	O
between	O
entities	O
of	O
the	O
spa	B-T047
group	B-T078
are	O
usually	O
more	O
severe	B-T080
in	O
terms	O
of	O
clinical	O
presentation	O
and	O
course	B-T079
of	O
uveitis	B-T047
and	O
are	O
associated	B-T080
with	I-T080
a	O
worse	B-T033
prognosis	I-T033
.	O
	
complications	O
of	O
uveitis	B-T047
are	O
more	O
likely	O
to	O
be	O
found	O
in	O
non-spa	B-T033
hla-b27	B-T116
-	O
negative	B-T033
patients	O
human	O
brucellosis	B-T047
in	O
south	O
africa	O
public	O
health	O
and	O
diagnostic	O
pitfalls	O
human	O
brucellosis	B-T047
in	O
south	O
africa	O
sa	O
is	O
under-diagnosed	O
and	O
under-reported	B-T033
.	O
	
this	O
is	O
because	O
many	O
clinicians	O
have	O
little	O
or	O
no	O
experience	O
in	O
managing	O
affected	B-T080
patients	I-T080
,	O
and	O
in	O
part	O
because	O
of	O
the	O
nonspecific	B-T078
and	O
insidious	B-T080
nature	B-T080
of	I-T080
the	I-T080
disease	I-T080
.	O
	
a	O
case	B-T169
of	O
human	O
brucellosis	B-T047
caused	O
by	O
brucella	O
melitensis	O
in	O
a	O
patient	O
from	O
the	O
western	O
cape	O
province	O
of	O
sa	O
is	O
described	B-T078
,	O
and	O
the	O
resulting	B-T169
exposure	O
of	O
staff	O
members	O
at	O
two	O
medical	O
microbiology	O
laboratories	O
,	O
as	O
well	O
as	O
the	O
public	O
health	O
investigation	O
that	O
was	O
conducted	O
,	O
are	O
discussed	O
.	O
	
this	O
article	O
aims	B-T078
to	O
highlight	O
the	O
need	O
for	O
strengthening	O
integration	B-T169
between	O
public	O
health	O
,	O
medical	O
and	O
veterinary	O
services	O
and	O
exposing	B-T169
deficiencies	I-T169
in	O
public	O
health	O
,	O
veterinary	O
and	O
laboratory	O
survey	O
of	O
trichinella	B-T047
infection	I-T047
from	O
domestic	O
pigs	O
in	O
the	O
historical	B-T033
endemic	O
areas	O
of	O
henan	O
province	O
,	O
central	O
china	O
the	O
aim	B-T078
of	O
this	O
work	O
was	O
to	O
investigate	B-T169
the	O
current	B-T033
situation	I-T033
of	O
trichinella	B-T047
infection	I-T047
from	O
domestic	O
pigs	O
in	O
the	O
historical	B-T033
endemic	O
areas	O
of	O
henan	O
province	O
,	O
central	O
china	O
.	O
	
a	O
total	O
of	O
823	O
diaphragm	O
samples	O
from	O
the	O
indoor-raised	O
pigs	O
were	O
collected	B-T169
in	O
five	B-T081
cities	O
of	O
henan	O
during	O
2014-2015	O
and	O
examined	B-T033
by	O
artificial	B-T169
digestion	I-T169
method	I-T169
.	O
	
the	O
overall	B-T081
prevalence	I-T081
of	O
trichinella	B-T047
infection	I-T047
in	O
pigs	O
was	O
0.61	O
%	O
5/823	O
.	O
	
trichinella	O
larvae	O
were	O
detected	B-T033
in	O
0.91	O
%	O
5/550	O
of	O
pigs	O
from	O
nanyang	O
city	O
of	O
henan	O
.	O
	
the	O
larval	O
burden	B-T078
in	O
infected	B-T033
animals	I-T033
was	O
0.03	O
larvae	O
per	O
gram	O
lpg	O
of	O
muscles	O
with	O
a	O
range	B-T081
from	O
0.02	O
to	O
0.05	O
lpg	O
.	O
	
the	O
larvae	O
were	O
identified	B-T080
as	O
trichinella	O
spiralis	O
by	O
multiple	O
pcr	O
.	O
	
our	O
study	O
confirms	B-T080
the	O
existence	O
of	O
swine	O
trichinellosis	B-T047
in	O
henan	O
,	O
but	O
the	O
infection	O
level	B-T080
was	O
under	O
the	O
minimum	B-T080
level	I-T080
for	O
defining	O
infectious	O
sources	O
for	O
humans	O
.	O
	
however	O
,	O
the	O
prevalence	B-T081
of	O
swine	O
trichinella	B-T047
infection	I-T047
in	O
henan	O
need	O
to	O
be	O
further	O
evaluated	O
with	O
a	O
large	B-T081
scale	I-T081
of	O
pork	O
samples	O
for	O
ensuring	O
meat	O
food	O
safety	O
.	O
	
voriconazole	B-T109
metabolism	O
is	O
influenced	O
by	O
severe	B-T080
inflammation	O
a	O
prospective	O
study	O
during	O
an	O
infection	O
or	O
inflammation	O
,	O
several	B-T081
drug	O
-	O
metabolizing	O
enzymes	B-T116
in	O
the	O
liver	O
are	O
down-regulated	O
,	O
including	O
cytochrome	B-T116
p450	I-T116
iso-enzymes	I-T116
.	O
	
since	O
voriconazole	B-T109
is	O
extensively	B-T080
metabolized	O
by	O
cytochrome	B-T116
p450	I-T116
iso-enzymes	I-T116
,	O
the	O
metabolism	O
of	O
voriconazole	B-T109
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	B-T080
clearance	O
of	O
the	O
drug	O
,	O
resulting	O
in	O
higher	B-T080
voriconazole	B-T109
trough	B-T081
concentrations	I-T081
.	O
	
to	O
investigate	O
prospectively	O
the	O
influence	O
of	O
inflammation	O
on	O
voriconazole	B-T109
metabolism	O
and	O
voriconazole	B-T109
trough	B-T081
concent	I-T081
ratio	I-T081
ns	I-T081
.	O
	
a	O
prospective	O
observational	O
study	O
was	O
performed	O
at	O
the	O
university	O
medical	O
center	O
groningen	O
.	O
	
patients	O
were	O
eligible	O
for	O
inclusion	O
if	O
they	O
were	O
18	O
years	O
old	O
and	O
treated	O
with	O
voriconazole	O
.	O
	
voriconazole	O
and	O
voriconazole-n-oxide	O
concentrations	O
were	O
determined	O
in	O
discarded	O
blood	O
samples	O
.	O
	
to	O
determine	O
the	O
degree	O
of	O
inflammation	O
,	O
c-reactive	O
protein	O
crp	O
concentrations	O
were	O
used	O
.	O
	
subsequently	O
,	O
a	O
longitudinal	O
data	O
analysis	O
was	O
performed	O
to	O
assess	O
the	O
effect	O
of	O
inflammation	O
on	O
the	O
metabolic	O
ratio	B-T081
and	O
voriconazole	O
trough	O
concentration	O
.	O
	
thirty-four	O
patients	O
were	O
included	O
.	O
	
in	O
total	O
489	O
voriconazole	O
trough	O
concentrations	O
were	O
included	O
in	O
the	O
longitudinal	O
data	O
analysis	O
.	O
	
this	O
analysis	O
showed	O
that	O
inflammation	O
,	O
reflected	O
by	O
crp	O
concentrations	O
,	O
significantly	O
influence	O
d	O
the	O
metabolic	O
ratio	O
,	O
voriconazole	O
trough	O
concentration	O
and	O
voriconazole-n-oxide	O
concentration	O
all	O
p	O
<	O
0.001	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	O
metabolism	O
.	O
	
the	O
metabolic	O
ratio	O
was	O
decreased	O
by	O
0.99229	O
and	O
the	O
voriconazole-n-oxide	O
concentration	O
by	O
0.99775	O
,	O
while	O
the	O
voriconazole	O
trough	O
concentration	O
was	O
increased	O
by	O
1.005321	O
,	O
where	O
n	O
is	O
the	O
difference	O
in	O
crp	O
units	O
in	O
mg/l	O
.	O
	
this	O
study	O
shows	O
that	O
voriconazole	O
metabolism	O
is	O
decreased	O
during	O
inflammation	O
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentration	O
s	O
.	O
	
therefore	O
,	O
frequent	O
monitoring	O
of	O
voriconazole	O
serum	O
concentrations	O
is	O
recommended	O
during	O
and	O
following	O
severe	O
inflammation	O
neoadjuvant	B-T061
chemotherapy	I-T061
of	O
ovarian	O
cancer	O
results	O
in	O
three	O
patterns	O
of	O
tumor-infiltrating	O
lymphocyte	O
response	O
with	O
distinct	O
implications	O
for	O
immunotherapy	B-T061
purpose	O
some	O
forms	O
of	O
chemotherapy	B-T061
can	O
enhance	O
antitumor	B-T080
immunity	O
through	O
immunogenic	B-T169
cell	O
death	O
,	O
resulting	O
in	O
increased	O
t-cell	O
activation	O
and	O
tumor	O
infiltration	O
.	O
	
such	O
effects	O
could	O
potentially	O
sensitize	O
tumors	O
to	O
immunotherapies	B-T061
,	O
including	O
checkpoint	O
blockade	O
.	O
	
we	O
investigated	O
whether	O
platinum	O
-	O
and	O
taxane	B-T109
-based	O
chemotherapy	B-T061
for	O
ovarian	O
cancer	O
induces	O
immunologic	B-T169
changes	O
consistent	O
with	O
this	O
possibility	O
.	O
	
experimental	O
design	O
matched	O
pre	B-T079
-	O
and	O
post	B-T079
-	O
neoadjuvant	B-T061
chemotherapy	I-T061
tumor	O
samples	O
from	O
26	O
high-grade	O
serous	O
carcinoma	O
hgsc	O
patients	O
were	O
analyzed	O
by	O
immunohistochemistry	O
ihc	O
for	O
a	O
large	O
panel	O
of	O
immune	O
cells	O
and	O
associated	O
factors	O
.	O
	
the	O
prognostic	O
significance	O
of	O
post	B-T079
-	O
chemotherapy	B-T061
til	O
patterns	O
was	O
assessed	O
in	O
an	O
expanded	O
cohort	O
n	O
=	O
90	O
neoadjuvant	B-T061
chemotherapy	I-T061
was	O
associated	O
with	O
increased	O
densities	O
of	O
cd3	B-T116
+	O
,	O
cd8	O
+	O
,	O
cd8	O
+	O
tia-1	B-T116
+	O
,	O
pd-1	B-T116
+	O
and	O
cd20	B-T116
+	O
til	O
.	O
	
other	O
immune	O
subsets	O
and	O
factors	O
were	O
unchanged	O
,	O
including	O
cd79a	B-T116
+	O
cd138	B-T116
+	O
plasma	O
cells	O
,	O
cd68	B-T116
+	O
macrophages	O
,	O
and	O
mhc	B-T116
class	I-T116
i	I-T116
on	O
tumor	O
cells	O
.	O
	
immunosuppressive	B-T047
cell	O
types	O
were	O
also	O
unchanged	O
,	O
including	O
foxp3	B-T116
+	O
pd-1	B-T116
+	O
cells	O
putative	O
regulatory	O
t	O
cells	O
,	O
ido-1	B-T116
+	O
cells	O
,	O
and	O
pd-l1	O
+	O
cells	O
both	O
macrophages	O
and	O
tumor	O
cells	O
.	O
	
hierarchical	O
clustering	O
revealed	O
three	O
response	O
patterns	O
i	O
til	O
high	O
tumors	O
showed	O
increases	O
in	O
multiple	O
immune	B-T080
markers	I-T080
after	O
chemotherapy	B-T061
ii	O
til	O
low	O
tumors	O
underwent	O
similar	O
increases	O
,	O
achieving	O
patterns	O
indistinguishable	O
from	O
the	O
first	O
group	O
and	O
iii	O
til	O
negative	B-T033
cases	O
generally	O
remained	O
negative	B-T033
.	O
	
despite	O
the	O
dramatic	O
increases	O
seen	O
in	O
the	O
first	O
two	O
patterns	O
,	O
post-	O
chemotherapy	B-T061
til	O
showed	O
limited	O
prognostic	O
significance.conclusions	O
chemotherapy	B-T061
augments	O
pre-existing	O
til	O
responses	O
but	O
fails	O
to	O
relieve	O
major	O
immune-suppressive	B-T047
mechanisms	I-T047
or	O
confer	O
significant	O
prognostic	O
benefit	O
.	O
	
our	O
findings	O
provide	O
rationale	O
for	O
multipronged	O
approaches	O
to	O
immunotherapy	B-T061
tailored	O
to	O
the	O
baseline	O
features	O
of	O
the	O
tumor	O
microenvironment	O
.	O
	
the	O
adder	O
vipera	O
berus	O
in	O
southern	O
altay	O
mountains	O
population	O
characteristics	O
,	O
distribution	O
,	O
morphology	B-T080
and	O
phylogenetic	B-T080
position	I-T080
as	O
the	O
most	O
widely	O
distributed	O
snake	O
in	O
eurasia	O
,	O
the	O
adder	O
vipera	O
berus	O
has	O
been	O
extensively	B-T080
investigated	B-T169
in	O
europe	O
but	O
poorly	O
understood	O
in	O
asia	O
.	O
	
the	O
southern	O
altay	O
mountains	O
represent	O
the	O
adder's	O
southern	O
distribution	O
limit	B-T169
in	O
central	O
asia	O
,	O
whereas	O
its	O
population	B-T081
status	I-T081
has	O
never	O
been	O
assessed	O
.	O
	
we	O
conducted	O
,	O
for	O
the	O
first	O
time	O
,	O
field	O
surveys	O
for	O
the	O
adder	O
at	O
two	O
areas	O
of	O
southern	O
altay	O
mountains	O
using	O
a	O
combination	B-T080
of	O
line	O
transects	O
and	O
random	B-T080
searches	O
.	O
	
we	O
also	O
described	O
the	O
morphological	B-T080
characteristics	I-T080
of	O
the	O
collected	O
specimens	O
and	O
conducted	O
analyses	O
of	O
external	O
morphology	B-T080
and	O
molecular	B-T078
phylogeny	I-T078
.	O
	
the	O
results	B-T033
showed	O
that	O
the	O
adder	O
distributed	O
in	O
both	O
survey	O
sites	O
and	O
we	O
recorded	O
a	O
total	O
of	O
34	O
sightings	O
.	O
	
in	O
kanas	O
river	O
valley	O
,	O
the	O
estimated	B-T081
encounter	O
rate	B-T081
over	O
a	O
total	O
of	O
137	O
km	O
transects	O
was	O
0.15	O
0.05	O
sightings	O
/km	O
.	O
	
the	O
occurrence	B-T079
of	O
melanism	B-T047
was	O
only	O
17%	O
.	O
	
the	O
small	B-T033
size	I-T033
was	O
typical	B-T080
for	O
the	O
adders	O
in	O
southern	O
altay	O
mountains	O
in	O
contrast	O
to	O
other	O
geographic	B-T081
populations	I-T081
of	O
the	O
nominate	O
subspecies	O
.	O
	
a	O
phylogenetic	B-T080
tree	I-T080
obtained	B-T169
by	O
bayesian	B-T081
inference	I-T081
based	O
on	O
dna	O
sequences	O
of	O
the	O
mitochondrial	B-T116
cytochrome	I-T116
b	I-T116
1	O
bp	O
grouped	O
them	O
within	O
the	O
northern	B-T081
clade	I-T081
of	O
the	O
species	O
but	O
failed	O
to	O
separate	B-T080
them	O
from	O
the	O
subspecies	O
v	O
.	O
	
b	O
.	O
	
sachalinensis	O
.	O
	
our	O
discovery	O
extends	O
the	O
distribution	O
range	B-T081
of	O
v	O
.	O
	
berus	O
and	O
provides	O
a	O
basis	B-T169
for	O
further	O
researches	O
.	O
	
we	O
discuss	O
the	O
hypothesis	B-T078
that	O
the	O
adder	O
expands	O
its	O
distribution	O
border	O
to	O
the	O
southwest	O
along	O
the	O
mountains	O
'	O
elevation	O
gradient	B-T081
,	O
but	O
the	O
population	O
abundance	B-T080
declines	B-T081
gradually	B-T080
due	O
to	O
a	O
drying	O
climate	O
.	O
	
binding	O
of	O
pollutants	O
to	O
biomolecules	O
a	O
simulation	O
study	O
a	O
number	O
of	O
cases	B-T169
around	O
the	O
world	O
have	O
been	O
reported	O
where	O
animals	O
were	O
found	B-T033
dead	I-T033
or	O
dying	O
with	O
symptoms	O
resembling	O
a	O
thiamine	B-T047
vitamin	B-T047
b	I-T047
deficiency	I-T047
,	O
and	O
for	O
some	O
of	O
these	O
,	O
a	O
link	O
to	O
pollutants	O
has	O
been	O
suggested	O
.	O
	
here	O
,	O
we	O
investigate	O
whether	O
biomolecules	O
involved	O
in	O
thiamin	O
binding	O
and	O
transport	O
could	O
be	O
blocked	B-T169
by	O
a	O
range	O
of	O
different	O
pollutants	O
.	O
	
we	O
used	O
in	O
silico	O
docking	O
of	O
five	O
compound	O
classes	O
25	O
compounds	O
in	O
total	O
to	O
each	O
of	O
five	O
targets	O
prion	B-T116
protein	I-T116
,	O
ecf-type	O
abc	O
transporter	O
,	O
thi-box	O
riboswitch	O
receptor	O
,	O
thiamin	B-T116
pyrophosphokinase	I-T116
,	O
and	O
ykof	B-T116
protein	I-T116
and	O
subsequently	O
performed	O
molecular	O
dynamics	O
md	O
simulations	O
to	O
assess	O
the	O
stability	B-T080
of	O
the	O
complexes	O
.	O
	
the	O
compound	O
classes	O
were	O
thiamin	B-T109
analogues	O
control	O
,	O
pesticides	O
,	O
veterinary	B-T080
medicines	O
,	O
polychlorinated	B-T109
biphenyls	I-T109
,	O
and	O
dioxins	B-T109
,	O
all	O
of	O
which	O
are	O
prevalent	B-T081
in	O
the	O
environment	O
to	O
some	O
extent	O
.	O
	
a	O
few	O
anthropogenic	O
compounds	O
were	O
found	O
to	O
bind	O
the	O
ecf-type	O
abc	O
transporter	O
,	O
but	O
none	B-T033
binds	I-T033
stably	I-T033
to	O
prion	B-T116
protein	I-T116
.	O
	
for	O
the	O
riboswitch	O
,	O
most	O
compounds	O
remained	O
in	O
their	O
binding	O
pockets	O
during	O
50	O
ns	O
of	O
md	O
simulation	O
,	O
indicating	O
that	O
rna	O
provides	O
a	O
promiscuous	O
binding	O
site	O
.	O
	
in	O
both	O
ykof	B-T116
and	O
thiamin	B-T116
pyrophosphokinase	I-T116
tpk	B-T116
,	O
most	O
compounds	O
remain	O
tightly	O
bound	O
.	O
	
however	O
,	O
tpk	B-T116
biomolecules	O
undergo	O
pollutant	O
-	O
induced	B-T169
conformational	O
changes	O
.	O
	
although	O
most	O
compounds	O
are	O
found	O
to	O
bind	O
to	O
some	O
of	O
these	O
targets	O
,	O
a	O
larger	O
data	O
set	O
is	O
needed	O
along	O
with	O
more	O
quantitative	O
methods	O
like	O
free	O
energy	O
perturbation	O
calculations	O
before	O
firm	O
conclusions	B-T078
can	O
be	O
drawn	O
.	O
	
this	O
study	O
is	O
in	O
part	O
a	O
test	O
bed	O
for	O
large-scale	O
quantitative	B-T081
computational	O
screening	O
of	O
interactions	B-T169
between	O
biological	O
entities	O
and	O
pollutant	O
molecules	O
.	O
	
characterisation	O
of	O
methicillin-resistant	O
staphylococcus	O
aureus	O
clinical	B-T080
isolates	O
from	O
animals	O
in	O
new	O
zealand	O
,	O
2012-2013	O
,	O
and	O
subclinical	B-T080
colonisation	B-T033
in	O
dogs	O
and	O
cats	O
in	O
auckland	O
to	O
characterise	O
methicillin-resistant	O
staphylococcus	O
aureus	O
mrsa	O
isolates	O
from	O
infection	B-T047
sites	I-T047
in	O
animals	O
in	O
new	O
zealand	O
and	O
assess	O
the	O
prevalence	B-T081
of	O
subclinical	B-T080
mrsa	B-T033
colonisation	I-T033
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	O
in	O
auckland	O
.	O
	
mrsa	O
isolates	O
from	O
clinical	B-T080
specimens	O
obtained	O
by	O
the	O
main	O
new	O
zealand	O
veterinary	O
diagnostic	O
laboratories	O
between	O
june	B-T079
2012	O
and	O
june	B-T079
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
dna	O
microarray	O
hybridisation	O
analysis	O
and	O
spa	B-T116
typing	O
.	O
	
in	O
addition	O
,	O
nasal	O
or	O
perineal	O
skin	O
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
n=361	O
and	O
cats	O
n=225	O
attending	O
29	O
veterinary	O
clinics	O
in	O
auckland	O
during	O
the	O
same	O
period	B-T079
were	O
analysed	O
for	O
mrsa	O
by	O
culture	O
.	O
	
eight	O
mrsa	O
clinical	B-T080
isolates	O
were	O
submitted	O
for	O
characterisation	O
by	O
the	O
participating	O
laboratories	O
.	O
	
the	O
isolates	O
originated	O
from	O
five	O
dogs	O
,	O
including	O
two	O
isolates	O
from	O
the	O
same	O
dog	O
,	O
one	O
foal	O
,	O
and	O
one	O
isolate	O
had	O
no	O
identification	O
of	O
the	O
source	B-T033
.	O
	
the	O
strain	O
-	O
types	B-T080
identified	B-T080
were	O
ak3	O
st-5	O
sccmeciv	O
t045	O
n=1	O
,	O
usa500	O
st8	O
sccmeciv	O
t064	O
n=1	O
,	O
wspp	O
st30	O
sccmeciv	O
t019	O
n=1	O
,	O
rhine	O
hesse	O
st5	O
sccmecii	O
t002	O
n=2	O
,	O
and	O
emrsa-15	O
st22	O
sccmeciv	O
t032	O
n=3	O
.	O
	
no	O
mrsa	O
were	O
isolated	B-T169
from	O
586	O
cultured	O
swabs	O
.	O
	
methicillin-susceptible	O
s	O
.	O
	
aureus	O
were	O
detected	B-T033
in	O
9/257	O
3.5	O
swabs	O
and	O
non-aureus	O
staphylococci	O
in	O
22/257	O
8.5	O
swabs	O
.	O
	
the	O
estimated	O
true	O
mrsa	O
subclinical	B-T080
colonisation	B-T033
prevalence	B-T081
was	O
0%	O
,	O
with	O
an	O
upper	O
95%	O
ci	B-T081
boundary	O
of	O
1.9	O
for	O
cats	O
and	O
1.4	O
for	O
dogs	O
.	O
	
the	O
modest	B-T081
number	I-T081
of	O
mrsa	O
isolates	O
submitted	O
for	O
this	O
study	O
by	O
the	O
participating	O
laboratories	O
suggests	O
clinical	B-T080
mrsa	B-T047
infection	I-T047
in	O
animals	O
in	O
new	O
zealand	O
continues	O
to	O
be	O
sporadic	B-T079
.	O
	
the	O
wide	O
variety	O
of	O
strain	O
-	O
types	B-T080
found	O
mirrored	O
the	O
evolving	O
strain	O
-	O
type	B-T080
diversity	B-T080
observed	O
in	O
humans	O
.	O
	
we	O
cannot	O
rule	O
out	O
bias	B-T078
due	O
to	O
the	O
non-random	O
sampling	O
of	O
dogs	O
and	O
cats	O
,	O
but	O
the	O
apparent	O
colonisation	B-T033
prevalence	B-T081
of	O
0%	O
was	O
consistent	B-T078
with	I-T078
the	O
low	O
prevalence	B-T081
of	O
subclinical	B-T080
colonisation	B-T033
in	O
humans	O
in	O
new	O
zealand	O
.	O
	
these	O
similarities	B-T080
indicate	O
the	O
epidemiology	O
of	O
animal	O
and	O
human	O
mrsa	B-T047
infections	I-T047
are	O
linked	O
.	O
	
in	O
the	O
last	O
decade	B-T081
,	O
the	O
prevalence	B-T081
of	O
human	O
mrsa	B-T047
infections	I-T047
in	O
new	O
zealand	O
has	O
steadily	O
increased	B-T081
.	O
	
this	O
is	O
the	O
second	O
published	O
study	O
of	O
mrsa	O
in	O
animals	O
in	O
new	O
zealand	O
.	O
	
the	O
results	O
indicate	O
clinical	B-T080
mrsa	B-T047
infection	I-T047
in	O
animals	O
remains	O
sporadic	B-T079
,	O
but	O
the	O
diversification	O
of	O
the	O
strain	O
-	O
types	B-T080
may	O
pose	O
new	O
therapeutic	B-T169
challenges	O
to	O
veterinarians	O
,	O
due	O
to	O
their	O
diverse	O
cloud-based	O
motifsim	O
detecting	B-T033
similarity	B-T080
in	O
large	O
dna	O
motif	O
data	O
sets	O
we	O
developed	O
the	O
cloud-based	O
motifsim	O
on	O
amazon	O
web	O
services	O
aws	O
cloud	O
.	O
	
the	O
tool	O
is	O
an	O
extended	O
version	O
from	O
our	O
web-based	O
tool	O
version	O
2.0	O
,	O
which	O
was	O
developed	O
based	O
on	O
a	O
novel	O
algorithm	O
for	O
detecting	B-T033
similarity	B-T080
in	O
multiple	O
dna	O
motif	O
data	O
sets	O
.	O
	
this	O
cloud	O
-based	O
version	O
further	O
allows	O
researchers	O
to	O
exploit	O
the	O
computing	B-T078
resources	I-T078
available	O
from	O
aws	O
to	O
detect	B-T033
similarity	B-T080
in	O
multiple	O
large-scale	O
dna	O
motif	O
data	O
sets	O
resulting	O
from	O
the	O
next-generation	O
sequencing	O
technology	O
.	O
	
the	O
tool	O
is	O
highly	O
scalable	O
with	O
expandable	O
utilization	B-T169
and	O
outcomes	O
of	O
sentinel	O
lymph	O
node	O
biopsy	O
for	O
vulvar	O
cancer	O
to	O
examine	O
the	O
use	O
and	O
predictors	O
of	O
sentinel	O
node	O
biopsy	O
in	O
women	O
with	O
vulvar	O
cancer	O
.	O
	
the	O
perspective	O
database	O
,	O
an	O
all-payer	O
database	O
that	O
collects	O
data	O
from	O
more	O
than	O
500	O
hospitals	O
,	O
was	O
used	O
to	O
perform	O
a	O
retrospective	O
cohort	O
study	O
of	O
women	O
with	O
vulvar	O
cancer	O
who	O
underwent	O
vulvectomy	B-T061
and	O
lymph	O
node	O
assessment	O
from	O
2006	O
to	O
2015	O
.	O
	
multivariable	O
models	O
were	O
used	O
to	O
determine	O
factors	B-T169
associated	O
with	O
sentinel	O
node	O
biopsy	O
.	O
	
length	B-T079
of	I-T079
stay	I-T079
and	O
cost	B-T081
were	O
compared	O
between	O
women	O
who	O
underwent	O
sentinel	O
node	O
biopsy	O
and	O
lymphadenectomy	B-T061
.	O
	
among	O
2	O
women	O
,	O
sentinel	O
node	O
biopsy	O
was	O
utilized	O
in	O
618	O
27.2	O
and	O
1	O
72.8	O
underwent	O
inguinofemoral	B-T061
lymphadenectomy	I-T061
.	O
	
performance	O
of	O
sentinel	O
node	O
biopsy	O
increased	O
from	O
17.0	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
12.0	O
in	O
2006	O
to	O
39.1	O
95%	O
ci	B-T081
27.1	O
in	O
2015	O
.	O
	
in	O
a	O
multivariable	O
model	O
,	O
women	O
treated	B-T169
more	O
recently	O
were	O
more	O
likely	O
to	O
have	O
undergone	O
sentinel	O
node	O
biopsy	O
,	O
whereas	O
women	O
with	O
more	O
comorbidities	B-T078
and	O
those	O
treated	B-T169
at	O
rural	O
hospitals	O
were	O
less	O
likely	O
to	O
have	O
undergone	O
the	O
procedure	O
.	O
	
the	O
median	O
length	B-T079
of	I-T079
stay	I-T079
was	O
shorter	O
for	O
those	O
undergoing	O
sentinel	O
node	O
biopsy	O
median	O
2	O
days	O
,	O
interquartile	B-T081
range	I-T081
1-3	O
compared	O
with	O
women	O
who	O
underwent	O
inguinofemoral	B-T061
lymphadenectomy	I-T061
median	O
3	O
days	O
,	O
interquartile	B-T081
range	I-T081
2-4	O
.	O
	
the	O
cost	O
of	O
sentinel	O
node	O
biopsy	O
was	O
7	O
interquartile	B-T081
range	I-T081
5	O
compared	O
with	O
8	O
interquartile	B-T081
range	I-T081
5	O
for	O
lymphadenectomy	B-T061
.	O
	
the	O
use	O
of	O
sentinel	O
node	O
biopsy	O
for	O
vulvar	O
cancer	O
has	O
more	O
than	O
doubled	O
since	O
2006	O
.	O
	
sentinel	O
lymph	O
node	O
biopsy	O
is	O
associated	O
with	O
a	O
shorter	B-T079
hospital	I-T079
stay	I-T079
and	O
decreased	B-T081
cost	I-T081
compared	O
with	O
inguinofemoral	B-T061
lymphadenectomy	I-T061
.	O
	
condition	B-T080
-	O
dependent	B-T080
co-regulation	O
of	O
genomic	O
clusters	O
of	O
virulence	B-T109
factors	I-T109
in	O
the	O
grapevine	B-T047
trunk	I-T047
pathogen	O
neofusicoccum	O
parvum	O
the	O
ascomycete	O
neofusicoccum	O
parvum	O
,	O
one	O
of	O
the	O
causal	B-T033
agents	I-T033
of	O
botryosphaeria	O
dieback	O
,	O
is	O
a	O
destructive	O
wood	O
-	O
infecting	B-T033
fungus	O
and	O
a	O
serious	O
threat	B-T078
to	O
grape	O
production	O
worldwide	O
.	O
	
the	O
capability	B-T080
of	O
colonizing	B-T033
woody	O
tissue	O
combined	B-T080
with	O
the	O
secretion	O
of	O
phytotoxic	B-T080
compounds	O
is	O
thought	O
to	O
underlie	O
its	O
pathogenicity	O
and	O
virulence	O
.	O
	
here	O
,	O
we	O
describe	O
the	O
repertoire	O
of	O
virulence	B-T109
factors	I-T109
and	O
their	O
transcriptional	O
dynamics	O
as	O
the	O
fungus	O
feeds	O
on	O
different	O
substrates	O
and	O
colonizes	B-T033
the	O
woody	O
stem	O
.	O
	
we	O
assembled	O
and	O
annotated	B-T080
a	O
highly	B-T080
contiguous	O
genome	O
using	O
single	O
molecule	O
real-time	O
dna	O
sequencing	O
.	O
	
transcriptome	O
profiling	O
by	O
rna-sequencing	O
determined	O
the	O
genome	O
-wide	O
patterns	O
of	O
expression	O
of	O
virulence	B-T109
factors	I-T109
both	O
in	O
vitro	O
potato	O
dextrose	O
agar	O
or	O
medium	O
amended	B-T080
with	O
grape	O
wood	O
as	O
substrate	O
and	O
in	O
planta	O
.	O
	
pairwise	O
statistical	O
testing	O
of	O
differential	B-T080
expression	O
followed	O
by	O
co-expression	O
network	O
analysis	O
revealed	O
that	O
physically	B-T169
clustered	O
genes	O
coding	O
for	O
putative	O
virulence	O
functions	B-T169
were	O
induced	O
depending	O
on	O
substrate	O
or	O
stage	B-T079
of	O
plant	O
infection	O
.	O
	
co-expressed	O
gene	O
clusters	O
were	O
significantly	O
enriched	O
not	O
only	O
in	O
genes	O
associated	B-T080
with	I-T080
secondary	O
metabolism	O
,	O
but	O
also	O
with	O
cell	O
wall	O
degradation	O
,	O
suggesting	O
that	O
dynamic	B-T169
co-regulation	O
of	O
transcriptional	O
networks	O
contribute	O
to	O
multiple	O
aspects	O
of	O
n	O
.	O
	
parvum	O
virulence	O
.	O
	
in	O
most	O
of	O
the	O
co-expressed	O
clusters	O
,	O
all	O
genes	O
shared	O
at	O
least	O
a	O
common	O
motif	O
in	O
their	O
promoter	O
region	O
indicative	O
of	O
co-regulation	O
by	O
the	O
same	O
transcription	B-T116
factor	I-T116
.	O
	
co-expression	O
analysis	O
also	O
identified	O
chromatin	B-T116
regulators	O
with	O
correlated	B-T080
expression	O
with	O
inducible	B-T169
clusters	O
of	O
virulence	B-T109
factors	I-T109
,	O
suggesting	O
a	O
complex	O
,	O
multi-layered	O
regulation	O
of	O
the	O
virulence	O
repertoire	O
of	O
n	O
.	O
	
parvum	O
.	O
	
congenital	O
anomalies	O
following	O
use	O
of	O
isotretinoin	B-T109
emphasis	O
on	O
its	O
legal	O
aspects	O
we	O
described	O
a	O
neonate	O
with	O
severe	B-T080
and	O
multiple	O
abnormalities	O
following	O
use	O
of	O
isotretinoin	B-T109
,	O
in	O
spite	O
of	O
the	O
mother	O
's	O
previous	O
knowledge	O
of	O
drug	O
complications	O
.	O
	
initial	O
physical	O
examination	O
after	O
delivery	B-T061
showed	O
congenital	O
absence	O
of	O
both	O
eyes	O
and	O
both	O
auricles	O
as	O
well	O
as	O
anal	O
atresia	O
and	O
a	O
cleft	O
palate	O
.	O
	
due	O
to	O
severe	B-T080
respiratory	O
distress	O
and	O
atresia	O
of	O
the	O
anus	O
,	O
the	O
neonate	O
was	O
admitted	O
to	O
a	O
neonatal	O
intensive	O
care	O
unit	O
and	O
underwent	O
reconstructive	B-T061
surgery	I-T061
.	O
	
the	O
drug	O
should	O
not	O
have	O
been	O
used	O
during	O
pregnancy	O
.	O
	
using	O
this	O
drug	O
within	O
pregnancy	O
with	O
awareness	O
of	O
its	O
side	O
effects	O
may	O
have	O
legal	B-T169
consequences	B-T169
.	O
	
functional	O
adaptation	O
of	O
crustacean	O
exoskeletal	O
elements	O
through	O
structural	O
and	O
compositional	O
diversity	B-T080
a	O
combined	B-T080
experimental	O
and	O
theoretical	O
study	O
the	O
crustacean	O
cuticle	O
is	O
a	O
composite	B-T080
material	O
that	O
covers	O
the	O
whole	O
animal	O
and	O
forms	O
the	O
continuous	O
exoskeleton	O
.	O
	
nano-fibers	O
composed	O
of	O
chitin	B-T109
and	O
protein	B-T116
molecules	I-T116
form	O
most	O
of	O
the	O
organic	B-T080
matrix	B-T109
of	O
the	O
cuticle	O
that	O
,	O
at	O
the	O
macroscale	B-T081
,	O
is	O
organized	O
in	O
up	O
to	O
eight	O
hierarchical	B-T169
levels	B-T080
.	O
	
at	O
least	O
two	O
of	O
them	O
,	O
the	O
exo-	O
and	O
endocuticle	O
,	O
contain	O
a	O
mineral	O
phase	O
of	O
mainly	O
mg	O
-	O
calcite	O
,	O
amorphous	B-T080
calcium	O
carbonate	O
and	O
phosphate	O
.	O
	
the	O
high	O
number	O
of	O
hierarchical	B-T169
levels	B-T080
and	O
the	O
compositional	O
diversity	B-T080
provide	O
a	O
high	O
degree	B-T080
of	I-T080
freedom	I-T080
for	O
varying	B-T169
the	O
physical	O
,	O
in	O
particular	O
mechanical	B-T169
,	O
properties	B-T080
of	O
the	O
material	O
.	O
	
this	O
makes	O
the	O
cuticle	O
a	O
versatile	O
material	O
ideally	O
suited	O
to	O
form	O
a	O
variety	O
of	O
skeletal	O
elements	O
that	O
are	O
adapted	O
to	O
different	O
functions	B-T169
and	O
the	O
eco-physiological	O
strains	O
of	O
individual	O
species	O
.	O
	
this	O
review	O
presents	O
our	O
recent	O
analytical	O
,	O
experimental	O
and	O
theoretical	O
studies	O
on	O
the	O
cuticle	O
,	O
summarising	O
at	O
which	O
hierarchical	B-T169
levels	B-T080
structure	O
and	O
composition	O
are	O
modified	O
to	O
achieve	O
the	O
required	O
physical	O
properties	O
.	O
	
we	O
describe	O
our	O
multi-scale	O
hierarchical	O
modeling	O
approach	O
based	O
on	O
the	O
results	B-T169
from	O
these	O
studies	O
,	O
aiming	O
at	O
systematically	B-T169
predicting	B-T078
the	O
structure	O
-	O
composition	O
-	O
property	B-T080
relations	B-T080
of	O
cuticle	O
composites	B-T080
from	O
the	O
molecular	B-T080
level	B-T080
to	O
the	O
macro-scale	B-T081
.	O
	
this	O
modeling	O
approach	O
provides	O
a	O
tool	O
to	O
facilitate	O
the	O
development	B-T169
of	O
optimized	O
biomimetic	O
materials	O
within	O
a	O
knowledge-based	O
design	O
approach	O
.	O
	
draft	O
genome	O
sequences	O
of	O
15	O
isolates	O
of	O
listeria	O
monocytogenes	O
serotype	O
1/2a	O
,	O
subgroup	O
st204	O
listeria	O
monocytogenes	O
sequence	O
type	O
204	O
st204	O
strains	O
have	O
been	O
isolated	B-T169
from	O
a	O
range	O
of	O
food	O
,	O
environmental	O
,	O
and	O
clinical	B-T080
sources	B-T033
in	O
australia	O
.	O
	
this	O
study	O
describes	O
the	O
draft	O
genome	O
sequences	O
of	O
15	O
isolates	O
collected	O
from	O
meat	O
and	O
dairy	O
associated	O
sources	O
.	O
	
high	O
transferability	B-T080
of	O
homoeolog-specific	O
markers	O
between	O
bread	O
wheat	O
and	O
newly	O
synthesized	O
hexaploid	O
wheat	O
lines	O
bread	O
wheat	O
triticum	O
aestivum	O
,	O
2n	O
=	O
6x	O
=	O
42	O
,	O
aabbdd	O
has	O
a	O
complex	O
allohexaploid	O
genome	O
,	O
which	O
makes	O
it	O
difficult	O
to	O
differentiate	B-T169
between	O
the	O
homoeologous	O
sequences	O
and	O
assign	O
them	O
to	O
the	O
chromosome	O
a	O
,	O
b	O
,	O
or	O
d	O
subgenomes	O
.	O
	
the	O
chromosome	O
-based	O
draft	O
genome	O
sequence	O
of	O
the	O
'	O
chinese	O
spring	O
'	O
common	O
wheat	O
cultivar	O
enables	O
the	O
large-scale	O
development	B-T169
of	O
polymerase	O
chain	O
reaction	O
pcr	O
markers	O
specific	O
for	O
homoeologs	O
.	O
	
based	O
on	O
high-confidence	O
'	O
chinese	O
spring	O
'	O
genes	O
with	O
known	O
functions	O
,	O
we	O
developed	O
183	O
putative	O
homoeolog-specific	O
markers	O
for	O
chromosomes	O
4b	O
and	O
7b	O
.	O
	
these	O
markers	O
were	O
used	O
in	O
pcr	O
assays	O
for	O
the	O
4b	O
and	O
7b	O
nullisomes	O
and	O
their	O
euploid	O
synthetic	O
hexaploid	O
wheat	O
shw	O
line	O
that	O
was	O
newly	O
generated	O
from	O
a	O
hybridization	O
between	O
triticum	O
turgidum	O
aabb	O
and	O
the	O
wild	O
diploid	O
species	O
aegilops	O
tauschii	O
dd	O
.	O
	
up	O
to	O
64%	O
of	O
the	O
markers	O
for	O
chromosomes	O
4b	O
or	O
7b	O
in	O
the	O
shw	O
background	O
were	O
confirmed	O
to	O
be	O
homoeolog-specific	O
.	O
	
thus	O
,	O
these	O
markers	O
were	O
highly	O
transferable	O
between	O
the	O
'	O
chinese	O
spring	O
'	O
bread	O
wheat	O
and	O
shw	O
lines	O
.	O
	
homoeolog-specific	O
markers	O
designed	O
using	O
genes	O
with	O
known	O
functions	O
may	O
be	O
useful	O
for	O
genetic	O
investigations	O
involving	O
homoeologous	O
chromosome	O
tracking	O
and	O
homoeolog	O
expression	O
participation	B-T169
in	O
and	O
adherence	B-T169
to	O
physical	O
exercise	O
after	O
completion	B-T080
of	O
primary	O
cancer	O
treatment	B-T061
the	O
purpose	B-T169
of	O
this	O
study	O
was	O
to	O
identify	O
demographic	B-T078
,	O
clinical	B-T080
,	O
psychosocial	B-T169
,	O
physical	B-T169
and	O
environmental	O
factors	B-T169
that	O
are	O
associated	B-T080
with	I-T080
participation	B-T169
in	O
and	O
adherence	B-T169
to	O
a	O
combined	B-T080
resistance	B-T169
and	O
endurance	B-T061
exercise	I-T061
program	B-T169
among	O
cancer	O
survivors	O
,	O
shortly	O
after	O
completion	B-T080
of	O
primary	O
cancer	O
treatment	B-T061
.	O
	
data	B-T078
from	O
the	O
randomized	B-T033
controlled	B-T169
resistance	O
and	O
endurance	O
exercise	O
after	O
chemotherapy	O
react	O
study	O
were	O
used	O
for	O
this	O
study	O
.	O
	
the	O
participants	O
of	O
the	O
react	O
study	O
were	O
randomly	B-T080
allocated	O
to	O
either	O
a	O
high	O
intensity	O
hi	O
or	O
low	B-T080
-to-	O
moderate	O
intensity	O
lmi	B-T080
exercise	O
program	B-T169
.	O
	
patients	O
'	O
participation	B-T169
rate	B-T081
was	O
defined	O
as	O
the	O
cancer	O
survivors	O
'	O
decision	O
to	O
participate	B-T169
in	O
the	O
react	O
study	O
.	O
	
exercise	O
adherence	B-T169
reflected	O
participants	O
'	O
attendance	O
to	O
the	O
scheduled	B-T080
exercise	O
sessions	O
and	O
their	O
compliance	O
to	O
the	O
prescribed	O
exercises	O
.	O
	
high	B-T080
session	O
attendance	O
rates	B-T081
were	O
defined	O
as	O
attending	B-T169
at	O
least	O
80	O
%	O
of	O
the	O
sessions	O
.	O
	
high	B-T080
compliance	O
rates	B-T081
were	O
defined	O
as	O
performing	B-T169
at	O
least	O
of	O
90	O
%	O
of	O
the	O
prescribed	O
exercise	O
across	O
all	O
sessions	O
.	O
	
correlates	B-T080
of	O
exercise	O
adherence	B-T169
were	O
studied	O
separately	B-T080
for	O
hi	O
and	O
lmi	B-T080
exercise	O
.	O
	
demographic	B-T078
,	O
clinical	B-T080
,	O
and	O
physical	B-T169
factors	B-T169
were	O
assessed	O
using	O
self-reported	O
questionnaires	O
.	O
	
relevant	B-T080
clinical	O
information	O
was	O
extracted	B-T169
from	O
medical	O
records	O
.	O
	
multivariable	O
logistic	O
regression	O
analyses	O
were	O
applied	B-T169
to	O
identify	O
correlates	B-T080
that	O
were	O
significantly	B-T078
associated	B-T080
with	I-T080
participation	B-T169
,	O
high	B-T080
session	O
attendance	O
,	O
high	B-T080
compliance	O
with	O
resistance	B-T169
and	O
high	B-T080
compliance	O
with	O
endurance	B-T061
exercises	I-T061
.	O
	
participants	O
were	O
more	B-T033
likely	I-T033
to	O
have	O
higher	O
education	O
,	O
be	O
non-smokers	B-T033
,	O
have	O
lower	B-T080
psychological	O
distress	O
,	O
higher	B-T080
outcome	B-T080
expectations	B-T078
,	O
and	O
perceive	O
more	B-T081
exercise	O
barriers	B-T080
than	O
non-participants	O
.	O
	
in	O
hi	O
exercise	O
,	O
higher	B-T080
self-efficacy	O
was	O
significantly	B-T078
associated	B-T080
with	I-T080
high	B-T080
session	O
attendance	O
and	O
high	B-T080
compliance	O
with	O
endurance	B-T061
exercises	I-T061
,	O
and	O
lower	B-T080
psychological	O
distress	O
was	O
significantly	B-T078
associated	B-T080
with	I-T080
high	B-T080
compliance	O
with	O
resistance	B-T169
exercise	O
s	O
.	O
	
in	O
lmi	B-T080
exercise	O
,	O
being	O
a	O
non-smoker	B-T033
was	O
significantly	B-T078
associated	B-T080
with	I-T080
high	B-T080
compliance	O
with	O
resistance	B-T169
exercises	O
and	O
higher	B-T080
bmi	O
was	O
significantly	B-T078
associated	B-T080
with	I-T080
high	B-T080
compliance	O
with	O
resistance	B-T169
and	O
endurance	B-T061
exercises	I-T061
.	O
	
furthermore	O
,	O
breast	O
cancer	O
survivors	O
were	O
less	B-T081
likely	B-T078
to	O
report	O
high	B-T080
compliance	O
with	O
resistance	B-T169
and	O
endurance	B-T061
exercises	I-T061
in	O
lmi	B-T080
exercise	O
compared	O
to	O
survivors	O
of	O
other	O
types	O
of	O
cancer	O
.	O
	
the	O
discriminative	O
ability	O
of	O
the	O
multivariable	B-T080
models	O
ranged	B-T081
from	O
0.62	O
to	O
0.75	O
.	O
	
several	O
demographic	B-T078
,	O
clinical	B-T080
and	O
psychosocial	B-T169
factors	B-T169
were	O
associated	B-T080
with	I-T080
participation	B-T169
in	O
and	O
adherence	B-T169
to	O
exercise	O
among	O
cancer	O
survivors	O
.	O
	
psychosocial	B-T169
factors	B-T169
were	O
more	B-T081
strongly	B-T080
associated	B-T080
with	I-T080
adherence	B-T169
in	O
hi	O
than	O
lmi	B-T080
exercise	O
.	O
	
this	O
study	O
was	O
registered	O
at	O
the	O
netherlands	O
trial	O
register	O
ntr2153	O
in	O
situ	O
stabilization	B-T080
of	O
heavy	O
metals	O
in	O
multiple-	O
metal	O
contaminated	B-T169
paddy	O
soil	O
using	O
different	O
steel	O
slag	O
-based	O
silicon	O
fertilizer	O
steel	O
slag	O
has	O
been	O
widely	O
used	O
as	O
amendment	O
and	O
silicon	O
fertilizer	O
to	O
alleviate	O
the	O
mobility	B-T033
and	O
bioavailability	B-T081
of	O
heavy	O
metals	O
in	O
soil	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
influence	O
of	O
particle	B-T081
size	I-T081
,	O
composition	O
,	O
and	O
application	O
rate	O
of	O
slag	O
on	O
metal	O
immobilization	B-T169
in	O
acidic	O
soil	O
,	O
metals	O
uptake	O
by	O
rice	O
and	O
rice	O
growth	O
.	O
	
the	O
results	O
indicated	O
that	O
application	O
of	O
slag	O
increased	O
soil	O
ph	B-T081
,	O
plant	O
-available	O
silicon	O
concentrations	B-T081
in	O
soil	O
,	O
and	O
decreased	B-T081
the	O
bioavailability	B-T081
of	O
metals	O
compared	O
with	O
control	B-T080
treatment	I-T080
,	O
whereas	O
pulverous	O
slag	O
s1	O
was	O
more	B-T080
effective	I-T080
than	O
granular	B-T080
slag	O
s2	O
and	O
s3	O
.	O
	
the	O
acid	O
-	O
extractable	B-T081
fraction	I-T081
of	I-T081
cd	O
in	O
the	O
spiked	O
soil	O
was	O
significantly	O
decreased	B-T081
with	O
application	O
of	O
s1	O
at	O
rates	O
of	O
1	O
and	O
3	O
%	O
,	O
acid-extractable	O
fractions	O
of	O
cu	O
and	O
zn	O
were	O
decreased	B-T081
when	O
treated	B-T169
at	O
3	O
%	O
.	O
	
use	O
of	O
s1	O
at	O
both	O
rates	O
resulted	O
in	O
significantly	B-T081
lower	I-T081
cd	O
,	O
cu	O
,	O
and	O
zn	O
concentrations	B-T081
in	O
rice	O
tissues	O
than	O
in	O
controls	O
by	O
82.6	O
,	O
88.4	O
,	O
and	O
67.4	O
%	O
,	O
respectively	O
.	O
	
however	O
,	O
use	O
of	O
pulverous	O
slag	O
at	O
1	O
%	O
significantly	O
promotes	O
rice	O
growth	O
,	O
restricted	O
rice	O
growth	O
when	O
treated	B-T169
at	O
3	O
%	O
.	O
	
thus	O
,	O
the	O
results	O
explained	O
that	O
reduced	B-T080
particle	B-T081
size	I-T081
and	O
suitable	O
application	O
rate	O
of	O
slag	O
could	O
be	O
beneficial	O
to	O
rice	O
growth	O
and	O
metals	O
stabilization	B-T080
.	O
	
plasmodium	O
falciparum	O
choline	B-T116
kinase	I-T116
inhibition	O
leads	O
to	O
a	O
major	O
decrease	B-T081
in	O
phosphatidylethanolamine	B-T109
causing	O
parasite	O
death	O
malaria	B-T047
is	O
a	O
life-threatening	B-T033
disease	B-T047
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	O
plasmodium	O
,	O
with	O
p	O
.	O
	
falciparum	O
being	O
the	O
deadliest	O
.	O
	
increasing	B-T169
parasitic	B-T169
resistance	B-T169
to	O
existing	O
antimalarials	O
makes	O
the	O
necessity	O
of	O
novel	B-T080
avenues	O
to	O
treat	B-T061
this	O
disease	B-T047
an	O
urgent	O
priority	O
.	O
	
the	O
enzymes	B-T116
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	B-T109
and	O
phosphatidylethanolamine	B-T109
are	O
attractive	O
drug	B-T169
targets	I-T169
to	O
treat	B-T061
malaria	B-T047
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite's	O
growth	O
and	O
cures	B-T033
malaria	B-T047
in	O
a	O
mouse	O
model	O
.	O
	
we	O
present	O
here	O
a	O
detailed	O
study	O
that	O
reveals	O
a	O
mode	B-T169
of	I-T169
action	I-T169
for	O
two	O
p	O
.	O
	
falciparum	O
choline	B-T116
kinase	I-T116
inhibitors	O
both	O
in	B-T080
vitro	I-T080
and	O
in	O
vivo	O
.	O
	
the	O
compounds	B-T080
present	O
distinct	O
binding	O
modes	O
to	O
the	O
choline	B-T109
/	O
ethanolamine	B-T109
-	O
binding	O
site	O
of	O
p	O
.	O
	
falciparum	O
choline	B-T116
kinase	I-T116
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O
	
strikingly	O
,	O
these	O
compounds	B-T080
primarily	O
inhibit	O
the	O
ethanolamine	O
kinase	O
activity	O
of	O
the	O
p	O
.	O
	
falciparum	O
choline	B-T116
kinase	I-T116
,	O
leading	O
to	O
a	O
severe	O
decrease	B-T081
in	O
the	O
phosphatidylethanolamine	B-T109
levels	B-T080
within	O
p	O
.	O
	
falciparum	O
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	O
death	O
.	O
	
these	O
studies	O
provide	O
an	O
understanding	O
of	O
the	O
mode	B-T169
of	I-T169
action	I-T169
,	O
and	O
act	O
as	O
a	O
springboard	O
for	O
continued	O
antimalarial	O
development	O
efforts	O
selectively	O
targeting	O
p	O
.	O
	
falciparum	O
choline	B-T116
kinase	I-T116
.	O
	
anti-cd45rb	B-T116
and	O
donor-specific	B-T169
spleen	I-T169
cells	I-T169
transfusion	I-T169
inhibition	O
allograft	O
skin	O
rejection	O
mediated	O
by	O
memory	O
t	O
cells	O
donor-reactive	O
memory	O
t	O
tm	O
mediate	O
accelerated	O
rejection	O
,	O
which	O
is	O
known	O
as	O
a	O
barrier	O
to	O
the	O
survival	O
of	O
transplanted	O
organs	O
.	O
	
selective	O
interference	O
with	O
the	O
anti-cd45rb	B-T116
monoclonal	I-T116
antibody	I-T116
α-cd45rb	I-T116
reliably	O
induces	O
donor	O
-	O
specific	B-T080
tolerance	O
.	O
	
in	O
this	O
study	O
,	O
pre-sensitization	B-T079
to	O
female	O
c57bl/6	O
mice	O
with	O
the	O
skin	O
of	O
female	O
blab/c	O
mice	O
generated	O
a	O
large	O
number	O
of	O
tm	O
cells	O
and	O
resulted	O
in	O
rapid	O
rejection	O
of	O
the	O
secondly	B-T081
transplanted	B-T169
allografts	O
.	O
	
α-cd45rb	B-T116
did	O
induce	O
the	O
tolerance	O
to	O
skin	O
allograft	O
primarily	B-T080
transplanted	B-T169
but	O
failed	O
to	O
induce	O
tolerance	O
in	O
the	O
pre-sensitized	O
mice	O
.	O
	
donor-specific	B-T169
spleen	I-T169
cell	I-T169
transfusion	I-T169
dst	B-T169
alone	O
also	O
failed	O
to	O
induce	O
the	O
tolerance	O
in	O
the	O
pre-sensitized	B-T079
recipients	O
.	O
	
interestingly	O
,	O
combination	O
of	O
α-cd45rb	B-T116
with	O
dst	B-T169
inhibited	O
the	O
rejection	O
induced	O
by	O
memory	O
t	O
cells	O
in	O
the	O
pre-sensitized	O
mice	O
.	O
	
cd25+	O
t-cell	O
depletion	B-T061
in	O
α-cd45rb	B-T116
combined	O
with	O
dst	B-T169
therapy	B-T061
recipients	O
could	O
prevent	O
skin	O
allograft	O
tolerance	O
from	O
establishing	O
.	O
	
in	O
addition	O
,	O
adoptive	B-T061
transfer	I-T061
of	O
donor	O
-primed	O
memory	O
t	O
cells	O
into	O
the	O
tolerant	O
recipients	O
markedly	O
broke	O
the	O
established	O
tolerance	O
.	O
	
our	O
findings	B-T033
indicate	O
that	O
α-cd45rb	B-T116
and	O
dst	B-T169
can	O
synergistically	O
inhibit	O
the	O
accelerated	O
rejection	O
mediated	O
by	O
memory	O
t	O
cells	O
and	O
induce	O
long-term	O
skin	O
allograft	O
acceptance	O
in	O
recruitment	O
of	O
minority	O
adolescents	O
and	O
young	O
adults	O
into	O
randomised	O
clinical	O
trials	O
testing	B-T169
the	O
design	O
of	O
the	O
technology	O
enhanced	O
community	O
health	O
nursing	O
tech-n	O
pelvic	B-T047
inflammatory	I-T047
disease	I-T047
trial	O
pelvic	B-T047
inflammatory	I-T047
disease	I-T047
pid	B-T047
disproportionately	B-T080
affects	O
adolescent	O
and	O
young	O
adult	O
aya	O
women	O
and	O
can	O
negatively	O
influence	O
reproductive	O
health	O
trajectories	O
.	O
	
few	O
randomized	O
controlled	O
trials	O
rcts	O
have	O
focused	O
on	O
strategies	O
to	O
improve	B-T033
outpatient	O
adherence	B-T169
or	O
to	O
reduce	B-T080
reproductive	O
morbidity	B-T081
in	O
this	O
population	O
.	O
	
this	O
paper	O
describes	O
the	O
research	O
methods	O
and	O
preliminary	B-T079
effectiveness	B-T080
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	O
strategies	O
employed	O
in	O
a	O
novel	O
rct	O
designed	O
to	O
test	O
a	O
technology-enhanced	O
community-health	O
nursing	O
tech-n	O
intervention	O
among	O
urban	O
aya	O
with	O
pid	B-T047
.	O
	
aya	O
women	O
aged	O
13-25	O
years	B-T079
were	O
recruited	O
during	O
acute	B-T047
pid	I-T047
visits	O
in	O
outpatient	O
clinics	O
and	O
emergency	O
departments	O
ed	O
to	O
participate	O
in	O
this	O
irb-approved	O
trial	O
.	O
	
participants	O
completed	B-T080
an	O
audio-computerized	O
self-interview	O
acasi	O
,	O
provided	O
vaginal	O
specimens	O
,	O
and	O
were	O
randomized	O
to	O
standard	B-T080
treatment	B-T061
or	O
the	O
intervention	O
.	O
	
intervention	O
participants	O
received	B-T080
text-messaging	O
support	O
for	O
30	O
days	B-T079
and	O
a	O
community	O
health	O
nurse	O
chn	O
interventionist	O
performed	B-T169
a	O
home	O
visit	O
with	O
clinical	O
assessment	O
within	O
5	O
days	B-T079
after	O
enrollment	O
.	O
	
all	O
patients	O
received	O
a	O
full	O
course	B-T079
of	O
medications	O
and	O
completed	B-T080
research	O
visits	O
at	O
14-	O
days	B-T079
adherence	B-T169
,	O
30	O
days	B-T079
and	O
90	O
days	B-T079
with	O
by	O
an	O
outreach	O
worker	O
.	O
	
sti	B-T047
testing	B-T169
performed	B-T169
at	O
the	O
30-and	O
90-	O
day	B-T079
visits	O
.	O
	
exploratory	O
analyses	O
using	O
descriptive	O
statistics	O
were	O
conducted	O
to	O
examine	O
recruitment	O
,	O
retention	O
,	O
and	O
follow-up	O
data	B-T078
to	O
test	O
the	O
overall	O
design	O
of	O
the	O
intervention	O
.	O
	
in	O
the	O
first	O
48	O
months	B-T079
,	O
64%	O
of	O
463	O
patients	O
were	O
eligible	B-T080
for	O
the	O
study	O
and	O
81.2	O
of	O
293	O
eligible	B-T080
patients	O
were	O
recruited	O
for	O
the	O
study	O
63.3	O
238	O
81.2	O
of	O
eligible	B-T080
patients	O
were	O
enrolled	O
.	O
	
most	O
participants	O
were	O
african	O
american	O
95.6	O
with	O
a	O
mean	B-T081
age	O
of	O
18.6	O
2.3	O
.	O
	
ninety-four	O
percent	O
of	O
individuals	O
assigned	O
to	O
the	O
tech-n	O
intervention	O
completed	B-T080
the	O
nursing	O
visits	O
.	O
	
all	O
completed	B-T080
visits	O
have	O
been	O
within	O
the	O
5-	O
day	B-T079
window	B-T079
and	O
over	O
90%	O
of	O
patients	O
in	O
both	O
arms	O
have	O
been	O
retained	B-T169
over	O
the	O
3-	O
month	B-T079
follow-up	O
period	B-T079
.	O
	
biological	B-T080
data	B-T078
suggests	O
a	O
shift	O
in	O
the	O
biological	O
milieu	O
with	O
the	O
predominance	O
of	O
chlamydia	B-T047
trachomatis	I-T047
,	O
mycoplasma	B-T047
genitalium	I-T047
,	O
and	O
trichomonas	B-T047
vaginalis	I-T047
infections	I-T047
.	O
	
preliminary	B-T079
data	B-T078
from	O
the	O
tech-n	O
study	O
demonstrated	O
that	O
urban	O
,	O
low-income	B-T033
,	O
minority	O
aya	O
with	O
pid	B-T047
can	O
effectively	O
be	O
recruited	O
and	O
retained	B-T169
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	O
rcts	O
with	O
sufficient	B-T080
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	O
the	O
study	O
.	O
	
community	O
-based	O
sexual	O
health	O
interventions	B-T061
appear	O
to	O
be	O
both	O
feasible	B-T080
and	O
acceptable	B-T080
in	O
this	O
extended	O
use	O
of	O
prostate	O
health	O
index	O
and	O
percentage	O
of	O
-2	B-T116
antigen	I-T116
in	O
chinese	O
men	O
with	O
prostate	B-T116
specific	I-T116
antigen	I-T116
10-20	O
ng/ml	O
and	O
normal	B-T080
digital	O
rectal	O
examination	O
we	O
investigated	O
the	O
extended	O
use	O
of	O
prostate	O
health	O
index	O
phi	O
and	O
percentage	O
of	O
-2	B-T116
antigen	I-T116
%p2psa	B-T116
in	O
chinese	O
men	O
with	O
prostate-specific	B-T116
antigen	I-T116
psa	B-T116
10-20	O
ng/ml	O
and	O
normal	B-T080
digital	O
rectal	O
examination	O
dre	O
.	O
	
all	O
consecutive	O
chinese	O
men	O
with	O
psa	B-T116
10-20	O
ng/ml	O
and	O
normal	B-T080
dre	O
who	O
agreed	O
for	O
transrectal	O
ultrasound	O
trus	O
10-core	O
prostate	O
biopsy	O
were	O
recruited	O
.	O
	
blood	O
samples	O
were	O
taken	O
immediately	O
before	O
trus	O
-guided	O
prostate	O
biopsy	O
.	O
	
the	O
performances	O
of	O
total	O
psa	O
tpsa	O
,	O
%	O
free-to-total	O
psa	O
%	O
fpsa	O
,	O
%p2psa	B-T116
,	O
and	O
phi	O
were	O
compared	O
using	O
logistic	O
regression	O
,	O
receiver	B-T081
operating	I-T081
characteristic	I-T081
,	O
and	O
decision	O
curve	O
analyses	O
dca	O
.	O
	
from	O
2008	O
to	O
2015	O
,	O
312	O
consecutive	O
chinese	O
men	O
were	O
included	O
.	O
	
among	O
them	O
,	O
53	O
out	O
of	O
312	O
17.0	O
men	O
were	O
diagnosed	B-T033
to	O
have	O
prostate	O
cancer	O
on	O
biopsy	O
.	O
	
the	O
proportions	O
of	O
men	O
with	O
positive	B-T033
biopsies	I-T033
were	O
6.7	O
in	O
phi	O
<35	O
,	O
22.8	O
in	O
phi	O
35-55	O
,	O
and	O
54.5	O
in	O
phi	O
>55	O
chi-square	O
test	O
,	O
p<0	O
.	O
	
the	O
area	O
under	O
curves	O
auc	O
of	O
the	O
base	O
model	O
including	O
age	O
,	O
tpsa	O
and	O
status	O
of	O
initial/repeated	O
biopsy	O
was	O
0.64	O
.	O
	
adding	O
%p2psa	O
and	O
phi	O
to	O
the	O
base	O
model	O
improved	O
the	O
auc	O
to	O
0.79	O
p<0	O
and	O
0.78	O
p<0	O
,	O
respectively	O
,	O
and	O
provided	O
net	O
clinical	O
benefit	O
in	O
dca	O
.	O
	
the	O
positive	O
biopsy	O
rates	O
of	O
gleason	O
7	O
or	O
above	O
prostate	O
cancers	O
were	O
2.2	O
for	O
phi	O
<35	O
,	O
7.9	O
for	O
phi	O
35-55	O
,	O
and	O
36.4	O
for	O
phi	O
>55	O
chi-square	O
test	O
,	O
p<0	O
.	O
	
by	O
utilizing	O
the	O
phi	O
cutoff	O
of	O
35	O
to	O
men	O
with	O
psa	O
10-20	O
ng/ml	O
and	O
normal	O
dre	O
,	O
57.1	O
178	O
of	O
312	O
biopsies	O
could	O
be	O
avoided	O
.	O
	
both	O
phi	O
and	O
%p2psa	O
performed	O
well	O
in	O
predicting	O
prostate	O
cancer	O
and	O
high	O
grade	O
prostate	O
cancer	O
.	O
	
the	O
use	O
of	O
phi	O
and	O
%p2psa	O
should	O
be	O
extended	O
to	O
chinese	O
men	O
with	O
psa	O
10-20	O
ng/ml	O
and	O
normal	O
dre	O
a	O
pilot	O
study	O
exploring	O
the	O
relationship	B-T080
between	O
self	B-T078
-	O
compassion	O
,	O
self	B-T078
-	O
judgement	O
,	O
self	B-T078
-	O
kindness	O
,	O
compassion	O
,	O
professional	B-T078
quality	I-T078
of	I-T078
life	I-T078
and	O
wellbeing	B-T033
among	O
uk	O
community	O
nurses	O
compassion	O
fatigue	O
and	O
burnout	O
can	O
impact	B-T080
on	O
performance	O
of	O
nurses	O
.	O
	
this	O
paper	O
explores	O
the	O
relationship	B-T080
between	O
self	B-T078
-	O
compassion	O
,	O
self	B-T078
-	O
judgement	O
,	O
self	B-T078
-	O
kindness	O
,	O
compassion	O
,	O
professional	B-T078
quality	I-T078
of	I-T078
life	I-T078
,	O
and	O
wellbeing	B-T033
among	O
community	O
nurses	O
.	O
	
to	O
measure	B-T081
associations	B-T080
between	O
self	B-T078
-	O
compassion	O
,	O
compassion	O
fatigue	O
,	O
wellbeing	B-T033
,	O
and	O
burnout	O
in	O
community	O
nurses	O
.	O
	
quantitative	B-T081
data	B-T078
were	O
collected	B-T169
using	O
standardised	B-T080
psychometric	O
questionnaires	O
1	O
professional	O
quality	O
of	O
life	O
scale	O
2	O
self-compassion	B-T081
scale	I-T081
3	O
short	O
warwick	O
edinburgh	O
mental	O
wellbeing	O
scale	O
4	O
compassion	B-T081
for	I-T081
others	I-T081
scale	I-T081
,	O
used	O
to	O
measure	B-T081
relationships	B-T080
between	O
self	B-T078
-	O
compassion	O
,	O
compassion	O
fatigue	O
,	O
wellbeing	B-T033
,	O
and	O
burnout	O
.	O
	
a	O
cross	O
sectional	O
sample	O
of	O
registered	O
community	O
nurses	O
n=37	O
studying	O
for	O
a	O
postgraduate	O
diploma	B-T033
at	O
a	O
university	O
in	O
the	O
north	O
of	O
england	O
took	O
part	O
in	O
this	O
study	O
.	O
	
results	B-T169
show	O
that	O
community	O
nurses	O
who	O
score	B-T081
high	B-T080
on	O
measures	B-T081
of	O
self	B-T078
-	O
compassion	O
and	O
wellbeing	B-T033
,	O
also	O
report	O
less	B-T080
burnout	O
.	O
	
greater	B-T081
compassion	O
satisfaction	O
was	O
also	O
positively	B-T033
associated	B-T080
with	I-T080
compassion	O
for	O
others	O
,	O
and	O
wellbeing	B-T033
,	O
whilst	O
also	O
being	O
negatively	B-T033
correlated	B-T080
with	O
burnout	O
.	O
	
high	B-T080
levels	B-T080
of	O
self	B-T078
-	O
compassion	O
were	O
linked	O
with	O
lower	O
levels	B-T080
of	O
burnout	O
.	O
	
furthermore	O
when	O
community	O
nurses	O
have	O
greater	B-T081
compassion	O
satisfaction	O
they	O
also	O
report	O
more	O
compassion	O
for	O
others	O
,	O
increased	B-T081
wellbeing	B-T033
,	O
and	O
less	B-T080
burnout	O
.	O
	
the	O
implications	B-T169
of	O
this	O
are	O
discussed	O
alongside	O
suggestions	B-T078
for	O
the	O
promotion	O
of	O
greater	B-T081
compassion	O
cd169	B-T116
identifies	B-T033
an	O
activated	O
cd8	O
t	O
cell	O
subset	O
in	O
regional	O
lymph	O
nodes	O
that	O
predicts	B-T078
favorable	B-T080
prognosis	O
in	O
colorectal	O
cancer	O
patients	O
cd169	B-T116
was	O
first	O
identified	O
on	O
macrophages	O
mϕ	O
and	O
linked	O
to	O
antigen	O
presentation	O
.	O
	
here	O
,	O
we	O
showed	O
cd169	O
expression	O
on	O
some	O
cd8	O
t	O
lymphocytes	O
in	O
regional	O
lymph	O
nodes	O
lns	O
and	O
investigated	B-T169
the	O
function	O
and	O
clinical	B-T033
relevance	I-T033
of	O
cd169	O
t	O
cells	O
in	O
tumor-draining	O
lns	O
of	O
colorectal	O
cancer	O
crc	O
patients	O
.	O
	
fresh	O
tumor-draining	O
ln	O
tissues	O
from	O
39	O
randomly	B-T080
enrolled	B-T033
patients	I-T033
were	O
assessed	O
by	O
flow	O
cytometry	O
for	O
activation	O
and	O
differentiation	O
of	O
cd169	O
t	O
cells	O
and	O
t	O
cell-mediated	O
killing	O
of	O
tumor	O
cells	O
.	O
	
in	O
total	O
,	O
114	O
tumor-draining	O
ln	O
paraffin	O
sections	O
from	O
crc	O
patients	O
were	O
analyzed	O
by	O
multiple-color	O
immunofluorescence	O
for	O
cd169	O
t	O
cell	O
distribution	B-T169
and	O
clinical	O
values	O
.	O
	
the	O
prognostic	O
significance	B-T080
of	O
cd169	O
t	O
cells	O
was	O
evaluated	O
by	O
kaplan-meier	B-T081
analysis	I-T081
.	O
	
a	O
fraction	B-T081
of	I-T081
cd8	O
t	O
cells	O
in	O
regional	O
lns	O
,	O
but	O
not	O
peripheral	O
blood	O
,	O
tonsils	O
,	O
or	O
tumors	O
,	O
expressed	B-T116
surface	I-T116
cd169	I-T116
.	O
	
in	O
situ	O
detection	B-T061
of	O
draining	O
lns	O
revealed	B-T080
preferential	O
localization	B-T169
of	O
cd169	O
t	O
cells	O
to	O
subcapsular	O
sinus	O
and	O
interfollicular	O
regions	O
,	O
closely	O
associated	B-T080
with	I-T080
cd169	O
mϕ	O
.	O
	
cd169	O
t	O
cell	O
ratios	B-T081
were	O
significantly	O
lower	O
in	O
peri-tumor	O
lns	O
than	O
distant-tumor	O
lns	O
.	O
	
cd169	O
t	O
cells	O
predominantly	B-T080
expressed	O
activation	O
markers	O
cd69	B-T116
,	O
hla-dr	B-T116
,	O
pd-1	B-T116
with	O
slightly	O
lower	O
cd45ra	B-T116
and	O
cd62l	B-T116
levels	B-T080
.	O
	
they	O
produced	O
high	B-T080
granzyme	B-T116
b	I-T116
,	O
perforin	B-T116
,	O
tnf-α	B-T116
,	O
and	O
ifnγ	B-T116
levels	B-T080
,	O
and	O
promoted	O
tumor-killing	B-T061
efficiency	I-T061
ex	O
vitro	O
.	O
	
moreover	O
,	O
cd169	O
t	O
cells	O
infiltrating	O
tumor-draining	O
lns	O
decreased	B-T081
with	O
disease	O
progression	O
and	O
were	O
strongly	O
associated	B-T080
with	I-T080
crc	O
patient	O
survival	O
.	O
	
we	O
identified	B-T080
novel	O
activated	O
/	O
cytolytic	O
cd169	O
t	O
cells	O
selectively	O
present	O
in	O
regional	O
lns	O
,	O
potentially	O
serving	O
as	O
a	O
powerful	O
prognostic	O
factor	O
and	O
indicator	B-T169
for	O
selecting	O
patients	O
for	O
appearance	B-T080
differences	B-T080
between	O
lots	O
and	O
brands	O
of	O
similar	O
shade	B-T080
designations	O
of	O
dental	B-T109
composite	I-T109
resins	I-T109
the	O
purposes	B-T169
of	O
this	O
study	O
were	O
to	O
investigate	B-T169
differences	B-T080
in	O
two	O
inherent	B-T080
appearance	B-T080
characteristics	B-T080
between	O
lots	O
of	O
an	O
enamel	B-T109
dental	I-T109
composite	I-T109
resin	I-T109
of	O
the	O
same	O
shade	B-T080
and	O
brand	O
,	O
and	O
to	O
further	O
compare	O
these	O
differences	B-T080
to	O
those	O
of	O
similar	O
shade	B-T080
designation	O
of	O
a	O
different	B-T080
brand	O
of	O
dental	B-T109
composite	I-T109
resins	I-T109
.	O
	
appearance	B-T080
analyses	O
proceeded	B-T079
for	O
three	O
different	O
lots	O
of	O
shades	B-T080
a1	O
,	O
b2	O
,	O
and	O
d3	O
manufactured	O
by	O
one	O
company	O
and	O
for	O
one	O
lot	O
of	O
shade	B-T080
ea1	O
manufactured	O
by	O
another	O
.	O
	
samples	O
were	O
measured	B-T080
on	O
black	B-T080
,	O
white	B-T080
,	O
and	O
gray	B-T080
backings	O
using	O
spectroradiometry	O
.	O
	
kubelka-munk	B-T078
theory	I-T078
was	O
used	O
to	O
determine	O
reflectivity	B-T081
of	O
each	O
lot	O
studied	O
.	O
	
cielab	B-T080
values	I-T080
and	O
color	B-T080
differences	B-T080
between	O
shades	B-T080
and	O
lots	O
were	O
analyzed	O
.	O
	
translucency	B-T080
indicators	O
were	O
compared	O
between	O
lots	O
over	O
thicknesses	B-T080
from	O
0.5	O
to	O
3.0	O
mm	O
.	O
	
differences	B-T080
in	O
inherent	B-T080
color	B-T080
between	O
some	O
lots	O
of	O
same	O
shade	B-T080
designations	O
within	O
a	O
brand	O
were	O
found	O
to	O
be	O
above	O
the	O
acceptability	B-T080
threshold	B-T080
.	O
	
color	B-T080
difference	B-T080
between	O
an	O
enamel	B-T109
composite	I-T109
resin	I-T109
of	O
shade	B-T080
a1	O
and	O
a	O
composite	B-T109
resin	I-T109
of	O
shade	B-T080
ea1	O
was	O
also	O
above	O
the	O
acceptability	B-T080
threshold	B-T080
.	O
	
statistically	B-T081
significant	I-T081
differences	B-T080
in	O
the	O
translucency	B-T080
were	O
found	O
between	O
some	O
lots	O
of	O
one	O
shade	B-T080
over	O
the	O
entire	O
range	B-T081
of	O
thicknesses	B-T080
studied	O
.	O
	
appearance	B-T080
analyses	O
indicate	B-T078
substantial	O
variation	B-T080
between	O
lots	O
of	O
same	O
shade	B-T080
designations	O
as	O
well	O
as	O
between	O
brands	O
of	O
similar	O
shade	B-T080
designations	O
.	O
	
optical	O
principles	O
applied	B-T169
to	O
important	B-T080
clinical	B-T080
appearance	B-T080
attributes	O
are	O
described	O
which	O
characterize	O
inherent	B-T080
appearance	B-T080
attributes	O
and	O
provide	O
aid	B-T080
in	O
the	O
appearance	B-T080
matching	B-T080
process	O
for	O
dental	B-T109
composite	I-T109
resins	I-T109
used	O
in	O
restorative	B-T061
and	O
operative	B-T061
dental	I-T061
procedures	I-T061
.	O
	
patient	B-T080
preferences	I-T080
in	O
treatment	B-T061
choices	O
for	O
early-stage	B-T079
lung	O
cancer	O
decision-making	O
for	O
lung	O
cancer	O
treatment	B-T061
can	O
be	O
complex	B-T080
because	O
it	O
involves	O
both	O
provider	O
recommendations	B-T078
based	O
on	O
the	O
patient's	O
clinical	B-T080
condition	B-T080
and	O
patient	B-T080
preferences	I-T080
.	O
	
this	O
study	O
describes	O
the	O
relative	O
importance	O
of	O
several	O
considerations	B-T033
in	O
lung	O
cancer	O
treatment	B-T061
from	O
the	O
patient's	O
perspective	O
.	O
	
a	O
conjoint	O
preference	O
experiment	O
began	O
by	O
asking	O
respondents	O
to	O
imagine	O
that	O
they	O
had	O
just	O
been	O
diagnosed	B-T033
with	O
lung	O
cancer	O
.	O
	
respondents	O
then	O
chose	O
among	O
procedures	B-T061
that	O
differed	O
regarding	O
treatment	B-T061
modalities	O
,	O
the	O
potential	O
for	O
treatment	B-T061
-related	O
complications	O
,	O
the	O
likelihood	B-T081
of	O
recurrence	O
,	O
provider	O
case	B-T169
volume	B-T081
,	O
and	O
distance	B-T081
needed	B-T169
to	O
travel	O
for	O
treatment	B-T061
.	O
	
conjoint	O
analysis	O
derived	O
relative	O
weights	O
for	O
these	O
attributes	B-T080
.	O
	
a	O
total	O
of	O
225	O
responses	O
were	O
analyzed	O
.	O
	
respondents	O
were	O
most	O
willing	O
to	O
accept	O
minimally	B-T080
invasive	B-T061
operations	I-T061
for	O
treatment	B-T061
of	O
their	O
hypothetical	O
lung	O
cancer	O
,	O
followed	O
by	O
stereotactic	B-T061
body	I-T061
radiation	I-T061
therapy	I-T061
sbrt	B-T061
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	B-T061
.	O
	
treatment	B-T061
type	O
and	O
risk	B-T081
of	I-T081
recurrence	I-T081
were	O
the	O
most	O
important	O
attributes	B-T080
from	O
the	O
conjoint	O
experiment	O
each	O
with	O
a	O
relative	O
weight	O
of	O
0.23	O
,	O
followed	O
by	O
provider	O
volume	B-T081
relative	O
weight	O
of	O
0.21	O
,	O
risk	B-T078
of	O
major	O
complications	O
relative	O
weight	O
of	O
0.18	O
,	O
and	O
distance	B-T081
needed	B-T169
to	O
travel	O
for	O
treatment	B-T061
relative	O
weight	O
of	O
0.15	O
.	O
	
procedural	B-T061
and	O
treatment	B-T061
preferences	B-T078
did	O
not	O
vary	O
with	O
demographics	B-T080
,	O
self-reported	O
health	B-T080
status	I-T080
,	O
or	O
familiarity	O
with	O
the	O
procedures	B-T061
.	O
	
survey	O
respondents	O
preferred	O
minimally	B-T080
invasive	B-T061
operations	I-T061
over	O
sbrt	B-T061
or	O
thoracotomy	B-T061
for	O
treatment	B-T061
of	O
early-stage	B-T079
non-small	O
cell	O
lung	O
cancer	O
.	O
	
treatment	B-T061
modality	O
and	O
risk	B-T078
of	O
cancer	O
recurrence	O
were	O
the	O
most	O
important	O
factors	O
associated	O
with	O
treatment	B-T061
preferences	B-T078
.	O
	
provider	O
experience	O
outweighed	O
the	O
potential	O
need	B-T169
to	O
travel	O
for	O
lung	O
cancer	O
treatment	B-T061
.	O
	
suppressed	B-T169
translation	O
and	O
ulk1	B-T116
degradation	O
as	O
potential	B-T080
mechanisms	B-T169
of	O
autophagy	O
limitation	O
under	O
prolonged	B-T079
starvation	B-T033
macroautophagy	O
/	O
autophagy	O
is	O
a	O
well-organized	O
process	O
of	O
intracellular	O
degradation	O
,	O
which	O
is	O
rapidly	O
activated	O
under	O
starvation	B-T033
conditions	O
.	O
	
recent	O
data	B-T078
demonstrate	O
a	O
transcriptional	O
upregulation	O
of	O
several	O
autophagy	O
genes	O
as	O
a	O
mechanism	B-T169
that	O
controls	B-T169
autophagy	O
in	O
response	O
to	O
starvation	B-T033
.	O
	
here	O
we	O
report	O
that	O
despite	O
the	O
significant	O
upregulation	O
of	O
mrna	O
of	O
the	O
essential	O
autophagy	O
initiation	O
gene	O
ulk1	O
,	O
its	O
protein	B-T116
level	B-T080
is	O
rapidly	O
reduced	B-T080
under	O
starvation	B-T033
.	O
	
although	O
both	O
autophagic	O
and	O
proteasomal	B-T116
systems	I-T116
contribute	O
to	O
the	O
degradation	O
of	O
ulk1	B-T116
,	O
under	O
prolonged	B-T079
nitrogen	O
deprivation	B-T080
,	O
its	O
level	B-T080
was	O
still	O
reduced	B-T080
in	O
atg7	O
knockout	O
cells	O
,	O
and	O
only	O
initially	O
stabilized	O
in	O
cells	O
treated	B-T169
with	O
the	O
lysosomal	O
or	O
proteasomal	O
inhibitors	O
.	O
	
we	O
demonstrate	O
that	O
under	O
starvation	B-T033
,	O
protein	O
translation	O
is	O
rapidly	O
diminished	B-T081
and	O
,	O
similar	O
to	O
treatments	B-T061
with	O
the	O
proteosynthesis	O
inhibitors	O
cycloheximide	B-T109
or	O
anisomycin	B-T109
,	O
is	O
associated	O
with	O
a	O
significant	O
reduction	B-T080
of	O
ulk1	B-T116
.	O
	
furthermore	O
,	O
it	O
was	O
found	O
that	O
inhibition	O
of	O
the	O
mitochondrial	O
respiratory	O
complexes	O
or	O
the	O
mitochondrial	O
atp	O
synthase	O
function	O
that	O
could	O
also	O
take	O
place	O
in	O
the	O
absence	B-T169
of	O
substrates	O
,	O
promote	O
upregulation	O
of	O
ulk1	O
mrna	O
and	O
protein	O
expression	O
in	O
an	O
ampk	B-T116
-	O
dependent	B-T169
manner	O
in	O
u1810	O
lung	O
cancer	O
cells	O
growing	O
in	O
complete	O
culture	O
medium	O
.	O
	
these	O
inhibitors	B-T080
could	O
also	O
drastically	O
increase	B-T169
the	O
ulk1	B-T116
protein	I-T116
in	O
u1810	O
cells	O
with	O
knockout	O
of	O
atg13	O
,	O
where	O
the	O
ulk1	B-T116
expression	O
is	O
significantly	O
diminished	B-T081
.	O
	
however	O
,	O
such	O
upregulation	O
of	O
ulk1	B-T116
protein	I-T116
is	O
negligible	O
under	O
starvation	B-T033
conditions	O
,	O
further	O
signifying	O
the	O
contribution	O
of	O
translation	O
and	O
suggesting	O
that	O
transcriptional	O
upregulation	O
of	O
ulk1	B-T116
protein	I-T116
will	O
be	O
diminished	B-T081
under	O
such	O
conditions	O
.	O
	
thus	O
,	O
we	O
propose	O
a	O
model	O
where	O
inhibition	O
of	O
protein	O
translation	O
,	O
together	O
with	O
the	O
degradation	O
systems	O
,	O
limit	O
autophagy	O
during	O
neuroprotective	B-T169
role	I-T169
of	O
microrna-22	O
in	O
a	O
6-hydroxydopamine	B-T109
-	O
induced	B-T169
cell	O
model	O
of	O
parkinson's	B-T047
disease	I-T047
via	O
regulation	O
of	O
its	O
target	B-T169
gene	O
trpm7	O
parkinson's	B-T047
disease	I-T047
pd	B-T047
,	O
the	O
second	O
most	O
prevalent	O
neurodegenerative	B-T047
disorder	I-T047
with	O
only	O
symptomatic	B-T169
treatment	B-T061
available	B-T169
,	O
is	O
characterized	O
by	O
a	O
progressive	B-T169
loss	B-T081
of	O
dopaminergic	O
neurons	O
in	O
the	O
midbrain	O
.	O
	
ample	O
evidence	O
indicated	O
that	O
micrornas	O
mirs	O
could	O
regulate	O
post-transcriptional	O
gene	O
expression	O
and	O
neuronal	B-T047
disease	I-T047
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
have	O
evaluated	O
the	O
effects	B-T080
and	O
mechanism	B-T169
of	O
mir-22	O
in	O
pc12	O
pheochromocytoma	O
cells	O
treated	B-T169
with	O
6-hydroxydopamine	B-T109
6-ohda	B-T109
to	O
mimic	O
pd	B-T047
.	O
	
rt-pcr	O
results	B-T169
showed	O
that	O
the	O
expression	O
of	O
mir-22	O
is	O
downregulated	O
in	O
6-ohda	B-T109
-	O
treated	B-T169
pc12	O
cells	O
,	O
and	O
the	O
overexpression	O
of	O
mir-22	O
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6-ohda	B-T109
-	O
induced	B-T169
pc12	O
cells	O
,	O
whereas	O
mir-22	O
inhibitor	B-T080
reversed	B-T169
these	O
effects	B-T080
.	O
	
in	O
addition	O
,	O
pc12	O
cells	O
were	O
treated	B-T169
with	O
mir-22	O
mimics	O
or	O
inhibitor	B-T080
following	B-T079
6-ohda	B-T109
administration	B-T061
,	O
which	O
medicated	O
ros	O
production	O
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase-3	O
activity	O
,	O
respectively	O
.	O
	
a	O
luciferase	B-T116
reporter	O
assay	O
revealed	B-T080
that	O
transient	O
receptor	O
potential	O
melastatin	O
7	O
trpm7	O
is	O
a	O
direct	B-T080
target	B-T169
gene	O
of	O
mir-22	O
,	O
and	O
mir-22	O
overexpression	O
markedly	O
downregulated	O
the	O
level	B-T080
of	O
trpm7	O
.	O
	
strikingly	O
,	O
further	O
analysis	O
showed	O
that	O
mir-22	O
mediated	O
6-ohda	B-T109
-	O
induced	B-T169
pc12	O
cell	O
survival	O
and	O
proliferation	O
by	O
targeting	B-T169
trpm7	O
.	O
	
taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
mir-22	O
overexpression	O
exhibited	O
neuroprotective	B-T169
and	O
reversal	B-T169
effects	B-T080
on	O
the	O
6-ohda	B-T109
-	O
induced	B-T169
pc12	O
cell	O
growth	O
and	O
apoptosis	O
by	O
targeting	B-T169
trpm7	O
.	O
	
obstacle	O
course	O
runs	O
review	O
of	O
acquired	O
injuries	O
and	O
illnesses	O
at	O
a	O
series	B-T081
of	O
canadian	B-T033
events	O
race	O
the	O
growing	O
popularity	O
of	O
obstacle	O
course	O
runs	O
ocrs	O
has	O
led	O
to	O
significant	B-T078
concerns	B-T078
regarding	O
their	O
safety	O
.	O
	
the	O
influx	O
of	O
injuries	O
and	O
illnesses	O
in	O
rural	O
areas	O
where	O
ocrs	O
are	O
often	O
held	O
can	O
impose	O
a	O
large	O
burden	O
on	O
emergency	O
medical	O
services	O
ems	O
and	O
local	O
eds	O
.	O
	
literature	O
concerning	B-T078
the	O
safety	O
of	O
these	O
events	O
is	O
minimal	B-T080
and	O
mostly	O
consists	O
of	O
media	O
reports	O
.	O
	
we	O
sought	O
to	O
characterise	O
the	O
injury	O
and	O
illness	O
profile	O
of	O
ocrs	O
and	O
the	O
level	B-T080
of	O
medical	B-T061
care	I-T061
required	O
.	O
	
this	O
study	O
analysed	O
ocr	O
events	O
occurring	O
in	O
eight	O
locations	O
across	O
canada	O
from	O
may	O
to	O
august	O
2015	O
total	O
45	O
285	O
participants	O
.	O
	
data	B-T078
were	O
extracted	O
from	O
event	O
medical	O
charts	O
of	O
patients	O
presenting	O
to	O
the	O
onsite	O
medical	O
team	O
,	O
including	O
injury	O
or	O
illness	O
type	O
,	O
onsite	O
treatment	B-T061
and	O
disposition	B-T078
.	O
	
there	O
were	O
557	O
race	O
participants	O
treated	B-T169
at	O
eight	O
ocr	O
events	O
1.2	O
of	O
all	O
participants	O
.	O
	
there	O
were	O
609	O
medical	O
complaints	O
in	O
total	O
.	O
	
three	O
quarters	O
of	O
injuries	O
were	O
musculoskeletal	B-T169
in	O
nature	O
.	O
	
eighty-nine	O
per	O
cent	O
returned	O
to	O
the	O
event	O
with	O
no	O
need	O
for	O
further	O
medical	B-T061
care	I-T061
.	O
	
the	O
majority	O
of	O
treatments	B-T061
were	O
completed	O
with	O
first	B-T061
aid	I-T061
and	O
basic	O
medical	O
equipment	O
.	O
	
eleven	O
patients	O
2%	O
of	O
patients	O
required	O
transfer	O
to	O
hospital	O
by	O
ems	O
for	O
presentations	O
including	O
fracture	O
,	O
dislocation	O
,	O
head	O
injury	O
,	O
chest	O
pain	O
,	O
fall	O
from	O
height	O
,	O
and	O
abdominal	O
pain	O
.	O
	
we	O
found	O
that	O
1.2	O
of	O
race	O
participants	O
presented	O
to	O
onsite	O
medical	O
services	O
.	O
	
the	O
majority	O
of	O
complaints	O
were	O
minor	O
and	O
musculoskeletal	O
in	O
nature	O
.	O
	
only	O
2%	O
of	O
those	O
treated	B-T169
were	O
transferred	O
to	O
hospital	O
through	O
ems	O
.	O
	
this	O
is	O
consistent	B-T078
with	I-T078
other	O
types	O
of	O
mass	B-T033
gathering	I-T033
events	O
.	O
	
is	O
modern	B-T079
medical	O
management	O
changing	B-T169
ultimate	O
patient	B-T078
outcomes	I-T078
in	O
inflammatory	B-T047
bowel	I-T047
disease	I-T047
the	O
impact	B-T080
of	O
modern	B-T079
medical	O
management	O
of	O
inflammatory	B-T047
bowel	I-T047
disease	I-T047
ibd	B-T047
on	O
surgical	O
necessity	O
and	O
outcomes	B-T169
remains	O
unclear	B-T033
.	O
	
we	O
hypothesized	O
that	O
surgery	B-T061
rates	B-T081
have	O
decreased	B-T081
while	O
outcomes	B-T169
have	O
worsened	B-T033
due	O
to	O
operating	B-T061
on	O
""""	O
sicker	O
""""	O
patients	O
since	O
the	O
introduction	B-T169
of	O
biologic	B-T061
medications	I-T061
.	O
	
the	O
nationwide	O
inpatient	O
sample	O
and	O
icd-9-cm	O
codes	O
were	O
used	O
to	O
identify	O
inpatient	O
admissions	O
for	O
crohn's	B-T047
disease	I-T047
and	O
ulcerative	B-T047
colitis	I-T047
.	O
	
trends	B-T079
in	O
ibd	B-T047
nutrition	B-T033
,	O
surgeries	B-T061
,	O
and	O
postoperative	O
complications	O
were	O
determined	O
.	O
	
there	O
were	O
191	O
admissions	O
for	O
ibd	B-T047
during	O
the	O
study	O
period	B-T079
.	O
	
surgery	B-T061
rates	B-T081
were	O
largely	O
unchanged	B-T033
over	O
the	O
study	O
period	B-T079
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	O
in	O
both	O
crohn's	B-T047
disease	I-T047
and	O
ulcerative	B-T047
colitis	I-T047
.	O
	
the	O
rate	B-T081
of	O
poor	B-T047
nutrition	I-T047
increased	B-T081
by	O
67	O
%	O
in	O
ulcerative	B-T047
colitis	I-T047
and	O
by	O
83	O
%	O
in	O
crohn's	B-T047
disease	I-T047
.	O
	
rates	B-T081
of	O
postoperative	B-T079
anastomotic	O
leak	O
10.2	O
%	O
were	O
unchanged	B-T033
over	O
the	O
years	O
.	O
	
postoperative	O
infection	O
rates	B-T081
decreased	B-T081
by	O
17	O
%	O
in	O
crohn's	B-T047
disease	I-T047
18	O
%	O
in	O
2003	O
to	O
15	O
%	O
in	O
2012	O
p	O
<	O
0.001	O
but	O
did	O
not	O
show	O
a	O
trend	B-T033
in	O
any	O
direction	O
in	O
ulcerative	B-T047
colitis	I-T047
.	O
	
rates	B-T081
of	O
ibd	B-T047
surgery	O
have	O
remained	O
stable	B-T080
while	O
postoperative	O
infectious	O
complications	O
have	O
remained	O
stable	B-T080
or	O
decreased	B-T081
since	O
the	O
implementation	O
of	O
biologic	B-T061
therapies	I-T061
.	O
	
we	O
identified	O
an	O
increase	B-T169
in	O
poor	B-T047
nutrition	I-T047
in	O
surgical	O
patients	O
.	O
	
clinical	B-T080
experience	O
with	O
the	O
subcutaneous	O
implantable	O
cardioverter-defibrillator	O
in	O
adults	O
with	O
congenital	O
heart	O
disease	O
sudden	O
cardiac	O
death	O
is	O
a	O
major	O
contributor	O
to	O
mortality	B-T081
for	O
adults	O
with	O
congenital	O
heart	O
disease	O
.	O
	
the	O
subcutaneous	O
implantable	O
cardioverter-defibrillator	O
icd	O
has	O
emerged	O
as	O
a	O
novel	B-T080
tool	O
for	O
prevention	B-T080
of	O
sudden	O
cardiac	O
death	O
,	O
but	O
clinical	B-T033
performance	I-T033
data	B-T078
for	O
adults	O
with	O
congenital	O
heart	O
disease	O
are	O
limited	O
.	O
	
a	O
retrospective	O
study	O
involving	O
7	O
centers	O
over	O
a	O
5-	O
year	B-T079
period	B-T079
beginning	O
in	O
2011	O
was	O
performed	B-T169
.	O
	
twenty-one	O
patients	O
median	B-T081
33.9	O
years	B-T079
were	O
identified	O
.	O
	
the	O
most	O
common	O
diagnosis	B-T033
was	O
single	O
ventricle	O
physiology	O
52%	O
,	O
9	O
palliated	B-T061
by	O
fontan	B-T061
operation	I-T061
and	O
2	O
by	O
aortopulmonary	B-T061
shunts	I-T061
d-transposition	O
of	O
the	O
great	O
arteries	O
after	O
mustard	B-T061
/	O
senning	B-T061
n=2	O
,	O
tetralogy	O
of	O
fallot	O
n=2	O
,	O
aortic	B-T047
valve	I-T047
disease	I-T047
n=2	O
,	O
and	O
other	O
biventricular	O
surgery	B-T061
n=4	O
.	O
	
a	O
prior	O
cardiac	O
device	O
had	O
been	O
implanted	B-T061
in	O
7	O
33%	O
.	O
	
the	O
icd	O
indication	B-T078
was	O
primary	B-T061
prevention	I-T061
in	O
67%	O
and	O
secondary	B-T061
in	O
33%	O
patient	O
s	O
.	O
	
the	O
most	O
common	O
reason	O
for	O
subcutaneous	O
icd	O
placement	O
was	O
limited	O
transvenous	O
access	O
for	O
ventricular	O
lead	O
placement	O
n=10	O
followed	O
by	O
intracardiac	B-T033
right-to-left	I-T033
shunt	I-T033
n=5	O
.	O
	
ventricular	B-T047
arrhythmia	I-T047
was	O
induced	B-T169
in	O
17	O
81%	O
and	O
was	O
converted	O
with	O
80	O
joules	B-T081
in	O
all	O
.	O
	
there	O
was	O
one	O
implant	O
complication	O
related	O
to	O
infection	O
,	O
not	B-T080
requiring	O
device	B-T061
removal	I-T061
.	O
	
over	O
a	O
median	B-T081
follow-up	O
of	O
14	O
months	B-T079
,	O
4	O
patients	O
21%	O
received	O
inappropriate	B-T047
and	O
1	O
5%	O
patient	O
received	O
appropriate	O
shocks	O
.	O
	
there	O
was	O
one	O
arrhythmic	B-T033
death	I-T033
related	O
to	O
asystole	B-T047
in	O
a	O
single	O
ventricle	O
patient	O
.	O
	
subcutaneous	O
icd	O
implantation	B-T061
is	O
feasible	O
for	O
adults	O
with	O
congenital	O
heart	O
disease	O
patients	O
.	O
	
most	O
candidates	O
have	O
single	O
ventricle	O
heart	B-T047
disease	I-T047
and	O
limited	O
transvenous	O
options	O
for	O
icd	O
placement	O
.	O
	
despite	O
variable	B-T080
anatomy	B-T080
,	O
this	O
study	O
demonstrates	O
successful	B-T080
conversion	B-T169
of	O
induced	B-T169
ventricular	B-T047
arrhythmia	I-T047
and	O
reasonable	B-T033
rhythm	O
discrimination	O
during	O
interaction	B-T169
of	O
multiple	B-T081
gene	O
variants	O
and	O
their	O
effects	B-T080
on	O
schizophrenia	O
phenotypes	O
schizophrenia	O
is	O
a	O
clinically	B-T080
heterogeneous	B-T033
disorder	I-T033
and	O
may	O
be	O
explained	O
by	O
its	O
complex	O
genetic	B-T169
architecture	I-T169
.	O
	
many	O
schizophrenia	O
susceptibility	O
genes	O
were	O
identified	B-T080
but	O
the	O
picture	O
remains	O
unclear	O
due	O
to	O
inconsistent	B-T080
or	O
contradictory	B-T080
genetic	O
association	O
studies	O
.	O
	
this	O
confusion	O
may	O
,	O
in	O
part	O
,	O
be	O
because	O
symptoms	O
result	O
from	O
the	O
combined	O
interaction	B-T169
of	O
many	O
genes	O
and	O
these	O
interacting	B-T169
genes	O
are	O
associated	B-T080
with	I-T080
specific	B-T080
sub-phenotypes	O
of	O
schizophrenia	O
rather	O
than	O
schizophrenia	O
as	O
a	O
whole	O
.	O
	
this	O
study	O
investigates	B-T169
the	O
relationship	B-T080
between	O
schizophrenia	O
susceptibility	O
genes	O
and	O
schizophrenia	O
sub-phenotypes	O
by	O
identifying	B-T080
multiple	B-T081
gene	O
variant	O
interactions	B-T169
.	O
	
fifty	O
snps	O
from	O
21	O
genes	O
were	O
genotyped	O
in	O
235	O
australian	O
participants	O
with	O
schizophrenia	O
screened	O
for	O
various	O
phenotypes	O
.	O
	
schizophrenia	O
participants	O
were	O
grouped	O
into	O
relevant	B-T080
phenotype	O
clusters	B-T081
using	O
cluster	O
analysis	O
and	O
normalized	O
phenotype	O
cluster	B-T081
scores	B-T081
were	O
calculated	O
for	O
each	O
patient	O
.	O
	
the	O
relationship	B-T080
between	O
genotypes	O
and	O
normalized	O
phenotype	O
cluster	B-T081
scores	B-T081
were	O
analyzed	O
by	O
linear	O
regression	O
analysis	O
.	O
	
three	O
phenotype	O
clusters	B-T081
were	O
identified	B-T080
.	O
	
there	O
was	O
some	O
overlap	O
in	O
symptoms	O
between	O
phenotype	O
clusters	B-T081
,	O
particularly	O
for	O
depression	O
.	O
	
however	O
,	O
cluster	B-T081
1	I-T081
appears	O
to	O
be	O
characterized	O
by	O
speech	B-T047
disorder	I-T047
and	O
affective	O
behavior	O
symptoms	O
,	O
cluster	B-T081
2	I-T081
has	O
predominantly	O
hallucination	O
symptoms	O
and	O
cluster	B-T081
3	I-T081
has	O
mainly	O
delusion	O
symptoms	O
.	O
	
interaction	B-T169
of	O
five	O
snps	O
was	O
found	O
to	O
have	O
an	O
effect	O
on	O
cluster	B-T081
1	I-T081
symptoms	O
ten	O
snps	O
on	O
cluster	B-T081
2	I-T081
symptoms	O
and	O
eight	O
snps	O
on	O
cluster	B-T081
3	I-T081
symptoms	O
.	O
	
the	O
interaction	B-T169
of	O
specific	B-T080
susceptibility	O
genes	O
is	O
likely	O
to	O
lead	O
to	O
specific	B-T080
clinical	B-T080
sub-phenotypes	O
of	O
schizophrenia	O
.	O
	
larger	O
patient	O
cohorts	O
with	O
more	O
extensive	O
clinical	B-T080
data	B-T078
will	O
improve	O
the	O
detection	B-T033
of	O
gene	O
interactions	O
and	O
the	O
resultant	O
schizophrenia	O
clinical	B-T080
phenotypes	O
.	O
	
evaluation	O
of	O
dnmt1	O
gene	B-T081
expression	I-T081
profile	I-T081
and	O
methylation	O
of	O
its	O
promoter	O
region	O
in	O
patients	O
with	O
ankylosing	B-T047
spondylitis	I-T047
ankylosing	B-T047
spondylitis	I-T047
as	B-T047
is	O
an	O
autoimmune	B-T047
disease	I-T047
with	O
a	O
chronic	B-T047
inflammatory	I-T047
arthritis	I-T047
.	O
	
the	O
critical	O
role	O
of	O
methylation	O
in	O
the	O
biology	O
of	O
immunocytes	O
has	O
increasingly	O
been	O
surveyed	O
to	O
discover	O
disease	B-T047
etiology	B-T169
.	O
	
dna	B-T116
methyltransferase	I-T116
1	I-T116
dnmt1	B-T116
is	O
an	O
enzyme	B-T116
,	O
which	O
establishes	O
and	O
regulates	O
patterns	O
of	O
methylated	B-T109
cytosine	I-T109
residues	O
.	O
	
the	O
aim	B-T078
of	O
the	O
current	O
investigation	O
was	O
to	O
unveil	O
if	O
methylation	O
circumstances	O
of	O
cpg	O
sites	O
in	O
dnmt1	O
promoter	O
could	O
affect	O
the	O
mrna	O
expression	O
level	B-T080
of	O
this	O
gene	O
in	O
peripheral	O
blood	O
mononuclear	O
cells	O
pbmcs	O
from	O
as	B-T047
patients	O
.	O
	
pbmcs	O
were	O
isolated	O
from	O
whole	O
blood	O
of	O
40	O
as	B-T047
patients	O
and	O
40	O
healthy	B-T080
individuals	O
.	O
	
total	O
rna	O
and	O
dna	O
contents	O
of	O
leukocytes	O
were	O
extracted	B-T061
.	O
	
afterward	O
,	O
quantitative	B-T081
analysis	I-T081
was	O
carried	O
out	O
by	O
real-time	O
pcr	O
using	O
the	O
sybr	O
green	O
pcr	O
master	O
mix	O
.	O
	
finally	O
,	O
to	O
determine	O
the	O
methylation	O
level	B-T080
,	O
pcr	O
products	O
of	O
bisulfite-treated	O
dna	O
from	O
patients	O
and	O
controls	O
were	O
sequenced	O
.	O
	
compared	O
with	O
healthy	B-T080
controls	O
,	O
expression	O
level	O
of	O
dnmt1	O
in	O
as	B-T047
patients	O
was	O
significantly	O
downregulated	O
.	O
	
methylation	O
of	O
dnmt1	O
promoter	O
was	O
significantly	O
higher	O
in	O
as	B-T047
patients	O
in	O
comparison	O
to	O
controls	O
.	O
	
while	O
a	O
negative	B-T033
correlation	B-T080
between	O
methylation	O
and	O
expression	O
level	O
of	O
dnmt1	O
was	O
observed	O
in	O
as	B-T047
patients	O
,	O
both	O
methylation	O
and	O
expression	O
level	O
of	O
dnmt1	O
did	O
not	O
correlate	B-T080
with	O
clinical	B-T080
manifestations	B-T169
.	O
	
considering	O
the	O
observation	O
that	O
decreased	B-T081
expression	O
level	O
of	O
dnmt1	O
was	O
associated	O
with	O
hypermethylation	O
of	O
dnmt1	O
promoter	O
in	O
pbmcs	O
from	O
as	B-T047
patients	O
,	O
this	O
survey	O
suggests	O
that	O
dysregulation	O
of	O
dnmt1	O
expression	O
through	O
altered	B-T169
methylation	O
level	B-T080
of	O
other	O
target	B-T169
genes	O
would	O
probably	O
contribute	O
to	O
as	B-T047
antibacterial	O
activity	O
of	O
polyaniline	B-T109
coated	B-T080
silver	O
nanoparticles	O
synthesized	O
from	O
piper	B-T109
betle	I-T109
leaves	I-T109
extract	I-T109
plants	O
or	O
natural	B-T078
resources	I-T078
have	O
been	O
found	O
to	O
be	O
a	O
good	O
alternative	O
method	B-T169
for	O
nanoparticles	O
synthesis	O
.	O
	
in	O
this	O
study	O
,	O
polyaniline	B-T109
coated	B-T080
silver	O
nanoparticles	O
agnps	O
synthesized	O
from	O
piper	B-T109
betle	I-T109
leaves	I-T109
extract	I-T109
were	O
investigated	O
for	O
their	O
antibacterial	O
activity	O
.	O
	
silver	O
nanoparticles	O
were	O
prepared	O
from	O
the	O
reduction	O
of	O
silver	O
nitrate	O
and	O
nabh4	O
was	O
used	O
as	O
reducing	O
agent	O
.	O
	
silver	O
nanoparticles	O
and	O
extracts	O
were	O
mixed	O
thoroughly	O
and	O
then	O
coated	O
by	O
polyaniline	O
.	O
	
prepared	O
nanoparticles	O
were	O
characterized	O
by	O
visual	O
inspection	O
,	O
ultraviolet-visible	O
spectroscopy	O
uv	O
,	O
fourier	O
transform	O
infrared	O
spectroscopy	O
ft-ir	O
,	O
transmission	O
electron	O
microscopy	O
tem	O
techniques	O
.	O
	
antibacterial	O
activities	O
of	O
the	O
synthesized	O
silver	O
nanoparticles	O
were	O
tested	O
against	O
staphylococcus	O
aureus	O
atcc	O
25923	O
,	O
salmonella	O
typhi	O
atcc	O
14028	O
,	O
escherichia	O
coli	O
atcc	O
25922	O
and	O
pseudomonas	O
aeruginosa	O
atcc	O
27853	O
.	O
	
uv-vis	O
spectrum	O
of	O
reaction	O
mixture	O
showed	O
strong	O
absorption	O
peak	O
with	O
centering	O
at	O
400	O
nm	O
.	O
	
the	O
ft-ir	O
results	O
imply	O
that	O
ag-nps	O
were	O
successfully	O
synthesized	O
and	O
capped	O
with	O
bio-compounds	O
present	O
in	O
p	O
.	O
	
betle	O
.	O
	
tem	O
image	O
showed	O
that	O
ag-nps	O
formed	O
were	O
well	O
dispersed	O
with	O
a	O
spherical	O
structures	O
and	O
particle	O
size	O
ranging	O
from	O
10	O
to	O
30	O
nm	O
.	O
	
the	O
result	O
revealed	O
that	O
ag-extract	O
nps	O
showed	O
32.78	O
mm	O
zone	O
of	O
inhibition	O
against	O
s	O
.	O
	
aureus	O
,	O
whereas	O
norfloxacin	O
positive	O
control	O
showed	O
maximum	O
32.15	O
mm	O
zone	O
of	O
inhibition	O
for	O
s	O
.	O
	
aureus	O
.	O
	
again	O
,	O
maximum	O
zone	O
of	O
inhibition	O
29.55	O
mm	O
was	O
found	O
for	O
s	O
.	O
	
typhi	O
,	O
27.12	O
mm	O
for	O
e	O
.	O
	
coli	O
and	O
21.95	O
mm	O
for	O
p	O
.	O
	
aeruginosa	O
.	O
	
the	O
results	O
obtained	O
by	O
this	O
study	O
can't	O
be	O
directly	O
extrapolated	O
to	O
human	O
so	O
further	O
studies	O
should	O
be	O
undertaken	O
to	O
established	O
the	O
strong	O
antimicrobial	O
activity	O
of	O
ag-extract	O
nps	O
for	O
drug	O
development	O
program	O
clinical	O
pearls	O
in	O
tremor	O
and	O
other	O
hyperkinetic	O
movement	O
disorders	O
hyperkinetic	O
movements	O
,	O
such	O
as	O
tremor	O
,	O
myoclonus	O
,	O
chorea	B-T047
,	O
and	O
dystonia	O
,	O
occur	O
in	O
many	O
neurologic	B-T047
and	O
medical	B-T047
conditions	I-T047
.	O
	
accurate	O
clinical	O
evaluation	O
is	O
the	O
important	O
first	O
step	O
for	O
the	O
proper	O
diagnosis	O
and	O
treatment	B-T061
of	O
patients	O
with	O
abnormal	B-T047
movements	I-T047
.	O
	
tracking	O
children	O
with	O
acute	O
lymphoblastic	O
leukemia	O
who	O
abandoned	B-T080
therapy	B-T061
experience	O
,	O
challenges	O
,	O
parental	O
perspectives	O
,	O
and	O
impact	O
of	O
treatment	B-T061
subsidies	O
and	O
intensified	O
counseling	O
refusal	O
for	O
treatment	O
and	O
therapy	B-T061
abandonment	B-T033
are	O
important	O
reasons	O
for	O
unfavorable	O
outcome	O
of	O
childhood	B-T079
acute	O
lymphoblastic	O
leukemia	O
all	O
in	O
resource	B-T078
-poor	O
countries	O
.	O
	
the	O
present	O
study	O
,	O
conducted	O
on	O
children	O
with	O
all	O
whose	O
treatment	B-T061
was	O
abandoned	B-T080
,	O
attempted	O
to	O
track	O
all	O
these	O
children	O
to	O
ascertain	O
the	O
causes	O
and	O
outcome	B-T169
of	O
therapy	B-T061
abandonment	B-T033
/	O
refusal	O
.	O
	
in	O
order	O
to	O
improve	O
outcome	B-T169
of	O
all	O
,	O
measures	O
to	O
prevent	O
abandonment	B-T033
were	O
introduced	O
in	O
the	O
form	O
of	O
treatment	B-T061
subsidies	O
and	O
intensified	O
multistage	O
counseling	O
.	O
	
of	O
the	O
77	O
of	O
418	O
children	O
abandoning	O
therapy	B-T061
,	O
17	O
22%	O
refused	O
upfront	O
,	O
whereas	O
the	O
rest	O
abandoned	B-T080
during	O
various	O
phases	O
of	O
chemotherapy	B-T061
.	O
	
only	O
39	O
50.6	O
of	O
these	O
77	O
families	O
could	O
be	O
subsequently	O
contacted	O
.	O
	
financial	B-T033
problems	I-T033
,	O
too	O
many	O
dependents	O
at	O
home	O
,	O
and	O
wrong	O
perceptions	O
about	O
cancer	O
led	O
to	O
abandonment	B-T033
in	O
majority	O
.	O
	
children	B-T033
abandoning	I-T033
treatment	I-T033
before	O
completion	O
of	O
induction	B-T061
had	O
a	O
significantly	O
shorter	O
survival	O
than	O
who	O
abandoned	B-T080
post	B-T079
induction	I-T079
p	O
<	O
0001	O
.	O
	
intensified	O
preabandonment	O
counseling	O
and	O
subsidized	O
treatment	B-T061
led	O
to	O
significant	O
reduction	B-T080
in	O
abandonment	B-T081
rates	I-T081
effect	B-T080
of	O
new-onset	B-T033
left	B-T047
bundle	I-T047
branch	I-T047
block	I-T047
after	O
transcatheter	B-T061
aortic	I-T061
valve	I-T061
implantation	I-T061
corevalve	O
on	O
mortality	B-T081
,	O
frequency	B-T079
of	O
re-hospitalization	O
,	O
and	O
need	O
for	O
pacemaker	O
new-onset	B-T033
conduction	O
disturbances	O
are	O
common	O
after	O
transcatheter	B-T061
aortic	I-T061
valve	I-T061
implantation	I-T061
tavi	B-T061
.	O
	
the	O
most	O
common	O
complication	O
is	O
left	B-T047
bundle	I-T047
branch	I-T047
block	I-T047
lbbb	B-T047
.	O
	
the	O
clinical	B-T080
impact	B-T080
of	O
new-onset	B-T033
lbbb	B-T047
after	O
tavi	B-T061
remains	O
controversial	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
clinical	B-T080
impact	B-T080
of	O
new-onset	B-T033
lbbb	B-T047
in	O
terms	O
of	O
mortality	B-T081
and	O
morbidity	B-T081
need	O
for	O
pacemakers	O
and	O
admissions	O
for	O
heart	B-T047
failure	I-T047
at	O
long-term	O
follow-up	O
.	O
	
from	O
april	O
2008	O
to	O
december	O
2014	O
,	O
220	O
patients	O
who	O
had	O
severe	O
aortic	B-T047
stenosis	I-T047
were	O
treated	B-T061
with	I-T061
the	O
implantation	B-T061
of	O
a	O
corevalve	O
prosthesis	O
.	O
	
sixty-seven	O
of	O
these	O
patients	O
were	O
excluded	O
from	O
the	O
analysis	O
,	O
including	O
22	O
patients	O
with	O
pre-existing	B-T080
lbbb	B-T047
and	O
45	O
with	O
a	O
permanent	O
pacemaker	O
,	O
implanted	O
previously	O
or	O
within	O
72	O
hours	B-T079
of	O
implantation	B-T061
.	O
	
the	O
remaining	O
153	O
patients	O
were	O
divided	O
into	O
2	O
groups	B-T078
group	B-T078
1	O
n	O
=	O
80	O
,	O
those	O
with	O
persistent	B-T079
new-onset	B-T033
lbbb	B-T047
,	O
and	O
group	B-T078
2	O
n	O
=	O
73	O
,	O
those	O
without	O
conduction	O
disturbances	O
after	O
treatment	B-T061
.	O
	
both	O
groups	B-T078
were	O
followed	O
up	O
at	O
1	O
month	B-T079
,	O
6	O
months	B-T079
,	O
12	O
months	B-T079
,	O
and	O
yearly	B-T079
thereafter	O
.	O
	
persistent	B-T079
new-onset	B-T033
lbbb	B-T047
occurred	O
in	O
80	O
patients	O
36%	O
immediately	O
after	O
tavi	B-T061
73	O
patients	O
33%	O
did	O
not	O
develop	O
conduction	O
disturbances	O
.	O
	
the	O
mean	O
follow-up	O
time	B-T079
of	O
both	O
groups	B-T078
was	O
32	O
22	O
months	B-T079
range	O
3	O
to	O
82	O
months	B-T079
,	O
and	O
there	O
were	O
no	O
differences	O
in	O
time	B-T079
between	O
the	O
groups	B-T078
.	O
	
there	O
were	O
no	O
differences	O
in	O
mortality	B-T081
between	O
the	O
groups	B-T078
39%	O
vs	O
48%	O
,	O
p	O
=	O
0.58	O
.	O
	
no	O
differences	O
were	O
observed	O
between	O
the	O
groups	B-T078
in	O
re-hospitalizations	O
for	O
heart	B-T047
failure	I-T047
11%	O
vs	O
16%	O
,	O
p	O
=	O
0.55	O
.	O
	
group	B-T078
1	O
did	O
not	O
require	O
pacemaker	B-T061
implantation	I-T061
more	O
often	O
at	O
follow-up	O
10%	O
vs	O
13%	O
,	O
p	O
=	O
0.38	O
than	O
group	B-T078
2	O
.	O
	
in	O
conclusion	O
,	O
new-onset	B-T033
lbbb	B-T047
was	O
not	O
associated	B-T080
with	I-T080
a	O
higher	B-T080
incidence	B-T081
of	O
late	O
need	O
for	O
a	O
permanent	O
pacemaker	O
after	O
corevalve	O
implantation	B-T061
.	O
	
in	O
addition	O
,	O
it	O
was	O
not	O
associated	B-T080
with	I-T080
a	O
higher	O
risk	O
of	O
late	O
mortality	B-T081
or	O
the	O
relationship	B-T080
between	O
polymorphisms	O
of	O
bdnfos	O
and	O
bdnf	O
genes	O
and	O
heroin	O
addiction	O
in	O
the	O
han	O
chinese	O
population	O
the	O
number	O
of	O
heroin	B-T109
addicts	O
is	O
increasing	B-T169
in	O
the	O
world	O
.	O
	
both	O
environmental	B-T080
and	O
genetic	B-T080
factors	I-T080
both	O
play	O
critical	B-T080
roles	O
in	O
the	O
process	O
of	O
heroin	O
addiction	O
.	O
	
we	O
aimed	B-T078
to	O
investigate	B-T169
the	O
associations	B-T080
between	O
single	O
nucleotide	O
polymorphisms	O
snps	O
in	O
lin7c	O
,	O
bdnfos	O
and	O
bdnf	O
genes	O
and	O
drug	O
addiction	O
in	O
the	O
han	O
chinese	O
population	O
.	O
	
we	O
conducted	O
a	O
case-control	O
study	O
among	O
692	O
cases	B-T169
and	O
700	O
healthy	B-T080
controls	I-T080
from	O
xi'an	O
,	O
china	O
.	O
	
eight	O
snps	O
were	O
selected	O
and	O
genotyped	O
using	O
massarray	O
technology	O
sequenom	O
,	O
san	O
diego	O
,	O
ca	O
,	O
usa	O
.	O
	
odds	B-T081
ratios	I-T081
or	B-T081
and	O
95%	O
confidence	B-T081
intervals	I-T081
cis	B-T081
were	O
calculated	O
by	O
unconditional	O
logistic	O
regression	O
adjusting	O
for	O
age	O
and	O
sex	O
.	O
	
using	O
the	O
chi-squared	O
test	O
,	O
we	O
found	O
that	O
rs7481311	O
or	B-T081
=1	O
,	O
95%	O
ci	B-T081
=	O
1.087	O
,	O
p	O
=	O
0.009	O
and	O
rs11030096	O
or	B-T081
=1	O
,	O
95%	O
ci	B-T081
=	O
1.049	O
,	O
p	O
=	O
0.011	O
in	O
the	O
bndfos	O
were	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
of	O
heroin	O
addiction	O
.	O
	
by	O
contrast	O
,	O
rs988712	O
located	O
in	O
bdnfos	O
showed	O
a	O
decreased	B-T081
risk	B-T078
of	O
heroin	O
addiction	O
or	B-T081
=0	O
,	O
95%	O
ci	B-T081
=	O
0.582	O
,	O
p	O
=	O
0.003	O
.	O
	
by	O
genetic	O
model	O
analysis	O
,	O
we	O
found	O
that	O
the	O
't'	O
allele	O
of	O
rs988712	O
in	O
bdnfos	O
had	O
a	O
protective	O
role	O
for	O
heroin	O
addiction	O
in	O
the	O
additive	O
model	O
and	O
dominant	O
model	O
p	O
<	O
0.05	O
.	O
	
by	O
contrast	O
,	O
the	O
allele	O
't'	O
of	O
rs7481311	O
in	O
bdnfos	O
significantly	O
elevated	B-T080
the	O
risk	B-T078
of	O
heroin	O
addiction	O
in	O
the	O
additive	O
model	O
,	O
recessive	O
model	O
and	O
dominant	O
model	O
p	O
<	O
0.05	O
.	O
	
we	O
also	O
found	O
that	O
allele	O
'c	O
'	O
of	O
rs11030096	O
was	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
of	O
addiction	O
in	O
the	O
dominant	O
model	O
and	O
additive	O
model	O
p	O
<	O
0.05	O
.	O
	
additionally	O
,	O
we	O
found	O
that	O
rs6265	O
,	O
rs11030104	O
and	O
rs10767664	O
in	O
bdnf	O
were	O
associated	B-T080
with	I-T080
a	O
decreased	B-T081
risk	B-T078
of	O
heroin	O
addiction	O
p	O
<	O
0.05	O
.	O
	
however	O
,	O
only	O
rs7481311	O
in	O
bdnfos	O
remained	O
significant	B-T078
after	O
bonferroni	B-T081
correction	I-T081
p	O
<	O
0.00625	O
.	O
	
these	O
results	B-T033
suggest	O
that	O
polymorphisms	O
of	O
bdnfos	O
play	O
an	O
important	B-T080
role	O
in	O
heroin	O
addiction	O
susceptibility	B-T169
in	O
the	O
chinese	O
han	O
population	O
.	O
	
risk	O
and	O
protective	O
factors	O
associated	B-T080
with	I-T080
adolescent	O
girls'	O
substance	O
use	O
data	B-T078
from	O
a	O
nationwide	O
facebook	O
sample	O
despite	O
overall	O
reductions	B-T081
in	O
teenage	B-T079
substance	O
use	O
,	O
adolescent	O
girls	O
'	O
rates	B-T081
of	O
substance	O
use	O
remain	O
unacceptably	B-T080
high	I-T080
.	O
	
this	O
article	O
examines	O
whether	O
girls	O
'	O
substance	O
use	O
is	O
associated	B-T080
with	I-T080
general	O
risk	O
and	O
protective	O
factors	O
goal	O
setting	O
,	O
problem	O
solving	O
,	O
refusal	O
skills	O
,	O
peer	O
use	O
,	O
and	O
self-efficacy	O
and	O
gender	O
-	O
specific	B-T080
risk	O
and	O
protective	O
factors	O
communication	O
style	O
,	O
coping	O
skills	O
,	O
self-esteem	O
,	O
body	O
image	O
,	O
perceived	O
stress	O
,	O
anxiety	O
,	O
and	O
depression	O
.	O
	
cross-sectional	O
data	O
were	O
collected	O
in	O
2013	O
via	O
online	O
surveys	O
from	O
a	O
nationwide	O
sample	O
of	O
adolescent	O
girls	O
n	O
=	O
788	O
,	O
aged	O
13	O
and	O
14	O
years	O
,	O
who	O
were	O
recruited	O
through	O
facebook	O
.	O
	
in	O
multivariate	B-T081
analyses	I-T081
,	O
controlling	O
for	O
correlates	O
of	O
adolescent	O
substance	O
use	O
,	O
11	O
of	O
the	O
13	O
general	O
and	O
gender	O
-	O
specific	B-T080
risk	O
and	O
protective	O
factors	O
were	O
consistently	O
associated	B-T080
with	I-T080
past-month	O
alcohol	O
,	O
cigarette	O
,	O
and	O
other	O
drug	O
use	O
in	O
the	O
expected	O
direction	O
past-month	O
marijuana	O
use	O
was	O
associated	B-T080
with	I-T080
8	O
of	O
the	O
13	O
factors	B-T169
.	O
	
refusal	O
skill	O
s	O
,	O
peer	O
use	O
,	O
coping	O
,	O
and	O
depressive	B-T033
mood	I-T033
were	O
most	O
consistently	O
and	O
strongly	O
associated	B-T080
with	I-T080
substance	O
use	O
.	O
	
substance	O
abuse	O
prevention	O
programs	O
targeting	O
adolescent	O
girls	O
should	O
focus	O
on	O
such	O
general	O
risk	O
and	O
protective	O
factors	O
as	O
problem	O
solving	O
,	O
refusal	O
skill	O
s	O
,	O
peer	O
influences	O
,	O
and	O
self-efficacy	O
,	O
as	O
well	O
as	O
such	O
gender	O
-	O
specific	B-T080
risk	O
and	O
protective	O
factors	O
as	O
communication	O
style	O
,	O
coping	O
,	O
self-esteem	O
,	O
body	O
image	O
,	O
perceived	O
stress	O
,	O
and	O
mood	B-T061
management	I-T061
.	O
	
ethics	B-T078
hype	B-T080
there	O
has	O
been	O
growing	O
concern	B-T078
about	O
the	O
phenomenon	O
of	O
science	O
hype	B-T080
,	O
the	O
tendency	O
to	O
exaggerate	B-T080
the	O
value	O
or	O
near	B-T080
-	O
future	B-T079
application	B-T169
of	O
research	B-T033
results	I-T033
.	O
	
although	O
this	O
is	O
a	O
problem	B-T033
that	O
touches	O
every	O
area	O
of	O
biomedicine	O
,	O
the	O
topic	O
of	O
genetics	O
seems	O
to	O
be	O
particularly	O
prone	O
to	O
enthusiastic	O
predictions	B-T078
.	O
	
the	O
world	O
has	O
been	O
told	O
for	O
over	O
two	O
decades	B-T079
-by	O
the	O
media	O
,	O
researchers	O
,	O
politicians	O
,	O
and	O
the	O
biotech	O
industry	O
-that	O
a	O
genome	O
-driven	O
health	O
care	O
revolution	O
is	O
just	O
around	O
the	O
corner	O
.	O
	
and	O
while	O
the	O
revolution	O
never	O
seems	O
to	O
arrive	O
,	O
the	O
hopeful	O
rhetoric	B-T169
continues	O
.	O
	
it	O
has	O
been	O
suggested	O
that	O
this	O
unrelenting	O
""""	O
genohype	B-T080
""""	O
is	O
having	O
a	O
range	O
of	O
adverse	B-T033
social	O
consequences	O
,	O
including	O
misleading	O
the	O
public	O
and	O
hurting	O
the	O
long-term	B-T079
legitimacy	O
of	O
the	O
field	O
.	O
	
while	O
we	O
need	O
more	O
good	O
data	B-T078
on	O
the	O
nature	B-T078
and	O
magnitude	B-T081
of	O
these	O
possible	O
harms	O
,	O
few	O
would	O
argue	O
with	O
the	O
proposition	O
that	O
sustained	B-T169
science	O
hype	B-T080
is	O
a	O
bad	O
thing	O
.	O
	
we	O
all	O
benefit	B-T081
from	O
robust	B-T080
science	O
and	O
accurate	B-T080
public	O
representations	O
of	O
biomedical	O
research	O
.	O
	
but	O
,	O
to	O
date	O
,	O
there	O
has	O
been	O
very	O
little	O
consideration	B-T033
of	O
the	O
degree	B-T081
to	O
which	O
the	O
scholarship	B-T078
on	O
the	O
related	O
ethical	B-T078
,	O
legal	O
,	O
and	O
social	O
issues	O
has	O
been	O
hyped	O
.	O
	
are	O
the	O
conclusions	B-T078
from	O
elsi	B-T078
scholarship	I-T078
also	O
lubiprostone	B-T109
accelerates	B-T169
intestinal	O
transit	O
and	O
alleviates	B-T169
small	B-T047
intestinal	I-T047
bacterial	I-T047
overgrowth	I-T047
in	O
patients	O
with	O
chronic	O
constipation	O
lubiprostone	B-T109
is	O
an	O
effective	B-T080
treatment	B-T169
for	O
chronic	O
constipation	O
cc	O
.	O
	
the	O
mechanism	B-T169
of	I-T169
action	I-T169
of	O
lubiprostone	B-T109
is	O
through	O
increasing	B-T169
fluid	O
secretion	O
and	O
lubrication	O
of	O
the	O
intestinal	O
lumen	O
.	O
	
the	O
effects	B-T080
of	O
lubiprostone	B-T109
on	O
gastrointestinal	O
transit	O
and	O
small	B-T047
intestinal	I-T047
bacterial	I-T047
overgrowth	I-T047
sibo	B-T047
have	O
not	O
been	O
adequately	O
explored	O
.	O
	
the	O
current	O
study	O
was	O
designed	O
to	O
investigate	B-T169
whether	O
lubiprostone	B-T109
1	O
alters	O
gastrointestinal	O
transit	O
and	O
2	O
affects	O
sibo	B-T047
in	O
patients	O
with	O
constipation	O
.	O
	
a	O
total	O
of	O
29	O
female	O
patients	O
mean	O
age	O
=	O
39	O
years	B-T079
range	B-T081
19-64	O
with	O
cc	O
received	B-T080
2	O
weeks	B-T079
of	O
lubiprostone	B-T109
24mcg	O
b.i	O
,	O
p.o	O
.	O
	
stool	B-T033
consistency	I-T033
based	O
on	O
bristol	O
stool	O
scale	O
and	O
the	O
frequency	B-T033
of	I-T033
bowel	I-T033
movements	I-T033
bms	O
were	O
recorded	O
.	O
	
gastric	B-T079
emptying	I-T079
time	I-T079
,	O
small	O
bowel	O
transit	O
time	O
,	O
colon	O
transit	O
time	O
ctt	O
,	O
combined	O
small	O
and	O
large	O
bowel	O
transit	O
time	O
slbtt	O
and	O
whole	O
gut	O
transit	O
time	O
were	O
measured	B-T080
using	O
wireless	O
motility	O
capsule	O
.	O
	
the	O
sibo	B-T047
status	B-T080
was	O
assessed	O
by	O
the	O
lactulose	O
breath	O
test	O
.	O
	
data	B-T078
were	O
analyzed	O
using	O
wilcoxon	B-T081
rank	I-T081
,	O
mann-whitney	B-T081
u	I-T081
,	O
spearman	B-T081
rank	I-T081
correlation	I-T081
and	O
chi-square	O
tests	O
.	O
	
lubiprostone	B-T109
significantly	O
softened	O
the	O
stool	O
and	O
increased	B-T081
the	O
frequency	B-T033
of	I-T033
bm	I-T033
from	O
median	B-T081
of	O
2	O
to	O
4	O
times	B-T081
per	O
week	B-T079
.	O
	
the	O
ctt	O
and	O
slbtt	O
were	O
significantly	O
shorter	B-T080
in	O
responders	O
to	O
lubiprostone	B-T109
i.e	O
,	O
those	O
with	O
2	O
times	B-T081
increase	B-T169
in	O
the	O
number	B-T081
of	O
their	O
weekly	B-T079
bm	O
compared	O
with	O
nonresponders	O
.	O
	
the	O
higher	B-T080
frequency	B-T033
of	I-T033
bm	I-T033
after	O
treatment	B-T169
was	O
significantly	O
correlated	B-T080
with	O
the	O
acceleration	O
of	O
ctt	O
,	O
slbtt	O
and	O
whole	O
gut	O
transit	O
time	O
.	O
	
in	O
all	O
,	O
17	O
out	O
of	O
25	O
68%	O
patients	O
,	O
who	O
were	O
tested	B-T169
for	O
sibo	B-T047
at	O
baseline	B-T081
,	O
were	O
positive	B-T033
.	O
	
in	O
addition	O
,	O
7	O
out	O
of	O
17	O
41%	O
sibo	B-T047
-	O
positive	B-T033
patients	O
became	O
sibo	B-T047
-	O
negative	B-T033
after	O
lubiprostone	B-T109
treatment	B-T169
p	O
<	O
0.05	O
.	O
	
in	O
cc	O
,	O
lubiprostone	B-T109
improves	O
the	O
frequency	B-T033
of	I-T033
bms	I-T033
,	O
softens	O
the	O
stool	O
,	O
accelerates	B-T169
intestinal	O
transit	O
and	O
decreases	B-T081
accompanying	O
sibo	B-T047
.	O
	
the	O
improvement	O
of	O
sibo	B-T047
could	O
be	O
explained	O
by	O
the	O
cleansing	O
effect	B-T080
of	O
increased	B-T081
intestinal	O
fluid	O
and	O
mucus	O
combined	O
with	O
enhanced	O
intestinal	O
motility	O
with	O
minimally	B-T061
invasive	I-T061
treatment	I-T061
of	O
difficult	O
bleeding	O
lesions	B-T033
of	O
the	O
small	O
bowel	O
bleeding	O
lesions	B-T033
of	O
the	O
small	O
bowel	O
are	O
often	O
difficult	O
to	O
identify	B-T080
due	O
to	O
the	O
obscure	B-T033
symptomatology	O
.	O
	
localizing	O
these	O
lesions	B-T033
requires	O
specific	B-T080
techniques	B-T169
.	O
	
the	O
double-balloon	O
enteroscopy	O
dbe	O
could	O
be	O
used	O
to	O
precisely	O
localize	O
and	O
mark	O
lesions	B-T033
,	O
so	O
that	O
a	O
minimally	B-T061
invasive	I-T061
surgical	I-T061
treatment	I-T061
could	O
be	O
performed	O
.	O
	
twenty	O
robot	O
-	O
assisted	B-T080
small	B-T061
bowel	I-T061
procedures	I-T061
are	O
presented	O
using	O
a	O
combination	B-T080
of	O
dbe	O
for	O
localization	O
and	O
robotic	B-T061
resection	I-T061
.	O
	
there	O
were	O
10	O
jejunal	B-T061
resections	I-T061
and	O
10	O
ileal	B-T061
resections	I-T061
.	O
	
mean	O
age	O
was	O
58.7	O
years	B-T079
.	O
	
mean	O
operative	B-T079
time	I-T079
was	O
153.4	O
minutes	B-T079
,	O
mean	O
blood	B-T033
loss	I-T033
of	O
46	O
ml	O
.	O
	
no	O
conversion-to-open	B-T061
and	O
there	O
were	O
4	O
post-operative	B-T079
complications	O
.	O
	
the	O
90-	O
day	B-T079
mortality	B-T081
was	O
nil	O
and	O
the	O
median	O
length	B-T079
of	I-T079
stay	I-T079
was	O
4.1	O
days	B-T079
.	O
	
final	O
pathology	O
was	O
consistent	B-T078
with	I-T078
malignancy	O
in	O
10	O
cases	B-T169
.	O
	
the	O
combination	B-T080
of	O
double-balloon	O
enteroscopy	O
and	O
robotic	B-T061
technology	I-T061
allows	O
accurate	B-T080
identification	B-T080
and	O
selective	O
treatment	B-T169
of	O
lesions	B-T033
that	O
could	O
be	O
otherwise	O
difficult	O
to	O
treat	B-T169
in	O
a	O
minimally	B-T061
invasive	I-T061
fashion	I-T061
.	O
	
kinematic	O
and	O
emg	O
responses	O
to	O
pelvis	O
and	O
leg	O
assistance	O
force	O
during	O
treadmill	O
walking	O
in	O
children	O
with	O
cerebral	B-T047
palsy	I-T047
treadmill	B-T061
training	I-T061
has	O
been	O
used	O
for	O
improving	O
locomotor	O
function	O
in	O
children	O
with	O
cerebral	B-T047
palsy	I-T047
cp	B-T047
,	O
but	O
the	O
functional	O
gains	O
are	O
relatively	O
small	O
,	O
suggesting	O
a	O
need	O
to	O
improve	O
current	O
paradigms	O
.	O
	
the	O
understanding	O
of	O
the	O
kinematic	O
and	O
emg	O
responses	O
to	O
force	O
s	O
applied	O
to	O
the	O
body	O
of	O
subjects	O
during	O
treadmill	O
walking	O
is	O
crucial	O
for	O
improving	O
current	O
paradigms	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
kinematic	O
s	O
and	O
emg	O
responses	O
to	O
the	O
pelvis	O
and/or	O
leg	O
assistance	O
force	O
.	O
	
ten	O
children	O
with	O
spastic	O
cp	O
were	O
recruited	O
to	O
participate	O
in	O
this	O
study	O
.	O
	
a	O
controlled	O
assistance	O
force	O
was	O
applied	O
to	O
the	O
pelvis	O
and/or	O
legs	O
during	O
stance	B-T033
and	O
swing	B-T033
phase	I-T033
of	I-T033
gait	I-T033
through	O
a	O
custom	O
designed	O
robotic	O
system	O
during	O
walking	O
.	O
	
muscle	O
activities	O
and	O
spatial	O
-	O
temporal	B-T079
gait	B-T033
parameters	I-T033
were	O
measured	O
at	O
different	O
loading	O
conditions	O
during	O
walking	O
.	O
	
in	O
addition	O
,	O
the	O
spatial-temporal	B-T033
gait	I-T033
parameters	I-T033
during	O
overground	O
walking	O
before	O
and	O
after	O
treadmill	B-T061
training	I-T061
were	O
also	O
collected	O
.	O
	
applying	O
pelvis	O
assistance	O
improved	B-T033
step	B-T033
height	I-T033
and	O
applying	O
leg	O
assistance	O
improved	B-T033
step	B-T033
length	I-T033
during	O
walking	O
,	O
but	O
applying	O
leg	O
assistance	O
also	O
reduced	B-T080
muscle	O
activation	O
of	O
ankle	O
flexor	O
during	O
the	O
swing	B-T033
phase	I-T033
of	I-T033
gait	I-T033
.	O
	
in	O
addition	O
,	O
step	B-T033
length	I-T033
and	O
self-selected	O
walking	O
speed	O
significantly	O
improved	B-T033
after	O
one	O
session	O
of	O
treadmill	B-T061
training	I-T061
with	O
combined	O
pelvis	O
and	O
leg	O
assistance	O
.	O
	
outlining	O
a	O
population	O
"""at"	O
"risk"""	O
of	O
parkinson's	B-T047
disease	I-T047
evidence	B-T078
from	O
a	O
case-control	O
study	O
the	O
multifactorial	O
pathogenesis	O
of	O
parkinson's	B-T047
disease	I-T047
pd	B-T047
requires	O
a	O
careful	O
identification	O
of	O
populations	O
"""at"	O
"risk"""	O
of	O
developing	O
the	O
disease	B-T047
.	O
	
in	O
this	O
case-control	O
study	O
we	O
analyzed	O
a	O
large	O
italian	O
population	O
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	B-T078
criteria	I-T078
to	O
define	O
a	O
population	O
"""at"	O
"risk"""	O
of	O
pd	B-T047
.	O
	
we	O
enrolled	O
300	O
pd	B-T047
patients	O
and	O
300	O
controls	O
,	O
gender	O
and	O
age	O
matched	O
,	O
from	O
the	O
same	O
urban	B-T080
geographical	O
area	O
.	O
	
all	O
subjects	O
were	O
interviewed	O
on	O
demographics	O
,	O
family	B-T033
history	I-T033
of	O
pd	B-T047
,	O
occupational	B-T033
and	I-T033
environmental	I-T033
toxicants	I-T033
exposure	I-T033
,	O
smoking	O
status	O
,	O
and	O
alcohol	O
consumption	O
.	O
	
a	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	O
dosing	B-T081
of	O
iron	O
,	O
copper	O
,	O
mercury	O
,	O
and	O
manganese	O
by	O
means	O
of	O
inductively	O
coupled-plasma-mass-spectrometry	O
icp-ms	O
.	O
	
positive	B-T033
family	B-T033
history	I-T033
,	O
toxicants	B-T033
exposure	I-T033
,	O
non-current-smoker	B-T033
,	O
and	O
alcohol	B-T033
nonconsumer	I-T033
status	I-T033
occurred	O
as	O
significant	O
risk	B-T033
factors	I-T033
in	O
our	O
population	O
.	O
	
the	O
number	O
of	O
concurring	B-T033
risk	I-T033
factors	I-T033
overlapping	B-T079
in	O
the	O
same	O
subject	O
impressively	O
increased	B-T081
the	O
overall	B-T080
risk	I-T080
.	O
	
no	B-T033
significant	I-T033
differences	I-T033
were	O
measured	B-T080
in	O
the	O
metal	O
serum	O
levels	B-T080
.	O
	
our	O
findings	B-T033
indicate	O
that	O
combination	O
of	O
three	O
to	O
four	O
concurrent	B-T079
pd	B-T047
-	O
risk	B-T033
factors	I-T033
defines	O
a	O
condition	O
""""	O
at	B-T080
risk	I-T080
""""	O
of	O
pd	B-T047
.	O
	
a	O
simple	O
stratification	O
,	O
based	O
on	O
these	O
questionnaires	O
,	O
might	O
be	O
of	O
help	O
in	O
identifying	O
subjects	O
suitable	O
for	O
neuroprotective	O
strategies	O
.	O
	
work	O
process	O
,	O
performance	B-T033
and	O
professional	O
profile	O
of	O
a	O
hearing	O
health	O
network	O
reference	O
for	O
satisfaction	O
to	O
analyze	O
the	O
correlation	B-T080
between	O
the	O
satisfaction	O
of	O
professionals	O
from	O
the	O
hearing	O
health	O
care	O
network	O
in	O
two	O
micro	O
-	O
regions	O
of	O
minas	O
gerais	O
state	O
and	O
the	O
sociodemographic	B-T169
profile	I-T169
,	O
work	O
process	O
,	O
and	O
work	B-T033
performance	I-T033
in	O
the	O
health	O
service	O
.	O
	
this	O
is	O
a	O
cross-sectional	O
,	O
observational	O
,	O
analytic	B-T081
study	I-T081
with	O
a	O
non-probabilistic	O
sample	O
including	O
34	O
professionals	O
from	O
the	O
hearing	O
health	O
care	O
services	O
.	O
	
data	O
collection	O
occurred	O
through	O
individual	O
interviews	O
in	O
the	O
municipality	O
of	O
professional	O
practice	O
.	O
	
associations	B-T080
between	O
the	O
professional	O
satisfaction	O
variable	B-T080
and	O
the	O
explanatory	O
variables	B-T080
sociodemographic	B-T078
data	I-T078
,	O
work	B-T080
routine	I-T080
,	O
and	O
developed	B-T169
actions	O
were	O
conducted	O
.	O
	
professionals	O
with	O
graduate	O
studies	O
were	O
more	O
satisfied	O
with	O
the	O
human	O
resources	O
policy	O
and	O
the	O
activities	O
developed	B-T169
,	O
whereas	O
health	O
civil	O
servants	O
showed	O
more	O
satisfaction	O
with	O
the	O
wage	B-T081
policy	O
and	O
the	O
work	B-T079
schedule	I-T079
.	O
	
the	O
correlation	O
analysis	O
between	O
work	O
process	O
and	O
satisfaction	O
revealed	B-T080
a	O
moderate	B-T081
positive	B-T033
correlation	B-T080
between	O
items	O
such	O
as	O
health	O
promotion	O
actions	O
,	O
satisfaction	O
with	O
diagnostic	O
equipment	O
,	O
and	O
satisfaction	O
with	O
maintenance	B-T033
equipment	I-T033
.	O
	
the	O
present	O
study	O
revealed	O
a	O
higher	B-T080
level	B-T080
of	O
satisfaction	O
among	O
professionals	O
with	O
graduate	O
studies	O
human	O
resources	O
policy	O
and	O
activities	O
developed	B-T169
and	O
civil	O
servants	O
wage	B-T081
policy	O
and	O
work	B-T079
schedule	I-T079
.	O
	
the	O
relevance	B-T080
of	O
this	O
study	O
lies	O
on	O
the	O
important	O
role	O
that	O
health	O
professionals	O
play	O
on	O
the	O
health	O
care	O
network	O
.	O
	
additionally	O
,	O
the	O
study	O
of	O
satisfaction	O
level	B-T080
can	O
provide	O
a	O
search	O
for	O
improvements	O
,	O
considering	O
that	O
satisfied	O
professionals	O
not	O
only	O
improve	B-T033
service	B-T080
quality	I-T080
,	O
but	O
also	O
show	B-T033
greater	I-T033
creativity	I-T033
,	O
commitment	O
,	O
and	O
application	O
of	O
laparoscopic	O
lumbar	B-T061
discectomy	I-T061
and	O
artificial	B-T061
disc	I-T061
replacement	I-T061
at	O
least	O
two	O
years	O
of	O
follow-up	O
this	O
prospective	O
observational	O
study	O
included	O
22	O
patients	O
who	O
were	O
diagnosed	B-T033
with	O
symptomatic	B-T169
degenerative	B-T047
disc	I-T047
disease	I-T047
treated	O
via	O
artificial	B-T061
disc	I-T061
replacement	I-T061
adr	B-T061
with	O
a	O
laparoscopic	O
technique	B-T169
.	O
	
the	O
current	O
study	O
aimed	B-T078
to	O
assess	O
the	O
safety	O
and	O
efficacy	B-T080
of	O
adr	B-T061
using	O
a	O
laparoscopic	O
technique	B-T169
for	O
lumbar	O
disc	O
herniation	O
.	O
	
symptomatic	B-T169
degenerative	B-T047
disc	I-T047
disease	I-T047
is	O
the	O
major	O
cause	O
of	O
low	O
back	O
pain	O
with	O
lumbar	O
segmental	O
instability	B-T033
.	O
	
adr	B-T061
has	O
increased	B-T081
in	O
popularity	O
as	O
an	O
alternative	O
treatment	O
for	O
lumbar	O
disc	O
herniation	O
.	O
	
however	O
,	O
the	O
traditional	B-T169
approach	O
to	O
spinal	B-T061
surgery	I-T061
carries	O
the	O
risk	B-T078
of	O
catastrophic	B-T047
bleeding	O
from	O
injury	O
to	O
major	O
vessels	O
,	O
as	O
well	O
as	O
iatrogenic	B-T080
injury	O
to	O
the	O
viscera	O
and	O
associated	O
structures	O
.	O
	
therefore	O
,	O
laparoscopic	O
lumbar	B-T061
discectomy	I-T061
and	O
adr	B-T061
may	O
represent	O
a	O
useful	O
alternative	O
.	O
	
twenty-two	O
patients	O
8	O
males	O
and	O
14	O
females	O
who	O
were	O
diagnosed	B-T033
with	O
symptomatic	B-T169
degenerative	B-T047
disc	I-T047
disease	I-T047
were	O
included	O
in	O
this	O
study	O
.	O
	
seven	O
cases	B-T169
involved	O
the	O
l4/5	O
level	O
,	O
and	O
15	O
cases	B-T169
involved	O
the	O
l5/s1	O
level	O
.	O
	
all	O
patients	O
were	O
ineffective	B-T078
after	O
at	O
least	O
6	O
months	O
of	O
conservative	B-T061
treatments	I-T061
all	O
patients	O
were	O
informed	O
of	O
the	O
surgery	B-T061
before	O
the	O
operation	B-T061
and	O
provided	O
consent	B-T169
.	O
	
three-dimensional	O
computed	O
tomographic	O
angiography	O
3d	O
-	O
cta	O
of	O
the	O
iliac	O
great	O
blood	O
vessels	O
was	O
completed	B-T080
before	O
the	O
surgery	B-T061
.	O
	
all	O
surgical	B-T061
procedures	I-T061
were	O
performed	O
under	O
a	O
laparoscope	O
.	O
	
all	O
patients	O
were	O
followed	O
up	O
.	O
	
all	O
surgeries	B-T061
were	O
successfully	B-T080
completed	B-T080
.	O
	
the	O
average	B-T081
operation	B-T061
time	B-T079
was	O
120	O
minutes	O
range	B-T081
110-150	O
min	O
,	O
and	O
the	O
average	B-T081
hemorrhage	O
was	O
145	O
ml	O
range	B-T081
80-360	O
ml	O
.	O
	
all	O
cases	B-T169
underwent	O
x-rays	O
at	O
3	O
days	O
,	O
3	O
months	O
,	O
6	O
months	O
,	O
1	O
year	O
,	O
and	O
the	O
final	O
postoperative	O
follow-up	O
.	O
	
the	O
outcome	B-T169
indicated	O
that	O
there	O
was	O
no	O
mobilization	B-T169
,	O
displacement	O
,	O
or	O
subsidence	O
in	O
all	O
patients	O
with	O
the	O
exception	O
of	O
one	O
case	B-T169
with	O
prosthesis	O
migration	O
.	O
	
the	O
follow-up	O
time	O
was	O
43.8	O
months	O
range	B-T081
24-64	O
months	O
.	O
	
the	O
mean	B-T081
visual	O
analog	O
scale	O
vas	O
and	O
oswestry	B-T033
scores	I-T033
were	O
decreased	B-T081
postoperatively	B-T079
.	O
	
the	O
mean	B-T081
improvement	O
rate	B-T081
of	O
the	O
vas	O
score	O
was	O
73.5	O
.	O
	
lumbar	O
adr	B-T061
using	O
a	O
laparoscope	O
represents	O
a	O
novel	O
,	O
minimally	B-T169
invasive	I-T169
treatment	B-T169
for	O
symptomatic	B-T169
degenerative	B-T047
disc	I-T047
disease	I-T047
and	O
severe	B-T080
lumbar	B-T047
discogenic	I-T047
pain	I-T047
.	O
	
low	B-T033
literacy	I-T033
and	O
written	O
drug	O
information	O
information-seeking	B-T033
,	O
leaflet	O
evaluation	B-T078
and	O
preferences	B-T078
,	O
and	O
roles	O
for	O
images	O
background	O
low-literate	O
patients	O
are	O
at	O
risk	B-T078
to	O
misinterpret	O
written	O
drug	O
information	O
.	O
	
for	O
the	O
co-	O
design	O
of	O
targeted	O
patient	O
information	O
,	O
it	O
is	O
key	O
to	O
involve	O
this	O
group	O
in	O
determining	O
their	O
communication	B-T078
barriers	I-T078
and	O
information	B-T078
needs	O
.	O
	
objective	O
to	O
gain	O
insight	O
into	O
how	O
people	O
with	O
low	B-T033
literacy	I-T033
use	O
and	O
evaluate	O
written	O
drug	O
information	O
,	O
and	O
to	O
identify	O
ways	O
in	O
which	O
they	O
feel	O
the	O
patient	O
leaflet	O
can	O
be	O
improved	O
,	O
and	O
in	O
particular	O
how	O
images	O
could	O
be	O
used	O
.	O
	
setting	O
food	O
banks	O
and	O
an	O
education	O
institution	O
for	O
dutch	O
language	O
training	O
in	O
the	O
netherlands	O
.	O
	
method	O
semi-structured	O
focus	O
groups	O
and	O
individual	O
interviews	O
were	O
held	O
with	O
low-literate	O
participants	O
n	O
=	O
45	O
.	O
	
the	O
thematic	O
framework	O
approach	O
was	O
used	O
for	O
analysis	O
to	O
identify	O
themes	O
in	O
the	O
data	B-T078
.	O
	
main	O
outcome	B-T169
measure	O
low-literate	O
people's	O
experience	B-T078
with	O
patient	O
information	O
leaflets	O
,	O
ideas	B-T078
for	O
improvements	O
,	O
and	O
perceptions	O
on	O
possible	O
uses	O
for	O
visuals	B-T169
.	O
	
results	O
patient	O
information	O
leaflets	O
were	O
considered	O
discouraging	O
to	O
use	O
,	O
and	O
information	B-T078
difficult	O
to	O
find	O
and	O
understand	O
.	O
	
many	O
rely	O
on	O
alternative	O
information	B-T033
sources	I-T033
.	O
	
the	O
leaflet	O
should	O
be	O
shorter	O
,	O
and	O
improved	O
in	O
terms	O
of	O
organisation	B-T169
,	O
legibility	B-T033
and	O
readability	B-T080
.	O
	
participants	O
thought	O
images	O
could	O
increase	O
the	O
leaflet's	O
appeal	O
,	O
help	O
ask	O
questions	O
,	O
provide	O
an	O
overview	O
,	O
help	O
understand	O
textual	O
information	B-T078
,	O
aid	O
recall	O
,	O
reassure	O
,	O
and	O
even	O
lead	O
to	O
increased	O
confidence	O
,	O
empowerment	O
and	O
feeling	O
of	O
safety	O
.	O
	
conclusion	O
already	O
at	O
the	O
stages	O
of	O
paying	O
attention	O
to	O
the	O
leaflet	O
and	O
maintaining	O
interest	O
in	O
the	O
message	O
,	O
low-literate	O
patients	O
experience	O
barriers	B-T078
in	I-T078
the	I-T078
communication	I-T078
process	O
through	O
written	O
drug	O
information	O
.	O
	
short	O
,	O
structured	O
,	O
visual	B-T169
/	O
textual	O
explanations	O
can	O
lower	O
the	O
motivational	O
threshold	O
to	O
use	O
the	O
leaflet	O
,	O
improve	B-T033
understanding	O
,	O
and	O
empower	O
the	O
low-literate	O
target	O
group	O
.	O
	
establishment	O
and	O
application	O
of	O
a	O
flow	O
cytometry	O
-based	O
method	O
for	O
detecting	B-T033
histone	O
acetylation	O
levels	B-T080
histone	B-T116
deacetylase	I-T116
inhibitors	I-T116
,	O
which	O
have	O
also	O
received	O
attention	O
in	O
aids	B-T047
and	O
other	O
diseases	B-T047
,	O
are	O
a	O
new	O
class	O
of	O
anticancer	B-T109
drugs	I-T109
developed	O
in	O
recent	O
years	O
.	O
	
however	O
,	O
there	O
is	O
still	O
a	O
lack	B-T080
of	O
a	O
unified	B-T080
and	O
reliable	O
method	O
for	O
detecting	B-T033
histone	O
acetylation	O
levels	B-T080
in	O
basic	O
and	O
clinical	O
research	O
.	O
	
in	O
this	O
study	O
,	O
we	O
developed	O
a	O
flow	O
cytometry	O
-based	O
method	O
to	O
detect	B-T061
histone	O
acetylation	O
levels	O
by	O
comparing	O
different	O
sample	O
processing	O
temperature	O
on	O
ice	O
vs	O
.	O
	
room	O
temperature	O
,	O
permeabilization	O
method	O
intracellular	O
vs	O
.	O
	
nuclear	O
,	O
antibody	O
dose	O
antibody	O
titration	O
and	O
antibody	O
incubation	O
time	O
time	O
gradient	O
using	O
whole	O
blood	O
and	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O
	
in	O
addition	O
,	O
we	O
applied	O
this	O
optimized	O
method	O
in	O
in	O
vitro	O
experiment	O
and	O
clinical	O
trial	O
of	O
chidamide	O
the	O
only	O
china	O
fda	O
approved	O
hdaci	O
,	O
the	O
result	O
of	O
which	O
confirmed	O
that	O
the	O
flow	O
cytometry	O
-based	O
method	O
for	O
detecting	O
histone	O
acetylation	O
levels	O
is	O
a	O
reliable	O
,	O
fast	O
and	O
convenient	O
method	O
which	O
can	O
be	O
used	O
in	O
basic	O
and	O
clinical	O
research	O
performance	O
and	O
safety	B-T080
of	O
collagenated	O
xenogeneic	O
bone	O
block	O
for	O
lateral	B-T061
alveolar	I-T061
ridge	I-T061
augmentation	I-T061
and	O
staged	B-T061
implant	I-T061
placement	I-T061
.	O
	
a	O
monocenter	O
,	O
prospective	O
single-arm	O
clinical	O
study	O
to	O
assess	O
the	O
clinical	B-T080
safety	I-T080
and	O
performance	O
of	O
collagenated	O
xenogeneic	O
bone	O
block	O
cxbb	O
for	O
lateral	B-T061
alveolar	I-T061
ridge	I-T061
augmentation	I-T061
and	O
two-stage	B-T079
implant	B-T061
placement	I-T061
.	O
	
in	O
ten	O
patients	O
exhibiting	B-T078
a	O
single	B-T081
-	O
tooth	O
gap	O
,	O
the	O
surgical	B-T061
procedure	I-T061
included	O
the	O
preparation	O
of	O
mucoperiosteal	O
flaps	O
,	O
a	O
rigid	B-T061
fixation	I-T061
of	O
cxbb	O
geistlich	O
bio-graft	O
using	O
an	O
osteosynthesis	O
screw	O
,	O
and	O
contour	O
augmentation	B-T061
.	O
	
after	O
24	O
weeks	O
of	O
submerged	O
healing	O
,	O
the	O
primary	O
endpoint	O
was	O
defined	O
as	O
the	O
final	B-T079
ridge	O
width	B-T081
sufficient	B-T080
to	O
place	O
an	O
adequately	B-T080
dimensioned	B-T081
titanium	B-T061
implant	I-T061
at	O
the	O
respective	O
sites	O
.	O
	
secondary	B-T080
outcomes	I-T080
included	O
,	O
for	O
example	O
,	O
the	O
gain	B-T081
in	O
ridge	O
width	B-T081
mm	O
.	O
	
clinical	O
parameters	O
e.g	O
,	O
bleeding	B-T033
on	I-T033
probing	I-T033
-	O
bop	B-T033
,	O
probing	B-T081
depth	I-T081
-	O
pd	B-T081
,	O
mucosal	O
recession	O
-	O
mr	O
were	O
assessed	O
immediately	O
after	O
the	O
cementation	B-T061
of	I-T061
the	I-T061
crown	I-T061
and	O
at	O
the	O
final	B-T061
visit	I-T061
.	O
	
at	O
24	O
weeks	O
,	O
implant	B-T061
placement	I-T061
could	O
be	O
achieved	O
in	O
8	O
of	O
10	O
patients	O
exhibiting	B-T078
a	O
mean	B-T081
gain	B-T081
in	O
ridge	O
width	B-T081
mean	B-T081
sd	B-T081
of	O
3.88	O
1.75	O
mm	O
.	O
	
histological	B-T080
analysis	O
has	O
pointed	O
to	O
a	O
homogeneous	O
osseous	O
organization	B-T169
of	O
cxbb	O
.	O
	
the	O
changes	B-T169
of	O
mean	B-T081
bop	B-T033
,	O
pd	B-T081
,	O
and	O
mr	O
values	B-T081
at	O
the	O
final	B-T061
visit	I-T061
amounted	B-T081
to	O
16.62	O
32.02	O
,	O
0.04	O
0.21	O
mm	O
,	O
and	O
-0	O
0.12	O
mm	O
,	O
respectively	O
.	O
	
cxbb	O
may	O
be	O
successfully	B-T080
used	O
to	O
support	O
lateral	B-T061
alveolar	I-T061
ridge	I-T061
augmentation	I-T061
and	O
two-stage	B-T079
implant	B-T061
placement	I-T061
.	O
	
the	O
link	O
between	O
self-perceptions	O
of	O
aging	O
,	O
cancer	O
view	O
and	O
physical	B-T169
and	O
mental	O
health	O
of	O
older	O
people	O
with	O
cancer	O
a	O
cross-sectional	O
study	O
older	O
people	O
may	O
suffer	O
from	O
stigmas	O
linked	O
to	O
cancer	O
and	O
aging	O
.	O
	
although	O
some	O
studies	O
suggested	O
that	O
a	O
negative	B-T033
view	O
of	O
cancer	O
may	O
increase	O
the	O
level	B-T033
of	I-T033
depression	I-T033
,	O
such	O
an	O
association	O
has	O
never	O
been	O
studied	O
in	O
the	O
elderly	O
population	O
.	O
	
similarly	O
,	O
even	O
though	O
it	O
is	O
established	O
that	O
a	O
negative	B-T033
self-perception	O
of	O
aging	O
has	O
deleterious	O
consequences	B-T169
on	O
mental	O
and	O
physical	B-T033
health	I-T033
in	O
normal	O
aging	O
,	O
the	O
influence	O
in	O
pathological	B-T169
contexts	B-T078
,	O
such	O
as	O
oncology	O
,	O
has	O
not	O
been	O
studied	O
.	O
	
the	O
main	O
aim	O
of	O
this	O
study	O
is	O
thus	O
to	O
analyze	O
the	O
effect	O
of	O
these	O
two	O
stigmas	O
on	O
the	O
health	B-T078
of	O
elderly	O
oncology	O
patients	O
.	O
	
101	O
patients	O
suffering	O
from	O
a	O
cancer	O
breast	O
,	O
gynecological	B-T047
,	O
lung	O
or	O
hematological	B-T047
were	O
seen	O
as	O
soon	O
as	O
possible	O
after	O
their	O
diagnosis	B-T033
.	O
	
their	O
self-perception	O
of	O
age	O
,	O
cancer	O
view	O
and	O
health	B-T078
physical	B-T033
and	O
mental	O
was	O
assessed	O
.	O
	
multiple	O
regressions	O
showed	O
that	O
patients	O
with	O
a	O
more	O
negative	B-T033
self-perception	O
of	O
aging	O
and/or	O
more	O
negative	B-T033
cancer	O
view	O
reported	O
poorer	B-T080
global	O
health	O
.	O
	
we	O
also	O
observed	O
that	O
negative	B-T033
self-perception	O
of	O
aging	O
was	O
associated	B-T080
with	I-T080
worse	O
physical	B-T033
and	O
mental	O
health	O
,	O
whereas	O
negative	B-T033
cancer	O
views	O
were	O
only	O
linked	O
to	O
worse	O
mental	O
health	O
.	O
	
no	O
interaction	O
was	O
observed	O
between	O
these	O
two	O
stigmas	O
,	O
suggesting	O
that	O
their	O
action	O
is	O
independent	B-T078
.	O
	
older	O
patients	O
with	O
cancer	O
face	O
double	O
stigmatization	B-T078
,	O
due	O
to	O
negative	B-T033
self-perception	O
of	O
aging	O
and	O
cancer	O
,	O
and	O
these	O
stigmas	O
have	O
impacts	O
on	O
global	O
and	O
mental	O
health	O
.	O
	
self-perception	O
of	O
aging	O
is	O
also	O
linked	O
to	O
physical	B-T033
health	I-T033
.	O
	
longitudinal	O
studies	O
will	O
be	O
necessary	O
to	O
analyze	O
the	O
direction	O
of	O
the	O
association	O
between	O
this	O
double	O
stigmatization	B-T078
and	O
the	O
aortic	O
root	O
natural	O
history	O
after	O
root-sparing	B-T061
ascending	I-T061
replacement	I-T061
in	O
nonsyndromic	B-T033
aneurysmal	O
patients	O
leaving	O
native	B-T169
aortic	O
tissue	O
in	O
situ	O
in	O
root-sparing	B-T061
ascending	I-T061
aortic	I-T061
replacement	I-T061
raises	O
concern	B-T078
regarding	O
potential	B-T080
later	B-T079
need	B-T080
for	O
root	O
reoperation	B-T061
or	O
for	O
the	O
potential	B-T080
occurrence	B-T079
of	O
localized	O
dissections	B-T047
or	O
rupture	O
in	O
the	O
residual	B-T080
root	O
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
natural	O
growth	O
of	O
the	O
aortic	O
root	O
after	O
root-sparing	B-T061
aortic	I-T061
replacement	I-T061
.	O
	
in	O
all	O
,	O
102	O
consecutive	B-T080
patients	O
mean	B-T081
age	O
61.8	O
12.5	O
years	B-T079
60%	O
male	O
who	O
had	O
undergone	O
root-sparing	B-T061
aortic	I-T061
replacement	I-T061
had	O
sufficient	B-T080
retrievable	B-T078
information	I-T078
regarding	O
their	O
aortic	O
root	O
diameter	B-T081
at	O
postoperative	B-T079
baseline	B-T081
and	O
follow-up	O
imaging	O
by	O
computed	O
tomography	O
or	O
echocardiography	O
.	O
	
the	O
annual	B-T079
growth	B-T079
rate	I-T079
was	O
evaluated	O
and	O
also	O
compared	O
according	O
to	O
the	O
influence	O
of	O
valve	B-T080
morphology	I-T080
and	O
concomitant	B-T079
aortic	B-T061
valve	I-T061
replacement	I-T061
.	O
	
furthermore	O
,	O
the	O
years	B-T079
of	O
natural	O
history	O
that	O
would	O
require	B-T169
for	O
root	O
enlargement	O
to	O
meet	O
a	O
50	O
mm	B-T081
threshold	B-T080
of	O
the	O
root	O
diameter	B-T081
were	O
calculated	O
.	O
	
the	O
estimated	B-T081
growth	B-T079
rate	I-T079
of	O
the	O
aortic	O
root	O
after	O
root-sparing	B-T061
aortic	I-T061
replacement	I-T061
is	O
between	O
0.27	O
and	O
0.51	O
mm	B-T081
per	B-T079
year	I-T079
mean	B-T081
0.41	O
mm	B-T081
,	O
varying	O
according	O
to	O
the	O
underlying	B-T081
diameter	I-T081
and	O
therefore	O
fivefold	O
less	B-T081
than	I-T081
other	O
aortic	O
regions	O
.	O
	
accordingly	O
,	O
a	O
root	B-T047
aneurysm	I-T047
indicating	O
reoperation	B-T061
would	O
not	O
be	O
expected	O
for	O
29.1	O
years	B-T079
on	O
average	B-T081
.	O
	
only	O
patients	O
with	O
a	O
diameter	B-T081
of	O
45	O
mm	B-T081
or	O
more	O
are	O
at	B-T080
risk	I-T080
for	O
reoperation	B-T061
,	O
and	O
not	O
until	O
at	O
least	O
after	B-T079
10.4	O
years	B-T079
have	B-T033
passed	I-T033
.	O
	
neither	B-T080
the	O
valve	B-T080
morphology	I-T080
p	O
=	O
0.62	O
nor	O
concomitant	B-T079
aortic	B-T061
valve	I-T061
replacement	I-T061
p	O
=	O
0.86	O
influenced	O
rate	B-T081
of	O
root	B-T047
dilation	I-T047
.	O
	
in	O
nonsyndromic	B-T033
patients	O
,	O
the	O
aortic	O
root	O
is	O
the	O
slowest	B-T080
growing	O
portion	O
of	O
the	O
thoracic	O
aorta	O
.	O
	
leaving	O
the	O
native	B-T169
root	O
,	O
as	O
in	O
root-sparing	B-T061
ascending	I-T061
aortic	I-T061
replacement	I-T061
,	O
is	O
a	O
safe	O
approach	O
regarding	O
secondary	O
root	O
intervention	B-T061
for	O
aortic	O
root	O
diameters	B-T081
of	O
45	O
mm	B-T081
physical	O
exercise	O
for	O
late-life	B-T079
depression	O
effects	B-T080
on	O
heart	O
rate	O
variability	O
late-life	B-T079
major	O
depression	O
is	O
associated	B-T080
with	I-T080
increased	B-T081
cardiovascular	B-T033
risk	I-T033
and	O
impaired	B-T047
autonomic	I-T047
control	I-T047
of	I-T047
the	I-T047
heart	I-T047
,	O
as	O
evident	O
from	O
reduced	B-T080
heart	O
rate	O
variability	O
hrv	O
.	O
	
moreover	O
,	O
antidepressant	O
drug	O
therapy	B-T061
also	O
might	O
be	O
associated	B-T080
with	I-T080
further	O
reductions	B-T080
of	O
hrv	O
.	O
	
in	O
the	O
seeds	O
study	O
,	O
we	O
investigated	O
whether	O
sertraline	B-T109
associated	B-T080
with	I-T080
physical	O
exercise	O
protocols	O
led	O
to	O
improvements	O
of	O
hrv	O
,	O
compared	O
with	O
antidepressant	O
drug	O
therapy	B-T061
alone	O
.	O
	
single-blind	O
randomized	O
controlled	O
trial	O
.	O
	
psychiatric	O
consultation	O
-liaison	O
program	O
for	O
primary	O
care	O
.	O
	
patients	O
aged	O
65-85	O
years	O
with	O
major	O
depression	O
,	O
recruited	O
from	O
primary	O
care	O
.	O
	
sertraline	B-T109
plus	O
structured	O
,	O
tailored	O
group	O
physical	O
exercise	O
s	O
+	O
ex	O
versus	O
sertraline	B-T109
alone	O
s	O
for	O
24	O
weeks	B-T079
.	O
	
hrv	O
indices	O
rr	O
,	O
percentage	B-T081
of	I-T081
nn	I-T081
intervals	I-T081
greater	I-T081
than	I-T081
50	I-T081
msec	I-T081
pnn50	B-T081
,	O
square	B-T081
root	I-T081
of	I-T081
the	I-T081
mean	I-T081
squared	I-T081
differences	I-T081
of	I-T081
successive	I-T081
nn	I-T081
intervals	I-T081
rmssd	B-T081
,	O
standard	B-T081
deviation	I-T081
of	O
heart	O
rate	O
sdhr	B-T081
,	O
standard	B-T081
deviation	I-T081
of	I-T081
the	I-T081
nn	I-T081
interval	I-T081
sdnn	B-T081
,	O
high-frequency	B-T081
band	I-T081
hf	B-T081
,	O
low-frequency	B-T081
band	I-T081
lf	B-T081
,	O
and	O
their	O
ratio	B-T081
lf/hf	B-T081
were	O
measured	B-T080
at	O
baseline	B-T081
,	O
week	B-T079
12	O
,	O
and	O
week	B-T079
24	O
.	O
	
psychiatric	O
and	O
medical	O
assessments	O
.	O
	
participants	O
displayed	O
significant	O
improvements	O
of	O
most	O
hrv	O
indices	O
over	O
time	O
,	O
irrespective	O
of	O
the	O
group	O
assignment	O
pnn50	B-T081
,	O
rmssd	B-T081
,	O
sdhr	B-T081
,	O
sdnn	B-T081
,	O
hf	B-T081
,	O
lf	B-T081
,	O
and	O
lf/hf	B-T081
.	O
	
moreover	O
,	O
patients	O
in	O
the	O
s	O
+	O
ex	O
group	O
displayed	O
greater	O
increases	B-T169
of	O
different	O
hrv	O
indices	O
rr	B-T081
,	O
pnn50	B-T081
,	O
rmssd	B-T081
,	O
sdhr	B-T081
,	O
sdnn	B-T081
,	O
hf	B-T081
,	O
and	O
lf	B-T081
compared	O
with	O
those	O
in	O
the	O
s	O
group	O
.	O
	
the	O
combination	B-T080
of	O
structured	O
physical	O
exercise	O
and	O
sertraline	B-T109
might	O
exert	O
positive	B-T033
effects	B-T080
on	O
the	O
autonomic	O
control	O
of	O
the	O
heart	O
among	O
older	O
patients	O
with	O
major	O
depression	O
.	O
	
genome-wide	O
snp	O
linkage	O
mapping	O
and	O
qtl	O
analysis	O
for	O
fiber	O
quality	B-T080
and	O
yield	B-T081
traits	O
in	O
the	O
upland	O
cotton	O
recombinant	O
inbred	O
lines	O
population	O
it	O
is	O
of	O
significance	O
to	O
discover	O
genes	O
related	O
to	O
fiber	O
quality	B-T080
and	O
yield	B-T081
traits	O
and	O
tightly	O
linked	O
markers	O
for	O
marker-assisted	O
selection	O
mas	O
in	O
cotton	O
breeding	O
.	O
	
in	O
this	O
study	O
,	O
188	O
f8	O
recombinant	O
inbred	O
lines	O
rils	O
,	O
derived	O
from	O
a	O
intraspecific	B-T080
cross	O
between	O
hs46	O
and	O
marcabucag8us-1-88	O
were	O
genotyped	O
by	O
the	O
cotton	O
63k	O
single	O
nucleotide	O
polymorphism	O
snp	O
assay	O
.	O
	
field	O
trials	O
were	O
conducted	O
in	O
sanya	O
,	O
hainan	O
province	O
,	O
during	O
the	O
2014-2015	O
cropping	O
seasons	B-T079
under	O
standard	B-T080
conditions	B-T080
.	O
	
results	O
revealed	O
significant	B-T081
differences	B-T080
p	O
<	O
0.05	O
among	O
rils	O
,	O
environments	O
and	O
replications	B-T080
for	O
fiber	O
quality	B-T080
and	O
yield	B-T081
traits	O
.	O
	
broad-sense	O
heritabilities	B-T169
of	O
all	O
traits	O
including	O
fiber	O
length	B-T081
,	O
fiber	O
uniformity	B-T080
,	O
micronaire	B-T080
,	O
fiber	O
elongation	O
,	O
fiber	O
strength	B-T081
,	O
boll	O
weight	B-T081
,	O
and	O
lint	O
percentage	B-T081
ranged	O
from	O
0.26	O
to	O
0.66	O
.	O
	
a	O
1784.28	O
cm	B-T081
centimorgans	B-T081
linkage	O
map	O
,	O
harboring	O
2618	O
polymorphic	B-T080
snp	O
markers	O
,	O
was	O
constructed	O
,	O
which	O
had	O
0.68	O
cm	B-T081
per	O
marker	O
density	O
.	O
	
seventy-one	O
quantitative	O
trait	O
locus	O
qtls	O
for	O
fiber	O
quality	B-T080
and	O
yield	B-T081
traits	O
were	O
detected	O
on	O
21	O
chromosomes	O
,	O
explaining	O
4.70	O
phenotypic	O
variance	B-T080
,	O
in	O
which	O
16	O
were	O
identified	O
as	O
stable	B-T080
qtls	O
across	O
two	O
environments	O
.	O
	
meanwhile	O
,	O
12	O
certain	O
regions	O
were	O
investigated	O
to	O
be	O
involved	O
in	O
the	O
control	O
of	O
one	O
hotspot	O
or	O
more	O
cluster	O
traits	O
,	O
mainly	O
focused	O
on	O
chr05	O
,	O
chr09	O
,	O
chr10	O
,	O
chr14	O
,	O
chr19	O
,	O
and	O
chr20	O
.	O
	
nineteen	O
pairs	O
of	O
epistatic	O
qtls	O
e-qtls	O
were	O
identified	O
,	O
of	O
which	O
two	O
pairs	O
involved	O
in	O
two	O
additive	B-T080
qtls	O
.	O
	
these	O
additive	B-T080
qtls	O
,	O
e-qtls	O
,	O
and	O
qtl	O
clusters	O
were	O
tightly	O
linked	O
to	O
snp	O
markers	O
,	O
which	O
may	O
serve	O
as	O
target	B-T169
regions	O
for	O
map-based	O
cloning	O
,	O
gene	O
discovery	O
,	O
and	O
mas	O
in	O
cotton	O
breeding	O
.	O
	
effects	B-T080
of	O
an	O
early	O
intervention	B-T061
using	O
human	O
amniotic	O
epithelial	O
cells	O
in	O
a	O
copd	B-T047
rat	O
model	O
the	O
study	O
aimed	O
to	O
investigate	B-T169
the	O
effect	B-T080
of	O
an	O
early	O
intervention	B-T061
using	O
human	O
amniotic	O
epithelial	O
cell	O
haec	O
in	O
a	O
rat	O
model	O
of	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
copd	B-T047
.	O
	
twenty-four	O
specific	O
pathogen-free	O
wistar	O
rats	O
were	O
randomized	O
to	O
the	O
control	O
,	O
copd	B-T047
,	O
and	O
copd	B-T047
+	O
haec	O
groups	B-T078
.	O
	
copd	B-T047
was	O
established	O
by	O
intratracheal	B-T169
lps	B-T109
injection	O
combined	O
with	O
smoke	O
fumigation	O
over	O
30	O
days	B-T079
.	O
	
on	O
the	O
first	O
day	B-T079
of	O
model	O
establishment	O
rats	O
in	O
the	O
aec	O
group	B-T078
also	O
received	O
intratracheal	B-T169
instillation	I-T169
of	O
500	O
haecs	O
isolated	O
from	O
the	O
placenta	O
of	O
healthy	B-T080
donors	O
.	O
	
the	O
mean	B-T081
linear	I-T081
intercept	I-T081
mli	B-T081
and	O
mean	B-T081
alveolar	I-T081
number	I-T081
man	B-T081
were	O
used	O
to	O
assess	O
the	O
degree	O
of	O
lung	B-T047
emphysema	I-T047
.	O
	
il-8	B-T116
was	O
measured	O
using	O
a	O
radioimmunoassay	O
,	O
surfactant	B-T116
protein	I-T116
d	I-T116
sp-d	B-T116
was	O
measured	O
by	O
elisa	O
,	O
and	O
matrix	B-T116
metalloproteinase	I-T116
mmp	I-T116
and	O
mmp8	B-T116
expression	O
was	O
assessed	O
by	O
pcr	O
.	O
	
smoke	O
fumigation	O
combined	O
to	O
lps	B-T109
injection	O
successfully	O
established	O
a	O
copd	B-T047
rat	O
model	O
with	O
significant	O
emphysema	B-T047
and	O
airway	O
inflammation	O
,	O
elevated	B-T080
mli	B-T081
and	O
man	B-T081
,	O
elevated	B-T080
systemic	B-T169
and	O
lung	O
tissue	O
levels	B-T080
of	O
il-8	B-T116
and	O
sp-d	B-T116
p<0	O
,	O
and	O
high	O
expression	O
of	O
mmp2	B-T116
and	O
mmp8	B-T116
.	O
	
rats	O
in	O
the	O
copd	B-T047
+	O
haec	O
group	B-T078
exhibited	O
alleviated	B-T080
lung	O
damage	O
,	O
mli	B-T081
and	O
man	B-T081
p<0	O
,	O
reduced	B-T080
systemic	B-T169
and	O
lung	O
tissue	O
levels	B-T080
of	O
il-8	B-T116
and	O
sp-d	B-T116
p<0	O
and	O
mmp2	B-T116
and	O
mmp8	B-T116
expression	O
p<0	O
.	O
	
early	O
intervention	B-T061
using	O
haecs	O
could	O
delay	O
disease	O
progression	O
in	O
rats	O
with	O
systematic	B-T169
identification	O
of	O
pharmacological	O
targets	B-T169
from	O
small-molecule	B-T109
phenotypic	O
screens	O
phenotypic	O
drug	O
discovery	O
offers	O
some	O
advantages	O
over	O
target	B-T169
-	O
based	B-T169
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	O
to	O
be	O
tested	B-T169
in	O
systems	B-T169
that	O
more	B-T081
closely	B-T033
model	O
distinct	B-T080
disease	B-T033
states	I-T033
.	O
	
however	O
,	O
a	O
potential	B-T080
disadvantage	B-T080
is	O
the	O
difficulty	B-T080
of	O
linking	O
the	O
observed	B-T169
phenotype	O
to	O
a	O
specific	B-T080
cellular	O
target	B-T169
.	O
	
to	O
address	O
this	O
problem	B-T033
,	O
we	O
developed	B-T169
depick	O
,	O
a	O
computational	O
target	O
de-convolution	O
tool	O
to	O
determine	O
targets	B-T169
specifically	B-T080
linked	O
to	O
small-molecule	B-T109
phenotypic	O
screens	O
.	O
	
we	O
applied	B-T169
depick	O
to	O
eight	O
publicly	O
available	O
screens	O
and	O
predicted	B-T078
59	O
drug	O
target	B-T169
-	O
phenotype	O
associations	B-T080
.	O
	
in	O
addition	O
to	O
literature	O
-	O
based	B-T169
evidence	B-T078
for	O
our	O
predictions	B-T078
,	O
we	O
provide	O
experimental	B-T080
support	O
for	O
seven	O
predicted	B-T078
associations	B-T080
.	O
	
interestingly	O
,	O
our	O
analysis	O
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	B-T079
unrecognized	B-T080
connection	O
between	O
the	O
wnt	O
signaling	O
pathway	O
and	O
an	O
aromatase	B-T116
,	O
cyp19a1	B-T116
.	O
	
these	O
results	B-T033
demonstrate	B-T080
that	O
the	O
depick	O
approach	O
can	O
not	O
only	O
accelerate	B-T169
target	B-T169
de-convolution	O
but	O
also	O
aid	B-T080
in	O
discovery	O
of	O
new	O
functionally	B-T169
relevant	B-T080
biological	B-T080
relationships	B-T080
.	O
	
'	O
yarn	O
with	O
me'	O
applying	O
clinical	O
yarning	O
to	O
improve	O
clinician	O
-	O
patient	O
communication	O
in	O
aboriginal	O
health	O
care	O
although	O
successful	O
communication	O
is	O
at	O
the	O
heart	O
of	O
the	O
clinical	O
consultation	O
,	O
communication	O
between	O
aboriginal	O
patients	O
and	O
practitioners	O
such	O
as	O
doctors	O
,	O
nurses	O
and	O
allied	O
health	O
professionals	O
,	O
continues	O
to	O
be	O
problematic	B-T033
and	O
is	O
arguably	O
the	O
biggest	O
barrier	O
to	O
the	O
delivery	O
of	O
successful	O
health	O
care	O
to	O
aboriginal	O
people	O
.	O
	
this	O
paper	O
presents	O
an	O
overarching	O
framework	O
for	O
practitioners	O
to	O
help	O
them	O
reorientate	O
their	O
communication	O
with	O
aboriginal	O
patients	O
using	O
'	O
clinical	O
yarning	O
'	O
.	O
	
clinical	O
yarning	O
is	O
a	O
patient	O
-centred	O
approach	O
that	O
marries	O
aboriginal	O
cultural	O
communication	O
preferences	O
with	O
biomedical	O
understandings	O
of	O
health	O
and	O
disease	O
.	O
	
clinical	O
yarning	O
consists	O
of	O
three	O
interrelated	O
areas	O
the	O
social	B-T169
yarn	O
,	O
in	O
which	O
the	O
practitioner	O
aims	O
to	O
find	O
common	O
ground	O
and	O
develop	O
the	O
interpersonal	O
relationship	O
the	O
diagnostic	B-T169
yarn	O
,	O
in	O
which	O
the	O
practitioner	O
facilitates	O
the	O
patient's	O
health	B-T078
story	I-T078
while	O
interpreting	O
it	O
through	O
a	O
biomedical	O
or	O
scientific	O
lens	O
and	O
the	O
management	O
yarn	O
,	O
that	O
employs	B-T078
stories	I-T078
and	O
metaphors	B-T078
as	O
tools	O
for	O
patients	O
to	O
help	O
them	O
understand	O
a	O
health	B-T033
issue	I-T033
so	O
a	O
collaborative	O
management	O
approach	O
can	O
be	O
adopted	O
.	O
	
there	O
is	O
cultural	B-T169
and	O
research	O
evidence	B-T078
that	O
supports	O
this	O
approach	O
.	O
	
clinical	O
yarning	O
has	O
the	O
potential	O
to	O
improve	O
outcomes	B-T169
for	O
patients	O
and	O
effect	O
of	O
single-dose	O
carbapenem	B-T109
exposure	B-T033
on	O
transcriptional	O
expression	O
of	O
blandm-1	O
and	O
mexa	O
in	O
pseudomonas	O
aeruginosa	O
the	O
therapeutic	B-T169
option	I-T169
of	O
a	O
carbapenem	B-T109
antibiotic	I-T109
is	O
compromised	O
in	O
pseudomonas	O
aeruginosa	O
owing	O
both	O
to	O
acquired	O
and	O
intrinsic	O
resistance	O
mechanisms	O
.	O
	
in	O
recent	O
years	O
,	O
new	B-T116
delhi	I-T116
metallo-β-lactamase	I-T116
has	O
been	O
the	O
focus	O
as	O
a	O
predominant	O
carbapenem	O
resistance	O
determinant	O
.	O
	
however	O
,	O
it	O
is	O
unclear	O
which	O
of	O
the	O
mechanisms	O
might	O
be	O
adopted	O
by	O
a	O
p	O
.	O
	
aeruginosa	O
strain	O
possessing	O
both	O
blandm-1	O
and	O
an	O
overexpressed	O
mexab-oprm	O
system	O
during	O
carbapenem	B-T109
therapy	B-T061
.	O
	
this	O
study	O
investigated	O
the	O
interplay	O
of	O
both	O
mechanisms	O
in	O
clinical	O
isolates	O
of	O
p	O
.	O
	
aeruginosa	O
when	O
exposed	O
to	O
meropenem	B-T109
.	O
	
five	O
strains	O
were	O
used	O
i	O
strain	O
overexpressing	O
mexab-oprm	O
but	O
with	O
no	B-T169
blandm-1	O
ii	O
strain	O
harbouring	O
blandm-1	O
but	O
expressing	O
mexab-oprm	O
at	O
basal	O
level	O
iii	O
strain	O
possessing	O
blandm-1	O
and	O
overexpressing	O
mexab-oprm	O
iv	O
p	O
.	O
	
aeruginosa	O
pao1	O
and	O
v	O
p	O
.	O
	
aeruginosa	O
k2733-pao1	O
δmexab-oprm	O
δmexcd-oprj	O
δmexef-oprn	O
δmexxy-oprm	O
into	O
which	O
blandm-1	O
was	O
cloned	O
.	O
	
strains	O
were	O
incubated	O
in	O
luria-bertani	O
broth	O
with	O
and	O
without	O
1μg/ml	O
meropenem	B-T109
.	O
	
total	O
rna	O
was	O
isolated	O
at	O
45-min	O
intervals	O
and	O
was	O
immediately	O
reverse	O
transcribed	O
to	O
cdna	O
.	O
	
this	O
was	O
repeated	O
for	O
6h	O
.	O
	
quantitative	O
real-time	O
pcr	O
was	O
performed	O
for	O
both	O
resistance	O
mechanisms	O
.	O
	
meropenem	B-T109
exposure	B-T033
did	O
not	O
significantly	O
elevate	O
transcription	O
of	O
either	O
the	O
blandm-1	O
or	O
mexa	O
gene	O
.	O
	
however	O
,	O
an	O
interesting	O
finding	O
was	O
that	O
upon	O
single-dose	O
exposure	B-T033
to	I-T033
carbapenem	I-T033
,	O
the	O
efflux	O
pump	O
system	O
played	O
a	O
major	O
role	B-T169
in	I-T169
bacterial	I-T169
survival	I-T169
compared	O
with	O
ndm-1	B-T116
.	O
	
this	O
study	O
gives	O
an	O
insight	O
into	O
the	O
bacterial	O
response	O
to	O
carbapenem	O
antibiotic	O
when	O
two	O
different	O
resistance	O
mechanisms	O
coexist	O
.	O
	
this	O
type	O
of	O
study	O
would	O
be	O
helpful	O
in	O
designing	O
future	O
inducible	B-T169
expression	O
of	O
both	O
ermb	O
and	O
ermt	O
conferred	O
high	B-T080
macrolide	B-T033
resistance	I-T033
in	O
streptococcus	O
gallolyticus	O
subsp	O
.	O
	
pasteurianus	O
isolates	O
in	O
china	O
streptococcus	O
gallolyticus	O
subsp	O
.	O
	
pasteurianus	O
is	O
an	O
under-recognized	O
pathogen	O
and	O
zoonotic	O
agent	O
causing	O
opportunistic	B-T047
infections	I-T047
in	O
humans	O
.	O
	
despite	O
increasing	O
recognition	B-T080
of	O
this	O
subspecies	O
as	O
a	O
cause	O
for	O
human	O
infectious	B-T047
diseases	I-T047
,	O
limited	O
information	O
is	O
known	O
about	O
its	O
antibiotic	O
resistance	O
mechanism	B-T169
.	O
	
in	O
this	O
study	O
,	O
we	O
aim	O
to	O
identify	O
the	O
molecular	O
mechanism	O
underlying	O
the	O
high	O
macrolide	B-T033
resistance	I-T033
of	O
six	O
s	O
.	O
	
gallolyticus	O
subsp	O
.	O
	
pasteurianus	O
isolates	O
from	O
dead	B-T033
ducklings	O
collected	O
in	O
several	O
natural	O
outbreaks	O
in	O
china	O
during	O
2010-2013	O
.	O
	
all	O
isolates	O
exhibited	O
multi-drug	O
resistance	O
including	O
high	O
macrolide	B-T033
resistance	I-T033
mic	O
1024	O
mg/l	O
for	O
erythromycin	O
,	O
and	O
512	O
mg/l	O
for	O
clarithromycin	O
.	O
	
efflux-encoding	O
mefa	O
and	O
mefe	O
genes	O
were	O
not	O
detectable	O
in	O
these	O
isolates	O
.	O
	
the	O
presence	O
of	O
23s	O
rrna	O
mutations	O
in	O
specific	O
isolates	O
did	O
not	O
significantly	O
change	O
macrolide	O
mic	O
s	O
.	O
	
no	O
nucleotide	O
substitutions	O
were	O
found	O
in	O
genes	O
encoding	O
ribosomal	O
proteins	O
l4	O
or	O
l22	O
.	O
	
the	O
ermb	O
and	O
ermt	O
genes	O
were	O
found	O
in	O
the	O
genomes	O
of	O
all	O
isolates	O
.	O
	
these	O
two	O
genes	O
were	O
acquired	O
independently	O
in	O
one	O
highly	O
virulent	O
isolate	O
al101002	O
,	O
and	O
clustered	O
with	O
tn916	O
and	O
is1216	O
,	O
respectively	O
.	O
	
the	O
expression	O
of	O
both	O
ermb	O
and	O
ermt	O
in	O
all	O
isolates	O
was	O
erythromycin	B-T109
inducible	O
and	O
yielded	O
comparable	O
macrolide	O
mics	O
in	O
all	O
six	O
isolates	O
.	O
	
taken	O
together	O
,	O
inducible	O
expression	O
of	O
both	O
ermb	O
and	O
ermt	O
conferred	O
high	O
macrolide	O
resistance	O
in	O
these	O
s	O
.	O
	
gallolyticus	O
subsp	O
.	O
	
pasterianus	O
isolates	O
.	O
	
our	O
findings	O
reveal	O
new	O
macrolide	O
resistance	O
features	O
in	O
s	O
.	O
	
gallolyticus	O
subsp	O
.	O
	
pasteurianus	O
by	O
both	O
ermb	O
and	O
ermt	O
bilateral	O
c1	O
laminar	O
hooks	O
combined	O
with	O
c2	O
pedicle	O
screw	O
fixation	B-T061
in	O
the	O
treatment	B-T061
of	O
atlantoaxial	O
subluxation	O
after	O
grisel	B-T047
syndrome	I-T047
many	O
etiologies	B-T169
can	O
lead	O
to	O
atlantoaxial	O
subluxaion	O
.	O
	
in	O
grisel	B-T047
syndrome	I-T047
gs	B-T047
,	O
this	O
subluxation	O
occurs	O
spontaneously	B-T169
after	O
inflammatory	B-T169
processes	O
of	O
the	O
head	O
and	O
neck	O
.	O
	
diagnosis	B-T033
is	O
typically	O
based	O
on	O
clinical	B-T033
history	I-T033
and	O
a	O
strong	O
suspicion	O
of	O
this	O
syndrome	B-T047
.	O
	
nonsurgical	B-T061
treatment	I-T061
most	O
often	O
resolves	O
the	O
symptoms	O
however	O
,	O
in	O
some	O
cases	B-T169
surgical	B-T061
treatment	I-T061
is	O
necessary	O
to	O
repair	B-T061
the	O
subluxation	O
.	O
	
various	O
surgical	O
techniques	O
and	O
instrumentation	O
systems	O
have	O
been	O
used	O
to	O
treat	B-T061
atlantoaxial	O
subluxation	O
,	O
although	O
there	O
is	O
no	O
consensus	O
regarding	O
the	O
best	O
treatment	B-T061
method	I-T061
for	O
the	O
pediatric	B-T080
population	O
.	O
	
to	O
describe	O
a	O
case	B-T169
of	O
atlantoaxial	O
subluxation	O
in	O
a	O
child	O
with	O
gs	B-T047
treated	B-T033
surgically	B-T061
with	O
an	O
alternative	O
construct	O
.	O
	
this	O
is	O
a	O
case	O
report	O
and	O
literature	O
review	O
.	O
	
our	O
case	O
study	O
involves	O
a	O
5-	O
year	B-T079
-old	O
girl	O
with	O
a	O
6-	O
month	B-T079
history	B-T033
of	O
unresolved	B-T080
fielding	O
type	O
ii	O
atlantoaxial	O
subluxation	O
caused	O
by	O
gs	B-T047
.	O
	
despite	O
conservative	B-T061
treatment	I-T061
,	O
the	O
patient's	O
symptoms	O
continued	B-T078
to	O
progress	B-T169
.	O
	
after	O
two	O
failed	B-T169
closed	B-T061
reduction	I-T061
attempts	O
,	O
open	B-T061
reduction	I-T061
and	O
c1-c2	B-T061
fusion	I-T061
were	O
performed	B-T169
with	O
atlas	O
laminar	O
hook	O
and	O
axis	O
pedicle	O
polyaxial	O
screws	O
.	O
	
a	O
literature	O
review	O
of	O
the	O
surgical	B-T061
treatment	I-T061
of	O
gs	B-T047
was	O
also	O
performed	B-T169
.	O
	
after	O
surgery	B-T169
,	O
the	O
patient	O
exhibited	O
full	O
clinical	B-T080
and	O
functional	O
recovery	O
with	O
complete	O
resolution	O
of	O
symptoms	O
.	O
	
at	O
the	O
36-	O
month	B-T079
follow-up	O
examination	O
,	O
there	O
was	O
continual	B-T079
evidence	B-T078
of	O
satisfactory	B-T033
reduction	B-T061
and	O
fusion	B-T061
.	O
	
no	O
complications	O
were	O
observed	B-T169
.	O
	
upon	O
completion	B-T080
of	O
the	O
literature	O
review	O
,	O
eight	O
gs	B-T047
cases	B-T169
were	O
found	O
to	O
have	O
been	O
treated	B-T169
surgically	B-T061
with	O
the	O
minimum	O
patient	O
age	O
being	O
9	O
years	B-T079
.	O
	
conservative	B-T061
management	I-T061
of	O
gs	B-T047
is	O
the	O
most	O
common	B-T081
and	O
effective	B-T080
treatment	B-T061
however	O
,	O
a	O
few	O
surgical	B-T169
cases	I-T169
have	O
been	O
reported	O
in	O
the	O
literature	O
with	O
good	O
results	B-T169
.	O
	
satisfactory	B-T033
clinical	B-T033
results	I-T033
and	O
fusion	B-T061
at	O
36	O
months	B-T079
post	B-T033
surgery	I-T033
were	O
seen	O
in	O
a	O
pediatric	B-T080
patient	O
with	O
atlantoaxial	O
subluxation	O
and	O
instability	B-T033
using	O
atlas	O
laminar	O
hook	O
and	O
axis	O
pedicle	O
polyaxial	O
screws	O
.	O
	
caries	B-T047
with	O
dental	B-T047
fluorosis	I-T047
and	O
oral	O
health	O
behaviour	O
among	O
12-year	B-T079
school	O
children	O
in	O
moderate-fluoride	O
drinking	O
water	O
community	O
in	O
quetta	O
,	O
pakistan	O
to	O
determine	O
the	O
prevalence	B-T081
of	O
dental	B-T047
caries	I-T047
and	O
its	O
relationship	B-T080
with	O
dental	B-T047
fluorosis	I-T047
,	O
oral	O
health	O
behaviour	O
and	O
dietary	B-T033
behaviour	I-T033
among	O
12-year	B-T079
school	O
children	O
in	O
moderate-fluoride	O
drinking	O
water	O
community	O
in	O
quetta	O
,	O
pakistan	O
.	O
	
cross-sectional	O
study	O
.	O
	
government	O
and	O
private	O
schools	O
of	O
quetta	O
,	O
from	O
november	B-T079
2012	O
to	O
february	B-T080
2013	O
.	O
	
atotal	O
of	O
349	O
children	O
aged	O
12-year	B-T079
from	O
14	O
randomly	O
selected	O
schools	O
were	O
included	O
.	O
	
the	O
data	O
collection	O
was	O
done	O
on	O
questionnaire	O
designed	O
for	O
children	O
.	O
	
dental	B-T047
caries	I-T047
status	B-T080
was	O
examined	O
by	O
using	O
who	O
criteria	O
.	O
	
dental	O
caries	O
was	O
found	O
in	O
81	O
children	O
23.2	O
with	O
mean	O
dmft	O
0.61	O
.	O
	
boys	O
had	O
1.6	O
times	O
more	O
chance	O
to	O
have	O
dental	O
caries	O
than	O
girls	O
.	O
	
dental	O
fluorosis	O
was	O
found	O
in	O
63.6	O
of	O
children	O
with	O
majority	O
of	O
moderate	O
degree	O
50.5	O
.	O
	
dental	O
fluorosis	O
status	B-T080
was	O
found	O
significantly	O
associated	O
with	O
dental	O
caries	O
status	O
in	O
children	O
.	O
	
the	O
children	O
who	O
had	O
mild	O
,	O
moderate	O
and	O
severe	O
fluorosis	O
,	O
had	O
4	O
times	O
more	O
chances	O
to	O
develop	O
caries	O
than	O
those	O
who	O
did	O
not	O
have	O
fluorosis	O
.	O
	
there	O
was	O
no	O
significant	O
association	O
between	O
children's	O
caries	O
status	O
and	O
use	O
of	O
paste	O
,	O
brushing	O
habit	O
,	O
miswak	O
,	O
and	O
visit	O
to	O
the	O
dentist	O
.	O
	
the	O
use	O
of	O
pastries	O
and	O
juices	O
had	O
a	O
direct	O
relation	O
with	O
the	O
children's	O
dental	O
caries	O
status	O
.	O
	
dental	O
caries	O
in	O
children	O
of	O
quetta	O
is	O
not	O
so	O
much	O
frequent	O
as	O
compared	O
to	O
the	O
fluoride	O
deficient	O
countries	O
.	O
	
however	O
,	O
the	O
high	O
prevalence	O
of	O
moderate	O
dental	O
fluorosis	O
and	O
consumption	O
of	O
pastries	O
and	O
juices	O
resulted	O
in	O
dental	O
caries	I-T047
proteomics	B-T116
analysis	O
of	O
the	O
endogenous	B-T169
,	O
constitutive	O
,	O
leaf	O
sumoylome	O
sumoylation	O
is	O
a	O
post-translational	O
modification	O
which	O
regulates	O
a	O
number	O
of	O
critical	B-T080
biological	O
processes	O
in	O
,	O
for	O
example	O
mammals	O
,	O
yeast	O
and	O
plants	O
.	O
	
in	O
order	O
to	O
fully	O
understand	O
the	O
functional	B-T033
effects	I-T033
of	O
sumoylation	O
an	O
essential	B-T080
first	O
step	O
is	O
the	O
identification	O
of	O
endogenous	B-T169
targets	B-T169
for	O
sumoylation	O
.	O
	
here	O
we	O
report	O
the	O
results	B-T169
of	O
using	O
a	O
recently	O
developed	O
proteomic	O
approach	O
based	O
on	O
the	O
use	O
of	O
3d	O
gels	O
to	O
identify	O
the	O
endogenous	B-T169
sumo	B-T116
targets	B-T169
in	O
leaves	O
of	O
solanum	O
tuberosum	O
.	O
	
by	O
using	O
3d	O
gels	O
we	O
avoid	O
the	O
problem	O
of	O
co-migration	O
of	O
proteins	B-T116
,	O
which	O
is	O
a	O
major	B-T080
limitation	B-T169
of	O
2d	O
gels	O
,	O
and	O
we	O
enable	O
the	O
use	O
of	O
the	O
highly	B-T080
sensitive	I-T080
cydye	O
dige	O
fluor	O
saturation	O
dyes	O
.	O
	
using	O
this	O
new	O
method	O
we	O
have	O
identified	B-T080
39	O
individual	B-T116
proteins	I-T116
as	O
probable	B-T081
sumo	B-T116
targets	B-T169
in	O
leaves	O
of	O
solanum	O
tuberosum	O
.	O
	
the	O
advantages	O
of	O
this	O
method	O
compared	O
with	O
other	O
approaches	B-T169
are	O
discussed	O
,	O
and	O
possible	B-T033
future	B-T079
developments	B-T169
are	O
outlined	O
.	O
	
the	O
authors	O
have	O
no	O
conflicts	B-T078
of	I-T078
interest	I-T078
to	O
declare	O
.	O
	
all	O
authors	O
have	O
approved	B-T080
the	O
manuscript	O
and	O
agree	B-T033
with	O
submission	B-T169
to	O
journal	O
of	O
proteomics	O
.	O
	
antenatal	B-T079
consultation	O
following	B-T079
limb	O
malformation	O
discovery	O
using	O
ultrasound	O
scan	O
our	O
unit	O
has	O
been	O
providing	O
antenatal	B-T079
consultations	O
for	O
30	O
years	O
following	B-T079
the	O
discovery	O
of	O
limb	O
malformation	O
with	O
the	O
fetus	O
.	O
	
each	O
of	O
these	O
consultations	O
is	O
specific	B-T080
and	O
carried	O
out	O
by	O
a	O
multi-professional	O
team	O
.	O
	
it	O
requires	B-T169
a	O
physical	O
and	O
rehabilitation	O
doctor	O
,	O
an	O
orthopedic	O
surgeon	O
,	O
an	O
occupational	O
therapist	O
for	O
upper	O
limb	O
malformation	O
,	O
a	O
physiotherapist	O
for	O
lower	O
malformation	O
and	O
a	O
psychologist	O
.	O
	
this	O
multidisciplinary	O
consultation	O
is	O
unique	B-T080
because	O
of	O
each	O
pregnancy	O
story	O
,	O
because	O
of	O
each	O
patient	O
life	O
story	O
but	O
also	O
because	O
of	O
the	O
words	O
used	O
by	O
the	O
sonologist	O
when	O
announcing	O
the	O
diagnosis	B-T033
.	O
	
we	O
deal	O
with	O
couples	O
shocked	B-T033
by	O
the	O
prenatal	O
diagnosis	O
.	O
	
we	O
help	O
them	O
get	O
acceptance	O
of	O
the	O
child	O
to	O
be	O
born	O
and	O
to	O
forget	O
about	O
their	O
imaginary	O
child	O
.	O
	
medical	O
information	O
is	O
often	O
perceived	O
as	O
being	O
"""a"	O
surfeit	B-T080
of	O
information	B-T078
""""	O
difficult	B-T080
to	O
handle	O
by	O
the	O
couple	O
stunned	B-T033
by	O
the	O
overwhelming	B-T080
diagnosis	B-T033
.	O
	
we	O
must	O
stress	O
that	O
it	O
is	O
critical	B-T080
to	O
not	O
only	O
have	O
a	O
good	O
medical	B-T033
description	I-T033
of	O
the	O
malformations	O
and	O
potential	B-T061
treatments	I-T061
but	O
also	O
a	O
good	O
psychological	O
support	O
parents	O
personal	O
life	O
story	O
,	O
self-defense	O
mechanism	O
,	O
guilt	O
feeling	O
.	O
	
the	O
ethical	B-T078
aspect	I-T078
of	O
this	O
consultation	O
is	O
also	O
important	B-T080
.	O
	
team	O
members	O
must	O
be	O
as	O
neutral	O
as	O
possible	B-T033
in	O
their	O
assessments	O
in	O
order	O
to	O
let	O
the	O
couple	O
take	O
the	O
final	O
decision	O
the	O
continuation	B-T033
of	O
the	O
pregnancy	O
or	O
a	O
request	O
of	O
voluntary	O
termination	B-T061
of	I-T061
pregnancy	I-T061
.	O
	
these	O
prenatal	O
consultations	O
highlight	O
the	O
importance	B-T080
of	O
the	O
multidisciplinary	B-T080
global	B-T080
care	O
.	O
	
bending	O
rules	O
the	O
shape	O
of	O
the	O
perceptual	O
generalisation	O
gradient	B-T081
is	O
sensitive	B-T169
to	O
inference	O
rules	O
generalising	O
what	O
is	O
learned	O
about	O
one	O
stimulus	O
to	O
other	O
but	O
perceptually	O
related	O
stimuli	O
is	O
a	O
basic	O
behavioural	O
phenomenon	O
.	O
	
we	O
evaluated	O
whether	O
a	O
rule	O
learning	O
mechanism	B-T169
may	O
serve	O
to	O
explain	O
such	O
generalisation	O
.	O
	
to	O
this	O
end	O
,	O
we	O
assessed	O
whether	O
inference	O
rules	O
communicated	B-T033
through	O
verbal	O
instructions	O
affect	O
generalisation	O
.	O
	
expectancy	B-T078
ratings	O
,	O
but	O
not	O
valence	O
ratings	O
,	O
proved	O
sensitive	B-T169
to	O
this	O
manipulation	O
.	O
	
in	O
addition	O
to	O
revealing	O
a	O
role	O
for	O
inference	O
rules	O
in	O
generalisation	O
,	O
our	O
study	O
has	O
clinical	B-T080
implications	B-T169
as	O
well	O
.	O
	
more	O
specifically	O
,	O
we	O
argue	O
that	O
targeting	B-T169
inference	O
rules	O
might	O
prove	O
to	O
be	O
an	O
effective	O
strategy	O
to	O
affect	O
the	O
excessive	B-T080
generalisation	O
that	O
is	O
often	O
observed	O
in	O
neuroticism	O
and	O
fatigue	O
3	B-T079
months	I-T079
after	O
ischemic	B-T047
stroke	I-T047
a	O
cross-sectional	O
study	O
to	O
examine	B-T033
the	O
relation	O
between	O
neuroticism	O
and	O
fatigue	O
in	O
chinese	O
patients	O
with	O
stroke	B-T047
.	O
	
cross-sectional	O
study	O
.	O
	
acute	B-T079
stroke	O
unit	O
.	O
	
survivors	O
of	O
ischemic	B-T047
stroke	I-T047
n=191	O
recruited	O
from	O
the	O
acute	B-T079
stroke	O
unit	O
between	O
may	O
1	O
,	O
2010	O
,	O
and	O
september	O
1	O
,	O
2011	O
.	O
	
not	O
applicable	O
.	O
	
the	O
personality	B-T033
trait	I-T033
of	O
neuroticism	O
was	O
measured	B-T080
with	O
the	O
neuroticism	O
subscale	B-T081
of	O
the	O
chinese	O
version	O
of	O
the	O
neo	O
five-factor	O
inventory	O
.	O
	
the	O
level	B-T080
of	O
fatigue	O
was	O
measured	B-T080
with	O
the	O
fatigue	O
assessment	O
scale	O
.	O
	
the	O
national	O
institutes	O
of	O
health	O
stroke	O
scale	O
,	O
geriatric	O
depression	O
scale	O
,	O
barthel	O
index	O
,	O
and	O
mini-mental	O
state	O
examination	O
were	O
administered	B-T169
to	O
obtain	O
demographic	O
and	O
clinical	O
information	O
.	O
	
fatigue	O
severity	O
3	B-T079
months	I-T079
after	O
stroke	B-T047
positively	O
correlated	B-T080
with	O
geriatric	O
depression	O
scale	O
and	O
neo	O
five-factor	O
inventory	O
neuroticism	O
scores	B-T081
and	O
negatively	B-T033
correlated	B-T080
with	O
the	O
barthel	B-T081
index	I-T081
score	I-T081
.	O
	
neuroticism	O
,	O
independent	B-T033
of	O
depressive	O
symptoms	O
,	O
is	O
a	O
predictor	O
of	O
fatigue	O
severity	O
3	B-T079
months	I-T079
after	O
stroke	B-T047
.	O
	
interventions	O
such	O
as	O
psychological	B-T169
screening	B-T169
programs	I-T169
are	O
warranted	O
for	O
early	O
detection	B-T061
of	O
patients	O
at	O
high	B-T033
risk	I-T033
of	I-T033
poststroke	B-T047
depression	I-T047
.	O
	
hematological	B-T033
,	O
biochemical	B-T033
,	O
and	O
toxicopathic	B-T033
effects	I-T033
of	O
subchronic	B-T080
acetamiprid	B-T109
toxicity	O
in	O
wistar	O
rats	O
acetamiprid	B-T109
is	O
one	O
of	O
the	O
most	O
widely	O
used	O
neonicotinoids	O
.	O
	
this	O
study	O
investigates	B-T169
toxic	O
effects	O
of	O
repeated	O
oral	B-T169
administration	I-T169
of	O
three	O
doses	B-T081
of	O
acetamiprid	B-T109
1/20	O
,	O
1/10	O
,	O
and	O
1/5	O
of	O
ld50	B-T081
during	O
60	O
days	B-T079
.	O
	
for	O
this	O
,	O
male	O
wistar	O
rats	O
were	O
divided	O
into	O
four	O
different	O
groups	B-T078
.	O
	
hematological	B-T033
,	O
biochemical	B-T033
,	O
and	O
toxicopathic	B-T033
effects	I-T033
of	O
acetamiprid	B-T109
were	O
evaluated	O
.	O
	
according	O
to	O
the	O
results	O
,	O
a	O
significant	O
decrease	B-T081
in	O
the	O
body	B-T033
weight	I-T033
gain	I-T033
at	O
the	O
highest	O
dose	B-T081
1/5	O
of	O
ld50	B-T081
of	O
acetamiprid	B-T109
was	O
noticed	O
.	O
	
an	O
increase	B-T169
in	O
the	O
relative	O
liver	O
weight	B-T081
was	O
also	O
observed	O
at	O
this	O
dose	B-T081
level	B-T080
.	O
	
the	O
hematological	O
constituents	O
were	O
affected	O
.	O
	
a	O
significant	O
decrease	B-T081
in	O
rbc	O
,	O
hgb	B-T116
,	O
and	O
hct	B-T033
in	O
rats	O
treated	B-T169
with	O
higher	O
doses	B-T081
of	O
acetamiprid	B-T109
1/10	O
and	O
1/5	O
of	O
ld50	B-T081
was	O
noted	O
.	O
	
however	O
,	O
a	O
significant	O
increase	B-T169
in	O
wbc	O
and	O
plt	O
were	O
observed	O
at	O
the	O
same	O
doses	B-T081
.	O
	
furthermore	O
,	O
acetamiprid	B-T109
induced	B-T047
liver	I-T047
toxicity	I-T047
measured	O
by	O
the	O
increased	B-T081
activities	O
of	O
aspartate	B-T116
aminotransferase	I-T116
ast	B-T116
,	O
alanine	B-T116
aminotransferase	I-T116
alt	B-T116
,	O
alkaline	B-T116
phosphates	I-T116
alps	B-T116
,	O
and	O
lactate	B-T116
dehydrogenase	I-T116
ldh	B-T116
which	O
may	O
be	O
due	O
to	O
the	O
loss	B-T081
of	O
hepatic	O
membrane	O
architecture	O
and	O
hepatocellular	O
damage	O
.	O
	
in	O
addition	O
,	O
exposure	B-T080
to	I-T080
acetamiprid	B-T109
resulted	O
in	O
a	O
significant	O
decrease	B-T081
in	O
the	O
levels	B-T080
of	O
superoxide	B-T116
dismutase	I-T116
and	O
catalase	B-T116
activities	O
p	O
0.01	O
with	O
concomitant	B-T079
increase	B-T169
in	O
lipid	O
peroxidation	O
in	O
rat	O
liver	O
.	O
	
these	O
findings	B-T033
highlight	O
the	O
subchronic	B-T080
hepatotoxicity	O
of	O
sustained	O
delivery	O
of	O
vincristine	B-T109
inside	O
an	O
orthotopic	O
mouse	O
sarcoma	O
model	O
decreases	B-T081
tumor	O
growth	O
sarcoma	O
accounts	O
for	O
20%	O
of	O
solid	O
tumors	O
in	O
children	O
.	O
	
surgery	B-T061
has	O
significant	O
morbidity	B-T081
.	O
	
we	O
hypothesized	O
that	O
delivering	O
chemotherapy	B-T061
directly	O
into	O
tumors	O
through	O
sustained	O
release	O
silk	B-T116
systems	O
could	O
slow	O
tumor	O
growth	O
.	O
	
human	O
ewing	O
sarcoma	O
cells	O
a673	O
were	O
cultured	O
with	O
vincristine	B-T109
and	O
doxorubicin	B-T109
to	O
determine	O
half	B-T081
maximal	I-T081
inhibitory	I-T081
concentration	I-T081
ic50	B-T081
.	O
	
cells	O
were	O
injected	O
into	O
mouse	O
hind	O
leg	O
to	O
create	O
orthotopic	O
tumors	O
.	O
	
tumor	B-T081
volumes	I-T081
were	O
measured	O
using	O
ultrasound	O
.	O
	
when	O
volume	O
reached	O
>250mm	O
interventions	B-T061
included	O
implantation	B-T061
of	O
drug-free	O
silk	B-T116
foam	O
control	O
-f	O
,	O
doxorubicin	B-T109
400μg	O
foam	O
dox400	B-T109
-f	O
,	O
vincristine	B-T109
50μg	O
foam	O
vin50	B-T109
-f	O
,	O
drug-free	O
silk	B-T116
gel	O
control	O
-g	O
,	O
vincristine	B-T109
50μg	O
gel	O
vin50	B-T109
-g	O
,	O
or	O
single	O
dose	O
intravenous	O
vincristine	B-T109
50μg	O
vin50	B-T109
-iv	O
.	O
	
end-point	B-T080
was	O
volume>1000mm	O
.	O
	
kaplan	B-T081
meier	I-T081
and	O
anova	B-T081
were	O
used	O
.	O
	
ic50	B-T081
for	O
vincristine	B-T109
and	O
doxorubicin	B-T109
was	O
0.5ng	O
and	O
200ng/ml	O
,	O
respectively	O
.	O
	
there	O
was	O
no	O
difference	O
between	O
dox400	B-T109
-f	O
6	O
1days	B-T079
to	O
end	B-T080
point	I-T080
dtep	B-T080
and	O
control	O
-f	O
5	O
dtep	B-T080
.	O
	
vin50	B-T109
-f	O
12.4	O
dtep	B-T080
had	O
slower	B-T033
growth	I-T033
compared	O
to	O
control	O
-f	O
p<0	O
,	O
and	O
there	O
was	O
no	O
difference	O
between	O
vin50	B-T109
-f	O
and	O
vin50	B-T109
-iv	O
14	O
dtep	B-T080
.	O
	
growth	B-T033
was	I-T033
slowest	I-T033
with	O
vin50	B-T109
-g	O
,	O
28	O
dtep	B-T080
compared	O
to	O
all	O
other	O
treatment	O
groups	O
p<0	O
.	O
	
sustained	O
delivery	O
of	O
vincristine	B-T109
inside	O
the	O
sarcoma	O
tumor	O
with	O
silk	B-T116
gel	O
decreased	B-T081
tumor	O
growth	O
.	O
	
applying	O
this	O
intratumoral	B-T061
treatment	I-T061
strategy	O
may	O
potentially	O
decrease	B-T081
the	O
extent	O
of	O
surgical	B-T061
excision	I-T061
.	O
	
spinal	O
load	O
in	O
nurses	O
during	O
emergency	O
lifting	O
of	O
obese	B-T047
patients	O
preliminary	B-T078
results	I-T078
nurses	O
are	O
exposed	O
to	O
the	O
risk	B-T078
of	O
injury	O
while	O
handling	B-T033
patients	O
.	O
	
this	O
is	O
particularly	O
true	O
for	O
obese	B-T047
patients	O
.	O
	
the	O
goal	O
of	O
this	O
paper	O
is	O
to	O
estimate	B-T081
the	O
spinal	O
loads	O
and	O
the	O
related	O
risk	B-T078
of	O
injury	O
to	O
nurses	O
while	O
lifting	O
obese	B-T047
patients	O
from	O
the	O
floor	O
with	O
a	O
bariatric	O
sheet	O
during	O
a	O
hospital	O
emergency	O
.	O
	
six	O
male	O
nurses	O
participated	O
in	O
this	O
study	O
.	O
	
the	O
biomechanical	O
analysis	O
focused	O
on	O
the	O
lifting	O
strategy	O
.	O
	
thirty	O
obese	B-T047
in-patients	O
were	O
enrolled	O
to	O
take	O
part	O
in	O
the	O
experimental	O
study	O
and	O
divided	O
into	O
three	O
groups	B-T078
according	O
to	O
their	O
body	O
mass	O
index	O
bmi	O
.	O
	
three-dimensional	O
motion	O
analysis	O
was	O
conducted	O
using	O
an	O
optoelectronic	O
system	O
.	O
	
the	O
trunk	O
kinematics	O
and	O
the	O
loading	O
on	O
the	O
spines	O
of	O
the	O
operating	O
nurses	O
were	O
computed	O
.	O
	
our	O
data	B-T078
showed	O
that	O
when	O
the	O
nurse	O
was	O
operating	O
from	O
the	O
central	O
handle	O
,	O
his	O
trunk	O
was	O
more	O
flexed	O
at	O
the	O
end	O
of	O
the	O
lift	O
with	O
a	O
reduced	B-T080
range	O
of	O
motion	O
.	O
	
the	O
values	B-T081
were	O
higher	B-T080
when	O
the	O
nurse	O
lifted	O
patients	O
with	O
higher	B-T080
bmis	O
.	O
	
all	O
kinetic	B-T081
parameters	I-T081
and	O
tension	O
in	O
the	O
lumbar	O
muscles	O
at	O
the	O
end	O
of	O
the	O
movement	O
were	O
characterised	O
by	O
lower	B-T080
values	B-T081
for	O
the	O
nurse	O
placed	O
beside	O
the	O
patient's	O
head	O
or	O
feet	O
if	O
compared	O
to	O
the	O
operator	O
positioned	O
beside	O
the	O
central	O
handle	O
in	O
all	O
patient	O
groups	O
.	O
	
our	O
preliminary	O
data	B-T078
suggest	O
that	O
only	O
the	O
reaction	O
load	O
on	O
the	O
spine	O
of	O
the	O
nurse	O
holding	O
the	O
central	O
handle	O
,	O
closest	O
to	O
the	O
patient's	O
centre	O
of	O
mass	O
,	O
seems	O
to	O
exceed	O
the	O
recommended	B-T078
safety	O
limits	B-T169
.	O
	
expectations	B-T078
for	O
the	O
methodology	B-T078
and	O
translation	O
of	O
animal	O
research	O
a	O
survey	O
of	O
the	O
general	O
public	O
,	O
medical	O
students	O
and	O
animal	O
researchers	O
in	O
north	O
america	O
to	O
determine	O
what	O
are	O
considered	O
acceptable	B-T080
standards	O
for	O
animal	O
research	O
ar	O
methodology	B-T078
and	O
translation	B-T081
rate	I-T081
to	O
humans	O
,	O
a	O
validated	O
survey	O
was	O
sent	O
to	O
a	O
a	O
sample	O
of	O
the	O
general	O
public	O
,	O
via	O
sampling	O
survey	O
international	O
ssi	O
canada	O
,	O
amazon	O
mechanical	O
turk	O
amt	O
usa	O
,	O
a	O
canadian	O
city	O
festival	O
cf	O
and	O
a	O
canadian	O
children's	O
hospital	O
ch	O
b	O
a	O
sample	O
of	O
medical	O
students	O
two	O
first-year	O
classes	O
and	O
c	O
a	O
sample	O
of	O
scientists	O
corresponding	O
authors	O
and	O
academic	O
paediatricians	O
.	O
	
there	O
were	O
1379	O
responses	O
from	O
the	O
general	O
public	O
sample	O
ssi	O
,	O
n	O
=	O
557	O
amt	O
,	O
n	O
=	O
590	O
cf	O
,	O
n	O
=	O
195	O
ch	O
,	O
n	O
=	O
102	O
,	O
205/330	O
62%	O
medical	O
student	O
responses	O
,	O
and	O
23/323	O
7%	O
,	O
too	O
few	O
to	O
report	O
scientist	O
responses	O
.	O
	
asked	O
about	O
methodological	O
quality	O
,	O
most	O
of	O
the	O
general	O
public	O
and	O
medical	O
student	O
respondents	O
expect	O
that	O
ar	O
is	O
of	O
high	B-T080
quality	I-T080
e.g	O
.	O
	
anaesthesia	B-T061
and	O
analgesia	B-T061
are	O
monitored	O
,	O
even	O
overnight	O
,	O
and	O
'humane'	O
euthanasia	O
,	O
optimal	B-T080
statistical	O
design	O
,	O
comprehensive	B-T080
literature	O
review	O
,	O
randomisation	O
and	O
blinding	O
,	O
are	O
performed	O
,	O
and	O
costs	B-T081
and	O
difficulty	O
are	O
not	O
acceptable	B-T080
justifications	B-T078
for	O
lower	B-T080
quality	I-T080
e.g	O
.	O
	
costs	B-T081
of	O
expert	O
consultation	O
,	O
or	O
more	O
laboratory	O
staff	O
.	O
	
asked	O
about	O
their	O
expectations	B-T078
of	O
translation	O
to	O
humans	O
of	O
toxicity	O
,	O
carcinogenicity	O
,	O
teratogenicity	O
and	O
treatment	B-T169
findings	B-T169
,	O
most	O
expect	O
translation	O
more	O
than	O
60%	O
of	O
the	O
time	O
.	O
	
if	O
translation	O
occurred	O
less	O
than	O
20%	O
of	O
the	O
time	O
,	O
a	O
minority	O
disagreed	O
that	O
this	O
would	O
"""significantly"	O
reduce	O
your	O
support	O
for	O
ar	O
""""	O
.	O
	
medical	O
students	O
were	O
more	O
supportive	O
of	O
ar	O
,	O
even	O
if	O
translation	O
occurred	O
less	O
than	O
20%	O
of	O
the	O
time	O
.	O
	
expectations	B-T078
for	O
ar	O
are	O
much	O
higher	O
than	O
empirical	B-T078
data	I-T078
predicting	B-T078
violence	O
and	O
recidivism	O
in	O
a	O
large	O
sample	O
of	O
males	O
on	O
probation	O
or	O
parole	O
this	O
study	O
evaluated	B-T078
the	O
utility	O
of	O
items	O
and	O
scales	O
from	O
the	O
iowa	O
violence	O
and	O
victimization	O
instrument	O
in	O
a	O
sample	O
of	O
1961	O
males	O
from	O
the	O
state	O
of	O
iowa	O
who	O
were	O
on	O
probation	O
or	O
released	B-T033
from	I-T033
prison	I-T033
to	O
parole	O
supervision	O
.	O
	
this	O
is	O
the	O
first	O
study	O
to	O
examine	O
the	O
potential	B-T080
of	O
the	O
iowa	O
violence	O
and	O
victimization	O
instrument	O
to	O
predict	B-T078
criminal	O
offenses	O
.	O
	
the	O
males	O
were	O
followed	O
for	O
30	O
months	B-T079
immediately	O
following	O
their	O
admission	B-T079
to	O
probation	O
or	O
parole	O
.	O
	
auc	B-T081
analyses	O
indicated	O
fair	O
to	O
good	O
predictive	B-T080
power	O
for	O
the	O
iowa	O
violence	O
and	O
victimization	O
instrument	O
for	O
charges	O
of	O
violence	O
and	O
victimization	O
,	O
but	O
chance	O
predictive	B-T080
power	O
for	O
drug	O
offenses	O
.	O
	
notably	O
,	O
both	O
scales	O
of	O
the	O
instrument	O
performed	O
equally	O
well	O
at	O
the	O
30-	O
month	B-T079
follow-up	O
.	O
	
items	O
on	O
the	O
iowa	O
violence	O
and	O
victimization	O
instrument	O
not	O
only	O
predicted	B-T078
violence	O
,	O
but	O
are	O
straightforward	O
to	O
score	O
.	O
	
violence	O
management	O
strategies	O
are	O
discussed	O
as	O
they	O
relate	O
to	O
the	O
current	B-T079
findings	B-T169
,	O
including	O
the	O
potential	B-T080
to	O
expand	O
the	O
measure	O
to	O
other	O
jurisdictions	O
and	O
prognostic	O
significance	O
of	O
non-hpv16	O
genotypes	O
in	O
oropharyngeal	O
squamous	O
cell	O
carcinoma	O
recent	O
studies	O
have	O
found	O
that	O
cases	O
with	O
oropharyngeal	O
squamous	O
cell	O
carcinoma	O
opscc	O
positive	O
for	O
hpv16	O
genotype	O
have	O
better	B-T080
overall	B-T081
survival	I-T081
compared	O
with	O
cases	O
positive	O
for	O
other	O
hpv	O
genotypes	O
.	O
	
we	O
sought	O
to	O
further	O
replicate	B-T080
these	O
studies	O
and	O
determine	O
if	O
this	O
relationship	O
is	O
modified	B-T080
by	I-T080
expression	O
of	O
p16	B-T116
tumor	I-T116
suppressor	I-T116
protein	I-T116
.	O
	
we	O
identified	O
238	O
opscc	O
cases	O
from	O
the	O
carolina	O
head	O
and	O
neck	O
cancer	O
study	O
chance	O
study	O
,	O
a	O
population	O
based	O
case-control	O
study	O
.	O
	
tumors	O
that	O
tested	O
positive	O
solely	O
for	O
hpv16	O
genotype	O
and	O
no	O
other	O
genotypes	O
with	O
pcr	O
were	O
classified	O
as	O
hpv16-positive	O
.	O
	
tumors	O
positive	O
for	O
any	O
other	O
high-risk	B-T033
hpv	O
genotype	O
were	O
classified	O
as	O
non-hpv16-positive	O
.	O
	
expression	O
of	O
p16	B-T116
in	O
the	O
tumor	O
was	O
determined	B-T080
with	O
immunohistochemistry	O
.	O
	
follow-up	O
time	O
was	O
calculated	O
from	O
the	O
date	B-T079
of	I-T079
diagnosis	I-T079
to	O
date	B-T079
of	I-T079
death	I-T079
or	O
december	O
31	O
,	O
2013	O
.	O
	
overall	B-T081
survival	I-T081
was	O
compared	O
with	O
the	O
kaplan-meier	B-T081
curves	I-T081
and	O
log-rank	B-T081
test	I-T081
.	O
	
hazard	B-T081
ratios	I-T081
hr	B-T081
adjusted	O
for	O
smoking	O
,	O
alcohol	O
use	O
,	O
sex	O
,	O
race	O
,	O
and	O
age	O
was	O
calculated	O
with	O
the	O
cox	B-T081
proportional	I-T081
hazard	I-T081
regression	I-T081
.	O
	
cases	O
with	O
hpv16-positive	O
opscc	O
had	O
better	B-T080
overall	B-T081
survival	I-T081
than	O
cases	O
with	O
non-hpv16-positive	O
opscc	O
log-rank	O
p-value	O
0.010	O
.	O
	
when	O
restricted	O
to	O
opscc	O
cases	O
positive	B-T033
for	O
p16	O
expression	O
,	O
the	O
same	O
trend	B-T079
continued	O
log-rank	O
p-value	O
0.002	O
.	O
	
in	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non-hpv16-positive	O
opscc	O
had	O
greater	B-T033
risk	I-T033
of	I-T033
death	B-T033
compared	O
to	O
cases	O
with	O
hpv16-positive	O
tumors	O
hr	B-T081
1.92	O
95%	O
ci	O
1.03	O
,	O
3.60	O
.	O
	
this	O
finding	B-T033
indicates	B-T033
that	O
hpv	O
genotyping	O
carries	O
valuable	O
prognostic	O
significance	O
in	O
addition	O
to	O
p16	B-T116
status	B-T080
and	O
future	O
survival	O
studies	O
of	O
opscc	O
should	O
take	O
into	O
account	O
differing	O
hpv	O
genotypes	O
.	O
	
randomized	O
trials	O
of	O
the	O
teen	O
outreach	O
program	O
in	O
louisiana	O
and	O
rochester	O
,	O
new	O
york	O
to	O
evaluate	O
the	O
teen	O
outreach	O
program	O
,	O
a	O
pregnancy	B-T061
prevention	I-T061
program	O
,	O
in	O
2	O
community	O
-based	O
settings	O
.	O
	
we	O
evaluated	O
the	O
teen	O
outreach	O
program	O
,	O
a	O
9-month	O
positive	O
youth	O
development	O
program	O
,	O
in	O
3	O
cohorts	O
of	O
youths	O
from	O
2012	O
to	O
2015	O
in	O
2	O
states	O
.	O
	
in	O
louisiana	O
,	O
7	O
agencies	O
participated	O
in	O
an	O
individualized	B-T080
randomized	O
controlled	O
trial	O
,	O
with	O
youths	O
randomly	O
assigned	O
to	O
a	O
treatment	B-T061
or	O
control	O
condition	O
.	O
	
fourteen	O
agencies	O
in	O
rochester	O
,	O
new	O
york	O
,	O
participated	O
in	O
a	O
cluster	B-T081
randomized	O
controlled	O
trial	O
.	O
	
we	O
found	O
no	B-T033
differences	I-T033
between	O
the	O
intervention	B-T061
and	O
control	O
youths	O
on	O
delay	B-T079
of	O
sexual	O
onset	B-T080
in	O
louisiana	O
adjusted	B-T081
odds	I-T081
ratio	I-T081
aor	B-T081
=	O
0.80	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
=	O
0.62	O
,	O
1.03	O
or	O
in	O
rochester	O
,	O
new	O
york	O
aor	B-T081
=	O
0.89	O
95%	O
ci	B-T081
=	O
0.45	O
,	O
1.77	O
,	O
or	O
for	O
sex	O
with	O
no	O
effective	O
means	O
of	O
birth	O
control	O
louisiana	O
,	O
aor	B-T081
=	O
1.18	O
95%	O
ci	B-T081
=	O
0.78	O
,	O
1.78	O
rochester	O
,	O
aor	B-T081
=	O
0.41	O
95%	O
ci	B-T081
=	O
0.13	O
,	O
1.27	O
after	O
controlling	O
for	O
relevant	O
covariates	B-T081
.	O
	
we	O
found	O
no	B-T033
short-term	B-T079
effects	B-T080
for	O
the	O
offer	O
of	O
the	O
intervention	B-T061
.	O
	
research	O
might	O
be	O
needed	O
for	O
the	O
long-term	O
and	O
intermediate	B-T080
impacts	I-T080
of	O
youth	O
development	O
programs	O
on	O
these	O
and	O
other	O
adolescent	O
risk	O
behaviors	O
.	O
	
a	O
single	O
session	O
of	O
exhaustive	O
exercise	O
markedly	O
decreases	B-T081
circulating	B-T169
levels	O
of	O
guanidinoacetic	B-T109
acid	I-T109
in	O
healthy	B-T080
men	O
and	O
women	O
we	O
evaluated	O
the	O
effects	B-T080
of	I-T080
exercise	O
on	O
circulating	B-T169
concentrations	B-T081
of	O
guanidinoacetic	B-T109
acid	I-T109
gaa	B-T109
and	O
creatine	B-T116
in	O
23	O
healthy	O
volunteers	O
subjected	O
to	O
running	O
to	O
exhaustion	O
and	O
free-weight	O
bench-press	O
to	O
volitional	O
failure	O
.	O
	
blood	O
was	O
taken	O
before	O
and	O
following	O
each	O
exercise	O
session	O
.	O
	
running	O
induced	B-T169
a	O
significant	O
decrease	B-T081
in	O
serum	O
gaa	B-T109
by	O
20.1	O
p	O
<	O
0.001	O
,	O
while	O
free-weight	O
exercise	O
reduced	B-T080
gaa	B-T109
by	O
11.7	O
p	O
<	O
0.001	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	O
gaa	B-T109
as	O
a	O
novel	O
biomarker	O
of	O
anti-helminthic	O
activity	B-T169
of	O
momordica	O
charantia	O
l	O
.	O
	
against	O
fasciola	O
hepatica	O
eggs	O
after	O
twelve	O
days	B-T079
of	O
incubation	O
in	B-T080
vitro	I-T080
fasciolosis	B-T047
,	O
a	O
parasitic	B-T047
disease	I-T047
caused	O
by	O
the	O
trematode	O
fasciola	O
hepatica	O
underreported	O
is	O
expanding	O
both	O
in	O
human	O
and	O
animal	O
population	O
,	O
throughout	O
the	O
world	O
.	O
	
the	O
constant	O
use	O
of	O
synthetic	O
drugs	O
to	O
treat	B-T061
this	O
condition	B-T047
has	O
led	O
to	O
the	O
natural	O
selection	O
of	O
resistant	B-T169
strains	O
of	O
the	O
parasite	O
.	O
	
hence	O
,	O
there	O
is	O
a	O
growing	O
focus	O
on	O
the	O
potential	O
anti-helminthic	O
properties	B-T169
of	O
medicinal	O
plants	O
and	O
phytopharmaceuticals	B-T109
.	O
	
the	O
current	O
study	O
assessed	O
the	O
potential	O
anti-fasciolicide	B-T169
action	O
of	O
momordica	O
charantia	O
leaf	O
extracts	O
and	O
fractions	B-T081
on	O
the	O
eggs	O
of	O
f	O
.	O
	
hepatica	O
parasites	O
.	O
	
the	O
lyophilized	B-T080
crude	O
extract	O
ce	O
of	O
m	O
.	O
	
charantia	O
leaves	O
and	O
its	O
sub-fractions	B-T081
,	O
obtained	O
from	O
liquid-liquid	O
partitioning	O
with	O
organic	B-T109
solvents	I-T109
,	O
were	O
analysed	O
by	O
high	O
performance	O
liquid	O
chromatography	O
hplc	O
,	O
suspended	B-T078
in	O
1%	O
dmso	B-T109
and	O
used	O
in	B-T080
in	O
vitro	I-T080
tests	O
.	O
	
quadruplicates	B-T081
of	O
50	O
f	O
.	O
	
hepatica	O
eggs	O
were	O
incubated	O
at	O
23	O
with	O
m	O
.	O
	
charantia	O
leaf	O
ce	O
in	O
different	O
concentrations	B-T081
.	O
	
after	O
12	O
days	B-T079
no	O
larvae	O
were	O
formed	O
in	O
eggs	O
incubated	O
with	O
ce	O
concentrations	B-T081
above	O
12.5mg	O
.	O
	
eggs	O
incubated	O
with	O
ce	O
sub-fractions	B-T081
at	O
concentrations	B-T081
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0.1	O
,	O
0.01μg	O
affected	B-T169
embryonic	O
development	O
,	O
with	O
n-butanol	B-T109
presenting	O
the	O
strongest	O
inhibition	O
of	O
miracidia	O
formation	B-T169
.	O
	
in	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90%	O
of	O
the	O
miracidia	O
hatched	O
in	O
the	O
control	O
experiments	O
using	O
0.03	O
dmso	B-T109
whereas	O
embryogenesis	O
was	O
completely	O
abolished	B-T079
with	O
any	O
concentration	B-T081
of	O
albendazole	B-T109
sulphoxide	I-T109
abz	B-T109
.	O
	
chemical	O
analysis	O
of	O
the	O
ce	O
and	O
sub-fractions	B-T081
revealed	O
a	O
prominent	O
presence	O
of	O
flavonoids	B-T109
.	O
	
hplc-ms	O
confirmed	O
quercetin	B-T109
to	O
be	O
one	O
of	O
the	O
main	O
flavonoids	B-T109
present	O
in	O
the	O
ce	O
and	O
the	O
n-butanol	B-T109
subfraction	B-T081
.	O
	
this	O
is	O
the	O
first	O
study	O
to	O
analyse	O
the	O
potential	O
anti-fasciolicide	B-T169
action	O
of	O
m	O
.	O
	
charantia	O
leaf	O
ce	O
and	O
dabigatran	B-T109
a	O
new	O
oral	B-T109
anticoagulant	I-T109
.	O
	
guidelines	O
to	O
follow	O
in	O
oral	B-T061
surgery	I-T061
procedures	I-T061
.	O
	
a	O
systematic	O
review	O
of	O
the	O
literature	O
dabigatran	B-T109
is	O
a	O
newly	O
commercialized	O
drug	O
that	O
is	O
replacing	O
other	O
anticoagulants	O
in	O
the	O
prevention	O
of	O
venous	B-T047
thromboembolism	I-T047
,	O
stroke	B-T047
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O
	
it	O
acts	O
directly	O
on	O
thrombin	B-T116
presenting	O
in	O
a	O
dynamic	O
and	O
predictable	O
way	O
,	O
which	O
does	O
not	O
require	O
monitoring	O
these	O
patients	O
.	O
	
therefore	O
,	O
we	O
consider	O
the	O
need	O
to	O
assess	O
whether	O
their	O
use	O
increases	B-T169
the	O
risk	B-T033
of	I-T033
bleeding	I-T033
involved	O
before	O
any	O
dental	B-T061
treatment	I-T061
.	O
	
we	O
performed	O
a	O
systematic	O
review	O
with	O
a	O
bibliographic	O
search	O
in	O
pubmed	O
/	O
medline	O
along	O
with	O
the	O
cochrane	O
library	O
.	O
	
we	O
excluded	O
articles	O
dealing	O
with	O
all	O
anticoagulants	O
other	O
than	O
dabigatran	B-T109
,	O
and	O
works	O
about	O
surgical	B-T061
treatments	I-T061
in	O
anatomical	O
locations	O
other	O
than	O
the	O
oral	O
cavity	O
.	O
	
we	O
included	O
a	O
total	O
of	O
13	O
papers	O
of	O
which	O
1	O
was	O
a	O
randomized	O
clinical	O
trial	O
,	O
9	O
narrative	O
literature	O
reviews	O
,	O
1	O
case	O
series	O
,	O
2	O
clinical	O
cases	O
and	O
1	O
expert	O
opinion	O
.	O
	
because	O
we	O
did	O
not	O
obtain	O
any	O
properly	O
designed	O
clinical	O
trials	O
,	O
we	O
were	O
unable	O
to	O
conduct	O
a	O
meta-analysis	O
.	O
	
currently	O
,	O
there	O
is	O
no	O
consensus	O
on	O
the	O
procedure	B-T061
to	O
be	O
followed	O
in	O
patients	O
taking	O
dabigatran	B-T109
.	O
	
however	O
,	O
all	O
authors	O
agree	O
to	O
treat	O
each	O
case	O
individually	O
in	O
accordance	O
to	O
the	O
risk	B-T078
of	O
embolism	O
,	O
postoperative	O
bleeding	O
and	O
renal	O
function	O
.	O
	
also	O
,	O
it	O
is	O
necessary	O
to	O
perform	O
minimally	O
invasive	B-T061
interventions	I-T061
,	O
and	O
take	O
the	O
appropriate	O
local	O
anti-hemolytic	B-T061
measures	I-T061
.	O
	
did	O
fidelis	O
projects	O
contribute	O
to	O
the	O
detection	B-T033
of	O
new	O
smear	O
-	O
positive	B-T033
pulmonary	B-T047
tuberculosis	I-T047
cases	O
in	O
china	O
setting	O
the	O
first	O
phase	O
of	O
the	O
fund	O
for	O
innovative	O
dots	O
expansion	O
through	O
local	O
initiatives	O
to	O
stop	O
tb	O
fidelis	O
projects	O
in	O
china	O
started	O
in	O
2003	O
.	O
	
objective	O
to	O
determine	O
whether	O
the	O
fidelis	O
projects	O
contribute	O
d	O
to	O
the	O
increased	B-T081
case	B-T169
detection	B-T033
rate	B-T081
for	O
new	O
smear	O
-	O
positive	B-T033
pulmonary	B-T047
tuberculosis	I-T047
ptb	B-T047
in	O
china	O
.	O
	
methods	O
we	O
compared	O
the	O
case	B-T081
notification	I-T081
rates	I-T081
cnrs	B-T081
in	O
the	O
intervention	B-T079
year	I-T079
with	O
those	O
of	O
the	O
previous	B-T079
year	B-T079
in	O
the	O
fidelis	O
areas	O
,	O
then	O
compared	O
the	O
difference	B-T080
between	O
the	O
cnrs	B-T081
of	O
the	O
intervention	B-T079
year	I-T079
and	O
the	O
previous	B-T079
year	B-T079
in	O
the	O
fidelis	O
areas	O
with	O
those	O
in	O
the	O
non-fi-delis	B-T033
areas	O
within	O
the	O
province	O
.	O
	
results	O
there	O
was	O
an	O
increase	B-T169
in	O
the	O
cnr	B-T081
in	O
the	O
intervention	B-T079
year	I-T079
compared	O
with	O
the	O
previous	B-T079
year	B-T079
for	O
all	O
the	O
project	O
sites	O
.	O
	
the	O
differences	B-T080
between	O
the	O
cnr	B-T081
in	O
the	O
intervention	B-T079
year	I-T079
and	O
the	O
previous	B-T079
year	B-T079
ranged	B-T081
from	O
6.4	O
to	O
31.1	O
per	O
100	O
000	O
population	O
in	O
the	O
fidelis	O
areas	O
and	O
from	O
2.9	O
to	O
20.4	O
000	O
in	O
the	O
non-fidelis	B-T033
areas	O
.	O
	
differences	B-T080
-in-	O
differences	B-T080
analysis	O
shows	O
that	O
the	O
differences	B-T080
in	O
the	O
cnrs	B-T081
in	O
the	O
fidelis	O
areas	O
were	O
not	O
statistically	B-T081
significantly	I-T081
different	B-T080
from	O
those	O
in	O
the	O
non-	O
fidelis	O
areas	O
p	O
=	O
0.393	O
.	O
	
conclusion	O
the	O
fidelis	O
projects	O
may	O
have	O
contributed	O
to	O
the	O
increase	B-T169
in	O
case	B-T169
detection	B-T033
of	O
new	O
smear	O
-	O
positive	B-T033
ptb	B-T047
in	O
china	O
,	O
but	O
the	O
level	B-T080
of	O
evidence	B-T078
is	O
liver	B-T116
fatty	I-T116
acid	I-T116
binding	I-T116
protein	I-T116
deficiency	B-T169
provokes	O
oxidative	O
stress	O
,	O
inflammation	O
,	O
and	O
apoptosis	O
-mediated	O
hepatotoxicity	O
induced	B-T169
by	O
pyrazinamide	B-T109
in	O
zebrafish	O
larvae	O
pyrazinamide	B-T109
pza	B-T109
is	O
an	O
essential	B-T080
antitubercular	O
drug	O
,	O
but	O
little	O
is	O
still	O
known	O
about	O
its	O
hepatotoxicity	O
potential	B-T080
.	O
	
this	O
study	O
examined	O
the	O
effects	B-T080
of	I-T080
pza	B-T109
exposure	B-T080
on	O
zebrafish	O
danio	O
rerio	O
larvae	O
and	O
the	O
mechanisms	O
underlying	O
its	O
hepatotoxicity	O
.	O
	
a	O
transgenic	O
line	O
of	O
zebrafish	O
larvae	O
that	O
expressed	O
enhanced	B-T116
green	I-T116
fluorescent	I-T116
protein	I-T116
egfp	B-T116
in	O
the	O
liver	O
was	O
incubated	O
with	O
1	O
,	O
2.5	O
,	O
and	O
5	O
mm	O
pza	B-T109
from	O
72	O
h	O
postfertilization	O
hpf	O
.	O
	
different	O
endpoints	B-T080
such	O
as	O
mortality	B-T081
,	O
morphology	B-T033
changes	B-T169
in	O
the	O
size	O
and	O
shape	O
of	O
the	O
liver	O
,	O
histological	O
changes	B-T169
,	O
transaminase	O
analysis	O
and	O
apoptosis	O
,	O
markers	O
of	O
oxidative	O
and	O
genetic	O
damage	O
,	O
as	O
well	O
as	O
the	O
expression	O
of	O
certain	O
genes	O
were	O
selected	O
to	O
evaluate	O
pza	B-T109
-	O
induced	B-T169
hepatotoxicity	O
.	O
	
our	O
results	O
confirm	B-T033
the	O
manner	O
of	O
pza	B-T109
dose-dependent	B-T081
hepatotoxicity	O
.	O
	
pza	B-T109
was	O
found	O
to	O
induce	B-T169
marked	B-T080
injury	O
in	O
zebrafish	O
larvae	O
,	O
such	O
as	O
liver	B-T047
atrophy	I-T047
,	O
elevations	B-T033
of	I-T033
transaminase	I-T033
levels	I-T033
,	O
oxidative	O
stress	O
,	O
and	O
hepatocyte	O
apoptosis	O
.	O
	
to	O
further	O
understand	O
the	O
mechanism	O
behind	O
pza	B-T109
-	O
induced	B-T169
hepatotoxicity	O
,	O
changes	B-T169
in	O
gene	B-T081
expression	I-T081
levels	I-T081
in	O
zebrafish	O
larvae	O
exposed	B-T080
to	I-T080
pza	B-T109
for	O
72	O
h	O
postexposure	B-T080
hpe	O
were	O
determined	O
.	O
	
the	O
results	O
of	O
this	O
study	O
demonstrated	O
that	O
pza	B-T109
decreased	B-T081
the	O
expression	B-T081
levels	I-T081
of	O
liver	B-T116
fatty	I-T116
acid	I-T116
binding	I-T116
protein	I-T116
l-fabp	B-T116
and	O
its	O
target	O
gene	O
,	O
peroxisome	B-T116
proliferator-activated	I-T116
receptor	I-T116
α	I-T116
ppar-α	B-T116
,	O
and	O
provoked	O
more	O
severe	B-T080
oxidative	O
stress	O
and	O
hepatitis	B-T047
via	O
the	O
upregulation	O
of	O
inflammatory	O
cytokines	O
such	O
as	O
tumor	B-T116
necrosis	I-T116
factor	I-T116
alpha	I-T116
tnf-α	B-T116
and	O
transforming	B-T116
growth	I-T116
factor	I-T116
β	I-T116
tgf-β	B-T116
.	O
	
these	O
findings	O
suggest	O
that	O
l-fabp	B-T116
-mediated	O
ppar-α	B-T116
downregulation	O
appears	O
to	O
be	O
a	O
hepatotoxic	O
response	O
resulting	O
from	O
zebrafish	O
larva	O
liver	O
cell	O
apoptosis	O
,	O
and	O
l-fabp	B-T116
can	O
be	O
used	O
as	O
a	O
biomarker	O
for	O
the	O
early	O
detection	O
of	O
pza	B-T109
-	O
induced	B-T169
liver	O
damage	O
in	O
zebrafish	O
larvae	O
.	O
	
smooth	B-T080
versus	O
textured	B-T080
surfaces	O
feature	B-T080
-based	O
category	O
selectivity	O
in	O
human	O
visual	O
cortex	O
in	O
fmri	O
studies	O
,	O
human	O
lateral	O
occipital	O
lo	O
cortex	O
is	O
thought	O
to	O
respond	O
selectively	O
to	O
images	O
of	O
objects	O
,	O
compared	O
with	O
nonobjects	O
.	O
	
however	O
,	O
it	O
remains	O
unresolved	B-T080
whether	O
all	O
objects	O
evoke	O
equivalent	B-T080
levels	B-T080
of	O
activity	O
in	O
lo	O
,	O
and	O
,	O
if	O
not	O
,	O
which	O
image	B-T080
features	I-T080
produce	O
stronger	B-T080
activation	O
.	O
	
here	O
,	O
we	O
used	O
an	O
unbiased	O
parametric	O
texture	O
model	O
to	O
predict	B-T078
preferred	O
versus	O
nonpreferred	O
stimuli	O
in	O
lo	O
.	O
	
observation	O
and	O
psychophysical	B-T169
results	I-T169
showed	O
that	O
predicted	B-T078
preferred	B-T078
stimuli	O
both	O
objects	O
and	O
nonobjects	O
had	O
smooth	B-T080
rather	O
than	O
textured	B-T080
surfaces	O
.	O
	
these	O
predictions	B-T078
were	O
confirmed	B-T080
using	O
fmri	O
,	O
for	O
objects	O
and	O
nonobjects	O
.	O
	
similar	O
preferences	B-T078
were	O
also	O
found	O
in	O
the	O
fusiform	O
face	O
area	O
ffa	O
.	O
	
consistent	B-T078
with	I-T078
this	O
1	O
ffa	O
and	O
lo	O
responded	O
more	O
strongly	O
to	O
nonfreckled	B-T080
smooth	B-T080
faces	O
,	O
compared	O
with	O
otherwise	O
identical	O
freckled	B-T033
textured	B-T080
faces	O
and	O
2	O
strong	O
functional	B-T169
connections	O
were	O
found	O
between	O
lo	O
and	O
ffa	O
.	O
	
thus	O
,	O
lo	O
and	O
ffa	O
may	O
be	O
part	O
of	O
an	O
information	B-T078
-	O
processing	O
stream	O
distinguished	O
by	O
feature	B-T080
-based	O
category	O
selectivity	O
smooth	B-T080
>	O
high-fructose	B-T061
diet	I-T061
is	O
as	O
detrimental	O
as	O
high-fat	B-T061
diet	I-T061
in	O
the	O
induction	B-T061
of	O
insulin	O
resistance	O
and	O
diabetes	B-T047
mediated	O
by	O
hepatic	O
/	O
pancreatic	O
endoplasmic	O
reticulum	O
er	O
stress	O
in	O
the	O
context	B-T078
of	O
high	B-T080
human	O
consumption	B-T169
of	O
fructose	B-T109
diets	O
,	O
there	O
is	O
an	O
imperative	O
need	B-T080
to	O
understand	O
how	O
dietary	B-T169
fructose	B-T033
intake	I-T033
influence	O
cellular	O
and	O
molecular	B-T080
mechanisms	B-T169
and	O
thereby	O
affect	B-T080
β-cell	B-T033
dysfunction	I-T033
and	O
insulin	O
resistance	O
.	O
	
while	O
evidence	B-T078
exists	O
for	O
a	O
relationship	B-T080
between	O
high	B-T080
-	O
fat	B-T109
-	O
induced	B-T169
insulin	O
resistance	O
and	O
metabolic	B-T047
disorders	I-T047
,	O
there	O
is	O
lack	B-T080
of	I-T080
studies	O
in	O
relation	O
to	O
high-fructose	B-T061
diet	I-T061
.	O
	
therefore	O
,	O
we	O
attempted	O
to	O
study	O
the	O
effect	B-T080
of	O
different	B-T080
diets	O
viz	O
,	O
high-fat	B-T061
diet	I-T061
hfd	B-T061
,	O
high-fructose	B-T061
diet	I-T061
hfs	B-T061
,	O
and	O
a	O
combination	B-T080
hfs	B-T061
+	O
hfd	B-T061
diet	O
on	O
glucose	O
homeostasis	O
and	O
insulin	O
sensitivity	O
in	O
male	O
wistar	O
rats	O
compared	O
to	O
control	O
animals	O
fed	O
with	O
normal	B-T080
pellet	B-T081
diet	O
.	O
	
investigations	B-T169
include	O
oral	O
glucose	O
tolerance	O
test	O
,	O
insulin	O
tolerance	O
test	O
,	O
histopathology	O
by	O
h	O
and	O
masson's	O
trichrome	O
staining	O
,	O
mrna	O
expression	O
by	O
real-time	O
pcr	O
,	O
protein	O
expression	O
by	O
western	O
blot	O
,	O
and	O
caspase-3	O
activity	O
by	O
colorimetry	O
.	O
	
rats	O
subjected	O
to	O
high-fat	B-T061
/	O
fructose	B-T061
diets	I-T061
became	O
glucose	B-T109
intolerant	B-T169
,	O
insulin-resistant	O
,	O
and	O
dyslipidemic	B-T033
.	O
	
compared	O
to	O
control	O
animals	O
,	O
rats	O
subjected	O
to	O
different	B-T080
combination	B-T080
of	O
fat	B-T061
/	O
fructose	B-T061
diets	I-T061
showed	O
increased	B-T081
mrna	O
and	O
protein	O
expression	O
of	O
a	O
battery	O
of	O
er	O
stress	O
markers	B-T080
both	O
in	O
pancreas	O
and	O
liver	O
.	O
	
transcription	B-T116
factors	I-T116
of	O
β-cell	O
function	O
insig1	B-T116
,	O
srebp1c	B-T116
and	O
pdx1	B-T116
as	O
well	O
as	O
hepatic	O
gluconeogenesis	O
foxo1	B-T116
and	O
pepck	B-T116
were	O
adversely	O
affected	O
in	O
diet	O
-	O
induced	B-T169
insulin-resistant	O
rats	O
.	O
	
the	O
convergence	O
of	O
chronic	B-T079
er	O
stress	O
towards	O
apoptosis	O
in	O
pancreas	O
/	O
liver	O
was	O
also	O
indicated	B-T033
by	O
increased	B-T081
levels	B-T080
of	O
chop	O
mrna	O
increased	B-T081
activity	O
of	O
both	O
jnk	O
and	O
caspase-3	O
in	O
rats	O
subjected	O
to	O
high-fat	B-T061
/	O
fructose	B-T061
diets	I-T061
.	O
	
our	O
study	O
exposes	O
the	O
experimental	B-T080
support	O
in	O
that	O
high-fructose	B-T061
diet	I-T061
is	O
equally	B-T080
detrimental	O
in	O
causing	B-T169
metabolic	B-T047
disorders	I-T047
.	O
	
immature	B-T080
stages	B-T079
and	O
larval	O
chaetotaxy	O
of	O
notofairchildia	O
stenygros	O
quate	O
alexander	O
diptera	O
psychodidae	O
bruchomyiinae	O
some	O
authors	O
have	O
hypothesized	O
that	O
bruchomyiinae	O
is	O
"""the"	O
most	O
plesiomorphic	O
subfamily	O
of	O
psychodidae	O
""""	O
and	O
its	O
members	O
"""are"	O
among	O
the	O
most	O
primitive	B-T080
living	B-T078
diptera	O
""""	O
.	O
	
although	O
bruchomyiinae	O
is	O
of	O
no	B-T033
medical	B-T169
importance	B-T080
,	O
it	O
is	O
of	O
great	O
evolutionary	O
significance	B-T078
,	O
having	O
long	O
been	O
placed	O
as	O
the	O
sister	B-T169
group	I-T169
of	O
phlebotominae	O
.	O
	
in	O
general	O
,	O
species	O
of	O
this	O
subfamily	O
are	O
rarely	O
collected	O
in	O
their	O
natural	O
environment	O
therefore	O
,	O
adults	O
and	O
,	O
even	O
more	O
so	O
,	O
the	O
immature	B-T080
stages	B-T079
of	O
these	O
flies	O
are	O
poorly	O
known	O
.	O
	
we	O
describe	O
the	O
egg	O
,	O
larvae	O
and	O
pupae	O
of	O
notofairchildia	O
stenygros	O
and	O
provide	O
nomenclatural	O
notes	O
on	O
larval	O
chaetotaxy	O
based	O
on	O
analyses	O
using	O
scanning	O
electron	O
microscopy	O
sem	O
and	O
optic	O
microscopy	O
.	O
	
the	O
morphology	B-T080
of	O
immature	B-T080
nt	O
.	O
	
stenygros	O
is	O
compared	O
with	O
other	O
bruchomyiinae	O
and	O
psychodidae	O
species	O
,	O
especially	O
with	O
species	O
of	O
phlebotominae	O
that	O
are	O
superficially	O
similar	B-T080
to	O
bruchomyiinae	O
.	O
	
results	B-T033
of	O
this	O
study	O
revealed	O
striking	O
morphological	O
differences	B-T080
between	O
the	O
immature	B-T080
stages	B-T079
of	O
bruchomyiinae	O
and	O
phlebotominae	O
the	O
former	O
are	O
lacking	O
abdominal	O
pseudopods	O
and	O
microtrichia	O
on	O
the	O
cephalic	O
integument	O
,	O
both	O
of	O
which	O
are	O
present	O
in	O
the	O
larvae	O
of	O
phlebotominae	O
.	O
	
these	O
morphological	O
differences	B-T080
observed	O
in	O
the	O
immature	B-T080
stages	B-T079
between	O
members	O
of	O
the	O
two	O
subfamilies	O
support	O
the	O
findings	B-T033
of	O
recent	O
molecular	O
studies	O
indicating	O
that	O
bruchomyiinae	O
and	O
phlebtominae	O
are	O
evolutionarily	O
not	B-T078
closely	I-T078
related	I-T078
.	O
	
notofairchildia	O
stenygros	O
is	O
now	O
the	O
fourth	B-T081
species	O
of	O
bruchomyiinae	O
for	O
which	O
the	O
immature	B-T080
stages	B-T079
initial	O
clinical	O
results	O
with	O
the	O
thermocool	O
smarttouch	O
surround	O
flow	O
catheter	O
the	O
biosense	O
webster	O
thermocool	O
smarttouch	O
surround	O
flow	O
stsf	O
catheter	O
is	O
a	O
recently	O
developed	O
ablation	B-T061
catheter	O
incorporating	O
surround	O
flow	O
sf	O
technology	O
to	O
ensure	O
efficient	O
cooling	O
and	O
force	O
sensing	O
to	O
quantify	B-T081
tissue	O
contact	B-T169
.	O
	
in	O
our	O
unit	O
,	O
it	O
superseded	O
the	O
thermocool	O
sf	O
catheter	O
from	O
the	O
time	O
of	O
its	O
introduction	O
in	O
may	O
2015	O
.	O
	
procedure	B-T061
-related	O
data	B-T078
were	O
collected	O
prospectively	O
for	O
the	O
first	O
100	O
ablation	B-T061
procedures	I-T061
performed	O
in	O
our	O
department	O
using	O
the	O
stsf	O
catheter	O
.	O
	
from	O
a	O
database	O
of	O
654	O
procedures	B-T061
performed	O
in	O
our	O
unit	O
using	O
the	O
sf	O
catheter	O
,	O
we	O
selected	O
one	O
to	O
match	O
each	O
stsf	B-T061
procedure	I-T061
,	O
matching	O
for	O
procedure	O
type	O
,	O
operator	O
experience	O
,	O
patient	O
age	O
,	O
and	O
gender	O
.	O
	
the	O
groups	O
were	O
well	O
matched	O
for	O
patient	O
age	O
,	O
gender	O
,	O
and	O
procedure	O
type	O
.	O
	
procedure	B-T079
duration	I-T079
was	O
similar	O
in	O
both	O
groups	O
mean	O
225.5	O
vs	O
.	O
	
221.4	O
min	O
,	O
iqr	B-T081
106.5	O
vs	O
.	O
	
91.5	O
,	O
p	O
=	O
0.55	O
,	O
but	O
fluoroscopy	B-T079
duration	I-T079
was	O
shorter	B-T081
in	O
the	O
stsf	O
group	O
mean	O
25.8	O
vs	O
.	O
	
30.0	O
,	O
iqr	B-T081
19.6	O
vs	O
.	O
	
18.5	O
,	O
p	O
=	O
0.03	O
.	O
	
no	B-T033
complication	I-T033
occurred	O
in	O
the	O
stsf	O
group	O
.	O
	
complications	O
occurred	O
in	O
two	O
cases	O
in	O
the	O
sf	O
group	O
one	O
pericardial	B-T047
effusion	I-T047
requiring	O
drainage	B-T061
and	O
one	O
need	O
for	O
permanent	B-T079
pacing	B-T061
.	O
	
complete	B-T033
procedural	I-T033
success	I-T033
was	O
achieved	O
in	O
98	O
cases	O
in	O
the	O
stsf	O
group	O
and	O
94	O
cases	O
in	O
the	O
sf	O
group	O
p	O
=	O
0.15	O
.	O
	
the	O
composite	O
endpoint	O
of	O
procedure	O
failure	O
or	O
acute	B-T079
complication	O
was	O
less	O
common	O
in	O
the	O
stsf	O
group	O
2	O
vs	O
.	O
	
8	O
,	O
p	O
=	O
0.05	O
.	O
	
the	O
stsf	O
catheter	O
is	O
safe	O
and	O
effective	B-T080
in	O
treating	B-T169
a	O
range	O
of	O
arrhythmias	B-T033
.	O
	
compared	O
with	O
the	O
sf	O
catheter	O
,	O
it	O
shows	O
a	O
trend	O
towards	O
improved	O
safety	O
-	O
efficacy	B-T080
low	B-T033
birth	I-T033
weight	I-T033
and	O
features	B-T080
of	O
neuroticism	O
and	O
mood	O
disorder	O
in	O
83	O
545	O
participants	O
of	O
the	O
uk	O
biobank	O
cohort	O
low	B-T033
birth	I-T033
weight	I-T033
has	O
been	O
inconsistently	O
associated	O
with	O
risk	B-T078
of	O
developing	O
affective	O
disorders	O
,	O
including	O
major	O
depressive	O
disorder	O
mdd	O
.	O
	
to	O
date	O
,	O
studies	O
investigating	B-T169
possible	O
associations	B-T080
between	O
birth	O
weight	O
and	O
bipolar	O
disorder	O
bd	O
,	O
or	O
personality	B-T033
traits	I-T033
known	O
to	O
predispose	O
to	O
affective	O
disorders	O
such	O
as	O
neuroticism	O
,	O
have	O
not	O
been	O
conducted	O
in	O
large	O
cohorts	O
.	O
	
to	O
assess	O
whether	O
very	O
low	O
birth	O
weight	O
<1500	O
g	O
and	O
low	B-T033
birth	I-T033
weight	I-T033
1500-2490	O
g	O
were	O
associated	B-T080
with	I-T080
higher	B-T033
neuroticism	I-T033
scores	B-T081
assessed	O
in	O
middle	B-T079
age	I-T079
,	O
and	O
lifetime	O
history	O
of	O
either	O
mdd	O
or	O
bd	O
.	O
	
we	O
controlled	O
for	O
possible	O
confounding	B-T169
factors	I-T169
.	O
	
retrospective	B-T080
cohort	B-T081
study	I-T081
using	O
baseline	B-T081
data	B-T078
on	O
the	O
83	O
545	O
uk	O
biobank	O
participants	O
with	O
detailed	O
mental	O
health	O
and	O
birth	O
weight	O
data	B-T078
.	O
	
main	O
outcomes	B-T169
were	O
prevalent	O
mdd	O
and	O
bd	O
,	O
and	O
neuroticism	O
assessed	O
using	O
the	O
eysenck	O
personality	O
inventory	O
neuroticism	O
scale	O
-	O
revised	O
epin-r	O
.	O
	
referent	O
to	O
normal	B-T033
birth	I-T033
weight	I-T033
,	O
very	O
low	O
/	O
low	B-T033
birth	I-T033
weight	I-T033
were	O
associated	O
with	O
higher	B-T033
neuroticism	I-T033
scores	B-T081
,	O
increased	B-T081
mdd	O
and	O
bd	O
.	O
	
the	O
associations	B-T080
between	O
birth	O
weight	O
category	O
and	O
mdd	O
were	O
partially	O
mediated	O
by	O
higher	B-T033
neuroticism	I-T033
.	O
	
these	O
findings	B-T033
suggest	O
that	O
intrauterine	O
programming	O
may	O
play	O
a	O
role	O
in	O
lifetime	B-T079
vulnerability	B-T033
to	O
affective	O
disorders	O
.	O
	
dna	O
annealing	O
by	O
redβ	B-T116
is	O
insufficient	O
for	O
homologous	O
recombination	O
and	O
the	O
additional	O
requirements	O
involve	O
intra-	O
and	O
inter-molecular	O
interactions	O
single	B-T116
strand	I-T116
annealing	I-T116
proteins	I-T116
ssaps	B-T116
like	O
redβ	B-T116
initiate	O
homologous	O
recombination	O
by	O
annealing	O
complementary	O
dna	O
strands	O
.	O
	
we	O
show	O
that	O
c-terminally	O
truncated	O
redβ	B-T116
,	O
whilst	O
still	O
able	O
to	O
promote	O
annealing	O
and	O
nucleoprotein	O
filament	O
formation	O
,	O
is	O
unable	O
to	O
mediate	O
homologous	O
recombination	O
.	O
	
mutations	O
of	O
the	O
c-terminal	O
domain	O
were	O
evaluated	O
using	O
both	O
single	O
-	O
and	O
double	O
stranded	O
ss	O
and	O
ds	O
substrates	O
in	O
recombination	O
assays	O
.	O
	
mutations	O
of	O
critical	B-T116
amino	I-T116
acids	I-T116
affected	O
either	O
dsdna	O
recombination	O
or	O
both	O
ssdna	O
and	O
dsdna	O
recombination	O
indicating	O
two	O
separable	O
functions	O
,	O
one	O
of	O
which	O
is	O
critical	O
for	O
dsdna	O
recombination	O
and	O
the	O
second	O
for	O
recombination	O
per	O
se	O
.	O
	
as	O
evaluated	O
by	O
co-immunoprecipitation	O
experiments	O
,	O
the	O
dsdna	O
recombination	O
function	O
relates	O
to	O
the	O
redα	B-T116
-	O
redβ	B-T116
protein-protein	O
interaction	O
,	O
which	O
requires	O
not	O
only	O
contacts	O
in	O
the	O
c-terminal	O
domain	O
but	O
also	O
a	O
region	O
near	O
the	O
n-terminus	O
.	O
	
because	O
the	O
nucleoprotein	O
filament	O
formed	O
with	O
c-terminally	O
truncated	O
redβ	B-T116
has	O
altered	O
properties	O
,	O
the	O
second	O
c-terminal	O
function	O
could	O
be	O
due	O
to	O
an	O
interaction	O
required	O
for	O
functional	B-T169
filaments	O
.	O
	
alternatively	O
the	O
second	O
c-terminal	O
function	O
could	O
indicate	O
a	O
requirement	O
for	O
a	O
redβ	B-T116
-	O
host	O
factor	O
interaction	O
.	O
	
these	O
data	O
further	O
advance	O
the	O
model	O
for	O
red	O
recombination	O
and	O
the	O
proposition	O
that	O
redβ	B-T116
and	O
rad52	B-T116
ssaps	B-T116
multi-drug-resistant	O
acinetobacter	O
calcoaceticus-acinetobacter	O
baumannii	O
complex	O
infection	O
outbreak	O
in	O
dogs	O
and	O
cats	O
in	O
a	O
veterinary	O
hospital	O
members	O
of	O
the	O
acinetobacter	O
calcoaceticus-acinetobacter	O
baumannii	O
complex	O
cause	O
severe	B-T080
outbreaks	O
in	O
humans	O
,	O
and	O
are	O
increasingly	B-T169
reported	O
in	O
animals	O
.	O
	
a	O
retrospective	O
study	O
,	O
describing	O
a	O
severe	B-T080
outbreak	O
in	O
dogs	O
and	O
cats	O
caused	O
by	O
a	O
multidrug	O
resistant	O
member	O
of	O
the	O
acinetobacter	O
calcoaceticus-acinetobacter	O
baumannii	O
complex	O
in	O
a	O
veterinary	O
hospital	O
,	O
between	O
july	O
2010	O
and	O
november	O
2012	O
.	O
	
the	O
study	O
included	B-T169
19	O
dogs	O
and	O
4	O
cats	O
.	O
	
acinetobacter	O
calcoaceticus-acinetobacter	O
baumannii	O
complex	O
bacteria	O
were	O
isolated	B-T169
from	O
urine	O
9	O
animals	O
,	O
respiratory	O
tract	O
11	O
,	O
tissues	O
3	O
and	O
blood	O
1	O
.	O
	
the	O
most	B-T081
common	B-T081
infection	O
-	O
associated	B-T033
findings	I-T033
included	B-T169
fever	O
,	O
purulent	O
discharge	O
from	O
endotracheal	O
tubes	O
,	O
hypotension	B-T033
,	O
and	O
neutropaenia	B-T047
.	O
	
infection	O
s	O
led	O
to	O
pneumonia	B-T047
,	O
urinary	B-T047
tract	I-T047
infection	I-T047
,	O
cellulitis	O
and	O
sepsis	B-T047
.	O
	
infection	O
was	O
transmitted	O
in	O
the	O
intensive	O
care	O
unit	O
,	O
where	O
22	O
of	O
23	O
animals	O
were	O
initially	B-T079
hospitalised	O
.	O
	
the	O
mortality	B-T081
rate	I-T081
was	O
70%	O
16	O
of	O
23	O
animals	O
,	O
and	O
was	O
higher	B-T080
in	O
cases	O
of	O
respiratory	B-T047
infection	I-T047
compared	O
to	O
other	O
infections	O
.	O
	
aggressive	O
environmental	O
cleaning	O
and	O
disinfection	B-T061
,	O
with	O
staff	O
education	O
for	O
personal	O
hygiene	O
and	O
antisepsis	B-T061
,	O
sharply	O
decreased	B-T081
the	O
infection	O
incidence	B-T081
.	O
	
health	B-T078
care	I-T078
-	O
associated	B-T080
outbreaks	O
with	O
multidrug	O
resistant	O
acinetobacter	O
calcoaceticus-acinetobacter	O
baumannii	O
complex	O
in	O
dogs	O
and	O
cats	O
are	O
potentially	O
highly	B-T080
fatal	B-T080
and	O
difficult	B-T080
to	O
eradicate	B-T061
,	O
warranting	O
monitoring	O
,	O
antiseptic	O
techniques	B-T169
and	O
judicious	O
antibiotic	O
use	B-T169
.	O
	
manipulation	O
of	O
an	O
existing	O
crystal	O
form	O
unexpectedly	B-T033
results	I-T033
in	O
interwoven	B-T116
packing	I-T116
networks	I-T116
with	O
pseudo-translational	O
symmetry	O
nonribosomal	B-T116
peptide	I-T116
synthetases	I-T116
nrpss	B-T116
are	O
multimodular	B-T116
enzymes	I-T116
that	O
synthesize	O
a	O
myriad	B-T081
of	O
diverse	O
molecules	O
.	O
	
tailoring	O
domains	O
have	O
been	O
co-opted	O
into	O
nrpss	B-T116
to	O
introduce	O
further	O
variety	O
into	O
nonribosomal	B-T116
peptide	I-T116
products	I-T116
.	O
	
linear	B-T116
gramicidin	I-T116
synthetase	I-T116
contains	O
a	O
unique	O
formylation	O
-	O
tailoring	O
domain	O
in	O
its	O
initiation	O
module	O
f-a	O
-	O
pcp	O
.	O
	
the	O
structure	O
of	O
the	O
f-a	O
di-domain	O
has	O
previously	O
been	O
determined	O
in	O
a	O
crystal	O
form	O
which	O
had	O
large	O
solvent	O
channels	O
and	O
no	B-T081
density	I-T081
for	O
the	O
minor	O
asub	O
subdomain	O
.	O
	
an	O
attempt	O
was	O
made	O
to	O
take	O
advantage	O
of	O
this	O
packing	O
by	O
removing	O
the	O
asub	O
subdomain	O
from	O
the	O
construct	O
f-a	O
δ	O
sub	O
in	O
order	O
to	O
produce	O
a	O
crystal	O
that	O
could	O
accommodate	O
the	O
pcp	O
domain	O
.	O
	
in	O
the	O
resulting	O
crystal	O
the	O
original	B-T116
packing	I-T116
network	I-T116
was	O
still	O
present	O
,	O
but	O
a	O
second	B-T116
network	I-T116
with	O
the	O
same	O
packing	O
and	O
almost	O
no	O
contact	O
with	O
the	O
original	B-T116
network	I-T116
took	O
the	O
place	O
of	O
the	O
solvent	O
channels	O
and	O
changed	O
the	O
space	O
group	O
of	O
the	O
crystal	O
.	O
	
folate	B-T109
-based	O
single	O
cell	O
screening	O
using	O
surface	O
enhanced	O
raman	O
microimaging	O
recent	O
progress	O
in	O
nanotechnology	O
and	O
its	O
application	O
to	O
biomedical	O
settings	O
have	O
generated	O
great	O
advantages	O
in	O
dealing	O
with	O
early	O
cancer	O
diagnosis	O
.	O
	
the	O
identification	O
of	O
the	O
specific	O
properties	O
of	O
cancer	O
cells	O
,	O
such	O
as	O
the	O
expression	O
of	O
particular	O
plasma	O
membrane	O
molecular	O
receptors	O
,	O
has	O
become	O
crucial	O
in	O
revealing	O
the	O
presence	O
and	O
in	O
assessing	O
the	O
stage	O
of	O
development	O
of	O
the	O
disease	O
.	O
	
here	O
we	O
report	O
a	O
single	O
cell	O
screening	O
approach	O
based	O
on	O
surface	O
enhanced	O
raman	O
scattering	O
sers	O
microimaging	O
.	O
	
we	O
fabricated	O
a	O
sers-labelled	O
nanovector	O
based	O
on	O
the	O
biofunctionalization	O
of	O
gold	O
nanoparticles	O
with	O
folic	O
acid	O
.	O
	
after	O
treating	O
the	O
cells	O
with	O
the	O
nanovector	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	O
cell	O
lines	O
cancer	O
hela	O
and	O
pc-3	O
,	O
and	O
normal	O
hacat	O
lines	O
,	O
suitably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	O
binding	O
proteins	O
.	O
	
the	O
nanovector	O
,	O
indeed	O
,	O
binds	O
much	O
more	O
efficiently	O
on	O
cancer	O
cell	O
lines	O
than	O
on	O
normal	O
ones	O
,	O
resulting	O
in	O
a	O
higher	O
sers	O
signal	O
measured	O
on	O
cancer	O
cells	O
.	O
	
these	O
results	O
pave	O
the	O
way	O
for	O
applications	O
in	O
single	O
cell	O
diagnostics	O
and	O
,	O
potentially	O
,	O
in	O
theranostics	O
self-reported	O
occupational	O
injuries	O
among	O
industrial	O
beef	O
slaughterhouse	O
workers	O
in	O
the	O
midwestern	O
united	O
states	O
although	O
workers	O
in	O
meatpacking	O
facilities	O
in	O
the	O
united	O
states	O
experience	O
high	B-T081
rates	I-T081
of	O
occupational	O
injury	O
,	O
their	O
injury	O
experiences	O
have	O
received	O
limited	O
research	O
attention	O
.	O
	
prior	O
research	O
indicates	O
underreporting	O
in	O
injury	B-T033
rates	I-T033
in	O
this	O
industry	O
as	O
well	O
significant	O
variation	O
in	O
injury	B-T033
rates	I-T033
among	O
facilities	O
.	O
	
to	O
add	O
detail	O
to	O
the	O
rates	O
and	O
circumstances	O
surrounding	O
occupational	O
injury	O
among	O
meatpacking	O
workers	O
,	O
we	O
conducted	O
a	O
cross-sectional	O
study	O
of	O
workers	O
employed	O
at	O
an	O
industrial	O
beefpacking	O
plant	O
in	O
nebraska	O
,	O
united	O
states	O
n	O
=	O
137	O
and	O
interviewed	O
workers	O
about	O
recent	O
injury	O
experiences	O
.	O
	
we	O
assessed	O
frequency	O
,	O
cause	O
and	O
nature	O
of	O
self-reported	O
injury	O
.	O
	
we	O
estimated	O
annual	B-T081
incidence	I-T081
rates	I-T081
of	O
self-reported	O
injuries	O
using	O
the	O
osha	O
formula	O
and	O
compared	O
these	O
rates	O
to	O
industry-wide	B-T078
data	I-T078
.	O
	
we	O
also	O
evaluated	O
psychological	O
distress	O
in	O
this	O
workforce	O
as	O
measured	O
by	O
the	O
kessler-6	O
scale	O
to	O
assess	O
whether	O
distress	B-T033
was	O
associated	B-T080
with	I-T080
recent	O
occupational	O
injury	O
.	O
	
in	O
this	O
study	O
,	O
15.1	O
of	O
workers	O
experienced	O
occupational	O
injuries	O
that	O
required	O
time	O
off	O
work	O
,	O
job	O
transfer	O
,	O
or	O
restriction	O
during	O
the	O
past	O
three	O
months	O
.	O
	
the	O
estimated	O
annual	O
incidence	O
rate	O
was	O
15.2	O
injuries	O
per	O
100	O
full-time	O
workers	O
for	O
these	O
injuries	O
at	O
this	O
plant	O
.	O
	
rushing	O
was	O
identified	O
as	O
the	O
cause	O
of	O
nearly	O
50%	O
of	O
injuries	O
,	O
and	O
repetitive	O
work	O
as	O
the	O
cause	O
of	O
an	O
additional	O
20%	O
of	O
injuries	O
.	O
	
use	O
of	O
metal	O
mesh	O
sleeves	O
por	O
0.10	O
p	O
=	O
0.008	O
and	O
metal	O
mesh	O
gloves	O
por	O
0.41	O
p	O
=	O
0.05	O
were	O
associated	O
with	O
reduced	O
risk	O
of	O
injury	O
.	O
	
use	O
of	O
a	O
carbon	O
steel	O
for	O
knife	O
sharpening	O
por	O
5.2	O
p	O
=	O
0.02	O
was	O
associated	O
with	O
elevated	O
risk	O
of	O
moderate	O
and	O
severe	O
injury	O
.	O
	
there	O
were	O
no	O
associations	O
between	O
self-reported	O
occupational	O
injury	O
and	O
overall	O
measures	O
of	O
psychological	O
distress	O
.	O
	
self-reported	O
incidence	O
rate	O
of	O
severe	O
injury	O
in	O
this	O
plant	O
was	O
more	O
than	O
twice	O
official	O
industry	O
estimates	O
.	O
	
worker	O
self-reports	O
may	O
illustrate	O
key	O
areas	O
for	O
injury	O
prevention	I-T061
the	O
effect	B-T080
of	O
l-arginine	B-T116
on	O
dural	O
healing	O
after	O
experimentally	O
induced	B-T169
dural	O
defect	B-T169
in	O
a	O
rat	O
model	O
incomplete	B-T080
repair	O
of	O
the	O
dura	O
mater	O
may	O
result	B-T169
in	O
numerous	B-T081
complications	O
such	O
as	O
cerebrospinal	B-T047
fluid	I-T047
leakage	I-T047
and	O
meningitis	B-T047
.	O
	
for	O
this	O
reason	O
,	O
accurate	B-T080
repair	O
of	O
the	O
dura	O
mater	O
is	O
essential	B-T080
.	O
	
in	O
this	O
study	O
,	O
the	O
effect	B-T080
of	O
systemic	B-T169
and	O
local	O
supplementation	B-T169
of	O
l-arginine	B-T116
on	O
dural	O
healing	O
was	O
evaluated	O
.	O
	
thirty	O
male	O
wistar	O
rats	O
were	O
used	O
and	O
divided	B-T169
into	O
control	O
,	O
local	O
,	O
and	O
systemic	B-T169
l-arginine	B-T116
groups	B-T078
,	O
with	O
10	O
rats	O
in	O
each	O
.	O
	
in	O
each	O
group	B-T078
,	O
a	O
5-mm	O
experimental	B-T061
incision	I-T061
was	O
made	O
at	O
the	O
lumbar	O
segment	O
of	O
the	O
dura	O
mater	O
and	O
cerebrospinal	B-T047
fluid	I-T047
leakage	I-T047
was	O
induced	B-T169
.	O
	
each	O
group	B-T078
was	O
divided	B-T169
into	O
2	O
subgroups	O
and	O
at	O
the	O
end	O
of	O
the	O
first	O
and	O
sixth	O
weeks	B-T079
,	O
the	O
rats	O
were	O
killed	O
and	O
the	O
damaged	B-T169
segments	O
of	O
the	O
dura	O
were	O
separated	B-T080
,	O
histologically	B-T169
evaluated	O
and	O
the	O
dural	O
healing	O
indicators	B-T169
including	O
cell	O
types	O
,	O
granulation	O
tissue	O
formation	B-T169
,	O
collagen	B-T116
deposit	B-T169
,	O
and	O
vascularization	B-T169
were	O
compared	O
between	O
groups	B-T078
.	O
	
the	O
systematic	B-T169
supplementation	B-T169
of	O
l-arginine	B-T116
showed	O
a	O
significant	B-T078
effect	B-T080
in	O
dural	O
healing	O
compared	O
with	O
the	O
control	O
group	O
.	O
	
after	O
the	O
first	O
week	B-T079
,	O
granulation	O
formation	B-T169
increased	B-T081
considerably	O
p	O
<	O
0.031	O
,	O
and	O
after	O
6	O
weeks	B-T079
,	O
collagen	B-T116
deposition	B-T169
and	O
neovascularization	O
were	O
significantly	O
different	B-T080
compared	O
with	O
the	O
control	O
group	O
p	O
<	O
0.030	O
p	O
<	O
0.009	O
.	O
	
in	O
comparison	O
between	O
different	B-T080
groups	B-T078
at	O
the	O
end	O
of	O
the	O
first	O
and	O
sixth	O
weeks	B-T079
,	O
maximum	B-T081
changes	B-T169
in	O
healing	O
indicators	B-T169
were	O
observed	B-T169
in	O
the	O
systemic	B-T169
group	B-T078
and	O
the	O
least	O
variations	B-T080
were	O
related	O
to	O
the	O
control	O
group	O
.	O
	
the	O
systemic	B-T169
supplementation	B-T169
of	O
l-arginine	B-T116
may	O
accelerate	B-T169
dural	O
healing	O
by	O
increasing	B-T169
the	O
level	B-T080
of	O
granulation	O
tissue	O
formation	B-T169
,	O
collagen	B-T116
deposition	B-T169
,	O
and	O
birth	O
preparedness	O
and	O
complication	O
readiness	O
practice	O
and	O
associated	B-T080
factors	B-T169
among	O
pregnant	O
women	O
,	O
northwest	O
ethiopia	O
background	O
.	O
	
little	O
is	O
known	O
about	O
birth	O
preparedness	O
and	O
complication	O
readiness	O
bpcr	O
plan	B-T169
in	O
resource	O
limited	O
settings	O
to	O
decrease	O
maternal	B-T081
mortality	I-T081
.	O
	
therefore	O
,	O
this	O
study	O
was	O
done	O
to	O
assess	O
the	O
status	B-T080
of	O
bpcr	O
and	O
associated	B-T080
factors	B-T169
among	O
pregnant	O
women	O
in	O
south	O
wollo	O
,	O
northwest	O
ethiopia	O
,	O
by	O
involving	O
819	O
pregnant	O
women	O
from	O
march	O
to	O
april	O
,	O
2014	O
.	O
	
data	B-T078
were	O
collected	O
by	O
using	O
pretested	O
interviewer	O
administered	O
questionnaire	O
and	O
analyzed	O
using	O
a	O
computer	O
program	O
of	O
spss	O
version	O
20.00	O
.	O
	
results	B-T169
.	O
	
pregnant	O
women	O
who	O
were	O
prepared	B-T033
for	O
at	O
least	O
three	O
elements	O
of	O
bpcr	O
were	O
24.1	O
.	O
	
pregnant	O
women	O
knowing	O
at	O
least	O
three	O
key	O
danger	O
signs	O
during	O
pregnancy	O
,	O
delivery	O
,	O
and	O
postnatal	B-T079
period	I-T079
were	O
23.2	O
,	O
22.6	O
,	O
and	O
9.6	O
,	O
respectively	O
.	O
	
women	O
having	O
secondary	O
education	O
and	O
higher	O
were	O
6.20	O
95%	O
ci	B-T081
=	O
1.36	O
,	O
28.120	O
times	O
more	O
likely	O
to	O
be	O
prepared	B-T033
than	O
illiterates	B-T033
.	O
	
women	O
having	O
a	O
lifetime	O
history	O
of	O
stillbirth	B-T033
5.80	O
1.13	O
,	O
29.63	O
,	O
attending	B-T169
anc	O
for	O
last	O
child	O
pregnancy	O
5.44	O
2.07	O
,	O
14.27	O
,	O
participating	B-T169
in	O
community	O
bpcr	O
group	O
discussion	O
4.36	O
1.17	O
,	O
16.26	O
,	O
and	O
having	O
their	O
male	O
partner	O
involved	O
in	O
bpcr	O
counseling	O
during	O
anc	O
follow-up	O
4.45	O
1.95	O
,	O
10.16	O
were	O
more	O
likely	O
to	O
be	O
prepared	B-T033
.	O
	
conclusions	B-T078
.	O
	
bpcr	O
was	O
very	O
low	O
and	O
should	O
be	O
strengthened	O
through	O
health	O
communication	O
by	O
involving	O
partner	O
in	O
bpcr	O
counseling	O
.	O
	
fluoranthene	B-T109
degradation	O
and	O
binding	O
mechanism	B-T169
study	O
based	O
on	O
the	O
active-site	B-T169
structure	O
of	O
ring-hydroxylating	B-T116
dioxygenase	I-T116
in	O
microbacterium	O
paraoxydans	O
jpm1	O
in	O
this	O
study	O
,	O
a	O
gram-positive	O
fluoranthene-degrading	O
bacterial	O
strain	O
was	O
isolated	B-T169
from	O
crude	B-T109
oil	I-T109
in	O
dagang	O
oilfield	O
and	O
identified	B-T080
as	O
microbacterium	O
paraoxydans	O
jpm1	O
by	O
the	O
analysis	O
of	O
16s	O
rdna	O
sequence	O
.	O
	
after	O
25	O
days	B-T079
of	O
incubation	O
,	O
the	O
strain	O
jpm1	O
could	O
degrade	O
91.78	O
%	O
of	O
the	O
initial	B-T079
amount	B-T081
of	O
fluoranthene	B-T109
.	O
	
moreover	O
,	O
four	O
metabolites	O
9-fluorenone-1-carboxylic	O
acid	O
,	O
9-fluorenone	B-T109
,	O
phthalic	B-T109
acid	I-T109
,	O
and	O
benzoic	B-T109
acid	I-T109
were	O
detected	O
in	O
the	O
culture	O
solution	O
.	O
	
the	O
gene	O
sequence	O
encoding	O
the	O
aromatic-ring-hydroxylating	B-T116
dioxygenase	I-T116
was	O
amplified	O
in	O
the	O
strain	O
jpm1	O
by	O
pcr	O
.	O
	
based	O
on	O
the	O
translated	O
protein	O
sequence	O
,	O
a	O
homology	O
modeling	O
method	O
was	O
applied	O
to	O
build	O
the	O
crystal	O
structure	O
of	O
dioxygenase	B-T116
.	O
	
subsequently	O
,	O
the	O
interaction	B-T169
mechanism	B-T169
between	O
fluoranthene	B-T109
and	O
the	O
active	B-T169
site	I-T169
of	O
dioxygenase	B-T116
was	O
simulated	O
and	O
analyzed	O
by	O
molecular	O
docking	O
.	O
	
consequently	O
,	O
a	O
feasible	O
degrading	O
pathway	O
of	O
fluoranthene	B-T109
in	O
the	O
strain	O
jpm1	O
was	O
proposed	O
based	O
on	O
the	O
metabolites	O
and	O
the	O
interaction	B-T081
analyses	I-T081
.	O
	
additionally	O
,	O
the	O
thermodynamic	O
analysis	O
showed	O
that	O
the	O
strain	O
jpm1	O
had	O
high	B-T080
tolerance	B-T080
for	O
fluoranthene	B-T109
,	O
and	O
the	O
influence	O
of	O
fluoranthene	B-T109
for	O
the	O
bacterial	O
growth	O
activity	O
was	O
negligible	B-T080
under	O
100	O
to	O
400	O
mg	O
l	O
concentrations	B-T081
.	O
	
taken	O
together	O
,	O
this	O
study	O
indicates	O
that	O
the	O
strain	O
jpm1	O
has	O
high	O
potential	B-T080
for	O
further	O
study	O
in	O
bioremediation	O
of	O
polycyclic	B-T109
aromatic	I-T109
hydrocarbon	I-T109
pah	B-T109
contaminated	B-T169
sites	O
.	O
	
ultrasonography	O
for	O
acute	B-T047
appendicitis	I-T047
-	O
the	O
way	O
it	O
looks	O
today	O
despite	O
sophisticated	O
physical	O
examination	O
and	O
laboratory	O
support	O
,	O
diagnosis	B-T033
of	O
acute	B-T047
appendicitis	I-T047
remained	O
challenging	O
in	O
clinical	O
practice	O
with	O
a	O
negative	B-T061
appendectomy	I-T061
rate	B-T081
of	O
15	O
-	O
30	O
%	O
.	O
	
as	O
a	O
remarkable	O
clue	O
and	O
as	O
early	O
as	O
1986	O
,	O
ultrasonography	O
us	O
has	O
been	O
proven	O
a	O
reliable	O
diagnostic	O
method	O
that	O
is	O
also	O
explicitly	O
helpful	O
in	O
difficult	O
cases	O
with	O
atypical	B-T080
presentation	B-T078
and	O
enables	O
to	O
rule	B-T169
out	I-T169
many	O
differential	O
diagnoses	O
recent	O
publications	O
emphasized	O
the	O
role	O
of	O
multidetector	O
computed	O
tomography	O
ct	O
resulting	O
in	O
a	O
significant	O
reduction	O
of	O
false	O
negative	O
findings	O
at	O
operation	B-T061
.	O
	
extensive	B-T080
as	O
well	O
as	O
uncritical	B-T061
application	I-T061
of	O
this	O
method	O
even	O
in	O
children	O
inevitably	O
causes	O
substantial	O
radiation	O
exposure	O
,	O
a	O
sequel	O
to	O
either	O
pure	O
ignorance	O
or	O
unqualified/	O
inadequate	B-T080
performance	O
of	O
us	O
in	O
this	O
particular	O
situation	O
,	O
which	O
in	O
turn	O
can	O
be	O
considered	O
sequel	O
to	O
either	O
egocentric	B-T033
or	O
economic	B-T169
preponderance	B-T081
recent	O
data	O
shed	O
new	O
light	O
on	O
the	O
role	O
of	O
us	O
and	O
ct	O
in	O
acute	B-T047
appendicitis	I-T047
.	O
	
therefore	O
,	O
1	O
generation	O
after	O
us	O
with	O
graded	O
compression	O
was	O
etched	O
in	O
stone	O
as	O
the	O
method	O
of	O
choice	O
for	O
diagnosing	B-T033
acute	B-T047
appendicitis	I-T047
puylaert	O
,	O
a	O
visual	B-T169
arousal	O
fostering	O
its	O
role	O
and	O
performance	O
in	O
clinical	O
medicine	O
mesenchymal	O
stem	O
cells	O
enhance	O
the	O
oncolytic	B-T080
effect	B-T080
of	O
newcastle	O
disease	O
virus	O
in	O
glioma	O
cells	O
and	O
glioma	O
stem	O
cells	O
via	O
the	O
secretion	O
of	O
trail	B-T116
newcastle	O
disease	O
virus	O
ndv	O
is	O
an	O
avian	O
paramyxovirus	O
,	O
which	O
selectively	O
exerts	O
oncolytic	B-T080
effects	B-T080
in	O
cancer	O
cells	O
.	O
	
mesenchymal	O
stem	O
cells	O
mscs	O
have	O
been	O
reported	O
to	O
affect	O
tumor	O
growth	O
and	O
deliver	B-T169
anti-tumor	B-T109
agents	I-T109
to	O
experimental	B-T080
glioblastoma	O
gbm	O
.	O
	
here	O
,	O
we	O
explored	O
the	O
effects	B-T080
of	I-T080
ndv	O
-	O
infected	B-T033
mscs	O
derived	O
from	O
different	O
sources	B-T033
,	O
on	O
glioma	O
cells	O
and	O
glioma	O
stem	O
cells	O
gscs	O
and	O
the	O
mechanisms	B-T169
involved	O
in	O
their	O
effects	B-T080
.	O
	
the	O
glioma	O
cell	O
lines	O
a172	O
and	O
u87	O
and	O
primary	B-T080
gscs	O
that	O
were	O
generated	O
from	O
gbm	O
tumors	O
were	O
used	O
in	O
this	O
study	O
.	O
	
mscs	O
derived	B-T080
from	O
bone	O
marrow	O
,	O
adipose	O
tissue	O
or	O
umbilical	O
cord	O
were	O
infected	B-T033
with	O
ndv	O
mth-68/h	B-T061
.	O
	
the	O
ability	O
of	O
these	O
cells	O
to	O
deliver	B-T169
the	O
virus	O
to	O
glioma	O
cell	O
lines	O
and	O
gscs	O
and	O
the	O
effects	B-T080
of	I-T080
ndv	O
-	O
infected	B-T033
mscs	O
on	O
cell	O
death	O
and	O
on	O
the	O
stemness	B-T080
and	O
self-renewal	O
of	O
gscs	O
were	O
examined	B-T033
.	O
	
the	O
mechanisms	B-T169
involved	B-T169
in	O
the	O
cytotoxic	B-T169
effects	B-T080
of	I-T080
the	O
ndv	O
-	O
infected	B-T033
mscs	O
and	O
their	O
influence	O
on	O
the	O
radiation	O
sensitivity	O
of	O
gscs	O
were	O
examined	B-T033
as	O
well	O
.	O
	
ndv	O
induced	B-T169
a	O
dose-dependent	B-T081
cell	O
death	O
in	O
glioma	O
cells	O
and	O
a	O
low	B-T080
level	B-T080
of	O
apoptosis	O
and	O
inhibition	O
of	O
self-renewal	O
in	O
gscs	O
.	O
	
mscs	O
derived	B-T080
from	O
bone	O
marrow	O
,	O
adipose	O
and	O
umbilical	O
cord	O
that	O
were	O
infected	B-T033
with	O
ndv	O
delivered	B-T169
the	O
virus	O
to	O
co-cultured	O
glioma	O
cells	O
and	O
gscs	O
.	O
	
conditioned	O
medium	O
of	O
ndv	O
-	O
infected	B-T033
mscs	O
induced	B-T169
higher	B-T080
level	B-T080
of	O
apoptosis	O
in	O
the	O
tumor	O
cells	O
compared	O
with	O
the	O
apoptosis	O
induced	B-T169
by	O
their	O
direct	B-T047
infection	I-T047
with	O
similar	B-T080
virus	B-T081
titers	I-T081
.	O
	
these	O
results	B-T033
suggest	B-T078
that	O
factor	B-T169
secreted	O
by	O
the	O
infected	B-T033
mscs	O
sensitized	O
the	O
glioma	O
cells	O
to	O
the	O
cytotoxic	B-T169
effects	B-T080
of	I-T080
ndv	O
.	O
	
we	O
identified	B-T080
trail	B-T116
as	O
a	O
mediator	B-T080
of	O
the	O
cytotoxic	B-T169
effects	B-T080
of	I-T080
the	O
infected	B-T033
mscs	O
and	O
demonstrated	B-T080
that	O
trail	B-T116
synergized	O
with	O
ndv	O
in	O
the	O
induction	B-T169
of	O
cell	O
death	O
in	O
glioma	O
cells	O
and	O
gscs	O
.	O
	
moreover	O
,	O
conditioned	B-T080
medium	B-T081
of	O
infected	B-T033
mscs	O
enhanced	O
the	O
sensitivity	O
of	O
gscs	O
to	O
γ-radiation	O
.	O
	
ndv	O
-	O
infected	B-T033
umbilical	O
cord	O
-	O
derived	B-T080
mscs	O
may	O
provide	O
a	O
novel	B-T080
effective	B-T080
therapeutic	B-T169
approach	O
for	O
targeting	B-T169
gscs	O
and	O
gbm	O
and	O
for	O
sensitizing	O
these	O
tumors	O
to	O
importance	B-T080
of	O
ecological	O
factors	O
and	O
colony	B-T078
handling	B-T033
for	O
optimizing	O
health	B-T080
status	I-T080
of	O
apiaries	O
in	O
mediterranean	O
ecosystems	O
we	O
analyzed	O
six	O
apiaries	O
in	O
several	O
natural	O
environments	O
with	O
a	O
mediterranean	O
ecosystem	O
in	O
madrid	O
,	O
central	O
spain	O
,	O
in	O
order	O
to	O
understand	O
how	O
landscape	O
and	O
management	O
characteristics	B-T080
may	O
influence	O
apiary	O
health	B-T078
and	O
bee	O
production	O
in	O
the	O
long	B-T079
term	I-T079
.	O
	
we	O
focused	B-T169
on	O
five	O
criteria	B-T078
habitat	O
quality	B-T080
,	O
landscape	O
heterogeneity	B-T080
,	O
climate	O
,	O
management	O
and	O
health	B-T078
,	O
as	O
well	O
as	O
30	O
subcriteria	B-T078
,	O
and	O
we	O
used	O
the	O
analytic	O
hierarchy	O
process	O
ahp	O
to	O
rank	O
them	O
according	O
to	O
relevance	B-T080
.	O
	
habitat	O
quality	B-T080
proved	O
to	O
have	O
the	O
highest	O
relevance	B-T080
,	O
followed	O
by	O
beehive	O
management	O
.	O
	
within	O
habitat	O
quality	B-T080
,	O
the	O
following	O
subcriteria	B-T078
proved	O
to	O
be	O
most	O
relevant	B-T080
orographic	B-T080
diversity	I-T080
,	O
elevation	O
range	B-T081
and	O
important	B-T080
plant	O
species	O
located	O
1.5	O
km	O
from	O
the	O
apiary	O
.	O
	
the	O
most	O
important	B-T080
subcriteria	B-T078
under	O
beehive	O
management	O
were	O
honey	O
production	O
,	O
movement	O
of	O
the	O
apiary	O
to	O
a	O
location	O
with	O
a	O
higher	O
altitude	B-T081
and	O
wax	O
renewal	B-T169
.	O
	
temperature	B-T081
was	O
the	O
most	O
important	O
subcriterion	B-T078
under	O
climate	O
,	O
while	O
pathogen	O
and	O
varroa	O
loads	B-T033
were	O
the	O
most	O
significant	B-T078
under	O
health	B-T078
.	O
	
two	O
of	O
the	O
six	O
apiaries	O
showed	O
the	O
best	B-T081
values	I-T081
in	O
the	O
ahp	O
analysis	O
and	O
showed	O
annual	B-T079
honey	O
production	O
of	O
70	O
and	O
28	O
kg/	O
colony	B-T078
.	O
	
this	O
high	O
productivity	B-T081
was	O
due	O
primarily	O
to	O
high	O
elevation	O
range	B-T081
and	O
high	O
orographic	B-T080
diversity	I-T080
,	O
which	O
favored	O
high	O
habitat	O
quality	B-T080
.	O
	
in	O
addition	O
,	O
one	O
of	O
these	O
apiaries	O
showed	O
the	O
best	B-T081
value	I-T081
for	O
beehive	O
management	O
,	O
while	O
the	O
other	O
showed	O
the	O
best	B-T081
value	I-T081
for	O
health	B-T078
,	O
reflected	O
in	O
the	O
low	B-T080
pathogen	O
load	B-T033
and	O
low	B-T080
average	B-T081
number	B-T081
of	O
viruses	O
.	O
	
these	O
results	B-T169
highlight	O
the	O
importance	B-T080
of	O
environmental	O
factors	O
and	O
good	O
sanitary	B-T169
practices	I-T169
to	O
maximize	O
apiary	O
health	B-T078
and	O
honey	O
productivity	B-T081
.	O
	
chordoma	O
dedifferentiation	O
after	O
proton	B-T061
beam	I-T061
therapy	I-T061
a	O
case	O
report	O
and	O
review	O
of	O
the	O
literature	O
chordoma	O
is	O
a	O
rare	B-T080
invasive	B-T080
bone	O
tumor	O
that	O
may	O
occur	O
anywhere	O
along	O
the	O
neuraxis	O
.	O
	
a	O
total	O
of	O
three	O
primary	B-T080
histological	O
varieties	O
have	O
been	O
identified	B-T080
conventional	O
,	O
chondroid	O
,	O
and	O
dedifferentiated	O
.	O
	
we	O
report	O
a	O
case	O
of	O
an	O
8-year-old	O
white	O
girl	O
who	O
presented	O
with	O
conventional	O
chordoma	O
,	O
was	O
treated	B-T033
with	O
surgical	B-T061
resection	I-T061
and	O
mixed	B-T169
proton	O
and	O
photon	B-T061
beam	I-T061
therapy	I-T061
,	O
and	O
had	O
a	O
recurrence	O
in	O
the	O
resection	O
cavity	O
2.5	O
years	O
later	O
with	O
dedifferentiated	O
morphology	O
.	O
	
the	O
recurrent	O
tumor	O
did	O
not	O
express	O
brachyury	B-T116
,	O
a	O
recently	B-T079
identified	B-T080
protein	B-T116
specific	B-T080
to	O
tissue	O
of	O
notochordal	O
origin	B-T079
.	O
	
the	O
short	B-T081
time	B-T079
period	I-T079
between	O
radiation	B-T061
therapy	I-T061
and	O
dedifferentiation	O
,	O
low	B-T081
dose	I-T081
of	O
photons	O
,	O
and	O
rarity	B-T080
of	O
dedifferentiated	O
skull	O
base	O
chordomas	O
in	O
pediatric	B-T080
patients	O
should	O
alert	B-T169
clinicians	O
to	O
the	O
possibility	B-T033
of	O
chordoma	O
dedifferentiation	O
after	O
proton	B-T061
beam	I-T061
therapy	I-T061
.	O
	
volumetric	O
absorptive	O
microsampling	O
at	O
home	O
as	O
an	O
alternative	O
tool	O
for	O
the	O
monitoring	O
of	O
hba1c	B-T116
in	O
diabetes	B-T047
patients	O
microsampling	B-T169
techniques	I-T169
have	O
several	O
advantages	O
over	O
traditional	O
blood	O
collection	O
.	O
	
dried	O
blood	O
spot	O
dbs	O
sampling	O
and	O
blood	O
collection	O
with	O
heparinized	O
capillaries	O
are	O
the	O
standard	B-T080
techniques	O
.	O
	
volumetric	O
absorptive	O
microsampling	O
vams	O
is	O
a	O
novel	O
technique	O
that	O
collects	O
a	O
fixed	O
volume	B-T081
of	O
blood	O
by	O
applying	O
an	O
absorbent	O
tip	B-T080
to	O
a	O
blood	O
drop	O
.	O
	
in	O
the	O
present	O
study	O
we	O
explored	O
the	O
feasibility	O
of	O
hba1c	B-T116
monitoring	O
with	O
vams	O
sampling	O
at	O
home	O
and	O
analysis	O
in	O
the	O
laboratory	O
.	O
	
diabetic	B-T047
patients	O
were	O
enrolled	O
in	O
this	O
study	O
during	O
consultation	O
with	O
the	O
endocrinologist	O
.	O
	
a	O
venous	O
adults	O
or	O
capillary	O
children	O
sample	O
was	O
taken	O
for	O
immediate	O
hba1c	B-T116
analysis	O
.	O
	
dbs	O
n=1	O
and	O
dried	O
vams	O
n=2	O
were	O
collected	O
at	O
home	O
and	O
sent	O
to	O
the	O
laboratory	O
.	O
	
for	O
25	O
pediatric	B-T080
patients	O
one	O
vams	O
was	O
collected	O
during	O
consultation	O
for	O
immediate	O
analysis	O
without	O
drying	O
,	O
referred	O
to	O
as	O
""""	O
wet	O
vams	O
""""	O
.	O
	
hba1c	B-T116
analyses	O
were	O
performed	O
on	O
a	O
tosoh	O
hlc-723	O
g8	O
high-performance	O
liquid	O
chromatography	O
hplc	O
analyzer	O
.	O
	
the	O
median	O
time	O
between	O
sampling	O
at	O
home	O
and	O
analysis	O
was	O
3	O
days	B-T079
.	O
	
results	B-T169
of	O
hba1c	B-T116
in	O
dried	O
vams	O
showed	O
a	O
poor	O
agreement	O
with	O
venous	O
/	O
capillary	O
blood	O
collected	O
in	O
hospital	O
concordance	B-T081
correlation	I-T081
coefficient	I-T081
ccc	B-T081
=0	O
.	O
	
similar	O
observations	O
were	O
found	O
with	O
standard	B-T080
dbs	O
.	O
	
an	O
excellent	O
agreement	O
was	O
obtained	O
between	O
hba1c	B-T116
results	B-T169
on	O
wet	O
vams	O
ccc	B-T081
=0	O
and	O
standard	B-T080
blood	O
samples	O
.	O
	
patients	O
experienced	O
vams	O
and	O
dbs	O
as	O
easy	B-T033
and	O
convenient	B-T080
to	O
use	B-T169
.	O
	
utilizing	O
equipment	O
standard	B-T080
available	O
in	O
the	O
clinical	B-T080
laboratory	O
,	O
the	O
use	O
of	O
home	O
-sampled	O
dried	O
vams	O
and	O
dbs	O
is	O
not	O
a	O
reliable	O
tool	O
for	O
the	O
monitoring	O
of	O
hba1c	B-T116
.	O
	
however	O
,	O
perfect	O
agreement	O
between	O
hba1c	B-T116
measured	O
on	O
wet	O
vams	O
and	O
capillary	O
microsamples	O
are	O
eyes	O
a	O
mirror	O
of	O
the	O
soul	B-T078
what	O
eye	O
wrinkles	O
reveal	B-T080
about	O
a	O
horse's	O
emotional	O
state	O
finding	O
valid	B-T080
indicators	B-T169
of	O
emotional	O
states	O
is	O
one	O
of	O
the	O
biggest	O
challenges	O
in	O
animal	O
welfare	O
science	O
.	O
	
here	O
,	O
we	O
investigated	B-T169
in	O
horses	O
whether	O
variation	B-T080
in	O
the	O
expression	B-T080
of	O
eye	O
wrinkles	O
caused	O
by	O
contraction	O
of	O
the	O
inner	O
eyebrow	O
raiser	O
reflects	O
emotional	B-T033
valence	I-T033
.	O
	
by	O
confronting	O
horses	O
with	O
positive	B-T033
and	O
negative	B-T033
conditions	B-T080
,	O
we	O
aimed	O
to	O
induce	B-T169
positive	B-T033
and	O
negative	B-T033
emotional	O
states	O
,	O
hypothesising	B-T078
that	O
positive	B-T033
emotions	O
would	O
reduce	B-T080
whereas	O
negative	B-T033
emotions	O
would	O
increase	B-T169
eye	O
wrinkle	O
expression	B-T080
.	O
	
sixteen	O
horses	O
were	O
individually	O
exposed	B-T080
in	O
a	O
balanced	B-T169
order	O
to	O
two	O
positive	B-T033
grooming	O
,	O
food	O
anticipation	O
and	O
two	O
negative	B-T033
condition	B-T080
s	O
food	O
competition	O
,	O
waving	O
a	O
plastic	O
bag	O
.	O
	
each	O
condition	B-T080
lasted	O
for	O
60	O
seconds	B-T079
and	O
was	O
preceded	O
by	O
a	O
60	O
second	B-T079
control	B-T079
phase	I-T079
.	O
	
throughout	O
both	O
phases	B-T079
,	O
pictures	O
of	O
the	O
eyes	O
were	O
taken	O
,	O
and	O
for	O
each	O
horse	O
four	O
pictures	O
per	O
condition	B-T080
and	O
phase	B-T079
were	O
randomly	O
selected	O
.	O
	
pictures	O
were	O
scored	O
in	O
random	B-T080
order	I-T080
and	O
by	O
two	O
experimenters	O
blind	O
to	O
condition	B-T080
and	O
phase	B-T079
for	O
six	O
outcome	B-T081
measures	I-T081
qualitative	B-T080
impression	B-T080
,	O
eyelid	O
shape	O
,	O
markedness	B-T080
of	O
the	O
wrinkles	O
,	O
presence	B-T033
of	O
eye	O
white	O
,	O
number	B-T081
of	O
wrinkles	O
,	O
and	O
the	O
angle	O
between	O
the	O
line	O
through	O
the	O
eyeball	O
and	O
the	O
highest	B-T080
wrinkle	O
.	O
	
the	O
angle	O
decreased	B-T081
during	O
grooming	O
and	O
increased	B-T081
during	O
food	O
competition	O
compared	O
to	O
control	B-T079
phase	I-T079
s	O
,	O
whereas	O
the	O
two	O
phases	B-T079
did	O
not	O
differ	O
during	O
food	O
anticipation	O
and	O
the	O
plastic	O
bag	O
condition	B-T080
.	O
	
no	B-T080
effects	I-T080
on	O
the	O
other	O
outcome	B-T081
measures	I-T081
were	O
detected	B-T033
.	O
	
taken	O
together	O
,	O
we	O
have	O
defined	O
a	O
set	O
of	O
measures	B-T081
to	O
assess	O
eye	O
wrinkle	O
expression	B-T080
reliably	O
,	O
of	O
which	O
one	O
measure	B-T081
was	O
affected	B-T169
by	O
the	O
conditions	B-T080
the	O
horses	O
were	O
exposed	B-T080
to	I-T080
.	O
	
variation	B-T080
in	O
eye	O
wrinkle	O
expression	B-T080
might	O
provide	O
valuable	O
information	B-T078
on	O
horse	O
welfare	O
but	O
further	O
validation	O
of	O
specific	B-T080
measures	B-T081
across	O
different	B-T080
conditions	B-T080
effective	B-T080
mercury	O
bioremoval	O
from	O
aqueous	O
solution	O
,	O
and	O
its	O
electrochemical	O
determination	O
this	O
work	O
proposed	O
mercury	O
elimination	O
using	O
agricultural	O
waste	O
allium	O
cepa	O
l	O
the	O
biomass	B-T081
removed	B-T080
99.4	O
of	O
mercury	O
,	O
following	O
a	O
pseudo-second	O
order	O
kinetics	O
r	O
=	O
0.9999	O
.	O
	
the	O
langmuir	O
model	O
was	O
adequately	B-T080
fitted	O
to	O
the	O
adsorption	O
isotherm	O
,	O
thereby	O
obtaining	O
the	O
maximum	B-T081
mercury	O
adsorption	O
capacity	B-T081
of	O
111.1	O
0.3	O
mg	O
g	O
.	O
	
the	O
biomass	B-T081
showed	O
high	B-T080
density	B-T081
of	O
strong	B-T080
mercury	O
chelating	O
groups	O
,	O
thus	O
making	O
it	O
economically	B-T169
attractive	B-T080
.	O
	
also	O
,	O
the	O
implementation	O
of	O
a	O
mercury	O
-	O
selective	O
electrode	O
for	O
continuous	B-T078
determination	O
in	O
real	B-T079
time	I-T079
is	O
proposed	B-T080
this	O
electrode	O
replaces	B-T078
techniques	B-T169
like	O
atomic	O
absorption	O
spectroscopy	O
,	O
thus	O
it	O
can	O
be	O
applied	O
to	O
real	B-T079
time	I-T079
studies	O
.	O
	
this	O
work	O
therefore	O
presents	O
a	O
new	O
perspective	B-T169
for	O
removing	O
mercury	O
from	O
contaminated	O
water	O
for	O
environmental	O
remediation	O
.	O
	
modeling	O
nurse-patient	O
assignments	O
considering	O
patient	B-T080
acuity	I-T080
and	O
travel	O
distance	B-T081
metrics	B-T169
balancing	B-T169
workload	B-T081
among	O
nurses	O
on	O
a	O
hospital	O
unit	O
is	O
important	O
for	O
the	O
satisfaction	O
and	O
safety	O
of	O
nurses	O
and	O
patients	O
.	O
	
to	O
balance	B-T169
nurse	O
workloads	B-T081
,	O
direct	B-T080
patient	O
care	O
activities	O
,	O
indirect	B-T080
patient	O
care	O
activities	O
,	O
and	O
non-patient	O
care	O
activities	O
that	O
occur	O
throughout	O
a	O
shift	B-T169
must	O
be	O
considered	O
.	O
	
the	O
layout	O
of	O
a	O
hospital	O
unit	O
and	O
the	O
location	O
of	O
a	O
nurse's	O
assigned	B-T169
patients	O
relative	B-T080
to	O
other	O
resources	B-T078
on	O
the	O
unit	O
are	O
also	O
important	B-T169
factors	I-T169
in	O
achieving	B-T033
workload	B-T081
balance	B-T169
.	O
	
in	O
most	O
hospitals	O
,	O
a	O
unit	O
charge	O
nurse	O
is	O
responsible	B-T033
for	O
the	O
shift	B-T169
assignment	B-T169
of	O
patients	O
to	O
nurses	O
based	O
on	O
experience	O
and	O
past	O
practices	O
.	O
	
the	O
nurse-patient	O
assignment	O
process	O
is	O
also	O
often	O
a	O
manual	O
process	O
in	O
which	O
the	O
charge	O
nurse	O
must	O
sort	O
through	O
multiple	B-T078
decision	I-T078
criteria	I-T078
in	O
a	O
limited	O
amount	O
of	O
time	B-T079
.	O
	
in	O
this	O
paper	O
,	O
a	O
methodology	B-T078
for	O
the	O
construction	O
of	O
balanced	B-T169
nurse-patient	O
workload	O
assignments	O
is	O
proposed	B-T080
.	O
	
through	O
the	O
illustration	O
of	O
this	O
methodology	B-T078
new	O
scoring	B-T081
metrics	B-T169
are	O
developed	B-T169
using	O
measures	B-T081
currently	O
available	B-T169
on	O
,	O
or	O
from	O
,	O
the	O
hospital	O
unit	O
.	O
	
it	O
was	O
demonstrated	B-T169
that	O
the	O
complex	B-T080
scheduling	I-T080
problem	B-T033
can	O
be	O
captured	O
.	O
	
while	O
the	O
methodology	B-T078
was	O
illustrated	O
for	O
a	O
scheduling	B-T080
problem	B-T033
commonly	O
encountered	O
on	O
a	O
hospital	O
unit	O
,	O
the	O
approach	O
can	O
be	O
adapted	O
to	O
other	O
workforce	B-T169
scheduling	B-T080
problems	B-T033
in	O
which	O
measures	B-T081
of	O
workload	B-T081
are	O
required	B-T169
and	O
composed	O
of	O
elements	O
imposed	O
by	O
the	O
work	O
environment	O
,	O
variability	O
within	O
the	O
required	B-T169
tasks	O
,	O
and	O
a	O
measurable	B-T169
perception	O
of	O
the	O
relative	B-T080
intensity	B-T080
of	O
the	O
work	O
elements	O
.	O
	
effect	B-T080
of	I-T080
alpha	B-T109
lipoic	I-T109
acid	I-T109
on	O
in	B-T080
vitro	I-T080
development	O
of	O
bovine	O
secondary	O
preantral	O
follicles	O
the	O
present	O
study	O
aimed	O
to	O
evaluate	O
the	O
in	B-T080
vitro	I-T080
effect	B-T080
of	I-T080
alpha	B-T109
lipoic	I-T109
acid	I-T109
ala	B-T109
addition	O
to	O
the	O
culture	O
medium	O
on	O
the	O
development	O
of	O
the	O
bovine	O
secondary	O
preantral	O
follicles	O
.	O
	
bovine	O
secondary	O
preantral	O
follicles	O
were	O
collected	B-T169
and	O
divided	B-T169
into	O
two	O
groups	B-T078
depending	O
on	O
their	O
size	O
80-100	O
μm	O
and	O
100-110	O
μm	O
.	O
	
they	O
were	O
cultured	O
in	B-T080
vitro	I-T080
for	O
15	O
days	O
d	O
using	O
different	O
media	O
including	O
at	O
three	O
different	O
doses	B-T081
of	O
ala	B-T109
.	O
	
the	O
genes	O
expression	O
levels	B-T080
of	O
follicle-stimulating	O
hormone	O
beta-subunit	O
fshr	O
,	O
insulin-like	O
growth	O
factor	O
igf-1	O
,	O
activin	O
,	O
luteinizing	O
hormone/choriogonadotropin	O
receptor	O
,	O
bone	O
morphogenetic	O
protein	O
receptor	O
type	O
ia	O
,	O
transforming	O
growth	O
factor	O
beta	O
receptor	O
1	O
,	O
growth	O
differentiation	O
factor	O
9	O
,	O
bcl2-associated	O
x	O
protein	O
bax	O
,	O
and	O
c-myc	O
were	O
studied	O
using	O
real-time	O
polymerase	O
chain	O
reaction	O
.	O
	
the	O
protein	O
expression	O
levels	B-T080
of	O
fshr	B-T116
,	O
igf-1	B-T116
,	O
and	O
bax	B-T116
were	O
measured	O
using	O
western	O
blot	O
analysis	O
.	O
	
the	O
results	O
of	O
the	O
present	O
work	O
revealed	O
that	O
in	B-T080
vitro	I-T080
addition	O
of	O
ala	B-T109
-	O
induced	B-T169
significant	B-T078
increase	O
in	O
the	O
growth	O
and	O
development	O
of	O
secondary	O
preantral	O
follicles	O
throughout	O
the	O
culture	O
period	B-T079
as	O
compared	O
to	O
control	O
.	O
	
the	O
fshr	O
,	O
igf-1	O
,	O
luteinizing	O
hormone/choriogonadotropin	O
receptor	O
,	O
bone	O
morphogenetic	O
protein	O
receptor	O
type	O
ia	O
,	O
transforming	O
growth	O
factor	O
beta	O
receptor	O
1	O
,	O
growth	O
differentiation	O
factor	O
9	O
,	O
and	O
activin	O
a	O
genes	O
were	O
upregulated	O
in	O
ala	B-T109
-	O
treated	B-T169
follicles	O
as	O
compared	O
to	O
the	O
control	O
.	O
	
on	O
contrary	O
,	O
preapoptotic	O
genes	O
bax	O
and	O
c-myc	O
were	O
downregulated	O
in	O
treated	B-T169
follicles	O
compared	O
to	O
control	O
ones	O
.	O
	
the	O
protein	O
levels	O
of	O
fshr	B-T116
and	O
igf-1	B-T116
were	O
highly	O
expressed	O
in	O
treated	B-T169
follicles	O
compared	O
to	O
control	O
however	O
,	O
bax	B-T116
protein	I-T116
was	O
downregulated	O
in	O
the	O
treated	B-T169
follicles	O
groups	B-T078
.	O
	
the	O
addition	O
of	O
ala	B-T109
to	O
the	O
culture	O
medium	O
enhances	O
secondary	O
preantral	O
follicles	O
development	O
and	O
how	O
should	O
proxies	B-T169
of	O
cognitive	O
reserve	O
be	O
evaluated	O
in	O
a	O
population	O
of	O
healthy	B-T080
older	O
adults	O
while	O
some	O
tools	O
have	O
been	O
developed	O
to	O
estimate	B-T081
an	O
individual's	O
cognitive	O
reserve	O
cr	O
,	O
no	O
study	O
has	O
assessed	O
the	O
adequacy	B-T080
of	O
the	O
method	O
used	O
for	O
assessing	O
these	O
cr	O
proxy	B-T169
indicators	O
.	O
	
therefore	O
,	O
we	O
aimed	O
to	O
determine	O
the	O
most	O
appropriate	B-T080
method	O
to	O
estimate	B-T081
cr	O
by	O
comparing	O
two	O
approaches	O
1	O
the	O
common	B-T081
assessment	O
of	O
cr	O
proxies	B-T169
in	O
the	O
literature	O
e.g	O
.	O
	
years	B-T081
of	I-T081
education	I-T081
and	O
2	O
the	O
calculation	O
of	O
a	O
comprehensive	B-T080
index	O
based	O
on	O
most	B-T080
significant	I-T080
parameters	B-T033
used	O
in	O
the	O
estimation	O
of	O
cr	O
.	O
	
data	O
on	O
cr	O
proxies	B-T169
i.e	O
.	O
	
education	O
,	O
occupation	O
,	O
and	O
leisure	O
activities	O
were	O
obtained	O
in	O
a	O
sample	O
of	O
204	O
older	O
adults	O
.	O
	
regression	O
analyses	O
were	O
used	O
to	O
develop	O
the	O
two	O
indices	O
of	O
cr	O
i.e	O
.	O
	
icr-standard	O
and	O
icr-detailed	O
and	O
to	O
determine	O
which	O
index	O
best	O
represented	O
the	O
level	O
of	O
one's	O
cr	O
.	O
	
the	O
icr-standard	O
was	O
calculated	O
using	O
a	O
combination	B-T080
of	O
the	O
three	O
most	O
common	B-T081
measures	B-T081
of	O
reserve	O
in	O
the	O
literature	O
number	B-T081
of	I-T081
schooling	I-T081
years	I-T081
,	O
complexity	B-T080
of	O
the	O
primary	O
occupation	O
,	O
and	O
amount	O
of	O
current	B-T079
participation	B-T169
in	O
stimulating	O
activities	O
.	O
	
the	O
icr-detailed	O
was	O
calculated	O
using	O
the	O
most	B-T080
significant	I-T080
parameters	B-T033
established	O
in	O
initial	B-T079
analyses	O
of	O
cr	O
highest	B-T033
level	I-T033
of	I-T033
education	I-T033
combined	B-T080
with	O
the	O
number	O
of	O
training	O
courses	O
,	O
last	B-T080
occupation	O
,	O
and	O
amount	B-T081
of	O
current	O
participation	B-T169
in	O
social	O
and	O
intellectual	O
activities	O
.	O
	
the	O
comparison	O
of	O
both	O
indices	O
showed	O
that	O
higher	O
levels	O
of	O
icr-standard	O
and	O
icr-detailed	O
were	O
associated	B-T080
with	I-T080
a	O
greater	B-T081
minimization	B-T080
of	O
the	O
effects	B-T080
of	I-T080
age	O
on	O
cognition	O
.	O
	
however	O
,	O
the	O
icr-detailed	O
was	O
more	O
strongly	O
associated	B-T080
to	O
this	O
minimization	B-T080
than	O
the	O
icr-standard	O
,	O
suggesting	O
that	O
the	O
icr-detailed	O
best	O
reflect	O
one's	O
cr	O
.	O
	
this	O
study	O
is	O
the	O
first	O
to	O
show	O
that	O
it	O
is	O
of	O
great	B-T081
importance	B-T080
to	O
question	O
methods	O
measuring	B-T080
cr	O
proxies	B-T169
in	O
order	O
to	O
develop	O
a	O
clinical	O
tool	O
allowing	O
a	O
comprehensive	B-T080
and	O
accurate	B-T080
estimation	O
of	O
discordance	O
in	O
pathology	O
report	O
after	O
central	O
pathology	O
review	O
implications	O
for	O
breast	O
cancer	O
adjuvant	B-T061
treatment	I-T061
pathological	B-T169
predictive	O
factors	O
are	O
the	O
most	O
important	O
markers	O
when	O
selecting	O
early	O
breast	O
cancer	O
adjuvant	B-T061
therapy	I-T061
.	O
	
in	O
randomized	O
clinical	O
trials	O
the	O
variability	O
in	O
pathology	O
report	O
after	O
central	O
pathology	O
review	O
is	O
noteworthy	O
.	O
	
we	O
evaluated	O
the	O
discordance	O
rate	B-T081
dr	B-T081
and	O
inter-rater	B-T081
agreement	I-T081
between	O
local	O
and	O
central	O
histopathological	O
report	O
and	O
the	O
clinical	B-T080
implication	O
on	O
treatment	B-T033
decision	I-T033
.	O
	
a	O
retrospective	O
analysis	O
was	O
conducted	O
in	O
a	O
series	O
of	O
consecutive	O
early	O
breast	O
cancer	O
tumors	O
diagnosed	O
by	O
local	O
pathologists	O
and	O
subsequently	O
reviewed	B-T080
at	O
the	O
pathology	O
division	O
of	O
european	O
institute	O
of	O
oncology	O
.	O
	
the	O
inter-rater	B-T081
agreement	I-T081
k	O
between	O
local	O
and	O
central	O
pathology	O
was	O
calculated	O
for	O
ki-67	B-T116
,	O
grading	O
,	O
hormone	B-T116
receptors	I-T116
er	B-T116
/	O
pgr	B-T116
and	O
her2/neu	O
.	O
	
the	O
bland-altman	O
plots	O
were	O
derived	O
to	O
determine	O
discrepancies	O
in	O
ki-67	B-T116
,	O
er	B-T116
and	O
pgr	B-T116
.	O
	
dr	B-T081
was	O
calculated	O
for	O
er	B-T116
/	O
pgr	B-T116
and	O
her2	B-T116
.	O
	
from	O
2007	O
to	O
2013	O
,	O
187	O
pathology	O
specimens	O
from	O
10	O
cancer	O
centers	O
were	O
reviewed	B-T080
.	O
	
substantial	O
agreement	O
was	O
observed	O
for	O
er	B-T116
k0.612	O
95%	O
ci	B-T081
,	O
0538-0	O
,	O
pgr	B-T116
k0.659	O
95%	O
ci	B-T081
,	O
0580-0	O
,	O
ki-67	B-T116
k0.609	O
95%	O
ci	B-T081
,	O
0.534	O
and	O
grading	O
k0.669	O
95%	O
ci	B-T081
,	O
0.569	O
.	O
	
moderate	O
agreement	O
was	O
found	O
for	O
her2	B-T116
k0.546	O
95%	O
ci	B-T081
,	O
0444-0	O
.	O
	
dr	B-T081
was	O
9.5	O
negativity	O
to	O
positivity	O
and	O
31.7	O
positivity	O
to	O
negativity	O
for	O
her2	B-T116
and	O
26.2	O
negativity	O
to	O
positivity	O
and	O
12.5	O
positivity	O
to	O
negativity	O
for	O
er	B-T116
/	O
pgr	B-T116
.	O
	
according	O
to	O
changes	O
in	O
her2	B-T116
and	O
er	B-T116
/	O
pgr	B-T116
status	O
,	O
23	O
12.2	O
and	O
33	O
17.6	O
systemic	B-T169
prescription	O
were	O
respectively	O
modified	O
.	O
	
in	O
our	O
retrospective	O
analysis	O
,	O
central	O
pathological	O
review	O
has	O
a	O
significant	O
impact	O
in	O
the	O
decision-making	O
process	O
in	O
early	O
breast	O
cancer	O
,	O
as	O
shown	O
in	O
clinical	O
trials	O
.	O
	
implementing	O
non-invasive	B-T169
prenatal	O
diagnosis	O
nipd	O
in	O
a	O
national	O
health	O
service	O
laboratory	O
from	O
dominant	B-T169
to	O
recessive	O
disorders	B-T047
our	O
uk	O
national	O
health	O
service	O
regional	O
genetics	O
laboratory	O
offers	O
nipd	O
for	O
autosomal	O
dominant	O
and	O
de	B-T078
novo	I-T078
conditions	B-T080
achondroplasia	O
,	O
thanataphoric	O
dysplasia	O
,	O
apert	O
syndrome	O
,	O
paternal	B-T080
mutation	O
exclusion	B-T169
for	O
cystic	B-T047
fibrosis	I-T047
and	O
a	O
range	O
of	O
bespoke	O
tests	O
.	O
	
nipd	O
avoids	O
the	O
risks	B-T033
associated	B-T080
with	I-T080
invasive	O
testing	O
,	O
making	O
prenatal	O
diagnosis	O
more	B-T081
accessible	O
to	O
families	O
at	O
high	B-T080
genetic	B-T081
risk	I-T081
.	O
	
however	O
,	O
the	O
challenge	O
remains	O
in	O
offering	O
definitive	B-T079
diagnosis	B-T033
for	O
autosomal	B-T047
recessive	I-T047
diseases	I-T047
,	O
which	O
is	O
complicated	B-T169
by	O
the	O
predominance	B-T080
of	O
the	O
maternal	O
mutant	O
allele	O
in	O
the	O
cell-free	O
dna	O
sample	O
and	O
thus	O
requires	O
a	O
variety	O
of	O
different	B-T080
approaches	O
.	O
	
validation	O
and	O
diagnostic	B-T169
implementation	O
for	O
nipd	O
of	O
congenital	B-T047
adrenal	I-T047
hyperplasia	I-T047
cah	B-T047
is	O
further	O
complicated	B-T169
by	O
presence	B-T033
of	O
a	O
pseudogene	O
that	O
requires	O
a	O
different	B-T080
approach	O
.	O
	
we	O
have	O
used	O
an	O
assay	O
targeting	B-T169
approximately	B-T080
6700	O
heterozygous	O
snps	O
around	O
the	O
cah	O
gene	O
cyp21a2	O
to	O
construct	O
the	O
high-risk	B-T033
parental	O
haplotypes	O
and	O
tested	O
this	O
approach	O
in	O
five	O
cases	O
,	O
showing	O
that	O
inheritance	B-T081
of	O
the	O
parental	O
alleles	O
can	O
be	O
correctly	O
identified	B-T080
using	O
nipd	O
.	O
	
we	O
are	O
evaluating	O
various	O
measures	B-T081
of	O
the	O
fetal	O
fraction	O
to	O
help	O
determine	O
inheritance	B-T081
of	O
parental	O
mutations	O
.	O
	
we	O
are	O
currently	O
exploring	O
the	O
utility	B-T080
of	O
an	O
nipd	O
multi-disorder	O
panel	O
for	O
autosomal	B-T047
recessive	I-T047
disease	I-T047
,	O
to	O
make	O
testing	B-T169
more	O
widely	O
applicable	B-T080
to	O
families	O
with	O
a	O
variety	O
of	O
serious	B-T080
genetic	B-T047
conditions	I-T047
.	O
	
silk	O
fibroin	O
based	O
carrier	O
system	O
for	O
delivery	B-T169
of	O
fibrinogen	B-T116
and	O
thrombin	B-T116
as	O
coagulant	O
supplements	B-T169
the	O
control	B-T169
of	O
bleeding	O
is	O
one	O
of	O
the	O
most	O
important	O
interventions	B-T061
after	O
a	O
traumatic	O
injury	O
.	O
	
hemostatic	O
devices	O
delivering	O
blood	O
clotting	O
accelerating	O
agents	O
such	O
as	O
fibrinogen	B-T116
are	O
increasingly	B-T169
used	O
due	O
to	O
their	O
efficacy	B-T080
and	O
their	O
ease	O
of	O
application	O
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
describe	O
a	O
method	O
to	O
incorporate	B-T169
the	O
coagulant	O
supplements	B-T169
fibrinogen	B-T116
and	O
thrombin	B-T116
in	O
silk	O
protein	O
sponges	O
by	O
mixing	O
the	O
coagulants	O
with	O
an	O
aqueous	O
silk	B-T116
solution	O
,	O
followed	O
by	O
molding	O
,	O
freeze-drying	O
and	O
water	O
annealing	O
.	O
	
in	O
this	O
combination	B-T080
system	B-T169
we	O
demonstrate	O
the	O
delivery	B-T169
of	O
fibrinogen	B-T116
while	O
maintaining	O
its	O
hemostatic	O
potential	O
.	O
	
concentration	B-T081
ratios	I-T081
of	O
silk	B-T116
to	O
fibrinogen	B-T116
of	O
1.0	O
,	O
2.3	O
and	O
3.0	O
were	O
used	O
.	O
	
the	O
thrombin	B-T116
-induced	O
fibrin	B-T116
polymeric	O
network	B-T169
filled	O
the	O
space	O
in	O
and	O
next	O
to	O
the	O
silk	B-T116
spongy	O
structure	O
but	O
also	O
remained	O
interconnected	O
to	O
the	O
silk	B-T116
,	O
providing	O
an	O
intact	B-T080
network	B-T169
.	O
	
the	O
mechanical	O
characterization	O
of	O
the	O
fibrinogen-releasing	B-T169
silk	B-T116
sponges	O
before	O
and	O
after	O
the	O
induction	B-T169
of	O
the	O
fibrinogen	B-T116
polymerization	O
demonstrated	O
that	O
the	O
fibrin	B-T116
network	B-T169
resulted	O
in	O
reduced	B-T080
permanent	B-T079
deformation	B-T169
from	O
21.1	O
to	O
6.5	O
,	O
19.6	O
to	O
5.7	O
and	O
12.7	O
to	O
9.4	O
for	O
the	O
2.8	O
,	O
1.5	O
and	O
0.8	O
fibrinogen	B-T116
-containing	O
silk	B-T116
sponges	O
,	O
respectively	O
.	O
	
moreover	O
,	O
the	O
fibrin	B-T116
formation	B-T169
lead	O
to	O
a	O
more	O
linear	O
elastic	O
behavior	O
over	O
longer	O
strain	O
ranges	O
.	O
	
in	O
combination	O
,	O
the	O
calcein-am	B-T109
/	O
pi	B-T109
stainings	O
and	O
mtt	O
assay	O
results	O
indicate	O
uniform	B-T080
cell	O
adhesion	O
on	O
the	O
surface	O
and	O
cytocompatibility	B-T080
of	O
the	O
silk	B-T116
/	O
fibrin	B-T116
sponges	O
,	O
respectively	O
.	O
	
moreover	O
,	O
the	O
co-delivery	B-T169
of	O
thrombin	B-T116
with	O
fibrinogen	B-T116
via	O
silk	B-T116
as	O
carrier	O
material	O
is	O
described	O
,	O
offering	O
a	O
more	O
mechanically	B-T169
robust	B-T080
and	O
durable	B-T080
system	I-T080
while	O
preserving	B-T169
hemostatic	O
features	O
of	O
the	O
coagulant	O
substances	O
for	O
the	O
generation	O
of	O
hemostatic	O
devices	O
.	O
	
adoptively	O
transferred	O
natural	O
killer	O
cells	O
maintain	O
long-term	O
antitumor	B-T033
activity	I-T033
by	O
epigenetic	O
imprinting	O
and	O
cd4	O
t	O
cell	O
help	O
natural	O
killer	O
nk	O
cell	O
infusions	B-T061
can	O
induce	O
remissions	O
in	O
subsets	O
of	O
patients	O
with	O
different	O
types	O
of	O
cancer	O
.	O
	
the	O
optimal	O
strategies	O
for	O
nk	O
cell	O
activation	O
prior	O
to	O
infusion	B-T061
are	O
still	O
under	O
debate	O
.	O
	
there	O
is	O
recent	O
evidence	O
that	O
nk	O
cells	O
can	O
acquire	O
long-term	O
functional	O
competence	O
by	O
preactivation	O
with	O
the	O
cytokines	B-T116
il-12	B-T116
/	O
15	B-T116
/	O
18	B-T116
.	O
	
the	O
mechanisms	O
supporting	O
the	O
maintenance	O
of	O
long-term	O
nk	O
cell	O
antitumor	B-T033
activity	I-T033
are	O
incompletely	O
under-stood	O
.	O
	
here	O
,	O
we	O
show	O
that	O
nk	O
cells	O
preactivated	O
in	O
vitro	O
with	O
il-12	B-T116
/	O
15	B-T116
/	O
18	B-T116
,	O
but	O
not	O
with	O
il-15	B-T116
alone	O
,	O
maintained	O
high	O
antitumor	B-T033
activity	I-T033
even	O
1	B-T079
mo	I-T079
after	O
transfer	O
into	O
lymphopenic	B-T047
rag-2	O
γc	O
mice	O
.	O
	
the	O
nk	O
cell	O
intrinsic	O
ability	O
for	O
ifnγ	B-T116
production	O
coincided	O
with	O
demethylation	O
of	O
the	O
conserved	O
non-coding	O
sequence	O
cns	O
1	O
in	O
the	O
ifng	O
locus	O
,	O
previously	O
shown	O
to	O
enhance	O
transcription	O
of	O
ifng	O
.	O
	
in	O
a	O
xenograft	O
melanoma	O
mouse	O
model	O
,	O
human	O
il-12	B-T116
/	O
15	B-T116
/	O
18	B-T116
-preactivated	O
nk	O
cells	O
rejected	O
tumors	O
more	O
efficiently	O
.	O
	
in	O
rag-2	O
γc	O
mice	O
,	O
co-transfer	O
of	O
cd4	O
t	O
cells	O
further	O
improved	O
the	O
long-term	O
competence	O
of	O
nk	O
cells	O
for	O
ifnγ	B-T116
production	O
that	O
was	O
dependent	O
on	O
il-2	B-T116
.	O
	
cd4	O
t	O
cell	O
activation	O
during	O
homeostatic	O
proliferation	O
required	O
macrophages	O
and	O
further	O
promoted	O
the	O
long-term	O
nk	O
cell	O
antitumor	B-T033
activity	I-T033
.	O
	
thus	O
,	O
nk	O
cells	O
can	O
"""remember"""	O
a	O
previous	O
exposure	O
to	O
cytokines	B-T116
by	O
epigenetic	O
imprinting	O
resulting	O
in	O
a	O
remarkable	O
stability	O
of	O
the	O
ifnγ	B-T116
-producing	O
phenotype	O
after	O
adoptive	O
transfer	O
.	O
	
in	O
addition	O
,	O
our	O
results	O
support	O
combination	O
of	O
cytokine	B-T116
-preactivated	O
nk	O
cells	O
with	O
cd4	O
t	O
cell	O
activation	O
upon	O
lymphopenic	B-T047
conditioning	O
to	O
achieve	O
long-term	O
nk	O
cell	O
effector	O
function	O
for	O
cancer	B-T061
immunotherapy	I-T061
.	O
	
survey	O
of	O
neonatal	O
intensive	O
care	O
unit	O
nurse	O
attitudes	O
toward	O
therapeutic	B-T061
hypothermia	I-T061
treatment	I-T061
the	O
traumatic	B-T169
experiences	O
of	O
parent	O
s	O
of	O
babies	O
treated	B-T061
with	I-T061
therapeutic	B-T061
hypothermia	I-T061
th	B-T061
have	O
been	O
described	O
.	O
	
no	O
research	O
has	O
assessed	O
neonatal	O
intensive	O
care	O
unit	O
nicu	O
nurse	O
experience	O
in	O
providing	O
care	O
to	O
hypothermic	B-T033
babies	O
and	O
emotional	O
support	O
to	O
their	O
parents	O
.	O
	
to	O
assess	O
nicu	O
nurse	O
attitudes	O
to	O
the	O
provision	O
of	O
th	B-T061
with	O
respect	O
to	O
perceptions	O
about	O
baby	O
pain	O
/	O
sedation	B-T061
,	O
need	O
for	O
nurse	O
and	O
parent	O
education	O
,	O
decision	O
making	O
about	O
initiation	B-T169
of	O
th	B-T061
,	O
and	O
barriers	O
to	O
best	O
care	O
.	O
	
a	O
survey	O
was	O
electronically	O
sent	O
to	O
219	O
nurses	O
at	O
2	O
affiliated	O
academic	O
level	O
iii	O
nicus	O
1	O
rural	O
and	O
1	O
urban	O
location	O
.	O
	
there	O
were	O
17	O
questions	O
where	O
responses	O
were	O
selected	O
from	O
a	O
preset	O
list	O
and	O
7	O
opportunities	O
for	O
nurses	O
to	O
provide	O
free	O
text	O
responses	O
.	O
	
the	O
response	O
rate	O
was	O
38%	O
n	O
=	O
83	O
.	O
	
overwhelming	B-T080
similarities	O
between	O
the	O
urban	O
and	O
rural	O
institutions	O
were	O
found	O
with	O
nicu	O
nurses	O
expressing	O
understanding	O
of	O
the	O
indications	O
for	O
initiating	O
th	B-T061
,	O
agreement	O
that	O
th	B-T061
improves	O
long-term	B-T079
outcomes	B-T080
and	O
that	O
the	O
benefits	O
of	O
th	B-T061
outweigh	O
the	O
risks	O
.	O
	
nurses	O
at	O
the	O
urban	O
institution	O
more	O
frequently	O
expressed	O
concerns	O
surrounding	O
inadequate	O
treatment	B-T061
of	O
baby	O
pain	O
/	O
sedation	B-T061
,	O
and	O
nurses	O
at	O
both	O
institutions	O
strongly	O
emphasized	O
the	O
need	O
for	O
more	O
nurse	O
and	O
parent	O
education	O
about	O
th	B-T061
and	O
improved	O
timeliness	O
of	O
decision	O
making	O
for	O
initiation	B-T169
of	O
th	B-T061
.	O
	
nicu	O
nurses	O
specifically	O
want	O
to	O
learn	O
more	O
about	O
outcomes	B-T080
of	O
babies	O
after	O
treatment	B-T061
with	O
th	B-T061
and	O
feel	O
that	O
parents	O
need	O
more	O
education	O
about	O
th	B-T061
.	O
	
research	O
is	O
urgently	O
needed	O
to	O
better	O
understand	O
the	O
implications	O
of	O
th	B-T061
treatment	I-T061
for	O
parent	O
-	O
baby	O
pharmacological	B-T061
venous	I-T061
thromboembolism	I-T061
prophylaxis	I-T061
in	O
meningioma	O
patients	O
should	O
it	O
be	O
earlier	O
than	O
clinical	B-T061
practice	I-T061
we	O
read	O
the	O
report	O
by	O
çeltikçi	O
et	O
al	O
in	O
the	O
turkish	O
neurosurgery	O
with	O
great	O
interest	O
.	O
	
in	O
this	O
single-center	O
retrospective	O
study	O
,	O
they	O
analysed	O
449	O
intracranial	O
meningioma	O
patients	O
underwent	O
open	B-T061
surgery	I-T061
.	O
	
they	O
stated	O
that	O
venous	B-T047
thromboembolism	I-T047
vte	B-T047
had	O
been	O
seen	O
in	O
21	O
4.6	O
of	O
their	O
patients	O
.	O
	
this	O
is	O
an	O
important	O
issue	O
because	O
vte	B-T047
,	O
including	O
deep	B-T047
vein	I-T047
thrombosis	I-T047
dvt	B-T047
and	O
pulmonary	B-T047
embolism	I-T047
pe	B-T047
,	O
is	O
the	O
most	O
common	O
overall	O
complication	O
in	O
meningioma	B-T061
surgery	I-T061
and	O
is	O
fatal	O
in	O
up	O
to	O
one	O
third	O
of	O
patients	O
2	O
.	O
	
we	O
suppose	O
that	O
prophylaxis	B-T061
of	O
vte	B-T047
is	O
most	O
effective	O
when	O
mechanical	O
and	O
pharmacological	B-T061
prophylaxis	I-T061
are	O
combined	O
.	O
	
we	O
consider	O
that	O
there	O
key	O
some	O
practical	O
questions	O
to	O
be	O
answered	O
for	O
a	O
proper	O
clinical	B-T169
extrapolation	I-T169
.	O
	
best	O
next-generation	B-T079
biomedical	O
entity	O
search	O
tool	O
for	O
knowledge	O
discovery	O
from	O
biomedical	B-T078
literature	I-T078
as	O
the	O
volume	B-T080
of	O
publications	O
rapidly	B-T080
increases	B-T081
,	O
searching	O
for	O
relevant	B-T080
information	B-T078
from	O
the	O
literature	O
becomes	O
more	O
challenging	B-T033
.	O
	
to	O
complement	O
standard	B-T080
search	O
engines	O
such	O
as	O
pubmed	O
,	O
it	O
is	O
desirable	B-T080
to	O
have	O
an	O
advanced	O
search	O
tool	O
that	O
directly	B-T080
returns	B-T080
relevant	B-T080
biomedical	B-T080
entities	O
such	O
as	O
targets	O
,	O
drugs	O
,	O
and	O
mutations	O
rather	O
than	O
a	O
long	O
list	O
of	O
articles	O
.	O
	
some	O
existing	B-T033
tools	O
submit	B-T169
a	O
query	O
to	O
pubmed	O
and	O
process	O
retrieved	O
abstracts	O
to	O
extract	O
information	B-T078
at	O
query	O
time	B-T079
,	O
resulting	B-T169
in	O
a	O
slow	B-T080
response	O
time	B-T079
and	O
limited	B-T169
coverage	B-T169
of	O
only	O
a	O
fraction	B-T081
of	I-T081
the	O
pubmed	O
corpus	O
.	O
	
other	O
tools	O
preprocess	O
the	O
pubmed	O
corpus	O
to	O
speed	O
up	O
the	O
response	O
time	B-T079
however	O
,	O
they	O
are	O
not	O
constantly	B-T080
updated	B-T079
,	O
and	O
thus	O
produce	B-T169
outdated	O
results	B-T169
.	O
	
further	O
,	O
most	O
existing	O
tools	O
cannot	O
process	O
sophisticated	B-T080
queries	O
such	O
as	O
searches	O
for	O
mutations	O
that	O
co-occur	O
with	O
query	O
terms	O
in	O
the	O
literature	O
.	O
	
to	O
address	O
these	O
problems	B-T033
,	O
we	O
introduce	B-T169
best	O
,	O
a	O
biomedical	O
entity	O
search	O
tool	O
.	O
	
best	O
returns	B-T080
,	O
as	O
a	O
result	B-T169
,	O
a	O
list	O
of	O
10	O
different	B-T080
types	O
of	O
biomedical	B-T080
entities	O
including	B-T169
genes	O
,	O
diseases	B-T047
,	O
drugs	O
,	O
targets	O
,	O
transcription	B-T116
factors	I-T116
,	O
mirnas	O
,	O
and	O
mutations	O
that	O
are	O
relevant	B-T080
to	O
a	O
user's	O
query	O
.	O
	
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
best	O
is	O
the	O
only	O
system	B-T169
that	O
processes	O
free	O
text	O
queries	O
and	O
returns	B-T080
up-to-date	B-T033
results	B-T169
in	O
real	B-T079
time	I-T079
including	B-T169
mutation	O
information	B-T078
in	O
the	O
results	B-T169
.	O
	
best	O
alanine	B-T116
to	O
serine	B-T116
variant	B-T080
at	O
position	O
986	O
of	O
calcium	B-T116
sensing	I-T116
receptor	I-T116
and	O
colorectal	O
cancer	O
risk	B-T078
with	O
regard	O
to	O
the	O
effect	B-T080
of	O
calcium	O
against	O
colorectal	O
cancer	O
crc	O
and	O
considering	O
the	O
key	O
role	O
of	O
calcium	B-T116
sensing	I-T116
receptor	I-T116
casr	B-T116
in	O
calcium	O
homeostasis	O
,	O
this	O
study	O
investigated	B-T169
whether	O
casr	O
gene	O
rs1801725	O
or	O
a986s	O
variant	O
was	O
associated	B-T080
with	I-T080
susceptibility	B-T169
to	O
crc	O
risk	B-T078
.	O
	
this	O
study	O
was	O
conducted	O
as	O
a	O
case-control	O
study	O
and	O
303	O
cases	B-T169
with	O
crc	O
and	O
354	O
controls	O
were	O
enrolled	O
.	O
	
all	O
657	O
subjects	O
were	O
genotyped	O
for	O
casr	O
gene	O
a986s	O
variant	O
using	O
pcr	O
-	O
rflp	O
method	O
.	O
	
no	B-T033
significant	I-T033
difference	B-T080
was	O
observed	B-T169
for	O
the	O
a986s	O
variant	O
of	O
casr	O
gene	O
in	O
either	O
genotype	O
or	O
allele	B-T081
frequencies	I-T081
between	O
the	O
cases	B-T169
and	O
the	O
controls	O
and	O
this	O
lack	B-T080
of	O
difference	B-T080
remained	O
non-significant	O
even	O
after	O
adjustment	B-T169
for	O
age	O
,	O
bmi	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
family	B-T033
history	I-T033
of	O
crc	O
.	O
	
no	B-T080
evidence	I-T080
for	O
the	O
effect	B-T080
modification	B-T033
of	O
the	O
association	B-T080
a986s	O
variant	O
and	O
crc	O
by	O
bmi	O
,	O
sex	O
,	O
or	O
tumor	O
site	O
was	O
also	O
observed	B-T169
.	O
	
furthermore	O
,	O
the	O
risk	B-T078
of	O
obesity	B-T047
in	O
relation	B-T080
to	O
the	O
a986s	O
variant	O
in	O
the	O
controls	O
and	O
the	O
cases	B-T169
was	O
separately	O
analyzed	O
and	O
we	O
observed	O
no	B-T033
significant	I-T033
difference	I-T033
between	O
normal	B-T033
weight	I-T033
bmi	O
<	O
25kg/m	O
and	O
overweight	O
/	O
obese	B-T047
bmi	O
25kg/m	O
subjects	O
.	O
	
our	O
findings	B-T033
do	O
not	O
support	O
a	O
role	O
for	O
effect	B-T080
of	O
the	O
casr	O
gene	O
a986s	O
variant	O
on	O
crc	O
risk	B-T078
nevertheless	O
,	O
this	O
finding	B-T033
requires	O
confirmation	B-T033
and	O
the	O
role	O
of	O
the	O
gene	O
variant	O
in	O
carcinogenesis	O
needs	O
to	O
be	O
further	O
treatment	B-T061
of	O
erythematotelangiectatic	B-T047
rosacea	I-T047
with	O
the	O
fractionation	B-T061
of	O
high-fluence	B-T079
,	O
long-pulsed	O
595-nm	O
pulsed	O
dye	O
laser	O
various	O
lasers	O
have	O
been	O
used	O
for	O
the	O
treatment	B-T061
of	O
erythematotelangiectatic	B-T047
rosacea	I-T047
etr	B-T047
that	O
does	O
not	O
respond	O
to	O
systemic	B-T061
or	O
topical	B-T061
therapy	I-T061
.	O
	
the	O
pulsed	O
dye	O
lasers	O
pdls	O
are	O
an	O
effective	O
option	O
for	O
etr	B-T047
,	O
and	O
the	O
purpuragenic	B-T047
fluence	B-T079
proved	O
to	O
be	O
superior	O
until	O
now	O
.	O
	
given	O
that	O
purpura	B-T047
and	O
subsequent	O
possible	O
postinflammatory	O
hyperpigmentation	O
pih	O
are	O
occasionally	O
unbearable	O
in	O
some	O
patients	O
,	O
and	O
several	O
studies	O
using	O
the	O
low	O
nonpurpuragenic	B-T033
fluence	B-T079
were	O
reported	O
.	O
	
to	O
deliver	O
the	O
sufficient	O
high	B-T079
fluence	I-T079
of	O
a	O
pdl	O
without	O
generating	O
purpura	B-T047
,	O
we	O
designed	O
the	O
fractionation	B-T061
of	O
high	B-T079
fluence	I-T079
using	O
five	O
passes	O
and	O
longer	O
pulse	O
duration	O
6	O
milliseconds	O
of	O
a	O
pdl	O
in	O
succession	O
.	O
	
a	O
total	O
of	O
eight	O
patients	O
with	O
etr	B-T047
were	O
enrolled	O
in	O
this	O
study	O
all	O
patients	O
were	O
treated	O
with	O
pdl	O
10	O
times	O
at	O
2-week	O
intervals	O
.	O
	
erythema	B-T047
and	O
telangiectasia	B-T047
scores	O
,	O
as	O
well	O
as	O
improvement	O
,	O
were	O
assessed	O
by	O
two	O
physicians	O
using	O
the	O
digital	O
photographs	O
.	O
	
moderate-to-marked	O
improvement	O
was	O
achieved	O
in	O
most	O
of	O
the	O
patients	O
,	O
and	O
erythema	B-T047
and	O
telangiectasia	B-T047
scores	O
were	O
significantly	O
decreased	O
.	O
	
purpura	B-T047
and	O
pih	O
were	O
not	O
reported	O
in	O
all	O
patients	O
.	O
	
the	O
fractionation	B-T061
of	O
high-fluence	B-T079
,	O
long-pulsed	O
595	O
nm	O
pdl	O
is	O
a	O
very	O
safe	O
and	O
effective	O
treatment	B-T061
for	O
propulsion	O
strategy	O
in	O
the	O
gait	B-T033
of	O
primary	O
school	O
children	O
the	O
effect	B-T080
of	O
age	O
and	O
speed	B-T081
the	O
strategy	O
used	O
to	O
generate	O
power	B-T081
for	O
forward	O
propulsion	O
in	O
walking	O
and	O
running	O
has	O
recently	O
been	O
highlighted	O
as	O
a	O
marker	O
of	O
gait	B-T033
maturation	O
and	O
elastic	B-T081
energy	I-T081
recycling	B-T169
.	O
	
this	O
study	O
investigated	O
ankle	O
and	O
hip	O
power	B-T081
generation	O
as	O
a	O
propulsion	O
strategy	O
ps	O
during	O
the	O
late	B-T033
stance	I-T033
/	O
early	B-T033
swing	I-T033
phases	I-T033
of	O
walking	O
and	O
running	O
in	O
typically	O
developing	O
td	O
children	O
15	O
six	O
to	O
nine	O
years	B-T079
17	O
nine	O
to	O
13	O
years	B-T079
using	O
three-dimensional	O
gait	O
analysis	O
.	O
	
peak	B-T080
ankle	O
power	B-T081
generation	O
at	O
push-off	B-T080
peaka2	B-T080
,	O
peak	B-T080
hip	O
power	B-T081
generation	O
in	O
early	B-T033
swing	I-T033
peakh3	B-T080
and	O
propulsion	O
strategy	O
ps	O
peaka2	B-T080
/	O
peaka2+peakh3	B-T080
were	O
calculated	B-T169
to	O
provide	O
the	O
relative	O
contribution	O
of	O
ankle	O
power	B-T081
to	O
total	O
propulsion	O
.	O
	
mean	B-T081
ps	O
values	B-T080
decreased	B-T081
as	O
speed	B-T081
increased	B-T081
for	O
comfortable	O
walking	O
p<0	O
,	O
fast	B-T080
walking	O
p<0	O
and	O
fast	B-T080
running	O
p<0	O
,	O
and	O
less	O
consistently	O
during	O
jogging	O
p=0	O
.	O
	
ps	O
varied	O
with	O
age	O
p<0	O
only	O
during	O
fast	B-T080
walking	O
.	O
	
at	O
any	O
speed	B-T081
of	O
fast	B-T080
walking	O
,	O
older	O
children	O
generated	O
more	O
peaka2	B-T080
p=0	O
and	O
less	O
peakh3	B-T080
p=0	O
than	O
younger	O
children	O
.	O
	
while	O
the	O
kinetics	O
of	O
running	O
propulsion	O
appear	O
to	O
be	O
developed	O
by	O
age	O
six	O
years	B-T079
,	O
the	O
skills	O
of	O
fast	B-T080
walking	O
appeared	O
to	O
require	O
additional	O
neuromuscular	B-T080
maturity	O
.	O
	
these	O
findings	B-T033
support	O
the	O
concept	O
that	O
running	O
is	O
a	O
skill	O
that	O
matures	O
early	B-T079
for	O
td	O
children	O
.	O
	
the	O
relationship	B-T080
between	O
anthropometry	O
and	O
body	O
composition	O
from	O
computed	O
tomography	O
the	O
mediators	O
of	O
atherosclerosis	B-T047
in	O
south	O
asians	O
living	B-T078
in	O
america	O
study	O
few	O
studies	O
examine	O
the	O
relationships	B-T080
between	O
anthropometry	O
and	O
the	O
body	O
composition	O
measures	O
they	O
approximate	O
,	O
or	O
whether	O
they	O
differ	O
by	O
sex	O
,	O
and	O
no	O
studies	O
have	O
examined	O
these	O
relationships	B-T080
in	O
south	O
asians	O
living	O
in	O
the	O
us	O
.	O
	
we	O
conducted	O
a	O
cross-sectional	O
study	O
of	O
871	O
participants	O
in	O
the	O
mediators	O
of	O
atherosclerosis	B-T047
in	O
south	O
asians	O
living	B-T078
in	O
america	O
masala	O
study	O
who	O
had	O
bmi	O
<	O
40	O
kg/m	O
and	O
underwent	O
abdominal	O
ct	O
scans	O
for	O
measurement	B-T169
of	O
visceral	O
and	O
subcutaneous	O
fat	O
.	O
	
linear	B-T081
regression	I-T081
was	O
used	O
to	O
model	O
the	O
associations	O
between	O
anthropometric	O
measures	O
and	O
naturally	O
log-transformed	O
body	O
composition	O
measures	O
.	O
	
all	O
measures	O
of	O
anthropometry	O
,	O
except	O
height	O
,	O
were	O
significantly	O
associated	B-T080
with	I-T080
visceral	O
fat	O
and	O
had	O
a	O
significant	B-T078
non-linear	O
component	O
p	O
<	O
05	O
.	O
	
the	O
only	O
associations	O
for	O
visceral	O
fat	O
that	O
exhibited	O
significant	B-T078
heterogeneity	B-T080
by	O
sex	O
were	O
waist	O
circumference	O
%	O
difference	O
in	O
visceral	O
fat	O
slope	O
women	O
1.92	O
,	O
men	O
2.74	O
,	O
p	O
=	O
007	O
for	O
interaction	O
and	O
waist-to-hip	O
ratio	O
women	O
25.9	O
,	O
men	O
717.4	O
,	O
p	O
<	O
001	O
.	O
	
except	O
for	O
height	O
,	O
all	O
measures	O
of	O
anthropometry	O
were	O
significantly	O
associated	B-T080
with	I-T080
subcutaneous	O
fat	O
,	O
had	O
a	O
significant	B-T078
quadratic	O
component	O
,	O
and	O
significant	B-T078
heterogeneity	B-T080
by	O
sex	O
weight	O
kg	O
2.74	O
for	O
women	O
,	O
4.08	O
for	O
men	O
bmi	O
kg/m	O
10.3	O
,	O
14.0	O
waist	O
circumference	O
cm	O
1.51	O
,	O
3.36	O
hip	O
circumference	O
cm	O
2.53	O
,	O
4.50	O
with	O
p	O
<	O
001	O
for	O
each	O
.	O
	
in	O
masala	O
participants	O
,	O
the	O
relationships	B-T080
of	O
anthropometric	O
measures	O
with	O
visceral	O
and	O
subcutaneous	O
fat	O
appear	O
similar	O
to	O
other	O
race	O
/	O
ethnic	O
groups	O
,	O
but	O
with	O
weaker	B-T080
non-linearity	O
and	O
heterogeneity	B-T080
by	O
sex	O
.	O
	
given	O
these	O
results	O
,	O
researchers	O
should	O
consider	O
separate	O
models	O
by	O
sex	O
for	O
us	O
south	O
asians	O
when	O
approximating	O
subcutaneous	O
fat	O
or	O
when	O
using	O
waist	O
circumference	O
to	O
approximate	O
visceral	O
fat	O
.	O
	
active	B-T169
packaging	O
of	O
chicken	O
meats	O
with	O
modified	B-T169
atmosphere	O
including	O
oxygen	O
scavengers	O
the	O
effects	B-T080
of	I-T080
modified	B-T169
atmosphere	O
packaging	O
map	O
-70%	O
co2	O
/30%	O
n2	O
and	O
iron	O
-based	O
oxygen	O
scavengers	O
os	O
with	O
various	O
absorption	O
capacities	O
ageless	O
ss100	O
,	O
ss300	O
,	O
and	O
ss500	O
as	O
an	O
active	O
packaging	O
system	O
on	O
microbiological	O
and	O
oxidative	B-T169
changes	B-T169
in	O
chicken	O
thigh	O
meats	O
were	O
evaluated	O
during	O
refrigerated	B-T169
storage	I-T169
4	O
for	O
19	O
d	O
at	O
3-	O
day	B-T079
intervals	B-T079
.	O
	
total	B-T081
aerobic	I-T081
mesophilic	I-T081
bacteria	I-T081
counts	I-T081
exceeded	O
the	O
acceptability	B-T081
limit	I-T081
at	O
d	O
7	O
in	O
the	O
control	O
group	O
without	O
map	O
air	O
,	O
and	O
at	O
d	O
19	O
in	O
map	O
and	O
os	O
containing	O
samples	O
.	O
	
os	O
utilization	B-T169
resulted	O
in	O
around	O
1.5	O
and	O
1.0	O
log	O
unit	O
reductions	B-T080
in	O
pseudomonas	O
spp	O
.	O
	
counts	B-T081
at	O
d	O
7	O
and	O
d	O
10	O
of	O
storage	B-T169
,	O
respectively	O
,	O
as	O
compared	O
with	O
air	O
and	O
map	O
groups	B-T078
p	O
<	O
0.05	O
.	O
	
map	O
and	O
os	O
groups	B-T078
had	O
fewer	O
p	O
<	O
0.05	O
coliform	B-T081
counts	I-T081
than	O
did	O
the	O
air	O
group	B-T078
,	O
with	O
an	O
approximately	O
1.0	O
log	O
reduction	B-T080
observed	O
at	O
d	O
10	O
.	O
	
although	O
in	O
some	O
cases	B-T169
os	O
utilization	B-T169
resulted	O
in	O
lower	O
tbars	B-T109
values	B-T081
and	O
carbonyl	O
and	O
sulphydryl	O
contents	O
,	O
particularly	O
during	O
later	O
stages	B-T079
of	O
refrigerated	B-T169
storage	I-T169
as	O
compared	O
to	O
air	O
and	O
map	O
groups	B-T078
,	O
in	O
general	O
,	O
these	O
effects	B-T080
were	O
not	O
always	O
apparent	O
.	O
	
the	O
results	O
of	O
this	O
study	O
suggested	O
that	O
map	O
suppressed	B-T169
microbiological	O
growth	O
and	O
retarded	O
lipid	O
and	O
protein	O
oxidation	O
in	O
chicken	O
thigh	O
meats	O
,	O
with	O
a	O
9-	O
day	B-T079
shelf-life	O
extention	O
with	O
insignificant	O
effects	B-T080
of	I-T080
os	O
.	O
	
multidrug	O
resistance	O
of	O
acinetobacter	O
baumannii	O
in	O
ladoke	O
akintola	O
university	O
teaching	O
hospital	O
,	O
osogbo	O
,	O
nigeria	O
acinetobacter	O
baumannii	O
is	O
a	O
ubiquitous	O
pathogen	O
that	O
has	O
emerged	O
as	O
a	O
major	O
cause	O
of	O
healthcare-associated	O
infections	O
at	O
ladoke	O
akintola	O
university	O
teaching	O
hospital	O
.	O
	
isolates	O
were	O
assayed	O
according	O
to	O
standard	O
protocol	O
.	O
	
the	O
isolates	O
were	O
subjected	O
to	O
molecular	O
techniques	O
to	O
detect	O
blaoxa	O
,	O
blatem	O
,	O
blactx-m	O
,	O
and	O
blashv	O
genes	O
in	O
strains	O
of	O
the	O
a	O
.	O
	
baumannii	O
isolates	O
.	O
	
the	O
prevalence	O
of	O
a	O
.	O
	
baumannii	O
was	O
8.5	O
and	O
was	O
most	O
prevalent	O
among	O
patients	O
in	O
the	O
age	O
group	O
51-60	O
36%	O
the	O
male	O
patients	O
63.6	O
were	O
more	O
infected	B-T033
than	O
their	O
female	O
counterparts	O
.	O
	
patients	O
72.7	O
in	O
the	O
intensive	O
care	O
unit	O
icu	O
were	O
most	O
infected	B-T033
with	O
this	O
organism	O
.	O
	
the	O
isolates	O
showed	O
100%	O
resistance	B-T169
to	O
both	O
amikacin	B-T109
and	O
ciprofloxacin	B-T109
and	O
90.9	O
to	O
both	O
ceftriaxone	B-T109
and	O
ceftazidime	B-T109
,	O
while	O
resistance	B-T169
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
piperacillin	B-T109
81.8	O
,	O
imipenem	B-T109
72.7	O
,	O
gentamycin	B-T109
72.2	O
,	O
and	O
meropenem	B-T109
63.6	O
.	O
	
none	O
of	O
the	O
isolates	O
was	O
,	O
however	O
,	O
resistant	B-T169
to	O
colistin	B-T109
.	O
	
pcr	O
results	O
showed	O
that	O
blaoxa	O
,	O
blatem	O
,	O
and	O
blactx-m	O
genes	O
were	O
positive	B-T033
in	O
some	O
isolates	O
,	O
while	O
blashv	O
was	O
not	B-T033
detected	I-T033
in	O
any	O
of	O
the	O
isolates	O
.	O
	
this	O
study	O
has	O
revealed	B-T080
that	O
the	O
strains	O
of	O
a	O
.	O
	
baumannii	O
isolated	B-T169
are	O
multiple	O
drug	O
resistant	O
.	O
	
regular	O
monitoring	O
,	O
judicious	O
prescription	O
,	O
and	O
early	O
detection	B-T061
of	O
resistance	B-T169
to	O
these	O
antibiotics	O
are	O
,	O
therefore	O
,	O
necessary	O
to	O
check	O
further	O
dissemination	O
of	O
the	O
dataset	O
of	O
the	O
molecular	O
dynamics	O
simulations	O
of	O
bilayers	B-T080
consisting	O
of	O
short	O
amyloidogenic	B-T116
peptide	I-T116
vdswnvlvag	O
from	O
bgl2p-glucantransferase	B-T116
of	O
s	O
.	O
	
cerevisiae	O
cell	O
wall	O
the	O
amyloidogenic	B-T116
peptide	I-T116
vdswnvlvag	O
from	O
bgl2p-glucantransferase	B-T116
of	O
saccharomyces	O
cerevisiae	O
cell	O
wall	O
and	O
its	O
modifying	O
analog	O
veswnvlvag	O
were	O
taken	O
for	O
the	O
construction	O
of	O
four	B-T081
types	O
of	O
bilayers	B-T080
which	O
differ	O
by	O
orientation	O
of	O
the	O
peptides	B-T116
in	O
the	O
layers	B-T080
and	O
of	O
the	O
layers	B-T080
relative	O
to	O
each	O
other	O
.	O
	
these	O
bilayers	B-T080
were	O
used	O
as	O
starting	O
models	O
for	O
the	O
molecular	O
dynamics	O
md	O
at	O
three	O
charge	O
states	O
neutral	O
,	O
ph3	O
,	O
and	O
ph5	O
.	O
	
the	O
changes	B-T169
of	O
the	O
fraction	O
of	O
secondary	O
structure	O
during	O
1	O
ns	O
simulations	O
were	O
received	O
for	O
96	O
md	O
trajectories	O
.	O
	
the	O
data	B-T078
article	O
contains	O
the	O
necessary	O
information	B-T078
for	O
the	O
construction	O
of	O
models	O
of	O
β-strands	O
organization	B-T169
in	O
the	O
oligomer	O
structure	O
.	O
	
these	O
results	B-T169
were	O
used	O
in	O
the	O
associated	O
research	O
article	O
""""	O
structural	O
model	O
of	O
amyloid	B-T116
fibrils	I-T116
for	O
amyloidogenic	B-T116
peptide	I-T116
from	O
bgl2p-glucantransferase	B-T116
of	O
s	O
.	O
	
cerevisiae	O
cell	O
wall	O
and	O
its	O
modifying	O
analog	O
.	O
	
new	O
morphology	B-T080
of	O
amyloid	B-T116
fibrils	I-T116
straight	O
configuration	O
saphenous	O
vein	O
transposition	B-T061
to	O
popliteal	O
artery	O
for	O
vascular	O
access	O
the	O
saphenous	O
vein	O
is	O
commonly	O
used	O
as	O
a	O
vascular	O
graft	O
in	O
peripheral	O
artery	O
surgery	B-T061
but	O
rarely	B-T080
used	O
for	O
vascular	O
access	O
.	O
	
the	O
literature	O
on	O
straight	O
configuration	O
saphenous	O
vein	O
transposition	B-T061
to	O
the	O
popliteal	O
artery	O
is	O
scarce	B-T080
.	O
	
here	O
we	O
present	O
two	O
cases	O
of	O
straight	O
configuration	O
saphenous	O
vein	O
transposition	B-T061
to	O
the	O
popliteal	O
artery	O
for	O
vascular	O
access	O
,	O
the	O
surgical	O
technique	O
and	O
respective	O
follow-up	O
.	O
	
two	O
young	O
men	O
,	O
aged	O
29	O
and	O
36	O
years	B-T079
,	O
were	O
chosen	O
for	O
lower-limb	B-T061
vascular	I-T061
access	I-T061
for	O
hemodialysis	B-T061
.	O
	
the	O
first	O
patient	O
was	O
paraplegic	B-T047
since	O
birth	O
.	O
	
he	O
used	O
his	O
arms	O
to	O
move	O
so	O
upper	O
extremity	O
vascular	O
access	O
was	O
avoided	O
.	O
	
the	O
second	O
patient	O
presented	O
with	O
an	O
infected	B-T033
upper	O
extremity	O
arteriovenous	O
graft	O
avg	O
and	O
after	O
multiple	O
closed	B-T169
avfs	O
he	O
had	O
no	O
more	O
available	O
arm	O
veins	O
.	O
	
both	O
patients	O
received	B-T080
autologous	B-T080
lower	O
extremity	O
straight	O
configuration	O
saphenous	O
vein	O
transpositions	B-T061
to	O
the	O
popliteal	O
artery	O
under	O
spinal	B-T061
anesthesia	I-T061
in	O
may	O
and	O
october	O
2012	O
,	O
respectively	O
.	O
	
cannulation	B-T061
of	O
the	O
fistula	O
was	O
allowed	O
after	O
one	O
month	B-T079
.	O
	
there	O
were	O
no	O
early	O
complications	O
.	O
	
slight	B-T033
swelling	I-T033
on	O
the	O
leg	O
appeared	B-T080
in	O
one	O
of	O
the	O
patients	O
.	O
	
both	O
fistulas	O
were	O
still	O
functional	B-T169
after	O
36	O
and	O
32	O
months	B-T079
,	O
respectively	O
.	O
	
the	O
straight	O
configuration	O
saphenous	O
vein	O
transposition	B-T061
to	O
popliteal	O
artery	O
is	O
simple	O
to	O
perform	O
,	O
offers	O
a	O
long	O
and	O
straight	O
segment	O
for	O
cannulation	B-T061
and	O
may	O
be	O
a	O
suitable	O
autologous	B-T080
vascular	O
access	O
in	O
selected	O
inhibited	B-T080
temperament	O
and	O
hippocampal	O
volume	B-T081
in	O
offspring	O
of	O
parents	O
with	O
bipolar	O
disorder	O
prior	O
studies	O
have	O
suggested	B-T078
that	O
inhibited	B-T080
temperament	O
may	O
be	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
for	O
developing	O
anxiety	O
or	O
mood	O
disorder	O
,	O
including	O
bipolar	O
disorder	O
.	O
	
however	O
,	O
the	O
neurobiological	O
basis	O
for	O
this	O
increased	B-T081
risk	B-T078
is	O
unknown	B-T080
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	B-T033
temperament	O
in	O
symptomatic	B-T169
and	O
asymptomatic	B-T033
child	O
offspring	O
of	O
parents	O
with	O
bipolar	O
disorder	O
obd	O
and	O
to	O
investigate	B-T169
whether	O
inhibited	B-T080
temperament	O
is	O
associated	O
with	O
aberrant	O
hippocampal	O
volumes	O
compared	O
with	O
healthy	O
control	O
hc	O
youth	O
.	O
	
the	O
obd	O
group	O
consisted	O
of	O
45	O
youth	O
,	O
24	O
of	O
whom	O
had	O
current	O
psychiatric	O
symptoms	O
obd	O
and	O
21	O
without	O
any	O
psychiatric	O
symptoms	O
obd	O
,	O
and	O
were	O
compared	O
with	O
24	O
hc	O
youth	O
.	O
	
temperament	O
characteristics	O
were	O
measured	O
by	O
using	O
the	O
revised	O
dimensions	O
of	O
temperament	O
survey	O
.	O
	
magnetic	O
resonance	O
imaging	O
was	O
used	O
to	O
measure	O
hippocampal	O
volumes	O
.	O
	
the	O
association	O
between	O
temperament	O
and	O
hippocampal	O
volumes	O
was	O
tested	O
by	O
using	O
multiple	O
regression	O
analysis	O
.	O
	
compared	O
with	O
the	O
obd	O
group	O
,	O
the	O
obd	O
group	O
had	O
significantly	O
more	O
inhibited	B-T080
temperament	O
traits	O
,	O
less	O
flexibility	O
,	O
more	O
negative	O
mood	O
,	O
and	O
less	O
regular	O
rhythm	O
in	O
their	O
daily	O
routines	O
.	O
	
in	O
contrast	O
,	O
the	O
obd	O
group	O
was	O
more	O
likely	O
to	O
approach	O
novel	O
situations	O
compared	O
with	O
obd	O
or	O
hc	O
groups	O
.	O
	
within	O
the	O
obd	O
group	O
,	O
a	O
more	O
inhibited	O
temperament	O
was	O
associated	B-T080
with	I-T080
smaller	O
right	O
hippocampal	O
volumes	O
.	O
	
in	O
this	O
study	O
,	O
symptomatic	O
obd	O
were	O
characterized	O
by	O
an	O
inhibited	O
temperament	O
that	O
was	O
inversely	O
correlated	O
with	O
hippocampal	O
volume	O
.	O
	
additional	O
longitudinal	O
studies	O
are	O
needed	O
to	O
determine	O
whether	O
inverse	O
correlations	O
between	O
hippocampal	O
volume	O
and	O
inhibited	O
temperament	O
represent	O
early	O
markers	O
of	O
risk	O
for	O
later	O
developing	O
bipolar	O
disorder	O
dynamic	B-T169
disorder	B-T080
can	O
explain	O
non-exponential	B-T081
kinetics	O
of	O
fast	O
protein	O
mechanical	O
unfolding	O
protein	O
unfolding	O
often	O
does	O
not	O
obey	O
a	O
simple	O
two-state	O
behavior	O
.	O
	
previous	O
single	O
molecule	O
force	O
spectroscopy	O
studies	O
demonstrated	O
stretched	B-T080
exponential	I-T080
kinetics	O
of	O
protein	O
unfolding	O
under	O
a	O
constant	O
pulling	O
force	O
,	O
the	O
molecular	B-T080
origin	B-T079
of	O
which	O
remains	O
subject	O
to	O
debate	O
.	O
	
we	O
here	O
set	O
out	O
to	O
extensively	O
sample	O
the	O
mechanical	O
unfolding	O
of	O
ubiquitin	B-T116
and	O
nug2	B-T116
by	O
molecular	O
dynamics	O
md	O
simulations	O
.	O
	
both	O
proteins	B-T116
show	O
kinetics	O
best	O
fit	O
by	O
stretched	B-T080
exponentials	I-T080
,	O
with	O
stretching	B-T081
exponents	I-T081
similar	O
to	O
those	O
found	O
in	O
experiments	O
,	O
even	O
though	O
static	O
disorder	O
is	O
absent	B-T169
in	O
our	O
short	O
md	O
simulations	O
.	O
	
instead	O
,	O
we	O
can	O
ascribe	O
non-exponential	B-T081
kinetics	O
to	O
dynamic	B-T169
disorder	B-T080
,	O
due	O
to	O
conformational	O
fluctuations	B-T079
on	O
the	O
nanosecond	B-T079
timescale	I-T079
.	O
	
our	O
study	O
highlights	O
the	O
general	O
role	O
of	O
dynamic	B-T169
disorder	B-T080
in	O
protein	O
kinetics	O
on	O
a	O
broad	O
range	O
of	O
time	B-T079
scales	I-T079
even	O
including	O
those	O
probed	O
in	O
md	O
simulations	O
.	O
	
identification	O
and	O
functional	O
analysis	O
of	O
the	O
gtpv	O
bidirectional	B-T080
promoter	O
region	O
the	O
goat	O
pox	O
chick	O
embryo-attenuated	O
virus	O
gtpv	O
has	O
been	O
developed	O
as	O
an	O
effective	O
vaccine	O
that	O
can	O
elicit	O
protective	O
immune	O
responses	O
.	O
	
it	O
possesses	O
a	O
large	O
genome	O
and	O
a	O
robust	O
ability	O
to	O
express	O
exogenous	B-T169
genes	O
.	O
	
thus	O
,	O
this	O
virus	O
is	O
an	O
ideal	B-T080
vector	O
for	O
recombinant	B-T116
live	I-T116
vaccines	I-T116
for	O
infectious	B-T047
diseases	I-T047
in	O
ruminant	O
animals	O
.	O
	
in	O
this	O
study	O
,	O
we	O
identified	O
a	O
novel	O
bidirectional	B-T080
promoter	O
region	O
of	O
gtpv	O
through	O
screening	O
named	O
pbvv	O
.	O
	
pbvv	O
is	O
located	O
between	O
etf-l	B-T116
and	O
vitf-3	B-T116
,	O
which	O
are	O
transcribed	O
in	O
opposite	O
directions	O
.	O
	
a	O
new	O
recombinant	O
goat	O
pox	O
virus	O
rgtpv	O
was	O
constructed	O
,	O
in	O
which	O
duplicate	O
pbvv	O
was	O
used	O
as	O
a	O
promoter	O
element	O
to	O
enhance	O
brucella	B-T116
omp31	I-T116
expression	O
,	O
and	O
duplicate	O
pbvv	O
-	O
was	O
used	O
as	O
a	O
promoter	O
element	O
to	O
regulate	O
enhanced	B-T116
green	I-T116
fluorescent	I-T116
protein	I-T116
egfp	B-T116
at	O
the	O
same	O
time	O
as	O
the	O
selection	O
marker	O
.	O
	
pbvv	O
promoter	O
activity	O
was	O
compared	O
to	O
that	O
of	O
the	O
p7.5	O
promoter	O
of	O
vaccinia	O
virus	O
,	O
as	O
measured	O
by	O
egfp	B-T116
expression	O
the	O
fluorescence	O
intensity	O
of	O
egfp	B-T116
expressed	O
in	O
cells	O
was	O
confirmed	O
by	O
fluorescence	O
microscopy	O
and	O
flow	O
cytometry	O
.	O
	
pbvv	O
promoter	O
activity	O
was	O
measured	O
by	O
brucella	B-T116
omp31	I-T116
expression	O
.	O
	
interaction	O
with	O
the	O
anti-brucella-omp31	B-T116
monoclonal	I-T116
antibody	I-T116
was	O
confirmed	O
by	O
western	O
blotting	O
,	O
and	O
omp31	B-T116
mrna	O
expression	O
was	O
assessed	O
by	O
qrt-pcr	O
.	O
	
the	O
results	O
of	O
this	O
study	O
will	O
be	O
useful	O
for	O
the	O
further	O
study	O
of	O
effective	B-T080
multivalent	O
vaccines	O
based	O
on	O
rgtpv	O
.	O
	
this	O
study	O
also	O
provides	O
a	O
theoretical	O
basis	O
for	O
overcoming	O
the	O
problem	O
of	O
low	O
expression	O
of	O
exogenous	B-T169
genes	O
.	O
	
psychometric	O
analysis	O
of	O
the	O
patient	O
health	O
questionnaire	O
in	O
danish	O
patients	O
with	O
an	O
implantable	O
cardioverter	O
defibrillator	O
the	O
defib-women	O
study	O
to	O
assess	O
the	O
psychometric	O
properties	O
of	O
the	O
patient	O
health	O
questionnaire	O
phq-9	O
,	O
a	O
measure	B-T081
of	O
depressive	O
symptoms	O
,	O
in	O
a	O
large	B-T081
danish	O
national	O
cohort	O
of	O
patients	O
with	O
heart	B-T047
disease	I-T047
,	O
implanted	B-T061
with	O
an	O
implantable	O
cardioverter	O
defibrillator	O
icd	O
,	O
using	O
item	O
response	O
theory	O
.	O
	
a	O
prospective	O
cohort	O
of	O
patients	O
implanted	B-T061
with	O
an	O
icd	O
n=1531	O
80.4	O
men	O
completed	O
the	O
phq-9	O
at	O
the	O
time	O
of	O
implant	B-T061
.	O
	
data	B-T078
were	O
analyzed	O
using	O
two	O
item	O
response	O
theory	O
models	O
,	O
the	O
partial	B-T081
credit	I-T081
model	I-T081
and	O
the	O
generalized	B-T081
partial	I-T081
credit	I-T081
model	I-T081
.	O
	
the	O
analysis	O
showed	O
disordered	O
response	O
thresholds	B-T080
in	O
eight	O
of	O
nine	O
items	B-T080
for	O
the	O
partial	B-T081
credit	I-T081
model	I-T081
and	O
five	O
of	O
nine	O
items	B-T080
for	O
the	O
generalized	B-T081
partial	I-T081
credit	I-T081
model	I-T081
,	O
indicating	O
that	O
respondents	O
have	O
difficulty	B-T080
discriminating	O
between	O
response	O
options	O
.	O
	
when	O
collapsing	O
response	O
options	B-T169
2	O
and	O
3	O
,	O
the	O
rescored	B-T081
phq-9	O
had	O
a	O
better	O
fit	O
to	O
both	O
models	B-T081
.	O
	
the	O
unidimensionality	B-T080
and	O
the	O
precision	B-T080
of	O
the	O
rescored	B-T081
phq-9	O
were	O
confirmed	O
.	O
	
items	O
did	O
not	O
have	O
any	O
differential	B-T169
functioning	I-T169
dif	B-T169
across	O
educational	B-T033
level	I-T033
,	O
age	O
,	O
indication	B-T078
for	O
icd	O
implantation	B-T061
,	O
and	O
severity	B-T080
of	O
heart	B-T047
failure	I-T047
that	O
influence	O
depression	O
outcomes	B-T169
in	O
patients	O
with	O
an	O
icd	O
.	O
	
one	O
item	O
exhibited	O
dif	B-T169
by	O
gender	O
.	O
	
three	O
items	O
did	O
not	O
fit	O
the	O
partial	B-T081
credit	I-T081
model	I-T081
,	O
but	O
the	O
generalized	B-T081
partial	I-T081
credit	I-T081
model	I-T081
could	O
be	O
fitted	O
to	O
the	O
full	O
item	O
set	O
.	O
	
the	O
unidimensionality	B-T080
and	O
reliability	B-T081
of	O
the	O
danish	O
version	O
of	O
the	O
phq-9	O
were	O
confirmed	B-T033
.	O
	
however	O
,	O
the	O
associated	B-T080
consequences	B-T169
of	O
the	O
number	O
of	O
response	O
options	B-T169
3-point	O
versus	O
4-point	O
likert	O
scale	O
need	O
to	O
be	O
further	O
examined	B-T033
for	O
the	O
phq-9	O
both	O
as	O
a	O
screening	O
tool	O
and	O
outcome	B-T081
measure	I-T081
.	O
	
geographical	B-T033
variations	I-T033
in	O
incidence	B-T081
,	O
management	O
and	O
survival	B-T081
of	O
hepatocellular	O
carcinoma	O
in	O
a	O
western	O
country	O
information	B-T078
on	O
the	O
incidence	B-T081
,	O
management	O
,	O
and	O
prognosis	O
of	O
hepatocellular	O
carcinoma	O
hcc	O
is	O
derived	O
from	O
population	O
samples	O
,	O
regional	O
data	B-T078
,	O
or	O
registries	O
.	O
	
comprehensive	B-T080
national	O
evaluations	O
within	O
a	O
given	O
country	O
are	O
lacking	B-T080
.	O
	
this	O
study	O
aimed	O
to	O
investigate	B-T169
regional	O
variations	B-T080
in	O
hcc	O
care	O
within	O
france	O
.	O
	
this	O
observational	O
study	O
analysed	O
data	B-T078
from	O
french	O
administrative	O
databases	O
for	O
more	O
than	O
30	O
patients	O
with	O
hcc	O
diagnosed	B-T033
between	O
2009	O
and	O
2012	O
,	O
and	O
followed-up	O
until	O
2013	O
.	O
	
the	O
incidence	B-T081
of	O
hcc	O
,	O
access	O
to	O
surgery	B-T061
,	O
and	O
survival	B-T081
,	O
at	O
both	O
the	O
national	O
level	O
and	O
two	O
geographical	O
levels	O
the	O
21	O
french	O
regions	O
and	O
95	O
french	O
departments	O
into	O
which	O
france	O
is	O
divided	O
administratively	O
,	O
were	O
determined	O
.	O
	
the	O
influence	O
on	O
outcome	B-T169
of	O
the	O
structure	O
of	O
the	O
hospital	O
where	O
hcc	O
was	O
first	O
managed	O
was	O
assessed	O
.	O
	
at	O
the	O
national	O
level	O
,	O
the	O
median	B-T079
survival	I-T079
was	O
9.4	O
months	B-T079
and	O
only	O
22.8	O
of	O
patients	O
had	O
curative	B-T033
treatment	I-T033
.	O
	
there	O
were	O
marked	O
variations	O
between	O
regions	O
and	O
departments	O
in	O
incidence	B-T081
,	O
access	O
to	O
curative	B-T033
treatment	I-T033
range	O
1.3	O
and	O
8.1	O
respectively	O
,	O
and	O
in	O
median	B-T079
survival	I-T079
range	B-T081
5.7	O
and	O
4.3	O
months	B-T079
respectively	O
.	O
	
the	O
administrative	O
type	O
and	O
annual	B-T079
hcc	O
-	O
caseload	B-T081
of	O
the	O
hospital	O
where	O
patients	O
were	O
first	O
admitted	O
also	O
had	O
an	O
independent	B-T078
influence	O
on	O
treatment	B-T061
and	O
survival	B-T081
.	O
	
despite	O
full	O
insurance	B-T078
coverage	I-T078
for	O
all	O
citizens	O
,	O
national	O
measures	B-T081
to	O
reduce	B-T080
inequities	I-T080
in	O
the	O
management	O
of	O
cancer	O
patients	O
,	O
standardised	O
recommendations	B-T078
for	O
hcc	O
surveillance	B-T061
and	O
management	O
,	O
the	O
percentage	B-T081
of	O
patients	O
undergoing	O
curative	B-T033
treatment	I-T033
and	O
their	O
survival	B-T081
may	O
vary	O
four-fold	O
depending	O
on	O
their	O
postcode	B-T033
.	O
	
the	O
hospital	O
in	O
which	O
patients	O
are	O
first	O
managed	O
has	O
a	O
clear	O
influence	O
on	O
accessibility	B-T080
to	O
both	O
good	O
care	O
and	O
survival	B-T081
.	O
	
population-based	O
studies	O
have	O
highlighted	O
large	O
and	O
sometimes	O
unexpected	O
differences	O
between	O
countries	O
in	O
the	O
survival	B-T081
of	O
patients	O
with	O
malignancy	O
.	O
	
as	O
these	O
differences	O
are	O
considered	O
to	O
indicate	O
the	O
overall	O
effectiveness	B-T080
of	O
health	O
systems	O
,	O
in	O
addition	O
to	O
the	O
incidence	B-T081
of	O
the	O
cancer	O
or	O
quality	B-T080
of	O
registration	O
,	O
variations	O
within	O
a	O
given	O
country	O
should	O
be	O
minimal	B-T080
.	O
	
however	O
,	O
similar	O
to	O
between	O
countries	O
differences	O
,	O
this	O
study	O
shows	O
differences	O
within	O
the	O
same	O
country	O
in	O
the	O
incidence	B-T081
,	O
curative	B-T033
treatment	I-T033
rate	B-T081
,	O
and	O
survival	B-T081
of	O
patients	O
with	O
hcc	O
.	O
	
evidence	B-T078
that	O
access	O
to	O
care	O
and	O
survival	B-T081
varies	O
within	O
a	O
country	O
can	O
strengthen	B-T080
the	I-T080
impetus	I-T080
for	O
government	O
and	O
clinicians	O
to	O
address	O
these	O
identification	B-T080
of	O
potential	O
predictive	B-T080
markers	B-T080
of	O
dexamethasone	B-T109
resistance	O
in	O
childhood	B-T079
acute	O
lymphoblastic	O
leukemia	O
response	O
to	O
dexamethasone	B-T109
dexa	B-T109
,	O
as	O
a	O
hallmark	O
drug	O
in	O
the	O
treatment	B-T169
of	O
childhood	B-T079
acute	O
lymphoblastic	O
leukemia	O
all	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	O
in	O
the	O
prediction	O
of	O
outcome	O
in	O
all	O
.	O
	
identification	B-T080
of	O
predictive	B-T080
markers	B-T080
of	O
chemoresistance	O
is	O
beneficial	O
to	O
selecting	O
of	O
the	O
best	O
therapeutic	B-T061
protocol	I-T061
with	O
the	O
lowest	O
effect	O
adverse	O
.	O
	
hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	O
using	O
the	O
2de	O
/	O
ms	O
proteomics	O
study	O
of	O
a	O
dexa	B-T109
-	O
resistant	O
cell	O
line	O
reh	O
as	O
a	O
model	O
for	O
poor	O
dexa	B-T109
responding	O
patients	O
before	O
and	O
after	O
drug	B-T061
treatment	I-T061
.	O
	
using	O
the	O
proteomic	O
methods	O
,	O
three	O
differentially	O
expressed	O
proteins	B-T116
were	O
detected	B-T033
,	O
including	O
voltage	B-T116
dependent	I-T116
anion	I-T116
channel	I-T116
1	I-T116
vdac1	B-T116
,	O
sorting	B-T116
nexin	I-T116
3	I-T116
snx3	B-T116
,	O
and	O
prefoldin	B-T116
subunit	I-T116
6	I-T116
pfdn6	B-T116
.	O
	
we	O
observed	O
low	O
expression	O
of	O
three	O
proteins	B-T116
after	O
dexa	B-T109
treatment	B-T169
in	O
reh	O
cells	O
.	O
	
we	O
subsequently	O
verified	O
low	O
expression	O
of	O
resulted	O
proteins	B-T116
at	O
the	O
mrna	O
level	B-T080
using	O
the	O
quantitative	O
pcr	O
method	O
.	O
	
these	O
proteins	B-T116
are	O
promising	O
proteins	B-T116
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	O
and	O
regulation	O
of	O
apoptosis	O
vdac1	B-T116
,	O
protein	O
trafficking	O
snx3	B-T116
,	O
and	O
protein	O
folding	O
pfdn6	B-T116
.	O
	
additionally	O
,	O
mrna	O
expression	B-T081
level	I-T081
of	O
these	O
proteins	B-T116
was	O
assessed	O
in	O
17	O
bone	O
marrow	O
samples	O
from	O
children	O
with	O
newly	B-T080
diagnosed	I-T080
all	O
and	O
7	O
non-cancerous	O
samples	O
as	O
controls	O
.	O
	
the	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	O
of	O
leukemia	O
,	O
mrna	O
expression	O
of	O
vdac1	B-T116
,	O
snx3	B-T116
,	O
and	O
pfdn6	B-T116
decreased	O
in	O
all	O
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
vdac1	B-T116
p	O
<	O
0.001	O
.	O
	
additionally	O
,	O
mrna	O
expression	O
of	O
three	O
proteins	B-T116
was	O
also	O
declined	O
in	O
high-risk	B-T033
samples	O
compared	O
with	O
standard	B-T080
risk	B-T078
cases	B-T169
.	O
	
these	O
results	O
demonstrated	O
diagnostic	B-T169
and	O
prognostic	O
value	B-T080
of	O
these	O
proteins	B-T116
in	O
childhood	B-T079
all	O
.	O
	
furthermore	O
,	O
investigation	O
of	O
protein-protein	O
interaction	O
using	O
string	O
database	O
indicated	O
that	O
these	O
proteins	B-T116
involved	O
in	O
the	O
signaling	O
pathway	O
of	O
nr3c1	B-T116
as	O
dexamethasone	B-T109
target	B-T033
.	O
	
in	O
conclusion	O
,	O
our	O
proteomic	O
study	O
in	O
dexa	B-T109
resistant	O
leukemic	O
cells	O
revealed	O
vdac1	B-T116
,	O
snx3	B-T116
,	O
and	O
pfdn6	B-T116
are	O
promising	O
proteins	B-T116
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	B-T061
in	O
childhood	B-T079
all	O
.	O
	
benthic	O
injury	O
dose-response	O
models	O
for	O
polychlorinated	B-T109
biphenyl	I-T109
-	O
contaminated	B-T169
sediment	O
using	O
equilibrium	O
partitioning	O
the	O
study	O
goal	O
was	O
to	O
develop	O
a	O
sediment	O
polychlorinated	B-T109
biphenyl	I-T109
pcb	B-T109
dose-response	O
model	O
based	O
on	O
benthic	O
invertebrate	O
effects	O
to	O
pcbs	B-T109
.	O
	
the	O
authors	O
used	O
an	O
equilibrium	O
partitioning	O
eqp	O
approach	O
to	O
generate	O
predicted	O
pcb	B-T109
sediment	O
effect	O
concentrations	B-T081
largely	O
aroclor	B-T109
1254	I-T109
associated	O
with	O
a	O
gradient	B-T081
of	O
toxic	O
effects	O
in	O
benthic	O
organisms	O
from	O
effects	O
observed	O
in	O
aquatic	O
toxicity	O
studies	O
.	O
	
the	O
present	O
study	O
differs	O
from	O
all	O
other	O
eqp	O
collective	O
sediment	O
investigations	O
in	O
that	O
the	O
authors	O
examined	O
a	O
common	O
dose-response	O
gradient	B-T081
of	O
effects	O
for	O
pcbs	B-T109
rather	O
than	O
a	O
single	O
,	O
protective	O
value	O
.	O
	
the	O
authors	O
reviewed	O
the	O
chronic	B-T079
aquatic	O
toxicity	O
literature	O
to	O
identify	O
measured	O
aqueous	B-T080
pcb	B-T109
concentrations	B-T081
and	O
associated	O
benthic	O
invertebrate	O
effects	O
.	O
	
the	O
authors	O
control-normalized	O
the	O
aquatic	O
toxic	O
effect	O
data	B-T078
and	O
expressed	O
results	O
from	O
various	O
studies	O
as	O
a	O
common	B-T081
metric	I-T081
,	O
percent	B-T081
injury	I-T081
.	O
	
then	O
,	O
they	O
calculated	O
organic	B-T109
carbon	I-T109
-normalized	O
sediment	O
pcb	B-T109
concentrations	B-T081
mg/kg	O
organic	B-T109
carbon	I-T109
from	O
the	O
aqueous	B-T080
pcb	B-T109
toxicity	O
data	O
set	O
using	O
eqp	O
theory	O
based	O
on	O
the	O
us	O
environmental	O
protection	O
agency's	O
epiweb	O
4.1	O
derivation	O
of	O
the	O
water-organic	B-T081
carbon	I-T081
partition	I-T081
coefficient	I-T081
koc	B-T081
.	O
	
lastly	O
,	O
the	O
authors	O
constructed	O
a	O
nonlinear	O
dose-response	O
numerical	O
model	O
for	O
these	O
synoptic	O
sediment	O
pcb	B-T109
concentrations	B-T081
and	O
biological	O
effects	O
y	O
=	O
100/1	O
+	O
10	O
hill	O
slope	O
ec50	O
=	O
median	B-T081
effective	I-T081
concentration	I-T081
.	O
	
these	O
models	O
were	O
used	O
to	O
generate	O
"""look-up"""	O
tables	O
reporting	O
percent	B-T081
injury	I-T081
in	O
benthic	O
biota	O
for	O
a	O
range	O
of	O
aroclor	B-T109
-specific	O
sediment	O
concentrations	B-T081
.	O
	
for	O
example	O
,	O
the	O
model	O
using	O
the	O
epiweb	O
koc	B-T081
estimate	O
predicts	O
mean	B-T081
benthic	I-T081
injury	I-T081
of	O
23.3	O
,	O
46.0	O
,	O
70.6	O
,	O
87.1	O
,	O
and	O
95%	O
for	O
hypothetical	O
sediment	O
concentrations	B-T081
of	O
1	O
mg/kg	O
,	O
2	O
mg/kg	O
,	O
4	O
mg/kg	O
,	O
8	O
mg/kg	O
,	O
and	O
16	O
mg/kg	O
dry	O
weight	O
of	O
aroclor	B-T109
1254	I-T109
,	O
respectively	O
at	O
1%	O
organic	B-T109
carbon	I-T109
.	O
	
the	O
authors	O
recommend	O
the	O
model	O
presented	O
for	O
screening	O
but	O
suggest	O
,	O
when	O
possible	O
,	O
determining	O
a	O
site-specific	O
koc	B-T081
that	O
,	O
along	O
with	O
the	O
tables	O
and	O
equations	O
,	O
allows	O
users	O
to	O
create	O
their	O
own	O
protective	O
dose-response	O
sediment	O
concentration	B-T081
.	O
	
extract	O
of	O
caulis	O
spatholobi	O
,	O
a	O
novel	O
blocker	O
targeting	O
tumor	O
cell	O
induced	O
platelet	O
aggregation	O
,	O
inhibits	O
breast	O
cancer	O
metastasis	O
metastasis	O
of	O
breast	O
cancer	O
is	O
the	O
vital	O
step	O
for	O
malignant	O
progression	O
.	O
	
during	O
such	O
a	O
process	O
,	O
hematogenous	O
metastasis	O
is	O
an	O
indispensable	O
approach	O
for	O
the	O
dissemination	O
of	O
cancer	O
cells	O
.	O
	
a	O
platelet	O
,	O
contributes	O
to	O
hypercoagulable	O
state	O
,	O
and	O
is	O
also	O
identified	O
the	O
crucial	O
factor	O
in	O
the	O
coagulation	O
system	O
for	O
supporting	O
metastasis	O
.	O
	
therefore	O
,	O
the	O
relationship	O
of	O
a	O
platelet	O
and	O
a	O
tumor	O
cell	O
plays	O
a	O
critical	O
role	O
in	O
tumor	O
cell	O
metastasis	O
.	O
	
consequently	O
,	O
inhibiting	O
tumor	O
cell	O
induced	O
platelet	O
aggregation	O
tcipa	O
is	O
recongnized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	O
of	O
tumor	O
metastasis	O
such	O
as	O
aspirin	O
asa	O
.	O
	
under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor	O
t	O
complex	O
,	O
80%	O
ethanol	O
extracts	O
of	O
caulis	O
spatholobi	O
set	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	O
,	O
thereby	O
reducing	O
tumor	O
metastasis	O
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	O
cell	O
model	O
.	O
	
through	O
mtt	O
and	O
anti	O
assay	O
stimulated	O
by	O
adp	O
,	O
we	O
detected	O
the	O
optimum	O
treatment	O
time	O
and	O
the	O
optimum	O
dose	O
of	O
set	O
.	O
	
by	O
using	O
confocal	O
microscopy	O
,	O
we	O
observed	O
that	O
set	O
can	O
strongly	O
block	O
the	O
formation	O
of	O
t	O
complex	O
i	O
n	O
vitro	O
.	O
	
the	O
result	O
was	O
further	O
quantified	O
and	O
confirmed	O
by	O
the	O
facs	O
analysis	O
.	O
	
the	O
fluorescent	O
value	O
of	O
t	O
complex	O
was	O
obviously	O
decreased	O
in	O
the	O
drug	O
groups	O
.	O
	
in	O
vivo	O
,	O
4t1	O
cells	O
were	O
injected	O
through	O
the	O
mouse	O
tail	O
vein	O
for	O
dynamic	O
visualization	O
by	O
small	O
animal	O
imaging	O
system	O
.	O
	
the	O
metastatic	O
intensity	O
was	O
quantified	O
and	O
the	O
survival	O
curve	O
was	O
analyzed	O
.	O
	
additionally	O
,	O
general	O
observation	O
and	O
hematoxylin	O
and	O
eosin	O
h	O
staining	O
of	O
lung	O
tissue	O
was	O
performed	O
.	O
	
set	O
exerted	O
an	O
obvious	O
effect	O
on	O
the	O
inhibition	O
of	O
metastasis	O
and	O
increasing	O
the	O
survival	O
rate	O
of	O
mice	O
.	O
	
for	O
the	O
molecular	O
mechanism	O
study	O
of	O
anti	O
,	O
zymography	O
and	O
r	O
t	O
assay	O
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	O
of	O
set	O
in	O
the	O
regulation	O
of	O
p	O
t	O
interaction	O
.	O
	
collectively	O
,	O
through	O
drug	O
efficacy	O
identification	O
and	O
pharmacological	O
revealing	O
,	O
we	O
have	O
obtained	O
a	O
promising	O
candidate	O
for	O
the	O
interference	O
of	O
breast	O
metastasis	O
by	O
suppressing	O
tcipa	O
,	O
which	O
will	O
be	O
beneficial	O
for	O
clinical	O
cancer	O
treatment	I-T079
generalized	B-T047
epilepsy	I-T047
and	O
myoclonic	B-T047
seizures	I-T047
in	O
22q11.2	B-T047
deletion	I-T047
syndrome	I-T047
prompted	O
by	O
the	O
observations	O
of	O
juvenile	B-T047
myoclonic	I-T047
epilepsy	I-T047
jme	B-T047
in	O
22q11.2	B-T047
deletion	I-T047
syndrome	I-T047
22q11ds	B-T047
and	O
recurrent	O
copy	O
number	O
variants	O
in	O
genetic	B-T169
generalized	B-T047
epilepsy	I-T047
gge	B-T047
,	O
we	O
searched	O
for	O
further	O
evidence	O
supporting	O
a	O
possible	O
correlation	B-T080
of	O
22q11ds	B-T047
with	O
gge	B-T047
and	O
with	O
myoclonic	B-T047
seizures	I-T047
.	O
	
through	O
routine	O
diagnostics	O
,	O
we	O
identified	O
3	O
novel	O
individuals	O
with	O
the	O
seemingly	O
uncommon	B-T080
combination	B-T080
of	O
22q11ds	B-T047
and	O
jme	B-T047
.	O
	
we	O
subsequently	O
screened	O
the	O
literature	O
for	O
reports	O
focussing	O
on	O
the	O
epilepsy	O
phenotype	O
in	O
22q11ds	B-T047
.	O
	
we	O
additionally	O
screened	O
a	O
database	O
of	O
173	O
22q11ds	B-T047
patients	O
and	O
identified	O
a	O
fourth	O
individual	O
with	O
jme	B-T047
as	O
well	O
as	O
2	O
additional	O
cases	B-T169
with	O
gge	B-T047
.	O
	
we	O
describe	O
6	O
novel	B-T080
and	O
22	O
published	O
cases	B-T169
with	O
co-occurrence	B-T033
of	O
22q11ds	B-T047
and	O
gge	B-T047
.	O
	
in	O
many	O
patients	O
,	O
gge	B-T047
was	O
associated	B-T080
with	I-T080
myoclonic	B-T047
seizures	I-T047
allowing	O
for	O
a	O
diagnosis	B-T033
of	O
jme	B-T047
in	O
at	O
least	O
6	O
individuals	O
.	O
	
seventeen	O
of	O
the	O
173	O
22q11ds	B-T047
cases	B-T169
10%	O
had	O
a	O
diagnosis	B-T033
of	O
either	O
focal	B-T047
or	O
generalized	B-T047
epilepsy	I-T047
.	O
	
in	O
these	O
cases	B-T169
,	O
focal	B-T047
epilepsy	I-T047
could	O
often	O
be	O
attributed	O
to	O
syndrome-associated	B-T047
hypocalcaemia	I-T047
,	O
cerebral	B-T033
bleeds	I-T033
,	O
or	O
structural	B-T033
brain	I-T033
anomalies	I-T033
.	O
	
however	O
,	O
the	O
cause	O
of	O
gge	B-T047
remained	O
unclear	O
.	O
	
in	O
this	O
study	O
,	O
we	O
describe	O
and	O
review	O
28	O
individuals	O
with	O
22q11ds	B-T047
and	O
gge	B-T047
especially	O
jme	B-T047
,	O
showing	O
that	O
both	O
disorders	B-T047
frequently	B-T033
co-occur	I-T033
.	O
	
compared	O
to	O
the	O
reported	B-T081
prevalence	I-T081
of	O
15-21%	O
,	O
in	O
our	O
case	O
series	O
only	O
10%	O
of	O
22q11ds	B-T047
individuals	O
were	O
found	O
to	O
have	O
epilepsy	B-T047
,	O
often	O
gge	B-T047
.	O
	
since	O
22q11.2	O
does	O
not	O
contain	O
convincing	O
gge	B-T047
candidate	O
genes	O
,	O
we	O
discuss	O
the	O
possibility	O
of	O
an	O
aetiological	B-T169
correlation	B-T080
through	O
a	O
possibly	O
disturbed	O
interaction	O
with	O
the	O
gabab	B-T116
receptor	I-T116
.	O
	
normal	B-T080
levels	I-T080
of	O
urinary	O
cc16	B-T116
protein	I-T116
.	O
	
comments	O
on	O
beamer	O
et	O
al	O
.	O
	
association	O
of	O
children's	O
urinary	O
cc16	B-T116
levels	O
with	O
arsenic	O
concentrations	O
in	O
multiple	O
environmental	O
media	O
.	O
	
int	O
.	O
	
j	O
.	O
	
environ	O
.	O
	
res	O
.	O
	
public	O
health	O
2016	O
,	O
13	O
,	O
521	O
in	O
1937	O
,	O
max	O
clara	O
described	O
a	O
new	O
type	O
of	O
cell	O
in	O
the	O
human	O
lung	O
,	O
which	O
was	O
later	O
determined	O
to	O
be	O
an	O
exocrine	O
secretory	O
cell	O
type	O
containing	O
granules	O
composed	O
of	O
proteins	B-T116
diverse	O
colletotrichum	O
species	O
cause	O
anthracnose	B-T047
of	O
tea	O
plants	O
camellia	O
sinensis	O
l	O
o	O
.	O
	
kuntze	O
in	O
china	O
anthracnose	B-T047
caused	O
by	O
colletotrichum	O
is	O
one	O
of	O
the	O
most	O
severe	O
diseases	B-T047
that	O
can	O
afflict	O
camellia	O
sinensis	O
.	O
	
however	O
,	O
research	O
on	O
the	O
diversity	B-T080
and	O
geographical	B-T079
distribution	I-T079
of	O
colletotrichum	O
in	O
china	O
remain	O
limited	O
.	O
	
in	O
this	O
study	O
,	O
106	O
colletotrichum	O
isolates	O
were	O
collected	B-T169
from	O
diseased	B-T047
leaves	O
of	O
ca	O
.	O
	
sinensis	O
cultivated	O
in	O
the	O
15	O
main	O
tea	O
production	O
provinces	O
in	O
china	O
.	O
	
multi-locus	O
phylogenetic	O
analysis	O
coupled	O
with	O
morphological	O
identification	O
showed	O
that	O
the	O
collected	B-T169
isolates	O
belonged	O
to	O
11	O
species	O
,	O
including	O
6	O
known	O
species	O
c	O
.	O
	
camelliae	O
,	O
c	O
.	O
	
cliviae	O
,	O
c	O
.	O
	
fioriniae	O
,	O
c	O
.	O
	
fructicola	O
,	O
c	O
.	O
	
karstii	O
,	O
and	O
c	O
.	O
	
siamense	O
,	O
3	O
new	O
record	O
species	O
c	O
.	O
	
aenigma	O
,	O
c	O
.	O
	
endophytica	O
,	O
and	O
c	O
.	O
	
truncatum	O
,	O
1	O
novel	O
species	O
c	O
.	O
	
wuxiense	O
,	O
and	O
1	O
indistinguishable	O
strain	O
,	O
herein	O
described	O
as	O
colletotrichum	O
sp	O
.	O
	
of	O
these	O
species	O
,	O
c	O
.	O
	
camelliae	O
and	O
c	O
.	O
	
fructicola	O
were	O
the	O
dominant	O
species	O
causing	O
anthracnose	B-T047
in	O
ca	O
.	O
	
sinensis	O
.	O
	
in	O
addition	O
,	O
our	O
study	O
provided	O
further	O
evidence	B-T078
that	O
phylogenetic	O
analysis	O
using	O
a	O
combination	O
of	O
apmat	O
and	O
gs	O
sequences	O
can	O
be	O
used	O
to	O
effectively	O
resolve	O
the	O
taxonomic	B-T169
relationships	B-T080
within	O
the	O
c	O
.	O
	
gloeosporioides	O
species	O
complex	O
.	O
	
finally	O
,	O
pathogenicity	O
tests	O
suggested	O
that	O
c	O
.	O
	
camelliae	O
,	O
c	O
.	O
	
aenigma	O
,	O
and	O
c	O
.	O
	
endophytica	O
are	O
more	O
invasive	B-T080
than	O
other	O
species	O
after	O
the	O
inoculation	B-T061
of	O
the	O
leaves	O
of	O
ca	O
.	O
	
sinensis	O
.	O
	
atp	O
release	B-T169
from	O
bladder	O
urothelium	O
and	O
serosa	O
in	O
a	O
rat	O
model	O
of	O
partial	B-T047
bladder	I-T047
outlet	I-T047
obstruction	I-T047
overactive	B-T047
bladder	I-T047
is	O
one	O
of	O
the	O
major	O
health	B-T033
problem	I-T033
especially	O
in	O
elderly	O
people	O
.	O
	
adenosine	O
triphosphate	O
atp	O
is	O
released	B-T169
from	O
urinary	O
bladder	O
cells	O
and	O
acts	O
as	O
a	O
smooth	O
muscle	O
contraction	O
and	O
sensory	O
signal	O
in	O
micturition	O
but	O
little	O
is	O
known	O
about	O
the	O
role	O
of	O
atp	O
release	O
in	O
the	O
pathophysiology	O
of	O
overactive	B-T047
bladder	I-T047
.	O
	
to	O
assess	O
the	O
relationship	O
between	O
atp	O
and	O
overactive	B-T047
bladder	I-T047
,	O
we	O
used	O
a	O
partial	B-T047
bladder	I-T047
outlet	I-T047
obstruction	I-T047
pboo	B-T047
model	O
in	O
rats	O
.	O
	
the	O
bladder	O
caused	O
several	O
changes	O
by	O
pboo	B-T047
an	O
increase	B-T169
in	O
bladder	O
weight	B-T081
,	O
hypertrophy	O
of	O
sub-urothelium	O
and	O
sub-serosal	O
area	O
,	O
and	O
frequent	O
non	B-T169
-	O
voiding	O
bladder	O
contraction	O
during	O
urine	O
storage	O
.	O
	
basal	O
atp	O
release	O
from	O
urothelium	O
and	O
serosa	O
of	O
pboo	B-T047
rats	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
normal	O
rats	O
.	O
	
distention	B-T033
induced	O
atp	O
release	B-T169
from	O
urothelium	O
of	O
normal	O
and	O
pboo	B-T047
rats	O
had	O
no	O
significant	O
change	O
.	O
	
however	O
,	O
distention	B-T033
-	O
induced	B-T169
atp	O
release	B-T169
from	O
serosa	O
of	O
pboo	B-T047
rats	O
was	O
higher	O
than	O
that	O
of	O
normal	O
.	O
	
these	O
findings	O
may	O
identify	O
atp	O
especially	O
released	B-T169
from	O
serosa	O
as	O
one	O
of	O
causes	O
of	O
non	B-T169
-	O
voiding	O
contractions	O
and	O
overactive	B-T047
bladder	I-T047
symptoms	O
.	O
	
determining	O
putative	O
vectors	O
of	O
the	O
bogia	B-T047
coconut	I-T047
syndrome	I-T047
phytoplasma	O
using	O
loop-mediated	O
isothermal	O
amplification	O
of	O
single-insect	O
feeding	O
media	O
phytoplasmas	O
are	O
insect	O
vectored	O
mollicutes	O
responsible	O
for	O
disease	B-T047
in	O
many	O
economically	O
important	O
crops	O
.	O
	
determining	O
which	O
insect	O
species	O
are	O
vectors	O
of	O
a	O
given	O
phytoplasma	O
is	O
important	O
for	O
managing	O
disease	B-T047
but	O
is	O
methodologically	O
challenging	O
because	O
disease-free	O
plants	O
need	O
to	O
be	O
exposed	O
to	O
large	O
numbers	O
of	O
insects	O
,	O
often	O
over	O
many	O
months	B-T079
.	O
	
a	O
relatively	O
new	O
method	O
to	O
detect	O
likely	O
transmission	O
involves	O
molecular	O
testing	O
for	O
phytoplasma	O
dna	O
in	O
sucrose	B-T109
solution	O
that	O
insects	O
have	O
fed	O
upon	O
.	O
	
in	O
this	O
study	O
we	O
combined	O
this	O
feeding	O
medium	O
method	O
with	O
a	O
loop-mediated	O
isothermal	O
amplification	O
lamp	O
assay	O
to	O
study	O
627	O
insect	O
specimens	O
of	O
11	O
hemiptera	O
taxa	O
sampled	O
from	O
sites	O
in	O
papua	O
new	O
guinea	O
affected	O
by	O
bogia	B-T047
coconut	I-T047
syndrome	I-T047
bcs	B-T047
.	O
	
the	O
lamp	O
assay	O
detected	O
phytoplasma	O
dna	O
from	O
the	O
feeding	O
solution	O
and	O
head	O
tissue	O
of	O
insects	O
from	O
six	O
taxa	O
belonging	O
to	O
four	O
families	O
derbidae	O
,	O
lophopidae	O
,	O
flatidae	O
and	O
ricaniidae	O
.	O
	
two	O
other	O
taxa	O
yielded	O
positives	O
only	O
from	O
the	O
heads	O
and	O
the	O
remainder	O
tested	O
negative	O
.	O
	
these	O
results	O
demonstrate	O
the	O
utility	O
of	O
combining	O
single-insect	O
feeding	O
medium	O
tests	O
with	O
lamp	O
assays	O
to	O
identify	O
putative	O
vectors	O
that	O
can	O
be	O
the	O
subject	O
of	O
transmission	O
tests	B-T169
and	O
to	O
better	O
understand	O
phytoplasma	O
pathosystems	O
.	O
	
non-toxigenic	B-T169
environmental	O
vibrio	O
cholerae	O
o1	O
strain	O
from	O
haiti	O
provides	O
evidence	B-T078
of	O
pre-pandemic	O
cholera	B-T047
in	O
hispaniola	O
vibrio	O
cholerae	O
is	O
ubiquitous	B-T080
in	O
aquatic	O
environments	O
,	O
with	O
environmental	O
toxigenic	O
v	O
.	O
	
cholerae	O
o1	O
strains	O
serving	B-T081
as	O
a	O
source	B-T033
for	O
recurrent	B-T079
cholera	B-T047
epidemics	I-T047
and	O
pandemic	O
disease	B-T047
.	O
	
however	O
,	O
a	O
number	O
of	O
questions	O
remain	O
about	O
long-term	B-T079
survival	B-T169
and	O
evolution	O
of	O
v	O
.	O
	
cholerae	O
strains	O
within	O
these	O
aquatic	O
environmental	O
reservoirs	O
.	O
	
through	O
monitoring	O
of	O
the	O
haitian	O
aquatic	O
environment	O
following	O
the	O
2010	O
cholera	B-T047
epidemic	I-T047
,	O
we	O
isolated	B-T169
two	B-T081
novel	B-T080
non-toxigenic	B-T169
ctxa/b	O
-	O
negative	B-T033
vibrio	O
cholerae	O
o1	O
.	O
	
these	O
two	B-T081
isolates	O
underwent	O
whole-genome	O
sequencing	O
and	O
were	O
investigated	B-T169
through	B-T169
comparative	O
genomics	O
and	O
bayesian	B-T081
coalescent	I-T081
analysis	I-T081
.	O
	
these	O
isolates	O
cluster	O
in	O
the	O
evolutionary	O
tree	O
with	O
strains	O
responsible	O
for	O
clinical	B-T080
cholera	B-T047
,	O
possessing	B-T078
genomic	O
components	O
of	O
6	O
and	O
7	O
pandemic	O
lineages	O
,	O
and	O
diverge	B-T080
from	O
""""	O
modern	B-T079
""""	O
cholera	B-T047
strains	O
around	O
1548	O
c.e	O
.	O
	
95%	O
hpd	O
1532-1555	O
.	O
	
vibrio	O
pathogenicity	O
island	O
vpi	O
was	O
present	B-T033
however	O
,	O
sxt/r391-family	O
ice	O
and	O
vpi-2	O
were	O
absent	B-T169
.	O
	
rugose	O
phenotype	O
conversion	B-T169
and	O
vibriophage	O
resistance	B-T169
evidenced	B-T169
adaption	O
for	O
persistence	O
in	O
aquatic	O
environments	O
.	O
	
the	O
identification	B-T080
of	O
v	O
.	O
	
cholerae	O
o1	O
strains	O
in	O
the	O
haitian	O
environment	O
,	O
which	O
predate	O
the	O
first	O
reported	O
cholera	B-T047
pandemic	O
in	O
1817	O
,	O
broadens	O
our	O
understanding	O
of	O
the	O
history	B-T169
of	O
pandemics	O
.	O
	
it	O
also	O
raises	O
the	O
possibility	O
that	O
these	O
and	O
similar	B-T080
environmental	O
strains	O
could	O
acquire	O
virulence	B-T080
genes	O
from	O
the	O
2010	O
haitian	O
epidemic	O
clone	O
,	O
including	O
the	O
cholera	B-T116
toxin	I-T116
producing	B-T169
ctxϕ	B-T116
.	O
	
the	O
pre-eclampsia	O
ontology	O
a	O
disease	O
ontology	O
representing	O
the	O
domain	O
knowledge	O
specific	O
to	O
pre-eclampsia	O
pre-eclampsia	O
pe	O
is	O
a	O
clinical	O
syndrome	O
characterized	O
by	O
new-onset	O
hypertension	O
and	O
proteinuria	B-T033
at	O
20	B-T033
weeks	I-T033
of	I-T033
gestation	I-T033
,	O
and	O
is	O
a	O
leading	O
cause	B-T169
of	O
maternal	B-T033
and	O
perinatal	O
morbidity	O
and	O
mortality	B-T081
.	O
	
previous	O
studies	O
have	O
gathered	O
abundant	B-T080
data	B-T078
about	O
pe	O
such	O
as	O
risk	B-T033
factors	I-T033
and	O
pathological	B-T169
findings	I-T169
.	O
	
however	O
,	O
most	O
of	O
these	O
data	B-T078
are	O
not	O
semantically	O
structured	O
.	O
	
clinical	O
data	O
on	O
pe	O
patients	O
are	O
often	O
generated	O
with	O
semantic	B-T078
heterogeneity	B-T080
such	O
as	O
using	O
disparate	O
terminology	O
to	O
describe	O
the	O
same	O
phenomena	O
.	O
	
in	O
clinical	O
studies	O
,	O
interoperability	O
of	O
heterogenic	B-T078
clinical	O
data	O
is	O
required	O
in	O
various	O
situations	B-T169
.	O
	
in	O
such	O
a	O
situation	B-T169
,	O
it	O
is	O
necessary	O
to	O
develop	O
an	O
interoperable	O
and	O
standardized	O
semantic	B-T078
framework	O
to	O
research	O
the	O
pathology	B-T169
of	O
pe	O
more	O
comprehensively	O
and	O
to	O
achieve	O
interoperability	O
of	O
heterogenic	B-T078
clinical	O
data	O
of	O
pe	O
patients	O
.	O
	
in	O
this	O
study	O
,	O
we	O
developed	O
an	O
ontology	O
representing	O
clinical	O
features	O
,	O
treatments	B-T061
,	O
genetic	B-T080
factors	I-T080
,	O
environmental	B-T080
factors	I-T080
,	O
and	O
other	O
aspects	B-T080
of	O
the	O
current	O
knowledge	O
in	O
the	O
domain	O
of	O
pe	O
.	O
	
we	O
call	O
this	O
pre-eclampsia	O
ontology	O
""""	O
peo	O
""""	O
.	O
	
to	O
achieve	O
interoperability	O
with	O
other	O
ontologies	O
,	O
the	O
core	O
structure	O
of	O
peo	O
was	O
compliant	O
with	O
the	O
hierarchy	O
of	O
the	O
basic	O
formal	O
ontology	O
bfo	O
.	O
	
the	O
peo	O
incorporates	O
a	O
wide	O
range	O
of	O
key	O
concepts	B-T078
and	O
terms	B-T079
of	O
pe	O
from	O
clinical	O
and	O
biomedical	O
research	O
in	O
structuring	O
the	O
knowledge	O
base	O
that	O
is	O
specific	O
to	O
pe	O
therefore	O
,	O
peo	O
is	O
expected	O
to	O
enhance	O
pe	O
-specific	O
information	O
retrieval	O
and	O
knowledge	O
discovery	O
in	O
both	O
clinical	O
and	O
biomedical	O
research	O
fields	O
.	O
	
predictors	B-T078
and	O
moderators	B-T080
of	O
spontaneous	B-T169
pretend	O
play	O
in	O
children	O
with	O
and	O
without	O
autism	O
spectrum	O
disorder	O
although	O
pretend	O
play	O
has	O
long	O
been	O
linked	O
to	O
children's	O
normative	B-T080
cognitive	O
development	O
,	O
inconsistent	B-T080
findings	B-T033
call	O
for	O
greater	O
rigor	O
in	O
examining	B-T169
this	O
relation	B-T080
lillard	O
et	O
al	O
,	O
2013	O
.	O
	
spontaneous	B-T169
pretend	O
play	O
is	O
often	O
impacted	O
in	O
atypical	B-T080
development	O
,	O
notably	O
in	O
autism	O
spectrum	O
disorder	O
asd	O
.	O
	
since	O
asd	O
traits	O
exist	O
along	O
a	O
continuum	O
in	O
the	O
general	O
population	O
,	O
investigating	B-T169
how	O
pretend	O
play	O
varies	O
across	O
the	O
range	O
of	O
asd	O
symptoms	O
by	O
indexing	O
variations	B-T080
in	O
asd	O
traits	O
in	O
both	O
typically	O
developing	O
and	O
asd	O
populations	O
may	O
provide	O
insight	O
into	O
how	O
asd	O
symptoms	O
may	O
influence	O
the	O
relation	B-T080
between	O
pretend	O
play	O
and	O
associated	O
processes	O
in	O
cognitive	O
development	O
.	O
	
this	O
study	O
used	O
rigorous	O
observational	O
methods	O
to	O
assess	O
spontaneous	B-T169
pretend	O
play	O
.	O
	
specifically	O
,	O
5-	O
min	B-T079
free-play	O
sessions	O
with	O
two	O
discrete	B-T080
toy	O
sets	O
were	O
double-coded	O
by	O
blinded	O
coders	O
coder	O
assignment	O
counterbalanced	O
.	O
	
key	O
facets	O
of	O
pretense	O
development	O
attribution	B-T080
of	I-T080
pretend	I-T080
properties	I-T080
app	B-T080
,	O
object	O
substitution	O
os	O
,	O
imaginary	O
objects	O
were	O
examined	B-T169
.	O
	
these	O
facets	O
of	O
pretend	O
play	O
production	O
were	O
then	O
analyzed	O
in	O
relation	B-T080
to	O
asd	O
symptoms	O
,	O
as	O
well	O
as	O
plausible	O
,	O
long-theorized	O
correlates	O
theory	B-T078
of	I-T078
mind	I-T078
tom	B-T078
,	O
verbal	O
ability	O
,	O
familiarity	O
,	O
and	O
interest	O
in	O
specific	B-T080
toys	O
.	O
	
forty	O
children	O
mage	O
=	O
6	O
,	O
sdage	O
=	O
1.45	O
29	O
males	O
,	O
six	O
of	O
whom	O
met	O
the	O
threshold	B-T080
for	O
asd	O
diagnosis	B-T033
via	O
parent	O
-reported	O
asd	O
symptoms	O
,	O
participated	O
in	O
play	O
sessions	O
and	O
completed	O
measures	B-T081
of	O
verbal	O
iq	O
and	O
tom	B-T078
.	O
	
besides	O
the	O
measure	B-T081
of	O
child	O
asd	O
symptoms	O
,	O
parents	O
completed	O
a	O
survey	O
of	O
their	O
child's	O
interest	O
in	O
and	O
familiarity	O
with	O
the	O
play	O
session	O
toys	O
.	O
	
overall	O
,	O
greater	O
tom	B-T078
predicted	B-T078
more	O
app	B-T080
,	O
and	O
more	O
interest	O
in	O
the	O
toys	O
presented	O
predicted	B-T078
more	O
os	O
.	O
	
in	O
terms	O
of	O
overall	O
pretend	O
play	O
production	O
,	O
two	O
results	O
were	O
counterintuitive	O
.	O
	
first	O
,	O
among	O
children	O
with	O
more	O
asd	O
symptoms	O
,	O
verbal	O
ability	O
marginally	O
negatively	O
predicted	B-T078
pretend	O
play	O
production	O
.	O
	
second	O
,	O
among	O
children	O
with	O
fewer	O
asd	O
symptoms	O
,	O
tom	B-T078
negatively	O
predicted	B-T078
pretend	O
play	O
production	O
.	O
	
further	O
probing	O
revealed	O
that	O
the	O
negative	O
effect	O
of	O
asd	O
symptoms	O
on	O
pretend	O
play	O
was	O
simultaneously	O
moderated	O
by	O
both	O
variables	O
low	O
tom	B-T078
and	O
high	O
verbal	O
ability	O
both	O
related	O
to	O
less	O
pretend	O
play	O
production	O
among	O
children	O
with	O
more	O
asd	O
symptoms	O
.	O
	
implications	O
for	O
assessment	O
and	O
subsequent	O
treatment	B-T061
for	O
pretend	O
ability	O
among	O
children	O
with	O
varying	O
degrees	O
of	O
asd	O
symptoms	O
,	O
allelic	O
diversity	B-T080
in	O
an	O
nlr	O
gene	O
bph9	O
enables	O
rice	O
to	O
combat	O
planthopper	O
variation	O
brown	O
planthopper	O
bph	O
,	O
nilaparvata	O
lugens	O
stål	O
,	O
is	O
one	O
of	O
the	O
most	O
devastating	O
insect	O
pests	O
of	O
rice	O
oryza	O
sativa	O
l	O
.	O
	
currently	O
,	O
30	O
bph	O
-	O
resistance	O
genes	O
have	O
been	O
genetically	O
defined	O
,	O
most	O
of	O
which	O
are	O
clustered	O
on	O
specific	O
chromosome	O
regions	O
.	O
	
here	O
,	O
we	O
describe	O
molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
bph	O
-	O
resistance	O
gene	O
,	O
bph9	O
,	O
mapped	O
on	O
the	O
long	O
arm	O
of	O
rice	O
chromosome	O
12	O
12l	O
.	O
	
bph9	O
encodes	O
a	O
rare	O
type	O
of	O
nucleotide-binding	O
and	O
leucine-rich	O
repeat	O
nlr	O
protein	B-T116
that	O
localizes	O
to	O
the	O
endomembrane	O
system	O
and	O
causes	O
a	O
cell	O
death	O
phenotype	O
.	O
	
bph9	O
activates	O
salicylic	B-T109
acid	I-T109
-	O
and	O
jasmonic	B-T109
acid	I-T109
-	O
signaling	O
pathways	O
in	O
rice	O
plants	O
and	O
confers	O
both	O
antixenosis	O
and	O
antibiosis	O
to	O
bph	O
.	O
	
we	O
further	O
demonstrated	O
that	O
the	O
eight	O
bph	O
-	O
resistance	O
genes	O
that	O
are	O
clustered	O
on	O
chromosome	O
12l	O
,	O
including	O
the	O
widely	O
used	O
bph1	O
,	O
are	O
allelic	O
with	O
each	O
other	O
.	O
	
to	O
honor	O
the	O
priority	O
in	O
the	O
literature	O
,	O
we	O
thus	O
designated	O
this	O
locus	O
as	O
bph1/9	O
these	O
eight	O
genes	O
can	O
be	O
classified	O
into	O
four	O
allelotypes	O
,	O
bph1/9-1	O
,	O
-2	O
,	O
-7	O
,	O
and	O
-9	O
these	O
allelotypes	O
confer	O
varying	O
levels	B-T080
of	O
resistance	O
to	O
different	O
biotypes	O
of	O
bph	O
.	O
	
the	O
coding	O
region	O
of	O
bph1/9	O
shows	O
a	O
high	O
level	O
of	O
diversity	B-T080
in	O
rice	O
germplasm	O
.	O
	
homologous	O
fragments	O
of	O
the	O
nucleotide-binding	O
nb	O
and	O
leucine-rich	O
repeat	O
lrr	O
domains	O
exist	O
,	O
which	O
might	O
have	O
served	O
as	O
a	O
repository	O
for	O
generating	O
allele	O
diversity	B-T080
.	O
	
our	O
findings	O
reveal	O
a	O
rice	O
plant	O
strategy	O
for	O
modifying	O
the	O
genetic	B-T169
information	I-T169
to	O
gain	O
the	O
upper	O
hand	O
in	O
the	O
struggle	O
against	O
insect	O
herbivores	O
.	O
	
further	O
exploration	O
of	O
natural	O
allelic	O
variation	O
and	O
artificial	O
shuffling	O
within	O
this	O
gene	O
may	O
allow	O
breeding	O
to	O
be	O
tailored	O
to	O
control	O
emerging	O
biotypes	O
of	O
nontoxic	B-T080
formulations	O
of	O
scintillation	O
nanocrystals	O
for	O
use	O
as	O
x-ray	O
computed	O
tomography	O
contrast	O
agents	O
x-ray	O
computed	O
tomography	O
ct	O
is	O
currently	O
one	O
of	O
the	O
most	O
powerful	O
,	O
noninvasive	O
,	O
clinical	B-T080
in	O
vivo	O
imaging	O
techniques	O
,	O
which	O
has	O
resulted	O
from	O
advances	O
in	O
both	O
x-ray	O
device	O
and	O
contrast	B-T080
enhancement	B-T061
technologies	I-T061
.	O
	
the	O
present	O
study	O
demonstrates	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
metal	O
tungstates	O
such	O
as	O
cawo4	O
are	O
promising	O
contrast	O
agents	O
for	O
x-ray	O
,	O
radiation	O
,	O
and	O
ct	O
imaging	O
,	O
because	O
of	O
the	O
high	O
x-ray	O
mass	O
attenuation	O
of	O
tungsten	O
w	O
.	O
	
we	O
have	O
developed	O
a	O
method	O
of	O
formulation	O
,	O
in	O
which	O
cawo4	O
cwo	O
nanoparticles	O
nps	O
are	O
encapsulated	B-T080
within	O
a	O
biocompatible	O
poly	B-T109
glycol-b-d	I-T109
acid	I-T109
peg-pla	I-T109
block	I-T109
copolymer	I-T109
bcp	I-T109
capsule	I-T109
.	O
	
we	O
show	O
that	O
these	O
peg-pla	B-T109
-	O
encapsulated	B-T080
cwo	O
nps	O
170	O
10	O
nm	O
hydrodynamic	O
diameter	O
produce	O
a	O
higher	O
ct	O
contrast	B-T080
by	O
a	O
factor	O
of	O
about	O
2	O
than	O
commercial	O
iodine	O
-based	O
radiocontrast	O
agents	O
e.g	O
,	O
iohexol	B-T109
at	O
identical	O
molar	O
concentrations	O
of	O
w	O
or	O
i	O
atoms	O
.	O
	
peg-pla	B-T109
-	O
coated	B-T080
cwo	O
nps	O
are	O
chemically	O
stable	O
and	O
completely	O
nontoxic	B-T080
.	O
	
it	O
was	O
confirmed	O
that	O
the	O
maximum	B-T081
tolerated	I-T081
dose	I-T081
mtd	B-T081
of	O
this	O
material	O
in	O
mice	O
is	O
significantly	O
higher	O
250	O
50	O
mg	O
per	O
kg	O
body	O
weight	O
following	O
a	O
single	O
intravenous	O
iv	O
administration	O
than	O
,	O
for	O
instance	O
,	O
commercially	O
available	O
dextran	B-T109
-	O
coated	B-T080
iron	O
oxide	O
nanoparticles	O
that	O
are	O
currently	O
used	O
clinically	B-T080
as	O
mri	O
contrast	O
agents	O
mtd	B-T081
in	O
mice	O
168	O
mg/kg	O
per	O
dose	B-T081
iv	O
.	O
	
iv-	O
injected	B-T169
peg-pla	B-T109
/	O
cwo	O
nps	O
caused	O
no	B-T033
histopathologic	O
damage	B-T169
in	O
major	O
excretory	O
organs	O
heart	O
,	O
liver	O
,	O
lungs	O
,	O
spleen	O
,	O
and	O
kidney	O
.	O
	
when	O
an	O
iv	O
dose	B-T081
of	O
100	O
mg/kg	O
was	O
given	O
to	O
mice	O
,	O
the	O
blood	O
circulation	O
half-life	B-T079
was	O
measured	O
to	O
be	O
about	O
4	O
h	O
,	O
and	O
more	O
than	O
90%	O
of	O
the	O
nps	O
were	O
cleared	O
from	O
the	O
mice	O
within	O
24	O
h	O
via	O
the	O
renal	O
and	O
hepatobiliary	O
systems	O
.	O
	
when	O
intratumorally	B-T169
administered	I-T169
,	O
peg-pla	B-T109
-	O
coated	B-T080
cwo	O
nps	O
showed	O
complete	O
retention	O
in	O
a	O
tumor-bearing	O
mouse	O
model	O
measurements	O
were	O
made	O
up	O
to	O
1	O
week	B-T079
.	O
	
these	O
results	O
suggest	O
that	O
peg-pla	B-T109
-	O
coated	B-T080
cwo	O
nps	O
are	O
promising	O
materials	O
for	O
use	O
in	O
ct	O
contrast	B-T080
.	O
	
albumin	B-T116
-bioinspired	O
gd	O
cus	O
nanotheranostic	O
agent	O
for	O
in	O
vivo	O
photoacoustic	O
/	O
magnetic	O
resonance	O
imaging	O
-guided	O
tumor	O
-targeted	O
photothermal	O
therapy	O
photothermal	O
therapy	O
ptt	O
is	O
attracting	O
increasing	O
interest	O
and	O
becoming	O
more	O
widely	O
used	O
for	O
skin	O
cancer	O
therapy	O
in	O
the	O
clinic	O
,	O
as	O
a	O
result	O
of	O
its	O
noninvasiveness	O
and	O
low	O
systemic	O
adverse	O
effects	O
.	O
	
however	O
,	O
there	O
is	O
an	O
urgent	O
need	O
to	O
develop	O
biocompatible	O
ptt	O
agents	O
,	O
which	O
enable	O
accurate	O
imaging	O
,	O
monitoring	O
,	O
and	O
diagnosis	O
.	O
	
herein	O
,	O
a	O
biocompatible	O
gd	O
-integrated	O
cus	O
nanotheranostic	O
agent	O
gd	O
cus	O
bsa	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	O
serum	O
albumin	O
bsa	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O
	
the	O
as-prepared	O
gd	O
cus	O
bsa	O
nanoparticles	O
nps	O
with	O
ultrasmall	O
sizes	O
ca	O
.	O
	
9	O
nm	O
exhibited	O
high	O
photothermal	O
conversion	O
efficiency	O
and	O
good	O
photostability	O
under	O
near-infrared	O
nir	O
laser	O
irradiation	O
.	O
	
with	O
doped	O
gd	O
species	O
and	O
strong	O
tunable	O
nir	O
absorbance	O
,	O
gd	O
cus	O
bsa	O
nps	O
demonstrate	O
prominent	O
tumor-contrasted	O
imaging	O
performance	O
both	O
on	O
the	O
photoacoustic	O
and	O
magnetic	O
resonance	O
imaging	O
modalities	O
.	O
	
the	O
subsequent	O
gd	O
cus	O
bsa	O
-mediated	O
ptt	O
result	O
shows	O
high	O
therapy	O
efficacy	O
as	O
a	O
result	O
of	O
their	O
potent	O
nir	O
absorption	O
and	O
high	O
photothermal	O
conversion	O
efficiency	O
.	O
	
the	O
immune	O
response	O
triggered	O
by	O
gd	O
cus	O
bsa	O
-mediated	O
ptt	O
is	O
preliminarily	O
explored	O
.	O
	
in	O
addition	O
,	O
toxicity	O
studies	O
in	O
vitro	O
and	O
in	O
vivo	O
verify	O
that	O
gd	O
cus	O
bsa	O
nps	O
qualify	O
as	O
biocompatible	O
agents	O
.	O
	
a	O
biodistribution	O
study	O
demonstrated	O
that	O
the	O
nps	O
can	O
undergo	O
hepatic	O
clearance	O
from	O
the	O
body	O
.	O
	
this	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	O
-mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
gd	O
cus	O
bsa	O
nps	O
possess	O
promising	O
imaging	O
guidance	O
and	O
effective	O
tumor	O
ablation	O
properties	O
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	O
penetration	I-T080
family	O
and	O
healthcare	O
professionals	O
'	O
perceptions	O
of	O
a	O
pilot	O
hospice	O
at	O
home	O
programme	O
for	O
children	O
a	O
qualitative	O
study	O
parents	O
commonly	O
report	O
a	O
significant	O
improvement	O
in	O
quality	B-T078
of	I-T078
life	I-T078
following	O
the	O
provision	O
of	O
hospice	O
and	O
supportive	B-T061
care	I-T061
and	O
have	O
identified	O
a	O
need	O
for	O
such	O
a	O
service	O
in	O
the	O
home	O
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
understand	O
the	O
experiences	O
of	O
families	O
receiving	O
a	O
nurse	O
led	O
pilot	O
hospice	O
at	O
home	O
programme	O
and	O
the	O
experiences	O
of	O
healthcare	O
professionals	O
delivering	O
and	O
engaging	O
with	O
the	O
programme	O
.	O
	
an	O
exploratory	O
,	O
qualitative	O
study	O
was	O
conducted	O
,	O
including	O
telephone	O
interviews	O
with	O
parents	O
and	O
focus	O
groups	O
and	O
individual	O
interviews	O
with	O
healthcare	O
professionals	O
.	O
	
all	O
parents	O
of	O
families	O
who	O
received	O
the	O
programme	O
of	O
care	O
between	O
june	O
2014	O
and	O
september	O
2015	O
and	O
healthcare	O
professionals	O
delivering	O
and	O
engaging	O
with	O
the	O
programme	O
were	O
invited	O
to	O
participate	O
.	O
	
seven	O
parents	O
participated	O
in	O
telephone	O
interviews	O
.	O
	
four	O
focus	O
groups	O
took	O
place	O
,	O
two	O
with	O
external	O
stakeholders	O
18	O
participants	O
in	O
total	O
,	O
one	O
with	O
in-patient	O
hospice	O
staff	O
13	O
participants	O
and	O
one	O
with	O
the	O
hospice	O
at	O
home	O
team	O
8	O
participants	O
.	O
	
two	O
additional	O
interviews	O
took	O
place	O
with	O
individual	O
stakeholders	O
who	O
were	O
unable	O
to	O
attend	O
a	O
scheduled	O
focus	O
group	O
.	O
	
themes	O
from	O
interviews	O
with	O
parents	O
focused	O
on	O
the	O
value	O
of	O
having	O
consistent	O
and	O
expert	O
care	O
.	O
	
the	O
findings	O
from	O
healthcare	O
professionals	O
centred	O
on	O
communication	O
within	O
and	O
across	O
services	O
,	O
education	O
and	O
training	O
and	O
lone	O
working	O
.	O
	
the	O
pilot	O
hospice	O
at	O
home	O
programme	O
was	O
welcomed	O
by	O
all	O
those	O
who	O
took	O
part	O
in	O
the	O
study	O
.	O
	
the	O
programme	O
may	O
be	O
improved	O
by	O
enhanced	O
clarification	O
of	O
roles	O
,	O
enhanced	O
access	O
to	O
multi-disciplinary	O
services	O
,	O
greater	O
communication	O
across	O
services	O
and	O
improved	O
information	O
provision	O
to	O
functional	B-T169
1	B-T109
scaffold	O
design	O
of	O
fluorescent	O
probes	O
for	O
kinesin	B-T116
spindle	I-T116
protein	I-T116
ksp	B-T116
1	B-T109
is	O
a	O
compact	O
fluorescent	O
chromophore	O
.	O
	
in	O
this	O
study	O
,	O
triazapentalene	B-T109
was	O
used	O
to	O
modify	O
a	O
series	O
of	O
biphenyl-type	B-T109
inhibitors	O
of	O
kinesin	B-T116
spindle	I-T116
protein	I-T116
ksp	B-T116
to	O
develop	O
fluorescent	O
probes	O
for	O
the	O
intracellular	O
visualization	B-T169
of	O
this	O
protein	B-T116
.	O
	
microscopic	B-T080
studies	O
demonstrated	O
that	O
these	O
novel	B-T080
triazapentalene	B-T109
-	O
labeled	B-T080
compounds	O
exhibited	O
inhibitory	O
activity	B-T169
towards	O
ksp	B-T116
in	O
cultured	O
cells	O
and	O
provided	O
important	O
information	B-T078
concerning	O
the	O
intracellular	O
distribution	B-T169
.	O
	
c4b	B-T116
binding	I-T116
protein	I-T116
negatively	O
regulates	O
tlr1	B-T116
/	O
2	B-T116
response	O
tlr2	B-T116
associates	B-T080
with	I-T080
tlr1	B-T116
and	O
recognizes	O
microbial	O
lipoproteins	B-T116
.	O
	
pam3csk4	B-T116
,	O
a	O
triacylated	B-T116
lipoprotein	I-T116
,	O
is	O
anchored	O
to	O
the	O
extracellular	O
domain	O
of	O
tlr1	B-T116
and	O
tlr2	B-T116
and	O
induces	B-T169
pro-inflammatory	O
signals	O
.	O
	
here	O
we	O
show	O
that	O
c4b	B-T116
binding	I-T116
protein	I-T116
c4bp	B-T116
,	O
which	O
is	O
a	O
complement	O
pathway	O
inhibitor	B-T080
,	O
is	O
a	O
tlr2	B-T116
-associated	O
molecule	O
.	O
	
immunoprecipitation	O
assay	O
using	O
anti-tlr2	O
mab	O
shows	O
that	O
c4bp	B-T116
binds	O
to	O
tlr2	B-T116
.	O
	
in	O
c4bp-deficient	O
mice	O
,	O
pam3csk4	B-T116
-	O
induced	B-T169
il-6	B-T116
levels	B-T080
were	O
increased	B-T081
compared	O
with	O
wild	O
type	O
mice	O
.	O
	
in	O
c4bp	B-T116
-	O
expressing	O
cells	O
,	O
pam3csk4	B-T116
-	O
induced	B-T169
il-8	O
production	O
was	O
reduced	B-T080
depending	O
on	O
the	O
c4bp	B-T116
expression	B-T081
levels	I-T081
.	O
	
these	O
results	O
reveal	B-T080
the	O
important	O
role	O
of	O
c4bp	B-T116
in	O
negative	O
regulation	O
of	O
tlr1	B-T116
/	O
2	B-T116
-	O
dependent	B-T116
pro-inflammatory	O
cytokine	O
production	O
.	O
	
furthermore	O
,	O
using	O
a	O
fluorescent	O
conjugated	O
pam3csk4	B-T116
,	O
we	O
show	O
that	O
c4bp	B-T116
blocks	B-T169
the	O
binding	O
of	O
pam3csk4	B-T116
to	O
tlr1	B-T116
/	O
2	B-T116
.	O
	
finally	O
,	O
we	O
show	O
that	O
exogenous	B-T169
c4bp	B-T116
also	O
inhibits	O
pam3csk4	B-T116
-	O
induced	O
signaling	O
leading	O
to	O
il-8	O
production	O
.	O
	
our	O
results	O
indicate	O
c4bp	B-T116
binding	O
to	O
tlr2	B-T116
and	O
consequent	B-T033
neutralization	B-T169
of	O
its	O
activity	O
otherwise	O
inducing	O
pro-inflammatory	O
cytokine	O
production	O
.	O
	
c4bp	B-T116
is	O
a	O
negative	O
regulator	O
of	O
tlr1	B-T116
/	O
2	B-T116
activity	O
.	O
	
effect	B-T080
of	O
emodin	B-T109
on	O
mobility	O
signal	O
transduction	O
system	O
of	O
gallbladder	O
smooth	O
muscle	O
in	O
guinea	O
pig	O
with	O
cholelithiasis	B-T047
to	O
study	O
the	O
effect	B-T080
of	O
emodin	B-T109
on	O
protein	O
and	O
gene	O
expressions	O
of	O
the	O
massagers	O
in	O
mobility	O
signal	O
transduction	O
system	O
of	O
cholecyst	O
smooth	O
muscle	O
cells	O
in	O
guinea	O
pig	O
with	O
cholesterol	O
calculus	O
.	O
	
the	O
guinea	O
pigs	O
were	O
randomly	O
divided	O
into	O
4	O
groups	B-T078
,	O
such	O
as	O
control	O
group	O
,	O
gall-stone	B-T047
gs	B-T047
group	B-T078
,	O
emodin	B-T109
group	B-T078
and	O
ursodeoxycholic	B-T109
acid	I-T109
ua	B-T109
group	B-T078
.	O
	
cholesterol	O
calculus	O
models	O
were	O
induced	O
in	O
guinea	O
pigs	O
of	O
gs	B-T047
,	O
emodin	B-T109
and	O
ua	B-T109
groups	B-T078
by	O
lithogenic	O
diet	O
,	O
while	O
emodin	B-T109
or	O
ua	B-T109
were	O
given	O
to	O
the	O
corresponding	O
group	B-T078
for	O
7	O
weeks	B-T079
.	O
	
the	O
histomorphological	B-T080
and	O
ultrastructure	B-T078
change	B-T169
of	O
gallbladder	O
were	O
detected	B-T033
by	O
microscope	O
and	O
electron	O
microscope	O
,	O
the	O
content	O
of	O
plasma	O
cholecystokinin	B-T116
cck	B-T116
and	O
ca	O
were	O
analyzed	O
successively	O
by	O
radioimmunoassay	O
and	O
flow	O
cytometry	O
.	O
	
the	O
protein	B-T116
and	O
mrna	O
of	O
gsα	B-T116
,	O
giα	B-T116
and	O
cap	B-T116
in	O
cholecyst	O
cells	O
were	O
determined	B-T080
by	I-T080
western	O
blotting	O
and	O
real	O
time	O
polymerase	O
chain	O
reaction	O
rt-pcr	O
.	O
	
emodin	B-T109
or	O
ua	B-T109
can	O
relieve	O
pathogenic	B-T033
changes	B-T169
in	O
epithelial	O
cells	O
and	O
muscle	O
cells	O
in	O
gallbladder	O
of	O
guinea	O
pig	O
with	O
cholesterol	O
calculus	O
by	O
microscope	O
and	O
transmission	O
electron	O
microscope	O
.	O
	
in	O
the	O
cholecyst	O
cells	O
of	O
gs	B-T047
group	B-T078
,	O
cck	B-T116
levels	B-T080
in	O
plasma	O
and	O
ca	O
decreased	B-T081
,	O
the	O
protein	B-T116
and	O
mrna	O
of	O
gs	B-T047
were	O
down-regulated	O
,	O
the	O
protein	B-T116
and	O
mrna	O
of	O
gi	B-T116
and	O
cap	B-T116
were	O
up-regulated	O
.	O
	
emodin	B-T109
significantly	B-T078
decreased	B-T081
the	O
formative	B-T169
rate	B-T081
of	O
gallstone	B-T047
,	O
improved	O
the	O
pathogenic	B-T033
change	B-T169
in	O
epithelial	O
cells	O
and	O
muscle	O
cells	O
,	O
increased	O
cck	B-T116
levels	B-T080
in	O
plasma	O
and	O
ca	O
in	O
cholecyst	O
cells	O
,	O
enhanced	O
the	O
protein	B-T116
and	O
mrna	O
of	O
gs	B-T116
in	O
cholecyst	O
cells	O
,	O
reduced	B-T080
the	O
protein	B-T116
and	O
mrna	O
of	O
gi	B-T116
and	O
cap	B-T116
in	O
cholecyst	O
cells	O
in	O
guinea	O
pig	O
with	O
cholesterol	O
calculus	O
.	O
	
the	O
dysfunction	O
of	O
gallbladder	O
contraction	O
gives	O
rise	O
to	O
the	O
disorders	B-T047
of	O
mobility	O
signal	O
transduction	O
system	O
in	O
cholecyst	O
smooth	O
muscle	O
cells	O
,	O
including	B-T169
low	O
content	O
of	O
plasma	O
cck	B-T116
and	O
ca	O
in	O
cholecyst	O
cells	O
,	O
abnormal	B-T116
protein	I-T116
and	O
mrna	O
of	O
gs	B-T116
,	O
gi	B-T116
and	O
cap	B-T116
.	O
	
emodin	B-T109
can	O
enhance	O
the	O
contractibility	O
of	O
gallbladder	O
and	O
alleviate	B-T081
cholestasis	B-T047
by	O
regulating	O
plasma	O
cck	B-T116
levels	B-T080
,	O
ca	O
in	O
cholecyst	O
cells	O
and	O
the	O
protein	B-T116
and	O
mrna	O
of	O
gs	B-T116
,	O
gi	B-T116
and	O
quantification	B-T081
of	O
urinary	B-T080
mono-hydroxylated	O
metabolites	O
of	O
polycyclic	B-T109
aromatic	I-T109
hydrocarbons	I-T109
by	O
on-line	O
solid	O
phase	O
extraction	O
-	O
high	O
performance	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
human	O
exposure	B-T080
to	I-T080
polycyclic	B-T109
aromatic	I-T109
hydrocarbons	I-T109
pahs	B-T109
can	O
be	O
assessed	O
through	O
monitoring	O
of	O
urinary	B-T080
mono-hydroxylated	B-T109
pahs	I-T109
oh-pahs	B-T109
.	O
	
gas	O
chromatography	O
gc	O
has	O
been	O
widely	O
used	O
to	O
separate	B-T080
oh-pahs	B-T109
before	O
quantification	B-T081
by	O
mass	O
spectrometry	O
in	O
biomonitoring	O
studies	O
.	O
	
however	O
,	O
because	O
gc	O
requires	O
derivatization	B-T169
,	O
it	O
can	O
be	O
time	B-T080
consuming	I-T080
.	O
	
we	O
developed	B-T169
an	O
on-line	O
solid	O
phase	O
extraction	O
coupled	B-T169
to	O
isotope	O
dilution	B-T169
-	O
high	O
performance	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
on-line-spe	O
-	O
hplc-ms	O
/	O
ms	O
method	O
for	O
the	O
quantification	B-T081
in	O
urine	O
of	O
1-oh-naphthalene	B-T109
,	O
2-oh-naphthalene	B-T109
,	O
2-oh-fluorene	B-T109
,	O
3-oh-fluorene	B-T109
,	O
1-oh-phenanthrene	B-T109
,	O
the	O
sum	O
of	O
2-oh	B-T109
and	O
3-oh-phenanthrene	B-T109
,	O
4-oh-phenanthrene	B-T109
,	O
and	O
1-oh-pyrene	B-T109
.	O
	
the	O
method	O
,	O
which	O
employed	B-T033
a	O
96-	O
well	O
plate	O
platform	O
and	O
on-line	O
spe	O
,	O
showed	O
good	O
sensitivity	O
i.e	O
,	O
limits	B-T169
of	O
detection	B-T061
ranged	B-T081
from	O
0.007	O
to	O
0.09	O
ng/ml	O
and	O
used	O
only	O
100	O
μl	O
of	O
urine	O
.	O
	
accuracy	B-T080
,	O
calculated	O
from	O
the	O
recovery	O
percentage	B-T081
at	O
three	O
spiking	O
levels	B-T080
,	O
varied	B-T080
from	O
94	O
to	O
113	O
%	O
,	O
depending	B-T080
on	O
the	O
analyte	O
.	O
	
the	O
inter	B-T079
-	O
and	O
intra	B-T079
-	O
day	B-T078
precision	I-T078
,	O
calculated	O
from	O
20	O
repeated	B-T169
measurements	B-T169
of	O
two	O
quality	B-T169
control	I-T169
materials	O
,	O
varied	B-T080
from	O
5.2	O
to	O
16.7	O
%	O
.	O
	
adequate	B-T080
method	O
performance	O
was	O
also	O
confirmed	B-T080
by	I-T080
acceptable	B-T080
recovery	O
83-102	O
%	O
of	O
two	O
nist	O
standard	B-T081
reference	I-T081
materials	O
3672	O
and	O
3673	O
.	O
	
this	O
high-throughput	O
on-line-spe	O
-	O
hplc-ms	O
/	O
ms	O
method	O
can	O
be	O
applied	O
in	O
large	B-T081
-	O
scale	O
epidemiological	O
studies	O
.	O
	
graphical	O
abstract	O
example	O
lc-ms	B-T169
chromatogram	I-T169
of	O
urinary	B-T080
mono-hydroxylated	B-T109
pah	I-T109
metabolites	O
.	O
	
utility	B-T169
and	O
applicability	B-T169
of	O
the	O
"""childhood"	O
obesity	O
risk	O
"evaluation"""	O
core	O
in	O
predicting	O
obesity	B-T047
in	O
childhood	B-T079
and	O
adolescence	B-T079
in	O
greece	O
from	O
early	B-T079
life	B-T078
the	O
""""	O
national	O
action	O
plan	O
for	O
public	O
health	O
""""	O
early	B-T079
identification	O
of	O
infants	O
being	O
at	O
high	B-T033
risk	I-T033
to	O
become	O
obese	B-T047
at	O
their	O
later	B-T079
childhood	B-T079
or	O
adolescence	B-T079
can	O
be	O
of	O
vital	O
importance	O
in	O
any	O
obesity	B-T047
prevention	B-T080
initiative	B-T033
.	O
	
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
the	O
utility	B-T169
and	O
applicability	B-T169
of	O
the	O
"""childhood"	O
obesity	O
risk	O
evaluation	O
core	O
index	O
as	O
a	O
screening	O
tool	O
for	O
the	O
early	B-T079
prediction	B-T078
of	O
obesity	B-T047
in	O
childhood	B-T079
and	O
adolescence	B-T079
.	O
	
anthropometric	B-T078
,	O
socio-demographic	B-T078
data	I-T078
were	O
collected	B-T078
cross-sectionally	B-T080
and	O
retrospectively	B-T080
from	O
a	O
representative	O
sample	O
of	O
5946	O
children	O
,	O
and	O
adolescents	O
and	O
were	O
combined	O
for	O
calculating	O
the	O
core-index	O
score	O
.	O
	
logistic	O
regression	O
analyses	O
were	O
performed	O
to	O
examine	O
the	O
associations	B-T080
of	O
the	O
core-index	O
score	O
with	O
obesity	B-T047
by	O
gender	O
and	O
age	O
group	O
,	O
and	O
cut-off	O
point	O
analysis	O
was	O
also	O
applied	O
to	O
identify	O
the	O
optimal	B-T080
value	B-T081
of	O
the	O
core-index	O
score	O
that	O
differentiates	B-T080
obese	B-T047
from	O
non-obese	O
children	O
.	O
	
mean	O
core-index	O
score	O
in	O
the	O
total	B-T080
sample	O
was	O
3.06	O
sd	B-T081
1.92	O
units	O
range	O
0-11	O
units	O
.	O
	
each	O
unit	O
increase	B-T169
in	O
the	O
core-index	O
score	O
was	O
found	O
to	O
be	O
associated	B-T080
with	I-T080
a	O
30	O
%	O
95	O
%	O
c.i	B-T081
.	O
	
1.24	O
increased	B-T081
likelihood	B-T081
for	O
obesity	B-T047
in	O
childhood	B-T079
or	O
adolescence	B-T079
,	O
while	O
the	O
optimal	B-T080
cut-off	B-T081
value	I-T081
of	O
the	O
core-index	O
score	O
that	O
predicted	B-T078
obesity	B-T047
with	O
the	O
highest	B-T080
possible	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
was	O
found	O
to	O
be	O
3.5	O
.	O
	
the	O
present	O
study	O
supports	O
the	O
utility	B-T169
and	O
applicability	B-T169
of	O
the	O
core-index	O
as	O
a	O
screening	O
tool	O
for	O
the	O
early	B-T079
identification	O
of	O
infants	O
that	O
are	O
potentially	O
at	O
a	O
higher	B-T033
risk	I-T033
for	O
becoming	O
obese	B-T047
at	O
their	O
childhood	B-T079
and	O
adolescence	B-T079
.	O
	
this	O
tool	O
could	O
be	O
routinely	O
used	O
by	O
health	O
professionals	O
to	O
identify	O
infants	O
at	O
high	B-T033
risk	I-T033
and	O
provide	O
appropriate	O
counselling	O
to	O
their	O
parents	O
and	O
caregivers	O
so	O
as	O
to	O
maximize	O
the	O
effectiveness	B-T080
of	O
early	B-T079
obesity	B-T047
prevention	B-T080
initiatives	B-T033
.	O
	
what	O
is	O
known	O
childhood	B-T079
obesity	B-T047
has	O
reached	O
epidemic	B-T081
proportions	I-T081
worldwide	O
.	O
	
certain	O
perinatal	B-T033
and	O
socio-demographic	B-T033
indices	I-T033
that	O
were	O
previously	O
identified	B-T080
as	O
correlates	O
of	O
childhood	B-T079
obesity	B-T047
in	O
children	O
were	O
combined	O
to	O
develop	O
the	O
core-index	O
,	O
a	O
screening	O
tool	O
that	O
estimates	O
obesity	B-T047
risk	B-T078
in	O
9-13	O
year-old	B-T079
children	O
.	O
	
what	O
is	O
new	O
the	O
utility	B-T169
and	O
applicability	B-T169
of	O
the	O
core-index	O
as	O
screening	O
tool	O
can	O
be	O
extended	O
to	O
the	O
age	O
range	O
of	O
6-15	O
years	B-T079
.	O
	
the	O
core-index	O
is	O
a	O
cost-effective	B-T080
screening	O
tool	O
that	O
can	O
assist	O
health	O
professionals	O
in	O
initiating	O
obesity	B-T047
preventive	O
measures	O
from	O
early	B-T079
life	B-T078
.	O
	
methodology	B-T078
development	B-T169
on	O
aquatic	O
environmental	O
assessment	O
the	O
water	O
framework	O
directive	O
aims	B-T078
at	O
reaching	O
the	O
good	O
ecological	O
status	B-T080
of	O
the	O
surface	O
and	O
ground	O
water	O
bodies	O
lászló	O
et	O
al	O
.	O
	
microchem	O
j	O
85	O
,	O
2007	O
.	O
	
the	O
paper	O
deals	O
with	O
quality	B-T080
evaluation	O
of	O
waters	O
with	O
special	B-T080
focus	O
on	O
the	O
water	O
chemistry	B-T169
parameters	O
as	O
defined	O
in	O
the	O
water	O
framework	O
directive	O
and	O
pertaining	O
legal	O
regulations	O
.	O
	
the	O
purpose	B-T169
of	O
this	O
paper	O
is	O
to	O
devise	O
a	O
quantitative	B-T081
type	O
of	O
water	O
quality	B-T080
assessment	O
method	O
which	O
could	O
provide	O
rapid	B-T080
,	O
accurate	B-T080
,	O
and	O
reliable	O
information	B-T078
on	O
the	O
quality	B-T080
of	O
the	O
surface	O
waters	O
by	O
using	O
water	O
chemistry	B-T169
parameters	O
.	O
	
quality	B-T080
classes	O
have	O
been	O
defined	B-T080
for	O
every	O
water	O
chemistry	B-T169
parameter	O
in	O
light	O
of	O
the	O
legal	O
limit	O
values	O
of	O
the	O
water	O
parameters	O
.	O
	
in	O
addition	O
to	O
this	O
,	O
weight	B-T081
indices	I-T081
were	O
calculated	O
on	O
the	O
basis	O
of	O
the	O
outcome	B-T169
of	O
the	O
paired	B-T081
comparison	I-T081
of	O
water	O
chemistry	B-T169
parameters	O
and	O
normalized	O
matrix	O
.	O
	
this	O
was	O
followed	O
by	O
the	O
parametric	O
level	O
analysis	O
of	O
the	O
water	O
chemistry	B-T169
parameters	O
,	O
and	O
finally	O
,	O
the	O
aquatic	O
environment	O
index	O
aei	O
was	O
calculated	O
,	O
which	O
provided	O
general	O
information	O
on	O
the	O
quality	B-T080
of	O
water	O
regarding	O
the	O
water	O
chemistry	B-T169
parameters	O
.	O
	
the	O
method	O
was	O
illustrated	O
on	O
lake	O
balaton	O
,	O
hungary	O
in	O
which	O
case	O
water	O
samples	O
taken	O
from	O
balatonfüred	O
city	O
lake	O
area	O
were	O
analyzed	O
and	O
evaluated	O
with	O
the	O
method	O
wdr26	B-T116
promotes	O
mitophagy	O
of	O
cardiomyocytes	O
induced	B-T169
by	O
hypoxia	O
through	O
parkin	B-T116
translocation	O
myocardial	B-T047
ischemia	I-T047
is	O
a	O
heart	O
condition	B-T080
caused	O
by	O
reduction	B-T080
of	O
blood	O
flow	O
to	O
the	O
heart	O
,	O
preventing	O
heart	O
from	O
receiving	B-T080
enough	O
oxygen	O
.	O
	
myocardial	B-T047
ischemia	I-T047
is	O
the	O
most	O
common	O
cause	B-T033
of	I-T033
death	I-T033
globally	O
.	O
	
heart	O
ischemic	B-T061
preconditioning	I-T061
ipc	B-T061
has	O
a	O
protective	B-T080
effect	I-T080
against	O
myocardial	O
cell	O
death	O
induced	B-T169
by	O
ischemia	O
and	O
ischemia-reperfusion	O
injury	O
.	O
	
wdr26	B-T116
has	O
recently	O
been	O
identified	B-T080
as	O
a	O
protein	B-T116
that	O
is	O
increased	B-T081
following	O
rat	O
cardiac	O
ipc	B-T061
.	O
	
wdr26	B-T116
can	O
promote	O
the	O
proliferation	O
of	O
h9c2	O
cells	O
and	O
protect	O
cardiomyocytes	O
against	O
oxidative	O
stress	O
through	O
inhibiting	O
apoptosis	O
.	O
	
however	O
,	O
its	O
role	O
in	O
myocardial	B-T047
ischemia	I-T047
is	O
unclear	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
explore	O
the	O
role	O
of	O
wdr26	B-T116
in	O
myocardial	B-T047
ischemia	I-T047
and	O
h9c2	O
cell	O
hypoxia	O
.	O
	
our	O
results	B-T169
showed	O
that	O
wdr26	B-T116
is	O
induced	B-T169
by	O
myocardial	B-T047
ischemia	I-T047
and	O
h9c2	O
cell	O
hypoxia	O
.	O
	
wdr26	B-T116
protects	O
h9c2	O
cells	O
against	O
hypoxia	O
injury	O
through	O
inhibiting	O
ldh	B-T116
release	O
and	O
increasing	O
cell	O
viability	O
.	O
	
wdr26	B-T116
promotes	O
hypoxia	O
-	O
induced	B-T169
autophagy	O
in	O
hypoxia	O
of	O
h9c2	O
cells	O
.	O
	
we	O
further	O
demonstrated	O
that	O
in	O
h9c2	O
cell	O
hypoxia	O
,	O
wdr26	B-T116
increases	B-T169
mitochondrial	O
membrane	O
potential	O
,	O
thereby	O
increases	B-T169
parkin	B-T116
translocation	O
of	O
mitochondria	O
.	O
	
after	O
parkin	B-T116
is	O
translocated	O
at	O
mitochondria	O
,	O
wdr26	B-T116
can	O
increase	B-T169
mitochondria	O
l	O
protein	O
ubiquitination	O
in	O
hypoxia	O
of	O
h9c2	O
cells	O
.	O
	
wdr26	B-T116
is	O
a	O
mediator	O
of	O
response	O
to	O
hypoxia	O
,	O
and	O
wdr26	B-T116
plays	O
an	O
important	O
role	O
in	O
hypoxia	O
-mediated	O
autophagy	O
and	O
mitophagy	O
.	O
	
this	O
study	O
provides	O
novel	B-T080
insights	O
into	O
the	O
protective	O
role	O
of	O
wdr26	B-T116
in	O
cardiomyocyte	O
injury	O
during	O
hypoxia	O
.	O
	
wdr26	B-T116
may	O
serve	O
as	O
a	O
potential	O
target	B-T169
for	O
the	O
treatment	B-T061
of	O
myocardial	B-T047
ischemia	I-T047
.	O
	
impact	B-T080
of	O
antibiotic	O
de-escalation	B-T061
on	O
clinical	B-T169
outcomes	I-T169
in	O
community-acquired	B-T080
pneumococcal	B-T047
pneumonia	I-T047
although	O
antibiotic	O
de-escalation	B-T061
is	O
regarded	O
as	O
a	O
measure	O
that	O
reduces	B-T080
selection	O
pressure	O
,	O
adverse	O
drug	O
effects	O
and	O
costs	B-T081
,	O
evidence	B-T078
supporting	O
this	O
practice	O
in	O
community-acquired	B-T047
pneumococcal	I-T047
pneumonia	I-T047
capp	B-T047
is	O
lacking	B-T080
.	O
	
we	O
carried	O
out	O
a	O
retrospective	B-T080
analysis	O
of	O
prospectively	O
collected	O
data	B-T078
of	O
a	O
cohort	O
of	O
hospitalized	O
adults	O
with	O
capp	B-T047
.	O
	
pneumococcal	B-T047
aetiology	B-T169
was	O
established	B-T080
in	O
patients	O
with	O
one	O
or	O
more	O
positive	B-T033
cultures	I-T033
for	O
streptococcus	O
pneumoniae	O
obtained	O
from	O
blood	O
,	O
sterile	O
fluids	O
or	O
sputum	O
,	O
and/or	O
a	O
positive	B-T033
urinary	O
antigen	O
test	O
.	O
	
de-escalation	B-T061
therapy	I-T061
was	O
considered	O
when	O
the	O
initial	O
antibiotic	B-T061
therapy	I-T061
was	O
narrowed	O
to	O
penicillin	B-T109
,	O
amoxicillin	B-T109
or	O
amoxicillin/clavulanate	O
within	O
the	O
first	O
72	O
h	O
after	O
admission	O
.	O
	
the	O
primary	O
outcomes	B-T169
were	O
30	O
day	B-T079
mortality	B-T081
and	O
length	B-T079
of	I-T079
hospital	I-T079
stay	I-T079
los	B-T079
.	O
	
adjustment	B-T169
for	O
confounders	O
was	O
performed	B-T169
with	O
multivariate	B-T081
and	O
propensity	B-T081
score	I-T081
analyses	O
.	O
	
of	O
1410	O
episodes	O
of	O
capp	B-T047
,	O
antibiotic	O
de-escalation	B-T061
within	O
the	O
first	O
72	O
h	O
after	O
admission	O
was	O
performed	B-T169
in	O
166	O
cases	B-T169
.	O
	
after	O
adjustment	B-T169
,	O
antibiotic	O
de-escalation	B-T061
was	O
not	O
associated	B-T080
with	I-T080
a	O
higher	O
risk	B-T078
of	O
mortality	B-T081
or	B-T081
=	O
0.83	O
,	O
95%	O
ci	B-T081
=	O
0.24	O
,	O
but	O
it	O
was	O
found	O
to	O
be	O
a	O
protective	O
factor	O
for	O
prolonged	B-T079
los	B-T079
above	O
the	O
median	B-T081
or	B-T081
=	O
0.46	O
,	O
95%	O
ci	B-T081
=	O
0.30	O
.	O
	
similar	O
results	B-T169
were	O
found	O
in	O
patients	O
classified	O
into	O
high-risk	B-T033
pneumonia	B-T047
severity	O
index	O
classes	O
iv-v	O
,	O
those	O
with	O
clinical	B-T033
instability	I-T033
and	O
those	O
with	O
bacteraemia	B-T047
.	O
	
no	B-T033
significant	I-T033
differences	I-T033
were	O
documented	O
in	O
adverse	O
drug	O
reactions	O
or	O
readmission	O
<30	O
days	B-T079
.	O
	
antibiotic	O
de-escalation	B-T061
seems	O
to	O
be	O
safe	O
and	O
effective	B-T080
in	O
reducing	B-T080
the	O
duration	B-T079
of	O
los	B-T079
,	O
and	O
did	O
not	O
adversely	O
affect	O
outcomes	B-T169
of	O
patients	O
with	O
capp	B-T047
,	O
even	O
those	O
with	O
bacteraemia	B-T047
and	O
severe	B-T047
disease	I-T047
,	O
and	O
those	O
who	O
were	O
clinically	B-T033
unstable	I-T033
.	O
	
radiation	O
-	O
induced	B-T169
parotid	O
gland	O
atrophy	O
in	O
patients	O
with	O
head	O
and	O
neck	O
cancer	O
after	O
carbon-ion	B-T061
radiotherapy	I-T061
this	O
study	O
aimed	O
to	O
clarify	O
the	O
relationship	B-T080
between	O
dosimetric	O
factors	B-T169
and	O
parotid	O
gland	O
pg	O
atrophy	O
after	O
carbon	B-T061
ion	I-T061
radiotherapy	I-T061
c-ion	B-T061
rt	I-T061
.	O
	
fifty-four	O
patients	O
with	O
head	O
and	O
neck	O
tumours	O
were	O
enrolled	O
and	O
93	O
irradiated	O
pgs	O
were	O
analyzed	O
.	O
	
thirty	O
and	O
24	O
patients	O
were	O
treated	B-T061
with	I-T061
total	B-T081
doses	I-T081
relative	B-T081
biological	I-T081
effectiveness	I-T081
rbe	B-T081
of	O
57.6	O
gy	O
and	O
64.0	O
gy	O
,	O
respectively	O
,	O
in	O
16	O
fractions	O
.	O
	
pg	O
volumes	B-T081
were	O
measured	O
using	O
computed	B-T078
tomographic	I-T078
images	I-T078
obtained	O
before	O
c-ion	B-T061
rt	I-T061
and	O
every	O
3-6	O
months	B-T079
thereafter	O
.	O
	
the	O
median	B-T081
follow-up	O
period	B-T079
was	O
46.4	O
months	B-T079
range	B-T081
=24	O
months	B-T079
.	O
	
univariate	O
analysis	O
showed	O
that	O
pg	O
volumes	B-T081
receiving	O
more	O
than	O
5	O
,	O
10	O
,	O
15	O
,	O
and	O
20	O
gy	O
rbe	B-T081
v5	B-T081
,	O
v10	B-T081
,	O
v15	B-T081
and	O
v20	B-T081
,	O
respectively	O
,	O
mean	B-T081
dose	B-T081
,	O
and	O
maximum	B-T081
dose	B-T081
were	O
significantly	O
associated	B-T080
with	I-T080
pg	O
atrophy	O
.	O
	
multivariate	B-T081
analysis	I-T081
indicated	O
that	O
only	O
v5	B-T081
was	O
significantly	O
associated	B-T080
with	I-T080
atrophy	O
.	O
	
increasing	B-T169
v5	B-T081
was	O
a	O
significant	O
risk	B-T033
factor	I-T033
for	O
pg	O
atrophy	O
after	O
c-ion	B-T061
rt	I-T061
.	O
	
il-27	B-T116
is	O
essential	O
for	O
suppression	B-T061
of	O
experimental	B-T080
allergic	B-T047
asthma	I-T047
by	O
the	O
tlr7	B-T116
/	O
8	B-T116
agonist	O
r848	B-T109
resiquimod	B-T109
different	O
models	O
of	O
experimental	O
allergic	B-T047
asthma	I-T047
have	O
shown	O
that	O
the	O
tlr7	B-T116
/	O
8	B-T116
agonist	O
resiquimod	B-T109
r848	B-T109
is	O
a	O
potential	O
inhibitor	B-T080
of	O
type	O
2	O
helper	O
cell	O
-driven	O
inflammatory	O
responses	O
.	O
	
however	O
,	O
the	O
mechanisms	O
mediating	O
its	O
therapeutic	O
effects	O
are	O
not	O
fully	O
understood	O
.	O
	
using	O
a	O
model	O
of	O
experimental	O
allergic	B-T047
asthma	I-T047
,	O
we	O
show	O
that	O
induction	B-T061
of	O
il-27	B-T116
by	O
r848	B-T109
is	O
critical	O
for	O
the	O
observed	O
ameliorative	B-T080
effects	O
.	O
	
r848	B-T109
significantly	O
inhibited	B-T080
all	O
hallmarks	O
of	O
experimental	B-T080
allergic	B-T047
asthma	I-T047
,	O
including	O
airway	B-T047
hyperreactivity	I-T047
,	O
eosinophilic	B-T169
airway	O
inflammation	O
,	O
mucus	B-T047
hypersecretion	I-T047
,	O
and	O
ag	O
-	O
specific	B-T116
ig	I-T116
production	O
.	O
	
whereas	O
r848	B-T109
significantly	O
reduced	O
il-5	B-T116
,	O
il-13	B-T116
,	O
and	O
il-17	B-T116
,	O
it	O
induced	O
ifn-γ	B-T116
and	O
il-27	B-T116
.	O
	
neutralization	B-T169
of	O
il-27	B-T116
completely	O
reversed	O
the	O
therapeutic	O
effect	O
of	O
r848	B-T109
in	O
the	O
experimental	B-T080
asthma	B-T047
model	O
,	O
demonstrating	O
dependence	O
of	O
r848	B-T109
-mediated	O
suppression	B-T061
on	O
il-27	B-T116
.	O
	
in	B-T080
vitro	I-T080
,	O
r848	B-T109
induced	B-T061
production	O
of	O
il-27	B-T116
by	O
murine	O
alveolar	O
macrophages	O
and	O
dendritic	O
cells	O
and	O
enhanced	O
expression	O
of	O
programmed	O
death-ligand	O
1	O
,	O
whose	O
expression	O
on	O
monocytes	O
and	O
dendritic	O
cells	O
has	O
been	O
shown	O
to	O
regulate	O
peripheral	O
tolerance	O
in	O
both	O
murine	O
and	O
human	O
studies	O
.	O
	
moreover	O
,	O
in	B-T080
vitro	I-T080
il-27	B-T116
enhanced	O
secretion	O
of	O
ifn-γ	B-T116
whereas	O
it	O
inhibited	B-T080
il-5	B-T116
and	O
il-13	B-T116
,	O
demonstrating	O
its	O
direct	O
effect	O
on	O
attenuating	O
th2	O
responses	O
.	O
	
taken	O
together	O
,	O
our	O
study	O
proves	O
that	O
r848	B-T109
-mediated	O
suppression	B-T061
of	O
experimental	B-T080
asthma	B-T047
is	O
dependent	O
on	O
il-27	B-T116
.	O
	
these	O
data	O
provide	O
evidence	O
of	O
a	O
central	O
role	O
of	O
il-27	B-T116
for	O
the	O
control	O
of	O
th2	O
-mediated	O
allergic	B-T047
diseases	I-T047
.	O
	
a	O
comparison	O
of	O
functional	B-T169
outcomes	O
in	O
patients	O
undergoing	O
revision	B-T061
arthroscopic	I-T061
repair	I-T061
of	O
massive	O
rotator	B-T047
cuff	I-T047
tears	I-T047
with	O
and	O
without	B-T080
arthroscopic	O
suprascapular	B-T061
nerve	I-T061
release	I-T061
this	O
study	O
was	O
designed	O
to	O
compare	O
functional	B-T169
outcomes	O
in	O
patients	O
undergoing	O
revision	B-T061
repair	I-T061
of	O
massive	O
rotator	B-T047
cuff	I-T047
tears	I-T047
retracted	O
medial	O
to	O
the	O
glenoid	O
with	O
goutallier	O
grade	O
4	O
atrophy	O
and	O
concomitant	O
release	B-T061
of	I-T061
the	I-T061
suprascapular	I-T061
nerve	I-T061
to	O
a	O
similar	O
group	O
of	O
patients	O
with	O
grade	O
3	O
atrophy	O
undergoing	O
revision	B-T061
rotator	I-T061
cuff	I-T061
repair	I-T061
rtcr	B-T061
without	O
nerve	B-T061
release	I-T061
.	O
	
we	O
hypothesized	O
that	O
patients	O
undergoing	O
nerve	B-T061
release	I-T061
would	O
have	O
more	O
favorable	O
functional	B-T169
outcomes	O
as	O
measured	O
by	O
the	O
modified	O
university	O
of	O
california	O
at	O
los	O
angeles	O
shoulder	B-T081
rating	I-T081
scale	I-T081
ucla	B-T081
.	O
	
twenty-two	O
patients	O
underwent	O
revision	B-T061
repair	I-T061
of	O
massive	O
rotator	B-T047
cuff	I-T047
tears	I-T047
with	O
release	B-T061
of	I-T061
the	I-T061
suprascapular	I-T061
nerve	I-T061
at	O
the	O
suprascapular	O
notch	O
.	O
	
we	O
compared	O
total	O
preoperative	B-T079
,	O
postoperative	B-T079
,	O
and	O
change	O
in	O
ucla	B-T080
score	I-T080
in	O
these	O
patients	O
to	O
a	O
similar	O
group	O
of	O
22	O
patients	O
undergoing	O
revision	B-T061
rtcr	I-T061
without	B-T080
suprascapular	B-T061
nerve	I-T061
release	I-T061
.	O
	
additionally	O
,	O
ucla	O
subscores	O
between	O
the	O
two	O
groups	O
were	O
compared	O
preoperatively	B-T079
and	O
at	O
final	O
follow-up	O
.	O
	
the	O
average	O
preoperative	B-T079
ucla	B-T080
score	I-T080
in	O
the	O
nerve-release	O
group	O
was	O
7.91	O
,	O
and	O
final	O
follow-up	O
average	O
was	O
27.86	O
average	O
3.05	O
grades	O
of	O
strength	O
were	O
recovered	O
.	O
	
in	O
the	O
comparison	O
group	O
,	O
average	O
preoperative	B-T079
ucla	B-T080
score	I-T080
was	O
11.77	O
,	O
and	O
final	O
follow-up	O
average	O
was	O
29.09	O
average	O
1.32	O
grades	O
of	O
strength	O
were	O
recovered	O
.	O
	
the	O
average	O
preoperative	B-T079
ucla	B-T080
score	I-T080
was	O
significantly	O
worse	O
in	O
the	O
nerve-release	O
group	O
p=0	O
.	O
	
the	O
average	O
postoperative	B-T079
ucla	B-T080
score	I-T080
was	O
not	O
significantly	O
different	O
p=0	O
between	O
the	O
groups	O
,	O
indicating	O
a	O
better	O
improvement	O
in	O
the	O
nerve-release	O
group	O
with	O
significantly	O
greater	O
improvement	O
in	O
active	O
forward	O
flexion	O
,	O
strength	O
,	O
and	O
pain	B-T061
relief	I-T061
.	O
	
patients	O
who	O
underwent	O
concomitant	O
release	B-T061
of	I-T061
the	I-T061
suprascapular	I-T061
nerve	I-T061
during	O
revision	B-T061
rtcr	I-T061
had	O
greater	O
overall	O
improvement	O
as	O
noted	O
in	O
pain	B-T061
relief	I-T061
,	O
active	O
forward	O
flexion	O
,	O
and	O
strength	O
,	O
than	O
a	O
comparable	O
group	O
without	B-T080
nerve	B-T061
release	I-T061
.	O
	
fading	B-T081
with	B-T079
time	I-T079
of	O
pd-l1	O
immunoreactivity	O
in	O
non-small	O
cells	O
lung	O
cancer	O
tissues	O
a	O
methodological	O
study	O
blockade	B-T169
of	O
inhibitory	O
immune	O
checkpoints	O
is	O
currently	O
arising	O
as	O
a	O
potential	O
immunologic	B-T169
option	B-T169
for	O
tumor	B-T061
therapy	I-T061
.	O
	
inhibition	O
of	O
programmed	B-T116
cell	I-T116
death	I-T116
protein	I-T116
1	I-T116
and/or	O
its	O
specific	O
ligand	O
programmed	O
death-ligand	O
1	O
pd-l1	O
was	O
effective	O
in	O
clinical	O
trials	O
in	O
advanced	B-T080
melanoma	O
,	O
non-small	O
cell	O
lung	O
cancer	O
nsclc	O
bladder	O
and	O
kidney	O
cancer	O
.	O
	
the	O
predictive	O
role	O
of	O
the	O
immunohistochemical	O
ihc	O
expression	O
of	O
pd-l1	O
is	O
highly	O
debated	O
.	O
	
different	O
reagents	O
,	O
clones	O
,	O
cutoffs	O
of	O
cell	O
expression	O
and	O
subjective	B-T080
interpretation	B-T033
of	O
pd-l1	O
immunoreactivity	O
in	O
epithelial	O
cells	O
and	O
lymphocytes	O
are	O
the	O
main	O
issue	B-T033
.	O
	
in	O
this	O
study	O
we	O
selected	O
58	O
consecutive	O
nsclc	O
surgical	O
specimens	O
that	O
underwent	O
pathologic	O
examination	O
from	O
january	B-T080
2014	O
to	O
july	B-T080
2015	O
.	O
	
using	O
a	O
tissue	O
microarray	O
approach	O
we	O
evaluated	O
the	O
ihc	O
expression	O
of	O
pd-l1	O
in	O
tumor-infiltrating	O
lymphocytes	O
and	O
tumor	O
cells	O
tcs	O
and	O
compared	O
the	O
ich	O
staining	O
with	O
tumor	O
histology	O
,	O
grade	O
and	O
the	O
age	O
of	O
the	O
tissue	O
blocks	O
.	O
	
the	O
main	O
new	O
finding	B-T033
was	O
the	O
fading	B-T081
of	O
pd-l1	O
ihc	O
expression	O
in	O
tcs	O
in	O
tissues	O
processed	O
in	O
2014	O
compared	O
with	O
2015	O
.	O
	
pd-l1	O
expression	O
in	O
tumor-infiltrating	O
lymphocytes	O
in	O
the	O
2	O
years	B-T079
was	O
similar	B-T080
.	O
	
we	O
also	O
found	O
a	O
significant	B-T080
higher	I-T080
immunoreactivity	O
of	O
tcs	O
in	O
high	B-T080
grade	I-T080
nsclc	O
and	O
in	O
the	O
squamous	O
carcinoma	O
histotype	O
compared	O
with	O
low	B-T080
grade	I-T080
tumors	O
and	O
the	O
adenocarcinoma	O
histology	O
p=0	O
.	O
	
we	O
demonstrated	O
that	O
the	O
ihc	O
evaluation	O
of	O
pd-l1	O
in	O
nsclc	O
archival	O
tissues	O
is	O
feasible	O
and	O
can	O
be	O
implemented	O
in	O
a	O
routine	O
pathology	O
setting	O
,	O
but	O
it	O
should	O
be	O
carefully	O
assessed	O
in	O
tissue	O
blocks	O
older	O
than	O
1	O
differential	B-T080
transcriptome	O
expression	O
in	O
human	O
nucleus	O
accumbens	O
as	O
a	O
function	O
of	O
loneliness	B-T033
loneliness	B-T033
is	O
associated	B-T080
with	I-T080
impaired	O
mental	O
and	O
physical	B-T078
health	I-T078
.	O
	
studies	O
of	O
lonely	O
individuals	O
reported	O
differential	O
expression	O
of	O
inflammatory	B-T169
genes	O
in	O
peripheral	O
leukocytes	O
and	O
diminished	B-T081
activation	O
in	O
brain	O
reward	O
regions	O
such	O
as	O
nucleus	O
accumbens	O
,	O
but	O
could	O
not	O
address	O
gene	O
expression	O
in	O
the	O
human	O
brain	O
.	O
	
here	O
,	O
we	O
examined	O
genome-wide	O
rna	O
expression	O
in	O
post-mortem	O
nucleus	O
accumbens	O
from	O
donors	O
n=26	O
with	O
known	O
loneliness	B-T033
measures	B-T081
.	O
	
loneliness	B-T033
was	O
associated	B-T080
with	I-T080
1710	O
differentially	O
expressed	O
transcripts	O
and	O
genes	O
from	O
1599	O
genes	O
degs	O
false	B-T081
discovery	I-T081
rate	I-T081
p<0	O
,	O
fold	O
change	O
|2|	O
,	O
controlling	O
for	O
confounds	O
previously	O
associated	B-T080
with	I-T080
behavioral	O
processes	O
,	O
neurological	B-T047
disease	I-T047
,	O
psychological	O
disorders	O
,	O
cancer	O
,	O
organismal	O
injury	O
and	O
skeletal	B-T047
and	O
muscular	B-T047
disorders	I-T047
,	O
as	O
well	O
as	O
networks	B-T169
of	O
upstream	O
rna	O
regulators	O
.	O
	
furthermore	O
,	O
a	O
number	O
of	O
degs	O
were	O
associated	B-T080
with	I-T080
alzheimer's	B-T047
disease	I-T047
ad	B-T047
genes	O
that	O
was	O
correlated	B-T080
with	O
loneliness	B-T033
in	O
this	O
sample	O
,	O
although	O
gene	O
expression	O
analyses	O
controlled	O
for	O
ad	B-T047
diagnosis	B-T033
.	O
	
these	O
results	O
identify	O
novel	O
targets	B-T169
for	O
future	O
mechanistic	O
studies	O
of	O
gene	O
networks	O
in	O
nucleus	O
accumbens	O
and	O
gene	O
regulatory	O
mechanisms	O
across	O
a	O
variety	O
of	O
diseases	B-T047
exacerbated	O
by	O
loneliness	B-T033
.	O
	
molecular	O
psychiatry	O
advance	O
online	O
publication	O
,	O
1	O
november	B-T079
overall	O
quality	B-T080
properties	I-T080
of	O
kiwifruit	O
treated	B-T061
by	I-T061
cinnamaldehyde	B-T109
and	O
citral	B-T109
microbial	O
,	O
antioxidant	O
capacity	O
during	O
cold	O
storage	O
this	O
work	O
was	O
undertaken	O
to	O
evaluate	O
the	O
microbiological	O
characteristics	B-T080
and	O
antioxidant	O
and	O
physiological	O
activities	O
in	O
kiwifruits	O
actinida	O
deliciosa	O
var	O
.	O
	
qinmei	O
with/without	O
cinnamaldehyde	B-T109
c1	O
and	O
citral	B-T109
c2	O
fumigation	O
treatments	B-T169
5	O
μl/l	O
during	O
0	O
,	O
3	O
,	O
6	O
,	O
9	O
,	O
and	O
12	O
d	O
of	O
storage	B-T169
at	O
4	O
c	O
.	O
	
essential	B-T109
oils	I-T109
eos	B-T109
treatment	B-T169
lowered	O
the	O
total	O
viable	B-T081
counts	I-T081
,	O
yeast	O
,	O
and	O
mold	O
to	O
1.54	O
,	O
2.36	O
,	O
and	O
2.05	O
log	O
cfu/g	O
,	O
respectively	O
.	O
	
moreover	O
,	O
eos	B-T109
improved	O
the	O
antioxidant	O
activities	O
of	O
kiwifruit	O
.	O
	
they	O
enhanced	O
phenolics	B-T109
and	O
flavonoids	B-T109
content	O
in	O
fruit	O
tissue	O
by	O
49.48	O
at	O
day	O
3	O
and	O
56.93	O
at	O
day	O
6	O
,	O
respectively	O
.	O
	
in	O
addition	O
,	O
ascorbic	B-T109
acid	I-T109
in	O
treated	B-T169
groups	B-T078
had	O
the	O
lower	O
losing	O
rate	B-T081
.	O
	
similarly	O
,	O
mda	B-T109
malondialdehyde	B-T109
,	O
h2	O
o2	O
hydrogen	O
peroxide	O
,	O
and	O
o2	O
superoxide	O
anion	O
production	O
were	O
effectively	B-T080
decreased	B-T081
in	O
the	O
range	O
of	O
27.27	O
to	O
54.38	O
.	O
	
physicochemical	B-T080
characteristics	I-T080
showed	O
that	O
kiwifruits	O
from	O
treated	B-T169
group	B-T078
maintained	O
higher	O
levels	O
of	O
flesh	B-T080
luminosity	I-T080
and	O
firmness	B-T080
.	O
	
eos	B-T109
also	O
decreased	B-T081
the	O
levels	O
of	O
reducing	B-T109
sugar	I-T109
by	O
45.97	O
at	O
day	O
3	O
,	O
and	O
increased	B-T081
the	O
content	O
of	O
soluble	B-T116
protein	I-T116
and	O
hydrolyzed	O
amino	B-T116
acid	I-T116
.	O
	
therefore	O
,	O
postharvest	O
eos	B-T109
treatment	B-T169
has	O
positive	B-T080
effects	I-T080
on	O
delaying	O
senescence	O
and	O
enhancing	O
antioxidant	O
capacities	O
in	O
anti-inflammatory	B-T080
effect	I-T080
of	O
yu-ping-feng-san	B-T109
via	O
tgf-β1	B-T116
signaling	O
suppression	O
in	O
rat	O
model	O
of	O
copd	B-T047
yu-ping-feng-san	B-T109
ypfs	B-T109
is	O
a	O
classical	O
traditional	O
chinese	O
medicine	O
that	O
is	O
widely	O
used	O
for	O
treatment	B-T169
of	O
the	O
diseases	B-T047
in	O
respiratory	O
systems	O
,	O
including	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
copd	B-T047
recognized	O
as	O
chronic	B-T047
inflammatory	I-T047
disease	I-T047
.	O
	
however	O
,	O
the	O
molecular	O
mechanism	O
remains	O
unclear	O
.	O
	
here	O
we	O
detected	O
the	O
factors	O
involved	O
in	O
transforming	B-T116
growth	I-T116
factor	I-T116
beta	I-T116
1	I-T116
tgf-β1	B-T116
smad2	B-T116
signaling	O
pathway	O
and	O
inflammatory	B-T116
cytokines	I-T116
,	O
to	O
clarify	O
whether	O
ypfs	B-T109
could	O
attenuate	O
inflammatory	O
response	O
dependent	O
on	O
tgf-β1	B-T116
/	O
smad2	B-T116
signaling	O
in	O
copd	B-T047
rats	O
or	O
cigarette	O
smoke	O
extract	O
cse	O
treated	B-T169
human	O
bronchial	O
epithelial	O
beas-2b	O
cells	O
.	O
	
the	O
copd	B-T047
rat	O
model	O
was	O
established	O
by	O
exposure	B-T080
to	O
cigarette	O
smoke	O
and	O
intratracheal	B-T169
instillation	I-T169
of	O
lipopolysaccharide	B-T109
,	O
ypfs	B-T109
was	O
administered	O
to	O
the	O
animals	O
.	O
	
the	O
efficacy	B-T080
of	O
ypfs	B-T109
was	O
evaluated	O
by	O
comparing	O
the	O
severity	B-T080
of	O
pulmonary	O
pathological	O
damage	O
,	O
pro-inflammation	B-T116
cytokines	I-T116
,	O
collagen	O
related	O
genes	O
and	O
the	O
activation	O
of	O
tgf-β1	B-T116
/	O
smad2	B-T116
signaling	O
pathway	O
.	O
	
furthermore	O
,	O
cse	O
-	O
treated	B-T169
cells	O
were	O
employed	O
to	O
confirm	O
whether	O
the	O
effect	B-T080
of	O
ypfs	B-T109
was	O
dependent	O
on	O
the	O
tgf-β1	B-T116
/	O
smad2	B-T116
signaling	O
via	O
knockdown	O
smad2	O
si-rna	O
,	O
or	O
pretreatment	O
with	O
the	O
inhibitor	B-T080
of	O
tgf-β1	B-T116
.	O
	
administration	O
of	O
ypfs	B-T109
effectively	O
alleviated	O
injury	O
of	O
lung	O
,	O
suppressed	B-T169
releasing	O
of	O
pro-inflammatory	B-T116
cytokines	I-T116
and	O
collagen	O
deposition	O
in	O
copd	B-T047
animals	O
p<0	O
,	O
whereas	O
exogenous	B-T116
tgf-β1	I-T116
promoted	O
releasing	O
of	O
il-1β	B-T116
,	O
il-6	B-T116
,	O
tnfα	B-T116
p<0	O
.	O
	
administration	O
ypfs	B-T109
reduced	O
inflammatory	O
response	O
significantly	O
,	O
also	O
down-regulated	O
tgf-β1	B-T116
/	O
smad2	B-T116
signaling	O
in	O
vivo	O
and	O
in	B-T080
vitro	I-T080
.	O
	
unexpectedly	O
,	O
knockdown	O
smad2	O
or	O
inhibition	O
of	O
tgf-β1	B-T116
abolished	O
anti-inflammatory	B-T080
effect	I-T080
of	O
ypfs	B-T109
in	O
cse	O
-	O
treated	B-T169
cells	O
.	O
	
ypfs	B-T109
accomplished	O
anti-inflammatory	B-T080
effects	I-T080
mainly	O
by	O
suppressing	B-T169
phosphorylation	O
of	O
smad2	B-T116
,	O
tgf-β1	B-T116
/	O
smad2	B-T116
signaling	O
pathway	O
was	O
required	O
for	O
ypfs	B-T109
-mediated	O
anti-inflammation	B-T080
in	O
copd	B-T047
rats	O
or	O
cse	O
-	O
treated	B-T169
beas-2b	O
cells	O
.	O
	
the	O
association	B-T080
between	O
maternal	B-T033
hydronephrosis	B-T047
and	O
acute	B-T079
flank	O
pain	O
during	O
pregnancy	O
a	O
prospective	O
pilot-study	O
maternal	B-T033
hydronephrosis	B-T047
may	O
cause	O
flank	O
pain	O
during	O
pregnancy	O
.	O
	
we	O
aimed	B-T078
to	O
investigate	B-T169
the	O
association	O
between	O
maternal	B-T033
hydronephrosis	B-T047
and	O
flank	O
pain	O
intensity	O
.	O
	
from	O
2014	O
to	O
2015	O
,	O
all	O
consecutive	B-T080
women	O
with	O
singleton	O
pregnancies	O
,	O
who	O
presented	O
at	O
our	O
tertiary	O
center	O
due	O
to	O
acute	B-T079
flank	O
pain	O
,	O
were	O
prospectively	O
evaluated	O
by	O
renal	O
ultrasonography	O
and	O
pain	O
questionnaires	O
.	O
	
a	O
visual	O
analogue	O
scale	O
was	O
used	O
to	O
assess	O
pain	O
intensity	O
.	O
	
the	O
study	O
had	O
90%	O
power	O
to	O
detect	O
a	O
significant	B-T078
correlation	B-T080
between	O
hydronephrosis	B-T047
and	O
flank	O
pain	O
spearman's	O
test	O
.	O
	
a	O
total	O
of	O
51	O
consecutive	B-T080
women	O
with	O
left-sided	O
13.7	O
,	O
right-sided	O
64.7	O
or	O
bilateral	O
21.6	O
pain	O
were	O
enrolled	O
.	O
	
the	O
mean	B-T081
gestational	O
age	O
of	O
these	O
women	O
,	O
who	O
presented	O
due	O
to	O
their	O
pain	O
,	O
was	O
27.5	O
6.8	O
weeks	B-T079
at	O
the	O
time	O
of	O
consultation	O
.	O
	
the	O
mean	B-T081
vas	O
score	O
was	O
7.6	O
2.2	O
.	O
	
in	O
43/51	O
84.3	O
women	O
,	O
hydronephrosis	B-T047
was	O
found	O
on	O
renal	O
sonograms	O
.	O
	
no	O
correlation	B-T080
was	O
found	O
between	O
the	O
grade	O
of	O
hydronephrosis	B-T047
and	O
pain	O
intensity	O
p	O
=	O
0.466	O
r=	O
-0	O
.	O
	
women	O
delivered	O
at	O
a	O
mean	B-T081
gestational	O
age	O
of	O
38.1	O
2.4	O
weeks	B-T079
and	O
their	O
infants	O
had	O
a	O
mean	B-T081
birthweight	O
of	O
3138	O
677	O
g	O
.	O
	
hydronephrosis	B-T047
is	O
a	O
common	O
finding	B-T033
among	O
pregnant	O
women	O
with	O
acute	B-T079
flank	O
pain	O
.	O
	
the	O
grade	O
of	O
hydronephrosis	B-T047
does	O
not	O
affect	O
pain	O
intensity	O
.	O
	
this	O
study	O
suggests	O
normal	B-T033
pregnancy	I-T033
outcomes	B-T033
in	O
these	O
simulating	O
the	O
potential	B-T080
role	O
of	O
media	O
coverage	O
and	O
infected	B-T033
bats	O
in	O
the	O
2014	O
ebola	B-T047
outbreak	O
multiple	O
epidemiological	B-T169
models	O
have	O
been	O
developed	B-T169
to	O
model	O
the	O
transmission	B-T078
dynamics	I-T078
of	O
ebola	B-T047
virus	I-T047
ebov	I-T047
disease	I-T047
in	O
west	O
africa	O
in	O
2014	O
because	O
the	O
severity	B-T080
of	O
the	O
epidemic	O
is	O
commonly	O
overestimated	O
.	O
	
a	O
compartmental	O
model	O
that	O
incorporates	O
the	O
media	B-T080
impact	I-T080
and	O
the	O
effect	B-T080
of	O
infected	B-T033
bats	O
was	O
constructed	O
and	O
calibrated	B-T081
using	O
data	B-T078
reported	O
until	O
the	O
end	O
of	O
2014	O
.	O
	
the	O
final	O
cumulative	B-T080
number	B-T081
of	I-T081
deaths	I-T081
and	O
confirmed	B-T033
cases	O
were	O
estimated	B-T081
to	O
be	O
1.0921	O
95%	O
ci	B-T081
9.7706	O
and	O
1.5193	O
95%	O
ci	B-T081
1.3593	O
,	O
respectively	O
.	O
	
the	O
epidemic	O
was	O
estimated	B-T081
to	O
end	O
on	O
june	O
2015	O
,	O
which	O
was	O
similar	B-T080
to	O
the	O
data	B-T078
reported	O
by	O
the	O
world	O
health	O
organization	O
.	O
	
a	O
sensitivity	O
analysis	O
indicated	B-T033
that	O
an	O
increase	B-T169
of	O
either	O
the	O
media	B-T080
impact	I-T080
or	O
the	O
number	B-T081
of	O
infectious	B-T080
bats	O
that	O
are	O
captured	O
daily	B-T079
can	O
increase	B-T169
the	O
cumulative	B-T080
number	B-T081
of	O
confirmed	B-T033
cases	O
/	O
deaths	B-T081
.	O
	
of	O
the	O
considered	O
epidemiological	B-T169
parameters	I-T169
,	O
only	O
the	O
media	O
coverage	O
can	O
significantly	O
reduce	O
both	O
the	O
peak	B-T033
time	I-T033
and	O
the	O
value	B-T081
of	O
the	O
cumulative	B-T080
confirmed	B-T033
cases	O
/	O
deaths	B-T081
.	O
	
thus	O
,	O
we	O
propose	O
'the	O
cumulative	B-T080
confirmed	B-T033
cases	O
and	O
deaths	B-T081
'	O
as	O
another	O
media	O
mechanism	B-T169
.	O
	
in	O
conclusion	O
,	O
the	O
media	B-T080
impact	I-T080
contributed	O
to	O
the	O
control	B-T080
of	O
the	O
2014	O
ebola	B-T047
outbreak	O
,	O
and	O
infectious	B-T080
bats	O
may	O
be	O
a	O
potential	B-T080
source	B-T033
of	O
the	O
body	O
diffusion	O
weighted	O
imaging	O
using	O
non-cpmg	O
fast	O
spin	O
echo	O
ss-fse	O
is	O
a	O
fast	B-T080
technique	O
that	O
does	O
not	O
suffer	O
from	O
off-resonance	B-T033
distortions	B-T080
to	O
the	O
degree	O
that	O
epi	O
does	O
.	O
	
unlike	O
epi	O
,	O
ss-fse	O
is	O
ill-suited	O
to	O
diffusion	O
weighted	O
imaging	O
dwi	O
due	O
to	O
the	O
carr-purcell-meiboom-geill	B-T033
cpmg	I-T033
condition	I-T033
.	O
	
non-cpmg	B-T033
phase	B-T079
cycling	B-T079
does	O
accommodate	O
ss-fse	O
and	O
dwi	O
but	O
places	O
constraints	B-T169
on	O
reconstruction	B-T169
,	O
which	O
are	O
resolved	B-T033
here	O
through	O
parallel	O
imaging	O
.	O
	
additionally	O
,	O
improved	B-T033
echo	B-T080
stability	I-T080
can	O
be	O
achieved	O
by	O
using	O
short	B-T080
duration	I-T080
and	O
highly	O
selective	O
diverse	B-T080
radiofrequency	O
pulses	O
.	O
	
here	O
,	O
signal-to-noise	B-T081
ratio	I-T081
snr	B-T081
comparisons	O
between	O
epi	O
and	O
ncpmg	B-T033
ss-fse	O
acquisitions	O
and	O
reconstruction	B-T169
techniques	I-T169
give	O
similar	B-T080
values	B-T080
.	O
	
diffusion	O
imaging	O
with	O
ncpmg	B-T033
ss-fse	O
gives	O
similar	B-T080
snr	B-T081
to	O
an	O
epi	O
acquisition	O
,	O
though	O
apparent	O
diffusion	O
coefficient	O
values	B-T080
are	O
higher	B-T080
than	O
seen	O
with	O
epi	O
.	O
	
in	O
vivo	O
images	O
have	O
good	O
image	B-T080
quality	I-T080
with	O
little	O
distortion	B-T080
.	O
	
this	O
method	O
has	O
the	O
ability	O
to	O
capture	O
distortion	B-T080
-	O
free	B-T169
dwi	O
images	O
near	O
areas	O
of	O
significant	B-T078
off-resonance	B-T033
as	O
well	O
as	O
preserve	O
adequate	O
snr	B-T081
.	O
	
parallel	O
imaging	O
and	O
diverse	B-T080
refocusing	O
rf	O
pulses	O
allow	O
shorter	B-T079
etl	I-T079
compared	O
to	O
previous	O
implementations	O
and	O
thus	O
reduces	B-T080
phase	B-T079
encode	O
direction	O
blur	B-T080
and	O
sar	O
accumulation	B-T033
.	O
	
modification	B-T169
of	O
mechanical	B-T080
properties	I-T080
,	O
polymerization	O
temperature	B-T081
,	O
and	O
handling	B-T079
time	I-T079
of	O
polymethylmethacrylate	B-T109
cement	O
for	O
enhancing	O
applicability	B-T169
in	O
vertebroplasty	B-T061
polymethylmethacrylate	B-T109
pmma	B-T109
bone	O
cement	O
is	O
a	O
popular	O
bone	O
void	O
filler	O
for	O
vertebroplasty	B-T061
.	O
	
however	O
,	O
the	O
use	O
of	O
pmma	B-T109
has	O
some	O
drawbacks	O
,	O
including	O
the	O
material's	O
excessive	O
stiffness	B-T080
,	O
exothermic	O
polymerization	O
,	O
and	O
short	B-T081
handling	B-T079
time	I-T079
.	O
	
this	O
study	O
aimed	O
to	O
create	O
an	O
ideal	O
modified	B-T169
bone	O
cement	O
to	O
solve	O
the	O
above-mentioned	O
problems	B-T033
.	O
	
modified	B-T169
bone	O
cements	O
were	O
prepared	O
by	O
combining	O
pmma	B-T109
with	O
three	O
different	O
volume	B-T081
fractions	I-T081
of	O
castor	B-T109
oil	I-T109
5%	O
,	O
10%	O
,	O
and	O
15%	O
.	O
	
the	O
peak	B-T080
polymerization	O
temperatures	B-T081
,	O
times	O
to	O
achieve	O
the	O
peak	B-T080
polymerization	O
temperature	B-T081
,	O
porosities	B-T080
,	O
densities	B-T081
,	O
modulus	B-T081
and	O
maximum	B-T081
compression	B-T081
strengths	I-T081
of	O
standard	B-T080
without	O
castor	B-T109
oil	I-T109
,	O
and	O
modified	B-T169
cements	O
were	O
investigated	B-T169
following	O
storage	O
at	O
ambient	O
temperature	O
22	O
or	O
under	O
precooling	O
conditions	B-T080
3	O
.	O
	
six	O
specimens	O
were	O
tested	O
in	O
each	O
group	O
of	O
the	O
aforementioned	O
parameters	O
.	O
	
increasing	B-T081
castor	B-T109
oil	I-T109
content	O
and	O
precooling	O
treatment	B-T169
effectively	O
decreased	B-T081
the	O
peak	B-T080
polymerization	O
temperatures	B-T081
and	O
increased	B-T081
the	O
duration	B-T079
to	O
achieve	O
the	O
peak	B-T080
polymerization	O
temperature	B-T081
p	O
<	O
0.05	O
.	O
	
furthermore	O
,	O
the	O
mechanical	B-T080
properties	I-T080
of	O
the	O
material	O
,	O
including	O
density	B-T081
,	O
modulus	B-T081
,	O
and	O
maximum	B-T081
compression	B-T081
strength	I-T081
,	O
decreased	B-T081
with	O
increasing	B-T081
castor	B-T109
oil	I-T109
content	O
.	O
	
however	O
,	O
preparation	O
temperature	B-T081
room	O
temperature	O
versus	O
precooling	O
had	O
no	O
significant	O
effect	O
p	O
>	O
0.05	O
on	O
these	O
mechanical	B-T080
properties	I-T080
.	O
	
in	O
conclusion	O
,	O
the	O
addition	O
of	O
castor	B-T109
oil	I-T109
to	O
pmma	B-T109
followed	O
by	O
precooling	O
created	O
an	O
ideal	O
modified	B-T169
bone	O
cement	O
with	O
a	O
low	O
modulus	B-T081
,	O
low	O
polymerization	O
temperature	B-T081
,	O
and	O
long	O
handling	B-T079
time	I-T079
,	O
enhancing	O
its	O
applicability	B-T169
and	O
safety	O
for	O
a	O
case	B-T169
of	O
retrograde	O
intussusception	O
at	O
roux-en-y	B-T061
anastomosis	I-T061
10	O
years	O
after	O
total	B-T061
gastrectomy	I-T061
review	O
of	O
the	O
literature	O
a	O
63-year-	O
old	O
man	O
,	O
who	O
had	O
undergone	O
total	B-T061
gastrectomy	I-T061
and	O
roux-en-y	B-T061
reconstruction	I-T061
for	O
gastric	O
cancer	O
10	O
years	O
previously	O
,	O
was	O
admitted	O
to	O
our	O
hospital	O
with	O
complaints	O
of	O
abdominal	O
pain	O
,	O
palpable	B-T080
abdominal	O
tumor	O
,	O
and	O
hematemesis	B-T033
.	O
	
on	O
admission	O
,	O
the	O
abdominal	O
tenderness	O
was	O
improving	B-T080
and	O
no	O
abdominal	O
tumor	O
was	O
palpable	B-T080
.	O
	
mild	O
inflammatory	O
changes	O
and	O
anemia	B-T047
were	O
noted	O
on	O
blood	O
examination	O
.	O
	
abdominal	O
computed	O
tomography	O
revealed	O
a	O
tumor	O
with	O
a	O
layered	B-T080
structure	I-T080
in	O
the	O
left	O
abdomen	O
.	O
	
the	O
patient	O
was	O
diagnosed	B-T033
with	O
intestinal	B-T047
obstruction	I-T047
secondary	O
to	O
intussusception	B-T047
,	O
and	O
surgery	B-T061
was	O
performed	B-T169
.	O
	
retrograde	O
intussusception	O
was	O
found	O
at	O
the	O
site	O
of	O
the	O
y	B-T061
anastomosis	I-T061
.	O
	
we	O
conducted	O
manual	B-T061
reduction	I-T061
using	O
the	O
hutchinson	B-T061
procedure	I-T061
.	O
	
the	O
intestinal	O
color	B-T080
after	O
the	O
reduction	B-T061
was	O
good	O
,	O
and	O
no	O
intestinal	B-T061
resection	I-T061
was	O
required	B-T169
.	O
	
postoperative	B-T033
recovery	I-T033
was	O
uneventful	O
,	O
and	O
the	O
patient	O
was	O
discharged	O
12	O
days	O
after	O
surgery	B-T061
.	O
	
reports	O
of	O
jejunal	O
intussusception	B-T047
after	O
total	B-T061
gastrectomy	I-T061
with	O
roux-en-y	B-T061
reconstruction	I-T061
are	O
relatively	O
rare	O
.	O
	
here	O
,	O
we	O
report	O
a	O
case	O
of	O
jejunal	O
intussusception	B-T047
after	O
total	B-T061
gastrectomy	I-T061
with	O
roux-en-y	B-T061
reconstruction	I-T061
.	O
	
brassinosteroid	B-T109
-	O
induced	B-T169
changes	B-T169
of	O
lipid	B-T109
composition	O
in	O
leaves	O
of	O
pisum	O
sativum	O
l	O
.	O
	
during	O
senescence	O
the	O
effect	B-T080
of	I-T080
steroid	B-T109
phytohormone	B-T116
24-epibrassinolide	B-T109
ebr	B-T109
on	O
the	O
composition	O
of	O
some	O
lipid	B-T109
classes	O
free	B-T109
fatty	I-T109
acids	I-T109
,	O
triacylglycerols	B-T109
and	O
galactolipids	B-T109
in	O
detached	B-T169
pea	O
leaves	O
was	O
studied	O
for	O
the	O
first	O
time	O
.	O
	
ebr	B-T109
0.1μm	O
promoted	O
senescence	O
and	O
increased	B-T081
the	O
content	O
of	O
14	O
,	O
16	O
and	O
18	O
free	B-T109
fatty	I-T109
acids	I-T109
as	O
well	O
as	O
18	O
and	O
18	O
bound	O
to	O
triacylglycerols	B-T109
in	O
the	O
detached	B-T169
leaves	O
in	O
contrast	O
to	O
mock-treated	O
leaves	O
.	O
	
the	O
content	O
of	O
all	O
identified	B-T080
fatty	B-T109
acids	I-T109
bound	O
to	O
galactolipids	B-T109
decreased	B-T081
in	O
the	O
detached	B-T169
leaves	O
treated	B-T169
with	O
ebr	B-T109
compared	O
to	O
that	O
in	O
mock-treated	O
leaves	O
.	O
	
these	O
findings	B-T169
suggest	O
that	O
free	B-T109
fatty	I-T109
acids	I-T109
are	O
liberated	O
from	O
polar	B-T081
lipids	B-T109
and	O
then	O
undergo	O
esterification	O
to	O
neutral	B-T109
lipids	I-T109
in	O
the	O
detached	B-T169
leaves	O
upon	O
ebr	B-T109
treatment	B-T169
.	O
	
we	O
propose	O
that	O
steroid	B-T109
phytohormones	B-T116
may	O
be	O
involved	O
into	O
regulation	O
of	O
leaf	O
senescence	O
via	O
alteration	B-T078
of	O
cell	O
lipid	B-T109
composition	O
.	O
	
posterior	O
dislocation	O
of	O
the	O
sternoclavicular	O
joint	O
report	O
of	O
two	O
cases	B-T169
the	O
authors	O
report	O
the	O
cases	B-T169
of	O
two	O
young	B-T079
patients	O
who	O
had	O
suffered	O
a	O
sporting	O
accident	O
with	O
posterior	O
traumatic	O
dislocation	O
of	O
sternoclavicular	O
joint	O
.	O
	
in	O
one	O
of	O
the	O
patients	O
closed	B-T061
reduction	I-T061
was	O
accomplished	O
by	O
keeping	O
the	O
limb	O
in	O
a	O
sling	O
.	O
	
the	O
second	O
patient	O
,	O
after	O
reduction	B-T061
was	O
done	O
,	O
presented	O
recurrence	O
of	O
the	O
dislocation	O
,	O
thus	O
requiring	O
surgical	B-T061
treatment	I-T061
.	O
	
it	O
is	O
important	O
to	O
observe	O
the	O
relevance	B-T080
of	O
computed	O
tomography	O
to	O
help	O
diagnosing	O
,	O
as	O
well	O
as	O
monitoring	O
the	O
reduction	B-T061
procedure	I-T061
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
demonstrate	O
two	O
different	O
types	O
of	O
treatment	B-T061
in	O
a	O
rare	B-T080
injury	O
such	O
as	O
the	O
posterior	O
dislocation	O
of	O
sternoclavicular	O
joint	O
.	O
	
using	O
a	O
graphical	O
risk	O
tool	O
to	O
examine	O
willingness	B-T033
to	I-T033
take	I-T033
migraine	B-T047
prophylactic	B-T061
medications	O
many	O
migraine	B-T047
sufferers	O
use	O
daily	B-T079
prophylactic	B-T061
therapy	I-T061
to	O
reduce	O
the	O
frequency	B-T079
of	O
their	O
headache	O
attacks	O
.	O
	
the	O
food	O
and	O
drug	O
administration	O
has	O
approved	B-T080
several	B-T081
different	O
medications	O
for	O
migraine	B-T047
prophylaxis	B-T061
,	O
but	O
it	O
is	O
not	O
clear	O
whether	O
sufferers	O
perceive	O
these	O
treatments	B-T061
to	O
provide	O
clinically	B-T078
significant	I-T078
benefits	B-T081
given	O
their	O
side	O
effect	O
profiles	O
.	O
	
three	O
hundred	O
headache	O
sufferers	O
were	O
recruited	O
from	O
the	O
community	O
and	O
local	O
headache	O
clinics	O
using	O
print	O
and	O
television	O
advertising	O
.	O
	
participants	O
reported	O
experiencing	O
problematic	O
headache	O
attacks	O
with	O
a	O
median	B-T081
iqr	O
frequency	B-T079
of	O
7.0	O
4-13	O
headache	O
days	B-T079
per	I-T079
month	I-T079
.	O
	
these	O
sufferers	O
participated	O
in	O
a	O
cross-sectional	O
,	O
single-site	O
,	O
study	O
that	O
used	O
a	O
specially	O
designed	O
computer	O
assessment	O
task	O
.	O
	
participants	O
were	O
instructed	O
on	O
the	O
probability	B-T081
of	O
experiencing	O
the	O
3	O
most	O
commonly	O
experienced	O
side	O
effects	O
for	O
several	B-T081
blinded	O
medication	O
profiles	O
divalproex	B-T109
sodium	I-T109
,	O
venlafaxine	B-T109
,	O
gabapentin	B-T109
,	O
propranolol	B-T109
,	O
and	O
topiramate	B-T109
.	O
	
after	O
learning	O
the	O
likelihood	B-T081
of	O
experiencing	O
side	O
effect	O
profiles	O
of	O
each	O
medication	O
,	O
participants	O
were	O
asked	O
whether	O
they	O
would	O
be	O
willing	B-T033
to	I-T033
take	I-T033
the	O
medication	O
for	O
a	O
given	O
headache	O
reduction	B-T080
level	B-T080
,	O
which	O
ranged	O
from	O
0	O
to	O
7	O
days	B-T079
per	I-T079
month	I-T079
.	O
	
the	O
side	O
effect	O
profile	O
for	O
divalproex	B-T109
sodium	I-T109
was	O
associated	B-T080
with	I-T080
the	O
smallest	B-T033
willingness	I-T033
to	I-T033
take	I-T033
,	O
with	O
gabapentin	B-T109
,	O
propranolol	B-T109
,	O
and	O
topiramate	B-T109
perceived	O
to	O
be	O
much	O
more	O
agreeable	O
.	O
	
however	O
,	O
<60%	O
of	O
participants	O
reported	O
willingness	B-T033
to	I-T033
take	I-T033
any	O
of	O
these	O
medications	O
even	O
if	O
they	O
provided	O
a	O
50%	O
reduction	B-T080
in	O
headache	O
frequency	B-T079
.	O
	
several	B-T081
general	O
predictors	B-T078
of	O
willingness	B-T033
to	I-T033
take	I-T033
were	O
observed	O
including	O
high	B-T080
headache	O
-related	O
disability	B-T033
,	O
depressive	O
symptoms	O
,	O
and	O
pain	B-T109
medication	I-T109
concerns	B-T078
including	O
fear	O
of	O
tolerance	O
.	O
	
these	O
findings	B-T033
suggest	O
that	O
if	O
properly	O
informed	B-T080
of	O
the	O
side	O
effect	O
profiles	O
of	O
these	O
medications	O
,	O
many	O
patients	O
might	O
opt	O
for	O
other	O
genome-wide	O
detection	O
of	O
selective	O
signatures	O
in	O
chicken	O
through	O
high	O
density	O
snps	O
chicken	O
is	O
recognized	O
as	O
an	O
excellent	O
model	O
for	O
studies	O
of	O
genetic	B-T169
mechanism	B-T169
of	O
phenotypic	O
and	O
genomic	O
evolution	O
,	O
with	O
large	O
effective	O
population	B-T081
size	I-T081
and	O
strong	O
human	O
-driven	O
selection	O
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
performed	O
extended	O
haplotype	O
homozygosity	O
ehh	O
tests	O
to	O
identify	O
significant	O
core	O
regions	O
employing	O
600k	O
snp	O
chicken	O
chip	O
in	O
an	O
f2	B-T078
population	I-T078
of	O
1	O
hens	O
,	O
which	O
was	O
derived	O
from	O
reciprocal	O
crosses	O
between	O
white	O
leghorn	O
and	O
dongxiang	O
chicken	O
.	O
	
results	O
indicated	O
that	O
a	O
total	O
of	O
49	O
core	O
regions	O
with	O
an	O
average	O
length	B-T081
of	O
9.79	O
kb	O
were	O
identified	B-T080
,	O
which	O
occupied	O
approximately	O
52.15	O
of	O
genome	O
across	O
all	O
autosomes	O
,	O
and	O
806	O
significant	O
core	O
regions	O
attracted	O
us	O
mostly	O
.	O
	
genes	O
in	O
candidate	O
regions	O
may	O
experience	O
positive	O
selection	O
and	O
were	O
considered	O
to	O
have	O
possible	O
influence	O
on	O
beneficial	O
economic	B-T080
traits	I-T080
.	O
	
a	O
panel	B-T078
of	O
genes	O
including	O
aasdhppt	O
,	O
gdpd5	O
,	O
par3	O
,	O
sox6	O
,	O
gpc1	O
and	O
a	O
signal	O
pathway	O
of	O
akt1	O
were	O
detected	B-T033
with	O
the	O
most	O
extreme	O
p-values	B-T081
.	O
	
further	O
enrichment	O
analyses	O
indicated	O
that	O
these	O
genes	O
were	O
associated	B-T080
with	I-T080
immune	O
function	O
,	O
sensory	O
organ	O
development	O
and	O
neurogenesis	O
,	O
and	O
may	O
have	O
experienced	O
positive	O
selection	O
in	O
chicken	O
.	O
	
moreover	O
,	O
some	O
of	O
core	O
regions	O
exactly	O
overlapped	O
with	O
genes	O
excavated	O
in	O
our	O
previous	O
gwas	O
,	O
suggesting	O
that	O
these	O
genes	O
have	O
undergone	O
positive	O
selection	O
may	O
affect	O
egg	O
production	O
.	O
	
findings	B-T169
in	O
our	O
study	O
could	O
draw	O
a	O
comparatively	O
integrate	O
genome-wide	O
map	O
of	O
selection	O
signature	O
in	O
the	O
chicken	O
genome	O
,	O
and	O
would	O
be	O
worthy	O
for	O
explicating	O
the	O
genetic	B-T169
mechanisms	B-T169
of	O
phenotypic	O
diversity	B-T080
in	O
poultry	O
breeding	O
.	O
	
high-throughput	O
genotyping	O
with	O
taqman	O
allelic	O
discrimination	O
and	O
allele-specific	O
genotyping	O
assays	O
real-time	O
pcr	O
-based	O
genotyping	O
methods	O
,	O
such	O
as	O
taqman	O
allelic	O
discrimination	O
assays	O
and	O
allele-specific	O
genotyping	O
,	O
are	O
particularly	O
useful	B-T080
when	O
screening	O
a	O
handful	O
of	O
single	O
nucleotide	O
polymorphisms	O
in	O
hundreds	O
of	O
samples	O
either	O
derived	O
from	O
different	B-T080
individuals	O
,	O
tissues	O
,	O
or	O
pre	B-T079
-	O
amplified	O
dna	O
.	O
	
although	O
real-time	O
pcr	O
-	O
based	B-T169
methods	O
such	O
as	O
taqman	O
are	O
well-established	B-T080
,	O
alternative	O
methods	O
,	O
like	O
allele-specific	O
genotyping	O
,	O
are	O
powerful	O
alternatives	O
,	O
especially	O
for	O
genotyping	O
short	O
tandem	O
repeat	O
str	O
length	B-T081
polymorphisms	O
.	O
	
here	O
,	O
we	O
describe	O
all	O
relevant	B-T080
aspects	B-T080
when	O
developing	B-T169
an	O
assay	O
for	O
a	O
new	O
snp	O
or	O
str	O
using	O
either	O
taqman	O
or	O
allele-specific	O
genotyping	O
,	O
respectively	O
,	O
such	O
as	O
primer	O
and	O
probe	O
design	O
,	O
optimization	O
of	O
reaction	B-T169
conditions	B-T080
,	O
the	O
experimental	O
procedure	O
for	O
typing	O
hundreds	O
of	O
samples	O
,	O
and	O
finally	O
the	O
data	B-T078
evaluation	O
.	O
	
our	O
goal	O
is	O
to	O
provide	O
a	O
guideline	O
for	O
developing	B-T169
genotyping	O
assays	O
using	O
these	O
two	O
approaches	B-T169
that	O
render	O
reliable	O
and	O
reproducible	B-T080
genotype	O
calls	O
involving	B-T169
minimal	B-T080
optimization	O
.	O
	
the	O
role	O
of	O
p2x7	B-T116
receptors	I-T116
in	O
a	O
rodent	O
pcp	B-T109
-	O
induced	B-T169
schizophrenia	O
model	O
p2x7	B-T116
receptors	I-T116
p2x7rs	B-T116
are	O
ligand-gated	B-T116
ion	I-T116
channels	I-T116
sensitive	B-T169
to	O
extracellular	O
atp	O
.	O
	
here	O
we	O
examined	B-T033
for	O
the	O
first	O
time	O
the	O
role	O
of	O
p2x7r	B-T116
in	O
an	O
animal	O
model	O
of	O
schizophrenia	O
.	O
	
using	O
the	O
pcp	B-T109
induced	B-T169
schizophrenia	O
model	O
we	O
show	O
that	O
both	O
genetic	O
deletion	O
and	O
pharmacological	B-T169
inhibition	O
of	O
p2x7rs	B-T116
alleviate	B-T169
schizophrenia-like	B-T033
behavioral	O
alterations	B-T078
.	O
	
in	O
p2rx7+/+	O
mice	O
,	O
pcp	B-T109
induced	B-T169
hyperlocomotion	B-T033
,	O
stereotype	O
behavior	O
,	O
ataxia	O
and	O
social	B-T033
withdrawal	I-T033
.	O
	
in	O
p2x7	O
receptor	O
deficient	B-T169
mice	O
p2rx7-/-	O
,	O
the	O
social	B-T033
interactions	I-T033
were	O
increased	B-T081
,	O
whereas	O
the	O
pcp	B-T109
induced	B-T169
hyperlocomotion	B-T033
and	O
stereotype	O
behavior	O
were	O
alleviated	B-T169
.	O
	
the	O
selective	O
p2x7	O
receptor	O
antagonist	O
jnj-47965567	O
partly	O
replicated	O
the	O
effect	B-T080
of	I-T080
gene	O
deficiency	O
on	O
pcp	B-T109
-	O
induced	B-T169
behavioral	O
changes	O
and	O
counteracted	O
pcp	B-T109
-	O
induced	B-T169
social	B-T033
withdrawal	I-T033
.	O
	
we	O
also	O
show	O
that	O
pcp	B-T109
treatment	B-T169
upregulates	O
and	O
increases	B-T169
the	O
functional	B-T169
responsiveness	B-T169
of	O
p2x7rs	B-T116
in	O
the	O
prefrontal	O
cortex	O
of	O
young	O
adult	O
animals	O
.	O
	
the	O
amplitude	O
of	O
nmda	B-T116
evoked	B-T080
currents	O
recorded	O
from	O
layer	O
v	O
pyramidal	O
neurons	O
of	O
cortical	O
slices	O
were	O
slightly	O
decreased	B-T081
by	O
both	O
genetic	O
deletion	O
of	O
p2rx7	O
and	O
by	O
jnj-47965567	O
.	O
	
pcp	B-T109
induced	B-T169
alterations	B-T078
in	O
mrna	O
expression	O
encoding	O
schizophrenia-related	O
genes	O
,	O
such	O
as	O
nr2a	O
,	O
nr2b	O
,	O
neuregulin	B-T116
1	I-T116
,	O
nr1	O
and	O
gaba	B-T116
α1	I-T116
subunit	O
were	O
absent	B-T169
in	O
the	O
pfc	O
of	O
young	O
adult	O
p2rx7-/-	O
animals	O
.	O
	
our	O
findings	B-T033
point	O
to	O
p2x7r	B-T116
as	O
a	O
potential	B-T080
therapeutic	B-T169
target	B-T169
in	O
the	O
flavor	O
and	O
nutritional	B-T080
characteristic	B-T080
of	O
four	O
strawberry	O
varieties	O
cultured	O
in	O
soilless	O
system	O
strawberry	O
fruits	O
cv	O
.	O
	
benihoppe	O
,	O
tochiotome	O
,	O
sachinoka	O
,	O
and	O
guimeiren	O
were	O
harvested	O
and	O
evaluated	O
the	O
flavor	O
and	O
nutritional	B-T080
parameters	O
.	O
	
by	O
principal	B-T081
component	I-T081
analysis	I-T081
and	O
hierarchical	O
clustering	O
analysis	O
,	O
differences	O
were	O
observed	O
based	O
on	O
the	O
volatile	B-T109
compounds	I-T109
composition	O
,	O
sugar	B-T109
and	O
acid	B-T109
concentration	B-T081
,	O
sweetness	B-T080
,	O
and	O
total	B-T109
soluble	I-T109
sugars	I-T109
/	O
total	B-T109
organic	I-T109
acids	I-T109
of	O
the	O
four	O
varieties	O
.	O
	
a	O
total	O
of	O
37	O
,	O
48	O
,	O
65	O
,	O
and	O
74	O
volatile	B-T109
compounds	I-T109
were	O
identified	B-T080
and	O
determined	B-T080
in	O
cv	O
.	O
	
benihoppe	O
,	O
tochiotome	O
,	O
sachinoka	O
,	O
and	O
guimeiren	O
strawberry	O
fruits	O
extracted	B-T061
by	O
head-space	O
solid-phase	O
microextraction	O
hs-spme	O
,	O
respectively	O
.	O
	
esters	B-T109
significantly	O
dominated	O
the	O
chemical	O
composition	O
of	O
the	O
four	O
varieties	O
.	O
	
furaneol	B-T109
was	O
detected	O
in	O
cultivars	O
of	O
sachinoka	O
and	O
guimeiren	O
,	O
but	O
mesifuran	O
was	O
only	O
found	O
in	O
cv	O
.	O
	
tochiotome	O
.	O
	
tochiotome	O
and	O
sachinoka	O
showed	O
higher	O
content	B-T081
of	O
linalool	B-T109
and	O
e	B-T109
.	O
	
sachinoka	O
showed	O
the	O
highest	B-T080
content	B-T081
of	O
total	B-T109
sugars	I-T109
and	O
total	B-T109
acids	I-T109
.	O
	
guimeiren	O
showed	O
higher	O
sweetness	B-T080
index	O
than	O
the	O
other	O
three	O
cultivars	O
.	O
	
firmness	B-T080
of	O
tochiotome	O
was	O
highest	B-T080
among	O
all	O
the	O
varieties	O
.	O
	
the	O
highest	B-T080
total	B-T081
soluble	I-T081
solids	I-T081
tss	I-T081
value	I-T081
was	O
found	O
in	O
cv	O
.	O
	
sachinoka	O
,	O
followed	O
by	O
the	O
guimeiren	O
and	O
tochiotome	O
varieties	O
.	O
	
sachinoka	O
had	O
the	O
highest	B-T080
titratable	O
acidity	O
ta	O
value	O
.	O
	
the	O
content	B-T081
of	O
ascorbic	B-T109
acid	I-T109
asa	B-T109
of	O
cv	O
.	O
	
tochiotome	O
was	O
higher	B-T080
than	O
the	O
others	O
,	O
but	O
there	O
was	O
no	B-T033
significant	I-T033
difference	B-T081
in	O
cultivars	O
of	O
benihoppe	O
,	O
tochiotome	O
,	O
and	O
sachinoka	O
.	O
	
fructose	B-T109
and	O
glucose	B-T109
were	O
the	O
major	O
sugars	B-T109
in	O
all	O
cultivars	O
.	O
	
citric	B-T109
acid	I-T109
was	O
the	O
major	O
organic	B-T109
acid	I-T109
in	O
cv	O
.	O
	
tochiotome	O
,	O
cv	O
.	O
	
sachinoka	O
,	O
and	O
cv	O
.	O
	
guimeiren	O
.	O
	
tochiotome	O
had	O
higher	B-T080
ratios	B-T081
of	O
tss	B-T109
/	O
ta	O
and	O
total	B-T109
sugars	I-T109
/	O
total	B-T109
organic	I-T109
acids	I-T109
than	O
others	O
,	O
arising	O
from	O
its	O
lower	O
acid	B-T109
content	B-T081
.	O
	
the	O
order	O
of	O
the	O
comprehensive	B-T081
evaluation	I-T081
score	I-T081
was	O
sachinoka	O
>	O
guimeiren	O
>	O
tochiotome	O
>	O
prognostic	B-T081
value	I-T081
of	O
glut-1	B-T116
expression	O
in	O
oral	O
squamous	O
cell	O
carcinoma	O
a	O
prisma-compliant	O
meta-analysis	O
a	O
variety	O
of	O
studies	O
have	O
evaluated	O
the	O
correlation	B-T080
between	O
glucose	B-T116
transporter-1	I-T116
glut-1	B-T116
expression	O
and	O
prognosis	O
of	O
oral	O
squamous	O
cell	O
carcinoma	O
oscc	O
however	O
,	O
the	O
results	B-T169
were	O
inconsistent	B-T080
and	O
inconclusive	B-T080
.	O
	
a	O
meta-analysis	O
was	O
performed	O
to	O
assess	O
the	O
prognostic	O
significance	B-T078
of	O
glut-1	B-T116
in	O
oscc	O
.	O
	
electronic	O
databases	O
of	O
pubmed	O
,	O
embase	O
,	O
and	O
web	O
of	O
science	O
were	O
searched	O
for	O
relevant	O
studies	O
.	O
	
the	O
last	O
search	O
was	O
updated	O
on	O
july	B-T080
2016	O
.	O
	
odds	B-T081
ratio	I-T081
or	B-T081
and	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
were	O
pooled	O
to	O
evaluate	O
the	O
relationship	B-T078
between	O
glut-1	B-T116
and	O
clinical	B-T033
features	I-T033
and	O
hazard	B-T081
ratio	I-T081
hr	B-T081
and	O
95%	O
ci	B-T081
were	O
combined	O
to	O
measure	B-T081
the	O
effect	B-T080
of	O
glut-1	B-T116
on	O
overall	B-T081
survival	I-T081
os	B-T081
.	O
	
p	O
value	O
<	O
0.05	O
was	O
considered	O
as	O
statistically	B-T081
significant	I-T081
.	O
	
a	O
total	O
of	O
13	O
studies	O
with	O
1301	O
subjects	O
were	O
included	O
for	O
meta-analysis	O
.	O
	
the	O
pooled	B-T078
data	I-T078
showed	O
that	O
high	O
glut-1	B-T116
expression	O
was	O
associated	B-T080
with	I-T080
advanced	O
tumor	O
stages	O
n	O
=	O
7	O
,	O
or	B-T081
=	O
2.99	O
,	O
95%	O
ci	B-T081
2.01	O
,	O
p	O
<	O
0.001	O
,	O
higher	O
tumor	O
grade	O
n	O
=	O
5	O
,	O
or	B-T081
=	O
3.34	O
,	O
95%	O
ci	B-T081
1.12	O
,	O
p	O
=	O
0.031	O
,	O
tumor	O
size	O
n	O
=	O
5	O
,	O
or	B-T081
=	O
3.36	O
,	O
95%	O
ci	B-T081
2.04	O
,	O
p	O
<	O
0.001	O
,	O
lymph	B-T033
node	I-T033
metastasis	I-T033
n	O
=	O
5	O
,	O
or	B-T081
=	O
3.15	O
,	O
95%	O
ci	B-T081
1.89	O
,	O
p	O
<	O
0.001	O
,	O
tobacco	O
use	O
n	O
=	O
3	O
,	O
or	B-T081
=	O
2.18	O
,	O
95%	O
ci	B-T081
1.18	O
,	O
p	O
=	O
0.013	O
,	O
and	O
distant	O
metastasis	O
n	O
=	O
2	O
,	O
or	B-T081
=	O
3.06	O
,	O
95%	O
ci	B-T081
1.19	O
,	O
p	O
=	O
0.02	O
.	O
	
furthermore	O
,	O
increased	B-T081
glut-1	B-T116
expression	O
was	O
also	O
correlated	B-T080
with	O
shorter	B-T081
os	I-T081
n	O
=	O
8	O
,	O
hr	B-T081
=	O
1.88	O
,	O
95%	O
ci	B-T081
1.51	O
,	O
p	O
<	O
0.001	O
.	O
	
no	O
significant	B-T080
publication	I-T080
bias	I-T080
was	O
detected	B-T033
in	O
this	O
meta-analysis	O
.	O
	
glut-1	B-T116
overexpression	O
was	O
in	O
connection	O
with	O
aggressive	B-T033
clinical	I-T033
features	I-T033
and	O
worse	B-T081
os	I-T081
in	O
oscc	O
.	O
	
however	O
,	O
further	O
studies	O
are	O
still	O
needed	O
to	O
verify	O
whether	O
glut-1	B-T116
could	O
serve	O
as	O
a	O
prognostic	O
biomarker	O
for	O
biogeography	O
and	O
character	O
evolution	O
of	O
the	O
ciliate	O
genus	O
euplotes	O
spirotrichea	O
,	O
euplotia	O
,	O
with	O
description	O
of	O
euplotes	O
curdsi	O
sp	O
.	O
	
nov	O
ciliates	O
comprise	O
a	O
diverse	B-T080
and	O
ecologically	O
important	B-T080
phylum	O
of	O
unicellular	O
protists	O
.	O
	
one	O
of	O
the	O
most	O
specious	O
and	O
best-defined	O
genera	O
is	O
euplotes	O
,	O
which	O
constitutes	O
more	O
than	O
70	O
morphospecies	O
,	O
many	O
of	O
which	O
have	O
never	O
been	O
molecularly	B-T169
tested	I-T169
.	O
	
the	O
increasing	O
number	O
of	O
described	O
euplotes	O
taxa	O
emphasizes	O
the	O
importance	O
for	O
detailed	O
characterizations	O
of	O
new	O
ones	O
,	O
requiring	O
standardized	O
morphological	O
observations	O
,	O
sequencing	B-T169
of	O
molecular	O
markers	O
and	O
careful	O
comparison	O
with	O
previous	O
literature	O
.	O
	
here	O
we	O
describe	O
euplotes	O
curdsi	O
sp	O
.	O
	
nov	O
distinguishable	B-T080
by	O
the	O
combination	B-T080
of	O
the	O
following	O
features	B-T080
45-65	O
μm	O
length	B-T081
,	O
oval	B-T080
or	I-T080
elongated	I-T080
shape	I-T080
with	O
both	O
ends	O
rounded	O
,	O
narrow	B-T080
peristome	I-T080
with	O
25-34	O
adoral	B-T080
membranelles	I-T080
,	O
conspicuous	O
paroral	O
membrane	O
,	O
double-eurystomus	B-T080
dorsal	I-T080
argyrome	I-T080
type	I-T080
,	O
6-7	O
dorsolateral	B-T080
kineties	I-T080
and	O
10	O
frontoventral	B-T080
cirri	I-T080
.	O
	
three	O
populations	B-T081
of	O
the	O
novel	O
species	O
have	O
been	O
found	O
in	O
brackish	O
and	O
marine	O
samples	O
in	O
the	O
mediterranean	O
and	O
the	O
white	O
sea	O
.	O
	
we	O
provide	O
the	O
ssu	O
rrna	O
gene	O
sequences	O
of	O
these	O
populations	B-T081
,	O
and	O
an	O
updated	O
phylogeny	B-T078
of	O
the	O
genus	O
euplotes	O
.	O
	
using	O
the	O
molecular	B-T080
phylogenetic	B-T080
tree	I-T080
,	O
we	O
inferred	O
aspects	B-T080
of	O
the	O
biogeographical	B-T169
history	I-T169
of	O
the	O
genus	O
and	O
the	O
evolution	O
of	O
its	O
most	O
important	O
taxonomic	B-T169
characters	B-T080
in	O
order	O
to	O
provide	O
a	O
frame	O
for	O
future	O
descriptions	O
.	O
	
ultimately	O
,	O
these	O
data	B-T078
reveal	O
recurrent	B-T079
trends	B-T079
of	O
freshwater	O
invasion	O
and	O
highlight	O
the	O
dynamic	O
,	O
yet	O
convergent	O
,	O
morphological	O
evolution	O
of	O
comparative	O
effectiveness	O
of	O
treatments	B-T061
for	O
chronic	B-T047
low	I-T047
back	I-T047
pain	I-T047
a	O
multiple	O
treatment	O
comparison	O
analysis	O
a	O
systematic	O
review	O
and	O
network	O
meta-analysis	O
.	O
	
to	O
determine	O
current	B-T061
treatment	I-T061
options	I-T061
of	O
chronic	B-T047
low	I-T047
back	I-T047
pain	I-T047
lbp	B-T047
as	O
defined	O
by	O
randomized	O
controlled	O
trials	O
rcts	O
and	O
to	O
compare	O
effectiveness	B-T080
of	O
those	O
treatments	B-T061
using	O
a	O
mixed-treatment	O
comparison	O
mtc	O
.	O
	
it	O
is	O
important	O
to	O
provide	O
an	O
evidence-based	B-T078
assessment	O
of	O
the	O
treatment	B-T061
options	I-T061
that	O
exist	O
for	O
lbp	B-T047
.	O
	
a	O
systematic	O
search	O
of	O
rcts	O
was	O
conducted	O
in	O
medline	O
and	O
the	O
cochrane	O
collaboration	O
library	O
from	O
1990	O
to	O
2014	O
.	O
	
from	O
the	O
selected	O
studies	O
,	O
we	O
extracted	O
preoperative	B-T079
and	O
postoperative	B-T079
odi	B-T033
and	O
vas	B-T081
back	I-T081
pain	I-T081
scores	I-T081
,	O
additional	O
surgeries	O
,	O
and	O
complications	O
.	O
	
standard	O
and	O
network	O
meta-analytic	O
techniques	O
were	O
used	O
.	O
	
twelve	O
rcts	O
were	O
included	O
in	O
the	O
analysis	O
5	O
total	B-T061
disk	I-T061
replacement	I-T061
tdr	B-T061
versus	O
fusion	B-T061
1	O
tdr	B-T061
versus	O
exercise	B-T061
and	O
cognitive	B-T061
behavioral	I-T061
therapy	I-T061
cbt	B-T061
5	O
fusion	B-T061
versus	O
exercise	B-T061
and	O
cbt	B-T061
and	O
1	O
fusion	B-T061
versus	O
physical	B-T061
therapy	I-T061
pt	B-T061
.	O
	
on	O
the	O
basis	O
of	O
mtc	O
,	O
with	O
respect	O
to	O
odi	B-T033
change	I-T033
scores	I-T033
,	O
the	O
pooled	B-T081
mean	I-T081
difference	I-T081
favoring	O
fusion	B-T061
over	O
exercise	B-T061
and	O
cbt	B-T061
was	O
2.0	O
points	O
95%	O
ci	O
,	O
-1	O
to	O
4.8	O
.	O
	
the	O
pooled	B-T081
mean	I-T081
difference	I-T081
favoring	O
tdr	B-T061
over	O
exercise	B-T061
and	O
cbt	B-T061
was	O
6.4	O
points	O
95%	O
ci	O
,	O
3.2	O
.	O
	
the	O
pooled	B-T081
mean	I-T081
difference	I-T081
favoring	O
fusion	B-T061
over	O
pt	B-T061
was	O
8.8	O
points	O
95%	O
ci	O
,	O
4.1	O
.	O
	
the	O
pooled	B-T081
mean	I-T081
differences	I-T081
favoring	O
tdr	B-T061
over	O
fusion	B-T061
was	O
4.4	O
points	O
95%	O
ci	O
,	O
2.37	O
.	O
	
for	O
pt	B-T061
versus	O
structured	B-T061
exercise	I-T061
with	O
cbt	B-T061
,	O
the	O
pooled	B-T081
mean	I-T081
difference	I-T081
favoring	O
exercise	B-T061
with	O
cbt	B-T061
over	O
pt	B-T061
was	O
6.8	O
points	O
95%	O
ci	O
,	O
1.5	O
.	O
	
for	O
tdr	B-T061
versus	O
pt	B-T061
,	O
the	O
pooled	B-T081
mean	I-T081
difference	I-T081
favoring	O
tdr	B-T061
over	O
pt	B-T061
was	O
13.2	O
points	O
95%	O
ci	O
,	O
8.0	O
.	O
	
additional	O
surgery	B-T081
rates	I-T081
were	O
similar	O
between	O
treatment	B-T061
options	I-T061
.	O
	
all	O
4	O
treatments	B-T061
provided	O
some	O
benefit	B-T081
to	O
patients	O
with	O
chronic	B-T047
lbp	I-T047
.	O
	
according	O
to	O
the	O
mtc	O
analysis	O
,	O
tdr	B-T061
may	O
be	O
the	O
most	B-T080
effective	I-T080
treatment	B-T061
and	O
pt	B-T061
the	O
least	B-T080
effective	I-T080
treatment	B-T061
for	O
chronic	B-T047
lbp	I-T047
.	O
	
this	O
review	O
is	O
based	O
on	O
a	O
limited	B-T081
number	I-T081
of	O
rct	O
studies	O
and	O
does	O
not	O
support	O
any	O
1	O
treatment	B-T061
modality	B-T078
for	O
all	O
a	O
novel	O
selective	O
inhibitor	O
of	O
delta-5	B-T116
desaturase	I-T116
lowers	O
insulin	O
resistance	O
and	O
reduces	B-T033
body	I-T033
weight	I-T033
in	O
diet	O
-induced	O
obese	B-T047
c57bl/6j	O
mice	O
obesity	B-T047
is	O
now	O
recognized	O
as	O
a	O
state	O
of	O
chronic	O
low-grade	O
inflammation	O
and	O
is	O
called	O
as	O
metabolic	B-T169
inflammation	O
.	O
	
delta-5	B-T116
desaturase	I-T116
d5d	B-T116
is	O
an	O
enzyme	B-T116
that	O
metabolizes	O
dihomo-γ-linolenic	B-T109
acid	I-T109
dgla	B-T109
to	O
arachidonic	B-T109
acid	I-T109
aa	B-T109
.	O
	
thus	O
,	O
d5d	B-T116
inhibition	O
increases	O
dgla	B-T109
precursor	O
to	O
anti-inflammatory	B-T080
eicosanoids	B-T109
while	O
decreasing	O
aa	B-T109
precursor	O
to	O
pro-inflammatory	O
eicosanoids	B-T109
,	O
and	O
could	O
result	O
in	O
synergistic	B-T080
improvement	O
in	O
the	O
low-grade	O
inflammatory	O
state	O
.	O
	
here	O
,	O
we	O
demonstrate	O
reduced	B-T080
insulin	O
resistance	O
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
d5d	B-T116
selective	O
inhibitor	O
compound-326	O
,	O
an	O
orally	O
active	O
small-molecule	B-T109
,	O
in	O
a	O
high-fat	O
diet	O
-induced	O
obese	O
dio	O
mouse	O
model	O
.	O
	
in	O
vivo	O
d5d	B-T116
inhibition	O
was	O
confirmed	O
by	O
determining	O
changes	O
in	O
blood	O
aa	B-T109
/	O
dgla	B-T109
profiles	O
.	O
	
in	O
dio	O
mice	O
,	O
chronic	O
treatment	O
with	O
compound-326	O
lowered	O
insulin	O
resistance	O
and	O
caused	O
body	B-T033
weight	I-T033
loss	I-T033
without	O
significant	O
impact	O
on	O
cumulative	O
calorie	B-T081
intake	I-T081
.	O
	
decreased	O
macrophage	B-T033
infiltration	I-T033
into	I-T033
adipose	I-T033
tissue	I-T033
was	O
expected	O
from	O
mrna	O
analysis	O
.	O
	
increased	O
daily	O
energy	O
expenditure	O
was	O
also	O
observed	O
following	O
administration	B-T061
of	O
compound-326	O
,	O
in	O
line	O
with	O
sustained	O
body	B-T033
weight	I-T033
loss	I-T033
.	O
	
these	O
data	O
indicate	O
that	O
the	O
novel	O
d5d	B-T116
selective	O
inhibitor	O
,	O
compound-326	O
,	O
will	O
be	O
a	O
new	O
class	O
of	O
drug	O
for	O
the	O
treatment	O
of	O
obese	B-T047
and	O
diabetic	B-T047
patients	O
.	O
	
blood	O
collection	O
tubes	O
and	O
storage	B-T080
temperature	I-T080
should	O
be	O
evaluated	O
when	O
using	O
the	O
siemens	O
advia	O
centaur	O
xp	O
for	O
measuring	O
25-hydroxyvitamin	O
d	O
a	O
significant	O
bias	O
was	O
found	O
when	O
using	O
the	O
siemens	O
advia	O
centaur	O
xp	O
system	O
for	O
measurement	O
of	O
25-hydroxyvitamin	O
d	O
25ohd	B-T109
with	O
vacuette	O
tubes	O
with	O
serum	O
clot	O
activator	O
and	O
gel	O
.	O
	
here	O
,	O
we	O
examined	O
whether	O
other	O
commonly	O
used	O
tubes	O
or	O
temperatures	B-T081
affected	O
25ohd	O
results	O
obtained	O
with	O
the	O
siemens	O
advia	O
centaur	O
xp	O
system	O
.	O
	
serum	O
was	O
collected	O
into	O
five	O
types	O
of	O
vacuum	O
blood	O
collection	O
tubes	O
from	O
three	O
manufacturers	O
,	O
and	O
25ohd	O
was	O
analyzed	O
using	O
the	O
siemens	O
advia	O
centaur	O
xp	O
system	O
and	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
lc-ms/ms	O
immediately	O
or	O
after	O
storage	O
at	O
4	O
or	O
-80	O
for	O
48	O
h	O
.	O
	
significantly	B-T081
higher	I-T081
25ohd	O
values	O
were	O
found	O
when	O
using	O
the	O
siemens	O
advia	O
centaur	O
xp	O
system	O
with	O
vacuette	O
tubes	O
with	O
serum	O
clot	O
activator	O
and	O
gel	O
and	O
vacuette	O
tubes	O
with	O
clot	O
activator	O
but	O
no	O
gel	O
compared	O
with	O
vacuette	O
tubes	O
with	O
no	O
additives	O
.	O
	
the	O
25ohd	O
values	O
in	O
all	O
of	O
these	O
tubes	O
were	O
not	O
significantly	O
different	O
from	O
those	O
obtained	O
by	O
lc-ms/ms	O
.	O
	
moreover	O
,	O
after	O
storage	O
at	O
-80	O
for	O
48	O
h	O
,	O
the	O
values	O
obtained	O
in	O
improvevacuter	O
tubes	O
with	O
serum	O
clot	O
activator	O
and	O
ge	O
l	O
significantly	B-T081
increased	I-T081
,	O
with	O
a	O
mean	O
bias	O
of	O
74.6	O
compared	O
with	O
the	O
values	O
before	O
storage	O
,	O
on	O
analysis	O
with	O
the	O
siemens	O
advia	O
centaur	O
xp	O
system	O
.	O
	
vacuette	O
tubes	O
containing	O
additives	O
significantly	O
affect	O
the	O
accuracy	O
of	O
25ohd	O
results	O
obtained	O
using	O
the	O
siemens	O
advia	O
centaur	O
xp	O
system	O
.	O
	
additionally	O
,	O
the	O
composition	O
of	O
serum	O
collected	O
in	O
improvevacuter	O
tubes	O
was	O
affected	O
by	O
freezing	O
,	O
resulting	O
in	O
different	O
measurements	O
when	O
using	O
the	O
siemens	O
25ohd	B-T109
assay	O
platform	O
.	O
	
evolution	O
of	O
fitness	O
cost-neutral	B-T033
mutant	O
pfcrt	B-T116
conferring	O
p	O
.	O
	
falciparum	O
4-aminoquinoline	B-T109
drug	O
resistance	O
is	O
accompanied	O
by	O
altered	B-T169
parasite	O
metabolism	O
and	O
digestive	O
vacuole	O
physiology	O
southeast	O
asia	O
is	O
an	O
epicenter	O
of	O
multidrug-resistant	O
plasmodium	O
falciparum	O
strains	O
.	O
	
selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	O
variants	O
of	O
parasite	O
drug	O
resistance	O
genes	O
,	O
including	O
the	O
p	O
.	O
	
falciparum	O
chloroquine	O
resistance	O
transporter	O
pfcrt	O
.	O
	
despite	O
significant	O
reductions	B-T061
in	O
the	O
deployment	O
of	O
the	O
4-aminoquinoline	B-T109
drug	O
chloroquine	B-T109
cq	B-T109
,	O
which	O
selected	O
for	O
the	O
mutant	O
pfcrt	O
alleles	O
that	O
halted	O
cq	B-T109
efficacy	B-T080
decades	O
ago	O
,	O
the	O
parasite	O
pfcrt	O
locus	O
is	O
continuously	O
evolving	O
.	O
	
this	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	B-T080
mutated	O
allele	O
,	O
cam734	O
pfcrt	O
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	O
cq	B-T109
resistance	O
without	O
an	O
associated	O
fitness	O
cost	B-T080
.	O
	
here	O
,	O
we	O
used	O
pfcrt	O
-specific	O
zinc-finger	B-T116
nucleases	I-T116
to	O
genetically	B-T169
dissect	I-T169
this	O
allele	O
in	O
the	O
pathogenic	B-T033
setting	O
of	O
asexual	O
blood-stage	O
infection	O
.	O
	
comparative	O
analysis	O
of	O
drug	O
resistance	O
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	O
that	O
express	O
cam734	O
or	O
variants	O
thereof	O
,	O
dd2	O
the	O
most	O
common	O
southeast	O
asian	O
variant	O
,	O
or	O
wild-type	O
pfcrt	O
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
pfcrt	B-T116
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	O
.	O
	
these	O
results	O
were	O
generated	O
in	O
the	O
gc03	O
strain	O
,	O
used	O
in	O
multiple	O
earlier	O
pfcrt	O
studies	O
,	O
and	O
might	O
differ	O
in	O
natural	O
isolates	O
harboring	O
this	O
allele	O
.	O
	
results	O
presented	O
herein	O
show	O
that	O
cam734	O
-mediated	O
cq	B-T109
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
a144f	O
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
southeast	O
asia	O
,	O
and	O
reveal	O
distinct	O
impacts	B-T080
of	O
this	O
and	O
other	O
cam734	O
-specific	O
mutations	O
on	O
cq	B-T109
resistance	O
and	O
parasite	O
growth	B-T079
rates	I-T079
.	O
	
biochemical	O
assays	O
revealed	O
a	O
broad	O
impact	B-T080
of	O
mutant	O
pfcrt	B-T116
isoforms	B-T116
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	B-T080
,	O
hemoglobin	O
catabolism	O
and	O
disposition	O
of	O
heme	B-T109
,	O
as	O
well	O
as	O
digestive	O
vacuole	O
volume	B-T081
and	O
ph	B-T081
.	O
	
results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	O
basis	O
and	O
physiological	B-T169
impact	B-T080
of	O
pfcrt	B-T116
-mediated	O
antimalarial	O
drug	O
resistance	O
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
pfcrt	O
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	B-T080
of	O
first-line	O
antimalarial	O
drug	O
regimens	B-T061
.	O
	
effect	B-T080
of	O
nutritionally	B-T033
induced	I-T033
hyperlipidaemia	B-T047
on	O
in	B-T080
vitro	I-T080
bovine	O
embryo	O
quality	O
depends	O
on	O
the	O
type	O
of	O
major	O
fatty	B-T109
acid	I-T109
in	O
the	O
diet	O
the	O
present	O
study	O
examined	B-T033
whether	O
the	O
effects	B-T080
of	I-T080
dietary	O
-induced	O
hyperlipidaemia	B-T047
on	O
preimplantation	O
embryo	O
development	O
depend	O
on	O
the	O
predominant	O
fatty	B-T109
acid	I-T109
fa	B-T109
type	O
in	O
the	O
diet	O
.	O
	
in	O
a	O
combined	O
in	O
vivo	O
-	O
in	B-T080
vitro	I-T080
bovine	O
model	O
,	O
two	O
groups	O
of	O
cows	O
n=3	O
in	O
each	O
group	O
were	O
fed	O
with	O
three	O
diets	O
consecutively	O
4	O
weeks	O
feeding	O
for	O
each	O
1	O
a	O
maintenance	O
control	O
diet	O
cont	O
2	O
a	O
high	B-T080
-	O
starch	O
diet	O
rich	O
in	O
saturated	O
fat	O
sat	O
and	O
3	O
a	O
high	B-T080
-	O
starch	O
diet	O
rich	O
in	O
omega-3	B-T109
unsaturated	B-T109
fat	I-T109
unsat	B-T109
.	O
	
two	O
feeding	O
sequences	B-T169
were	O
used	O
to	O
test	O
for	O
carry-over	O
effects	O
group	O
a	O
was	O
fed	O
cont	O
,	O
sat1	O
and	O
then	O
unsat2	B-T109
,	O
whereas	O
group	O
b	O
was	O
fed	O
cont	O
,	O
unsat1	B-T109
and	O
then	O
sat2	O
.	O
	
serum	O
was	O
collected	O
after	O
each	O
dietary	O
period	B-T079
,	O
analysed	O
and	O
tested	B-T169
in	O
bovine	O
in	B-T080
vitro	I-T080
embryo	O
culture	O
.	O
	
introducing	O
sat	O
and	O
unsat	B-T109
diets	O
induced	O
hyperlipidaemia	B-T047
specifically	O
hypercholesterolaemia	B-T047
and	O
elevated	O
free	B-T109
fas	I-T109
and	O
reduced	O
insulin	O
sensitivity	O
.	O
	
carry-over	O
effects	O
in	O
serum	O
metabolites	O
and	O
fa	O
profile	O
were	O
dependent	O
on	O
the	O
diet	O
and	O
feeding	O
sequence	B-T169
.	O
	
sat1	O
and	O
sat2	O
serum	O
decreased	O
blastocyst	O
rates	O
and	O
altered	O
blastocyst	O
mrna	O
expression	O
related	O
to	O
apoptosis	O
and	O
oxidative	O
stress	O
.	O
	
unsat1	B-T109
and	O
unsat2	B-T109
serum	O
resulted	O
in	O
normal	O
embryo	O
development	O
and	O
quality	B-T080
.	O
	
other	O
in	B-T080
vitro	I-T080
effects	O
depended	O
on	O
the	O
sequence	B-T169
of	O
feeding	O
.	O
	
in	O
conclusion	O
,	O
substitution	O
of	O
saturated	O
fat	O
with	O
omega-3	B-T109
fat	I-T109
in	O
a	O
high-caloric	B-T061
diet	I-T061
induced	O
hyperlipidaemia	B-T047
with	O
an	O
fa	O
profile	O
yielding	O
similar	O
rates	O
and	O
quality	O
of	O
blastocysts	O
compared	O
with	O
normolipidaemic	O
controls	O
.	O
	
draft	O
genome	O
sequence	O
of	O
the	O
soil	O
isolate	O
lysinibacillus	O
fusiformis	O
m5	O
,	O
a	O
potential	B-T080
hypoxanthine	B-T109
producer	O
lysinibacillus	O
fusiformis	O
strain	O
m5	O
is	O
a	O
potential	B-T080
hypoxanthine	B-T109
producer	O
that	O
was	O
isolated	O
from	O
clay	O
soil	O
.	O
	
here	O
,	O
we	O
present	O
the	O
draft	O
genome	O
sequence	O
that	O
was	O
annotated	O
in	O
order	O
to	O
facilitate	O
future	O
studies	O
of	O
l	O
.	O
	
fusiformis	O
m5	O
.	O
	
impact	B-T080
of	O
clinical	O
trial	O
results	O
on	O
the	O
temporal	B-T079
trends	B-T079
of	O
carotid	B-T061
endarterectomy	I-T061
and	O
stenting	B-T061
from	O
2002	O
to	O
2014	O
randomized	O
trials	O
provide	O
conflicting	B-T080
data	B-T078
for	O
the	O
efficacy	B-T080
of	O
carotid-artery	B-T061
stenting	I-T061
compared	O
with	O
endarterectomy	B-T061
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
impact	B-T080
of	O
conflicting	B-T080
clinical	O
trial	O
publications	O
on	O
the	O
utilization	O
rates	O
of	O
carotid	O
revascularization	O
procedures	O
.	O
	
we	O
conducted	O
a	O
population-level	O
time-series	O
analysis	O
of	O
all	O
individuals	O
who	O
underwent	O
carotid	O
endarterectomy	O
and	O
stenting	O
in	O
ontario	O
,	O
canada	O
2002-2014	O
.	O
	
the	O
primary	O
analysis	O
examined	O
temporal	O
changes	O
in	O
the	O
rates	O
of	O
carotid	O
revascularization	O
procedures	O
after	O
publications	O
of	O
major	O
randomized	O
trials	O
.	O
	
secondary	O
analyses	O
examined	O
changes	O
in	O
overall	O
and	O
age	O
,	O
sex	O
,	O
carotid-artery	O
symptom	O
,	O
and	O
operator	O
specialty-specific	O
procedure	O
rates	O
.	O
	
a	O
total	O
of	O
16	O
772	O
patients	O
were	O
studied	O
14	O
394	O
endarterectomy	O
86%	O
2378	O
stenting	O
14%	O
.	O
	
the	O
overall	O
rate	O
of	O
carotid	O
revascularization	O
decreased	O
from	O
6.0	O
procedures	O
per	O
100	O
000	O
individuals	O
40	O
years	O
old	O
in	O
april	O
2002	O
to	O
4.3	O
procedures	O
in	O
the	O
first	O
quarter	O
of	O
2014	O
29%	O
decrease	O
p<0	O
.	O
	
the	O
rate	O
of	O
endarterectomy	O
decreased	O
by	O
36%	O
p<0	O
,	O
whereas	O
the	O
rate	O
of	O
carotid-artery	O
stenting	O
increased	O
by	O
72%	O
p=0	O
.	O
	
we	O
observed	O
a	O
marked	O
increase	O
p=0	O
in	O
stenting	O
after	O
publication	O
of	O
the	O
sapphire	O
trial	O
stenting	O
and	O
angioplasty	O
with	O
protection	O
in	O
patients	O
at	O
high	O
risk	O
for	O
endarterectomy	O
in	O
2004	O
,	O
whereas	O
stenting	O
remained	O
relatively	O
unchanged	O
after	O
subsequent	O
randomized	O
trials	O
published	O
in	O
2006	O
p=0	O
and	O
2010	O
p=0	O
.	O
	
in	O
contrast	O
,	O
endarterectomy	O
decreased	O
after	O
trials	O
published	O
in	O
2006	O
p=0	O
and	O
2010	O
p=0	O
.	O
	
although	O
the	O
overall	O
rates	O
of	O
carotid	O
revascularization	O
and	O
endarterectomy	O
have	O
fallen	O
since	O
2002	O
,	O
the	O
rate	O
of	O
carotid-artery	O
stenting	O
has	O
risen	O
since	O
the	O
publication	O
of	O
stenting	O
-favorable	O
sapphire	O
trial	O
.	O
	
subsequent	O
conflicting	O
randomized	O
trials	O
were	O
associated	O
with	O
a	O
decreasing	O
rate	O
of	O
carotid	O
endarterectomy	I-T061
electronic	O
tongues	O
to	O
assess	O
wine	O
sensory	B-T080
descriptors	O
this	O
work	O
reports	O
the	O
application	B-T169
of	O
an	O
electronic	O
tongue	O
as	O
a	O
tool	O
towards	O
the	O
analysis	O
of	O
wine	O
in	O
tasks	O
such	O
as	O
its	O
discrimination	B-T078
based	O
on	O
the	O
maturing	B-T079
in	O
barrels	O
or	O
the	O
prediction	B-T078
of	O
the	O
global	B-T080
scores	B-T081
assigned	O
by	O
a	O
sensory	O
panel	O
.	O
	
to	O
this	O
aim	O
,	O
red	O
wine	O
samples	O
were	O
first	O
analysed	O
with	O
the	O
voltammetric	O
sensor	O
array	O
,	O
without	O
performing	O
any	O
sample	O
pretreatment	O
.	O
	
afterwards	O
,	O
obtained	O
responses	B-T169
were	O
preprocessed	O
employing	O
fast	O
fourier	O
transform	O
fft	O
for	O
the	O
compression	O
and	O
reduction	B-T080
of	O
signal	O
complexity	B-T080
,	O
and	O
obtained	O
coefficients	B-T081
were	O
then	O
used	O
as	O
inputs	O
to	O
build	O
the	O
qualitative	B-T080
and	O
quantitative	B-T081
models	O
employing	O
either	O
linear	O
discriminant	O
analysis	O
lda	O
or	O
partial	O
least	O
squares	O
regression	O
pls	O
,	O
respectively	O
.	O
	
satisfactory	O
results	B-T033
were	O
obtained	O
overall	O
,	O
with	O
a	O
classification	O
rate	B-T081
of	O
100%	O
in	O
the	O
discrimination	B-T078
of	O
the	O
type	O
of	O
barrel	O
used	O
during	O
wine	O
maturing	B-T079
,	O
a	O
normalized	B-T081
nrmse	I-T081
of	O
0.077	O
in	O
the	O
estimation	O
of	O
ageing	O
time	B-T079
months	B-T079
or	O
0.11	O
in	O
the	O
prediction	B-T078
of	O
the	O
scores	B-T081
0-10	O
from	O
a	O
trained	O
sensory	O
panel	O
all	O
for	O
the	O
external	O
test	B-T169
subset	O
.	O
	
toward	O
optimizing	O
dental	O
implant	O
performance	O
surface	O
characterization	O
of	O
ti	O
and	O
tizr	O
implant	O
materials	O
targeting	B-T169
understanding	O
enhanced	O
osseointegration	O
kinetics	O
,	O
the	O
goal	O
of	O
this	O
study	O
was	O
to	O
characterize	O
the	O
surface	O
morphology	B-T080
and	O
composition	O
of	O
ti	O
and	O
tizr	O
dental	O
implant	O
substrates	O
subjected	O
to	O
one	O
of	O
two	O
surface	O
treatments	B-T169
developed	O
by	O
straumann	O
.	O
	
these	O
two	O
treatments	B-T169
are	O
typically	O
known	O
as	O
sla	O
and	O
slactive	O
,	O
with	O
the	O
latter	O
resulting	O
in	O
more	O
rapid	B-T080
osseointegration	O
.	O
	
a	O
range	O
of	O
techniques	B-T169
was	O
applied	B-T169
to	O
characterize	O
four	O
different	B-T080
substrate	O
/	O
surface	O
treatment	B-T169
combinations	B-T080
tisla	O
,	O
tislactive	O
,	O
tizrsla	O
,	O
and	O
tizrslactive	O
.	O
	
contact	B-T169
angle	O
measurements	B-T169
establish	O
establish	O
their	O
hydrophilic	B-T080
/	O
hydrophobic	B-T080
nature	O
.	O
	
surface	O
morphology	B-T080
was	O
probed	O
with	O
scanning	O
electron	O
microscopy	O
.	O
	
x-ray	O
diffraction	O
,	O
raman	O
μ-spectroscopy	O
,	O
and	O
x-ray	O
photoelectron	O
spectroscopy	O
were	O
used	O
to	O
elucidate	O
the	O
composition	O
of	O
the	O
near-	O
surface	O
region	O
.	O
	
consistent	B-T078
with	I-T078
previous	B-T079
work	O
,	O
surface	O
morphology	B-T080
was	O
found	O
to	O
differ	B-T080
only	O
at	O
the	O
nanoscale	B-T081
,	O
with	O
both	O
slactive	O
substrates	O
displaying	B-T169
nano	B-T081
-	O
protrusions	O
.	O
	
spectroscopic	O
data	B-T078
indicate	O
that	O
all	O
substrates	O
exhibit	O
surface	O
films	B-T080
of	O
titanium	O
oxide	O
displaying	O
near	O
tio2	O
stoichiometry	B-T081
.	O
	
raman	O
μ-spectroscopy	O
reveals	B-T080
that	O
amorphous	B-T080
tio2	O
is	O
most	O
likely	O
the	O
only	O
phase	B-T079
present	B-T033
on	O
tisla	O
,	O
whilst	O
rutile	O
-	O
tio2	O
is	O
also	O
evidenced	B-T078
on	O
tislactive	O
,	O
tizrsla	O
,	O
and	O
tizrslactive	O
.	O
	
for	O
tizr	O
alloy	O
substrates	O
,	O
there	O
is	O
no	O
evidence	B-T078
of	O
discrete	B-T080
phases	B-T079
of	O
oxidized	O
zr	O
.	O
	
x-ray	O
photoelectron	O
spectra	O
demonstrate	O
that	O
all	O
samples	O
are	O
terminated	B-T078
by	O
adventitious	B-T080
carbon	O
,	O
with	O
it	O
being	O
somewhat	O
thicker	B-T080
1nm	O
on	O
tisla	O
and	O
tizrsla	O
.	O
	
given	O
previous	B-T079
in	O
vivo	O
studies	O
,	O
acquired	B-T080
data	B-T078
suggest	O
that	O
both	O
nanoscale	B-T081
protrusions	O
,	O
and	O
a	O
thinner	B-T080
layer	B-T080
of	O
adventitious	B-T080
carbon	O
contribute	O
to	O
the	O
more	O
rapid	B-T080
osseointegration	O
of	O
slactive	O
dental	O
implants	O
.	O
	
composition	O
of	O
the	O
surface	O
oxide	O
layer	B-T080
is	O
apparently	O
less	B-T080
important	B-T080
in	O
determining	O
osseointegration	O
kinetics	O
.	O
	
cocaine	B-T109
use	B-T169
reverses	B-T169
striatal	O
plasticity	O
produced	B-T169
during	B-T079
cocaine	B-T109
seeking	O
relapse	O
is	O
a	O
two	B-T081
-	O
component	O
process	O
consisting	O
of	O
a	O
highly	B-T080
motivated	O
drug-seeking	O
phase	B-T079
that	O
,	O
if	O
successful	O
,	O
is	O
followed	B-T079
by	I-T079
a	O
drug-using	O
phase	B-T079
resulting	B-T169
in	I-T169
temporary	B-T079
satiation	O
.	O
	
in	O
rodents	O
,	O
cue-induced	O
drug	O
seeking	O
requires	B-T169
transient	O
synaptic	O
potentiation	O
t-sp	O
of	O
cortical	O
glutamatergic	O
synapses	O
on	O
nucleus	O
accumbens	O
core	O
medium	O
spiny	O
neurons	O
,	O
but	O
it	O
is	O
unknown	B-T080
how	O
achieving	O
drug	O
use	O
affects	O
this	O
plasticity	O
.	O
	
we	O
modeled	O
the	O
two	O
phases	B-T079
of	O
relapse	O
after	O
extinction	O
from	O
cocaine	B-T109
self-administration	B-T061
to	O
assess	O
how	O
cocaine	B-T109
use	O
affects	O
t-sp	O
associated	B-T080
with	I-T080
cue-induced	O
drug	O
seeking	O
.	O
	
rats	O
were	O
trained	O
to	O
self-administer	B-T061
cocaine	B-T109
n	O
=	O
96	O
or	O
were	O
used	O
as	O
yoked	O
-	O
saline	O
control	O
animals	O
n	O
=	O
21	O
.	O
	
after	O
extinction	O
,	O
reinstatement	B-T079
was	O
initiated	B-T169
by	O
10	O
minutes	B-T079
of	O
cue-induced	O
drug	O
seeking	O
,	O
followed	B-T079
by	I-T079
45	O
minutes	B-T079
with	O
contingent	B-T080
cocaine	B-T109
access	B-T169
,	O
after	O
which	O
cocaine	B-T109
was	O
discontinued	B-T033
and	O
unreinforced	B-T033
lever	I-T033
pressing	I-T033
ensued	I-T033
.	O
	
three	B-T081
measures	B-T081
of	O
t-sp	O
were	O
assayed	O
during	B-T079
reinstatement	B-T079
dendritic	O
spine	O
morphology	B-T080
,	O
alpha-amino-3-hydroxy-5-methyl-4-isoxazole	B-T109
propionic	I-T109
acid	I-T109
ampa	B-T109
to	O
n-methyl-d-aspartate	B-T116
nmda	B-T116
ratios	B-T081
,	O
and	O
matrix	B-T116
metalloproteinase	I-T116
activity	O
.	O
	
we	O
found	B-T033
that	O
cocaine	B-T109
use	O
for	O
10	O
minutes	B-T079
collapsed	B-T169
all	O
three	B-T081
measures	B-T081
of	O
cue-potentiated	O
t-sp	O
back	O
to	O
baseline	B-T081
.	O
	
moreover	O
,	O
when	O
cocaine	B-T109
use	O
was	O
discontinued	B-T033
45	O
minutes	B-T079
later	O
,	O
dendritic	O
spine	O
morphology	B-T080
and	O
ampa	B-T109
to	O
nmda	B-T116
ratios	B-T081
were	O
restored	O
as	O
animals	O
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	B-T033
pressing	I-T033
.	O
	
nonreinforced	O
drug	O
seeking	O
was	O
positively	B-T033
correlated	B-T080
with	O
changes	B-T169
in	O
spine	O
morphology	B-T080
,	O
and	O
cocaine	B-T109
access	B-T169
reversed	B-T169
this	O
relationship	B-T080
.	O
	
using	O
a	O
novel	B-T080
modification	B-T169
of	O
the	O
reinstatement	B-T079
paradigm	O
,	O
we	O
show	O
that	O
achieving	O
cocaine	B-T109
use	O
reversed	B-T169
the	O
synaptic	O
plasticity	O
underpinning	O
the	O
motivation	O
to	O
seek	O
the	O
delicaflavone	O
induces	B-T169
autophagic	O
cell	O
death	O
in	O
lung	O
cancer	O
via	O
akt	O
/	O
mtor	O
/	O
p70s6k	B-T116
signaling	O
pathway	O
searching	O
for	O
potential	B-T080
anticancer	B-T109
agents	I-T109
from	O
natural	B-T033
sources	I-T033
is	O
an	O
effective	B-T080
strategy	O
for	O
developing	O
novel	B-T080
chemotherapeutic	O
agents	O
.	O
	
in	O
this	O
study	O
,	O
data	B-T078
supporting	O
the	O
in	B-T080
vitro	I-T080
and	O
in	O
vivo	O
anticancer	B-T033
effects	I-T033
of	O
delicaflavone	O
,	O
a	O
rarely	O
occurring	O
biflavonoid	B-T109
from	O
selaginella	O
doederleinii	O
,	O
were	O
reported	O
.	O
	
delicaflavone	O
exhibited	O
favorable	B-T080
anticancer	B-T033
properties	O
,	O
as	O
shown	O
by	O
the	O
mtt	O
assay	O
and	O
xenograft	O
model	O
of	O
human	O
non-small	O
cell	O
lung	O
cancer	O
in	O
male	O
balb/c	O
nude	O
mice	O
without	O
observable	O
adverse	O
effect	O
.	O
	
by	O
transmission	O
electron	O
microscopy	O
with	O
acridine	B-T109
orange	I-T109
and	O
cyto-id	O
detection	O
dyes	O
,	O
western	O
blot	O
analysis	O
,	O
and	O
rt-pcr	O
assay	O
,	O
we	O
confirmed	O
that	O
delicaflavone	O
induces	B-T169
autophagic	O
cell	O
death	O
by	O
increasing	B-T169
the	O
ratio	O
of	O
lc3-ii	B-T116
to	O
lc3-i	B-T116
,	O
which	O
are	O
autophagy-related	B-T116
proteins	I-T116
,	O
and	O
promoting	O
the	O
generation	O
of	O
acidic	O
vesicular	O
organelles	O
and	O
autolysosomes	O
in	O
the	O
cytoplasm	O
of	O
human	O
lung	O
cancer	O
a549	O
and	O
pc-9	O
cells	O
in	O
a	O
time	B-T079
-	O
and	O
dose-dependent	B-T081
manner	O
.	O
	
delicaflavone	O
downregulated	O
the	O
expression	B-T033
of	I-T033
phospho-akt	I-T033
,	O
phospho-mtor	B-T116
,	O
and	O
phospho-p70s6k	B-T116
in	O
a	O
time	B-T079
-	O
and	O
dose-dependent	B-T081
manner	O
,	O
suggesting	B-T078
that	O
it	O
induced	B-T169
autophagy	O
by	O
inhibiting	O
the	O
akt	O
/	O
mtor	O
/	O
p70s6k	B-T116
pathway	O
in	O
a549	O
and	O
pc-9	O
cells	O
.	O
	
delicaflavone	O
is	O
a	O
potential	B-T080
anticancer	B-T109
agent	I-T109
that	O
can	O
induce	B-T169
autophagic	O
cell	O
death	O
in	O
human	O
non-small	O
cell	O
lung	O
cancer	O
via	O
the	O
akt	O
/	O
mtor	O
/	O
p70s6k	B-T116
signaling	O
pathway	O
.	O
	
delicaflavone	O
showed	O
anti-lung	B-T033
cancer	I-T033
effects	I-T033
in	B-T080
vitro	I-T080
and	O
in	O
vivo	O
.	O
	
delicaflavone	O
induced	B-T169
autophagic	O
cell	O
death	O
via	O
akt	O
/	O
mtor	O
/	O
p70s6k	B-T116
signaling	O
pathway	O
.	O
	
delicaflavone	O
did	O
not	O
show	O
observable	O
side	O
effects	O
in	O
a	O
xenograft	O
mouse	O
model	O
.	O
	
delicaflavone	O
may	O
represent	O
a	O
potential	B-T080
therapeutic	O
agent	O
for	O
lung	O
cancer	O
.	O
	
delicaflavone	O
showed	O
anti-lung	B-T033
cancer	I-T033
effects	I-T033
in	B-T080
vitro	I-T080
and	O
in	O
vivo	O
.	O
	
delicaflavone	O
induced	O
autophagic	O
cell	O
death	O
via	O
akt	O
/	O
mtor	O
/	O
p70s6k	B-T116
signaling	O
pathway	O
.	O
	
delicaflavone	O
did	O
not	O
show	O
observable	O
side	O
effects	O
in	O
a	O
xenograft	O
mouse	O
model	O
.	O
	
delicaflavone	O
may	O
represent	O
a	O
potential	B-T080
therapeutic	O
agent	O
for	O
lung	O
cancer	O
.	O
	
determinants	B-T169
of	O
on-road	O
driving	O
in	O
multiple	B-T047
sclerosis	I-T047
to	O
investigate	B-T169
the	O
cognitive	B-T169
,	O
visual	B-T169
,	O
and	O
motor	B-T033
deficits	I-T033
underlying	O
poor	O
performance	O
on	O
different	O
dimensions	B-T033
of	O
on-road	O
driving	O
in	O
individuals	O
with	O
multiple	B-T047
sclerosis	I-T047
ms	B-T047
.	O
	
prospective	O
cross-sectional	O
study	O
.	O
	
ms	O
clinic	O
and	O
driving	O
simulator	O
lab	O
.	O
	
active	O
drivers	O
n=102	O
with	O
various	O
types	O
of	O
ms	B-T047
.	O
	
not	O
applicable	O
.	O
	
off-road	O
cognitive	B-T169
,	O
visual	B-T169
,	O
and	O
motor	O
functions	O
,	O
as	O
well	O
as	O
13	O
specific	B-T080
driving	O
skills	O
.	O
	
these	O
skills	O
were	O
categorized	O
into	O
hierarchic	O
clusters	O
of	O
operational	O
,	O
tactical	O
,	O
visuo-integrative	B-T169
,	O
and	O
mixed	O
driving	O
.	O
	
stepwise	O
regression	O
analysis	O
was	O
used	O
to	O
determine	O
the	O
off-road	O
functions	O
influencing	O
performance	O
on	O
the	O
on-road	O
test	B-T169
and	O
each	O
cluster	B-T081
.	O
	
visuospatial	O
function	O
p=	O
,	O
inhibition	O
p=	O
,	O
binocular	B-T033
acuity	I-T033
p=	O
,	O
vertical	O
visual	O
field	O
p=	O
,	O
and	O
stereopsis	O
p=	O
best	O
determined	O
variance	B-T080
in	O
total	O
on-road	O
score	B-T081
unadjusted	O
r	O
.	O
	
attentional	B-T033
shift	I-T033
p=	O
,	O
stereopsis	O
p=	O
,	O
glare	O
recovery	O
p=	O
,	O
and	O
use	O
of	O
assistive	O
devices	O
p=	O
best	O
predicted	O
the	O
operational	O
cluster	O
unadjusted	O
r	O
.	O
	
visuospatial	O
function	O
p=	O
,	O
inhibition	O
p=	O
,	O
reasoning	O
p=	O
,	O
binocular	B-T033
acuity	I-T033
p=	O
,	O
and	O
stereopsis	O
p=	O
best	O
determined	O
the	O
tactical	O
cluster	O
unadjusted	O
r	O
.	O
	
the	O
visuo-integrative	O
mode	O
l	O
unadjusted	O
r	O
comprised	O
binocular	B-T033
acuity	I-T033
p=	O
and	O
stereopsis	O
p=	O
.	O
	
inhibition	O
p=	O
and	O
binocular	B-T033
acuity	I-T033
p=	O
provided	O
the	O
best	O
model	B-T081
of	O
the	O
mixed	O
cluster	O
unadjusted	O
r	O
.	O
	
our	O
results	O
provide	O
more	O
insights	O
into	O
the	O
specific	O
impairments	B-T169
that	O
influence	O
different	O
dimensions	O
of	O
on-road	O
driving	O
and	O
may	O
be	O
used	O
as	O
a	O
framework	O
for	O
targeted	B-T169
driving	O
intervention	B-T061
programs	I-T061
in	O
netarsudil	O
increases	B-T169
outflow	O
facility	O
in	O
human	O
eyes	O
through	O
multiple	B-T081
mechanisms	B-T169
netarsudil	O
is	O
a	O
rho	O
kinase/norepinephrine	O
transporter	O
inhibitor	O
currently	O
in	O
phase	O
3	O
clinical	O
development	O
for	O
glaucoma	B-T047
treatment	B-T061
.	O
	
we	O
investigated	O
the	O
effects	O
of	O
its	O
active	O
metabolite	O
,	O
netarsudil-m1	O
,	O
on	O
outflow	O
facility	O
c	O
,	O
outflow	O
hydrodynamics	O
,	O
and	O
morphology	B-T080
of	O
the	O
conventional	B-T080
outflow	O
pathway	O
in	O
enucleated	O
human	O
eyes	O
.	O
	
paired	B-T080
human	O
eyes	O
n	O
=	O
5	O
were	O
perfused	B-T061
with	O
either	O
0.3	O
μm	O
netarsudil-m1	O
or	O
vehicle	O
solution	O
at	O
constant	O
pressure	O
15	O
mm	O
hg	O
.	O
	
after	O
3	O
hours	B-T079
,	O
fluorescent	O
microspheres	O
were	O
added	O
to	O
perfusion	B-T061
media	O
to	O
trace	B-T081
the	O
outflow	O
patterns	O
before	O
perfusion	B-T061
-	O
fixation	B-T061
.	O
	
the	O
percentage	B-T081
effective	I-T081
filtration	I-T081
length	I-T081
pefl	B-T081
was	O
calculated	O
from	O
the	O
measured	B-T080
lengths	B-T081
of	O
tracer	O
distribution	B-T169
in	O
the	O
trabecular	O
meshwork	O
tm	O
,	O
episcleral	O
veins	O
esvs	O
,	O
and	O
along	O
the	O
inner	O
wall	O
iw	O
of	O
schlemm's	O
canal	O
after	O
global	B-T080
and	O
confocal	O
imaging	O
.	O
	
morphologic	O
changes	O
along	O
the	O
trabecular	O
outflow	O
pathway	O
were	O
investigated	O
by	O
confocal	O
,	O
light	O
,	O
and	O
electron	O
microscopy	O
.	O
	
perfusion	B-T061
with	O
netarsudil-m1	O
significantly	B-T078
increased	B-T081
c	O
when	O
compared	O
to	O
baseline	O
51%	O
,	O
p	O
<	O
0.01	O
and	O
to	O
paired	B-T080
controls	O
102%	O
,	O
p	O
<	O
0.01	O
,	O
as	O
well	O
as	O
significantly	B-T078
increased	B-T081
pefl	B-T081
in	O
both	O
iw	O
p	O
<	O
0.05	O
and	O
esvs	O
p	O
<	O
0.01	O
.	O
	
in	O
treated	O
eyes	O
,	O
pefl	B-T081
was	O
significantly	B-T078
higher	O
in	O
esvs	O
than	O
in	O
the	O
iw	O
p	O
<	O
0.01	O
and	O
was	O
associated	B-T080
with	I-T080
increased	B-T081
cross-sectional	O
area	O
of	O
esvs	O
p	O
<	O
0.01	O
.	O
	
percentage	B-T081
effective	I-T081
filtration	I-T081
length	I-T081
in	O
esvs	O
positively	O
correlated	O
with	O
the	O
percentage	O
change	O
in	O
c	O
r2	O
=	O
0.58	O
,	O
p	O
=	O
0.01	O
.	O
	
a	O
significant	B-T078
increase	B-T169
in	O
juxtacanalicular	O
connective	O
tissue	O
jct	O
thickness	B-T080
p	O
<	O
0.05	O
was	O
found	O
in	O
treated	O
eyes	O
compared	O
to	O
controls	O
.	O
	
netarsudil	O
acutely	B-T079
increased	B-T081
c	O
by	O
expansion	O
of	O
the	O
jct	O
and	O
dilating	O
the	O
esvs	O
,	O
which	O
led	O
to	O
redistribution	B-T169
of	O
aqueous	O
outflow	O
through	O
a	O
larger	O
area	O
of	O
the	O
iw	O
and	O
geographical	O
factors	B-T169
associated	B-T080
with	I-T080
health	B-T033
disparities	I-T033
in	O
prostate	O
cancer	O
treatment	B-T061
variation	B-T080
in	O
prostate	O
cancer	O
is	O
common	O
,	O
and	O
it	O
is	O
driven	O
by	O
clinical	B-T080
and	O
clinician	O
factors	B-T169
,	O
patient	B-T080
preferences	I-T080
,	O
availability	B-T169
of	I-T169
resources	B-T078
,	O
and	O
access	O
to	O
physicians	O
and	O
treating	O
facilities	O
.	O
	
most	O
research	O
on	O
treatment	B-T061
disparities	B-T080
in	O
men	O
with	O
prostate	O
cancer	O
has	O
focused	O
on	O
race	O
and	O
socioeconomic	O
factors	O
.	O
	
however	O
,	O
the	O
geography	O
of	O
disparities	B-T080
-	O
capturing	O
racial	B-T033
and	O
socioeconomic	B-T033
differences	I-T033
based	O
on	O
where	O
patients	B-T080
live	O
-	O
can	O
provide	O
insight	O
into	O
barriers	B-T080
to	O
care	O
and	O
help	O
identify	O
outlier	O
areas	O
in	O
which	O
access	O
to	O
care	O
,	O
health	B-T078
resources	I-T078
,	O
or	O
both	O
are	O
more	O
pronounced	O
.	O
	
research	O
regarding	O
treatment	B-T061
patterns	O
and	O
disparities	B-T080
in	O
prostate	O
cancer	O
using	O
the	O
geographical	O
information	O
system	O
gis	O
was	O
searched	O
.	O
	
studies	O
were	O
limited	O
to	O
english-language	O
articles	O
and	O
research	O
focused	O
on	O
us	O
populations	O
.	O
	
a	O
total	O
of	O
43	O
articles	O
were	O
found	O
of	O
those	O
,	O
30	O
provided	O
information	B-T078
about	O
or	O
used	O
spatial	O
or	O
geographical	O
analyses	O
to	O
assess	O
and	O
describe	O
differences	B-T080
or	O
disparities	B-T080
in	O
prostate	O
cancer	O
and	O
its	O
treatment	B-T061
.	O
	
two	O
additional	O
gis	O
resources	O
were	O
included	O
.	O
	
the	O
research	O
on	O
geographical	O
and	O
spatial	B-T169
determinants	I-T169
of	O
prostate	O
cancer	O
disparities	B-T080
was	O
reviewed	B-T080
.	O
	
we	O
also	O
examined	O
geographical	O
analyses	O
at	O
the	O
state	O
level	O
,	O
focusing	O
on	O
florida	O
.	O
	
overall	O
,	O
we	O
described	O
a	O
geographical	O
framework	O
to	O
disparities	B-T080
that	O
affect	O
men	O
with	O
prostate	O
cancer	O
and	O
reviewed	B-T080
existing	O
published	O
evidence	B-T078
supporting	O
the	O
interplay	O
of	O
geographical	O
factors	B-T169
and	O
disparities	B-T080
in	O
prostate	O
cancer	O
.	O
	
disparities	B-T080
in	O
prostate	O
cancer	O
are	O
common	B-T081
and	O
persistent	B-T079
,	O
and	O
notable	O
differences	O
in	O
treatment	B-T061
are	O
observable	O
across	O
racial	O
and	O
socioeconomic	O
strata	O
.	O
	
geographical	O
analysis	O
provides	O
additional	O
information	B-T078
about	O
where	O
disparate	B-T080
groups	O
live	O
and	O
also	O
helps	O
to	O
map	O
access	O
to	O
care	O
.	O
	
this	O
information	B-T078
can	O
be	O
used	O
by	O
public	O
health	O
officials	O
,	O
health-systems	O
administrators	O
,	O
clinicians	O
,	O
and	O
policymakers	O
to	O
better	O
understand	O
and	O
respond	O
to	O
geographical	O
barriers	B-T080
that	O
contribute	O
to	O
disparities	B-T080
in	I-T080
care	I-T080
.	O
	
the	O
novel	O
mir-9600	O
suppresses	B-T169
tumor	O
progression	O
and	O
promotes	O
paclitaxel	B-T109
sensitivity	B-T080
in	O
non-small-cell	O
lung	O
cancer	O
through	O
altering	B-T078
stat3	O
expression	O
micrornas	O
have	O
been	O
identified	B-T080
to	O
be	O
involved	O
in	O
center	O
stage	O
of	O
cancer	O
biology	O
.	O
	
they	O
accommodate	O
cell	O
proliferation	O
and	O
migration	O
by	O
negatively	B-T033
regulate	O
gene	O
expression	O
either	O
by	O
hampering	O
the	O
translation	O
of	O
targeted	O
mrnas	O
or	O
by	O
promoting	O
their	O
degradation	B-T169
.	O
	
we	O
characterized	O
and	O
identified	B-T080
the	O
novel	O
mir-9600	O
and	O
its	O
target	B-T169
in	O
human	O
non-small-cell	O
lung	O
cancer	O
nsclc	O
.	O
	
our	O
results	O
demonstrated	O
that	O
the	O
mir-9600	O
were	O
downregulated	O
in	O
nsclc	O
tissues	O
and	O
cells	O
.	O
	
it	O
is	O
confirmed	O
that	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
3	O
stat3	O
,	O
a	O
putative	O
target	O
gene	O
,	O
is	O
directly	O
inhibited	B-T080
by	O
mir-9600	O
.	O
	
the	O
mir-9600	O
markedly	O
suppressed	B-T169
the	O
protein	O
expression	O
of	O
stat3	O
,	O
but	O
with	O
no	B-T033
significant	I-T033
influence	O
in	O
corresponding	O
mrna	O
levels	B-T080
,	O
and	O
the	O
direct	O
combination	O
of	O
mir-9600	O
and	O
stat3	O
was	O
confirmed	O
by	O
a	O
luciferase	O
reporter	O
assay	O
.	O
	
mir-9600	O
inhibited	B-T080
cell	O
growth	O
,	O
hampered	O
expression	O
of	O
cell	O
cycle	O
-related	O
proteins	B-T116
and	O
inhibited	B-T080
cell	O
migration	O
and	O
invasion	O
in	O
human	O
nsclc	O
cell	O
lines	O
.	O
	
further	O
,	O
mir-9600	O
significantly	O
suppressed	B-T169
tumor	O
growth	O
in	O
nude	O
mice	O
.	O
	
similarly	O
,	O
mir-9600	O
impeded	O
tumorigenesis	O
and	O
metastasis	O
through	O
directly	O
targeting	O
stat3	O
.	O
	
furthermore	O
,	O
we	O
identified	B-T080
that	O
mir-9600	O
augmented	O
paclitaxel	B-T109
and	O
cisplatin	O
sensitivity	B-T080
by	O
downregulating	O
stat3	O
and	O
promoting	O
chemotherapy	B-T061
-	O
induced	B-T169
apoptosis	O
.	O
	
these	O
data	O
demonstrate	O
that	O
mir-9600	O
might	O
be	O
a	O
useful	O
and	O
novel	O
therapeutic	B-T169
target	B-T169
for	O
beneficial	O
effects	O
of	O
natural	B-T109
eggshell	I-T109
membrane	I-T109
nem	B-T109
on	O
multiple	O
indices	O
of	O
arthritis	B-T047
in	O
collagen-induced	O
arthritic	O
rats	O
this	O
study	O
was	O
performed	O
to	O
evaluate	O
the	O
potential	B-T080
efficacy	I-T080
of	O
natural	B-T109
eggshell	I-T109
membrane	I-T109
nem	B-T109
in	O
collagen-induced	O
arthritic	O
rats	O
,	O
a	O
well-established	O
rodent	O
model	O
of	O
inflammation	O
and	O
rheumatoid	B-T047
arthritis	I-T047
.	O
	
rats	O
with	O
developing	O
type	O
ii	O
collagen-induced	O
arthritis	O
cia	O
were	O
treated	O
once	O
daily	B-T079
by	O
oral	B-T169
gavage	I-T169
on	O
study	B-T079
days	I-T079
-14	O
to	O
17	O
with	O
vehicle	O
or	O
nem	B-T109
52	O
mg/kg	O
body	O
weight	O
.	O
	
rats	O
were	O
euthanized	O
on	O
study	B-T079
day	I-T079
17	O
.	O
	
efficacy	B-T080
was	O
assessed	O
by	O
daily	B-T079
ankle	O
caliper	O
measurements	B-T169
,	O
ankle	O
diameter	O
expressed	O
as	O
area	O
under	O
the	O
curve	O
aucd0-17	O
,	O
and	O
histopathologic	O
evaluation	O
of	O
ankles	O
and	O
knees	O
.	O
	
serum	O
biomarkers	O
of	O
cartilage	O
function	O
and	O
inflammation	O
collagen	O
type	O
ii	O
c-telopeptide	O
ctxii	O
,	O
cartilage	O
oligomeric	O
matrix	O
protein	O
comp	O
,	O
and	O
alpha-2-macroglobulin	O
a2m	O
were	O
measured	O
by	O
elisa	O
.	O
	
treatment	O
with	O
nem	O
resulted	O
in	O
significant	O
beneficial	O
effects	O
on	O
the	O
daily	O
ankle	O
diameter	O
measurements	B-T169
and	O
ankle	O
diameter	B-T081
auc	O
.	O
	
ankle	O
and	O
knee	O
histopathology	O
scores	O
were	O
significantly	O
reduced	O
36%	O
and	O
43%	O
reduction	O
of	O
summed	O
individual	O
histopathology	O
scores	O
for	O
ankle	O
and	O
knee	O
,	O
respectively	O
p	O
<	O
0.05	O
toward	O
normal	O
for	O
rats	O
given	O
nem	O
compared	O
to	O
vehicle	O
controls	O
.	O
	
the	O
percent	O
reduction	O
of	O
serum	O
ctxii	O
,	O
comp	O
,	O
and	O
a2m	O
in	O
nem	O
-	O
treated	O
rats	O
ranged	O
from	O
30%	O
to	O
72%	O
p	O
<	O
0.05	O
.	O
	
nem	O
significantly	O
improved	O
multiple	O
aspects	O
of	O
inflammatory	O
arthritis	O
including	O
inflammation	O
,	O
pannus	O
,	O
cartilage	O
damage	O
,	O
bone	O
resorption	O
,	O
and	O
periosteal	O
bone	O
formation	O
.	O
	
this	O
study	O
provides	O
further	O
support	O
for	O
the	O
use	O
of	O
ctxii	O
,	O
comp	O
,	O
and	O
a2m	O
as	O
relevant	O
biomarkers	O
that	O
were	O
responsive	O
to	O
nem	B-T109
mimicking	O
the	O
cell	O
membrane	O
bio-inspired	O
simultaneous	B-T079
functions	O
with	O
monovalent	O
anion	O
selectivity	O
and	O
antifouling	O
properties	O
of	O
anion	O
exchange	O
membrane	O
a	O
new	O
bio-inspired	O
method	O
was	O
applied	O
in	O
this	O
study	O
to	O
simultaneously	B-T079
improve	O
the	O
monovalent	O
anion	O
selectivity	O
and	O
antifouling	O
properties	O
of	O
anion	O
exchange	O
membranes	O
aems	O
.	O
	
three-layer	O
architecture	O
was	O
developed	O
by	O
deposition	O
of	O
polydopamine	B-T109
pda	B-T109
and	O
electro-deposition	O
of	O
n-o-sulfonic	B-T109
acid	I-T109
benzyl	I-T109
chitosan	I-T109
nsbc	B-T109
.	O
	
the	O
innermost	O
and	O
outermost	O
layers	O
were	O
pda	B-T109
with	O
different	O
deposition	O
time	O
.	O
	
the	O
middle	O
layer	O
was	O
prepared	O
by	O
nsbc	B-T109
.	O
	
fourier	O
transform	O
infrared	O
spectroscopy	O
and	O
scanning	O
electron	O
microscopy	O
confirmed	O
that	O
pda	B-T109
and	O
nsbc	B-T109
were	O
successfully	O
modified	O
on	O
the	O
surfaces	O
of	O
aems	O
.	O
	
the	O
contact	O
angle	O
of	O
the	O
membranes	O
indicated	O
an	O
improved	O
hydrophilicity	B-T080
of	O
the	O
modified	O
membranes	O
.	O
	
a	O
series	O
of	O
electrodialysis	O
experiments	O
in	O
which	O
cl	O
/	O
so4	O
separation	O
was	O
studied	O
,	O
demonstrating	O
the	O
monovalent	O
anion	O
selectivity	O
of	O
the	O
samples	O
.	O
	
the	O
cl	O
/	O
so4	O
permselectivity	O
of	O
the	O
modified	O
membranes	O
can	O
reach	O
up	O
to	O
2.20	O
,	O
higher	O
than	O
that	O
of	O
the	O
commercial	O
membrane	O
only	O
0.78	O
during	O
90	O
minutes	O
in	O
electrodialysis	O
ed	O
.	O
	
the	O
increase	O
value	O
of	O
the	O
resistance	O
of	O
the	O
membranes	O
was	O
also	O
measured	O
to	O
evaluate	O
the	O
antifouling	O
properties	O
.	O
	
sodium	B-T109
dodecyl	I-T109
benzene	I-T109
sulfonate	I-T109
sdbs	B-T109
was	O
used	O
as	O
the	O
fouling	O
material	O
in	O
the	O
ed	O
process	O
and	O
the	O
membrane	O
area	O
resistance	O
of	O
modified	O
membrane	O
the	O
loop	O
2	O
region	O
of	O
ribosomal	B-T116
protein	I-T116
us5	I-T116
influences	O
spectinomycin	B-T109
sensitivity	B-T033
,	O
translational	O
fidelity	O
,	O
and	O
ribosome	O
biogenesis	O
ribosomal	B-T116
protein	I-T116
us5	I-T116
is	O
an	O
essential	O
component	O
of	O
the	O
small	O
ribosomal	O
subunit	O
that	O
is	O
involved	O
in	O
subunit	O
assembly	O
,	O
maintenance	O
of	O
translational	O
fidelity	O
,	O
and	O
the	O
ribosome's	O
response	O
to	O
the	O
antibiotic	B-T109
spectinomycin	I-T109
.	O
	
while	O
many	O
of	O
the	O
characterized	O
us5	O
mutations	O
that	O
affect	O
decoding	O
map	O
to	O
its	O
interface	O
with	O
us4	B-T116
,	O
more	O
recent	O
work	O
has	O
shown	O
that	O
residues	O
distant	O
from	O
the	O
us4-us5	O
interface	O
can	O
also	O
affect	O
the	O
decoding	O
process	O
.	O
	
we	O
targeted	O
one	O
such	O
interface-remote	O
area	O
,	O
the	O
loop	O
2	O
region	O
residues	O
20	O
to	O
31	O
,	O
for	O
mutagenesis	O
in	O
escherichia	O
.	O
	
coli	O
and	O
generated	O
21	O
unique	O
mutants	O
.	O
	
a	O
majority	O
of	O
the	O
loop	O
2	O
alterations	O
confer	O
resistance	B-T169
to	O
spectinomycin	B-T109
and	O
affect	O
the	O
fidelity	O
of	O
translation	O
.	O
	
however	O
,	O
only	O
a	O
minority	O
show	O
altered	O
rrna	O
processing	O
or	O
ribosome	O
biogenesis	O
defects	B-T169
.	O
	
multiplex	B-T080
social	B-T169
ecological	O
network	O
analysis	O
reveals	B-T080
how	O
social	O
changes	O
affect	B-T169
community	O
robustness	B-T080
more	O
than	O
resource	B-T081
depletion	B-T080
network	O
analysis	O
provides	O
a	O
powerful	O
tool	O
to	O
analyze	O
complex	B-T080
influences	O
of	O
social	O
and	O
ecological	O
structures	O
on	O
community	O
and	O
household	O
dynamics	O
.	O
	
most	O
network	O
studies	O
of	O
social	B-T169
-	O
ecological	O
systems	O
use	O
simple	B-T080
,	O
undirected	O
,	O
unweighted	B-T169
networks	I-T169
.	O
	
we	O
analyze	O
multiplex	B-T080
,	O
directed	O
,	O
and	O
weighted	B-T169
networks	I-T169
of	O
subsistence	O
food	O
flows	O
collected	B-T078
in	O
three	O
small	O
indigenous	O
communities	O
in	O
arctic	O
alaska	O
potentially	O
facing	O
substantial	O
economic	B-T169
and	O
ecological	O
changes	B-T169
.	O
	
our	O
analysis	O
of	O
plausible	O
future	B-T079
scenarios	B-T169
suggests	O
that	O
changes	B-T169
to	O
social	B-T169
relations	B-T080
and	O
key	O
households	O
have	O
greater	O
effects	B-T080
on	O
community	O
robustness	B-T080
than	O
changes	B-T169
to	O
specific	B-T080
wild	B-T081
food	I-T081
resources	I-T081
.	O
	
heavy	B-T061
resistance	I-T061
training	I-T061
in	O
hypoxia	O
enhances	O
1rm	B-T081
squat	B-T033
performance	O
purpose	O
to	O
determine	O
if	O
heavy	B-T061
resistance	I-T061
training	I-T061
in	O
hypoxia	O
ihrt	B-T061
is	O
more	O
effective	B-T080
at	O
improving	B-T080
strength	B-T081
,	O
power	B-T033
,	O
and	O
increasing	B-T169
lean	O
mass	O
than	O
the	O
same	O
training	B-T080
in	O
normoxia	O
.	O
	
methods	O
a	O
pair-matched	B-T080
,	O
placebo-controlled	O
study	O
design	O
included	O
20	O
resistance-trained	B-T061
participants	O
assigned	O
to	O
ihrt	B-T061
fio2	B-T061
0.143	O
or	O
placebo	O
fio2	B-T061
0.20	O
,	O
n	O
=	O
10	O
per	O
group	O
.	O
	
participants	O
were	O
matched	B-T080
for	O
strength	B-T081
and	O
training	B-T061
.	O
	
both	B-T080
groups	O
performed	B-T169
20	O
sessions	O
over	O
7	O
weeks	B-T079
either	O
with	O
ihrt	B-T061
or	O
placebo	O
.	O
	
all	O
participants	O
were	O
tested	B-T169
for	O
1rm	B-T081
,	O
20-m	B-T081
sprint	B-T061
,	O
body	O
composition	O
,	O
and	O
countermovement	O
jump	O
pre	B-T079
-	O
,	O
mid	B-T079
-	O
,	O
and	O
post	B-T079
-	O
training	B-T061
and	O
compared	O
via	O
magnitude	B-T081
-	O
based	B-T169
inferences	O
.	O
	
presentation	O
of	O
results	O
groups	O
were	O
not	B-T033
clearly	I-T033
different	B-T080
for	O
any	O
test	B-T169
at	O
baseline	B-T081
.	O
	
training	B-T061
improved	B-T033
both	B-T080
absolute	B-T080
ihrt	B-T061
13.1	O
3.9	O
,	O
effect	B-T081
size	I-T081
es	B-T081
0.60	O
,	O
placebo	O
9.8	O
4.7	O
,	O
es	B-T081
0.31	O
and	O
relative	B-T080
1rm	B-T081
ihrt	B-T061
13.4	O
5.1	O
,	O
es	B-T081
0.76	O
,	O
placebo	O
9.7	O
5.3	O
,	O
es	B-T081
0.48	O
at	O
mid	O
.	O
	
similarly	O
,	O
at	O
post	B-T079
both	B-T080
groups	O
increased	B-T081
absolute	B-T080
ihrt	B-T061
20.7	O
7.6	O
,	O
es	B-T081
0.74	O
,	O
placebo	O
14.1	O
6.0	O
,	O
es	B-T081
0.58	O
and	O
relative	B-T080
1rm	B-T081
ihrt	B-T061
21.6	O
8.5	O
,	O
es	B-T081
1.08	O
,	O
placebo	O
13.2	O
6.4	O
,	O
es	B-T081
0.78	O
.	O
	
importantly	O
,	O
the	O
change	B-T169
in	O
ihrt	B-T061
was	O
greater	B-T081
than	O
placebo	O
at	O
mid	O
for	O
both	B-T080
absolute	B-T080
4.4	O
greater	B-T081
change	B-T169
,	O
90%	O
confidence	B-T081
interval	I-T081
ci	B-T081
1.0	O
,	O
es	B-T081
0.21	O
,	O
and	O
relative	B-T080
strength	B-T081
5.6	O
greater	B-T081
change	B-T169
,	O
90%	O
ci	B-T081
1.0	O
,	O
es	B-T081
0.31	O
relative	B-T080
.	O
	
there	O
was	O
also	O
a	O
greater	B-T081
change	B-T169
for	O
ihrt	B-T061
at	O
post	O
for	O
both	B-T080
absolute	B-T080
7.0	O
greater	B-T081
change	B-T169
,	O
90%	O
ci	B-T081
1.3	O
,	O
es	B-T081
0.33	O
,	O
and	O
relative	B-T080
1rm	B-T081
9.2	O
greater	B-T081
change	B-T169
,	O
90%	O
ci	B-T081
1.6	O
,	O
es	B-T081
0.49	O
.	O
	
only	O
ihrt	B-T061
increased	B-T081
countermovement	O
jump	O
peak	B-T080
power	B-T033
at	O
post	B-T079
4.9	O
,	O
es	B-T081
0.35	O
,	O
however	O
the	O
difference	B-T080
between	O
ihrt	B-T061
and	O
placebo	O
was	O
unclear	B-T033
2.7	O
,	O
90%	O
ci	B-T081
-2	O
,	O
es	B-T081
0.20	O
with	O
no	B-T033
clear	I-T033
differences	B-T080
in	O
speed	B-T081
or	O
body	O
composition	O
throughout	O
.	O
	
conclusion	O
heavy	B-T061
resistance	I-T061
training	I-T061
in	O
hypoxia	O
is	O
more	O
effective	B-T080
than	O
placebo	O
for	O
improving	B-T080
absolute	B-T080
and	O
relative	B-T080
strength	B-T081
.	O
	
ultrasonography	O
and	O
magnetic	O
resonance	O
imaging	O
evaluation	O
of	O
pediatric	B-T080
spinal	O
anomalies	O
spinal	O
dysraphisms	O
are	O
congenital	O
abnormalities	O
of	O
the	O
spine	O
due	O
to	O
imperfect	O
fusion	B-T169
of	O
midline	O
mesenchymal	B-T080
,	O
bony	B-T169
and	O
neural	B-T169
structures	O
.	O
	
imaging	O
plays	O
a	O
vital	O
role	O
in	O
their	O
evaluation	O
as	O
significant	O
portion	O
of	O
patients	O
may	O
present	O
with	O
concurrent	B-T079
anomalies	O
that	O
need	O
to	O
be	O
corrected	B-T080
simultaneously	B-T079
to	O
avoid	O
repeat	B-T061
surgeries	I-T061
.	O
	
the	O
aims	O
of	O
the	O
study	O
were	O
to	O
evaluate	O
spinal	O
dysraphisms	O
using	O
usg	O
and	O
mri	O
and	O
to	O
correlate	B-T080
imaging	O
findings	B-T169
with	O
operative	B-T079
findings	B-T169
in	O
patients	O
undergoing	O
surgery	B-T061
.	O
	
hospital	O
based	O
observational	O
study	O
conducted	O
over	O
a	O
period	B-T079
of	O
year	B-T079
.	O
	
38	O
cases	O
of	O
both	O
sexes	O
and	O
below	O
12	O
years	B-T079
of	O
age	O
with	O
spinal	O
dysraphism	O
were	O
studied	O
.	O
	
usg	O
was	O
performed	O
in	O
29	O
cases	O
where	O
acoustic	O
window	O
was	O
available	O
for	O
proper	O
evaluation	O
.	O
	
mri	O
was	O
performed	O
in	O
all	O
cases	O
.	O
	
usg	O
findings	B-T169
were	O
compared	O
with	O
mri	O
findings	B-T169
and	O
operative	B-T079
follow	O
up	O
was	O
taken	O
in	O
23	O
cases	O
who	O
underwent	O
operative	O
management	O
.	O
	
results	O
were	O
analysed	O
using	O
percentage	B-T081
and	O
arithmetic	B-T081
mean	I-T081
.	O
	
39.47	O
%	O
cases	O
were	O
male	O
and	O
60.53	O
%	O
cases	O
were	O
female	O
.	O
	
neonatal	B-T079
period	I-T079
was	O
the	O
most	O
common	O
presenting	O
age	O
group	O
.	O
	
closed	B-T169
spinal	O
dysraphism	O
63.16	O
was	O
more	O
common	O
than	O
open	O
36.84	O
.	O
	
79.31	O
cases	O
showed	O
full	O
agreement	O
between	O
spinal	O
usg	O
and	O
mri	O
examinations	O
and	O
6	O
out	O
of	O
20.69	O
showed	O
partial	O
agreement	O
.	O
	
on	O
operative	B-T079
correlation	B-T080
,	O
usg	O
findings	B-T169
were	O
confirmatory	B-T033
in	O
91.30	O
cases	O
and	O
mri	O
findings	B-T169
were	O
confirmatory	B-T033
in	O
100%	O
cases	O
.	O
	
usg	O
can	O
be	O
used	O
as	O
the	O
initial	O
modality	B-T169
for	O
evaluation	O
of	O
spinal	O
dysraphism	O
as	O
well	O
as	O
for	O
screening	O
of	O
suspected	B-T078
cases	O
.	O
	
mri	O
is	O
indicated	O
to	O
confirm	O
abnormal	B-T033
usg	O
findings	B-T169
,	O
which	O
shows	O
all	O
concurrent	B-T079
abnormalities	O
and	O
also	O
provides	O
additional	O
anatomical	B-T080
details	B-T080
relevant	O
to	O
surgical	O
planning	O
.	O
	
bora	O
-dependent	O
plk1	B-T116
regulation	O
a	O
new	O
weapon	O
for	O
cancer	B-T061
therapy	I-T061
the	O
mitotic	B-T116
kinase	I-T116
polo	I-T116
like	I-T116
kinase	I-T116
1	I-T116
plk1	B-T116
is	O
overexpressed	O
in	O
many	O
cancers	O
and	O
its	O
inhibition	O
slows	O
down	O
proliferation	O
and	O
increases	O
apoptosis	O
in	O
cancer	O
cell	O
lines	O
.	O
	
understanding	O
how	O
plk1	O
is	O
activated	O
is	O
therefore	O
crucial	O
for	O
the	O
development	O
of	O
novel	O
plk1	B-T116
inhibitors	I-T116
with	O
anticancer	B-T109
properties	I-T109
.	O
	
we	O
recently	O
identified	O
a	O
conserved	O
regulatory	O
loop	O
leading	O
to	O
plk1	O
activation	O
that	O
involves	O
cyclin-dependent	B-T116
kinase	I-T116
1	I-T116
cdk1	B-T116
.	O
	
activation	O
of	O
transcription	O
enforces	O
the	O
formation	O
of	O
distinct	O
nuclear	O
bodies	O
in	O
zebrafish	O
embryos	O
nuclear	O
bodies	O
are	O
cellular	O
compartments	O
that	O
lack	B-T080
lipid	O
bilayers	O
and	O
harbor	O
specific	B-T080
rnas	O
and	O
proteins	B-T116
.	O
	
recent	O
proposals	O
that	O
nuclear	O
bodies	O
form	O
through	O
liquid-liquid	O
phase	O
separation	O
leave	O
the	O
question	O
of	O
how	O
different	O
nuclear	O
bodies	O
maintain	O
their	O
distinct	O
identities	O
unanswered	O
.	O
	
here	O
we	O
investigate	B-T169
cajal	O
bodies	O
cbs	O
,	O
histone	O
locus	O
bodies	O
hlbs	O
and	O
nucleoli	O
-	O
involved	O
in	O
assembly	O
of	O
the	O
splicing	O
machinery	O
,	O
histone	O
mrna	O
3'	O
end	O
processing	O
,	O
and	O
rrna	O
processing	O
,	O
respectively	O
-	O
in	O
the	O
embryos	O
of	O
the	O
zebrafish	O
,	O
danio	O
rerio	O
.	O
	
we	O
take	O
advantage	O
of	O
the	O
transcriptional	O
silence	O
of	O
the	O
1-cell	O
embryo	O
and	O
follow	O
nuclear	O
body	O
appearance	O
as	O
zygotic	O
transcription	O
becomes	O
activated	O
.	O
	
cbs	O
are	O
present	O
from	O
fertilization	O
onwards	O
,	O
while	O
hlb	O
and	O
nucleolar	O
components	O
formed	O
foci	O
several	O
hours	O
later	O
when	O
histone	B-T116
genes	O
and	O
rdna	O
became	O
active	B-T169
.	O
	
hlb	O
formation	O
was	O
blocked	B-T169
by	O
transcription	O
inhibition	O
,	O
suggesting	O
nascent	O
histone	O
transcripts	O
recruit	O
hlb	O
components	O
like	O
u7	O
snrnp	O
.	O
	
surprisingly	O
,	O
we	O
found	O
that	O
u7	O
base-pairing	O
with	O
nascent	O
histone	O
transcripts	O
was	O
not	O
required	O
for	O
localization	O
to	O
hlbs	O
.	O
	
rather	O
,	O
the	O
type	O
of	O
sm	O
ring	O
assembled	O
on	O
u7	O
determined	O
its	O
targeting	O
to	O
hlbs	O
or	O
cbs	O
the	O
spliceosomal	O
sm	O
ring	O
targeted	O
snrnas	O
to	O
cbs	O
while	O
the	O
specialized	O
u7	O
sm-ring	O
localized	O
to	O
hlbs	O
,	O
demonstrating	O
the	O
contribution	O
of	O
protein	B-T116
constituents	O
to	O
the	O
distinction	O
among	O
nuclear	O
bodies	O
.	O
	
thus	O
,	O
nucleolar	O
,	O
hlb	O
,	O
and	O
cb	O
components	O
can	O
mix	O
in	O
early	B-T079
embryogenesis	O
when	O
transcription	O
is	O
naturally	O
or	O
artificially	O
silenced	O
.	O
	
these	O
data	O
support	O
a	O
model	O
in	O
which	O
transcription	O
of	O
specific	B-T080
gene	O
loci	O
nucleates	O
nuclear	O
body	O
components	O
with	O
high	O
specificity	B-T081
and	O
fidelity	O
to	O
perform	O
distinct	O
regulatory	O
functions	O
.	O
	
variation	O
in	O
the	O
age	O
of	O
first	O
reproduction	O
different	B-T080
strategies	I-T080
or	O
individual	B-T080
quality	I-T080
although	O
age	O
at	O
first	O
reproduction	O
is	O
a	O
key	O
demographic	B-T078
parameter	I-T078
that	O
is	O
probably	O
under	O
high	B-T033
selective	I-T033
pressure	I-T033
,	O
it	O
is	O
highly	O
variable	B-T080
and	O
the	O
cause	O
of	O
this	O
variability	O
is	O
not	O
well	O
understood	O
.	O
	
two	O
non-exclusive	O
hypotheses	B-T078
may	O
explain	O
such	O
variability	O
.	O
	
it	O
could	O
be	O
the	O
expression	O
of	O
different	O
individual	B-T080
strategies	I-T080
,	O
i.e	O
,	O
different	O
allocation	O
strategies	O
in	O
fitness	B-T078
components	I-T078
,	O
or	O
the	O
consequences	O
of	O
individual	O
difference	O
in	O
intrinsic	O
quality	O
,	O
i.e	O
,	O
some	O
individuals	O
always	O
doing	O
better	O
than	O
others	O
in	O
all	O
fitness	B-T078
components	I-T078
.	O
	
we	O
tested	B-T169
these	O
hypotheses	B-T078
in	O
the	O
wandering	O
albatross	O
investigating	O
relationships	B-T080
between	O
the	O
age	O
at	O
first	O
reproduction	O
and	O
subsequent	O
adult	O
demographic	O
traits	O
.	O
	
using	O
finite	O
mixture	O
capture	O
recapture	O
modeling	O
,	O
we	O
demonstrate	O
that	O
the	O
age	O
at	O
first	O
reproduction	O
is	O
negatively	B-T033
related	O
to	O
both	O
reproductive	O
performances	O
and	O
adult	O
survival	O
,	O
suggesting	O
that	O
individual	B-T080
quality	I-T080
was	O
an	O
important	O
factor	O
explaining	O
variation	O
in	O
the	O
age	O
at	O
first	O
reproduction	O
.	O
	
our	O
results	O
suggest	O
that	O
age	O
at	O
first	O
breeding	O
is	O
a	O
good	O
predictor	B-T078
of	O
quality	B-T080
in	O
this	O
long-lived	O
seabird	O
species	O
.	O
	
heterogeneity	B-T080
of	O
colorectal	O
cancer	O
risk	B-T078
by	O
tumour	O
characteristics	B-T080
large	O
prospective	O
study	O
of	O
uk	O
women	O
associations	B-T080
between	O
behavioural	O
and	O
other	O
personal	O
factors	B-T169
and	O
colorectal	O
cancer	O
risk	B-T078
have	O
been	O
reported	O
to	O
vary	O
by	O
tumour	O
characteristics	B-T080
,	O
but	O
evidence	O
is	O
inconsistent	O
.	O
	
in	O
a	O
large	O
uk	O
-based	O
prospective	O
study	O
we	O
examined	O
associations	O
of	O
14	O
postulated	O
risk	B-T033
factors	I-T033
with	O
colorectal	O
cancer	O
risk	B-T078
overall	O
,	O
and	O
across	O
three	O
anatomical	O
sites	O
and	O
four	O
morphological	O
subtypes	O
.	O
	
among	O
1.3	O
million	O
women	O
,	O
18	O
incident	O
colorectal	O
cancers	O
were	O
identified	O
during	O
13.8	O
sd	O
3.4	O
years	O
follow-up	O
via	O
record	O
linkage	O
to	O
national	O
cancer	O
registry	O
data	B-T078
.	O
	
cox	B-T081
regression	I-T081
yielded	O
adjusted	O
relative	B-T081
risks	I-T081
.	O
	
statistical	B-T081
significance	I-T081
was	O
assessed	O
using	O
correction	O
for	O
multiple	O
testing	O
.	O
	
overall	O
,	O
colorectal	O
cancer	O
risk	B-T078
was	O
significantly	O
associated	B-T080
with	I-T080
height	O
,	O
body	O
mass	O
index	O
bmi	O
,	O
smoking	O
,	O
alcohol	O
intake	O
,	O
physical	O
activity	O
,	O
parity	B-T033
and	O
menopausal	B-T061
hormone	I-T061
therapy	I-T061
use	O
.	O
	
for	O
smoking	O
there	O
was	O
substantial	O
heterogeneity	B-T080
across	O
morphological	O
types	B-T080
relative	B-T081
risks	I-T081
around	O
two	O
or	O
greater	O
were	O
seen	O
in	O
current	O
smokers	B-T033
both	O
for	O
signet	O
ring	O
cell	O
and	O
for	O
neuroendocrine	O
tumours	O
.	O
	
obese	B-T047
women	O
were	O
also	O
at	B-T033
higher	I-T033
risk	I-T033
for	O
signet	O
ring	O
cell	O
tumours	O
.	O
	
for	O
adenocarcinomas	O
,	O
the	O
large	O
majority	O
of	O
colorectal	O
cancers	O
in	O
the	O
cohort	O
,	O
all	O
risk	B-T033
factor	I-T033
associations	B-T080
were	O
weak	O
.	O
	
there	O
was	O
little	O
or	O
no	O
heterogeneity	B-T080
in	O
risk	B-T078
between	O
tumours	O
of	O
the	O
right	O
colon	O
,	O
left	O
colon	O
and	O
rectum	O
for	O
any	O
of	O
the	O
14	O
factors	B-T033
examined	O
.	O
	
these	O
epidemiological	O
findings	B-T033
complement	O
an	O
emerging	O
picture	O
from	O
molecular	O
studies	O
of	O
possible	O
different	O
developmental	B-T080
pathways	O
for	O
different	O
tumour	O
types	B-T080
.	O
	
impact	B-T080
of	O
alcohol	O
use	O
on	O
eeg	O
dynamics	O
of	O
response	O
inhibition	O
a	O
cotwin	O
control	O
analysis	O
research	O
indicates	O
that	O
alcohol	O
misuse	O
is	O
associated	B-T080
with	I-T080
behavioral	O
disinhibition	O
,	O
but	O
the	O
neurophysiological	O
mechanisms	O
governing	O
this	O
relationship	B-T080
remain	O
largely	O
unknown	O
.	O
	
recent	O
work	O
suggests	O
that	O
successful	O
inhibition	O
and	O
cognitive	O
control	O
involve	O
electrophysiological	O
theta-band	O
dynamics	O
,	O
including	O
medial	O
frontal	O
cortex	O
mfc	O
power	O
enhancement	O
and	O
functional	O
connectivity	O
between	O
the	O
mfc	O
and	O
dorsal	O
prefrontal	O
cortex	O
dpfc	O
regions	O
,	O
which	O
may	O
be	O
disrupted	O
by	O
alcohol	O
misuse	O
.	O
	
in	O
addition	O
,	O
research	O
suggests	O
that	O
,	O
compared	O
to	O
men	O
,	O
women	O
are	O
at	O
heightened	O
risk	B-T078
of	O
experiencing	O
the	O
negative	O
physical	O
and	O
neurocognitive	O
correlates	O
of	O
drinking	O
.	O
	
the	O
present	O
study	O
tested	O
the	O
hypothesis	O
that	O
alcohol	O
misuse	O
has	O
a	O
deleterious	O
effect	O
on	O
theta-band	B-T061
response	O
inhibition	O
eeg	O
dynamics	O
in	O
a	O
sample	O
of	O
300	O
24-year-old	O
same-sex	O
twins	O
.	O
	
a	O
cotwin	O
control	O
ctc	O
design	O
was	O
used	O
to	O
disentangle	O
premorbid	O
risk	B-T078
for	O
alcohol	O
use	O
from	O
the	O
causal	B-T080
effects	I-T080
of	O
alcohol	O
exposure	O
.	O
	
drinking	O
was	O
negatively	O
associated	B-T080
with	I-T080
theta-band	B-T061
mfc	O
power	O
and	O
mfc	O
-	O
dpfc	O
connectivity	O
during	O
response	O
inhibition	O
,	O
and	O
this	O
effect	B-T080
was	O
stronger	O
among	O
women	O
.	O
	
the	O
ctc	O
analysis	O
suggested	O
that	O
,	O
for	O
women	O
,	O
reduced	O
nogo-related	O
theta-band	B-T061
mfc	O
power	O
and	O
mfc	O
-	O
dpfc	O
connectivity	O
were	O
both	O
consistent	O
with	O
the	O
potential	O
deleterious	O
causal	O
effects	O
of	O
alcohol	O
exposure	O
.	O
	
these	O
findings	O
suggest	O
that	O
diminished	B-T081
theta-band	B-T061
mfc	O
power	O
and	O
mfc	O
-	O
dpfc	O
connectivity	O
may	O
be	O
neurophysiological	O
mechanisms	O
underlying	O
alcohol-related	O
disinhibition	O
.	O
	
although	O
preliminary	O
,	O
these	O
results	O
suggest	O
that	O
normative	B-T033
levels	I-T033
of	O
alcohol	O
use	O
during	O
emerging	O
adulthood	B-T079
have	O
potential	O
sex-specific	O
causal	B-T080
effects	I-T080
on	O
response	O
inhibition	O
eeg	O
dynamics	O
,	O
neutrophil	O
and	O
monocyte	O
function	O
in	O
patients	O
with	O
chronic	B-T047
hepatitis	I-T047
c	I-T047
undergoing	O
antiviral	B-T061
therapy	I-T061
with	O
regimens	B-T061
containing	O
protease	O
inhibitors	O
with	O
and	O
without	O
interferon	B-T116
real-life	B-T078
data	I-T078
showed	O
an	O
increased	B-T081
incidence	B-T081
of	O
bacterial	B-T047
infections	I-T047
in	O
patients	O
with	O
advanced	O
liver	B-T047
disease	I-T047
receiving	B-T080
a	O
protease	O
inhibitor	O
pi	O
antiviral	B-T061
regimen	I-T061
against	O
hepatitis	O
c	O
hcv	O
.	O
	
however	O
,	O
the	O
causes	O
of	O
this	O
event	O
are	O
unknown	O
.	O
	
we	O
hypothesized	O
that	O
pis	O
might	O
impair	O
innate	O
immune	O
responses	O
through	O
the	O
inhibition	O
of	O
proteases	O
participating	O
in	O
the	O
anti-bacterial	O
functions	O
of	O
neutrophils	O
and	O
monocytes	O
.	O
	
the	O
aims	O
of	O
the	O
study	O
were	O
to	O
assess	O
phagocytic	O
and	O
oxidative	O
burst	O
capacity	B-T081
in	O
neutrophils	O
and	O
monocytes	O
obtained	O
from	O
patients	O
receiving	B-T080
a	O
pi	O
containing-	O
antiviral	B-T061
regimen	I-T061
,	O
and	O
to	O
determine	O
cytokine	O
secretion	O
after	O
neutrophil	O
stimulation	O
with	O
flagellin	B-T116
.	O
	
forty	O
patients	O
with	O
chronic	B-T047
hcv	I-T047
80%	O
with	O
cirrhosis	B-T047
were	O
enrolled	O
in	O
the	O
study	O
,	O
28	O
received	B-T080
triple	B-T061
therapy	I-T061
group	O
a	O
with	O
pegylated-interferon	B-T116
and	O
ribavirin	O
for	O
4	O
weeks	B-T079
followed	O
by	O
the	O
addition	O
of	O
a	O
pi	O
telaprevir	B-T116
,	O
boceprevir	B-T116
or	O
simeprevir	B-T109
,	O
and	O
12	O
patients	O
received	B-T080
an	O
interferon	B-T116
-free	O
regimen	O
group	O
b	O
with	O
simeprevir	O
and	O
sofosbuvir	O
.	O
	
phagocytosis	O
and	O
oxidative	O
burst	O
capacity	O
were	O
analyzed	O
by	O
flow	O
cytometry	O
at	O
baseline	O
,	O
week	O
4	O
,	O
and	O
week	O
8	O
of	O
therapy	O
.	O
	
in	O
neutrophils	O
from	O
group	O
a	O
patients	O
,	O
oxidative	O
burst	O
rate	O
and	O
oxidative	O
enzymatic	O
activity	O
per	O
cell	O
significantly	O
decreased	O
throughout	O
the	O
study	O
period	O
p	O
=	O
0.014	O
and	O
p	O
=	O
0.010	O
,	O
respectively	O
.	O
	
pairwise	O
comparisons	O
showed	O
a	O
decrease	O
between	O
baseline	O
and	O
week	O
4	O
and	O
8	O
of	O
therapy	O
.	O
	
no	O
differences	O
were	O
observed	O
after	O
the	O
introduction	O
of	O
the	O
pi	O
.	O
	
the	O
oxidative	O
enzymatic	O
activity	O
per	O
cell	O
in	O
monocytes	O
significantly	O
decrease	O
during	O
the	O
study	O
period	O
p	O
=	O
0.042	O
due	O
to	O
a	O
decrease	O
from	O
baseline	O
to	O
week	O
8	O
of	O
therapy	O
p	O
=	O
0.037	O
in	O
patients	O
from	O
group	O
a	O
.	O
	
none	O
of	O
these	O
findings	O
were	O
observed	O
in	O
group	O
b	O
patients	O
.	O
	
cytokine	O
secretion	O
did	O
not	O
significantly	O
change	O
during	O
the	O
study	O
in	O
both	O
groups	O
.	O
	
in	O
conclusion	O
,	O
our	O
data	O
suggest	O
that	O
the	O
use	O
interferon	B-T061
rather	O
than	O
the	O
pi	O
has	O
a	O
deleterious	O
effect	O
on	O
neutrophil	O
and	O
monocyte	O
phagocytic	O
and	O
oxidative	O
burst	O
capacity	O
in	O
this	O
cohort	O
of	O
patients	O
with	O
hcv	O
-related	O
advanced	O
liver	O
fibrosis	I-T047
child	B-T033
death	I-T033
and	O
maternal	B-T033
psychosis-like	O
experiences	O
in	O
44	O
low-	O
and	O
middle-income	B-T080
countries	O
the	O
role	O
of	O
depression	O
studies	O
on	O
the	O
effect	O
of	O
child	B-T033
death	I-T033
on	O
the	O
mental	O
wellbeing	O
of	O
women	O
in	O
low-	O
and	O
middle-income	B-T080
countries	O
lmics	O
are	O
scarce	O
despite	O
the	O
high	O
child	B-T081
mortality	I-T081
rates	O
.	O
	
thus	O
,	O
the	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
assess	O
the	O
association	B-T080
between	O
child	B-T033
death	I-T033
and	O
psychosis-like	O
experiences	O
ples	O
,	O
as	O
well	O
as	O
the	O
role	O
of	O
depression	O
in	O
this	O
association	B-T080
.	O
	
data	B-T081
from	O
44	O
lmics	O
which	O
participated	O
in	O
the	O
world	O
health	O
survey	O
whs	O
were	O
analyzed	O
.	O
	
a	O
total	O
of	O
59	O
women	O
who	O
ever	O
gave	O
birth	O
,	O
aged	O
18-49	O
years	B-T079
,	O
without	O
a	O
self-reported	O
lifetime	B-T079
psychosis	O
diagnosis	O
,	O
were	O
included	O
in	O
the	O
analysis	O
.	O
	
the	O
world	O
mental	O
health	O
survey	O
version	O
of	O
the	O
composite	O
international	O
diagnostic	O
interview	O
cidi	O
was	O
used	O
to	O
establish	O
the	O
diagnosis	O
of	O
past	O
12-	O
month	B-T079
dsm-iv	O
depression	O
,	O
and	O
assess	O
four	O
positive	O
psychotic	O
symptoms	O
.	O
	
depression	O
was	O
defined	O
as	O
self-reported	O
lifetime	B-T079
depression	O
diagnosis	O
and/or	O
past	O
12-	O
month	B-T079
depression	O
.	O
	
multivariable	O
logistic	O
regression	O
analyses	O
were	O
performed	O
.	O
	
after	O
adjustment	O
for	O
potential	B-T169
confounders	I-T169
,	O
women	O
who	O
experienced	O
child	B-T033
death	I-T033
had	O
higher	O
odds	O
for	O
all	O
types	O
of	O
ples	O
when	O
unadjusted	O
for	O
depression	O
or	B-T081
1.20	O
p<0	O
and	O
depression	O
or	B-T081
=1	O
95%	O
ci	B-T081
=1	O
.	O
	
when	O
adjusted	O
for	O
depression	O
,	O
only	O
delusion	O
of	O
control	O
was	O
strongly	O
associated	B-T080
with	I-T080
child	B-T033
death	I-T033
or	B-T081
=1	O
95%	O
ci	B-T081
=1	O
.	O
	
child	B-T033
death	I-T033
may	O
be	O
an	O
important	O
determinant	O
of	O
mental	O
wellbeing	O
among	O
women	O
in	O
lmics	O
.	O
	
given	O
the	O
known	O
adverse	O
health	O
outcomes	O
associated	B-T080
with	I-T080
ples	O
and	O
depression	O
,	O
as	O
well	O
as	O
the	O
co-occurrence	O
of	O
these	O
symptoms	O
,	O
mental	B-T061
health	I-T061
care	I-T061
may	O
be	O
particularly	O
important	O
for	O
mothers	O
who	O
have	O
experienced	O
child	B-T033
loss	I-T033
in	O
prednisolone	B-T109
is	O
associated	B-T080
with	I-T080
a	O
worse	B-T033
lipid	I-T033
profile	I-T033
than	O
hydrocortisone	B-T109
in	O
patients	O
with	O
adrenal	B-T047
insufficiency	I-T047
prednisolone	B-T109
is	O
used	O
as	O
glucocorticoid	B-T109
replacement	B-T061
therapy	I-T061
for	O
adrenal	B-T047
insufficiency	I-T047
ai	B-T047
.	O
	
recent	O
data	B-T078
indicate	O
that	O
its	O
use	O
in	O
ai	B-T047
is	O
associated	B-T080
with	I-T080
low	O
bone	O
mineral	O
density	O
.	O
	
data	B-T078
on	O
risk	B-T033
factors	I-T033
for	O
cardiovascular	B-T047
disease	I-T047
in	O
patients	O
with	O
ai	B-T047
treated	B-T169
with	O
prednisolone	B-T109
are	O
scarce	O
,	O
despite	O
this	O
condition	O
being	O
the	O
predominant	O
cause	B-T033
of	O
excess	O
mortality	B-T081
.	O
	
we	O
aimed	O
to	O
address	O
this	O
question	O
using	O
real-world	O
data	B-T078
from	O
the	O
european	O
adrenal	O
insufficiency	O
registry	O
eu-air	O
.	O
	
eu-air	O
,	O
comprising	O
of	O
19	O
centres	O
across	O
germany	O
,	O
the	O
netherlands	O
,	O
sweden	O
and	O
the	O
uk	O
,	O
commenced	O
enrolling	O
patients	O
with	O
ai	B-T047
in	O
august	O
2012	O
.	O
	
patients	O
receiving	O
prednisolone	B-T109
3-6	O
mg/day	O
,	O
n	O
=	O
50	O
or	O
hydrocortisone	B-T109
15-30	O
mg/day	O
,	O
n	O
=	O
909	O
were	O
identified	B-T080
and	O
grouped	O
at	O
a	O
ratio	O
of	O
1	O
prednisolone	B-T109
hydrocortisone	B-T109
by	O
matching	O
for	O
gender	O
,	O
age	O
,	O
duration	B-T079
and	O
type	O
of	O
disease	O
.	O
	
data	B-T078
from	O
baseline	B-T081
and	O
follow-up	O
visits	O
were	O
analysed	O
.	O
	
data	B-T078
from	O
patients	O
with	O
congenital	B-T047
adrenal	I-T047
hyperplasia	I-T047
were	O
excluded	O
.	O
	
significantly	O
higher	O
mean	B-T081
s.d	I-T081
.	O
	
total	I-T081
6.3	O
1.6	O
vs	O
5.4	O
1.1	O
mmol/l	O
p	O
=	O
0.003	O
and	O
low-density	B-T109
lipoprotein	I-T109
ldl	I-T109
cholesterol	I-T109
levels	O
3.9	O
1.4	O
vs	O
3.2	O
1.0	O
mmol/l	O
p	O
=	O
0.013	O
were	O
identified	O
in	O
47	O
patients	O
on	O
prednisolone	O
vs	O
141	O
receiving	O
hydrocortisone	O
at	O
baseline	O
and	O
at	O
follow-up	O
p	O
=	O
0.005	O
and	O
p	O
=	O
0.006	O
,	O
respectively	O
.	O
	
hba1c	O
,	O
high-density	O
lipoprotein	O
and	O
triglyceride	O
levels	O
,	O
body	O
mass	O
index	O
,	O
systolic	O
and	O
diastolic	O
blood	O
pressure	O
and	O
waist	O
circumference	O
were	O
not	O
significantly	O
different	O
.	O
	
this	O
is	O
the	O
first	O
matched	O
analysis	O
of	O
its	O
kind	O
.	O
	
significantly	O
higher	O
ldl	B-T109
levels	B-T080
in	O
patients	O
receiving	O
prednisolone	O
relative	O
to	O
hydrocortisone	O
could	O
predict	O
a	O
higher	O
relative	O
risk	O
of	O
cardiovascular	O
disease	O
in	O
the	O
former	O
group	B-T078
oxytocin	B-T116
reduces	B-T080
face	O
processing	O
time	B-T079
but	O
leaves	B-T080
recognition	O
accuracy	B-T080
and	O
eye	O
-	O
gaze	B-T033
unaffected	O
previous	B-T079
studies	O
have	O
found	O
that	O
oxytocin	B-T116
oxt	B-T116
can	O
improve	B-T033
the	O
recognition	O
of	O
emotional	B-T033
facial	B-T033
expressions	I-T033
it	O
has	O
been	O
proposed	B-T080
that	O
this	O
effect	B-T080
is	O
mediated	O
by	O
an	O
increase	B-T169
in	O
attention	O
to	O
the	O
eye-region	O
of	O
faces	O
.	O
	
nevertheless	O
,	O
evidence	B-T078
in	O
support	O
of	O
this	O
claim	O
is	O
inconsistent	B-T080
,	O
and	O
few	B-T081
studies	O
have	O
directly	B-T080
tested	B-T169
the	O
effect	B-T080
of	O
oxytocin	B-T116
on	O
emotion	O
recognition	O
via	O
altered	B-T169
eye	O
-	O
gaze	B-T033
methods	O
in	O
a	O
double-blind	O
,	O
within	O
-	O
subjects	O
,	O
randomized	O
control	O
experiment	O
,	O
40	O
healthy	B-T080
male	O
participants	O
received	B-T080
24	O
iu	B-T081
intranasal	B-T061
oxt	B-T116
and	O
placebo	O
in	O
two	O
identical	B-T080
experimental	B-T080
sessions	O
separated	B-T080
by	O
a	O
2-	O
week	B-T079
interval	B-T079
.	O
	
visual	O
attention	O
to	O
the	O
eye-region	O
was	O
assessed	O
on	O
both	O
occasions	O
while	O
participants	O
completed	B-T080
a	O
static	B-T080
facial	O
emotion	O
recognition	O
task	O
using	O
medium	B-T080
intensity	I-T080
facial	B-T033
expressions	I-T033
.	O
	
although	O
oxt	B-T116
had	O
no	B-T080
effect	I-T080
on	O
emotion	O
recognition	O
accuracy	B-T080
,	O
recognition	O
performance	O
was	O
improved	B-T033
because	O
face	O
processing	O
was	O
faster	B-T080
across	O
emotions	O
under	O
the	O
influence	O
of	O
oxt	B-T116
.	O
	
this	O
effect	B-T080
was	O
marginally	B-T080
significant	B-T078
p<	O
.	O
	
consistent	B-T078
with	I-T078
a	O
previous	B-T079
study	O
using	O
dynamic	O
stimuli	O
,	O
oxt	B-T116
had	O
no	B-T080
effect	I-T080
on	O
eye	O
-	O
gaze	B-T033
patterns	O
when	O
viewing	O
static	B-T080
emotional	B-T033
faces	O
and	O
this	O
was	O
not	O
related	O
to	O
recognition	O
accuracy	B-T080
or	O
face	O
processing	O
time	B-T079
.	O
	
these	O
findings	B-T033
suggest	B-T078
that	O
oxt	B-T116
-	O
induced	B-T169
enhanced	O
facial	O
emotion	O
recognition	O
is	O
not	O
necessarily	O
mediated	O
by	O
an	O
increase	B-T169
in	O
attention	O
to	O
the	O
eye-region	O
of	O
faces	O
,	O
as	O
previously	B-T079
assumed	O
.	O
	
we	O
discuss	O
several	B-T081
methodological	B-T078
issues	B-T033
which	O
may	O
explain	O
discrepant	B-T033
findings	I-T033
and	O
suggest	B-T078
the	O
effect	B-T080
of	O
oxt	B-T116
on	O
visual	O
attention	O
may	O
differ	O
depending	O
on	O
task	O
requirements	B-T169
.	O
	
new	O
directions	O
for	O
psychiatric	B-T061
rehabilitation	I-T061
in	O
the	O
usa	O
american	O
researchers	O
have	O
led	O
the	O
world	O
in	O
developing	B-T169
,	O
evaluating	O
,	O
and	O
disseminating	O
evidence	B-T078
-based	O
psychiatric	B-T061
rehabilitation	I-T061
practices	B-T169
for	O
people	O
with	O
serious	B-T080
mental	O
illness	O
.	O
	
paradoxically	O
,	O
however	O
,	O
the	O
usa	O
lags	O
behind	O
most	O
industrialized	B-T080
nations	I-T080
in	O
providing	O
access	B-T080
to	O
high-quality	O
mental	O
health	O
and	O
psychiatric	O
services	O
.	O
	
this	O
essay	O
examines	O
several	O
evidence-based	B-T169
practices	I-T169
developed	O
in	O
the	O
usa	O
,	O
the	O
spread	O
of	O
these	O
practices	O
,	O
the	O
barriers	B-T033
to	O
ensuring	O
availability	B-T080
to	O
people	O
who	O
could	O
benefit	B-T081
from	O
these	O
services	O
,	O
and	O
some	O
promising	O
directions	O
for	O
overcoming	O
the	O
barriers	B-T033
.	O
	
factors	B-T169
influencing	O
the	O
growth	O
and	O
sustainment	O
of	O
effective	B-T080
client	O
-centred	O
practices	O
include	O
the	O
availability	B-T169
of	O
adequate	B-T081
and	I-T081
stable	I-T081
funding	I-T081
,	O
committed	O
leadership	O
,	O
and	O
the	O
influence	O
of	O
vested	O
interests	O
.	O
	
two	O
strategies	O
for	O
promoting	O
the	O
spread	B-T080
and	O
sustainment	O
of	O
well-implemented	B-T169
evidence-based	I-T169
practices	I-T169
are	O
the	O
adoption	O
of	O
fidelity	O
scales	O
and	O
learning	O
communities	O
.	O
	
modifiable	B-T169
healthy	O
lifestyle	O
behaviors	O
10-year	O
health	O
outcomes	O
from	O
a	O
health	O
promotion	O
program	O
previous	O
studies	O
have	O
examined	O
the	O
impact	B-T080
of	I-T080
healthy	O
lifestyle	O
choices	O
on	O
health-related	O
outcomes	O
however	O
,	O
given	O
their	O
fragmented	B-T080
,	O
often	O
cross-sectional	O
nature	O
,	O
assessing	O
the	O
relative	O
impact	O
of	O
daily	O
modifiable	B-T169
behaviors	O
on	O
overall	O
long-term	B-T079
outcomes	O
,	O
particularly	O
for	O
a	O
diverse	O
working	O
adult	O
population	O
,	O
remains	B-T080
challenging	I-T080
.	O
	
relationships	O
between	O
ten	O
self-reported	O
healthy	O
lifestyle	O
behaviors	O
and	O
health	O
outcomes	O
during	O
the	O
subsequent	O
9	O
years	O
in	O
a	O
cohort	O
of	O
10	O
participants	O
enrolled	O
during	O
2003	O
in	O
a	O
voluntary	O
workplace	O
wellness	O
program	O
were	O
assessed	O
.	O
	
cox	B-T081
proportional-hazards	I-T081
models	I-T081
computed	B-T081
hazard	I-T081
ratios	I-T081
hrs	B-T081
for	O
lifestyle	O
characteristics	O
associated	O
with	O
time	B-T079
to	O
one	O
of	O
seven	O
self-reported	O
chronic	B-T047
diseases	I-T047
or	O
death	O
.	O
	
data	B-T033
were	I-T033
collected	I-T033
between	O
2003	O
and	O
2012	O
and	O
analyzed	O
between	O
2014	O
and	O
2016	O
.	O
	
behaviors	O
that	O
most	O
significantly	O
affected	O
future	B-T081
outcomes	I-T081
were	O
low-fat	B-T061
diet	I-T061
,	O
aerobic	B-T061
exercise	I-T061
,	O
nonsmoking	O
,	O
and	O
adequate	B-T033
sleep	I-T033
.	O
	
a	O
dose-response	O
effect	O
was	O
seen	O
between	O
dietary	B-T033
fat	I-T033
intake	I-T033
and	O
hypertension	B-T047
,	O
obesity	B-T047
,	O
diabetes	B-T047
,	O
heart	B-T047
disease	I-T047
,	O
and	O
hypercholesterolemia	B-T047
.	O
	
after	O
dietary	B-T033
fat	I-T033
intake	I-T033
,	O
aerobic	B-T061
exercise	I-T061
was	O
the	O
next	O
most	O
significant	O
behavior	O
associated	O
with	O
development	O
of	O
outcomes	O
.	O
	
compared	O
with	O
sedentary	B-T080
participants	O
,	O
those	O
who	O
exercised	O
4	O
days	O
per	O
week	O
were	O
less	O
likely	O
to	O
develop	O
new-onset	O
diabetes	O
hr	B-T081
=0	O
,	O
95%	O
ci	B-T081
=0	O
,	O
0.48	O
heart	B-T047
disease	I-T047
hr	B-T081
=0	O
,	O
95%	O
ci	B-T081
=0	O
,	O
0.80	O
and	O
hypercholesterolemia	B-T047
hr	B-T081
=0	O
,	O
95%	O
ci	B-T081
=0	O
,	O
0.74	O
.	O
	
low-fat	B-T061
diet	I-T061
and	O
adequate	B-T033
sleep	I-T033
were	O
more	O
significant	O
than	O
commonly	O
promoted	O
healthy	O
behaviors	O
,	O
such	O
as	O
eating	O
a	O
daily	O
breakfast	O
.	O
	
modifiable	B-T169
lifestyle	O
behaviors	O
targeted	O
in	O
health	O
promotion	O
programs	O
should	O
be	O
prioritized	O
in	O
an	O
evidence-based	B-T169
manner	I-T169
.	O
	
top	O
priorities	O
for	O
workplace	O
health	O
promotion	O
should	O
include	O
low-fat	B-T061
diet	I-T061
,	O
aerobic	B-T061
exercise	I-T061
,	O
nonsmoking	O
,	O
and	O
adequate	B-T033
sleep	I-T033
.	O
	
diazoxide	B-T109
prevents	B-T169
reactive	O
oxygen	O
species	O
and	O
mitochondrial	O
damage	O
,	O
leading	O
to	O
anti-hypertrophic	B-T033
effects	I-T033
pathological	B-T169
cardiac	O
hypertrophy	O
is	O
characterized	O
by	O
wall	O
thickening	B-T033
or	O
chamber	O
enlargement	O
of	O
the	O
heart	O
in	O
response	O
to	O
pressure	B-T081
or	O
volume	B-T081
overload	O
,	O
respectively	O
.	O
	
this	O
condition	B-T080
will	O
,	O
initially	O
,	O
improve	B-T033
the	O
organ	O
contractile	O
function	O
,	O
but	O
if	O
sustained	B-T169
will	O
render	O
dysfunctional	O
mitochondria	O
and	O
oxidative	O
stress	O
.	O
	
mitochondrial	B-T116
atp-sensitive	I-T116
k	I-T116
channels	I-T116
mitokatp	B-T116
modulate	O
the	O
redox	O
status	O
of	O
the	O
cell	O
and	O
protect	B-T033
against	O
several	O
cardiac	O
insults	B-T169
.	O
	
here	O
,	O
we	O
tested	O
the	O
hypothesis	B-T078
that	O
mitokatp	B-T116
opening	O
using	O
diazoxide	B-T109
will	O
avoid	O
isoproterenol	B-T109
-	O
induced	B-T169
cardiac	O
hypertrophy	O
in	O
vivo	O
by	O
decreasing	O
reactive	O
oxygen	O
species	O
ros	O
production	O
and	O
mitochondrial	O
ca	O
-	O
induced	B-T169
swelling	B-T033
.	O
	
to	O
induce	B-T169
cardiac	O
hypertrophy	O
,	O
swiss	O
mice	O
were	O
treated	B-T169
intraperitoneally	O
with	O
isoproterenol	B-T109
30	O
mg/kg/	O
day	B-T079
for	O
8	O
days	B-T079
.	O
	
diazoxide	B-T109
5	O
mg/kg/	O
day	B-T079
was	O
used	O
to	O
open	O
mitokatp	B-T116
and	O
5-hydroxydecanoate	B-T109
5	O
mg/kg/	O
day	B-T079
was	O
administrated	O
as	O
a	O
mitokatp	B-T116
blocker	O
.	O
	
isoproterenol	B-T109
-	O
treated	B-T169
mice	O
had	O
elevated	B-T080
heart	O
weight	B-T081
/	O
tibia	O
length	B-T081
ratios	B-T081
and	O
increased	B-T081
myocyte	O
cross-sectional	B-T033
areas	I-T033
.	O
	
additionally	O
,	O
hypertrophic	B-T169
hearts	O
produced	O
higher	B-T080
levels	B-T080
of	O
h2o2	O
and	O
had	O
lower	O
glutathione	O
peroxidase	O
activity	O
.	O
	
in	O
contrast	O
,	O
mitokatp	B-T116
opening	O
with	O
diazoxide	B-T109
blocked	B-T169
all	O
isoproterenol	B-T109
effects	B-T080
in	O
a	O
manner	O
reversed	B-T169
by	O
5-hydroxydecanoate	B-T109
.	O
	
isolated	B-T169
mitochondria	O
from	O
isoproterenol	B-T109
-	O
induced	B-T169
hypertrophic	B-T169
hearts	O
had	O
increased	B-T081
susceptibility	B-T169
to	O
ca	O
-	O
induced	B-T169
swelling	B-T033
secondary	O
to	O
mitochondrial	B-T116
permeability	I-T116
transition	I-T116
pore	I-T116
opening	O
.	O
	
mitokatp	B-T116
opening	O
was	O
accompanied	O
by	O
lower	O
ca	O
-	O
induced	B-T169
mitochondrial	O
swelling	O
,	O
an	O
effect	B-T080
blocked	B-T169
by	O
5-hydroxydecanoate	B-T109
.	O
	
our	O
results	O
suggest	O
that	O
mitokatp	B-T116
opening	O
negatively	B-T033
regulates	O
cardiac	O
hypertrophy	O
by	O
avoiding	O
oxidative	B-T169
impairment	B-T169
and	O
mitochondrial	O
damage	O
.	O
	
anticholinergic	O
premedication	B-T061
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	B-T061
anesthesia	I-T061
and	O
dexmedetomidine	B-T109
sedation	B-T061
a	O
randomized	O
,	O
double-blind	O
,	O
placebo-controlled	O
study	O
when	O
dexmedetomidine	B-T109
is	O
used	O
in	O
patients	O
undergoing	O
spinal	B-T061
anesthesia	I-T061
,	O
high	O
incidence	B-T169
of	O
bradycardia	O
in	O
response	O
to	O
parasympathetic	O
activation	O
is	O
reported	O
.	O
	
therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	B-T080
of	O
atropine	B-T109
premedication	B-T061
for	O
preventing	B-T169
the	O
incidence	B-T169
of	O
bradycardia	O
and	O
the	O
hemodynamic	O
effect	O
on	O
patients	O
undergoing	O
spinal	B-T061
anesthesia	I-T061
with	O
sedation	B-T061
by	O
dexmedetomidine	B-T109
.	O
	
randomized	O
,	O
double-blind	O
,	O
placebo-controlled	O
study	O
.	O
	
operating	O
room	O
.	O
	
one	O
hundred	O
fourteen	O
patients	B-T109
age	O
range	O
,	O
2-65	O
years	B-T079
american	O
society	O
of	O
anesthesiology	O
class	O
i-ii	O
participated	O
in	O
this	O
study	O
,	O
willing	O
to	O
be	O
sedated	O
and	O
to	O
undergo	O
spinal	B-T061
anesthesia	I-T061
.	O
	
the	O
patients	B-T109
were	O
divided	O
into	O
2	O
groups	O
group	O
a	O
and	O
group	O
c	O
.	O
	
after	O
performing	O
spinal	B-T061
anesthesia	I-T061
,	O
dexmedetomidine	B-T109
was	O
infused	B-T061
at	O
a	O
loading	O
dose	O
of	O
0.6	O
μg/kg	O
for	O
10	O
minutes	B-T079
,	O
followed	O
by	O
an	O
infusion	B-T061
at	O
0.25	O
μg/	O
h	O
.	O
	
simultaneously	O
with	O
the	O
loading	O
dose	O
of	O
dexmedetomidine	B-T109
,	O
patients	B-T109
in	O
group	O
a	O
received	O
an	O
intravenous	B-T169
bolus	I-T169
of	O
0.5	O
mg	O
atropine	B-T109
,	O
whereas	O
patients	B-T109
in	O
group	O
c	O
received	O
an	O
intravenous	B-T061
normal	I-T061
saline	I-T061
bolus	B-T061
.	O
	
data	B-T078
on	O
administration	B-T061
of	O
atropine	B-T109
and	O
ephedrine	B-T109
were	O
collected	O
.	O
	
hemodynamic	O
data	B-T078
including	O
heart	O
rate	O
,	O
systolic	O
blood	O
pressure	O
,	O
diastolic	O
blood	O
pressure	O
dbp	O
,	O
and	O
mean	B-T033
blood	I-T033
pressure	I-T033
mbp	B-T033
were	O
also	O
recorded	O
.	O
	
the	O
incidence	B-T169
of	O
bradycardia	O
requiring	O
atropine	B-T109
treatment	B-T061
was	O
significantly	B-T081
higher	I-T081
in	O
group	O
c	O
than	O
group	O
a	O
p=	O
.	O
	
however	O
,	O
the	O
incidence	B-T169
of	O
hypotension	B-T033
needing	O
ephedrine	B-T109
treatment	B-T061
showed	O
no	B-T033
significant	I-T033
difference	I-T033
between	O
the	O
2	O
groups	O
p=	O
.	O
	
systolic	O
blood	O
pressure	O
and	O
heart	O
rate	O
showed	O
no	B-T033
significant	I-T033
differences	I-T033
between	O
the	O
2	O
groups	O
p=	O
and	O
464	O
,	O
respectively	O
.	O
	
however	O
,	O
group	O
a	O
showed	O
significant	O
increases	B-T081
in	O
dbp	O
and	O
mbp	B-T033
,	O
and	O
group	O
c	O
did	O
not	O
p=	O
and	O
008	O
,	O
respectively	O
.	O
	
prophylactic	B-T061
atropine	B-T109
reduces	O
the	O
incidence	B-T169
of	O
bradycardia	O
in	O
patients	B-T109
undergoing	O
spinal	B-T061
anesthesia	I-T061
with	O
dexmedetomidine	B-T109
sedation	B-T061
.	O
	
however	O
,	O
dbp	O
and	O
mbp	B-T033
showed	O
significant	O
increases	B-T081
in	O
patients	B-T109
when	O
prophylactic	B-T061
atropine	B-T109
was	O
administrated	B-T061
.	O
	
therefore	O
,	O
atropine	B-T109
premedication	B-T061
should	O
be	O
administered	B-T061
downregulation	O
of	O
endothelial	B-T116
transient	I-T116
receptor	I-T116
potential	I-T116
vanilloid	I-T116
type	I-T116
4	I-T116
channel	I-T116
and	O
small-conductance	B-T116
of	I-T116
ca2+-activated	I-T116
k+	I-T116
channels	I-T116
underpins	O
impaired	B-T169
endothelium-dependent	O
hyperpolarization	O
in	O
hypertension	B-T047
endothelium-dependent	O
hyperpolarization	O
edh	O
responses	B-T033
are	O
impaired	B-T169
in	O
hypertension	B-T047
,	O
but	O
the	O
underlying	O
mechanisms	B-T169
have	O
not	O
yet	O
been	O
determined	O
.	O
	
the	O
activation	O
of	O
small-	B-T116
and	O
intermediate-conductance	B-T116
of	I-T116
ca	I-T116
k	I-T116
channels	I-T116
skca	B-T116
and	O
ikca	B-T116
underpins	O
edh	O
-mediated	O
responses	B-T033
.	O
	
it	O
was	O
recently	O
reported	O
that	O
ca	O
influx	O
through	O
endothelial	B-T116
transient	I-T116
receptor	I-T116
potential	I-T116
vanilloid	I-T116
type	I-T116
4	I-T116
channel	I-T116
trpv4	B-T116
is	O
a	O
prerequisite	B-T078
for	O
the	O
activation	O
of	O
skca	B-T116
/	O
ikca	B-T116
in	O
endothelial	O
cells	O
in	O
specific	O
beds	O
.	O
	
here	O
,	O
we	O
attempted	O
to	O
determine	O
whether	O
the	O
impairment	B-T169
of	O
edh	O
in	O
hypertension	B-T047
is	O
attributable	O
to	O
the	O
dysfunction	O
of	O
trpv4	B-T116
and	O
s	B-T116
/	O
ikca	B-T116
,	O
using	O
isolated	O
superior	O
mesenteric	O
arteries	O
of	O
20-week-old	O
stroke-prone	O
spontaneously	O
hypertensive	O
rats	O
shrsp	O
and	O
age-matched	O
wistar-kyoto	O
wky	O
rats	O
.	O
	
in	O
the	O
wky	O
arteries	O
,	O
edh	O
-mediated	O
responses	B-T033
were	O
reduced	B-T080
by	O
a	O
combination	B-T080
of	O
skca	B-T116
/	O
ikca	B-T116
blockers	O
apamin	B-T116
plus	O
tram-34	B-T109
1-	B-T109
and	O
by	O
the	O
blockade	B-T169
of	O
trpv4	B-T116
with	O
the	O
selective	O
antagonist	O
rn-1734	B-T109
or	O
hc-067047	B-T109
.	O
	
in	O
the	O
shrsp	O
arteries	O
,	O
edh-mediated	O
hyperpolarization	O
and	O
relaxation	O
were	O
significantly	B-T078
impaired	B-T169
when	O
compared	O
with	O
wky	O
.	O
	
gsk1016790a	B-T109
,	O
a	O
selective	O
trpv4	B-T116
activator	O
,	O
evoked	O
robust	O
hyperpolarization	O
and	O
relaxation	O
in	O
wky	O
arteries	O
.	O
	
in	O
contrast	O
,	O
in	O
shrsp	O
arteries	O
,	O
the	O
gsk1016790a	B-T109
-evoked	O
hyperpolarization	O
was	O
small	O
and	O
relaxation	O
was	O
absent	B-T169
.	O
	
hyperpolarization	O
and	O
relaxation	O
to	O
cyclohexyl-	B-T109
,	O
a	O
selective	O
skca	B-T116
activator	O
,	O
were	O
marginally	B-T080
decreased	B-T081
in	O
shrsp	O
arteries	O
compared	O
with	O
wky	O
arteries	O
.	O
	
the	O
expression	O
of	O
endothelial	B-T116
trpv4	I-T116
and	O
skca	B-T116
protein	O
was	O
significantly	B-T081
decreased	I-T081
in	O
the	O
shrsp	O
mesenteric	O
arteries	O
compared	O
with	O
those	O
of	O
wky	O
,	O
whereas	O
function	B-T169
and	O
expression	O
of	O
ikca	B-T116
were	O
preserved	O
in	O
shrsp	O
arteries	O
.	O
	
these	O
findings	B-T033
suggest	O
that	O
edh	O
-mediated	O
responses	B-T033
are	O
impaired	B-T169
in	O
superior	O
mesenteric	O
arteries	O
of	O
shrsp	O
because	O
of	O
a	O
reduction	B-T061
in	O
both	O
trpv4	B-T116
and	O
skca	B-T116
input	O
to	O
bioavailability	O
and	O
health	B-T061
risk	I-T061
assessment	I-T061
of	O
potentially	B-T080
toxic	O
elements	O
in	O
thriasio	O
plain	O
,	O
near	O
athens	O
,	O
greece	O
elevated	O
concentrations	B-T081
of	O
potentially	B-T080
toxic	O
elements	O
ptes	O
are	O
usually	O
found	O
in	O
areas	B-T033
of	I-T033
intense	I-T033
industrial	I-T033
activity	I-T033
.	O
	
thriasio	O
plain	O
is	O
a	O
plain	O
near	O
athens	O
,	O
greece	O
,	O
where	O
most	O
of	O
the	O
heavy	O
industry	O
of	O
the	O
country	O
has	O
been	O
situated	O
for	O
decades	O
,	O
but	O
it	O
also	O
is	O
a	O
residential	O
and	O
horticultural	O
area	O
.	O
	
we	O
aimed	O
at	O
measuring	O
the	O
levels	O
of	O
ptes	O
in	O
soils	O
and	O
indigenous	O
plant	O
species	O
and	O
assessing	O
the	O
health	O
risk	O
associated	O
with	O
direct	O
soil	O
ingestion	O
.	O
	
samples	O
of	O
soils	O
at	O
roadsides	O
and	O
growing	O
plants	O
were	O
collected	O
from	O
31	O
sites	O
of	O
that	O
area	O
.	O
	
concentrations	O
of	O
al	O
,	O
as	O
,	O
cd	O
,	O
co	O
,	O
cr	O
,	O
cu	O
,	O
fe	O
,	O
mn	O
,	O
mo	O
,	O
ni	O
,	O
pb	O
,	O
v	O
and	O
zn	O
were	O
measured	O
in	O
both	O
soils	O
as	O
pseudo-total	O
and	O
aerial	O
plant	O
tissues	O
.	O
	
we	O
found	O
that	O
as	O
,	O
cd	O
,	O
cr	O
,	O
cu	O
,	O
ni	O
,	O
pb	O
and	O
zn	O
were	O
higher	O
than	O
maximum	O
regulatory	O
limits	O
.	O
	
element	O
concentrations	O
in	O
plants	O
were	O
rather	O
lower	O
than	O
expected	O
,	O
probably	O
because	O
indigenous	B-T169
plants	O
have	O
developed	O
excluder	O
behaviour	O
over	O
time	O
.	O
	
copper	O
and	O
zn	O
soil	O
-to-	O
plant	O
coefficients	O
were	O
highest	O
among	O
the	O
other	O
elements	O
for	O
cu	O
this	O
was	O
unexpected	O
,	O
and	O
probably	O
associated	O
with	O
recent	O
cu	O
-	O
releasing	O
industrial	O
activity	O
.	O
	
risk	O
assessment	O
analysis	O
indicated	O
that	O
as	O
was	O
the	O
element	O
contributing	O
more	O
than	O
50	O
%	O
of	O
the	O
health	O
risk	O
related	O
to	O
direct	O
soil	O
ingestion	O
,	O
followed	O
by	O
cr	O
,	O
pb	O
,	O
and	O
,	O
surprisingly	O
,	O
mn	O
.	O
	
we	O
concluded	O
that	O
in	O
a	O
multi	O
-	O
element	O
contamination	O
situation	O
,	O
elevated	O
risk	O
of	O
ptes	O
such	O
as	O
as	O
,	O
cr	O
and	O
pb	O
may	O
reduce	O
the	O
tolerance	O
limits	O
of	O
exposure	O
to	O
less-	O
toxic	O
elements	O
here	O
,	O
mn	O
nutrients	O
influence	O
the	O
thermal	O
ecophysiology	O
of	O
an	O
intertidal	O
macroalga	O
multiple	B-T078
stressors	I-T078
or	O
multiple	B-T078
drivers	I-T078
urbanization	O
of	O
coastlines	O
is	O
leading	O
to	O
increased	O
introduction	O
of	O
nutrients	O
from	O
the	O
terrestrial	O
environment	O
to	O
nearshore	O
habitats	O
.	O
	
while	O
such	O
nutrient	O
influxes	O
can	O
be	O
detrimental	O
to	O
coastal	O
marine	O
organisms	O
due	O
to	O
increased	O
eutrophication	O
and	O
subsequent	O
reduced	B-T080
oxygen	O
,	O
they	O
could	O
also	O
have	O
positive	B-T080
effects	I-T080
i.e	O
,	O
increased	O
food	O
availability	B-T169
on	O
species	O
that	O
are	O
nitrogen-limited	O
such	O
as	O
macroalgae	O
.	O
	
nutrient	O
enrichment	O
in	O
this	O
environment	O
thus	O
has	O
the	O
potential	B-T080
to	O
counteract	O
some	O
of	O
the	O
negative	B-T080
impacts	I-T080
of	O
increasing	B-T169
temperatures	B-T081
,	O
at	O
least	O
for	O
some	O
species	O
.	O
	
characterizing	O
the	O
physiological	O
response	O
of	O
organisms	O
to	O
simultaneous	B-T079
changes	B-T169
in	O
multiple	B-T078
drivers	I-T078
such	O
as	O
these	O
is	O
an	O
important	O
first	O
step	O
in	O
predicting	O
how	O
global	B-T080
climate	O
change	O
may	O
lead	O
to	O
ecological	O
responses	O
at	O
more	O
local	O
levels	O
.	O
	
we	O
evaluated	O
how	O
nutrient	O
enrichment	O
i.e	O
,	O
nitrogen	O
availability	B-T169
affected	O
the	O
growth	O
of	O
fucus	O
vesiculosus	O
,	O
a	O
foundational	O
macroalgal	O
species	O
in	O
the	O
north	O
atlantic	O
rocky	O
intertidal	O
zone	O
,	O
and	O
found	O
that	O
nutrient	O
-enriched	O
algal	O
blades	O
showed	O
a	O
significant	O
increase	O
in	O
tissue	O
growth	O
compared	O
to	O
individuals	B-T078
grown	O
under	O
ambient	B-T080
conditions	O
.	O
	
we	O
further	O
quantified	O
net	O
photosynthesis	O
by	O
ambient	O
and	O
nutrient	O
-enriched	O
tissues	O
at	O
saturating	O
irradiance	O
over	O
a	O
range	O
of	O
temperature	B-T081
conditions	O
6-30	O
.	O
	
respiration	O
was	O
unaffected	O
by	O
nutrient	O
treatment	B-T169
however	O
,	O
there	O
was	O
a	O
significant	O
increase	O
in	O
photosynthetic	O
oxygen	O
production	O
for	O
nutrient	O
-enriched	O
tissue	O
compared	O
to	O
ambient	B-T080
,	O
but	O
only	O
at	O
elevated	B-T080
18	O
temperatures	B-T081
.	O
	
this	O
study	O
contributes	O
to	O
a	O
growing	O
body	O
of	O
literature	O
showing	O
the	O
complexity	O
of	O
responses	O
to	O
changes	O
in	O
multiple	B-T078
drivers	I-T078
,	O
and	O
highlights	O
the	O
importance	O
of	O
studying	O
the	O
impacts	O
of	O
global	B-T080
climate	O
change	O
within	O
the	O
context	O
of	O
more	O
local	O
environmental	O
conditions	B-T080
.	O
	
a	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	O
-	O
reversal	B-T169
is	O
quicker	B-T080
in	O
pediatric	B-T080
patients	O
randomized	O
to	O
an	O
early	B-T079
goal-directed	B-T061
fluid-sparing	I-T061
strategy	I-T061
versus	O
usual	O
care	O
squeeze	O
study	O
protocol	O
for	O
a	O
pilot	O
randomized	O
controlled	O
trial	O
current	B-T079
pediatric	B-T080
septic	O
shock	O
resuscitation	B-T061
guidelines	O
from	O
the	O
american	O
college	O
of	O
critical	O
care	O
medicine	O
focus	O
on	O
the	O
early	B-T079
and	O
goal-directed	B-T061
administration	I-T061
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	B-T080
medication	O
infusions	B-T061
for	O
persistent	B-T079
and	O
fluid-refractory	B-T047
shock	I-T047
.	O
	
however	O
,	O
accumulating	B-T033
adult	O
and	O
pediatric	B-T080
data	B-T078
suggest	O
that	O
excessive	B-T080
fluid	B-T061
administration	I-T061
is	O
associated	O
with	O
worse	B-T033
patient	O
outcomes	B-T169
and	O
even	O
increased	B-T033
risk	I-T033
of	I-T033
death	I-T033
.	O
	
the	O
optimal	B-T081
amount	I-T081
of	O
intravascular	O
fluid	O
required	O
in	O
early	B-T079
pediatric	B-T080
septic	O
shock	O
resuscitation	B-T061
prior	O
to	O
the	O
initiation	B-T169
of	O
vasoactive	B-T080
support	I-T080
remains	O
unanswered	O
.	O
	
the	O
squeeze	O
pilot	O
trial	O
is	O
a	O
pragmatic	O
,	O
two-arm	O
,	O
parallel-group	O
,	O
open-label	O
,	O
prospective	O
pilot	O
randomized	O
controlled	O
trial	O
.	O
	
participants	O
are	O
children	O
aged	O
29	O
days	B-T079
to	O
under	O
18	O
years	B-T079
with	O
suspected	B-T078
or	O
confirmed	B-T033
septic	O
shock	O
and	O
a	O
need	O
for	O
ongoing	O
resuscitation	B-T061
.	O
	
eligible	O
participants	O
are	O
enrolled	O
under	O
an	O
exception	O
to	O
consent	B-T169
process	O
and	O
randomly	B-T080
assigned	B-T169
via	O
concealed	B-T080
allocation	O
to	O
either	O
the	O
usual	O
care	O
control	O
or	O
fluid	B-T061
sparing	I-T061
intervention	I-T061
resuscitation	I-T061
strategy	I-T061
.	O
	
the	O
primary	B-T080
objective	O
of	O
this	O
pilot	O
trial	O
is	O
to	O
determine	O
feasibility	O
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	O
participants	O
and	O
to	O
adhere	O
to	O
the	O
study	O
protocol	O
.	O
	
the	O
primary	B-T080
outcome	I-T080
measure	I-T080
by	O
which	O
success	B-T080
will	O
be	O
determined	O
is	O
participant	O
enrollment	O
rate	B-T081
"""pass"""	O
defined	O
as	O
at	O
least	O
two	O
participants	O
/	O
site	O
/	O
month	B-T079
,	O
recognizing	O
that	O
enrollment	O
may	O
be	O
slower	O
during	O
the	O
run-in	O
phase	O
.	O
	
secondary	O
objectives	O
include	O
assessing	O
1	O
appropriateness	B-T080
of	O
eligibility	B-T080
criteria	I-T080
,	O
and	O
2	O
completeness	B-T080
of	O
clinical	B-T169
outcomes	I-T169
to	O
inform	O
the	O
endpoints	B-T080
for	O
the	O
planned	B-T169
multisite	O
trial	O
.	O
	
to	O
support	O
the	O
nested	O
translational	O
study	O
,	O
squeeze-d	O
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell-free	O
dna	O
a	O
procoagulant	B-T116
molecule	I-T116
with	O
prognostic	O
utility	O
in	O
blood	O
samples	O
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
squeeze	O
pilot	O
trial	O
at	O
baseline	B-T081
and	O
at	O
24	O
h	O
.	O
	
the	O
optimal	O
degree	B-T081
of	O
fluid	O
resuscitation	B-T061
and	O
the	O
timing	B-T079
of	O
initiation	B-T169
of	O
vasoactive	B-T080
support	I-T080
in	O
order	O
to	O
achieve	O
recommended	O
therapeutic	B-T169
targets	B-T169
in	O
children	O
with	O
septic	O
shock	O
remains	O
unanswered	O
.	O
	
no	O
prospective	O
study	O
to	O
date	B-T079
has	O
examined	O
this	O
important	O
question	O
for	O
children	O
in	O
developed	B-T080
countries	I-T080
including	O
canada	O
.	O
	
recruitment	O
for	O
the	O
squeeze	O
pilot	O
trial	O
opened	B-T033
on	O
6	O
january	O
2014	O
.	O
	
findings	B-T033
will	O
inform	O
the	O
feasibility	O
of	O
the	O
planned	B-T169
multicenter	O
trial	O
to	O
answer	O
our	O
overall	B-T080
research	B-T078
question	I-T078
.	O
	
entropy-driven	B-T169
reactions	I-T169
in	O
living	B-T078
cells	O
for	O
assay	O
let-7a	O
microrna	O
imaging	O
of	O
microrna	O
mirna	O
in	O
living	B-T078
cells	O
could	O
facilitate	O
the	O
monitoring	O
of	O
the	O
expression	O
and	O
distribution	B-T169
of	O
mirna	O
and	O
research	O
on	O
mirna	O
-related	O
diseases	B-T047
.	O
	
given	O
the	O
low	O
expression	B-T081
levels	I-T081
and	O
even	O
down-regulation	O
of	O
cellular	O
mirna	O
that	O
is	O
associated	B-T080
with	I-T080
some	O
diseases	B-T047
,	O
enzyme	B-T116
-	O
free	B-T169
amplification	O
strategies	O
are	O
imperative	O
for	O
intracellular	O
mirna	O
assay	O
.	O
	
in	O
this	O
work	O
,	O
we	O
report	O
an	O
entropy-driven	B-T169
reaction	I-T169
for	O
amplification	O
assay	O
mirna	O
with	O
a	O
detection	B-T081
limit	I-T081
of	O
0.27	O
pm	O
.	O
	
the	O
resulting	O
signal	O
amplification	O
provides	O
excellent	O
recognition	O
and	O
signal	O
enhancement	O
of	O
specific	B-T080
mirna	O
s	O
in	O
living	B-T078
cells	O
.	O
	
this	O
method	O
supplies	O
accurate	B-T080
information	B-T078
regarding	O
cellular	O
mirna	O
-related	O
biological	O
events	O
and	O
provides	O
a	O
new	O
tool	O
for	O
highly	B-T080
sensitive	I-T080
and	O
simultaneous	B-T079
imaging	O
of	O
multiple	B-T081
low-level	O
biomarkers	O
,	O
thereby	O
improving	O
the	O
accuracy	B-T080
of	O
early	O
disease	O
diagnosis	O
.	O
	
iterative	B-T033
development	B-T169
and	O
evaluation	O
of	O
a	O
pharmacogenomic	O
-guided	O
clinical	O
decision	O
support	O
system	O
for	O
warfarin	B-T081
dosing	I-T081
pharmacogenomic	O
-guided	O
dosing	B-T081
has	O
the	O
potential	O
to	O
improve	O
patient	O
outcomes	O
but	O
its	O
implementation	O
has	O
been	O
met	O
with	O
clinical	B-T080
challenges	O
.	O
	
our	O
objective	O
was	O
to	O
develop	O
and	O
evaluate	O
a	O
clinical	O
decision	O
support	O
system	O
cdss	O
for	O
pharmacogenomic	O
-guided	O
warfarin	B-T081
dosing	I-T081
designed	O
for	O
physicians	O
and	O
pharmacists	O
.	O
	
twelve	O
physicians	O
and	O
pharmacists	O
completed	O
6	O
prescribing	O
tasks	O
using	O
simulated	O
patient	O
scenarios	B-T169
in	O
two	O
iterations	B-T033
development	B-T169
and	O
validation	O
phases	B-T079
of	O
a	O
newly	O
developed	O
pharmacogenomic	O
-driven	O
cdss	O
prototype	B-T080
.	O
	
for	O
each	O
scenario	B-T169
,	O
usability	O
was	O
measured	B-T080
via	O
efficiency	B-T081
,	O
recorded	O
as	O
time	O
to	O
task	O
completion	O
,	O
and	O
participants	O
'	O
perceived	O
satisfaction	O
which	O
were	O
compared	O
using	O
kruskal-wallis	O
and	O
mann	O
whitney	O
u	O
tests	O
,	O
respectively	O
.	O
	
debrief	O
interviews	O
were	O
conducted	O
and	O
qualitatively	O
analyzed	O
.	O
	
usability	O
findings	O
from	O
the	O
first	O
i.e	O
.	O
	
development	B-T169
iteration	B-T033
were	O
incorporated	O
into	O
the	O
cdss	O
design	O
for	O
the	O
second	B-T079
i.e	O
.	O
	
validation	O
iteration	B-T033
.	O
	
during	O
the	O
cdss	O
validation	O
iteration	B-T033
,	O
participants	O
took	O
more	O
time	O
to	O
complete	O
tasks	O
with	O
a	O
median	O
iqr	O
of	O
183	O
124-247	O
seconds	B-T079
versus	O
101	O
73.5	O
seconds	B-T079
in	O
the	O
development	B-T169
iteration	B-T033
p=0	O
.	O
	
this	O
increase	B-T169
in	O
time	B-T079
on	I-T079
task	I-T079
was	O
due	O
to	O
the	O
increase	B-T169
in	O
time	B-T079
spent	O
in	O
the	O
cdss	O
corresponding	O
to	O
several	O
design	O
changes	O
.	O
	
efficiency	B-T081
differences	O
that	O
were	O
observed	O
between	O
pharmacists	O
and	O
physicians	O
in	O
the	O
development	B-T169
iteration	B-T033
were	O
eliminated	O
in	O
the	O
validation	O
iteration	B-T033
.	O
	
the	O
increased	B-T081
use	O
of	O
the	O
cdss	O
corresponded	O
to	O
a	O
greater	O
acceptance	O
of	O
cdss	O
recommended	O
doses	B-T081
in	O
the	O
validation	O
iteration	B-T033
4%	O
in	O
the	O
first	O
iteration	B-T033
vs	O
.	O
	
37.5	O
in	O
the	O
second	B-T079
iteration	B-T033
,	O
p<0	O
.	O
	
overall	O
satisfaction	O
did	O
not	O
change	O
statistically	O
between	O
the	O
iterations	B-T033
but	O
the	O
qualitative	O
analysis	O
revealed	O
greater	O
trust	O
in	O
the	O
second	B-T079
prototype	B-T080
.	O
	
a	O
pharmacogenomic	O
-guided	O
cdss	O
has	O
been	O
developed	O
using	O
warfarin	B-T109
as	O
the	O
test	O
drug	O
.	O
	
the	O
final	O
cdss	O
prototype	B-T080
was	O
trusted	O
by	O
prescribers	O
and	O
significantly	O
increased	B-T081
the	O
time	B-T079
using	O
the	O
tool	B-T033
and	O
acceptance	O
of	O
the	O
recommended	O
doses	B-T081
.	O
	
this	O
study	O
is	O
an	O
important	O
step	O
toward	O
incorporating	O
pharmacogenomics	O
into	O
cdss	O
design	O
for	O
clinical	O
testing	O
.	O
	
pedicle	O
screw	O
combined	B-T080
with	O
lateral	O
mass	O
screw	O
fixation	B-T061
in	O
the	O
treatment	B-T061
of	O
basilar	O
invagination	O
and	O
congenital	O
c2-c3	O
fusion	O
clinical	O
evaluation	O
of	O
a	O
surgical	B-T061
fixation	B-T061
technique	B-T169
featuring	O
combined	B-T080
use	O
of	O
pedicle	O
screw	O
and	O
lateral	O
mass	O
screw	O
lms	O
.	O
	
introduction	O
of	O
a	O
novel	O
technique	B-T169
for	O
the	O
treatment	B-T061
of	O
congenital	O
c2-c3	O
fusion	O
and	O
basilar	O
invagination	O
bi	O
.	O
	
posterior	O
occipitocervical	O
fixation	B-T061
using	O
c2	O
pedicle	O
screw	O
was	O
widely	O
used	O
for	O
bi	O
.	O
	
however	O
,	O
in	O
cases	B-T169
where	O
bi	O
is	O
concurrent	B-T079
with	O
congenital	O
c2-c3	O
fusion	O
,	O
the	O
c2	O
pedicles	O
tend	O
to	O
be	O
thinner	B-T080
than	O
that	O
in	O
normal	B-T080
population	O
and	O
hence	O
more	O
likely	O
to	O
fail	B-T169
.	O
	
we	O
prompted	O
to	O
tackle	O
the	O
issue	B-T033
by	O
combining	B-T080
the	O
pedicle	O
screw	O
with	O
the	O
additional	O
use	O
of	O
lms	O
in	O
attempt	O
to	O
strengthen	B-T078
the	O
fixation	B-T061
.	O
	
twenty-five	O
patients	O
who	O
underwent	O
combined	B-T080
pedicle	O
screw	O
with	O
lms	O
fixation	B-T061
were	O
retrospectively	O
studied	O
.	O
	
the	O
instrument	O
position	O
,	O
fusion	B-T169
status	B-T080
,	O
and	O
complications	O
were	O
analyzed	O
.	O
	
none	O
had	O
spinal	O
cord	O
or	O
vertebral	O
artery	O
injury	O
.	O
	
the	O
average	O
follow-up	O
time	B-T079
was	O
20	O
months	B-T079
.	O
	
solid	O
fusion	B-T169
was	O
achieved	O
in	O
23	O
patients	O
92%	O
as	O
detected	O
radiologically	O
.	O
	
two	O
cases	B-T169
suffered	O
from	O
recurred	O
bi	O
and	O
instrument	O
failure	B-T033
but	O
eventually	O
achieved	O
solid	O
fusion	B-T169
between	O
the	O
occiput	O
and	O
c2	O
was	O
after	O
revision	B-T061
.	O
	
among	O
all	O
25	O
patients	O
,	O
4	O
suffered	O
from	O
complications	O
including	O
instrument	O
s	O
failure	B-T033
,	O
cerebrospinal	B-T047
fluid	I-T047
leakage	I-T047
,	O
and	O
intracranial	O
infection	O
.	O
	
the	O
clinical	B-T080
outcome	B-T169
indicates	O
that	O
the	O
technique	B-T169
is	O
reliable	O
for	O
the	O
treatment	B-T061
of	O
bi	O
with	O
congenital	O
c2-c3	O
fusion	O
.	O
	
co-occurrence	B-T079
and	O
clustering	B-T081
of	O
health	B-T078
conditions	B-T080
at	O
age	O
11	O
cross-sectional	O
findings	B-T169
from	O
the	O
millennium	B-T081
cohort	I-T081
study	I-T081
to	O
identify	O
patterns	O
of	O
co-occurrence	B-T079
and	O
clustering	B-T081
of	O
6	O
common	O
adverse	O
health	B-T078
conditions	B-T080
in	O
11-	O
year	B-T079
-old	O
children	O
and	O
explore	O
differences	B-T080
by	O
sociodemographic	B-T078
factors	I-T078
.	O
	
nationally	O
representative	O
prospective	O
cohort	O
study	O
.	O
	
children	O
born	O
in	O
the	O
uk	O
between	O
2000	O
and	O
2002	O
.	O
	
11	O
399	O
11-	O
year	B-T079
-old	O
singleton	O
children	O
for	O
whom	O
data	B-T078
on	O
all	O
6	O
health	B-T078
conditions	B-T080
and	O
sociodemographic	B-T078
information	I-T078
were	O
available	O
complete	B-T080
cases	B-T169
.	O
	
prevalence	B-T081
,	O
co-occurrence	B-T079
and	O
clustering	B-T081
of	O
6	O
common	O
health	B-T078
conditions	B-T080
wheeze	O
eczema	B-T047
long-standing	O
illness	O
excluding	O
wheeze	O
and	O
eczema	B-T047
injury	O
socioemotional	O
difficulties	O
measured	O
using	O
strengths	O
and	O
difficulties	O
questionnaire	O
and	O
unfavourable	O
weight	O
thin	B-T033
/	O
overweight	O
/	O
obese	B-T047
vs	O
normal	O
.	O
	
42.4	O
of	O
children	O
had	O
2	O
or	O
more	O
adverse	O
health	B-T078
conditions	B-T080
co-occurrence	B-T079
.	O
	
co-occurrence	B-T079
was	O
more	O
common	O
in	O
boys	O
and	O
children	O
from	O
lower	O
income	B-T081
households	O
.	O
	
latent	O
class	O
analysis	O
identified	O
6	O
classes	O
'	O
normative	B-T080
'	O
57.4	O
'	O
atopic	O
burdened	B-T078
'	O
14.0	O
'	O
socioemotional	O
burdened	O
'	O
11.0	O
'	O
unfavourable	O
weight	O
/	O
injury	O
'	O
7.7	O
'	O
eczema	B-T047
/	O
injury	O
'	O
6.0	O
and	O
'	O
eczema	B-T047
/	O
unfavourable	O
weight	O
'	O
3.9	O
.	O
	
as	O
with	O
co-occurrence	B-T079
,	O
class	O
membership	O
differed	O
by	O
sociodemographic	B-T078
factors	I-T078
boys	O
,	O
children	O
of	O
mothers	O
with	O
lower	O
educational	B-T033
attainment	I-T033
and	O
children	O
from	O
lower	O
income	B-T081
households	O
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
'	O
socioemotional	O
burdened	O
'	O
class	O
.	O
	
children	O
of	O
mothers	O
with	O
higher	O
educational	B-T033
attainment	I-T033
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
'	O
normative	B-T080
'	O
and	O
'	O
eczema	B-T047
/	O
unfavourable	O
weight	O
'	O
classes	O
.	O
	
co-occurrence	B-T079
of	O
adverse	O
health	B-T078
conditions	B-T080
at	O
age	O
11	O
is	O
common	O
and	O
is	O
associated	B-T080
with	I-T080
adverse	O
socioeconomic	O
circumstances	O
.	O
	
holistic	B-T078
,	O
child	O
focused	O
care	O
,	O
particularly	O
in	O
boys	O
and	O
those	O
in	O
lower	O
income	B-T081
groups	B-T078
,	O
may	O
help	O
to	O
prevent	B-T080
and	O
reduce	B-T080
co-occurrence	B-T079
in	O
later	B-T079
childhood	B-T079
and	O
genomic	O
characterization	O
of	O
a	O
wild-bird	O
-	O
origin	B-T033
pigeon	O
paramyxovirus	O
type	O
1	O
ppmv-1	O
first	O
isolated	B-T169
in	O
the	O
northwest	O
region	O
of	O
china	O
pigeon	O
paramyxovirus	O
type-1	O
ppmv-1	O
is	O
an	O
enzootic	B-T169
in	O
pigeon	O
flocks	O
and	O
causes	O
severe	B-T080
economic	B-T081
losses	I-T081
in	O
the	O
poultry	O
industry	O
in	O
many	O
countries	O
.	O
	
a	O
ppmv-1	O
isolate	O
,	O
abbreviated	O
as	O
ppmv-1/ql-01/ch/15	O
,	O
was	O
isolated	B-T169
from	O
a	O
great	O
spotted	O
woodpecker	O
in	O
the	O
northwest	O
region	O
of	O
china	O
in	O
2015	O
.	O
	
the	O
complete	O
genome	O
was	O
sequenced	O
,	O
and	O
the	O
results	B-T169
showed	O
that	O
the	O
virus	O
genome	O
was	O
15	O
nt	O
in	O
length	B-T081
,	O
in	O
the	O
gene	O
arrangement	O
3'-np-p-m-f-hn-l-5'	O
.	O
	
several	O
amino	B-T116
acid	I-T116
mutations	O
were	O
identified	B-T080
in	O
the	O
functional	O
domains	O
of	O
the	O
f	B-T116
and	O
hn	B-T116
proteins	I-T116
.	O
	
the	O
pathogenicity	O
index	O
of	O
the	O
isolate	O
was	O
evaluated	O
,	O
and	O
the	O
mean	B-T079
death	I-T079
time	I-T079
mdt	B-T079
was	O
72	O
h	O
and	O
the	O
intracerebral	O
pathogenicity	O
index	O
icpi	O
was	O
0.925	O
,	O
indicating	O
that	O
this	O
isolate	O
was	O
mesogenic	B-T080
.	O
	
sequencing	O
results	B-T169
showed	O
that	O
it	O
had	O
a	O
virulent	B-T080
newcastle	O
disease	O
virus	O
cleavage	O
motif	O
112	O
at	O
the	O
fusion	B-T116
protein	I-T116
cleavage	O
site	O
.	O
	
morbidity	B-T081
and	O
mortality	B-T081
were	O
70%	O
and	O
50%	O
,	O
after	O
inoculation	B-T061
of	O
pigeons	O
,	O
whereas	O
this	O
virus	O
was	O
nonpathogenic	B-T033
in	O
chickens	O
.	O
	
different	O
immune	O
responses	O
of	O
pigeons	O
and	O
chickens	O
were	O
induced	B-T169
in	O
vivo	O
,	O
which	O
led	O
to	O
different	O
hi	O
serum	O
antibody	O
titers	O
.	O
	
the	O
results	B-T169
of	O
phylogenetic	O
and	O
evolutionary	O
distance	O
analysis	O
showed	O
that	O
this	O
ppmv-1	O
strain	O
belonged	O
to	O
sub-genotype	O
via	O
in	O
class	O
ii	O
.	O
	
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
identification	O
and	O
analysis	O
of	O
ppmv-1	O
co-circulation	B-T033
among	O
wild	O
birds	O
and	O
domestic	O
pigeon	O
flocks	O
in	O
china	O
.	O
	
the	O
data	B-T078
from	O
this	O
study	O
highlight	O
the	O
important	O
role	O
of	O
wild	O
birds	O
in	O
the	O
dissemination	O
of	O
ppmv-1	O
and	O
provide	O
useful	O
references	O
for	O
improving	B-T080
our	O
understanding	O
of	O
the	O
distribution	O
and	O
evolution	O
of	O
ppmv-1	O
in	O
memory	O
consolidation	O
effects	B-T080
on	O
memory	O
stabilization	O
and	O
item	O
integration	O
in	O
older	O
adults	O
this	O
study	O
examined	O
the	O
differential	B-T169
effects	I-T169
of	O
aging	O
on	O
consolidation	O
processes	O
that	O
strengthen	O
newly	O
acquired	O
memory	O
traces	O
in	O
veridical	O
form	O
memory	O
stabilization	O
versus	O
consolidation	O
processes	O
that	O
are	O
responsible	O
for	O
integrating	O
these	O
memory	O
traces	O
into	O
an	O
existing	O
body	O
of	O
knowledge	O
item	O
integration	O
.	O
	
older	O
adults	O
learned	O
13	O
nonwords	O
and	O
were	O
tested	O
on	O
their	O
memory	O
for	O
the	O
nonwords	O
,	O
and	O
on	O
whether	O
these	O
nonwords	O
impacted	O
upon	O
processing	O
of	O
similar-sounding	O
english	O
words	O
immediately	O
and	O
24	O
hours	B-T079
later	O
.	O
	
participants	O
accurately	O
recognized	O
the	O
nonwords	O
immediately	O
,	O
but	O
showed	O
significant	O
decreases	O
in	O
delayed	O
recognition	O
and	O
recall	O
.	O
	
in	O
comparison	O
,	O
the	O
nonwords	O
impacted	O
upon	O
processing	O
of	O
similar-sounding	O
words	O
only	O
in	O
the	O
delayed	O
test	O
.	O
	
together	O
,	O
these	O
findings	O
suggest	O
that	O
memory	O
consolidation	O
processes	O
may	O
be	O
more	O
evident	O
in	O
item	O
integration	O
than	O
memory	O
stabilization	O
processes	O
for	O
new	O
declarative	O
memories	O
in	O
older	O
adults	O
.	O
	
mucosa	O
-	O
associated	B-T080
biohydrogenating	O
microbes	O
protect	O
the	O
simulated	O
colon	O
microbiome	O
from	O
stress	B-T033
associated	B-T080
with	I-T080
high	B-T081
concentrations	I-T081
of	O
poly-unsaturated	B-T109
fat	I-T109
polyunsaturated	B-T109
fatty	I-T109
acids	I-T109
pufas	B-T109
may	O
affect	O
colon	O
microbiome	O
homeostasis	O
by	O
exerting	O
specific	B-T080
antimicrobial	O
effects	B-T080
and/or	O
interfering	O
with	O
mucosal	O
biofilm	O
formation	B-T169
at	O
the	O
gut	O
mucosal	O
interface	O
.	O
	
we	O
used	O
standardized	O
batch	O
incubations	O
and	O
the	O
mucosal-simulator	O
of	O
the	O
human	O
microbial	O
intestinal	O
ecosystem	O
m-shime	O
to	O
show	O
the	O
in	B-T080
vitro	I-T080
luminal	O
and	O
mucosal	O
effects	B-T080
of	I-T080
the	O
main	O
pufa	B-T109
in	O
the	O
western	B-T061
diet	I-T061
,	O
linoleic	B-T109
acid	I-T109
la	B-T109
.	O
	
high	B-T081
concentrations	I-T081
of	O
la	B-T109
were	O
found	O
to	O
decrease	B-T081
butyrate	B-T109
production	B-T169
and	O
faecalibacterium	O
prausnitzii	O
numbers	O
dependent	O
on	O
la	B-T109
biohydrogenation	O
to	O
vaccenic	B-T109
acid	I-T109
va	B-T109
and	O
stearic	B-T109
acid	I-T109
sa	B-T109
.	O
	
in	O
faecal	O
batch	O
incubations	O
,	O
la	B-T109
biohydrogenation	O
and	O
butyrate	B-T109
production	B-T169
were	O
positively	B-T080
correlated	I-T080
and	O
sa	B-T109
did	O
not	O
inhibit	O
butyrate	B-T109
production	B-T169
.	O
	
in	O
the	O
m-shime	O
,	O
addition	O
of	O
a	O
mucosal	O
environment	O
stimulated	O
biohydrogenation	O
to	O
sa	B-T109
and	O
protected	O
f	O
.	O
	
prausnitzii	O
from	O
inhibition	O
by	O
la	B-T109
.	O
	
this	O
was	O
probably	O
due	O
to	O
the	O
preference	B-T078
of	O
two	O
biohydrogenating	O
genera	O
roseburia	O
and	O
pseudobutyrivibrio	O
for	O
the	O
mucosal	O
niche	O
.	O
	
co-culture	O
batch	O
incubations	O
using	O
roseburia	O
hominis	O
and	O
f	O
.	O
	
prausnitzii	O
validated	O
these	O
observations	O
.	O
	
correlations	B-T080
networks	B-T169
further	O
uncovered	O
the	O
central	O
role	O
of	O
roseburia	O
and	O
pseudobutyrivibrio	O
in	O
protecting	O
luminal	O
and	O
mucosal	O
shime	O
microbiota	O
from	O
la	B-T109
-	O
induced	B-T033
stress	I-T033
.	O
	
our	O
results	B-T169
confirm	O
how	O
cross-shielding	B-T169
interactions	I-T169
provide	O
resilience	O
to	O
the	O
microbiome	O
and	O
demonstrate	O
the	O
importance	B-T080
of	O
biohydrogenating	O
,	O
mucosal	O
bacteria	O
for	O
recovery	O
from	O
la	B-T109
stress	B-T033
.	O
	
genetic	B-T169
parameters	B-T033
for	O
tick	B-T081
count	I-T081
and	O
udder	O
health	B-T078
in	O
commercial	O
and	O
indigenous	O
ewes	O
in	O
south	O
africa	O
the	O
genetics	B-T169
of	O
tick	B-T047
infestation	I-T047
in	O
sheep	O
need	O
study	O
,	O
as	O
host	B-T169
resistance	I-T169
often	O
forms	O
part	O
of	O
integrated	O
pest	O
control	O
programs	O
.	O
	
repeated	O
udder	O
health	O
scores	O
,	O
site-specific	O
tick	B-T081
count	I-T081
,	O
mating	O
weight	B-T081
and	O
reproduction	O
records	O
n=879-1204	O
were	O
recorded	O
annually	O
from	O
2010	O
to	O
2015	O
on	O
ewes	O
of	O
the	O
indigenous	O
namaqua	O
afrikaner	O
na	O
fat-tailed	O
breed	O
,	O
as	O
well	O
as	O
the	O
commercial	O
dorper	O
and	O
sa	O
mutton	O
merino	O
samm	O
breeds	O
.	O
	
udder	O
s	O
were	O
scored	B-T081
subjectively	O
on	O
a	O
1-5	O
scale	O
1	O
-	O
udder	O
intact	B-T080
and	O
5	O
-	O
udder	O
damaged	O
severely	O
and	O
ticks	B-T047
were	O
counted	B-T081
on	O
three	O
locations	O
.	O
	
the	O
body	O
sites	O
counted	B-T081
were	O
the	O
head	O
and	O
thoracic	O
limb	O
htltc	O
,	O
udder-pelvic	O
limb	O
upltc	O
and	O
perineum-breech-tail	O
pbttc	O
.	O
	
these	O
counts	B-T081
were	O
also	O
totaled	O
for	O
a	O
total	B-T081
tick	I-T081
count	I-T081
ttc	B-T081
.	O
	
reproduction	O
traits	O
were	O
number	O
of	O
lambs	O
weaned	B-T033
per	O
ewe	B-T033
lambed	I-T033
and	O
total	O
weight	O
of	O
lamb	B-T033
weaned	I-T033
per	O
ewe	B-T033
lambed	I-T033
.	O
	
udder	O
health	O
scores	O
of	O
na	O
ewes	O
were	O
lower	O
than	O
those	O
of	O
dorpers	O
,	O
which	O
in	O
turn	O
had	O
lower	O
scores	O
than	O
samm	O
ewes	O
.	O
	
na	O
ewes	O
had	O
lower	O
values	O
for	O
htltc	O
,	O
upltc	O
and	O
ttc	B-T081
than	O
the	O
commercial	O
breeds	O
,	O
but	O
higher	O
values	O
for	O
pbttc	O
than	O
dorpers	O
.	O
	
heritability	B-T033
estimates	B-T081
amounted	O
to	O
0.26	O
for	O
htltc	O
,	O
0.53	O
for	O
upltc	O
,	O
0.07	O
for	O
pbttc	O
,	O
0.44	O
for	O
ttc	B-T081
and	O
0.61	O
for	O
udder	O
health	O
score	O
.	O
	
animal	O
permanent	O
environment	O
also	O
affected	O
pbttc	O
0.14	O
.	O
	
significant	O
genetic	O
correlations	O
were	O
found	O
between	O
the	O
htltc	O
and	O
upltc	O
0.47	O
,	O
upltc	O
and	O
udder	O
health	O
score	O
0.52	O
,	O
htltc	O
and	O
upltc	O
0.24	O
as	O
well	O
as	O
upltc	O
and	O
pbttc	O
-0	O
.	O
	
heavier	O
ewes	O
had	O
higher	O
upltc	O
0.38	O
,	O
ttc	B-T081
0.33	O
and	O
impaired	B-T169
udder	O
health	B-T078
0.21	O
.	O
	
udder	O
health	O
score	O
s	O
and	O
tick	B-T081
counts	I-T081
at	O
all	O
sites	O
were	O
not	O
related	O
to	O
reproduction	O
traits	O
.	O
	
the	O
indigenous	O
na	O
breed	O
outperformed	O
the	O
commercial	O
breeds	O
with	O
lower	O
values	O
for	O
htltc	O
,	O
upltc	O
,	O
ttc	B-T081
and	O
a	O
better	O
udder	O
health	O
score	O
.	O
	
mechanisms	O
contributing	O
to	O
the	O
better	O
performance	O
of	O
the	O
na	O
breed	O
under	O
pastoral	O
conditions	O
and	O
the	O
scope	O
for	O
selection	O
for	O
tick	B-T047
tolerance	B-T080
within	O
breeds	O
starvation	B-T033
-	O
and	O
antibiotics	O
-induced	O
formation	O
of	O
persister	O
cells	O
in	O
pseudomonas	O
aeruginosa	O
planktonic	O
stationary	O
and	O
exponential	O
cultures	O
of	O
pseudomonas	O
aeruginosa	O
are	O
highly	B-T169
resistant	I-T169
to	O
killing	B-T033
by	O
bactericidal	O
antimicrobials	O
because	O
of	O
the	O
presence	O
of	O
persisters	O
,	O
cells	O
that	O
are	O
multidrug	B-T033
tolerant	I-T033
and	O
play	O
a	O
key	O
role	O
in	O
the	O
recalcitrance	B-T169
of	O
biofilm	O
infections	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	B-T169
the	O
formation	O
of	O
persister	O
cells	O
in	O
p	O
.	O
	
aeruginosa	O
stationary	O
vs	O
.	O
	
exponential	O
cultures	O
using	O
different	B-T080
class	O
antimicrobials	O
.	O
	
the	O
susceptibilities	B-T169
of	O
p	O
.	O
	
aeruginosa	O
pao1	O
wild-type	O
and	O
mutant	O
strains	O
to	O
antimicrobials	O
were	O
determined	O
by	O
standard	O
microtiter	O
broth	O
dilution	O
method	O
.	O
	
in	O
order	O
to	O
determine	O
persister	O
formation	O
,	O
dose	B-T081
-	O
and	O
time	B-T079
-dependent	O
killing	O
experiments	O
were	O
performed	B-T169
with	O
antibiotics	O
.	O
	
ceftazidime	B-T109
cephalosporin	B-T109
showed	O
little	O
efficacy	B-T080
against	O
either	O
culture	O
.	O
	
stationary-phase	O
cells	O
were	O
more	O
tolerant	B-T033
to	O
imipenem	B-T109
carbapenem	B-T109
than	O
exponential	O
cells	O
,	O
leaving	O
a	O
small	O
fraction	B-T081
of	I-T081
persisters	O
at	O
high	B-T080
imipenem	B-T109
concentration	B-T081
in	O
both	O
populations	O
.	O
	
polymyxin	B-T116
b	I-T116
polymyxin	B-T116
appeared	O
to	O
be	O
ineffective	O
at	O
low	B-T081
concentrations	I-T081
against	O
both	O
cell	O
populations	O
.	O
	
very	O
high	O
polymyxin	B-T116
b	I-T116
concentration	B-T081
completely	O
eradicated	O
exponential	O
cells	O
and	O
regrowth	B-T169
was	O
seen	O
in	O
a	O
stationary	O
population	O
.	O
	
stationary	O
cells	O
were	O
more	O
tolerant	B-T033
to	O
tobramycin	B-T109
aminoglycoside	B-T109
than	O
exponential	O
cells	O
but	O
a	O
higher	B-T081
concentration	I-T081
of	O
tobramycin	B-T109
completely	O
eliminated	B-T080
survivors	B-T078
.	O
	
ciprofloxacin	B-T109
fluoroquinolone	B-T109
at	O
a	O
low	B-T081
concentration	I-T081
resulted	O
in	O
killing	B-T033
of	O
both	O
cultures	O
of	O
p	O
.	O
	
aeruginosa	O
,	O
producing	O
persisters	O
that	O
were	O
invulnerable	O
to	O
killing	B-T033
.	O
	
stationary	O
cells	O
appear	O
to	O
be	O
somewhat	O
more	O
tolerant	B-T033
than	O
exponential	O
cells	O
in	O
all	O
of	O
these	O
assays	O
.	O
	
we	O
also	O
showed	O
that	O
nutrient	O
deprivation	B-T080
serine	B-T116
starvation	B-T033
regulated	O
by	O
stringent	O
and	O
general	O
stress	O
response	O
,	O
contribute	O
to	O
the	O
increased	B-T033
tolerance	I-T033
of	O
p	O
.	O
	
aeruginosa	O
exponential	O
and	O
stationary	O
planktonic	O
cells	O
via	O
production	O
of	O
chaetomium	O
thermophilum	O
formate	B-T116
dehydrogenase	I-T116
has	O
high	O
activity	O
in	O
the	O
reduction	O
of	O
hydrogen	O
carbonate	O
hco3	O
-	O
to	O
formate	B-T109
while	O
formate	B-T116
dehydrogenases	I-T116
fdhs	B-T116
have	O
been	O
used	O
for	O
cofactor	O
recycling	O
in	O
chemoenzymatic	O
synthesis	O
,	O
the	O
ability	O
of	O
fdh	B-T116
to	O
reduce	O
co2	O
could	O
also	O
be	O
utilized	O
in	O
the	O
conversion	B-T169
of	O
co2	O
to	O
useful	O
products	O
via	O
formate	B-T109
hcoo	B-T109
.	O
	
in	O
this	O
study	O
,	O
we	O
investigated	B-T169
the	O
reduction	O
of	O
co2	O
in	O
the	O
form	O
of	O
hydrogen	O
carbonate	O
hco3	O
to	O
formate	B-T109
by	O
fdhs	B-T116
from	O
candida	O
methylica	O
cmfdh	B-T116
and	O
chaetomium	O
thermophilum	O
ctfdh	B-T116
in	O
a	O
nadh	O
-dependent	O
reaction	B-T169
.	O
	
the	O
catalytic	O
performance	O
with	O
hco3	O
as	O
a	O
substrate	O
was	O
evaluated	O
by	O
measuring	B-T080
the	O
kinetic	B-T079
rates	I-T079
and	O
conducting	O
productivity	O
assays	O
.	O
	
ctfdh	B-T116
showed	O
a	O
higher	O
efficiency	B-T081
in	O
converting	B-T169
hco3	O
to	O
formate	B-T109
than	O
cmfdh	B-T116
,	O
whereas	O
cmfdh	B-T116
was	O
better	O
in	O
the	O
oxidation	O
of	O
formate	B-T109
.	O
	
the	O
ph	B-T081
optimum	O
of	O
the	O
reduction	O
was	O
at	O
ph	B-T081
7-8	O
.	O
	
however	O
,	O
the	O
high	B-T081
concentrations	I-T081
of	O
hco3	O
reduced	O
the	O
reaction	B-T079
rate	I-T079
.	O
	
ctfdh	B-T116
was	O
modeled	O
in	O
the	O
presence	O
of	O
hco3	O
showing	O
that	O
it	O
fits	O
to	O
the	O
active	B-T169
site	I-T169
.	O
	
the	O
active	B-T169
site	I-T169
setting	O
for	O
hydride	O
transfer	O
in	O
co2	O
reduction	O
was	O
modeled	O
.	O
	
the	O
hydride	O
donated	O
by	O
nadh	O
would	O
form	O
a	O
favorable	O
contact	O
to	O
the	O
carbon	O
atom	O
of	O
hco3	O
,	O
resulting	O
in	O
a	O
surplus	O
of	O
electrons	O
within	O
the	O
molecule	O
.	O
	
this	O
would	O
cause	O
the	O
complex	O
formed	O
by	O
hydrogen	O
carbonate	O
and	O
the	O
hydride	O
to	O
break	O
into	O
formate	B-T109
and	O
hydroxide	O
ions	O
.	O
	
evaluation	O
of	O
an	O
international	B-T078
educational	O
programme	O
for	O
health	O
care	O
professionals	O
on	O
best	O
practice	O
in	O
the	O
management	O
of	O
a	O
perinatal	B-T079
death	O
improving	O
perinatal	O
mortality	O
review	O
and	O
outcomes	O
via	O
education	O
improve	O
stillbirths	B-T033
and	O
neonatal	B-T033
deaths	I-T033
are	O
devastating	O
events	O
for	O
both	O
parents	O
and	O
clinicians	B-T080
and	O
are	O
global	O
public	O
health	O
concerns	B-T078
.	O
	
careful	O
clinical	O
management	O
after	O
these	O
deaths	O
is	O
required	O
,	O
including	O
appropriate	O
investigation	O
and	O
assessment	O
to	O
determine	O
cause	O
s	O
to	O
prevent	O
future	O
losses	O
,	O
and	O
to	O
improve	O
bereavement	O
care	O
for	O
families	O
.	O
	
an	O
educational	O
programme	O
for	O
health	O
care	O
professionals	O
working	O
in	O
maternal	B-T033
and	O
child	O
health	O
has	O
been	O
designed	O
to	O
address	O
these	O
needs	O
according	O
to	O
the	O
perinatal	O
society	O
of	O
australia	O
and	O
new	O
zealand	O
guideline	O
for	O
perinatal	O
mortality	O
improving	O
perinatal	O
mortality	O
review	O
and	O
outcomes	O
via	O
education	O
improve	O
.	O
	
the	O
programme	O
has	O
a	O
major	O
focus	O
on	O
stillbirth	B-T033
and	O
is	O
delivered	O
as	O
six	O
interactive	O
skills	O
-based	O
stations	O
.	O
	
we	O
aimed	O
to	O
determine	O
participants	O
'	O
pre-	O
and	O
post-programme	O
knowledge	O
of	O
and	O
confidence	O
in	O
the	O
management	O
of	O
perinatal	B-T079
deaths	O
,	O
along	O
with	O
satisfaction	O
with	O
the	O
programme	O
.	O
	
we	O
also	O
aimed	O
to	O
determine	O
suitability	O
for	O
international	B-T078
use	O
.	O
	
the	O
improve	O
programme	O
was	O
delivered	O
to	O
health	O
professionals	O
in	O
maternity	O
hospitals	O
in	O
all	O
seven	O
australian	O
states	O
and	O
territories	O
and	O
modified	O
for	O
use	O
internationally	B-T078
with	O
piloting	O
in	O
vietnam	O
,	O
fiji	O
,	O
and	O
the	O
netherlands	O
with	O
the	O
assistance	O
of	O
the	O
international	O
stillbirth	O
alliance	O
,	O
isa	O
.	O
	
modifications	O
were	O
made	O
to	O
programme	O
materials	O
in	O
consultation	O
with	O
local	O
teams	O
and	O
included	O
translation	O
for	O
the	O
vietnam	O
programme	O
.	O
	
participants	O
completed	O
pre-	O
and	O
post-programme	O
evaluation	O
questionnaires	O
on	O
knowledge	O
and	O
confidence	O
on	O
six	O
key	O
components	O
of	O
perinatal	B-T079
death	O
management	O
as	O
well	O
as	O
a	O
satisfaction	O
questionnaire	O
.	O
	
over	O
the	O
period	O
may	O
2012	O
to	O
may	O
2015	O
,	O
30	O
improve	O
workshops	O
were	O
conducted	O
,	O
including	O
26	O
with	O
758	O
participants	O
in	O
australia	O
and	O
four	O
with	O
136	O
participants	O
internationally	B-T078
.	O
	
evaluations	O
showed	O
a	O
significant	B-T078
improvement	O
between	O
pre-	O
and	O
post-programme	O
knowledge	O
and	O
confidence	O
in	O
all	O
six	O
stations	O
and	O
overall	O
,	O
and	O
a	O
high	O
degree	O
of	O
satisfaction	O
in	O
all	O
settings	O
.	O
	
the	O
improve	O
programme	O
has	O
been	O
well	O
received	O
in	O
australia	O
and	O
in	O
three	O
different	O
international	B-T078
settings	O
and	O
is	O
now	O
being	O
made	O
available	O
through	O
isa	O
.	O
	
future	O
research	O
is	O
required	O
to	O
determine	O
whether	O
the	O
immediate	O
improvements	O
in	O
knowledge	O
are	O
sustained	B-T169
with	O
less	O
causes	O
of	O
death	O
being	O
classified	O
as	O
unknown	O
,	O
changes	O
in	O
clinical	O
practice	O
and	O
improvement	O
in	O
parents'	O
experiences	O
with	O
care	O
.	O
	
the	O
suitability	O
for	O
this	O
programme	O
in	O
low-income	B-T033
countries	O
experiences	O
of	O
support	O
in	O
working	O
toward	O
personal	O
recovery	O
goals	O
a	O
collaborative	O
,	O
qualitative	O
study	O
recovery	O
can	O
be	O
understood	O
as	O
a	O
subjective	O
process	O
guided	O
by	O
personal	O
expectations	B-T078
,	O
goals	O
and	O
hopes	O
.	O
	
the	O
aim	O
of	O
the	O
study	O
was	O
to	O
explore	O
how	O
persons	O
using	O
a	O
community	O
mental	O
health	O
centre	O
cmhc	O
experienced	O
that	O
their	O
expectations	B-T078
for	O
treatment	B-T061
,	O
and	O
goals	O
and	O
hopes	O
for	O
recovery	O
were	O
supported	O
by	O
the	O
health	O
professionals	O
during	O
treatment	B-T061
.	O
	
employing	O
a	O
hermeneutic	B-T078
-phenomenological	O
approach	O
,	O
eight	O
service	O
users	O
were	O
interviewed	O
about	O
their	O
expectations	B-T078
for	O
treatment	B-T061
and	O
their	O
goals	O
and	O
hopes	O
for	O
recovery	O
at	O
the	O
start	O
of	O
their	O
contact	O
with	O
health	O
professionals	O
at	O
a	O
cmhc	O
.	O
	
two	O
years	B-T079
later	O
,	O
they	O
were	O
re-interviewed	O
about	O
their	O
experiences	O
of	O
treatment	B-T061
and	O
support	O
from	O
the	O
health	O
professionals	O
in	O
their	O
work	O
towards	O
these	O
goals	O
and	O
hopes	O
.	O
	
a	O
collaborative	O
approach	O
was	O
adopted	O
.	O
	
a	O
co-researcher	O
with	O
lived	O
experience	O
took	O
part	O
in	O
all	O
stages	O
of	O
the	O
study	O
.	O
	
data	B-T078
were	O
analysed	O
by	O
means	O
of	O
a	O
data	B-T078
-driven	O
stepwise	O
approach	O
in	O
line	O
with	O
thematic	O
analysis	O
.	O
	
five	O
themes	O
reflecting	O
how	O
participants	O
experienced	O
support	O
from	O
health	O
professionals	O
at	O
the	O
cmhc	O
in	O
their	O
work	O
towards	O
their	O
recovery	O
goals	O
were	O
elicited	O
,	O
as	O
follows	O
developing	B-T080
an	I-T080
understanding	I-T080
of	I-T080
oneself	I-T080
and	O
one's	O
mental	B-T033
health	I-T033
problems	I-T033
learning	O
how	O
to	O
change	O
feelings	O
and	O
behaviours	O
being	B-T033
'pushed'	I-T033
into	I-T033
social	I-T033
arenas	I-T033
finding	B-T033
helpful	I-T033
medication	I-T033
and	O
counselling	O
in	O
family	B-T033
,	O
practical	B-T033
and	O
financial	B-T033
issues	I-T033
.	O
	
the	O
participants	O
'	O
expectations	B-T078
about	O
counselling	O
with	O
regard	O
to	O
longer-term	O
family	B-T033
,	O
practical	B-T033
,	O
and	O
financial	B-T033
challenges	I-T033
were	O
insufficiently	O
met	O
by	O
the	O
cmhc	O
.	O
	
in	O
the	O
experience	O
of	O
the	O
service	O
users	O
,	O
recovery	O
occurred	O
within	O
the	O
context	O
of	O
their	O
everyday	B-T078
life	I-T078
with	O
or	O
without	O
the	O
support	O
of	O
their	O
professional	O
helpers	O
.	O
	
to	O
facilitate	O
recovery	O
,	O
health	O
professionals	O
should	O
acknowledge	O
the	O
service	O
user's	O
personal	O
goals	O
and	O
hopes	O
and	O
take	O
a	O
more	O
comprehensive	O
and	O
longer-term	O
approach	O
to	O
his	O
or	O
her	O
needs	B-T080
and	O
desires	O
.	O
	
acknowledging	O
and	O
facilitating	O
recovery	O
goals	O
by	O
offering	O
counselling	O
with	O
regard	O
to	O
family	B-T033
,	O
practical	B-T033
and	O
financial	B-T033
issues	I-T033
pathogenesis	O
of	O
copd	B-T047
and	O
asthma	B-T047
asthma	B-T047
and	O
copd	B-T047
remain	O
two	O
diseases	B-T047
of	I-T047
the	I-T047
respiratory	I-T047
tract	I-T047
with	O
unmet	O
medical	B-T169
needs	B-T080
.	O
	
this	O
review	O
considers	O
the	O
current	O
state	O
of	O
play	O
with	O
respect	O
to	O
what	O
is	O
known	O
about	O
the	O
underlying	O
pathogenesis	O
of	O
these	O
two	O
chronic	B-T047
inflammatory	I-T047
diseases	I-T047
of	O
the	O
lung	O
.	O
	
the	O
review	O
highlights	O
why	O
they	O
are	O
different	O
conditions	B-T080
requiring	O
different	O
approaches	O
to	O
treatment	B-T061
and	O
provides	O
a	O
backdrop	O
for	O
the	O
subsequent	O
chapters	O
in	O
this	O
volume	O
discussing	O
recent	O
advances	O
in	O
the	O
pharmacology	O
and	O
treatment	B-T061
of	O
asthma	B-T047
and	O
antigen	O
specificity	O
determines	O
anti-red	B-T116
blood	I-T116
cell	I-T116
igg-fc	I-T116
alloantibody	I-T116
glycosylation	O
and	O
thereby	O
severity	B-T080
of	O
haemolytic	B-T047
disease	I-T047
of	I-T047
the	I-T047
fetus	I-T047
and	I-T047
newborn	I-T047
haemolytic	B-T047
disease	I-T047
of	I-T047
the	I-T047
fetus	I-T047
and	I-T047
newborn	I-T047
hdfn	B-T047
is	O
a	O
severe	O
disease	B-T047
in	O
which	O
fetal	O
red	O
blood	O
cells	O
rbc	O
are	O
destroyed	O
by	O
maternal	B-T116
anti-rbc	I-T116
igg	I-T116
alloantibodies	I-T116
.	O
	
hdfn	B-T047
is	O
most	O
often	O
caused	O
by	O
anti-d	B-T116
but	O
may	O
also	O
occur	O
due	B-T169
to	I-T169
anti-k	B-T116
,	O
-c	B-T116
-	O
or	O
-e	B-T116
.	O
	
we	O
recently	O
found	O
n-linked	O
glycosylation	O
of	O
anti-d	B-T116
to	O
be	O
skewed	O
towards	O
low	B-T080
fucosylation	O
,	O
thereby	O
increasing	B-T169
the	O
affinity	O
to	O
igg-fc	B-T116
receptor	I-T116
iiia	I-T116
and	O
iiib	B-T116
,	O
which	O
correlated	B-T080
with	O
hdfn	B-T047
disease	B-T047
severity	B-T080
.	O
	
here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	O
with	O
anti-c	B-T116
,	O
-e	B-T116
or	O
-k	B-T116
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	O
and	O
investigated	B-T169
the	O
type	O
of	O
fc-tail	O
glycosylation	O
of	O
these	O
antibodies	B-T116
in	O
relation	O
to	O
the	O
trigger	B-T080
of	O
immunisation	B-T061
and	O
pregnancy	B-T033
outcome	I-T033
.	O
	
anti-c	B-T116
,	O
-e	B-T116
and	O
-k	B-T116
show	O
-	O
independent	B-T169
of	I-T169
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	B-T061
-	O
a	O
different	B-T080
kind	O
of	O
fc-glycosylation	O
compared	O
to	O
that	O
of	O
the	O
total	O
igg	B-T116
fraction	O
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-d	O
.	O
	
high	O
fc-galactosylation	O
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
hdfn	O
disease	O
severity	O
,	O
while	O
low	O
anti-k	O
fc-fucosylation	O
correlated	O
with	O
severe	O
fetal	O
anaemia	O
.	O
	
igg-fc	O
glycosylation	O
of	O
anti-rbc	O
antibodies	O
is	O
shaped	O
depending	O
on	O
the	O
antigen	O
.	O
	
these	O
features	O
influence	O
their	O
clinical	O
potency	O
and	O
may	O
therefore	O
be	O
used	O
to	O
predict	O
severity	O
and	O
identify	O
those	O
needing	O
treatment	B-T169
shout	O
louder	O
about	O
poor	B-T081
pay	I-T081
it	O
seems	O
increasingly	O
clear	O
to	O
me	O
that	O
the	O
nhs	O
pay	B-T081
campaign	O
is	O
not	O
making	O
waves	O
either	O
in	O
the	O
nhs	O
or	O
with	O
the	O
sars	B-T047
-	O
cov	O
fusion	O
peptides	B-T116
induce	O
membrane	O
surface	O
ordering	O
and	O
curvature	O
viral	O
membrane	O
fusion	O
is	O
an	O
orchestrated	O
process	O
triggered	O
by	O
membrane-anchored	O
viral	B-T116
fusion	I-T116
glycoproteins	I-T116
.	O
	
the	O
s2	B-T116
subunit	B-T116
of	O
the	O
spike	B-T116
glycoprotein	I-T116
from	O
severe	B-T047
acute	I-T047
respiratory	I-T047
syndrome	I-T047
sars	B-T047
coronavirus	O
cov	O
contains	O
internal	O
domains	O
called	O
fusion	B-T116
peptides	I-T116
fp	B-T116
that	O
play	O
essential	O
roles	O
in	O
virus	O
entry	O
.	O
	
although	O
membrane	O
fusion	O
has	O
been	O
broadly	O
studied	O
,	O
there	O
are	O
still	O
major	O
gaps	O
in	O
the	O
molecular	B-T080
details	O
of	O
lipid	B-T109
rearrangements	O
in	O
the	O
bilayer	O
during	O
fusion	B-T116
peptide	I-T116
-	O
membrane	O
interactions	B-T169
.	O
	
here	O
we	O
employed	O
differential	O
scanning	O
calorimetry	O
dsc	O
and	O
electron	O
spin	O
resonance	O
esr	O
to	O
gather	O
information	O
on	O
the	O
membrane	O
fusion	O
mechanism	B-T169
promoted	O
by	O
two	O
putative	O
sars	B-T047
fps	B-T116
.	O
	
dsc	O
data	B-T078
showed	O
the	O
peptides	B-T116
strongly	O
perturb	O
the	O
structural	O
integrity	B-T080
of	O
anionic	O
vesicles	O
and	O
support	O
the	O
hypothesis	B-T078
that	O
the	O
peptides	B-T116
generate	O
opposing	O
curvature	O
stresses	O
on	O
phosphatidylethanolamine	B-T109
membranes	O
.	O
	
esr	O
showed	O
that	O
both	O
fps	B-T116
increase	O
lipid	B-T109
packing	O
and	O
head	O
group	O
ordering	O
as	O
well	O
as	O
reduce	O
the	O
intramembrane	O
water	B-T081
content	I-T081
for	O
anionic	O
membranes	O
.	O
	
therefore	O
,	O
bending	O
moment	O
in	O
the	O
bilayer	O
could	O
be	O
generated	O
,	O
promoting	O
negative	O
curvature	O
.	O
	
the	O
significance	B-T078
of	O
the	O
ordering	B-T080
effect	I-T080
,	O
membrane	O
dehydration	B-T033
,	O
changes	O
in	O
the	O
curvature	O
properties	O
and	O
the	O
possible	O
role	O
of	O
negatively	O
charged	O
phospholipids	B-T109
in	O
helping	O
to	O
overcome	O
the	O
high	O
kinetic	O
barrier	O
involved	O
in	O
the	O
different	O
stages	O
of	O
the	O
sars	B-T047
-	O
cov	O
-mediated	O
membrane	O
fusion	O
elucidating	O
a	O
chemical	O
defense	O
mechanism	O
of	O
antarctic	O
sponges	O
a	O
computational	O
study	O
in	O
2000	O
,	O
a	O
novel	O
secondary	O
metabolite	O
erebusinone	O
,	O
ereb	O
was	O
isolated	O
from	O
the	O
antarctic	O
sea	O
sponge	O
,	O
isodictya	O
erinacea	O
.	O
	
the	O
bioactivity	O
of	O
ereb	O
was	O
investigated	O
,	O
and	O
it	O
was	O
found	O
to	O
inhibit	O
molting	O
when	O
fed	O
to	O
the	O
arthropod	O
species	O
orchomene	O
plebs	O
.	O
	
xanthurenic	B-T109
acid	I-T109
xa	B-T109
is	O
a	O
known	O
endogenous	B-T169
molt	O
regulator	O
present	O
in	O
arthropods	O
.	O
	
experimental	O
studies	O
have	O
confirmed	O
that	O
xa	B-T109
inhibits	O
molting	O
by	O
binding	O
to	O
either	O
or	O
both	O
of	O
two	O
p450	B-T116
enzymes	I-T116
cyp315a1	B-T116
or	O
cyp314a1	B-T116
that	O
are	O
responsible	O
for	O
the	O
final	O
two	O
hydroxylations	O
in	O
the	O
production	O
of	O
the	O
molt-inducing	O
hormone	O
,	O
20-hydroxyecdysone	B-T109
20e	B-T109
.	O
	
the	O
lack	O
of	O
crystal	O
structures	O
and	O
biochemical	O
assays	O
for	O
cyp315a1	B-T116
or	O
cyp314a1	B-T116
,	O
has	O
prevented	O
further	O
experimental	O
exploration	O
of	O
xa	B-T109
and	O
ereb's	O
molt	O
inhibition	O
mechanisms	B-T169
.	O
	
herein	O
,	O
a	O
wide	O
array	O
of	O
computational	O
techniques	O
-	O
homology	O
modeling	O
,	O
molecular	O
dynamics	O
simulations	O
,	O
binding	O
site	O
bioinformatics	O
,	O
flexible	O
receptor-flexible	O
ligand	O
docking	O
,	O
and	O
molecular	O
mechanics-generalized	O
born	O
surface	O
area	O
calculations	O
-	O
have	O
been	O
employed	O
to	O
elucidate	O
the	O
structure-function	B-T080
relationships	I-T080
between	O
the	O
aforementioned	O
p450s	B-T116
and	O
the	O
two	O
described	O
small	O
molecule	O
inhibitors	O
ereb	O
and	O
xa	B-T109
.	O
	
results	O
indicate	O
that	O
ereb	O
likely	O
targets	O
cyp315a1	B-T116
by	O
interacting	O
with	O
a	O
network	O
of	O
aromatic	O
residues	O
in	O
the	O
binding	O
site	O
,	O
while	O
xa	B-T109
may	O
inhibit	O
both	O
cyp315a1	B-T116
and	O
cyp314a1	B-T116
because	O
of	O
its	O
aromatic	O
,	O
as	O
well	O
as	O
charged	O
nature	O
.	O
	
the	O
anatomical	O
mummies	O
of	O
mombello	O
detection	B-T033
of	O
cocaine	B-T109
,	O
nicotine	B-T109
,	O
and	O
caffeine	B-T109
in	O
the	O
hair	O
of	O
psychiatric	O
patients	O
of	O
the	O
early	O
20th	O
century	O
the	O
mombello	O
psychiatric	O
hospital	O
in	O
limbiate	O
,	O
near	O
milan	O
,	O
replaced	O
the	O
old	O
senavra	O
hospital	O
as	O
the	O
psychiatric	O
hospital	O
for	O
the	O
province	O
of	O
milan	O
in	O
the	O
19th	O
century	O
.	O
	
during	O
the	O
early	O
20th	O
century	O
,	O
bodies	O
of	O
several	O
mombello	O
patients	O
were	O
dissected	B-T169
and	O
preserved	O
by	O
giuseppe	O
paravicini	O
,	O
an	O
anatomist	O
who	O
operated	O
within	O
the	O
asylum	O
.	O
	
the	O
aim	B-T078
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
and	O
memorialize	O
this	O
important	O
assemblage	O
.	O
	
to	O
this	O
end	O
,	O
we	O
were	O
allowed	O
to	O
sample	O
the	O
head	O
hair	O
of	O
six	O
such	O
preparations	O
for	O
toxicological	B-T169
analysis	O
.	O
	
by	O
means	O
of	O
high	O
performance	O
liquid	O
chromatography	O
,	O
cocaine	B-T109
and	O
its	O
main	O
metabolite	O
,	O
benzoylecgonine	B-T109
,	O
were	O
detected	B-T033
in	O
two	O
out	O
of	O
six	O
hair	O
samples	O
.	O
	
the	O
concentrations	B-T081
for	O
cocaine	B-T109
were	O
0.151	O
and	O
0.09ng	O
and	O
for	O
benzoylecgonine	B-T109
0.103	O
and	O
0.147ng	O
,	O
respectively	O
.	O
	
given	O
that	O
cocaine	B-T109
was	O
a	O
commonly	O
used	O
medicine	O
,	O
beginning	O
in	O
the	O
mid-19th	O
century	O
and	O
persisting	O
into	O
the	O
20th	O
century	O
,	O
it	O
is	O
not	O
surprising	O
that	O
some	O
patients	O
may	O
have	O
ingested	O
this	O
drug	O
.	O
	
in	O
addition	O
to	O
the	O
detection	B-T033
of	O
cocaine	B-T109
,	O
these	O
analyses	O
also	O
provided	O
evidence	O
of	O
nicotine	B-T109
and	O
caffeine	B-T109
intake	B-T169
.	O
	
terahertz	O
identification	O
and	O
quantification	B-T081
of	O
neurotransmitter	O
and	O
neurotrophy	B-T116
mixture	I-T116
terahertz	O
spectroscopy	O
has	O
been	O
widely	O
used	O
for	O
investigating	B-T169
the	O
fingerprint	O
spectrum	O
of	O
different	O
substances	O
.	O
	
for	O
cancerous	O
tissues	O
,	O
the	O
greatest	O
difficulty	O
is	O
the	O
absorption	O
peaks	O
of	O
various	O
substances	O
contained	O
in	O
tissues	O
overlap	B-T079
with	O
each	O
other	O
,	O
which	O
are	O
hard	O
to	O
identify	O
and	O
quantitative	B-T081
analyze	O
.	O
	
as	O
a	O
result	O
,	O
it	O
is	O
very	O
hard	O
to	O
measure	O
the	O
presence	O
of	O
cancer	O
cell	O
and	O
then	O
to	O
diagnose	B-T033
accurately	B-T080
.	O
	
in	O
this	O
paper	O
,	O
we	O
select	O
three	O
typical	O
neurotransmitters	O
γ-aminobutyric	B-T116
acid	I-T116
,	O
l-glutamic	B-T116
acid	I-T116
,	O
dopamine	B-T109
hydrochloride	I-T109
and	O
two	O
typical	O
metabolites	O
inositol	B-T109
and	O
creatine	B-T116
in	O
neurons	O
to	O
measure	O
their	O
terahertz	O
spectra	O
with	O
different	O
mixture	B-T081
ratios	I-T081
.	O
	
by	O
choosing	O
characteristic	B-T080
absorption	O
peaks	O
,	O
removing	O
baseline	B-T081
and	O
using	O
the	O
least	B-T081
square	I-T081
method	I-T081
,	O
we	O
can	O
identify	O
the	O
components	O
and	O
proportions	B-T081
of	O
each	O
mixture	O
,	O
where	O
the	O
goodness	B-T080
of	I-T080
fit	I-T080
to	O
practical	O
situation	O
is	O
up	O
to	O
94%	O
.	O
	
these	O
results	O
provide	O
important	O
evidences	O
for	O
identifying	O
nerve	O
substances	O
and	O
obtaining	O
exact	O
quantitative	B-T081
analysis	O
.	O
	
comparing	O
the	O
bulking	O
effect	O
of	O
calcium	O
hydroxyapatite	O
and	O
deflux	B-T109
injection	B-T061
into	O
the	O
bladder	O
neck	O
for	O
improvement	O
of	O
urinary	O
incontinence	O
in	O
bladder	B-T047
exstrophy-epispadias	I-T047
complex	I-T047
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	B-T080
of	O
the	O
endoscopic	B-T061
injection	I-T061
of	O
calcium	O
hydroxyapatite	O
caha	O
into	O
the	O
bladder	O
neck	O
bn	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	O
and	O
bladder	B-T047
exstrophy-epispadias	I-T047
complex	I-T047
beec	B-T047
.	O
	
we	O
designed	O
a	O
retrospective	O
cohort	O
study	O
in	O
which	O
we	O
retrospectively	O
studied	O
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
beec	B-T047
who	O
had	O
undergone	O
caha	O
or	O
deflux	B-T109
injection	B-T061
for	O
continence	B-T061
improvement	I-T061
between	O
2009	O
and	O
2014	O
.	O
	
sixteen	O
incontinent	B-T047
patients	O
with	O
a	O
mean	O
sd	O
age	O
of	O
8.09	O
3.5	O
years	O
received	O
an	O
endoscopic	B-T061
submucosal	I-T061
injection	I-T061
of	O
5.4	O
ml	O
of	O
pure	O
caha	O
powder	O
with	O
autologous	B-T080
plasma	O
group	O
a	O
.	O
	
patients	O
in	O
group	O
b	O
n	O
=	O
21	O
,	O
control	O
group	O
,	O
with	O
a	O
mean	O
sd	O
age	O
of	O
7.51	O
2.8	O
years	O
received	O
deflux	B-T109
injection	B-T061
5.1	O
ml	O
.	O
	
the	O
mean	O
follow-up	O
after	O
injection	B-T061
was	O
38	O
5.2	O
and	O
33	O
4.1	O
months	O
in	O
groups	O
a	O
and	O
b	O
,	O
respectively	O
.	O
	
no	O
post-injection	O
complication	O
was	O
detected	B-T033
in	O
none	O
of	O
the	O
patients	O
during	O
the	O
follow-up	O
.	O
	
eleven	O
patients	O
68.75	O
in	O
group	O
a	O
became	O
socially	O
dry	B-T080
following	O
1-2	O
injections	B-T061
,	O
the	O
degree	O
of	O
incontinence	B-T047
was	O
improved	O
in	O
4	O
patients	O
25%	O
,	O
and	O
there	O
was	O
no	B-T033
change	I-T033
in	O
one	O
patient	O
6.25	O
.	O
	
however	O
,	O
deflux	B-T109
injection	B-T061
resulted	O
in	O
complete	B-T080
dryness	I-T080
in	O
14	O
66.66	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	B-T047
in	O
5	O
23.81	O
and	O
no	B-T033
change	I-T033
in	O
2	O
patients	O
9.52	O
,	O
leading	O
to	O
no	B-T033
significant	I-T033
difference	I-T033
in	O
continence	B-T061
achievement	I-T061
between	O
caha	O
and	O
deflux	B-T109
groups	O
p	O
=	O
0.9	O
.	O
	
the	O
statistical	O
analysis	O
was	O
not	B-T033
significantly	I-T033
different	I-T033
in	O
terms	O
of	O
bladder	B-T033
capacity	I-T033
p	O
=	O
0.7	O
or	O
q	O
max	O
p	O
=	O
0.8	O
.	O
	
the	O
preliminary	B-T078
results	I-T078
of	O
this	O
study	O
revealed	B-T080
that	O
caha	O
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulking	O
agent	O
in	O
treatment	B-T061
of	O
urinary	O
incontinence	O
in	O
opportunities	O
for	O
genomic	O
prediction	B-T078
for	O
fertility	O
using	O
endocrine	O
and	O
classical	B-T169
fertility	O
traits	O
in	O
dairy	O
cattle	O
endocrine	O
fertility	O
traits	O
,	O
defined	O
from	O
progesterone	B-T109
concentration	B-T081
levels	B-T080
in	O
milk	O
,	O
have	O
been	O
suggested	O
as	O
alternative	O
indicators	B-T169
for	O
fertility	O
in	O
dairy	O
cows	O
because	O
they	O
are	O
less	O
biased	O
by	O
farm	O
management	O
decisions	O
and	O
more	O
directly	O
reflect	O
a	O
cow	O
's	O
reproductive	O
physiology	O
than	O
classical	B-T169
traits	O
derived	O
from	O
insemination	O
and	O
calving	O
data	B-T078
.	O
	
to	O
determine	O
the	O
potential	O
use	B-T169
of	I-T169
endocrine	O
fertility	O
traits	O
in	O
genomic	O
evaluations	O
,	O
the	O
improvement	O
in	O
accuracy	B-T080
from	O
using	O
endocrine	O
fertility	O
traits	O
concurrent	B-T079
with	O
classical	B-T169
traits	O
in	O
the	O
genomic	O
prediction	B-T078
of	O
fertility	O
was	O
quantified	B-T081
.	O
	
the	O
impact	B-T080
of	O
recording	O
all	O
traits	O
on	O
all	O
training	O
animals	O
was	O
also	O
investigated	B-T169
.	O
	
endocrine	O
and	O
classical	B-T169
fertility	O
records	O
were	O
available	O
on	O
5	O
lactations	O
from	O
2	O
holstein	O
cows	O
in	O
ireland	O
,	O
the	O
netherlands	O
,	O
sweden	O
,	O
and	O
the	O
united	O
kingdom	O
.	O
	
the	O
endocrine	O
traits	O
were	O
commencement	O
of	O
luteal	O
activity	O
c-la	O
and	O
proportion	B-T081
of	O
samples	O
with	O
luteal	O
activity	O
pla	O
the	O
classical	B-T169
trait	O
was	O
the	O
interval	B-T079
from	O
calving	O
to	O
first	O
service	O
cfs	O
.	O
	
the	O
interval	B-T079
from	O
c-la	O
to	O
first	O
service	O
c-lafs	O
,	O
which	O
is	O
a	O
combination	O
of	O
an	O
endocrine	O
trait	O
and	O
a	O
classical	B-T169
trait	O
,	O
was	O
also	O
investigated	B-T169
.	O
	
the	O
target	B-T169
breeding	B-T169
goal	I-T169
trait	O
for	O
fertility	O
was	O
cfs	O
or	O
c-lafs	O
,	O
whereas	O
c-la	O
and	O
pla	O
served	O
as	O
predictor	B-T078
traits	O
.	O
	
genomic	O
ebv	O
gebv	O
for	O
fertility	O
were	O
derived	O
using	O
genomic	O
blup	O
in	O
bivariate	O
models	O
with	O
85	O
snp	O
.	O
	
genomic	O
ebv	O
for	O
the	O
separate	O
fertility	O
traits	O
were	O
also	O
computed	O
,	O
in	O
univariate	O
models	O
.	O
	
the	O
accuracy	B-T080
of	O
gebv	O
was	O
evaluated	O
by	O
5-fold	O
cross-validation	O
.	O
	
the	O
highest	O
accuracy	B-T080
of	O
gebv	O
was	O
achieved	O
using	O
bivariate	O
predictions	B-T078
,	O
where	O
both	O
an	O
endocrine	O
fertility	O
trait	O
and	O
the	O
classical	B-T169
fertility	O
trait	O
were	O
used	O
.	O
	
accuracy	B-T080
of	O
gebv	O
for	O
predicting	B-T078
adjusted	O
phenotypes	O
for	O
cfs	O
in	O
the	O
univariate	O
model	O
was	O
0.04	O
,	O
but	O
when	O
predicting	B-T078
cfs	O
using	O
a	O
bivariate	O
model	O
with	O
c-la	O
,	O
the	O
accuracy	B-T080
increased	B-T081
to	O
0.14	O
when	O
all	O
training	O
animals	O
were	O
phenotyped	O
for	O
c-la	O
and	O
or	O
not	O
for	O
cfs	O
.	O
	
on	O
phenotyping	O
all	O
training	O
animals	O
for	O
both	O
c-la	O
and	O
cfs	O
,	O
accuracy	B-T080
for	O
cfs	O
increased	B-T081
to	O
0.18	O
however	O
,	O
when	O
validation	O
animals	O
were	O
also	O
phenotyped	O
for	O
c-la	O
,	O
there	O
was	O
no	B-T033
substantial	B-T169
increase	I-T169
in	O
accuracy	B-T080
.	O
	
when	O
predicting	B-T078
cfs	O
in	O
bivariate	O
analysis	O
with	O
pla	O
,	O
accuracy	B-T080
ranged	O
from	O
0.07	O
to	O
0.14	O
.	O
	
this	O
first	O
study	O
on	O
genomic	O
predictions	B-T078
for	O
fertility	O
using	O
endocrine	O
traits	O
suggests	O
some	O
improvement	O
in	O
the	O
accuracy	B-T080
of	O
prediction	B-T078
over	O
using	O
only	O
the	O
classical	B-T169
traits	O
.	O
	
further	O
studies	O
with	O
larger	B-T081
training	O
populations	O
may	O
show	O
greater	B-T081
improvements	O
.	O
	
a	O
microfluidic	O
platform	O
to	O
design	O
crosslinked	O
hyaluronic	O
acid	O
nanoparticles	O
chanps	O
for	O
enhanced	O
mri	O
recent	B-T079
advancements	B-T079
in	O
imaging	O
diagnostics	O
have	O
focused	O
on	O
the	O
use	O
of	O
nanostructures	O
that	O
entrap	O
magnetic	O
resonance	O
imaging	O
mri	O
contrast	O
agents	O
cas	O
,	O
without	O
the	O
need	O
to	O
chemically	O
modify	B-T169
the	O
clinically	B-T080
approved	B-T080
compounds	O
.	O
	
nevertheless	O
,	O
the	O
exploitation	O
of	O
microfluidic	O
platforms	O
for	O
their	O
controlled	B-T169
and	O
continuous	B-T078
production	O
is	O
still	O
missing	O
.	O
	
here	O
,	O
a	O
microfluidic	O
platform	O
is	O
used	O
to	O
synthesize	O
crosslinked	O
hyaluronic	O
acid	O
nanoparticles	O
chanps	O
in	O
which	O
a	O
clinically	B-T080
relevant	B-T080
mri	O
-	O
cas	O
,	O
gadolinium	B-T109
diethylenetriamine	I-T109
penta-acetic	I-T109
acid	I-T109
gd-dtpa	B-T109
,	O
is	O
entrapped	O
.	O
	
this	O
microfluidic	O
process	O
facilitates	O
a	O
high	O
degree	B-T080
of	O
control	B-T169
over	O
particle	O
synthesis	O
,	O
enabling	O
the	O
production	O
of	O
monodisperse	O
particles	O
as	O
small	O
as	O
35	O
nm	O
.	O
	
furthermore	O
,	O
the	O
interference	B-T169
of	O
gd-dtpa	B-T109
during	O
polymer	O
precipitation	O
is	O
overcome	O
by	O
finely	O
tuning	O
process	O
parameters	O
and	O
leveraging	O
the	O
use	O
of	O
hydrophilic-lipophilic	B-T081
balance	I-T081
hlb	B-T081
of	O
surfactants	O
and	O
ph	B-T081
conditions	B-T080
.	O
	
for	O
both	O
production	O
strategies	O
proposed	O
to	O
design	O
gd	B-T109
-loaded	O
chanps	O
,	O
a	O
boosting	O
of	O
the	O
relaxation	B-T081
rate	I-T081
t1	I-T081
is	O
observed	O
since	O
a	O
t1	B-T081
of	O
1562	O
is	O
achieved	O
with	O
a	O
10	O
μm	O
of	O
gd	B-T109
-loaded	O
chanps	O
while	O
a	O
similar	O
value	B-T081
is	O
reached	O
with	O
100	O
μm	O
of	O
the	O
relevant	B-T080
clinical	B-T080
gd-dtpa	B-T109
in	O
solution	O
.	O
	
the	O
advanced	O
microfluidic	O
platform	O
to	O
synthesize	O
intravascularly	O
-	O
injectable	O
and	O
completely	O
biocompatible	B-T109
hydrogel	I-T109
nanoparticles	O
entrapping	O
clinically	B-T080
approved	B-T080
cas	O
enables	O
the	O
implementation	O
of	O
straightforward	O
and	O
scalable	O
strategies	O
in	O
diagnostics	B-T080
and	O
therapy	B-T061
applications	B-T169
.	O
	
arthrobacter	O
ginkgonis	O
sp	O
.	O
	
nov	O
,	O
an	O
actinomycete	O
isolated	B-T169
from	O
rhizosphere	O
of	O
ginkgo	O
biloba	O
l	O
a	O
gram-stain-positive	O
,	O
aerobic	B-T080
actinobacterial	O
strain	O
designated	O
syp-a7299t	O
,	O
which	O
displayed	O
a	O
rod-coccus	O
growth	O
lifecycle	O
,	O
was	O
isolated	B-T169
from	O
the	O
rhizosphere	O
of	O
ginkgo	O
biloba	O
l	O
.	O
	
phylogenetic	O
analyses	O
based	O
on	O
16s	O
rrna	O
gene	O
sequences	O
indicated	O
that	O
strain	O
syp-a7299t	O
belongs	O
to	O
the	O
genus	O
arthrobacter	O
and	O
is	O
most	O
closely	O
related	O
to	O
arthrobacter	O
halodurans	O
jsm	O
078085t	O
97.4	O
%	O
16s	O
rrna	O
gene	O
sequence	O
similarity	B-T080
.	O
	
the	O
dna	O
-	O
dna	O
relatedness	B-T081
value	I-T081
between	O
strain	O
syp-a7299t	O
and	O
a	O
.	O
	
halodurans	O
jsm	O
078085t	O
was	O
37	O
%	O
2.9	O
.	O
	
the	O
cell-wall	O
peptidoglycan	B-T109
was	O
a4α	B-T109
,	O
and	O
glucose	B-T109
and	O
galactose	B-T109
were	O
whole-cell	B-T109
sugars	I-T109
.	O
	
the	O
polar	B-T109
lipids	I-T109
consisted	O
of	O
diphosphatidylglycerol	O
,	O
phosphatidylglycerol	B-T109
,	O
phosphatidylinositol	B-T109
,	O
two	O
glycolipids	B-T109
and	O
an	O
unknown	O
polar	B-T109
lipid	I-T109
.	O
	
the	O
major	O
menaquinone	B-T109
were	O
mk-8	B-T109
72	O
%	O
and	O
mk-9	B-T109
28	O
%	O
,	O
and	O
the	O
predominant	O
cellular	B-T109
fatty	I-T109
acids	I-T109
were	O
anteiso-c15	B-T109
0	I-T109
,	O
iso-c15	B-T109
0	I-T109
and	O
anteiso-c17	B-T109
0	I-T109
.	O
	
the	O
dna	O
g+c	B-T081
content	I-T081
was	O
68.9	O
mol%	O
.	O
	
based	O
on	O
the	O
morphological	O
,	O
physiological	B-T169
,	O
biochemical	B-T169
and	O
chemotaxonomic	B-T169
characters	I-T169
presented	O
in	O
this	O
study	O
,	O
strain	O
syp-a7299t	O
represents	O
a	O
novel	O
species	O
of	O
the	O
genus	O
arthrobacter	O
,	O
for	O
which	O
the	O
name	O
arthrobacter	O
ginkgonis	O
sp	O
.	O
	
nov	O
.	O
	
is	O
proposed	O
.	O
	
the	O
type	O
strain	O
is	O
syp-a7299t	O
=dsm	O
100491t=kctc	O
39	O
592t	O
.	O
	
decoding	O
the	O
interactions	O
regulating	B-T080
the	O
active	B-T033
state	I-T033
mechanics	O
of	O
eukaryotic	O
protein	B-T116
kinases	I-T116
eukaryotic	O
protein	B-T116
kinases	I-T116
regulate	B-T080
most	O
cellular	O
functions	O
by	O
phosphorylating	O
targeted	B-T169
protein	B-T116
substrates	O
through	B-T169
a	O
highly	B-T080
conserved	B-T169
catalytic	O
core	O
.	O
	
in	O
the	O
active	B-T033
state	I-T033
,	O
the	O
catalytic	O
core	O
oscillates	B-T061
between	O
open	O
,	O
intermediate	O
,	O
and	O
closed	O
conformations	O
.	O
	
currently	B-T079
,	O
the	O
intramolecular	O
interactions	O
that	O
regulate	B-T080
the	O
active	B-T033
state	I-T033
mechanics	O
are	O
not	B-T080
well	I-T080
understood	I-T080
.	O
	
here	O
,	O
using	O
camp-dependent	B-T116
protein	I-T116
kinase	I-T116
as	O
a	O
representative	O
model	O
coupled	B-T169
with	O
biochemical	B-T169
,	O
biophysical	O
,	O
and	O
computational	O
techniques	O
,	O
we	O
define	O
a	O
set	O
of	O
highly	B-T080
conserved	B-T080
electrostatic	O
and	O
hydrophobic	O
interactions	O
working	O
harmoniously	O
to	O
regulate	B-T080
these	O
mechanics	O
.	O
	
these	O
include	B-T169
the	O
previously	B-T079
identified	B-T080
salt	O
bridge	O
between	O
a	O
lysine	B-T116
from	O
the	O
β3-strand	O
and	O
a	O
glutamate	B-T116
from	O
the	O
αc-helix	O
as	O
well	O
as	O
an	O
electrostatic	O
interaction	O
between	O
the	O
phosphorylated	O
activation	O
loop	O
and	O
αc-helix	O
and	O
an	O
ensemble	B-T081
of	O
hydrophobic	B-T080
residues	O
of	O
the	O
regulatory	O
spine	O
and	O
shell	O
.	O
	
moreover	O
,	O
for	O
over	O
three	O
decades	B-T081
it	O
was	O
thought	O
that	O
the	O
highly	B-T080
conserved	B-T169
β3	O
-lysine	O
was	O
essential	O
for	O
phosphoryl	O
transfer	O
,	O
but	O
our	O
findings	O
show	O
that	O
the	O
β3	B-T116
-lysine	I-T116
is	O
not	O
required	O
for	O
phosphoryl	O
transfer	O
but	O
is	O
essential	B-T080
for	O
the	O
active	O
state	O
mechanics	O
acute	B-T079
clinical	B-T080
adverse	O
radiation	O
effects	O
after	O
gamma	B-T061
knife	I-T061
surgery	I-T061
for	O
vestibular	O
schwannomas	O
objective	O
vestibular	O
schwannomas	O
vss	O
represent	O
a	O
common	O
indication	O
of	O
gamma	B-T061
knife	I-T061
surgery	I-T061
gks	B-T061
.	O
	
while	O
most	O
studies	O
focus	O
on	O
the	O
long-term	B-T079
morbidity	B-T081
and	O
adverse	O
radiation	O
effects	O
ares	O
,	O
none	O
describe	O
the	O
acute	B-T079
clinical	B-T080
ares	O
that	O
might	O
appear	O
on	O
a	O
short-term	B-T079
basis	O
.	O
	
these	O
types	O
of	O
events	O
are	O
investigated	B-T169
,	O
and	O
their	O
incidence	B-T081
,	O
type	B-T080
,	O
and	O
outcomes	O
are	O
reported	O
in	O
the	O
present	O
paper	O
.	O
	
methods	O
the	O
included	O
patients	O
were	O
treated	B-T169
between	O
july	O
2010	O
and	O
march	O
2016	O
,	O
underwent	O
at	O
least	O
6	O
months	B-T079
of	O
follow-up	O
,	O
and	O
presented	O
with	O
a	O
disabling	B-T047
symptom	O
during	O
the	O
first	O
6	O
months	B-T079
after	O
gks	B-T061
that	O
affected	B-T169
their	O
quality	B-T078
of	I-T078
life	I-T078
.	O
	
the	O
timing	O
of	O
appearance	O
,	O
as	O
well	O
as	O
the	O
type	O
of	O
main	O
symptom	O
and	O
outcome	O
,	O
were	O
noted	O
.	O
	
the	O
prescribed	O
dose	B-T081
was	O
12	O
gy	O
at	O
the	O
margin	O
.	O
	
results	O
thirty-five	O
22%	O
of	O
159	O
patients	O
who	O
fulfilled	O
the	O
inclusion	B-T080
criteria	O
had	O
acute	B-T079
clinical	B-T080
ares	O
.	O
	
the	O
mean	B-T081
followup	O
period	O
was	O
30	O
months	B-T079
range	B-T081
6-49	O
months	B-T079
.	O
	
the	O
mean	B-T081
time	O
of	O
appearance	O
was	O
37.9	O
days	B-T079
median	B-T081
31	O
days	B-T079
range	B-T081
3-110	O
days	B-T079
.	O
	
in	O
patients	O
with	O
de	B-T078
novo	I-T078
symptoms	O
,	O
the	O
more	O
frequent	O
symptoms	O
were	O
vertigo	O
n	O
=	O
4	O
11.4	O
and	O
gait	B-T033
disturbance	I-T033
n	O
=	O
3	O
8.6	O
.	O
	
the	O
exacerbation	B-T033
of	O
a	O
preexisting	O
symptom	O
was	O
more	O
frequently	O
related	O
to	O
hearing	B-T033
loss	I-T033
n	O
=	O
10	O
28.6	O
,	O
followed	O
by	O
gait	B-T033
disturbance	I-T033
n	O
=	O
7	O
20%	O
and	O
vertigo	O
n	O
=	O
3	O
,	O
8.6	O
.	O
	
in	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	B-T169
were	O
statistically	B-T081
significant	I-T081
age	O
p	O
=	O
0.002	O
odds	B-T081
ratio	I-T081
or	B-T081
0.96	O
,	O
hearing	O
at	O
baseline	B-T081
by	O
gardner-robertson	O
gr	O
class	O
p	O
=	O
0.006	O
or	B-T081
0.21	O
,	O
pure	B-T081
tone	I-T081
average	I-T081
at	O
baseline	B-T081
p	O
=	O
0.006	O
or	B-T081
0.97	O
,	O
and	O
koos	O
grade	O
at	O
baseline	B-T081
with	O
koos	O
grade	O
i	O
used	O
as	O
a	O
reference	O
for	O
koos	O
grade	O
ii	O
,	O
or	B-T081
0.17	O
and	O
p	O
=	O
0.002	O
for	O
koos	O
grade	O
iii	O
,	O
or	B-T081
0.42	O
and	O
p	O
=	O
0.05	O
.	O
	
the	O
following	O
were	O
not	O
statistically	B-T081
significant	I-T081
but	O
showed	O
a	O
tendency	O
toward	O
significance	O
the	O
number	O
of	O
isocenters	O
p	O
=	O
0.06	O
or	B-T081
0.94	O
and	O
the	O
maximal	B-T081
dose	B-T081
received	O
by	O
the	O
cochlea	B-T047
p	O
=	O
0.07	O
or	B-T081
0.74	O
.	O
	
fractional	O
polynomial	O
regression	O
analysis	O
showed	O
a	O
nonlinear	O
relationship	O
between	O
the	O
outcome	O
and	O
the	O
radiation	B-T081
dose	I-T081
rate	I-T081
minimum	O
reached	O
at	O
a	O
cutoff	O
of	O
2.5	O
gy/minute	O
and	O
the	O
maximal	B-T081
vestibular	O
dose	B-T081
maximum	O
reached	O
at	O
a	O
cutoff	O
of	O
8	O
gy	O
,	O
but	O
the	O
small	O
sample	B-T081
size	I-T081
precludes	B-T169
a	O
detailed	O
analysis	O
of	O
the	O
former	O
.	O
	
the	O
clinical	B-T080
acute	B-T079
ares	O
disappeared	O
in	O
32	O
91.4	O
patients	O
during	O
the	O
first	O
6	O
months	B-T079
after	O
appearance	O
.	O
	
permanent	O
and	O
somewhat	O
disabling	B-T047
morbidity	B-T081
was	O
found	O
in	O
3	O
cases	O
1.9	O
from	O
the	O
whole	O
series	O
1	O
each	O
with	O
complete	B-T033
hearing	I-T033
loss	I-T033
gr	O
class	O
i	O
before	O
and	O
v	O
after	O
,	O
hemifacial	B-T033
spasm	I-T033
persistent	B-T079
but	O
alleviated	O
,	O
and	O
dysgeusia	B-T033
.	O
	
conclusions	O
acute	B-T079
effects	B-T080
after	O
radiosurgery	B-T061
for	O
vs	O
are	O
not	O
rare	O
.	O
	
they	O
concern	O
predominantly	O
de	B-T078
novo	I-T078
vertigo	O
and	O
gait	B-T033
disturbance	I-T033
and	O
the	O
exacerbation	B-T033
of	O
preexistent	O
hearing	B-T033
loss	I-T033
.	O
	
in	O
de	B-T078
novo	I-T078
vestibular	O
symptom	O
s	O
,	O
a	O
vestibular	O
dose	B-T081
of	O
more	O
than	O
8	O
gy	O
is	O
thought	O
to	O
play	O
a	O
role	O
.	O
	
in	O
most	O
cases	O
,	O
none	O
of	O
these	O
effects	B-T080
are	O
permanent	O
,	O
and	O
they	O
will	O
ultimately	O
improve	O
or	O
disappear	O
with	O
steroid	B-T061
therapy	I-T061
.	O
	
permanent	O
ares	O
remain	O
very	O
long-chain	B-T109
n-3	I-T109
pufa	I-T109
supplied	O
by	O
the	O
usual	B-T080
diet	O
decrease	B-T081
plasma	B-T116
stearoyl-coa	I-T116
desaturase	I-T116
index	O
in	O
non-hypertriglyceridemic	B-T033
older	O
adults	O
at	O
high	O
vascular	O
risk	B-T078
the	O
activity	O
of	O
stearoyl-coa	B-T116
desaturase-1	I-T116
scd1	B-T116
,	O
the	O
central	B-T116
enzyme	I-T116
in	O
the	O
synthesis	O
of	O
monounsaturated	B-T109
fatty	I-T109
acids	I-T109
mufa	B-T109
,	O
has	O
been	O
associated	B-T080
with	I-T080
de	B-T078
novo	I-T078
lipogenesis	O
.	O
	
in	O
experimental	O
models	O
scd1	B-T116
is	O
down-regulated	O
by	O
polyunsaturated	B-T109
fatty	I-T109
acids	I-T109
pufa	B-T109
,	O
but	O
clinical	O
studies	O
are	O
scarce	O
.	O
	
the	O
effect	B-T080
of	O
long-chain	B-T109
n-3	I-T109
pufa	I-T109
lcn-3pufa	B-T109
supplied	O
by	O
the	O
regular	O
diet	O
,	O
in	O
the	O
absence	B-T169
of	O
fatty	O
fish	O
or	O
fish	O
oil	O
supplementation	O
,	O
remains	O
to	O
be	O
explored	O
.	O
	
we	O
related	B-T080
1-y	O
changes	B-T169
in	O
plasma	B-T116
scd1	I-T116
index	O
,	O
as	O
assessed	O
by	O
the	O
c16	B-T109
/	O
c16	B-T109
ratio	B-T081
,	O
to	O
both	O
adiposity	O
traits	O
and	O
nutrient	B-T033
intake	I-T033
changes	B-T169
in	O
a	O
sub-cohort	O
n	O
=	O
243	O
of	O
non-hypertriglyceridemic	B-T033
subjects	O
of	O
the	O
predimed	O
prevención	O
con	O
dieta	O
mediterranea	O
trial	O
.	O
	
after	O
adjustment	O
for	O
confounders	O
,	O
including	O
changes	B-T169
in	O
fasting	B-T033
triglycerides	B-T109
,	O
plasma	B-T116
scd1	I-T116
index	O
increased	B-T081
in	O
parallel	O
with	O
body	O
weight	O
0.221	O
95%	O
confidence	B-T081
interval	I-T081
,	O
0.021	O
to	O
0.422	O
,	O
p	O
=	O
0.031	O
and	O
bmi	O
0.115	O
0.027	O
to	O
0.202	O
,	O
p	O
=	O
0.011	O
.	O
	
additionally	O
,	O
dietary	O
lcn-3pufa	B-T109
but	O
not	O
mufa	B-T109
or	O
plant-derived	B-T109
pufa	I-T109
were	O
associated	B-T080
with	I-T080
decreased	B-T081
plasma	B-T116
scd1	I-T116
index	O
-0	O
-1	O
to	O
-0	O
,	O
p	O
=	O
0.033	O
,	O
for	O
each	O
1	O
g/d-	O
increase	B-T169
in	O
lcn-3pufa	B-T109
.	O
	
no	O
associations	B-T080
were	O
found	O
for	O
other	O
food	O
groups	B-T078
,	O
but	O
there	O
was	O
a	O
trend	O
for	O
fatty	O
fish	O
intake	B-T169
-0	O
-0	O
to	O
0.012	O
,	O
p	O
=	O
0.085	O
,	O
for	O
each	O
10	O
g/d-	O
increase	B-T169
.	O
	
our	O
data	B-T078
add	O
clinical	B-T080
evidence	B-T078
on	O
the	O
down-regulation	O
of	O
plasma	B-T116
scd1	I-T116
index	O
by	O
lcn-3pufa	B-T109
in	O
the	O
context	B-T078
of	O
realistic	O
changes	B-T169
in	O
fish	O
consumption	O
in	O
the	O
customary	B-T080
,	O
non-supplemented	B-T033
diet	O
.	O
	
distinct	O
cortical	O
and	O
sub-cortical	O
neurogenic	O
domains	O
for	O
gabaergic	O
interneuron	O
precursor	B-T078
transcription	B-T116
factors	I-T116
nkx2.1	B-T116
,	O
olig2	B-T116
and	O
coup-tfii	B-T116
in	O
early	O
fetal	B-T169
human	O
telencephalon	O
the	O
extent	O
of	O
similarities	B-T080
and	O
differences	B-T080
between	O
cortical	O
gabaergic	O
interneuron	O
generation	O
in	O
rodent	O
and	O
primate	O
telencephalon	O
remains	O
contentious	O
.	O
	
we	O
examined	O
expression	O
of	O
three	O
interneuron	O
precursor	B-T078
transcription	B-T116
factors	I-T116
,	O
alongside	O
other	O
markers	O
,	O
using	O
immunohistochemistry	O
on	O
8-12	O
post-conceptional	O
weeks	O
pcw	O
human	O
telencephalon	O
sections	O
.	O
	
nkx2.1	B-T116
,	O
olig2	B-T116
,	O
and	O
coup-tfii	B-T116
expression	O
occupied	O
distinct	O
although	O
overlapping	O
neurogenic	O
domains	O
which	O
extended	O
into	O
the	O
cortex	O
and	O
revealed	O
three	O
cge	O
compartments	O
lateral	O
,	O
medial	O
,	O
and	O
ventral	O
.	O
	
nkx2.1	B-T116
expression	O
was	O
very	O
largely	O
confined	O
to	O
the	O
mge	O
,	O
medial	O
cge	O
,	O
and	O
ventral	O
septum	O
confirming	O
that	O
,	O
at	O
this	O
developmental	B-T079
stage	I-T079
,	O
interneuron	O
generation	O
from	O
nkx2.1	B-T116
+	O
precursor	B-T078
s	O
closely	O
resembles	O
the	O
process	O
observed	O
in	O
rodents	O
.	O
	
olig2	B-T116
immunoreactivity	O
was	O
observed	O
in	O
gabaergic	O
cells	O
of	O
the	O
proliferative	O
zones	O
of	O
the	O
mge	O
and	O
septum	O
,	O
but	O
not	O
necessarily	O
co-expressed	O
with	O
nkx2.1	B-T116
,	O
and	O
olig2	B-T116
expression	O
was	O
also	O
extensively	O
seen	O
in	O
the	O
lge	O
,	O
cge	O
,	O
and	O
cortex	O
.	O
	
at	O
8	O
pcw	O
,	O
olig2	B-T116
+	O
cells	O
were	O
only	O
present	O
in	O
the	O
medial	O
and	O
anterior	O
cortical	O
wall	O
suggesting	O
a	O
migratory	B-T169
pathway	O
for	O
interneuron	O
precursor	B-T078
s	O
via	O
the	O
septum	O
into	O
the	O
medial	O
cortex	O
.	O
	
by	O
12	O
pcw	O
,	O
olig2	B-T116
+	O
cells	O
were	O
present	O
throughout	O
the	O
cortex	O
and	O
many	O
were	O
actively	O
dividing	B-T169
but	O
without	O
co-expressing	O
cortical	O
progenitor	O
markers	O
.	O
	
dividing	O
coup-tfii	B-T116
+	O
progenitor	O
cells	O
were	O
localized	O
to	O
ventral	O
cge	O
as	O
previously	O
described	O
but	O
were	O
also	O
numerous	O
in	O
adjacent	O
ventral	O
cortex	O
in	O
both	O
the	O
cases	O
,	O
coup-tfii	B-T116
was	O
co-expressed	O
with	O
pax6	B-T116
in	O
proliferative	O
zones	O
and	O
tbr1	B-T116
or	O
calretinin	B-T116
in	O
post-	O
mitotic	B-T080
cortical	O
neurons	O
.	O
	
thus	O
coup-tfii	B-T116
+	O
progenitors	O
gave	O
rise	O
to	O
pyramidal	O
cells	O
,	O
but	O
also	O
interneurons	O
which	O
not	O
only	O
migrated	B-T169
posteriorly	O
into	O
the	O
cortex	O
from	O
ventral	O
cge	O
but	O
also	O
anteriorly	O
via	O
the	O
primary	O
neuroendocrine	O
carcinoma	O
of	O
the	O
breast	O
a	O
single	O
center	O
experience	O
and	O
review	O
of	O
the	O
literature	O
neuroendocrine	O
carcinoma	O
of	O
the	O
breast	O
is	O
an	O
extremely	B-T080
rare	B-T080
tumor	O
.	O
	
a	O
standard	B-T080
treatment	B-T061
has	O
yet	O
to	O
be	O
established	B-T080
because	O
only	O
a	O
few	O
cases	O
have	O
been	O
reported	O
in	O
literature	O
.	O
	
the	O
authors	O
report	O
five	O
cases	O
observed	O
from	O
january	B-T080
2007	O
to	O
december	B-T080
2014	O
and	O
a	O
review	O
of	O
literature	O
.	O
	
four	O
patients	O
underwent	O
quadrantectomy	B-T061
and	O
in	O
two	O
cases	O
axillary	B-T061
nodal	I-T061
dissection	I-T061
and	O
only	O
one	O
to	O
mastectomy	B-T061
with	O
axillary	B-T061
nodal	I-T061
dissection	I-T061
.	O
	
tumor	O
size	O
was	O
from	O
t1	B-T033
to	O
t2	B-T033
with	O
n0	B-T033
to	O
n1	B-T033
,	O
according	O
tnm	O
classification	O
.	O
	
pathological	O
specimens	O
were	O
stained	B-T080
with	O
hematoxylin	B-T109
and	O
eosin	O
and	O
an	O
immunohistochemical	O
panel	B-T078
of	O
antibodies	O
neuron-specific	O
enolase	O
,	O
chromogranin	B-T116
,	O
synaptophysin	B-T116
,	O
estrogen	B-T116
and	O
progesterone	B-T116
receptors	I-T116
,	O
c-erb	O
and	O
ki-67	B-T116
.	O
	
all	O
cases	O
showed	O
markers	B-T080
positivity	O
to	O
neuron-specific	O
enolase	O
,	O
chromogranin	B-T116
,	O
synaptophysin	B-T116
and	O
estrogen	B-T116
and	O
progesterone	B-T116
receptors	I-T116
were	O
found	O
.	O
	
ki-67	B-T116
was	O
higher	O
than	O
40%	O
in	O
four	O
patients	O
.	O
	
adjuvant	B-T061
chemotherapy	I-T061
was	O
administrated	B-T061
in	O
patients	O
with	O
ki-67	B-T116
>10%	O
every	O
patients	O
were	O
treated	B-T169
with	O
radiotherapy	B-T061
and	O
with	O
hormonal	B-T061
therapy	I-T061
too	O
.	O
	
although	O
neuroendocrine	O
breast	O
tumor	O
is	O
considered	O
a	O
distinct	O
entity	O
,	O
the	O
best	O
treatment	B-T061
seems	O
to	O
be	O
correlate	B-T080
to	O
the	O
size	O
of	O
tumor	O
and	O
to	O
the	O
lymph	O
node	O
status	B-T080
and	O
to	O
ki-67	B-T116
index	O
like	O
the	O
common	O
breast	O
cancer	O
.	O
	
diagnosis	B-T033
,	O
neuroendocrine	O
breast	O
carcinoma	O
.	O
	
a	O
new	O
parametric	O
model	O
to	O
assess	O
delay	B-T079
and	O
compression	B-T080
of	O
mortality	B-T081
a	O
decrease	B-T081
in	O
mortality	B-T081
across	O
all	O
ages	O
causes	O
a	O
shift	O
of	O
the	O
age	O
pattern	O
of	O
mortality	B-T081
,	O
or	O
mortality	B-T081
delay	B-T079
,	O
while	O
differences	B-T080
in	O
the	O
rate	B-T081
of	O
decrease	B-T081
across	O
ages	O
cause	O
a	O
change	O
in	O
the	O
shape	O
of	O
the	O
age-at-death	B-T033
distribution	B-T169
,	O
mortality	B-T081
compression	B-T080
or	O
expansion	B-T169
.	O
	
evidence	B-T078
exists	O
for	O
both	O
compression	B-T080
and	O
delay	B-T079
of	O
mortality	B-T081
.	O
	
existing	O
parametric	O
models	O
to	O
describe	O
the	O
full	O
age	O
pattern	O
of	O
mortality	B-T081
are	O
not	O
able	O
to	O
capture	O
mortality	B-T081
delay	B-T079
versus	O
mortality	B-T081
compression	B-T080
.	O
	
more	O
recent	O
models	O
that	O
assess	O
delay	B-T079
versus	O
compression	B-T080
mostly	O
focused	O
on	O
the	O
adult	O
or	O
old	O
ages	O
alone	O
and	O
did	O
not	O
distinguish	O
mortality	B-T081
compression	B-T080
below	O
and	O
above	O
the	O
modal	O
age	O
at	O
death	B-T033
,	O
although	O
they	O
represent	O
different	B-T080
mechanisms	B-T169
.	O
	
this	O
paper	O
presents	O
a	O
new	O
parametric	O
model	O
that	O
describes	O
the	O
full	O
age	O
pattern	O
of	O
mortality	B-T081
and	O
assesses	O
compression	B-T080
-	O
at	O
different	B-T080
stages	B-T079
of	I-T079
life	I-T079
-	O
and	O
delay	B-T079
of	O
mortality	B-T081
the	O
code	O
model	O
.	O
	
the	O
model	O
includes	O
10	O
parameters	O
,	O
of	O
which	O
five	O
are	O
constant	B-T080
over	O
time	B-T079
.	O
	
the	O
five	O
time	B-T079
-varying	O
parameters	O
reflect	O
delay	B-T079
of	O
mortality	B-T081
and	O
compression	B-T080
of	O
mortality	B-T081
in	O
infancy	B-T079
,	O
adolescence	B-T079
,	O
young	O
adulthood	O
,	O
late	B-T079
adulthood	I-T079
,	O
and	O
old	O
age	O
.	O
	
the	O
model	O
describes	O
infant	O
and	O
background	O
mortality	B-T081
by	O
two	O
simple	O
functions	B-T169
,	O
uses	O
a	O
mixed	B-T081
logistic	I-T081
model	I-T081
with	O
different	B-T080
slopes	B-T081
in	O
adult	O
,	O
middle	B-T079
,	O
and	O
old	O
age	O
,	O
and	O
includes	O
the	O
modal	O
age	O
at	O
death	B-T033
as	O
a	O
parameter	O
to	O
account	O
for	O
the	O
delay	B-T079
in	O
mortality	B-T081
.	O
	
applying	O
the	O
code	O
model	O
to	O
age	O
-	O
specific	B-T080
probabilities	B-T081
of	O
death	B-T033
for	O
japanese	O
,	O
french	O
,	O
american	O
,	O
and	O
danish	O
men	O
and	O
women	O
between	O
1950	O
and	O
2010	O
showed	O
a	O
very	O
good	O
fit	O
of	O
the	O
full	O
age	O
pattern	O
of	O
mortality	B-T081
.	O
	
delay	B-T079
of	O
mortality	B-T081
explained	O
about	O
two-thirds	O
of	O
the	O
increase	B-T169
in	O
life	O
expectancy	O
at	O
birth	O
,	O
whereas	O
compression	B-T080
of	O
mortality	B-T081
due	O
to	O
mortality	B-T081
declines	I-T081
in	O
young	B-T033
age	I-T033
explained	O
about	O
one-third	O
.	O
	
no	O
strong	O
compression	B-T080
of	O
mortality	B-T081
in	O
late	B-T079
adulthood	I-T079
age	I-T079
was	O
observed	O
.	O
	
mortality	B-T081
compression	B-T080
in	O
old	O
age	O
has	O
had	O
a	O
small	O
negative	O
impact	O
on	O
life	O
expectancy	O
.	O
	
the	O
code	O
model	O
proved	O
a	O
valid	O
instrument	O
for	O
describing	O
the	O
full	O
age	O
pattern	O
of	O
mortality	B-T081
and	O
for	O
disentangling	O
the	O
effects	O
of	O
mortality	B-T081
delay	B-T079
and	O
compression	B-T080
-	O
at	O
different	B-T080
stages	B-T079
of	I-T079
life	I-T079
-	O
on	O
the	O
increase	B-T169
in	O
life	O
expectancy	O
.	O
	
prevalence	B-T081
of	O
hypothyroidism	B-T047
in	O
andalusia	O
,	O
spain	O
,	O
determined	O
by	O
thyroid	B-T116
hormone	I-T116
comsumption	O
hypothyroidism	B-T047
is	O
the	O
most	O
common	O
condition	O
linked	O
to	O
a	O
hormone	B-T047
deficiency	I-T047
,	O
nevertheless	O
data	O
on	O
its	O
prevalence	B-T081
are	O
scarce	O
in	O
spain	O
.	O
	
for	O
that	O
reason	O
,	O
we	O
have	O
estimated	O
its	O
prevalence	B-T081
through	O
the	O
registration	O
of	O
patients	O
who	O
had	O
used	O
thyroid	B-T116
hormones	I-T116
in	O
andalusia	O
south	O
spain	O
.	O
	
data	O
of	O
patients	O
who	O
had	O
withdrawn	O
levothyroxine	B-T109
under	O
the	O
public	O
system	O
during	O
2014	O
from	O
the	O
base	O
of	O
the	O
andalusian	O
health	O
service	O
were	O
considered	O
.	O
	
prevalence	B-T081
were	O
calculated	O
with	O
confidence	B-T081
intervals	I-T081
of	O
95%	O
for	O
each	O
management	O
area	O
,	O
stratified	O
by	O
sex	O
and	O
age	O
groups	O
,	O
and	O
differences	O
between	O
them	O
were	O
evaluated	O
.	O
	
321	O
people	O
98%	O
older	O
than	O
18	O
years	O
and	O
83%	O
female	O
were	O
identified	O
as	O
levothyroxine	B-T109
users	O
and	O
a	O
prevalence	B-T081
of	O
hypothyroidism	B-T047
of	O
3.95	O
95%	O
ci	B-T081
3.94	O
was	O
estimated	O
for	O
the	O
general	O
population	O
.	O
	
the	O
condition	O
was	O
more	O
common	O
in	O
females	O
,	O
in	O
the	O
older	O
18	O
years	O
7.81	O
95%	O
ci	B-T081
7.80	O
to	O
7.82	O
compared	O
to	O
males	O
1.75	O
95%	O
ci	B-T081
1.73	O
with	O
a	O
ratio	O
of	O
4.5	B-T079
.	O
	
it	O
increases	O
in	O
the	O
population	O
of	O
women	O
older	O
than	O
45	O
years	O
,	O
10.32	O
95%	O
ci	B-T081
10.30	O
and	O
in	O
the	O
over	O
60	O
years	O
11.37	O
95%	O
ci	B-T081
11.35	O
.	O
	
the	O
prevalence	B-T081
in	O
adult	O
women	O
in	O
the	O
western	O
provinces	O
is	O
7.38	O
95%	O
ci	B-T081
7.36	O
,	O
in	O
the	O
eastern	O
provinces	O
8.59	O
95%	O
ci	B-T081
8.57	O
and	O
in	O
coastal	O
areas	O
6.70	O
95%	O
ci	B-T081
6.68	O
compared	O
to	O
the	O
mountainous	O
ones	O
,	O
which	O
is	O
8.91	O
95%	O
ci	B-T081
8.88	O
.	O
	
the	O
results	O
denote	O
a	O
high	B-T081
prevalence	I-T081
of	O
hypothyroidism	B-T047
in	O
the	O
adult	O
population	O
of	O
andalusia	O
compared	O
to	O
the	O
nearby	O
countries	O
,	O
with	O
a	O
clear	O
increased	O
associated	B-T080
with	I-T080
females	O
and	O
age	O
.	O
	
furthermore	O
,	O
the	O
prevalence	B-T081
of	O
the	O
illness	O
presents	O
also	O
a	O
geographically-related	O
variability	O
.	O
	
disease	B-T047
activity	I-T047
and	O
increased	B-T033
risk	I-T033
of	I-T033
cardiovascular	O
death	O
among	O
patients	O
with	O
psoriatic	B-T047
arthritis	I-T047
recent	O
studies	O
indicate	O
increased	O
cardiovascular	B-T047
cv	I-T047
morbidity	I-T047
and	O
mortality	O
in	O
patients	O
with	O
psoriatic	B-T047
arthritis	I-T047
psa	B-T047
,	O
but	O
results	O
are	O
inconsistent	O
.	O
	
this	O
prompted	O
our	O
investigation	O
of	O
the	O
mortality	B-T081
rate	I-T081
,	O
cause	B-T033
of	I-T033
death	I-T033
,	O
and	O
incidence	O
of	O
acute	O
cv	B-T033
events	I-T033
in	O
patients	O
from	O
northern	O
sweden	O
with	O
psa	B-T047
.	O
	
patients	O
with	O
established	O
psa	B-T047
464	O
were	O
included	O
.	O
	
to	O
calculate	O
standardized	B-T081
mortality	I-T081
ratio	I-T081
smr	B-T081
and	O
standardized	B-T081
incidence	I-T081
ratio	I-T081
sir	B-T081
for	O
cv	B-T033
events	I-T033
,	O
data	O
were	O
extracted	O
from	O
the	O
national	O
causes	O
of	O
death	O
register	O
and	O
the	O
national	O
inpatient	O
care	O
register	O
in	O
sweden	O
,	O
and	O
compared	O
with	O
the	O
general	O
population	O
.	O
	
the	O
study	O
period	O
was	O
1995-2011	O
.	O
	
to	O
study	O
the	O
effect	O
of	O
inflammatory	B-T169
activity	O
,	O
a	O
composite	O
disease	O
activity	O
index	O
dai	O
was	O
used	O
.	O
	
the	O
smr	B-T081
95%	O
ci	O
for	O
overall	B-T081
mortality	I-T081
and	O
diseases	B-T047
of	I-T047
the	I-T047
circulatory	I-T047
system	I-T047
international	O
classification	O
of	O
diseases	O
,	O
10th	O
edition	O
i00-i99	O
was	O
1.22	O
0.89	O
and	O
1.64	O
1.02	O
,	O
respectively	O
.	O
	
in	O
regression	O
analysis	O
,	O
dai	O
was	O
significantly	O
associated	O
with	O
death	B-T033
or	O
1.99	O
,	O
95%	O
ci	O
1.41	O
when	O
adjusted	O
for	O
age	O
and	O
sex	O
p	O
<	O
0.001	O
,	O
and	O
remained	O
significant	O
after	O
stratifying	B-T080
patients	O
into	O
the	O
2	O
major	O
causes	B-T033
of	I-T033
death	I-T033
diseases	B-T047
of	I-T047
the	I-T047
circulatory	I-T047
system	I-T047
and	O
malignant	O
neoplasms	O
.	O
	
peripheral	B-T047
and	O
axial	B-T033
disease	I-T033
was	O
associated	O
with	O
death	B-T033
or	O
4.02	O
,	O
95%	O
ci	O
1.84	O
,	O
p	O
<	O
0.001	O
compared	O
with	O
peripheral	B-T047
disease	I-T047
only	O
.	O
	
the	O
sir	B-T081
95%	O
ci	O
for	O
a	O
cv	B-T033
event	I-T033
myocardial	B-T047
infarction	I-T047
or	O
stroke	O
was	O
0.597	O
0.40	O
this	O
association	O
was	O
only	O
significant	O
in	O
men	O
.	O
	
patients	O
with	O
psa	B-T047
had	O
a	O
small	O
but	O
significant	O
increase	O
in	O
smr	B-T081
for	O
death	B-T033
due	O
to	O
diseases	B-T047
of	I-T047
the	I-T047
circulatory	I-T047
system	I-T047
compared	O
with	O
the	O
general	O
population	O
.	O
	
among	O
patients	O
,	O
death	B-T033
was	O
associated	O
with	O
dai	O
,	O
as	O
well	O
as	O
axial	B-T033
involvement	I-T033
in	O
combination	O
with	O
peripheral	B-T047
disease	I-T047
,	O
indicating	O
more	O
aggressive	O
disease	O
phenotypes	O
.	O
	
histomorphometric	O
and	O
transcriptome	O
evaluation	O
of	O
early	O
healing	B-T033
bone	I-T033
treated	B-T061
with	I-T061
a	O
novel	B-T080
human	O
particulate	O
dentin	O
powder	O
human	O
particulate	O
dentin	O
hpd	O
shows	O
potential	B-T080
as	O
an	O
alternative	O
bone	B-T061
grafting	I-T061
material	O
.	O
	
however	O
,	O
the	O
mechanism	B-T169
of	O
bone	B-T033
healing	I-T033
at	O
the	O
molecular	B-T080
level	B-T080
after	O
grafting	B-T061
with	O
hpd	O
is	O
unclear	O
.	O
	
this	O
study	O
assessed	O
the	O
histological	B-T169
and	O
global	B-T080
gene	O
expression	O
of	O
bone	O
tissues	O
grafted	B-T169
with	O
hpd	O
.	O
	
the	O
hpd	O
was	O
prepared	B-T033
to	O
250-500	O
µm	O
in	O
size	O
.	O
	
x-ray	O
diffraction	O
xrd	O
and	O
energy	O
dispersive	O
x-ray	O
spectroscopy	O
edx	O
were	O
performed	B-T169
to	O
confirm	B-T080
the	O
crystal	O
structure	O
,	O
organic	B-T109
compound	I-T109
residues	O
,	O
and	O
surface	B-T080
morphology	I-T080
,	O
respectively	O
.	O
	
bony	B-T169
defects	B-T169
were	O
created	O
on	O
the	O
heads	O
of	O
24	O
new	O
zealand	O
white	O
rabbits	O
.	O
	
sterilized	B-T080
hpd	O
was	O
used	O
as	O
the	O
grafting	O
material	O
.	O
	
the	O
quality	B-T080
and	O
quantity	B-T081
of	O
new	O
bone	O
formation	O
was	O
evaluated	O
using	O
micro-ct	O
and	O
histologic	B-T169
analyses	O
during	B-T079
the	O
8	O
week	O
experimental	B-T080
periods	B-T079
.	O
	
for	O
microarray	O
assay	O
,	O
bone	O
tissue	O
and	O
blood	O
samples	O
were	O
taken	O
at	O
3	O
,	O
5	O
and	O
7	O
d	O
post-implantation	B-T079
.	O
	
the	O
results	O
of	O
xrd	O
and	O
edx	O
showed	O
that	O
hpd	O
exhibited	O
physical	O
and	O
chemical	O
properties	O
similar	B-T080
to	O
natural	B-T169
hydroxyapatite	O
.	O
	
new	O
bone	O
formation	O
was	O
observed	B-T169
after	O
hpd	O
implantation	B-T061
compared	O
to	O
the	O
controls	O
,	O
as	O
shown	O
on	O
hematoxylin	O
and	O
eosin	O
staining	O
and	O
micro-ct	O
.	O
	
the	O
bone	O
volume	O
of	O
hpd	O
treated	B-T169
animals	O
was	O
higher	B-T080
than	O
that	O
of	O
the	O
control	O
group	O
at	O
all	O
observation	O
times	B-T081
.	O
	
microarray	O
analysis	O
showed	O
that	O
vascular	O
development	O
coupled	O
with	O
immune	B-T169
and	O
inflammatory	B-T169
related	O
genes	O
were	O
expressed	O
in	O
the	O
early	B-T079
healing	O
stage	B-T079
.	O
	
the	O
gene	O
coding	O
for	O
the	O
il-1	O
antagonist	O
,	O
il1rn	O
,	O
was	O
expressed	O
to	O
inhibit	O
the	O
inflammatory	O
response	O
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
ccl2	O
gene	O
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	B-T080
level	B-T080
.	O
	
bmp2	O
,	O
runx2	O
,	O
col1a	O
,	O
and	O
opn	O
expression	O
were	O
also	O
up-regulated	O
.	O
	
ccl2	O
predominated	B-T080
in	O
osteoblastogenesis	O
of	O
the	O
hpd	O
-	O
treated	B-T169
bony	B-T169
defect	B-T169
in	O
the	O
early	B-T079
stage	I-T079
of	O
healing	O
.	O
	
hpd	O
accelerated	B-T169
bone	O
regeneration	O
and	O
augmentation	B-T033
.	O
	
these	O
results	O
suggested	B-T078
that	O
hpd	O
provided	O
potential	B-T080
as	O
a	O
bone	B-T061
graft	I-T061
resource	B-T078
during	B-T079
the	O
bone	O
healing	O
process	O
.	O
	
'you	O
can't	O
be	O
a	O
person	O
and	O
a	O
docto	O
r'	O
the	O
work-life	O
balance	O
of	O
doctors	O
in	O
training	O
-a	O
qualitative	O
study	O
investigate	B-T169
the	O
work-life	O
balance	O
of	O
doctors	O
in	O
training	O
in	O
the	O
uk	O
from	O
the	O
perspectives	O
of	O
trainers	O
and	O
trainees	O
.	O
	
qualitative	B-T080
semistructured	O
focus	O
groups	O
and	O
interviews	O
with	O
trainees	O
and	O
trainers	O
.	O
	
postgraduate	O
medical	O
training	O
in	O
london	O
,	O
yorkshire	O
and	O
humber	O
,	O
kent	O
,	O
surrey	O
and	O
sussex	O
,	O
and	O
wales	O
during	O
the	O
junior	O
doctor	O
contract	O
dispute	O
at	O
the	O
end	O
of	O
2015	O
.	O
	
part	O
of	O
a	O
larger	O
general	O
medical	O
council	O
study	O
about	O
the	O
fairness	O
of	O
postgraduate	O
medical	O
training	O
.	O
	
96	O
trainees	O
and	O
41	O
trainers	O
.	O
	
trainees	O
comprised	O
uk	O
graduates	O
and	O
international	O
medical	O
graduates	O
,	O
across	O
all	O
stages	O
of	O
training	O
in	O
6	O
specialties	O
general	O
practice	O
,	O
medicine	O
,	O
obstetrics	O
and	O
gynaecology	O
,	O
psychiatry	O
,	O
radiology	O
,	O
surgery	O
and	O
foundation	O
.	O
	
postgraduate	O
training	O
was	O
characterised	O
by	O
work-life	O
imbalance	O
.	O
	
long	B-T080
hours	B-T079
at	O
work	O
were	O
typically	O
supplemented	O
with	O
revision	B-T079
and	O
completion	B-T080
of	O
the	O
e-portfolio	B-T080
.	O
	
trainees	O
regularly	O
moved	O
workplaces	O
which	O
could	O
disrupt	B-T080
their	O
personal	O
lives	O
and	O
sometimes	O
led	O
to	O
separation	O
from	O
friends	O
and	O
family	O
.	O
	
this	O
made	O
it	O
challenging	O
to	O
cope	O
with	O
personal	O
pressures	O
,	O
the	O
stresses	O
of	O
which	O
could	O
then	O
impinge	O
on	O
learning	O
and	O
training	O
,	O
while	O
also	O
leaving	O
trainees	O
with	O
a	O
lack	B-T080
of	O
social	O
support	O
outside	O
work	O
to	O
buffer	O
against	O
the	O
considerable	O
stresses	O
of	O
training	O
.	O
	
low	B-T080
morale	B-T033
and	O
harm	B-T033
to	O
well-being	B-T033
resulted	O
in	O
some	O
trainees	O
feeling	O
dehumanised	O
.	O
	
work-life	O
imbalance	O
was	O
particularly	O
severe	B-T080
for	O
those	O
with	O
children	O
and	O
especially	O
women	O
who	O
faced	O
a	O
lack	B-T080
of	O
less-than	B-T081
-	O
full-time	O
positions	O
and	O
discriminatory	O
attitudes	O
.	O
	
female	O
trainees	O
frequently	O
talked	O
about	O
having	O
to	O
choose	O
a	O
specialty	O
they	O
felt	O
was	O
more	O
conducive	O
to	O
a	O
work-life	O
balance	O
such	O
as	O
general	O
practice	O
.	O
	
the	O
proposed	O
junior	O
doctor	O
contract	O
was	O
felt	O
to	O
exacerbate	B-T033
existing	B-T080
problems	B-T033
.	O
	
a	O
lack	B-T080
of	O
work-life	O
balance	O
in	O
postgraduate	O
medical	O
training	O
negatively	B-T080
impacted	B-T169
on	O
trainees	O
'	O
learning	O
and	O
well-being	B-T033
.	O
	
women	O
with	O
children	O
were	O
particularly	O
affected	B-T169
,	O
suggesting	O
this	O
group	B-T078
would	O
benefit	B-T081
the	O
greatest	B-T081
from	O
changes	B-T169
to	O
improve	B-T033
the	O
work-life	O
balance	O
reappraisal	O
modulates	O
attentional	O
bias	O
to	O
angry	O
faces	O
heightened	O
attentional	O
bias	O
to	O
emotional	O
information	O
is	O
one	O
of	O
the	O
main	O
characteristics	O
of	O
disorders	O
related	O
to	O
emotion	O
dysregulation	O
such	O
as	O
anxiety	O
,	O
depression	O
,	O
and	O
substance	O
abuse	O
.	O
	
although	O
reappraisal	O
,	O
an	O
emotion	O
regulation	O
strategy	O
,	O
is	O
known	O
to	O
effectively	O
modulate	O
subjective	O
experience	O
of	O
emotions	O
,	O
it	O
remains	O
unknown	O
whether	O
reappraisal	O
can	O
alter	O
attentional	O
biases	O
to	O
emotional	O
information	O
.	O
	
in	O
the	O
current	O
research	O
,	O
we	O
investigated	O
the	O
influence	O
of	O
instruction-induced	O
state	O
reappraisal	O
study	O
1	O
and	O
trait	O
reappraisal	O
study	O
2	O
on	O
attentional	O
biases	O
to	O
happy	O
and	O
angry	O
faces	O
.	O
	
in	O
study	O
1	O
,	O
healthy	O
young	O
women	O
were	O
recruited	O
and	O
randomly	O
assigned	O
to	O
one	O
of	O
the	O
three	O
groups	O
up	O
-	O
,	O
down	O
-	O
,	O
and	O
no-regulation	O
.	O
	
participants	O
were	O
instructed	O
to	O
reappraise	O
their	O
emotions	O
to	O
increase	O
and	O
decrease	O
emotional	O
experience	O
while	O
viewing	O
an	O
emotionally	O
negative	O
film	O
clip	O
.	O
	
attentional	O
bias	O
was	O
assessed	O
with	O
a	O
dot-probe	O
task	O
with	O
pictures	O
of	O
angry	O
and	O
happy	O
facial	O
expressions	O
.	O
	
in	O
study	O
2	O
,	O
a	O
separate	O
group	O
of	O
healthy	O
young	O
men	O
and	O
women	O
participated	O
.	O
	
participants	O
'	O
trait	O
reappraisal	O
and	O
suppression	O
as	O
well	O
as	O
state	O
and	O
trait	O
anxiety	O
were	O
assessed	O
.	O
	
a	O
dot-probe	O
task	O
was	O
completed	O
by	O
all	O
participants	O
.	O
	
statistical	O
tests	O
in	O
study	O
1	O
revealed	O
that	O
participants	O
who	O
reappraised	O
to	O
decrease	O
negative	O
emotions	O
while	O
viewing	O
an	O
emotionally	O
negative	O
film	O
clip	O
had	O
reduced	O
attentional	O
bias	O
to	O
subsequently	O
presented	O
angry	O
faces	O
compared	O
to	O
participants	O
who	O
reappraised	O
to	O
increase	O
negative	O
emotions	O
.	O
	
multiple	O
regression	O
analyses	O
in	O
study	O
2	O
revealed	O
that	O
trait	O
reappraisal	O
predicted	O
slower	O
orienting	O
toward	O
angry	O
faces	O
,	O
whereas	O
state	O
anxiety	O
predicted	O
slower	O
disengagement	O
from	O
angry	O
faces	O
.	O
	
interestingly	O
,	O
trait	O
suppression	O
predicted	O
slower	O
disengagement	O
from	O
happy	O
faces	O
.	O
	
taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
both	O
instruction-induced	O
state	O
reappraisal	O
and	O
trait	O
reappraisal	O
are	O
linked	O
to	O
reduced	O
attentional	O
bias	O
to	O
negative	O
information	O
and	O
contribute	O
to	O
better	O
understanding	O
of	O
how	O
everyday	O
emotion	O
regulation	O
styles	O
contribute	O
to	O
attentional	O
processing	O
of	O
emotional	O
information	B-T078
graded	O
structure	O
in	O
sexual	O
definitions	O
categorizations	O
of	O
having	O
""""	O
had	B-T033
sex	I-T033
""""	O
and	O
virginity	O
loss	B-T169
among	O
homosexual	O
and	O
heterosexual	O
men	O
and	O
women	O
definitions	O
of	O
sexual	O
behavior	O
display	O
a	O
robust	O
hierarchy	B-T080
of	O
agreement	O
regarding	O
whether	O
or	O
not	O
acts	O
should	O
be	O
classed	O
as	O
,	O
for	O
example	O
,	O
sex	O
or	O
virginity	O
loss	B-T169
.	O
	
the	O
current	O
research	O
offers	O
a	O
theoretical	B-T078
explanation	O
for	O
this	O
hierarchy	B-T080
,	O
proposing	O
that	O
sexual	O
definitions	O
display	O
graded	O
categorical	O
structure	O
,	O
arising	O
from	O
goodness	O
of	O
membership	O
judgments	O
.	O
	
moderation	B-T080
of	O
this	O
graded	O
structure	O
is	O
also	O
predicted	O
,	O
with	O
the	O
focus	O
here	O
on	O
how	O
sexual	O
orientation	O
identity	O
affects	O
sexual	O
definitions	O
.	O
	
a	O
total	O
of	O
300	O
18-	O
to	O
30-	O
year	B-T079
-old	O
participants	O
completed	O
an	O
online	O
survey	O
,	O
rating	O
18	O
behaviors	O
for	O
how	O
far	O
each	O
constitutes	O
having	O
""""	O
had	B-T033
sex	I-T033
""""	O
and	O
virginity	O
loss	B-T169
.	O
	
participants	O
fell	O
into	O
one	O
of	O
four	O
groups	O
heterosexual	O
male	O
or	O
female	O
,	O
gay	O
male	O
or	O
lesbian	O
.	O
	
the	O
predicted	O
ratings	O
hierarchy	B-T080
emerged	O
,	O
in	O
which	O
bidirectional	O
genital	O
acts	O
were	O
rated	O
significantly	O
higher	B-T080
than	O
unidirectional	O
or	O
nonpenetrative	B-T033
contact	I-T033
,	O
which	O
was	O
in	O
turn	O
rated	O
significantly	O
higher	B-T080
than	O
acts	O
involving	O
no	B-T033
genital	I-T033
contact	I-T033
.	O
	
moderation	B-T080
of	O
graded	O
structure	O
was	O
also	O
in	O
line	O
with	O
predictions	B-T078
.	O
	
compared	O
to	O
the	O
other	O
groups	O
,	O
the	O
lesbian	O
group	O
significantly	O
upgraded	O
ratings	O
of	O
genital	O
contact	O
that	O
was	O
either	O
unidirectional	O
or	O
nonpenetrative	B-T033
.	O
	
there	O
was	O
also	O
evidence	B-T078
of	O
upgrading	O
by	O
the	O
gay	O
male	O
sample	O
of	O
anal	O
intercourse	O
ratings	O
.	O
	
these	O
effects	B-T080
are	O
theorized	O
to	O
reflect	O
group	O
-level	O
variation	B-T080
in	O
experience	O
,	O
contextual	O
perspective	O
,	O
and	O
identity	O
-management	O
.	O
	
the	O
implications	B-T078
of	O
the	O
findings	B-T033
in	O
relation	O
to	O
previous	O
research	O
are	O
discussed	O
.	O
	
it	O
is	O
suggested	O
that	O
a	O
graded	O
structure	O
approach	O
can	O
greatly	O
benefit	B-T081
future	O
research	O
into	O
sexual	O
definitions	O
,	O
by	O
permitting	O
variable	O
definitions	O
effects	O
of	O
soybean	B-T109
isoflavone	I-T109
on	O
intestinal	O
antioxidant	O
capacity	O
and	O
cytokines	B-T116
in	O
young	O
piglets	O
fed	O
oxidized	O
fish	B-T109
oil	I-T109
to	O
investigate	O
the	O
effect	O
of	O
glycitein	B-T109
,	O
a	O
synthetic	O
soybean	B-T109
isoflavone	I-T109
isf	B-T109
,	O
on	O
the	O
intestinal	O
antioxidant	O
capacity	O
,	O
morphology	B-T080
,	O
and	O
cytokine	B-T116
content	O
in	O
young	O
piglets	O
fed	O
oxidized	O
fish	B-T109
oil	I-T109
,	O
72	O
4-d-old	O
male	O
piglets	O
were	O
assigned	O
to	O
three	O
treatments	B-T061
.	O
	
the	O
control	O
group	O
was	O
fed	O
a	O
basal	O
diet	O
containing	O
fresh	B-T080
fish	B-T109
oil	I-T109
,	O
and	O
the	O
other	O
two	O
groups	O
received	O
the	O
same	O
diet	O
except	O
for	O
the	O
substitution	O
with	O
the	O
same	O
dosage	B-T081
of	O
oxidized	O
fish	B-T109
oil	I-T109
alone	O
or	O
with	O
isf	B-T109
oxidized	O
fish	B-T109
oil	I-T109
plus	O
isf	B-T109
.	O
	
after	O
21	O
d	O
of	O
feeding	O
,	O
supplementation	B-T061
of	O
oxidized	O
fish	B-T109
oil	I-T109
increased	O
the	O
levels	O
of	O
malondialdehyde	B-T109
mda	B-T109
,	O
oxidized	B-T116
glutathione	I-T116
gssg	B-T116
,	O
interleukin-1β	B-T116
il-1β	B-T116
,	O
tumor	B-T116
necrosis	I-T116
factor-α	I-T116
tnf-α	B-T116
,	O
interleukin-2	B-T116
il-2	B-T116
,	O
nuclear	B-T116
factor	I-T116
κ	I-T116
b	I-T116
nf-κb	B-T116
,	O
inducible	B-T116
nitric	I-T116
oxide	I-T116
synthase	I-T116
inos	B-T116
,	O
no	O
,	O
and	O
caspase-3	B-T116
in	O
jejunal	O
mucosa	O
,	O
and	O
decreased	O
the	O
villous	O
height	O
in	O
duodenum	O
and	O
the	O
levels	O
of	O
secretory	B-T116
immunoglobulin	I-T116
a	I-T116
siga	B-T116
and	O
il-4	B-T116
in	O
the	O
jejunal	O
mucosa	O
compared	O
with	O
supplementation	B-T061
with	O
fresh	B-T080
oil	B-T109
.	O
	
the	O
addition	O
of	O
oxidized	O
fish	B-T109
oil	I-T109
plus	O
isf	B-T109
partially	O
alleviated	O
this	O
negative	O
effect	O
.	O
	
the	O
addition	O
of	O
oxidized	O
fish	B-T109
oil	I-T109
plus	O
isf	B-T109
increased	O
the	O
villous	O
height	O
and	O
levels	O
of	O
siga	B-T116
and	O
il-4	B-T116
in	O
jejunal	O
mucosa	O
,	O
but	O
decreased	O
the	O
levels	O
of	O
il-1β	B-T116
and	O
il-2	B-T116
in	O
jejunal	O
mucosa	O
p<0	O
compared	O
with	O
oxidized	O
fish	B-T109
oil	I-T109
.	O
	
collectively	O
,	O
these	O
results	O
show	O
that	O
dietary	B-T061
supplementation	I-T061
of	O
isf	B-T109
could	O
partly	O
alleviate	O
the	O
negative	O
effect	O
of	O
oxidized	O
fish	B-T109
oil	I-T109
by	O
improving	O
the	O
intestinal	O
morphology	O
as	O
well	O
as	O
the	O
antioxidant	O
capacity	O
and	O
immune	O
function	O
in	O
young	O
piglets	O
.	O
	
evolution	O
enhanced	O
footing	B-T169
for	O
snake	O
limb	O
development	O
two	O
groups	O
have	O
studied	O
the	O
loss	B-T081
of	O
limbs	O
in	O
snake	O
evolution	O
by	O
focusing	O
on	O
a	O
long-distance	B-T033
cis-acting	O
enhancer	O
of	O
sonic	O
hedgehog	O
.	O
	
they	O
find	O
a	O
progressive	B-T169
degeneration	B-T169
of	O
binding	O
sites	O
for	O
key	O
transcription	B-T116
factors	I-T116
,	O
mirroring	O
the	O
progressive	B-T169
limblessness	B-T080
occurring	O
in	O
these	O
dynamin-related	B-T116
protein	I-T116
1	I-T116
mediates	B-T169
low	B-T109
glucose	I-T109
-	O
induced	B-T169
endothelial	B-T047
dysfunction	I-T047
in	O
human	O
arterioles	O
intensive	O
glycemic	O
regulation	O
has	O
resulted	O
in	O
an	O
increased	B-T081
incidence	B-T081
of	O
hypoglycemia	B-T047
.	O
	
hypoglycemic	B-T047
burden	B-T078
correlates	O
with	O
adverse	B-T169
cardiovascular	O
complications	O
and	O
contributes	O
acutely	B-T079
and	O
chronically	B-T079
to	O
endothelial	B-T047
dysfunction	I-T047
.	O
	
prior	O
data	B-T078
indicate	O
that	O
mitochondrial	B-T033
dysfunction	I-T033
contributes	O
to	O
hypoglycemia	B-T047
-	O
induced	B-T169
endothelial	B-T047
dysfunction	I-T047
,	O
but	O
the	O
mechanisms	B-T169
behind	O
this	O
linkage	B-T169
remain	O
unknown	B-T080
.	O
	
we	O
attempt	O
to	O
determine	O
whether	O
clinically	B-T080
relevant	B-T080
low-glucose	B-T109
lg	B-T109
exposures	B-T080
acutely	B-T079
induce	B-T169
endothelial	B-T047
dysfunction	I-T047
through	O
activation	O
of	O
the	O
mitochondrial	O
fission	O
process	O
.	O
	
characterization	O
of	O
mitochondrial	B-T033
morphology	I-T033
was	O
carried	O
out	O
in	O
cultured	B-T169
endothelial	O
cells	O
by	O
using	O
confocal	O
microscopy	O
.	O
	
isolated	B-T169
human	O
arterioles	O
were	O
used	O
to	O
explore	O
the	O
effect	B-T080
lg	B-T109
-	O
induced	B-T169
mitochondrial	O
fission	O
has	O
on	O
the	O
formation	B-T169
of	O
detrimental	O
reactive	O
oxygen	O
species	O
ros	O
,	O
bioavailability	B-T081
of	O
nitric	O
oxide	O
no	O
,	O
and	O
endothelial-dependent	O
vascular	O
relaxation	O
.	O
	
fluorescence	O
microscopy	O
was	O
employed	O
to	O
visualize	O
changes	B-T169
in	O
mitochondrial	O
ros	O
and	O
no	O
levels	B-T080
and	O
videomicroscopy	O
applied	O
to	O
measure	B-T081
vasodilation	O
response	B-T169
.	O
	
pharmacological	B-T169
disruption	B-T169
of	O
the	O
profission	B-T116
protein	I-T116
drp1	B-T116
with	O
mdivi-1	B-T109
during	O
lg	B-T109
exposure	B-T080
reduced	B-T080
mitochondrial	O
fragmentation	O
among	O
vascular	O
endothelial	O
cells	O
lg	B-T109
0.469	O
lg	B-T109
+	O
mdivi-1	B-T109
0.276	O
p	O
=	O
0.003	O
,	O
prevented	B-T169
formation	B-T169
of	O
vascular	O
ros	O
lg	B-T109
2.036	O
lg	B-T109
+	O
mdivi-1	B-T109
1.774	O
p	O
=	O
0.005	O
,	O
increased	B-T081
the	O
presence	B-T033
of	O
no	O
lg	B-T109
1.352	O
lg	B-T109
+	O
mdivi-1	B-T109
1.502	O
p	O
=	O
0.048	O
,	O
and	O
improved	B-T033
vascular	O
dilation	O
response	B-T169
to	O
acetylcholine	B-T109
lg	B-T109
31.6	O
lg	B-T109
+	O
mdivi-1	B-T109
78.5	O
at	O
maximum	B-T081
dose	B-T081
p	O
<	O
0.001	O
.	O
	
additionally	O
,	O
decreased	B-T081
expression	O
of	O
drp1	B-T116
via	O
sirna	O
knockdown	O
during	O
lg	B-T109
conditions	B-T080
also	O
improved	B-T033
vascular	O
relaxation	O
.	O
	
exposure	B-T080
to	I-T080
lg	B-T109
imparts	O
endothelial	B-T047
dysfunction	I-T047
coupled	B-T169
with	O
altered	B-T169
mitochondrial	O
phenotypes	O
among	O
isolated	B-T169
human	O
arterioles	O
.	O
	
disruption	B-T169
of	O
drp1	B-T116
and	O
subsequent	B-T079
mitochondrial	O
fragmentation	O
events	O
prevents	B-T169
impaired	B-T169
vascular	O
dilation	O
,	O
restores	B-T169
mitochondrial	O
phenotype	O
,	O
and	O
implicates	O
mitochondrial	O
fission	O
as	O
a	O
primary	B-T080
mediator	B-T080
of	O
lg	B-T109
-	O
induced	B-T169
endothelial	B-T047
dysfunction	I-T047
new	O
noteworthy	O
acute	B-T079
low-glucose	B-T109
exposure	B-T080
induces	B-T169
mitochondrial	O
fragmentation	O
in	O
endothelial	O
cells	O
via	O
drp1	B-T116
and	O
is	O
associated	B-T080
with	I-T080
impaired	B-T169
endothelial	O
function	O
in	O
human	O
arterioles	O
.	O
	
targeting	O
of	O
drp1	B-T116
prevents	B-T169
fragmentation	O
,	O
improves	O
vasofunction	O
,	O
and	O
may	O
provide	O
a	O
therapeutic	B-T169
target	B-T169
for	O
improving	O
cardiovascular	O
complications	O
among	O
diabetics	B-T033
listen	O
to	O
this	O
article's	O
corresponding	O
podcast	O
a	O
16	O
yin	O
yang	O
gene	O
expression	O
ratio	B-T081
signature	B-T169
for	O
er+	O
/	O
node-	O
breast	O
cancer	O
breast	O
cancer	O
is	O
one	O
of	O
the	O
leading	O
causes	B-T169
of	O
cancer	O
death	O
in	O
women	O
.	O
	
it	O
is	O
a	O
complex	B-T080
and	O
heterogeneous	B-T080
disease	B-T047
with	O
different	O
clinical	B-T080
outcomes	B-T080
.	O
	
stratifying	B-T080
patients	O
into	O
subgroups	O
with	O
different	O
outcomes	B-T080
could	O
help	O
guide	O
clinical	O
decision	O
making	O
.	O
	
in	O
this	O
study	O
,	O
we	O
used	O
two	O
opposing	O
groups	B-T078
of	O
genes	O
,	O
yin	O
and	O
yang	O
,	O
to	O
develop	O
a	O
prognostic	O
expression	O
ratio	B-T081
signature	B-T169
.	O
	
using	O
the	O
metabric	O
cohort	O
we	O
identified	O
a16-	O
gene	B-T169
signature	I-T169
capable	O
of	O
stratifying	B-T080
breast	O
cancer	O
patients	O
into	O
four	O
risk	B-T080
levels	I-T080
with	O
intention	O
that	O
low-risk	B-T081
patients	O
would	O
not	O
undergo	O
adjuvant	B-T169
systemic	B-T061
therapy	I-T061
,	O
intermediate	O
-	O
low-risk	B-T081
patients	O
will	O
be	O
treated	B-T061
with	I-T061
hormonal	B-T061
therapy	I-T061
only	O
,	O
and	O
intermediate	O
-high-	O
and	O
high-risk	O
groups	O
will	O
be	O
treated	B-T061
by	O
chemotherapy	B-T061
in	O
addition	O
to	O
the	O
hormonal	B-T061
therapy	I-T061
.	O
	
the	O
16-	O
gene	B-T169
signature	I-T169
for	O
four	O
risk	B-T080
level	I-T080
stratifications	O
of	O
breast	O
cancer	O
patients	O
has	O
been	O
validated	O
using	O
14	O
independent	O
datasets	O
.	O
	
notably	O
,	O
the	O
low-risk	B-T081
group	O
n	O
=	O
51	O
of	O
205	O
estrogen	O
receptor-positive	O
and	O
node	O
negative	O
er+	O
/	O
node-	O
patients	O
from	O
three	O
different	O
datasets	O
who	O
had	O
not	O
had	O
any	O
systemic	O
adjuvant	B-T061
therapy	I-T061
had	O
100%	O
15-	O
year	B-T079
disease-specific	B-T081
survival	I-T081
rate	I-T081
.	O
	
the	O
concordance	O
index	O
of	O
ymr	O
for	O
er+	O
/	O
node	O
negative	O
patients	O
is	O
close	O
to	O
the	O
commercially	O
available	O
signatures	B-T169
.	O
	
however	O
,	O
ymr	O
showed	O
more	O
significance	B-T078
hr	B-T081
=	O
3.7	O
,	O
p	O
=	O
8.7e	O
in	O
stratifying	B-T080
er+	O
/	O
node-	O
subgroup	O
than	O
oncotypedx	O
hr	B-T081
=	O
2.7	O
,	O
p	O
=	O
1.3e	O
,	O
mammaprint	O
hr	B-T081
=	O
2.5	O
,	O
p	O
=	O
5.8e	O
,	O
rors	O
hr	B-T081
=	O
2.4	O
,	O
p	O
=	O
1.4e	O
,	O
and	O
npi	O
hr	B-T081
=	O
2.6	O
,	O
p	O
=	O
1.2e	O
.	O
	
ymr	O
signature	B-T169
may	O
be	O
developed	O
as	O
a	O
clinical	B-T080
tool	O
to	O
select	O
a	O
subgroup	O
of	O
low-risk	B-T081
er+	O
/	O
node-	O
patients	O
who	O
do	O
not	O
require	O
any	O
adjuvant	B-T169
hormonal	B-T061
therapy	I-T061
aht	B-T061
.	O
	
risk	B-T033
factors	I-T033
associated	B-T080
with	I-T080
repeated	B-T169
hiv	O
testing	O
among	O
internet	O
-using	O
men	O
who	O
have	O
sex	O
with	O
men	O
men	O
who	O
have	O
sex	O
with	O
men	O
msm	O
represent	O
a	O
disproportionately	B-T080
impacted	B-T169
risk	O
group	O
for	O
hiv	O
incidence	B-T081
among	O
at-risk	B-T080
u.s	O
.	O
	
few	O
studies	O
have	O
identified	B-T080
risk	B-T033
factors	I-T033
associated	B-T080
with	I-T080
hiv	O
testing	O
frequency	B-T081
both	O
within	O
and	O
outside	O
of	O
traditional	O
health	O
care	O
settings	O
.	O
	
msm	O
enrolled	O
in	O
a	O
prospective	O
cohort	O
were	O
mailed	O
at-home	O
specimen	O
collection	O
kits	O
and	O
followed	B-T079
for	O
a	O
year	B-T079
.	O
	
incidence	B-T081
density	I-T081
rate	I-T081
ratios	I-T081
idrr	B-T081
of	O
testing	B-T169
were	O
calculated	O
,	O
and	O
generalized	O
estimating	B-T081
equations	O
were	O
used	O
to	O
analyze	O
the	O
association	B-T080
between	O
hiv	O
testing	O
and	O
behavioral	O
factors	B-T169
.	O
	
the	O
incidence	B-T081
rate	I-T081
of	O
testing	B-T169
was	O
higher	B-T080
among	O
black	O
msm	O
than	O
white	O
msm	O
idrr	B-T081
1.3	O
,	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
1.1	O
,	O
1.5	O
and	O
higher	B-T080
among	O
msm	O
who	O
reported	O
3+	O
condomless	B-T033
anal	O
intercourse	O
partners	O
cai	O
than	O
msm	O
who	O
reported	O
no	O
cai	O
idrr	O
1.6	O
,	O
95%	O
ci	O
1.3	O
,	O
2.0	O
.	O
	
increasing	O
availability	O
of	O
hiv	O
testing	O
outside	O
traditional	O
health	O
care	O
settings	O
,	O
including	O
at-home	O
testing	O
kits	O
,	O
in	O
conjunction	O
with	O
targeted	O
behavioral	O
interventions	O
and	O
biomedical	O
treatment	O
preventions	O
is	O
nursingstandard.com	O
1	O
nurse	O
donna	O
wood	O
has	O
been	O
suspended	B-T169
for	O
2	O
months	B-T079
by	O
the	O
nursing	O
and	O
midwifery	O
council	O
nmc	O
for	O
concealing	B-T080
the	O
high	O
temperature	O
of	O
colleague	O
pauline	O
cafferkey	O
,	O
who	O
later	O
developed	O
ebola	B-T047
.	O
	
read	O
more	O
theory	B-T078
of	I-T078
mind	I-T078
in	O
adolescents	O
with	O
bipolar	O
disorder	O
in	O
euthymic	O
phase	O
using	O
the	O
strange	O
stories	O
test	O
objective	O
this	O
study	O
evaluated	O
the	O
theory	B-T078
of	I-T078
mind	I-T078
tom	B-T078
in	O
adolescents	O
diagnosed	B-T033
with	O
bipolar	O
disorder	O
bd	O
during	O
their	O
euthymic	O
period	O
compared	O
to	O
a	O
typically	B-T078
developing	I-T078
td	I-T078
group	I-T078
method	O
the	O
bd	O
group	B-T078
consisted	O
of	O
thirty	O
11-18	O
year	O
old	O
inpatients	O
in	O
euthymic	O
phase	O
.	O
	
the	O
td	B-T078
group	I-T078
included	O
30	O
age	O
,	O
gender	O
,	O
and	O
iq	O
matched	O
volunteer	O
students	O
.	O
	
to	O
assess	O
the	O
diagnosis	B-T033
and	O
comorbid	B-T047
disorders	I-T047
,	O
we	O
performed	O
the	O
semi-structured	O
interview	O
of	O
the	O
kiddie	O
schedule	O
for	O
affective	O
disorders	O
and	O
schizophrenia-present	O
and	O
lifetime	O
version	O
k-sads-pl	O
for	O
the	O
bd	O
adolescents	O
.	O
	
to	O
evaluate	O
the	O
severity	O
of	O
attention	O
deficit	O
hyperactivity	O
disorder	O
adhd	O
and	O
mania	O
,	O
conner's	B-T081
parent	I-T081
rating	I-T081
scale-revised	I-T081
version	I-T081
cprs-r	I-T081
,	O
and	O
young	O
mania	O
rating	O
scale	O
ymrs	O
were	O
used	O
,	O
respectively	O
.	O
	
ravens	O
progressive	O
matrices	O
was	O
conducted	O
to	O
evaluate	O
intellectual	B-T033
ability	I-T033
in	O
the	O
both	O
groups	B-T078
.	O
	
happe	O
strange	O
stories	O
test	O
was	O
performed	O
to	O
assess	O
tom	B-T078
in	O
the	O
participants	O
.	O
	
data	B-T078
were	O
analyzed	O
using	O
the	O
independent	O
t-test	O
,	O
analysis	B-T081
of	I-T081
covariance	I-T081
,	O
and	O
pearson	O
correlation	O
analysis	O
results	O
the	O
two	O
groups	B-T078
did	O
not	O
show	O
any	O
differences	O
in	O
comprehending	O
the	O
stories	O
however	O
,	O
the	O
bd	O
group's	B-T078
mentalizing	O
scores	O
were	O
significantly	O
weaker	O
than	O
the	O
td	B-T078
group	I-T078
p<0	O
conclusion	O
the	O
tom	B-T078
impairments	B-T169
in	O
adolescents	O
with	O
bd	O
may	O
be	O
explained	O
as	O
a	O
trait	O
marker	O
which	O
may	O
lead	O
to	O
continuation	O
of	O
social	B-T033
problems	I-T033
even	O
during	O
remission	O
structural	O
and	O
functional	O
characterization	O
of	O
the	O
tyw3	B-T116
/	O
taw3	B-T116
class	O
of	O
sam-dependent	B-T116
methyltransferases	I-T116
s-adenosylmethionine	B-T116
sam	I-T116
methyltransferases	I-T116
regulate	O
a	O
wide	O
range	O
of	O
biological	O
processes	O
through	O
the	O
modification	O
of	O
proteins	B-T116
,	O
nucleic	O
acids	O
,	O
polysaccharides	B-T109
,	O
as	O
well	O
as	O
various	O
metabolites	O
.	O
	
tyw3	B-T116
/	O
taw3	B-T116
is	O
a	O
sam-dependent	B-T116
methyltransferase	I-T116
responsible	O
for	O
the	O
formation	O
of	O
a	O
trna	O
modification	O
known	O
as	O
wybutosine	O
and	O
its	O
derivatives	O
that	O
are	O
required	O
for	O
accurate	O
decoding	O
in	O
protein	O
synthesis	O
.	O
	
here	O
,	O
we	O
report	O
the	O
crystal	O
structure	O
of	O
taw3	B-T116
,	O
a	O
homolog	O
of	O
tyw3	B-T116
from	O
sulfolobus	O
solfataricus	O
,	O
which	O
revealed	O
a	O
novel	O
α/β	O
fold	O
.	O
	
the	O
sequence	O
motif	O
s/t	O
and	O
invariant	O
aspartate	B-T116
and	O
histidine	B-T116
,	O
conserved	O
in	O
tyw3	B-T116
/	O
taw3	B-T116
,	O
cluster	B-T081
to	O
form	O
the	O
catalytic	O
center	O
.	O
	
these	O
structural	B-T116
and	O
sequence	O
features	O
indicate	O
that	O
tyw3	B-T116
/	O
taw3	B-T116
proteins	O
constitute	O
a	O
distinct	O
class	O
of	O
sam-dependent	B-T116
methyltransferases	I-T116
.	O
	
using	O
site-directed	O
mutagenesis	O
along	O
with	O
in	O
vivo	O
complementation	O
assays	O
combined	O
with	O
mass	O
spectrometry	O
as	O
well	O
as	O
ligand	O
docking	O
and	O
cofactor	O
binding	O
assays	O
,	O
we	O
have	O
identified	O
the	O
active	B-T169
site	I-T169
of	O
tyw3	B-T116
and	O
residues	O
essential	O
for	O
cofactor	O
binding	O
and	O
methyltransferase	O
activity	O
.	O
	
developmental	B-T080
profile	O
and	O
diagnoses	O
in	O
children	O
presenting	O
with	O
motor	B-T033
stereotypies	I-T033
motor	B-T033
stereotypies	I-T033
represent	O
a	O
typical	O
example	O
of	O
the	O
difficulty	B-T080
in	O
distinguishing	O
non-clinical	O
behaviors	O
physiological	O
and	O
transient	B-T079
from	O
symptoms	O
or	O
among	O
different	O
disorders	B-T047
""""	O
primary	O
stereotypies	O
""""	O
associated	B-T080
with	I-T080
autistic	O
spectrum	O
disorder	O
asd	O
,	O
intellectual	O
disabilities	O
,	O
genetic	B-T047
syndromes	I-T047
,	O
and	O
sensory	B-T033
impairment	I-T033
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
obtain	B-T169
an	O
accurate	O
assessment	O
on	O
the	O
relationship	B-T080
between	O
stereotypies	O
and	O
neurodevelopmental	O
disorders	O
.	O
	
we	O
studied	O
23	O
children	O
3	O
girls	O
,	O
aged	O
36-95	O
months	B-T079
,	O
who	O
requested	O
a	O
consultation	O
due	O
to	O
the	O
persistence	B-T033
or	O
increased	B-T081
severity	B-T080
of	O
motor	B-T033
stereotypies	I-T033
.	O
	
none	O
of	O
the	O
patients	O
had	O
a	O
previous	O
diagnosis	O
of	O
asd	O
.	O
	
the	O
assessment	O
included	O
the	O
motor	O
severity	O
stereotypy	O
scale	O
msss	O
,	O
the	O
repetitive	O
behavior	O
scale-revised	O
rbs-r	O
,	O
the	O
raven's	B-T033
colored	I-T033
progressive	I-T033
matrices	I-T033
,	O
the	O
child	O
behavior	O
checklist	O
for	O
ages	O
1½-5	O
or	O
4-18	O
cbcl	O
,	O
the	O
social	O
responsiveness	O
scale	O
srs	O
,	O
and	O
the	O
autism	O
diagnostic	O
observation	O
schedule-second	O
edition	O
ados	O
2	O
.	O
	
all	O
patients	O
were	O
showing	O
motor	B-T033
stereotypies	I-T033
for	O
periods	B-T079
of	I-T079
time	I-T079
varying	O
from	O
6	O
to	O
77	O
months	B-T079
.	O
	
the	O
msss	O
showed	O
that	O
each	O
child	O
had	O
a	O
limited	B-T169
number	B-T081
of	O
stereotypies	O
their	O
frequency	B-T081
and	O
intensity	B-T080
were	O
mild	B-T080
.	O
	
the	O
interference	B-T169
of	O
stereotypies	O
was	O
variable	B-T080
the	O
impairment	B-T169
in	O
daily	O
life	B-T078
was	O
mild	B-T080
.	O
	
the	O
rbs-r	O
scores	B-T081
were	O
positive	O
for	O
the	O
subscale	O
of	O
""""	O
stereotypic	O
behaviors	O
""""	O
in	O
all	O
children	O
.	O
	
moreover	O
,	O
several	O
children	O
presented	O
other	O
repetitive	B-T033
behaviors	I-T033
,	O
mainly	O
""""	O
ritualistic	O
behavior	O
""""	O
and	O
""""	O
sameness	B-T033
behavior	I-T033
""""	O
all	O
patients	O
showed	O
a	O
normal	B-T033
cognitive	I-T033
level	I-T033
.	O
	
the	O
cbcl	O
evidenced	B-T078
behavioral	O
problems	O
in	O
22%	O
of	O
the	O
children	O
internalizing	O
problems	O
,	O
attention	O
,	O
and	O
withdrawn	O
were	O
the	O
main	O
complaints	O
.	O
	
on	O
the	O
srs	O
,	O
all	O
but	O
one	O
of	O
the	O
tested	B-T169
patients	O
obtained	B-T169
clinical	B-T033
scores	I-T033
in	O
the	O
clinical	B-T080
range	B-T081
for	O
at	O
least	O
one	O
area	O
.	O
	
on	O
the	O
ados	O
2	O
,	O
4	O
patients	O
obtained	B-T169
scores	B-T081
indicating	O
a	O
moderate	B-T080
level	B-T080
of	O
asd	O
symptoms	O
,	O
4	O
had	O
a	O
mild	B-T080
level	B-T080
,	O
and	O
15	O
showed	O
no	O
or	O
minimal	O
signs	O
of	O
asd	O
.	O
	
motor	B-T033
stereotypies	I-T033
in	O
children	O
with	O
normal	B-T033
cognitive	I-T033
level	I-T033
represent	O
a	O
challenging	O
diagnostic	B-T169
issue	B-T033
for	O
which	O
a	O
finely	O
tailored	O
assessment	O
is	O
mandatory	O
in	O
order	O
to	O
define	O
a	O
precise	O
developmental	B-T080
profile	B-T169
.	O
	
thus	O
,	O
careful	O
and	O
cautious	O
use	O
of	O
standardized	O
tests	O
is	O
warranted	O
to	O
avoid	O
misdiagnosis	B-T033
.	O
	
furthermore	O
,	O
it	O
is	O
hard	O
to	O
consider	O
motor	B-T033
stereotypies	I-T033
,	O
even	O
the	O
primary	O
ones	O
,	O
exclusively	O
as	O
a	O
movement	B-T047
disorder	I-T047
.	O
	
left	O
ventricular	O
rotational	O
mechanics	O
in	O
infants	O
with	O
hypoxic	B-T047
ischemic	I-T047
encephalopathy	I-T047
and	O
preterm	O
infants	O
at	O
36	O
weeks	B-T079
postmenstrual	O
age	O
a	O
comparison	O
with	O
healthy	B-T080
term	O
controls	O
there	O
is	O
a	O
paucity	O
of	O
data	B-T078
on	O
left	O
ventricle	O
lv	O
rotational	O
physiology	O
in	O
neonates	O
.	O
	
we	O
aimed	O
to	O
assess	O
rotational	O
mechanics	O
in	O
infants	O
with	O
hypoxic	B-T047
ischemic	I-T047
encephalopathy	I-T047
hie	B-T047
and	O
premature	O
infants	O
<32	O
weeks	B-T079
at	O
36	O
weeks	B-T079
postmenstrual	O
age	O
pma	O
preterm	O
group	O
and	O
compare	O
them	O
with	O
healthy	B-T080
term	O
controls	O
term	O
controls	O
.	O
	
we	O
also	O
compared	O
the	O
parameters	O
in	O
preterm	O
infants	O
with	O
and	O
without	O
chronic	B-T047
lung	I-T047
disease	I-T047
cld	B-T047
.	O
	
echocardiography	O
was	O
performed	O
within	O
48	O
hours	B-T079
of	O
birth	O
or	O
at	O
36	O
weeks	B-T079
pma	O
.	O
	
lv	O
basal	O
and	O
apical	O
rotation	B-T169
,	O
twist	O
and	O
torsion	O
=	O
twist	O
/	O
lv	B-T081
length	I-T081
,	O
twist	B-T081
rate	I-T081
lvtr	B-T081
,	O
and	O
untwist	B-T081
rate	I-T081
lvutr	B-T081
were	O
measured	O
.	O
	
one-way	B-T081
anova	I-T081
was	O
used	O
to	O
compare	O
values	B-T080
.	O
	
there	O
was	O
no	O
difference	O
in	O
gestation	O
40.0	O
39.1	O
vs	O
39.9	O
39.0	O
,	O
p>	O
or	O
birthweight	O
3.7	O
3.4	O
vs	O
3.5	O
3.2	O
,	O
p>	O
between	O
the	O
hie	B-T047
group	O
n=16	O
and	O
term	O
controls	O
n=30	O
.	O
	
the	O
preterm	O
group	O
n=35	O
had	O
a	O
gestation	O
and	O
weight	B-T081
of	O
36.0	O
34.6	O
weeks	B-T079
and	O
2.3	O
2.0	O
kg	O
.	O
	
the	O
hie	B-T047
group	O
had	O
lower	O
twist	O
,	O
torsion	O
,	O
lvtr	B-T081
,	O
and	O
lvutr	B-T081
than	O
the	O
other	O
two	O
groups	O
.	O
	
the	O
preterm	O
group	O
had	O
a	O
more	O
negative	O
clockwise	B-T169
basal	O
rotation	B-T169
while	O
the	O
term	O
group	O
had	O
a	O
more	O
positive	O
counterclockwise	B-T169
apical	O
rotation	B-T169
.	O
	
preterm	O
infants	O
with	O
cld	B-T047
had	O
higher	O
apical	O
rotation	B-T169
,	O
twist	O
,	O
and	O
torsion	O
when	O
compared	O
to	O
infants	O
without	O
cld	B-T047
.	O
	
infants	O
with	O
hie	B-T047
have	O
reduced	O
rotational	O
mechanics	O
.	O
	
preterm	O
infants	O
at	O
36	O
weeks	B-T079
pma	O
have	O
comparable	O
measurements	B-T169
of	O
twist	O
to	O
term	O
infants	O
.	O
	
this	O
is	O
achieved	O
by	O
predominant	O
basal	O
rather	O
than	O
apical	O
rotation	O
.	O
	
infants	O
with	O
cld	O
have	O
increased	O
apical	O
rotation	B-T169
comparing	O
the	O
effects	B-T080
of	I-T080
different	B-T080
dynamic	B-T061
sitting	I-T061
strategies	I-T061
in	O
wheelchair	O
seating	O
on	O
lumbar-pelvic	O
angle	O
prolonged	B-T079
static	B-T033
sitting	I-T033
in	O
a	O
wheelchair	O
is	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
of	O
lower	O
back	O
pain	O
.	O
	
the	O
wheelchair	O
seating	O
system	O
is	O
a	O
key	B-T169
factor	I-T169
of	O
this	O
risk	B-T078
because	O
it	O
affects	O
spinal	O
loading	B-T169
in	O
the	O
sitting	B-T033
position	I-T033
.	O
	
in	O
this	O
study	O
,	O
7	O
dynamic	B-T061
sitting	I-T061
strategies	I-T061
dsss	B-T061
are	O
examined	B-T033
lumbar	B-T061
prominent	I-T061
dynamic	I-T061
sitting	I-T061
lpds	B-T061
,	O
back	B-T061
reclined	I-T061
dynamic	I-T061
sitting	I-T061
brds	B-T061
,	O
femur	B-T061
upward	I-T061
dynamic	I-T061
sitting	I-T061
fuds	B-T061
,	O
lumbar	B-T061
prominent	I-T061
with	I-T061
back	I-T061
reclined	I-T061
dynamic	I-T061
sitting	I-T061
lbds	B-T061
,	O
lumbar	B-T061
prominent	I-T061
with	I-T061
femur	I-T061
upward	I-T061
dynamic	I-T061
sitting	I-T061
lfds	B-T061
,	O
back	B-T061
reclined	I-T061
with	I-T061
femur	I-T061
upward	I-T061
dynamic	I-T061
sitting	I-T061
bfds	B-T061
,	O
and	O
lumbar	B-T061
prominent	I-T061
with	I-T061
back	I-T061
reclined	I-T061
with	I-T061
femur	I-T061
upward	I-T061
dynamic	I-T061
sitting	I-T061
lbfds	B-T061
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
biomechanical	O
effects	B-T080
of	I-T080
these	O
sitting	B-T061
strategies	I-T061
on	O
lumbar-pelvic	O
angles	O
.	O
	
twenty	O
able-bodied	B-T033
participants	O
were	O
recruited	B-T169
for	O
the	O
study	O
.	O
	
all	O
participants	O
performed	B-T169
lpds	B-T061
,	O
brds	B-T061
,	O
fuds	B-T061
,	O
lbds	B-T061
,	O
lfds	B-T061
,	O
bfds	B-T061
,	O
and	O
lbfds	B-T061
in	O
a	O
random	B-T080
order	B-T080
.	O
	
all	O
lumbar-pelvic	O
angle	O
parameters	O
,	O
including	O
the	O
static	B-T080
lumbar	O
angle	O
,	O
static	B-T080
pelvic	O
angle	O
,	O
lumbar	B-T033
range	I-T033
of	I-T033
motion	I-T033
,	O
and	O
pelvic	B-T033
range	I-T033
of	I-T033
motion	I-T033
were	O
measured	B-T080
and	O
compared	O
.	O
	
results	B-T169
show	O
that	O
lbds	B-T061
and	O
lbfds	B-T061
enabled	O
the	O
most	O
beneficial	B-T080
lumbar	O
movements	O
,	O
although	O
the	O
difference	B-T080
between	O
the	O
2	O
strategies	O
was	O
nonsignificant	B-T033
.	O
	
brds	B-T061
and	O
bfds	B-T061
enabled	O
the	O
most	O
beneficial	B-T080
pelvic	B-T061
movements	I-T061
,	O
although	O
the	O
difference	B-T080
between	O
the	O
2	O
strategies	O
was	O
nonsignificant	B-T033
.	O
	
among	O
all	O
the	O
upright	O
dsss	B-T061
,	O
lpds	B-T061
and	O
lfds	B-T061
enabled	O
the	O
most	O
beneficial	B-T080
lumbar	O
and	O
pelvic	B-T061
movements	I-T061
,	O
although	O
no	B-T033
significant	I-T033
difference	B-T080
was	O
observed	B-T169
between	O
these	O
2	O
strategies	O
.	O
	
we	O
identified	B-T080
the	O
effects	B-T080
and	O
differences	B-T080
among	O
7	O
dsss	B-T061
on	O
lumbar-pelvic	O
angles	O
.	O
	
wheelchair	O
users	O
can	O
choose	O
the	O
most	O
suitable	B-T080
dss	B-T061
that	O
meets	O
their	O
needs	B-T080
.	O
	
these	O
findings	B-T033
may	O
serve	O
as	O
a	O
reference	O
for	O
practicing	O
physicians	O
or	O
wheelchair	O
users	O
to	O
choose	O
an	O
appropriate	B-T080
dynamic	O
wheelchair	O
seating	O
source	O
apportionment	O
and	O
heavy	O
metal	O
health	B-T061
risk	I-T061
hmhr	B-T061
quantification	B-T081
from	O
sources	B-T033
in	O
a	O
southern	O
city	O
in	O
china	O
,	O
using	O
an	O
me2	O
-	O
hmhr	B-T061
model	O
heavy	O
metals	O
cr	O
,	O
co	O
,	O
ni	O
,	O
as	O
,	O
cd	O
,	O
and	O
pb	O
can	O
be	O
bound	O
to	O
pm	O
adversely	O
affecting	O
human	O
health	B-T078
.	O
	
quantifying	O
the	O
source	B-T033
impacts	O
on	O
heavy	O
metals	O
can	O
provide	O
source	B-T033
-	O
specific	B-T080
estimates	O
of	O
the	O
heavy	O
metal	O
health	B-T061
risk	I-T061
hmhr	B-T061
to	O
guide	O
effective	B-T080
development	O
of	O
strategies	O
to	O
reduce	O
such	O
risks	B-T078
from	O
exposure	B-T080
to	I-T080
heavy	O
metals	O
in	O
pm2.5	O
particulate	O
matter	O
pm	O
with	O
aerodynamic	B-T081
diameter	I-T081
less	O
than	O
or	O
equal	O
to	O
2.5	O
μm	O
.	O
	
in	O
this	O
study	O
,	O
a	O
method	O
combining	O
multilinear	O
engine	O
2	O
me2	O
and	O
a	O
risk	O
assessment	O
model	O
is	O
developed	O
to	O
more	O
effectively	O
quantify	B-T081
source	B-T033
contributions	O
to	O
hmhr	B-T061
,	O
including	O
heavy	O
metal	O
non-cancer	B-T033
risk	I-T033
non-hmcr	B-T033
and	O
cancer	B-T081
risk	I-T081
hmcr	B-T081
.	O
	
the	O
combined	O
model	O
called	O
me2-hmhr	O
has	O
two	O
steps	O
step1	O
,	O
source	B-T033
contributions	O
to	O
heavy	O
metals	O
are	O
estimated	O
by	O
employing	O
the	O
me2	O
model	O
step2	O
,	O
the	O
source	B-T033
contributions	O
in	O
step	O
1	O
are	O
introduced	O
into	O
the	O
risk	O
assessment	O
model	O
to	O
calculate	O
the	O
source	B-T033
contributions	O
to	O
hmhr	B-T061
.	O
	
the	O
approach	O
was	O
applied	O
to	O
huzou	O
,	O
china	O
and	O
five	O
significant	O
sources	B-T033
were	O
identified	O
.	O
	
soil	O
dust	O
is	O
the	O
largest	O
source	B-T033
of	O
non-hmcr	B-T033
.	O
	
for	O
hmcr	B-T081
,	O
the	O
source	B-T033
contributions	O
of	O
soil	O
dust	O
,	O
coal	B-T109
combustion	O
,	O
cement	B-T033
dust	I-T033
,	O
vehicle	O
,	O
and	O
secondary	O
sources	O
are	O
1.0	O
10	O
,	O
3.7	O
10	O
,	O
2.7	O
10	O
,	O
1.6	O
10	O
and	O
1.9	O
10	O
,	O
respectively	O
.	O
	
the	O
soil	O
dust	O
is	O
the	O
largest	O
contributor	O
to	O
hmcr	O
,	O
being	O
driven	O
by	O
the	O
high	O
impact	O
of	O
soil	O
dust	O
on	O
pm2.5	O
and	O
the	O
abundance	O
of	O
heavy	O
metals	O
in	O
soil	O
dust	O
aspirin	B-T109
suppresses	B-T169
growth	O
in	O
pi3k	O
-	O
mutant	O
breast	O
cancer	O
by	O
activating	O
ampk	B-T116
and	O
inhibiting	O
mtorc1	B-T116
signaling	O
despite	O
the	O
high	O
incidence	B-T081
of	O
oncogenic	O
mutations	O
in	O
pik3ca	O
,	O
the	O
gene	O
encoding	O
the	O
catalytic	O
subunit	O
of	O
pi3k	B-T116
,	O
pi3k	B-T116
inhibitors	O
have	O
yielded	O
little	O
clinical	B-T033
benefit	I-T033
for	O
breast	O
cancer	O
patients	O
.	O
	
recent	B-T079
epidemiologic	O
studies	O
have	O
suggested	B-T078
a	O
therapeutic	B-T169
benefit	B-T081
from	O
aspirin	B-T109
intake	O
in	O
cancers	O
harboring	O
oncogenic	B-T116
pik3ca	I-T116
here	O
,	O
we	O
show	O
that	O
mutant	O
pik3ca	B-T116
-	O
expressing	O
breast	O
cancer	O
cells	O
have	O
greater	O
sensitivity	B-T169
to	O
aspirin	B-T109
-mediated	O
growth	O
suppression	O
than	O
their	O
wild-type	O
counterparts	O
.	O
	
aspirin	B-T109
decreased	B-T081
viability	O
and	O
anchorage-independent	O
growth	O
of	O
mutant	O
pik3ca	B-T116
breast	O
cancer	O
cells	O
independently	B-T033
of	O
its	O
effects	B-T080
on	O
cox-2	B-T116
and	O
nf-κb	B-T116
.	O
	
we	O
ascribed	O
the	O
effects	B-T080
of	I-T080
aspirin	B-T109
to	O
amp-activated	B-T116
protein	I-T116
kinase	I-T116
ampk	B-T116
activation	O
,	O
mtorc1	B-T116
inhibition	O
,	O
and	O
autophagy	O
induction	O
.	O
	
in	O
vivo	O
,	O
oncogenic	O
pik3ca	B-T116
-driven	O
mouse	O
mammary	O
tumors	O
treated	B-T169
daily	O
with	O
aspirin	B-T109
resulted	O
in	O
decreased	B-T081
tumor	O
growth	O
kinetics	O
,	O
whereas	O
combination	B-T080
therapy	B-T061
of	O
aspirin	B-T109
and	O
a	O
pi3k	B-T116
inhibitor	B-T080
further	O
attenuated	O
tumor	O
growth	O
.	O
	
our	O
study	O
supports	O
the	O
evaluation	O
of	O
aspirin	B-T109
and	O
pi3k	B-T116
pathway	O
inhibitors	O
as	O
a	O
combination	B-T080
therapy	B-T061
for	O
targeting	B-T169
breast	O
cancer	O
.	O
	
prevalence	B-T081
of	O
psychiatric	O
disorders	O
among	O
female	O
juvenile	O
offenders	O
inmates	O
of	O
juvenile	O
developmental	O
centers	O
are	O
the	O
special	B-T080
group	O
of	O
youth	O
population	O
who	O
are	O
in	O
conflict	O
with	O
law	O
.	O
	
they	O
are	O
vulnerable	B-T169
to	O
psychiatric	O
illness	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
see	O
the	O
prevalence	B-T081
and	O
type	B-T080
of	O
psychiatric	O
disorders	O
in	O
institutionalized	B-T033
female	O
juvenile	O
offenders	O
and	O
non-offenders	O
of	O
same	B-T080
age	O
,	O
sex	O
and	O
socioeconomic	B-T080
group	I-T080
in	O
the	O
community	O
.	O
	
the	O
association	O
of	O
mental	O
disorders	O
was	O
examined	B-T033
in	O
43	O
female	O
inmates	O
of	O
juvenile	O
development	O
centers	O
and	O
43	O
randomly	B-T080
selected	O
comparison	O
subjects	O
in	O
community	O
.	O
	
one	O
stage-structured	O
assessment	O
of	O
psychopathology	O
was	O
carried	O
out	O
by	O
using	O
a	O
structured	B-T169
and	O
valid	B-T080
bangla	O
version	O
of	O
the	O
development	O
and	O
well-being	O
assessment	O
dawba	O
.	O
	
development	O
and	O
well-being	O
assessment	O
generated	O
psychiatric	B-T169
diagnosis	B-T033
was	O
assigned	O
based	O
on	O
icd-10	O
diagnostic	O
criteria	O
for	O
research	O
.	O
	
the	O
result	B-T033
revealed	B-T080
that	O
,	O
of	O
those	O
who	O
were	O
in	O
conflict	O
with	O
law	O
,	O
93%	O
had	O
mental	O
disorder	O
,	O
whereas	O
14%	O
of	O
non-offenders	O
had	O
psychiatric	O
disorder	O
.	O
	
among	O
the	O
offenders	O
with	O
psychiatric	O
disorders	O
,	O
most	O
of	O
them	O
32.6	O
suffered	O
from	O
major	O
depressive	O
disorder	O
mdd	O
,	O
followed	O
by	O
combined	B-T080
mdd	O
post	O
traumatic	O
stress	O
disorder	O
ptsd	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
among	O
the	O
non-offenders	O
with	O
psychiatric	O
disorder	O
9.3	O
suffered	O
from	O
mdd	O
.	O
	
it	O
can	O
be	O
concluded	B-T078
that	O
considerable	B-T080
psychiatric	O
disorders	O
are	O
prevalent	B-T081
among	O
the	O
female	O
juvenile	O
offenders	O
with	O
comparison	O
to	O
non-offenders	O
.	O
	
broad	O
-based	O
replication	O
study	O
could	O
confirm	B-T080
these	O
association	B-T080
between	O
neutrophil	O
-to-	O
lymphocyte	O
ratio	B-T081
and	O
differentiated	O
thyroid	O
cancer	O
a	O
meta-analysis	O
the	O
association	B-T080
between	O
neutrophil	O
-to-	O
lymphocyte	O
ratio	B-T081
nlr	B-T081
and	O
differentiated	O
thyroid	O
cancer	O
dtc	O
is	O
undecided	O
.	O
	
to	O
rectify	O
this	O
question	O
,	O
we	O
conducted	B-T169
a	O
systematic	B-T169
meta-analysis	O
based	O
on	O
7	O
prospective	O
cohort	O
studies	O
published	O
between	O
2013	O
and	O
2015	O
,	O
comprising	O
7349	O
patients	O
.	O
	
six	O
of	O
these	O
cohorts	O
included	O
pretreatment	O
baseline	B-T081
nlr	B-T081
data	B-T078
for	O
patients	O
with	O
thyroid	O
nodules	O
.	O
	
the	O
meta-analysis	O
of	O
these	O
6	O
cohorts	O
showed	O
that	O
the	O
nlr	B-T081
of	O
patients	O
with	O
dtc	O
4617	O
cases	O
was	O
statistically	B-T081
similar	O
to	O
patients	O
with	O
benign	O
nodules	O
only	O
1666	O
cases	O
,	O
with	O
a	O
mean	O
difference	O
md	O
of	O
0.19	O
95%	O
ci	B-T081
-0	O
to	O
0.46	O
i	O
=	O
93%	O
p	B-T081
<	O
0.001	O
.	O
	
no	O
significant	O
difference	O
in	O
nlr	B-T081
was	O
found	O
between	O
patients	O
with	O
dtc	O
and	O
patients	O
with	O
benign	O
nodules	O
.	O
	
two	O
studies	O
addressed	O
an	O
association	B-T080
between	O
nlr	B-T081
and	O
papillary	O
thyroid	O
carcinoma	O
in	O
patients	O
stratified	B-T080
by	O
age	O
<45	O
and	O
45	O
years	B-T079
496	O
and	O
891	O
cases	O
,	O
respectively	O
the	O
pooled	O
md	O
was	O
0.09	O
95%	O
ci	B-T081
-0	O
to	O
0.55	O
i	O
=	O
92.2	O
,	O
p	B-T081
<	O
0.001	O
.	O
	
an	O
elevated	B-T080
nlr	B-T081
seems	O
not	O
a	O
reliable	O
indicator	B-T169
of	O
progressing	B-T169
dtc	O
in	O
patients	O
with	O
goiters	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
nlr	B-T081
between	O
patients	O
aged	O
<45	O
years	B-T079
and	O
those	O
aged	O
45	O
years	B-T079
.	O
	
well-designed	O
and	O
large-scale	O
investigations	O
are	O
warranted	O
to	O
understand	O
the	O
value	O
of	O
nlr	B-T081
in	O
the	O
prognosis	B-T033
of	O
transcriptomic	O
insights	O
into	O
the	O
allelopathic	O
effects	B-T080
of	I-T080
the	O
garlic	O
allelochemical	O
diallyl	B-T109
disulfide	I-T109
on	O
tomato	O
roots	O
garlic	O
is	O
an	O
allelopathic	O
crop	O
that	O
can	O
alleviate	O
the	O
obstacles	O
to	O
continuous	B-T078
cropping	O
of	O
vegetable	O
crops	O
.	O
	
diallyl	B-T109
disulfide	I-T109
dads	B-T109
,	O
one	O
of	O
the	O
most	O
important	O
allelochemicals	O
in	O
garlic	O
,	O
promotes	O
tomato	O
root	O
growth	O
.	O
	
therefore	O
,	O
the	O
global	B-T080
transcriptome	O
profiles	B-T081
of	O
dads	B-T109
-	O
treated	B-T169
tomato	O
roots	O
over	O
time	O
were	O
investigated	B-T169
to	O
reveal	O
the	O
potential	B-T080
growth-promoting	O
mechanisms	O
.	O
	
we	O
detected	B-T033
1828	O
,	O
1296	O
and	O
1190	O
differentially	O
expressed	O
genes	O
degs	O
in	O
the	O
4	O
,	O
24	O
and	O
48	O
h	O
samples	O
,	O
respectively	O
.	O
	
most	O
degs	O
involved	O
in	O
assimilatory	O
sulfate	O
reduction	O
and	O
glutathione	O
metabolism	O
were	O
up-regulated	O
after	O
short-term	B-T079
4	O
h	O
dads	B-T109
treatment	B-T169
.	O
	
in	O
addition	O
,	O
increased	B-T033
activity	I-T033
of	I-T033
defensive	I-T033
enzymes	I-T033
and	O
up-regulation	O
of	O
six	O
peroxidase	O
genes	O
were	O
observed	B-T169
,	O
suggesting	O
that	O
dads	B-T109
could	O
induce	B-T169
tomato	O
resistance	B-T169
.	O
	
in	O
plant-pathogen	O
interactions	O
,	O
degs	O
related	O
to	O
calcium	O
signaling	O
were	O
primarily	O
inhibited	B-T080
,	O
while	O
those	O
encoding	O
pathogenesis-related	B-T116
proteins	I-T116
were	O
primarily	O
up-regulated	O
.	O
	
although	O
plant	O
hormone	O
synthesis	O
and	O
signal	O
transduction	O
were	O
both	O
significantly	B-T169
affected	I-T169
by	O
dads	B-T109
,	O
the	O
expression	O
trends	B-T079
of	O
the	O
genes	O
in	O
these	O
two	O
pathways	O
were	O
conflicting	O
.	O
	
this	O
research	O
provides	O
comprehensive	B-T080
information	B-T078
concerning	O
the	O
changes	B-T169
in	O
the	O
tomato	O
root	O
transcriptome	O
affected	B-T169
by	O
dads	B-T109
and	O
may	O
help	O
direct	O
further	O
studies	O
on	O
dads	B-T109
-	O
responsive	B-T169
genes	O
to	O
enhance	O
the	O
current	B-T079
understanding	O
of	O
the	O
mechanisms	O
by	O
which	O
dads	B-T109
alleviates	O
the	O
obstacles	O
to	O
continuous	B-T078
cropping	O
.	O
	
mitotic	B-T080
phosphotyrosine	B-T116
network	O
analysis	O
reveals	O
that	O
tyrosine	O
phosphorylation	O
regulates	O
polo-like	B-T116
kinase	I-T116
1	I-T116
plk1	B-T116
tyrosine	O
phosphorylation	O
is	O
closely	O
associated	B-T080
with	I-T080
cell	O
proliferation	O
.	O
	
during	O
the	O
cell	O
cycle	O
,	O
serine	O
and	O
threonine	O
phosphorylation	O
plays	O
the	O
leading	O
role	O
,	O
and	O
such	O
phosphorylation	O
events	O
are	O
most	O
dynamic	B-T169
during	O
the	O
mitotic	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O
	
however	O
,	O
mitotic	B-T080
phosphotyrosine	B-T116
is	O
not	O
well	O
characterized	O
.	O
	
although	O
a	O
few	O
functionally	B-T169
-	O
relevant	B-T080
mitotic	B-T080
phosphotyrosine	B-T116
sites	O
have	O
been	O
characterized	O
,	O
evidence	O
suggests	O
that	O
this	O
modification	B-T169
may	O
be	O
more	O
prevalent	B-T081
than	O
previously	O
appreciated	O
.	O
	
here	O
,	O
we	O
examined	B-T033
tyrosine	O
phosphorylation	O
in	O
mitotic	O
human	O
cells	O
including	O
those	O
on	O
spindle-associated	B-T116
proteins	I-T116
database	O
mining	O
confirmed	O
2000	O
mitotic	B-T080
phosphotyrosine	B-T116
sites	O
,	O
and	O
network	O
analysis	O
revealed	O
a	O
number	O
of	O
subnetworks	O
that	O
were	O
enriched	O
in	O
tyrosine-phosphorylated	B-T116
proteins	I-T116
,	O
including	O
components	O
of	O
the	O
kinetochore	O
or	O
spindle	O
and	O
src	B-T116
family	I-T116
kinases	I-T116
.	O
	
we	O
identified	O
polo-like	B-T116
kinase	I-T116
1	I-T116
plk1	B-T116
,	O
a	O
major	O
signaling	O
hub	O
in	O
the	O
spindle	O
subnetwork	B-T169
,	O
as	O
phosphorylated	B-T116
at	O
the	O
conserved	O
tyr	B-T116
in	O
the	O
kinase	O
domain	O
.	O
	
substitution	O
of	O
tyr	B-T116
with	O
a	O
phosphomimetic	O
residue	O
eliminated	O
plk1	B-T116
activity	O
in	B-T080
vitro	I-T080
and	O
in	O
cells	O
.	O
	
further	O
analysis	O
showed	O
that	O
tyr	B-T116
phosphorylation	O
reduced	O
the	O
phosphorylation	O
of	O
thr	O
in	O
the	O
activation	O
loop	O
,	O
a	O
phosphorylation	O
event	O
necessary	O
for	O
plk1	B-T116
activity	O
.	O
	
our	O
data	O
indicate	O
that	O
mitotic	B-T080
tyrosine	O
phosphorylation	O
regulated	O
a	O
key	O
serine/threonine	B-T116
kinase	I-T116
hub	O
in	O
mitotic	O
cells	O
and	O
suggested	O
that	O
spatially	O
separating	O
tyrosine	O
phosphorylation	O
events	O
can	O
reveal	O
previously	O
unrecognized	B-T080
regulatory	B-T169
events	I-T169
and	O
complexes	B-T080
associated	O
with	O
specific	O
structures	O
of	O
the	O
cell	O
cycle	O
.	O
	
divided	B-T169
and	O
sliding	B-T169
superficial	O
temporal	O
artery	O
flap	O
for	O
primary	B-T080
donor-site	O
closure	B-T061
superficial	O
temporal	O
artery	O
sta	O
flaps	O
are	O
often	O
used	O
for	O
reconstruction	B-T061
of	O
hair-bearing	O
areas	O
.	O
	
however	O
,	O
primary	B-T061
closure	I-T061
of	O
the	O
donor	O
site	O
is	O
not	O
easy	O
when	O
the	O
size	O
of	O
the	O
necessary	O
skin	O
island	O
is	O
relatively	O
large	B-T081
.	O
	
in	O
such	O
cases	O
,	O
skin	O
grafts	O
are	O
needed	O
at	O
the	O
donor	O
site	O
,	O
resulting	O
in	O
baldness	B-T047
.	O
	
we	O
have	O
solved	O
this	O
issue	O
by	O
applying	O
the	O
divided	B-T169
and	O
sliding	B-T169
flap	O
technique	B-T169
,	O
which	O
was	O
first	O
reported	O
for	O
primary	B-T061
donor-site	I-T061
closure	I-T061
of	O
a	O
latissimus	O
dorsi	O
musculocutaneous	O
flap	O
.	O
	
we	O
applied	O
this	O
technique	B-T169
to	O
the	O
hair-bearing	O
sta	O
flap	O
,	O
where	O
primary	B-T061
donor-site	I-T061
closure	I-T061
is	O
extremely	O
beneficial	O
for	O
preventing	B-T080
baldness	B-T047
consequent	O
to	O
skin	B-T061
grafting	I-T061
.	O
	
the	O
sta	O
flap	O
was	O
divided	B-T169
into	O
3	O
,	O
and	O
creation	O
of	O
large	O
flap	O
was	O
possible	O
.	O
	
therefore	O
,	O
we	O
concluded	O
that	O
the	O
divided	B-T169
and	O
sliding	B-T169
sta	O
flap	O
could	O
at	O
least	O
partially	O
solve	O
the	O
donor-site	O
problem	B-T033
.	O
	
although	O
further	O
investigation	O
is	O
necessary	O
to	O
validate	O
the	O
maximum	B-T081
possible	B-T033
flap	O
size	O
,	O
this	O
technique	B-T169
may	O
be	O
applicable	O
to	O
at	O
least	O
small	B-T081
defects	B-T169
that	O
are	O
common	O
after	O
skin	O
cancer	O
ablation	B-T061
or	O
influence	O
of	O
surface	O
properties	O
on	O
adhesion	O
forces	O
and	O
attachment	O
of	O
streptococcus	O
mutans	O
to	O
zirconia	O
in	B-T080
vitro	I-T080
zirconia	O
is	O
becoming	O
a	O
prevalent	O
material	O
in	O
dentistry	O
.	O
	
however	O
,	O
any	O
foreign	O
bodies	O
inserted	O
may	O
provide	O
new	O
niches	O
for	O
the	O
bacteria	O
in	O
oral	O
cavity	O
.	O
	
the	O
object	O
of	O
this	O
study	O
was	O
to	O
explore	O
the	O
effect	B-T080
of	O
surface	O
properties	O
including	O
surface	B-T033
roughness	I-T033
and	O
hydrophobicity	B-T080
on	O
the	O
adhesion	O
and	O
biofilm	O
formation	O
of	O
streptococcus	O
mutans	O
s	O
.	O
	
mutans	O
to	O
zirconia	O
.	O
	
atomic	O
force	O
microscopy	O
was	O
employed	O
to	O
determine	O
the	O
zirconia	O
surface	O
morphology	B-T080
and	O
the	O
adhesion	O
forces	O
between	O
the	O
s	O
.	O
	
mutans	O
and	O
zirconia	O
.	O
	
the	O
results	B-T169
showed	O
that	O
the	O
surface	B-T033
roughness	I-T033
was	O
nanoscale	B-T081
and	O
significantly	O
different	B-T080
among	O
tested	B-T078
groups	I-T078
p	O
<	O
0.05	O
coarse	B-T080
23.94	O
2.52	O
nm	O
>	O
medium	B-T081
17.00	O
3.81	O
nm	O
>	O
fine	B-T080
11.89	O
1.68	O
nm	O
.	O
	
the	O
contact	O
angles	O
of	O
the	O
coarse	B-T078
group	I-T078
were	O
the	O
highest	O
,	O
followed	O
by	O
the	O
medium	B-T081
and	O
the	O
fine	B-T078
groups	I-T078
.	O
	
increasing	O
the	O
surface	B-T033
roughness	I-T033
and	O
hydrophobicity	B-T080
resulted	O
in	O
an	O
increase	O
of	O
adhesion	O
forces	O
and	O
early	O
attachment	O
2	O
h	O
and	O
4	O
h	O
of	O
s	O
.	O
	
mutans	O
on	O
the	O
zirconia	O
but	O
no	O
influence	O
on	O
the	O
further	O
development	B-T169
of	O
biofilm	O
6	O
h	O
h	O
.	O
	
our	O
findings	O
suggest	O
that	O
the	O
surface	B-T033
roughness	I-T033
in	O
nanoscale	B-T081
and	O
hydrophobicity	B-T080
of	O
zirconia	O
had	O
influence	O
on	O
the	O
s	O
.	O
	
mutans	O
initial	O
adhesion	O
force	O
and	O
early	O
attachment	O
instead	O
of	O
whole	O
stages	O
of	O
biofilm	O
formation	O
.	O
	
the	O
relationship	O
between	O
thiamine	B-T109
and	O
two	O
symbioses	O
root	O
nodule	O
symbiosis	O
and	O
arbuscular	O
mycorrhiza	O
lotus	O
japonicus	O
thic	O
is	O
expressed	O
in	O
all	O
organs	O
,	O
and	O
the	O
encoded	B-T116
protein	I-T116
catalyzes	O
thiamine	O
biosynthesis	O
.	O
	
loss	B-T033
of	I-T033
function	I-T033
produces	O
chlorosis	B-T047
,	O
a	O
typical	O
thiamine	B-T109
-deficiency	O
phenotype	O
,	O
and	O
mortality	B-T081
.	O
	
to	O
investigate	O
thiamine's	B-T109
role	O
in	O
symbiosis	O
,	O
we	O
focused	O
on	O
thi1	O
,	O
a	O
thiamine-biosynthesis	O
gene	O
expressed	O
in	O
roots	O
,	O
nodules	O
,	O
and	O
seeds	O
.	O
	
the	O
thi1	O
mutant	O
had	O
green	O
leaves	O
,	O
but	O
formed	O
small	B-T081
nodules	O
and	O
immature	B-T080
seeds	O
.	O
	
these	O
phenotypes	O
were	O
rescued	O
by	O
thi1	O
complementation	O
and	O
by	O
exogenous	B-T169
thiamine	B-T109
.	O
	
thus	O
,	O
thi1	O
is	O
required	O
for	O
nodule	O
enlargement	B-T169
and	O
seed	O
maturation	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
colonization	B-T033
by	O
arbuscular	O
mycorrhiza	O
am	O
fungus	O
rhizophagus	O
irregularis	O
was	O
not	O
affected	O
in	O
the	O
thi1	O
mutant	O
or	O
by	O
exogenous	B-T169
thiamine	B-T109
.	O
	
however	O
,	O
spores	O
of	O
r	O
.	O
	
irregularis	O
stored	O
more	O
thiamine	B-T109
than	O
the	O
source	O
host	O
plants	O
,	O
despite	O
lacking	O
thiamine	O
biosynthesis	O
genes	O
.	O
	
therefore	O
,	O
disturbance	O
of	O
the	O
thiamine	B-T109
supply	O
would	O
affect	O
progeny	O
phenotypes	O
such	O
as	O
spore	O
formation	O
and	O
hyphal	O
growth	O
.	O
	
further	O
investigation	O
will	O
be	O
required	O
to	O
elucidate	O
thiamine's	B-T109
effect	O
on	O
bilateral	O
sternal	O
infusion	B-T061
of	O
ropivacaine	B-T109
and	O
length	B-T079
of	I-T079
stay	I-T079
in	O
icu	O
after	O
cardiac	B-T061
surgery	I-T061
with	O
increased	B-T081
respiratory	O
risk	O
a	O
randomised	O
controlled	O
trial	O
the	O
continuous	O
bilateral	O
infusion	B-T061
of	O
a	O
local	B-T109
anaesthetic	I-T109
solution	O
around	O
the	O
sternotomy	B-T061
wound	O
bilateral	O
sternal	O
is	O
an	O
innovative	O
technique	B-T169
for	O
reducing	B-T080
pain	O
after	O
sternotomy	B-T061
.	O
	
to	O
assess	O
the	O
effects	B-T080
of	O
the	O
technique	B-T169
on	O
the	O
need	O
for	O
intensive	O
care	O
in	O
cardiac	O
patients	O
at	O
increased	B-T081
risk	B-T078
of	O
respiratory	O
complications	O
.	O
	
randomised	O
,	O
observer-blind	O
controlled	O
trial	O
.	O
	
single	O
centre	O
,	O
french	O
university	O
hospital	O
.	O
	
in	O
total	O
,	O
120	O
adults	O
scheduled	O
for	O
open-heart	B-T061
surgery	I-T061
,	O
with	O
one	O
of	O
the	O
following	O
conditions	O
age	O
more	O
than	O
75	O
years	B-T079
,	O
bmi	O
>30	O
kg	O
m	O
,	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
,	O
active	B-T169
smoking	I-T169
habit	I-T169
.	O
	
either	O
a	O
bilateral	O
sternal	O
infusion	B-T061
of	O
0.2	O
ropivacaine	B-T109
3	O
ml	O
h	O
through	O
each	O
catheter	O
'intervention'	O
group	O
,	O
or	O
standardised	O
care	O
only	O
'control'	O
group	O
.	O
	
analgesia	B-T061
was	O
provided	O
with	O
paracetamol	B-T109
and	O
self-administered	B-T169
intravenous	B-T169
morphine	B-T109
.	O
	
the	O
length	B-T079
of	I-T079
time	I-T079
to	O
readiness	B-T033
for	O
discharge	O
from	O
icu	O
,	O
blindly	O
assessed	O
by	O
a	O
committee	O
of	O
experts	O
.	O
	
no	B-T080
effect	I-T080
was	O
found	O
between	O
groups	B-T078
for	O
the	O
primary	B-T080
outcome	I-T080
p	O
=	O
0.680	O
,	O
intention	O
to	O
treat	O
the	O
median	B-T080
values	I-T080
were	O
42.4	O
and	O
37.7	O
h	O
,	O
respectively	O
for	O
the	O
control	O
and	O
intervention	O
groups	O
p	O
=	O
0.873	O
.	O
	
similar	O
nonsignificant	O
trends	O
were	O
noted	O
for	O
other	O
postoperative	B-T033
delays	B-T079
.	O
	
significant	O
effects	B-T080
favouring	O
the	O
intervention	B-T061
were	O
noted	O
for	O
dynamic	O
pain	O
,	O
patient	B-T080
satisfaction	I-T080
,	O
occurrence	O
of	O
nausea	O
and	O
vomiting	O
,	O
occurrence	B-T079
of	O
delirium	O
or	O
mental	O
confusion	O
and	O
occurrence	B-T079
of	O
pulmonary	O
complications	O
.	O
	
in	O
12	O
patients	O
,	O
although	O
no	O
symptoms	O
actually	O
occurred	O
,	O
the	O
total	O
ropivacaine	O
plasma	O
level	O
exceeded	O
the	O
lowest	O
value	O
for	O
which	O
neurological	O
symptoms	O
have	O
been	O
observed	O
in	O
healthy	O
volunteers	O
.	O
	
because	O
of	O
a	O
small	B-T081
size	I-T081
effect	I-T081
,	O
and	O
despite	O
significant	O
analgesic	B-T033
effects	I-T033
,	O
this	O
strategy	O
failed	O
to	O
reduce	O
the	O
time	B-T079
spent	O
in	O
icu	O
.	O
	
eudract	O
n	O
2012-005225-69	O
clinicaltrials.gov	O
pupil	O
sizes	O
scale	O
with	O
attentional	O
load	O
and	O
task	O
experience	O
in	O
a	O
multiple	B-T081
object	O
tracking	O
task	O
previous	O
studies	O
have	O
related	O
changes	B-T169
in	O
attentional	O
load	O
to	O
pupil	O
size	O
modulations	O
.	O
	
however	O
,	O
studies	O
relating	O
changes	B-T169
in	O
attentional	O
load	O
and	O
task	O
experience	O
on	O
a	O
finer	O
scale	O
to	O
pupil	O
size	O
modulations	O
are	O
scarce	O
.	O
	
here	O
,	O
we	O
investigated	B-T169
how	O
these	O
changes	B-T169
affect	O
pupil	O
sizes	O
.	O
	
to	O
manipulate	O
attentional	O
load	O
,	O
participants	O
covertly	O
tracked	O
between	O
zero	B-T081
and	O
five	B-T081
objects	O
among	O
several	O
randomly	B-T080
moving	O
objects	O
on	O
a	O
computer	O
screen	O
.	O
	
to	O
investigate	B-T169
effects	B-T080
of	I-T080
task	O
experience	O
,	O
the	O
experiment	O
was	O
conducted	O
on	O
three	B-T081
consecutive	B-T080
days	B-T079
.	O
	
we	O
found	O
that	O
pupil	O
sizes	O
increased	O
with	O
each	O
increment	B-T081
in	O
attentional	O
load	O
.	O
	
across	O
days	B-T079
,	O
we	O
found	O
systematic	B-T169
pupil	O
size	O
reductions	B-T080
.	O
	
we	O
compared	O
the	O
model	B-T080
fit	I-T080
for	O
predicting	O
pupil	O
size	O
modulations	O
using	O
attentional	O
load	O
,	O
task	O
experience	O
,	O
and	O
task	B-T061
performance	I-T061
as	O
predictors	B-T078
.	O
	
we	O
found	O
that	O
a	O
model	O
which	O
included	O
attentional	O
load	O
and	O
task	O
experience	O
as	O
predictors	B-T078
had	O
the	O
best	O
model	B-T080
fit	I-T080
while	O
adding	O
performance	B-T061
as	O
a	O
predictor	B-T078
to	O
this	O
model	O
reduced	O
the	O
overall	O
model	B-T080
fit	I-T080
.	O
	
overall	O
,	O
results	B-T169
suggest	O
that	O
pupillometry	O
provides	O
a	O
viable	B-T080
metric	B-T081
for	O
precisely	O
assessing	O
attentional	O
load	O
and	O
task	O
experience	O
in	O
visuospatial	O
tasks	O
.	O
	
back	O
to	O
the	O
roots	O
deep	O
view	O
into	O
the	O
evolutionary	O
history	B-T169
of	O
adp-ribosylation	O
opened	O
by	O
the	O
dna	O
-	O
targeting	B-T169
toxin	O
-	O
antitoxin	O
module	O
dartg	O
in	O
this	O
issue	O
of	O
molecular	O
cell	O
,	O
jankevicius	O
et	O
al	O
.	O
	
2016	O
characterize	O
the	O
dartg	O
toxin	O
-	O
antitoxin	O
module	O
in	O
which	O
the	O
dart	B-T116
toxin	O
adp-ribosylates	O
single-stranded	O
dna	O
and	O
the	O
darg	B-T116
antitoxin	O
counteracts	B-T169
dart	B-T116
by	O
direct	O
binding	O
and	O
by	O
enzymatic	B-T116
remova	O
l	O
of	O
the	O
growth	B-T116
differentiation	I-T116
factor	I-T116
15	I-T116
is	O
a	O
myomitokine	O
governing	O
systemic	O
energy	O
homeostasis	O
reduced	B-T080
mitochondrial	O
electron	O
transport	O
chain	O
activity	O
promotes	O
longevity	B-T079
and	O
improves	B-T033
energy	O
homeostasis	O
via	O
cell-autonomous	O
and	O
-	O
non-autonomous	O
factors	O
in	O
multiple	O
model	O
systems	O
.	O
	
this	O
mitohormetic	O
effect	B-T080
is	O
thought	O
to	O
involve	O
the	O
mitochondrial	O
unfolded	O
protein	O
response	O
upr	O
,	O
an	O
adaptive	O
stress-response	O
pathway	O
activated	O
by	O
mitochondrial	O
proteotoxic	O
stress	O
.	O
	
using	O
mice	O
with	O
skeletal	O
muscle-specific	O
deficiency	B-T169
of	O
crif1	B-T116
muscle-specific	O
knockout	O
mko	O
,	O
an	O
integral	B-T116
protein	I-T116
of	O
the	O
large	O
mitoribosomal	O
subunit	O
39s	O
,	O
we	O
identified	O
growth	B-T116
differentiation	I-T116
factor	I-T116
15	I-T116
gdf15	B-T116
as	O
a	O
upr	O
-associated	O
cell-non-autonomous	O
myomitokine	O
that	O
regulates	O
systemic	O
energy	O
homeostasis	O
.	O
	
mko	O
mice	O
were	O
protected	B-T033
against	O
obesity	B-T047
and	O
sensitized	O
to	O
insulin	B-T116
,	O
an	O
effect	O
associated	B-T080
with	I-T080
elevated	B-T080
gdf15	B-T116
secretion	O
after	O
upr	O
activation	O
.	O
	
in	O
ob/ob	O
mice	O
,	O
administration	O
of	O
recombinant	B-T116
gdf15	B-T116
decreased	B-T081
body	O
weight	O
and	O
improved	B-T033
insulin	O
sensitivity	O
,	O
which	O
was	O
attributed	O
to	O
elevated	B-T080
oxidative	O
metabolism	O
and	O
lipid	O
mobilization	O
in	O
the	O
liver	O
,	O
muscle	O
,	O
and	O
adipose	O
tissue	O
.	O
	
thus	O
,	O
gdf15	B-T116
is	O
a	O
potent	B-T080
mitohormetic	O
signal	O
that	O
safeguards	O
against	O
the	O
onset	B-T033
of	I-T033
obesity	I-T033
and	O
insulin	O
resistance	O
.	O
	
synthesis	O
and	O
characterization	O
of	O
acetylated	B-T109
amylose	I-T109
and	O
development	B-T169
of	O
inclusion	O
complexes	O
with	O
rifampicin	B-T109
amylose	B-T109
am	B-T109
tends	O
to	O
form	O
single	O
helical	O
inclusion	O
complexes	O
with	O
suitable	O
agents	O
.	O
	
these	O
complexes	O
are	O
considered	B-T078
promising	O
biomaterial	O
carrier	O
since	O
the	O
guest	O
molecules	O
can	O
be	O
released	B-T169
later	B-T079
,	O
leading	O
to	O
many	O
applications	B-T169
,	O
especially	O
in	O
the	O
pharmaceutical	O
industry	O
.	O
	
rifampicin	B-T109
rif	B-T109
has	O
long	O
been	O
recognized	O
as	O
an	O
active	B-T169
drug	O
against	O
mycobacterium	O
tuberculosis	O
,	O
however	O
,	O
the	O
administration	B-T061
of	O
rif	B-T109
in	O
high	O
dosages	B-T081
can	O
originate	O
unwanted	O
side-effects	B-T169
.	O
	
due	O
to	O
the	O
fact	O
that	O
the	O
use	O
of	O
native	B-T169
amylose	B-T109
am	B-T109
in	O
the	O
formation	B-T169
of	O
complexes	O
is	O
limited	O
by	O
their	O
low	O
water	B-T081
solubility	I-T081
,	O
it	O
was	O
acetylated	O
with	O
a	O
medium	O
degree	B-T081
of	O
substitution	O
ds	O
,	O
allowing	O
solubilizing	B-T080
0.5gl	O
acetylated	B-T109
amylose	I-T109
ama	B-T109
in	O
water	O
at	O
neutral	B-T080
ph	I-T080
,	O
in	O
opposition	O
to	O
that	O
observed	B-T169
with	O
native	B-T169
amylose	B-T109
trace	B-T081
solubility	B-T080
.	O
	
the	O
resulting	O
acetylated	B-T109
amylose	I-T109
was	O
characterized	O
by	O
means	O
of	O
fourier	O
transform	O
infrared	O
ft-ir	O
spectroscopy	O
and	O
scanning	O
electron	O
microscopy	O
sem	O
.	O
	
ft-ir	O
results	B-T169
indicated	B-T033
that	O
the	O
acetylation	O
of	O
anhydroglucose	B-T109
units	B-T081
of	O
amylose	B-T109
corresponds	O
to	O
a	O
low	B-T080
ds	O
,	O
whereas	O
sem	O
results	B-T169
suggested	O
that	O
the	O
smooth	O
surfaces	O
of	O
amylose	B-T109
granules	O
were	O
changed	B-T169
into	O
rougher	O
surfaces	O
after	O
acetylation	O
.	O
	
ultraviolet	O
absorption	O
spectroscopy	O
uv-vis	O
analysis	O
confirmed	B-T080
the	O
formation	B-T169
and	O
allowed	O
the	O
quantification	B-T081
of	O
both	O
native	B-T169
am	B-T109
-	O
rif	B-T109
and	O
acetylated	O
ama	B-T109
-	O
rif	B-T109
amylose	B-T109
inclusion	O
complexes	O
.	O
	
their	O
characterization	O
in	O
solution	O
was	O
performed	B-T169
by	O
dynamic	O
light	O
scattering	O
dls	O
and	O
zeta	O
potential	O
zp	O
measurements	B-T169
.	O
	
the	O
average	O
size	O
of	O
inclusion	O
complexes	O
as	O
determined	B-T080
by	I-T080
dls	O
,	O
ranged	B-T081
between	O
70	O
and	O
100nm	O
.	O
	
besides	O
,	O
zp	O
analysis	O
showed	O
that	O
both	O
complexes	O
are	O
more	O
stable	B-T080
in	O
the	O
presence	B-T033
of	O
rif	B-T109
.	O
	
this	O
study	O
may	O
lead	O
to	O
the	O
development	B-T169
of	O
an	O
effective	B-T080
method	O
for	O
the	O
preparation	O
of	O
amylose	B-T109
inclusion	O
complexes	O
,	O
which	O
is	O
beneficial	O
to	O
their	O
further	O
application	B-T169
in	O
drug	O
delivery	O
systems	O
.	O
	
selective	O
reaching	O
in	O
macaques	O
evidence	B-T078
for	O
action	O
-centred	O
attention	O
when	O
a	O
monkey	O
selects	O
a	O
piece	O
of	O
food	O
lying	O
on	O
the	O
ground	O
from	O
among	O
other	B-T080
viable	B-T080
objects	O
in	O
the	O
near	B-T080
vicinity	O
,	O
only	O
the	O
desired	O
item	O
governs	B-T080
the	O
particular	O
pattern	O
and	O
direction	O
of	O
the	O
animal's	O
reaching	O
action	O
.	O
	
it	O
would	O
seem	O
then	O
that	O
selection	O
is	O
an	O
important	B-T080
component	B-T078
controlling	B-T169
the	O
animal's	O
action	O
.	O
	
but	O
,	O
we	O
may	O
ask	O
,	O
is	O
the	O
selection	O
process	O
in	O
such	O
cases	B-T169
impervious	O
to	O
the	O
presence	B-T080
of	O
other	B-T080
objects	O
that	O
could	O
constitute	B-T169
potential	B-T080
obstacles	O
to	O
or	O
constraints	B-T169
on	O
movement	O
execution	O
and	O
if	O
it	O
is	O
,	O
in	O
fact	O
,	O
pervious	B-T169
to	O
other	B-T080
objects	O
,	O
do	O
they	O
have	O
a	O
direct	B-T080
influence	O
on	O
the	O
organization	O
of	O
the	O
response	O
the	O
kinematics	O
of	O
macaques	O
'	O
reaching	O
movements	O
were	O
examined	B-T033
by	O
the	O
current	B-T079
study	O
that	O
analysed	O
some	O
exemplars	O
as	O
they	O
selectively	O
reached	O
to	O
grasp	O
a	O
food	O
item	O
in	O
the	O
absence	B-T169
as	O
well	O
as	O
in	O
the	O
presence	B-T080
of	O
potential	B-T080
obstacles	O
i.e	O
,	O
stones	O
that	O
could	O
affect	O
the	O
arm	O
trajectory	O
.	O
	
changes	B-T169
in	O
movement	O
parameterization	O
were	O
noted	B-T080
in	O
temporal	B-T079
measures	B-T081
,	O
such	O
as	O
movement	O
time	B-T079
,	O
as	O
well	O
as	O
in	O
spatial	O
ones	O
,	O
such	O
as	O
paths	O
of	O
trajectory	O
.	O
	
generally	O
speaking	O
,	O
the	O
presence	B-T080
of	O
stones	O
in	O
the	O
vicinity	O
of	O
the	O
acting	O
hand	O
stalled	O
the	O
reaching	O
movement	O
and	O
affected	O
the	O
arm	O
trajectory	O
as	O
the	O
hand	O
veered	B-T033
away	I-T033
from	O
the	O
stone	O
even	O
when	O
it	O
was	O
not	B-T169
a	O
physical	B-T169
obstacle	O
.	O
	
we	O
concluded	O
that	O
nearby	B-T080
objects	O
evoke	O
a	O
motor	O
response	O
in	O
macaques	O
,	O
and	O
the	O
attentional	O
mechanisms	B-T169
that	O
allow	O
for	O
a	O
successful	B-T080
action	O
selection	O
are	O
revealed	B-T080
in	O
the	O
reaching	O
path	O
.	O
	
the	O
data	B-T078
outlined	O
here	O
concur	O
with	O
human	O
studies	O
indicating	B-T078
that	O
potential	B-T080
obstacles	O
are	O
internally	O
represented	O
,	O
a	O
finding	B-T033
implying	O
basic	B-T169
cognitive	B-T169
operations	O
allowing	O
for	O
action	O
selection	O
in	O
a	O
novel	B-T080
method	O
for	O
interactive	B-T169
multi-objective	B-T080
dose-guided	O
patient	O
positioning	O
in	O
intensity-modulated	B-T061
radiation	I-T061
therapy	I-T061
imrt	B-T061
,	O
3d	O
in-room	O
imaging	O
data	B-T078
is	O
typically	O
utilized	O
for	O
accurate	B-T080
patient	O
alignment	O
on	O
the	O
basis	O
of	O
anatomical	O
landmarks	O
.	O
	
in	O
the	O
presence	O
of	O
non-rigid	O
anatomical	B-T169
changes	I-T169
,	O
it	O
is	O
often	O
not	O
obvious	O
which	O
patient	B-T033
position	I-T033
is	O
most	O
suitable	O
.	O
	
thus	O
,	O
dose	B-T081
-guided	O
patient	O
alignment	O
is	O
an	O
interesting	O
approach	O
to	O
use	O
available	O
in-room	O
imaging	O
data	B-T078
for	O
up-to-date	O
dose	B-T081
calculation	O
,	O
aimed	O
at	O
finding	B-T033
the	O
position	O
that	O
yields	O
the	O
optimal	B-T080
dose	B-T081
distribution	B-T169
.	O
	
this	O
contribution	O
presents	O
the	O
first	O
implementation	O
of	O
dose	B-T081
-guided	O
patient	O
alignment	O
as	O
multi-criteria	O
optimization	O
problem	O
.	O
	
user-defined	O
clinical	B-T080
objectives	O
are	O
employed	O
for	O
setting	O
up	O
a	O
multi-objective	B-T080
problem	O
.	O
	
using	O
pre-calculated	O
dose	B-T081
distributions	B-T169
at	O
a	O
limited	O
number	O
of	O
patient	O
shifts	O
and	O
dose	B-T081
interpolation	O
,	O
a	O
continuous	O
space	O
of	O
pareto-efficient	O
patient	O
shifts	O
becomes	O
accessible	O
.	O
	
pareto	O
sliders	O
facilitate	O
interactive	B-T169
browsing	O
of	O
the	O
possible	O
shifts	O
with	O
real-time	O
dose	B-T081
display	O
to	O
the	O
user	O
.	O
	
dose	B-T081
interpolation	O
accuracy	B-T080
is	O
validated	O
and	O
the	O
potential	O
of	O
multi-objective	B-T080
dose-guided	O
positioning	O
demonstrated	O
for	O
three	O
head	O
and	O
neck	O
h	O
and	O
three	O
prostate	O
cancer	O
patients	O
.	O
	
dose-guided	O
positioning	O
is	O
compared	O
to	O
replanning	O
for	O
all	O
cases	O
.	O
	
a	O
delineated	O
replanning	O
ct	O
served	O
as	O
surrogate	O
for	O
in-room	O
imaging	O
data	B-T078
.	O
	
dose	B-T081
interpolation	O
accuracy	B-T080
was	O
high	B-T080
.	O
	
using	O
a	O
formula	O
see	O
text	O
dose	B-T081
difference	O
criterion	O
,	O
a	O
median	O
pass-rate	O
of	O
95.7	O
for	O
h	O
and	O
99.6	O
for	O
prostate	O
cases	O
was	O
determined	O
in	O
a	O
comparison	O
to	O
exact	O
dose	B-T081
calculations	O
.	O
	
for	O
all	O
patients	O
,	O
dose-guided	O
positioning	O
allowed	O
to	O
find	O
a	O
clinically	O
preferable	O
dose	B-T081
distribution	B-T169
compared	O
to	O
bony	B-T081
anatomy	I-T081
based	I-T081
alignment	I-T081
.	O
	
for	O
all	O
h	O
cases	O
,	O
mean	O
dose	B-T081
to	O
the	O
spared	O
parotid	O
glands	O
was	O
below	O
formula	O
see	O
text	O
up	O
to	O
formula	O
see	O
text	O
with	O
bony	B-T081
alignment	I-T081
and	O
clinical	B-T081
target	I-T081
volume	I-T081
ctv	B-T081
formula	O
see	O
text	O
above	O
99.1	O
compared	O
to	O
95.1	O
.	O
	
for	O
all	O
prostate	O
patients	O
,	O
ctv	B-T081
formula	O
see	O
text	O
was	O
above	O
98.9	O
compared	O
to	O
88.5	O
and	O
formula	O
see	O
text	O
to	O
the	O
rectum	O
below	O
formula	O
see	O
text	O
compared	O
to	O
56.1	O
.	O
	
replanning	O
yielded	O
improved	O
results	O
for	O
the	O
h	O
cases	O
.	O
	
for	O
the	O
prostate	O
cases	O
,	O
differences	O
to	O
dose-guided	O
positioning	O
clinical	B-T033
and	O
radiological	O
outcome	B-T169
following	O
pneumothorax	B-T047
after	O
endoscopic	B-T061
lung	I-T061
volume	I-T061
reduction	I-T061
with	O
valves	O
valve	O
implantation	B-T061
has	O
evolved	O
as	O
a	O
therapy	B-T061
for	O
patients	O
with	O
advanced	B-T080
emphysema	B-T047
.	O
	
although	O
it	O
is	O
a	O
minimally	B-T061
invasive	I-T061
treatmen	I-T061
t	O
,	O
it	O
is	O
associated	B-T080
with	I-T080
complications	O
,	O
the	O
most	O
common	B-T081
being	O
pneumothorax	B-T047
.	O
	
pneumothorax	B-T047
occurs	O
due	O
to	O
the	O
rapid	B-T080
target	B-T169
lobe	O
volume	B-T061
reduction	I-T061
and	O
may	O
be	O
a	O
predictor	B-T078
of	O
clinical	B-T080
benefit	B-T081
despite	O
this	O
complication	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
conduct	O
an	O
exploratory	B-T080
data	I-T080
analysis	I-T080
of	O
patients	O
who	O
developed	O
a	O
pneumothorax	B-T047
following	O
endoscopic	B-T061
valve	I-T061
therapy	I-T061
for	O
emphysema	B-T047
.	O
	
this	O
study	O
performed	B-T169
a	O
retrospective	O
evaluation	O
of	O
pneumothorax	B-T047
management	O
and	O
the	O
impact	B-T080
of	O
pneumothorax	B-T047
on	O
clinical	B-T033
outcomes	I-T033
in	O
70	O
patients	O
following	O
valve	B-T061
therapy	I-T061
in	O
381	O
consecutive	B-T080
patients	O
.	O
	
pneumothorax	B-T047
rate	B-T081
following	O
valve	B-T061
therapy	I-T061
was	O
18%	O
.	O
	
pneumothorax	B-T047
management	O
consisted	O
of	O
chest	B-T061
tube	I-T061
insertion	I-T061
,	O
valve	O
removal	B-T061
,	O
and	O
surgical	B-T033
intervention	I-T033
in	O
87%	O
61/70	O
,	O
44%	O
31/70	O
,	O
and	O
19%	O
13/70	O
of	O
the	O
patients	O
,	O
respectively	O
.	O
	
despite	O
pneumothorax	B-T047
,	O
patients	O
experienced	O
modest	B-T080
but	O
significant	B-T078
improvements	O
in	O
lung	O
function	O
parameters	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
55	O
ml	O
,	O
residual	O
volume	O
-390	O
ml	O
,	O
total	B-T033
lung	I-T033
capacity	I-T033
-348	O
all	O
p<0	O
.	O
	
persistent	B-T079
lobar	O
atelectasis	O
3	O
months	O
after	O
recovering	O
from	O
pneumothorax	B-T047
,	O
which	O
was	O
associated	B-T080
with	I-T080
relevant	B-T080
clinical	B-T080
improvement	O
,	O
was	O
observed	B-T169
in	O
only	O
21%	O
15/70	O
of	O
the	O
patients	O
.	O
	
pneumothorax	B-T047
is	O
a	O
frequent	B-T079
severe	B-T080
complication	O
following	O
valve	B-T061
therapy	I-T061
that	O
requires	O
further	O
intervention	B-T061
.	O
	
nevertheless	O
,	O
the	O
pneumothorax	B-T047
does	O
not	O
impair	B-T169
the	O
clinical	B-T080
status	I-T080
in	O
the	O
majority	O
of	O
patients	O
.	O
	
patients	O
with	O
lobar	O
atelectasis	O
benefit	B-T081
after	O
recovering	O
from	O
pneumothorax	B-T047
in	O
terms	O
of	O
lung	O
function	O
parameters	O
.	O
	
3mo	O
a	O
model	O
for	O
music	O
-	O
based	B-T169
biofeedback	B-T061
in	O
the	O
domain	B-T169
of	O
sports	O
and	O
motor	O
rehabilitation	B-T169
,	O
it	O
is	O
of	O
major	B-T080
importance	B-T080
to	O
regulate	O
and	O
control	B-T169
physiological	O
processes	O
and	O
physical	O
motion	O
in	O
most	B-T081
optimal	B-T080
ways	O
.	O
	
for	O
that	O
purpose	B-T169
,	O
real-time	B-T079
auditory	O
feedback	O
of	O
physiological	B-T169
and	O
physical	B-T169
information	B-T078
based	B-T169
on	O
sound	O
signals	O
,	O
often	O
termed	O
""""	O
sonification	B-T169
""""	O
has	O
been	O
proven	B-T080
particularly	O
useful	B-T080
.	O
	
however	O
,	O
the	O
use	B-T169
of	O
music	O
in	O
biofeedback	B-T061
systems	B-T169
has	O
been	O
much	O
less	B-T081
explored	B-T061
.	O
	
in	O
the	O
current	B-T079
article	O
,	O
we	O
assert	O
that	O
the	O
use	B-T169
of	O
music	O
,	O
and	O
musical	O
principles	B-T078
,	O
can	O
have	O
a	O
major	B-T080
added	O
value	O
,	O
on	O
top	O
of	O
mere	B-T080
sound	O
signals	O
,	O
to	O
the	O
benefit	B-T081
of	O
psychological	B-T169
and	O
physical	B-T169
optimization	O
of	O
sports	O
and	O
motor	O
rehabilitation	B-T169
tasks	O
.	O
	
in	O
this	O
article	O
,	O
we	O
present	B-T078
the	O
3mo	O
model	O
to	O
describe	O
three	O
main	B-T080
functions	B-T169
of	O
music	O
that	O
contribute	O
to	O
these	O
benefits	B-T081
.	O
	
these	O
functions	B-T169
relate	O
the	O
power	B-T078
of	O
music	O
to	O
motivate	O
,	O
and	O
to	O
monitor	O
and	O
modify	B-T169
physiological	B-T169
and	O
physical	B-T169
processes	O
.	O
	
the	O
model	O
brings	O
together	O
concepts	B-T078
and	O
theories	B-T078
related	O
to	O
human	O
sensorimotor	O
interaction	O
with	O
music	O
,	O
and	O
specifies	B-T080
the	O
underlying	O
psychological	B-T169
and	O
physiological	B-T169
principles	B-T078
.	O
	
this	O
3mo	O
model	O
is	O
intended	B-T080
to	O
provide	O
a	O
conceptual	O
framework	O
that	O
guides	O
future	B-T079
research	O
on	O
musical	O
biofeedback	B-T061
systems	B-T169
in	O
the	O
domain	B-T169
of	O
sports	O
and	O
motor	O
rehabilitation	B-T169
.	O
	
analysis	O
of	O
tilianin	B-T109
and	O
acacetin	B-T109
in	O
agastache	O
rugosa	O
by	O
high-performance	O
liquid	O
chromatography	O
with	O
ionic	O
liquids	O
-	O
ultrasound	B-T169
based	O
extraction	O
ionic	O
liquid	O
1-butyl-3-methylimidazolium	B-T109
bromide	I-T109
-	O
methanol	B-T109
-based	O
ultrasonic	B-T169
-assisted	O
extraction	O
iluae	O
was	O
used	O
to	O
extract	O
tilianin	B-T109
and	O
acacetin	B-T109
from	O
the	O
aerial	O
parts	O
of	O
agastache	O
rugose	O
a	O
.	O
	
rugose	O
,	O
and	O
simultaneously	O
determined	O
by	O
reversed	O
phase	O
high	O
performance	O
liquid	O
chromatographic	O
rp-hplc	O
method	O
with	O
ultraviolet	O
detection	O
rp-hplc-uv	O
.	O
	
an	O
inertsustain	O
rp-c18	O
column	O
was	O
used	O
with	O
the	O
mobile	O
phase	O
consisting	O
of	O
methanol	B-T109
and	O
0.2	O
acetic	B-T109
acid	I-T109
as	O
gradient	B-T081
elution	O
at	O
the	O
detection	B-T081
wavelength	I-T081
of	O
332	O
nm	O
.	O
	
the	O
flow	B-T081
rate	I-T081
was	O
0.8	O
ml/min	O
,	O
and	O
the	O
column	O
temperature	B-T081
was	O
30	O
c	O
.	O
	
under	O
the	O
optimized	O
conditions	B-T080
,	O
tilianin	B-T109
and	O
acacetin	B-T109
displayed	O
good	O
linearity	O
in	O
the	O
ranges	O
of	O
0.0595	O
and	O
0.0585	O
μg/ml	O
,	O
respectively	O
,	O
with	O
the	O
average	O
recoveries	O
being	O
96.93	O
and	O
97.88	O
,	O
respectively	O
.	O
	
the	O
method	B-T169
of	O
iluae	O
was	O
compared	O
with	O
the	O
traditional	B-T169
methods	I-T169
,	O
it	O
exhibited	O
higher	B-T080
efficiency	B-T081
,	O
higher	B-T080
reproducibility	B-T080
and	O
environmental	O
friendly	O
in	O
analyzing	O
the	O
active	B-T169
compounds	O
in	O
traditional	O
chinese	O
medicines	O
tcms	O
.	O
	
evaluation	O
of	O
mif	O
-173	O
g/c	O
polymorphism	O
in	O
turkish	O
patients	O
with	O
ankylosing	B-T047
spondylitis	I-T047
ankylosing	B-T047
spondylitis	I-T047
as	B-T047
is	O
a	O
chronic	B-T047
inflammatory	I-T047
disease	I-T047
mainly	O
affecting	O
the	O
spine	O
and	O
sacroiliac	O
joints	O
.	O
	
macrophage	B-T116
migration	I-T116
inhibitory	I-T116
mif	I-T116
factor	I-T116
is	O
a	O
regulatory	O
cytokine	B-T116
that	O
inhibits	O
random	O
immune	O
cell	O
migration	O
.	O
	
mif	O
gene	O
promoter	O
polymorphisms	O
play	O
a	O
role	O
in	O
the	O
progression	O
of	O
several	O
inflammatory	B-T047
disorders	I-T047
.	O
	
to	O
investigate	B-T169
the	O
relationship	O
between	O
the	O
mif	O
gene	O
-173	O
g/c	O
single-nucleotide	O
polymorphism	O
snp	O
and	O
as	B-T047
.	O
	
cross-sectional	O
study	O
.	O
	
in	O
this	O
study	O
,	O
a	O
total	O
of	O
161	O
as	B-T047
and	O
194	O
normal	B-T080
controls	O
were	O
recruited	O
.	O
	
the	O
mif	O
gene	O
-173	O
g/c	O
snp	O
was	O
analyzed	O
by	O
polymerase	O
chain	O
reaction	O
using	O
the	O
restriction	O
fragment	O
length	O
polymorphism	O
method	O
.	O
	
there	O
was	O
no	O
significant	B-T078
difference	O
between	O
groups	O
in	O
terms	O
of	O
genotype	O
distribution	O
p>0	O
.	O
	
when	O
wild-type	O
g/g	O
and	O
g/c+c/c	O
genotypes	O
are	O
compared	O
in	O
terms	O
of	O
clinical	O
characteristics	O
,	O
there	O
is	O
a	O
significant	B-T078
difference	O
between	O
the	O
average	O
age	O
and	O
the	O
duration	B-T079
of	I-T079
disease	I-T079
in	O
as	B-T047
patients	O
p<0	O
.	O
	
no	O
significant	B-T078
relationship	O
between	O
as	B-T047
disease	B-T047
and	O
mif	O
-173	O
g/c	O
polymorphism	O
was	O
found	O
.	O
	
mif	O
-173	O
g/c	O
polymorphism	O
c	O
allele	O
may	O
affect	O
the	O
time	O
of	O
onset	O
and	O
the	O
duration	B-T079
of	I-T079
disease	I-T079
in	O
as	B-T047
patients	O
.	O
	
mechanisms	O
of	O
global	B-T080
cerebral	O
edema	O
formation	O
in	O
aneurysmal	O
subarachnoid	O
hemorrhage	O
a	O
growing	O
body	O
of	O
clinical	B-T080
literature	O
emphasizes	O
the	O
impact	O
of	O
cerebral	O
edema	O
in	O
early	O
brain	O
injury	O
following	O
aneurysmal	O
subarachnoid	O
hemorrhage	O
asah	O
.	O
	
aneurysm	B-T047
rupture	I-T047
itself	O
initiates	O
global	B-T080
cerebral	O
edema	O
in	O
up	O
to	O
two	O
thirds	O
of	O
cases	O
.	O
	
although	O
cerebral	O
edema	O
is	O
not	O
a	O
universal	O
feature	O
of	O
asah	O
,	O
it	O
portends	O
a	O
poor	O
clinical	B-T079
course	I-T079
,	O
with	O
quantitative	B-T081
analysis	I-T081
revealing	O
a	O
direct	O
correlation	O
between	O
cerebral	O
edema	O
and	O
poor	B-T033
outcome	I-T033
,	O
including	O
mortality	O
and	O
cognitive	O
deficits	O
.	O
	
mechanistically	O
,	O
global	B-T080
cerebral	O
edema	O
has	O
been	O
linked	O
to	O
global	B-T080
ischemia	O
at	O
the	O
time	O
of	O
aneurysm	B-T047
rupture	I-T047
,	O
dysfunction	O
of	O
autoregulation	O
,	O
blood	O
breakdown	O
products	O
,	O
neuroinflammation	O
,	O
and	O
hyponatremia	B-T047
/	O
endocrine	O
abnormalities	O
.	O
	
at	O
a	O
molecular	B-T080
level	B-T080
,	O
several	O
culprits	O
have	O
been	O
identified	O
,	O
including	O
aquaporin-4	B-T116
,	O
matrix	B-T116
metalloproteinase-9	I-T116
,	O
sur1	B-T116
-	O
trpm4	B-T116
cation	I-T116
channels	I-T116
,	O
vascular	B-T116
endothelial	I-T116
growth	I-T116
factor	I-T116
,	O
bradykinin	B-T116
,	O
and	O
others	O
.	O
	
here	O
,	O
we	O
review	O
these	O
cellular	O
and	O
molecular	B-T080
mechanisms	O
of	O
global	B-T080
cerebral	O
edema	O
formation	O
in	O
asah	O
.	O
	
given	O
the	O
importance	O
of	O
edema	O
to	O
the	O
outcome	O
of	O
patients	O
with	O
asah	O
and	O
its	O
status	B-T080
as	O
a	O
highly	O
modifiable	O
pathological	O
process	O
,	O
a	O
better	O
understanding	O
of	O
cerebral	O
edema	O
in	O
asah	O
promises	O
to	O
hasten	O
the	O
development	O
of	O
medical	B-T061
therapies	I-T061
to	O
improve	O
outcomes	O
in	O
this	O
frequently	O
devastating	B-T169
disease	B-T047
.	O
	
biliary	O
phospholipids	B-T109
sustain	B-T169
enterocyte	O
proliferation	O
and	O
intestinal	O
tumor	O
progression	O
via	O
nuclear	B-T116
receptor	I-T116
lrh1	B-T116
in	O
mice	O
the	O
proliferative-	O
crypt	O
compartment	O
of	O
the	O
intestinal	O
epithelium	O
is	O
enriched	O
in	O
phospholipids	B-T109
and	O
accumulation	B-T033
of	O
phospholipids	B-T109
has	O
been	O
described	O
in	O
colorectal	O
tumors	O
.	O
	
here	O
we	O
hypothesize	O
that	O
biliary	O
phospholipid	B-T109
flow	O
could	O
directly	O
contribute	O
to	O
the	O
proliferative	B-T169
power	I-T169
of	O
normal	O
and	O
dysplastic	O
enterocytes	O
.	O
	
we	O
used	O
abcb4	O
-/-	O
mice	O
which	O
lack	O
biliary	O
phospholipid	B-T109
secretion	O
.	O
	
we	O
first	O
show	O
that	O
abcb4	O
-/-	O
mice	O
are	O
protected	B-T033
against	O
intestinal	O
tumorigenesis	O
.	O
	
at	O
the	O
molecular	B-T080
level	B-T080
,	O
the	O
transcriptional	O
activity	O
of	O
the	O
nuclear	B-T116
receptor	I-T116
liver	B-T116
receptor	I-T116
homolog-1	I-T116
lrh1	B-T116
is	O
reduced	B-T080
in	O
abcb4	O
-/-	O
mice	O
and	O
its	O
re-activation	O
re-establishes	O
a	O
tumor	O
burden	B-T078
comparable	O
to	O
control	O
mice	O
.	O
	
feeding	O
abcb4	O
-/-	O
mice	O
a	O
diet	O
supplemented	O
with	O
phospholipids	B-T109
completely	O
overcomes	O
the	O
intestinal	O
tumor	O
protective	O
phenotype	O
,	O
thus	O
corroborating	O
the	O
hypothesis	O
that	O
the	O
absence	B-T169
of	O
biliary	O
phospholipids	B-T109
and	O
not	O
lack	O
of	O
abcb4	O
gene	O
per	O
se	O
is	O
responsible	O
for	O
the	O
protection	B-T033
.	O
	
in	O
turn	O
,	O
phospholipids	B-T109
cannot	O
re-establish	O
intestinal	O
tumorigenesis	O
in	O
abcb4	O
-/-	O
mice	O
crossed	O
with	O
mice	O
with	O
intestinal	O
specific	B-T080
ablation	B-T061
of	O
lrh1	B-T116
,	O
a	O
nuclear	B-T116
hormone	I-T116
receptor	I-T116
that	O
is	O
activates	O
by	O
phospholipids	B-T109
.	O
	
our	O
data	B-T078
identify	O
the	O
key	O
role	O
of	O
biliary	O
phospholipids	B-T109
in	O
sustaining	O
intestinal	O
mucosa	O
proliferation	B-T169
and	O
tumor	O
progression	O
through	O
the	O
activation	O
of	O
nuclear	B-T116
receptor	I-T116
lrh1	B-T116
.	O
	
metalloproteinase	B-T116
meprin	B-T116
α	I-T116
regulates	O
migration	O
and	O
invasion	B-T033
of	O
human	O
hepatocarcinoma	O
cells	O
and	O
is	O
a	O
mediator	O
of	O
the	O
oncoprotein	B-T116
reptin	B-T116
hepatocellular	O
carcinoma	O
is	O
associated	B-T080
with	I-T080
a	O
high	B-T080
rate	B-T081
of	O
intra-hepatic	O
invasion	B-T033
that	O
carries	O
a	O
poor	B-T033
prognosis	I-T033
.	O
	
meprin	B-T116
alpha	I-T116
mep1a	B-T116
is	O
a	O
secreted	O
metalloproteinase	B-T116
with	O
many	O
substrates	O
relevant	O
to	O
cancer	B-T033
invasion	I-T033
.	O
	
we	O
found	O
that	O
mep1a	B-T116
was	O
a	O
target	B-T169
of	O
reptin	B-T116
,	O
a	O
protein	B-T116
that	I-T116
is	I-T116
oncogenic	I-T116
in	O
hcc	O
.	O
	
we	O
studied	O
mep1a	B-T116
regulation	O
by	O
reptin	B-T116
,	O
its	O
role	O
in	O
hcc	O
,	O
and	O
whether	O
it	O
mediates	O
reptin	B-T116
oncogenic	O
effects	B-T080
.	O
	
mepa	B-T116
and	O
reptin	B-T116
expression	O
was	O
measured	O
in	O
human	O
hcc	O
by	O
qrt-pcr	O
and	O
in	O
cultured	O
cells	O
by	O
pcr	O
,	O
western	O
blot	O
and	O
enzymatic	O
activity	O
measurements	O
.	O
	
cell	O
growth	O
was	O
assessed	O
by	O
counting	O
and	O
mts	O
assay	O
.	O
	
cell	O
migration	O
was	O
measured	O
in	O
boyden	O
chambers	O
and	O
wound	O
healing	O
assays	O
,	O
and	O
cell	B-T033
invasion	I-T033
in	O
boyden	O
chambers	O
.	O
	
silencing	O
reptin	O
decreased	B-T081
mep1a	B-T116
expression	O
and	O
activity	O
,	O
without	O
affecting	O
meprin	B-T116
β	I-T116
.	O
	
mep1a	B-T116
,	O
but	O
not	O
meprin	B-T116
β	I-T116
,	O
was	O
overexpressed	O
in	O
a	O
series	O
of	O
242	O
human	O
hcc	O
2.04	O
fold	O
,	O
p	O
<	O
0.0001	O
,	O
and	O
a	O
high	B-T080
expression	O
correlated	B-T080
with	O
a	O
poor	B-T033
prognosis	I-T033
.	O
	
mep1a	B-T116
and	O
reptin	B-T116
expressions	O
were	O
positively	O
correlated	B-T080
r	O
=	O
0.39	O
,	O
p	O
<	O
0.0001	O
.	O
	
silencing	O
mep1a	O
had	O
little	O
effect	O
on	O
cell	O
proliferation	O
,	O
but	O
decreased	B-T081
cell	O
migration	O
and	O
invasion	B-T033
of	O
huh7	O
and	O
hep3b	O
cells	O
.	O
	
conversely	O
,	O
overexpression	O
of	O
mep1a	B-T116
or	O
addition	O
of	O
recombinant	O
mep1a	B-T116
increased	B-T081
migration	O
and	O
invasion	B-T033
.	O
	
finally	O
,	O
overexpression	O
of	O
mep1a	B-T116
restored	O
a	O
normal	B-T080
cell	O
migration	O
in	O
cells	O
where	O
reptin	B-T116
was	O
depleted	B-T169
.	O
	
mep1a	B-T116
is	O
overexpressed	O
in	O
most	O
hcc	O
and	O
induces	B-T169
hcc	O
cell	O
migration	O
and	O
invasion	B-T033
.	O
	
mep1a	B-T116
expression	O
is	O
regulated	O
by	O
reptin	B-T116
,	O
and	O
mep1a	B-T116
mediates	O
reptin	B-T116
-	O
induced	B-T169
migration	O
.	O
	
overall	O
,	O
we	O
suggest	O
that	O
mep1a	B-T116
may	O
be	O
a	O
useful	O
target	B-T169
in	O
psychosocial	B-T080
impact	I-T080
on	O
families	O
with	O
an	O
infant	O
with	O
a	O
hypoplastic	B-T047
left	I-T047
heart	I-T047
syndrome	I-T047
during	B-T079
and	I-T079
after	I-T079
the	I-T079
interstage	I-T079
monitoring	I-T079
period	I-T079
-	O
a	O
prospective	O
mixed-method	O
study	O
to	O
investigate	O
parents'	O
experiences	O
,	O
coping	O
ability	O
and	O
quality	B-T078
of	I-T078
life	I-T078
while	O
monitoring	O
their	O
sick	O
child	O
with	O
hypoplastic	B-T047
left	I-T047
heart	I-T047
syndrome	I-T047
at	O
home	O
.	O
	
interstage	O
home	O
monitoring	O
for	O
children	O
with	O
hypoplastic	B-T047
left	I-T047
heart	I-T047
syndrome	I-T047
reduces	O
interstage	O
mortality	B-T081
between	O
norwood	B-T061
stages	I-T061
i	I-T061
and	I-T061
ii	I-T061
.	O
	
little	O
is	O
known	O
about	O
the	O
psychosocial	B-T080
impact	I-T080
of	O
interstage	O
home	O
monitoring	O
.	O
	
prospective	O
mixed-method	O
study	O
.	O
	
this	O
study	O
assessed	O
the	O
psychosocial	B-T080
impact	I-T080
on	O
parents	O
during	O
interstage	O
home	O
monitoring	O
.	O
	
this	O
contains	O
for	O
quantitative	B-T081
assessment	I-T081
the	O
short	O
form	O
health	O
survey	O
questionnaire	O
and	O
the	O
impact	O
of	O
family	B-T033
scale	I-T033
administered	I-T033
one	O
and	O
five	O
weeks	O
following	O
discharge	O
before	B-T079
and	I-T079
after	I-T079
stage	I-T079
ii	I-T079
.	O
	
for	O
qualitative	B-T080
assessment	I-T080
,	O
semi-structured	O
interviews	O
focussing	O
on	O
the	O
postdischarge	B-T033
coping	B-T061
strategies	I-T061
were	O
conducted	O
twice	O
,	O
five	O
weeks	O
after	B-T033
hospital	I-T033
discharge	I-T033
before	B-T079
and	I-T079
after	I-T079
stage	I-T079
ii	I-T079
.	O
	
ten	O
infants	O
eight	O
males	O
with	O
hypoplastic	B-T047
left	I-T047
heart	I-T047
syndrome	I-T047
n	O
=	O
7	O
or	O
other	O
types	O
of	O
univentricular	O
heart	O
malformations	O
n	O
=	O
3	O
,	O
and	O
their	O
parents	O
nine	O
mother/father	O
two-	O
parent	O
households	O
,	O
one	O
single	O
mother	O
were	O
included	O
.	O
	
there	O
were	O
no	B-T033
interstage	I-T033
deaths	I-T033
.	O
	
mental	O
health	O
composite	B-T081
summary	I-T081
scores	I-T081
were	O
low	O
in	O
both	O
parents	O
mothers	O
40	O
9	O
fathers	O
40	O
9	O
and	O
lowest	O
for	O
the	O
item	O
'	O
vitality	B-T033
'	O
mothers	O
37	O
19	O
fathers	O
43	O
25	O
before	B-T079
and	I-T079
after	I-T079
stage	I-T079
ii	I-T079
.	O
	
impact	O
of	O
family	B-T033
scale	I-T033
values	I-T033
showed	O
higher	O
daily	O
and	O
social	B-T078
burdens	I-T078
for	O
mothers	O
.	O
	
'becoming	O
a	O
family'	O
was	O
the	O
most	O
important	O
task	O
as	O
coping	B-T061
strategy	I-T061
to	O
equilibrate	O
the	O
fragile	O
emotional	O
balance	O
.	O
	
the	O
parents	O
judged	O
interstage	O
home	O
monitoring	O
as	O
a	O
protective	B-T061
intervention	I-T061
.	O
	
although	O
psychosocial	B-T080
burden	I-T080
before	B-T079
and	I-T079
after	I-T079
stage	I-T079
ii	I-T079
remains	O
high	O
,	O
becoming	O
a	O
family	O
is	O
an	O
essential	O
experience	O
for	O
parents	O
and	O
confirms	O
their	O
parenthood	O
.	O
	
healthcare	O
professionals	O
must	O
be	O
aware	O
of	O
parents	O
'	O
needs	O
during	O
this	O
vulnerable	B-T079
interstage	I-T079
period	I-T079
and	O
to	O
provide	O
psychosocial	B-T169
and	O
nursing	B-T061
support	I-T061
.	O
	
rates	B-T081
and	O
predictors	B-T078
of	O
injury	O
in	O
a	O
population	B-T081
-	O
based	B-T169
cohort	O
of	O
people	O
living	B-T078
with	O
hiv	B-T047
injuries	O
are	O
responsible	O
for	O
10%	O
of	O
the	O
global	B-T080
burden	B-T078
of	O
disease	B-T047
however	O
,	O
the	O
epidemiology	B-T169
of	O
injury	O
among	O
people	B-T047
living	I-T047
with	I-T047
hiv	I-T047
plhiv	B-T047
has	O
not	B-T033
been	I-T033
well	I-T033
elucidated	O
.	O
	
this	O
study	O
seeks	O
to	O
characterize	O
rates	B-T081
and	O
predictors	B-T078
of	O
injury	O
among	O
plhiv	B-T047
compared	O
to	O
the	O
general	O
population	O
in	O
british	O
columbia	O
bc	O
,	O
canada	O
.	O
	
a	O
population	B-T081
-	O
based	B-T169
dataset	O
was	O
created	B-T080
via	O
linkage	O
between	O
the	O
bc	O
centre	O
for	O
excellence	O
in	O
hiv/aids	O
and	O
populationdatabc	B-T078
.	O
	
plhiv	B-T047
aged	O
20	B-T079
years	I-T079
and	O
older	B-T079
were	O
compared	O
to	O
a	O
random	B-T080
10%	O
sample	O
of	O
the	O
adult	O
general	O
population	O
.	O
	
the	O
international	B-T078
classification	O
of	O
diseases	B-T047
9	O
and	O
10	O
codes	O
were	O
used	B-T169
to	O
classify	O
unintentional	O
and	O
intentional	O
injuries	O
based	B-T169
on	O
the	O
external	B-T033
cause	I-T033
of	O
the	O
injury	O
from	O
1996	O
to	O
2013	O
.	O
	
generalized	B-T081
estimating	I-T081
equation	I-T081
gee	B-T081
poisson	B-T081
regression	I-T081
models	I-T081
were	O
fit	O
to	O
estimate	B-T081
the	O
effect	B-T080
of	O
hiv	B-T047
status	B-T080
on	O
rates	B-T081
of	O
unintentional	O
and	O
intentional	O
injury	O
,	O
and	O
to	O
identify	B-T080
correlates	B-T080
of	O
injury	O
among	O
plhiv	B-T047
.	O
	
the	O
crude	O
incidence	B-T081
rate	I-T081
of	O
unintentional	O
injury	O
was	O
18.56	O
person	O
-	O
years	B-T079
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
17.77	O
among	O
plhiv	B-T047
and	O
8.51	O
person	O
-	O
years	B-T079
95%	O
ci	B-T081
8.42	O
in	O
the	O
general	O
population	O
.	O
	
among	O
plhiv	B-T047
,	O
13.45	O
of	O
deaths	B-T033
were	O
due	B-T169
to	I-T169
injury	O
,	O
compared	O
to	O
5.52	O
of	O
deaths	B-T033
in	O
the	O
general	O
population	O
.	O
	
in	O
adjusted	O
models	B-T081
,	O
plhiv	B-T047
were	O
more	O
likely	O
to	O
report	O
unintentional	O
incidence	B-T081
rate	I-T081
ratio	B-T081
1.42	O
,	O
95%	O
ci	B-T081
1.32	O
and	O
intentional	O
injury	O
incidence	B-T081
rate	I-T081
ratio	B-T081
1.93	O
,	O
95%	O
ci	B-T081
1.70	O
compared	O
to	O
the	O
general	O
population	O
.	O
	
we	O
identified	B-T080
elevated	B-T080
rates	B-T081
of	O
intentional	O
and	O
unintentional	O
injury	O
among	O
plhiv	B-T047
.	O
	
injuries	O
are	O
largely	B-T081
preventable	O
as	O
such	O
,	O
targeted	B-T169
efforts	O
are	O
needed	B-T080
to	O
decrease	B-T081
the	O
burden	B-T078
of	O
injury	O
-	O
related	B-T080
disability	B-T033
and	O
death	B-T033
among	O
trek-1	B-T116
k2p2.1	I-T116
k	I-T116
channels	I-T116
are	O
suppressed	B-T169
in	O
patients	O
with	O
atrial	B-T047
fibrillation	I-T047
and	O
heart	B-T047
failure	I-T047
and	O
provide	O
therapeutic	B-T169
targets	I-T169
for	O
rhythm	B-T080
control	I-T080
atrial	B-T047
fibrillation	I-T047
af	B-T047
is	O
the	O
most	O
common	O
cardiac	B-T033
arrhythmia	I-T033
.	O
	
concomitant	B-T047
heart	I-T047
failure	I-T047
hf	B-T047
poses	O
a	O
particular	O
therapeutic	B-T169
challenge	O
and	O
is	O
associated	O
with	O
prolonged	B-T079
atrial	O
electrical	O
refractoriness	O
compared	O
with	O
non-failing	O
hearts	O
.	O
	
we	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	O
trek-1	B-T116
k2p2.1	I-T116
k	I-T116
channels	I-T116
contributes	O
to	O
electrical	O
remodeling	O
during	O
af	B-T047
with	O
hf	B-T047
,	O
and	O
that	O
trek-1	O
gene	O
transfer	O
would	O
provide	O
rhythm	B-T080
control	I-T080
via	O
normalization	O
of	O
atrial	B-T033
effective	I-T033
refractory	I-T033
periods	I-T033
in	O
this	O
af	B-T047
subset	O
.	O
	
in	O
patients	O
with	O
chronic	B-T047
af	I-T047
and	O
hf	B-T047
,	O
atrial	B-T116
trek-1	I-T116
mrna	O
levels	B-T080
were	O
reduced	O
by	O
82%	O
left	O
atrium	O
and	O
81%	O
right	O
atrium	O
compared	O
with	O
sinus	B-T033
rhythm	I-T033
sr	B-T033
subjects	O
.	O
	
human	O
findings	B-T033
were	O
recapitulated	O
in	O
a	O
porcine	O
model	O
of	O
atrial	B-T047
tachypacing-induced	I-T047
af	I-T047
and	O
reduced	B-T080
left	O
ventricular	O
function	O
.	O
	
trek-1	B-T116
mrna	O
-66%	O
and	O
protein	B-T116
-61%	O
was	O
suppressed	B-T169
in	O
af	B-T047
animals	O
at	O
14-day	O
follow-up	O
compared	O
with	O
sr	B-T033
controls	O
.	O
	
downregulation	O
of	O
repolarizing	O
trek-1	B-T116
channels	I-T116
was	O
associated	O
with	O
prolongation	B-T079
of	O
atrial	B-T033
effective	I-T033
refractory	I-T033
periods	I-T033
versus	O
baseline	B-T081
conditions	O
,	O
consistent	B-T078
with	I-T078
prior	B-T079
observations	O
in	O
humans	O
with	O
hf	B-T047
.	O
	
in	O
a	O
preclinical	B-T080
therapeutic	B-T169
approach	I-T169
,	O
pigs	O
were	O
randomized	O
to	O
either	O
atrial	B-T061
ad-trek-1	I-T061
gene	I-T061
therapy	I-T061
or	O
sham	B-T061
treatment	I-T061
.	O
	
gene	O
transfer	O
effectively	B-T080
increased	B-T081
trek-1	B-T116
protein	I-T116
levels	B-T080
and	O
attenuated	O
atrial	B-T033
effective	I-T033
refractory	I-T033
period	I-T033
prolongation	B-T079
in	O
the	O
porcine	O
af	O
model	O
.	O
	
ad-trek-1	B-T116
increased	O
the	O
sr	B-T033
prevalence	B-T081
to	O
62%	O
during	O
follow-up	O
in	O
af	B-T047
animals	O
,	O
compared	O
to	O
35%	O
in	O
the	O
untreated	O
af	B-T047
group	O
.	O
	
in	O
conclusion	B-T078
,	O
trek-1	B-T116
downregulation	O
and	O
rhythm	B-T080
control	I-T080
by	O
ad-trek-1	O
transfer	O
suggest	B-T078
mechanistic	B-T061
and	I-T061
potential	I-T061
therapeutic	I-T061
significance	B-T078
of	O
trek-1	B-T116
channels	I-T116
in	O
a	O
subgroup	O
of	O
af	B-T047
patients	O
with	O
hf	B-T047
and	O
prolonged	B-T079
atrial	B-T033
effective	I-T033
refractory	I-T033
periods	I-T033
.	O
	
functional	B-T169
correction	I-T169
of	O
ionic	O
remodeling	O
through	O
trek-1	B-T061
gene	I-T061
therapy	I-T061
represents	O
a	O
novel	B-T080
paradigm	O
to	O
optimize	O
and	O
specify	O
af	B-T047
a	O
rasch	O
rating	O
scale	O
analysis	O
of	O
the	O
presence	B-T033
of	O
nursing	O
scale	B-T081
-	O
rn	O
the	O
phenomenon	O
of	O
nursing	O
presence	B-T033
encompasses	O
the	O
emotional	B-T033
connection	O
between	O
nurse	O
and	O
patient	O
,	O
and	O
technical	B-T169
skills	I-T169
performed	B-T169
by	O
the	O
nurse	O
.	O
	
the	O
presence	B-T033
of	O
nursing	O
scale	B-T081
-	O
rn	O
version	O
pons	B-T081
-	O
rn	O
was	O
developed	B-T169
to	O
measure	B-T081
nurses'	O
perceptions	O
of	O
their	O
ability	O
to	O
be	O
present	B-T033
to	O
their	O
patients	O
.	O
	
this	O
study	O
summarizes	O
the	O
process	O
of	O
re-evaluation	O
of	O
the	O
psychometric	O
properties	O
of	O
the	O
pons	B-T081
-	O
rn	O
instrument	O
.	O
	
a	O
sample	O
of	O
76	O
registered	O
nurses	O
providing	O
direct	B-T080
patient	O
care	O
responded	O
to	O
the	O
31-	O
item	O
questionnaire	O
.	O
	
the	O
rasch	O
rating	O
scale	O
model	O
was	O
used	O
for	O
assessing	O
construct	B-T080
validity	I-T080
of	O
pons	B-T081
-	O
rn	O
data	B-T078
.	O
	
a	O
principal	B-T081
component	I-T081
analysis	I-T081
pca	B-T081
of	O
residuals	B-T080
supported	O
appropriateness	B-T080
of	O
the	O
subscales	B-T081
defined	O
by	O
a	O
2-dimensional	O
structure	O
.	O
	
the	O
results	B-T033
of	O
item	O
and	O
person	O
fit	O
analysis	O
,	O
rating	B-T081
scale	I-T081
functioning	B-T169
analysis	O
and	O
reliability	O
analysis	O
have	O
demonstrated	B-T080
that	O
the	O
thirty-one	O
item	O
presence	B-T033
of	O
nursing	O
scale	B-T081
-	O
rn	O
instrument	O
yielded	O
measures	B-T081
with	O
high	B-T080
validity	O
and	O
reliability	O
as	O
two	O
sub-scales	B-T081
.	O
	
jou	O
elastin	B-T116
is	O
differentially	O
regulated	O
by	O
pressure	B-T061
therapy	I-T061
in	O
a	O
porcine	O
model	O
of	O
hypertrophic	O
scar	O
beneficial	B-T080
effects	I-T080
of	O
pressure	B-T061
therapy	I-T061
for	O
hypertrophic	O
scars	O
have	O
been	O
reported	O
,	O
but	O
the	O
mechanisms	B-T169
of	O
action	O
are	O
not	O
fully	O
understood	O
.	O
	
this	O
study	O
evaluated	O
elastin	B-T116
and	O
its	O
contribution	O
to	O
scar	O
pliability	B-T080
.	O
	
the	O
relationship	B-T080
between	O
changes	O
in	O
vancouver	O
scar	O
scale	O
vss	O
scores	B-T081
of	O
pressure-treated	B-T061
scars	O
and	O
differential	O
regulation	O
of	O
elastin	B-T116
was	O
assessed	O
.	O
	
hypertrophic	O
scars	O
were	O
created	O
and	O
assessed	O
weekly	B-T079
using	O
vss	O
and	O
biopsy	O
procurement	B-T033
.	O
	
pressure	B-T061
treatment	I-T061
began	O
on	O
day	B-T079
70	O
postinjury	B-T079
.	O
	
treated	B-T061
scars	O
were	O
compared	O
with	O
untreated	O
shams	B-T061
.	O
	
treatment	B-T061
lasted	O
2	O
weeks	B-T079
,	O
through	O
day	B-T079
84	O
,	O
and	O
scars	O
were	O
assessed	O
weekly	B-T079
through	O
day	B-T079
126	O
.	O
	
transcript	O
and	O
protein	O
levels	O
of	O
elastin	B-T116
were	O
quantified	B-T081
.	O
	
pressure	B-T061
treatment	I-T061
resulted	O
in	O
lower	O
vss	O
scores	B-T081
compared	O
with	O
sham-treated	B-T061
scars	O
.	O
	
pliability	B-T080
vssp	B-T080
was	O
a	O
key	O
contributor	O
to	O
this	O
difference	O
.	O
	
at	O
day	B-T079
70	O
pretreatment	O
,	O
vssp	B-T080
=	O
2	O
.	O
	
without	B-T061
treatment	I-T061
,	O
sham-treated	B-T061
scars	O
became	O
less	O
pliable	B-T080
,	O
while	O
pressure-treated	B-T061
scars	O
became	O
more	O
pliable	B-T080
.	O
	
the	O
percentage	O
of	O
elastin	B-T116
in	O
scars	O
at	O
day	B-T079
70	O
was	O
higher	O
than	O
in	O
uninjured	O
skin	O
.	O
	
following	O
treatment	B-T061
,	O
the	O
percentage	O
of	O
elastin	B-T116
increased	B-T081
and	O
continued	O
to	O
increase	B-T169
through	O
day	B-T079
126	O
.	O
	
untreated	O
sham	B-T061
scars	O
did	O
not	O
show	O
a	O
similar	O
increase	B-T169
.	O
	
quantification	B-T081
of	O
verhoeff-van	O
gieson	O
staining	O
corroborated	O
the	O
findings	B-T033
and	O
immunofluorescence	O
revealed	O
the	O
alignment	B-T081
of	O
elastin	B-T116
fibers	I-T116
.	O
	
pressure	B-T061
treatment	I-T061
results	O
in	O
increased	B-T081
protein	O
level	O
expression	O
of	O
elastin	B-T116
compared	O
with	O
sham	B-T061
-untreated	O
scars	O
.	O
	
these	O
findings	B-T033
further	O
characterize	O
the	O
extracellular	O
matrix's	O
response	O
to	O
the	O
application	O
of	O
pressure	O
as	O
a	O
scar	O
treatment	B-T061
,	O
which	O
will	O
contribute	O
to	O
the	O
refinement	O
of	O
rehabilitation	B-T169
practices	O
and	O
ultimately	O
improvements	O
in	O
functional	B-T169
and	O
psychosocial	B-T169
outcomes	B-T169
for	O
epigenome-wide	O
analysis	O
links	O
smad3	O
methylation	O
at	O
birth	O
to	O
asthma	B-T047
in	I-T047
children	I-T047
of	O
asthmatic	B-T047
mothers	O
the	O
timing	O
and	O
mechanisms	B-T169
of	O
asthma	B-T047
inception	B-T169
remain	O
imprecisely	O
defined	O
.	O
	
although	O
epigenetic	O
mechanisms	B-T169
likely	O
contribute	O
to	O
asthma	B-T047
pathogenesis	O
,	O
little	O
is	O
known	O
about	O
their	O
role	O
in	O
asthma	B-T047
inception	B-T169
.	O
	
we	O
sought	O
to	O
assess	O
whether	O
the	O
trajectory	O
to	O
asthma	B-T047
begins	O
already	O
at	O
birth	O
and	O
whether	O
epigenetic	O
mechanisms	B-T169
,	O
specifically	O
dna	O
methylation	O
,	O
contribute	O
to	O
asthma	B-T047
inception	B-T169
.	O
	
we	O
used	O
the	O
methylated	O
cpg	O
island	O
recovery	O
assay	O
chip	O
to	O
survey	O
dna	O
methylation	O
in	O
cord	O
blood	O
mononuclear	O
cells	O
from	O
36	O
children	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	B-T047
subjects	O
by	O
age	O
9	O
years	B-T079
from	O
the	O
infant	O
immune	B-T169
study	O
iis	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	B-T047
for	O
a	O
decade	O
.	O
	
smad3	O
methylation	O
in	O
iis	O
n	O
=	O
60	O
and	O
in	O
2	O
replication	O
cohorts	O
the	O
manchester	O
asthma	B-T047
and	O
allergy	O
study	O
n	O
=	O
30	O
and	O
the	O
childhood	B-T047
origins	I-T047
of	I-T047
asthma	I-T047
study	O
n	O
=	O
28	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	O
or	O
illumina	O
450k	O
arrays	O
.	O
	
cord	O
blood	O
mononuclear	O
cell	O
-derived	O
il-1β	B-T116
levels	B-T080
were	O
measured	B-T080
by	O
means	O
of	O
elisa	O
.	O
	
neonatal	O
immune	B-T169
cells	O
harbored	O
589	O
differentially	O
methylated	O
regions	O
that	O
distinguished	O
iis	O
children	O
who	O
did	O
and	O
did	O
not	O
have	O
asthma	B-T047
by	O
age	O
9	O
years	B-T079
.	O
	
in	O
all	O
3	O
cohorts	O
methylation	O
in	O
smad3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	B-T047
-	O
associated	B-T080
,	O
differentially	O
methylated	O
regions	O
,	O
was	O
selectively	O
increased	B-T081
in	O
asthmatic	B-T047
children	O
of	O
asthmatic	B-T047
mothers	O
and	O
was	O
associated	B-T080
with	I-T080
childhood	B-T047
asthma	I-T047
risk	B-T078
.	O
	
moreover	O
,	O
smad3	O
methylation	O
in	O
iis	O
neonates	O
with	O
maternal	O
asthma	B-T047
was	O
strongly	O
and	O
positively	O
associated	B-T080
with	I-T080
neonatal	O
production	O
of	O
il-1β	B-T116
,	O
an	O
innate	O
inflammatory	O
mediator	O
.	O
	
the	O
trajectory	O
to	O
childhood	B-T047
asthma	I-T047
begins	O
at	O
birth	O
and	O
involves	O
epigenetic	O
modifications	B-T169
in	O
immunoregulatory	O
and	O
proinflammatory	B-T169
pathways	O
.	O
	
maternal	O
asthma	B-T047
influences	O
epigenetic	O
mechanisms	B-T169
that	O
contribute	O
to	O
the	O
inception	B-T169
clinical	B-T080
correlates	B-T080
of	O
faecal	B-T047
incontinence	I-T047
in	O
systemic	B-T047
sclerosis	I-T047
identifying	O
therapeutic	O
avenues	O
the	O
aim	O
was	O
to	O
establish	O
the	O
prevalence	B-T081
and	O
severity	B-T080
of	O
faecal	B-T047
incontinence	I-T047
fi	B-T047
in	O
ssc	B-T047
,	O
its	O
association	B-T080
with	O
other	O
intestinal	O
manifestations	B-T169
and	O
potential	B-T080
predictors	B-T078
of	O
fi	B-T047
,	O
and	O
its	O
impact	B-T080
on	O
quality	B-T078
of	I-T078
life	I-T078
.	O
	
a	O
multicentre	O
,	O
cross-sectional	O
study	O
of	O
298	O
ssc	B-T047
subjects	O
followed	O
in	O
the	O
canadian	O
scleroderma	O
research	O
group	O
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
jorge-wexner	O
score	O
an	O
fi	B-T047
severity	O
scale	O
,	O
bristol	O
stool	O
scale	O
a	O
visual	O
scale	O
of	O
stool	B-T033
consistency	I-T033
and	O
fi	B-T047
quality-of-life	O
scale	O
.	O
	
constipation	O
was	O
defined	O
by	O
the	O
rome	O
iii	O
criteria	O
.	O
	
associations	B-T080
between	O
the	O
jorge-wexner	O
score	O
and	O
other	O
clinical	B-T033
variables	I-T033
were	O
determined	O
using	O
multivariate	O
regression	O
analyses	O
.	O
	
eighty-one	O
27.2	O
subjects	O
had	O
fi	B-T047
,	O
which	O
was	O
mild	B-T080
in	O
37	O
12.4	O
and	O
moderate	B-T080
to	I-T080
severe	I-T080
in	O
44	O
14.8	O
.	O
	
most	O
patients	O
had	O
well-formed	O
stools	O
,	O
111	O
38.8	O
reported	O
constipation	O
and	O
38	O
13.4	O
had	O
been	O
previously	B-T079
treated	B-T169
for	O
small	B-T047
intestinal	I-T047
bacterial	I-T047
overgrowth	I-T047
sibo	B-T047
.	O
	
variables	B-T080
independently	B-T078
associated	B-T080
with	I-T080
fi	B-T047
were	O
loose	O
vs	O
well-formed	O
stools	O
odds	B-T081
ratio	I-T081
or	B-T081
=	O
7.01	O
,	O
95%	O
ci	B-T081
2.09	O
,	O
23.51	O
,	O
constipation	O
or	B-T081
=	O
3.64	O
,	O
95%	O
ci	B-T081
1.61	O
,	O
8.27	O
,	O
p	B-T081
=	O
0.002	O
,	O
history	B-T033
of	O
sibo	B-T047
or	B-T081
=	O
2.97	O
,	O
95%	O
ci	B-T081
1.06	O
,	O
8.27	O
and	O
urinary	O
incontinence	O
or	B-T081
=	O
2.45	O
,	O
95%	O
ci	B-T081
1.14	O
,	O
5.27	O
.	O
	
quality	B-T078
of	I-T078
life	I-T078
measured	B-T080
with	O
the	O
fi	B-T047
quality-of-life	O
scale	O
was	O
inversely	B-T080
correlated	B-T080
with	O
fi	B-T047
severity	B-T080
correlation	B-T080
coefficients	B-T081
between	O
-0	O
and	O
-0	O
,	O
p	B-T081
<	O
0.001	O
.	O
	
fi	B-T047
was	O
common	B-T081
and	O
often	O
severe	B-T080
in	O
ssc	B-T047
.	O
	
loose	O
stools	O
,	O
sibo	B-T047
,	O
constipation	O
and	O
urinary	O
incontinence	O
were	O
strongly	B-T080
associated	B-T080
with	I-T080
fi	B-T047
.	O
	
other	O
than	O
targeting	B-T169
anorectal	O
dysfunction	O
,	O
concomitant	B-T079
treatment	B-T061
of	O
clinical	B-T080
correlates	B-T080
could	O
lead	O
to	O
improvement	O
in	O
fi	B-T047
and	O
quality	B-T078
of	I-T078
life	I-T078
in	O
from	O
training	O
to	O
practice	O
the	O
impact	B-T080
of	O
engage	O
,	O
ireland's	O
national	O
men's	O
health	O
training	O
programme	O
ireland's	O
national	O
men's	O
health	O
policy	O
recommended	B-T078
developing	O
training	O
programmes	O
tailored	O
to	O
the	O
needs	B-T080
of	O
those	O
working	O
in	O
health	O
and	O
allied	O
health	O
professionals	O
and	O
engage	O
was	O
developed	O
to	O
meet	O
that	O
recommendation	B-T078
.	O
	
this	O
study	O
evaluated	O
the	O
impact	B-T080
of	O
engage	O
on	O
frontline	O
service	O
providers'	O
self-reported	B-T033
knowledge	I-T033
,	O
skills	O
,	O
capacity	B-T081
and	O
practice	O
up	O
to	O
5-months	O
post	B-T079
training	O
.	O
	
between	O
2012	O
and	O
2015	O
,	O
engage	O
trainers	O
n	O
=	O
57	O
delivered	O
62	O
1-day	O
training	O
programmes	O
to	O
810	O
participants	O
.	O
	
this	O
study	O
was	O
conducted	O
on	O
a	O
subset	O
of	O
those	O
training	O
days	O
n	O
=	O
26	O
and	O
participants	O
.	O
	
quantitative	B-T081
methodologies	O
were	O
used	O
to	O
collect	O
pre	O
n	O
=	O
295	O
,	O
post	B-T079
n	O
=	O
295	O
and	O
5-month	O
post	B-T079
n	O
=	O
128	O
training	O
questionnaire	O
data	O
.	O
	
overall	B-T080
,	O
participants	O
were	O
highly	O
satisfied	O
with	O
the	O
training	O
immediately	B-T079
post	B-T079
training	O
8.60	O
1.60	O
out	O
of	O
10	O
and	O
at	O
5-month	O
follow	B-T033
up	I-T033
8.06	O
1.43	O
out	O
of	O
10	O
.	O
	
participants'	O
self-reported	B-T033
level	I-T033
of	I-T033
knowledge	I-T033
,	O
skill	O
and	O
capacity	B-T081
in	O
identifying	O
priorities	B-T079
,	O
engaging	O
men	O
and	O
influencing	O
practice	O
beyond	O
their	O
own	O
organisation	O
increased	B-T081
immediately	B-T079
following	O
training	O
p	O
<	O
0.001	O
and	O
,	O
with	O
the	O
exception	O
of	O
improving	B-T080
capacity	B-T081
to	O
engage	O
men	O
and	O
influencing	O
practice	O
beyond	O
their	O
organisation	O
,	O
these	O
improvements	O
were	O
sustained	B-T169
at	O
5-month	O
post	B-T079
training	O
p	O
<	O
0.001	O
.	O
	
the	O
vast	O
majority	O
of	O
service	O
providers	O
93.4	O
reported	O
that	O
engage	O
had	O
impacted	B-T080
their	O
work	O
practice	O
up	O
to	O
5-month	O
post	B-T079
training	O
.	O
	
the	O
findings	B-T033
suggest	B-T078
that	O
engage	O
has	O
succeeded	B-T033
in	O
improving	B-T080
service	O
providers'	O
capacity	B-T081
to	O
engage	O
and	O
work	O
with	O
men	O
improving	B-T080
gender	O
competency	B-T080
in	O
the	O
delivery	O
of	O
health	B-T078
and	O
health	O
related	O
services	O
may	O
increase	B-T081
the	O
utilisation	O
of	O
such	O
services	O
by	O
men	O
and	O
thereby	O
improve	B-T033
health	O
outcomes	O
for	O
double	O
strand	O
break	O
induction	B-T169
and	O
kinetics	O
indicate	O
preserved	O
hypersensitivity	O
in	O
keratinocytes	O
to	O
subtherapeutic	B-T169
doses	B-T081
for	O
7	O
weeks	B-T079
of	O
radiotherapy	B-T061
previously	O
we	O
reported	O
that	O
hyper-radiosensitivity	O
hrs	O
was	O
evidenced	O
by	O
quantifying	B-T081
dna	O
double	O
strand	O
break	O
dsb	O
foci	O
in	O
epidermis	O
biopsies	O
collected	O
after	O
delivering	O
radiotherapeutic	O
one	O
and	O
five	O
dose	B-T081
fractions	I-T081
.	O
	
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
hrs	O
was	O
preserved	O
throughout	O
a	O
7-	O
week	B-T079
radiotherapy	B-T061
treatment	B-T061
,	O
and	O
also	O
to	O
examine	O
the	O
rate	O
of	O
foci	O
decline	O
and	O
foci	O
persistence	O
between	O
dose	B-T081
fractions	I-T081
.	O
	
42	O
patients	O
with	O
prostate	O
cancer	O
received	O
7-	O
week	B-T079
fractionated	O
radiotherapy	B-T061
treatment	I-T061
rt	B-T061
with	O
daily	O
dose	B-T081
fractions	I-T081
of	O
0.05	O
to	O
the	O
skin	O
.	O
	
before	O
rt	B-T061
,	O
and	O
at	O
several	O
times	O
throughout	O
treatment	B-T061
,	O
skin	O
biopsies	O
n=452	O
were	O
collected	O
at	O
30min	O
,	O
and	O
2	O
,	O
3	O
,	O
24	O
,	O
and	O
72h	O
after	O
dose	B-T081
fractions	I-T081
.	O
	
dsb-foci	O
markers	O
,	O
γh2ax	O
and	O
53bp1	O
,	O
were	O
labelled	O
in	O
epidermal	O
keratinocytes	O
with	O
immunofluorescence	O
and	O
immunohistochemical	O
staining	O
.	O
	
foci	O
were	O
counted	O
both	O
with	O
digital	O
image	O
analysis	O
and	O
manually	O
.	O
	
hrs	O
in	O
keratinocytes	O
was	O
evidenced	O
by	O
the	O
dose-response	O
relationships	O
of	O
dsb	O
foci	O
,	O
observed	O
throughout	O
the	O
treatment	B-T079
course	I-T079
,	O
independent	B-T169
of	I-T169
sampling	O
time	B-T079
and	O
quantification	B-T081
method	O
.	O
	
foci	O
observed	O
at	O
24h	O
after	O
dose	B-T081
fractions	I-T081
indicated	O
considerable	O
dsb	O
persistence	O
.	O
	
accordingly	O
,	O
foci	O
significantly	O
accumulated	O
after	O
5	O
consecutive	O
dose	B-T081
fractions	I-T081
.	O
	
for	O
doses	B-T081
below	O
0.3gy	O
,	O
persistent	O
foci	O
could	O
be	O
observed	O
even	O
at	O
72h	O
after	O
damage	O
induction	B-T169
.	O
	
a	O
comparison	O
of	O
γh2ax	O
and	O
53bp1	O
quantifications	B-T081
in	O
double-staine	B-T080
d	O
biopsies	O
showed	O
similar	O
hrs	O
dose-response	O
relationships	O
.	O
	
these	O
results	O
represented	O
the	O
first	O
evidence	B-T078
of	O
preserved	O
hrs	O
,	O
assessed	O
by	O
γh2ax	O
-	O
and	O
53bp1	O
-labelled	O
dsb	O
foci	O
,	O
throughout	O
a	O
7-	O
week	B-T079
treatment	B-T079
course	I-T079
with	O
daily	B-T079
repeated	O
subtherapeutic	B-T169
dose	B-T081
fractions	I-T081
.	O
	
ct	O
angiography	O
for	O
planning	B-T169
transcatheter	B-T061
aortic	I-T061
valve	I-T061
replacement	I-T061
using	O
automated	B-T081
tube	I-T081
voltage	I-T081
selection	I-T081
image	B-T080
quality	I-T080
and	O
radiation	O
exposure	B-T080
to	O
assess	O
image	B-T080
quality	I-T080
and	O
accuracy	B-T080
of	O
ct	O
angiography	O
cta	O
for	O
transcatheter	B-T061
aortic	I-T061
valve	I-T061
replacement	I-T061
tavr	B-T061
planning	B-T169
performed	O
with	O
3rd	O
generation	O
dual-source	O
ct	O
dsct	O
.	O
	
we	O
evaluated	O
125	O
patients	O
who	O
underwent	O
tavr	B-T061
-	O
planning	B-T169
cta	O
on	O
3rd	O
generation	O
dsct	O
.	O
	
a	O
two-part	B-T061
protocol	I-T061
was	O
performed	O
including	O
retrospectively	B-T080
ecg-gated	O
coronary	O
cta	O
ccta	O
and	O
prospectively	B-T080
ecg-triggered	O
aortoiliac	O
cta	O
using	O
60ml	O
of	O
contrast	O
medium	O
.	O
	
automated	B-T081
tube	I-T081
voltage	I-T081
selection	I-T081
and	O
advanced	O
iterative	O
reconstruction	O
were	O
applied	O
.	O
	
effective	B-T081
dose	I-T081
ed	B-T081
,	O
signal-to-noise	B-T081
snr	B-T081
and	O
contrast-to-noise	B-T081
ratios	I-T081
cnr	B-T081
were	O
calculated	O
.	O
	
five-point	O
scales	O
were	O
used	O
for	O
subjective	B-T080
image	O
quality	O
analysis	O
.	O
	
in	O
patients	O
who	O
underwent	O
tavr	B-T061
,	O
sizing	B-T033
parameters	I-T033
were	O
obtained	O
.	O
	
image	B-T080
quality	I-T080
was	O
rated	O
good	O
to	O
excellent	O
in	O
97.6	O
of	O
ccta	O
and	O
100%	O
of	O
aortoiliac	O
ctas	O
.	O
	
cta	O
studies	O
at	O
>100kv	O
showed	O
decreased	B-T081
objective	B-T080
image	B-T080
quality	I-T080
compared	O
to	O
70-100kv	O
snr	B-T081
,	O
all	O
p	O
cnr	B-T081
,	O
all	O
p	O
.	O
	
mean	B-T081
ed	B-T081
increased	B-T081
continuously	O
from	O
70	O
to	O
>100kv	O
ccta	O
4.5	O
,	O
all	O
p	O
aortoiliac	O
cta	O
2.4	O
,	O
all	O
p	O
.	O
	
in	O
39	O
patients	O
tavr	B-T061
was	O
performed	O
and	O
annulus	O
diameter	B-T081
was	O
within	O
the	O
recommended	O
range	O
in	O
all	O
patients	O
.	O
	
no	B-T033
severe	B-T080
cardiac	O
or	O
vascular	O
complications	O
were	O
noted	O
.	O
	
3rd	O
generation	O
dsct	O
provides	O
diagnostic	B-T169
image	B-T080
quality	I-T080
in	O
tavr	B-T061
-	O
planning	B-T169
cta	O
and	O
facilitates	O
reliable	O
assessment	O
of	O
tavr	B-T061
device	O
and	O
delivery	B-T169
option	O
while	O
reducing	B-T080
radiation	B-T081
dose	I-T081
.	O
	
a	O
giant	O
aneurysmal	B-T047
bone	I-T047
cyst	I-T047
in	O
the	O
mandibular	O
condyle	O
aneurysmal	B-T047
bone	I-T047
cyst	I-T047
abc	B-T047
is	O
a	O
rare	B-T080
,	O
rapidly	B-T080
expanding	O
,	O
locally	O
destructive	O
,	O
and	O
easily	B-T033
misdiagnosed	B-T033
lesion	B-T033
.	O
	
an	O
abc	B-T047
of	O
the	O
condyle	O
is	O
rare	B-T080
.	O
	
this	O
report	O
presents	O
a	O
25-	O
year	B-T079
-	O
old	B-T079
female	O
with	O
a	O
giant	O
abc	B-T047
in	O
the	O
left	O
mandibular	O
condyle	O
.	O
	
this	O
patient	O
was	O
treated	O
with	O
surgical	O
resection	O
of	O
the	O
affected	O
bone	O
and	O
immediate	O
mandibular	O
reconstruction	O
using	O
autologous	O
bone	O
.	O
	
follow-up	O
to	O
date	O
showed	O
no	O
signs	O
of	O
recurrence	O
.	O
	
the	O
clinical	O
feature	O
,	O
imaging	O
finding	O
,	O
pathogenesis	O
,	O
and	O
treatment	O
methods	O
of	O
abcs	O
are	O
association	B-T080
between	O
postpartum	O
depression	O
and	O
the	O
practice	O
of	O
exclusive	O
breastfeeding	O
in	O
the	O
first	O
three	O
months	B-T079
of	O
life	B-T078
to	O
investigate	B-T169
the	O
association	B-T080
between	O
postpartum	O
depression	O
and	O
the	O
occurrence	B-T079
of	O
exclusive	O
breastfeeding	O
.	O
	
this	O
is	O
a	O
cross-sectional	O
study	O
conducted	O
in	O
the	O
states	O
of	O
the	O
northeast	O
region	O
,	O
during	O
the	O
vaccination	O
campaign	O
in	O
2010	O
.	O
	
the	O
sample	O
consisted	O
of	O
2583	O
mother	O
-	O
child	O
pairs	B-T080
,	O
with	O
children	O
aged	O
from	O
15	O
days	B-T079
to	O
3	O
months	B-T079
.	O
	
the	O
edinburgh	O
postnatal	O
depression	O
scale	O
was	O
used	O
to	O
screen	O
for	O
postpartum	O
depression	O
.	O
	
the	O
outcome	B-T169
was	O
lack	B-T080
of	O
exclusive	O
breastfeeding	O
,	O
defined	O
as	O
the	O
occurrence	B-T079
of	O
this	O
practice	B-T078
in	O
the	O
24h	O
preceding	B-T079
the	O
interview	O
.	O
	
postpartum	O
depression	O
was	O
the	O
explanatory	O
variable	O
of	O
interest	O
and	O
the	O
covariates	O
were	O
socioeconomic	O
and	O
demographic	B-T078
conditions	I-T078
maternal	O
health	O
care	O
prenatal	O
,	O
delivery	B-T061
,	O
and	O
postnatal	O
care	O
and	O
the	O
child's	B-T080
biological	I-T080
factors	I-T080
.	O
	
multivariate	B-T081
logistic	I-T081
regression	I-T081
analysis	I-T081
was	O
conducted	O
to	O
control	O
for	O
possible	O
confounding	B-T169
factors	I-T169
.	O
	
exclusive	O
breastfeeding	O
was	O
observed	B-T169
in	O
50.8	O
of	O
the	O
infants	O
and	O
11.8	O
of	O
women	O
had	O
symptoms	O
of	O
postpartum	O
depression	O
.	O
	
in	O
the	O
multivariate	B-T081
logistic	I-T081
regression	I-T081
analysis	I-T081
,	O
a	O
higher	O
chance	O
of	O
exclusive	O
breastfeeding	O
absence	B-T169
was	O
found	O
among	O
mothers	O
with	O
symptoms	O
of	O
postpartum	O
depression	O
or=1	O
p<0	O
,	O
among	O
younger	O
subjects	O
or=1	O
p<0	O
,	O
those	O
who	O
reported	O
receiving	O
benefits	B-T081
from	O
the	O
bolsa	O
família	O
program	O
or=1	O
p=0	O
,	O
and	O
those	O
started	O
antenatal	O
care	O
later	O
during	O
pregnancy	O
or=2	O
p=0	O
.	O
	
postpartum	O
depression	O
contributed	O
to	O
reducing	B-T080
the	O
practice	B-T078
of	O
exclusive	O
breastfeeding	O
.	O
	
therefore	O
,	O
this	O
disorder	B-T047
should	O
be	O
included	O
in	O
the	O
prenatal	O
and	O
early	B-T079
postpartum	I-T079
support	O
guidelines	O
for	O
breastfeeding	O
,	O
especially	O
in	O
low	B-T081
socioeconomic	I-T081
status	I-T081
women	O
.	O
	
evidence	B-T169
of	I-T169
toothpick	O
groove	O
formation	B-T169
in	O
neandertal	O
anterior	O
and	O
posterior	O
teeth	O
during	O
the	O
microscopic	O
examination	O
of	O
the	O
neandertal	O
dentitions	O
from	O
el	O
sidrón	O
spain	O
and	O
hortus	O
france	O
,	O
we	O
found	O
unusual	B-T080
fine	O
parallel	O
microstriations	O
on	O
the	O
mesial	O
and	O
distal	O
sides	O
of	O
all	O
tooth	O
types	O
,	O
near	O
the	O
cervix	O
.	O
	
as	O
its	O
appearance	O
was	O
similar	B-T080
to	O
toothpick	O
grooves	O
described	O
in	O
other	O
homo	O
species	O
,	O
it	O
could	O
correspond	O
to	O
early	B-T079
stages	I-T079
on	O
its	O
formation	B-T169
.	O
	
to	O
test	O
this	O
hypothesis	O
we	O
developed	O
an	O
experimental	O
replication	O
of	O
a	O
groove	O
using	O
grass	O
stalks	O
.	O
	
comparisons	O
between	O
204	O
isolated	B-T169
neandertal	O
teeth	O
and	O
the	O
two	O
experimental	B-T080
dental	B-T080
specimens	O
corroborate	O
that	O
the	O
marks	O
correspond	O
to	O
initial	B-T079
stages	I-T079
of	O
toothpick	O
groove	O
formation	B-T169
,	O
and	O
we	O
propose	O
a	O
five-grade	O
recording	O
scale	O
that	O
summarized	O
the	O
groove	O
formation	B-T169
process	I-T169
.	O
	
using	O
this	O
new	O
recording	O
procedure	O
,	O
we	O
found	O
that	O
hortus	O
individuals	O
have	O
higher	O
incidence	B-T081
of	O
this	O
trait	O
eight	O
individuals	O
out	O
of	O
nine	O
than	O
the	O
el	O
sidrón	O
individuals	O
nine	O
out	O
of	O
11	O
.	O
	
toothpick	O
grooves	O
from	O
el	O
sidrón	O
show	O
the	O
earliest	B-T079
stages	I-T079
of	O
development	B-T169
,	O
whereas	O
the	O
grooves	O
found	O
on	O
hortus	O
neandertals	O
were	O
well-developed	B-T080
.	O
	
toothpick	O
grooves	O
were	O
also	O
found	O
in	O
21	O
incisors	O
and	O
canines	O
.	O
	
these	O
differences	B-T080
could	O
be	O
due	O
to	O
the	O
more	O
advanced	O
occlusal	O
dental	O
wear	O
in	O
hortus	O
individuals	O
,	O
maybe	O
age	O
-related	O
and	O
with	O
a	O
more	O
meat	O
-based	O
diet	O
maybe	O
favoring	O
the	O
inclusion	O
of	O
food	O
debris	O
and	O
thus	O
probing	B-T169
as	O
the	O
cleaning	O
methodology	O
.	O
	
our	O
results	O
allow	O
the	O
identification	B-T080
and	O
characterization	O
of	O
incipient	B-T079
toothpick	O
grooves	O
on	O
the	O
human	O
fossil	O
record	O
and	O
contribute	O
to	O
increase	B-T169
our	O
knowledge	O
on	O
neandertals	O
behavioral	O
and	O
oral	B-T033
care	I-T033
habits	I-T033
.	O
	
thsd7a	B-T116
expression	O
in	O
human	O
cancer	O
we	O
recently	O
described	O
a	O
case	O
of	O
a	O
thrombospondin	B-T116
type-1	I-T116
domain	I-T116
containing	I-T116
7a	I-T116
thsd7a	B-T116
associated	O
membranous	B-T047
nephropathy	I-T047
in	O
a	O
female	O
patient	O
who	O
was	O
synchronously	B-T079
suffering	O
from	O
a	O
thsd7a	B-T116
-	O
positive	B-T033
malignancy	B-T080
.	O
	
we	O
here	O
investigated	O
the	O
role	O
of	O
thsd7a	B-T116
as	O
a	O
new	O
potential	O
tumor	B-T116
antigen	I-T116
by	O
evaluating	O
over	O
20	O
000	O
tissue	O
spots	O
in	O
more	O
than	O
70	O
different	O
tumor	B-T033
entities	I-T033
by	O
immunohistochemistry	O
using	O
tissue	O
microarrays	O
.	O
	
thsd7a	B-T116
expression	O
was	O
highly	O
variable	O
in	O
different	O
neoplasias	O
with	O
differing	O
staining	O
patterns	O
.	O
	
both	O
gain	B-T033
and	I-T033
loss	I-T033
of	O
thsd7a	B-T116
expression	O
compared	O
to	O
expression	O
status	O
in	O
non-tumor	O
tissue	O
were	O
linked	O
to	O
tumor-specific	O
markers	O
in	O
the	O
different	O
tumor	B-T033
entities	I-T033
and	O
were	O
of	O
prognostic	B-T081
value	I-T081
.	O
	
the	O
potential	O
role	O
of	O
thsd7a	B-T116
in	O
tumor	B-T033
development	I-T033
and	O
therapy	B-T061
civil	O
society	O
-driven	O
drug	O
policy	O
reform	O
for	O
health	B-T078
and	O
human	O
welfare	O
-	O
india	O
the	O
lack	B-T080
of	O
adequate	B-T080
access	O
to	O
opioids	B-T109
in	O
india	O
as	O
analgesics	B-T109
and	O
for	O
agonist	O
therapies	B-T061
,	O
forces	O
millions	O
to	O
live	O
with	O
severe	B-T080
unalleviated	O
pain	O
,	O
or	O
languish	B-T080
with	O
suffering	O
associated	O
with	O
drug	O
dependence	O
.	O
	
although	O
india	O
is	O
a	O
major	O
opium	B-T109
exporter	O
,	O
the	O
excessively	O
prohibitive	O
1985	O
narcotics	O
law	O
formulated	O
to	O
control	B-T080
harmful	O
use	O
of	O
drugs	O
,	O
impeded	O
the	O
availability	B-T169
and	O
access	O
to	O
opioids	B-T109
for	O
medical	O
and	O
scientific	O
purposes	B-T169
.	O
	
amendment	O
of	O
this	O
law	O
in	O
2014	O
established	O
a	O
new	O
national	O
regulatory	O
framework	O
for	O
improved	O
access	O
to	O
essential	B-T080
opioid	B-T109
analgesics	I-T109
.	O
	
this	O
article	O
reflects	O
on	O
key	O
elements	O
and	O
processes	O
that	O
led	O
to	O
this	O
landmark	O
achievement	O
.	O
	
unlike	O
quick	O
timelines	O
associated	O
with	O
effecting	O
policy	O
reforms	O
for	O
law	O
enforcement	O
,	O
realizing	O
the	O
2014	O
drug	O
policy	O
change	O
primarily	O
to	O
mitigate	O
human	O
suffering	O
,	O
was	O
a	O
22-year-long	O
process	O
.	O
	
the	O
most	O
exacting	O
challenges	O
included	O
recognizing	O
the	O
multilayered	B-T033
complexities	I-T033
of	O
the	O
prior	O
policy	O
framework	O
and	O
understanding	O
their	O
adverse	B-T080
impact	O
on	O
field	O
practices	O
to	O
chart	O
an	O
appropriate	O
and	O
viable	O
path	O
for	O
reform	O
.	O
	
the	O
evolution	O
of	O
an	O
informal	O
civil	O
society	O
movement	O
involving	O
health	O
care	O
professionals	O
,	O
lawyers	O
,	O
media	O
,	O
policy	O
analysts	O
,	O
government	O
officials	O
,	O
and	O
the	O
public	O
was	O
pivotal	O
in	O
addressing	O
these	O
challenges	O
and	O
garnering	O
momentum	O
for	O
reform	O
.	O
	
the	O
success	O
of	O
the	O
effort	O
for	O
improving	O
access	B-T080
to	O
opioid	B-T109
medications	O
was	O
underpinned	O
by	O
a	O
three-pronged	O
strategy	O
of	O
1	O
persuading	O
the	O
executive	O
arm	O
of	O
the	O
government	O
to	O
take	O
interim	B-T079
enabling	O
measures	O
2	O
leveraging	O
judicial	O
intervention	O
through	O
public	O
interest	O
litigation	O
and	O
3	O
crafting	O
a	O
viable	O
policy	O
document	O
for	O
legislative	O
approval	O
and	O
implementation	O
.	O
	
we	O
hope	O
our	O
findings	O
are	O
useful	O
for	O
realizing	O
drug	O
policy	O
reforms	O
,	O
given	O
the	O
current	O
transformed	O
global	B-T080
policy	O
mandates	O
emphasizing	O
humanitarian	O
,	O
healthcare	O
,	O
and	O
quality-of-life	B-T078
considerations	B-T033
.	O
	
efficacy	B-T080
of	O
synbiotics	O
for	O
treatment	B-T061
of	O
bacillary	B-T047
dysentery	I-T047
in	O
children	O
a	O
double-blind	O
,	O
randomized	O
,	O
placebo-controlled	O
study	O
bacillary	B-T047
dysentery	I-T047
is	O
a	O
major	O
cause	O
of	O
children's	O
admission	O
to	O
hospitals	O
.	O
	
to	O
assess	O
the	O
probiotic	O
and	O
prebiotic	B-T109
synbiotics	O
effects	B-T080
in	O
children	O
with	O
dysentery	B-T047
in	O
a	O
randomized	O
clinical	O
trial	O
,	O
200	O
children	O
with	O
dysentery	B-T047
were	O
studied	O
in	O
2	O
groups	B-T078
the	O
synbiotic	O
group	B-T078
received	O
1	O
tablet	O
/day	B-T079
of	O
synbiotic	O
for	O
3-5	O
days	B-T079
and	O
the	O
placebo	O
group	B-T078
received	O
placebo	O
tablets	O
identical	O
tablet	O
form	O
like	O
probiotics	O
.	O
	
the	O
standard	B-T080
treatment	B-T061
was	O
administered	B-T169
for	O
all	O
patients	O
.	O
	
duration	B-T079
of	O
hospitalization	O
,	O
dysentery	B-T047
,	O
fever	O
,	O
and	O
the	O
weight	B-T033
loss	I-T033
were	O
assessed	O
in	O
each	O
group	B-T078
.	O
	
it	O
was	O
concluded	O
that	O
there	O
was	O
no	B-T033
significant	I-T033
difference	I-T033
in	O
both	O
groups	B-T078
in	O
the	O
baseline	B-T081
characteristics	B-T080
.	O
	
the	O
mean	B-T079
duration	I-T079
of	O
dysentery	B-T047
reduced	B-T080
p	O
<	O
0.05	O
.	O
	
the	O
mean	B-T079
duration	I-T079
of	O
fever	O
has	O
been	O
significantly	O
reduced	B-T080
in	O
the	O
synbiotic	O
group	B-T078
1.64	O
0.87	O
days	B-T079
in	O
comparison	O
to	O
the	O
placebo	O
group	B-T078
2.13	O
0.94	O
days	B-T079
p	O
<	O
0.001	O
.	O
	
average	B-T081
amount	I-T081
of	O
weight	B-T033
loss	I-T033
was	O
significantly	O
lower	O
in	O
the	O
synbiotic	O
group	B-T078
in	O
comparison	O
to	O
that	O
in	O
the	O
placebo	O
group	B-T078
129.5	O
23.388	O
grams	O
and	O
278	O
28.385	O
grams	O
,	O
resp	O
p	O
<	O
0.001	O
.	O
	
there	O
was	O
no	B-T033
significant	I-T033
difference	I-T033
in	O
the	O
mean	B-T079
duration	I-T079
of	O
hospitalization	O
in	O
both	O
groups	B-T078
p	O
>	O
0.05	O
.	O
	
the	O
use	O
of	O
synbiotics	O
as	O
an	O
adjuvant	B-T061
therapy	I-T061
to	O
the	O
standard	B-T080
treatment	B-T061
of	O
dysentery	B-T047
significantly	O
reduces	B-T080
the	O
duration	B-T079
of	O
dysentery	B-T047
,	O
fever	O
,	O
and	O
rate	B-T033
of	I-T033
weight	I-T033
losses	I-T033
.	O
	
the	O
trial	O
is	O
registered	O
effect	B-T080
of	O
type	B-T047
2	I-T047
diabetes	I-T047
mellitus	I-T047
on	O
the	O
pharmacokinetics	B-T169
and	O
transplacental	O
transfer	O
of	O
nifedipine	B-T109
in	O
hypertensive	B-T047
pregnant	O
women	O
diabetes	B-T047
mellitus	I-T047
can	O
inhibit	O
cytochrome	B-T116
p450	I-T116
3a4	I-T116
,	O
an	O
enzyme	B-T116
responsible	O
for	O
the	O
metabolism	O
of	O
nifedipine	B-T109
,	O
used	O
for	O
the	O
treatment	B-T061
of	O
hypertension	B-T047
in	O
pregnant	O
women	O
.	O
	
we	O
aimed	B-T078
to	O
assess	O
the	O
effect	B-T080
of	O
type	B-T047
2	I-T047
diabetes	I-T047
mellitus	I-T047
t2dm	B-T047
on	O
the	O
pharmacokinetics	B-T169
,	O
placental	O
transfer	O
and	O
distribution	O
of	O
nifedipine	B-T109
in	O
amniotic	O
fluid	O
in	O
hypertensive	B-T047
pregnant	O
women	O
.	O
	
the	O
study	O
was	O
conducted	O
in	O
12	O
hypertensive	B-T047
pregnant	O
women	O
control	O
group	O
cg	O
and	O
10	O
hypertensive	B-T047
pregnant	O
women	O
with	O
t2dm	B-T047
taking	O
slow-release	O
nifedipine	B-T109
20	O
mg	O
,	O
12/12	O
h	O
.	O
	
on	O
the	O
34th	O
week	B-T079
of	O
gestation	O
,	O
serial	O
blood	O
samples	O
were	O
collected	O
0-12	O
h	O
after	O
administration	B-T061
of	O
the	O
medication	O
.	O
	
at	B-T079
delivery	I-T079
,	O
samples	O
of	O
maternal	O
and	O
fetal	O
blood	O
and	O
amniotic	O
fluid	O
were	O
collected	O
for	O
determination	O
of	O
nifedipine	B-T109
distribution	O
in	O
these	O
compartments	O
.	O
	
the	O
median	B-T081
pharmacokinetic	B-T169
parameters	O
of	O
cg	O
were	O
peak	B-T081
plasma	I-T081
concentration	I-T081
cmax	B-T081
26.41	O
ng	O
ml	O
,	O
time	B-T081
to	I-T081
reach	I-T081
cmax	I-T081
tmax	B-T081
1.79	O
h	O
,	O
area	B-T081
under	I-T081
the	I-T081
plasma	I-T081
concentration	I-T081
vs	O
.	O
	
time	B-T081
curve	I-T081
from	O
0-12	O
h	O
auc	B-T081
0-12	O
235.99	O
ng.h	O
ml	O
,	O
half-life	B-T079
t½	O
4.34	O
h	O
,	O
volume	B-T081
of	I-T081
distribution	I-T081
divided	O
by	O
bioavailability	B-T081
vd	B-T081
/	O
f	B-T081
560.96	O
l	O
,	O
and	O
clt	O
/	O
f	B-T081
84.77	O
l	O
h	O
.	O
	
the	O
parameters	O
for	O
t2dm	B-T047
group	O
were	O
cmax	B-T081
23.52	O
ng	O
ml	O
,	O
tmax	B-T081
1.48	O
h	O
,	O
auc	B-T081
0-12	O
202.23	O
ng.h	O
ml	O
,	O
t½	O
5.00	O
h	O
,	O
vd	B-T081
/	O
f	B-T081
609.40	O
l	O
,	O
and	O
apparent	O
total	O
clearance	O
clt	O
/	O
f	B-T081
98.94	O
l	O
h	O
.	O
	
the	O
ratios	B-T081
of	O
plasma	B-T081
concentrations	I-T081
of	O
nifedipine	B-T109
in	O
the	O
umbilical	O
vein	O
,	O
intervillous	O
space	O
and	O
amniotic	O
fluid	O
to	O
those	O
in	O
the	O
maternal	O
vein	O
for	O
cg	O
and	O
t2dm	B-T047
were	O
0.53	O
and	O
0.44	O
,	O
0.78	O
and	O
0.87	O
,	O
respectively	O
,	O
with	O
an	O
amniotic	O
fluid	O
/	O
maternal	O
plasma	O
ratio	B-T081
of	O
0.05	O
for	O
both	O
groups	O
.	O
	
the	O
ratios	B-T081
of	O
plasma	B-T081
concentrations	I-T081
in	O
the	O
umbilical	O
artery	O
to	O
those	O
in	O
the	O
umbilical	O
vein	O
were	O
0.82	O
for	O
cg	O
and	O
0.88	O
for	O
t2dm	B-T047
.	O
	
there	O
was	O
no	O
influence	O
of	O
t2dm	B-T047
on	O
the	O
pharmacokinetics	B-T169
or	O
placental	O
transfer	O
of	O
nifedipine	B-T109
in	O
hypertensive	B-T047
women	O
with	O
controlled	B-T033
diabetes	B-T047
.	O
	
results	B-T169
of	O
an	O
international	O
postmarketing	O
surveillance	O
study	O
of	O
pl-vegf165	O
safety	O
and	O
efficacy	B-T080
in	O
210	O
patients	O
with	O
peripheral	B-T047
arterial	I-T047
disease	I-T047
the	O
effective	O
treatment	B-T061
of	O
chronic	B-T079
lower	O
limb	O
ischemia	O
is	O
one	O
of	O
the	O
most	O
challenging	O
issues	O
confronting	O
vascular	O
surgeons	O
.	O
	
current	O
pharmacological	B-T169
therapies	B-T061
play	O
an	O
auxiliary	O
role	O
and	O
cannot	O
prevent	O
disease	O
progression	O
,	O
and	O
new	O
treatment	B-T061
methods	I-T061
are	O
needed	O
.	O
	
pl-vegf165	O
,	O
a	O
gene	B-T061
therapy	I-T061
drug	O
,	O
was	O
approved	O
in	O
russia	O
for	O
the	O
treatment	B-T061
of	O
atherosclerotic	B-T169
peripheral	B-T047
arterial	I-T047
disease	I-T047
pad	B-T047
after	O
clinical	O
studies	O
in	O
2011	O
.	O
	
the	O
study	O
drug	O
is	O
an	O
original	O
gene	O
construction	O
in	O
which	O
pl-vegf165	O
1.2	O
mg	O
is	O
the	O
active	O
substance	O
.	O
	
this	O
postmarketing	O
surveillance	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
safety	O
identification	O
of	O
uncommon	O
side	O
effects	O
and	O
efficacy	B-T080
of	O
gene	B-T061
therapy	I-T061
in	O
patients	O
in	O
routine	O
clinical	O
practice	O
.	O
	
in	O
total	O
,	O
210	O
patients	O
with	O
stage	B-T079
ii-iii	I-T079
chronic	B-T079
limb	O
ischemia	O
according	O
to	O
the	O
fontaine	O
classification	O
modified	O
by	O
av	O
pokrovsky	O
in	O
33	O
healthcare	O
facilities	O
in	O
russia	O
and	O
the	O
ukraine	O
were	O
enrolled	O
in	O
the	O
study	O
.	O
	
the	O
control	O
group	O
n	O
=	O
60	O
received	O
conservative	B-T061
therapy	I-T061
without	O
prostaglandins	B-T109
and	O
prostacyclins	B-T109
,	O
and	O
the	O
treatment	O
group	O
n	O
=	O
150	O
received	O
treatment	B-T061
with	O
pl-vegf165	O
as	O
two	O
intramuscular	B-T169
injections	I-T169
for	O
a	O
total	O
dose	B-T081
of	O
2.4	O
mg	O
.	O
	
pain-free	B-T033
walking	I-T033
distance	I-T033
pwd	B-T033
the	O
primary	O
efficacy	B-T080
criterion	O
for	O
fontaine	O
stages	B-T079
ii-iii	I-T079
,	O
blood	B-T033
flow	I-T033
linear	I-T033
velocity	I-T033
bflv	B-T033
,	O
and	O
ankle-brachial	O
index	O
abi	O
were	O
monitored	O
for	O
6	O
months	B-T079
.	O
	
the	O
safety	O
of	O
pl-vegf165	O
gene	O
transfer	O
in	O
terms	O
of	O
the	O
trial	O
protocol	O
was	O
initially	O
evaluated	O
6	O
months	B-T079
after	O
the	O
start	O
of	O
the	O
study	O
adverse	O
events	O
aes	O
and	O
serious	O
adverse	O
events	O
saes	O
were	O
recorded	O
during	O
both	O
routine	O
visits	O
and	O
unscheduled	O
requests	O
for	O
medical	O
care	O
.	O
	
overall	O
,	O
pwd	B-T033
increased	O
by	O
177%	O
,	O
from	O
100.3	O
6.9	O
to	O
277.1	O
16.2	O
m	O
p	O
=	O
0.0001	O
,	O
in	O
the	O
treatment	O
group	O
,	O
whereas	O
the	O
mean	B-T081
value	O
was	O
unchanged	O
in	O
the	O
control	O
group	O
p	O
=	O
0.218	O
.	O
	
both	O
bflv	B-T033
and	O
abi	O
values	O
increased	O
by	O
24%	O
p	O
=	O
0.0001	O
in	O
the	O
treatment	O
group	O
but	O
decreased	O
in	O
the	O
control	O
group	O
.	O
	
the	O
greatest	O
therapeutic	O
effect	O
was	O
observed	O
for	O
stage	B-T080
iii	I-T080
disease	B-T047
pwd	B-T033
increased	O
by	O
683%	O
p	O
=	O
0.0001	O
.	O
	
no	B-T033
angiogenic	B-T061
therapy	I-T061
-related	O
aes	O
or	O
side	O
effects	O
were	O
recorded	O
,	O
and	O
target	O
limb	B-T061
salvage	I-T061
was	O
96	O
and	O
97%	O
in	O
the	O
treatment	O
and	O
control	O
groups	O
,	O
respectively	O
.	O
	
the	O
results	B-T169
obtained	O
in	O
this	O
study	O
are	O
not	O
significantly	O
different	O
from	O
those	O
observed	O
in	O
the	O
phase	O
iib	O
/	O
iii	O
registration	O
clinical	O
study	O
completed	O
in	O
2011	O
.	O
	
pl-vegf165	O
intramuscular	O
gene	O
transfer	O
is	O
an	O
effective	O
treatment	B-T061
for	O
moderate	O
to	O
severe	O
claudication	B-T047
due	O
to	O
chronic	B-T079
lower	O
limb	O
ischemia	O
in	O
routine	O
clinical	O
practice	O
.	O
	
psychological	O
factors	O
associated	B-T080
with	I-T080
nafld	B-T047
/	O
nash	B-T047
a	O
systematic	O
review	O
nonalcoholic	B-T047
fatty	I-T047
liver	I-T047
disease	I-T047
nafld	B-T047
represents	O
one	O
of	O
the	O
most	O
common	O
chronic	B-T047
liver	I-T047
diseases	I-T047
worldwide	O
.	O
	
so	O
far	O
,	O
the	O
pathogenesis	O
of	O
nafld	B-T047
and	O
its	O
more	O
severe	B-T080
variant	O
nonalcoholic	B-T047
steatohepatitis	I-T047
nash	B-T047
is	O
yet	O
unclear	O
,	O
with	O
many	O
mechanisms	B-T169
being	O
proposed	O
as	O
possible	O
causes	O
.	O
	
this	O
article	O
aims	O
to	O
review	B-T078
the	O
psychological	O
factors	O
associated	B-T080
with	I-T080
nafld	B-T047
/	O
nash	B-T047
.	O
	
three	O
main	O
categories	O
of	O
factors	B-T169
have	O
been	O
investigated	B-T169
emotional	B-T033
,	O
cognitive	B-T169
and	O
behavioral	O
.	O
	
five	O
electronic	O
databases	O
were	O
searched	O
,	O
limited	O
to	O
studies	O
published	O
in	O
the	O
english	O
language	O
,	O
during	O
the	O
period	B-T079
2005-2015	O
pubmed	O
,	O
thomson	O
isi	O
-	O
web	O
of	O
science	O
,	O
scopus	O
,	O
proquest	O
,	O
and	O
sciencedirect	O
.	O
	
results	O
indicated	O
the	O
most	O
relevant	O
emotional	B-T033
factors	B-T169
to	O
be	O
depression	O
and	O
anxiety	B-T033
.	O
	
the	O
areas	O
of	O
investigation	B-T169
for	O
cognitive	O
functioning	O
concern	O
those	O
contents	O
and	O
processes	O
related	O
to	O
the	O
ability	O
to	O
initiate	B-T169
and	O
maintain	O
lifestyle	O
changes	O
.	O
	
the	O
most	O
important	O
behavioral	O
factors	B-T169
identified	O
are	O
physical	O
activity	O
,	O
nutrition	O
/	O
food	O
intake	O
and	O
substance	O
consumption	O
coffee	O
,	O
alcohol	O
,	O
cigarettes	O
.	O
	
some	O
of	O
the	O
factors	B-T169
identified	O
act	O
as	O
protective	O
factors	O
,	O
other	O
as	O
vulnerability	B-T033
factors	I-T033
.	O
	
nafld	B-T047
/	O
nash	B-T047
may	O
be	O
considered	O
a	O
cognitive-behavioral	O
disease	O
,	O
the	O
most	O
effective	O
management	O
being	O
lifestyle	O
changes	O
,	O
with	O
emphasis	O
on	O
diet	O
and	O
an	O
approach	O
to	O
functionally	O
relevant	O
clustering	B-T169
of	O
the	O
protein	B-T116
universe	I-T116
active	B-T169
site	I-T169
profile-based	I-T169
clustering	I-T169
of	O
protein	B-T116
structures	I-T116
and	O
sequences	O
protein	O
function	O
identification	O
remains	O
a	O
significant	O
problem	O
.	O
	
solving	O
this	O
problem	O
at	O
the	O
molecular	B-T080
functional	I-T080
level	I-T080
would	O
allow	O
mechanistic	O
determinant	O
identification-	O
amino	B-T116
acids	I-T116
that	O
distinguish	O
details	O
between	O
functional	B-T078
families	I-T078
within	O
a	O
superfamily	B-T078
.	O
	
active	O
site	O
profiling	O
was	O
developed	O
to	O
identify	O
mechanistic	O
determinants	O
.	O
	
dasp	O
and	O
dasp2	O
were	O
developed	O
as	O
tools	O
to	O
search	O
sequence	O
databases	O
using	O
active	O
site	O
profiling	O
.	O
	
here	O
,	O
tulip	O
two-level	O
iterative	O
clustering	O
process	O
is	O
introduced	O
as	O
an	O
iterative	O
,	O
divisive	O
clustering	B-T169
process	I-T169
that	O
utilizes	O
active	O
site	O
profiling	O
to	O
separate	O
structurally	O
characterized	O
superfamily	B-T078
members	O
into	O
functionally	O
relevant	O
clusters	B-T081
.	O
	
underlying	O
tulip	O
is	O
the	O
observation	O
that	O
functionally	B-T078
relevant	I-T078
families	I-T078
curated	O
by	O
structure-function	O
linkage	O
database	O
,	O
sfld	O
self-identify	O
in	O
dasp2	O
searches	O
clusters	B-T081
containing	O
multiple	B-T078
functional	I-T078
families	I-T078
do	O
not	O
.	O
	
each	O
tulip	O
iteration	O
produces	O
candidate	O
clusters	B-T081
,	O
each	O
evaluated	O
to	O
determine	O
if	O
it	O
self-identifies	O
using	O
dasp2	O
.	O
	
if	O
so	O
,	O
it	O
is	O
deemed	O
a	O
functionally	B-T078
relevant	I-T078
group	I-T078
.	O
	
divisive	O
clustering	B-T169
continues	O
until	O
each	O
structure	O
is	O
either	O
a	O
functionally	B-T078
relevant	I-T078
group	I-T078
member	O
or	O
a	O
singlet	O
.	O
	
tulip	O
is	O
validated	O
on	O
enolase	B-T116
and	O
glutathione	B-T116
transferase	I-T116
structures	B-T116
,	O
superfamilies	B-T078
well-curated	O
by	O
sfld	O
.	O
	
correlation	B-T080
is	O
strong	O
small	O
numbers	O
of	O
structures	O
prevent	O
statistically	O
significant	O
analysis	O
.	O
	
tulip	O
-identified	O
enolase	B-T116
clusters	B-T081
are	O
used	O
in	O
dasp2	O
genbank	O
searches	O
to	O
identify	O
sequences	O
sharing	O
functional	O
site	O
features	O
.	O
	
analysis	O
shows	O
a	O
true	O
positive	O
rate	O
of	O
96%	O
,	O
false	O
negative	O
rate	O
of	O
4%	O
,	O
and	O
maximum	O
false	O
positive	O
rate	O
of	O
4%	O
.	O
	
f-measure	B-T081
and	O
performance	O
analysis	O
on	O
the	O
enolase	B-T116
search	O
results	O
and	O
comparison	O
to	O
gemma	O
and	O
sci-phy	O
demonstrate	O
that	O
tulip	O
avoids	O
the	O
over-division	O
problem	O
of	O
these	O
methods	O
.	O
	
mechanistic	O
determinants	O
for	O
enolase	B-T116
families	I-T116
are	O
evaluated	O
and	O
shown	O
to	O
correlate	O
well	O
with	O
literature	O
early	B-T079
high	O
school	O
engagement	O
in	O
students	O
with	O
attention/deficit	O
hyperactivity	O
disorder	O
students	O
with	O
attention/deficit	O
hyperactivity	O
disorder	O
adhd	O
continue	O
to	O
languish	O
behind	O
their	O
peers	O
with	O
regard	O
to	O
academic	O
achievement	O
and	O
education	B-T033
attainment	I-T033
.	O
	
school	O
engagement	O
is	O
potentially	O
modifiable	O
,	O
and	O
targeting	O
engagement	O
may	O
be	O
a	O
means	O
to	O
improve	O
education	O
outcomes	B-T169
.	O
	
to	O
investigate	O
school	O
engagement	O
for	O
students	O
with	O
adhd	O
during	O
the	O
crucial	O
high	B-T078
school	I-T078
transition	I-T078
period	B-T079
and	O
to	O
identify	O
factors	O
associated	O
with	O
low	B-T033
school	I-T033
engagement	I-T033
.	O
	
participants	O
are	O
adolescents	O
12-15	O
years	B-T079
in	O
the	O
first	O
and	O
third	O
year	B-T079
of	O
high	O
school	O
with	O
diagnosed	O
adhd	O
n	O
=	O
130	O
.	O
	
participants	O
were	O
recruited	O
from	O
21	O
paediatric	O
practices	O
.	O
	
cross-sectional	O
study	O
assessing	O
school	O
engagement	O
.	O
	
data	B-T078
were	O
collected	O
through	O
direct	O
assessment	O
and	O
child	O
,	O
parent	O
,	O
and	O
teacher	O
surveys	O
.	O
	
school	O
engagement	O
is	O
measured	O
as	O
student	O
attitudes	O
to	O
school	O
cognitive	O
and	O
emotional	O
and	O
suspension	B-T033
rates	B-T081
behavioural	O
.	O
	
multivariable	O
regression	O
analyses	O
examined	O
student	O
,	O
family	O
,	O
and	O
school	O
factors	O
affecting	O
engagement	O
.	O
	
in	O
comparison	O
with	O
state	O
data	O
,	O
students	O
with	O
adhd	O
in	O
the	O
first	O
year	B-T079
of	O
high	O
school	O
were	O
less	O
motivated	O
p	O
<	O
01	O
and	O
less	O
connected	O
to	O
peers	O
p	O
<	O
01	O
.	O
	
overall	O
,	O
there	O
was	O
no	O
discordance	O
in	O
third	O
year	B-T079
attitudes	O
.	O
	
there	O
were	O
high	B-T033
rates	I-T033
of	I-T033
suspension	I-T033
in	O
both	O
years	B-T079
in	O
comparison	O
to	O
state-wide	O
suspensions	B-T033
21%	O
vs	O
.	O
	
6%	O
,	O
p	O
<	O
01	O
.	O
	
explanatory	O
factors	O
for	O
poor	O
attitudes	O
include	O
adolescent	O
depression	O
,	O
poor	O
adolescent	O
supervision	B-T061
,	O
and	O
devaluing	O
education	O
.	O
	
conduct	O
problems	O
and	O
increased	O
hyperactivity	O
were	O
related	O
to	O
increased	B-T033
likelihood	I-T033
of	I-T033
being	I-T033
suspended	I-T033
,	O
whilst	O
higher	O
cognitive	O
ability	O
,	O
family	O
socio-economic	B-T080
status	I-T080
,	O
and	O
independent	O
schools	O
reduced	O
risk	B-T078
.	O
	
potentially	O
modifiable	O
individual	O
and	O
family	O
factors	B-T033
including	O
adolescent	O
depression	O
,	O
behavioural	O
problems	O
,	O
education	O
values	B-T080
,	O
and	O
family	O
supervision	B-T061
could	O
be	O
targeted	O
to	O
better	O
manage	O
the	O
high	B-T078
school	I-T078
transition	I-T078
for	O
students	O
with	O
proliferation	O
-related	O
activity	O
in	O
endothelial	O
cells	O
is	O
enhanced	O
by	O
micropower	O
plasma	O
nonthermal	O
plasma	O
has	O
received	O
a	O
lot	O
of	O
attention	O
as	O
a	O
medical	O
treatment	O
technique	O
in	O
recent	O
years	O
.	O
	
it	O
can	O
easily	O
create	O
various	O
reactive	O
chemical	O
species	O
ros	O
and	O
is	O
harmless	O
to	O
living	O
body	O
.	O
	
although	O
plasma	O
at	O
gas	O
-	O
liquid	O
interface	O
has	O
a	O
potential	O
for	O
a	O
biomedical	O
application	O
,	O
the	O
interactions	O
between	O
the	O
gas	O
-	O
liquid	O
plasma	O
and	O
living	O
cells	O
remain	O
unclear	O
.	O
	
here	O
,	O
we	O
show	O
characteristics	O
of	O
a	O
micropower	O
plasma	O
with	O
0.018	O
w	O
of	O
the	O
power	O
input	O
,	O
generated	O
at	O
gas	O
-	O
liquid	O
interface	O
.	O
	
we	O
also	O
provide	O
the	O
evidence	O
of	O
plasma	O
-induced	O
enhancement	O
in	O
proliferation	O
activity	O
of	O
endothelial	O
cells	O
.	O
	
the	O
plasma	O
produced	O
h2o2	O
,	O
hno2	O
,	O
and	O
hno3	O
in	O
phosphate	O
buffered	O
saline	O
containing	O
mg	O
and	O
ca	O
pbs	O
+	O
,	O
and	O
their	O
concentration	O
increased	O
linearly	O
during	O
600-second	O
discharge	O
.	O
	
the	O
value	O
of	O
ph	O
in	O
pbs	O
+	O
against	O
the	O
plasma	O
discharge	O
time	O
was	O
stable	O
at	O
about	O
7.0	O
.	O
	
temperature	O
in	O
pbs	O
+	O
rose	O
monotonically	O
,	O
and	O
its	O
rise	O
was	O
up	O
to	O
0.8	O
at	O
the	O
bottom	O
of	O
a	O
cell-cultured	O
dish	O
by	O
the	O
plasma	O
discharge	O
for	O
600	O
s	O
.	O
	
short-time	O
treatment	O
of	O
the	O
plasma	O
enhanced	O
proliferation	O
activity	O
of	O
endothelial	O
cells	O
.	O
	
in	O
contrast	O
,	O
the	O
treatment	O
of	O
h2o2	O
does	O
not	O
enhance	O
the	O
cell	O
proliferation	O
.	O
	
thus	O
,	O
the	O
ros	O
production	O
and	O
the	O
nuclear	O
factor-kappa	O
b	O
nf-κb	O
activation	O
due	O
to	O
the	O
plasma	O
treatment	O
might	O
be	O
related	O
to	O
enhancement	O
of	O
the	O
cell	O
proliferation	O
.	O
	
our	O
results	O
may	O
potentially	O
provide	O
the	O
basis	O
for	O
developing	O
the	O
biomedical	O
applications	O
using	O
the	O
gas	O
-	O
liquid	O
plasma	O
ph	B-T081
-dependent	O
transmembrane	O
activity	O
of	O
peptide	B-T116
-functionalized	O
gold	O
nanostars	O
for	O
computed	O
tomography	O
/	O
photoacoustic	O
imaging	O
and	O
photothermal	B-T061
therapy	I-T061
progress	B-T169
in	O
multifunctional	O
nanomaterials	O
for	O
tumor	B-T061
therapy	I-T061
mostly	O
depends	O
on	O
the	O
development	B-T169
of	O
tumor	O
-	O
targeting	B-T169
delivery	B-T061
strategies	I-T061
.	O
	
one	O
approach	B-T169
is	O
to	O
explore	O
a	O
ph	B-T081
-responsive	O
strategy	B-T169
to	O
target	B-T169
the	O
slightly	O
acidic	O
solid	O
tumor	O
microenvironment	O
.	O
	
a	O
novel	O
class	O
of	O
ph	B-T116
low	I-T116
insertion	I-T116
peptides	I-T116
phlips	B-T116
with	O
ph	B-T081
-dependent	O
transmembrane	O
activity	O
can	O
fold	O
and	O
rapidly	O
insert	B-T169
into	O
the	O
lipid	O
bilayer	O
of	O
tumor	O
cells	O
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronously	B-T079
.	O
	
here	O
,	O
we	O
innovatively	O
decorated	O
gold	O
nanostars	O
gnss	O
with	O
phlips	B-T116
gns	O
-	O
phlip	B-T116
to	O
improve	O
their	O
targeting	B-T169
ability	O
and	O
photothermal	B-T061
therapeutic	I-T061
ptt	B-T061
efficiency	B-T081
.	O
	
the	O
obtained	O
gns	O
-	O
phlip	B-T116
exhibited	O
the	O
excellent	O
characteristics	B-T080
of	O
uniform	O
size	O
and	O
good	O
biocompatibility	O
.	O
	
as	O
compared	O
to	O
gns	O
-	O
mpeg	B-T109
,	O
the	O
cellular	O
internalization	O
of	O
gns	O
-	O
phlip	B-T116
was	O
1-fold	O
higher	O
after	O
a	O
2	O
h	O
incubation	O
with	O
cells	O
in	O
media	O
at	O
ph	B-T081
6.4	O
than	O
at	O
ph	B-T081
7.4	O
.	O
	
moreover	O
,	O
the	O
tumor	O
accumulation	B-T033
of	O
the	O
gns	O
-	O
phlip	B-T116
was	O
3-fold	O
higher	O
than	O
that	O
of	O
gns	O
-	O
mpeg	B-T109
after	O
intravenous	B-T169
injection	I-T169
into	O
mcf-7	O
breast	O
tumor	O
animal	O
models	O
for	O
24	O
h	O
.	O
	
furthermore	O
,	O
gns	O
-	O
phlip	B-T116
exhibited	O
stronger	O
signals	O
than	O
the	O
gns	O
-	O
mpeg	B-T109
through	O
computed	O
tomography	O
ct	O
and	O
photoacoustic	O
pa	O
imaging	O
.	O
	
simultaneously	O
,	O
the	O
desirable	O
targeting	B-T169
efficiency	B-T081
significantly	O
improved	O
the	O
ptt	B-T061
efficacy	B-T080
to	O
tumors	O
,	O
with	O
low	O
side	O
effects	O
on	O
normal	O
tissues	O
.	O
	
the	O
results	O
clearly	O
demonstrate	O
that	O
the	O
gns	O
-	O
phlip	B-T116
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	B-T169
ability	O
of	O
phlips	B-T116
and	O
the	O
good	O
characteristics	B-T080
of	O
gns	O
s	O
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	O
and	O
therapy	B-T061
stepwise	O
cyclopropanation	O
on	O
the	O
polycyclopropanated	B-T109
polyketide	I-T109
formation	O
in	O
jawsamycin	B-T109
biosynthesis	B-T169
jawsamycin	B-T109
is	O
a	O
polyketide	B-T109
-	O
nucleoside	O
hybrid	O
with	O
a	O
unique	O
polycyclopropane	B-T109
moiety	O
on	O
a	O
single	O
polyketide	B-T109
chain	I-T109
.	O
	
the	O
unexpected	O
isolation	O
of	O
cyclopropane	B-T109
deficient	O
jawsamycin	B-T109
analogs	O
allowed	O
us	O
to	O
propose	O
a	O
stepwise	O
cyclopropanation	O
mechanism	B-T169
for	O
the	O
enzymatic	B-T116
synthesis	B-T169
of	O
this	O
polyketide	B-T109
.	O
	
the	O
concise	O
timing	O
of	O
the	O
cyclopropanation	O
could	O
be	O
regulated	O
by	O
a	O
delicate	O
balance	O
between	O
reaction	B-T079
rates	I-T079
of	O
the	O
condensation	O
and	O
cyclopropanation	O
reactions	O
.	O
	
initial	O
experience	O
with	O
laparoscopic	B-T061
radical	I-T061
antegrade	I-T061
modular	I-T061
pancreatosplenectomy	I-T061
for	O
left-sided	O
pancreatic	O
cancer	O
in	O
a	O
single	O
institution	O
technical	O
aspects	O
and	O
oncological	B-T033
outcomes	I-T033
laparoscopic	B-T061
surgery	I-T061
has	O
been	O
performed	O
less	O
frequently	O
in	O
the	O
era	O
of	O
pancreatic	O
cancer	O
due	O
to	O
technical	O
difficulties	O
and	O
concerns	O
about	O
oncological	O
safety	O
.	O
	
radical	B-T061
antegrade	I-T061
modular	I-T061
pancreatosplenectomy	I-T061
ramps	B-T061
is	O
expected	O
to	O
be	O
helpful	O
to	O
obtain	O
a	O
negative	B-T033
margin	I-T033
during	O
radical	B-T061
lymph	I-T061
node	I-T061
dissection	I-T061
.	O
	
we	O
hypothesized	O
that	O
it	O
would	O
also	O
be	O
favorable	B-T080
as	O
a	O
laparoscopic	O
application	O
due	O
to	O
unique	O
features	O
.	O
	
fifteen	O
laparoscopic	O
ramps	B-T061
for	O
well-selected	O
patients	O
with	O
left-sided	O
pancreatic	O
cancer	O
were	O
performed	O
from	O
july	O
2011	O
to	O
april	O
2016	O
.	O
	
five	O
trocars	O
were	O
usually	O
used	O
,	O
and	O
the	O
operative	B-T061
procedures	I-T061
and	O
range	B-T061
of	I-T061
dissection	I-T061
were	O
similar	O
to	O
or	O
the	O
same	O
as	O
those	O
of	O
open	O
ramps	B-T061
described	O
by	O
strasberg	O
.	O
	
all	O
medical	O
records	O
and	O
follow-up	O
data	O
were	O
reviewed	O
and	O
analyzed	O
.	O
	
all	O
patients	O
had	O
pancreatic	O
ductal	O
adenocarcinoma	O
.	O
	
mean	O
operative	B-T079
time	I-T079
was	O
219.3	O
53.8	O
min	O
,	O
and	O
estimated	B-T033
blood	I-T033
loss	I-T033
was	O
250	O
70	O
ml	O
.	O
	
the	O
length	B-T079
of	I-T079
postoperative	I-T079
hospital	I-T079
stay	I-T079
was	O
6.1	O
1.2	O
days	O
,	O
and	O
postoperative	O
morbidities	B-T081
developed	O
in	O
two	O
patients	O
13.3	O
with	O
urinary	B-T033
retention	I-T033
.	O
	
the	O
median	O
number	O
of	O
retrieved	O
lymph	O
nodes	O
was	O
18.1	O
6.2	O
and	O
all	O
had	O
negative	B-T033
margins	I-T033
.	O
	
median	O
follow-up	O
time	O
was	O
46.0	O
months	O
,	O
and	O
the	O
3-year	O
disease	B-T081
free	I-T081
survival	I-T081
and	O
overall	B-T081
survival	I-T081
rates	I-T081
were	O
56.3	O
and	O
74.1	O
,	O
respectively	O
.	O
	
our	O
early	O
experience	O
with	O
laparoscopic	O
ramps	B-T061
achieved	O
feasible	O
perioperative	B-T079
results	O
accompanied	O
by	O
acceptable	O
survival	B-T081
outcomes	I-T081
.	O
	
laparoscopic	O
ramps	B-T061
could	O
be	O
a	O
safe	O
and	O
oncologically	O
feasible	B-T080
procedure	I-T080
in	O
well-selected	O
patients	O
with	O
left-sided	O
pancreatic	O
cancer	O
.	O
	
individual	O
classification	O
of	O
strong	B-T080
risk	B-T078
attitudes	O
an	O
application	O
across	O
lottery	B-T081
types	B-T080
and	O
age	O
groups	O
empirical	B-T080
evaluations	B-T169
of	O
risk	B-T078
attitudes	O
often	O
rely	O
on	O
a	O
weak	B-T080
definition	O
of	O
risk	B-T078
that	O
concerns	O
preferences	O
towards	O
risky	B-T078
and	O
riskless	B-T169
options	I-T169
e.g	O
,	O
a	O
lottery	B-T081
vs	O
.	O
	
a	O
sure	O
outcome	B-T169
.	O
	
a	O
large	O
body	O
of	O
work	O
has	O
shown	O
that	O
individuals	O
tend	O
to	O
be	O
weak	B-T080
risk	B-T078
averse	O
in	O
choice	O
contexts	B-T078
involving	O
risky	B-T078
and	O
riskless	B-T081
gains	I-T081
but	O
weak	B-T080
risk	B-T078
seeking	O
in	O
contexts	B-T078
involving	O
losses	B-T081
,	O
a	O
phenomenon	O
known	O
as	O
the	O
reflection	O
effect	O
.	O
	
recent	O
attempts	O
to	O
evaluate	O
age	O
differences	O
in	O
risk	B-T078
attitudes	O
have	O
relied	O
on	O
this	O
weak	B-T080
definition	O
,	O
testing	O
whether	O
the	O
reflection	O
effect	O
increases	B-T169
or	O
diminishes	B-T081
as	O
we	O
grow	O
older	B-T079
.	O
	
the	O
present	O
work	O
argues	O
that	O
weak	B-T080
risk	B-T078
attitudes	O
have	O
limited	O
generalizability	B-T080
and	O
proposes	O
the	O
use	B-T169
of	I-T169
a	O
strong	B-T080
definition	O
of	O
risk	O
that	O
is	O
concerned	O
with	O
preferences	O
towards	O
options	O
with	O
the	O
same	O
expected	O
value	O
but	O
different	O
degrees	O
of	O
risk	O
i.e	O
,	O
outcome	O
variance	O
.	O
	
a	O
reanalysis	O
of	O
previously-published	O
data	O
and	O
the	O
results	O
from	O
a	O
new	O
study	O
show	O
that	O
only	O
a	O
minority	O
of	O
individuals	O
manifests	O
the	O
reflection	O
effect	O
under	O
a	O
strong	B-T080
definition	O
of	O
risk	B-T078
,	O
and	O
that	O
,	O
when	O
facing	O
certain	O
lottery	O
-	O
pair	O
types	O
,	O
older	O
adults	O
appear	O
to	O
be	O
more	O
risk	O
seeking	O
than	O
younger	O
adults	O
treating	B-T169
the	O
binge	O
or	O
the	O
fat	O
body	O
representations	O
of	O
fatness	B-T033
in	O
a	O
gold	B-T080
standard	I-T080
psychological	B-T169
treatment	O
manual	O
for	O
binge	O
eating	O
disorder	O
this	O
article	O
reports	O
the	O
results	O
of	O
a	O
foucauldian	O
-informed	O
discourse	O
analysis	O
exploring	O
representations	O
of	O
fatness	B-T033
embedded	O
within	O
an	O
empirically	B-T080
based	O
psychological	B-T169
treatment	O
manual	O
for	O
binge	O
eating	O
disorder	O
,	O
a	O
condition	B-T080
characterized	O
by	O
overvaluation	O
of	O
weight	O
and	O
shape	B-T080
.	O
	
analyses	O
indicate	B-T033
that	O
the	O
manual	O
prioritizes	O
weight	B-T033
loss	I-T033
with	O
relatively	B-T080
less	O
emphasis	O
placed	O
on	O
treating	B-T169
the	O
diagnostic	B-T169
symptoms	O
and	O
underlying	O
mechanisms	B-T169
of	O
binge	O
eating	O
disorder	O
.	O
	
we	O
raise	O
critical	B-T033
concerns	I-T033
about	O
these	O
observations	O
and	O
link	O
our	O
findings	B-T033
to	O
mainstream	O
psychology's	O
adoption	O
of	O
the	O
medical	B-T080
framing	I-T080
of	O
fatness	B-T033
as	O
obesity	B-T047
within	O
the	O
""""	O
gold	B-T080
standard	I-T080
""""	O
approach	O
to	O
intervention	O
.	O
	
we	O
recommend	O
that	O
psychology	O
as	O
a	O
discipline	O
abandons	O
the	O
weight	B-T033
loss	I-T033
imperative	O
associated	B-T080
with	I-T080
binge	O
eating	O
disorder	O
and	O
fat	O
bodies	O
.	O
	
we	O
recommend	O
that	O
practitioners	O
locate	O
the	O
problem	B-T033
of	O
fat	O
shame	O
in	O
society	O
as	O
opposed	O
to	O
the	O
individual	O
person's	O
body	O
and	O
provide	O
individuals	O
with	O
tools	O
to	O
identify	O
and	O
resist	O
fat	B-T033
stigma	I-T033
and	O
oppression	O
,	O
rather	O
than	O
provide	O
them	O
with	O
tools	O
to	O
reshape	O
their	O
high	O
diversity	B-T080
of	O
planctomycetes	O
in	O
soils	O
of	O
two	O
lichen	O
-dominated	O
sub-arctic	O
ecosystems	O
of	O
northwestern	O
siberia	O
a	O
wide	O
variety	O
of	O
terrestrial	O
ecosystems	O
in	O
tundra	O
have	O
a	O
ground	O
vegetation	O
cover	O
composed	O
of	O
reindeer	O
lichens	O
genera	O
cladonia	O
and	O
cetraria	O
.	O
	
the	O
microbial	O
communities	O
of	O
two	O
lichen	O
-dominated	O
ecosystems	O
typical	O
of	O
the	O
sub-arctic	O
zone	O
of	O
northwestern	O
siberia	O
,	O
that	O
is	O
a	O
forested	O
tundra	O
soil	O
and	O
a	O
shallow	O
acidic	O
peatland	O
,	O
were	O
examined	O
in	O
our	O
study	O
.	O
	
as	O
revealed	O
by	O
molecular	O
analyses	O
,	O
soil	O
and	O
peat	O
layers	O
just	O
beneath	O
the	O
lichen	O
cover	O
were	O
abundantly	O
colonized	B-T033
by	O
bacteria	O
from	O
the	O
phylum	O
planctomycetes	O
.	O
	
highest	O
abundance	O
of	O
planctomycetes	O
detected	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
was	O
in	O
the	O
range	O
2.2	O
10	O
cells	B-T081
per	I-T081
gram	I-T081
of	I-T081
wet	I-T081
weight	I-T081
.	O
	
16s	O
rrna	O
gene	O
fragments	O
from	O
the	O
planctomycetes	O
comprised	O
8-13%	O
of	O
total	O
16s	O
rrna	O
gene	O
reads	O
retrieved	O
using	O
illumina	O
pair-end	O
sequencing	O
from	O
the	O
soil	O
and	O
peat	O
samples	O
.	O
	
lichen	O
-associated	O
assemblages	O
of	O
planctomycetes	O
displayed	O
unexpectedly	O
high	O
diversity	B-T080
,	O
with	O
a	O
total	O
of	O
89	O
reads	O
representing	O
1723	O
operational	O
taxonomic	O
units	O
determined	O
at	O
97%	O
sequence	B-T081
identity	I-T081
.	O
	
the	O
soil	O
of	O
forested	O
tundra	O
was	O
dominated	O
by	O
uncultivated	O
members	O
of	O
the	O
family	O
planctomycetaceae	O
53-71%	O
of	O
total	O
planctomycetes	O
-like	O
reads	O
,	O
while	O
sequences	O
affiliated	O
with	O
the	O
phycisphaera-related	O
group	O
wd2101	O
recently	O
assigned	O
to	O
the	O
order	O
tepidisphaerales	O
were	O
most	O
abundant	O
in	O
peat	O
28-51%	O
of	O
total	O
reads	O
.	O
	
representatives	O
of	O
the	O
isosphaera	O
-	O
singulisphaera	O
group	O
14-28%	O
of	O
total	O
reads	O
and	O
the	O
lineages	O
defined	O
by	O
the	O
genera	O
gemmata	O
1-4%	O
and	O
planctopirus	O
-	O
rubinisphaera	O
1-3%	O
were	O
present	O
in	O
both	O
habitats	O
.	O
	
two	O
strains	O
of	O
singulisphaera-like	O
bacteria	O
were	O
isolated	O
from	O
studied	O
soil	O
and	O
peat	O
samples	O
.	O
	
these	O
planctomycetes	O
displayed	O
good	O
tolerance	O
of	O
low	O
temperatures	O
4-15	O
and	O
were	O
capable	O
of	O
growth	O
on	O
a	O
number	O
of	O
polysaccharides	B-T109
,	O
including	O
lichenan	B-T109
,	O
a	O
characteristic	O
component	O
of	O
lichen	O
-derived	O
relationship	B-T080
between	O
polycythemia	B-T047
and	O
in-hospital	B-T080
mortality	I-T080
in	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
patients	O
with	O
low-risk	B-T081
pulmonary	B-T047
embolism	I-T047
pulmonary	B-T047
embolism	I-T047
pe	B-T047
is	O
frequent	B-T079
in	O
subjects	O
with	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
copd	B-T047
and	O
associated	B-T080
with	I-T080
high	O
mortality	B-T081
.	O
	
this	O
multi-center	O
retrospective	O
study	O
was	O
performed	O
to	O
investigate	B-T169
if	O
secondary	O
polycythemia	B-T047
is	O
associated	B-T080
with	I-T080
in-hospital	B-T080
mortality	I-T080
in	O
copd	B-T047
patients	O
with	O
low-risk	B-T081
pe	B-T047
.	O
	
we	O
identified	O
copd	B-T047
patients	O
with	O
proven	O
pe	B-T047
between	O
october	O
,	O
2005	O
and	O
october	O
,	O
2015	O
.	O
	
patients	O
in	O
risk	O
classes	O
iii-v	O
on	O
the	O
basis	O
of	O
the	O
pesi	B-T033
score	I-T033
were	O
excluded	O
.	O
	
we	O
extracted	O
demographic	O
,	O
clinical	B-T080
and	O
laboratory	O
information	O
at	O
the	O
time	B-T079
of	I-T079
admission	I-T079
from	O
medical	O
records	O
.	O
	
all	O
subjects	O
were	O
followed	O
until	O
hospital	O
discharge	O
to	O
identify	O
all-cause	O
mortality	B-T081
.	O
	
we	O
enrolled	O
629	O
consecutive	O
patients	O
with	O
copd	B-T047
and	O
pe	B-T047
at	O
low	B-T081
risk	I-T081
132	O
of	O
them	O
21.0	O
with	O
and	O
497	O
79.0	O
without	O
secondary	O
polycythemia	B-T047
.	O
	
compared	O
with	O
those	O
without	O
polycythemia	B-T047
,	O
the	O
polycythemia	B-T047
group	O
had	O
significantly	B-T081
lower	I-T081
forced	O
expiratory	O
volume	O
in	O
one	O
second	O
fev1	O
level	O
0.9	O
vs	O
.	O
	
1.4	O
,	O
p=0	O
,	O
lower	B-T033
pao2	I-T033
and	O
spo2	O
as	O
well	O
as	O
higher	O
paco2	O
p=0	O
,	O
p=0	O
and	O
p=0	O
,	O
respectively	O
.	O
	
copd	B-T047
patients	O
with	O
polycythemia	B-T047
had	O
a	O
higher	B-T080
proportion	B-T081
of	O
arrhythmia	B-T033
in	O
electrocardiogram	B-T033
ecg	B-T033
49.5	O
vs	O
.	O
	
35.7	O
,	O
p=0	O
,	O
a	O
longer	O
hospital	B-T081
duration	I-T081
time	I-T081
15.3	O
vs	O
.	O
	
9.7	O
,	O
p=0	O
,	O
a	O
higher	B-T080
mechanical	B-T061
ventilation	I-T061
rate	I-T061
noninvasive	O
and	O
invasive	B-T080
,	O
51.7	O
vs	O
.	O
	
30.3	O
,	O
p=0	O
and	O
31.0	O
vs	O
.	O
	
7.9	O
,	O
p=0	O
,	O
respectively	O
,	O
and	O
a	O
higher	B-T080
in-hospital	B-T080
mortality	I-T080
12.1	O
vs	O
.	O
	
6.6	O
,	O
p=0	O
.	O
	
multivariate	O
logistic	O
regression	O
analysis	O
revealed	O
that	O
polycythemia	B-T047
was	O
associated	B-T080
with	I-T080
mortality	B-T081
in	O
copd	B-T047
patients	O
with	O
low-risk	B-T081
pe	B-T047
adjusted	O
or	O
1.11	O
95%	O
ci	O
,	O
1.04	O
.	O
	
polycythemia	B-T047
is	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
all-cause	O
in-hospital	B-T080
mortality	I-T080
in	O
copd	B-T047
patients	O
with	O
pe	B-T047
at	O
low	B-T081
risk	I-T081
.	O
	
masitinib	B-T109
for	O
treatment	B-T061
of	O
severely	B-T080
symptomatic	B-T169
indolent	B-T047
systemic	I-T047
mastocytosis	I-T047
a	O
randomised	O
,	O
placebo-controlled	O
,	O
phase	O
3	O
study	O
indolent	B-T047
systemic	I-T047
mastocytosis	I-T047
,	O
including	O
the	O
subvariant	B-T080
of	O
smouldering	O
systemic	O
mastocytosis	O
,	O
is	O
a	O
lifelong	B-T079
condition	O
associated	B-T080
with	I-T080
reduced	B-T033
quality	I-T033
of	I-T033
life	I-T033
.	O
	
masitinib	B-T109
inhibits	O
kit	B-T116
and	O
lyn	B-T116
kinases	I-T116
that	O
are	O
involved	O
in	O
indolent	B-T047
systemic	I-T047
mastocytosis	I-T047
pathogenesis	O
.	O
	
we	O
aimed	O
to	O
assess	O
safety	O
and	O
efficacy	O
of	O
masitinib	B-T109
versus	O
placebo	O
in	O
severely	B-T033
symptomatic	I-T033
patients	O
who	O
were	O
unresponsive	B-T169
to	O
optimal	B-T080
symptomatic	B-T169
treatments	B-T061
.	O
	
in	O
this	O
randomised	O
,	O
double-blind	O
,	O
placebo-controlled	O
,	O
phase	O
3	O
study	O
,	O
we	O
enrolled	O
adults	O
aged	O
18-75	O
years	O
with	O
indolent	B-T047
or	O
smouldering	O
systemic	O
mastocytosis	O
,	O
according	O
to	O
who	O
classification	O
or	O
documented	O
mastocytosis	B-T047
based	O
on	O
histological	O
criteria	O
,	O
at	O
50	O
centres	O
in	O
15	O
countries	O
.	O
	
we	O
excluded	O
patients	O
with	O
cutaneous	O
or	O
non-severe	O
systemic	B-T047
mastocytosis	I-T047
after	O
a	O
protocol	O
amendment	O
.	O
	
patients	O
were	O
centrally	O
randomised	O
1	O
to	O
receive	O
either	O
oral	B-T169
masitinib	B-T109
6	O
mg/kg	O
per	O
day	O
over	O
24	O
weeks	O
with	O
possible	O
extension	O
or	O
matched	O
placebo	O
with	O
minimisation	O
according	O
to	O
severe	B-T033
symptoms	I-T033
.	O
	
the	O
primary	O
endpoint	O
was	O
cumulative	O
response	O
75%	O
improvement	O
from	O
baseline	B-T081
within	O
weeks	O
8-24	O
in	O
at	O
least	O
one	O
severe	B-T033
baseline	I-T033
symptom	I-T033
from	O
the	O
following	O
pruritus	O
score	B-T081
of	O
9	O
or	O
more	O
,	O
eight	O
or	O
more	O
flushes	O
per	O
week	O
,	O
hamilton	O
rating	O
scale	O
for	O
depression	O
of	O
19	O
or	O
more	O
,	O
or	O
fatigue	O
impact	O
scale	O
of	O
75	O
or	O
more	O
.	O
	
we	O
assessed	O
treatment	B-T080
effect	I-T080
using	O
repeated	O
measures	O
methodology	O
for	O
rare	B-T047
diseases	I-T047
via	O
the	O
generalised	O
estimating	O
equation	O
model	O
in	O
a	O
modified	O
intention-to-treat	O
population	O
,	O
including	O
all	O
participants	O
assigned	O
to	O
treatment	B-T061
minus	O
those	O
who	O
withdrew	O
due	O
to	O
a	O
non-treatment-related	B-T033
cause	I-T033
.	O
	
we	O
assessed	O
safety	O
in	O
all	O
patients	O
who	O
received	O
at	O
least	O
one	O
dose	B-T081
of	O
study	O
drug	O
.	O
	
this	O
trial	O
is	O
registered	O
with	O
clinicaltrials.gov	O
,	O
number	O
nct00814073	O
.	O
	
between	O
feb	B-T080
19	O
,	O
2009	O
,	O
and	O
july	B-T080
15	O
,	O
2015	O
,	O
135	O
patients	O
were	O
randomly	O
assigned	O
to	O
masitinib	B-T109
n=71	O
or	O
placebo	O
n=64	O
.	O
	
by	O
24	O
weeks	B-T079
,	O
masitinib	B-T109
was	O
associated	B-T080
with	I-T080
a	O
cumulative	O
response	O
of	O
18	O
in	O
the	O
primary	O
endpoint	O
122	O
responses	O
of	O
656	O
possible	O
responses	O
weighted	B-T080
generalised	I-T080
estimating	I-T080
equation	I-T080
compared	O
with	O
7	O
for	O
placebo	O
48	O
of	O
656	O
difference	O
11	O
odds	B-T081
ratio	I-T081
3	O
95%	O
ci	O
1	O
p=0	O
.	O
	
frequent	B-T079
severe	B-T033
adverse	I-T033
events	I-T033
>4%	O
difference	O
from	O
placebo	O
were	O
diarrhoea	O
eight	O
11%	O
of	O
70	O
in	O
the	O
masitinib	B-T109
group	B-T078
vs	O
one	O
2%	O
of	O
63	O
in	O
the	O
placebo	O
group	B-T078
,	O
rash	O
four	O
6%	O
vs	O
none	O
,	O
and	O
asthenia	O
four	O
6%	O
vs	O
one	O
2%	O
.	O
	
the	O
most	O
frequent	B-T079
serious	B-T033
adverse	I-T033
events	I-T033
were	O
diarrhoea	O
three	O
patients	O
4%	O
vs	O
one	O
2%	O
and	O
urticaria	B-T047
two	O
3%	O
vs	O
none	O
,	O
and	O
no	O
life-threatening	B-T033
toxicities	O
occurred	O
.	O
	
one	O
patient	O
in	O
the	O
placebo	O
group	B-T078
died	B-T033
unrelated	B-T080
to	O
study	O
treatment	O
.	O
	
these	O
study	B-T033
findings	I-T033
indicate	O
that	O
masitinib	B-T109
is	O
an	O
effective	B-T080
and	O
well	O
tolerated	O
agent	O
for	O
the	O
treatment	B-T061
of	O
severely	B-T033
symptomatic	I-T033
indolent	B-T047
or	O
smouldering	O
systemic	O
mastocytosis	O
.	O
	
attributable	B-T080
risk	I-T080
of	O
ambient	B-T080
pm10	O
on	O
daily	O
mortality	B-T081
and	O
years	B-T081
of	I-T081
life	I-T081
lost	I-T081
in	O
chengdu	O
,	O
china	O
attributable	B-T080
risk	I-T080
is	O
an	O
important	O
indicator	O
for	O
planning	O
and	O
evaluating	O
public	O
health	O
interventions	O
.	O
	
however	O
,	O
most	O
current	O
measures	O
of	O
the	O
attributable	B-T080
risk	I-T080
of	O
air	O
pollutants	O
have	O
not	O
considered	O
temporal	B-T079
relationships	I-T079
between	O
exposure	B-T080
and	O
risk	B-T078
.	O
	
more	O
importantly	O
,	O
limited	O
information	O
is	O
available	O
regarding	O
the	O
attributable	B-T080
risk	I-T080
due	O
to	O
ambient	B-T080
air	O
pollutants	O
in	O
basin	O
regions	O
like	O
the	O
sichuan	O
basin	O
,	O
china	O
.	O
	
to	O
quantify	O
the	O
association	O
between	O
pm10	O
and	O
deaths	B-T033
in	O
the	O
basin	O
region	O
,	O
we	O
used	O
a	O
measure	O
proposed	O
recently	O
within	O
the	O
framework	O
of	O
the	O
distributed	B-T081
lag	I-T081
non-linear	I-T081
model	I-T081
to	O
estimate	O
the	O
attributable	B-T080
risk	I-T080
in	O
chengdu	O
,	O
china	O
.	O
	
meanwhile	O
,	O
we	O
examined	O
the	O
association	B-T080
between	O
pm10	O
and	O
years	B-T081
of	I-T081
life	I-T081
lost	I-T081
yll	B-T081
.	O
	
our	O
analysis	O
showed	O
that	O
population-attributable	B-T081
fractions	I-T081
for	O
non-accidental	B-T169
,	O
respiratory	B-T169
,	O
and	O
cardiovascular	B-T081
mortality	I-T081
were	O
0.569	O
95%	O
ci	O
-3	O
,	O
4.374	O
,	O
0.695	O
95%	O
ci	O
-5	O
,	O
6.457	O
,	O
and	O
0.631	O
95%	O
ci	O
-6	O
,	O
7.390	O
,	O
respectively	O
.	O
	
on	O
average	O
,	O
a	O
1μg/m	O
increase	O
in	O
pm10	O
was	O
associated	O
with	O
cumulative	B-T169
increases	I-T169
of	O
0.26893	O
,	O
0.30437	O
,	O
and	O
0.21924	O
yll	B-T081
for	O
non-accidental	B-T169
,	O
respiratory	B-T169
,	O
and	O
cardiovascular	B-T081
mortality	I-T081
,	O
respectively	O
,	O
referring	O
to	O
20μg/m	O
.	O
	
in	O
addition	O
,	O
we	O
found	O
an	O
inverse	O
u-shaped	O
pattern	O
for	O
the	O
cumulative	B-T078
risk	I-T078
with	O
350μg/m	O
as	O
the	O
reverse	O
point	O
.	O
	
with	O
a	O
1μg/m	O
increase	O
in	O
pm10	O
,	O
yll	B-T081
changed	O
more	O
significantly	O
than	O
mortality	B-T081
.	O
	
moreover	O
,	O
pm10	O
demonstrated	O
remarkable	O
effects	B-T080
on	O
yll	B-T081
among	O
men	O
and	O
the	O
far-infrared	O
protects	B-T033
vascular	O
endothelial	O
cells	O
from	O
advanced	B-T109
glycation	I-T109
end	I-T109
products	I-T109
-	O
induced	B-T169
injury	O
via	O
plzf	B-T116
-mediated	O
autophagy	O
in	O
diabetic	O
mice	O
the	O
accumulation	O
of	O
advanced	B-T109
glycation	I-T109
end	I-T109
products	I-T109
ages	B-T109
in	O
diabetic	B-T047
patients	O
induces	B-T169
vascular	O
endothelial	O
injury	O
.	O
	
promyelocytic	B-T116
leukemia	I-T116
zinc	I-T116
finger	I-T116
protein	I-T116
plzf	B-T116
is	O
a	O
transcription	B-T116
factor	I-T116
that	O
can	O
be	O
activated	O
by	O
low-temperature	O
far-infrared	O
fir	O
irradiation	O
to	O
exert	O
beneficial	O
effects	O
on	O
the	O
vascular	O
endothelium	O
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
investigated	B-T169
the	O
influence	O
of	O
fir	O
-	O
induced	B-T169
plzf	B-T116
activation	O
on	O
age	B-T109
-	O
induced	B-T169
endothelial	O
injury	O
both	B-T080
in	O
vitro	O
and	O
in	O
vivo	O
.	O
	
fir	O
irradiation	O
inhibited	B-T080
age	B-T109
-	O
induced	B-T169
apoptosis	O
in	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
huvecs	O
.	O
	
plzf	B-T116
activation	O
increased	B-T081
the	O
expression	O
of	O
phosphatidylinositol-3	B-T116
kinases	I-T116
pi3k	B-T116
,	O
which	O
are	O
important	B-T080
kinases	B-T116
in	O
the	O
autophagic	O
signaling	O
pathway	O
.	O
	
fir	O
-	O
induced	B-T169
plzf	B-T116
activation	O
led	O
to	O
autophagy	O
in	O
huvec	O
,	O
which	O
was	O
mediated	O
through	B-T169
the	O
upregulation	O
of	O
pi3k	B-T116
.	O
	
immunofluorescence	O
staining	O
showed	O
that	O
ages	B-T109
were	O
engulfed	O
by	O
huvecs	O
and	O
localized	O
to	O
lysosomes	O
.	O
	
fir	O
-	O
induced	B-T169
autophagy	O
promoted	O
ages	B-T109
degradation	B-T169
in	O
huvecs	O
.	O
	
in	O
nicotinamide	B-T109
/	O
streptozotocin	B-T109
-	O
induced	B-T169
diabetic	O
mice	O
,	O
fir	O
therapy	B-T061
reduced	B-T080
serum	B-T116
ages	I-T116
and	O
ages	B-T109
deposition	B-T169
at	O
the	O
vascular	O
endothelium	O
.	O
	
fir	O
therapy	B-T061
also	O
reduced	B-T080
diabetes	B-T047
-	O
induced	B-T169
inflammatory	B-T033
markers	I-T033
in	O
the	O
vascular	O
endothelium	O
and	O
improved	B-T033
vascular	O
endothelial	O
function	O
.	O
	
these	O
protective	O
effects	O
of	O
fir	O
therapy	B-T061
were	O
not	B-T033
found	I-T033
in	O
plzf	B-T116
-	O
knockout	O
mice	O
.	O
	
our	O
data	B-T078
suggest	B-T078
that	O
fir	O
-	O
induced	B-T169
plzf	B-T116
activation	O
in	O
vascular	O
endothelial	O
cells	O
protects	O
the	O
vascular	O
endothelium	O
in	O
diabetic	O
mice	O
from	O
age	B-T109
-	O
induced	B-T169
injury	O
.	O
	
ultrasonic	O
computed	O
tomography	O
imaging	O
of	O
iron	O
oxide	O
nanoparticles	O
iron	O
oxide	O
nanoparticles	O
ionps	O
are	O
becoming	O
increasingly	B-T169
used	O
and	O
intensively	B-T169
investigated	I-T169
in	O
the	O
field	O
of	O
medical	O
imaging	O
.	O
	
they	O
are	O
currently	B-T079
fda	O
approved	B-T080
for	O
magnetic	O
resonance	O
imaging	O
mri	O
,	O
and	O
it	O
would	O
be	O
highly	B-T080
desirable	O
to	O
visualize	B-T169
them	O
by	O
ultrasound	O
as	O
well	O
.	O
	
previous	B-T079
reports	O
using	O
the	O
conventional	B-T080
ultrasound	O
b-scan	O
pulse-echo	O
imaging	O
technique	O
have	O
shown	O
very	O
limited	B-T169
detectability	O
of	O
these	O
particles	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	O
is	O
to	O
explore	O
the	O
feasibility	B-T080
of	O
imaging	O
ionps	O
using	O
the	O
through-transmission	B-T078
ultrasound	I-T078
methodology	I-T078
and	O
demonstrate	O
their	O
detectability	O
using	O
ultrasonic	O
computed	O
tomography	O
uct	O
.	O
	
commercially	O
available	O
ionps	O
were	O
acoustically	O
analysed	O
to	O
quantify	B-T081
their	O
effect	B-T080
on	O
the	O
speed	B-T081
of	O
sound	O
sos	O
and	O
acoustic	O
attenuation	O
as	O
a	O
function	B-T169
of	O
concentration	B-T081
.	O
	
next	O
,	O
through-transmission	O
projection	O
and	O
uct	O
imaging	O
were	O
performed	B-T169
on	O
a	O
breast	O
mimicking	O
phantom	O
and	O
on	O
an	O
ex	O
vivo	O
tissue	O
model	O
,	O
to	O
which	O
ionps	O
were	O
injected	O
.	O
	
finally	O
,	O
an	O
mri	O
scan	O
was	O
performed	O
to	O
verify	O
that	O
the	O
same	O
particles	O
examined	O
in	O
the	O
ultrasound	O
experiment	O
can	O
be	O
imaged	O
by	O
magnetic	O
resonance	O
,	O
using	O
the	O
same	O
clinically	O
relevant	O
concentrations	O
.	O
	
the	O
results	O
have	O
shown	O
a	O
consistent	O
concentration	O
dependent	O
speed	O
of	O
sound	O
increase	O
1.86	O
formula	O
see	O
text	O
rise	O
per	O
100	O
µg	O
ml	O
ionps	O
.	O
	
imaging	O
based	O
on	O
this	O
property	O
has	O
shown	O
a	O
substantial	O
contrast-to-noise	O
ratio	O
improvement	O
up	O
to	O
5	O
fold	O
,	O
p	O
<	O
0.01	O
.	O
	
the	O
sos	O
-related	O
effect	O
generated	O
a	O
well	O
discernible	O
image	O
contrast	O
and	O
allowed	O
the	O
detection	O
of	O
the	O
particles	O
existence	O
and	O
location	O
,	O
in	O
both	O
raster-scan	O
projection	O
and	O
uct	O
imaging	O
.	O
	
conversely	O
,	O
no	O
significant	O
change	O
in	O
the	O
acoustic	O
attenuation	O
coefficient	O
was	O
noted	O
.	O
	
based	O
on	O
these	O
findings	O
,	O
it	O
is	O
concluded	O
that	O
ionps	O
can	O
be	O
used	O
as	O
an	O
effective	O
sos	O
-	O
based	O
contrast	O
agent	O
,	O
potentially	O
useful	O
for	O
ultrasonic	O
breast	O
imaging	O
.	O
	
furthermore	O
,	O
the	O
particle	O
offers	O
the	O
capacity	O
of	O
significantly	O
enhancing	O
diagnosis	O
accuracy	O
using	O
multimodal	O
mri	O
-	O
ultrasound	O
imaging	O
capabilities	B-T080
genetically	B-T169
encoded	O
calcium	O
indicators	O
for	O
studying	O
long-term	B-T079
calcium	O
dynamics	O
during	O
apoptosis	O
intracellular	O
calcium	O
release	O
is	O
essential	B-T080
for	O
regulating	O
almost	O
all	O
cellular	O
functions	O
.	O
	
specific	B-T080
spatio-temporal	O
patterns	O
of	O
cytosolic	O
calcium	O
elevations	B-T080
are	O
critical	B-T080
determinants	B-T169
of	O
cell	O
fate	O
in	O
response	O
to	O
pro-apoptotic	B-T080
cellular	O
stressors	B-T078
.	O
	
as	O
the	O
apoptotic	O
program	O
can	O
take	O
hours	B-T079
or	O
days	B-T079
,	O
measurement	B-T169
of	O
long-term	B-T079
calcium	O
dynamics	O
are	O
essential	B-T080
for	O
understanding	O
the	O
mechanistic	B-T169
role	O
of	O
calcium	O
in	O
apoptotic	O
cell	O
death	O
.	O
	
due	O
to	O
the	O
technical	B-T169
limitations	B-T169
of	O
using	O
calcium	O
-	O
sensitive	B-T169
dyes	O
to	O
measure	B-T081
cytosolic	O
calcium	O
little	O
is	O
known	O
about	O
long-term	B-T079
calcium	O
dynamics	O
in	O
living	O
cells	O
after	O
treatment	B-T061
with	O
apoptosis	O
-	O
inducing	B-T169
drugs	O
.	O
	
genetically	B-T169
encoded	O
calcium	O
indicators	O
could	O
potentially	O
overcome	O
some	O
of	O
the	O
limitations	B-T169
of	O
calcium	O
-	O
sensitive	B-T169
dyes	O
.	O
	
here	O
,	O
we	O
compared	O
the	O
performance	O
of	O
the	O
genetically	B-T169
encoded	O
calcium	O
indicators	O
gcamp6s	O
and	O
gcamp6f	O
with	O
the	O
ratiometric	O
dye	O
fura-2	B-T109
.	O
	
gcamp6s	O
performed	O
as	O
well	O
or	O
better	O
than	O
fura-2	B-T109
in	O
detecting	O
agonist	O
-	O
induced	B-T169
calcium	O
transients	B-T079
.	O
	
we	O
then	O
examined	O
the	O
utility	B-T169
of	O
gcamp6s	O
for	O
continuously	B-T078
measuring	B-T080
apoptotic	B-T080
calcium	O
release	O
over	O
the	O
course	B-T079
of	O
ten	O
hours	B-T079
after	O
treatment	B-T061
with	O
staurosporine	B-T109
.	O
	
we	O
found	O
that	O
gcamp6s	O
was	O
suitable	O
for	O
measuring	B-T080
apoptotic	B-T080
calcium	O
release	O
over	O
long	O
time	O
courses	B-T079
and	O
revealed	O
significant	B-T078
heterogeneity	B-T080
in	O
calcium	O
release	O
dynamics	O
in	O
individual	O
cells	O
challenged	O
with	O
staurosporine	B-T109
.	O
	
our	O
results	O
suggest	O
gcamp6s	O
is	O
an	O
excellent	B-T080
indicator	O
for	O
monitoring	O
long-term	B-T079
changes	B-T169
cytosolic	O
calcium	O
during	O
staphylococcus	O
pseudintermedius	O
human	O
infection	O
cases	B-T169
in	O
spain	O
dog	O
-to-	O
human	O
transmission	O
staphylococcus	O
pseudintermedius	O
is	O
an	O
opportunistic	O
pathogen	O
that	O
has	O
been	O
identified	B-T080
as	O
infectious	O
agent	O
or	O
colonizer	B-T033
mainly	O
in	O
dogs	O
.	O
	
s	O
.	O
	
pseudintermedius	O
has	O
been	O
also	O
detected	B-T033
in	O
humans	O
and	O
more	O
specifically	O
in	O
people	O
in	O
contact	B-T169
with	I-T169
dogs	O
.	O
	
in	O
this	O
study	O
,	O
the	O
possible	B-T033
s	O
.	O
	
pseudintermedius	O
pet	O
-to-	O
human	O
transmission	O
was	O
analyzed	O
in	O
four	O
clinical	B-T080
human	O
cases	B-T169
.	O
	
two	O
patients	O
were	O
dog	O
owners	O
and	O
s	O
.	O
	
pseudintermedius	O
was	O
also	O
detected	B-T033
as	O
colonizer	B-T033
in	O
these	O
healthy	B-T080
animals	O
.	O
	
s	O
.	O
	
pseudintermedius	O
isolates	O
from	O
patients	O
and	O
dogs	O
of	O
the	O
same	O
household	O
showed	O
identical	B-T080
pulsed-field	O
gel	O
electrophoresis	O
patterns	O
,	O
sequence	B-T033
types	I-T033
sts	B-T033
,	O
and	O
antimicrobial	O
resistance	O
phenotypes	O
and	O
genotypes	O
,	O
and	O
were	O
methicillin	O
susceptible	O
.	O
	
resistance	B-T169
to	O
erythromycin	B-T109
,	O
clindamycin	B-T109
,	O
tetracycline	B-T109
,	O
trimetoprim-sulfamethoxazole	O
,	O
and/or	O
ciprofloxacin	B-T109
was	O
identified	B-T080
among	O
s	O
.	O
	
pseudintermedius	O
strains	O
.	O
	
the	O
lineages	O
st241	B-T033
and	O
the	O
new	O
st521	B-T033
were	O
detected	B-T033
in	O
the	O
strains	O
of	O
the	O
two	O
dog	O
-	O
owner	O
patients	O
,	O
respectively	O
.	O
	
the	O
strains	O
from	O
the	O
other	B-T080
two	O
patients	O
presented	B-T078
two	O
new	O
sts	B-T033
,	O
st719	B-T033
and	O
st720	B-T033
.	O
	
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
description	O
of	O
human	O
infections	O
caused	O
by	O
s	O
.	O
	
pseudintermedius	O
in	O
tango	O
-	O
a	O
screening	O
tool	O
to	O
identify	O
comorbidities	B-T078
on	O
the	O
causal	O
pathway	O
of	O
nocturia	B-T047
to	O
develop	O
a	O
robust	O
screening	O
metric	O
for	O
use	O
in	O
identifying	O
non-lower	O
urinary	O
tract	O
comorbidities	B-T078
pertinent	O
to	O
the	O
multidisciplinary	O
assessment	O
of	O
patients	O
with	O
nocturia	B-T047
.	O
	
variables	B-T080
having	O
a	O
significant	O
risk	O
association	B-T080
with	I-T080
nocturia	B-T047
of	O
greater	O
than	O
once	O
per	O
night	B-T079
were	O
identified	O
.	O
	
discriminating	B-T080
items	O
from	O
validated	O
and	O
reliable	O
tools	O
measuring	O
these	O
comorbidities	B-T078
were	O
identified	O
.	O
	
a	O
self-completed	O
57-item	O
questionnaire	O
was	O
developed	O
and	O
a	O
medical	B-T169
checklist	O
and	O
pertinent	O
clinical	B-T033
measures	I-T033
added	O
.	O
	
pre-determined	O
criteria	O
were	O
applied	O
to	O
retain	O
or	O
remove	O
items	O
in	O
the	O
development	O
of	O
the	O
short-form	O
sf	O
screening	O
tool	O
.	O
	
the	O
tool	O
was	O
administered	O
to	O
252	O
individuals	O
with	O
nocturia	B-T047
who	O
were	O
attending	O
either	O
a	O
tertiary	O
level	O
sleep	O
,	O
continence	B-T061
,	O
falls	B-T033
or	O
rehabilitation	O
service	O
for	O
routine	O
care	O
.	O
	
data	B-T033
collected	I-T033
were	O
subjected	O
to	O
descriptive	O
analysis	O
criteria	O
were	O
applied	O
to	O
reduce	O
the	O
number	O
of	O
items	O
.	O
	
using	O
pre-determined	O
domains	O
,	O
a	O
nocturia	B-T047
screening	O
metric	O
,	O
entitled	O
tango	O
,	O
was	O
generated	O
.	O
	
the	O
acronym	O
tango	O
stands	O
for	O
targeting	B-T169
the	O
individual's	B-T169
aetiology	I-T169
of	O
nocturia	B-T047
to	O
guide	O
outcomes	O
.	O
	
the	O
demographic	O
characteristics	O
of	O
the	O
sample	O
are	O
described	O
,	O
along	O
with	O
item	O
endorsement	O
levels	O
.	O
	
the	O
statistical	O
and	O
structural	O
framework	O
to	O
justify	O
deleting	O
or	O
retaining	O
of	O
items	O
from	O
the	O
tango	O
long-form	O
to	O
the	O
sf	O
is	O
presented	O
.	O
	
the	O
resultant	O
tango	O
-	O
sf	O
patient	O
-completed	O
nocturia	B-T047
screening	O
tool	O
is	O
reported	O
.	O
	
a	O
novel	O
all-cause	O
diagnostic	B-T169
metric	O
for	O
identifying	O
co-existing	O
morbidities	B-T081
of	O
clinical	O
relevance	O
to	O
nocturia	B-T047
in	O
patients	O
who	O
present	O
across	O
disciplines	O
and	O
medical	O
specialties	O
has	O
been	O
developed	O
.	O
	
tango	O
has	O
the	O
potential	O
to	O
improve	O
practice	O
and	O
smooth	B-T080
inequalities	I-T080
associated	B-T080
with	I-T080
a	O
siloed	O
approach	O
to	O
assessment	O
and	O
subsequent	O
care	O
of	O
patients	O
with	O
probabilistic	B-T081
acute	B-T079
risk	O
assessment	O
of	O
cumulative	O
exposure	O
to	O
organophosphorus	B-T109
and	O
carbamate	B-T109
pesticides	I-T109
from	O
dietary	O
vegetables	O
and	O
fruits	O
in	O
shanghai	O
populations	O
organophosphorus	B-T109
pesticides	I-T109
ops	B-T109
and	O
carbamate	B-T109
pesticides	I-T109
cps	B-T109
are	O
among	O
the	O
most	O
widely	O
used	O
pesticides	O
in	O
china	O
,	O
playing	O
a	O
major	O
role	O
in	O
protecting	B-T033
agricultural	O
commodities	O
.	O
	
in	O
this	O
study	O
,	O
we	O
determined	B-T080
the	O
cumulative	O
acute	O
exposure	O
to	O
ops	B-T109
and	O
cps	B-T109
of	O
shanghai	O
residents	O
from	O
vegetables	O
and	O
fruits	O
vfs	O
.	O
	
the	O
food	O
consumption	O
data	B-T078
were	O
obtained	B-T169
from	O
the	O
shanghai	O
food	O
consumption	O
survey	O
shfcs	O
of	O
2012-14	O
including	O
a	O
total	O
of	O
1973	O
participants	O
aged	O
2-90	O
years	B-T079
.	O
	
the	O
pesticide	O
residue	O
data	B-T078
were	O
obtained	B-T169
from	O
the	O
shanghai	O
monitoring	O
programme	B-T169
during	O
2008-11	O
with	O
34	O
organophosphates	B-T109
and	O
11	O
carbamates	B-T109
analysed	O
in	O
a	O
total	O
of	O
5335	O
samples	O
of	O
vfs	O
.	O
	
a	O
probabilistic	B-T081
approach	O
was	O
performed	B-T169
as	O
recommended	B-T078
by	O
the	O
efsa	O
,	O
using	O
the	O
optimistic	O
model	O
with	O
non-detects	O
set	O
as	O
zero	B-T081
and	O
with	O
processing	O
factors	B-T169
pfs	B-T169
being	O
used	O
and	O
the	O
pessimistic	O
model	O
with	O
non-detects	O
replaced	B-T169
by	I-T169
limit	B-T081
of	I-T081
detection	I-T081
lod	B-T081
and	O
without	B-T080
pfs	B-T169
.	O
	
we	O
used	O
the	O
relative	O
potency	O
factor	O
rpf	O
method	O
to	O
normalise	O
the	O
various	O
pesticides	O
to	O
the	O
index	O
compound	O
ic	O
of	O
methamidophos	B-T109
and	O
chlorpyrifos	B-T109
separately	B-T080
.	O
	
only	O
in	O
the	O
pessimistic	O
model	O
using	O
methamidophos	B-T109
as	O
the	O
ic	O
was	O
there	O
was	O
small	O
risk	B-T078
of	O
exposure	B-T080
exceeding	O
the	O
arfd	B-T081
3	O
µg	O
kg	O
bw	O
day	B-T079
-	O
in	O
the	O
populations	O
of	O
preschool	O
children	O
0.029	O
,	O
school-age	O
children	O
0.022	O
and	O
adults	O
0.002	O
.	O
	
there	O
were	O
no	B-T033
risk	I-T033
of	O
exposure	B-T080
exceeding	O
the	O
arfd	B-T081
of	O
methamidophos	B-T109
in	O
the	O
optimistic	O
model	O
and	O
of	O
chlorpyrifos	B-T109
100	O
µg	O
kg	O
bw	O
day	B-T079
-	O
in	O
both	O
optimistic	B-T033
and	O
pessimistic	O
models	O
in	O
all	O
three	O
populations	O
.	O
	
considering	O
the	O
chinese	B-T033
habits	I-T033
of	O
overwhelmingly	O
eating	O
processed	O
food	O
vegetables	O
being	O
cooked	O
,	O
and	O
fruits	O
being	O
washed	B-T078
or	O
peeled	B-T169
,	O
we	O
conclude	O
that	O
little	O
acute	B-T079
risk	B-T078
was	O
found	O
for	O
the	O
exposure	B-T080
to	I-T080
vf	O
-	O
sourced	B-T033
ops	B-T109
and	O
cps	B-T109
in	O
modem	O
a	O
comprehensive	B-T080
approach	O
to	O
modelling	O
outcome	B-T080
and	O
costs	B-T081
impacts	B-T080
of	O
interventions	B-T061
for	O
dementia	O
.	O
	
protocol	O
paper	O
the	O
modem	O
project	O
a	O
comprehensive	B-T080
approach	O
to	O
modelling	O
outcome	B-T080
and	O
costs	B-T081
impacts	B-T080
of	O
interventions	B-T061
for	O
dementia	O
explores	O
how	O
changes	B-T169
in	O
arrangements	O
for	O
the	O
future	B-T079
treatment	B-T061
and	O
care	O
of	O
people	O
living	O
with	O
dementia	O
,	O
and	O
support	B-T061
for	O
family	O
and	O
other	O
unpaid	B-T033
carers	O
,	O
could	O
result	B-T169
in	O
better	O
outcomes	B-T080
and	O
more	O
efficient	B-T080
use	B-T169
of	I-T169
resources	B-T078
.	O
	
modem	O
starts	O
with	O
a	O
systematic	B-T169
mapping	O
of	O
the	O
literature	O
on	O
effective	B-T080
and	O
potentially	O
cost	B-T081
-	O
effective	B-T080
interventions	B-T061
in	O
dementia	O
care	O
.	O
	
those	O
findings	B-T169
,	O
as	O
well	O
as	O
data	B-T078
from	O
a	O
cohort	O
,	O
will	O
then	O
be	O
used	O
to	O
model	O
the	O
quality	B-T078
of	I-T078
life	I-T078
and	O
cost	B-T081
impacts	B-T080
of	O
making	O
these	O
evidence	B-T078
-based	O
interventions	B-T061
more	O
widely	O
available	B-T169
in	O
england	O
over	O
the	O
period	B-T079
from	O
now	O
to	O
2040	O
.	O
	
modelling	O
will	O
use	O
a	O
suite	O
of	O
models	O
,	O
combining	B-T080
microsimulation	O
and	O
macrosimulation	O
methods	O
,	O
modelling	O
the	O
costs	B-T081
and	O
outcomes	B-T080
of	O
care	O
,	O
both	O
for	O
an	O
individual	O
over	O
the	O
life-course	B-T079
from	O
the	O
point	O
of	O
dementia	O
diagnosis	O
,	O
and	O
for	O
individuals	O
and	O
england	O
as	O
a	O
whole	B-T081
in	O
a	O
particular	O
year	O
.	O
	
project	O
outputs	O
will	O
include	O
an	O
online	O
dementia	O
evidence	O
toolkit	O
,	O
making	O
evidence	B-T078
summaries	O
and	O
a	O
literature	O
database	O
available	B-T169
free	O
to	O
anyone	O
,	O
papers	O
in	O
academic	O
journals	O
and	O
other	O
written	O
outputs	O
,	O
and	O
a	O
modem	O
legacy	O
model	O
,	O
which	O
will	O
enable	O
local	O
commissioners	O
of	O
services	O
to	O
apply	O
the	O
model	O
to	O
their	O
own	O
populations	O
.	O
	
modelling	O
the	O
effects	B-T080
of	I-T080
evidence	B-T078
-based	O
cost	B-T081
-	O
effective	B-T080
interventions	B-T061
and	O
making	O
this	O
information	B-T078
widely	O
available	B-T169
has	O
the	O
potential	B-T080
to	O
improve	B-T033
the	O
health	B-T078
and	O
quality	B-T078
of	I-T078
life	I-T078
both	O
of	O
people	O
with	O
dementia	O
and	O
their	O
carers	O
,	O
while	O
ensuring	O
that	O
resources	B-T078
assessment	O
of	O
neuroanatomical	B-T080
and	O
behavioural	O
effects	O
of	O
in	B-T169
ovo	I-T169
methylmercury	B-T109
exposure	B-T080
in	O
zebra	O
finches	O
taeniopygia	O
guttata	O
methylmercury	B-T109
mehg	B-T109
readily	O
crosses	O
the	O
blood	O
brain	O
barrier	O
and	O
is	O
a	O
known	B-T080
neuro	B-T080
-	O
toxicant	O
.	O
	
mehg	B-T109
accumulation	B-T033
in	O
the	O
brain	O
causes	B-T169
histopathological	B-T169
alterations	B-T169
,	O
neurobehavioral	B-T080
changes	B-T169
,	O
and	O
impairments	B-T169
to	O
cognitive	B-T169
motor	O
functions	O
in	O
mammalian	O
models	O
.	O
	
however	O
,	O
in	O
birds	O
the	O
neurotoxic	O
effects	O
of	O
mehg	B-T109
on	O
the	O
developing	O
pre	B-T079
-	O
hatching	O
brain	O
and	O
consequent	B-T033
behavioral	O
alterations	O
in	O
adult	O
birds	O
have	O
not	B-T169
received	B-T080
much	O
attention	O
.	O
	
moreover	O
,	O
passerine	O
birds	O
are	O
poorly	B-T080
represented	O
in	O
mehg	B-T109
neurotoxicology	O
studies	O
in	O
comparison	O
to	O
other	O
avian	O
orders	O
.	O
	
hence	O
in	O
this	O
study	O
,	O
we	O
used	B-T169
the	O
egg	O
injection	O
method	O
to	O
investigate	B-T169
the	O
long	O
term	O
effects	O
of	O
in	B-T169
ovo	I-T169
mehg	B-T109
exposure	B-T080
on	O
brain	O
histopathology	B-T169
and	O
courtship	O
behavior	O
in	O
a	O
model	O
songbird	O
species	O
,	O
the	O
zebra	O
finch	O
taeniopygia	O
guttata	O
.	O
	
egg	O
treatment	B-T169
groups	O
included	B-T169
a	O
low	B-T080
mehg	B-T109
dose	B-T081
of	O
0.2μg	O
hg	O
g	O
egg	O
,	O
a	O
high	B-T080
mehg	B-T109
dose	B-T081
of	O
3.2μg	O
hg	O
g	O
egg	O
,	O
and	O
a	O
vehicle	O
control	O
water	O
.	O
	
no	O
adverse	O
effects	O
of	O
in	B-T169
ovo	I-T169
mehg	B-T109
treatment	B-T169
were	O
detected	B-T033
on	O
courtship	O
song	O
quality	O
or	O
on	O
mating	O
behavior	O
in	O
experimental	O
males	O
at	O
sexually	O
maturity	O
which	O
would	O
suggest	O
that	O
observable	O
neurobehavioral	O
effects	O
of	O
mehg	O
exposure	O
may	O
depend	O
on	O
the	O
timing	O
of	O
exposure	O
during	O
offspring	O
development	O
.	O
	
however	O
,	O
neuroanatomical	O
analysis	O
indicated	O
an	O
increase	O
in	O
telencephalon	O
volume	O
with	O
increased	O
mehg	O
concentrations	O
which	O
may	O
suggest	O
a	O
prolonged	O
inflammatory	O
response	O
in	O
this	O
region	O
of	O
the	O
brain	O
evaluation	O
of	O
the	O
condom	O
barriers	O
scale	O
for	O
young	O
black	O
men	O
who	O
have	O
sex	O
with	O
men	O
reliability	B-T080
and	I-T080
validity	I-T080
of	O
3	O
subscales	O
reliable	B-T080
and	O
valid	B-T080
scale	O
measures	B-T081
of	O
barriers	B-T061
to	O
condom	O
use	O
are	O
not	O
available	O
for	O
young	O
black	O
men	O
who	O
have	O
sex	O
with	O
men	O
ybmsm	O
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
condom	O
barriers	O
scales	O
for	O
application	O
with	O
ybmsm	O
.	O
	
a	O
clinic-based	B-T080
sample	O
of	O
600	O
ybmsm	O
completed	O
a	O
computer-assisted	O
self-interview	O
.	O
	
the	O
primary	O
measure	B-T081
was	O
a	O
14-item	O
abbreviated	O
version	O
of	O
the	O
condom	O
barriers	O
scale	O
.	O
	
reliability	B-T080
and	O
criterion	B-T081
validity	I-T081
were	O
assessed	O
.	O
	
all	O
3	O
subscales	O
were	O
reliable	B-T080
partner	O
-related	O
barriers	B-T061
cronbach	B-T081
α	I-T081
=0	O
,	O
sensation	O
-related	O
barriers	B-T061
α=0	O
,	O
and	O
motivation	O
-related	O
barriers	B-T061
α	O
=0	O
.	O
	
a	O
complete	B-T033
absence	I-T033
of	I-T033
barriers	I-T033
was	O
common	O
47.0	O
partner	O
-related	O
,	O
30.7	O
sensation	O
-related	O
,	O
and	O
46.5	O
motivation	O
-related	O
.	O
	
dichotomized	O
subscales	O
were	O
significantly	B-T081
associated	B-T080
with	I-T080
reporting	O
any	O
condomless	B-T033
insertive	O
anal	O
sex	O
all	O
ps	B-T081
<	O
0.001	O
and	O
any	O
condomless	B-T033
receptive	O
anal	O
sex	O
all	O
ps	B-T081
<	O
0.001	O
.	O
	
the	O
subscales	O
were	O
significantly	B-T081
associated	B-T080
with	I-T080
these	O
measures	B-T081
of	O
condomless	B-T033
sex	O
preserved	O
at	O
a	O
continuous	B-T078
level	B-T080
all	O
ps	B-T081
<0	O
,	O
except	O
for	O
sensation	O
barriers	B-T061
associated	B-T080
with	I-T080
condomless	B-T033
receptive	O
anal	O
sex	O
=	O
0.03	O
.	O
	
further	O
,	O
the	O
subscales	O
were	O
significantly	B-T081
associated	B-T080
with	I-T080
reporting	O
any	O
condom	O
use	O
problems	B-T078
all	O
ps	B-T081
<0	O
and	O
a	O
measure	B-T081
of	O
condomless	B-T033
oral	O
sex	O
all	O
ps	B-T081
<0	O
,	O
except	O
for	O
partner	O
-related	O
barriers	B-T061
=0	O
.	O
	
finally	O
,	O
the	O
sensation	O
-related	O
barriers	B-T061
subscale	O
was	O
significantly	B-T081
associated	B-T080
with	I-T080
testing	O
positive	B-T033
for	O
chlamydia	O
and/or	O
gonorrhea	B-T047
p=0	O
.	O
	
the	O
3	O
identified	O
subscales	O
yielded	O
adequate	O
reliability	B-T080
and	O
strong	O
evidence	O
of	O
validity	B-T080
,	O
thereby	O
suggesting	O
the	O
utility	O
of	O
these	O
brief	O
measures	B-T081
for	O
use	O
in	O
observational	O
and	O
experimental	O
research	O
with	O
variation	O
in	O
the	O
intensity	B-T080
of	O
selection	O
on	O
codon	O
bias	B-T078
over	O
time	B-T079
causes	O
contrasting	O
patterns	O
of	O
base	B-T081
composition	I-T081
evolution	O
in	O
drosophila	O
four-fold	O
degenerate	B-T169
coding	O
sites	O
form	O
a	O
major	O
component	O
of	O
the	O
genome	O
,	O
and	O
are	O
often	O
used	O
to	O
make	O
inferences	O
about	O
selection	O
and	O
demography	B-T078
,	O
so	O
that	O
understanding	O
their	O
evolution	O
is	O
important	O
.	O
	
despite	O
previous	O
efforts	O
,	O
many	O
questions	O
regarding	O
the	O
causes	O
of	O
base	B-T081
composition	I-T081
changes	B-T169
at	O
these	O
sites	O
in	O
drosophila	O
remain	O
unanswered	O
.	O
	
to	O
shed	O
further	O
light	O
on	O
this	O
issue	B-T033
,	O
we	O
obtained	O
a	O
new	O
whole-genome	O
polymorphism	O
data	O
set	O
from	O
d	O
.	O
	
simulans	O
.	O
	
we	O
analyzed	O
samples	O
from	O
the	O
putatively	O
ancestral	O
range	O
of	O
d	O
.	O
	
simulans	O
,	O
as	O
well	O
as	O
an	O
existing	O
polymorphism	O
data	O
set	O
from	O
an	O
african	O
population	O
of	O
d	O
.	O
	
melanogaster	O
.	O
	
by	O
using	O
d	O
.	O
	
yakuba	O
as	O
an	O
outgroup	O
,	O
we	O
found	O
clear	O
evidence	B-T078
for	O
selection	O
on	O
4-fold	O
sites	O
along	O
both	O
lineages	B-T078
over	O
a	O
substantial	B-T079
period	I-T079
,	O
with	O
the	O
intensity	B-T080
of	O
selection	O
increasing	O
with	O
gc	B-T081
content	I-T081
.	O
	
based	O
on	O
an	O
explicit	O
model	O
of	O
base	B-T081
composition	I-T081
evolution	O
,	O
we	O
suggest	O
that	O
the	O
observed	B-T169
at-	O
biased	B-T078
substitution	O
pattern	O
in	O
both	O
lineages	B-T078
is	O
probably	O
due	O
to	O
an	O
ancestral	B-T080
reduction	I-T080
in	O
selection	O
intensity	B-T080
,	O
and	O
is	O
unlikely	O
to	O
be	O
the	O
result	O
of	O
an	O
increase	B-T169
in	O
mutational	O
bias	B-T078
towards	O
at	O
alone	O
.	O
	
by	O
using	O
two	O
polymorphism-based	O
methods	O
for	O
estimating	B-T081
selection	O
coefficients	B-T081
over	O
different	O
timescales	O
,	O
we	O
show	O
that	O
the	O
selection	O
intensity	B-T080
on	O
codon	O
usage	O
has	O
been	O
rather	O
stable	B-T080
in	O
d	O
.	O
	
simulans	O
in	O
the	O
recent	O
past	O
,	O
but	O
the	O
long-term	B-T079
estimates	B-T081
in	O
d	O
.	O
	
melanogaster	O
are	O
much	O
higher	B-T080
than	O
the	O
short-term	B-T079
ones	O
,	O
indicating	O
a	O
continuing	B-T078
decline	B-T081
in	O
selection	O
intensity	B-T080
,	O
to	O
such	O
an	O
extent	O
that	O
the	O
short-term	B-T079
estimates	B-T081
suggest	O
that	O
selection	O
is	O
only	O
active	B-T169
in	O
the	O
most	O
gc	B-T081
-rich	O
parts	O
of	O
the	O
genome	O
.	O
	
finally	O
,	O
we	O
provide	O
evidence	B-T078
for	O
complex	B-T080
evolutionary	O
patterns	O
in	O
the	O
putatively	O
neutral	O
short	O
introns	O
,	O
which	O
cannot	O
be	O
explained	O
by	O
the	O
standard	B-T081
gc	B-T081
-	O
biased	B-T078
gene	O
conversion	O
model	O
.	O
	
these	O
results	O
reveal	O
a	O
dynamic	B-T169
picture	O
of	O
base	B-T081
composition	I-T081
evolution	O
.	O
	
a	O
case	B-T169
of	O
koch's	B-T047
spine	I-T047
treated	B-T169
with	O
modified	B-T169
transpedicular	B-T061
vertebral	I-T061
curettage	I-T061
and	O
posterior	O
fixation	B-T061
a	O
novel	O
technique	B-T169
tuberculosis	B-T047
tb	B-T047
is	O
a	O
chronic	B-T079
granulomatous	B-T047
infection	I-T047
caused	O
by	O
acid-fast	O
mycobacterium	O
tuberculosis	O
bacilli	O
.	O
	
spinal	O
involvement	O
occurs	O
in	O
less	O
than	O
one	O
percent	O
of	O
tb	B-T047
.	O
	
spinal	B-T047
tb	I-T047
pott's	B-T047
disease	I-T047
accounts	O
for	O
50%	O
of	O
skeletal	O
tb	O
.	O
	
though	O
it	O
most	O
commonly	O
affects	O
the	O
thoracolumbar	O
junction	O
,	O
it	O
can	O
occur	O
at	O
any	O
level	B-T080
of	O
the	O
spine	O
.	O
	
early	O
diagnosis	B-T033
and	O
treatment	B-T061
is	O
mandatory	O
in	O
order	O
to	O
avoid	O
neurological	O
complications	O
and	O
spinal	O
deformity	O
.	O
	
we	O
report	O
a	O
case	B-T169
of	O
a	O
young	B-T079
female	O
with	O
tuberculosis	B-T047
of	O
d12-l1	O
who	O
was	O
treated	B-T169
with	O
posterior	O
decompression	B-T061
using	O
a	O
modified	B-T169
transpedicular	B-T061
approach	I-T061
and	O
posterior	O
instrumentation	B-T061
with	O
a	O
successful	O
a	O
comparison	O
of	O
two	O
comorbidity	B-T081
indices	I-T081
for	O
predicting	B-T078
inpatient	O
rehabilitation	B-T061
outcomes	B-T080
comorbid	B-T033
conditions	I-T033
are	O
important	O
in	O
health	O
care	O
.	O
	
the	O
best	O
comorbidity	B-T081
index	I-T081
for	O
predicting	B-T078
the	O
impact	B-T080
of	O
comorbidities	B-T078
on	O
rehabilitation	B-T061
outcomes	B-T080
has	O
not	O
been	O
determined	B-T080
.	O
	
compare	O
the	O
associations	B-T080
of	O
comorbidity	B-T078
measured	B-T080
using	O
the	O
charlson	B-T081
comorbidity	I-T081
index	I-T081
cci	B-T081
and	O
the	O
cumulative	B-T081
index	I-T081
rating	I-T081
scale	I-T081
cirs	B-T081
with	O
key	O
rehabilitation	B-T061
outcomes	B-T080
.	O
	
aim	O
was	O
to	O
determine	B-T080
whether	O
either	O
of	O
these	O
comorbidity	B-T081
indices	I-T081
helped	O
explain	O
the	O
variation	B-T080
in	O
key	O
rehabilitation	B-T061
outcomes	B-T080
.	O
	
prospective	O
open-cohort	O
study	O
.	O
	
inpatient	O
rehabilitation	B-T061
ward	O
,	O
melbourne	O
,	O
australia	O
.	O
	
adults	O
admitted	O
for	O
inpatient	O
rehabilitation	B-T061
n=280	O
.	O
	
the	O
main	O
outcomes	B-T080
were	O
demographic	B-T078
e.g	O
.	O
	
age	O
,	O
gender	O
,	O
discharge	O
destination	O
and	O
clinical	B-T080
outcomes	B-T080
reason	B-T033
for	O
rehabilitation	B-T061
,	O
length	B-T079
of	I-T079
stay	I-T079
,	O
functional	O
independence	O
measure	O
,	O
cci	B-T081
and	O
cirs	B-T081
.	O
	
a	O
series	O
of	O
regression	O
analyses	O
were	O
performed	B-T169
to	O
determine	B-T080
the	O
influence	O
of	O
comorbidity	B-T078
on	O
three	O
dependent	B-T169
variables	I-T169
los	B-T079
in	O
rehabilitation	B-T061
2	O
the	O
change	B-T081
in	O
functional	O
independence	O
measure-motor	O
score	B-T081
between	O
rehabilitation	B-T061
discharge	O
and	O
admission	O
and	O
3	O
the	O
discharge	O
destination	O
home	O
vs	O
other	O
.	O
	
the	O
mean	B-T081
age	O
was	O
57.7	O
years	B-T079
,	O
there	O
were	O
slightly	O
more	O
females	O
51%	O
,	O
most	O
95%	O
patients	O
previously	B-T079
lived	B-T033
at	I-T033
home	I-T033
with	O
family	O
or	O
other	O
relatives	O
63%	O
.	O
	
the	O
most	O
common	O
reason	B-T033
for	O
rehabilitation	B-T061
was	O
orthopaedic	B-T061
or	O
other	O
conditions	B-T080
52%	O
and	O
most	O
80%	O
people	O
were	O
discharged	O
home	O
.	O
	
the	O
median	O
los	B-T079
was	O
27	O
days	B-T079
.	O
	
there	O
were	O
100	O
35.7	O
patients	O
who	O
had	O
no	O
comorbidity	B-T078
recorded	O
using	O
the	O
cci	B-T081
,	O
112	O
40.0	O
and	O
26	O
9.3	O
who	O
three	O
or	O
more	O
.	O
	
all	O
patients	O
had	O
at	O
least	O
one	O
comorbidity	B-T078
recorded	O
with	O
the	O
cirs	B-T081
,	O
and	O
264	O
94.3	O
had	O
3	O
or	O
more	O
comorbidities	B-T078
.	O
	
there	O
was	O
little	O
or	O
no	O
difference	B-T080
between	O
the	O
cci	B-T081
or	O
cirs	B-T081
in	O
terms	O
of	O
their	O
ability	O
to	O
explain	O
the	O
variance	B-T080
in	O
los	B-T079
adjusted	O
r2	B-T081
=0	O
with	O
and	O
without	O
comorbidities	B-T078
,	O
change	B-T081
in	O
disability	B-T033
during	O
rehabilitation	B-T061
adjusted	O
r2	B-T081
=0	O
-	O
0.33	O
with	O
and	O
without	O
comorbidities	B-T078
or	O
the	O
discharge	O
destination	O
auc=0	O
without	O
comorbidities	B-T078
0.73	O
-	O
0.74	O
with	O
comorbidities	B-T078
beyond	O
that	O
accounted	O
for	O
by	O
demographic	B-T078
and	O
clinical	O
information	O
.	O
	
neither	O
the	O
cirs	B-T081
nor	O
the	O
cci	B-T081
in	O
our	O
patient	O
sample	O
provide	O
additional	O
information	B-T078
that	O
explains	O
the	O
impact	B-T080
of	O
comorbidities	B-T078
on	O
key	O
rehabilitation	B-T061
outcomes	B-T080
.	O
	
further	O
research	O
is	O
needed	O
to	O
determine	B-T080
the	O
most	O
appropriate	B-T080
measure	B-T081
of	O
comorbidity	B-T078
of	O
relevance	B-T080
to	O
inpatient	O
rehabilitation	B-T061
outcomes	B-T080
.	O
	
internet	O
gaming	O
disorder	O
explains	O
unique	B-T080
variance	I-T080
in	O
psychological	O
distress	O
and	O
disability	B-T033
after	O
controlling	O
for	O
comorbid	B-T033
depression	O
,	O
ocd	O
,	O
adhd	O
,	O
and	O
anxiety	B-T033
this	O
study	O
extends	O
knowledge	O
about	O
the	O
relationship	B-T080
of	O
internet	O
gaming	O
disorder	O
igd	O
to	O
other	O
established	O
mental	O
disorders	O
by	O
exploring	O
comorbidities	B-T078
with	O
anxiety	B-T033
,	O
depression	O
,	O
attention	O
deficit	O
hyperactivity	O
disorder	O
adhd	O
,	O
and	O
obsessive	O
compulsive	O
disorder	O
ocd	O
,	O
and	O
assessing	O
whether	O
igd	O
accounts	O
for	O
unique	B-T080
variance	I-T080
in	O
distress	B-T033
and	O
disability	B-T033
.	O
	
an	O
online	O
survey	O
was	O
completed	O
by	O
a	O
convenience	O
sample	O
that	O
engages	O
in	O
internet	O
gaming	O
n	O
=	O
404	O
.	O
	
participants	O
meeting	O
criteria	O
for	O
igd	O
based	O
on	O
the	O
personal	O
internet	O
gaming	O
disorder	O
evaluation-9	O
pie-9	O
reported	O
higher	B-T078
comorbidity	I-T078
with	O
depression	O
,	O
ocd	O
,	O
adhd	O
,	O
and	O
anxiety	B-T033
compared	O
with	O
those	O
who	O
did	O
not	O
meet	O
the	O
igd	O
criteria	B-T078
.	O
	
igd	O
explained	O
a	O
small	O
proportion	B-T081
of	O
unique	B-T080
variance	I-T080
in	O
distress	B-T033
1%	O
and	O
disability	B-T033
3%	O
.	O
	
igd	O
accounted	O
for	O
a	O
larger	B-T081
proportion	I-T081
of	O
unique	B-T080
variance	I-T080
in	O
disability	B-T033
than	O
anxiety	B-T033
and	O
adhd	O
,	O
and	O
a	O
similar	O
proportion	B-T081
to	O
depression	O
.	O
	
replications	B-T080
with	O
clinical	O
samples	O
using	O
longitudinal	O
designs	O
and	O
structured	O
diagnostic	O
interviews	O
what	O
is	O
the	O
real	B-T080
impact	B-T080
of	O
urinary	O
incontinence	O
on	O
female	O
sexual	O
dysfunction	O
a	O
case	O
control	O
study	O
urinary	O
incontinence	O
ui	O
has	O
been	O
associated	B-T080
with	I-T080
negative	B-T033
effects	B-T080
on	O
women's	O
sexuality	O
.	O
	
women's	O
sexuality	O
and	O
sexual	O
function	O
are	O
a	O
complex	B-T080
issue	B-T033
,	O
and	O
the	O
role	O
of	O
ui	O
is	O
not	B-T080
completely	I-T080
clear	O
.	O
	
to	O
assess	O
the	O
impact	B-T080
of	O
ui	O
on	O
female	O
sexual	O
function	O
by	O
comparing	O
this	O
population	O
with	O
a	O
control	O
group	O
of	O
continent	B-T080
women	O
.	O
	
we	O
performed	O
a	O
case-control	O
study	O
from	O
august	O
2012	O
to	O
september	O
2013	O
.	O
	
we	O
evaluated	O
continent	B-T080
and	O
incontinent	B-T169
women	O
age	O
range	B-T081
=	O
30-70	O
years	O
for	O
their	O
sexuality	O
.	O
	
all	O
patients	O
were	O
evaluated	O
by	O
anamnesis	O
,	O
physical	O
examination	O
,	O
and	O
self-report	O
quality-of-life	O
questionnaires	O
.	O
	
in	O
addition	O
,	O
incontinent	B-T169
women	O
underwent	O
a	O
1-hour	O
pad	O
test	O
.	O
	
patients	O
without	O
sexual	O
activity	O
were	O
evaluated	O
for	O
the	O
role	O
of	O
ui	O
in	O
their	O
sexual	O
abstinence	O
.	O
	
sexual	O
abstinence	O
was	O
defined	O
as	O
the	O
absence	B-T033
of	I-T033
sexual	I-T033
activity	I-T033
for	O
more	O
than	O
6	O
months	O
.	O
	
all	O
sexually	B-T033
active	I-T033
women	O
completed	O
the	O
self-report	O
sexuality	O
quotient	B-T081
-	O
female	O
version	O
sq-f	O
questionnaire	O
.	O
	
a	O
total	O
of	O
356	O
women	O
were	O
included	O
in	O
the	O
study	O
incontinent	B-T169
,	O
n	O
=	O
243	O
continent	B-T080
,	O
n	O
=	O
113	O
.	O
	
sexual	O
abstinence	O
was	O
found	O
in	O
162	O
women	O
45%	O
.	O
	
incontinent	B-T169
women	O
presented	O
a	O
higher	B-T081
prevalence	I-T081
p	O
<	O
001	O
of	O
sexual	O
abstinence	O
than	O
their	O
counterparts	O
129	O
53%	O
and	O
33	O
29.2	O
,	O
respectively	O
.	O
	
age	O
,	O
marital	O
status	O
,	O
and	O
ui	O
were	O
found	O
to	O
be	O
isolated	B-T169
predictive	O
factors	O
for	O
more	O
sexual	O
abstinence	O
in	O
incontinent	B-T169
women	O
.	O
	
sexually	B-T033
active	I-T033
women	O
incontinent	B-T169
,	O
n	O
=	O
114	O
continent	B-T080
,	O
n	O
=	O
80	O
presented	O
similar	O
demographic	O
data	B-T078
.	O
	
despite	O
a	O
similar	O
frequency	B-T079
of	O
sexual	O
activity	O
,	O
incontinent	B-T169
women	O
had	O
less	O
sexual	O
desire	O
,	O
foreplay	B-T033
,	O
harmony	O
with	O
a	O
partner	O
,	O
sexual	O
comfort	O
,	O
and	O
sexual	O
satisfaction	O
than	O
their	O
counterparts	O
.	O
	
women	O
with	O
greater	B-T081
urinary	B-T033
leakage	I-T033
during	O
the	O
1-hour	O
pad	O
test	O
weight	B-T081
>	O
11	O
g	O
had	O
the	O
worst	O
sexual	O
function	O
sq-f	O
score	B-T081
.	O
	
women	O
with	O
ui	O
were	O
more	O
likely	O
to	O
be	O
sexual	O
abstinent	O
than	O
continent	B-T080
women	O
.	O
	
furthermore	O
,	O
women	O
with	O
ui	O
showed	O
less	O
sexual	O
desire	O
,	O
sexual	O
comfort	O
,	O
and	O
sexual	O
satisfaction	O
than	O
their	O
counterparts	O
despite	O
having	O
a	O
similar	O
frequency	B-T079
of	O
sexual	O
activity	O
.	O
	
salvianolic	B-T109
acids	I-T109
for	O
injection	O
safi	O
suppresses	B-T169
inflammatory	O
responses	O
in	O
activated	O
microglia	O
to	O
attenuate	O
brain	O
damage	O
in	O
focal	B-T047
cerebral	I-T047
ischemia	I-T047
inflammatory	O
reactions	O
induced	O
by	O
microglia	O
in	O
the	O
brain	O
play	O
crucial	O
roles	O
in	O
ischemia	B-T047
/	O
reperfusion	O
i/r	O
cerebral	O
injuries	O
.	O
	
microglia	O
activation	O
has	O
been	O
shown	O
to	O
be	O
closely	O
related	O
to	O
tlr4	O
/	O
nf-κb	O
signal	O
pathways	O
.	O
	
salvianolic	B-T109
acids	I-T109
for	O
injection	O
safi	O
have	O
been	O
used	O
in	O
clinical	O
practice	O
to	O
treat	B-T169
ischemic	B-T047
stroke	I-T047
with	O
reported	O
neuroprotective	B-T169
effects	I-T169
however	O
,	O
the	O
underlying	O
mechanisms	B-T169
are	O
still	O
uncertain	O
.	O
	
first	O
,	O
we	O
studied	O
the	O
effect	B-T080
of	O
safi	O
on	O
inflammatory	O
responses	O
in	O
lps	B-T109
-	O
stimulated	O
bv-2	O
microglia	O
.	O
	
then	O
,	O
to	O
discover	O
whether	O
the	O
beneficial	B-T081
in	O
vitro	O
effects	B-T080
of	O
safi	O
lead	O
to	O
in	O
vivo	O
therapeutic	O
effect	O
s	O
,	O
an	O
mcao	O
middle	O
cerebral	O
artery	O
occlusion	O
rat	O
model	O
was	O
further	O
employed	B-T033
to	O
elucidate	O
the	O
probable	O
mechanism	B-T169
of	O
safi	O
in	O
treating	B-T169
ischemic	B-T047
stroke	I-T047
.	O
	
rats	O
in	O
the	O
safi	O
group	B-T078
were	O
given	O
safi	O
23	O
or	O
46mg/kg	O
before	O
i	B-T047
/	O
r	O
injury	O
.	O
	
the	O
results	B-T169
showed	O
that	O
safi	O
treatment	B-T169
significantly	B-T081
decreased	I-T081
neuroinflammation	O
and	O
the	O
infarction	O
volume	B-T081
compared	O
with	O
the	O
vehicle	O
group	B-T078
.	O
	
activation	O
of	O
microglia	O
cells	O
was	O
reduced	B-T080
,	O
and	O
tlr4	O
/	O
nf-κb	O
signals	O
,	O
which	O
were	O
markedly	O
inhibited	B-T080
by	O
safi	O
treatment	B-T169
in	O
ischemic	B-T169
hemisphere	O
,	O
were	O
accompanied	O
by	O
reduced	B-T080
expression	O
and	O
release	O
of	O
cytokines	B-T116
il-1β	B-T116
and	O
il-6	B-T116
.	O
	
this	O
study	O
provides	O
evidence	B-T078
that	O
safi	O
effectively	B-T080
protects	O
the	O
brain	O
after	O
cerebral	B-T047
ischemia	I-T047
,	O
which	O
may	O
be	O
caused	O
by	O
attenuating	O
inflammation	O
in	O
dynamics	O
of	O
bacterial	B-T080
class	O
bacilli	O
in	O
the	O
deepest	O
valley	O
lake	O
of	O
kashmir	O
-the	O
manasbal	O
lake	O
in	O
recognition	O
of	O
the	O
importance	O
of	O
bacteria	O
as	O
ecological	O
indicators	O
of	O
the	O
aquatic	O
systems	O
a	O
comprehensive	O
and	O
systematic	O
analysis	O
was	O
carried	O
out	O
on	O
manasbal	O
lake	O
,	O
the	O
deepest	O
spring	O
fed	O
valley	O
lake	O
of	O
kashmir	O
.	O
	
the	O
main	O
objective	O
envisaged	O
was	O
to	O
analyze	O
bacterial	B-T080
community	I-T080
composition	I-T080
bcc	B-T080
and	O
for	O
this	O
purpose	O
systematic	B-T081
and	O
regular	O
sampling	O
of	O
waters	O
from	O
ten	O
different	O
sampling	O
stations	O
,	O
predetermined	O
in	O
the	O
lake	O
according	O
to	O
differences	O
in	O
degree	O
of	O
human	O
interference	O
and	O
also	O
as	O
zones	O
of	O
special	O
ecological	O
interests	O
were	O
selected	O
.	O
	
the	O
isolated	O
species	O
were	O
identified	O
according	O
to	O
bergey's	O
manual	O
specification	O
by	O
examining	O
their	O
micro	O
and	O
macro	O
morphological	O
characteristics	O
and	O
biochemical	O
characteristics	O
on	O
different	O
culture	O
media	O
.	O
	
further	O
confirmation	O
was	O
done	O
by	O
sequencing	O
the	O
16s	O
rrna	O
gene	O
by	O
using	O
universal	O
bacterial	O
primers	O
27f	O
and	O
1429r	O
.	O
	
from	O
all	O
the	O
sampling	O
stations	O
the	O
class	O
bacilli	O
showed	O
a	O
maximum	O
relative	O
abundance	O
with	O
a	O
contribution	O
of	O
16	O
bacterial	O
species	O
.	O
	
the	O
whole	O
process	O
resulted	O
in	O
the	O
identification	O
of	O
bacillus	O
aerius	O
,	O
bacillus	O
altitudinis	O
,	O
bacillus	O
anthracis	O
,	O
bacillus	O
cereus	O
,	O
bacillus	O
ginsengisoli	O
,	O
bacillus	O
pumilus	O
,	O
bacillus	O
safensis	O
,	O
bacillus	O
stratosphericus	O
,	O
bacillus	O
subtilis	O
,	O
bacillus	O
tequilensis	O
,	O
bacillus	O
thermocopriae	O
,	O
bacillus	O
thuringiensis	O
,	O
brevibacillus	O
agri	O
strain	O
,	O
lysinibacillus	O
boronitolerans	O
,	O
lysinibacillus	O
pakistanensis	O
and	O
lysinibacillus	O
sphaericus	O
a	O
new	O
angle	O
and	O
its	O
relationship	O
with	O
early	O
fixation	O
failure	O
of	O
femoral	O
neck	O
fractures	O
treated	O
with	O
three	O
cannulated	O
compression	O
screws	O
the	O
pauwels	O
angle	O
has	O
been	O
used	O
widely	O
,	O
however	O
an	O
accurate	O
evaluation	O
of	O
this	O
angle	O
is	O
difficult	O
because	O
of	O
deformity	O
of	O
the	O
affected	B-T169
lower	O
extremity	O
.	O
	
therefore	O
we	O
designed	O
a	O
new	O
measurement	B-T169
of	O
the	O
orientation	O
of	O
femoral	O
neck	O
fracture	O
and	O
applied	O
this	O
in	O
a	O
retrospective	O
study	O
to	O
assess	O
1	O
its	O
reproducibility	B-T080
,	O
2	O
its	O
advantages	O
compared	O
with	O
the	O
pauwels	O
angle	O
,	O
3	O
its	O
relationship	O
with	O
the	O
short-term	O
prognosis	O
treated	B-T169
with	O
three	O
cannulated	O
compression	O
screws	O
.	O
	
this	O
new	O
measurement	B-T169
is	O
reproducible	O
and	O
has	O
some	O
reference	O
meaning	O
for	O
the	O
treatment	B-T061
of	O
femoral	O
neck	O
fractures	O
.	O
	
two	O
hundred	O
and	O
twenty-eight	O
patients	O
with	O
femoral	O
neck	O
fractures	O
treated	O
with	O
three	O
cannulated	O
compression	O
screws	O
were	O
retrospectively	O
analyzed	O
.	O
	
the	O
vn	O
angle	O
,	O
which	O
was	O
the	O
angle	O
between	O
the	O
fracture	O
line	O
and	O
the	O
vertical	O
of	O
the	O
neck	O
axis	O
,	O
and	O
the	O
pauwels	O
angle	O
were	O
measured	O
respectively	O
.	O
	
the	O
method	O
of	O
icc	B-T081
was	O
performed	O
to	O
assess	O
the	O
reproducibility	B-T080
of	O
the	O
two	O
angles	O
,	O
and	O
the	O
absolute	O
value	O
of	O
difference	O
in	O
pre-operative	B-T079
and	O
post-operative	B-T079
radiographs	O
was	O
used	O
to	O
evaluate	O
the	O
uniformity	O
of	O
the	O
two	O
angles	O
.	O
	
these	O
fractures	O
were	O
divided	O
into	O
four	O
groups	B-T078
according	O
to	O
vn	O
angle	O
vn<0	O
n=92	O
,	O
0	O
n=82	O
,	O
10	O
n=26	O
,	O
vn	O
n=28	O
,	O
and	O
the	O
short-term	O
within	O
6	O
months	B-T079
fixation	B-T061
results	O
of	O
radiographs	O
in	O
these	O
fractures	O
were	O
evaluated	O
.	O
	
the	O
icc	B-T081
of	O
the	O
vn	O
angle	O
and	O
the	O
pauwels	O
angle	O
in	O
pre-operative	B-T079
radiographs	O
were	O
0.937	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
0.922	O
and	O
0.942	O
respectively	O
95%	O
ci	B-T081
0.914	O
,	O
indicating	O
both	O
angles	O
had	O
a	O
good	O
inter-rater	B-T080
reproducibility	I-T080
.	O
	
however	O
,	O
there	O
was	O
a	O
great	O
difference	O
between	O
the	O
pauwels	O
angle	O
in	O
pre-operative	B-T079
and	O
post-operative	B-T079
radiographs	O
p=0	O
,	O
the	O
absolute	O
difference	O
was	O
10.66	O
range	O
1.72	O
,	O
while	O
no	O
statistical	O
difference	O
for	O
the	O
vn	O
angle	O
p=0	O
and	O
the	O
absolute	O
difference	O
was	O
2.20	O
range	O
0.05	O
.	O
	
the	O
overall	O
fixation	O
failure	O
rate	B-T081
which	O
was	O
defined	O
as	O
screw	O
loosening	O
,	O
varus	O
collapse	O
,	O
obvious	O
fracture	O
displacement	O
or	O
femoral	O
neck	O
shortening	O
was	O
11.84	O
,	O
and	O
the	O
mean	O
failure	O
rates	O
according	O
to	O
vn	O
angles	O
were	O
respectively	O
0%	O
,	O
3.24	O
95%	O
ci	B-T081
1.64	O
,	O
22.69	O
95%	O
ci	B-T081
16.43	O
,	O
65.45	O
95%	O
ci	B-T081
59.36	O
.	O
	
the	O
mean	O
failure	B-T081
rates	I-T081
of	O
fractures	O
according	O
to	O
post-operative	B-T079
pauwels	O
angle	O
<30	O
,	O
30-50	O
,	O
>50	O
were	O
respectively	O
0%	O
,	O
1.46	O
95%	O
ci	B-T081
1.42	O
and	O
36.24	O
95%	O
ci	B-T081
34.93	O
.	O
	
the	O
vn	O
angle	O
has	O
a	O
good	O
inter-rater	B-T080
reproducibility	I-T080
,	O
a	O
higher	O
reliability	O
than	O
the	O
pauwels	O
angle	O
and	O
is	O
closely	O
related	O
to	O
the	O
short-term	O
prognosis	O
of	O
femoral	O
neck	O
fractures	O
treated	O
with	O
cannulated	O
compression	O
screws	O
.	O
	
retirement	B-T033
crisis	B-T033
warnings	B-T080
becoming	O
a	O
reality	B-T078
the	O
figures	B-T081
are	O
startling	B-T033
the	O
number	O
of	O
nhs	O
staff	O
applying	O
to	O
retire	B-T033
has	O
surged	B-T169
by	O
a	O
quarter	O
since	O
2012	O
.	O
	
the	O
potential	O
consequences	B-T169
are	O
alarming	B-T080
a	O
serious	O
shortage	B-T081
of	O
nurses	O
and	O
other	O
healthcare	O
professionals	O
now	O
seems	O
the	O
burden	B-T081
of	O
mental	O
disorders	O
in	O
the	O
eastern	O
mediterranean	O
region	O
,	O
1990-2013	O
the	O
eastern	O
mediterranean	O
region	O
emr	O
is	O
witnessing	O
an	O
increase	B-T169
in	O
chronic	B-T047
disorders	I-T047
,	O
including	O
mental	O
illness	O
.	O
	
with	O
ongoing	O
unrest	O
,	O
this	O
is	O
expected	O
to	O
rise	O
.	O
	
this	O
is	O
the	O
first	O
study	O
to	O
quantify	O
the	O
burden	B-T081
of	O
mental	O
disorders	O
in	O
the	O
emr	O
.	O
	
we	O
used	O
data	B-T078
from	O
the	O
global	O
burden	O
of	O
disease	O
study	O
gbd	O
2013	O
.	O
	
dalys	O
disability-adjusted	O
life	O
years	O
allow	O
assessment	O
of	O
both	O
premature	B-T033
mortality	I-T033
years	B-T081
of	I-T081
life	I-T081
lost	I-T081
-	O
ylls	B-T081
and	O
nonfatal	O
outcomes	O
years	B-T079
lived	I-T079
with	I-T079
disability	I-T079
-	O
ylds	B-T079
.	O
	
dalys	O
are	O
computed	O
by	O
adding	O
ylls	B-T081
and	O
ylds	B-T079
for	O
each	O
age-sex-country	O
group	O
.	O
	
in	O
2013	O
,	O
mental	O
disorders	O
contributed	O
to	O
5.6	O
of	O
the	O
total	B-T081
disease	I-T081
burden	I-T081
in	O
the	O
emr	O
1894	O
dalys	O
/100	O
population	O
2519	O
dalys	O
/100	O
2590/100	O
males	O
,	O
2426/100	O
females	O
in	O
high-income	B-T033
countries	O
,	O
1884	O
dalys	O
/100	O
1618/100	O
males	O
,	O
2157/100	O
females	O
in	O
middle-income	O
countries	O
,	O
1607	O
dalys	O
/100	O
1500/100	O
males	O
,	O
1717/100	O
females	O
in	O
low-income	O
countries	O
.	O
	
females	O
had	O
a	O
greater	O
proportion	O
of	O
burden	O
due	O
to	O
mental	O
disorders	O
than	O
did	O
males	O
of	O
equivalent	O
ages	O
,	O
except	O
for	O
those	O
under	O
15	O
years	O
of	O
age	O
.	O
	
the	O
highest	O
proportion	O
of	O
dalys	O
occurred	O
in	O
the	O
25-49	O
age	O
group	O
,	O
with	O
a	O
peak	O
in	O
the	O
35-39	O
years	O
age	O
group	O
5344	O
dalys	O
/100	O
.	O
	
the	O
burden	O
of	O
mental	O
disorders	O
in	O
emr	O
increased	O
from	O
1726	O
dalys	O
/100	O
in	O
1990	O
to	O
1912	O
dalys	O
/100	O
in	O
2013	O
10.8	O
increase	O
.	O
	
within	O
the	O
mental	O
disorders	O
group	O
in	O
emr	O
,	O
depressive	O
disorders	O
accounted	O
for	O
most	O
dalys	O
,	O
followed	O
by	O
anxiety	O
disorders	O
.	O
	
among	O
emr	O
countries	O
,	O
palestine	O
had	O
the	O
largest	O
burden	O
of	O
mental	O
disorders	O
.	O
	
nearly	O
all	O
emr	O
countries	O
had	O
a	O
higher	O
mental	O
disorder	O
burden	O
compared	O
to	O
the	O
global	O
level	O
.	O
	
our	O
findings	O
call	O
for	O
emr	O
ministries	O
of	O
health	O
to	O
increase	O
provision	O
of	O
mental	O
health	O
services	O
and	O
to	O
address	O
the	O
stigma	O
of	O
mental	O
illness	O
.	O
	
moreover	O
,	O
our	O
results	O
showing	O
the	O
accelerating	O
burden	O
of	O
mental	O
health	O
are	O
alarming	O
as	O
the	O
region	O
is	O
seeing	O
an	O
increased	O
level	O
of	O
instability	O
.	O
	
indeed	O
,	O
mental	O
health	O
problems	O
,	O
if	O
not	O
properly	O
addressed	O
,	O
will	O
lead	O
to	O
an	O
increased	O
burden	O
of	O
diseases	O
in	O
the	O
region	O
like	O
father	O
,	O
like	O
daughter	O
-	O
inherited	B-T169
cutis	O
aplasia	O
occurring	O
in	O
a	O
family	O
with	O
marfan	B-T047
syndrome	I-T047
a	O
case	O
report	O
we	O
present	O
the	O
case	B-T169
of	O
a	O
newborn	O
with	O
co-occurrence	B-T079
of	O
marfan	B-T047
syndrome	I-T047
and	O
aplasia	O
cutis	O
congenita	O
acc	O
and	O
a	O
family	B-T033
history	I-T033
significant	B-T078
for	O
marfan	B-T047
syndrome	I-T047
and	O
acc	O
in	O
the	O
father	O
.	O
	
this	O
case	B-T169
details	B-T080
a	O
previously	O
unreported	O
mutation	O
in	O
marfan	B-T047
syndrome	I-T047
and	O
describes	O
a	O
novel	O
coinheritance	B-T169
of	O
marfan	B-T047
syndrome	I-T047
and	O
hyperandrogenemia	B-T033
in	O
women	O
with	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
prevalence	B-T081
,	O
characteristics	B-T080
and	O
association	B-T080
with	I-T080
body	O
mass	O
index	O
hyperandrogenemia	B-T033
is	O
one	O
of	O
the	O
major	O
diagnostic	B-T169
features	O
for	O
the	O
diagnosis	B-T033
of	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
pcos	B-T047
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	B-T081
the	O
prevalence	B-T081
and	O
the	O
characteristics	B-T080
of	O
hyperandrogenemia	B-T033
in	O
women	O
with	O
pcos	B-T047
and	O
to	O
investigate	B-T169
the	O
association	O
of	O
clinical	B-T080
and	O
biochemical	B-T169
characteristics	B-T080
with	O
body	O
mass	O
index	O
bmi	O
according	O
to	O
the	O
presence	B-T033
of	O
hyperandrogenemia	B-T033
.	O
	
we	O
studied	O
266	O
women	O
diagnosed	B-T033
with	O
pcos	B-T047
.	O
	
hyperandrogenemia	B-T033
was	O
defined	O
by	O
testosterone	B-T109
t	B-T109
and/or	O
free	B-T109
testosterone	I-T109
ft	B-T109
and/or	O
4	B-T109
androstenedione	I-T109
δ4-a	B-T109
higher	O
than	O
75%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O
	
patients	O
were	O
stratified	B-T080
in	O
two	O
groups	O
according	O
to	O
a	O
bmi	O
threshold	B-T080
of	O
25	O
kg/m2	O
.	O
	
hyperandrogenemia	B-T033
was	O
present	B-T033
in	O
78.2	O
of	O
the	O
patients	O
.	O
	
elevated	B-T080
levels	O
of	O
t	B-T109
were	O
found	O
in	O
58.4	O
,	O
while	O
elevated	B-T080
levels	O
of	O
ft	B-T109
and	O
δ4-a	B-T109
were	O
found	O
in	O
42.5	O
and	O
34.1	O
of	O
patients	O
.	O
	
in	O
normal	B-T033
weight	I-T033
women	O
bmi	O
25	O
kg/m2	O
with	O
hyperandrogenemia	B-T033
lower	O
values	O
of	O
hip	O
circumference	O
and	O
homa-ir	O
and	O
increased	B-T081
levels	O
of	O
t	B-T109
,	O
ft	B-T109
,	O
δ4-a	B-T109
,	O
17-hydroxyprogesterone	B-T109
17-ohp	B-T109
,	O
dehydroepiandrosterone	B-T109
sulfate	I-T109
dheas	B-T109
,	O
white	O
blood	O
cells	O
wbc	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	B-T033
.	O
	
also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
t	B-T109
,	O
ft	B-T109
,	O
δ4-a	B-T109
,	O
17-ohp	B-T109
,	O
dheas	B-T109
and	O
cortisol	B-T109
were	O
measured	B-T080
,	O
while	O
lower	O
thyroid-stimulating	O
hormone	O
tsh	O
levels	O
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	B-T033
.	O
	
this	O
study	O
showed	O
high	O
prevalence	B-T081
of	O
hyperandrogenemia	B-T033
in	O
pcos	B-T047
women	O
.	O
	
women	O
with	O
bmi	O
25	O
kg/m2	O
have	O
significant	B-T078
differences	O
in	O
androgens	O
,	O
wbc	O
,	O
neutrophils	O
and	O
homa-ir	O
and	O
women	O
with	O
bmi	O
25	O
kg/m2	O
in	O
androgens	O
,	O
tsh	O
and	O
cortisol	B-T109
according	O
to	O
the	O
presence	B-T033
or	O
not	O
of	O
a	O
course	B-T079
-based	O
approach	O
to	O
the	O
doctor	O
of	O
nursing	O
practice	O
project	O
supporting	O
student	O
growth	O
from	O
concept	B-T078
to	O
completion	B-T080
we	O
describe	O
a	O
course	B-T079
-based	O
approach	O
to	O
the	O
doctor	O
of	O
nursing	O
practice	O
project	O
in	O
which	O
students	O
work	O
in	O
groups	B-T078
of	O
8	O
to	O
12	O
with	O
a	O
faculty	O
member	O
to	O
complete	B-T080
individual	O
final	O
projects	O
that	O
require	O
a	O
minimum	B-T080
of	O
360	O
practicum	O
hours	B-T079
in	O
3-	O
semester	B-T079
-long	O
courses	B-T079
.	O
	
project	O
teams	O
include	O
agency	O
or	O
community	O
-based	O
mentors	O
.	O
	
project	B-T033
findings	I-T033
are	O
disseminated	O
through	O
written	O
and	O
oral	O
reports	O
.	O
	
this	O
approach	O
preserves	O
faculty	O
resources	B-T169
and	O
provides	O
students	O
with	O
mentoring	O
,	O
opportunities	B-T078
for	O
reflection	O
,	O
and	O
time	B-T079
for	O
project	B-T169
development	I-T169
.	O
	
clinical	B-T080
and	O
angiographic	O
correlation	B-T080
of	O
high-sensitivity	B-T116
c-reactive	I-T116
protein	I-T116
with	O
acute	B-T047
st	I-T047
elevation	I-T047
myocardial	I-T047
infarction	I-T047
vascular	B-T047
inflammation	I-T047
and	O
associated	O
ongoing	O
inflammatory	O
responses	O
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	B-T079
atherothrombotic	O
events	O
such	O
as	O
acute	B-T047
coronary	I-T047
syndrome	I-T047
acs	B-T047
and	O
myocardial	B-T047
infarction	I-T047
mi	B-T047
.	O
	
st	B-T047
segment	I-T047
elevation	I-T047
myocardial	I-T047
infarction	I-T047
stemi	B-T047
is	O
considered	O
as	O
one	O
of	O
the	O
prominent	O
clinical	B-T080
forms	B-T080
of	O
acs	B-T047
.	O
	
moreover	O
,	O
c-reactive	B-T116
protein	I-T116
crp	B-T116
is	O
an	O
important	O
acute	B-T116
phase	I-T116
prsotein	I-T116
,	O
which	O
may	O
be	O
estimated	O
using	O
high-sensitivity	O
methods	O
hs-crp	O
,	O
and	O
its	O
elevated	B-T080
level	O
in	O
body	O
fluids	O
reflects	O
chronic	O
inflammatory	O
status	B-T080
.	O
	
the	O
circulating	O
hs-crp	O
level	O
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	O
marker	O
of	O
coronary	B-T047
artery	I-T047
disease	I-T047
cad	B-T047
.	O
	
the	O
present	O
study	O
investigated	B-T169
the	O
correlation	B-T080
of	O
hs-crp	O
level	O
with	O
clinical	B-T080
and	O
angiographic	O
features	B-T080
of	O
stemi	B-T047
,	O
various	O
other	O
traditional	O
risk	B-T033
factors	I-T033
,	O
complications	O
of	O
myocardial	B-T047
infarction	I-T047
and	O
angiographically	B-T078
significant	I-T078
cad	B-T047
.	O
	
out	O
of	O
190	O
patients	O
with	O
stemi	B-T047
that	O
were	O
analyzed	O
,	O
the	O
interval	B-T079
between	O
symptom	B-T079
onset	I-T079
and	O
reperfusion	B-T061
therapy	I-T061
window	B-T079
period	I-T079
varied	O
from	O
0.5	O
to	O
24	O
h	B-T079
.	O
	
the	O
hs-crp	O
value	O
was	O
found	O
to	O
be	O
higher	O
in	O
non-diabetic	O
patients	O
0.61	O
mg/dl	O
compared	O
with	O
diabetic	B-T047
patients	O
0.87	O
mg/dl	O
.	O
	
moreover	O
,	O
a	O
significant	O
correlation	B-T080
between	O
hs-crp	O
and	O
hs-troponin	O
t	O
was	O
also	O
recorded	O
p<0	O
.	O
	
however	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
mean	O
hs-crp	O
values	B-T080
in	O
patients	O
with	O
or	O
without	O
mortality	B-T081
.	O
	
it	O
is	O
considered	O
that	O
the	O
present	O
study	O
will	O
increase	O
the	O
understanding	O
of	O
atherosclerosis	B-T047
in	O
general	O
and	O
may	O
also	O
have	O
clinical	O
applications	O
in	O
the	O
targeting	O
of	O
therapy	B-T061
for	O
this	O
harmful	O
bioelectrochemical	O
anaerobic	B-T080
sewage	O
treatment	O
technology	O
for	O
arctic	O
communities	O
this	O
study	O
describes	O
a	O
novel	O
wastewater	O
treatment	B-T169
technology	O
suitable	O
for	O
small	O
remote	O
northern	O
communities	O
.	O
	
the	O
technology	O
is	O
based	B-T169
on	O
an	O
enhanced	O
biodegradation	O
of	O
organic	O
carbon	O
through	O
a	O
combination	O
of	O
anaerobic	B-T080
methanogenic	O
and	O
microbial	O
electrochemical	O
bioelectrochemical	O
degradation	B-T169
processes	I-T169
leading	O
to	O
biomethane	B-T109
production	B-T169
.	O
	
the	O
microbial	O
electrochemical	O
degradation	B-T169
is	O
achieved	O
in	O
a	O
membraneless	B-T033
flow	I-T033
-through	O
bioanode	O
-	O
biocathode	O
setup	O
operating	B-T169
at	O
an	O
applied	B-T169
voltage	B-T081
below	O
the	O
water	O
electrolysis	B-T061
threshold	B-T080
.	O
	
laboratory	O
wastewater	O
treatment	B-T169
tests	O
conducted	O
through	O
a	O
broad	O
range	O
of	O
mesophilic	B-T080
and	O
psychrophilic	O
temperatures	O
5-23	O
c	O
using	O
synthetic	B-T080
wastewater	O
showed	O
a	O
biochemical	O
oxygen	O
demand	O
bod5	O
removal	O
efficiency	B-T081
of	O
90-97%	O
and	O
an	O
effluent	O
bod5	O
concentration	B-T081
as	O
low	O
as	O
7	O
mg	O
l	O
.	O
	
an	O
electricity	O
consumption	B-T169
of	O
0.6	O
kwh	O
kg	O
of	O
chemical	O
oxygen	O
demand	O
cod	O
removed	B-T080
was	O
observed	B-T169
.	O
	
low	B-T080
energy	B-T081
consumption	B-T169
coupled	O
with	O
enhanced	O
methane	B-T109
production	B-T169
led	O
to	O
a	O
net	O
positive	B-T033
energy	B-T081
balance	B-T169
in	O
the	O
bioelectrochemical	O
treatment	B-T169
system	B-T169
.	O
	
impact	B-T080
of	O
femoral	O
artery	O
puncture	O
using	O
digital	O
subtraction	O
angiography	O
and	O
road	O
mapping	O
on	O
vascular	B-T047
and	O
bleeding	O
complications	O
after	O
transfemoral	O
transcatheter	B-T061
aortic	I-T061
valve	I-T061
implantation	I-T061
the	O
use	O
of	O
large	B-T081
-	O
diameter	B-T081
sheaths	O
carries	O
the	O
risk	B-T078
of	O
significant	O
vascular	B-T047
and	O
bleeding	O
complications	O
after	O
transfemoral	O
transcatheter	B-T061
aortic	I-T061
valve	I-T061
implantation	I-T061
tavi	B-T061
.	O
	
in	O
this	O
analysis	O
,	O
we	O
sought	O
to	O
assess	O
the	O
impact	B-T080
of	O
a	O
modified	O
femoral	O
artery	O
puncture	O
technique	B-T169
using	O
digital	O
subtraction	O
angiography	O
dsa	O
and	O
road	O
mapping	O
during	O
transfemoral	O
tavi	B-T061
on	O
periprocedural	O
vascular	O
and	O
bleeding	O
events	O
.	O
	
this	O
is	O
a	O
retrospective	O
analysis	O
of	O
transfemoral	O
tavi	B-T061
patients	O
included	O
in	O
a	O
prospective	O
institutional	O
database	O
.	O
	
the	O
modified	O
femoral	O
artery	O
puncture	O
technique	B-T169
using	O
dsa	O
-derived	O
road	O
mapping	O
guidance	O
was	O
introduced	O
in	O
october	O
2012	O
.	O
	
before	O
the	O
introduction	O
of	O
this	O
technique	B-T169
,	O
vascular	O
puncture	O
was	O
acquired	O
based	O
on	O
an	O
integration	O
of	O
angiographic	O
data	B-T078
,	O
the	O
bony	B-T169
iliofemoral	O
landmarks	O
and	O
a	O
radiopaque	O
object	O
.	O
	
consecutive	O
patients	O
who	O
underwent	O
tavi	B-T061
with	O
the	O
road	O
mapping	O
technique	B-T169
rm	B-T078
group	I-T078
,	O
n=160	O
were	O
compared	O
with	O
consecutive	O
patients	O
who	O
underwent	O
tavi	B-T061
without	O
road	O
mapping	O
control	O
group	O
,	O
n=160	O
prior	O
to	O
its	O
introduction	O
.	O
	
a	O
standardised	O
strategy	O
of	O
periprocedural	B-T061
anticoagulation	I-T061
was	O
adopted	O
in	O
both	O
groups	B-T078
as	O
well	O
as	O
the	O
use	O
of	O
a	O
single	O
suture-based	O
closure	O
device	O
.	O
	
all	O
endpoints	B-T080
were	O
defined	O
according	O
to	O
the	O
varc-2	O
criteria	O
for	O
event	O
definition	O
.	O
	
the	O
mean	O
age	O
in	O
the	O
rm	B-T078
group	I-T078
was	O
80	O
years	B-T079
compared	O
to	O
81	O
years	B-T079
in	O
the	O
control	O
group	O
p=0	O
,	O
and	O
females	O
were	O
equally	O
distributed	O
between	O
both	O
groups	B-T078
63.1	O
vs	O
.	O
	
58.1	O
,	O
p=0	O
.	O
	
the	O
baseline	O
logistic	O
euroscore	O
was	O
20.7	O
vs	O
.	O
	
24.9	O
in	O
the	O
rm	B-T078
and	O
control	O
group	O
,	O
respectively	O
p=0	O
.	O
	
notably	O
,	O
sheath	O
size	O
was	O
significantly	O
larger	O
in	O
the	O
rm	B-T078
compared	O
to	O
the	O
control	O
group	O
due	O
to	O
the	O
more	O
frequent	O
use	O
of	O
the	O
20	O
fr	O
sheath	O
23.8	O
vs	O
.	O
	
1.8	O
,	O
p<0	O
,	O
respectively	O
associated	B-T080
with	I-T080
the	O
more	O
frequent	O
implantation	B-T061
of	O
the	O
29	O
mm	O
edwards	O
sapien	O
xt	O
valve	O
in	O
the	O
rm	B-T078
group	I-T078
43.8	O
vs	O
.	O
	
7%	O
,	O
respectively	O
,	O
p<0	O
.	O
	
despite	O
the	O
latter	O
finding	O
,	O
both	O
major	O
vascular	B-T047
complications	I-T047
and	O
major	O
bleeding	O
at	O
30	O
days	B-T079
were	O
significantly	O
lower	B-T080
in	O
the	O
rm	B-T078
group	I-T078
compared	O
to	O
the	O
control	O
group	O
4.3	O
vs	O
.	O
	
11.8	O
,	O
p=0	O
,	O
and	O
14.4	O
vs	O
.	O
	
25.6	O
,	O
p=0	O
.	O
	
an	O
analysis	O
limited	O
to	O
access	O
site-related	O
complications	O
also	O
revealed	O
lower	O
events	O
in	O
the	O
road	B-T078
map	I-T078
group	I-T078
but	O
did	O
not	O
reach	O
statistical	B-T081
significance	I-T081
8.1	O
vs	O
.	O
	
13.8	O
,	O
p=0	O
.	O
	
other	O
forms	O
of	O
vascular	B-T047
and	O
bleeding	O
complications	O
as	O
well	O
as	O
all-cause	B-T081
mortality	I-T081
were	O
comparable	O
in	O
both	O
groups	B-T078
.	O
	
a	O
modified	O
femoral	O
artery	O
puncture	O
technique	B-T169
using	O
dsa	O
and	O
road	O
mapping	O
was	O
associated	B-T080
with	I-T080
a	O
reduction	O
in	O
major	O
vascular	B-T047
and	O
bleeding	O
complications	O
after	O
transfemoral	O
tavi	B-T061
,	O
and	O
provides	O
a	O
simple	B-T080
and	O
effective	B-T080
strategy	O
for	O
potentially	O
improving	O
patient	O
outcomes	O
.	O
	
differential	B-T080
roles	B-T078
of	O
axin1	B-T116
and	O
axin2	B-T116
in	O
tankyrase	B-T116
inhibitor-induced	O
formation	B-T169
of	O
degradasomes	B-T116
and	O
β-catenin	B-T116
degradation	B-T169
inhibition	O
of	O
the	O
tankyrase	B-T116
enzymes	I-T116
tnks1	B-T116
and	O
tnks2	B-T116
has	O
recently	O
been	O
shown	O
to	O
induce	O
highly	B-T080
dynamic	B-T169
assemblies	O
of	O
β-catenin	B-T116
destruction	O
complex	O
components	B-T116
known	O
as	O
degradasomes	B-T116
,	O
which	O
promote	O
degradation	B-T169
of	O
β-catenin	B-T116
and	O
reduced	B-T080
wnt	O
signaling	O
activity	B-T169
in	O
colorectal	O
cancer	O
cells	O
.	O
	
axin1	B-T116
and	O
axin2	B-T116
/	O
conductin	B-T116
,	O
the	O
rate-limiting	B-T169
factors	B-T169
for	O
the	O
stability	B-T080
and	O
function	B-T169
of	O
endogenous	B-T169
destruction	O
complexes	O
,	O
are	O
stabilized	B-T033
upon	O
tnks	B-T116
inhibition	O
due	O
to	O
abrogated	O
degradation	B-T169
of	O
axin	B-T116
by	O
the	O
proteasome	B-T116
.	O
	
since	O
the	O
role	B-T078
of	O
axin1	B-T116
versus	O
axin2	B-T116
as	O
scaffolding	B-T116
proteins	I-T116
in	O
the	O
wnt	O
signaling	O
pathway	O
still	O
remains	B-T080
incompletely	B-T080
understood	O
,	O
we	O
sought	O
to	O
elucidate	O
their	O
relative	B-T080
contribution	O
in	O
the	O
formation	B-T169
of	O
degradasomes	B-T116
,	O
as	O
these	O
protein	B-T116
assemblies	O
most	O
likely	O
represent	O
the	O
morphological	O
and	O
functional	B-T169
correlates	B-T080
of	O
endogenous	B-T169
β-catenin	B-T116
destruction	O
complexes	O
.	O
	
in	O
sw480	O
colorectal	O
cancer	O
cells	O
treated	B-T169
with	O
the	O
tankyrase	O
inhibitor	O
tnksi	O
g007-lk	B-T109
we	O
found	B-T033
that	O
axin1	B-T116
was	O
not	O
required	O
for	O
degradasome	B-T116
formation	B-T169
.	O
	
in	O
contrast	O
,	O
the	O
formation	B-T169
of	O
degradasomes	B-T116
as	O
well	O
as	O
their	O
capacity	B-T081
to	O
degrade	B-T169
β-catenin	B-T116
were	O
considerably	B-T078
impaired	B-T169
in	O
g007-lk-treated	B-T109
cells	O
depleted	O
of	O
axin2	B-T116
.	O
	
these	O
findings	B-T033
give	O
novel	B-T080
insights	O
into	O
differential	B-T080
functional	O
roles	O
of	O
axin1	B-T116
versus	O
axin2	B-T116
in	O
the	O
β-catenin	B-T116
destruction	O
complex	O
.	O
	
mri	O
-based	O
prostate	O
cancer	O
detection	B-T033
with	O
high-level	O
representation	O
and	O
hierarchical	B-T169
classification	O
extracting	O
the	O
high-level	O
feature	O
representation	O
by	O
using	O
deep	O
neural	O
networks	O
for	O
detection	B-T033
of	O
prostate	O
cancer	O
,	O
and	O
then	O
based	O
on	O
high-level	O
feature	O
representation	O
constructing	O
hierarchical	B-T169
classification	O
to	O
refine	O
the	O
detection	B-T033
results	B-T169
.	O
	
high-level	O
feature	O
representation	O
is	O
first	O
learned	O
by	O
a	O
deep	O
learning	O
network	O
,	O
where	O
multiparametric	O
mr	O
images	O
are	O
used	O
as	O
the	O
input	O
data	B-T078
.	O
	
then	O
,	O
based	O
on	O
the	O
learned	O
high-level	B-T080
features	I-T080
,	O
a	O
hierarchical	B-T169
classification	O
method	O
is	O
developed	O
,	O
where	O
multiple	O
random	O
forest	O
classifiers	O
are	O
iteratively	O
constructed	O
to	O
refine	O
the	O
detection	B-T033
results	B-T169
of	O
prostate	O
cancer	O
.	O
	
the	O
experiments	O
were	O
carried	O
on	O
21	O
real	O
patient	O
subjects	O
,	O
and	O
the	O
proposed	O
method	O
achieves	O
an	O
averaged	O
section-based	O
evaluation	O
sbe	O
of	O
89.90	O
,	O
an	O
averaged	O
sensitivity	B-T169
of	O
91.51	O
,	O
and	O
an	O
averaged	O
specificity	B-T081
of	O
88.47	O
.	O
	
the	O
high-level	B-T080
features	I-T080
learned	O
from	O
our	O
proposed	O
method	O
can	O
achieve	O
better	O
performance	O
than	O
the	O
conventional	B-T081
handcrafted	B-T080
features	I-T080
e.g	O
,	O
lbp	B-T080
and	O
haar-like	B-T080
features	I-T080
in	O
detecting	B-T033
prostate	O
cancer	O
regions	O
,	O
also	O
the	O
context	B-T078
features	B-T080
obtained	O
from	O
the	O
proposed	O
hierarchical	B-T169
classification	O
approach	O
are	O
effective	B-T080
in	O
refining	O
cancer	O
detection	B-T033
result	B-T169
.	O
	
quantitative	O
susceptibility	O
mapping	O
using	O
structural	O
feature	O
based	O
collaborative	O
reconstruction	O
sfcr	O
in	O
the	O
human	O
brain	O
the	O
reconstruction	O
of	O
mr	O
quantitative	O
susceptibility	O
mapping	O
qsm	O
from	O
local	B-T079
phase	I-T079
measurements	B-T169
is	O
an	O
ill	O
posed	O
inverse	O
problem	O
and	O
different	O
regularization	B-T169
strategies	I-T169
incorporating	O
a	O
priori	B-T079
information	B-T078
extracted	O
from	O
magnitude	B-T081
and	O
phase	O
images	O
have	O
been	O
proposed	B-T080
.	O
	
however	O
,	O
the	O
anatomy	O
observed	O
in	O
magnitude	B-T081
and	O
phase	O
images	O
does	O
not	O
always	O
coincide	O
spatially	O
with	O
that	O
in	O
susceptibility	O
maps	O
,	O
which	O
could	O
give	O
erroneous	B-T078
estimation	B-T081
in	O
the	O
reconstructed	O
susceptibility	O
map	O
.	O
	
in	O
this	O
paper	O
,	O
we	O
develop	O
a	O
structural	O
feature	O
based	O
collaborative	O
reconstruction	O
sfcr	O
method	O
for	O
qsm	O
including	O
both	O
magnitude	B-T081
and	O
susceptibility	B-T081
based	O
information	B-T078
.	O
	
the	O
sfcr	O
algorithm	O
is	O
composed	O
of	O
two	O
consecutive	O
steps	O
corresponding	O
to	O
complementary	O
reconstruction	O
models	O
,	O
each	O
with	O
a	O
structural	O
feature	O
based	O
l1	O
norm	B-T169
constraint	I-T169
and	O
a	O
voxel	O
fidelity	O
based	O
l2	O
norm	B-T169
constraint	I-T169
,	O
which	O
allows	O
both	O
the	O
structure	O
edges	O
and	O
tiny	O
features	B-T080
to	O
be	O
recovered	O
,	O
whereas	O
the	O
noise	O
and	O
artifacts	O
could	O
be	O
reduced	O
.	O
	
in	O
the	O
m-step	O
,	O
the	O
initial	O
susceptibility	O
map	O
is	O
reconstructed	O
by	O
employing	O
a	O
k-space	O
based	O
compressed	O
sensing	O
model	O
incorporating	O
magnitude	B-T081
prior	O
.	O
	
in	O
the	O
s-step	O
,	O
the	O
susceptibility	O
map	O
is	O
fitted	O
in	O
spatial	O
domain	O
using	O
weighted	O
constraints	B-T169
derived	O
from	O
the	O
initial	O
susceptibility	O
map	O
from	O
the	O
m-step	O
.	O
	
simulations	O
and	O
in	O
vivo	O
human	O
experiments	O
at	O
7t	O
mri	O
show	O
that	O
the	O
sfcr	O
method	O
provides	O
high	O
quality	B-T080
susceptibility	O
maps	O
with	O
improved	O
rmse	B-T081
and	O
mssim	B-T081
.	O
	
finally	O
,	O
the	O
susceptibility	B-T081
values	O
of	O
deep	O
gray	O
matter	O
are	O
analyzed	O
in	O
multiple	O
head	O
positions	O
,	O
with	O
the	O
supine	O
position	O
most	O
approximate	O
to	O
the	O
gold	O
standard	O
cosmos	B-T169
result	B-T169
.	O
	
high	B-T080
hba1c	B-T116
at	O
onset	B-T080
cannot	O
be	O
used	O
as	O
a	O
predictor	B-T078
for	O
future	O
metabolic	O
control	O
for	O
the	O
individual	O
child	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
mellitus	I-T047
to	O
study	O
how	O
metabolic	O
control	O
at	O
onset	B-T080
of	O
type	B-T047
1	I-T047
diabetes	I-T047
correlates	O
to	O
metabolic	O
control	O
and	O
clinical	B-T080
parameters	B-T033
during	O
childhood	B-T079
until	O
transition	O
from	O
pediatric	B-T061
care	I-T061
to	O
adult	O
diabetes	B-T061
care	I-T061
.	O
	
data	B-T078
at	O
onset	B-T080
,	O
three	O
months	B-T079
,	O
one	O
,	O
three	O
,	O
and	O
five	O
years	B-T079
after	O
diagnosis	B-T033
and	O
at	O
transition	O
,	O
on	O
hba1c	B-T116
and	O
clinical	B-T080
parameters	B-T033
,	O
on	O
8084	O
patients	O
in	O
the	O
swedish	O
pediatric	O
quality	O
registry	O
,	O
swediabkids	O
,	O
were	O
used	O
.	O
	
of	O
these	O
patients	O
,	O
26%	O
had	O
been	O
referred	O
to	O
adult	O
diabetes	B-T061
care	I-T061
by	O
2014	O
.	O
	
children	O
with	O
hba1c	B-T116
<	O
72	O
mmol/mol	O
8.7	O
20%	O
of	O
patients	O
,	O
low	B-T080
group	O
at	O
diagnosis	B-T033
continued	O
to	O
have	O
good	O
metabolic	O
control	O
during	O
childhood	B-T079
,	O
in	O
contrast	O
to	O
children	O
with	O
hba1c	B-T116
>	O
114	O
mmol/mol	O
12.6	O
20%	O
of	O
patients	O
,	O
high	B-T080
group	O
at	O
diagnosis	B-T033
,	O
who	O
continued	O
to	O
have	O
high	B-T080
hba1c	B-T116
at	O
follow-up	O
.	O
	
for	O
the	O
individual	O
,	O
there	O
was	O
no	B-T033
significant	I-T033
correlation	B-T080
between	O
high	B-T080
hba1c	B-T116
at	O
onset	B-T080
and	O
during	O
follow-up	O
.	O
	
during	O
follow-up	O
,	O
children	O
in	O
the	O
high	B-T080
group	O
were	O
more	O
often	O
smokers	B-T033
,	O
less	O
physically	B-T033
active	I-T033
,	O
and	O
more	O
often	O
had	O
retinopathy	B-T047
than	O
children	O
in	O
the	O
low	B-T080
group	O
p	O
<	O
01	O
,	O
01	O
,	O
03	O
respectively	O
.	O
	
high	B-T080
hba1c	B-T116
at	O
onset	B-T080
was	O
associated	B-T080
with	I-T080
high	B-T080
hba1c	B-T116
during	O
follow-up	O
on	O
a	O
group	O
level	O
,	O
but	O
it	O
cannot	O
be	O
used	O
as	O
a	O
predictor	B-T078
of	O
future	O
metabolic	O
control	O
on	O
an	O
individual	O
level	O
.	O
	
these	O
results	O
emphasize	O
the	O
important	O
work	O
done	O
by	O
the	O
diabetes	B-T047
team	O
in	O
the	O
first	O
years	O
after	O
diagnosis	B-T033
.	O
	
it	O
is	O
important	O
to	O
continuously	O
set	O
high	B-T080
goals	O
for	O
the	O
achievement	O
of	O
tight	O
metabolic	O
control	O
,	O
in	O
order	O
to	O
decrease	B-T081
the	O
risk	B-T078
of	O
microvascular	B-T047
complications	I-T047
.	O
	
photosensitizer	O
decorated	O
red	O
blood	O
cells	O
as	O
an	O
ultra-sensitive	O
light-responsive	O
drug	O
delivery	O
system	O
red	O
blood	O
cells	O
rbcs	O
,	O
the	O
most	O
abundant	B-T080
type	O
of	O
cells	O
in	O
our	O
blood	O
,	O
have	O
shown	O
promises	O
as	O
a	O
natural	O
drug	O
delivery	O
system	O
dds	O
with	O
inherent	O
biocompatibility	O
.	O
	
herein	O
,	O
we	O
uncover	O
that	O
a	O
photosensitizer	O
,	O
chlorin	B-T109
e6	I-T109
ce6	B-T109
,	O
could	O
be	O
decorated	O
into	O
the	O
membrane	O
of	O
rbcs	O
upon	O
simple	O
mixing	B-T080
,	O
without	O
affecting	O
the	O
membrane	O
integrity	B-T080
and	O
stability	B-T080
in	O
dark	O
.	O
	
upon	O
light	O
irradiation	O
with	O
a	O
rather	O
low	O
power	O
density	B-T081
,	O
the	O
generated	O
singlet	O
oxygen	O
by	O
ce6	B-T109
as	O
the	O
result	O
of	O
photodynamic	O
effect	O
would	O
lead	O
to	O
rather	O
efficient	O
disruption	B-T169
of	O
rbc	O
membrane	O
.	O
	
with	O
doxorubicin	B-T109
dox	B-T109
,	O
a	O
typical	O
chemotherapy	O
drug	O
,	O
as	O
the	O
model	O
,	O
we	O
engineer	O
a	O
unique	O
type	O
of	O
light-responsive	O
rbc-based	O
dds	O
by	O
decorating	O
ce6	O
on	O
the	O
cell	O
membrane	O
and	O
loading	O
dox	B-T109
inside	O
cells	O
.	O
	
the	O
light	O
triggered	O
cell	O
membrane	O
break	O
down	O
would	O
thus	O
trigger	O
instant	O
release	O
of	O
dox	O
,	O
enabling	O
light-controlled	O
chemotherapy	B-T061
with	O
great	O
specificity	O
.	O
	
beyond	O
that	O
,	O
our	O
rbc	O
system	O
could	O
also	O
be	O
utilized	O
for	O
loading	O
of	O
larger	O
biomolecules	O
such	O
as	O
enzymes	O
,	O
whose	O
release	O
as	O
well	O
as	O
catalytic	O
function	O
is	O
also	O
controlled	O
by	O
light	O
.	O
	
our	O
work	O
thus	O
presents	O
a	O
unique	O
type	O
of	O
biocompatible	O
cell-based	O
dds	O
that	O
can	O
be	O
precisely	O
controlled	O
by	O
mild	O
external	O
stimuli	O
,	O
promising	O
not	O
only	O
for	O
cancer	O
therapy	O
but	O
also	O
for	O
other	O
potential	O
applications	O
in	O
biotechnologies	O
validation	O
of	O
the	O
neogen	B-T109
fentanyl	I-T109
elisa	O
kit	O
for	O
blood	O
and	O
urine	O
the	O
neogen	B-T109
fentanyl	I-T109
ready-to-use	O
enzyme-linked	O
immunosorbent	O
assay	O
kit	O
was	O
validated	O
following	O
the	O
scientific	O
working	O
group	O
for	O
forensic	O
toxicology	O
standard	O
practices	O
for	O
method	O
validation	O
in	O
forensic	O
toxicology	O
laboratory	O
guidelines	O
.	O
	
two	O
decision	O
points	O
,	O
0.5	O
and	O
1	O
ng/ml	O
,	O
were	O
successfully	O
validated	O
for	O
whole	O
blood	O
.	O
	
for	O
urine	O
,	O
two	O
decision	O
points	O
,	O
1	O
and	O
5	O
ng/ml	O
,	O
were	O
also	O
successfully	O
validated	O
.	O
	
the	O
validation	O
included	O
the	O
evaluation	O
of	O
sensitivity	B-T081
,	O
precision	B-T080
,	O
specificity	B-T081
,	O
carryover	B-T080
,	O
plate	B-T080
drift	I-T080
,	O
ruggedness/robustness	O
and	O
a	O
case	O
sample	O
evaluation	O
.	O
	
the	O
empirically	O
determined	O
limit	B-T081
of	I-T081
detection	I-T081
was	O
0.25	O
ng/ml	O
for	O
blood	O
and	O
0.5	O
ng/ml	O
for	O
urine	O
.	O
	
precision	B-T080
was	O
determined	O
at	O
five	O
different	O
concentrations	B-T081
ranging	O
from	O
0.25	O
to	O
1.5	O
ng/ml	O
with	O
15	O
replicates	B-T080
at	O
each	O
level	O
for	O
whole	O
blood	O
and	O
demonstrated	O
a	O
<2	O
coefficient	B-T081
of	I-T081
variation	I-T081
cv	B-T081
.	O
	
in	O
urine	O
,	O
the	O
cv	B-T081
was	O
<5	O
at	O
six	O
different	O
concentrations	B-T081
from	O
0.5	O
to	O
7.5	O
ng/ml	O
with	O
15	O
replicates	B-T080
at	O
each	O
level	O
.	O
	
cross-reactivity	O
was	O
evaluated	O
for	O
norfentanyl	B-T109
,	O
acetyl	B-T109
fentanyl	I-T109
,	O
4-anilino-n-phenethylpiperidine	B-T109
,	O
beta-hydroxythiofentanyl	O
,	O
butyryl	O
fentanyl	O
and	O
furanyl	B-T109
fentanyl	I-T109
.	O
	
everolimus	B-T109
for	O
treatment	B-T061
of	O
pseudomyogenic	O
hemangioendothelioma	O
pseudomyogenic	O
hemangioendothelioma	O
pmh	O
is	O
a	O
recently	O
described	O
vascular	O
neoplasm	O
that	O
occurs	O
most	O
commonly	O
in	O
the	O
soft	O
tissue	O
of	O
the	O
distal	O
extremities	O
of	O
young	O
adults	O
.	O
	
metastatic	B-T169
pmh	O
can	O
be	O
fatal	B-T080
and	O
there	O
are	O
no	O
effective	B-T080
medications	O
.	O
	
we	O
describe	O
a	O
case	O
of	O
a	O
15-year-old	O
boy	O
with	O
metastatic	B-T169
pmh	O
,	O
who	O
responded	O
to	O
treatment	O
with	O
everolimus	B-T109
,	O
a	O
mammalian	O
target	O
of	O
rapamycin	O
inhibitor	O
.	O
	
immunohistochemistry	O
showed	O
that	O
mammalian	B-T116
target	I-T116
of	I-T116
rapamycin	I-T116
was	O
expressed	O
in	O
pmh	O
biopsy	O
specimens	O
,	O
which	O
may	O
explain	O
the	O
reduction	B-T080
in	O
pmh	O
tumor	O
size	O
following	O
opposing	O
roles	B-T080
of	O
acetylation	O
and	O
phosphorylation	O
in	O
lifr	B-T116
-	O
dependent	B-T169
self-renewal	O
growth	O
signaling	O
in	O
mouse	O
embryonic	O
stem	O
cells	O
lif	B-T116
promotes	O
self-renewal	O
of	O
mouse	O
embryonic	O
stem	O
cells	O
mescs	O
,	O
and	O
in	O
its	O
absence	B-T080
,	O
the	O
cells	O
differentiate	B-T169
.	O
	
lif	B-T116
binds	O
to	O
the	O
lif	B-T116
receptor	I-T116
lifr	B-T116
and	O
activates	O
the	O
jak-stat3	O
pathway	O
,	O
but	O
it	O
remains	B-T080
unknown	I-T080
how	O
the	O
receptor	O
complex	O
triggers	B-T080
differentiation	B-T169
or	O
self-renewal	O
.	O
	
here	O
,	O
we	O
report	O
that	O
the	O
lifr	B-T116
cytoplasmic	O
domain	O
contains	O
a	O
self-renewal	O
domain	B-T169
within	O
the	O
juxtamembrane	O
region	O
and	O
a	O
differentiation	B-T169
domain	B-T169
within	O
the	O
c-terminal	O
region	O
.	O
	
the	O
differentiation	B-T169
domain	B-T169
contains	O
four	O
spxx	B-T116
repeats	I-T116
that	O
are	O
phosphorylated	O
by	O
mapk	B-T116
to	O
restrict	B-T169
stat3	O
activation	O
the	O
self-renewal	O
domain	B-T169
is	O
characterized	O
by	O
a	O
3k	B-T116
motif	I-T116
that	O
is	O
acetylated	O
by	O
p300	O
.	O
	
in	O
mescs	O
,	O
acetyl-	O
lifr	B-T116
undergoes	O
homodimerization	O
,	O
leading	O
to	O
stat3	B-T116
hypo-	O
or	O
hyper-activation	O
depending	B-T169
on	O
the	O
presence	B-T033
or	O
absence	B-T169
of	O
gp130	B-T116
.	O
	
lifr	B-T116
-	O
activated	O
stat3	B-T116
restricts	B-T169
differentiation	B-T169
via	O
cytokine	B-T116
induction	B-T169
.	O
	
thus	O
,	O
lifr	B-T116
acetylation	O
and	O
serine	O
phosphorylation	O
differentially	B-T169
promote	O
stem	O
cell	O
self-renewal	O
and	O
interprofessional	O
primary	O
care	O
team	O
meetings	O
a	O
qualitative	B-T080
approach	O
comparing	O
observations	O
with	O
personal	O
opinions	O
the	O
number	O
of	O
people	O
with	O
multiple	B-T047
chronic	I-T047
conditions	I-T047
requiring	O
primary	O
care	O
services	O
increases	B-T169
.	O
	
professionals	O
from	O
different	O
disciplines	O
collaborate	O
and	O
coordinate	B-T169
care	O
to	O
deal	O
with	O
the	O
complex	O
health	O
care	O
needs	O
.	O
	
there	O
is	O
lack	B-T080
of	O
information	B-T078
on	O
current	O
practices	O
regarding	O
interprofessional	O
team	O
ipt	O
meetings	O
.	O
	
this	O
study	O
aimed	O
to	O
improve	O
our	O
understanding	O
of	O
the	O
process	O
of	O
interprofessional	O
collaboration	O
in	O
primary	O
care	O
team	O
meetings	O
in	O
the	O
netherlands	O
by	O
observing	O
the	O
current	O
practice	O
and	O
exploring	O
personal	O
opinions	O
.	O
	
qualitative	O
study	O
involving	O
observations	O
of	O
team	O
meeting	O
s	O
and	O
interviews	O
with	O
participants	O
.	O
	
eight	O
different	O
ipt	O
meetings	O
n	O
=	O
8	O
in	O
different	O
primary	O
care	O
practices	O
were	O
observed	O
by	O
means	O
of	O
video	O
recordings	O
.	O
	
experiences	O
were	O
explored	O
by	O
conducting	O
individual	O
semi-structured	O
interviews	O
n	O
=	O
60	O
with	O
participants	O
i.e	O
.	O
	
health	O
care	O
professionals	O
from	O
different	O
disciplines	O
of	O
the	O
observed	O
team	O
meetings	O
.	O
	
the	O
data	B-T078
were	O
analysed	O
by	O
means	O
of	O
content	O
analysis	O
.	O
	
most	O
participants	O
expressed	O
favourable	O
opinions	O
about	O
their	O
team	O
meetings	O
.	O
	
however	O
,	O
observations	O
showed	O
that	O
team	O
meetings	O
were	O
more	O
or	O
less	O
hectic	O
,	O
and	O
lacked	B-T080
a	O
clear	O
structure	O
and	O
team	O
coordinator	O
or	O
leader	O
.	O
	
there	O
appears	O
to	O
be	O
a	O
discrepancy	B-T033
between	O
findings	B-T033
from	O
observations	O
and	O
interviews	O
.	O
	
from	O
the	O
interviews	O
,	O
four	O
main	O
themes	O
were	O
extracted	O
1	O
team	O
structure	O
and	O
composition	O
,	O
2	O
patient-centredness	O
,	O
3	O
interaction	O
and	O
4	O
attitude	O
and	O
motivation	O
.	O
	
ipt	O
meetings	O
could	O
benefit	O
from	O
improvements	O
in	O
structure	O
,	O
patient-centredness	O
and	O
leadership	O
by	O
the	O
chairpersons	O
.	O
	
given	O
the	O
discrepancy	B-T033
between	O
observations	O
and	O
interviews	O
,	O
it	O
would	O
appear	O
useful	O
to	O
improve	O
team	O
members	O
'	O
awareness	O
of	O
aspects	B-T080
that	O
could	O
be	O
improved	O
before	O
training	O
them	O
in	O
dealing	O
with	O
specific	O
urachal	B-T047
carcinoma	I-T047
report	O
of	O
two	O
cases	O
and	O
review	B-T169
of	I-T169
the	O
literature	O
urachal	B-T047
carcinoma	I-T047
is	O
a	O
rare	B-T080
tumor	O
that	O
most	O
commonly	O
occurs	O
in	O
ovaries	O
and	O
less	B-T033
often	I-T033
in	O
the	O
adnexal	O
region	O
and	O
urinary	O
system	O
.	O
	
we	O
herein	O
present	B-T078
two	O
cases	O
of	O
urachal	B-T047
carcinoma	I-T047
one	O
case	O
was	O
a	O
32-year-old	O
male	O
patient	O
who	O
presented	B-T078
with	O
painless	O
hematuria	O
with	O
blood	O
clots	O
for	O
1	O
month	B-T079
,	O
whereas	O
the	O
other	O
case	O
was	O
a	O
50-year-old	O
woman	O
who	O
presented	B-T078
with	O
gross	B-T033
hematuria	I-T033
with	O
mild	B-T080
dysuria	O
,	O
urgency	B-T047
and	I-T047
frequent	I-T047
urination	I-T047
for	O
1	O
year	B-T079
.	O
	
following	O
surgical	B-T061
resection	I-T061
,	O
the	O
two	O
patients	O
were	O
diagnosed	B-T033
with	O
urachal	B-T047
adenocarcinoma	I-T047
mixed	B-T169
type	B-T080
and	O
urachal	B-T047
mucinous	I-T047
adenocarcinoma	I-T047
,	O
respectively	O
,	O
based	O
on	O
the	O
histopathological	B-T169
examination	O
.	O
	
a	O
review	B-T169
of	I-T169
previously	O
published	O
cases	O
and	O
relevant	B-T080
literature	O
is	O
also	O
presented	B-T078
.	O
	
the	O
aim	B-T078
of	O
the	O
present	B-T033
study	O
was	O
to	O
help	O
understand	O
this	O
disease	O
better	B-T080
,	O
in	O
order	O
to	O
reduce	B-T080
the	O
rate	B-T081
of	O
clinical	B-T080
and	O
pathological	B-T169
misdiagnosis	B-T033
.	O
	
a	O
recombinant	O
human	O
anti-platelet	B-T116
scfv	I-T116
antibody	I-T116
produced	O
in	O
pichia	O
pastoris	O
for	O
atheroma	O
targeting	O
cells	O
of	O
the	O
innate	O
and	O
adaptive	O
immune	O
system	O
are	O
key	O
factors	O
in	O
the	O
progression	O
of	O
atherosclerotic	O
plaque	O
,	O
leading	O
to	O
plaque	O
instability	O
and	O
rupture	O
,	O
potentially	O
resulting	O
in	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
coronary	O
artery	O
disease	O
,	O
cerebrovascular	O
disease	O
and	O
peripheral	O
arterial	O
disease	O
.	O
	
here	O
,	O
we	O
describe	O
the	O
cloning	O
,	O
expression	O
,	O
purification	O
,	O
and	O
immunoreactivity	O
assessment	O
of	O
a	O
recombinant	O
single-chain	O
variable	O
fragment	O
scfv	O
derived	O
from	O
a	O
human	O
anti-αiibβ3	O
antibody	O
huab	O
selected	O
to	O
target	O
atheromatous	O
lesions	O
for	O
the	O
presence	O
of	O
platelets	O
.	O
	
indeed	O
,	O
platelets	O
within	O
atheroma	O
plaques	O
have	O
been	O
shown	O
to	O
play	O
a	O
role	O
in	O
inflammation	O
,	O
in	O
platelet	O
-	O
leucocyte	O
aggregates	O
and	O
in	O
thrombi	O
formation	O
and	O
might	O
thus	O
be	O
considered	O
relevant	O
biomarkers	O
of	O
atherosclerotic	O
progression	O
.	O
	
the	O
dna	O
sequence	O
that	O
encodes	O
the	O
anti-αiibβ3	O
teg4	O
scfv	O
previously	O
obtained	O
from	O
a	O
phage-display	O
selection	O
on	O
activated	O
platelets	O
,	O
was	O
inserted	O
into	O
the	O
eukaryote	O
vector	O
ppiczαa	O
in	O
fusion	O
with	O
a	O
tag	O
sequence	O
encoding	O
2	O
cysteines	O
useable	O
for	O
specific	O
probes	O
grafting	O
experiments	O
.	O
	
the	O
recombinant	O
protein	O
was	O
expressed	O
at	O
high	O
yields	O
in	O
pichia	O
pastoris	O
30	O
mg/l	O
culture	O
.	O
	
the	O
advantage	O
of	O
p	O
.	O
	
pastoris	O
as	O
an	O
expression	O
system	O
is	O
the	O
production	O
and	O
secretion	O
of	O
recombinant	O
proteins	O
in	O
the	O
supernatant	O
,	O
ruling	O
out	O
the	O
difficulties	O
encountered	O
when	O
scfv	O
are	O
produced	O
in	O
the	O
cytoplasm	O
of	O
bacteria	O
low	O
yield	O
,	O
low	O
solubility	O
and	O
reduced	O
affinity	O
.	O
	
the	O
improved	O
conditions	O
allowed	O
for	O
the	O
recovery	O
of	O
highly	O
purified	O
and	O
biologically	O
active	O
scfv	O
fragments	O
ready	O
to	O
be	O
grafted	O
in	O
a	O
site	O
-directed	O
way	O
to	O
nanoparticles	O
for	O
the	O
imaging	O
of	O
atherosclerotic	O
plaques	O
involving	O
inflammatory	O
processes	O
and	O
thus	O
at	O
high	O
risk	O
of	O
instability	B-T033
identification	B-T080
of	O
mir-21-5p	O
as	O
a	O
functional	O
regulator	O
of	O
mesothelin	O
expression	O
using	O
microrna	O
capture	O
affinity	O
coupled	B-T169
with	O
next	O
generation	O
sequencing	O
micrornas	O
mirnas	O
are	O
small	O
non-coding	O
rnas	O
that	O
regulate	O
mrna	O
expression	O
mainly	O
by	O
silencing	O
target	B-T169
transcripts	O
via	O
binding	O
to	O
mirna	O
recognition	O
elements	O
mres	O
in	O
the	O
3'untranslated	O
region	O
3'utr	O
.	O
	
the	O
identification	B-T080
of	O
bona	O
fide	O
targets	B-T169
is	O
challenging	O
for	O
researchers	B-T033
working	I-T033
on	O
the	O
functional	B-T169
aspect	I-T169
of	O
mirnas	O
.	O
	
recently	O
,	O
we	O
developed	O
a	O
method	B-T169
mir-catch	I-T169
based	O
on	O
biotinylated	O
dna	O
antisense	O
oligonucleotides	O
that	O
capture	O
the	O
mrna	O
of	O
interest	O
and	O
facilitates	O
the	O
characterisation	O
of	O
mirnas	O
interactions	O
in	O
a	O
physiological	O
cellular	O
context	O
.	O
	
here	O
,	O
the	O
mir-catch	B-T169
technique	I-T169
was	O
applied	O
to	O
the	O
mesothelin	O
msln	O
gene	O
and	O
coupled	B-T169
with	O
next	O
generation	O
sequencing	O
ngs	O
,	O
to	O
identify	O
mirnas	O
that	O
regulate	O
msln	O
mrna	O
and	O
that	O
may	O
be	O
responsible	O
for	O
its	O
increased	O
protein	O
levels	O
found	O
in	O
malignant	O
pleural	O
mesothelioma	O
mpm	O
.	O
	
biotinylated	O
msln	O
oligos	O
were	O
employed	O
to	O
isolate	O
mirna	O
mrna	O
complexes	O
from	O
a	O
normal	O
cell	O
line	O
met-5a	O
which	O
expresses	O
low	O
levels	O
of	O
msln	B-T116
.	O
	
mirnas	O
targeting	B-T169
the	O
msln	O
mrna	O
were	O
identified	O
by	O
ngs	O
and	O
mir-21-5p	O
and	O
mir-100-5p	O
were	O
selected	O
for	O
further	O
validation	O
analyses	O
.	O
	
mir-21-5p	O
was	O
shown	O
to	O
be	O
able	O
to	O
modulate	O
msln	O
expression	O
in	O
mirna	O
mimic	B-T061
experiments	O
in	O
a	O
panel	O
of	O
malignant	O
and	O
non-malignant	O
cell	O
lines	O
.	O
	
further	O
mirna	O
inhibitor	B-T080
experiments	O
and	O
luciferase	B-T116
assays	O
in	O
mero-14	O
cells	O
validated	O
mir-21-5p	O
as	O
a	O
true	O
regulator	O
of	O
msln	O
.	O
	
moreover	O
,	O
in	O
vitro	O
experiments	O
showed	O
that	O
treatment	B-T061
with	O
mir-21-5p	O
mimic	B-T061
reduced	O
proliferation	B-T169
of	O
mpm	O
cell	O
lines	O
.	O
	
altogether	O
,	O
this	O
work	O
shows	O
that	O
the	O
mir-catch	B-T169
technique	I-T169
,	O
coupled	B-T169
with	O
ngs	O
and	O
in	B-T080
vitro	I-T080
validation	O
,	O
represents	O
a	O
reliable	O
method	B-T169
to	O
identify	O
native	O
mirna	O
interactions	O
.	O
	
mir-21-5p	O
is	O
suggested	O
as	O
novel	O
regulator	O
of	O
msln	O
with	O
a	O
possible	O
functional	B-T169
role	I-T169
in	O
cellular	O
growth	O
.	O
	
zoonotic	O
and	O
non-zoonotic	B-T033
parasites	O
of	O
wild	O
rodents	O
in	O
turkman	O
sahra	O
,	O
northeastern	O
iran	O
this	O
study	O
was	O
conducted	O
to	O
collect	O
informative	O
data	O
on	O
the	O
parasitic	B-T047
infection	I-T047
of	O
wild	O
rodents	O
,	O
emphasizing	O
on	O
finding	B-T033
parasites	O
,	O
which	O
have	O
medical	B-T169
importance	B-T080
to	O
human	O
.	O
	
during	O
2012-2014	O
,	O
a	O
total	B-T081
number	I-T081
of	O
91	O
wild	O
rodents	O
were	O
captured	B-T169
from	O
rural	O
areas	O
of	O
turkmen	O
sahra	O
,	O
golestan	O
province	O
,	O
using	O
handmade	O
traps	O
.	O
	
animals	O
were	O
anesthetized	B-T033
,	O
surveyed	O
for	O
any	O
ectoparasite	O
and	O
then	O
their	O
carcasses	O
were	O
carefully	O
dissected	B-T169
for	O
examination	B-T033
of	O
endoparsites	O
.	O
	
four	O
species	O
of	O
rodents	O
including	B-T169
mus	O
musculus	O
52.75	O
,	O
rattus	O
norvegicus	O
38.46	O
,	O
rhombomys	O
opimus	O
4.40	O
and	O
meriones	O
libycus	O
4.40	O
were	O
captured	B-T169
.	O
	
parasitic	B-T047
infestation	I-T047
was	O
detected	B-T033
in	O
38.5	O
of	O
sampled	B-T078
rodents	O
.	O
	
parasite	B-T047
infestation	I-T047
rates	B-T081
of	O
sampled	B-T078
rodents	O
was	O
hymenolepis	O
diminuta	O
=	O
7.7	O
,	O
cryptosporidium	O
spp	O
=	O
6.6	O
,	O
trichuris	O
spp	O
=	O
5.5	O
,	O
cysticercus	O
fasciolaris	O
=	O
2.20	O
,	O
angiostrongylus	O
spp	O
=	O
2.20	O
,	O
capillaria	O
sp	O
=	O
1.09	O
,	O
rhipicephalus	O
spp	O
.	O
	
=	O
8.70	O
,	O
nosopsyllus	O
fasciatus	O
=	O
1.09	O
,	O
and	O
laelaps	O
nuttalli	O
=	O
3.29	O
.	O
	
among	O
10	O
genera	O
/	O
species	O
of	O
identified	B-T080
parasites	O
,	O
at	O
least	O
8	O
of	O
them	O
were	O
zoonotic	O
with	O
public	O
health	O
importance	B-T080
.	O
	
l	O
.	O
	
nuttalli	O
and	O
n	O
.	O
	
fasciatus	O
were	O
the	O
only	O
two	O
non-zoonotic	B-T033
detected	B-T033
parasites	O
in	O
this	O
survey	O
.	O
	
harboring	B-T169
a	O
wide	O
variety	O
of	O
zoonotic	O
parasites	O
in	O
sampled	B-T078
wild	O
rodents	O
particularly	B-T080
when	O
they	O
live	O
nearby	B-T080
villages	O
,	O
represents	O
a	O
potential	B-T080
risk	B-T078
to	O
native	O
inhabitants	O
.	O
	
hence	O
,	O
controlling	B-T169
rodents	O
'	O
population	O
in	O
residential	O
regions	O
and	O
improving	B-T033
awareness	O
of	O
local	O
people	O
about	O
the	O
risk	B-T078
of	O
disease	O
transmission	O
through	O
rodents	O
seems	O
to	O
be	O
entirely	O
creative	O
approach	O
for	O
successful	B-T080
aging	O
a	O
pilot	O
study	O
of	O
an	O
intergenerational	B-T079
health	O
promotion	O
program	O
to	O
develop	O
and	O
evaluate	O
the	O
effectiveness	B-T080
of	O
an	O
intergenerational	B-T079
health	O
promotion	O
program	O
.	O
	
this	O
was	O
an	O
action	O
research	O
project	O
.	O
	
a	O
total	B-T080
of	O
34	O
participants	O
attended	O
the	O
12-	O
week	B-T079
program	O
and	O
completed	B-T080
the	O
pre-test	O
and	O
post-test	O
.	O
	
there	O
were	O
16	O
middle-aged	O
and	O
nine	O
older	O
adults	O
recruited	O
from	O
a	O
district	O
of	O
taipei	O
,	O
and	O
nine	O
young	O
adults	O
recruited	O
from	O
the	O
principal	O
investigator's	O
university	O
.	O
	
the	O
""""	O
attitudes	O
toward	O
aging	O
scale	O
""""	O
and	O
the	O
""""	O
spiritual	O
health	O
scale	O
""""	O
were	O
two	O
assessment	O
instruments	O
used	O
in	O
the	O
study	O
.	O
	
the	O
results	B-T033
showed	O
that	O
there	O
were	O
significant	B-T078
improvements	O
in	O
the	O
attitudes	O
toward	O
aging	O
scale	O
for	O
the	O
young	O
adult	O
group	B-T078
aged	O
18-29	O
years	B-T079
and	O
in	O
the	O
spiritual	O
health	O
scale	O
for	O
the	O
older	O
adult	O
group	B-T078
aged	O
65-80	O
years	B-T079
.	O
	
the	O
evaluation	O
showed	O
that	O
participants	O
were	O
satisfied	O
with	O
the	O
program	O
.	O
	
the	O
results	B-T033
of	O
the	O
present	O
study	O
provide	O
future	O
directions	O
for	O
successful	B-T080
aging	O
and	O
intergenerational	B-T079
learning	O
.	O
	
signs	O
of	O
dysarthria	O
in	O
adults	O
with	O
22q11.2	B-T047
deletion	I-T047
syndrome	I-T047
the	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
how	O
adults	O
with	O
22q11.2	B-T047
deletion	I-T047
syndrome	I-T047
22q11ds	B-T047
performed	O
on	O
dysarthria	O
and	O
intelligibility	O
tests	O
compared	O
with	O
a	O
control	O
group	O
.	O
	
ten	O
participants	O
with	O
confirmed	O
22q11.2	O
deletion	O
,	O
five	O
males	O
and	O
five	O
females	O
with	O
a	O
mean	O
age	O
of	O
31	O
years	B-T079
range	O
19-49	O
,	O
were	O
compared	O
with	O
a	O
control	O
group	O
matched	O
for	O
gender	O
and	O
age	O
five	O
males	O
and	O
five	O
females	O
,	O
mean	O
age	O
32	O
years	B-T079
,	O
range	O
19-49	O
.	O
	
assessment	O
of	O
non-verbal	O
and	O
verbal	O
tasks	O
reflecting	O
respiration	O
,	O
phonation	O
,	O
oral	O
motor	O
function	O
,	O
velopharyngeal	O
function	O
,	O
articulation	O
,	O
and	O
prosody	B-T033
was	O
performed	O
as	O
well	O
as	O
the	O
swedish	O
test	O
of	O
intelligibility	O
sti	O
.	O
	
all	O
assessments	O
were	O
made	O
by	O
two	O
raters	O
inter-rater	B-T081
and	O
intra-rater	B-T081
reliability	I-T081
was	O
acceptable	O
.	O
	
the	O
participants	O
with	O
22q11ds	B-T047
had	O
significantly	O
more	O
problems	B-T033
than	O
the	O
control	O
group	O
on	O
all	O
investigated	O
dimensions	O
except	O
the	O
sti	O
.	O
	
overall	O
,	O
the	O
severity	O
of	O
their	O
speech	B-T033
deviation	I-T033
was	O
rated	O
as	O
mild	O
to	O
moderate	O
.	O
	
the	O
largest	O
difficulties	O
were	O
found	O
regarding	O
speech	O
respiration	O
,	O
phonation	O
,	O
oral	O
motor	O
function	O
,	O
and	O
velopharyngeal	O
function	O
.	O
	
the	O
results	O
of	O
the	O
present	O
study	O
suggest	O
that	O
a	O
neurological	B-T169
etiology	I-T169
could	O
be	O
added	O
to	O
the	O
previously	O
described	O
structural	B-T169
etiology	I-T169
explaining	O
the	O
speech	B-T033
difficulties	I-T033
found	O
in	O
22q11ds	B-T047
.	O
	
signs	O
of	O
difficulties	O
in	O
both	O
speech	O
motor	O
planning	O
and	O
speech	O
motor	O
programming	O
were	O
found	O
.	O
	
further	O
studies	O
are	O
needed	O
to	O
confirm	O
the	O
results	B-T169
,	O
as	O
are	O
studies	O
of	O
the	O
association	O
between	O
structural	B-T033
brain	I-T033
abnormalities	I-T033
and	O
neurological	O
speech	O
symptoms	O
.	O
	
for	O
clinical	B-T169
purposes	I-T169
,	O
it	O
is	O
important	O
that	O
clinicians	O
have	O
knowledge	O
about	O
the	O
variable	O
speech	O
symptoms	O
that	O
may	O
occur	O
in	O
individuals	O
with	O
22q11ds	B-T047
and	O
that	O
they	O
be	O
aware	O
of	O
the	O
complexity	O
of	O
the	O
etiology	B-T169
of	O
such	O
speech	O
symptoms	O
.	O
	
sulfur	O
and	O
zinc	O
availability	B-T169
from	O
co-granulated	O
zn	O
-enriched	O
elemental	O
sulfur	O
fertilizers	O
acidification	O
by	O
oxidation	O
of	O
elemental	O
sulfur	O
es	O
can	O
solubilize	O
zno	O
,	O
providing	O
slow	B-T080
release	B-T169
of	O
both	O
sulfur	O
s	O
and	O
zinc	O
zn	O
in	O
soil	O
.	O
	
for	O
this	O
study	O
,	O
a	O
new	O
granular	O
fertilizer	O
with	O
es	O
and	O
zno	O
was	O
produced	O
and	O
evaluated	O
.	O
	
the	O
effect	B-T080
of	O
incorporating	O
microorganisms	O
or	O
a	O
carbon	O
source	B-T033
in	O
the	O
granule	O
was	O
also	O
evaluated	O
.	O
	
four	O
granulated	O
es-zn	O
fertilizers	O
with	O
and	O
without	B-T080
s-oxidizing	O
microorganisms	O
,	O
a	O
commercial	O
es	O
pastille	O
,	O
znso4	O
,	O
and	O
zno	O
were	O
applied	O
to	O
the	O
center	O
of	O
petri	O
dishes	O
containing	O
two	O
contrasting	B-T080
ph	B-T081
soils	O
.	O
	
soil	O
ph	B-T081
,	O
cacl2	O
-extractable	O
s	O
and	O
zn	O
,	O
and	O
remaining	O
es	O
were	O
evaluated	O
at	O
30	O
and	O
60	O
days	O
in	O
two	O
soil	O
sections	O
0-5	O
and	O
5-9	O
mm	O
from	O
the	O
fertilizer	O
application	O
site	O
.	O
	
a	O
visualization	O
test	O
was	O
performed	O
to	O
evaluate	O
zn	O
diffusion	O
over	O
time	O
.	O
	
a	O
significant	B-T078
ph	B-T033
decrease	I-T033
was	O
observed	B-T169
in	O
the	O
acidic	O
soil	O
for	O
all	O
es-zn	O
fertilizer	O
treatments	B-T169
and	O
in	O
the	O
alkaline	B-T080
soil	O
for	O
the	O
acidithiobacillus	O
thiooxidans	O
-	O
inoculated	O
treatment	O
only	O
.	O
	
in	O
agreement	O
with	O
zn	O
visualization	O
tests	O
,	O
extractable-	O
zn	O
concentrations	B-T081
were	O
higher	B-T080
from	O
the	O
point	O
of	O
application	O
in	O
the	O
acidic	O
62.9	O
mg	O
dm	O
compared	O
to	O
the	O
alkaline	B-T080
soil	O
5.5	O
mg	O
dm	O
.	O
	
elemental	O
s	O
oxidation	O
was	O
greater	B-T081
in	O
the	O
acidic	O
soil	O
20.9	O
than	O
slightly	O
alkaline	B-T080
soil	O
12%	O
.	O
	
the	O
es-zn	O
granular	O
fertilizers	O
increased	B-T081
s	O
and	O
zn	O
concentrations	B-T081
in	O
soil	O
and	O
can	O
provide	O
a	O
strategically	O
slow	B-T080
release	B-T169
of	O
nutrients	O
to	O
the	O
impact	B-T080
of	O
blood	B-T061
transfusions	I-T061
on	O
survival	O
of	O
locally	O
advanced	B-T080
cervical	O
cancer	O
patients	O
undergoing	O
neoadjuvant	B-T061
chemotherapy	I-T061
plus	O
radical	B-T061
surgery	I-T061
transfusions	B-T061
represent	O
one	O
of	O
the	O
main	O
progresses	B-T169
of	O
modern	B-T079
medicine	I-T079
.	O
	
however	O
,	O
accumulating	O
evidence	B-T078
supports	O
that	O
transfusions	B-T061
correlate	O
with	O
worse	O
survival	O
outcomes	B-T080
in	O
patients	O
affected	B-T169
by	O
solid	O
cancers	O
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
aimed	B-T078
to	O
investigate	B-T169
the	O
effects	O
of	O
perioperative	B-T079
blood	B-T061
transfusion	I-T061
in	O
locally	O
advanced	B-T080
cervical	O
cancer	O
.	O
	
data	O
of	O
consecutive	O
patients	O
affected	B-T169
by	O
locally	O
advanced	B-T080
cervical	O
cancer	O
scheduled	O
to	O
undergo	O
neoadjuvant	B-T061
chemotherapy	I-T061
plus	O
radical	B-T061
surgery	I-T061
were	O
retrospectively	O
searched	O
to	O
test	B-T169
the	O
impact	B-T080
of	O
perioperative	B-T079
transfusions	B-T061
on	O
survival	O
outcomes	B-T080
.	O
	
five-	O
year	B-T079
survival	O
outcomes	B-T080
were	O
evaluated	O
using	O
kaplan-meier	O
and	O
cox	B-T081
models	I-T081
.	O
	
the	O
study	O
included	O
275	O
patients	O
.	O
	
overall	O
,	O
170	O
62%	O
patients	O
had	O
blood	B-T061
transfusion	I-T061
.	O
	
via	O
univariate	O
analysis	O
,	O
we	O
observed	B-T169
that	O
transfusion	B-T061
correlated	O
with	O
an	O
increased	O
risk	B-T078
of	O
developing	B-T169
recurrence	O
hazard	B-T081
ratio	I-T081
hr	B-T081
,	O
2.2	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
,	O
1.09	O
p	B-T081
=	O
0.02	O
.	O
	
other	O
factors	O
associated	O
with	O
5-	O
year	B-T079
disease-free	B-T081
survival	I-T081
were	O
noncomplete	B-T033
clinical	B-T033
response	I-T033
after	O
neoadjuvant	B-T061
chemotherapy	I-T061
hr	B-T081
,	O
2.99	O
95%	O
ci	B-T081
,	O
0.92	O
p	B-T081
=	O
0.06	O
and	O
pathological	B-T033
p	B-T081
=	O
0.03	O
response	B-T033
at	O
neoadjuvant	B-T061
chemotherapy	I-T061
as	O
well	O
as	O
parametrial	O
p	B-T081
=	O
0.004	O
,	O
vaginal	O
p	B-T081
<	O
0.001	O
,	O
and	O
lymph	O
node	O
p	B-T081
=	O
0.002	O
involvements	O
.	O
	
however	O
,	O
via	O
multivariate	B-T081
analysis	I-T081
,	O
only	O
vaginal	O
hr	B-T081
,	O
3.07	O
95%	O
ci	B-T081
,	O
1.20	O
p	B-T081
=	O
0.01	O
and	O
lymph	O
node	O
involvements	O
hr	B-T081
,	O
2.4	O
95%	O
ci	B-T081
,	O
1.00	O
p	B-T081
=	O
0.05	O
correlate	O
with	O
worse	O
disease-free	O
survival	O
.	O
	
no	O
association	O
with	O
worse	O
outcomes	O
was	O
observed	O
for	O
patients	O
undergoing	O
blood	O
transfusion	O
hr	O
,	O
2.71	O
95%	O
ci	O
,	O
0.91	O
p	B-T081
=	O
0.07	O
.	O
	
looking	O
at	O
factors	O
influencing	O
overall	O
survival	O
,	O
we	O
observed	O
that	O
lymph	O
node	O
status	O
p	O
=	O
0.01	O
and	O
vaginal	O
involvement	O
p	O
=	O
0.06	O
were	O
independently	O
associated	O
with	O
survival	O
.	O
	
the	O
role	O
of	O
blood	O
transfusions	O
in	O
increasing	O
the	O
risk	O
of	O
developing	O
recurrence	O
in	O
laac	O
patients	O
treated	O
by	O
neoadjuvant	O
chemotherapy	O
plus	O
radical	O
surgery	O
remains	O
unclear	O
further	O
prospective	O
studies	O
are	O
tissue	O
reservoirs	O
of	O
antiviral	B-T033
t	O
cell	O
immunity	O
in	O
persistent	O
human	O
cmv	B-T047
infection	I-T047
t	O
cell	O
responses	O
to	O
viruses	O
are	O
initiated	O
and	O
maintained	O
in	O
tissue	O
sites	O
however	O
,	O
knowledge	O
of	O
human	O
antiviral	B-T033
t	O
cells	O
is	O
largely	O
derived	O
from	O
blood	O
.	O
	
cytomegalovirus	O
cmv	O
persists	O
in	O
most	O
humans	O
,	O
requires	O
t	O
cell	O
immunity	O
to	O
control	O
,	O
yet	O
tissue	O
immune	O
responses	O
remain	O
undefined	O
.	O
	
here	O
,	O
we	O
investigated	O
human	O
cmv	O
-specific	O
t	O
cells	O
,	O
virus	O
persistence	O
and	O
cmv	O
-associated	O
t	O
cell	O
homeostasis	O
in	O
blood	O
,	O
lymphoid	O
,	O
mucosa	O
l	O
and	O
secretory	O
tissues	O
of	O
44	O
cmv	O
seropositive	O
and	O
28	O
seronegative	O
donors	O
.	O
	
cmv	O
-specific	O
t	O
cells	O
were	O
maintained	O
in	O
distinct	O
distribution	O
patterns	O
,	O
highest	O
in	O
blood	O
,	O
bone	O
marrow	O
bm	O
,	O
or	O
lymph	O
nodes	O
ln	O
,	O
with	O
the	O
frequency	O
and	O
function	O
in	O
blood	O
distinct	O
from	O
tissues	O
.	O
	
cmv	O
genomes	O
were	O
detected	O
predominantly	O
in	O
lung	O
and	O
also	O
in	O
spleen	O
,	O
bm	O
,	O
blood	O
and	O
ln	O
.	O
	
high	O
frequencies	O
of	O
activated	O
cmv	O
-specific	O
t	O
cells	O
were	O
found	O
in	O
blood	O
and	O
bm	O
samples	O
with	O
low	O
virus	O
detection	O
,	O
whereas	O
in	O
lung	O
,	O
cmv	O
-specific	O
t	O
cells	O
were	O
present	O
along	O
with	O
detectable	O
virus	O
.	O
	
in	O
lns	O
,	O
cmv	O
-specific	O
t	O
cells	O
exhibited	O
quiescent	O
phenotypes	O
independent	O
of	O
virus	O
.	O
	
overall	O
,	O
t	O
cell	O
differentiation	O
was	O
enhanced	O
in	O
sites	O
of	O
viral	O
persistence	B-T081
with	O
age	O
.	O
	
together	O
,	O
our	O
results	O
suggest	O
tissue	O
t	O
cell	O
reservoirs	O
for	O
cmv	O
control	O
shaped	O
by	O
both	O
viral	O
and	O
tissue	O
-	O
intrinsic	O
factors	O
,	O
with	O
global	O
effects	O
on	O
homeostasis	O
of	O
tissue	O
t	O
cells	O
over	O
the	O
lifespan	O
lipid	O
levels	O
and	O
risk	B-T078
of	O
recurrent	O
venous	O
thrombosis	O
results	B-T169
from	O
the	O
mega	O
follow-up	O
study	O
essentials	O
the	O
role	O
of	O
lipid	O
levels	O
in	O
the	O
risk	B-T078
of	O
recurrent	O
venous	O
thrombosis	O
is	O
unclear	B-T033
.	O
	
lipids	B-T109
were	O
assessed	O
in	O
patients	O
with	O
a	O
first	O
venous	O
thrombosis	O
n	O
=	O
2106	O
followed	B-T079
for	O
6.9	O
years	B-T079
.	O
	
lipids	B-T109
were	O
not	O
associated	B-T080
with	I-T080
recurrence	O
,	O
overall	O
or	O
in	O
patients	O
with	O
unprovoked	O
first	O
events	O
.	O
	
testing	O
lipid	O
levels	O
is	O
not	O
useful	B-T080
to	O
identify	B-T080
patients	O
at	O
an	O
increased	B-T081
risk	B-T078
of	O
recurrence	O
.	O
	
background	O
knowledge	O
of	O
risk	B-T033
factors	I-T033
for	O
recurrent	O
venous	O
thrombosis	O
may	O
guide	O
decisions	O
on	O
duration	B-T079
of	O
anticoagulation	B-T061
.	O
	
the	O
association	B-T080
between	O
lipid	O
levels	O
and	O
first	O
venous	O
thrombosis	O
has	O
been	O
studied	O
extensively	O
.	O
	
however	O
,	O
data	B-T078
on	O
the	O
role	O
of	O
lipids	B-T109
in	O
the	O
risk	B-T078
of	O
recurrence	O
are	O
scarce	O
.	O
	
objective	O
to	O
assess	O
the	O
association	B-T080
between	O
lipid	O
levels	O
and	O
recurrent	O
venous	O
thrombosis	O
.	O
	
patients	O
/methods	O
patients	O
with	O
a	O
first	O
venous	O
thrombosis	O
from	O
the	O
mega	O
study	O
were	O
included	B-T169
.	O
	
follow-up	O
started	B-T080
at	O
the	O
date	B-T079
of	O
end	O
of	O
anticoagulant	B-T061
treatment	I-T061
.	O
	
percentile	B-T081
categories	O
of	O
total	B-T109
/	O
low-density	B-T109
lipoprotein	I-T109
/	O
high-density	B-T109
lipoprotein	I-T109
cholesterol	I-T109
,	O
triglycerides	B-T109
and	O
apolipoproteins	B-T116
b	I-T116
and	O
a1	B-T116
were	O
established	B-T080
<	O
10th	O
,	O
10th-25th	O
,	O
25th-75th	O
reference	B-T081
,	O
75th-90th	O
,	O
>	O
90th	O
percentile	B-T081
.	O
	
lipids	B-T109
were	O
measured	B-T080
at	O
least	O
3	O
months	B-T079
after	O
discontinuing	B-T033
anticoagulation	B-T061
.	O
	
results	B-T169
of	O
2106	O
patients	O
followed	O
for	O
a	O
median	O
of	O
6.9	O
years	B-T079
,	O
326	O
developed	O
recurrence	O
incidence	B-T081
rate	I-T081
,	O
2.7	O
patient	O
-	O
years	B-T079
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
,	O
2.5	O
.	O
	
with	O
hazard	B-T081
ratios	I-T081
ranging	B-T081
from	O
0.88	O
95%	O
ci	B-T081
,	O
0.55	O
to	O
1.33	O
95%	O
ci	B-T081
,	O
0.86	O
in	O
the	O
highest	O
percentile	B-T081
category	O
vs	O
.	O
	
the	O
reference	B-T081
,	O
we	O
found	O
no	O
association	B-T080
across	O
percentile	B-T081
categories	O
between	O
recurrence	O
and	O
lipid	O
levels	O
in	O
age-	O
and	O
sex	O
-adjusted	O
models	O
,	O
nor	O
after	O
further	O
adjustments	B-T169
for	O
body	O
mass	O
index	O
,	O
diabetes	B-T047
,	O
estrogen	B-T109
and	O
statin	B-T109
use	B-T169
,	O
and	O
duration	B-T079
of	O
anticoagulation	B-T061
.	O
	
subgroup	O
analyses	O
stratified	B-T080
by	O
unprovoked	O
or	O
provoked	B-T080
first	O
events	O
,	O
location	O
deep	B-T047
vein	I-T047
thrombosis	I-T047
or	O
pulmonary	B-T047
embolism	I-T047
and	O
sex	O
also	O
did	O
not	O
reveal	B-T080
an	O
association	B-T080
with	O
any	O
of	O
the	O
lipid	O
levels	O
studied	O
.	O
	
conclusions	O
testing	O
lipid	O
levels	O
did	O
not	O
identify	B-T080
patients	O
at	O
an	O
increased	B-T081
risk	B-T078
of	O
recurrent	O
venous	O
thrombosis	O
in	O
this	O
study	O
,	O
including	O
those	O
with	O
unprovoked	O
first	O
events	O
,	O
and	O
these	O
should	O
not	O
influence	O
decisions	O
on	O
duration	B-T079
of	O
insecticidal	O
effects	O
of	O
deltamethrin	B-T109
in	O
laboratory	O
and	O
field	O
populations	B-T081
of	O
culicoides	O
species	O
how	O
effective	O
are	O
host	O
-	O
contact	O
reduction	B-T080
methods	O
in	O
india	O
bluetongue	O
virus	O
btv	O
is	O
transmitted	O
by	O
culicoides	O
biting	O
midges	O
and	O
causes	O
bluetongue	B-T047
bt	B-T047
,	O
a	O
clinical	B-T047
disease	I-T047
observed	O
primarily	O
in	O
sheep	O
.	O
	
bt	B-T047
has	O
a	O
detrimental	O
effect	O
on	O
subsistence	O
farmers	O
in	O
india	O
,	O
where	O
hyperendemic	B-T047
outbreaks	I-T047
impact	O
on	O
smallholdings	O
in	O
the	O
southern	O
states	O
of	O
the	O
country	O
.	O
	
in	O
this	O
study	O
,	O
we	O
establish	O
a	O
reliable	O
method	O
for	O
testing	O
the	O
toxic	O
effects	O
of	O
deltamethrin	B-T109
on	O
culicoides	O
and	O
then	O
compare	O
deltamethrin	B-T109
with	O
traditional	O
control	O
methods	O
used	O
by	O
farmers	O
in	O
india	O
.	O
	
effects	O
of	O
deltamethrin	B-T109
were	O
initially	O
tested	O
using	O
a	O
colonised	B-T080
strain	I-T080
of	O
culicoides	O
nubeculosus	O
meigen	O
and	O
a	O
modified	O
world	O
health	O
organisation	O
exposure	O
assay	O
.	O
	
this	O
method	O
was	O
then	O
applied	O
to	O
field	O
populations	B-T081
of	O
culicoides	O
spp	O
.	O
	
in	O
india	O
.	O
	
the	O
field	O
population	B-T081
of	O
c	O
.	O
	
oxystoma	O
in	O
india	O
had	O
a	O
greater	O
lc50	O
0.012	O
0.009	O
for	O
deltamethrin	B-T109
than	O
laboratory-reared	O
c.nubeculosus	O
0.0013	O
0.0002	O
.	O
	
exposure	O
of	O
c	O
.	O
	
nubeculosus	O
to	O
deltamethrin	B-T109
at	O
higher	O
ambient	O
temperatures	O
resulted	O
in	O
greater	O
rates	O
of	O
knockdown	O
but	O
a	O
lower	O
mortality	B-T081
rate	I-T081
at	O
24	O
h	O
post-exposure	O
.	O
	
behavioural	O
assays	O
with	O
c	O
.	O
	
nubeculosus	O
in	O
who	O
tubes	O
provided	O
evidence	O
for	O
contact	O
irritancy	O
and	O
spatial	O
repellence	O
caused	O
by	O
deltamethrin	B-T109
.	O
	
the	O
field	O
experiments	O
in	O
india	O
,	O
however	O
,	O
provided	O
no	O
evidence	O
for	O
repellent	O
or	O
toxic	O
effects	O
of	O
deltamethrin	B-T109
.	O
	
traditional	O
methods	O
such	O
as	O
the	O
application	B-T169
of	O
neem	B-T109
oil	I-T109
and	O
burning	O
of	O
neem	O
leaves	O
also	O
provided	O
no	B-T033
protection	B-T033
.	O
	
our	O
study	O
demonstrates	O
that	O
field	O
-collected	O
culicoides	O
in	O
india	O
are	O
less	O
susceptible	O
to	O
deltamethrin	B-T109
exposure	O
than	O
laboratory-bred	O
c	O
.	O
	
nubeculosus	O
and	O
traditional	O
methods	O
of	O
insect	O
control	O
do	O
not	O
provide	O
protection	B-T033
to	O
sheep	O
.	O
	
these	O
low	O
levels	O
of	O
susceptibility	O
to	O
deltamethrin	B-T109
have	O
not	O
been	O
recorded	O
before	O
in	O
field	O
populations	B-T081
of	O
culicoides	O
and	O
suggest	O
resistance	O
to	O
synthetic	O
pyrethrioids	O
.	O
	
alternative	O
insect	O
control	O
methods	O
,	O
in	O
addition	O
to	O
vaccination	B-T061
,	O
may	O
be	O
needed	O
to	O
protect	O
indian	O
livestock	O
from	O
btv	O
transmission	O
.	O
	
correlation	B-T080
of	O
the	O
lipid	B-T109
profile	O
,	O
bmi	O
and	O
bone	O
mineral	O
density	O
in	O
postmenopausal	O
women	O
to	O
the	O
reduction	B-T080
of	O
bone	O
density	O
and	O
osteoporosis	B-T047
in	O
postmenopausal	O
women	O
contribute	O
elevated	B-T080
lipid	B-T109
parameters	B-T033
and	O
body	O
mass	O
index	O
bmi	O
.	O
	
the	O
goal	O
of	O
our	O
study	O
was	O
to	O
determine	O
the	O
correlation	B-T080
between	O
lipid	B-T109
parameters	B-T033
,	O
bmi	O
and	O
osteoporosis	B-T047
in	O
postmenopausal	O
women	O
.	O
	
the	O
study	O
was	O
carried	O
out	O
by	O
matched	B-T080
type	B-T080
between	O
experimental	B-T080
group	B-T078
and	O
controls	O
.	O
	
the	O
experimental	B-T080
group	B-T078
consisted	O
of	O
100	O
females	O
at	O
postmenopausal	O
age	O
,	O
in	O
which	O
by	O
the	O
dexa	O
method	O
was	O
diagnosed	B-T033
osteoporosis	B-T047
at	O
the	O
department	O
of	O
endocrinology	O
,	O
diabetes	O
and	O
metabolic	O
diseases	O
,	O
university	O
medical	O
center	O
of	O
rs	O
during	O
2015-2016	O
,	O
while	O
the	O
control	O
group	O
consisted	O
of	O
100	O
females	O
in	O
a	O
postmenopausal	O
age	O
but	O
without	O
diagnosed	B-T033
osteoporosis	B-T047
.	O
	
the	O
groups	B-T078
were	O
matched	B-T080
by	O
age	O
2	O
years	B-T079
.	O
	
to	O
all	O
participants	O
of	O
the	O
study	O
were	O
carried	O
out	O
biochemical	O
analysis	O
of	O
blood	O
,	O
or	O
the	O
analysis	O
of	O
the	O
lipid	B-T109
profile	O
that	O
included	O
total	B-T109
cholesterol	I-T109
,	O
ldl	B-T109
cholesterol	I-T109
,	O
triglycerides	B-T109
tg	B-T109
and	O
hdl	B-T109
cholesterol	I-T109
,	O
and	O
was	O
determined	O
the	O
values	B-T080
of	O
bmi	O
and	O
waist	O
circumference	O
wc	O
.	O
	
analysis	O
of	O
the	O
data	B-T078
of	O
our	O
research	O
shows	O
that	O
by	O
the	O
univariate	O
logistic	O
regression	O
the	O
values	B-T080
of	O
lipid	B-T109
parameters	B-T033
total	B-T109
cholesterol	I-T109
p=0	O
,	O
ldl	B-T109
p=0	O
and	O
tg	B-T109
p=0	O
were	O
significantly	B-T078
associated	B-T080
with	I-T080
osteoporosis	B-T047
,	O
while	O
in	O
multivariate	B-T081
logistic	I-T081
model	I-T081
only	O
total	B-T109
cholesterol	I-T109
p=	O
0.018	O
was	O
found	O
as	O
an	O
independent	B-T078
risk	B-T033
factor	I-T033
for	O
osteoporosis	B-T047
in	O
postmenopausal	O
women	O
.	O
	
bmi	O
values	B-T080
were	O
not	B-T033
statistically	B-T081
significantly	I-T081
associated	B-T080
with	I-T080
osteoporosis	B-T047
p=0	O
.	O
	
on	O
the	O
decrease	B-T081
in	O
bone	O
mineral	O
density	O
and	O
osteoporosis	B-T047
in	O
postmenopausal	O
women	O
influence	O
many	O
risk	B-T033
factors	I-T033
whose	O
identification	B-T080
has	O
the	O
aim	O
to	O
develop	O
more	O
effective	B-T080
prevention	B-T080
of	O
this	O
disease	B-T047
in	O
the	O
heterotopic	O
ossification	O
after	O
the	O
use	O
of	O
recombinant	B-T116
human	I-T116
bone	I-T116
morphogenetic	I-T116
protein-7	I-T116
to	O
present	O
the	O
incidence	B-T081
of	O
heterotopic	O
ossification	O
after	O
the	O
use	O
of	O
recombinant	B-T116
human	I-T116
bone	I-T116
morphogenetic	I-T116
protein-7	I-T116
rhbmp-7	B-T116
for	O
the	O
treatment	B-T061
of	O
nonunions	B-T033
.	O
	
bone	B-T116
morphogenetic	I-T116
proteins	I-T116
bmps	B-T116
promote	O
bone	O
formation	O
by	O
auto-induction	O
.	O
	
recombinant	B-T116
human	I-T116
bmp-7	I-T116
in	O
combination	O
with	O
bone	O
grafts	O
was	O
used	O
in	O
84	O
patients	O
for	O
the	O
treatment	B-T061
of	O
long	B-T033
bone	I-T033
nonunions	I-T033
.	O
	
all	O
patients	O
were	O
evaluated	O
radiographicaly	O
for	O
the	O
development	B-T169
of	O
heterotopic	O
ossification	O
during	O
the	O
standard	B-T080
assessment	O
for	O
the	O
nonunion	B-T033
healing	O
.	O
	
in	O
all	O
patients	O
80.9	O
with	O
radiographic	O
signs	O
of	O
heterotopic	O
ossification	O
,	O
a	O
ct	O
scan	O
was	O
performed	O
.	O
	
nonunion	B-T033
site	O
palpation	O
and	O
rom	O
evaluation	O
of	O
the	O
adjacent	O
joints	O
were	O
also	O
carried	O
out	O
.	O
	
factors	B-T169
related	O
to	O
the	O
patient	O
age	O
,	O
gender	O
,	O
the	O
nonunion	B-T033
location	O
,	O
size	O
,	O
chronicity	B-T079
,	O
number	B-T169
of	I-T169
previous	I-T169
procedures	I-T169
,	O
infection	O
,	O
surrounding	O
tissues	O
condition	B-T080
and	O
the	O
surgical	B-T061
procedure	I-T061
graft	O
and	O
fixation	B-T061
type	B-T080
,	O
amount	B-T081
of	O
rhbmp-7	B-T116
were	O
correlated	B-T080
with	O
the	O
development	B-T169
of	O
heterotopic	O
ossification	O
and	O
statistical	O
analysis	O
with	O
pearsons	O
χ	O
2	O
test	O
was	O
performed	O
.	O
	
eighty	O
point	O
nine	O
percent	O
of	O
the	O
nonunions	B-T033
treated	B-T169
with	O
rhbmp-7	B-T116
,	O
healed	B-T169
with	O
no	O
need	O
for	O
further	O
procedures	B-T169
.	O
	
heterotopic	O
bone	O
formation	O
occurred	O
in	O
15	O
of	O
84	O
patients	O
17.8	O
and	O
it	O
was	O
apparent	O
in	O
the	O
routine	O
radiological	O
evaluation	O
of	O
the	O
nonunion	B-T033
site	O
,	O
in	O
a	O
mean	B-T079
time	I-T079
of	O
5.5	O
mo	O
after	O
the	O
rhbmp-7	B-T116
application	B-T169
range	O
3-12	O
.	O
	
the	O
heterotopic	O
ossification	O
was	O
located	O
at	O
the	O
femur	O
in	O
8	O
cases	O
,	O
at	O
the	O
tibia	O
in	O
6	O
,	O
and	O
at	O
the	O
humerus	O
in	O
οne	O
patient	O
.	O
	
in	O
4	O
patients	O
a	O
palpable	B-T033
mass	I-T033
was	O
present	O
and	O
only	O
in	O
one	O
patient	O
,	O
with	O
a	O
para-articular	B-T033
knee	I-T033
nonunion	I-T033
treated	B-T169
with	O
rhbmp-7	B-T116
,	O
the	O
size	O
of	O
heterotopic	O
ossification	O
affected	O
the	O
knee	B-T033
range	I-T033
of	I-T033
motion	I-T033
.	O
	
all	O
the	O
patients	O
with	O
heterotopic	O
ossification	O
were	O
male	O
.	O
	
statistical	O
analysis	O
proved	O
that	O
patient's	O
gender	O
was	O
the	O
only	O
important	O
factor	B-T169
for	O
the	O
development	B-T169
of	O
heterotopic	O
ossification	O
p	O
=	O
0.007	O
.	O
	
heterotopic	O
ossification	O
after	O
the	O
use	O
of	O
rhbmp-7	B-T116
in	O
nonunions	B-T033
was	O
common	O
but	O
it	O
did	O
not	O
compromise	O
the	O
final	O
clinical	B-T169
outcome	I-T169
in	O
most	O
cases	O
,	O
and	O
affected	O
only	O
male	O
patients	O
.	O
	
hypocretin/orexin	B-T116
peptides	I-T116
excite	O
rat	O
neuroendocrine	O
dopamine	O
neurons	O
through	O
orexin	B-T116
2	I-T116
receptor	I-T116
-mediated	O
activation	O
of	O
a	O
mixed	B-T169
cation	O
current	O
hypocretin/orexin	B-T116
h/o	B-T116
neurons	O
of	O
the	O
lateral	O
hypothalamus	O
are	O
compelling	O
modulator	O
candidates	O
for	O
the	O
chronobiology	O
of	O
neuroendocrine	O
output	O
and	O
,	O
as	O
a	O
consequence	B-T169
,	O
hormone	O
release	O
from	O
the	O
anterior	O
pituitary	O
.	O
	
here	O
we	O
investigate	O
the	O
effects	B-T080
of	O
h/o	B-T116
peptides	I-T116
upon	O
tuberoinfundibular	O
dopamine	O
tida	O
neurons	O
-	O
cells	O
which	O
control	B-T080
,	O
via	O
inhibition	O
,	O
the	O
pituitary	O
secretion	O
of	O
prolactin	O
.	O
	
in	O
whole	O
cell	O
recordings	O
performed	B-T169
in	O
male	O
rat	O
hypothalamic	O
slices	O
,	O
application	O
of	O
h/o-a	B-T116
,	O
as	O
well	O
as	O
h/o-b	B-T116
,	O
excited	O
oscillating	O
tida	O
neurons	O
,	O
inducing	B-T169
a	O
reversible	B-T169
depolarising	O
switch	O
from	O
phasic	O
to	O
tonic	O
discharge	O
.	O
	
the	O
h/o	B-T116
-	O
induced	B-T169
inward	O
current	O
underpinning	O
this	O
effect	B-T080
was	O
post-synaptic	O
as	O
it	O
endured	O
in	O
the	O
presence	B-T033
of	O
tetrodotoxin	B-T109
,	O
appeared	B-T080
to	O
be	O
carried	O
by	O
a	O
na	B-T116
-	O
dependent	B-T080
transient	B-T116
receptor	I-T116
potential-like	I-T116
channel	I-T116
as	O
it	O
was	O
blocked	B-T169
by	O
2-apb	B-T109
and	O
was	O
diminished	B-T081
by	O
removal	O
of	O
extracellular	O
na	B-T116
,	O
and	O
was	O
a	O
consequence	B-T169
of	I-T169
ox2r	B-T116
receptor	I-T116
activation	O
as	O
it	O
was	O
blocked	B-T169
by	O
the	O
ox2r	B-T116
receptor	I-T116
antagonist	O
tcs	B-T109
ox2	I-T109
29	I-T109
,	O
but	O
not	O
the	O
ox1r	B-T116
receptor	I-T116
antagonist	O
sb	B-T109
334867	I-T109
.	O
	
application	O
of	O
the	O
hormone	O
,	O
melatonin	B-T109
,	O
failed	B-T169
to	O
alter	B-T169
tida	O
membrane	O
potential	O
or	O
oscillatory	B-T061
activity	I-T061
.	O
	
this	O
first	O
description	O
of	O
the	O
electrophysiological	O
effects	O
of	O
h/os	B-T116
upon	O
the	O
tida	O
network	O
identifies	B-T080
cellular	O
mechanisms	O
that	O
may	O
contribute	O
to	O
the	O
circadian	O
rhythmicity	O
of	O
prolactin	O
secretion	O
.	O
	
improving	B-T080
exchange	O
with	O
consumers	O
within	O
mental	O
health	O
organizations	O
recognizing	O
mental	O
ill	O
health	O
experience	O
as	O
a	O
'sneaky	O
,	O
special	O
degree'	O
stigmatizing	B-T033
views	O
towards	O
consumers	O
may	O
be	O
held	O
even	O
by	O
those	O
working	O
within	O
mental	O
health	O
organizations	O
.	O
	
contemporary	O
mental	O
health	O
policies	O
require	O
organizations	O
to	O
work	O
collaboratively	O
with	O
consumers	O
in	O
producing	B-T169
and	O
delivering	O
services	O
.	O
	
using	O
social	O
exchange	O
theory	O
,	O
which	O
emphasises	O
mutual	B-T080
exchange	O
to	O
maximise	B-T081
benefits	B-T081
in	O
partnership	O
,	O
the	O
current	B-T079
study	O
explores	O
the	O
perspectives	O
of	O
those	O
working	O
within	O
organizations	O
that	O
have	O
some	O
level	B-T080
of	O
consumer	O
leadership	O
.	O
	
interviews	O
were	O
conducted	O
with	O
14	O
participants	O
from	O
a	O
range	B-T081
of	O
mental	O
health	O
organizations	O
.	O
	
data	B-T078
were	O
transcribed	O
,	O
and	O
analyzed	O
using	O
thematic	O
analytic	O
and	O
discursive	B-T033
psychological	O
techniques	O
.	O
	
findings	B-T033
suggest	O
stigma	B-T033
is	O
still	O
prevalent	O
even	O
in	O
organizations	O
that	O
have	O
consumers	O
in	O
leadership	O
positions	O
,	O
and	O
consumers	O
are	O
often	O
perceived	O
as	O
less	O
able	O
to	O
work	O
in	O
mental	O
health	O
organizations	O
than	O
non-consumers	O
.	O
	
several	O
discourses	O
challenged	O
such	O
a	O
view	O
-	O
showing	O
how	O
consumers	O
bring	O
value	O
to	O
mental	O
health	O
organizations	O
through	O
their	O
expertise	O
in	O
the	O
mental	O
health	O
system	O
,	O
and	O
their	O
ability	O
to	O
provide	O
safety	O
and	O
support	O
to	O
other	O
consumers	O
.	O
	
through	O
a	O
social	O
exchange	O
theory	O
lens	O
,	O
the	O
authors	O
call	O
for	O
organizations	O
to	O
challenge	O
stigma	B-T033
and	O
promote	O
the	O
value	O
that	O
consumers	O
can	O
bring	O
to	O
maximize	B-T081
mutual	B-T080
benefits	B-T081
.	O
	
does	O
sex	O
really	O
matter	O
explaining	O
intraspecies	O
variation	B-T080
in	O
ocean	O
acidification	O
responses	O
ocean	O
acidification	O
oa	O
poses	O
a	O
major	B-T078
threat	I-T078
to	O
marine	O
ecosystems	O
globally	B-T080
,	O
having	O
significant	B-T078
ecological	O
and	O
economic	B-T169
importance	B-T080
.	O
	
the	O
number	B-T081
and	O
complexity	B-T169
of	O
experiments	O
examining	B-T033
the	O
effects	B-T080
of	I-T080
oa	O
has	O
substantially	B-T078
increased	B-T081
over	O
the	O
past	B-T079
decade	B-T081
,	O
in	O
an	O
attempt	O
to	O
address	B-T078
multi-stressor	B-T078
interactions	B-T169
and	O
long-term	B-T079
responses	O
in	O
an	O
increasing	B-T169
range	B-T081
of	O
aquatic	O
organisms	O
.	O
	
however	O
,	O
differences	B-T080
in	O
the	O
response	O
of	O
males	O
and	O
females	O
to	O
elevated	B-T033
pco2	I-T033
have	O
been	O
investigated	B-T169
in	O
fewer	B-T081
than	O
4%	O
of	O
studies	O
to	O
date	B-T079
,	O
often	O
being	O
precluded	O
by	O
the	O
difficulty	B-T080
of	O
determining	O
sex	O
non-destructively	B-T078
,	O
particularly	O
in	O
early	B-T079
life	I-T079
stages	I-T079
.	O
	
here	O
we	O
highlight	O
that	O
sex	O
can	O
significantly	B-T078
impact	B-T080
organism	O
responses	O
to	O
oa	O
,	O
differentially	O
affecting	B-T169
physiology	O
,	O
reproduction	O
,	O
biochemistry	B-T169
and	O
ultimately	B-T169
survival	I-T169
.	O
	
what	O
is	O
more	O
,	O
these	O
impacts	B-T080
do	O
not	O
always	O
conform	O
to	O
ecological	B-T078
theory	I-T078
based	O
on	O
differential	B-T080
resource	B-T081
allocation	I-T081
towards	O
reproduction	O
,	O
which	O
would	O
predict	B-T078
females	O
to	O
be	O
more	O
sensitive	B-T169
to	O
oa	O
owing	O
to	O
the	O
higher	O
production	B-T169
cost	I-T169
of	O
eggs	O
compared	O
with	O
sperm	O
.	O
	
therefore	O
,	O
non-	O
sex	O
-	O
specific	O
studies	O
may	O
overlook	O
subtle	O
but	O
ecologically	O
significant	B-T078
differences	B-T080
in	O
the	O
responses	O
of	O
males	O
and	O
females	O
to	O
oa	O
,	O
with	O
consequences	B-T169
for	O
forecasting	B-T079
the	O
fate	O
of	O
natural	B-T169
populations	O
in	O
a	O
near-future	B-T079
ocean	O
.	O
	
computational	O
analysis	O
of	O
conserved	O
coil	O
functional	O
residues	O
in	O
the	O
mitochondrial	O
genomic	O
sequences	O
of	O
dermatophytes	O
dermatophyte	O
is	O
a	O
group	O
of	O
closely	O
related	O
fungi	O
that	O
have	O
the	O
capacity	O
to	O
invade	B-T080
keratinized	B-T169
tissue	O
of	O
humans	O
and	O
other	O
animals	O
.	O
	
the	O
infection	O
known	O
as	O
dermatophytosis	B-T047
,	O
caused	O
by	O
members	O
of	O
the	O
genera	O
microsporum	O
,	O
trichophyton	O
,	O
and	O
epidermophyton	O
includes	O
infection	O
to	O
the	O
groin	O
tinea	B-T047
cruris	I-T047
,	O
beard	O
tinea	B-T047
barbae	I-T047
,	O
scalp	O
tinea	B-T047
capitis	I-T047
,	O
feet	O
tinea	B-T047
pedis	I-T047
,	O
glabrous	O
skin	O
tinea	B-T047
corporis	I-T047
,	O
nail	O
tinea	B-T047
unguium	I-T047
,	O
and	O
hand	O
tinea	B-T047
manuum	I-T047
.	O
	
the	O
identification	O
of	O
evolutionary	O
relationship	B-T080
between	O
these	O
three	O
genera	O
of	O
dermatophyte	O
is	O
epidemiologically	B-T169
important	I-T169
to	O
understand	O
their	O
pathogenicity	O
.	O
	
mitochondrial	O
dna	O
evolves	O
more	B-T080
rapidly	I-T080
than	O
a	O
nuclear	O
dna	O
due	O
to	O
higher	O
rate	B-T080
of	I-T080
mutation	I-T080
but	O
is	O
very	O
less	B-T169
affected	I-T169
by	O
genetic	O
recombination	O
,	O
making	O
it	O
an	O
important	O
tool	O
for	O
phylogenetic	O
studies	O
.	O
	
thus	O
,	O
here	O
we	O
present	O
a	O
novel	O
scheme	O
to	O
identify	O
the	O
conserved	O
coil	O
functional	O
residues	O
of	O
trichophyton	O
rubrum	O
,	O
trichophyton	O
mentagrophytes	O
,	O
epidermophyton	O
floccosum	O
and	O
microsporum	O
canis	O
.	O
	
protein	O
coding	O
sequences	O
of	O
the	O
mitochondrial	O
genome	O
were	O
aligned	O
for	O
their	O
similar	O
sequences	O
and	O
homology	O
modelling	O
was	O
performed	O
for	O
structure	B-T116
and	O
pocket	O
identification	O
.	O
	
the	O
results	O
obtained	O
from	O
comparative	O
analysis	O
of	O
the	O
protein	O
sequences	O
revealed	O
the	O
presence	O
of	O
functionally	O
active	B-T169
sites	I-T169
in	O
all	O
the	O
species	O
of	O
the	O
genera	O
trichophyton	O
and	O
microsporum	O
.	O
	
however	O
in	O
epidermophyton	O
floccosum	O
it	O
was	O
observed	O
in	O
three	O
protein	O
sequences	O
of	O
the	O
five	O
studied	O
.	O
	
the	O
absence	O
of	O
these	O
conserved	O
coil	O
functional	O
residues	O
in	O
e	O
.	O
	
floccusum	O
may	O
be	O
correlated	O
with	O
lesser	B-T080
infectivity	I-T080
of	O
this	O
organism	O
.	O
	
the	O
functional	O
residues	O
identified	O
in	O
the	O
present	O
study	O
could	O
be	O
responsible	O
for	O
the	O
disease	B-T047
and	O
thus	O
can	O
act	O
as	O
putative	B-T169
target	I-T169
sites	I-T169
for	O
drug	O
designing	O
.	O
	
non-intubated	B-T061
subxiphoid	O
uniportal	B-T061
video-assisted	I-T061
thoracoscopic	I-T061
thymectomy	I-T061
using	O
glasses-free	O
3d	O
vision	O
trans-sternal	O
thymectomy	B-T061
has	O
long	O
been	O
accepted	O
as	O
the	O
standard	O
surgical	O
procedure	O
for	O
thymic	O
masses	O
.	O
	
recently	O
,	O
minimally	O
invasive	O
methods	O
,	O
such	O
as	O
video-assisted	O
thoracoscopic	O
surgery	O
vats	O
and	O
,	O
even	O
more	O
recently	O
,	O
non-intubated	O
anesthesia	O
,	O
have	O
emerged	O
.	O
	
these	O
methods	O
provide	O
advantages	O
including	O
reductions	O
in	O
surgical	O
trauma	O
,	O
postoperative	O
associated	O
pain	O
,	O
and	O
in	O
regards	O
to	O
vats	O
,	O
provide	O
certain	O
cosmetic	O
benefits	O
.	O
	
considering	O
these	O
advantages	O
,	O
we	O
herein	O
present	O
a	O
case	O
of	O
subxiphoid	O
uniportal	O
vats	O
for	O
thymic	O
mass	O
using	O
a	O
glasses-free	B-T033
3d	O
thoracoscopic	O
display	O
system	O
trends	B-T079
in	O
dietary	O
intake	O
among	O
adults	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
nhanes	O
1988-2012	O
dietary	O
recommendations	B-T078
for	O
adults	O
with	O
diabetes	B-T047
are	O
to	O
follow	O
a	O
healthy	B-T061
diet	I-T061
in	O
appropriate	O
portion	B-T081
sizes	I-T081
.	O
	
we	O
determined	O
recent	O
trends	B-T079
in	O
energy	B-T081
and	O
nutrient	B-T081
intakes	I-T081
among	O
a	O
nationally	O
representative	O
sample	O
of	O
us	O
adults	O
with	O
and	O
without	O
type	B-T047
2	I-T047
diabetes	I-T047
.	O
	
participants	O
were	O
adults	O
aged	O
20	O
years	B-T079
from	O
the	O
cross-sectional	O
national	O
health	O
and	O
nutrition	O
examination	O
surveys	O
,	O
1988-2012	O
n	O
=	O
49	O
770	O
.	O
	
diabetes	B-T047
was	O
determined	O
by	O
self-report	O
of	O
a	O
physician's	O
diagnosis	B-T033
n	O
=	O
4885	O
.	O
	
intake	B-T081
of	I-T081
energy	I-T081
and	O
nutrients	O
were	O
determined	O
from	O
a	O
24-	O
h	B-T079
recall	O
by	O
participants	O
of	O
all	O
food	O
consumed	O
.	O
	
linear	B-T081
regression	I-T081
was	O
used	O
to	O
test	B-T169
for	O
trends	B-T079
in	O
mean	O
intake	O
over	O
time	B-T079
for	O
all	O
participants	O
and	O
by	O
demographic	O
characteristics	O
.	O
	
among	O
adults	O
with	O
diabetes	B-T047
,	O
overall	O
total	O
energy	B-T081
intake	I-T081
increased	B-T081
between	O
1988-1994	O
and	O
2011-2012	O
1689	B-T081
kcal	I-T081
versus	O
1895	B-T081
kcal	I-T081
ptrend	O
<	O
0.001	O
with	O
evidence	O
of	O
a	O
plateau	B-T081
between	O
2003-2006	O
and	O
2011-2012	O
.	O
	
in	O
2007-2012	O
,	O
energy	B-T081
intake	I-T081
was	O
greater	O
for	O
younger	O
than	O
older	O
adults	O
,	O
for	O
men	O
than	O
women	O
,	O
and	O
for	O
non-hispanic	O
whites	O
versus	O
non-hispanic	O
blacks	O
.	O
	
there	O
was	O
no	O
change	O
in	O
the	O
percentage	B-T081
of	O
calories	B-T081
from	O
carbohydrate	O
,	O
total	B-T109
fat	I-T109
or	O
protein	O
.	O
	
percentage	B-T081
of	O
calories	B-T081
from	O
saturated	O
fat	O
was	O
similar	O
across	O
study	O
periods	B-T079
but	O
remained	O
above	O
recommendations	B-T078
11.2	O
in	O
2011-2012	O
.	O
	
fibre	B-T033
intake	I-T033
significantly	O
decreased	O
and	O
remained	O
below	O
recommendations	B-T078
ptrend	O
=	O
0.002	O
.	O
	
sodium	O
,	O
cholesterol	B-T109
and	O
calcium	O
intakes	O
increased	B-T081
.	O
	
there	O
was	O
no	O
change	O
in	O
energy	B-T081
intake	I-T081
among	O
adults	O
without	O
diabetes	B-T047
and	O
dietary	O
trends	B-T079
were	O
similar	O
to	O
those	O
with	O
diabetes	B-T047
.	O
	
future	O
data	B-T078
are	O
needed	O
to	O
confirm	O
a	O
plateau	B-T081
in	O
energy	B-T081
intake	I-T081
among	O
adults	O
with	O
diabetes	B-T047
,	O
although	O
the	O
opportunity	O
exists	O
to	O
increase	B-T169
fibre	O
and	O
reduce	B-T081
saturated	O
fat	O
.	O
	
clonal	O
and	O
serotype	O
dynamics	O
of	O
serogroup	O
6	O
isolates	O
causing	O
invasive	B-T047
pneumococcal	I-T047
disease	I-T047
in	O
portugal	O
1999-2012	O
although	O
serogroup	O
6	O
was	O
among	O
the	O
first	O
to	O
be	O
recognized	O
among	O
streptococcus	O
pneumoniae	O
,	O
several	O
new	O
serotypes	O
were	O
identified	B-T080
since	O
the	O
introduction	B-T169
of	O
pneumococcal	O
conjugate	O
vaccines	O
pcvs	O
.	O
	
a	O
decrease	B-T081
of	O
the	O
6b-2	B-T080
variant	I-T080
among	O
invasive	B-T047
pneumococcal	I-T047
disease	I-T047
ipd	B-T047
,	O
but	O
not	O
6b-1	B-T080
,	O
was	O
noted	O
post	B-T079
conjugate	O
vaccine	O
introduction	B-T169
,	O
underpinned	O
by	O
a	O
decrease	B-T081
of	O
cc273	O
isolates	O
.	O
	
serotype	O
6c	O
was	O
associated	B-T080
with	I-T080
adult	O
ipd	B-T047
and	O
increased	B-T081
in	O
this	O
age	O
group	O
representing	O
two	O
lineages	B-T078
cc315	B-T078
and	O
cc395	B-T078
,	O
while	O
the	O
same	O
lineages	B-T078
expressed	O
other	O
serogroup	O
6	O
serotypes	O
in	O
children	O
.	O
	
taken	O
together	O
,	O
these	O
findings	B-T169
suggest	O
a	O
potential	O
cross-protection	O
of	O
pcvs	O
against	O
serotype	O
6c	O
ipd	B-T047
among	O
vaccinated	B-T033
children	O
but	O
not	O
among	O
adults	O
.	O
	
serotype	O
6a	O
became	O
the	O
most	O
important	O
serogroup	O
6	O
serotype	O
in	O
children	O
but	O
it	O
decreased	B-T081
in	O
adult	O
ipd	B-T047
.	O
	
no	O
other	O
serogroup	O
6	O
serotypes	O
were	O
detected	B-T033
,	O
so	O
available	O
phenotypic	O
or	O
simple	O
genotypic	O
assays	O
remain	O
adequate	B-T080
for	O
distinguishing	O
serotypes	O
within	O
serogroup	O
6	O
isolates	O
.	O
	
minimally	B-T169
invasive	I-T169
percutaneous	B-T061
nephrolithotomy	I-T061
improves	O
stone-free	O
rates	O
for	O
impacted	B-T169
proximal	O
ureteral	B-T047
stones	I-T047
a	O
systematic	O
review	O
and	O
meta-analysis	O
urinary	B-T047
stones	I-T047
are	O
common	O
medical	B-T169
disorders	B-T047
and	O
the	O
treatment	B-T169
of	O
impacted	B-T047
proximal	I-T047
ureteral	I-T047
stones	I-T047
ipus	O
is	O
still	O
a	O
challenge	O
for	O
urologists	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
efficacy	O
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	O
mi	O
-	O
pcnl	O
and	O
ureteroscopic	O
lithotripsy	O
url	O
in	O
the	O
treatment	O
of	O
ipus	O
via	O
a	O
meta-analysis	O
.	O
	
we	O
collected	O
studies	O
using	O
pubmed	O
,	O
embase	O
,	O
and	O
cochrane	O
library	O
from	O
1978	O
to	O
november	O
2016	O
and	O
analyzed	O
them	O
using	O
stata	O
12.0	O
and	O
revman	O
5.3	O
.	O
	
odds	O
ratios	O
or	O
s	O
and	O
standard	O
mean	O
difference	O
smd	O
were	O
calculated	O
for	O
binary	O
and	O
continuous	O
variables	O
respectively	O
,	O
accompanied	O
with	O
95%	O
confidence	O
intervals	O
cis	O
.	O
	
all	O
study	O
procedures	O
followed	O
the	O
prisma	O
guidelines	O
.	O
	
five	O
prospective	O
studies	O
were	O
included	O
in	O
our	O
meta-analysis	O
,	O
with	O
242	O
mi	O
-	O
pcnl	O
and	O
256	O
url	O
cases	O
.	O
	
mi	O
-	O
pcnl	O
was	O
associated	O
with	O
a	O
longer	O
postoperative	O
hospital	O
stay	O
than	O
url	O
smd	O
,	O
3.14	O
95%	O
ci	O
,	O
1.27	O
to	O
5.55	O
.	O
	
however	O
,	O
no	O
significant	O
difference	O
was	O
observed	O
in	O
operative	O
time	O
smd	O
,	O
-0	O
95%	O
ci	O
,	O
-3	O
to	O
2.38	O
.	O
	
in	O
addition	O
,	O
mi	O
-	O
pcnl	O
had	O
higher	O
initial	O
or	O
,	O
11.12	O
95%	O
ci	O
,	O
5.56	O
to	O
22.24	O
and	O
overall	O
stone-free	O
rates	O
or	O
,	O
8.70	O
95%	O
ci	O
,	O
3.23	O
to	O
23.45	O
than	O
url	O
,	O
along	O
with	O
lower	O
possibilities	O
of	O
surgical	O
conversion	O
or	O
,	O
0.11	O
95%	O
ci	O
,	O
0.03	O
to	O
0.49	O
and	O
postoperative	O
shock	O
wave	O
lithotripsy	O
or	O
,	O
0.06	O
95%	O
ci	O
,	O
0.02	O
to	O
0.18	O
.	O
	
regarding	O
complications	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
between	O
mi	O
-	O
pcnl	O
and	O
url	O
or	O
,	O
1.39	O
95%	O
ci	O
,	O
0.93	O
to	O
2.10	O
,	O
except	O
for	O
hematuria	O
or	O
,	O
4.80	O
95%	O
ci	O
,	O
1.45	O
to	O
15.94	O
.	O
	
mi	O
-	O
pcnl	O
is	O
optimal	O
and	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
treatment	O
method	O
for	O
ipus	O
,	O
as	O
it	O
has	O
better	O
efficacy	O
and	O
a	O
safety	O
profile	O
similar	O
to	O
that	O
of	O
url	O
.	O
	
however	O
,	O
further	O
high	O
quality	O
studies	O
with	O
larger	O
sample	O
size	O
are	O
required	O
in	O
future	B-T079
predictive	O
factors	O
for	O
long-term	B-T079
outcome	B-T169
of	O
subthalamic	O
nucleus	O
deep	B-T061
brain	I-T061
stimulation	I-T061
for	O
parkinson's	B-T047
disease	I-T047
despite	O
the	O
recognition	O
of	O
the	O
usefulness	B-T080
of	O
subthalamic	O
nucleus	O
deep	B-T061
brain	I-T061
stimulation	I-T061
stn	O
-	O
dbs	B-T061
for	O
the	O
treatment	B-T169
of	O
parkinson's	B-T047
disease	I-T047
pd	B-T047
,	O
preoperative	B-T079
predictive	O
factors	O
for	O
the	O
long-term	B-T079
outcome	B-T169
of	O
stn	O
-	O
dbs	B-T061
are	O
not	B-T169
sufficiently	B-T080
established	B-T080
.	O
	
we	O
performed	O
this	O
study	O
to	O
determine	O
such	O
predictive	O
factors	O
.	O
	
the	O
subjects	O
were	O
66	O
patients	O
who	O
were	O
classified	O
into	O
two	B-T081
groups	O
on	O
the	O
basis	B-T169
of	O
their	O
activities	O
of	O
daily	O
living	O
adl	O
evaluated	O
five	B-T079
years	I-T079
after	B-T079
the	O
stn	O
-	O
dbs	B-T061
surgery	B-T061
33	O
patients	O
were	O
assigned	B-T169
to	O
the	O
independent	B-T169
adl	O
group	O
group	O
i	O
and	O
the	O
remaining	O
33	O
patients	O
to	O
the	O
dependent	B-T169
adl	O
group	O
group	O
d	O
.	O
	
group	O
i	O
patients	O
showed	O
a	O
schwab	O
and	O
england	O
s	O
scale	O
score	O
of	O
more	O
than	O
70	O
during	O
the	O
off-period	O
,	O
indicating	O
that	O
these	O
patients	O
can	O
maintain	O
their	O
independent	O
adl	O
all	O
the	O
time	O
.	O
	
group	O
d	O
patients	O
showed	O
a	O
score	O
of	O
70	O
or	O
lower	O
during	O
the	O
off-period	O
,	O
indicating	O
that	O
these	O
patients	O
cannot	O
maintain	O
their	O
independent	O
adl	O
for	O
an	O
entire	O
day	O
.	O
	
we	O
studied	O
the	O
differences	O
in	O
the	O
preoperative	O
state	O
between	O
these	O
two	O
groups	O
.	O
	
statistically	O
significant	O
differences	O
were	O
noted	O
in	O
pd	O
onset	O
age	O
,	O
age	O
at	O
surgery	O
,	O
preoperative	O
unified	O
parkinson's	O
disease	O
rating	O
scale	O
updrs	O
part	O
i	O
score	O
,	O
part	O
ii	O
score	O
,	O
total	O
subscore	O
for	O
axial	O
symptoms	O
in	O
part	O
iii	O
,	O
mini-mental	O
state	O
examination	O
mmse	O
score	O
and	O
s	O
score	B-T081
.	O
	
multiple	O
logistic	O
regression	O
analysis	O
showed	O
that	O
the	O
significant	O
independent	O
variables	O
related	O
to	O
long-term	O
independent	O
adl	O
were	O
the	O
age	O
at	O
surgery	O
,	O
mmse	O
score	O
and	O
preoperative	O
s	O
scale	O
score	O
during	B-T079
the	O
off-period	B-T079
.	O
	
the	O
pd	O
onset	O
age	O
,	O
age	O
at	O
surgery	O
,	O
preoperative	O
high	O
-	O
level	O
adl	O
,	O
cognitive	O
function	O
,	O
and	O
axial	O
symptoms	O
are	O
important	O
predictive	O
factors	O
for	O
the	O
long-term	O
outcome	O
of	O
stn	O
-	O
dbs	B-T061
who	O
persuades	B-T078
who	O
an	O
analysis	O
of	O
persuasion	B-T078
choices	O
related	O
to	O
antibiotic	O
-	O
free	B-T080
food	O
personal	O
communication	O
,	O
in	O
which	O
one	O
person	O
persuades	B-T078
another	O
to	O
engage	O
in	O
a	O
particular	O
behavior	O
,	O
is	O
one	O
means	O
through	O
which	O
behaviors	O
spread	B-T080
.	O
	
to	O
better	O
understand	O
how	O
personal	O
communication	O
spreads	B-T080
behavior	O
,	O
we	O
investigated	B-T169
adults'	O
n	O
=	O
228	O
likelihood	B-T081
of	O
persuading	B-T078
others	O
in	O
a	O
fictitious	O
social	O
network	O
to	O
buy	O
antibiotic	O
-	O
free	B-T080
food	O
,	O
and	O
who	O
they	O
attempted	O
to	O
persuade	B-T078
,	O
based	O
on	O
behavioral	O
determinants	B-T169
,	O
homophily	B-T080
,	O
and	O
superdiffuser	B-T080
traits	O
.	O
	
for	O
potential	B-T080
consumers	O
,	O
the	O
findings	B-T033
showed	O
that	O
behavioral	O
determinants	B-T169
,	O
behavioral	O
intentions	O
,	O
and	O
mavenism	B-T080
predicted	B-T078
intentions	O
to	O
persuade	B-T078
others	O
.	O
	
homophily	B-T080
,	O
mavenism	B-T080
,	O
and	O
connectivity	B-T169
predicted	B-T078
patterns	O
of	O
interpersonal	O
persuasion	B-T078
.	O
	
for	O
vegetarians	O
without	O
homophily	B-T080
in	O
action	O
,	O
behavioral	O
determinants	B-T169
and	O
mavenism	B-T080
predicted	B-T078
persuasion	B-T078
intentions	O
.	O
	
persuasiveness	B-T078
was	O
associated	B-T080
with	I-T080
targeting	B-T169
more	O
network	O
members	O
mavenism	B-T080
was	O
associated	B-T080
with	I-T080
selecting	O
structurally	O
central	O
members	O
.	O
	
modeling	O
the	O
flux	O
of	O
metabolites	O
in	O
the	O
juvenile	O
hormone	O
biosynthesis	O
pathway	O
using	O
generalized	O
additive	O
models	O
and	O
ordinary	O
differential	O
equations	O
juvenile	O
hormone	O
jh	O
regulates	O
development	B-T169
and	O
reproductive	O
maturation	O
in	O
insects	O
.	O
	
the	O
corpora	O
allata	O
ca	O
from	O
female	O
adult	O
mosquitoes	O
synthesize	O
fluctuating	B-T079
levels	B-T080
of	O
jh	O
,	O
which	O
have	O
been	O
linked	O
to	O
the	O
ovarian	O
development	O
and	O
are	O
influenced	O
by	O
nutritional	B-T080
signals	O
.	O
	
the	O
rate	B-T081
of	O
jh	O
biosynthesis	O
is	O
controlled	O
by	O
the	O
rate	B-T081
of	O
flux	O
of	O
isoprenoids	B-T109
in	O
the	O
pathway	O
,	O
which	O
is	O
the	O
outcome	O
of	O
a	O
complex	O
interplay	O
of	O
changes	B-T169
in	O
precursor	O
pools	O
and	O
enzyme	B-T116
levels	B-T080
.	O
	
a	O
comprehensive	B-T080
study	O
of	O
the	O
changes	B-T169
in	O
enzymatic	O
activities	O
and	O
precursor	O
pool	O
sizes	O
have	O
been	O
previously	O
reported	O
for	O
the	O
mosquito	O
aedes	O
aegypti	O
jh	O
biosynthesis	O
pathway	O
.	O
	
in	O
the	O
present	O
studies	O
,	O
we	O
used	O
two	O
different	O
quantitative	O
approaches	O
to	O
describe	O
and	O
predict	O
how	O
changes	B-T169
in	O
the	O
individual	O
metabolic	B-T169
reactions	B-T169
in	O
the	O
pathway	O
affect	O
jh	O
synthesis	O
.	O
	
first	O
,	O
we	O
constructed	O
generalized	O
additive	O
models	O
gams	O
that	O
described	O
the	O
association	O
between	O
changes	B-T169
in	O
specific	O
metabolite	O
concentrations	B-T081
with	O
changes	B-T169
in	O
enzymatic	O
activities	O
and	O
substrate	O
concentrations	B-T081
.	O
	
changes	B-T169
in	O
substrate	O
concentrations	B-T081
explained	O
50%	O
or	O
more	O
of	O
the	O
model	O
deviances	O
in	O
7	O
of	O
the	O
13	O
metabolic	B-T169
steps	O
analyzed	O
.	O
	
addition	O
of	O
information	O
on	O
enzymatic	O
activities	O
almost	O
always	O
improved	O
the	O
fitness	O
of	O
gams	O
built	O
solely	O
based	O
on	O
substrate	O
concentrations	B-T081
.	O
	
gams	O
were	O
validated	O
using	O
experimental	B-T080
data	B-T078
that	O
were	O
not	O
included	O
when	O
the	O
model	O
was	O
built	O
.	O
	
in	O
addition	O
,	O
a	O
system	O
of	O
ordinary	O
differential	O
equations	O
ode	O
was	O
developed	O
to	O
describe	O
the	O
instantaneous	O
changes	B-T169
in	O
metabolites	O
as	O
a	O
function	B-T169
of	O
the	O
levels	B-T080
of	O
enzymatic	O
catalytic	O
activities	O
.	O
	
the	O
results	B-T169
demonstrated	O
the	O
ability	O
of	O
the	O
models	O
to	O
predict	O
changes	B-T169
in	O
the	O
flux	O
of	O
metabolites	O
in	O
the	O
jh	O
pathway	O
,	O
and	O
can	O
be	O
used	O
in	O
the	O
future	O
to	O
design	O
and	O
validate	O
experimental	B-T080
manipulations	B-T169
of	O
jh	O
synthesis	O
.	O
	
associations	B-T080
between	O
human	B-T109
breast	I-T109
milk	I-T109
hormones	O
and	O
adipocytokines	B-T116
and	O
infant	O
growth	O
and	O
body	O
composition	O
in	O
the	O
first	B-T033
6	I-T033
months	I-T033
of	I-T033
life	I-T033
much	O
is	O
to	O
be	O
learnt	O
about	O
human	B-T109
breast	I-T109
milk	I-T109
hbm	B-T109
.	O
	
the	O
purpose	O
of	O
this	O
study	O
is	O
to	O
extend	O
our	O
knowledge	O
of	O
hbm	B-T109
by	O
investigating	O
the	O
role	O
of	O
maternal	B-T033
body	O
mass	O
index	O
bmi	O
,	O
sex	O
and	O
stage	O
of	O
lactation	O
month	O
1	O
vs	O
.	O
	
6	O
on	O
hbm	B-T109
insulin	B-T116
,	O
glucose	B-T109
,	O
leptin	B-T116
,	O
il-6	B-T116
and	O
tnf-α	B-T116
and	O
their	O
associations	B-T080
with	O
infant	O
body	O
composition	O
.	O
	
thirty-seven	O
exclusively	O
breastfeeding	B-T033
infants	I-T033
n	O
=	O
37	O
16	O
,	O
21	O
,	O
and	O
their	O
mothers	B-T033
19-47	O
kg	O
m	O
were	O
studied	O
at	O
1	O
and	O
6	O
months	O
of	O
lactation	O
.	O
	
infants	O
had	O
body	O
composition	O
measured	O
using	O
dual-energy	O
x-ray	O
absorptiometry	O
and	O
hbm	B-T109
collected	O
.	O
	
a	O
significant	O
interaction	B-T169
between	O
maternal	B-T033
bmi	O
and	O
infant	O
sex	O
on	O
insulin	O
levels	O
p	O
=	O
0.0322	O
was	O
observed	O
such	O
that	O
insulin	O
was	O
229%	O
higher	O
in	O
obese	B-T047
mothers	O
nursing	O
female	B-T033
infants	I-T033
than	O
in	O
normal	B-T033
weight	I-T033
mothers	O
nursing	O
female	O
infants	O
and	O
179%	O
higher	O
than	O
obese	O
mothers	O
nursing	O
male	O
infants	O
.	O
	
for	O
leptin	O
,	O
a	O
significant	O
association	O
with	O
bmi	O
category	O
was	O
observed	O
p	O
<	O
0.0001	O
such	O
that	O
overweight	O
and	O
obese	O
mothers	O
had	O
96.5	O
and	O
315.1	O
higher	O
leptin	O
levels	O
than	O
normal	O
weight	O
mothers	O
,	O
respectively	O
.	O
	
leptin	O
was	O
also	O
found	O
to	O
have	O
a	O
significant	O
p	O
=	O
0.0004	O
33.7	O
decrease	O
from	O
months	O
1	O
to	O
6	O
,	O
controlling	O
for	O
bmi	O
category	O
and	O
sex	O
.	O
	
a	O
significant	O
inverse	O
relationship	O
between	O
month	O
1	O
leptin	O
levels	O
and	O
infant	O
length	O
p	O
=	O
0.0257	O
,	O
percent	O
fat	O
p	O
=	O
0.0223	O
,	O
total	O
fat	O
mass	O
p	O
=	O
0.0226	O
and	O
trunk	O
fat	O
mass	O
p	O
=	O
0.0111	O
at	O
month	O
6	O
was	O
also	O
found	O
.	O
	
no	O
associations	O
or	O
interactions	O
were	O
observed	O
for	O
glucose	O
,	O
tnf-α	O
or	O
il-6	O
.	O
	
these	O
data	O
demonstrate	O
that	O
maternal	O
bmi	O
,	O
infant	O
sex	O
and	O
stage	O
of	O
lactation	O
affect	O
the	O
compositional	O
make-up	O
of	O
insulin	O
and	O
leptin	B-T116
aryl	O
hydrocarbon	O
receptor	O
ahr	O
rs2066853	O
gene	O
polymorphism	O
association	O
with	O
infertile	O
oligoasthenoteratozoospermic	B-T047
men	O
and	O
seminal	O
oxidative	O
stress	O
this	O
study	O
aimed	O
to	O
assess	O
the	O
association	O
between	O
aryl	O
hydrocarbon	O
receptor	O
ahr	O
rs2066853	O
gene	O
polymorphism	O
with	O
infertile	O
oligoasthenoteratozoospermic	B-T047
oat	B-T047
men	O
and	O
seminal	O
oxidative	O
stress	O
os	O
.	O
	
a	O
total	O
of	O
170	O
egyptian	O
men	O
were	O
allocated	O
according	O
to	O
their	O
semen	O
analysis	O
into	O
fertile	O
normozoospermic	B-T033
controls	I-T033
n	O
=	O
50	O
and	O
infertile	O
oat	B-T047
men	O
n	O
=	O
120	O
.	O
	
they	O
were	O
subjected	O
to	O
history	O
taking	O
,	O
clinical	O
examination	O
,	O
semen	O
analysis	O
,	O
estimation	B-T081
of	O
seminal	O
glutathione	B-T116
peroxidase	I-T116
gpx	B-T116
,	O
and	O
malondialdehyde	B-T109
mda	B-T109
.	O
	
ahr	O
rs2066853	O
gene	O
polymorphism	O
was	O
identified	O
in	O
the	O
blood	O
by	O
pcr	O
-	O
rflp	O
.	O
	
comparing	O
infertile	O
oat	B-T047
men	O
with	O
fertile	O
controls	O
,	O
ahr	O
rs2066853	O
genotypes	O
showed	O
decreased	B-T081
prevalence	B-T081
for	O
wild	O
homozygous	O
genotype	O
gg	O
35.8	O
vs	O
56%	O
and	O
for	O
heterozygous	O
genotype	O
ga	O
17.5	O
vs	O
30%	O
and	O
an	O
increased	B-T081
prevalence	B-T081
for	O
homozygous	O
genotype	O
aa	O
46.7	O
vs	O
14%	O
.	O
	
distribution	O
of	O
alleles	O
of	O
ahr	O
rs2066853	O
among	O
oat	B-T047
men	O
compared	O
with	O
fertile	O
men	O
showed	O
decreased	B-T081
prevalence	B-T081
of	O
g	O
allele	O
44.6	O
vs	O
71%	O
and	O
an	O
increased	B-T081
prevalence	B-T081
of	O
a	O
allele	O
55.4	O
vs	O
29%	O
.	O
	
seminal	O
mda	B-T109
demonstrated	O
significant	O
increase	B-T081
whereas	O
seminal	O
gpx	B-T116
demonstrated	O
significant	O
decrease	B-T081
in	O
cases	O
with	O
aa	O
and	O
ga	O
/	O
aa	O
genotypes	O
compared	O
to	O
cases	O
with	O
gg	O
genotype	O
.	O
	
it	O
is	O
concluded	O
that	O
there	O
is	O
a	O
significant	O
association	O
between	O
ahr	O
rs2066853	O
genotype	O
polymorphism	O
with	O
decreased	B-T081
sperm	O
parameters	O
as	O
well	O
as	O
increased	B-T081
seminal	O
oxidative	O
stress	O
in	O
infertile	O
oat	B-T047
men	O
.	O
	
associations	B-T080
of	O
gender	O
and	O
a	O
proxy	O
of	O
female	O
menopausal	O
status	O
with	O
histological	B-T169
features	B-T080
of	O
drug-induced	B-T047
liver	I-T047
injury	I-T047
gender	O
and	O
menopause	O
may	O
contribute	O
to	O
type	B-T080
and	O
severity	B-T080
of	O
drug-induced	B-T047
liver	I-T047
injury	I-T047
dili	B-T047
by	O
influencing	O
host	O
responses	B-T033
to	O
injury	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
associations	B-T080
of	O
gender	O
and	O
female	O
age	O
50	O
a	O
proxy	O
of	O
menopause	O
with	O
histological	B-T169
features	B-T080
of	O
liver	O
injury	O
in	O
212	O
adults	O
enrolled	O
in	O
the	O
drug-induced	B-T047
liver	I-T047
injury	I-T047
network	B-T169
dilin	B-T169
registry	O
.	O
	
all	O
participants	O
had	O
a	O
causality	B-T169
score	B-T081
of	O
at	O
least	O
'	O
probable	B-T033
'	O
,	O
a	O
liver	O
biopsy	O
within	O
30	O
days	O
of	O
dili	B-T047
onset	O
,	O
and	O
no	O
prior	O
chronic	B-T047
liver	I-T047
disease	I-T047
.	O
	
biochemical	B-T169
and	O
histological	B-T169
injury	O
types	B-T080
were	O
classified	O
as	O
hepatocellular	O
or	O
cholestatic/mixed	B-T047
injury	I-T047
.	O
	
the	O
cohort	O
was	O
divided	B-T169
into	O
three	O
gender	O
/	O
age	O
categories	O
men	O
41.0	O
,	O
women	O
<50	O
years	O
27.4	O
and	O
women	O
50	O
years	O
of	O
age	O
31.6	O
.	O
	
interaction	B-T169
of	O
gender	O
and	O
age	O
category	O
50	O
or	O
not	O
was	O
assessed	O
.	O
	
hepatocellular	O
injury	O
was	O
more	O
prevalent	O
in	O
women	O
<50	O
years	O
vs	O
.	O
	
others	O
p=	O
.	O
	
after	O
adjusting	O
for	O
biochemical	B-T169
injury	O
types	B-T080
,	O
black	O
race	O
and	O
possible	B-T033
ageing	O
effects	B-T080
,	O
more	O
severe	B-T080
interface	O
hepatitis	B-T047
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
50	O
years	O
p=	O
and	O
p=	O
respectively	O
.	O
	
compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	B-T081
plasma	B-T047
cell	I-T047
infiltration	I-T047
,	O
hepatocyte	O
apoptosis	O
,	O
hepatocyte	O
rosettes	B-T033
and	O
lobular	B-T080
disarray	O
but	O
less	O
iron	O
-	O
positive	B-T033
hepatocytes	O
and	O
histological	B-T169
cholestasis	B-T047
p<	O
.	O
	
these	O
associations	B-T080
persisted	O
after	O
excluding	O
cases	B-T169
of	O
amoxicillin/clavulanic	O
acid	O
,	O
anabolic	B-T109
steroids	I-T109
or	O
nitrofurantoin	B-T109
dili	B-T047
which	O
showed	O
gender	O
-specific	O
distributions	B-T169
.	O
	
gender	O
and	O
a	O
proxy	O
of	O
menopause	O
were	O
associated	B-T080
with	I-T080
various	O
features	B-T080
of	O
inflammation	O
and	O
injury	O
in	O
a	O
novel	O
potent	O
anticancer	B-T109
compound	I-T109
optimized	O
from	O
a	O
natural	B-T169
oridonin	B-T109
scaffold	O
induces	O
apoptosis	O
and	O
cell	O
cycle	O
arrest	O
through	O
the	O
mitochondrial	O
pathway	O
the	O
cytotoxicity	O
of	O
the	O
natural	B-T169
ent-kaurene	O
diterpenoid	O
,	O
oridonin	B-T109
,	O
has	O
been	O
extensively	O
studied	O
.	O
	
however	O
,	O
the	O
application	O
of	O
oridonin	B-T109
for	O
cancer	B-T061
therapy	I-T061
was	O
hampered	O
primarily	O
by	O
its	O
moderate	O
potency	O
.	O
	
in	O
this	O
study	O
,	O
a	O
series	O
of	O
oridonin	B-T109
a-ring	O
modified	O
analogues	O
,	O
and	O
their	O
derivatives	O
bearing	O
various	O
substituents	O
on	O
14-oh	O
position	O
,	O
were	O
designed	O
,	O
synthesized	O
,	O
and	O
evaluated	O
for	O
anticancer	B-T109
efficacy	B-T080
.	O
	
some	O
of	O
the	O
derivatives	O
were	O
significantly	O
more	O
potent	O
than	O
oridonin	B-T109
against	O
both	O
drug	O
-	O
sensitive	B-T169
and	O
drug-resistant	O
cancer	O
cells	O
.	O
	
the	O
most	O
potent	O
compound	B-T109
,	O
13p	I-T109
,	O
was	O
200-fold	B-T079
more	O
efficacious	B-T080
than	O
oridonin	B-T109
in	O
mcf-7	O
cancer	O
cells	O
.	O
	
furthermore	O
,	O
13p	B-T109
induced	O
apoptosis	O
and	O
cell	O
cycle	O
arrest	O
at	O
the	O
g2/m	O
phase	O
.	O
	
a	O
decrease	O
in	O
mitochondrial	O
membrane	O
potential	O
and	O
an	O
increase	O
in	O
bax/bcl-2	B-T116
ratio	O
,	O
accompanied	O
by	O
activated	B-T116
caspase-3	I-T116
cleavage	O
,	O
were	O
observed	O
in	O
mcf-7	O
cells	O
after	O
treatment	B-T061
with	O
13p	B-T109
,	O
suggesting	O
that	O
the	O
mitochondrial	O
pathway	O
was	O
involved	O
in	O
the	O
13p	B-T109
-mediated	O
apoptosis	O
.	O
	
moreover	O
,	O
13p	B-T109
significantly	O
inhibited	O
tumor	O
growth	O
in	O
mouse	O
xenograft	O
models	O
and	O
had	O
no	O
observable	O
toxic	O
effect	O
.	O
	
stromal	B-T033
alterations	I-T033
in	O
ovarian	O
cancers	O
via	O
wavelength	B-T081
dependent	B-T080
second	O
harmonic	O
generation	O
microscopy	O
and	O
optical	O
scattering	O
ovarian	O
cancer	O
remains	O
the	O
most	O
deadly	O
gynecological	O
cancer	O
with	O
a	O
poor	O
aggregate	O
survival	B-T081
rate	I-T081
however	O
,	O
the	O
specific	B-T081
rates	I-T081
are	O
highly	O
dependent	B-T080
on	O
the	O
stage	O
of	O
the	O
disease	B-T047
upon	O
diagnosis	B-T033
.	O
	
current	O
screening	O
and	O
imaging	O
tools	O
are	O
insufficient	O
to	O
detect	O
early	B-T033
lesions	I-T033
and	O
are	O
not	O
capable	O
of	O
differentiating	O
the	O
subtypes	O
of	O
ovarian	O
cancer	O
that	O
may	O
benefit	O
from	O
specific	O
treatments	B-T061
.	O
	
as	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	O
,	O
we	O
utilized	O
wavelength	B-T081
dependent	B-T080
collagen	B-T116
-specific	O
second	O
harmonic	O
generation	O
shg	O
imaging	O
microscopy	O
and	O
optical	O
scattering	O
measurements	O
to	O
probe	O
the	O
structural	B-T116
differences	B-T080
in	O
the	O
extracellular	O
matrix	O
ecm	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	O
,	O
endometrioid	O
tumors	O
,	O
and	O
low	O
and	O
high-grade	O
serous	O
tumors	O
.	O
	
the	O
shg	O
signatures	B-T169
of	O
the	O
emission	O
directionality	O
and	O
conversion	B-T169
efficiency	B-T081
as	O
well	O
as	O
the	O
optical	O
scattering	O
are	O
related	O
to	O
the	O
organization	B-T169
of	O
collagen	B-T116
on	O
the	O
sub-micron	B-T081
size	O
scale	O
and	O
encode	O
structural	B-T116
information	B-T078
.	O
	
the	O
wavelength	B-T081
dependence	B-T080
of	O
these	O
readouts	O
adds	O
additional	O
characterization	O
of	O
the	O
size	O
and	O
distribution	B-T169
of	O
collagen	O
fibrils	O
/	O
fibers	O
relative	O
to	O
the	O
interrogating	O
wavelengths	B-T081
.	O
	
we	O
found	O
a	O
strong	O
wavelength	B-T081
dependence	B-T080
of	O
these	O
metrics	O
that	O
are	O
related	O
to	O
significant	O
structural	B-T116
differences	B-T080
in	O
the	O
collagen	B-T116
organization	B-T169
and	O
are	O
consistent	O
with	O
the	O
dualistic	O
classification	O
of	O
type	O
i	O
and	O
ii	O
serous	O
tumors	O
.	O
	
moreover	O
,	O
type	O
i	O
endometrioid	O
tumors	O
have	O
strongly	O
differing	O
ecm	O
architecture	O
than	O
the	O
serous	O
malignancies	O
.	O
	
the	O
shg	O
metrics	O
and	O
optical	O
scattering	O
measurements	O
were	O
used	O
to	O
form	O
a	O
linear	O
discriminant	O
model	O
to	O
classify	O
the	O
tissues	O
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
>90%	O
between	O
high-grade	O
serous	O
tumors	O
from	O
the	O
other	O
tissue	O
types	O
.	O
	
high-grade	O
serous	O
tumors	O
account	O
for	O
70%	O
of	O
ovarian	O
cancers	O
,	O
and	O
this	O
delineation	O
has	O
potential	O
clinical	O
applications	O
in	O
terms	O
of	O
supplementing	O
histological	O
analysis	O
,	O
understanding	O
the	O
etiology	B-T169
,	O
as	O
well	O
as	O
development	O
of	O
an	O
in	O
vivo	O
screening	O
tool	O
.	O
	
shg	O
and	O
optical	O
scattering	O
measurements	O
provide	O
sub-resolution	O
information	B-T078
and	O
when	O
combined	O
provide	O
superior	O
diagnostic	O
power	O
over	O
clinical	O
imaging	O
modalities	B-T169
.	O
	
additionally	O
the	O
measurements	B-T169
are	O
able	O
to	O
delineate	O
the	O
different	O
subtypes	O
of	O
ovarian	O
cancer	O
and	O
may	O
potentially	O
assist	O
in	O
treatment	B-T061
protocols	I-T061
.	O
	
understanding	O
the	O
altered	B-T078
collagen	B-T116
assembly	O
can	O
supplement	O
histological	O
analysis	O
and	O
provide	O
new	O
insight	O
into	O
the	O
etiology	B-T169
.	O
	
these	O
methods	O
could	O
become	O
an	O
in	O
vivo	O
screening	O
tool	O
for	O
earlier	O
detection	O
which	O
is	O
important	O
since	O
ovarian	O
malignancies	O
can	O
metastasize	O
while	O
undetectable	O
by	O
current	O
clinical	O
imaging	O
the	O
role	O
of	O
metal-on-metal	O
bearings	O
in	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
and	O
hip	B-T061
resurfacing	I-T061
review	O
article	O
the	O
current	O
role	O
of	O
metal-on-metal	O
mom	O
bearings	O
in	O
hip	B-T061
arthroplasty	I-T061
remains	O
controversial	O
.	O
	
the	O
low	O
wear	O
offered	O
by	O
mom	O
bearings	O
compared	O
to	O
metal-on-polyethylene	O
and	O
the	O
possibility	O
of	O
a	O
lower	B-T081
risk	I-T081
of	I-T081
dislocation	O
with	O
larger	B-T080
head	I-T080
sizes	I-T080
,	O
encouraged	O
a	O
trend	B-T079
towards	O
the	O
re-introduction	B-T061
of	O
the	O
mom	O
bearing	O
couple	O
.	O
	
however	O
,	O
recent	O
evidence	B-T078
has	O
shown	O
that	O
not	O
all	O
designs	O
of	O
the	O
mom	O
bearing	O
have	O
been	O
successful	B-T080
.	O
	
the	O
purpose	O
of	O
this	O
paper	O
is	O
to	O
provide	O
an	O
update	O
on	O
the	O
use	O
of	O
mom	O
bearings	O
and	O
address	O
the	O
following	O
issues	O
1	O
the	O
reintroduction	B-T061
of	O
metal-on-metal	O
bearings	O
in	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
,	O
2	O
the	O
failure	O
of	O
metal-on-metal	O
bearings	O
in	O
stemmed	B-T061
total	I-T061
hip	I-T061
arthroplasty	I-T061
,	O
3	O
the	O
role	O
of	O
metal-on-metal	B-T061
hip	I-T061
resurfacing	I-T061
in	O
modern	O
orthopaedics	O
and	O
4	O
metal-on-metal	B-T061
hip	I-T061
resurfacing	I-T061
versus	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
.	O
	
a	O
literature	O
search	O
strategy	O
was	O
conducted	O
using	O
various	O
search	O
terms	O
in	O
medline	O
and	O
embase	O
.	O
	
the	O
highest	O
quality	O
articles	O
that	O
met	O
the	O
inclusion	B-T080
criteria	I-T080
and	O
best	O
answered	O
the	O
topics	O
of	O
focus	O
of	O
this	O
review	O
were	O
selected	O
.	O
	
key	O
search	O
terms	O
included	O
'	O
metal-on-metal	O
'	O
,	O
'	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
'	O
and	O
'	O
hip	B-T061
resurfacing	I-T061
'	O
.	O
	
the	O
initial	O
search	O
retrieved	O
1240	O
articles	O
.	O
	
twenty-two	O
articles	O
were	O
selected	O
and	O
used	O
in	O
the	O
review	O
.	O
	
metal-on-metal	O
hip	O
resurfacing	O
is	O
still	O
a	O
suitable	O
treatment	B-T061
option	O
in	O
specific	B-T080
patient	B-T081
populations	I-T081
with	O
the	O
appropriate	B-T080
implant	B-T061
design	I-T061
and	O
surgical	O
skill	O
,	O
while	O
stemmed	O
metal-on-metal	O
total	O
hip	O
arthroplasty	O
should	O
be	O
avoided	O
in	O
all	B-T081
patient	I-T081
populations	I-T081
.	O
	
continued	O
follow-up	O
of	O
patients	O
undergoing	O
metal-on-metal	B-T061
hip	I-T061
resurfacing	I-T061
is	O
critical	B-T080
in	O
order	O
to	O
further	O
understand	O
the	O
long-term	B-T079
outcomes	B-T080
of	O
these	O
patients	O
and	O
why	O
certain	O
complications	O
morphogenetic	O
alterations	B-T078
of	O
alternaria	O
alternata	O
exposed	B-T080
to	I-T080
dicarboximide	O
fungicide	O
,	O
iprodione	B-T109
fungicide-resistant	B-T169
alternaria	O
alternata	O
impede	O
the	O
practical	O
control	B-T169
of	O
the	O
alternaria	B-T047
diseases	I-T047
in	O
crop	O
fields	O
.	O
	
this	O
study	O
aimed	O
to	O
investigate	B-T169
cytological	B-T169
fungicide	O
resistance	O
mechanisms	B-T169
of	O
a	O
.	O
	
alternata	O
against	O
dicarboximide	O
fungicide	O
iprodione	B-T109
.	O
	
a	O
.	O
	
alternata	O
isolated	B-T169
from	O
cactus	O
brown	O
spot	O
was	O
cultured	O
on	O
potato-dextrose	O
agar	O
pda	O
with	O
or	O
without	B-T080
iprodione	B-T109
,	O
and	O
the	O
fungal	O
cultures	O
with	O
different	B-T080
growth	O
characteristics	B-T080
from	O
no	O
,	O
initial	B-T079
and	O
full	B-T080
growth	O
were	O
observed	B-T169
by	O
light	O
and	O
electron	O
microscopy	O
.	O
	
mycelia	O
began	O
to	O
grow	O
from	O
one	B-T079
day	I-T079
after	I-T079
incubation	I-T079
dai	B-T079
and	O
continued	B-T078
to	O
be	O
in	O
full	B-T080
growth	O
control-growth	O
,	O
con-g	O
on	O
pda	O
without	O
fungicide	O
,	O
while	O
on	O
pda	O
with	O
iprodione	B-T109
,	O
no	O
fungal	O
growth	O
iprodione-no	O
growth	O
,	O
ipr-n	O
occurred	O
for	O
the	O
first	O
3	O
dai	B-T079
,	O
but	O
once	O
the	O
initial	B-T079
growth	O
iprodione-initial	O
growth	O
,	O
ipr-i	O
began	O
at	O
4-5	O
dai	B-T079
,	O
the	O
colonies	O
grew	O
and	O
expanded	O
continuously	B-T078
to	O
be	O
in	O
full	B-T080
growth	O
iprodione-growth	O
,	O
ipr-g	O
,	O
suggesting	O
ipr-i	O
may	O
be	O
a	O
turning	O
moment	O
of	O
the	O
morphogenetic	O
changes	B-T169
resisting	O
fungicidal	O
toxicity	B-T080
.	O
	
con-g	O
formed	O
multicellular	O
conidia	O
with	O
cell	O
walls	O
and	O
septa	O
and	O
intact	B-T080
dense	B-T080
cytoplasm	O
.	O
	
in	O
ipr-n	O
,	O
fungal	O
sporulation	O
was	O
inhibited	B-T080
by	O
forming	O
mostly	O
undeveloped	B-T033
unicellular	O
conidia	O
with	O
degraded	B-T033
and	O
necrotic	O
cytoplasm	O
.	O
	
however	O
,	O
in	O
ipr-i	O
,	O
conspicuous	O
cellular	O
changes	O
occurred	O
during	O
sporulation	O
by	O
forming	O
multicellular	O
conidia	O
with	O
double	B-T033
layered	I-T033
thickened	B-T033
cell	O
walls	O
and	O
accumulation	B-T033
of	O
proliferated	B-T169
lipid	O
bodies	O
in	O
the	O
conidial	O
cytoplasm	O
,	O
which	O
may	O
inhibit	B-T080
the	O
penetration	B-T169
of	O
the	O
fungicide	O
into	O
conidial	O
cells	O
,	O
reducing	O
fungicide	O
-	O
associated	B-T080
toxicity	B-T080
,	O
and	O
may	O
be	O
utilized	O
as	O
energy	B-T081
and	O
nutritional	B-T080
sources	B-T033
,	O
respectively	O
,	O
for	O
the	O
further	O
fungal	O
growth	O
to	O
form	O
mature	B-T079
colonies	O
as	O
in	O
ipr-g	O
that	O
formed	O
multicellular	O
conidia	O
with	O
cell	O
walls	O
and	O
intact	B-T080
cytoplasm	O
with	O
lipid	O
bodies	O
as	O
in	O
limits	O
of	O
the	O
possible	O
diagnostic	B-T078
image	I-T078
quality	B-T080
in	O
coronary	O
angiography	O
with	O
third-generation	O
dual-source	O
ct	O
the	O
usage	B-T169
of	O
coronary	O
ct	O
angiography	O
cta	O
is	O
appropriate	O
in	O
patients	O
with	O
acute	O
or	O
chronic	O
chest	O
pain	O
however	O
the	O
diagnostic	B-T080
accuracy	I-T080
may	O
be	O
challenged	O
with	O
increased	O
agatston	B-T081
score	I-T081
as	B-T081
,	O
increased	O
heart	O
rate	O
,	O
arrhythmia	B-T033
and	O
severe	B-T047
obesity	I-T047
.	O
	
thus	O
,	O
we	O
aim	O
to	O
determine	O
the	O
potential	O
of	O
the	O
recently	O
introduced	O
third-generation	O
dual-source	O
ct	O
dsct	O
for	O
cta	O
in	O
a	O
'real-life'	O
clinical	O
setting	O
.	O
	
two	O
hundred	O
and	O
sixty-eight	O
consecutive	O
patients	O
age	O
67	O
10	O
years	O
bmi	O
27	O
5	O
kg/m²	O
61%	O
male	O
undergoing	O
clinically	O
indicated	O
cta	O
with	O
dsct	O
were	O
included	O
in	O
the	O
retrospective	O
single-center	O
analysis	O
.	O
	
a	O
contrast-enhanced	O
volume	O
dataset	O
was	O
acquired	O
in	O
sequential	O
ssm	O
n	O
=	O
151	O
or	O
helical	O
scan	O
mode	O
hsm	O
n	O
=	O
117	O
.	O
	
coronary	O
segments	O
were	O
classified	O
in	O
diagnostic	B-T080
or	O
non-diagnostic	B-T080
image	I-T080
quality	I-T080
.	O
	
a	O
subset	O
underwent	O
invasive	O
angiography	O
to	O
determine	O
the	O
diagnostic	B-T080
accuracy	I-T080
of	O
cta	O
.	O
	
ssm	O
96.8	O
6%	O
and	O
hsm	O
97.5	O
8%	O
provided	O
no	O
significant	O
differences	O
in	O
the	O
overall	O
diagnostic	B-T078
image	I-T078
quality	B-T080
.	O
	
however	O
,	O
as	B-T081
had	O
significant	O
influence	O
on	O
diagnostic	B-T078
image	I-T078
quality	B-T080
exclusively	O
in	O
ssm	O
b	O
=	O
0.003	O
p	O
=	O
0.0001	O
,	O
but	O
not	O
in	O
hsm	O
.	O
	
diagnostic	B-T078
image	I-T078
quality	B-T080
significantly	O
decreased	O
in	O
ssm	O
in	O
patients	O
with	O
as	B-T081
2	O
p	O
=	O
0.03	O
.	O
	
ssm	O
sensitivity	B-T081
93.9	O
specificity	B-T081
96.7	O
ppv	B-T081
88.6	O
npv	B-T081
98.3	O
and	O
hsm	O
sensitivity	B-T081
97.4	O
specificity	B-T081
94.3	O
ppv	B-T081
86.0	O
npv	B-T081
99.0	O
provided	O
comparable	O
diagnostic	B-T080
accuracy	I-T080
p	O
=	O
n.s	O
.	O
	
ssm	O
yielded	O
significantly	O
lower	O
radiation	B-T081
doses	I-T081
as	O
compared	O
to	O
hsm	O
2.1	O
2.0	O
vs	O
.	O
	
5.1	O
3.3	O
msv	O
p	O
=	O
0.0001	O
in	O
age	O
and	O
bmi	O
-matched	O
cohorts	O
.	O
	
ssm	O
in	O
third-generation	O
dsct	O
enables	O
significant	O
dose	B-T081
savings	O
and	O
provides	O
robust	O
diagnostic	B-T078
image	I-T078
quality	B-T080
in	O
patients	O
with	O
as	B-T081
2000	O
independent	O
of	O
heart	O
rate	O
,	O
heart	O
rhythm	O
or	O
antagonistic	O
self-organizing	O
patterning	O
systems	O
control	B-T169
maintenance	O
and	O
regeneration	O
of	O
the	O
anteroposterior	O
axis	O
in	O
planarians	O
planarian	O
flatworms	O
maintain	O
their	O
body	O
plan	O
in	O
the	O
face	O
of	O
constant	O
internal	O
turnover	O
and	O
can	O
regenerate	B-T169
from	O
arbitrary	B-T080
tissue	O
fragments	O
.	O
	
both	O
phenomena	O
require	O
self-maintaining	O
and	O
self-organizing	O
patterning	O
mechanisms	B-T169
,	O
the	O
molecular	B-T080
mechanisms	B-T169
of	O
which	O
remain	O
poorly	O
understood	O
.	O
	
we	O
show	O
that	O
a	O
morphogenic	O
gradient	B-T081
of	O
canonical	O
wnt	O
signaling	O
patterns	O
gene	O
expression	O
along	O
the	O
planarian	O
anteroposterior	O
a/p	O
axis	O
.	O
	
our	O
results	B-T033
demonstrate	O
that	O
gradient	B-T081
formation	B-T169
likely	O
occurs	O
autonomously	B-T169
in	O
the	O
tail	O
and	O
that	O
an	O
autoregulatory	O
module	O
of	O
wnt	B-T116
-mediated	O
wnt	O
expression	O
both	O
shapes	O
the	O
gradient	B-T081
at	O
steady	O
state	O
and	O
governs	O
its	O
re-establishment	O
during	O
regeneration	O
.	O
	
functional	B-T169
antagonism	O
between	O
the	O
tail	O
wnt	B-T116
gradient	B-T081
and	O
an	O
unknown	B-T080
head	O
patterning	O
system	O
further	O
determines	O
the	O
spatial	O
proportions	B-T081
of	O
the	O
planarian	O
a/p	O
axis	O
and	O
mediates	O
mutually	B-T080
exclusive	B-T078
molecular	O
fate	O
choices	O
during	B-T079
regeneration	O
.	O
	
overall	O
,	O
our	O
results	B-T033
suggest	O
that	O
the	O
planarian	O
a/p	O
axis	O
is	O
patterned	O
by	O
self-organizing	O
patterning	O
systems	O
deployed	O
from	O
either	O
end	O
that	O
are	O
functionally	B-T169
coupled	B-T169
by	O
mutual	B-T080
antagonism	O
.	O
	
characterization	O
and	O
ectopic	O
expression	O
of	O
cowri1	O
,	O
an	O
ap2/erebp	O
domain-containing	O
transcription	B-T116
factor	I-T116
from	O
coconut	O
cocos	O
nucifera	O
l	O
endosperm	O
,	O
changes	O
the	O
seeds	O
oil	B-T109
content	O
in	O
transgenic	O
arabidopsis	O
thaliana	O
and	O
rice	O
oryza	O
sativa	O
l	O
coconut	O
cocos	O
nucifera	O
l	O
is	O
a	O
key	O
tropical	O
crop	O
and	O
a	O
member	O
of	O
the	O
monocotyledonous	O
family	O
arecaceae	O
palmaceae	O
.	O
	
few	O
genes	O
and	O
related	O
metabolic	O
processes	O
involved	O
in	O
coconut	O
endosperm	O
development	O
have	O
been	O
investigated	B-T169
.	O
	
in	O
this	O
study	O
,	O
a	O
new	O
member	O
of	O
the	O
wri1	O
gene	O
family	O
was	O
isolated	O
from	O
coconut	O
endosperm	O
and	O
was	O
named	O
cowri1	O
.	O
	
its	O
transcriptional	O
activities	O
and	O
interactions	B-T169
with	O
the	O
acetyl-coa	B-T116
carboxylase	I-T116
bccp2	B-T116
promoter	O
of	O
cowri1	O
were	O
confirmed	O
by	O
the	O
yeast	O
two-hybrid	O
and	O
yeast	O
one-hybrid	O
approaches	O
,	O
respectively	O
.	O
	
functional	O
characterization	O
was	O
carried	O
out	O
through	O
seed	O
-specific	O
expression	O
in	O
arabidopsis	O
and	O
endosperm	O
-specific	O
expression	O
in	O
rice	O
.	O
	
in	O
transgenic	O
arabidopsis	O
,	O
high	O
over-expressions	O
of	O
cowri1	O
in	O
seven	O
independent	O
t2	O
lines	O
were	O
detected	O
by	O
quantitative	O
real-time	O
pcr	O
.	O
	
the	O
relative	O
mrna	O
accumulation	O
of	O
genes	O
encoding	O
enzymes	B-T116
involved	O
in	O
either	O
fatty	O
acid	O
biosynthesis	O
or	O
triacylglycerols	B-T109
assembly	O
bccp2	O
,	O
kasi	O
,	O
mat	O
,	O
enr	O
,	O
fata	O
,	O
and	O
gpdh	O
were	O
also	O
assayed	O
in	O
mature	O
seeds	O
.	O
	
furthermore	O
,	O
lipid	B-T109
and	O
fatty	B-T109
acids	I-T109
c16	B-T109
and	O
c18	B-T109
significantly	O
increased	O
.	O
	
in	O
two	O
homozygous	O
t2	O
transgenic	O
rice	O
lines	O
g5	O
and	O
g2	O
,	O
different	O
cowri1	O
expression	O
levels	O
were	O
detected	O
,	O
but	O
no	O
cowri1	O
transcripts	O
were	O
detected	O
in	O
the	O
wild	O
type	O
.	O
	
analyses	O
of	O
the	O
seed	O
oil	B-T109
content	O
,	O
starch	B-T109
content	O
,	O
and	O
total	O
protein	B-T116
content	O
indicated	O
that	O
the	O
two	O
t2	O
transgenic	O
lines	O
showed	O
a	O
significant	O
increase	O
p	O
<	O
0.05	O
in	O
seed	O
oil	B-T109
content	O
.	O
	
the	O
transgenic	O
lines	O
also	O
showed	O
a	O
significant	O
increase	O
in	O
starch	B-T109
content	O
,	O
whereas	O
total	O
protein	B-T116
content	O
decreased	O
significantly	O
.	O
	
further	O
analysis	O
of	O
the	O
fatty	B-T109
acid	I-T109
composition	O
revealed	O
that	O
palmitic	B-T109
acid	I-T109
c16	B-T109
and	O
linolenic	B-T109
acid	I-T109
c18	B-T109
increased	O
significantly	O
in	O
the	O
seeds	O
of	O
the	O
transgenic	O
rice	O
lines	O
,	O
but	O
oleic	B-T109
acid	I-T109
c18	B-T109
tooth	B-T033
discoloration	I-T033
resulting	B-T169
from	O
a	O
nano	B-T081
zinc	O
oxide-eugenol	O
sealer	O
a	O
desirable	O
quality	B-T080
of	O
any	O
endodontic	O
sealer	O
is	O
its	O
ability	O
to	O
be	O
tooth	B-T033
color	I-T033
friendly	B-T080
.	O
	
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
tooth	B-T033
discoloration	I-T033
potential	B-T080
of	O
a	O
nano	B-T081
zinc	O
oxide-eugenol	O
nzoe	O
sealer	O
.	O
	
in	O
order	O
to	O
evaluate	O
tooth	B-T033
discoloration	I-T033
,	O
the	O
pulp	O
chamber	O
of	O
60	O
human	O
maxillary	O
central	O
and	O
lateral	O
incisors	O
were	O
filled	O
with	O
one	O
of	O
the	O
sealers	O
,	O
naming	O
ah-26	O
resin-based	O
sealer	O
,	O
pulpdent	O
sealer	O
zoe	O
-based	O
and	O
a	O
nzoe	O
experimental	O
sealer	O
.	O
	
color	B-T080
measurements	B-T169
was	O
assessed	O
at	O
the	O
baseline	B-T081
before	B-T080
placement	I-T080
of	O
sealers	O
t0	O
,	O
24	O
h	B-T079
t1	O
and	O
72	O
h	B-T079
t2	O
h	B-T079
,	O
1-	O
week	B-T079
t3	O
,	O
and	O
1-	O
month	B-T079
t4	O
after	O
the	O
placement	O
of	O
sealers	O
using	O
the	O
easy	O
shade	O
spectrophotometer	O
.	O
	
data	B-T078
were	O
analyzed	O
in	O
spss	O
software	O
using	O
one-way	B-T081
anova	I-T081
,	O
and	O
repeated	O
measured	O
anova	B-T081
.	O
	
no	O
significant	O
differences	O
were	O
observed	B-T169
when	O
the	O
paired	O
comparison	O
test	O
was	O
performed	O
p>0	O
.	O
	
the	O
tested	O
nzoe	O
sealer	O
had	O
similar	O
tooth	B-T033
discoloration	I-T033
potential	B-T080
in	O
comparison	O
with	O
ah-26	O
and	O
zoe	O
sealer	O
.	O
	
on	O
the	O
identity	B-T078
of	O
the	O
palearctic	O
species	O
of	O
the	O
wolf	O
spider	O
genus	O
<i>	O
trebacosa	O
</i>	O
lycosidae	O
in	O
this	O
paper	O
we	O
propose	O
trebacosa	O
brunhesi	O
villepoux	O
,	O
2007	O
as	O
a	O
junior	O
synonym	O
of	O
trebacosa	O
europaea	O
szinetár	O
kan-csal	O
,	O
2007	O
based	O
on	O
the	O
examination	O
of	O
specimens	O
from	O
all	O
the	O
localities	O
from	O
where	O
those	O
species	O
are	O
known	O
.	O
	
illustration	O
of	O
the	O
type	O
species	O
of	O
the	O
genus	O
,	O
trebacosa	O
marxi	O
stone	O
,	O
1890	O
and	O
specimens	O
from	O
all	O
known	O
localities	O
of	O
t	O
.	O
	
europaea	O
are	O
given	O
to	O
show	O
both	O
the	O
inter-	O
and	O
the	O
intraspecific	O
differences	O
of	O
the	O
genus	O
.	O
	
scanning	O
electron	O
micrographs	O
were	O
used	O
to	O
illustrate	O
the	O
detailed	O
structure	O
of	O
the	O
female's	O
genitalia	O
a	O
numerical	B-T081
study	O
on	O
the	O
application	O
of	O
the	O
functionally	O
graded	O
materials	O
in	O
the	O
stent	O
design	O
undesirable	B-T080
deformation	B-T080
of	O
the	O
stent	O
can	O
induce	O
a	O
significant	O
amount	O
of	O
injure	O
not	O
only	O
to	O
the	O
blood	O
vessel	O
but	O
also	O
to	O
the	O
plaque	B-T033
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
reduce/minimize	B-T033
these	O
undesirable	B-T080
deformations	B-T080
by	O
the	O
application	O
of	O
functionally	O
graded	O
materials	O
fgm	O
.	O
	
to	O
do	O
this	O
,	O
finite	O
element	O
fe	O
method	O
was	O
employed	B-T033
to	O
simulate	O
the	O
expansion	B-T169
of	O
a	O
stent	O
and	O
the	O
corresponding	O
displacement	O
of	O
the	O
stenosis	O
plaque	B-T033
.	O
	
three	O
hyperelastic	O
plaque	B-T033
types	O
as	O
well	O
as	O
five	O
elastoplastic	O
stents	O
were	O
simulated	O
.	O
	
dogboning	B-T169
,	O
foreshortening	B-T033
,	O
maximum	B-T081
stress	B-T033
in	O
the	O
plaque	B-T033
,	O
and	O
the	O
pressure	O
which	O
is	O
needed	O
to	O
fully	O
expand	O
the	O
stent	O
for	O
different	O
stent	O
materials	O
,	O
were	O
acquired	O
.	O
	
while	O
all	O
fgms	O
had	O
lower	B-T080
dogboning	B-T169
in	O
comparison	O
to	O
the	O
stents	O
made	O
of	O
the	O
uniform	B-T080
materials	O
,	O
the	O
stent	O
with	O
the	O
lowest	B-T080
heterogeneous	O
index	O
displayed	O
the	O
lowest	B-T080
amount	O
of	O
dogboning	B-T169
.	O
	
steel	O
stent	O
showed	O
the	O
lowest	B-T080
foreshortening	B-T033
and	O
fully	O
expansion	B-T081
pressure	I-T081
but	O
the	O
difference	B-T081
was	O
much	O
lower	B-T080
than	O
that	O
the	O
one	O
for	O
dogboning	B-T169
.	O
	
therefore	O
,	O
the	O
fgm	O
with	O
the	O
heterogeneous	O
index	O
of	O
0.5	O
is	O
expected	O
to	O
exhibit	O
the	O
most	O
suitable	B-T080
results	B-T169
.	O
	
in	O
addition	O
,	O
the	O
results	B-T169
revealed	O
that	O
the	O
material	O
parameters	O
has	O
crucial	B-T080
effects	B-T080
on	O
the	O
deformation	B-T080
of	O
the	O
stent	O
and	O
,	O
as	O
a	O
result	B-T169
,	O
as	O
a	O
design	O
point	O
of	O
view	O
the	O
fgm	O
parameters	O
can	O
be	O
tailored	O
to	O
achieve	O
the	O
goal	O
of	O
the	O
biomechanical	B-T081
optimization	O
.	O
	
women's	O
perspectives	O
on	O
human	O
papillomavirus	O
self-sampling	O
in	O
the	O
context	O
of	O
the	O
uk	O
cervical	O
screening	O
programme	O
testing	B-T169
for	O
human	O
papillomavirus	O
hpv	O
is	O
being	O
incorporated	O
into	O
the	O
cervical	O
screening	O
programme	O
,	O
with	O
the	O
probable	O
future	O
introduction	O
of	O
hpv	O
as	O
a	O
primary	O
test	O
and	O
a	O
possibility	O
of	O
hpv	O
self-sampling	O
.	O
	
in	O
anticipation	O
of	O
this	O
development	O
,	O
we	O
sought	O
to	O
inform	O
future	O
policy	O
and	O
practice	O
by	O
identifying	O
potential	B-T080
barriers	B-T033
to	O
hpv	O
self-sampling	O
.	O
	
a	O
cross-sectional	O
survey	O
of	O
194	O
women	O
aged	O
20-64	O
years	O
was	O
conducted	O
.	O
	
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
identify	O
determinants	B-T169
of	O
self-sampling	O
intentions	O
.	O
	
a	O
purposive	O
subsample	O
of	O
19	O
women	O
who	O
reported	O
low	O
self-sampling	O
intentions	O
were	O
interviewed	O
.	O
	
interviews	O
were	O
framework-analysed	O
.	O
	
most	O
survey	O
participants	O
n=133	O
,	O
69.3	O
intended	O
to	O
hpv	O
self-sample	O
.	O
	
lower	B-T080
intention	O
was	O
associated	B-T080
with	I-T080
lower	B-T080
self-efficacy	O
or=24	O
,	O
p	O
,	O
lower	B-T080
education	O
or=6	O
,	O
p	O
and	O
lower	B-T080
perceived	O
importance	O
of	O
hpv	O
as	O
a	O
cause	O
of	O
cervical	O
cancer	O
or=2	O
,	O
p	O
.	O
	
interviews	O
revealed	O
personal	O
and	O
system-related	O
barriers	B-T033
.	O
	
personal	O
barriers	B-T033
included	O
a	O
lack	O
of	O
knowledge	O
about	O
hpv	O
self-sampling	O
,	O
women's	O
low	B-T033
confidence	I-T033
in	O
their	O
ability	O
to	O
self-sample	O
correctly	O
and	O
low	B-T033
confidence	I-T033
in	O
the	O
subsequent	O
results	O
.	O
	
system-related	O
factors	O
included	O
a	O
lack	B-T033
of	I-T033
confidence	I-T033
in	O
the	O
rationale	O
for	O
modifying	O
the	O
current	O
cervical	O
screening	O
programme	O
,	O
and	O
concerns	O
about	O
sample	O
contamination	B-T078
and	O
identity	O
theft	O
.	O
	
insights	O
gained	O
from	O
this	O
research	O
can	O
be	O
used	O
to	O
guide	O
further	O
enquiry	O
into	O
the	O
possibility	O
of	O
hpv	O
self-sampling	O
and	O
to	O
help	O
inform	O
future	O
policy	O
and	O
practice	O
.	O
	
personal	O
and	O
system-related	B-T033
barriers	I-T033
including	O
low	B-T033
confidence	I-T033
in	O
the	O
reasons	O
for	O
changing	O
current	O
cervical	O
screening	O
provision	O
need	O
to	O
be	O
addressed	O
,	O
should	O
hpv	O
self-sampling	O
be	O
incorporated	O
into	O
the	O
cervical	O
screening	O
programme	O
.	O
	
n-terminal	O
hypothesis	B-T078
for	O
alzheimer's	B-T047
disease	I-T047
although	O
the	O
amyloid	B-T116
abeta	B-T116
peptide	I-T116
,	O
aβ	B-T116
hypothesis	B-T078
is	O
25	O
years	B-T079
old	O
,	O
is	O
the	O
dominant	B-T169
model	O
of	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
pathogenesis	O
,	O
and	O
guides	O
the	O
development	B-T169
of	O
potential	O
treatments	B-T061
,	O
it	O
is	O
still	O
controversial	O
.	O
	
one	O
possible	O
reason	O
is	O
a	O
lack	B-T080
of	O
a	O
mechanistic	B-T169
path	I-T169
from	O
the	O
cleavage	O
products	O
of	O
the	O
amyloid	B-T116
precursor	I-T116
protein	I-T116
app	B-T116
such	O
as	O
soluble	B-T080
aβ	B-T116
monomer	I-T116
and	O
soluble	O
molecular	B-T080
fragments	B-T169
to	O
the	O
deleterious	B-T080
effects	I-T080
on	O
synaptic	O
form	O
and	O
function	B-T169
.	O
	
from	O
a	O
review	B-T169
of	I-T169
the	O
recent	O
literature	O
and	O
our	O
own	O
published	O
work	O
including	O
aggregation	O
kinetics	O
and	O
structural	O
morphology	B-T080
,	O
aβ	B-T116
clearance	B-T080
,	O
molecular	B-T080
simulations	O
,	O
long-term	O
potentiation	O
measurements	B-T169
with	O
inhibition	O
binding	O
,	O
and	O
the	O
binding	O
of	O
a	O
commercial	O
monoclonal	B-T116
antibody	I-T116
,	O
aducanumab	O
,	O
we	O
hypothesize	B-T078
that	O
the	O
n-terminal	O
domains	O
of	O
neurotoxic	O
aβ	B-T116
oligomers	I-T116
are	O
implicated	O
in	O
causing	B-T169
the	O
generation	O
of	O
high-quality	B-T080
swath	O
acquisition	O
data	B-T078
for	O
label-free	B-T033
quantitative	B-T081
proteomics	O
studies	O
using	O
tripletof	O
mass	O
spectrometers	O
data	B-T078
-	O
independent	B-T169
acquisition	O
is	O
a	O
powerful	O
mass	O
spectrometry	O
technique	O
that	O
enables	O
comprehensive	O
ms	O
and	O
ms/ms	O
analysis	O
of	O
all	O
detectable	O
species	O
,	O
providing	O
an	O
information	B-T078
rich	O
data	B-T078
file	O
that	O
can	O
be	O
mined	O
deeply	O
.	O
	
here	O
,	O
we	O
describe	O
how	O
to	O
acquire	O
high-quality	B-T080
swath	O
acquisition	O
data	B-T078
to	O
be	O
used	O
for	O
large	B-T081
quantitative	B-T081
proteomic	O
studies	O
.	O
	
we	O
specifically	O
focus	O
on	O
using	O
variable	B-T080
sized	O
q1	O
windows	O
for	O
acquisition	O
of	O
ms/ms	O
data	B-T078
for	O
generating	O
higher	O
specificity	B-T081
quantitative	B-T081
data	B-T078
.	O
	
a	O
new	O
light	O
on	O
alkaptonuria	B-T047
a	O
fourier-transform	O
infrared	O
microscopy	O
ftirm	O
and	O
low	O
energy	O
x-ray	O
fluorescence	O
microscopy	O
lexrf	O
correlative	O
study	O
on	O
a	O
rare	B-T047
disease	I-T047
alkaptonuria	B-T047
aku	B-T047
is	O
an	O
ultra-rare	B-T047
disease	I-T047
associated	B-T080
to	O
the	O
lack	B-T080
of	O
an	O
enzyme	B-T116
involved	O
in	O
tyrosine	O
catabolism	O
.	O
	
this	O
deficiency	B-T169
results	O
in	O
the	O
accumulation	B-T033
of	O
homogentisic	B-T109
acid	I-T109
hga	B-T109
in	O
the	O
form	O
of	O
ochronotic	O
pigment	O
in	O
joint	O
cartilage	O
,	O
leading	O
to	O
a	O
severe	B-T080
arthropathy	B-T047
.	O
	
secondary	B-T047
amyloidosis	I-T047
has	O
been	O
also	O
unequivocally	B-T080
assessed	O
as	O
a	O
comorbidity	B-T078
of	O
aku	B-T047
arthropathy	B-T047
.	O
	
composition	O
of	O
ochronotic	O
pigment	O
and	O
how	O
it	O
is	O
structurally	O
related	O
to	O
amyloid	B-T116
is	O
still	O
unknown	O
.	O
	
we	O
exploited	O
synchrotron	O
radiation	O
infrared	O
and	O
x-ray	O
fluorescence	O
microscopies	O
in	O
combination	O
with	O
conventional	O
bio-assays	O
and	O
analytical	O
tools	O
to	O
characterize	O
chemical	O
composition	O
and	O
morphology	B-T080
of	O
aku	B-T047
cartilage	O
.	O
	
we	O
evinced	B-T169
that	O
aku	B-T047
cartilage	O
is	O
characterized	O
by	O
proteoglycans	B-T116
depletion	B-T169
,	O
increased	B-T033
sodium	I-T033
levels	I-T033
,	O
accumulation	B-T033
of	O
lipids	B-T109
in	O
the	O
peri-lacunar	O
regions	O
and	O
amyloid	B-T116
formation	B-T169
.	O
	
we	O
also	O
highlighted	O
an	O
increase	B-T169
of	O
aromatic	B-T109
compounds	I-T109
and	O
oxygen-containing	O
species	O
,	O
depletion	B-T169
in	O
overall	O
magnesium	O
content	B-T081
although	O
localized	O
in	O
the	O
peri-lacunar	O
region	O
and	O
the	O
presence	B-T033
of	O
calcium	O
carbonate	O
fragments	O
in	O
proximity	O
of	O
cartilage	O
lacunae	O
.	O
	
we	O
highlighted	O
common	B-T081
features	O
between	O
aku	B-T047
and	O
arthropathy	B-T047
,	O
but	O
also	O
specific	O
signatures	O
of	O
the	O
disease	B-T047
,	O
like	O
presence	B-T033
of	O
amyloids	B-T116
and	O
peculiar	B-T033
calcifications	O
.	O
	
our	O
analyses	O
provide	O
a	O
unified	O
picture	O
of	O
aku	B-T047
cartilage	O
,	O
shedding	O
a	O
new	O
light	O
on	O
the	O
disease	B-T047
and	O
opening	O
new	B-T080
perspectives	O
.	O
	
ochronotic	O
pigment	O
is	O
a	O
hallmark	O
of	O
aku	B-T047
and	O
responsible	O
of	O
tissue	O
degeneration	O
.	O
	
conventional	O
bio-assays	O
have	O
not	O
yet	O
clarified	O
its	O
composition	O
and	O
its	O
structural	O
relationship	B-T080
with	O
amyloids	B-T116
.	O
	
the	O
present	B-T079
work	O
proposes	O
new	O
strategies	O
for	O
filling	O
the	O
aforementioned	O
gap	O
that	O
encompass	O
the	O
integration	B-T169
of	O
new	O
analytical	O
approaches	O
with	O
standardized	B-T080
analyses	O
.	O
	
unbiased	O
estimates	O
of	O
cerebrospinal	O
fluid	O
β-amyloid	B-T116
1-42	I-T116
cutoffs	B-T169
in	O
a	O
large	O
memory	O
clinic	O
population	O
we	O
sought	O
to	O
define	O
a	O
cutoff	B-T169
for	O
β-amyloid	B-T116
1-42	I-T116
in	O
cerebrospinal	O
fluid	O
csf	O
,	O
a	O
key	O
marker	O
for	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
,	O
with	O
data-driven	B-T080
gaussian	B-T081
mixture	I-T081
modeling	I-T081
in	O
a	O
memory	O
clinic	O
population	O
.	O
	
we	O
performed	O
a	O
combined	O
cross-sectional	O
and	O
prospective	O
cohort	O
study	O
.	O
	
we	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	O
decline	O
,	O
mild	O
cognitive	O
impairment	O
,	O
ad	B-T047
-type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
ad	B-T047
from	O
the	O
amsterdam	O
dementia	O
cohort	O
.	O
	
we	O
defined	O
csf	O
β-amyloid	B-T116
1-42	I-T116
cutoffs	B-T169
by	O
data-driven	B-T080
gaussian	B-T081
mixture	I-T081
modeling	I-T081
in	O
the	O
total	B-T081
population	I-T081
and	O
in	O
subgroups	O
based	O
on	O
clinical	O
diagnosis	O
,	O
age	O
,	O
and	O
apolipoprotein	O
e	O
apoe	O
genotype	O
.	O
	
we	O
investigated	B-T169
whether	O
abnormal	B-T033
β-amyloid	B-T116
1-42	I-T116
as	O
defined	O
by	O
the	O
data-driven	B-T080
cutoff	B-T169
could	O
better	O
predict	B-T078
progression	B-T169
to	O
ad	B-T047
-type	O
dementia	O
than	O
abnormal	B-T033
β-amyloid	B-T116
1-42	I-T116
defined	O
by	O
a	O
clinical	O
diagnosis	O
-based	O
cutoff	B-T169
using	O
cox	B-T081
proportional	I-T081
hazards	I-T081
regression	I-T081
.	O
	
in	O
the	O
total	O
group	B-T078
of	O
patients	O
,	O
we	O
found	O
a	O
cutoff	B-T169
for	O
abnormal	B-T033
csf	O
β-amyloid	B-T116
1-42	I-T116
of	O
680	O
pg/ml	O
95%	O
ci	B-T081
660-705	O
pg/ml	O
.	O
	
similar	O
cutoffs	B-T169
were	O
found	O
within	O
diagnostic	B-T033
and	O
apoe	O
genotype	O
subgroups	O
.	O
	
the	O
cutoff	B-T169
was	O
higher	B-T080
in	O
elderly	O
subjects	O
than	O
in	O
younger	O
subjects	O
.	O
	
the	O
data-driven	B-T080
cutoff	B-T169
was	O
higher	B-T080
than	O
our	O
clinical	O
diagnosis	O
-based	O
cutoff	B-T169
and	O
had	O
a	O
better	O
predictive	B-T080
accuracy	B-T080
for	O
progression	B-T169
to	O
ad	B-T047
-type	O
dementia	O
in	O
nondemented	O
subjects	O
hr	B-T081
7.6	O
versus	O
5.2	O
,	O
p	B-T081
<	O
0.01	O
.	O
	
mixture	B-T081
modeling	I-T081
is	O
a	O
robust	B-T080
method	O
to	O
determine	O
cutoffs	B-T169
for	O
csf	O
β-amyloid	B-T116
1-42	I-T116
.	O
	
it	O
might	O
better	O
capture	O
biological	B-T080
changes	B-T169
that	O
are	O
related	O
to	O
ad	B-T047
than	O
cutoffs	B-T169
based	O
on	O
clinical	O
diagnosis	O
.	O
	
identification	B-T080
of	O
the	O
anti-mycobacterial	O
functional	B-T169
properties	B-T080
of	O
piperidinol	O
derivatives	O
tuberculosis	B-T047
tb	B-T047
remains	O
a	O
major	O
global	B-T080
health	B-T078
threat	B-T078
and	O
is	O
now	O
the	O
leading	O
cause	B-T033
of	I-T033
death	I-T033
from	O
a	O
single	O
infectious	O
agent	O
worldwide	B-T080
.	O
	
the	O
current	O
tb	B-T047
drug	O
regimen	B-T061
is	O
inadequate	B-T080
,	O
and	O
new	O
anti-tubercular	O
agents	O
are	O
urgently	O
required	O
to	O
be	O
able	O
to	O
successfully	O
combat	O
the	O
increasing	O
prevalence	B-T081
of	O
drug-resistant	B-T047
tb	I-T047
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	B-T169
a	O
piperidinol	O
compound	O
derivative	O
that	O
is	O
highly	O
active	B-T169
against	O
the	O
mycobacterium	O
tuberculosis	O
bacillus	O
.	O
	
the	O
antibacterial	O
properties	B-T080
of	O
the	O
piperidinol	O
compound	O
and	O
its	O
corresponding	O
bis-mannich	B-T109
base	I-T109
analogue	O
were	O
evaluated	O
against	O
m	O
.	O
	
smegmatis	O
and	O
gram-negative	O
organisms	O
.	O
	
cytotoxicity	O
studies	O
were	O
undertaken	O
in	O
order	O
to	O
determine	O
the	O
selectivity	O
index	O
for	O
these	O
compounds	O
.	O
	
spontaneous	O
resistant	B-T169
mutants	O
of	O
m	O
.	O
	
smegmatis	O
were	O
generated	O
against	O
the	O
piperidinol	O
and	O
corresponding	O
bis-mannich	O
base	O
lead	O
derivatives	O
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	O
modifications	O
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	O
.	O
	
the	O
piperidinol	O
and	O
the	O
bis-mannich	O
base	O
analogue	O
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	O
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	O
selectivity	O
index	O
for	O
mycobacteria	O
of	O
>30-fold	O
.	O
	
whole	O
genome	O
sequencing	O
of	O
m	O
.	O
	
smegmatis	O
strains	O
resistant	B-T169
to	O
the	O
lead	O
compounds	O
led	O
to	O
the	O
identification	B-T080
of	O
a	O
number	O
of	O
single	O
nucleotide	O
polymorphisms	O
indicating	O
multiple	O
targets	O
.	O
	
our	O
results	B-T033
indicate	O
that	O
the	O
piperidinol	O
moiety	O
represents	O
an	O
attractive	O
compound	O
class	O
in	O
the	O
pursuit	O
of	O
novel	O
anti-tubercular	O
agents	O
.	O
	
metatranscriptomics	O
reveals	O
the	O
active	O
bacterial	O
and	O
eukaryotic	O
fibrolytic	O
communities	O
in	O
the	O
rumen	O
of	O
dairy	O
cow	O
fed	O
a	O
mixed	B-T169
diet	O
ruminants	O
have	O
a	O
unique	O
ability	O
to	O
derive	O
energy	B-T081
from	O
the	O
degradation	B-T169
of	O
plant	O
polysaccharides	B-T109
through	O
the	O
activity	O
of	O
the	O
rumen	O
microbiota	O
.	O
	
although	O
this	O
process	O
is	O
well	O
studied	O
in	B-T080
vitro	I-T080
,	O
knowledge	O
gaps	O
remain	O
regarding	O
the	O
relative	O
contribution	O
of	O
the	O
microbiota	O
members	O
and	O
enzymes	B-T116
in	O
vivo	O
.	O
	
the	O
present	O
study	O
used	O
rna-sequencing	O
to	O
reveal	O
both	O
the	O
expression	O
of	O
genes	O
encoding	O
carbohydrate-active	B-T116
enzymes	I-T116
cazymes	B-T116
by	O
the	O
rumen	O
microbiota	O
of	O
a	O
lactating	O
dairy	O
cow	O
and	O
the	O
microorganisms	O
forming	O
the	O
fiber	O
-degrading	O
community	O
.	O
	
functional	O
analysis	O
identified	O
12	O
cazymes	B-T116
,	O
accounting	O
for	O
1%	O
of	O
the	O
transcripts	O
.	O
	
the	O
cazyme	B-T116
profile	O
was	O
dominated	O
by	O
families	O
gh94	B-T116
cellobiose-phosphorylase	B-T116
,	O
gh13	B-T116
amylase	B-T116
,	O
gh43	B-T116
and	O
gh10	B-T116
hemicellulases	B-T116
,	O
gh9	B-T116
and	O
gh48	B-T116
cellulases	B-T116
,	O
pl11	B-T116
pectinase	B-T116
as	O
well	O
as	O
gh2	B-T116
and	O
gh3	B-T116
oligosaccharidases	B-T116
.	O
	
our	O
data	O
support	O
the	O
pivotal	O
role	O
of	O
the	O
most	O
characterized	O
fibrolytic	O
bacteria	O
prevotella	O
,	O
ruminocccus	O
and	O
fibrobacter	O
,	O
and	O
highlight	O
a	O
substantial	O
,	O
although	O
most	O
probably	O
underestimated	O
,	O
contribution	O
of	O
fungi	O
and	O
ciliate	O
protozoa	O
to	O
polysaccharide	B-T109
degradation	B-T169
.	O
	
particularly	O
these	O
results	O
may	O
motivate	O
further	O
exploration	O
of	O
the	O
role	O
and	O
the	O
functions	O
of	O
protozoa	O
in	O
the	O
rumen	O
.	O
	
moreover	O
,	O
an	O
important	O
part	O
of	O
the	O
fibrolytic	O
bacterial	O
community	O
remains	O
to	O
be	O
characterized	O
since	O
one	O
third	O
of	O
the	O
cazyme	B-T116
transcripts	O
originated	O
from	O
distantly	O
related	O
strains	O
.	O
	
these	O
findings	O
are	O
used	O
to	O
highlight	O
limitations	O
of	O
current	O
metatranscriptomics	O
approaches	O
to	O
understand	O
the	O
functional	O
rumen	O
microbial	O
community	O
fine	O
mapping	O
of	O
carbon	O
assimilation	O
rate	O
8	O
,	O
a	O
quantitative	O
trait	O
locus	O
for	O
flag	O
leaf	O
nitrogen	O
content	O
,	O
stomatal	O
conductance	B-T081
and	O
photosynthesis	O
in	O
rice	O
increasing	B-T169
the	O
rate	B-T081
of	O
leaf	O
photosynthesis	O
is	O
one	O
important	O
approach	O
for	O
increasing	O
grain	B-T081
yield	I-T081
in	O
rice	O
oryza	O
sativa	O
.	O
	
exploiting	O
the	O
natural	O
variation	B-T080
in	O
co2	B-T081
assimilation	I-T081
rate	I-T081
a	O
between	O
rice	O
cultivars	O
using	O
quantitative	O
genetics	O
is	O
one	O
promising	O
means	O
to	O
identify	O
genes	O
contributing	O
to	O
higher	O
photosynthesis	O
.	O
	
in	O
this	O
study	O
,	O
we	O
determined	O
precise	O
location	O
of	O
carbon	O
assimilation	O
rate	O
8	O
car8	O
by	O
crossing	O
a	O
high-yielding	O
indica	O
cultivar	O
with	O
a	O
japanese	O
commercial	O
cultivar	O
.	O
	
fine	O
mapping	O
suggested	O
that	O
car8	O
encodes	O
a	O
putative	B-T116
heme	I-T116
activator	I-T116
protein	I-T116
3	I-T116
oshap3	B-T116
subunit	O
of	O
a	O
ccaat-box-binding	B-T116
transcription	I-T116
factor	I-T116
called	O
oshap3h	O
.	O
	
sequencing	O
analysis	O
revealed	O
that	O
the	O
indica	O
allele	O
of	O
car8	O
has	O
a	O
1-bp	O
deletion	O
at	O
322	O
bp	O
from	O
the	O
start	O
codon	O
,	O
resulting	O
in	O
a	O
truncated	B-T116
protein	I-T116
of	O
125	O
amino	B-T116
acids	I-T116
.	O
	
in	O
addition	O
,	O
car8	O
is	O
identical	B-T080
to	O
dth8	O
/	O
ghd8	O
/	O
lhd1	O
,	O
which	O
was	O
reported	O
to	O
control	O
rice	O
flowering	O
date	B-T079
.	O
	
the	O
increase	B-T169
of	O
a	B-T081
is	O
largely	O
due	O
to	O
an	O
increase	B-T169
of	O
rubp	B-T081
regeneration	I-T081
rate	I-T081
via	O
increased	B-T081
leaf	O
nitrogen	O
content	O
,	O
and	O
partially	O
explained	O
by	O
reduced	B-T080
stomatal	O
limitation	B-T169
via	O
increased	B-T081
stomatal	O
conductance	B-T081
relative	O
to	O
a	B-T081
.	O
	
this	O
allele	O
also	O
increases	O
hydraulic	B-T080
conductivity	I-T080
,	O
which	O
would	O
promote	O
higher	O
stomatal	O
conductance	B-T081
.	O
	
this	O
indicates	O
that	O
car8	O
affects	O
multiple	O
physiological	O
aspects	O
relating	O
to	O
photosynthesis	O
.	O
	
the	O
detailed	O
analysis	O
of	O
molecular	O
functions	O
of	O
car8	O
would	O
help	O
to	O
understand	O
the	O
association	B-T080
between	O
photosynthesis	O
and	O
flowering	O
and	O
demonstrate	O
specific	O
genetic	B-T169
mechanisms	B-T169
that	O
can	O
be	O
exploited	O
to	O
improve	B-T033
photosynthesis	O
in	O
rice	O
and	O
potentially	O
other	O
allogeneic	B-T061
stem	I-T061
cell	I-T061
transplantation	I-T061
for	O
adult	O
patients	O
with	O
acute	O
lymphoblastic	O
leukemia	O
who	O
had	O
central	B-T033
nervous	I-T033
system	I-T033
involvement	I-T033
a	O
study	O
from	O
the	O
adult	O
all	O
working	O
group	O
of	O
the	O
japan	O
society	O
for	O
hematopoietic	B-T061
cell	I-T061
transplantation	I-T061
the	O
prognosis	O
for	O
adult	O
acute	O
lymphoblastic	O
leukemia	O
all	O
patients	O
with	O
central	B-T033
nervous	I-T033
system	I-T033
cns	I-T033
involvement	I-T033
cns+	B-T033
who	O
received	O
allogeneic	B-T061
hematopoietic	I-T061
stem	I-T061
cell	I-T061
transplantation	I-T061
allo-sct	B-T061
remains	O
unclear	O
.	O
	
we	O
retrospectively	B-T080
compared	O
the	O
outcomes	B-T080
of	O
allo-sct	B-T061
for	O
patients	O
with	O
cns	B-T033
involvement	I-T033
and	O
for	O
patients	O
without	B-T080
cns	B-T033
involvement	I-T033
cns-	B-T033
using	O
a	O
database	O
in	O
japan	O
.	O
	
the	O
eligibility	O
criteria	B-T078
for	O
this	O
study	O
were	O
as	O
follows	O
diagnosis	O
of	O
all	O
,	O
aged	O
more	O
than	O
16	O
years	B-T079
,	O
allo-sct	B-T061
between	O
2005	O
and	O
2012	O
,	O
and	O
first	B-T081
sct	B-T061
.	O
	
data	B-T078
for	O
2582	O
patients	O
including	O
136	O
cns+	O
patients	O
and	O
2446	O
cns-	O
patients	O
were	O
used	O
for	O
analyses	O
.	O
	
as	O
compared	O
with	O
cns-	O
patients	O
,	O
cns+	O
patients	O
were	O
younger	B-T079
,	O
had	O
worse	B-T033
disease	B-T047
status	B-T080
at	O
sct	B-T061
and	O
had	O
poorer	O
performance	O
status	O
ps	O
at	O
sct	B-T061
p	O
<	O
0.01	O
.	O
	
incidence	B-T081
of	O
relapse	O
was	O
higher	O
in	O
cns+	O
patients	O
p	O
=	O
0.02	O
,	O
and	O
incidence	B-T081
of	O
cns	O
relapse	O
was	O
also	O
higher	O
p	O
<	O
0.01	O
.	O
	
the	O
probability	B-T081
of	O
3-	O
year	B-T079
overall	B-T081
survival	I-T081
os	B-T081
was	O
better	O
in	O
cns-	O
patients	O
p	O
<	O
0.01	O
by	O
univariate	O
analysis	O
.	O
	
however	O
,	O
in	O
patients	O
who	O
received	B-T080
sct	B-T061
in	O
cr	B-T033
,	O
there	O
was	O
no	B-T033
difference	I-T033
in	O
the	O
probability	B-T081
of	O
os	B-T081
between	O
cns+	B-T033
and	O
cns-	B-T033
patients	O
p	O
=	O
0.38	O
and	O
cns	B-T033
involvement	I-T033
did	O
not	O
have	O
an	O
unfavorable	B-T080
effect	B-T080
on	O
os	B-T081
by	O
multivariate	B-T081
analysis	I-T081
.	O
	
cns+	O
patients	O
who	O
achieved	O
cr	B-T033
showed	O
os	B-T081
comparable	O
to	O
that	O
of	O
cns-	O
patients	O
.	O
	
silent	O
strain	O
of	O
caregiving	O
exploring	O
the	O
best	B-T033
predictors	I-T033
of	O
distress	B-T033
in	O
family	O
carers	O
of	O
geriatric	O
patients	O
the	O
aim	O
of	O
this	O
article	O
was	O
to	O
identify	O
the	O
best	B-T033
predictors	I-T033
of	O
distress	B-T033
suffered	I-T033
by	O
family	O
carers	O
fcs	O
of	O
geriatric	O
patients	O
.	O
	
a	O
cross-sectional	O
study	O
of	O
100	O
fc	O
-	O
geriatric	O
patient	O
dyads	O
was	O
conducted	O
.	O
	
the	O
negative	B-T033
impact	I-T033
of	I-T033
care	I-T033
nioc	B-T033
subscale	B-T081
of	O
the	O
cope	B-T081
index	I-T081
was	O
dichotomized	O
to	O
identify	O
lower	B-T033
stress	I-T033
score	O
of	O
15	O
on	O
the	O
scale	O
and	O
higher	B-T033
stress	I-T033
score	O
of	O
16	O
on	O
the	O
scale	O
exerted	O
on	O
fcs	O
by	O
the	O
process	O
of	O
providing	O
care	O
.	O
	
the	O
set	O
of	O
explanatory	O
variables	B-T033
comprised	O
a	O
wide	O
range	O
of	O
sociodemographic	B-T078
and	O
care-related	O
attributes	O
,	O
including	O
patient-related	B-T033
results	I-T033
from	O
comprehensive	O
geriatric	O
assessments	O
and	O
disease	B-T047
profiles	O
.	O
	
the	O
best	O
combination	O
of	O
explanatory	O
variables	B-T033
that	O
provided	O
the	O
highest	B-T080
predictive	I-T080
powe	I-T080
r	O
for	O
distress	B-T033
among	O
fcs	O
in	O
the	O
multiple	O
logistic	O
regression	O
lr	O
model	O
was	O
determined	O
according	O
to	O
statistical	O
information	O
criteria	O
.	O
	
the	O
statistical	O
robustness	O
of	O
the	O
observed	O
relationships	O
and	O
the	O
discriminative	O
power	O
of	O
the	O
model	O
were	O
verified	O
with	O
the	O
cross-validation	O
method	O
.	O
	
the	O
mean	O
age	O
of	O
fcs	O
was	O
57.2	O
10.6	O
years	O
,	O
whereas	O
that	O
of	O
geriatric	O
patients	O
was	O
81.7	O
6.4	O
years	O
.	O
	
despite	O
the	O
broad	O
initial	O
set	O
of	O
potential	O
explanatory	O
variables	O
,	O
only	O
five	O
predictors	O
were	O
jointly	O
selected	O
for	O
the	O
best	O
statistical	O
model	O
.	O
	
a	O
higher	O
level	O
of	O
distress	O
was	O
independently	O
predicted	O
by	O
lower	O
self-evaluation	O
of	O
health	O
worse	O
self-appraisal	O
of	O
coping	O
well	O
as	O
a	O
caregiver	O
lower	O
sense	O
of	O
general	O
support	O
more	O
hours	O
of	O
care	O
per	O
week	O
and	O
the	O
motor	O
retardation	O
of	O
the	O
cared	O
-for	O
person	O
measured	O
with	O
the	O
speed	O
of	O
the	O
timed	O
up	O
and	O
go	O
tug	O
test	O
.	O
	
worse	O
performance	O
on	O
the	O
tug	O
test	O
was	O
only	O
the	O
patient	O
-related	O
predictor	O
of	O
distress	O
among	O
the	O
variables	O
examined	O
as	O
contributors	O
to	O
the	O
higher	O
nioc	O
.	O
	
enhancing	O
the	O
mobility	O
of	O
geriatric	O
patients	O
through	O
suitably	O
tailored	O
kinesitherapeutic	O
methods	O
during	O
their	O
hospital	O
stay	O
may	O
mitigate	O
the	O
burden	O
endured	O
by	O
fcs	O
microbiological	O
and	O
clinical	O
characteristics	O
of	O
hypermucoviscous	O
klebsiella	O
pneumoniae	O
isolates	O
associated	B-T080
with	I-T080
invasive	B-T047
infections	I-T047
in	O
china	O
a	O
distinctive	B-T047
syndrome	I-T047
caused	B-T169
by	I-T169
hypermucoviscous	O
klebsiella	O
pneumoniae	O
hmkp	O
including	O
pyogenic	B-T047
liver	I-T047
abscess	I-T047
pla	B-T047
is	O
now	O
becoming	O
a	O
globally	B-T047
emerging	I-T047
disease	I-T047
.	O
	
in	O
the	O
present	O
study	O
,	O
22.8	O
84/369	O
of	O
k	O
.	O
	
pneumoniae	O
clinical	O
isolates	O
associated	B-T080
with	I-T080
various	B-T080
types	I-T080
of	O
invasive	B-T047
infections	I-T047
were	O
identified	O
as	O
hmkp	O
,	O
with	O
45.2	O
associated	B-T080
with	I-T080
pla	B-T047
.	O
	
multivariate	B-T081
regression	I-T081
analysis	I-T081
showed	O
that	O
male	O
patients	O
with	O
41-50	O
years	B-T079
,	O
pla	B-T047
,	O
diabetes	B-T047
mellitus	I-T047
,	O
and	O
hypertension	B-T047
were	O
independent	B-T078
risk	B-T033
factors	I-T033
for	O
hmkp	B-T047
infections	I-T047
.	O
	
k2	O
42.9	O
,	O
36/84	O
was	O
the	O
most	O
common	O
capsular	O
serotype	O
among	O
hmkp	O
isolates	O
,	O
followed	O
by	O
k1	O
23.8	O
,	O
20/84	O
.	O
	
seventy-five	B-T081
percentage	I-T081
of	O
k1	O
hmkp	O
isolates	O
were	O
associated	B-T080
with	I-T080
pla	B-T047
,	O
while	O
k2	O
hmkp	O
isolates	O
accounted	B-T078
for	O
more	B-T080
types	I-T080
of	O
invasive	B-T047
infections	I-T047
.	O
	
the	O
positive	B-T033
rates	B-T081
of	O
iuta	O
,	O
mrkd	O
,	O
aerobactin	O
,	O
iron	O
,	O
and	O
rmpa	O
among	O
hmkp	O
isolates	O
were	O
significantly	B-T081
higher	I-T081
than	O
those	O
among	O
non-hmkp	O
isolates	O
p	O
<	O
0.05	O
.	O
	
there	O
was	O
a	O
correlation	B-T080
between	O
maga	O
,	O
ybts	O
,	O
alls	O
,	O
and	O
wcag	O
and	O
k1	O
isolates	O
.	O
	
interestingly	O
,	O
mrkd	O
was	O
exclusively	B-T033
detected	I-T033
among	O
hmkp	O
32.1	O
,	O
27/84	O
and	O
k2	O
isolates	O
65.9	O
,	O
27/41	O
.	O
	
all	O
k1	O
and	O
k2	O
hmkp	O
and	O
non-hmkp	O
isolates	O
were	O
positive	B-T033
for	O
rmpa	O
.	O
	
aerobactin	O
was	O
found	B-T033
among	O
95.0	O
and	O
97.5	O
of	O
k1	O
and	O
k2	O
isolates	O
.	O
	
st23	O
was	O
found	B-T033
to	O
be	O
the	O
most	B-T079
prevalent	I-T079
st	O
among	O
69	O
hmkp	O
isolates	O
with	O
k1	O
,	O
k2	O
,	O
k5	O
,	O
k20	O
,	O
and	O
k57	O
27.5	O
,	O
19/69	O
and	O
was	O
only	O
found	B-T033
among	O
k1	O
isolates	O
.	O
	
st65	O
was	O
the	O
second	O
most	B-T079
prevalent	I-T079
st	O
26.1	O
,	O
18/69	O
and	O
was	O
also	O
only	O
found	B-T033
among	O
k2	O
isolates	O
.	O
	
st23-k1	O
hmkp	O
isolates	O
84.2	O
,	O
16/19	O
were	O
associated	B-T080
with	I-T080
pla	B-T047
,	O
while	O
st65-k2	O
isolates	O
were	O
correlated	B-T080
with	O
more	O
types	O
of	O
infections	O
relative	O
to	O
st23-k1	O
isolates	O
.	O
	
pfge	O
results	B-T169
showed	O
that	O
the	O
homology	B-T080
of	O
84	O
hmkp	O
isolates	O
was	O
diverse	B-T080
.	O
	
only	O
five	B-T081
pfge	O
clusters	B-T081
with	O
more	O
than	O
75%	O
similarity	B-T080
accounted	B-T078
for	O
more	O
than	O
three	B-T081
isolates	O
.	O
	
these	O
five	B-T081
pfge	O
clusters	B-T081
only	O
accounted	B-T078
for	O
35	O
41.7	O
,	O
35/84	O
isolates	O
.	O
	
in	O
conclusion	O
,	O
our	O
study	O
first	O
found	B-T033
that	O
hypertension	B-T047
and	O
male	O
patients	O
with	O
41-50	O
years	B-T079
old	B-T079
were	O
independent	B-T078
risk	B-T033
factors	I-T033
.	O
	
the	O
composition	O
of	O
st	O
types	O
and	O
pfge	O
clusters	B-T081
among	O
k	O
.	O
	
pneumoniae	O
k2	O
isolates	O
was	O
more	O
diverse	B-T080
than	O
k1	O
isolates	O
.	O
	
k1	O
and	O
k2	O
hmkp	O
isolates	O
had	O
respective	O
specific	B-T169
profiles	I-T169
of	O
virulence	O
-	O
associated	B-T078
genes	O
.	O
	
haemoglobinopathies	B-T047
and	O
β-thalassaemia	B-T047
among	O
the	O
tribals	O
working	O
in	O
the	O
tea	O
gardens	B-T080
of	O
assam	O
,	O
india	O
prevalence	B-T081
of	O
haemoglobinopathies	B-T047
and	O
β-thalassaemia	B-T047
are	O
very	B-T080
high	I-T080
in	O
india	O
but	O
information	B-T078
about	O
its	O
status	O
among	O
the	O
tribals	O
working	O
in	O
the	O
tea	O
gardens	B-T080
of	O
assam	O
is	O
very	B-T080
less	I-T080
.	O
	
the	O
present	O
study	O
was	O
carried	O
out	O
to	O
determine	O
the	O
prevalence	B-T081
of	O
haemoglobinopathies	B-T047
and	O
β-thalassaemia	B-T047
among	O
the	O
tribals	O
working	O
in	O
the	O
tea	O
gardens	B-T080
of	O
assam	O
.	O
	
a	O
total	O
1204	O
samples	O
from	O
the	O
tribals	O
working	O
in	O
tea	O
gardens	B-T080
of	O
assam	O
were	O
analysed	O
for	O
both	O
complete	O
blood	O
count	O
cbc	O
and	O
high	O
pressure	O
liquid	O
chromatography	O
hplc	O
for	O
detection	B-T061
of	O
haemoglobinopathies	B-T047
and	O
β-thalassaemia	B-T047
.	O
	
this	O
study	O
showed	O
that	O
the	O
prevalence	B-T081
of	O
sickle	B-T047
cell	I-T047
anaemia	I-T047
and	O
β-thalassaemia	B-T047
were	O
very	B-T080
high	I-T080
among	O
this	O
population	O
.	O
	
our	O
results	B-T169
indicated	B-T033
a	O
higher	O
prevalence	B-T081
of	O
β-thalassaemia	B-T047
3.07	O
among	O
the	O
munda	O
ethnic	O
group	O
and	O
higher	O
prevalence	B-T081
of	O
sickle	B-T047
cell	I-T047
anaemia	I-T047
4.73	O
among	O
the	O
lohar	O
ethnic	O
group	O
.	O
	
this	O
was	O
the	O
first	O
study	O
to	O
report	O
the	O
presence	B-T033
of	O
hbe	B-T116
among	O
the	O
tribals	O
working	O
in	O
the	O
tea	O
gardens	B-T080
of	O
assam	O
.	O
	
based	O
on	O
the	O
present	O
findings	B-T033
,	O
sickle	B-T047
cell	I-T047
anaemia	I-T047
and	O
β-thalassaemia	B-T047
were	O
major	O
health	B-T078
problem	B-T033
for	O
the	O
tribals	O
working	O
in	O
the	O
tea	O
gardens	B-T080
of	O
assam	O
.	O
	
proper	O
diagnostic	O
facilities	O
for	O
haemoglobinopathy	B-T047
and	O
thalassaemia	B-T047
should	O
be	O
established	B-T080
in	O
these	O
areas	O
,	O
including	O
establishment	O
of	O
haemoglobinopathy	B-T047
and	O
thalassaemia	B-T047
database	O
collection	B-T169
,	O
haematological	O
analysis	O
laboratories	O
,	O
genetic	O
counselling	O
clinics	O
,	O
prenatal	O
diagnosis	O
centres	O
and	O
neonatal	O
screening	O
centres	O
.	O
	
long	B-T079
term	I-T079
outcome	B-T169
in	O
patients	O
with	O
esophageal	B-T061
stenting	I-T061
for	O
cancer	O
esophagus	O
-	O
our	O
experience	O
at	O
a	O
rural	O
hospital	O
of	O
punjab	O
,	O
india	O
cancer	O
of	O
the	O
esophagus	O
is	O
among	O
the	O
leading	O
cause	B-T078
of	O
cancer	B-T081
deaths	I-T081
in	O
punjab	O
,	O
india	O
.	O
	
patients	O
generally	O
present	B-T033
with	O
dysphagia	B-T047
as	O
their	O
first	O
symptom	O
and	O
more	O
often	O
they	O
have	O
advanced	O
disease	O
at	O
the	O
time	B-T079
of	O
presentation	B-T078
to	O
a	O
tertiary	O
care	O
centre	O
.	O
	
palliative	B-T061
procedures	I-T061
have	O
important	B-T080
roles	O
in	O
this	O
setting	O
.	O
	
stenting	B-T061
is	O
the	O
best	O
option	B-T169
to	O
palliate	B-T080
the	O
symptoms	O
of	O
dysphagia	B-T047
,	O
from	O
which	O
patient	O
is	O
suffering	B-T033
the	I-T033
most	I-T033
.	O
	
to	O
know	O
the	O
success	B-T080
rate	B-T081
,	O
early	O
and	O
long	B-T079
term	I-T079
complications	O
and	O
mortality	B-T081
in	O
esophageal	B-T061
stenting	I-T061
,	O
when	O
it	O
was	O
done	O
in	O
malignant	B-T047
esophageal	I-T047
stricture	I-T047
patients	O
.	O
	
one	B-T081
hundred	I-T081
patients	O
,	O
who	O
had	O
undergone	O
esophageal	B-T061
stenting	I-T061
from	O
january	B-T080
2012	O
to	O
january	B-T080
2015	O
,	O
were	O
included	B-T169
in	O
the	O
study	O
.	O
	
we	O
retrospectively	O
analysed	O
the	O
data	B-T078
for	O
patient	O
characteristics	B-T080
,	O
causes	B-T169
of	O
non-operability	B-T080
,	O
early	O
and	O
long	B-T079
term	I-T079
complications	O
,	O
re-interventions	B-T061
,	O
efficacy	B-T080
and	O
mortality	B-T081
.	O
	
out	O
of	O
100	O
patients	O
,	O
indications	B-T078
for	O
stenting	B-T061
were	O
locally	O
advanced	O
disease	O
not	O
amenable	B-T080
to	O
surgery	B-T061
52%	O
,	O
metastatic	O
disease	O
35%	O
,	O
cva	B-T047
1%	O
,	O
cardiac	B-T033
and	O
respiratory	O
problem	O
8%	O
,	O
un-willing	O
for	O
surgery	B-T061
in	O
5%	O
of	O
patients	O
.	O
	
majority	O
of	O
patients	O
94%	O
had	O
squamous	O
cell	O
carcinoma	O
,	O
while	O
only	O
6%	O
had	O
adenocarcinoma	O
.	O
	
84%	O
of	O
patients	O
presented	B-T078
with	O
dysphagia	B-T047
with	O
or	O
without	O
chest	O
pain	O
and	O
recurrent	B-T033
cough	I-T033
while	O
16%	O
had	O
recurrent	O
vomiting	O
.	O
	
58%	O
had	O
dysphagia	B-T047
to	O
liquids	O
and	O
solids	O
and	O
17%	O
had	O
complete	B-T047
dysphagia	I-T047
.	O
	
after	O
stenting	B-T061
93%	O
had	O
significant	B-T078
improvement	O
in	O
dysphagia	B-T047
score	B-T081
from	O
median	O
of	O
3	O
to	O
1	O
.	O
	
post	B-T079
procedure	I-T079
stay	B-T079
was	O
3.61	O
days	B-T079
.	O
	
one	O
patient	O
had	O
procedure	B-T061
related	O
major	O
complication	O
in	O
the	O
form	O
of	O
post	O
procedural	O
bleed	O
after	O
16	O
days	B-T079
of	O
stenting	B-T061
leading	O
to	O
death	B-T033
of	O
that	O
patient	O
.	O
	
minor	O
complications	O
were	O
present	B-T033
in	O
52	O
patients	O
treated	B-T169
conservatively	O
not	O
affecting	B-T169
the	O
efficacy	B-T080
of	O
procedure	B-T061
.	O
	
these	O
include	O
pain	O
after	O
stenting	B-T061
38%	O
,	O
stent	O
obstruction	O
23%	O
and	O
stent	O
migration	O
6%	O
.	O
	
all	O
the	O
minor	O
complications	O
were	O
treated	B-T169
conservatively	O
except	B-T169
in	O
six	O
patients	O
in	O
whom	O
re-stenting	B-T061
was	O
done	O
.	O
	
esophageal	B-T061
stenting	I-T061
is	O
relatively	O
safe	O
procedure	B-T061
with	O
short	O
stay	B-T079
of	O
the	O
patient	O
in	O
the	O
hospital	O
.	O
	
although	O
,	O
it	O
helps	O
in	O
alleviating	O
patients	O
'	O
morbidity	B-T081
very	O
effectively	B-T080
and	O
reliably	O
,	O
there	O
are	O
many	O
technical	O
glitches	O
,	O
which	O
needs	O
to	O
be	O
kept	O
into	O
account	O
and	O
patient	O
should	O
be	O
properly	O
counseled	B-T061
before	O
the	O
procedure	B-T061
to	O
prevent	B-T169
and	O
manage	B-T169
post	B-T079
procedure	I-T079
complications	O
treatment	B-T169
of	O
carcinoma	O
in	O
situ	O
of	O
the	O
glans	O
penis	O
with	O
topical	O
imiquimod	O
followed	O
by	O
carbon	O
dioxide	O
laser	O
excision	B-T061
different	B-T080
approaches	B-T169
have	O
been	O
described	B-T078
in	O
published	O
studies	O
for	O
carcinoma	O
in	O
situ	O
cis	O
of	O
the	O
glans	O
penis	O
erythroplasia	O
of	O
queyrat	O
,	O
including	B-T169
topical	B-T061
chemotherapy	I-T061
or	O
immunotherapy	B-T061
and	O
laser	O
or	O
surgical	B-T061
excision	I-T061
.	O
	
we	O
evaluated	B-T061
the	O
efficacy	B-T080
of	O
topical	O
imiquimod	O
iq	O
followed	O
by	O
carbon	O
dioxide	O
laser	O
ablation	B-T061
of	O
the	O
lesion	B-T033
.	O
	
from	O
2010	O
to	O
2015	O
,	O
10	O
patients	B-T080
affected	I-T080
by	O
cis	O
of	O
the	O
glans	O
were	O
treated	B-T061
by	O
iq	O
,	O
followed	O
by	O
carbon	O
dioxide	O
laser	O
ablation	B-T061
.	O
	
for	O
every	O
patient	O
,	O
we	O
performed	B-T169
histologic	O
examination	O
before	B-T079
and	O
after	B-T079
iq	O
.	O
	
local	O
toxicity	O
and	O
adverse	O
effects	O
were	O
recorded	O
.	O
	
after	B-T079
treatment	I-T079
,	O
histologic	O
examination	O
showed	O
no	O
residual	O
tumor	O
in	O
6	O
patients	O
complete	B-T033
response	I-T033
cr	B-T033
,	O
stable	B-T033
disease	I-T033
in	O
2	O
patients	O
,	O
and	O
progressive	B-T047
disease	I-T047
in	O
2	O
patients	O
.	O
	
those	O
with	O
a	O
cr	B-T033
had	O
human	O
papillomavirus	O
-	O
related	B-T080
lesions	B-T033
,	O
and	O
they	O
had	O
no	B-T033
experienced	O
relapses	O
after	B-T079
a	O
mean	O
follow-up	O
of	O
26	O
months	B-T079
.	O
	
the	O
2	O
patients	O
with	O
progressive	B-T047
disease	I-T047
underwent	O
total	O
penectomy	B-T061
.	O
	
all	O
patients	O
were	O
alive	B-T033
at	O
the	O
last	O
follow-up	B-T033
examination	I-T033
.	O
	
all	O
patients	O
experienced	O
a	O
mild	B-T080
local	O
toxicity	O
burning	O
erythema	O
but	O
no	B-T033
major	B-T080
adverse	O
effects	O
.	O
	
local	O
treatment	B-T169
with	O
iq	O
for	O
glans	O
cis	O
is	O
effective	B-T080
mainly	O
for	O
human	O
papillomavirus	O
-	O
related	B-T080
lesions	B-T033
.	O
	
the	O
present	O
study	O
is	O
the	O
first	O
to	O
record	O
the	O
histologic	O
examination	O
findings	O
before	B-T079
and	O
after	B-T079
iq	O
treatment	B-T169
.	O
	
the	O
small	O
number	O
of	O
patients	O
,	O
owing	O
to	O
the	O
rarity	B-T080
of	O
this	O
disease	B-T047
,	O
was	O
the	O
main	O
limitation	B-T169
of	O
the	O
present	O
study	O
.	O
	
iq	O
must	O
be	O
used	O
carefully	O
,	O
and	O
a	O
close	O
follow-up	O
protocol	O
is	O
mandatory	B-T061
because	O
of	O
the	O
lack	B-T080
of	O
long-term	B-T079
efficacy	B-T080
progressive	B-T169
subcortical	O
calcifications	O
secondary	O
to	O
venous	B-T047
hypertension	I-T047
in	O
an	O
intracranial	O
dural	O
arteriovenous	O
fistula	O
intracranial	O
dural	O
arteriovenous	O
fistulas	O
davf	O
are	O
acquired	B-T033
lesions	I-T033
,	O
with	O
the	O
most	O
commonly	O
reported	O
findings	B-T033
on	O
ct	O
haemorrhage	O
or	O
focal	O
oedema	O
.	O
	
we	O
describe	O
a	O
case	O
of	O
progressive	B-T169
subcortical	O
calcification	O
on	O
ct	O
secondary	O
to	O
venous	B-T047
hypertension	I-T047
from	O
a	O
high	O
grade	O
effects	O
of	O
static	O
cold	O
storage	O
and	O
hypothermic	B-T061
machine	I-T061
perfusion	I-T061
on	O
oxidative	O
stress	O
factors	O
,	O
adhesion	B-T116
molecules	I-T116
,	O
and	O
zinc	B-T116
finger	I-T116
transcription	I-T116
factor	I-T116
proteins	I-T116
before	O
and	O
after	O
liver	B-T061
transplantation	I-T061
background	O
this	O
study	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
static	O
cold	O
storage	O
scs	O
and	O
hypothermic	B-T061
machine	I-T061
perfusion	I-T061
hmp	B-T061
on	O
the	O
oxidative	O
stress	O
factors	O
osf	O
,	O
adhesion	B-T116
molecules	I-T116
am	B-T116
,	O
and	O
zinc	B-T116
finger	I-T116
transcription	I-T116
factor	I-T116
snail	B-T116
before	O
and	O
after	O
liver	B-T061
transplantation	I-T061
.	O
	
material	O
and	O
methods	O
experimental	O
dogs	O
were	O
randomly	O
divided	O
into	O
donor	O
group	B-T078
a	O
,	O
scs	O
group	B-T078
b	O
,	O
and	O
hmp	B-T061
group	B-T078
c	O
n=30	O
groups	B-T078
.	O
	
livers	B-T061
retrieved	I-T061
from	O
group	B-T078
a	O
were	O
transplanted	B-T061
into	O
group	B-T078
b	O
after	O
scs	O
,	O
and	O
the	O
livers	O
sampled	O
from	O
group	B-T078
b	O
were	O
transplanted	B-T061
into	O
group	B-T078
c	O
after	O
hmp	B-T061
.	O
	
the	O
dogs	O
in	O
group	B-T078
a	O
were	O
euthanized	O
and	O
discarded	O
,	O
and	O
the	O
livers	O
sampled	O
from	O
group	B-T078
c	O
were	O
used	O
for	O
other	O
experiments	O
.	O
	
twenty	O
dogs	O
with	O
successful	O
liver	B-T061
transplants	I-T061
were	O
randomly	O
selected	O
from	O
groups	B-T078
b	O
and	O
c	O
for	O
analysis	O
.	O
	
results	O
during	O
the	O
liver	O
sampling	O
process	O
,	O
the	O
levels	O
of	O
osf	O
,	O
am	B-T116
,	O
and	O
snail	O
between	O
the	O
2	O
groups	B-T078
showed	O
no	B-T033
significant	I-T033
differences	I-T033
p>0	O
before	O
the	O
transplantation	B-T061
,	O
the	O
levels	O
of	O
chemokine	B-T116
cxcl14	I-T116
and	O
snail	B-T116
between	O
the	O
2	O
groups	B-T078
showed	O
no	B-T033
significant	I-T033
differences	I-T033
p>0	O
,	O
and	O
compared	O
with	O
group	B-T078
b	O
,	O
hif-1α	O
and	O
p-selectin	B-T116
in	O
group	B-T078
c	O
were	O
lower	O
p<0	O
60	O
min	O
after	O
the	O
transplantation	B-T061
,	O
hif-1α	B-T116
,	O
chemokine	B-T116
cxcl14	I-T116
,	O
p-selectin	B-T116
,	O
and	O
snail	B-T116
in	O
group	B-T078
c	O
were	O
lower	O
than	O
that	O
in	O
group	B-T078
b	O
p<0	O
.	O
	
conclusions	O
hmp	B-T061
can	O
significantly	O
reduce	O
the	O
levels	O
of	O
osf	O
and	O
inflammatory	B-T169
factors	I-T169
,	O
which	O
is	O
conducive	B-T033
for	O
liver	B-T061
transplantation	I-T061
.	O
	
physiology	O
of	O
respiratory	B-T033
disturbances	I-T033
in	O
muscular	B-T047
dystrophies	I-T047
muscular	B-T047
dystrophy	I-T047
is	O
a	O
group	O
of	O
inherited	O
myopathies	B-T047
characterised	O
by	O
progressive	B-T169
skeletal	O
muscle	O
wasting	O
,	O
including	O
of	O
the	O
respiratory	O
muscles	O
.	O
	
respiratory	B-T047
failure	I-T047
,	O
i.e	O
.	O
	
when	O
the	O
respiratory	O
system	O
fails	B-T169
in	O
its	O
gas	O
exchange	O
functions	O
,	O
is	O
a	O
common	O
feature	B-T080
in	O
muscular	B-T047
dystrophy	I-T047
,	O
being	O
the	O
main	O
cause	O
of	O
death	B-T033
,	O
and	O
it	O
is	O
a	O
consequence	B-T169
of	I-T169
lung	O
failure	B-T047
,	O
pump	B-T047
failure	I-T047
or	O
a	O
combination	O
of	O
the	O
two	O
.	O
	
the	O
former	O
is	O
due	O
to	O
recurrent	B-T079
aspiration	O
,	O
the	O
latter	O
to	O
progressive	B-T169
weakness	B-T033
of	I-T033
respiratory	I-T033
muscles	I-T033
and	O
an	O
increase	B-T169
in	O
the	O
load	O
against	O
which	O
they	O
must	O
contract	O
.	O
	
in	O
fact	O
,	O
both	O
the	O
resistive	B-T080
and	I-T080
elastic	I-T080
components	I-T080
of	O
the	O
work	O
of	O
breathing	O
increase	B-T169
due	O
to	O
airway	B-T047
obstruction	I-T047
and	O
chest	O
wall	O
and	O
lung	O
stiffening	O
,	O
respectively	O
.	O
	
the	O
respiratory	B-T033
disturbances	I-T033
in	O
muscular	B-T047
dystrophy	I-T047
are	O
restrictive	B-T033
pulmonary	I-T033
function	I-T033
,	O
hypoventilation	O
,	O
altered	O
thoracoabdominal	O
pattern	O
,	O
hypercapnia	B-T033
,	O
dyspnoea	O
,	O
impaired	O
regulation	O
of	O
breathing	O
,	O
inefficient	B-T033
cough	I-T033
and	O
sleep	B-T047
disordered	I-T047
breathing	I-T047
.	O
	
they	O
can	O
be	O
present	O
at	O
different	O
rates	O
according	O
to	O
the	O
type	O
of	O
muscular	B-T047
dystrophy	I-T047
and	O
its	O
progression	O
,	O
leading	O
to	O
different	O
onset	O
of	O
each	O
symptom	O
,	O
prognosis	O
and	O
degree	B-T033
of	I-T033
respiratory	I-T033
involvement	I-T033
.	O
	
a	O
common	O
feature	B-T080
of	O
muscular	B-T047
dystrophy	I-T047
is	O
respiratory	B-T047
failure	I-T047
,	O
i.e	O
.	O
	
the	O
inability	O
of	O
the	O
respiratory	O
system	O
to	O
provide	O
proper	O
oxygenation	O
and	O
carbon	O
dioxide	O
elimination	O
in	O
the	O
lung	O
,	O
respiratory	B-T047
failure	I-T047
is	O
caused	O
by	O
recurrent	B-T079
aspiration	O
,	O
and	O
leads	O
to	O
hypoxaemia	B-T033
and	O
hypercarbia	B-T033
.	O
	
ventilatory	O
failure	O
in	O
muscular	B-T047
dystrophy	I-T047
is	O
caused	O
by	O
increased	B-T081
respiratory	B-T033
load	I-T033
and	O
respiratory	B-T033
muscles	I-T033
weakness	I-T033
.	O
	
respiratory	B-T033
load	I-T033
increases	B-T169
in	O
muscular	B-T047
dystrophy	I-T047
because	O
scoliosis	O
makes	O
chest	O
wall	O
compliance	O
decrease	B-T081
,	O
atelectasis	O
and	O
fibrosis	O
make	O
lung	O
compliance	O
decrease	B-T081
,	O
and	O
airway	B-T047
obstruction	I-T047
makes	O
airway	O
resistance	O
increase	B-T169
the	O
consequences	B-T169
of	I-T169
respiratory	B-T047
pump	I-T047
failure	I-T047
are	O
restrictive	B-T033
pulmonary	I-T033
function	I-T033
,	O
hypoventilation	O
,	O
altered	O
thoracoabdominal	O
pattern	O
,	O
hypercapnia	B-T033
,	O
dyspnoea	O
,	O
impaired	O
regulation	O
of	O
breathing	O
,	O
inefficient	B-T033
cough	I-T033
and	O
sleep	B-T047
disordered	I-T047
breathing	I-T047
.	O
	
to	O
understand	O
the	O
mechanisms	B-T033
leading	O
to	O
respiratory	B-T033
disturbances	I-T033
in	O
patients	O
with	O
muscular	B-T047
dystrophy	I-T047
to	O
understand	O
the	O
impact	O
of	O
respiratory	B-T033
disturbances	I-T033
in	O
patients	O
with	O
muscular	B-T047
dystrophy	I-T047
to	O
provide	O
a	O
brief	O
description	O
of	O
the	O
main	O
forms	O
of	O
muscular	B-T047
dystrophy	I-T047
with	O
their	O
respiratory	B-T033
implications	I-T033
.	O
	
significance	B-T078
of	O
uterine	O
corpus	O
tumor	O
invasion	B-T033
in	O
early-stage	O
cervical	O
cancer	O
to	O
examine	O
characteristics	B-T080
and	O
survival	O
outcomes	B-T169
of	O
women	O
with	O
surgically-treated	B-T061
cervical	O
cancer	O
exhibiting	O
uterine	O
corpus	O
tumor	O
invasion	B-T033
.	O
	
we	O
utilized	O
the	O
surveillance	O
,	O
epidemiology	O
,	O
and	O
end	O
results	O
program	O
to	O
identify	O
cervical	O
cancer	O
patients	O
who	O
underwent	O
hysterectomy	B-T061
between	O
1973	O
and	O
2003	O
.	O
	
logistic	O
regression	O
models	O
were	O
used	O
to	O
identify	O
risk	B-T033
factors	I-T033
for	O
uterine	O
corpus	O
tumor	O
invasion	B-T033
on	O
multivariable	B-T081
analysis	I-T081
.	O
	
association	B-T080
of	O
uterine	O
corpus	O
tumor	O
invasion	B-T033
and	O
cause-specific	B-T081
survival	I-T081
css	B-T081
from	O
cervical	O
cancer	O
was	O
examined	O
with	O
cox	O
proportional	O
hazard	O
regression	O
models	O
on	O
multivariable	B-T081
analysis	I-T081
.	O
	
we	O
identified	O
837	O
4.9	O
cases	O
of	O
uterine	O
corpus	O
invasion	B-T033
and	O
16	O
95.1	O
cases	O
of	O
non-invasion	B-T169
.	O
	
median	B-T081
follow-up	O
time	B-T079
was	O
14.0	O
years	O
.	O
	
there	O
were	O
1642	O
deaths	O
due	O
to	O
cervical	O
cancer	O
.	O
	
uterine	O
corpus	O
invasion	B-T033
was	O
independently	B-T078
associated	B-T080
with	I-T080
older	O
age	O
,	O
non-squamous	B-T169
histology	I-T169
,	O
high-grade	O
tumors	O
,	O
large	O
tumor	O
size	O
,	O
and	O
nodal	O
metastasis	O
on	O
multivariable	B-T081
analysis	I-T081
all	O
,	O
p	O
<	O
0.001	O
.	O
	
on	O
univariable	O
analysis	O
,	O
uterine	O
corpus	O
tumor	O
invasion	B-T033
was	O
significantly	O
associated	B-T080
with	I-T080
decreased	B-T081
css	B-T081
compared	O
to	O
the	O
non-invasion	B-T169
5-year	O
rates	O
,	O
79.0	O
versus	O
94.5	O
,	O
p	O
<	O
0.001	O
.	O
	
after	O
controlling	O
for	O
other	O
significant	B-T078
prognostic	O
factors	O
,	O
uterine	O
corpus	O
tumor	O
invasion	B-T033
remained	O
an	O
independent	B-T078
prognostic	O
factor	O
for	O
decreased	B-T081
css	B-T081
adjusted-hazard	B-T081
ratio	I-T081
1.45	O
,	O
95%	O
confidence	B-T081
interval	I-T081
1.21	O
.	O
	
among	O
stage	O
t1b	O
cases	O
n	O
=	O
6730	O
,	O
uterine	O
corpus	O
tumor	O
invasion	B-T033
remained	O
an	O
independent	B-T078
prognostic	O
factor	O
for	O
decreased	B-T081
css	B-T081
adjusted-hazard	B-T081
ratio	I-T081
1.95	O
,	O
95%ci	O
1.47	O
.	O
	
uterine	O
corpus	O
tumor	O
invasion	B-T033
was	O
significantly	O
associated	B-T080
with	I-T080
decreased	B-T081
css	B-T081
in	O
stage	O
t1b1	O
disease	O
74.5	O
versus	O
90.7	O
,	O
p	O
<	O
0.001	O
and	O
in	O
stage	O
t1b2	O
disease	O
67.0	O
versus	O
79.5	O
,	O
p	O
=	O
0.01	O
.	O
	
uterine	O
corpus	O
tumor	O
invasion	B-T033
is	O
an	O
independent	B-T078
prognostic	O
factor	O
for	O
decreased	B-T081
survival	O
of	O
women	O
with	O
early-stage	O
cervical	O
cancer	O
.	O
	
efficient	O
gene	O
targeting	O
in	O
non-homologous	B-T169
end-joining	I-T169
-deficient	O
lipomyces	O
starkeyi	O
strains	O
microbial	O
lipids	B-T109
are	O
sustainable	O
feedstock	O
for	O
the	O
production	O
of	O
oleochemicals	O
and	O
biodiesel	B-T109
.	O
	
oleaginous	O
yeasts	O
have	O
recently	O
been	O
proposed	O
as	O
alternative	O
lipid	B-T109
producers	O
to	O
plants	O
and	O
animals	O
to	O
promote	O
sustainability	O
in	O
the	O
chemical	O
and	O
fuel	O
industries	O
.	O
	
the	O
oleaginous	O
yeast	O
lipomyces	O
starkeyi	O
has	O
great	O
industrial	O
potential	O
as	O
an	O
excellent	O
lipid	B-T109
producer	O
.	O
	
however	O
,	O
improvement	O
of	O
its	O
lipid	B-T109
productivity	O
is	O
essential	O
for	O
the	O
cost-effective	O
production	O
of	O
oleochemicals	O
and	O
fuels	O
.	O
	
genetic	O
and	O
metabolic	O
engineering	O
of	O
l	O
.	O
	
starkeyi	O
via	O
gene	O
manipulation	O
techniques	O
may	O
result	O
in	O
improvements	O
in	O
lipid	B-T109
production	O
and	O
our	O
understanding	O
of	O
the	O
mechanisms	B-T169
behind	O
lipid	B-T109
biosynthesis	B-T169
pathways	I-T169
.	O
	
we	O
previously	O
described	O
an	O
integrative	B-T169
transformation	I-T169
system	I-T169
using	O
a	O
drug	O
-resistant	O
marker	O
for	O
l	O
.	O
	
starkeyi	O
.	O
	
however	O
,	O
gene-targeting	O
frequencies	B-T081
were	O
very	O
low	O
because	O
non-homologous	O
recombination	O
is	O
probably	O
predominant	O
in	O
l	O
.	O
	
starkeyi	O
.	O
	
genetic	O
engineering	O
tools	O
for	O
l	O
.	O
	
starkeyi	O
have	O
not	O
been	O
sufficiently	O
developed	O
.	O
	
in	O
this	O
study	O
,	O
we	O
describe	O
a	O
new	O
genetic	O
tool	O
and	O
its	O
application	B-T169
in	O
l	O
.	O
	
starkeyi	O
.	O
	
to	O
develop	O
a	O
highly	O
efficient	O
gene-targeting	O
system	O
for	O
l	O
.	O
	
starkeyi	O
,	O
we	O
constructed	O
a	O
series	O
of	O
mutants	O
by	O
disrupting	B-T080
genes	O
for	O
lsku70p	B-T116
,	O
lsku80p	B-T116
,	O
and/or	O
lslig4p	B-T116
,	O
which	O
share	O
homology	B-T080
with	O
other	O
yeasts	O
ku70p	B-T116
,	O
ku80p	B-T116
,	O
and	O
lig4p	B-T116
,	O
respectively	O
,	O
being	O
involved	O
in	O
non-homologous	B-T169
end-joining	I-T169
pathway	I-T169
.	O
	
deletion	O
of	O
the	O
lslig4	O
gene	O
dramatically	O
improved	O
the	O
homologous	O
recombination	O
efficiency	B-T081
80.0	O
at	O
the	O
lsura3	O
locus	O
compared	O
with	O
that	O
in	O
the	O
wild-type	O
strain	O
1.4	O
,	O
when	O
2000-bp	O
homologous	O
flanking	O
regions	O
were	O
used	O
.	O
	
the	O
homologous	O
recombination	O
efficiencies	B-T081
of	O
the	O
double	O
mutant	O
l	O
sku70	O
and	O
the	O
triple	O
mutant	O
lsku70	O
were	O
also	O
markedly	O
enhanced	O
.	O
	
therefore	O
,	O
the	O
l	O
.	O
	
starkeyi	O
lslig4	O
background	O
strains	O
have	O
promise	O
as	O
efficient	O
recipient	O
strains	O
for	O
genetic	O
and	O
metabolic	O
engineering	O
approaches	B-T169
in	O
this	O
evaluating	O
clinical	B-T080
,	O
dietary	O
and	O
psychological	B-T169
risk	B-T033
factors	I-T033
for	O
relapse	O
of	O
ulcerative	B-T047
colitis	I-T047
in	O
clinical	B-T080
,	O
endoscopic	O
and	O
histological	B-T169
remission	O
the	O
literature	O
on	O
possible	O
factors	O
that	O
could	O
trigger	O
a	O
relapse	O
in	O
patients	O
with	O
ulcerative	B-T047
colitis	I-T047
uc	B-T047
in	O
clinical	B-T080
,	O
endoscopic	O
and	O
histological	B-T169
remission	O
on	O
long	O
term	O
follow	O
up	O
is	O
scarce	O
.	O
	
to	O
determine	O
the	O
relapse	O
rate	O
in	O
patients	O
with	O
uc	B-T047
in	O
clinical	B-T080
,	O
endoscopic	O
and	O
histological	B-T169
remission	O
and	O
identify	O
factors	O
that	O
may	O
influence	O
the	O
risk	B-T078
of	O
relapse	O
.	O
	
patients	O
with	O
uc	B-T047
in	O
clinical	B-T080
,	O
endoscopic	O
and	O
histological	B-T169
remission	O
were	O
enrolled	O
between	O
january-july	O
2010	O
and	O
followed	O
up	O
for	O
1	O
year	B-T079
to	O
determine	O
the	O
effect	O
of	O
clinical	B-T080
,	O
dietary	O
and	O
psychological	B-T169
factors	B-T033
on	O
relapse	O
.	O
	
information	O
regarding	O
factors	O
that	O
may	O
affect	O
relapse	O
such	O
as	O
infection	O
,	O
antibiotic	O
or	O
nsaids	O
use	O
and	O
any	O
other	O
factor	O
which	O
the	O
patient	O
felt	O
important	O
,	O
and	O
compliance	O
with	O
medications	O
was	O
obtained	O
.	O
	
97	O
patients	O
59	O
males	O
,	O
mean	O
age	O
39	O
+	O
11.9	O
years	B-T079
were	O
followed	O
up	O
for	O
a	O
mean	O
duration	O
of	O
9	O
+	O
2.3	O
months	B-T079
.	O
	
18	O
relapsed	O
with	O
the	O
median	O
time	O
to	O
relapse	O
being	O
3.5	O
months	B-T079
.	O
	
on	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
nsaids	O
use	O
within	O
15	O
days	B-T079
of	O
relapse	O
,	O
respiratory	B-T047
tract	I-T047
infection	I-T047
within	O
4	O
weeks	B-T079
,	O
use	O
of	O
steroids	B-T109
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	B-T109
,	O
vitamin	B-T109
a	I-T109
and	O
lower	O
consumption	O
of	O
sugars	B-T109
.	O
	
on	O
multivariate	B-T081
analysis	I-T081
,	O
nsaids	O
use	O
hr	O
intake	B-T169
of	O
vitamin	B-T109
a	I-T109
hr	O
were	O
statistically	O
significant	O
predictors	B-T078
of	O
relapse	O
.	O
	
with	O
a	O
relapse	O
rate	O
of	O
18.6	O
over	O
a	O
follow	O
up	O
of	O
9	O
months	B-T079
in	O
patients	O
with	O
uc	B-T047
in	O
clinical	B-T080
,	O
endoscopic	O
and	O
histological	B-T169
remission	O
,	O
independent	O
predictors	B-T078
of	O
relapse	O
were	O
history	O
of	O
nsaids	O
use	O
within	O
15	O
days	B-T079
of	O
relapse	O
and	O
higher	O
intake	O
of	O
vitamin	B-T109
a	I-T109
.	O
	
high	O
performance	O
reduction	O
of	O
h2o2	O
with	O
an	O
electron	O
transport	O
decaheme	B-T116
cytochrome	I-T116
on	O
a	O
porous	O
ito	O
electrode	O
the	O
decaheme	B-T116
cytochrome	I-T116
mtrc	I-T116
from	O
shewanella	O
oneidensis	O
mr-1	O
immobilized	B-T116
on	O
an	O
ito	O
electrode	O
displays	O
unprecedented	O
h2o2	O
reduction	O
activity	O
.	O
	
although	O
mtrc	B-T116
showed	O
lower	O
peroxidase	O
activity	O
in	O
solution	O
compared	O
to	O
horseradish	B-T116
peroxidase	I-T116
,	O
the	O
ten	O
heme	B-T109
cofactors	B-T109
enable	O
excellent	O
electronic	O
communication	O
and	O
a	O
superior	O
activity	O
on	O
the	O
electrode	O
surface	O
.	O
	
a	O
hierarchical	O
ito	O
electrode	O
enabled	O
optimal	O
immobilization	O
of	O
mtrc	B-T116
and	O
a	O
high	O
current	B-T081
density	I-T081
of	O
1	O
ma	O
cm	O
at	O
0.4	O
v	O
vs	O
she	O
could	O
be	O
obtained	O
at	O
ph	O
6.5	O
eonset	O
=	O
0.72	O
v	O
.	O
	
uv-visible	O
and	O
resonance	O
raman	O
spectroelectrochemical	O
studies	O
suggest	O
the	O
formation	O
of	O
a	O
high	O
valent	O
iron-oxo	O
species	O
as	O
the	O
catalytic	O
intermediate	O
.	O
	
our	O
findings	O
demonstrate	O
the	O
potential	B-T080
of	O
multiheme	B-T116
cytochromes	I-T116
to	O
catalyze	O
technologically	O
relevant	O
reactions	O
and	O
establish	O
mtrc	B-T116
as	O
a	O
new	O
benchmark	O
in	O
biotechnological	O
h2o2	O
reduction	O
with	O
scope	O
for	O
applications	O
in	O
fuel	O
cells	O
and	O
ophthalmic	O
manifestations	O
of	O
facial	O
dog	O
bites	O
in	O
children	O
to	O
characterize	O
ophthalmic	O
manifestations	O
and	O
periocular	O
injuries	O
of	O
pediatric	B-T080
facial	O
dog	O
bites	O
.	O
	
a	O
retrospective	B-T080
review	O
of	O
all	O
children	O
younger	B-T079
than	O
18	O
years	B-T079
who	O
sought	O
medical	B-T169
attention	O
after	O
a	O
dog	O
bite	O
to	O
the	O
face	O
between	O
january	B-T080
1	O
,	O
2003	O
and	O
may	B-T079
22	O
,	O
2014	O
was	O
performed	B-T169
at	O
a	O
large	B-T081
tertiary	I-T081
pediatric	O
hospital	O
.	O
	
data	B-T078
on	O
type	B-T080
and	O
location	B-T033
of	I-T033
injury	I-T033
,	O
surgical	B-T033
intervention	I-T033
,	O
and	O
complications	O
were	O
collected	B-T169
.	O
	
a	O
total	B-T080
of	O
1	O
children	O
aged	O
0.19	O
to	O
17	O
years	B-T079
were	O
identified	B-T080
with	O
dog	O
bite	O
s	O
.	O
	
dog	O
bite	O
s	O
to	O
the	O
face	O
occurred	O
in	O
most	O
patients	O
n	O
=	O
1	O
,	O
414	O
71%	O
.	O
	
of	O
those	O
children	O
with	O
facial	O
dog	O
bite	O
injuries	O
,	O
230	O
16%	O
suffered	O
ophthalmic	O
manifestations	O
.	O
	
the	O
average	O
age	O
was	O
4.3	O
years	O
.	O
	
eyelid	O
injuries	O
occurred	O
in	O
227	O
99%	O
of	O
children	O
,	O
47	O
20%	O
sustained	O
canalicular	O
system	O
injuries	O
,	O
3	O
1.3	O
suffered	O
corneal	O
abrasions	O
,	O
and	O
2	O
patients	O
sustained	O
facial	O
nerve	O
injury	O
resulting	O
in	O
lagophthalmos	O
.	O
	
no	O
patients	O
suffered	O
vision	O
loss	O
.	O
	
complications	O
occurred	O
in	O
32	O
patients	O
14%	O
,	O
with	O
the	O
most	O
common	O
being	O
epiphora	O
in	O
9	O
patients	O
28%	O
,	O
upper	O
eyelid	O
ptosis	O
in	O
8	O
25%	O
,	O
and	O
prominent	O
scar	O
formation	O
in	O
4	O
patients	O
13%	O
.	O
	
thirteen	O
children	O
5.7	O
needed	O
one	O
or	O
more	O
secondary	O
procedure	O
to	O
correct	O
complications	O
.	O
	
the	O
authors	O
report	O
the	O
clinical	O
features	O
and	O
management	O
on	O
the	O
largest	O
series	O
of	O
ophthalmic	O
and	O
periocular	O
injuries	O
associated	O
with	O
pediatric	O
facial	O
dog	O
bite	O
s	O
.	O
	
these	O
injuries	O
occur	O
in	O
about	O
1	O
in	O
6	O
dog	O
bite	O
s	O
to	O
the	O
face	O
and	O
primarily	O
involve	O
the	O
ocular	O
adnexa	O
.	O
	
despite	O
early	O
and	O
appropriate	O
surgical	O
management	O
,	O
complications	O
and	O
the	O
need	O
for	O
revision	O
surgery	O
are	O
relatively	O
common	B-T169
blastocystis	O
subtyping	O
and	O
its	O
association	O
with	O
intestinal	B-T047
parasites	I-T047
in	O
children	O
from	O
different	O
geographical	O
regions	O
of	O
colombia	O
blastocystis	O
is	O
a	O
common	O
enteric	B-T033
protist	I-T033
colonizing	I-T033
probably	O
more	O
than	O
1	O
billion	O
people	O
with	O
a	O
large	O
variety	O
of	O
non-human	O
hosts	O
.	O
	
remarkable	O
genetic	O
diversity	O
has	O
been	O
observed	O
,	O
leading	O
to	O
the	O
subdivision	O
of	O
the	O
genus	O
into	O
multiple	O
subtypes	O
st	O
,	O
some	O
of	O
which	O
are	O
exclusively	O
found	O
in	O
non-human	O
hosts	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
distribution	O
of	O
blastocystis	O
sts	O
/	O
18s	O
alleles	O
in	O
symptomatic	B-T169
abdominal	O
pain	O
,	O
anal	O
pruritus	O
,	O
diarrhea	O
,	O
headache	O
,	O
nauseas	O
and/or	O
vomit	O
and	O
asymptomatic	B-T033
children	O
from	O
nine	O
geographical	O
regions	O
of	O
colombia	O
.	O
	
a	O
total	O
of	O
2026	O
fecal	O
samples	O
were	O
collected	O
as	O
part	O
of	O
a	O
national	O
survey	O
to	O
estimate	O
the	O
frequency	O
of	O
intestinal	B-T047
parasites	I-T047
in	O
children	O
.	O
	
a	O
set	O
of	O
256	O
samples	O
that	O
were	O
blastocystis	O
positive	O
was	O
finally	O
selected	O
.	O
	
the	O
samples	O
were	O
submitted	O
to	O
dna	O
extraction	O
,	O
real	O
time	O
pcr	O
and	O
sequencing	O
using	O
blastocystis	B-T047
-specific	O
primers	O
targeting	O
the	O
small	O
subunit	O
rrna	O
gene	O
for	O
st	O
identification	O
.	O
	
dna	O
of	O
ascaris	O
lumbricoides	O
16.4	O
,	O
trichuris	O
trichiura	O
8.2	O
,	O
hookworms	O
necator	O
americanus	O
/	O
ancylostoma	O
duodenale	O
7.3	O
,	O
giardia	O
duodenalis	O
23.1	O
,	O
entamoeba	O
complex	O
82%	O
,	O
entamoeba	O
coli	O
55%	O
,	O
hymenolepis	O
nana	O
0.8	O
,	O
endolimax	O
nana	O
33.2	O
and	O
neobalantidium	O
coli	O
2.7	O
was	O
detected	O
in	O
the	O
blastocystis	O
-	O
positive	B-T033
samples	I-T033
.	O
	
we	O
detected	O
st1	O
21.4	O
,	O
st2	O
19.5	O
,	O
st3	O
55.5	O
,	O
st4	O
0.8	O
,	O
st6	O
2%	O
and	O
st7	O
0.8	O
alleles	O
1	O
,	O
2	O
,	O
4	O
,	O
81	O
,	O
82	O
and	O
83	O
for	O
st1	O
alleles	O
9	O
,	O
11	O
,	O
12	O
,	O
15	O
,	O
67	O
,	O
71	O
and	O
73	O
for	O
st2	O
alleles	O
34	O
,	O
36	O
,	O
38	O
,	O
45	O
,	O
49	O
,	O
55	O
,	O
134	O
and	O
128	O
for	O
st3	O
allele	O
42	O
for	O
st4	O
allele	O
122	O
for	O
st6	O
,	O
and	O
allele	O
142	O
for	O
st7	O
.	O
	
further	O
studies	O
implementing	O
high-resolution	O
molecular	O
markers	O
are	O
necessary	O
to	O
understand	O
the	O
dynamics	O
of	O
blastocystis	O
transmission	O
and	O
the	O
role	O
of	O
this	O
stramenopila	O
in	O
health	O
and	O
disease	O
.	O
	
did	O
municipal	O
solid	O
waste	O
landfill	O
have	O
obvious	O
influence	O
on	O
polychlorinated	B-T109
dibenzo-p-dioxins	I-T109
and	O
polychlorinated	B-T109
dibenzofurans	I-T109
pcdd	B-T109
/	O
fs	B-T109
in	O
ambient	O
air	O
a	O
case	O
study	O
in	O
east	O
china	O
municipal	O
solid	O
waste	O
msw	O
landfill	O
was	O
a	O
main	O
way	O
to	O
disposal	O
of	O
msw	O
and	O
almost	O
95%	O
of	O
msw	O
was	O
disposed	O
by	O
landfills	O
in	O
the	O
world	O
.	O
	
in	O
order	O
to	O
understand	O
the	O
influence	O
of	O
msw	O
landfill	O
on	O
polychlorinated	B-T109
dibenzo-p-dioxins	I-T109
and	O
polychlorinated	B-T109
dibenzofurans	I-T109
pcdd	B-T109
/	O
fs	B-T109
in	O
surrounding	O
atmosphere	O
,	O
42	O
ambient	O
air	O
samples	O
were	O
collected	O
and	O
analyzed	O
from	O
surrounding	O
sites	O
,	O
background	O
site	O
,	O
upwind	O
site	O
and	O
downwind	O
site	O
of	O
a	O
msw	O
landfill	O
in	O
east	O
china	O
.	O
	
the	O
results	O
of	O
present	O
study	O
were	O
summarized	O
as	O
follows	O
.	O
	
1	O
the	O
total	O
concentrations	B-T081
of	O
pcdd	B-T109
/	O
fs	B-T109
pcdd	B-T109
/	O
fs	B-T109
in	O
ambient	O
air	O
from	O
surrounding	O
sites	O
,	O
background	O
site	O
,	O
upwind	O
site	O
and	O
downwind	O
site	O
were	O
2.215	O
,	O
2.058	O
,	O
2.617	O
and	O
1.822	O
,	O
respectively	O
.	O
	
2	O
the	O
toxic	B-T081
equivalent	I-T081
concentrations	I-T081
teq	B-T081
of	O
pcdd	B-T109
/	O
fs	B-T109
in	O
ambient	O
air	O
from	O
surrounding	O
sites	O
,	O
background	O
site	O
,	O
upwind	O
site	O
and	O
downwind	O
site	O
were	O
0.103	O
,	O
0.096	O
,	O
0.120	O
and	O
0.108	O
i-teqnm	O
,	O
respectively	O
.	O
	
3	O
the	O
congener	O
profiles	O
,	O
pcdd	B-T109
/	O
fs	B-T109
and	O
teq	B-T081
between	O
background	O
atmosphere	O
and	O
surrounding	O
atmosphere	O
of	O
landfill	O
did	O
not	O
show	O
statistically	B-T081
significant	I-T081
difference	O
.	O
	
4	O
the	O
pcdd	B-T109
/	O
fs	B-T109
and	O
teq	B-T081
in	O
ambient	O
air	O
of	O
downwind	O
site	O
were	O
not	O
higher	O
than	O
that	O
of	O
upwind	O
site	O
,	O
suggesting	O
that	O
studied	O
landfill	O
did	O
not	O
have	O
obvious	O
influence	O
on	O
pcdd	B-T109
/	O
fs	B-T109
in	O
ambient	O
air	O
from	O
downwind	O
site	O
.	O
	
5	O
the	O
95th	O
percentile	B-T081
carcinogenic	B-T081
risk	I-T081
cr	B-T081
of	O
pcdd	B-T109
/	O
fs	B-T109
in	O
ambient	O
air	O
from	O
s	O
urrounding	O
sites	O
,	O
background	O
site	O
,	O
upwind	O
site	O
and	O
downwind	O
site	O
were	O
8.03	O
,	O
7.57	O
,	O
9.69	O
and	O
8.15	O
,	O
respectively	O
,	O
which	O
were	O
much	B-T080
lower	I-T080
than	I-T080
the	I-T080
threshold	I-T080
value	I-T080
of	O
cr	B-T081
10	O
,	O
suggesting	O
that	O
studied	O
landfill	O
did	O
not	O
influence	O
the	O
cr	B-T081
of	O
pcdd	B-T109
/	O
fs	B-T109
in	O
surrounding	O
atmosphere	O
and	O
negligible	O
cancer	B-T081
risk	I-T081
occurred	O
.	O
	
6	O
the	O
non-carcinogenic	B-T033
risk	I-T033
non-cr	B-T033
analysis	O
indicated	O
that	O
landfill	O
did	O
not	O
have	O
influence	O
on	O
the	O
non-cr	B-T033
of	O
pcdd	B-T109
/	O
fs	B-T109
in	O
surrounding	O
atmosphere	O
and	O
no	O
obvious	O
non-carcinogenic	B-T080
effects	I-T080
methodological	B-T080
considerations	I-T080
for	O
designing	O
a	O
community	O
water	O
fluoridation	O
cessation	O
study	O
high-quality	O
,	O
up-to-date	O
research	O
on	O
community	O
water	O
fluoridation	O
cwf	O
,	O
and	O
especially	O
on	O
the	O
implications	O
of	O
cwf	O
cessation	O
for	O
dental	O
health	O
,	O
is	O
limited	O
.	O
	
although	O
cwf	O
cessation	O
studies	O
have	O
been	O
conducted	O
,	O
they	O
are	O
few	O
in	O
number	O
one	O
of	O
the	O
major	O
reasons	O
is	O
the	O
methodological	B-T169
complexity	I-T169
of	O
conducting	O
such	O
a	O
study	O
.	O
	
this	O
article	O
draws	O
on	O
a	O
systematic	O
review	O
of	O
existing	O
cessation	O
studies	O
n=15	O
to	O
explore	O
methodological	B-T080
considerations	I-T080
of	O
conducting	O
cwf	O
cessation	O
studies	O
in	O
future	B-T079
.	O
	
we	O
review	O
nine	O
important	O
methodological	B-T080
aspects	I-T080
study	O
design	O
,	O
comparison	O
community	O
,	O
target	O
population	O
,	O
time	B-T079
frame	I-T079
,	O
sampling	O
strategy	O
,	O
clinical	B-T169
indicators	I-T169
,	O
assessment	O
criteria	O
,	O
covariates	O
and	O
biomarkers	O
and	O
provide	O
recommendations	B-T078
for	O
planning	O
future	B-T079
cwf	O
cessation	O
studies	O
that	O
examine	O
effects	O
on	O
dental	B-T047
caries	I-T047
.	O
	
there	O
is	O
no	O
one	O
ideal	O
study	O
design	O
to	O
answer	O
a	O
research	B-T078
question	I-T078
.	O
	
however	O
,	O
recommendations	B-T078
proposed	O
regarding	O
methodological	B-T080
aspects	I-T080
to	O
conduct	O
an	O
epidemiological	O
study	O
to	O
observe	O
the	O
effects	O
of	O
cwf	O
cessation	O
on	O
dental	B-T047
caries	I-T047
,	O
coupled	O
with	O
our	O
identification	O
of	O
important	O
methodological	O
gaps	O
,	O
will	O
be	O
useful	O
for	O
researchers	O
who	O
are	O
looking	O
to	O
optimize	O
resources	B-T078
to	O
conduct	O
such	O
a	O
study	O
central	O
myxoma	O
/	O
myxofibroma	O
of	O
the	O
jaws	O
a	O
clinico	O
-	O
epidemiologic	B-T169
review	O
myxomas	O
are	O
a	O
group	O
of	O
benign	B-T080
rare	B-T047
tumors	I-T047
of	O
connective-tissue	O
origin	B-T079
that	O
occur	O
in	O
both	O
hard	O
central	O
and	O
soft	O
tissues	O
of	O
the	O
body	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	O
is	O
to	O
highlight	O
our	O
experience	O
in	O
the	O
management	O
of	O
central	O
myxoma	O
of	O
the	O
jaw	O
,	O
with	O
emphasis	O
on	O
its	O
clinic	O
-	O
epidemiologic	B-T169
features	O
as	O
seen	O
in	O
our	O
environment	O
.	O
	
all	O
patients	O
who	O
were	O
managed	O
for	O
central	O
myxoma	O
of	O
the	O
jaw	O
at	O
the	O
oral	O
and	O
maxillofacial	O
surgery	O
department	O
of	O
a	O
regional	O
university	O
teaching	O
hospital	O
between	O
september	O
1997	O
and	O
october	O
2015	O
were	O
retrospectively	O
studied	O
.	O
	
details	O
sourced	O
included	O
age	O
,	O
sex	O
,	O
site	O
of	O
tumor	O
,	O
duration	B-T079
,	O
signs/symptoms	B-T033
,	O
treatment	B-T033
given	I-T033
,	O
and	O
complications	O
.	O
	
data	B-T078
were	O
analyzed	O
using	O
statistical	O
package	O
for	O
social	O
sciences	O
spss	O
version	O
16	O
spss	O
inc	O
chicago	O
,	O
il	O
,	O
usa	O
and	O
microsoft	O
excel	O
2007	O
microsoft	O
,	O
redmond	O
,	O
wa	O
,	O
usa	O
.	O
	
results	B-T169
from	O
descriptive	B-T081
statistics	I-T081
were	O
represented	O
in	O
the	O
form	O
of	O
tables	O
and	O
charts	O
,	O
with	O
a	O
test	O
for	O
significance	O
ρ	O
using	O
pearson	O
chi-square	O
χ	O
set	O
at	O
0.05	O
.	O
	
a	O
total	O
of	O
16	O
patients	O
were	O
managed	O
within	O
the	O
period	B-T079
reviewed	B-T080
,	O
consisting	O
of	O
10	O
62.5	O
females	O
and	O
six	O
37.5	O
males	O
,	O
giving	O
a	O
male-to-female	O
ratio	O
of	O
1	O
.	O
	
the	O
ages	O
of	O
patients	O
ranged	B-T081
from	O
5	O
to	O
70	O
years	B-T079
,	O
with	O
a	O
mean	O
of	O
27.06	O
years	B-T079
.	O
	
the	O
mandible	O
accounted	O
for	O
nine	O
56.3	O
cases	B-T169
and	O
the	O
maxilla	O
for	O
six	O
37.5	O
cases	B-T169
,	O
while	O
a	O
combination	B-T080
of	O
the	O
maxilla	O
and	O
the	O
zygoma	O
were	O
involved	O
in	O
one	O
6.3	O
case	B-T169
.	O
	
bucco-lingual	O
or	O
bucco-palatal	O
expansion	O
were	O
the	O
most	O
common	O
presentation	O
six	O
46.2	O
cases	B-T169
each	O
.	O
	
histological	B-T169
assessment	O
of	O
tissue	O
specimens	O
showed	O
that	O
fibromyxoma	O
accounted	B-T078
for	O
seven	O
43.8	O
cases	B-T169
,	O
while	O
the	O
remaining	O
nine	O
56.3	O
cases	B-T169
were	O
diagnosed	B-T033
as	O
myxoma	O
.	O
	
all	O
patients	O
had	O
jaw	B-T061
resections	I-T061
,	O
and	O
these	O
consisted	O
of	O
mandibulectomies	B-T061
in	O
nine	O
60.0	O
patients	O
and	O
maxillectomies	B-T061
in	O
six	O
40.0	O
patients	O
.	O
	
the	O
duration	B-T079
of	I-T079
hospital	I-T079
stay	I-T079
ranged	B-T081
from	O
5	O
to	O
29	O
days	B-T079
,	O
with	O
a	O
mean	O
of	O
17.86	O
days	B-T079
.	O
	
complications	O
were	O
noted	O
in	O
three	O
patients	O
,	O
and	O
all	O
were	O
surgical	O
wound	O
infections	O
.	O
	
most	O
patients	O
in	O
our	O
environment	O
present	O
late	O
with	O
large	B-T080
tumors	I-T080
and	O
are	O
usually	O
not	O
compliant	O
with	O
follow-up	O
review	B-T078
.	O
	
thus	O
,	O
a	O
radical	B-T080
approach	O
is	O
favored	O
in	O
most	O
pediatric	B-T080
hypovitaminosis	B-T047
d	I-T047
molecular	O
perspectives	B-T080
and	O
clinical	O
implications	B-T078
vitamin	B-T109
d	I-T109
,	O
a	O
secosteroid	B-T109
,	O
is	O
essential	B-T080
for	O
the	O
development	O
and	O
maintenance	O
of	O
healthy	B-T080
bone	O
in	O
both	O
the	O
adult	O
and	O
pediatric	B-T080
populations	O
.	O
	
low	B-T081
level	I-T081
of	O
25-hydroxy	O
vitamin	O
d	O
25-	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	B-T047
,	O
osteomalacia	B-T047
,	O
osteomalacic	B-T047
myopathy	I-T047
,	O
sarcopenia	B-T047
,	O
and	O
weakness	O
,	O
growth	O
retardation	O
,	O
hypocalcemia	B-T047
,	O
seizure	O
and	O
tetany	B-T047
,	O
autism	O
,	O
cardiovascular	B-T047
diseases	I-T047
,	O
diabetes	B-T047
mellitus	I-T047
,	O
cancers	O
prostate	O
,	O
colon	O
,	O
breast	O
,	O
infectious	B-T047
diseases	I-T047
viral	B-T047
,	O
tuberculosis	B-T047
,	O
and	O
autoimmune	B-T047
diseases	I-T047
,	O
such	O
as	O
multiple	B-T047
sclerosis	I-T047
and	O
hashimoto's	B-T047
thyroiditis	I-T047
.	O
	
risk	B-T033
factors	I-T033
for	O
hypovitaminosis	B-T047
d	I-T047
are	O
people	O
with	O
darker	O
skin	O
pigmentation	O
,	O
use	B-T169
of	O
sunscreen	O
,	O
insufficient	B-T080
ultraviolet	O
b	O
exposure	B-T080
,	O
prematurity	B-T047
,	O
living	O
in	O
northern	O
latitudes	O
,	O
malnutrition	B-T047
,	O
obesity	B-T047
,	O
exclusive	O
breastfeeding	O
,	O
low	B-T033
maternal	I-T033
vitamin	I-T033
d	I-T033
level	I-T033
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow's	O
milk	O
,	O
liver	B-T047
failure	I-T047
,	O
chronic	B-T047
renal	I-T047
insufficiency	I-T047
,	O
cystic	B-T047
fibrosis	I-T047
,	O
asthma	B-T047
,	O
and	O
sickle	B-T047
cell	I-T047
hemoglobinopathy	I-T047
.	O
	
this	O
review	O
highlights	O
and	O
summarizes	O
the	O
molecular	O
perspectives	O
of	O
vitamin	B-T047
d	I-T047
deficiency	I-T047
and	O
its	O
potential	O
adverse	O
health	O
outcomes	O
in	O
pediatric	B-T080
age	O
groups	O
.	O
	
the	O
recommended	B-T033
treatment	I-T033
regimen	I-T033
is	O
beyond	O
the	O
scope	O
of	O
this	O
causes	O
of	O
ecological	O
gradients	B-T081
in	O
leaf	O
margin	O
entirety	B-T081
evaluating	O
the	O
roles	O
of	O
biomechanics	O
,	O
hydraulics	O
,	O
vein	O
geometry	O
,	O
and	O
bud	O
packing	O
a	O
recent	B-T079
commentary	O
by	O
edwards	O
et	O
al	O
.	O
	
am	O
.	O
	
j	O
.	O
	
bot	O
.	O
	
103	O
975-978	O
proposed	B-T080
that	O
constraints	B-T169
imposed	O
by	O
the	O
packing	O
of	O
young	B-T079
leaves	O
in	O
buds	O
could	O
explain	O
the	O
positive	B-T033
association	B-T078
between	O
non-entire	B-T080
leaf	O
margins	O
and	O
latitude	B-T081
but	O
did	O
not	O
thoroughly	O
consider	B-T078
alternative	O
explanations	O
.	O
	
we	O
review	B-T078
the	O
logic	B-T078
and	O
evidence	B-T078
underlying	O
six	O
major	B-T080
hypotheses	B-T078
for	O
the	O
functional	B-T169
significance	B-T078
of	O
marginal	O
teeth	O
,	O
involving	O
putative	B-T078
effects	B-T080
on	O
1	O
leaf	O
cooling	O
,	O
2	O
optimal	B-T080
support	O
and	O
supply	O
of	O
the	O
areas	O
served	O
by	O
major	B-T080
veins	O
,	O
3	O
enhanced	B-T081
leaf	O
-	O
margin	O
photosynthesis	O
,	O
4	O
hydathodal	O
function	O
,	O
5	O
defense	O
against	B-T080
herbivores	O
,	O
and	O
6	O
bud	O
packing	O
.	O
	
theoretical	B-T078
and	O
empirical	B-T080
problems	B-T033
undermine	O
all	O
hypotheses	B-T078
except	B-T169
the	O
support-supply	B-T078
hypothesis	I-T078
,	O
which	O
implies	O
that	O
thinner	B-T080
leaves	O
should	O
have	O
non-entire	B-T080
margins	O
.	O
	
phylogenetically	B-T078
structured	O
analyses	O
across	O
angiosperms	O
,	O
the	O
el	O
yunque	O
flora	B-T033
,	O
and	O
the	O
genus	O
viburnum	O
all	O
demonstrate	O
that	O
non-entire	B-T080
margins	O
are	O
indeed	B-T080
more	O
common	B-T081
in	O
thinner	B-T080
leaves	O
.	O
	
across	O
angiosperms	O
,	O
the	O
association	B-T078
of	O
leaf	O
thickness	B-T080
with	O
non-entire	B-T080
leaf	O
margins	O
is	O
stronger	B-T080
than	O
that	O
of	O
latitude	B-T081
.	O
	
we	O
outline	O
a	O
synthetic	O
model	O
showing	O
how	O
biomechanics	O
,	O
hydraulics	O
,	O
vein	O
geometry	O
,	O
rates	B-T079
of	O
leaf	O
expansion	O
,	O
and	O
length	O
of	O
development	B-T169
within	O
resting	B-T033
buds	O
,	O
all	O
tied	O
to	O
leaf	O
thickness	B-T080
,	O
drive	B-T033
patterns	O
in	O
the	O
distribution	O
of	O
entire	B-T081
vs	O
.	O
	
non-entire	B-T080
leaf	O
margins	O
.	O
	
our	O
model	O
accounts	O
for	O
dominance	B-T078
of	O
entire	B-T081
margins	O
in	O
the	O
tropics	O
,	O
mediterranean	O
scrub	O
,	O
and	O
tundra	O
,	O
non-entire	B-T080
margins	O
in	O
cold	O
temperate	O
deciduous	O
forests	O
and	O
tropical	O
vines	O
and	O
early-successional	O
trees	O
,	O
and	O
entire	B-T081
leaf	O
margins	O
in	O
monocots	O
.	O
	
spinose-toothed	O
leaves	O
should	O
be	O
favored	O
in	O
short-statured	B-T033
evergreen	O
trees	O
and	O
shrubs	O
,	O
primarily	O
in	O
mediterranean	O
scrub	O
and	O
related	O
semiarid	O
habitats	O
.	O
	
viral	O
vector	O
biosafety	O
in	O
laboratory	O
animal	O
research	O
viral	O
vector	O
research	O
presents	B-T078
unique	B-T080
occupational	O
health	O
and	O
safety	O
challenges	O
to	O
institutions	O
due	O
to	O
the	O
rapid	B-T080
development	B-T169
ofboth	O
in	O
vivo	O
and	O
in	B-T080
vitro	I-T080
gene-editing	O
technologies	O
.	O
	
risks	B-T078
to	O
human	O
and	O
animal	O
health	B-T078
make	O
it	O
incumbent	B-T080
on	O
institutions	O
to	O
appropriately	B-T080
evaluate	O
viral	O
vector	O
usage	B-T169
in	O
research	O
on	O
the	O
basis	B-T169
of	O
available	B-T169
information	B-T078
and	O
governmental	O
regulations	O
and	O
guidelines	O
here	O
we	O
review	B-T078
the	O
factors	B-T169
related	O
to	O
risk	O
assessment	O
regarding	O
viral	O
vector	O
usage	B-T169
in	O
animals	O
and	O
the	O
relevant	B-T080
regulatory	O
documents	O
associated	B-T080
with	I-T080
this	O
research	O
,	O
and	O
we	O
highlight	O
the	O
most	B-T081
commonly	B-T081
used	O
viral	O
vectors	O
in	O
research	O
today	O
.	O
	
this	O
review	B-T078
is	O
particularly	B-T080
focused	B-T169
on	O
the	O
background	O
,	O
use	O
in	O
research	O
and	O
associated	B-T080
health	B-T078
and	O
environmental	B-T080
risks	I-T080
related	B-T080
to	O
adenoviral	O
,	O
adeno-associated	O
viral	O
,	O
lentiviral	O
,	O
and	O
herpesviral	O
vectors	O
.	O
	
liver	B-T047
inflammation	I-T047
relates	O
to	O
decreased	B-T081
canalicular	O
bile	B-T116
transporter	I-T116
expression	O
in	O
pediatric	B-T080
onset	B-T081
intestinal	B-T047
failure	I-T047
although	O
liver	B-T047
disease	I-T047
is	O
a	O
major	O
complication	O
of	O
parenteral	B-T061
nutrition	I-T061
pn	B-T061
for	O
intestinal	B-T047
failure	I-T047
if	B-T047
,	O
its	O
pathogenesis	O
remains	O
unclear	O
.	O
	
we	O
investigated	B-T169
potential	O
molecular	B-T080
mechanisms	B-T169
of	O
liver	O
injury	O
in	O
pediatric	B-T080
onset	B-T081
if	B-T047
.	O
	
liver	O
expression	O
of	O
canalicular	O
phospholipid	B-T109
abcb4	B-T116
,	O
bile	B-T109
acid	I-T109
abcb11	B-T116
,	O
and	O
sterol	B-T109
abcg5/8	B-T116
transporters	B-T116
,	O
their	O
upstream	B-T116
regulators	I-T116
lxr	B-T116
and	O
fxr	B-T116
as	O
well	O
as	O
pro-inflammatory	B-T116
cytokines	I-T116
interleukin-6	B-T116
il6	B-T116
and	O
tumor	B-T116
necrosis	I-T116
factor	I-T116
tnf	B-T116
were	O
investigated	B-T169
among	O
patients	O
with	O
if	B-T047
age	O
median	O
3.8	O
iqr	B-T081
1.2	O
to	O
11	O
in	O
relation	O
to	O
biochemical	B-T169
and	O
histologic	B-T169
liver	O
injury	O
,	O
pn	B-T061
,	O
serum	O
plant	B-T109
sterols	I-T109
,	O
fibroblast	B-T116
growth	I-T116
factor	I-T116
19	I-T116
,	O
and	O
α-tocopherol	B-T109
.	O
	
patients	O
receiving	O
pn	B-T061
currently	O
n	O
=	O
18	O
showed	O
more	O
advanced	O
liver	O
injury	O
than	O
patients	O
after	O
weaning	B-T033
off	O
pn	B-T061
n	O
=	O
30	O
.	O
	
histologic	B-T169
portal	B-T033
inflammation	I-T033
strongly	O
segregated	O
pn	B-T061
-	O
dependent	B-T169
44%	O
from	O
weaned	B-T033
off	O
patients	O
3%	O
,	O
p	O
=	O
0.001	O
and	O
coupled	O
with	O
progression	O
of	O
cholestasis	B-T047
and	O
liver	B-T047
fibrosis	I-T047
.	O
	
patients	O
with	O
portal	B-T033
inflammation	I-T033
demonstrated	O
markedly	O
induced	O
liver	O
rna	O
expression	O
of	O
il6	O
and	O
tnf	O
,	O
repression	O
of	O
fxr	B-T116
and	O
its	O
canalicular	O
bile	B-T116
transporter	I-T116
target	O
gene	O
rna	O
expression	O
,	O
including	O
abcb4	O
and	O
abcb11	O
as	O
well	O
as	O
decreased	B-T081
protein	O
expression	O
of	O
abcb11	B-T116
and	O
abcb4	B-T116
.	O
	
furthermore	O
,	O
upregulation	O
of	O
lxr	B-T116
and	O
abcg5/8	O
rna	O
expression	O
was	O
suppressed	B-T169
in	O
patients	O
with	O
portal	B-T033
inflammation	I-T033
.	O
	
current	O
pn	B-T061
,	O
increased	B-T081
serum	O
levels	B-T080
of	O
plant	B-T109
sterols	I-T109
stigmasterol	B-T109
,	O
avenasterol	B-T109
,	O
and	O
sitosterol	B-T109
along	O
with	O
serum	O
citrulline	B-T116
,	O
a	O
marker	O
of	O
enterocyte	O
mass	O
,	O
predicted	O
portal	B-T033
inflammation	I-T033
.	O
	
in	O
pediatric	B-T080
onset	B-T081
if	B-T047
,	O
current	O
pn	B-T061
delivery	O
synergistically	O
with	O
intestinal	O
compromise	B-T033
promote	O
liver	B-T047
inflammation	I-T047
,	O
which	O
associates	B-T080
with	O
progression	O
of	O
biochemical	B-T169
and	O
histologic	B-T169
liver	O
injury	O
,	O
while	O
reducing	B-T080
expression	O
of	O
canalicular	O
bile	B-T116
transporters	I-T116
.	O
	
impaired	B-T033
mobility	I-T033
,	O
depressed	B-T033
mood	I-T033
,	O
cognitive	O
impairment	O
and	O
polypharmacy	B-T033
are	O
independently	O
associated	O
with	O
disability	B-T033
in	O
older	O
cancer	O
outpatients	O
the	O
prospective	O
physical	B-T033
frailty	I-T033
in	O
elderly	O
cancer	O
patients	O
pf	B-T033
-	O
ec	O
cohort	B-T081
study	I-T081
to	O
assess	O
the	O
prevalence	O
of	O
disability	B-T033
and	O
the	O
oncologic	B-T033
factors	I-T033
associated	O
with	O
disability	B-T033
in	O
older	O
outpatients	O
with	O
cancer	O
.	O
	
the	O
physical	B-T033
frailty	I-T033
in	O
elderly	O
cancer	O
patients	O
pf	B-T033
-	O
ec	O
study	O
france	O
is	O
a	O
prospective	O
bicentric	O
observational	O
cohort	O
study	O
.	O
	
two	O
hundred	O
and	O
ninety	O
outpatients	O
with	O
cancer	O
were	O
included	O
.	O
	
a	O
cross-sectional	O
analysis	O
of	O
oncologic	B-T033
factors	I-T033
and	O
geriatric	B-T080
variables	B-T080
associated	O
with	O
disability	B-T033
that	O
were	O
collected	O
using	O
a	O
comprehensive	B-T080
geriatric	O
assessment	O
cga	O
was	O
conducted	O
.	O
	
disability	B-T033
was	O
defined	O
as	O
impairment	B-T169
in	O
activities	O
of	O
daily	O
living	O
adl	O
and/or	O
instrumental	B-T033
activities	I-T033
of	I-T033
daily	I-T033
living	I-T033
iadl	B-T033
,	O
simplified	O
to	O
four	O
items	O
.	O
	
univariate	O
and	O
multivariate	B-T081
logistic	B-T081
models	I-T081
of	O
disabled	O
patients	O
were	O
performed	O
.	O
	
the	O
three	O
final	O
multivariate	B-T081
models	B-T081
were	O
compared	O
using	O
the	O
area	O
under	O
the	O
receiver	B-T081
operating	I-T081
characteristic	I-T081
curve	I-T081
auc	B-T081
/	O
roc	B-T081
of	O
the	O
logistic	B-T081
model	I-T081
.	O
	
the	O
mean	O
age	O
was	O
80.6years	O
,	O
and	O
51%	O
of	O
the	O
patients	O
were	O
women	O
with	O
various	O
types	O
of	O
cancer	O
.	O
	
the	O
prevalence	O
of	O
disability	B-T033
was	O
67.6	O
.	O
	
no	O
oncologic	B-T033
factors	I-T033
cancer	O
site	O
,	O
cancer	O
extension	O
were	O
associated	O
with	O
disability	B-T033
.	O
	
impaired	B-T033
mobility	I-T033
,	O
poor	B-T033
functional	I-T033
status	I-T033
,	O
depressive	B-T033
mood	I-T033
,	O
cognitive	O
impairment	O
and	O
polypharmacy	B-T033
were	O
independently	O
associated	O
with	O
disability	B-T033
p<0	O
.	O
	
the	O
auc/roc	O
of	O
the	O
final	O
models	O
was	O
similar	O
.	O
	
disability	B-T033
was	O
highly	O
prevalent	O
in	O
older	O
cancer	O
outpatients	O
before	O
cancer	B-T061
treatment	I-T061
but	O
was	O
not	O
associated	O
with	O
oncologic	B-T033
factors	I-T033
.	O
	
impaired	B-T033
mobility	I-T033
,	O
depressed	B-T033
mood	I-T033
,	O
cognitive	O
impairment	O
and	O
polypharmacy	B-T033
were	O
the	O
geriatric	O
variables	O
significantly	O
and	O
independently	O
associated	O
with	O
disability	B-T033
.	O
	
identifying	O
these	O
factors	O
prior	O
to	O
cancer	B-T061
treatment	I-T061
could	O
enable	O
the	O
implementation	O
of	O
corrective	B-T169
actions	I-T169
to	O
improve	O
patient	O
autonomy	O
before	O
treatment	B-T061
and	O
during	O
synthesis	O
,	O
sar	B-T080
and	O
molecular	O
docking	O
study	O
of	O
novel	O
non-β-lactam	O
inhibitors	O
of	O
tem	B-T116
type	I-T116
β-lactamase	I-T116
the	O
novel	O
classes	O
of	O
acylated	O
phenoxyanilide	O
and	O
thiourea	O
compounds	O
were	O
investigated	B-T169
for	O
their	O
ability	O
to	O
inhibit	O
tem	B-T116
type	I-T116
β-lactamase	I-T116
enzyme	I-T116
.	O
	
two	O
compounds	O
4g	O
and	O
5c	O
reveal	O
the	O
inhibition	O
potency	B-T081
in	O
micromolar	B-T081
range	O
and	O
show	O
their	O
action	O
by	O
non-covalent	O
binding	O
in	O
the	O
vicinity	O
of	O
the	O
tem-171	B-T116
active	B-T169
site	I-T169
.	O
	
the	O
structure	B-T080
activity	I-T080
relationship	I-T080
around	O
carbon	B-T081
chain	I-T081
length	I-T081
and	O
different	O
substituents	O
in	O
ortho-	O
and	O
para-positions	O
of	O
acylated	O
phenoxyanilide	O
as	O
well	O
as	O
molecular	O
modelling	O
study	O
metabolic	B-T033
responses	I-T033
of	O
the	O
growing	O
daphnia	O
similis	O
to	O
chronic	B-T079
agnps	O
exposure	O
as	O
revealed	O
by	O
gc-q-tof/ms	O
and	O
lc-q-tof/ms	O
silver	O
nanoparticles	O
agnps	O
are	O
one	O
of	O
the	O
most	O
widely	O
used	O
nanomaterials	O
.	O
	
their	O
fast-growing	B-T033
utilization	O
has	O
increased	B-T081
the	O
occurrence	O
of	O
agnps	O
in	O
the	O
environment	O
,	O
posing	O
potential	O
health	B-T078
and	I-T078
ecological	I-T078
risks	I-T078
.	O
	
in	O
this	O
study	O
,	O
we	O
conducted	O
chronic	O
toxicity	O
tests	O
and	O
investigated	O
the	O
metabolic	O
changes	B-T169
of	O
the	O
growing	O
daphna	O
similis	O
with	O
exposure	B-T080
to	I-T080
0	O
,	O
0.02	O
,	O
and	O
1	O
ppb	O
agnps	O
,	O
using	O
non-targeted	O
mass	O
spectrometry	O
-based	O
metabolomics	O
.	O
	
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
study	O
is	O
the	O
first	O
to	O
report	O
the	O
baseline	B-T081
metabolite	O
change	B-T169
of	O
a	O
common	O
aquatic	O
organism	O
daphnia	O
crustacean	O
through	O
its	O
life-cycle	B-T079
.	O
	
the	O
results	O
show	O
a	O
dynamic	B-T033
kinetic	I-T033
pattern	I-T033
of	O
the	O
growing	O
daphnia's	O
metabolome	O
underwent	O
a	O
cycle	B-T079
from	O
day	B-T079
0	O
to	O
day	B-T079
21	O
,	O
with	O
the	O
level	B-T080
of	O
metabolites	O
gradually	O
increasing	B-T169
from	O
day	B-T079
0	O
to	O
day	B-T079
13	O
,	O
before	O
falling	O
back	O
to	O
the	O
baseline	B-T081
level	B-T080
of	O
day	B-T079
0	O
on	O
day	B-T079
21	O
.	O
	
as	O
for	O
the	O
samples	O
exposed	B-T080
to	I-T080
environmental	B-T081
concentrations	I-T081
of	O
agnps	O
,	O
although	O
without	O
morphological	B-T033
or	I-T033
structural	I-T033
changes	I-T033
,	O
numerous	O
metabolite	O
changes	B-T169
occurred	O
abruptly	O
during	O
the	O
first	O
10	O
days	B-T079
,	O
and	O
these	O
changes	B-T169
reached	O
steady	O
state	O
by	O
day	B-T079
13	O
.	O
	
the	O
significant	O
changes	B-T169
in	O
certain	O
metabolites	O
,	O
such	O
as	O
amino	B-T116
acids	I-T116
serine	B-T116
,	O
threonine	B-T116
and	O
tyrosine	B-T116
,	O
sugars	B-T109
d-allose	B-T109
and	O
fatty	B-T109
acids	I-T109
arachidonic	B-T109
acid	I-T109
revealed	O
new	O
insights	O
into	O
how	O
these	O
metabolites	O
in	O
daphnia	O
respond	O
to	O
chronic	B-T079
agnps	O
stress	O
.	O
	
these	O
findings	B-T169
highlight	O
the	O
capability	B-T080
of	O
metabolomics	O
to	O
discover	O
early	O
metabolic	B-T033
responses	I-T033
to	O
environmental	O
silver	O
nanoparticles	O
.	O
	
evaluating	O
the	O
relative	B-T081
effectiveness	I-T081
of	O
high-intensity	O
and	O
low-intensity	B-T081
models	I-T081
of	O
behaviour	O
change	O
communication	B-T061
interventions	I-T061
for	O
abortion	B-T033
care-seeking	O
in	O
bihar	O
and	O
jharkhand	O
,	O
india	O
a	O
cross-sectional	O
study	O
this	O
study	O
aimed	O
to	O
compare	O
the	O
effectiveness	B-T080
of	O
a	O
high-intensity	O
model	O
him	O
and	O
a	O
low-intensity	B-T081
model	I-T081
lim	B-T081
of	O
behaviour	O
change	O
communication	B-T061
interventions	I-T061
in	O
bihar	O
and	O
jharkhand	O
states	O
of	O
india	O
designed	O
to	O
improve	O
women's	O
knowledge	B-T033
and	O
usage	O
of	O
safe	B-T033
abortion	I-T033
services	O
,	O
as	O
well	O
as	O
the	O
dose	O
effect	O
of	O
intervention	B-T061
exposure	O
.	O
	
we	O
conducted	O
two	O
cross-sectional	O
household	O
surveys	O
among	O
married	B-T033
women	O
aged	O
15-49	O
years	O
in	O
intervention	B-T061
and	O
comparison	O
districts	O
.	O
	
difference-in-difference	B-T081
models	I-T081
were	O
used	O
to	O
assess	O
the	O
efficacy	B-T080
of	O
the	O
intervention	B-T061
,	O
adjusting	O
for	O
sociodemographic	B-T033
characteristics	I-T033
.	O
	
although	O
both	O
intervention	B-T061
types	O
improved	O
abortion	B-T033
knowledge	O
,	O
the	O
him	O
intervention	B-T061
was	O
more	O
effective	O
in	O
improving	O
comprehensive	O
knowledge	O
about	O
abortion	B-T033
.	O
	
in	O
particular	O
,	O
there	O
were	O
improvements	O
in	O
knowledge	O
on	O
legality	B-T061
of	I-T061
abortion	I-T061
aor=2	O
95%	O
ci	O
1.6	O
to	O
2.9	O
and	O
nearby	O
sources	O
of	O
safe	O
abortion	O
care	O
aor=1	O
95%	O
ci	O
1.2	O
to	O
1.3	O
.	O
	
higher	O
level	O
of	O
exposure	O
to	O
abortion-related	O
messages	O
was	O
related	O
to	O
more	O
accurate	O
knowledge	O
about	O
abortion	B-T033
within	O
both	O
intervention	B-T061
groups	O
.	O
	
evidence	O
was	O
mixed	O
on	O
changes	O
in	O
abortion	B-T033
care-seeking	O
behaviour	O
.	O
	
more	O
work	O
is	O
needed	O
to	O
ensure	O
that	O
women	O
seek	O
safe	B-T033
abortion	I-T033
services	O
in	O
lieu	O
of	O
informal	O
services	O
that	O
may	O
be	O
more	O
likely	O
to	O
lead	O
to	O
postabortion	O
complications	O
.	O
	
tissue	O
microrna	O
profiles	O
as	O
diagnostic	O
and	O
prognostic	B-T080
biomarkers	I-T080
in	O
patients	O
with	O
resectable	B-T061
pancreatic	O
ductal	O
adenocarcinoma	O
and	O
periampullary	O
cancers	O
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
validate	O
previously	O
described	O
diagnostic	B-T169
and	O
prognostic	O
microrna	O
expression	B-T081
profiles	I-T081
in	O
tissue	O
samples	O
from	O
patients	O
with	O
pancreatic	O
cancer	O
and	O
other	O
periampullary	O
cancers	O
.	O
	
expression	O
of	O
46	O
selected	O
micrornas	O
was	O
studied	O
in	O
formalin	B-T109
-fixed	O
paraffin-embedded	O
tissue	O
from	O
patients	O
with	O
resected	B-T061
pancreatic	O
ductal	O
adenocarcinoma	O
n	O
=	O
165	O
,	O
ampullary	O
cancer	O
n=59	O
,	O
duodenal	O
cancer	O
n	O
=	O
6	O
,	O
distal	O
common	O
bile	O
duct	O
cancer	O
n	O
=	O
21	O
,	O
and	O
gastric	O
cancer	O
n	O
=	O
20	O
chronic	B-T047
pancreatitis	I-T047
n	O
=	O
39	O
and	O
normal	B-T033
pancreas	I-T033
n	O
=	O
35	O
.	O
	
the	O
micrornas	O
were	O
analyzed	O
by	O
pcr	O
using	O
the	O
fluidigm	O
platform	O
.	O
	
twenty-two	O
micrornas	O
were	O
significantly	O
differently	O
expressed	O
in	O
patients	O
with	O
pancreatic	O
cancer	O
when	O
compared	O
to	O
healthy	B-T080
controls	I-T080
and	O
chronic	B-T047
pancreatitis	I-T047
patients	O
17	O
mirnas	O
were	O
upregulated	O
mir-21-5p	O
,	O
-	O
23a-3p	O
,	O
-	O
31-5p	O
,	O
-	O
34c-5p	O
,	O
-	O
93-3p	O
,	O
-	O
135b-3p	O
,	O
-	O
155-5p	O
,	O
-	O
186-5p	O
,	O
-	O
196b-5p	O
,	O
-	O
203	O
,	O
-	O
205-5p	O
,	O
-	O
210	O
,	O
-	O
222-3p	O
,	O
-	O
451	O
,	O
-	O
492	O
,	O
-	O
614	O
,	O
and	O
mir-622	O
and	O
5	O
were	O
downregulated	O
mir-122-5p	O
,	O
-	O
130b-3p	O
,	O
-	O
216b	O
,	O
-	O
217	O
,	O
and	O
mir-375	O
.	O
	
micrornas	O
were	O
grouped	O
into	O
diagnostic	B-T169
indices	O
of	O
varying	O
complexity	B-T080
.	O
	
ten	O
micrornas	O
associated	B-T080
with	I-T080
prognosis	O
were	O
identified	O
let-7	O
g	O
,	O
mir-29a-5p	O
,	O
-	O
34a-5p	O
,	O
-	O
125a-3p	O
,	O
-	O
146a-5p	O
,	O
-	O
187	O
,	O
-	O
205-5p	O
,	O
-	O
212-3p	O
,	O
-	O
222-5p	O
,	O
and	O
mir-450b-5p	O
.	O
	
prognostic	B-T081
indices	I-T081
based	O
on	O
differences	O
in	O
expression	O
of	O
2	O
different	O
micrornas	O
were	O
constructed	O
for	O
pancreatic	O
and	O
ampullary	O
cancer	O
combined	O
and	O
separately	O
30	O
,	O
5	O
,	O
and	O
21	O
indices	O
.	O
	
the	O
study	O
confirms	O
that	O
pancreatic	O
cancer	O
tissue	O
has	O
a	O
microrna	O
expression	B-T081
profile	I-T081
that	O
is	O
different	O
from	O
that	O
of	O
other	O
periampullary	O
cancers	O
,	O
chronic	B-T047
pancreatitis	I-T047
,	O
and	O
normal	B-T033
pancreas	I-T033
.	O
	
we	O
identified	O
prognostic	O
micrornas	O
and	O
microrna	O
indices	O
that	O
were	O
associated	B-T080
with	I-T080
shorter	O
overall	B-T081
survival	I-T081
in	O
patients	O
with	O
radically	O
resected	B-T061
pancreatic	O
cancer	O
.	O
	
effectiveness	B-T080
of	O
workers	O
'	O
general	O
health	O
examination	O
in	O
korea	O
by	O
health	O
examination	O
period	O
and	O
compliance	B-T033
retrospective	O
cohort	O
study	O
using	O
nationwide	O
data	O
our	O
study	O
evaluated	O
the	O
effectiveness	B-T080
of	O
the	O
workers	O
'	O
general	O
health	O
examination	O
by	O
health	O
examination	O
period	O
and	O
compliance	B-T033
.	O
	
a	O
retrospective	O
cohort	O
of	O
the	O
health	O
examination	O
participants	O
in	O
2006	O
baseline	O
year	O
n	O
was	O
used	O
.	O
	
we	O
identified	O
newly	O
occurring	O
cardio	B-T047
-	O
cerebrovascular	B-T047
disease	I-T047
over	O
7	O
years	O
from	O
2007	O
to	O
2013	O
.	O
	
after	O
stratification	O
by	O
age	O
,	O
sex	O
,	O
and	O
national	O
health	O
insurance	O
type	O
,	O
we	O
identified	O
7	O
years'	O
cumulative	B-T080
incidence	B-T081
of	O
cardio	B-T047
-	O
cerebrovascular	B-T047
disease	I-T047
by	O
health	O
examination	O
compliance	B-T033
and	O
estimated	O
its	O
relative	O
risk	O
by	O
health	O
examination	O
period	O
and	O
compliance	B-T033
.	O
	
the	O
compliant	O
group	O
presented	O
a	O
lower	O
cumulative	B-T080
incidence	B-T081
of	O
cardio	B-T047
-	O
cerebrovascular	B-T047
disease	I-T047
than	O
the	O
non-compliant	O
group	O
this	O
result	O
was	O
consistent	O
across	O
sex	O
,	O
working	O
age	O
40s	O
and	O
50s	O
,	O
and	O
workplace	O
policyholder	B-T078
.	O
	
relative	O
risk	O
of	O
cardio	B-T047
-	O
cerebrovascular	B-T047
disease	I-T047
by	O
health	O
examination	O
period	O
1	O
and	O
2	O
years	O
showed	O
statistically	B-T081
significant	I-T081
results	O
in	O
ischemic	B-T047
heart	I-T047
disease	I-T047
for	O
male	O
participants	O
.	O
	
of	O
men	O
in	O
their	O
40s	O
,	O
office	B-T033
workers	I-T033
over	O
a	O
2-year	O
period	O
presented	O
statistically	O
higher	B-T033
relative	I-T033
risk	I-T033
of	I-T033
ischemic	B-T047
heart	I-T047
disease	I-T047
than	O
non-office	O
workers	O
over	O
a	O
1-year	O
period	O
1.03	O
95%	O
confidence	B-T081
interval	I-T081
,	O
1.02	O
.	O
	
however	O
,	O
there	O
were	O
no	O
consistent	O
results	O
in	O
ischemic	B-T169
cerebrovascular	B-T047
disease	I-T047
and	O
hemorrhagic	B-T080
cerebrovascular	B-T047
disease	I-T047
for	O
men	O
or	O
cardio	B-T047
-	O
cerebrovascular	B-T047
disease	I-T047
for	O
women	O
.	O
	
a	O
1-year	O
period	O
of	O
workers	O
'	O
general	O
health	O
examinations	O
in	O
non-office	O
workers	O
had	O
a	O
more	O
significant	O
prevention	B-T061
effect	O
on	O
ischemic	B-T047
heart	I-T047
disease	I-T047
than	O
a	O
2-year	O
period	O
in	O
office	B-T033
workers	I-T033
among	O
working	O
age	O
40s-50s	O
men	O
.	O
	
it	O
is	O
,	O
however	O
,	O
necessary	O
to	O
consider	O
that	O
prevention	B-T061
of	O
cardio	B-T047
-	O
cerebrovascular	B-T047
disease	I-T047
can	O
be	O
partially	O
explained	O
by	O
their	O
occupational	B-T169
characteristics	I-T169
rather	O
than	O
by	O
health	O
examination	O
period	O
.	O
	
calibration	B-T081
of	O
self-report	O
measures	B-T081
of	O
physical	O
activity	O
and	O
sedentary	B-T033
behavior	I-T033
calibration	B-T081
equations	O
offer	O
potential	B-T080
to	O
improve	B-T080
the	O
accuracy	B-T080
and	O
utility	O
of	O
self-report	O
measures	B-T081
of	O
physical	O
activity	O
pa	O
and	O
sedentary	B-T033
behavior	I-T033
sb	B-T033
by	O
re-scaling	O
potentially	B-T080
biased	O
estimates	B-T081
.	O
	
the	O
present	O
study	O
evaluates	O
calibration	B-T081
models	B-T081
designed	O
to	O
estimate	B-T081
pa	O
and	O
sb	B-T033
in	O
a	O
representative	B-T081
sample	O
of	O
adults	O
from	O
the	O
physical	O
activity	O
measurement	O
survey	O
pams	O
.	O
	
participants	O
in	O
the	O
pams	O
project	O
completed	O
replicate	O
single	O
day	O
trials	O
that	O
involved	O
wearing	O
a	O
sensewear	O
armband	O
swa	O
monitor	O
for	O
24	B-T079
hours	I-T079
followed	O
by	O
a	O
telephone	O
administered	B-T169
24-hour	O
physical	O
activity	O
recall	O
par	O
.	O
	
comprehensive	O
statistical	B-T081
model	I-T081
selection	O
and	O
validation	B-T169
procedures	B-T169
were	O
used	O
to	O
develop	O
and	O
test	O
separate	O
calibration	B-T081
models	B-T081
designed	O
to	O
predict	O
objectively	O
-	O
measured	B-T081
sb	B-T033
and	O
moderate	O
to	O
vigorous	O
pa	O
mvpa	O
from	O
self-reported	O
par	O
data	O
.	O
	
equivalence	O
testing	O
was	O
used	O
to	O
evaluate	O
the	O
equivalence	O
of	O
the	O
model-	O
predicted	O
values	O
with	O
the	O
objective	O
measures	B-T081
in	O
a	O
separate	O
holdout	O
sample	O
.	O
	
the	O
final	O
prediction	O
model	O
for	O
both	O
sb	B-T033
and	O
mvpa	O
included	O
reported	O
time	O
spent	O
in	O
sb	B-T033
and	O
mvpa	O
,	O
as	O
well	O
as	O
terms	O
capturing	O
sex	O
,	O
age	B-T033
,	O
education	B-T033
,	O
and	O
bmi	O
.	O
	
cross-validation	O
analyses	B-T081
on	O
an	O
independent	O
sample	O
exhibited	O
high	O
correlations	O
with	O
observed	O
sb	B-T033
r	O
=	O
0.72	O
and	O
mvpa	O
r	O
=	O
0.75	O
.	O
	
equivalence	O
testing	O
demonstrated	O
that	O
the	O
model-	O
predicted	O
values	O
were	O
statistically	B-T081
equivalent	O
to	O
the	O
corresponding	O
objective	O
values	O
for	O
both	O
sb	B-T033
and	O
mvpa	O
.	O
	
the	O
results	O
demonstrate	O
that	O
simple	O
regression	O
models	B-T081
can	O
be	O
used	O
to	O
statistically	B-T081
adjust	O
for	O
over	O
or	O
underestimation	O
in	O
self-report	O
measures	B-T081
among	O
different	O
segments	O
of	O
the	O
population	O
.	O
	
the	O
models	B-T081
produced	O
group	O
estimates	B-T081
from	O
the	O
par	O
that	O
were	O
statistically	B-T081
equivalent	O
to	O
the	O
observed	O
time	O
spent	O
in	O
sb	B-T033
and	O
mvpa	O
obtained	O
from	O
the	O
objective	O
swa	O
monitor	O
however	O
additional	O
work	O
is	O
needed	O
to	O
correct	O
for	O
estimates	B-T081
of	O
individual	O
behavior	O
.	O
	
human	O
amnion	O
epithelial	O
cells	O
rescue	O
cell	O
death	O
via	O
immunomodulation	B-T061
of	O
microglia	O
in	O
a	O
mouse	O
model	O
of	O
perinatal	O
brain	O
injury	O
human	O
amnion	O
epithelial	O
cells	O
haecs	O
are	O
clonogenic	B-T081
and	O
have	O
been	O
proposed	O
to	O
reduce	B-T081
inflammatory	O
-	O
induced	B-T169
tissue	O
injury	O
.	O
	
perturbation	B-T169
of	O
the	O
immune	O
response	O
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
perinatal	O
brain	O
injury	O
modulating	O
this	O
response	O
could	O
thus	O
be	O
a	O
novel	B-T080
therapy	B-T061
for	O
treating	B-T169
or	O
preventing	O
such	O
injury	O
.	O
	
the	O
immunomodulatory	B-T061
properties	O
of	O
haecs	O
have	O
been	O
shown	O
in	O
other	O
animal	O
models	O
,	O
but	O
a	O
detailed	O
investigation	O
of	O
the	O
effects	B-T080
on	O
brain	O
immune	B-T169
cells	O
following	O
injury	O
has	O
not	O
been	O
undertaken	O
.	O
	
here	O
,	O
we	O
investigate	O
the	O
effects	B-T080
of	O
haecs	O
on	O
microglia	O
,	O
the	O
first	O
immune	O
responders	O
to	O
injury	O
within	O
the	O
brain	O
.	O
	
we	O
generated	O
a	O
mouse	O
model	O
combining	O
neonatal	B-T079
inflammation	O
and	O
perinatal	B-T079
hyperoxia	O
,	O
both	O
of	O
which	O
are	O
risk	B-T033
factors	I-T033
associated	O
with	O
perinatal	O
brain	O
injury	O
.	O
	
on	O
embryonic	O
day	B-T079
16	O
we	O
administered	B-T061
lipopolysaccharide	B-T109
lps	B-T109
,	O
or	O
saline	O
control	O
,	O
intra-amniotically	B-T169
to	O
c57bl/6	O
j	O
mouse	O
pups	O
.	O
	
on	O
postnatal	B-T079
day	B-T079
p	O
,	O
lps	B-T109
pups	O
were	O
placed	O
in	O
hyperoxia	O
65%	O
oxygen	O
and	O
control	O
pups	O
in	O
normoxia	O
for	O
14	O
days	B-T079
.	O
	
pups	O
were	O
given	O
either	O
haecs	O
or	O
saline	O
intravenously	B-T061
on	O
p4	O
.	O
	
at	O
p14	O
,	O
relative	O
to	O
controls	O
,	O
lps	B-T109
and	O
hyperoxia	O
pups	O
had	O
reduced	B-T081
body	O
weight	O
,	O
increased	B-T081
density	B-T081
of	O
apoptotic	B-T080
cells	O
tunel	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	O
,	O
astrocytes	O
gfap	B-T116
in	O
the	O
white	O
matter	O
and	O
activated	B-T169
microglia	O
cd68	B-T116
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	B-T081
iba1	B-T116
.	O
	
haec	O
administration	B-T061
rescued	O
the	O
decreased	B-T081
body	O
weight	O
and	O
reduced	B-T081
apoptosis	O
and	O
astrocyte	O
areal	B-T169
coverage	I-T169
in	O
the	O
white	O
matter	O
,	O
but	O
increased	B-T081
the	O
density	B-T081
of	O
total	O
and	O
activated	B-T169
microglia	O
.	O
	
we	O
then	O
stimulated	O
primary	B-T080
microglia	O
cd45	B-T116
low	O
cd11b	B-T116
+	O
with	O
lps	B-T109
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	O
with	O
haec	O
conditioned	O
medium	O
for	O
48	O
h	O
.	O
	
haec	O
conditioned	O
medium	O
increased	B-T081
microglial	O
phagocytic	O
activity	O
,	O
decreased	B-T081
microglia	O
apoptosis	O
and	O
decreased	B-T081
m1	O
activation	O
markers	O
cd86	B-T116
.	O
	
stimulating	O
haecs	O
for	O
24	O
h	O
with	O
lps	B-T109
did	O
not	O
alter	O
release	B-T061
of	O
cytokines	B-T116
known	O
to	O
modulate	O
microglia	O
activity	O
.	O
	
these	O
data	B-T078
demonstrate	O
that	O
haecs	O
can	O
directly	O
immunomodulate	B-T061
brain	O
microglia	O
,	O
probably	O
via	O
release	B-T061
of	O
trophic	B-T116
factors	I-T116
.	O
	
this	O
observation	O
offers	O
promise	O
that	O
haecs	O
may	O
afford	O
therapeutic	B-T061
utility	I-T061
in	O
the	O
management	O
of	O
perinatal	O
brain	O
injury	O
.	O
	
identification	B-T080
of	O
predictive	O
dna	O
methylation	O
biomarkers	O
for	O
chemotherapy	B-T061
response	O
in	O
colorectal	O
cancer	O
resistance	O
to	O
5-fluorouracil	O
5-fu	O
is	O
a	O
major	O
obstacle	O
to	O
the	O
successful	O
treatment	B-T169
of	O
colorectal	O
cancer	O
crc	O
and	O
posed	O
an	O
increased	O
risk	B-T081
of	I-T081
recurrence	I-T081
.	O
	
dna	O
methylation	O
has	O
been	O
suggested	O
as	O
one	O
of	O
the	O
underlying	O
mechanisms	O
for	O
recurrent	B-T047
disease	I-T047
and	O
its	O
contribution	O
to	O
the	O
development	O
of	O
drug	O
resistance	O
remains	O
to	O
be	O
clarified	O
.	O
	
this	O
study	O
aimed	O
to	O
determine	O
the	O
methylation	O
phenotype	O
in	O
crc	O
for	O
identification	B-T080
of	O
predictive	O
markers	O
for	O
chemotherapy	B-T061
response	O
.	O
	
we	O
performed	O
dna	O
methylation	O
profiling	B-T169
on	O
43	O
non-recurrent	B-T079
and	O
five	O
recurrent	B-T079
crc	O
patients	O
using	O
the	O
illumina	O
infinium	O
humanmethylation450	O
beadchip	O
assay	O
.	O
	
in	O
addition	O
,	O
crc	O
cells	O
with	O
different	O
genetic	O
backgrounds	O
,	O
response	O
to	O
5-fu	O
and	O
global	O
methylation	O
levels	B-T080
ht29	O
and	O
sw48	O
were	O
treated	B-T169
with	O
5-fu	O
and	O
dna	O
methylation	O
inhibitor	B-T080
5-aza-2'-deoxycytidine	O
5-azadc	O
.	O
	
the	O
singular	O
and	O
combined	O
effects	B-T080
of	O
these	O
two	O
drug	O
classes	O
on	O
cell	O
viability	O
and	O
global	O
methylation	O
profiles	O
were	O
investigated	O
.	O
	
our	O
genome-wide	O
methylation	O
study	O
on	O
the	O
clinical	B-T080
specimens	O
showed	O
that	O
recurrent	B-T079
crcs	O
exhibited	O
higher	O
methylation	O
levels	B-T080
compared	O
to	O
non-recurrent	B-T079
crcs	O
.	O
	
we	O
identified	B-T080
4787	O
significantly	O
differentially	O
methylated	O
genes	O
p	O
<	O
0.05	O
3112	O
genes	O
were	O
hyper	B-T033
-	O
while	O
1675	O
genes	O
were	O
hypomethylated	B-T033
in	O
the	O
recurrent	B-T079
group	B-T078
compared	O
to	O
the	O
non-recurrent	B-T079
.	O
	
fifty	O
eight	O
and	O
47	O
of	O
the	O
significantly	O
hypermethylated	O
and	O
hypomethylated	O
genes	O
have	O
an	O
absolute	O
recurrent	B-T079
/	O
non-recurrent	B-T079
methylation	O
difference	O
of	O
20%	O
.	O
	
most	O
of	O
the	O
hypermethylated	O
genes	O
were	O
involved	O
in	O
the	O
mapk	O
signaling	O
pathway	O
which	O
is	O
a	O
key	O
regulator	O
for	O
apoptosis	O
while	O
the	O
hypomethylated	O
genes	O
were	O
involved	O
in	O
the	O
pi3k-akt	O
signaling	O
pathway	O
and	O
proliferation	B-T169
process	I-T169
.	O
	
we	O
also	O
demonstrate	O
that	O
5-azadc	O
treatment	B-T169
enhanced	O
response	O
to	O
5-fu	O
which	O
resulted	O
in	O
significant	O
growth	O
inhibition	O
compared	O
to	O
5-fu	O
alone	O
in	O
hypermethylated	O
cell	O
lines	O
sw48	O
.	O
	
in	O
conclusion	O
,	O
we	O
found	O
the	O
evidence	O
of	O
five	O
potentially	O
biologically	O
important	O
genes	O
in	O
recurrent	B-T079
crcs	O
that	O
could	O
possibly	O
serve	O
as	O
a	O
new	O
potential	O
therapeutic	B-T061
targets	B-T169
for	O
patients	O
with	O
chemoresistance	O
.	O
	
we	O
postulate	O
that	O
aberrant	B-T080
methylation	O
of	O
ccnei	O
,	O
ccndbp1	O
,	O
pon3	O
,	O
ddx43	O
,	O
and	O
chl1	O
in	O
crc	O
might	O
be	O
associated	B-T080
with	I-T080
the	O
recurrence	O
of	O
crc	O
and	O
5-azadc	O
-mediated	O
restoration	O
of	O
5-fu	O
sensitivity	O
is	O
mediated	O
at	O
least	O
in	O
part	O
by	O
mapk	O
signaling	O
pathway	O
.	O
	
effect	B-T080
of	O
successive	B-T061
administration	I-T061
of	O
vancomycin	B-T116
and	O
amikacin	B-T109
on	O
auditory	O
function	O
of	O
immature	O
animals	O
effect	B-T080
of	O
successive	B-T061
administration	I-T061
vancomycin	B-T116
and	O
amikacin	B-T109
in	O
therapeutic	B-T169
doses	B-T081
on	O
immature	B-T080
auditory	O
organ	O
was	O
compared	O
to	O
single	B-T081
administration	O
of	O
the	O
same	B-T080
drugs	O
in	O
chronic	B-T079
experiments	O
on	O
immature	B-T080
rabbits	O
by	O
recording	B-T080
of	O
short-latency	B-T079
auditory	O
brainstem	O
response	O
abr	O
and	O
distortion	O
product	O
otoacoustic	O
emission	O
dpoae	O
.	O
	
drug	O
administration	O
always	O
increased	B-T081
significantly	O
the	O
abr	O
peak	O
i	O
threshold	B-T081
.	O
	
ototoxic	O
antibiotics	O
did	O
not	O
change	O
dpoae	O
,	O
but	O
selectively	O
affected	B-T169
activity	B-T033
of	O
outer	O
hair	O
cells	O
.	O
	
no	B-T033
enhancement	O
of	O
the	O
ototoxic	O
effects	O
was	O
observed	B-T169
after	O
successive	B-T061
administration	I-T061
of	O
the	O
two	O
water	O
safety	O
in	O
healthcare	O
facilities	O
.	O
	
the	O
vieste	O
charter	O
the	O
study	O
group	O
on	O
hospital	O
hygiene	O
of	O
the	O
italian	O
society	O
of	O
hygiene	O
,	O
preventive	O
medicine	O
and	O
public	O
health	O
gisio-siti	O
and	O
the	O
local	O
health	O
authority	O
of	O
foggia	O
,	O
apulia	O
,	O
italy	O
,	O
after	O
the	O
national	O
convention	O
"""safe"	O
water	O
in	O
healthcare	O
facilities	O
""""	O
held	O
in	O
vieste-pugnochiuso	O
on	O
27-28	O
may	O
2016	O
,	O
present	O
the	O
""""	O
vieste	O
charter	O
""""	O
,	O
drawn	O
up	O
in	O
collaboration	O
with	O
experts	O
from	O
the	O
national	O
institute	O
of	O
health	O
and	O
the	O
ministry	O
of	O
health	O
.	O
	
this	O
paper	O
considers	O
the	O
risk	B-T033
factors	I-T033
that	O
may	O
affect	O
the	O
water	O
safety	O
in	O
healthcare	O
facilities	O
and	O
reports	O
the	O
current	O
regulatory	O
frameworks	O
governing	O
the	O
management	O
of	O
installations	O
and	O
the	O
quality	B-T080
of	O
the	O
water	O
.	O
	
the	O
authors	O
promote	O
a	O
careful	O
analysis	O
of	O
the	O
risks	B-T078
that	O
characterize	O
the	O
health	O
facilities	O
,	O
for	O
the	O
control	O
of	O
which	O
specific	O
actions	O
are	O
recommended	O
in	O
various	O
areas	O
,	O
including	O
water	O
safety	O
plans	O
approval	O
of	O
treatments	B-T169
healthcare	O
facilities	O
responsibility	O
,	O
installation	O
and	O
maintenance	O
of	O
facilities	O
multidisciplinary	O
approach	O
education	O
and	O
research	O
regional	B-T169
and	I-T169
national	I-T169
coordination	I-T169
communication	O
.	O
	
in	O
vivo	O
three-dimensional	O
patellar	O
mechanics	O
normal	B-T080
knees	O
compared	O
with	O
domed	O
and	O
anatomic	B-T080
patellar	O
components	O
patellofemoral	O
complications	B-T169
are	O
a	O
major	O
cause	O
of	O
revision	B-T061
surgery	I-T061
following	B-T079
total	B-T061
knee	I-T061
arthroplasty	I-T061
tka	B-T061
.	O
	
high	B-T080
forces	O
occurring	O
at	O
the	O
patellofemoral	O
articulation	O
coupled	B-T169
with	O
a	O
small	B-T081
patellofemoral	O
contact	O
area	O
pose	O
substantial	O
design	O
challenges	O
.	O
	
in	O
this	O
study	O
,	O
the	O
three-dimensional	O
3d	O
in	O
vivo	O
mechanics	O
of	O
domed	O
and	O
anatomically	B-T080
shaped	O
patellar	O
components	O
were	O
compared	O
with	O
those	O
of	O
native	B-T169
patellae	O
.	O
	
ten	O
normal	B-T080
knees	O
,	O
10	O
treated	B-T061
with	I-T061
an	O
lcs-ps	B-T061
low	I-T061
contact	I-T061
stress-posterior	I-T061
stabilized	I-T061
tka	I-T061
anatomically	B-T080
shaped	O
patellar	O
component	O
,	O
and	O
10	O
treated	B-T061
with	I-T061
a	O
pfc	B-T061
sigma	I-T061
rp-ps	I-T061
press-fit	I-T061
condylar	I-T061
sigma	I-T061
rotating	I-T061
platform-posterior	I-T061
stabilized	I-T061
tka	I-T061
domed	O
patellar	O
component	O
were	O
analyzed	O
under	O
fluoroscopic	O
surveillance	B-T169
while	O
the	O
patient	O
performed	B-T169
a	O
weight-bearing	B-T033
deep	O
knee	B-T033
bend	I-T033
from	O
full	B-T080
knee	B-T033
extension	I-T033
to	O
maximum	B-T081
knee	B-T033
flexion	I-T033
.	O
	
relevant	O
bone	O
geometries	O
were	O
segmented	O
out	O
from	O
computed	O
tomography	O
ct	O
scans	O
,	O
and	O
computer-assisted-design	O
cad	O
models	O
of	O
the	O
implanted	O
components	O
were	O
obtained	O
from	O
the	O
manufacturer	O
.	O
	
three-dimensional	O
patellofemoral	O
kinematics	O
were	O
obtained	O
using	O
a	O
3d	O
-to-	O
2d	O
registration	O
process	O
.	O
	
contact	O
mechanics	O
were	O
calculated	O
using	O
a	O
distance	O
map	O
between	O
the	O
articulating	O
patellar	O
and	O
femoral	O
surfaces	O
.	O
	
both	O
patellar	O
component	O
designs	O
exhibited	O
good	B-T080
rotational	O
kinematics	O
and	O
tracked	O
well	O
within	O
the	O
femoral	O
trochlea	O
when	O
compared	O
with	O
the	O
normal	B-T080
patella	O
.	O
	
the	O
contact	O
areas	O
in	O
the	O
tka	B-T061
groups	B-T078
peaked	O
at	O
60	O
of	O
knee	B-T033
flexion	I-T033
mean	B-T081
and	O
standard	B-T081
deviation	I-T081
,	O
201	O
63.4	O
mm	O
for	O
the	O
lcs-ps	B-T078
group	I-T078
and	O
218	O
95.4	O
mm	O
for	O
the	O
sigma	B-T078
rp-ps	I-T078
group	I-T078
,	O
and	O
the	O
areas	O
were	O
substantially	O
smaller	B-T080
than	O
those	O
previously	O
reported	O
for	O
the	O
normal	B-T080
patella	O
.	O
	
contact	O
points	O
in	O
the	O
tka	B-T061
groups	B-T078
stayed	O
close	O
to	O
the	O
center	O
of	O
the	O
patellar	O
components	O
.	O
	
both	O
designs	O
performed	B-T169
satisfactorily	B-T080
,	O
although	O
patellofemoral	O
contact	O
areas	O
were	O
reduced	B-T080
in	O
comparison	O
with	O
those	O
in	O
the	O
native	B-T169
patella	O
.	O
	
assessment	O
of	O
the	O
extravascular	O
implantable	O
defibrillator	O
feasibility	B-T080
of	O
substernal	B-T061
ventricular	I-T061
pacing	I-T061
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
feasibility	B-T080
of	O
ventricular	B-T061
pacing	I-T061
and	O
thresholds	B-T080
from	O
within	O
the	O
substernal	O
space	O
to	O
examine	O
a	O
new	B-T080
extravascular	O
icd	O
configuration	O
with	O
pacing	B-T061
capabilities	B-T080
.	O
	
in	O
patients	O
undergoing	O
midline	B-T061
sternotomy	I-T061
,	O
a	O
duodecapolar	O
diagnostic	O
pacing	O
catheter	O
was	O
positioned	O
in	O
the	O
substernal	O
space	O
anterior	O
to	O
the	O
pericardium	O
,	O
and	O
a	O
cutaneous	B-T033
patch	I-T033
in	O
left	O
lateral	O
position	O
.	O
	
different	B-T080
unipolar	O
and	O
bipolar	O
pacing	B-T061
configurations	O
were	O
assessed	O
.	O
	
strength-duration	O
curves	O
were	O
performed	B-T169
to	O
identify	O
the	O
optimal	B-T080
output	O
,	O
starting	O
at	O
25	O
ma	B-T081
with	O
a	O
pulse	B-T081
width	I-T081
of	O
10	O
milliseconds	B-T079
.	O
	
eight	O
patients	O
with	O
mean	B-T081
age	O
69	O
9	O
years	B-T079
were	O
included	B-T169
.	O
	
in	O
5	O
,	O
ventricular	O
capture	O
was	O
achieved	O
in	O
1	O
configuration	O
.	O
	
the	O
mean	B-T081
bipolar	O
pacing	B-T061
thresholds	B-T080
at	O
pw	O
10	O
,	O
5	O
,	O
3	O
,	O
1	O
milliseconds	B-T079
were	O
12.4	O
3.7	O
ma	B-T081
5	O
patients	O
,	O
13.3	O
5.8	O
ma	B-T081
3	O
patients	O
,	O
18.3	O
5.7	O
ma	B-T081
3	O
patients	O
,	O
and	O
25	O
0	O
ma	B-T081
2	O
patients	O
,	O
respectively	O
.	O
	
the	O
60-mm	O
electrode	O
spacing	B-T081
was	O
the	O
most	O
successful	B-T080
bipolar	O
configuration	O
.	O
	
unipolar	O
pacing	B-T061
was	O
successful	B-T080
in	O
3	O
out	O
of	O
4	O
patients	O
with	O
mean	B-T081
thresholds	B-T080
of	O
10	O
0	O
ma	B-T081
at	O
10	O
milliseconds	B-T079
3	O
patients	O
,	O
15	O
0	O
ma	B-T081
at	O
5	O
milliseconds	B-T079
3	O
patients	O
,	O
16.7	O
2.9	O
ma	B-T081
at	O
3	O
milliseconds	B-T079
3	O
patients	O
,	O
and	O
20	O
7.1	O
ma	B-T081
at	O
1	O
milliseconds	B-T079
2	O
patients	O
.	O
	
ventricular	B-T061
pacing	I-T061
from	O
the	O
substernal	O
space	O
in	O
patients	O
with	O
midline	O
sternotomy	O
is	O
feasible	O
.	O
	
closed	O
sternum	O
studies	O
are	O
needed	O
to	O
determine	O
pacing	B-T061
thresholds	O
more	O
accurately	B-T080
effects	B-T080
of	O
a	O
specific	O
blend	O
of	O
essential	B-T109
oils	I-T109
on	O
apparent	B-T078
nutrient	O
digestion	O
,	O
rumen	O
fermentation	O
and	O
rumen	O
microbial	O
populations	O
in	O
sheep	O
fed	O
a	O
50	O
alfalfa	O
hay	O
concentrate	O
diet	O
an	O
experiment	O
was	O
conducted	O
to	O
investigate	B-T169
the	O
effects	B-T080
of	O
a	O
specific	O
mixture	O
of	O
essential	B-T109
oils	I-T109
meo	B-T109
,	O
containing	O
thyme	B-T109
,	O
clove	B-T109
and	O
cinnamon	B-T109
eo	I-T109
,	O
on	O
rumen	O
microbial	O
fermentation	O
,	O
nutrient	O
apparent	B-T078
digestibility	B-T033
and	O
blood	O
metabolites	O
in	O
fistulated	O
sheep	O
.	O
	
six	O
sheep	O
fitted	O
with	O
ruminal	O
fistulas	O
were	O
used	O
in	O
a	O
repeated	O
measurement	O
design	O
with	O
two	O
24-d	O
periods	B-T079
to	O
investigate	O
the	O
effect	B-T080
of	O
adding	O
meo	B-T109
at	O
0	O
control	O
,	O
0.8	O
,	O
and	O
1.6	O
ml/d	O
on	O
apparent	B-T078
nutrient	O
digestibility	B-T033
,	O
rumen	O
fermentation	O
characteristics	B-T080
,	O
rumen	O
microbial	O
population	O
and	O
blood	O
chemical	O
metabolites	O
.	O
	
animals	O
were	O
fed	O
with	O
a	O
50	O
alfalfa	O
hay	O
concentrate	O
diet	O
.	O
	
ruminal	B-T081
ph	I-T081
,	O
total	O
volatile	B-T109
fatty	I-T109
acids	I-T109
vfa	B-T109
concentration	B-T081
,	O
molar	B-T081
proportion	I-T081
of	I-T081
individual	I-T081
vfa	B-T109
,	O
acetate	B-T081
propionate	I-T081
ratio	I-T081
and	O
methane	O
production	O
were	O
not	O
affected	O
with	O
meo	B-T109
.	O
	
relative	O
to	O
the	O
control	O
,	O
small	B-T116
peptides	I-T116
plus	O
amino	O
acid	O
nitrogen	O
and	O
large	O
peptides	O
nitrogen	O
concentration	O
in	O
rumen	O
fluid	O
were	O
not	O
affected	O
with	O
meo	O
supplementation	O
while	O
,	O
rumen	O
fluid	O
ammonia	O
nitrogen	O
concentration	O
at	O
0	O
and	O
6	O
h	O
after	O
morning	O
feeding	O
in	O
sheep	O
fed	O
with	O
1.6	O
ml/d	O
of	O
meo	O
was	O
lower	O
p<0	O
compared	O
to	O
the	O
control	O
and	O
0.8	O
ml/d	O
of	O
meo	O
.	O
	
at	O
0	O
h	O
after	O
morning	O
feeding	O
,	O
ammonia	O
nitrogen	O
concentration	O
was	O
higher	O
p<0	O
in	O
sheep	O
fed	O
0.8	O
ml/d	O
of	O
meo	O
relative	O
to	O
1.6	O
ml/d	O
and	O
control	O
diet	O
.	O
	
ruminal	O
protozoa	O
and	O
hyper	O
ammonia	O
producing	O
hap	O
bacteria	O
counts	O
were	O
not	O
affected	O
by	O
addition	O
of	O
meo	O
in	O
the	O
diet	O
.	O
	
relative	O
to	O
the	O
control	O
,	O
no	O
changes	O
were	O
observed	O
in	O
the	O
red	O
and	O
white	O
blood	O
cells	O
,	O
hemoglobin	O
,	O
hematocrit	O
,	O
glucose	O
,	O
beta-hydroxybutyric	O
acid	O
,	O
cholesterol	O
,	O
total	O
protein	O
,	O
albumin	O
,	O
blood	O
urea	O
nitrogen	O
and	O
aspartate	O
aminotransferase	O
and	O
alanine	O
aminotransferase	O
concentration	O
.	O
	
apparent	O
total	O
tract	O
digestibility	O
of	O
dry	O
matter	O
,	O
crude	O
proten	O
,	O
organic	O
matter	O
,	O
and	O
neutral	O
detergent	O
fiber	O
were	O
not	O
influenced	O
by	O
meo	O
supplementation	O
.	O
	
the	O
results	O
of	O
the	O
present	O
study	O
suggested	O
that	O
supplementation	O
of	O
meo	O
may	O
have	O
limited	O
effects	O
on	O
apparent	O
nutrient	O
digestibility	O
,	O
ruminal	O
fermentation	O
and	O
protozoa	O
and	O
hap	O
bacteria	O
count	O
,	O
blood	O
cells	O
and	O
metabolites	O
high	O
throughput	O
selection	O
of	O
antibiotic-resistant	O
transgenic	O
arabidopsis	O
plants	O
kanamycin	B-T109
resistance	O
is	O
the	O
most	B-T081
frequently	B-T079
used	O
antibiotic-resistance	O
marker	O
for	O
arabidopsis	O
transformations	O
,	O
however	O
,	O
this	O
method	O
frequently	B-T079
causes	O
escape	O
of	O
untransformed	O
plants	O
,	O
particularly	O
at	O
the	O
high	B-T080
seedling	O
density	B-T081
during	O
the	O
selection	O
.	O
	
here	O
we	O
developed	B-T169
a	O
robust	B-T080
high	B-T080
-	O
density	B-T081
selection	O
method	O
using	O
top	O
agar	B-T109
for	O
arabidopsis	O
thaliana	O
.	O
	
top	O
agar	B-T109
effectively	B-T080
suppressed	B-T080
growth	O
of	O
untransformed	O
wild-type	O
plants	O
on	O
selection	O
media	O
at	O
high	B-T080
density	B-T081
.	O
	
survival	O
of	O
the	O
transformed	O
plants	O
during	O
the	O
selection	O
were	O
confirmed	B-T033
by	O
production	O
of	O
green	B-T080
true	B-T080
leaves	O
and	O
expression	O
of	O
a	O
firefly	B-T116
luciferase	I-T116
reporter	O
gene	O
.	O
	
top	O
agar	B-T109
method	O
allowed	O
selection	O
using	O
a	O
large	B-T081
amount	B-T081
of	O
seeds	O
in	O
arabidopsis	O
transformation	O
.	O
	
limb	O
remote	B-T061
ischaemic	I-T061
postconditioning	I-T061
-	O
induced	B-T169
elevation	B-T081
of	O
fibulin-5	B-T116
confers	O
neuroprotection	O
to	O
rats	O
with	O
cerebral	B-T047
ischaemia	I-T047
/	O
reperfusion	O
injury	O
activation	O
of	O
the	O
akt	O
pathway	O
limb	O
remote	B-T061
ischaemic	I-T061
postconditioning	I-T061
ripostc	B-T061
is	O
an	O
effective	O
and	O
well-acknowledged	O
treatment	B-T061
for	O
brain	O
ischaemia	O
injury	O
.	O
	
the	O
present	O
study	O
aimed	O
to	O
evaluate	O
the	O
role	O
of	O
fibulin-5	B-T116
in	O
the	O
neuroprotection	O
of	O
ripostc	B-T061
against	O
cerebral	B-T047
ischaemia	I-T047
/	O
reperfusion	O
i/r	O
injury	O
in	O
rats	O
.	O
	
the	O
middle	O
cerebral	O
artery	O
occlusion	O
mcao	O
model	O
was	O
established	O
in	O
rats	O
and	O
then	O
ripostc	B-T061
was	O
carried	O
out	O
by	O
three	O
cycles	O
of	O
10	O
minutes	B-T079
occlusion	O
/10	O
minutes	B-T079
release	O
of	O
the	O
bilateral	O
femoral	O
artery	O
at	O
the	O
beginning	O
of	O
the	O
reperfusion	B-T061
.	O
	
to	O
downregulate	O
the	O
fibulin-5	B-T116
level	B-T080
,	O
fibulin-5	O
sirna	O
was	O
injected	B-T061
into	O
the	O
lateral	O
ventricle	O
24	O
hours	B-T079
before	O
mcao	O
.	O
	
according	O
to	O
our	O
present	O
study	O
,	O
ripostc	B-T061
attenuated	O
cerebral	B-T047
i	I-T047
/	O
r	O
injury	O
by	O
decreasing	B-T033
infarct	O
volume	B-T081
,	O
improving	O
neurobehavioral	B-T081
score	I-T081
and	O
suppressing	B-T169
blood	O
brain	O
barrier	O
bbb	O
leakage	O
.	O
	
moreover	O
,	O
the	O
mrna	O
and	O
protein	O
levels	O
of	O
fibulin-5	B-T116
were	O
upregulated	O
by	O
ripostc	B-T061
at	O
24	O
hours	B-T079
and	O
72	O
hours	B-T079
after	O
reperfusion	B-T061
.	O
	
downregulation	O
of	O
fibulin-5	B-T116
attenuated	O
the	O
neuroprotection	O
of	O
ripostc	B-T061
.	O
	
finally	O
,	O
the	O
result	O
showed	O
that	O
fibulin-5	B-T116
was	O
upregulated	O
by	O
ripostc	B-T061
via	O
activation	O
of	O
the	O
pi3k/akt	O
pathway	O
.	O
	
taken	O
together	O
,	O
these	O
results	B-T169
provide	O
evidence	B-T078
that	O
upregulation	O
of	O
fibulin-5	B-T116
is	O
involved	O
in	O
the	O
beneficial	O
effect	O
of	O
ripostc	B-T061
against	O
cerebral	B-T047
i	I-T047
/	O
r	O
injury	O
.	O
	
optomechanical	B-T169
control	I-T169
of	O
quantum	B-T081
yield	I-T081
in	O
trans-cis	O
ultrafast	O
photoisomerization	O
of	O
a	O
retinal	B-T109
chromophore	O
model	O
the	O
quantum	B-T081
yield	I-T081
of	O
a	O
photochemical	O
reaction	O
is	O
one	O
of	O
the	O
most	O
fundamental	B-T081
quantities	I-T081
in	O
photochemistry	O
,	O
as	O
it	O
measures	O
the	O
efficiency	O
of	O
the	O
transduction	O
of	O
light	O
energy	O
into	O
chemical	O
energy	O
.	O
	
nature	B-T078
has	O
evolved	O
photoreceptors	O
in	O
which	O
the	O
reactivity	O
of	O
a	O
chromophore	O
is	O
enhanced	O
by	O
its	O
molecular	O
environment	O
to	O
achieve	O
high	O
quantum	B-T081
yields	I-T081
.	O
	
the	O
retinal	B-T109
chromophore	O
sterically	O
constrained	O
inside	O
rhodopsin	B-T116
proteins	I-T116
represents	O
an	O
outstanding	O
example	O
of	O
such	O
a	O
control	O
.	O
	
in	O
a	O
more	O
general	O
framework	O
,	O
mechanical	O
forces	O
acting	O
on	O
a	O
molecular	B-T080
system	I-T080
can	O
strongly	O
modify	O
its	O
reactivity	O
.	O
	
herein	O
,	O
we	O
show	O
that	O
the	O
exertion	O
of	O
tensile	B-T081
forces	I-T081
on	O
a	O
simplified	O
retinal	B-T109
chromophore	O
model	O
provokes	O
a	O
substantial	B-T080
and	I-T080
regular	I-T080
increase	I-T080
in	O
the	O
trans-to-cis	O
photoisomerization	O
quantum	B-T081
yield	I-T081
in	O
a	O
counterintuitive	O
way	O
,	O
as	O
these	O
extension	O
forces	O
facilitate	O
the	O
formation	O
of	O
the	O
more	O
compressed	O
cis	O
photoisomer	O
.	O
	
a	O
rationale	B-T078
for	O
the	O
mechanochemical	O
effect	O
on	O
this	O
photoisomerization	O
mechanism	O
quality	B-T080
of	O
nursing	O
intensity	O
data	O
inter-rater	B-T081
reliability	I-T081
of	O
the	O
patient	O
classification	O
after	O
two	B-T081
decades	I-T081
in	O
clinical	B-T080
use	B-T169
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
measure	B-T081
the	O
inter-rater	B-T081
reliability	I-T081
of	O
the	O
oulu	O
patient	O
classification	O
and	O
to	O
discuss	O
existing	O
methods	B-T169
of	O
reliability	B-T081
testing	I-T081
.	O
	
the	O
oulu	O
patient	O
classification	O
,	O
part	O
of	O
the	O
rafaela	O
system	O
,	O
has	O
been	O
developed	O
to	O
assist	B-T080
nursing	O
managers	O
with	O
the	O
proper	O
allocation	O
of	O
nursing	O
resources	B-T078
.	O
	
due	O
to	O
the	O
increased	B-T081
intensity	B-T080
of	O
inpatient	O
care	O
during	O
recent	O
years	B-T079
,	O
there	O
is	O
a	O
need	O
for	O
the	O
reliability	B-T081
testing	I-T081
of	O
the	O
classification	O
,	O
which	O
has	O
been	O
in	O
clinical	B-T080
use	B-T169
for	O
20	O
years	B-T079
.	O
	
retrospective	B-T080
statistical	O
study	O
.	O
	
to	O
test	B-T081
inter-rater	B-T081
reliability	I-T081
,	O
a	O
pair	O
of	O
nurses	O
classified	O
the	O
same	O
patients	O
,	O
without	O
knowledge	O
of	O
each	O
other's	O
ratings	O
,	O
as	O
a	O
part	O
of	O
annually	B-T079
conducted	O
standardization	O
.	O
	
data	B-T078
on	O
the	O
parallel	O
classifications	O
n	O
=	O
19	O
was	O
obtained	B-T169
from	O
inpatient	O
units	O
n	O
=	O
32	O
with	O
different	B-T080
specialties	O
at	O
a	O
university	O
hospital	O
in	O
finland	O
during	O
2010-2015	O
.	O
	
parallel	O
classification	O
practices	O
were	O
also	O
analysed	O
.	O
	
the	O
reliability	B-T081
of	O
the	O
overall	O
classification	O
and	O
its	O
subareas	O
were	O
calculated	O
using	O
suitable	O
statistical	B-T081
coefficients	I-T081
.	O
	
inter-rater	B-T081
reliability	I-T081
coefficients	B-T081
were	O
a	O
reliable	O
or	O
almost	O
perfect	O
means	O
of	O
considering	O
the	O
nursing	O
intensity	B-T080
category	O
and	O
various	O
practices	O
,	O
but	O
there	O
were	O
detectable	B-T033
differences	B-T080
between	O
subareas	O
.	O
	
the	O
lowest	O
agreement	B-T080
levels	B-T080
occurred	O
in	O
the	O
subareas	O
'	O
planning	O
and	O
coordination	O
of	O
nursing	O
care	O
'	O
and	O
'	O
guiding	O
of	O
care	O
/	O
continued	O
care	O
and	O
emotional	O
support	O
'	O
.	O
	
there	O
is	O
a	O
need	O
to	O
develop	O
the	O
descriptions	O
of	O
subareas	O
and	O
to	O
clarify	O
the	O
related	O
concepts	B-T078
.	O
	
precise	O
nursing	O
documentation	O
can	O
promote	O
a	O
high	O
level	B-T080
of	O
agreement	B-T080
and	O
reliable	O
results	B-T169
.	O
	
the	O
traditional	O
overall	O
proportion	O
of	O
agreement	B-T080
does	O
not	O
provide	O
an	O
adequate	O
picture	O
of	O
reliability	O
-	O
weighted	O
kappa	B-T081
coefficients	I-T081
water	O
pipe	O
shisha	O
,	O
hookah	O
,	O
arghile	O
smoking	O
and	O
secondhand	O
tobacco	O
smoke	O
effects	B-T080
on	O
cyp1a2	B-T116
and	O
cyp2a6	B-T116
phenotypes	O
as	O
measured	O
by	O
caffeine	O
urine	O
test	O
public	O
policies	O
to	O
stop	O
or	O
reduce	O
cigarette	O
smoking	O
and	O
exposure	B-T080
to	O
secondhand	O
smoke	O
and	O
associated	O
diseases	O
have	O
yielded	O
successful	O
results	O
over	O
the	O
past	O
decade	O
.	O
	
yet	O
,	O
the	O
growing	O
worldwide	O
popularity	O
of	O
another	O
form	O
of	O
tobacco	O
consumption	O
,	O
water	O
pipe	O
smoking	O
,	O
has	O
received	O
relatively	O
less	O
attention	O
.	O
	
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
no	O
study	O
to	O
date	O
has	O
evaluated	O
the	O
effects	O
of	O
water	O
pipe	O
smoking	O
on	O
cytochrome	O
p450	O
cyp450	O
activities	O
and	O
drug	O
interaction	O
potential	B-T080
in	O
humans	O
,	O
whereas	O
only	O
limited	O
information	O
is	O
available	O
on	O
the	O
impact	O
of	O
secondhand	O
smoke	O
on	O
drug	O
metabolism	O
.	O
	
in	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	O
smoke	O
exposed	O
persons	O
,	O
and	O
41	O
controls	O
,	O
we	O
systematically	O
compared	O
cyp1a2	B-T116
and	O
cyp2a6	B-T116
enzyme	O
activities	O
in	O
vivo	O
using	O
caffeine	O
urine	O
test	O
.	O
	
the	O
median	O
self-reported	O
duration	B-T079
of	O
water	O
pipe	O
smoking	O
was	O
7.5	O
h	B-T079
/	O
week	B-T079
and	O
3	O
years	B-T079
of	O
exposure	B-T080
in	O
total	O
.	O
	
the	O
secondhand	O
smoke	O
group	O
had	O
a	O
median	O
of	O
14	O
h	B-T079
of	O
self-reported	O
weekly	B-T079
exposure	B-T080
to	O
tobacco	O
smoke	O
indoor	O
where	O
a	O
minimum	O
of	O
five	O
cigarettes	O
were	O
smoked	O
/	O
hour	B-T079
for	O
a	O
total	O
of	O
3.5	O
years	B-T079
median	O
.	O
	
analysis	O
of	O
variance	B-T080
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
cyp1a2	B-T116
and	O
cyp2a6	B-T116
activities	O
among	O
the	O
three	O
study	O
groups	O
p	O
>	O
0.05	O
.	O
	
nor	O
was	O
there	O
a	O
significant	O
association	O
between	O
the	O
extent	O
of	O
water	O
pipe	O
or	O
secondhand	O
smoke	O
exposure	B-T080
and	O
the	O
cyp1a2	B-T116
and	O
cyp2a6	B-T116
activities	O
p	O
>	O
0.05	O
.	O
	
further	O
analysis	O
in	O
a	O
subsample	O
with	O
smoke	O
exposure	B-T080
more	O
than	O
the	O
median	O
values	O
also	O
did	O
not	O
reveal	O
a	O
significant	O
difference	O
from	O
the	O
controls	O
.	O
	
although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	O
smoke	O
on	O
in	O
vivo	O
activities	O
of	O
these	O
two	O
drug	O
metabolism	O
pathways	O
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
e.g	O
,	O
water	O
pipe	O
might	O
affect	O
drug	O
metabolism	O
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	O
smoke	O
.	O
	
further	O
studies	O
in	O
larger	O
prospective	O
samples	O
are	O
recommended	O
to	O
evaluate	O
water	O
pipe	O
and	O
secondhand	O
tobacco	O
smoke	O
effects	O
on	O
cyp450	B-T116
function	O
,	O
particularly	O
at	O
higher	O
smoke	O
exposure	B-T080
how	O
do	O
wettability	B-T080
,	O
zeta	O
potential	O
and	O
hydroxylation	O
degree	O
affect	O
the	O
biological	O
response	O
of	O
biomaterials	O
it	O
is	O
well	O
known	O
that	O
composition	O
,	O
electric	O
charge	O
,	O
wettability	O
and	O
roughness	O
of	O
implant	O
surfaces	O
have	O
great	O
influence	O
on	O
their	O
interaction	O
with	O
the	O
biological	O
fluids	O
and	O
tissues	O
,	O
but	O
systematic	O
studies	O
of	O
different	O
materials	O
in	O
the	O
same	O
experimental	O
conditions	O
are	O
still	O
lacking	O
in	O
the	O
scientific	O
literature	O
.	O
	
the	O
aim	O
of	O
this	O
research	O
is	O
to	O
investigate	O
the	O
correlations	O
between	O
some	O
surface	O
characteristics	O
wettability	O
,	O
zeta	O
potential	O
and	O
hydroxylation	B-T033
degree	I-T033
and	O
the	O
biological	B-T033
response	I-T033
protein	O
adsorption	O
,	O
blood	O
wettability	O
,	O
cell	O
and	O
bacterial	O
adhesion	O
to	O
some	O
model	O
biomaterials	O
.	O
	
the	O
resulting	O
knowledge	O
can	O
be	O
applied	O
for	O
the	O
development	O
of	O
future	O
innovative	O
surfaces	O
for	O
implantable	O
biomaterials	O
.	O
	
roughness	O
was	O
not	O
considered	O
as	O
a	O
variable	O
because	O
it	O
is	O
a	O
widely	O
explored	O
feature	O
smooth	O
surfaces	O
prepared	O
by	O
a	O
controlled	O
protocol	O
were	O
compared	O
in	O
order	O
to	O
have	O
no	O
roughness	O
effects	O
.	O
	
three	O
oxides	O
zro2	O
,	O
al2o3	O
,	O
sio2	O
,	O
three	O
metals	O
316lss	O
steel	O
,	O
ti	O
,	O
nb	O
and	O
two	O
polymers	O
corona	O
treated	O
polystyrene	O
for	O
cell	O
culture	O
and	O
untreated	O
polystyrene	O
for	O
bacteria	O
culture	O
,	O
widely	O
used	O
for	O
biomedical	O
applications	O
,	O
were	O
considered	O
.	O
	
the	O
surfaces	O
were	O
characterized	O
by	O
contact	O
profilometry	O
,	O
sem	O
-	O
eds	O
,	O
xps	O
,	O
ftir	O
,	O
zeta	O
potential	O
and	O
wettability	O
with	O
different	O
fluids	O
.	O
	
protein	O
adsorption	O
,	O
blood	O
wettability	O
,	O
bacterial	O
and	O
cell	O
adhesion	O
were	O
evaluated	O
in	O
order	O
to	O
investigate	O
the	O
correlations	O
between	O
the	O
surface	O
physiochemical	O
properties	O
and	O
biological	O
responses	O
.	O
	
from	O
a	O
methodological	O
standpoint	O
,	O
xps	O
and	O
electrokinetic	O
measurements	O
emerged	O
as	O
the	O
more	O
suitable	O
techniques	O
respectively	O
for	O
the	O
evaluation	O
of	O
hydroxylation	O
degree	O
and	O
surface	O
charge	O
/	O
isoelectric	O
point	O
.	O
	
moreover	O
,	O
determination	O
of	O
wettability	O
by	O
blood	O
appeared	O
a	O
specific	O
and	O
crucial	O
test	O
,	O
the	O
results	O
of	O
which	O
are	O
not	O
easily	O
predictable	O
by	O
using	O
other	O
type	O
of	O
tests	O
.	O
	
hydroxylation	O
degree	O
resulted	O
correlated	O
to	O
the	O
wettability	O
by	O
water	O
,	O
but	O
not	O
directly	O
to	O
surface	O
charge	O
.	O
	
wetting	O
tests	O
with	O
different	O
media	O
showed	O
the	O
possibility	O
to	O
highlight	O
some	O
differences	O
among	O
look-alike	O
materials	O
.	O
	
a	O
dependence	O
of	O
protein	O
absorption	O
on	O
hydroxylation	O
degree	O
,	O
charge	O
and	O
wettability	O
was	O
evidenced	O
and	O
its	O
maximum	O
was	O
registered	O
for	O
surfaces	O
with	O
low	O
wettability	O
in	O
both	O
water	O
based	O
and	O
protein	O
containing	O
media	O
and	O
a	O
moderate	O
surface	O
charge	O
.	O
	
as	O
far	O
as	O
bacterial	O
adhesion	O
is	O
concerned	O
,	O
no	O
effect	O
of	O
surface	O
charge	O
or	O
protein	O
adsorption	O
was	O
evidenced	O
,	O
while	O
the	O
presence	O
of	O
a	O
high	O
acid	O
component	O
of	O
the	O
surface	O
energy	O
appeared	O
significant	O
.	O
	
finally	O
,	O
the	O
combination	O
of	O
hydroxylation	O
degree	O
,	O
wettability	O
,	O
surface	O
charge	O
and	O
energy	O
polar	O
component	O
emerged	O
as	O
a	O
key	O
parameter	O
for	O
cell	O
adhesion	O
and	O
viability	O
persistent	B-T079
effects	B-T080
of	O
pre-columbian	B-T081
plant	O
domestication	B-T078
on	O
amazonian	O
forest	O
composition	O
the	O
extent	O
to	O
which	O
pre-columbian	B-T081
societies	O
altered	O
amazonian	O
landscapes	O
is	O
hotly	O
debated	O
.	O
	
we	O
performed	O
a	O
basin-wide	O
analysis	O
of	O
pre-columbian	B-T081
impacts	B-T080
on	O
amazonian	O
forests	O
by	O
overlaying	O
known	O
archaeological	O
sites	O
in	O
amazonia	O
with	O
the	O
distributions	O
and	O
abundances	B-T080
of	O
85	O
woody	O
species	O
domesticated	B-T078
by	O
pre-columbian	B-T081
peoples	O
.	O
	
domesticated	B-T078
species	O
are	O
five	O
times	O
more	O
likely	O
than	O
nondomesticated	O
species	O
to	O
be	O
hyperdominant	B-T169
.	O
	
across	O
the	O
basin	O
,	O
the	O
relative	O
abundance	B-T080
and	O
richness	B-T080
of	O
domesticated	B-T078
species	O
increase	O
in	O
forests	O
on	O
and	O
around	O
archaeological	O
sites	O
.	O
	
in	O
southwestern	O
and	O
eastern	O
amazonia	O
,	O
distance	O
to	O
archaeological	O
sites	O
strongly	O
influences	O
the	O
relative	O
abundance	B-T080
and	O
richness	O
of	O
domesticated	B-T078
species	O
.	O
	
our	O
analyses	O
indicate	O
that	O
modern	O
tree	O
communities	O
in	O
amazonia	O
are	O
structured	O
to	O
an	O
important	O
extent	O
by	O
a	O
long	O
history	B-T169
of	O
plant	O
domestication	B-T078
by	O
amazonian	O
peoples	O
.	O
	
halogenated	B-T109
phenolic	I-T109
compounds	I-T109
in	O
wild	O
fish	O
from	O
canadian	O
areas	O
of	O
concern	B-T078
concentrations	O
of	O
halogenated	B-T109
phenolic	I-T109
compounds	I-T109
were	O
measured	O
in	O
the	O
plasma	O
of	O
brown	O
bullhead	O
ameiurus	O
nebulosus	O
from	O
4	O
canadian	O
areas	O
of	O
concern	B-T078
aocs	O
,	O
to	O
assess	O
exposure	O
to	O
suspected	O
thyroid	O
-	O
disrupting	O
chemicals	O
.	O
	
hydroxylated	B-T109
polychlorinated	I-T109
biphenyls	I-T109
oh-pcbs	B-T109
were	O
detected	O
in	O
every	O
sample	O
collected	O
in	O
3	O
of	O
the	O
aocs	O
the	O
detection	B-T061
frequency	B-T079
was	O
lower	O
in	O
samples	O
from	O
the	O
detroit	O
river	O
aoc	O
.	O
	
the	O
oh-pcbs	B-T109
most	O
frequently	O
detected	O
were	O
pentachloro	O
,	O
hexachloro	O
,	O
and	O
heptachloro	O
congeners	O
,	O
which	O
are	O
structurally	O
similar	O
to	O
thyroid	B-T116
hormones	I-T116
.	O
	
pentachlorophenol	B-T109
pcp	B-T109
was	O
detected	O
at	O
highest	O
concentrations	O
1.8	O
ng/g	O
in	O
fish	O
from	O
prince	O
edward	O
bay	O
,	O
the	O
bay	O
of	O
quinte	O
lake	O
reference	O
site	O
,	O
and	O
hillman	O
marsh	O
the	O
wheatley	O
harbour	O
reference	O
site	O
,	O
suggesting	O
local	O
sources	O
of	O
contamination	O
.	O
	
elevated	O
pcp	O
concentrations	O
were	O
also	O
detected	O
in	O
the	O
plasma	O
of	O
brown	O
bullhead	O
from	O
exposed	O
sites	O
in	O
the	O
toronto	O
and	O
region	O
aoc	O
0.4	O
ng/g	O
.	O
	
triclosan	B-T109
was	O
consistently	O
detected	O
in	O
the	O
toronto	O
and	O
region	O
aoc	O
0.05	O
ng/g	O
,	O
consistent	O
with	O
wastewater	O
emission	O
.	O
	
greater	O
concentrations	O
were	O
occasionally	O
detected	O
in	O
the	O
plasma	O
of	O
brown	O
bullhead	O
from	O
the	O
bay	O
of	O
quinte	O
aoc	O
.	O
	
concentrations	O
of	O
polybrominated	B-T109
diphenyl	I-T109
ethers	I-T109
were	O
highest	O
in	O
the	O
toronto	O
and	O
region	O
aoc	O
,	O
and	O
at	O
2	O
of	O
the	O
bay	O
of	O
quinte	O
aoc	O
exposed	O
sites	O
near	O
trenton	O
and	O
belleville	O
.	O
	
distribution	O
patterns	O
reflected	O
the	O
properties	O
and	O
usage	B-T169
of	O
the	O
compounds	O
under	O
investigation	O
and	O
the	O
characteristics	B-T080
of	O
each	O
aoc	O
.	O
	
the	O
genetic	B-T169
basis	O
for	O
variation	O
in	O
resistance	O
to	O
infection	O
in	O
the	O
drosophila	O
melanogaster	O
genetic	O
reference	O
panel	O
individuals	O
vary	O
extensively	O
in	O
the	O
way	O
they	O
respond	O
to	O
disease	B-T047
but	O
the	O
genetic	B-T169
basis	O
of	O
this	O
variation	O
is	O
not	O
fully	O
understood	O
.	O
	
we	O
found	O
substantial	O
individual	O
variation	O
in	O
resistance	O
and	O
tolerance	B-T080
to	O
the	O
fungal	O
pathogen	O
metarhizium	O
anisopliae	O
ma549	O
using	O
the	O
drosophila	O
melanogaster	O
genetic	O
reference	O
panel	O
dgrp	O
.	O
	
in	O
addition	O
,	O
we	O
found	O
that	O
host	O
defense	O
to	O
ma549	O
was	O
correlated	O
with	O
defense	O
to	O
the	O
bacterium	O
pseudomonas	O
aeruginosa	O
pa14	O
,	O
and	O
several	O
previously	O
published	O
dgrp	O
phenotypes	O
including	O
oxidative	O
stress	O
sensitivity	B-T169
,	O
starvation	B-T033
stress	O
resistance	O
,	O
hemolymph	O
glucose	O
levels	O
,	O
and	O
sleep	O
indices	O
.	O
	
we	O
identified	O
polymorphisms	O
associated	B-T080
with	I-T080
differences	B-T080
between	O
lines	O
in	O
both	O
their	O
mean	B-T081
survival	I-T081
times	I-T081
and	O
microenvironmental	O
plasticity	O
,	O
suggesting	O
that	O
lines	O
differ	B-T080
in	O
their	O
ability	O
to	O
adapt	O
to	O
variable	B-T080
pathogen	O
exposures	B-T080
.	O
	
the	O
majority	O
of	O
polymorphisms	O
increasing	B-T169
resistance	O
to	O
ma549	O
were	O
sex	B-T078
biased	I-T078
,	O
located	O
in	O
non-coding	O
regions	O
,	O
had	O
moderately	O
large	O
effect	B-T080
and	O
were	O
rare	O
,	O
suggesting	O
that	O
there	O
is	O
a	O
general	O
cost	O
to	O
defense	O
.	O
	
nevertheless	O
,	O
host	O
defense	O
was	O
not	O
negatively	O
correlated	B-T080
with	O
overall	O
longevity	B-T079
and	O
fecundity	O
.	O
	
in	O
contrast	O
to	O
ma549	O
,	O
minor	O
alleles	O
were	O
concentrated	O
in	O
the	O
most	O
pa14	O
-	O
susceptible	B-T169
as	O
well	O
as	O
the	O
most	O
pa14	O
-	O
resistant	O
lines	O
.	O
	
a	O
pathway	O
based	O
analysis	O
revealed	O
a	O
network	O
of	O
pa14	O
and	O
ma549	O
-	O
resistance	O
genes	O
that	O
are	O
functionally	B-T169
connected	O
through	O
processes	O
that	O
encompass	O
phagocytosis	O
and	O
engulfment	O
,	O
cell	O
mobility	O
,	O
intermediary	O
metabolism	O
,	O
protein	O
phosphorylation	O
,	O
axon	O
guidance	O
,	O
response	O
to	O
dna	O
damage	O
,	O
and	O
drug	O
metabolism	O
.	O
	
functional	B-T169
testing	B-T169
with	O
insertional	O
mutagenesis	O
lines	O
indicates	O
that	O
12/13	O
candidate	O
genes	O
tested	B-T169
influence	O
susceptibility	B-T169
to	O
ma549	O
.	O
	
many	O
candidate	O
genes	O
have	O
homologs	O
identified	O
in	O
studies	O
of	O
human	O
disease	B-T047
,	O
suggesting	O
that	O
genes	O
affecting	O
variation	O
in	O
susceptibility	B-T169
are	O
conserved	O
across	O
surrogate	O
inaccuracy	B-T080
in	O
predicting	O
older	O
adults'	O
desire	O
for	O
life-sustaining	B-T061
interventions	I-T061
in	O
the	O
event	O
of	O
decisional	O
incapacity	O
is	O
it	O
due	O
in	O
part	O
to	O
erroneous	B-T078
quality-of-life	O
assessments	O
family	O
members	O
are	O
often	O
called	O
upon	O
to	O
make	O
decisions	O
for	O
an	O
incapacitated	O
relative	O
.	O
	
yet	O
they	O
have	O
difficulty	O
predicting	O
a	O
loved	O
one's	O
desire	O
to	O
receive	O
treatments	B-T061
in	O
hypothetical	O
situations	O
.	O
	
we	O
tested	O
the	O
hypothesis	O
that	O
this	O
difficulty	O
could	O
in	O
part	O
be	O
explained	O
by	O
discrepant	O
quality-of-life	O
assessments	O
.	O
	
the	O
data	B-T078
come	O
from	O
235	O
community-dwelling	O
adults	O
aged	O
70	O
years	B-T079
and	O
over	O
who	O
rated	O
their	O
quality	B-T078
of	I-T078
life	I-T078
and	O
desire	O
for	O
specified	O
interventions	B-T061
in	O
four	O
health	B-T033
states	I-T033
current	B-T033
state	I-T033
,	O
mild	B-T080
to	O
moderate	B-T080
stroke	B-T047
,	O
incurable	O
brain	O
cancer	O
,	O
and	O
severe	B-T080
dementia	O
.	O
	
all	O
ratings	O
were	O
made	O
on	O
likert-type	O
scales	O
.	O
	
using	O
identical	O
rating	B-T081
scales	I-T081
,	O
a	O
surrogate	O
chosen	O
by	O
the	O
older	O
adult	O
was	O
asked	O
to	O
predict	O
the	O
latter's	O
responses	O
.	O
	
linear	O
mixed	O
models	O
were	O
fitted	O
to	O
determine	O
whether	O
differences	O
in	O
quality-of-life	B-T078
ratings	O
between	O
the	O
older	O
adult	O
and	O
surrogate	O
were	O
associated	O
with	O
surrogates'	O
inaccuracy	B-T080
in	O
predicting	O
desire	O
for	O
treatment	B-T061
.	O
	
the	O
difference	O
in	O
quality-of-life	B-T078
ratings	O
was	O
a	O
significant	O
predictor	B-T078
of	O
prediction	O
inaccuracy	B-T080
for	O
the	O
three	O
hypothetical	O
health	B-T033
states	I-T033
p	O
<	O
0.01	O
and	O
nearly	O
significant	O
for	O
the	O
current	B-T033
health	I-T033
state	I-T033
p	O
=	O
0.077	O
.	O
	
all	O
regression	B-T081
coefficients	I-T081
were	O
negative	B-T033
,	O
implying	O
that	O
the	O
more	O
the	O
surrogate	O
overestimated	O
quality	B-T078
of	I-T078
life	I-T078
compared	O
to	O
the	O
older	O
adult	O
,	O
the	O
more	O
he	O
or	O
she	O
overestimated	O
the	O
older	O
adult	O
's	O
desire	O
to	O
be	O
treated	O
.	O
	
discrepant	O
quality-of-life	B-T078
ratings	O
are	O
associated	O
with	O
surrogates'	O
difficulty	O
in	O
predicting	O
desire	O
for	O
life-sustaining	B-T061
interventions	I-T061
in	O
hypothetical	O
situations	O
.	O
	
this	O
finding	O
underscores	O
the	O
importance	O
of	O
discussing	O
anticipated	O
quality	B-T078
of	I-T078
life	I-T078
in	O
states	O
of	O
cognitive	O
decline	O
,	O
to	O
better	O
prepare	O
family	O
members	O
for	O
making	O
difficult	O
decisions	O
gain-of-function	O
mutation	O
in	O
scn5a	O
causes	O
ventricular	B-T047
arrhythmias	I-T047
and	O
early	B-T033
onset	I-T033
atrial	B-T047
fibrillation	I-T047
mutations	O
in	O
scn5a	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	B-T116
channel	I-T116
nav1.5	I-T116
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	B-T169
cardiac	B-T033
arrhythmia	I-T033
disorders	I-T033
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
genetic	B-T169
and	O
functional	B-T169
determinants	I-T169
underlying	O
a	O
dutch	O
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	B-T047
arrhythmias	I-T047
with	O
a	O
likely	O
adrenergic	B-T169
component	O
,	O
either	O
in	O
isolation	B-T169
or	O
in	O
combination	B-T080
with	O
a	O
mildly	O
decreased	O
heart	O
function	O
and	O
early	B-T033
onset	I-T033
<55	O
years	B-T079
atrial	B-T047
fibrillation	I-T047
.	O
	
we	O
performed	O
next	O
generation	B-T079
sequencing	O
in	O
the	O
proband	O
of	O
a	O
two-	O
generation	B-T079
dutch	O
family	O
and	O
demonstrated	O
a	O
novel	O
missense	O
mutation	O
in	O
scn5a-	O
which	O
co-segregated	O
with	O
the	O
clinical	B-T080
phenotype	O
in	O
the	O
family	O
.	O
	
we	O
functionally	B-T169
evaluated	O
the	O
putative	O
genetic	B-T169
defect	B-T169
by	O
patch	O
clamp	O
electrophysiological	O
studies	O
in	O
human	O
embryonic	O
kidney	O
cells	O
transfected	O
with	O
mutant	O
or	O
wild-type	O
nav1.5	O
.	O
	
the	O
current	O
inactivation	B-T169
was	O
slower	O
and	O
recovery	O
from	O
inactivation	B-T169
was	O
faster	O
in	O
scn5a-m1851v	B-T116
channels	I-T116
.	O
	
the	O
voltage	B-T081
dependence	B-T169
of	O
inactivation	B-T169
was	O
shifted	O
towards	O
more	O
positive	B-T033
potentials	B-T080
and	O
consequently	O
,	O
a	O
larger	O
ttx	B-T109
-	O
sensitive	B-T169
window	O
current	O
was	O
observed	O
in	O
scn5a-m1851v	B-T116
channels	I-T116
.	O
	
furthermore	O
,	O
a	O
higher	O
upstroke	B-T081
velocity	I-T081
was	O
observed	O
for	O
the	O
scn5a-m1851v	B-T116
channels	I-T116
,	O
while	O
the	O
depolarization	B-T081
voltage	I-T081
was	O
more	O
negative	B-T033
,	O
both	O
indicating	O
increased	O
excitability	O
.	O
	
this	O
mutation	O
leads	O
to	O
a	O
gain-of-function	B-T169
mechanism	I-T169
based	O
on	O
increased	O
channel	B-T116
availability	O
and	O
increased	O
window	O
current	O
,	O
fitting	O
the	O
observed	O
clinical	B-T080
phenotype	O
of	O
likely	O
adrenergic-induced	O
ventricular	B-T047
arrhythmias	I-T047
and	O
atrial	B-T047
fibrillation	I-T047
.	O
	
these	O
findings	B-T033
further	O
expand	O
the	O
range	O
of	O
cardiac	B-T033
arrhythmias	I-T033
associated	O
with	O
mutations	O
in	O
the	O
cancer	O
warburg	O
effect	O
may	O
be	O
a	O
testable	B-T169
example	O
of	O
the	O
minimum	B-T080
entropy	O
production	B-T081
rate	I-T081
principle	B-T078
cancer	O
cells	O
consume	B-T169
more	O
glucose	B-T109
by	O
glycolytic	O
fermentation	O
to	O
lactate	B-T109
than	O
by	O
respiration	O
,	O
a	O
characteristic	B-T080
known	O
as	O
the	O
warburg	O
effect	O
.	O
	
in	O
contrast	O
with	O
the	O
34	O
moles	B-T081
of	O
atp	O
produced	O
by	O
respiration	O
,	O
fermentation	O
produces	O
two	O
moles	B-T081
of	O
atp	O
per	O
mole	B-T081
of	O
glucose	B-T109
consumed	B-T169
,	O
which	O
poses	O
a	O
puzzle	O
on	O
the	O
function	B-T169
of	O
the	O
warburg	O
effect	O
.	O
	
productions	B-T169
of	O
free	O
energy	O
δg	O
,	O
enthalpy	B-T081
δh	B-T081
and	O
entropy	O
δs	B-T080
per	O
mole	B-T081
linearly	O
vary	O
with	O
the	O
fraction	B-T081
x	I-T081
of	I-T081
glucose	B-T109
consumed	B-T169
by	O
fermentation	O
that	O
is	O
frequently	B-T079
estimated	B-T081
around	O
0.9	O
.	O
	
hence	O
,	O
calculation	O
shows	O
that	O
,	O
in	O
respect	O
to	O
pure	B-T080
respiration	O
,	O
the	O
predominant	O
fermentative	O
metabolism	O
decreases	B-T081
around	O
10%	O
the	O
production	B-T169
of	O
entropy	O
per	O
mole	B-T081
of	O
glucose	B-T109
consumed	B-T169
in	O
cancer	O
cells	O
.	O
	
we	O
hypothesize	B-T078
that	O
increased	B-T081
fermentation	O
could	O
allow	O
cancer	O
cells	O
to	O
accomplish	B-T080
the	O
prigogine	O
theorem	O
of	O
the	O
trend	B-T079
to	O
minimize	B-T081
the	O
rate	B-T081
of	O
production	B-T169
of	O
entropy	O
.	O
	
according	O
the	O
theorem	O
,	O
open	O
cellular	O
systems	O
near	O
the	O
steady	O
state	O
could	O
evolve	B-T169
to	O
minimize	B-T081
the	O
rates	B-T081
of	O
entropy	O
production	B-T169
that	O
may	O
be	O
reached	O
by	O
modified	B-T033
replicating	B-T080
cells	O
producing	O
entropy	O
at	O
low	O
rate	B-T081
.	O
	
remarkably	O
,	O
at	O
co2	O
concentrations	B-T081
above	O
930	O
ppm	B-T081
,	O
glucose	B-T109
respiration	O
produces	O
less	O
entropy	O
than	O
fermentation	O
,	O
which	O
suggests	O
experimental	B-T080
tests	O
to	O
validate	B-T080
the	O
hypothesis	B-T078
of	O
minimization	B-T081
of	O
the	O
rate	B-T081
of	O
entropy	O
production	B-T169
through	O
the	O
warburg	O
effect	O
.	O
	
potential	B-T080
drug-drug	O
interactions	O
among	O
prescriptions	O
for	O
elderly	O
patients	O
in	O
primary	O
health	O
care	O
elderly	O
patients	O
are	O
at	O
high	B-T033
risk	I-T033
from	O
drug-drug	O
interactions	O
ddis	O
.	O
	
this	O
study	O
evaluates	O
the	O
potential	B-T080
ddis	O
in	O
turkish	O
elderly	O
patients	O
at	O
a	O
primary	O
health	O
care	O
outpatient	O
clinic	O
.	O
	
online	O
database	O
systems	O
were	O
used	O
to	O
examine	O
ddis	O
on	O
the	O
prescriptions	O
of	O
patients	O
n	O
=	O
1206	O
.	O
	
the	O
clinical	B-T033
severity	I-T033
of	O
ddis	O
was	O
classified	O
by	O
the	O
lexi-interact	O
online	O
database	O
.	O
	
of	O
the	O
5059	O
prescriptions	O
,	O
33%	O
were	O
found	O
to	O
have	O
ddis	O
.	O
	
we	O
detected	B-T033
29	O
0.9	O
a	O
,	O
380	O
11.8	O
b	O
,	O
2494	O
77.7	O
c	O
,	O
289	O
9%	O
d	O
,	O
and	O
18	O
0.6	O
x	O
risk	O
rating	O
category	O
ddis	O
among	O
the	O
prescriptions	O
.	O
	
prescriptions	O
of	O
female	O
patients	O
and	O
patients	O
aged	O
between	O
65	O
and	O
72	O
years	O
showed	O
significantly	B-T081
higher	I-T081
number	O
of	O
ddis	O
.	O
	
the	O
frequency	B-T079
of	O
ddis	O
increased	B-T081
both	O
with	O
the	O
number	O
of	O
drugs	O
and	O
combined	O
preparations	O
per	O
prescription	O
.	O
	
acetylsalicylic	B-T109
acid	I-T109
and	O
salbutamol	B-T109
were	O
the	O
most	O
frequently	B-T079
prescribed	O
drugs	O
contributing	O
to	O
clinically	B-T033
important	I-T033
ddis	O
.	O
	
additionally	O
,	O
acetylsalicylic	B-T109
acid	I-T109
and	O
escitalopram	B-T109
,	O
which	O
interact	B-T169
with	O
each	O
other	O
,	O
were	O
found	O
on	O
the	O
list	O
of	O
beers	B-T080
criteria	I-T080
.	O
	
the	O
most	O
predicted	B-T033
clinical	I-T033
outcomes	I-T033
of	O
ddis	O
were	O
increase	O
in	O
therapeutic	B-T080
efficacy	I-T080
and	O
adverse	O
/	O
toxic	B-T033
reactions	I-T033
.	O
	
conclusions	O
prediction	B-T078
of	O
ddis	O
in	O
elderly	O
patients	O
will	O
provide	O
better	O
prescribing	O
and	O
drug	B-T080
safety	I-T080
.	O
	
use	O
of	O
nonsteroidal	O
anti-inflammatory	O
agents	O
,	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
,	O
and	O
beta-2	O
adrenergic	O
receptor	O
agonists	O
discontinued	B-T033
splenogonadal	O
fusion	O
and	O
bilateral	O
empty	O
scrotum	O
in	O
an	O
18-	O
month	O
-old	O
boy	O
splenogonadal	O
fusion	O
is	O
a	O
rare	B-T080
benign	O
congenital	O
anomaly	O
defined	O
as	O
the	O
presence	O
of	O
splenic	O
tissue	O
adherent	B-T169
to	O
gonads	O
.	O
	
it	O
was	O
first	O
described	O
in	O
1883	O
by	O
bostroem	O
,	O
a	O
german	O
pathologist	O
.	O
	
we	O
present	O
a	O
case	O
of	O
an	O
18-	O
month	O
-old	O
boy	O
who	O
was	O
referred	O
as	O
a	O
case	O
of	O
bilateral	O
empty	O
scrotum	O
since	O
birth	O
.	O
	
during	O
routine	B-T080
laparoscopic	O
exploration	B-T061
,	O
right	O
vas	O
deferens	O
and	O
testicular	O
vessels	O
were	O
entering	O
the	O
right	O
internal	O
inguinal	O
ring	O
so	O
right	O
inguinal	O
exploration	B-T061
was	O
done	O
,	O
which	O
revealed	O
blind	B-T033
ending	I-T033
vas	O
deferens	O
and	O
testicular	O
vessels	O
and	O
the	O
left	O
testis	O
was	O
found	O
intra-abdominally	O
near	O
the	O
left	O
internal	O
ring	O
with	O
a	O
mass	O
on	O
its	O
upper	O
pole	O
.	O
	
wedge	O
biopsy	O
was	O
taken	O
from	O
the	O
upper	O
pole	O
of	O
the	O
testicle	O
site	O
of	O
the	O
mass	O
for	O
tissue	O
diagnosis	O
followed	O
by	O
orchidopexy	B-T061
.	O
	
histology	O
showed	O
splenic	O
tissue	O
.	O
	
although	O
splenogonadal	O
fusion	O
is	O
a	O
rare	B-T080
condition	B-T047
,	O
surgeons	O
should	O
be	O
aware	O
of	O
this	O
rare	B-T047
disease	I-T047
entity	O
to	O
avoid	O
unnecessary	O
aggressive	O
interventions	B-T061
such	O
as	O
real-world	B-T080
impact	I-T080
of	O
non-breast	B-T033
cancer-specific	I-T033
death	I-T033
on	O
overall	B-T081
survival	I-T081
in	O
resectable	B-T080
breast	O
cancer	O
the	O
real-world	O
occurrence	B-T081
rate	I-T081
of	O
non-breast	B-T033
cancer-specific	I-T033
death	I-T033
non-bcsd	B-T033
and	O
its	O
impact	B-T080
on	O
patients	O
with	O
breast	O
cancer	O
are	O
poorly	O
recognized	O
.	O
	
women	O
with	O
resectable	B-T080
breast	O
cancer	O
from	O
1990	O
to	O
2007	O
in	O
the	O
surveillance	O
,	O
epidemiology	O
,	O
and	O
end	O
results	O
database	O
n	O
=	O
199	O
were	O
analyzed	O
.	O
	
the	O
outcome	B-T169
events	O
of	O
breast	O
cancer	O
were	O
classified	O
as	O
breast	B-T081
cancer-specific	I-T081
death	I-T081
bcsd	B-T081
,	O
non-bcsd	B-T033
,	O
or	O
survival	O
.	O
	
binary	O
logistics	O
was	O
used	O
to	O
estimate	B-T081
the	O
occurrence	B-T081
rates	I-T081
of	O
non-bcsd	B-T033
and	O
bcsd	B-T081
with	O
different	O
clinicopathological	B-T169
factors	I-T169
.	O
	
the	O
gray	O
method	O
was	O
used	O
to	O
measure	B-T081
the	O
cumulative	B-T081
incidence	I-T081
of	O
non-bcsd	B-T033
and	O
bcsd	B-T081
.	O
	
the	O
ratio	B-T081
of	O
non-bcsds	B-T033
to	O
all	O
causes	B-T033
of	I-T033
death	I-T033
and	O
stacked	O
cumulative	B-T081
incidence	I-T081
function	O
plots	O
were	O
used	O
to	O
present	O
the	O
impact	B-T080
of	O
non-bcsd	B-T033
on	O
overall	B-T081
survival	I-T081
os	B-T081
.	O
	
models	B-T081
of	I-T081
cox	I-T081
proportional	I-T081
hazards	I-T081
regression	I-T081
and	O
competing	O
risk	O
regression	O
were	O
compared	O
to	O
highlight	O
the	O
suitable	O
model	O
.	O
	
there	O
were	O
12	O
non-bcsds	B-T033
6.44	O
and	O
28	O
bcsds	B-T081
14.39	O
.	O
	
the	O
oldest	O
age	O
group	O
>62	O
years	O
,	O
black	O
race	O
,	O
and	O
a	O
single	B-T033
or	I-T033
divorced	I-T033
marital	I-T033
status	I-T033
were	O
associated	B-T080
with	I-T080
more	O
non-bcsds	B-T033
.	O
	
with	O
adjustments	O
for	O
age	O
,	O
a	O
hormone	O
receptor-positive	O
hor+	O
status	O
was	O
no	O
longer	O
related	O
to	O
increased	B-T081
non-bcsd	B-T033
s	O
.	O
	
in	O
patients	O
with	O
grade	B-T047
1	I-T047
,	O
stage	I-T047
i	I-T047
disease	I-T047
and	O
an	O
hor+	O
status	O
as	O
well	O
as	O
the	O
oldest	O
subgroup	O
,	O
a	O
great	O
dilution	O
of	O
non-bcsd	B-T033
on	O
all	O
causes	B-T033
of	I-T033
death	I-T033
could	O
be	O
observed	O
,	O
and	O
this	O
led	O
to	O
incorrect	B-T033
interpretations	I-T033
.	O
	
the	O
inaccuracy	B-T080
,	O
caused	O
by	O
the	O
commonly	O
used	O
cox	B-T081
proportional	I-T081
hazards	I-T081
model	I-T081
,	O
could	O
be	O
corrected	O
by	O
a	O
competing	O
risk	O
model	O
.	O
	
os	B-T081
was	O
largely	O
impaired	B-T169
by	O
non-bcsd	B-T033
during	O
early	O
breast	O
cancer	O
.	O
	
for	O
some	O
future	O
clinical	O
trial	O
planning	O
,	O
especially	O
for	O
the	O
oldest	O
patients	O
and	O
those	O
with	O
hor+	O
breast	O
cancer	O
,	O
non-bcsd	B-T033
should	O
be	O
considered	O
a	O
competing	O
risk	O
event	O
.	O
	
cancer	O
2017	O
.	O
	
2017	O
american	O
cancer	O
society	O
.	O
	
hip	O
segmentation	O
from	O
mri	O
volumes	O
in	O
infants	O
for	O
ddh	O
diagnosis	B-T033
and	O
treatment	O
planning	O
diagnosis	B-T033
and	O
surgical	O
management	O
of	O
developmental	O
dysplasia	O
of	O
the	O
hip	O
ddh	O
relies	O
on	O
physical	O
examination	O
and	O
2d	O
ultrasound	O
scanning	O
.	O
	
magnetic	O
resonance	O
imaging	O
mri	O
can	O
be	O
used	O
to	O
complement	O
existing	O
techniques	B-T169
and	O
could	O
be	O
advantageous	O
in	O
treatment	O
planning	O
due	O
to	O
its	O
larger	O
field	O
of	O
view	O
.	O
	
in	O
this	O
paper	O
we	O
propose	O
a	O
semi-automatic	B-T169
method	O
to	O
segment	O
surface	O
models	O
of	O
the	O
acetabulum	O
from	O
mri	O
images	B-T078
.	O
	
the	O
method	O
incorporates	O
clinical	B-T080
knowledge	O
in	O
the	O
form	O
of	O
intensity	O
priors	O
which	O
are	O
integrated	O
into	O
a	O
random	O
walker	O
rw	O
formulation	O
.	O
	
we	O
use	O
a	O
modified	B-T169
rw	O
framework	O
which	O
compensates	B-T080
for	O
incomplete	B-T080
or	O
blurred	B-T080
boundaries	O
in	O
the	O
image	B-T078
by	O
using	O
information	B-T078
from	O
neighboring	O
slices	O
in	O
the	O
sequence	B-T169
incorporated	O
as	O
node	B-T081
weights	I-T081
.	O
	
we	O
conducted	O
a	O
pilot	O
study	O
to	O
evaluate	O
the	O
segmentation	O
on	O
a	O
set	O
of	O
10	O
infant	O
hip	O
mri	O
sequences	B-T169
using	O
a	O
1.5	O
tesla	O
mr	O
scanner	O
.	O
	
contours	O
obtained	O
from	O
the	O
semi-automated	B-T169
segmentation	O
were	O
compared	O
against	O
manually	B-T033
segmented	O
hip	O
contours	O
using	O
dice	B-T081
ratio	I-T081
dr	B-T081
,	O
hausdorff	B-T081
distance	I-T081
hd	B-T081
and	O
root	B-T081
mean	I-T081
square	I-T081
rms	B-T081
distance	O
.	O
	
the	O
proposed	O
method	O
gave	O
values	O
of	O
dr	B-T081
=	O
0.84	O
0.5	O
,	O
hd	B-T081
=3	O
0.7	O
,	O
rms	B-T081
=1	O
0.3	O
and	O
dr	B-T081
=0	O
0.2	O
,	O
hd	B-T081
=3	O
0.1	O
,	O
rms	B-T081
=	O
2.0	O
0.6	O
for	O
right	O
and	O
left	O
acetabular	O
contours	O
respectively	O
which	O
was	O
higher	B-T080
than	O
the	O
corresponding	O
values	O
obtained	O
from	O
conventional	B-T080
rw	O
segmentation	O
.	O
	
the	O
execution	O
time	B-T079
of	O
the	O
segmentation	O
algorithm	O
was	O
less	O
than	O
4	O
seconds	B-T079
on	O
a	O
3.5	O
ghz	O
automated	O
basal	O
cell	O
carcinoma	O
detection	O
in	O
high-definition	O
optical	O
coherence	O
tomography	O
basal	O
cell	O
carcinoma	O
bcc	O
is	O
the	O
most	O
common	O
non-melanoma	O
skin	O
cancer	O
.	O
	
conventional	O
diagnosis	O
of	O
bcc	O
requires	O
invasive	B-T080
biopsies	O
.	O
	
recently	O
,	O
a	O
high-definition	O
optical	O
coherence	O
tomography	O
hd-oct	O
technique	O
has	O
been	O
developed	O
,	O
which	O
provides	O
a	O
non-invasive	B-T169
in	O
vivo	O
imaging	O
method	O
of	O
skin	O
.	O
	
good	O
agreements	O
of	O
bcc	O
features	O
between	O
hd-oct	O
images	B-T078
and	O
histopathological	B-T169
architecture	I-T169
have	O
been	O
found	O
.	O
	
therefore	O
it	O
is	O
possible	O
to	O
automatically	O
detect	O
bcc	O
using	O
hd-oct	O
.	O
	
this	O
paper	O
presents	O
a	O
novel	O
bcc	O
detection	O
method	O
that	O
consists	O
of	O
four	O
steps	O
graph	O
based	O
skin	O
surface	O
segmentation	O
,	O
surface	B-T169
flattening	I-T169
,	O
deep	O
feature	O
extraction	O
and	O
the	O
bcc	O
classification	O
.	O
	
the	O
effectiveness	B-T080
of	O
the	O
proposed	O
method	O
is	O
well	O
demonstrated	O
on	O
a	O
dataset	O
of	O
5	O
images	O
.	O
	
it	O
can	O
therefore	O
serve	O
as	O
an	O
automatic	O
tool	O
for	O
screening	O
fall	B-T033
risk	B-T033
factors	I-T033
analysis	O
based	O
on	O
sample	O
entropy	O
of	O
plantar	O
kinematic	O
signal	O
during	O
stance	B-T033
phase	I-T033
falls	B-T033
are	O
a	O
multi-causal	O
phenomenon	O
with	O
a	O
complex	B-T080
interaction	B-T169
.	O
	
the	O
aim	O
of	O
our	O
research	O
is	O
to	O
study	O
the	O
effect	B-T080
of	O
multiple	B-T081
variables	B-T080
for	O
potential	B-T080
risk	B-T033
of	I-T033
falls	I-T033
and	O
construct	O
an	O
elderly	O
fall	O
risk	O
assessment	O
model	O
based	O
on	O
demographics	O
data	B-T078
and	O
gait	B-T033
characteristics	I-T033
.	O
	
a	O
total	O
of	O
101	O
subjects	O
,	O
whom	O
belong	O
to	O
malianwa	O
street	O
,	O
aged	O
above	O
50	O
years	B-T079
old	I-T079
and	O
participated	B-T169
in	O
questionnaire	O
survey	O
.	O
	
participants	O
were	O
classified	O
into	O
three	O
groups	B-T078
high	O
,	O
medium	O
and	O
low	B-T081
risk	I-T081
group	B-T078
according	O
to	O
the	O
score	B-T081
of	O
elderly	O
fall	O
risk	O
assessment	O
scale	O
.	O
	
in	O
addition	O
,	O
the	O
data	B-T078
of	O
ground	O
reaction	O
force	O
grf	O
and	O
ground	O
reaction	O
moment	O
grm	O
was	O
record	B-T080
when	O
they	O
performed	B-T169
walking	O
at	O
comfortable	B-T033
state	I-T033
.	O
	
the	O
demographic	O
variables	B-T080
,	O
sample	O
entropy	O
of	O
grf	O
and	O
grm	O
,	O
and	O
impulse	B-T081
difference	I-T081
of	O
bilateral	O
foot	O
were	O
considered	O
as	O
potential	B-T080
explanatory	O
variables	B-T080
of	O
risk	O
assessment	O
model	O
.	O
	
firstly	O
,	O
we	O
investigated	B-T169
whether	O
different	O
groups	B-T078
could	O
present	O
difference	B-T081
in	O
every	O
variable	B-T080
.	O
	
statistical	B-T081
differences	I-T081
were	O
found	B-T033
for	O
the	O
following	O
variables	B-T080
age	O
p=2	O
impulse	B-T081
difference	I-T081
p=0	O
sample	O
entropy	O
of	O
grf	O
in	O
vertical	O
direction	O
p=0	O
sample	O
entropy	O
of	O
grm	O
in	O
anterior-posterior	O
direction	O
p=0	O
.	O
	
finally	O
,	O
the	O
multiple	B-T081
regression	O
analysis	O
results	B-T169
indicated	B-T033
that	O
age	O
,	O
impulse	B-T081
difference	I-T081
and	O
sample	O
entropy	O
of	O
resultant	O
grm	O
could	O
identify	O
individuals	O
who	O
had	O
different	O
levels	O
of	O
fall	O
risk	O
.	O
	
therefore	O
,	O
those	O
results	B-T169
could	O
potentially	B-T080
be	O
useful	B-T080
in	O
the	O
fall	O
risk	O
assessment	O
and	O
monitor	O
the	O
state	B-T169
of	O
physical	B-T033
function	I-T033
in	O
elderly	O
population	O
.	O
	
endurance	B-T033
based	O
personalized	O
fitness	O
planner	O
endurance	B-T033
is	O
an	O
important	B-T080
factor	B-T169
of	O
cardiovascular	O
fitness	O
indicating	O
the	O
capacity	B-T081
of	O
an	O
individual	O
to	O
perform	B-T169
exercise	O
for	O
a	O
longer	B-T079
duration	I-T079
with	O
increased	B-T081
intensity	B-T080
.	O
	
various	O
subject	B-T080
specific	I-T080
and	O
exercise	O
related	O
parameters	O
affect	O
endurance	B-T033
of	O
an	O
individual	O
.	O
	
in	O
this	O
work	O
,	O
we	O
propose	O
a	O
statistical	O
technique	O
to	O
model	O
endurance	B-T033
as	O
a	O
function	O
of	O
these	O
factors	B-T169
incorporating	O
the	O
serial	O
dependence	O
of	O
observations	O
generated	O
by	O
individuals	O
over	B-T079
time	I-T079
.	O
	
the	O
proposed	B-T080
model	O
provides	O
a	O
device	O
to	O
predict	O
future	O
endurance	B-T033
of	O
a	O
test	O
subject	O
following	O
particular	O
exercise	B-T061
regime	I-T061
.	O
	
this	O
facilitates	O
a	O
test	B-T078
user	I-T078
with	O
a	O
fitness	O
planner	O
with	O
the	O
provision	O
to	O
fix	O
exercise	B-T061
regimes	I-T061
to	O
reach	O
a	O
set	O
fitness	O
goal	O
.	O
	
heart	O
rate	O
variability	O
as	O
a	O
biomarker	O
for	O
sedation	B-T033
depth	I-T033
estimation	B-T081
in	O
icu	O
patients	O
an	O
automated	O
patient-specific	O
system	O
to	O
classify	O
the	O
level	B-T033
of	I-T033
sedation	I-T033
in	O
icu	O
patients	O
using	O
heart	O
rate	O
variability	O
signal	O
is	O
presented	B-T078
in	O
this	O
paper	O
.	O
	
ecg	B-T033
from	O
70	O
mechanically	B-T061
ventilated	I-T061
adult	O
patients	O
with	O
administered	B-T169
sedatives	O
in	O
an	O
icu	O
setting	O
were	O
used	O
to	O
develop	O
a	O
support	B-T081
vector	I-T081
machine	I-T081
based	O
system	O
for	O
sedation	B-T033
depth	I-T033
monitoring	O
using	O
several	O
heart	O
rate	O
variability	O
measures	B-T081
.	O
	
a	O
leave-one-subject-out	O
cross	O
validation	O
was	O
used	O
for	O
classifier	B-T169
training	O
and	O
performance	O
evaluations	O
.	O
	
the	O
proposed	O
patient-specific	O
system	O
provided	O
a	O
sensitivity	B-T081
,	O
specificity	B-T081
and	O
an	O
auc	B-T081
of	O
64%	O
,	O
84.8	O
and	O
0.72	O
,	O
respectively	O
.	O
	
it	O
is	O
hoped	O
that	O
with	O
the	O
help	O
of	O
additional	O
physiological	B-T169
signals	O
the	O
proposed	O
patient	O
-	O
specific	B-T080
sedation	B-T033
level	I-T033
prediction	B-T078
system	B-T169
could	O
lead	O
to	O
a	O
fully	O
automated	O
multimodal	O
system	O
to	O
assist	O
clinical	B-T080
staff	O
in	O
icus	O
to	O
interpret	B-T169
the	O
sedation	B-T033
level	I-T033
of	O
the	O
reliability	B-T080
and	I-T080
validity	I-T080
of	O
the	O
diabetes	O
eating	O
problem	O
survey-revised	O
on	O
turkish	O
children	O
and	O
adolescents	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
mellitus	I-T047
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	B-T169
the	O
reliability	B-T080
and	I-T080
validity	I-T080
of	O
turkish	O
version	O
of	O
diabetes	O
eating	O
problem	O
survey-revised	O
deps-r	O
for	O
children	O
and	O
adolescent	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
mellitus	I-T047
.	O
	
a	O
total	O
of	O
200	O
children	O
and	O
adolescents	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
,	O
ages	O
9-18	O
years	B-T079
,	O
completed	O
the	O
deps-r	O
turkish	O
version	O
.	O
	
in	O
addition	O
to	O
tests	B-T169
of	O
validity	B-T081
,	O
confirmatory	B-T080
factor	I-T080
analysis	I-T080
was	O
conducted	O
to	O
investigate	B-T169
the	O
factor	B-T081
structure	I-T081
of	O
the	O
16-item	O
turkish	O
version	O
of	O
deps-r	O
.	O
	
the	O
turkish	O
version	O
of	O
deps-r	O
demonstrated	O
satisfactory	B-T080
cronbach's	B-T081
0.847	O
and	O
was	O
significantly	O
correlated	B-T080
with	O
ag	O
e	O
r=0	O
p<0	O
,	O
hemoglobin	O
a1c	O
levels	O
r=0	O
p<0	O
and	O
bmi	O
-	O
sds	B-T081
r=0	O
p<0	O
indicating	O
criterion	B-T081
validity	I-T081
.	O
	
median	O
deps-r	O
scores	B-T081
of	O
turkish	O
version	O
for	O
the	O
total	O
samples	O
,	O
females	O
and	O
males	O
were	O
as	O
follows	O
11.0	O
,	O
11.5	O
and	O
10.5	O
respectively	O
.	O
	
disturbed	O
eating	O
behaviors	O
and	O
insulin	B-T116
restriction	B-T169
were	O
associated	O
with	O
poor	O
metabolic	O
control	O
.	O
	
a	O
short	O
,	O
self-administered	B-T169
diabetes	B-T047
specific	O
screening	O
tool	O
for	O
disordered	O
eating	O
behavior	O
can	O
be	O
used	O
routinely	O
in	O
the	O
clinical	B-T080
care	O
of	O
adolescents	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
.	O
	
the	O
turkish	O
version	O
of	O
deps-r	O
is	O
a	O
valid	O
screening	O
tool	O
for	O
disordered	O
eating	O
behaviors	O
in	O
type	B-T047
1	I-T047
diabetes	I-T047
and	O
it	O
is	O
potentially	O
important	O
to	O
early	O
detect	O
disordered	O
eating	O
behaviors	O
.	O
	
a	O
comparison	O
of	O
the	O
localization	B-T169
of	O
rectal	O
carcinomas	O
according	O
to	O
the	O
general	O
rules	O
of	O
the	O
japanese	O
classification	O
of	O
colorectal	O
carcinoma	O
jccrc	O
and	O
western	O
guidelines	O
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
localization	B-T169
of	O
rectal	O
cancers	O
as	O
classified	O
according	O
to	O
the	O
general	O
rules	O
of	O
the	O
japanese	O
classification	O
of	O
colorectal	O
carcinoma	O
jccrc	O
and	O
also	O
according	O
to	O
the	O
european	O
society	O
for	O
medical	O
oncology	O
esmo	O
and	O
the	O
national	O
comprehensive	O
cancer	O
network	O
nccn	O
guidelines	O
,	O
which	O
are	O
based	O
on	O
rigid	O
endoscopic	O
measurements	B-T169
.	O
	
the	O
medical	O
records	O
of	O
patients	O
scheduled	B-T080
to	O
receive	B-T080
curative	B-T061
surgery	I-T061
for	O
histologically	B-T169
proven	O
rectal	O
adenocarcinoma	O
during	B-T079
2009-2015	O
were	O
investigated	B-T169
n	O
=	O
230	O
.	O
	
rigid	O
proctoscopy	O
was	O
performed	B-T169
in	O
patients	O
with	O
rectal	O
cancer	O
located	O
in	O
the	O
upper	O
ra	O
or	O
lower	O
rb	O
division	B-T061
using	O
double-contrast	O
barium	O
enema	O
.	O
	
the	O
median	B-T081
values	O
of	O
height	O
from	O
the	O
anal	O
verge	O
were	O
7.5	O
cm	O
range	B-T081
2-12	O
and	O
3	O
cm	O
0-9	O
on	O
rigid	O
proctoscopy	O
for	O
cancers	O
assigned	B-T169
as	O
ra	O
and	O
rb	O
,	O
respectively	O
.	O
	
all	O
159	O
cancers	O
at	O
ra	O
or	O
rb	O
were	O
located	O
within	O
12	O
cm	O
from	O
the	O
anal	O
verge	O
by	O
rigid	O
proctoscopy	O
,	O
while	O
only	O
79.7	O
of	O
ra	O
or	O
82.1	O
of	O
rb	O
cancers	O
were	O
located	O
in	O
the	O
mid	O
5.1	O
cm	O
or	O
low	B-T080
5	O
cm	O
rectum	O
,	O
respectively	O
.	O
	
ra	O
and	O
rb	O
cancers	O
are	O
deemed	O
to	O
be	O
rectal	O
cancers	O
according	O
to	O
nccn	O
guidelines	O
,	O
but	O
these	O
classifications	O
are	O
not	O
interchangeable	O
with	O
mid-	O
and	O
low	B-T080
-	O
rectal	O
cancers	O
,	O
respectively	O
,	O
according	O
to	O
the	O
esmo	O
guidelines	O
.	O
	
natural	B-T061
orifice	I-T061
transluminal	I-T061
endoscopic	I-T061
surgery	I-T061
with	O
a	O
snake-mechanism	B-T169
using	O
a	O
movable	O
pulley	O
natural	B-T061
orifice	I-T061
transluminal	I-T061
endoscopic	I-T061
surgery	I-T061
is	O
an	O
emerging	O
technique	B-T169
.	O
	
we	O
aimed	O
to	O
develop	B-T169
an	O
advanced	B-T080
surgical	O
robot	O
mechanism	B-T169
for	O
natural	B-T061
orifice	I-T061
surgery	I-T061
.	O
	
we	O
propose	O
the	O
active-controlled	O
overtube-type	O
platform	O
with	O
multiple	O
channels	O
for	O
an	O
endoscopic	O
camera	O
and	O
surgical	B-T061
tools	O
.	O
	
to	O
make	O
such	O
a	O
platform	O
,	O
we	O
suggest	B-T078
an	O
advanced	B-T080
snake	B-T169
mechanism	I-T169
comprising	O
movable	O
pulleys	O
to	O
make	O
a	O
snake	B-T169
mechanism	I-T169
with	O
multiple	O
degrees	B-T169
of	I-T169
freedom	I-T169
and	O
high	O
operating	O
force	O
.	O
	
the	O
stiffness	B-T080
and	O
maneuverability	B-T080
of	O
the	O
active-controlled	O
platform	O
appeared	O
satisfactory	B-T080
.	O
	
using	O
prototypes	O
and	O
ex	B-T169
vivo	I-T169
experiments	O
,	O
we	O
confirmed	O
that	O
the	O
mechanism	B-T169
was	O
suitable	O
for	O
a	O
snake-like	O
robotic	O
platform	O
for	O
natural	B-T061
orifice	I-T061
surgery	I-T061
.	O
	
the	O
suggested	B-T078
snake	B-T169
mechanism	I-T169
using	O
movable	O
pulleys	O
has	O
the	O
advantages	O
of	O
stiffness	B-T080
and	O
maneuverability	B-T080
.	O
	
this	O
new	O
mechanism	B-T169
can	O
be	O
an	O
alternative	O
platform	O
for	O
natural	B-T061
orifice	I-T061
surgery	I-T061
.	O
	
real	O
role	O
of	O
β-blockers	O
in	O
regression	O
of	O
left	B-T033
ventricular	I-T033
mass	I-T033
in	O
hypertension	B-T047
patients	O
bayesian	B-T081
network	I-T081
meta-analysis	O
left	B-T047
ventricular	I-T047
hypertrophy	I-T047
lvh	B-T047
is	O
commonly	O
present	O
in	O
patients	O
with	O
hypertension	B-T047
ht	B-T047
.	O
	
according	O
to	O
the	O
expert	O
consensus	O
document	O
from	O
american	O
,	O
angiotensin-converting	O
enzyme	O
inhibitor	O
acei	O
and	O
angiotensin	O
receptor	O
blockers	O
arbs	O
were	O
recommended	O
as	O
1st-line	O
therapeutic	O
drugs	O
.	O
	
however	O
,	O
none	O
noticed	O
the	O
different	O
efficacy	B-T080
between	O
fat-soluble	O
and	O
selective	O
β1-receptor	O
blockers	O
fs-β-b	O
and	O
other	O
β-blockers	O
on	O
regression	O
of	O
lvh	B-T047
before	O
.	O
	
the	O
aim	O
of	O
this	O
analysis	O
was	O
to	O
compare	O
the	O
efficacy	B-T080
of	O
fs-β-b	O
with	O
the	O
other	O
4	O
different	O
classes	O
of	O
antihypertensive	O
drugs	O
acei	O
,	O
arbs	O
,	O
calcium	O
channel	O
blockers	O
ccbs	O
,	O
and	O
diuretics	O
on	O
regression	O
of	O
lvh	B-T047
.	O
	
relative	B-T080
trials	O
were	O
identified	O
in	O
the	O
pubmed	O
,	O
web	O
of	O
science	O
,	O
ovid	O
ebm	O
reviews	O
and	O
cochrane	O
databases	O
,	O
and	O
the	O
relevant	O
papers	O
were	O
examined	B-T169
.	O
	
we	O
performed	O
both	O
traditional	O
and	O
bayesian	B-T081
meta-analysis	O
of	O
randomized	O
controlled	O
trials	O
rcts	O
about	O
the	O
regression	O
of	O
lvh	B-T047
.	O
	
sensitivity	O
analysis	O
and	O
regression	O
analysis	O
were	O
performed	O
to	O
explore	O
possible	O
sources	O
of	O
heterogeneity	B-T080
.	O
	
inconsistency	O
analysis	O
was	O
performed	O
to	O
check	O
whether	O
the	O
analysis	O
of	O
the	O
trials	O
in	O
the	O
network	B-T081
was	O
indeed	O
consistent	B-T078
.	O
	
a	O
total	O
of	O
41	O
rcts	O
involving	O
2566	O
patients	O
with	O
ht	B-T047
and	O
lvh	B-T047
were	O
included	O
in	O
this	O
analysis	O
.	O
	
bayesian	B-T081
network	I-T081
meta-analysis	O
indicated	O
no	O
statistically	B-T081
significant	I-T081
differences	O
between	O
these	O
groups	B-T078
fs-β-b	O
and	O
acei	O
md	O
,	O
-7	O
95%	O
ci	B-T081
,	O
-14	O
,	O
1.27	O
fs-β-b	O
and	O
arb	O
md	O
,	O
-2	O
95%	O
cl	B-T081
,	O
-12	O
,	O
6.31	O
.	O
	
although	O
fs-β-b	O
showed	O
greater	O
efficacy	B-T080
when	O
compared	O
with	O
diuretic	O
md	O
,	O
13.04	O
95%	O
ci	B-T081
,	O
3.38	O
,	O
22.59	O
or	O
ccb	O
md	O
,	O
10.90	O
95%	O
ci	B-T081
,	O
1.98	O
,	O
19.49	O
.	O
	
the	O
probabilities	B-T081
of	O
being	O
among	O
the	O
most	O
efficacious	B-T080
treatments	B-T061
were	O
fs-β-b	O
72%	O
,	O
arb	O
27%	O
,	O
acei	O
0.01	O
,	O
ccb	O
0.00	O
,	O
and	O
diuretic	O
0.00	O
.	O
	
evidence	O
from	O
our	O
analysis	O
reveals	O
that	O
fs-β-b	O
have	O
potential	O
to	O
become	O
1st-line	O
therapeutic	O
drugs	O
in	O
ht	B-T047
and	O
lvh	B-T047
patients	O
.	O
	
however	O
,	O
the	O
real	O
efficacy	B-T080
of	O
fs-β-b	O
on	O
regression	O
of	O
lvh	B-T047
should	O
be	O
confirmed	O
by	O
further	O
large	O
,	O
high	O
quality	B-T080
trials	O
improved	B-T033
risk	B-T078
stratification	O
for	O
patients	O
with	O
high-grade	O
urothelial	O
carcinoma	O
following	O
application	O
of	O
the	O
paris	O
system	B-T169
for	O
reporting	O
urinary	O
cytology	O
the	O
paris	O
system	B-T169
for	O
reporting	O
urinary	O
cytology	O
tps	O
requires	O
4	O
cytomorphologic	O
criteria	B-T078
for	O
a	O
definitive	O
diagnosis	B-T033
of	O
high-grade	O
urothelial	O
carcinoma	O
hguc	O
in	O
urinary	O
tract	O
cytology	O
utc	O
specimens	O
an	O
elevated	B-T080
nuclear-to-cytoplasmic	O
n/c	O
ratio	O
at	O
or	O
above	O
0.7	O
,	O
markedly	O
atypical	B-T080
nuclear	O
borders	O
,	O
moderate	B-T080
to	O
severe	B-T080
hyperchromasia	B-T033
,	O
and	O
coarse	B-T033
chromatin	I-T033
.	O
	
however	O
,	O
malignant	B-T080
utc	O
specimens	O
often	O
contain	O
degenerative	B-T169
changes	B-T169
,	O
and	O
this	O
limits	O
the	O
number	O
of	O
malignant	O
cells	O
meeting	O
all	O
4	O
tps	O
cytomorphologic	O
criteria	B-T078
.	O
	
one	O
hundred	O
twelve	O
utc	O
specimens	O
from	O
patients	O
with	O
a	O
subsequent	O
diagnosis	B-T033
of	O
hguc	O
were	O
reviewed	B-T080
and	O
reclassified	B-T080
according	O
to	O
tps	O
criteria	B-T078
.	O
	
the	O
presence	B-T033
of	O
tps	O
cytomorphologic	O
criteria	B-T078
for	O
hguc	O
in	O
each	O
specimen	O
was	O
recorded	O
,	O
as	O
was	O
the	O
proportion	O
of	O
atypical	B-T080
cells	O
meeting	O
all	O
4	O
criteria	B-T078
.	O
	
the	O
number	O
of	O
specimens	O
definitively	O
diagnosed	B-T033
as	O
hguc	O
did	O
not	O
significantly	B-T078
change	B-T169
upon	O
reclassification	O
.	O
	
however	O
,	O
approximately	B-T080
40%	O
of	O
indeterminate	B-T078
specimens	O
21	O
of	O
51	O
were	O
reclassified	B-T080
into	O
a	O
higher	O
risk	B-T078
category	O
.	O
	
the	O
most	O
restrictive	O
cytomorphologic	O
criterion	O
was	O
an	O
n/c	O
ratio	O
of	O
0.7	O
or	O
higher	O
seen	O
in	O
78%	O
of	O
specimens	O
,	O
and	O
approximately	B-T080
half	O
of	O
specimens	O
containing	O
all	O
4	O
cytomorphologic	O
criteria	O
did	O
not	O
meet	O
tps	O
's	O
numerical	O
criterion	O
for	O
hguc	O
at	O
least	O
5	O
malignant	O
cells	O
.	O
	
in	O
the	O
majority	O
of	O
specimens	O
qualifying	O
for	O
hguc	O
by	O
tps	O
standards	O
,	O
only	O
a	O
small	O
fraction	O
of	O
atypical	O
cells	O
10%-20%	O
met	O
all	O
the	O
criteria	O
.	O
	
when	O
applied	O
to	O
malignant	O
utc	O
specimens	O
,	O
tps	O
criteria	O
improved	O
specimen	O
risk	O
stratification	O
by	O
upgrading	O
approximately	O
40%	O
of	O
indeterminate	O
specimens	O
into	O
higher	O
risk	O
categories	O
while	O
not	O
significantly	O
changing	O
the	O
frequency	O
of	O
hguc	O
diagnoses	O
.	O
	
cancer	O
cytopathol	O
2017	O
.	O
	
2017	O
american	O
cancer	O
society	O
questionable	O
diagnostic	B-T169
benefit	B-T081
of	O
the	O
commercially	O
available	O
panel	O
of	O
bee	B-T116
venom	I-T116
components	O
for	O
many	O
years	B-T079
,	O
only	O
the	O
major	O
allergen	O
rapi	O
m	O
1	O
has	O
been	O
available	O
on	O
the	O
immunocap	O
system	O
for	O
routine	O
diagnosis	B-T033
of	O
bee	O
venom	O
bv	O
allergy	O
.	O
	
now	O
,	O
there	O
are	O
five	O
components	O
available	O
,	O
and	O
we	O
aimed	O
to	O
detect	O
the	O
sensitivity	B-T081
and	O
specificity	B-T081
of	O
rapi	O
m	O
1	O
,	O
2	O
,	O
3	O
,	O
5	O
,	O
and	O
10	O
in	O
bv-allergic	O
patients	O
.	O
	
we	O
further	O
evaluated	O
the	O
sensitivity	B-T081
of	O
rapi	O
m	O
1	O
and	O
2	O
of	O
an	O
alternative	O
platform	O
and	O
investigated	B-T169
possible	O
differences	O
in	O
the	O
sensitization	O
profile	O
between	O
monosensitization	O
and	O
clinically	O
relevant	O
double	O
sensitization	O
.	O
	
analysis	O
of	O
the	O
whole	O
panel	O
of	O
bv	B-T116
allergens	O
of	O
the	O
cap	O
system	O
still	O
resulted	O
in	O
a	O
lower	O
sensitivity	B-T081
than	O
analysis	O
of	O
the	O
combination	O
of	O
rapi	O
m	O
1	O
and	O
2	O
of	O
the	O
immulite	O
71.6	O
vs	O
85.8	O
.	O
	
sensitization	O
rate	B-T081
of	O
rapi	O
m	O
5	O
was	O
more	O
than	O
doubled	O
in	O
double-sensitized	O
patients	O
,	O
while	O
there	O
was	O
no	O
difference	O
for	O
rapi	O
m	O
2	O
.	O
	
the	O
benefit	B-T081
of	O
the	O
commercially	O
available	O
panel	O
of	O
bv	B-T116
components	O
is	O
questionable	O
,	O
due	O
to	O
the	O
insufficient	B-T080
sensitivity	B-T081
and	O
still	O
unavailable	O
important	O
cross-reacting	O
allergens	O
.	O
	
orai1	B-T116
-mediated	O
antimicrobial	O
secretion	O
from	O
pancreatic	O
acini	O
shapes	O
the	O
gut	O
microbiome	O
and	O
regulates	O
gut	O
innate	O
immunity	O
the	O
gut	O
microbiome	O
participates	O
in	O
numerous	O
physiologic	O
functions	O
and	O
communicates	B-T033
intimately	O
with	O
the	O
host	O
immune	O
system	O
.	O
	
antimicrobial	B-T116
peptides	I-T116
are	O
critica	B-T080
l	O
components	B-T116
of	O
intestinal	O
innate	O
immunity	O
.	O
	
we	O
report	O
a	O
prominent	B-T080
role	O
for	O
antimicrobials	O
secreted	O
by	O
pancreatic	O
acini	O
in	O
shaping	O
the	O
gut	O
microbiome	O
that	O
is	O
essential	O
for	O
intestinal	O
innate	O
immunity	O
,	O
barrier	O
function	O
,	O
and	O
survival	B-T169
.	O
	
deletion	O
of	O
the	O
ca	O
channel	O
orai1	O
in	O
pancreatic	O
acini	O
of	O
adult	O
mice	O
resulted	O
in	O
60%-70%	O
mortality	B-T081
within	O
3	O
weeks	O
.	O
	
despite	O
robust	O
activation	O
of	O
the	O
intestinal	O
innate	O
immune	O
response	O
,	O
mice	O
lacking	O
acinar	O
orai1	O
exhibited	O
intestinal	O
bacterial	B-T080
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	B-T169
translocation	O
,	O
inflammation	O
,	O
and	O
death	O
.	O
	
while	O
digestive	B-T116
enzyme	I-T116
supplementation	B-T061
was	O
ineffective	B-T078
,	O
treatments	B-T061
constraining	O
bacterial	B-T080
outgrowth	O
purified	B-T169
liquid	B-T061
diet	I-T061
,	O
broad-spectrum	O
antibiotics	O
rescued	O
survival	B-T169
,	O
feeding	O
,	O
and	O
weight	B-T033
gain	I-T033
.	O
	
pancreatic	O
levels	O
of	O
cathelicidin	B-T116
-related	O
antimicrobial	B-T116
peptide	I-T116
cramp	B-T116
were	O
reduced	B-T080
,	O
and	O
supplement	B-T169
of	O
synthetic	O
cramp	B-T116
prevented	O
intestinal	B-T047
disease	I-T047
.	O
	
these	O
findings	B-T033
reveal	O
a	O
critical	B-T080
role	O
for	O
antimicrobial	O
pancreatic	O
secretion	O
in	O
gut	O
innate	O
immunity	O
.	O
	
palliative	O
care	O
with	O
attachment	O
hybrid	B-T061
removable	I-T061
prosthesis	I-T061
abutment	O
injury	O
,	O
unsatisfactory	B-T080
aesthetics	O
and	O
lesser	O
retention	B-T061
exist	O
with	O
the	O
cast	O
partial	O
denture	O
.	O
	
though	O
these	O
constraints	O
exist	O
in	O
the	O
removable	O
partial	O
denture	O
rpd	O
it	O
is	O
still	O
widely	O
used	O
because	O
of	O
the	O
simplicity	O
in	O
design	O
,	O
fabrication	O
,	O
economics	B-T169
and	O
patient	O
comfort	O
.	O
	
this	O
clinical	O
report	O
describes	O
a	O
hybrid	O
rpd	O
technique	B-T169
which	O
uses	O
extra	O
coronal	O
attachment	O
that	O
reduces	B-T080
the	O
limitations	O
and	O
provides	O
better	O
comfort	O
for	O
the	O
cxcl5	B-T116
plays	O
a	O
promoting	O
role	O
in	O
osteosarcoma	O
cell	O
migration	O
and	O
invasion	O
in	O
autocrine	O
-	O
and	O
paracrine	O
-dependent	O
manners	O
cxcl5	B-T116
,	O
a	O
cxc-type	B-T116
chemokine	I-T116
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	O
cells	O
by	O
binding	O
to	O
its	O
receptor	O
cxcr2	O
.	O
	
recently	O
,	O
cxcl5	B-T116
/	O
cxcr2	B-T116
has	O
been	O
found	O
to	O
play	O
an	O
oncogenic	B-T116
role	O
in	O
many	O
human	O
cancers	O
.	O
	
however	O
,	O
the	O
exact	O
role	O
of	O
cxcl5	B-T116
in	O
osteosarcoma	O
cell	O
migration	O
and	O
invasion	O
has	O
not	O
been	O
revealed	O
.	O
	
here	O
we	O
found	O
that	O
the	O
protein	O
expression	O
of	O
cxcl5	B-T116
was	O
significantly	O
increased	B-T081
in	O
osteosarcoma	O
tissues	O
compared	O
with	O
that	O
in	O
matched	O
adjacent	O
nontumor	O
tissues	O
.	O
	
moreover	O
,	O
the	O
expression	O
of	O
cxcl5	B-T116
was	O
significantly	O
associated	O
with	O
advanced	B-T079
clinical	I-T079
stage	I-T079
and	O
metastasis	O
.	O
	
further	O
investigation	O
showed	O
that	O
the	O
cxcl5	B-T116
expression	B-T081
levels	I-T081
were	O
also	O
significantly	O
increased	B-T081
in	O
osteosarcoma	O
cell	O
lines	O
,	O
including	O
saos-2	O
,	O
mg63	O
,	O
u2os	O
,	O
and	O
sw1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	O
hfob1.19	O
cells	O
.	O
	
u2os	O
cells	O
were	O
further	O
transfected	O
with	O
cxcl5	O
-	O
specific	O
sirna	O
or	O
overexpression	O
plasmid	O
.	O
	
knockdown	O
of	O
cxcl5	O
significantly	O
suppressed	B-T169
u2os	O
cell	O
migration	O
and	O
invasion	O
.	O
	
on	O
the	O
contrary	O
,	O
overexpression	O
of	O
cxlc5	B-T116
remarkably	O
promoted	O
the	O
migration	O
and	O
invasion	O
of	O
u2os	O
cells	O
.	O
	
interestingly	O
,	O
both	O
exogenous	B-T169
cxcl5	B-T116
treatment	B-T169
and	O
the	O
conditioned	O
medium	O
of	O
cxcl5	B-T116
-	O
overexpressing	O
hfob1.19	O
cells	O
could	O
also	O
enhance	O
the	O
migration	O
and	O
invasion	O
of	O
u2os	O
cells	O
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
cxcl5	B-T116
in	O
u2os	O
cell	O
migration	O
and	O
invasion	O
is	O
also	O
in	O
a	O
paracrine	O
-dependent	O
manner	O
.	O
	
according	O
to	O
these	O
data	O
,	O
our	O
study	O
demonstrates	O
that	O
cxcl5	B-T116
is	O
upregulated	O
in	O
osteosarcoma	O
and	O
may	O
play	O
an	O
oncogenic	B-T116
role	O
in	O
osteosarcoma	O
metastasis	O
.	O
	
therefore	O
,	O
cxcl5	B-T116
may	O
become	O
a	O
potential	B-T080
therapeutic	B-T169
target	I-T169
for	O
osteosarcoma	O
treatment	B-T169
.	O
	
integrating	O
molecular	B-T080
qtl	O
data	B-T078
into	O
genome-wide	O
genetic	O
association	O
analysis	O
probabilistic	B-T081
assessment	B-T169
of	O
enrichment	O
and	O
colocalization	B-T169
we	O
propose	O
a	O
novel	O
statistical	B-T081
framework	I-T081
for	O
integrating	O
the	O
result	B-T169
from	O
molecular	B-T080
quantitative	O
trait	O
loci	O
qtl	O
mapping	O
into	O
genome-wide	O
genetic	O
association	O
analysis	O
of	O
complex	B-T080
traits	O
,	O
with	O
the	O
primary	O
objectives	O
of	O
quantitatively	B-T081
assessing	B-T169
the	O
enrichment	O
of	O
the	O
molecular	B-T080
qtls	O
in	O
complex	B-T080
trait	O
-	O
associated	B-T080
genetic	O
variants	O
and	O
the	O
colocalizations	B-T169
of	O
the	O
two	O
types	B-T080
of	O
association	B-T080
signals	O
.	O
	
we	O
introduce	O
a	O
natural	B-T081
bayesian	I-T081
hierarchical	I-T081
model	I-T081
that	O
treats	O
the	O
latent	O
association	B-T080
status	O
of	O
molecular	B-T080
qtls	O
as	O
snp	O
-	O
level	B-T080
annotations	O
for	O
candidate	O
snps	O
of	O
complex	B-T080
traits	O
.	O
	
we	O
detail	O
a	O
computational	O
procedure	B-T169
to	O
seamlessly	O
perform	O
enrichment	O
,	O
fine-mapping	O
and	O
colocalization	B-T169
analyses	O
,	O
which	O
is	O
a	O
distinct	B-T080
feature	I-T080
compared	O
to	O
the	O
existing	O
colocalization	B-T169
analysis	O
procedures	B-T169
in	O
the	O
literature	O
.	O
	
the	O
proposed	O
approach	O
is	O
computationally	O
efficient	B-T080
and	O
requires	O
only	O
summary	O
-	O
level	B-T080
statistics	B-T081
.	O
	
we	O
evaluate	B-T169
and	O
demonstrate	O
the	O
proposed	O
computational	O
approach	O
through	O
extensive	B-T080
simulation	O
studies	O
and	O
analyses	O
of	O
blood	B-T109
lipid	I-T109
data	B-T078
and	O
the	O
whole	O
blood	O
eqtl	O
data	B-T078
from	O
the	O
gtex	O
project	O
.	O
	
in	O
addition	O
,	O
a	O
useful	O
utility	O
from	O
our	O
proposed	O
method	O
enables	O
the	O
computation	O
of	O
expected	O
colocalization	B-T169
signals	O
using	O
simple	O
characteristics	B-T080
of	O
the	O
association	B-T080
data	B-T078
.	O
	
using	O
this	O
utility	O
,	O
we	O
further	O
illustrate	O
the	O
importance	O
of	O
enrichment	O
analysis	O
on	O
the	O
ability	O
to	O
discover	O
colocalized	B-T169
signals	O
and	O
the	O
potential	B-T080
limitations	B-T169
of	O
currently	O
available	O
molecular	B-T080
qtl	O
data	B-T078
.	O
	
the	O
software	O
pipeline	O
that	O
implements	O
the	O
proposed	O
computation	O
procedures	B-T169
,	O
enloc	O
,	O
is	O
freely	O
available	O
at	O
engineering	O
the	O
ribosomal	O
dna	O
in	O
a	O
megabase	O
synthetic	O
chromosome	O
we	O
designed	O
and	O
synthesized	O
a	O
976	O
pair	O
linear	O
chromosome	O
,	O
synxii	O
,	O
based	O
on	O
native	O
chromosome	O
xii	O
in	O
saccharomyces	O
cerevisiae	O
synxii	O
was	O
assembled	O
using	O
a	O
two-step	B-T169
method	I-T169
,	O
specified	O
by	O
successive	O
megachunk	O
integration	O
and	O
meiotic	O
recombination-mediated	O
assembly	O
,	O
producing	O
a	O
functional	B-T169
chromosome	O
in	O
s	O
.	O
	
cerevisiae	O
.	O
	
minor	B-T169
growth	I-T169
defect	I-T169
""""	O
bugs	B-T169
""""	O
detected	B-T033
in	O
synxii	O
,	O
caused	O
by	O
deletion	O
of	O
trna	O
genes	O
,	O
were	O
rescued	O
by	O
introducing	O
an	O
ectopic	O
copy	O
of	O
a	O
single	O
trna	O
gene	O
.	O
	
the	O
ribosomal	O
gene	O
cluster	O
rdna	O
on	O
synxii	O
was	O
left	O
intact	O
during	O
the	O
assembly	O
process	O
and	O
subsequently	O
replaced	O
by	O
a	O
modified	B-T169
rdna	O
unit	O
used	O
to	O
regenerate	B-T169
rdna	O
at	O
three	O
distinct	O
chromosomal	O
locations	O
.	O
	
the	O
signature	O
sequences	O
within	O
rdna	O
,	O
which	O
can	O
be	O
used	O
to	O
determine	O
species	O
identity	B-T033
,	O
were	O
swapped	O
to	O
generate	O
a	O
saccharomyces	O
synxii	O
strain	O
that	O
would	O
be	O
identified	B-T080
as	O
saccharomyces	O
bayanus	O
by	O
standard	B-T080
reversible	O
humidity	O
sensitive	B-T169
clothing	O
for	O
personal	B-T061
thermoregulation	I-T061
two	O
kinds	O
of	O
humidity	O
-	O
induced	B-T169
,	O
bendable	O
smart	O
clothing	O
have	O
been	O
designed	O
to	O
reversibly	O
adapt	O
their	O
thermal	O
insulation	O
functionality	O
.	O
	
the	O
first	O
design	O
mimics	O
the	O
pores	O
in	O
human	O
skin	O
,	O
in	O
which	O
pre-cut	O
flaps	O
open	O
to	O
produce	O
pores	O
in	O
nafion	B-T109
sheets	O
when	O
humidity	O
increases	O
,	O
as	O
might	O
occur	O
during	O
human	B-T033
sweating	I-T033
thus	O
permitting	O
air	O
flow	O
and	O
reducing	O
both	O
the	O
humidity	O
level	O
and	O
the	O
apparent	B-T081
temperature	I-T081
.	O
	
like	O
the	O
smart	O
human	O
sweating	O
pores	O
,	O
the	O
flaps	O
can	O
close	O
automatically	O
after	O
the	O
perspiration	B-T033
to	O
keep	O
the	O
wearer	O
warm	O
.	O
	
the	O
second	O
design	O
involves	O
thickness	B-T080
adjustable	O
clothes	O
by	O
inserting	O
the	O
bent	O
polymer	O
sheets	O
between	O
two	O
fabrics	O
.	O
	
as	O
the	O
humidity	O
increases	O
,	O
the	O
sheets	O
become	O
thinner	O
,	O
thus	O
reducing	O
the	O
gap	O
between	O
the	O
two	O
fabrics	O
to	O
reduce	O
the	O
thermal	B-T169
insulation	I-T169
.	O
	
the	O
insulation	O
layer	O
can	O
recover	O
its	O
original	O
thickness	B-T080
upon	O
humidity	O
reduction	O
to	O
restore	O
its	O
warmth-preservation	O
function	O
.	O
	
such	O
humidity	O
sensitive	B-T169
smart	O
polymer	O
materials	O
can	O
be	O
utilized	O
to	O
adjust	O
personal	O
comfort	O
,	O
and	O
be	O
effective	O
in	O
reducing	B-T033
energy	I-T033
consumption	I-T033
for	O
building	O
heating	B-T169
or	I-T169
cooling	I-T169
with	O
numerous	O
smart	O
design	O
.	O
	
development	O
of	O
an	O
automaton	O
model	O
of	O
rotational	O
activity	O
driving	O
atrial	B-T047
fibrillation	I-T047
atrial	B-T047
fibrillation	I-T047
af	B-T047
is	O
difficult	O
to	O
treat	B-T061
effectively	B-T080
,	O
owing	O
to	O
uncertainty	B-T033
in	O
where	O
to	O
best	O
ablate	B-T061
to	O
eliminate	O
arrhythmogenic	O
substrate	O
.	O
	
a	O
model	O
providing	O
insight	O
into	O
the	O
electrical	B-T169
activation	O
events	O
would	O
be	O
useful	O
to	O
guide	O
catheter	B-T061
ablation	I-T061
strategy	I-T061
.	O
	
method	O
a	O
two-dimensional	O
,	O
576	O
node	O
automaton	O
was	O
developed	O
to	O
simulate	O
atrial	O
electrical	O
activity	O
.	O
	
the	O
substrate	O
field	O
was	O
altered	O
by	O
the	O
presence	O
of	O
differing	O
refractory	O
period	O
at	O
varying	O
locations	O
.	O
	
fibrosis	O
was	O
added	O
in	O
the	O
form	O
of	O
short	O
,	O
randomly	O
positioned	O
lines	O
of	O
conduction	O
block	O
.	O
	
larger	O
areas	O
of	O
block	O
were	O
used	O
to	O
simulate	O
ablation	O
lesions	O
.	O
	
anisotropy	O
was	O
imposed	O
in	O
a	O
2	O
ratio	O
.	O
	
a	O
premature	O
electrical	O
impulse	O
from	O
one	O
of	O
four	O
grid	O
corners	O
was	O
utilized	O
to	O
initiate	O
activation	O
.	O
	
rotational	O
activity	O
was	O
uninducible	O
when	O
refractory	O
patch	O
dimensions	O
were	O
less	O
than	O
20	O
.	O
	
for	O
larger	O
refractory	O
regions	O
,	O
a	O
single	O
premature	O
stimulus	O
was	O
capable	O
of	O
inducing	O
an	O
average	O
of	O
1.19	O
rotors	O
,	O
which	O
often	O
formed	O
near	O
the	O
patch	O
edges	O
.	O
	
a	O
maximum	O
of	O
5	O
rotors	O
formed	O
when	O
refractory	O
patch	O
dimensions	O
approached	O
the	O
size	O
of	O
the	O
entire	O
left	O
atrial	O
virtual	O
field	O
.	O
	
rotors	O
formed	O
along	O
a	O
refractory	O
patch	O
edge	O
,	O
after	O
wavefront	O
arrival	O
was	O
delayed	O
at	O
turning	O
points	O
or	O
due	O
to	O
the	O
presence	O
of	O
a	O
fiber	O
cluster	O
of	O
sufficient	O
size	O
.	O
	
however	O
,	O
rotational	O
activity	O
could	O
also	O
occur	O
around	O
a	O
large	O
fiber	O
cluster	O
without	O
the	O
need	O
of	O
spatially	O
variable	O
refractoriness	O
.	O
	
when	O
obstacles	O
to	O
conduction	O
were	O
lacking	O
in	O
size	O
,	O
nascent	O
rotors	O
drifted	O
and	O
either	O
extinguished	O
,	O
or	O
stabilized	O
upon	O
anchoring	O
at	O
a	O
sufficiently	O
large	O
fiber	O
cluster	O
elsewhere	O
in	O
the	O
field	O
.	O
	
transient	O
rotors	O
terminated	O
when	O
traversing	O
a	O
region	O
with	O
differing	O
refractory	O
periods	O
,	O
if	O
no	O
obstacle	O
to	O
conduction	O
was	O
present	O
to	O
sufficiently	O
delay	O
wavefront	O
arrival	O
beyond	O
the	O
longest	O
refractory	O
period	O
.	O
	
other	O
rotors	O
were	O
annihilated	O
when	O
a	O
nearby	O
rotor	O
with	O
faster	O
spin	O
rate	O
gradually	O
interrupted	O
the	O
activation	O
pathway	O
.	O
	
elimination	O
of	O
anchors	O
by	O
removal	O
,	O
or	O
by	O
simulated	O
ablation	O
over	O
a	O
sufficient	O
region	O
,	O
prevented	O
rotor	O
onset	O
at	O
a	O
particular	O
location	O
where	O
it	O
would	O
otherwise	O
form	O
.	O
	
the	O
presence	O
of	O
obstacles	O
to	O
conduction	O
and	O
spatial	O
differences	O
in	O
refractory	O
period	O
are	O
important	O
parameters	O
for	O
initiating	O
and	O
maintaining	O
rotational	O
activity	O
in	O
this	O
simulation	O
of	O
an	O
atrial	O
substrate	O
multimodal	O
brain	O
imaging	O
with	O
magnetoencephalography	O
a	O
method	O
for	O
measuring	B-T169
blood	O
pressure	O
and	O
cardiorespiratory	O
oscillations	O
studies	O
with	O
magnetoencephalography	O
meg	O
are	O
still	O
quite	O
rarely	O
combined	O
simultaneously	O
with	O
methods	O
that	O
can	O
provide	O
a	O
metabolic	B-T169
dimension	I-T169
to	O
meg	O
investigation	O
s	O
.	O
	
in	O
addition	O
,	O
continuous	O
blood	O
pressure	O
measurements	O
which	O
comply	O
with	O
meg	O
compatibility	O
requirements	O
are	O
lacking	O
.	O
	
for	O
instance	O
,	O
by	O
combining	O
methods	O
reflecting	O
neurovascular	O
status	O
one	O
could	O
obtain	O
more	O
information	O
on	O
low	B-T079
frequency	I-T079
fluctuations	O
that	O
have	O
recently	O
gained	O
increasing	O
interest	O
as	O
a	O
mediator	O
of	O
functional	B-T169
connectivity	I-T169
within	O
brain	O
networks	O
.	O
	
this	O
paper	O
presents	O
a	O
multimodal	O
brain	O
imaging	O
setup	O
,	O
capable	O
to	O
non-invasively	B-T169
and	O
continuously	O
measure	O
cerebral	O
hemodynamic	O
,	O
cardiorespiratory	O
and	O
blood	O
pressure	O
oscillations	O
simultaneously	O
with	O
meg	O
.	O
	
in	O
the	O
setup	O
,	O
all	O
methods	O
apart	O
from	O
meg	O
rely	O
on	O
the	O
use	O
of	O
fibre	O
optics	O
.	O
	
in	O
particular	O
,	O
we	O
present	O
a	O
method	O
for	O
measuring	B-T169
of	O
blood	O
pressure	O
and	O
cardiorespiratory	O
oscillations	O
continuously	O
with	O
meg	O
.	O
	
the	O
potential	B-T080
of	O
this	O
type	O
of	O
multimodal	O
setup	O
for	O
brain	O
research	O
is	O
demonstrated	O
by	O
our	O
preliminary	O
studies	O
on	O
human	O
,	O
showing	O
effects	B-T080
of	I-T080
mild	B-T033
hypercapnia	I-T033
,	O
gathered	O
simultaneously	O
with	O
the	O
presented	O
effect	B-T080
of	I-T080
peritoneal	O
lavage	O
solution	O
temperature	B-T081
on	O
body	O
temperature	O
in	O
anaesthetised	B-T033
cats	O
and	O
small	O
dogs	O
a	O
prospective	O
,	O
randomised	O
,	O
non-blinded	O
,	O
clinical	O
study	O
to	O
assess	O
the	O
effect	B-T080
of	I-T080
peritoneal	O
lavage	O
using	O
warmed	O
fluid	O
on	O
body	O
temperature	O
in	O
anesthetised	B-T033
cats	O
and	O
dogs	O
of	O
less	O
than	O
10	O
kg	O
body	B-T033
mass	I-T033
undergoing	O
coeliotomy	B-T061
.	O
	
a	O
standardised	O
anaesthetic	O
protocol	O
was	O
used	O
.	O
	
oesophageal	O
and	O
rectal	B-T033
temperatures	I-T033
were	O
measured	B-T080
at	O
various	B-T079
time	I-T079
points	I-T079
.	O
	
at	O
the	O
end	O
of	O
surgery	B-T061
,	O
group	O
1	O
patients	O
n=10	O
were	O
lavaged	B-T061
with	O
200	O
ml/kg	O
sterile	B-T080
isotonic	O
saline	O
at	O
34	O
and	O
group	O
2	O
n=10	O
at	O
40	O
.	O
	
groups	O
were	O
similar	O
with	O
respect	O
to	O
age	O
,	O
mass	B-T081
,	O
body	B-T033
condition	I-T033
and	O
surgical	B-T061
incision	I-T061
length	O
.	O
	
duration	B-T079
of	O
anaesthesia	B-T061
,	O
surgical	B-T061
procedures	I-T061
and	O
peritoneal	O
lavage	O
was	O
similar	O
between	O
groups	O
.	O
	
linear	B-T081
regression	I-T081
showed	O
no	B-T033
significant	I-T033
change	I-T033
in	O
oesophageal	O
temperature	O
during	O
the	O
lavage	B-T061
period	B-T079
for	O
group	O
1	O
p=0	O
,	O
but	O
a	O
significant	O
increase	O
for	O
group	O
2	O
patients	O
p<0	O
,	O
with	O
mean	B-T081
temperature	B-T080
changes	I-T080
of	O
-0	O
from	O
36.3	O
to	O
35.9	O
and	O
+0	O
from	O
35.4	O
to	O
36.3	O
,	O
respectively	O
.	O
	
similar	O
results	B-T033
were	O
found	O
for	O
rectal	B-T033
temperature	I-T033
,	O
with	O
mean	B-T081
changes	O
of	O
-0	O
and	O
+0	O
p=0	O
and	O
0.045	O
,	O
respectively	O
.	O
	
the	O
use	O
of	O
isotonic	O
crystalloid	O
solution	O
for	O
peritoneal	O
lavage	O
at	O
a	O
temperature	B-T081
of	O
40	O
significantly	O
warms	O
small	O
animal	O
patients	O
,	O
when	O
applied	O
in	O
a	O
clinical	O
setting	O
,	O
compared	O
with	O
lavage	B-T061
bioengineered	O
3d	O
models	O
for	O
studying	O
human	O
cell	O
-	O
tuberculosis	O
interactions	B-T169
in	O
vivo	O
animal	O
models	O
have	O
intrinsic	O
limitations	O
for	O
studying	O
relationships	B-T080
between	O
tuberculosis	O
and	O
its	O
host	O
and	O
there	O
is	O
a	O
need	O
for	O
alternative	O
,	O
in	B-T080
vitro	I-T080
cellular	O
models	O
.	O
	
a	O
microsphere	O
-based	O
3d	O
in	B-T080
vitro	I-T080
culture	O
system	O
of	O
mycobacterium	O
tuberculosis	O
-infected	O
human	O
blood	O
mononuclear	O
cells	O
was	O
reported	O
to	O
address	O
specific	O
aspects	O
of	O
host	O
-	O
pathogen	O
interactions	B-T169
.	O
	
perspectives	B-T078
on	O
cardiovascular	O
effects	B-T080
of	I-T080
incretin	B-T116
-based	O
drugs	O
from	O
bedside	O
to	O
bench	O
,	O
return	O
trip	O
recently	O
,	O
cardiovascular	O
outcome	B-T169
trials	O
with	O
glucose	B-T109
-lowering	O
drugs	O
used	O
in	O
type	B-T047
2	I-T047
diabetes	I-T047
mellitus	I-T047
,	O
namely	O
glucagon-like	O
peptide-1	O
receptor	O
agonists	O
glp-1ra	O
,	O
liraglutide	B-T116
and	O
semaglutide	B-T116
,	O
showed	O
a	O
reduction	B-T081
in	O
cardiovascular	B-T033
events	I-T033
,	O
which	O
had	O
not	O
been	O
observed	O
in	O
trials	O
with	O
other	O
incretin	B-T116
-based	O
drugs	O
,	O
such	O
as	O
lixisenatide	B-T116
or	O
with	O
dipeptidyl	O
peptidase-4	O
inhibitors	O
dpp4i	O
.	O
	
mechanisms	B-T169
underlying	O
the	O
observed	O
cardiovascular	O
differences	B-T080
between	O
dpp4i	O
and	O
glp1-ra	O
,	O
and	O
across	O
individual	O
glp1-ra	O
are	O
poorly	O
understood	O
.	O
	
this	O
review	O
is	O
aimed	O
at	O
collecting	O
and	O
summarizing	O
available	O
evidence	B-T078
from	O
experimental	O
and	O
mechanistic	O
studies	O
on	O
the	O
action	O
of	O
glp1-ra	O
and	O
dpp4i	O
on	O
the	O
cardiovascular	O
system	O
,	O
both	O
deriving	O
from	O
clinical	B-T081
and	O
pre-clinical	B-T081
sources	I-T081
.	O
	
the	O
results	B-T169
of	O
cardiovascular	O
outcome	B-T169
trials	O
are	O
interpreted	O
on	O
the	O
basis	O
of	O
the	O
experimental	O
preclinical	O
data	O
available	O
,	O
paying	O
particular	O
attention	O
to	O
the	O
heart	B-T047
failure	I-T047
results	B-T169
,	O
and	O
suggesting	O
some	O
novel	O
intriguing	O
hypotheses	B-T078
to	O
explain	O
some	O
of	O
the	O
unexpected	O
findings	B-T169
of	O
cardioprotection	B-T169
of	O
incretin	B-T116
-based	O
drugs	O
.	O
	
in	O
particular	O
,	O
we	O
discuss	O
the	O
possible	O
contribution	O
to	O
the	O
incretin	B-T116
cardiovascular	O
effects	B-T080
of	I-T080
a	O
direct	O
cardiac	O
action	O
of	O
glp-1	B-T116
metabolites	O
through	O
glp-1	O
receptor	O
-independent	O
pathways	O
,	O
and	O
of	O
dpp4	B-T116
substrates	O
other	O
than	O
role	O
of	O
breast	O
magnetic	O
resonance	O
imaging	O
in	O
predicting	B-T078
residual	B-T080
lobular	O
carcinoma	O
in	O
situ	O
after	O
initial	B-T079
excision	B-T061
breast	O
magnetic	O
resonance	O
mr	O
imaging	O
is	O
a	O
useful	O
screening	O
modality	B-T078
in	O
detecting	B-T061
suspicious	B-T033
lesions	B-T033
in	O
patients	O
with	O
a	O
history	B-T033
of	O
lobular	O
carcinoma	O
in	O
situ	O
lcis	O
.	O
	
this	O
study	O
aimed	B-T078
to	O
evaluate	O
the	O
effectiveness	B-T080
of	O
breast	O
mr	O
imaging	O
in	O
detecting	B-T061
remnant	O
lcis	O
lesions	B-T033
after	B-T079
initial	B-T079
excision	B-T061
.	O
	
between	O
2011	O
and	O
2015	O
,	O
29	O
patients	O
with	O
lcis	O
who	O
underwent	B-T033
initial	B-T079
excision	B-T061
were	O
enrolled	O
.	O
	
breast	O
ultrasonography	O
and	O
breast	O
mr	O
imaging	O
was	O
conducted	O
after	B-T079
initial	B-T079
excision	B-T061
.	O
	
imaging	O
findings	O
were	O
compared	O
with	O
pathologic	O
results	B-T169
.	O
	
there	O
were	O
nine	O
31.0	O
cases	O
with	O
positive	B-T033
margins	I-T033
after	B-T079
initial	B-T079
excision	B-T061
they	O
were	O
lcis	O
n=8	O
and	O
atypical	O
lobular	O
hyperplasia	O
n=1	O
.	O
	
residual	B-T080
lesions	B-T033
were	O
identified	B-T080
in	O
12	O
cases	O
they	O
were	O
invasive	O
lobular	O
carcinoma	O
n=1	O
3.4	O
,	O
lcis	O
n=9	O
31.0	O
,	O
atypical	O
lobular	O
hyperplasia	O
n=1	O
3.4	O
,	O
and	O
papillary	O
carcinoma	O
in	O
situ	O
n=1	O
3.4	O
.	O
	
prior	B-T079
to	O
the	O
second	B-T081
operation	B-T061
,	O
these	O
lesions	B-T033
could	O
be	O
detected	O
in	O
seven	O
cases	O
using	O
ultrasonography	O
sensitivity	B-T081
,	O
53.3	O
specificity	B-T081
,	O
100%	O
and	O
in	O
10	O
cases	O
using	O
breast	O
mr	O
imaging	O
sensitivity	B-T081
,	O
83.3	O
specificity	B-T081
,	O
100%	O
.	O
	
breast	O
mr	O
imaging	O
showed	O
higher	B-T080
sensitivity	B-T081
than	O
breast	O
ultrasonography	O
in	O
detecting	B-T061
remnant	O
lcis	O
lesions	B-T033
.	O
	
if	O
a	O
suspicious	B-T033
lesion	B-T033
was	O
found	O
using	O
breast	O
mr	O
imaging	O
,	O
a	O
second	B-T081
operation	B-T061
should	O
be	O
considered	B-T078
because	O
of	O
the	O
possibility	B-T033
of	O
multifocality	B-T033
,	O
even	O
if	O
lcis	O
was	O
confirmed	B-T033
at	O
the	O
initial	B-T079
operation	B-T061
.	O
	
construction	O
of	O
fused	O
polyheterocycles	O
through	O
sequential	B-T080
4	O
+	O
2	O
and	O
3	O
+	O
2	O
cycloadditions	O
a	O
method	O
for	O
pd	O
-	O
catalyzed	O
aerobic	B-T080
oxidative	O
reaction	O
of	O
quinazolinones	B-T109
and	O
alkynes	B-T109
has	O
been	O
developed	O
for	O
sequential	B-T080
4	O
+	O
2	O
and	O
3	O
+	O
2	O
cycloadditions	O
to	O
assemble	O
a	O
novel	B-T080
fused-polycyclic	O
system	O
containing	O
tetrahydropyridine	B-T109
and	O
dihydrofuran	B-T109
rings	I-T109
.	O
	
the	O
reaction	O
process	O
involves	O
c-h	O
and	O
n-h	O
bond	O
functionalization	O
for	O
the	O
formation	B-T169
of	O
tetrahydropyridine	B-T109
and	O
an	O
oxygen	O
radical	O
cyclization	O
for	O
the	O
dihydrofuran	B-T109
ring	I-T109
.	O
	
this	O
atom	O
-	O
and	O
step-	O
economical	O
synthesis	O
is	O
highly	O
efficient	O
and	O
has	O
good	O
substrate	O
tolerance	B-T080
,	O
which	O
provides	O
a	O
new	O
approach	O
for	O
the	O
construction	O
of	O
polycyclic	O
molecules	O
with	O
potential	O
pharmaceutical	O
interest	O
.	O
	
biological	B-T080
basis	O
of	O
radiation	B-T061
protection	I-T061
needs	O
rejuvenation	B-T061
human	O
beings	O
encounter	O
radiation	O
in	O
many	O
different	O
situations	O
-	O
from	O
proximity	O
to	O
radioactive	O
waste	O
sites	O
to	O
participation	B-T169
in	O
medical	O
procedures	O
using	O
x-rays	O
etc	O
.	O
	
limits	O
for	O
radiation	O
exposures	O
are	O
legally	O
regulated	O
however	O
,	O
current	O
radiation	B-T061
protection	I-T061
policy	O
does	O
not	O
explicitly	O
acknowledge	O
that	O
biological	B-T080
,	O
cellular	O
and	O
molecular	B-T080
effects	B-T080
of	I-T080
low	B-T081
doses	I-T081
and	O
low	O
dose	B-T081
rates	I-T081
of	O
radiation	O
differ	O
from	O
effects	O
induced	O
by	O
medium	O
and	O
high	B-T081
dose	I-T081
radiation	O
exposures	O
.	O
	
recent	O
technical	B-T169
developments	I-T169
in	O
biology	O
and	O
medicine	O
,	O
from	O
single	O
cell	O
techniques	O
to	O
big	O
data	O
computational	O
research	O
,	O
have	O
enabled	O
new	O
approaches	B-T169
for	O
study	O
of	O
biology	O
of	O
low	B-T081
doses	I-T081
of	O
radiation	O
.	O
	
results	O
of	O
the	O
work	O
done	O
so	O
far	O
support	O
the	O
idea	B-T078
that	O
low	B-T081
doses	I-T081
of	O
radiation	O
have	O
effects	O
that	O
differ	O
from	O
those	O
associated	B-T080
with	I-T080
high	B-T081
dose	I-T081
exposures	O
this	O
work	O
,	O
however	O
,	O
is	O
far	O
from	O
sufficient	B-T080
for	O
the	O
development	B-T169
of	O
a	O
new	O
theoretical	O
framework	O
needed	O
for	O
the	O
understanding	O
of	O
low	B-T081
dose	I-T081
radiation	O
exposures	O
.	O
	
mechanistic	O
understanding	O
of	O
radiation	O
effects	O
at	O
low	B-T081
doses	I-T081
is	O
necessary	O
in	O
order	O
to	O
develop	O
better	O
radiation	B-T061
protection	I-T061
policy	O
.	O
	
gleason	O
grade	O
grouping	O
of	O
prostate	O
cancer	O
is	O
of	O
prognostic	O
value	O
in	O
asian	O
men	O
the	O
international	O
society	O
of	O
urological	O
pathology	O
made	O
recommendations	O
for	O
the	O
use	O
of	O
grade	O
groups	O
gg	O
originally	O
described	O
by	O
epstein	O
and	O
colleagues	O
over	O
gleason	B-T033
score	I-T033
gs	B-T033
alone	O
in	O
2014	O
,	O
which	O
was	O
subsequently	O
adopted	B-T033
by	O
the	O
who	O
classification	O
in	O
2016	O
.	O
	
the	O
majority	O
of	O
studies	O
validating	O
this	O
revision	B-T079
have	O
been	O
in	O
caucasian	O
populations	O
.	O
	
we	O
therefore	O
asked	O
whether	O
the	O
new	O
gg	O
system	O
was	O
retrospectively	O
associated	O
with	O
biochemical	B-T081
disease-free	I-T081
survival	I-T081
in	O
a	O
mixed-ethnicity	O
cohort	O
of	O
asian	O
men	O
.	O
	
a	O
total	O
of	O
680	O
radical	B-T061
prostatectomies	I-T061
rps	B-T061
from	O
2005	O
to	O
2014	O
were	O
included	O
.	O
	
gs	B-T033
from	O
initial	O
biopsy	O
and	O
rp	B-T061
were	O
compared	O
and	O
used	O
to	O
allocate	O
cases	B-T169
to	O
gg	O
,	O
defined	O
as	O
1	O
gs	B-T033
6	O
2	O
gs	B-T033
3+4=7	O
3	O
gs	B-T033
4+3=7	O
4	O
gs	B-T033
4+4=8/5+3=8/3+5=8	O
and	O
5	O
gs	B-T033
9-10	O
.	O
	
biochemical	B-T033
recurrence	I-T033
was	O
defined	O
as	O
two	O
consecutive	O
post-	O
rp	B-T061
prostate-specific	B-T116
antigen	I-T116
psa	B-T116
levels	O
of	O
>0	O
ng/ml	O
after	O
post-	O
rp	B-T061
psa	B-T116
reaching	O
the	O
nadir	B-T080
of	O
<0	O
ng/ml	O
.	O
	
our	O
data	B-T078
showed	O
that	O
kaplan-meier	B-T081
analysis	I-T081
revealed	O
significant	O
differences	O
in	O
biochemical	B-T033
recurrence	I-T033
within	O
gleason	O
gg	O
based	O
on	O
either	O
biopsy	O
or	O
prostatectomy	B-T061
scoring	B-T081
.	O
	
multivariate	B-T081
analysis	I-T081
further	O
confirmed	O
that	O
a	O
higher	O
gg	O
was	O
significantly	O
associated	O
with	O
risk	B-T078
of	O
biochemical	B-T033
recurrence	I-T033
.	O
	
this	O
gg	O
system	O
had	O
a	O
higher	O
prognostic	B-T081
discrimination	B-T169
for	O
both	O
initial	O
biopsy	O
and	O
rp	B-T061
than	O
gs	B-T033
.	O
	
our	O
study	O
validates	O
the	O
use	O
of	O
the	O
revised	B-T079
and	O
updated	B-T079
gg	O
system	O
in	O
a	O
mixed-ethnicity	O
population	O
of	O
asian	O
men	O
.	O
	
higher	O
gg	O
was	O
significantly	O
associated	O
with	O
increased	O
risk	B-T078
of	O
biochemical	B-T033
recurrence	I-T033
.	O
	
we	O
therefore	O
recommend	O
its	O
use	O
to	O
inform	O
clinical	O
management	O
for	O
patients	O
with	O
prostate	O
cancer	O
.	O
	
membrane	O
nanoclusters	B-T081
of	O
fcγri	B-T116
segregate	O
from	O
inhibitory	O
sirpα	B-T116
upon	O
activation	O
of	O
human	O
macrophages	O
signal	O
integration	O
between	O
activating	O
fc	B-T116
receptors	I-T116
and	O
inhibitory	O
signal	B-T116
regulatory	I-T116
protein	I-T116
α	I-T116
sirpα	B-T116
controls	O
macrophage	O
phagocytosis	O
.	O
	
here	O
,	O
using	O
dual-color	O
direct	O
stochastic	O
optical	O
reconstruction	O
microscopy	O
,	O
we	O
report	O
that	O
fcγ	B-T116
receptor	I-T116
i	I-T116
fcγri	B-T116
,	O
fcγrii	B-T116
,	O
and	O
sirpα	B-T116
are	O
not	O
homogeneously	B-T080
distributed	O
at	O
macrophage	O
surfaces	O
but	O
are	O
organized	O
in	O
discrete	B-T080
nanoclusters	B-T081
,	O
with	O
a	O
mean	O
radius	O
of	O
71	O
11	O
nm	O
,	O
60	O
6	O
nm	O
,	O
and	O
48	O
3	O
nm	O
,	O
respectively	O
.	O
	
nanoclusters	B-T081
of	O
fcγri	B-T116
,	O
but	O
not	O
fcγrii	B-T116
,	O
are	O
constitutively	O
associated	B-T080
with	I-T080
nanoclusters	B-T081
of	O
sirpα	B-T116
,	O
within	O
62	O
5	O
nm	O
,	O
mediated	O
by	O
the	O
actin	O
cytoskeleton	O
.	O
	
upon	O
fc	B-T116
receptor	I-T116
activation	O
,	O
src-family	B-T116
kinase	I-T116
signaling	O
leads	O
to	O
segregation	O
of	O
fcγri	B-T116
and	O
sirpα	B-T116
nanoclusters	B-T081
to	O
be	O
197	O
3	O
nm	O
apart	O
.	O
	
co-ligation	O
of	O
sirpα	B-T116
with	O
cd47	B-T116
abrogates	O
nanocluster	B-T081
segregation	O
.	O
	
if	O
the	O
balance	O
of	O
signals	O
favors	O
activation	O
,	O
fcγri	B-T116
nanoclusters	B-T081
reorganize	B-T078
into	O
periodically	B-T079
spaced	O
concentric	O
rings	O
.	O
	
thus	O
,	O
a	O
nanometer	B-T081
-	O
and	O
micron-scale	B-T081
reorganization	B-T078
of	O
activating	O
and	O
inhibitory	O
receptors	B-T116
occurs	O
at	O
the	O
surface	O
of	O
human	O
macrophages	O
concurrent	B-T079
with	O
signal	O
integration	O
.	O
	
firecracker	O
eye	B-T033
exposure	I-T033
experimental	O
study	O
and	O
simulation	O
understanding	O
the	O
mechanisms	B-T169
of	O
traumatic	B-T169
ocular	O
injury	O
is	O
helpful	O
to	O
make	O
accurate	B-T080
diagnoses	B-T033
before	O
the	O
symptoms	O
emerge	O
and	O
to	O
develop	O
specific	O
eye	O
protection	O
.	O
	
the	O
comprehension	O
of	O
the	O
dynamics	O
of	O
primary	B-T080
blast	O
injury	O
mechanisms	B-T169
is	O
a	O
challenging	O
issue	B-T033
.	O
	
the	O
question	O
is	O
whether	O
the	O
pressure	O
wave	O
propagation	O
and	O
reflection	B-T081
alone	O
could	O
cause	B-T078
ocular	B-T033
damage	I-T033
.	O
	
to	O
date	O
,	O
there	O
are	O
dissenting	O
opinions	O
and	O
no	O
conclusive	B-T080
evidence	B-T078
thereupon	O
.	O
	
a	O
previous	O
numerical	O
investigation	O
of	O
blast	O
trauma	O
highlighted	O
the	O
dynamic	B-T169
effect	B-T080
of	O
pressure	O
propagation	O
and	O
its	O
amplification	O
by	O
the	O
geometry	O
of	O
the	O
bony	O
orbit	O
,	O
inducing	B-T169
a	O
resonance	O
cavity	O
effect	B-T080
and	O
a	O
standing	O
wave	O
hazardous	B-T080
for	O
eye	O
tissues	O
.	O
	
the	O
objective	O
of	O
the	O
current	O
work	O
is	O
to	O
find	O
experimental	B-T080
evidence	B-T078
of	O
the	O
numerically	B-T081
identified	B-T080
phenomenon	O
.	O
	
therefore	O
,	O
tests	O
aimed	O
at	O
evaluating	O
the	O
response	O
of	O
porcine	O
eyes	O
to	O
blast	O
overpressure	O
generated	O
by	O
firecrackers	O
explosion	O
were	O
performed	B-T169
.	O
	
the	O
orbital	O
cavity	O
effect	B-T080
was	O
considered	O
mounting	O
the	O
enucleated	O
eyes	O
inside	O
a	O
dummy	O
orbit	O
.	O
	
the	O
experimental	B-T080
measurements	B-T169
obtained	B-T169
during	O
the	O
explosion	O
tests	O
presented	O
in	O
this	O
paper	O
corroborate	B-T080
the	O
numerical	B-T078
evidence	I-T078
of	O
a	O
high-frequency	B-T079
pressure	O
amplification	O
,	O
enhancing	O
the	O
loading	O
on	O
the	O
ocular	O
tissues	O
,	O
attributable	O
to	O
the	O
orbital	O
bony	O
walls	O
surrounding	O
the	O
the	O
platelet-activating	B-T116
receptor	I-T116
c-type	B-T116
lectin	I-T116
receptor-2	I-T116
plays	O
an	O
essential	O
role	O
in	O
liver	O
regeneration	O
after	O
partial	B-T061
hepatectomy	I-T061
in	O
mice	O
essentials	O
regeneration	O
role	O
of	O
c-type	B-T116
lectin	I-T116
receptor-2	I-T116
clec-2	B-T116
after	O
70%	B-T061
hepatectomy	I-T061
hpx	B-T061
was	O
investigated	O
.	O
	
wild-type	O
or	O
clec-2	O
deleted	O
from	O
platelets	O
of	O
chimeric	O
mice	O
flko	O
underwent	O
hpx	B-T061
.	O
	
the	O
liver/body	B-T081
weight	I-T081
ratio	I-T081
was	O
significantly	O
lower	O
in	O
the	O
flko	O
than	O
in	O
the	O
wild-type	O
.	O
	
clec-2	B-T116
plays	O
an	O
essential	O
role	O
in	O
liver	O
regeneration	O
after	O
hpx	B-T061
.	O
	
background	O
and	O
aim	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
c-type	B-T116
lectin	I-T116
receptor	I-T116
clec	I-T116
in	O
liver	O
regeneration	O
following	O
partial	B-T061
liver	I-T061
resection	I-T061
in	O
mice	O
.	O
	
materials	O
and	O
methods	O
irradiated	O
chimeric	O
mice	O
transplanted	B-T169
with	O
fetal	B-T169
liver	O
cells	O
from	O
wild-type	O
wt	O
mice	O
,	O
clec-2	O
-	O
deleted	O
ko	O
mice	O
or	O
mice	O
with	O
clec-2	O
deleted	O
specifically	O
from	O
platelets	O
flko	O
were	O
generated	O
.	O
	
mice	O
underwent	O
70%	B-T061
partial	I-T061
hepatectomy	I-T061
ph	B-T061
.	O
	
immunohistochemical	O
staining	O
was	O
performed	O
to	O
investigate	O
the	O
expression	O
of	O
the	O
endogenous	B-T169
ligand	O
for	O
clec-2	B-T116
,	O
podoplanin	B-T116
.	O
	
the	O
accumulation	O
of	O
platelets	O
in	O
the	O
liver	O
was	O
also	O
quantified	B-T081
.	O
	
the	O
hepatic	O
expression	O
of	O
the	O
il-6	B-T116
/	O
gp130	B-T116
and	O
stat3	B-T116
,	O
akt	B-T116
and	O
erk1/2	B-T116
was	O
also	O
examined	O
.	O
	
results	O
the	O
liver/body	B-T081
weight	I-T081
ratio	I-T081
and	O
expression	O
of	O
all	O
cell	O
proliferation	O
markers	O
were	O
significantly	O
lower	O
in	O
the	O
flko	O
group	O
than	O
in	O
the	O
wt	O
group	O
.	O
	
the	O
expression	O
of	O
phosphorylated	B-T116
p	I-T116
akt	I-T116
and	O
perk1	B-T116
/2	O
was	O
similar	O
in	O
the	O
wt	O
and	O
flko	O
groups	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
the	O
expression	O
of	O
pstat3	B-T116
and	O
il-6	B-T116
was	O
significantly	O
stronger	O
in	O
the	O
wt	O
group	O
than	O
in	O
the	O
flko	O
group	O
.	O
	
the	O
expression	O
of	O
podoplanin	B-T116
was	O
detected	O
in	O
the	O
hepatic	O
sinusoids	O
of	O
both	O
groups	B-T078
.	O
	
however	O
,	O
the	O
extent	O
to	O
which	O
platelets	O
accumulated	O
in	O
hepatic	O
sinusoids	O
was	O
significantly	O
less	O
in	O
the	O
flko	O
group	O
than	O
in	O
the	O
wt	O
group	O
.	O
	
conclusion	O
clec-2	B-T116
was	O
involved	O
in	O
hepatic	O
regeneration	O
after	O
liver	B-T061
resection	I-T061
and	O
clec-2	B-T116
-related	O
liver	O
regeneration	O
was	O
attributed	O
to	O
the	O
interaction	O
between	O
platelets	O
and	O
sinusoidal	O
endothelial	O
cells	O
.	O
	
temporal	B-T079
stability	B-T080
of	O
heavy	B-T033
drinking	I-T033
days	O
and	O
drinking	O
reductions	B-T061
among	O
heavy	O
drinkers	O
in	O
the	O
combine	O
study	O
recently	O
,	O
the	O
food	O
and	O
drug	O
administration	O
fda	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	B-T080
end	B-T080
points	I-T080
in	O
the	O
development	B-T169
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	B-T061
from	O
alcohol	O
or	O
a	O
nonabstinent	B-T033
outcome	B-T169
no	O
heavy	B-T033
drinking	I-T033
days	O
with	O
a	O
heavy	B-T033
drinking	I-T033
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
>3/>4	O
cutoff	B-T169
.	O
	
the	O
fda	O
also	O
suggested	B-T078
that	O
6	O
months	B-T079
would	O
be	O
the	O
most	O
appropriate	B-T080
length	O
for	O
a	O
clinical	O
trial	O
to	O
demonstrate	O
the	O
stability	B-T080
of	O
this	O
nonabstinent	B-T033
drinking	O
outcome	B-T169
.	O
	
however	O
,	O
few	O
alcohol	O
clinical	O
trials	O
have	O
examined	B-T033
the	O
stability	B-T080
of	O
nonheavy	B-T033
drinking	I-T033
during	B-T079
and	O
after	O
treatment	O
.	O
	
in	O
a	O
secondary	O
analysis	O
of	O
the	O
combine	O
study	O
data	B-T078
n	O
=	O
1	O
,	O
we	O
examined	B-T033
transitions	O
in	O
heavy	B-T033
drinking	I-T033
days	O
during	B-T079
the	I-T079
course	I-T079
of	I-T079
treatment	I-T079
months	B-T079
1	O
through	O
4	O
,	O
during	B-T079
the	O
transition	O
out	O
of	O
treatment	B-T061
months	B-T079
4	O
through	O
7	O
,	O
and	O
up	O
to	O
12	O
months	B-T079
afterward	O
months	B-T079
13	O
through	O
16	O
using	O
latent	O
variable	O
mixture	O
models	O
.	O
	
heavy	B-T033
drinking	I-T033
and	O
nonheavy	B-T033
drinking	I-T033
were	O
relatively	O
stable	B-T080
in	O
consecutive	B-T080
months	B-T079
minimum	B-T080
agreement	O
kappa	O
=	O
0.64	O
for	O
months	B-T079
1	O
to	O
2	O
.	O
	
most	O
individuals	O
were	O
stable	B-T080
low-risk	B-T081
drinkers	B-T033
/	O
abstainers	O
or	O
heavy	O
drinkers	O
by	O
the	O
end	O
of	O
treatment	B-T061
,	O
as	O
characterized	O
by	O
a	O
10%	O
probability	B-T081
or	O
less	O
of	O
transitioning	O
out	O
of	O
either	O
a	O
no	O
heavy	B-T033
drinking	I-T033
state	B-T169
or	O
a	O
heavy	B-T033
drinking	I-T033
state	B-T169
.	O
	
more	O
than	O
two-thirds	O
of	O
the	O
heavy	O
drinkers	O
who	O
exceeded	O
the	O
heavy	B-T033
drinking	I-T033
threshold	B-T080
during	B-T079
treatment	I-T079
reported	O
,	O
on	O
average	B-T081
,	O
a	O
64%	O
reduction	B-T061
in	O
drinking	B-T033
frequency	I-T033
and	O
a	O
38%	O
reduction	B-T061
in	O
drinking	O
intensity	O
from	O
pretreatment	O
drinking	O
levels	B-T080
.	O
	
the	O
results	O
show	O
stability	B-T080
of	O
no	O
heavy	B-T033
drinking	I-T033
as	O
an	O
outcome	B-T169
within	O
the	O
first	O
4	O
months	B-T079
of	O
treatment	B-T061
and	O
that	O
the	O
>3/>4	O
drink	O
cutoff	B-T169
may	O
mask	O
substantial	O
reductions	B-T061
in	O
alcohol	O
consumption	O
among	O
some	O
patients	O
.	O
	
future	O
studies	O
should	O
explore	O
the	O
clinical	B-T080
utility	O
of	O
reduction	B-T061
end	B-T080
points	I-T080
.	O
	
oral	O
health	O
in	O
transition	O
the	O
hadza	O
foragers	O
of	O
tanzania	O
conventional	B-T080
wisdom	O
holds	O
that	O
a	O
decline	B-T081
in	O
oral	O
health	O
accompanies	O
the	O
transition	O
from	O
hunting	O
and	O
gathering	O
to	O
agriculture	O
,	O
given	O
increased	B-T081
consumption	O
of	O
carbohydrates	B-T109
.	O
	
this	O
widely	O
touted	O
example	O
of	O
the	O
mismatch	B-T080
between	O
our	O
biology	O
and	O
modern	O
lifestyle	O
has	O
been	O
intuited	O
largely	O
from	O
the	O
bioarchaeological	O
record	O
of	O
the	O
neolithic	B-T109
revolution	I-T109
in	O
the	O
new	O
world	O
.	O
	
recent	O
studies	O
of	O
other	O
populations	B-T081
have	O
,	O
however	O
,	O
challenged	O
the	O
universality	O
of	O
this	O
assertion	B-T080
.	O
	
here	O
,	O
we	O
present	O
the	O
first	O
comprehensive	B-T080
study	O
of	O
oral	O
health	O
among	O
a	O
living	O
population	O
in	O
transition	O
from	O
the	O
bush	O
to	O
village	O
life	O
,	O
the	O
hadza	O
hunter	O
-	O
gatherers	O
of	O
tanzania	O
,	O
to	O
test	O
the	O
hypothesis	B-T078
that	O
the	O
shift	O
from	O
foraging	O
to	O
farming	O
,	O
or	O
agricultural	O
intensification	O
,	O
inevitably	O
leads	O
to	O
increased	B-T081
periodontal	B-T047
disease	I-T047
,	O
caries	B-T047
,	O
and	O
orthodontic	B-T169
disorders	B-T047
.	O
	
our	O
results	B-T169
showed	O
that	O
women	O
living	B-T080
in	O
villages	O
consuming	O
a	O
mostly	O
agricultural	O
diet	O
exhibited	O
more	O
caries	B-T047
and	O
periodontal	B-T047
disease	I-T047
than	O
those	O
living	B-T080
in	O
the	O
bush	O
consuming	O
a	O
mostly	O
wild-food	O
diet	O
.	O
	
furthermore	O
,	O
men	O
living	B-T080
in	O
the	O
bush	O
consuming	O
mostly	O
a	O
wild-food	O
diet	O
had	O
more	O
than	O
those	O
living	B-T080
in	O
the	O
village	O
consuming	O
a	O
mostly	O
agricultural	O
diet	O
.	O
	
these	O
findings	B-T033
are	O
explained	O
by	O
the	O
high	B-T080
incidence	B-T081
of	O
maize	O
consumption	O
in	O
village	O
settings	O
,	O
along	O
with	O
previously	O
recognized	O
variation	B-T080
in	O
rate	B-T081
of	O
caries	B-T047
between	O
men	O
and	O
women	O
.	O
	
the	O
unexpected	O
discovery	O
of	O
high	B-T080
caries	B-T047
incidences	B-T081
for	O
men	O
in	O
the	O
bush	O
is	O
likely	O
explained	O
by	O
heavy	O
reliance	O
on	O
honey	O
,	O
and	O
perhaps	O
differential	O
access	O
to	O
tobacco	O
and	O
marijuana	B-T109
.	O
	
these	O
data	B-T078
support	O
the	O
notions	O
that	O
mechanisms	B-T169
of	O
cariogenesis	B-T047
are	O
multifactorial	B-T033
and	O
that	O
the	O
relationships	B-T080
between	O
oral	O
health	O
and	O
the	O
shift	O
from	O
a	O
predominantly	O
wild-food	O
diet	O
to	O
one	O
dominated	O
by	O
cultigens	O
the	O
r2r3myb	B-T116
vvmybpa1	B-T116
from	O
grape	O
reprograms	O
the	O
phenylpropanoid	O
pathway	O
in	O
tobacco	O
flowers	O
this	O
work	O
shows	O
that	O
,	O
in	O
tobacco	O
,	O
the	O
ectopic	O
expression	O
of	O
vvmybpa1	B-T116
,	O
a	O
grape	O
regulator	O
of	O
proanthocyanidin	B-T109
biosynthesis	O
,	O
up-	O
or	O
down-regulates	O
different	O
branches	O
of	O
the	O
phenylproanoid	O
pathway	O
,	O
in	O
a	O
structure-specific	O
fashion	O
.	O
	
proanthocyanidins	B-T109
are	O
flavonoids	B-T109
of	O
paramount	O
importance	O
for	O
animal	O
and	O
human	O
diet	O
.	O
	
research	O
interest	O
increasingly	O
tilts	O
towards	O
generating	O
crops	O
enriched	O
with	O
these	O
health	B-T078
-promoting	O
compounds	B-T080
.	O
	
flavonoids	B-T109
synthesis	O
is	O
regulated	O
by	O
the	O
mbw	O
transcriptional	O
complex	O
,	O
made	O
of	O
r2r3myb	B-T116
,	O
bhlh	B-T116
and	O
wd40	B-T116
proteins	I-T116
,	O
with	O
the	O
myb	B-T116
components	O
liable	O
for	O
channeling	O
the	O
complex	O
towards	O
specific	O
branches	O
of	O
the	O
pathway	O
.	O
	
hence	O
,	O
using	O
tobacco	O
as	O
a	O
model	O
,	O
here	O
,	O
we	O
tested	B-T169
if	O
the	O
ectopic	O
expression	O
of	O
the	O
proanthocyanidin	B-T109
regulator	O
vvmybpa1	B-T116
from	O
grape	O
induces	B-T169
the	O
biosynthesis	B-T169
of	O
these	O
compounds	B-T080
in	O
not-naturally	O
committed	O
cells	O
.	O
	
here	O
,	O
we	O
show	O
,	O
via	O
targeted	O
transcriptomic	O
and	O
metabolic	B-T169
analyses	O
of	O
primary	O
transgenic	O
lines	O
and	O
their	O
progeny	O
,	O
that	O
vvmybpa1	B-T116
alters	O
the	O
phenylpropanoid	O
pathway	O
in	O
tobacco	O
floral	O
organs	O
,	O
in	O
a	O
structure-specific	O
fashion	O
.	O
	
we	O
also	O
report	O
that	O
a	O
modest	O
vvmybpa1	B-T116
expression	O
is	O
sufficient	O
to	O
induce	O
the	O
expression	O
of	O
both	O
proanthocyanidin	B-T109
-specific	O
and	O
early	O
genes	O
of	O
the	O
phenylpropanoid	O
pathway	O
.	O
	
consequently	O
,	O
proanthocyanidins	B-T109
and	O
chlorogenic	B-T109
acids	I-T109
are	O
induced	O
or	O
de	B-T078
novo	I-T078
synthetised	O
in	O
floral	O
limbs	O
,	O
tubes	O
and	O
stamens	O
.	O
	
other	O
phenylpropanoid	O
branches	O
are	O
conversely	O
induced	O
or	O
depleted	B-T169
according	O
to	O
the	O
floral	O
structure	O
.	O
	
our	O
study	O
documents	O
a	O
novel	B-T080
and	O
distinct	O
function	O
of	O
vvmybpa1	B-T116
with	O
respect	O
to	O
other	O
mybs	B-T116
regulating	O
proanthocyanidins	B-T109
.	O
	
present	O
findings	B-T169
may	O
have	O
major	O
implications	O
in	O
designing	O
strategies	O
for	O
enriching	O
crops	O
with	O
health	B-T078
-promoting	O
genome-wide	O
association	O
mapping	O
in	O
winter	O
barley	O
for	O
grain	O
yield	B-T081
and	O
culm	O
cell	O
wall	O
polymer	O
content	B-T081
using	O
the	O
high-throughput	O
compp	O
technique	O
a	O
collection	B-T169
of	O
112	O
winter	O
barley	O
varieties	O
hordeum	O
vulgare	O
l	O
was	O
grown	O
in	O
the	O
field	O
for	O
two	O
years	B-T079
2008/09	O
and	O
2009/10	O
in	O
northern	O
italy	O
and	O
grain	O
and	O
straw	B-T109
yields	B-T081
recorded	O
.	O
	
in	O
the	O
first	O
year	B-T079
of	O
the	O
trial	O
,	O
a	O
severe	O
attack	O
of	O
barley	O
yellow	O
mosaic	O
virus	O
baymv	O
strongly	O
influenced	O
final	O
performances	O
with	O
an	O
average	B-T081
reduction	B-T080
of	O
50%	O
for	O
grain	O
and	O
straw	B-T109
harvested	B-T169
in	O
comparison	O
to	O
the	O
second	B-T081
year	B-T079
.	O
	
the	O
genetic	O
determination	O
gd	O
for	O
grain	O
yield	B-T081
was	O
0.49	O
and	O
0.70	O
,	O
for	O
the	O
two	O
years	B-T079
respectively	O
,	O
and	O
for	O
straw	B-T109
yield	B-T081
gd	O
was	O
low	O
in	O
2009	O
0.09	O
and	O
higher	O
in	O
2010	O
0.29	O
.	O
	
cell	O
wall	O
polymers	O
in	O
culms	O
were	O
quantified	O
by	O
means	O
of	O
the	O
monoclonal	O
antibodies	O
lm6	O
,	O
lm11	O
,	O
jim13	O
and	O
bs-400-3	O
and	O
the	O
carbohydrate-binding	O
module	O
cbm3a	O
using	O
the	O
high-throughput	O
compp	O
technique	O
.	O
	
of	O
these	O
,	O
lm6	O
,	O
which	O
detects	O
arabinan	O
components	O
,	O
showed	O
a	O
relatively	O
high	O
gd	O
in	O
both	O
years	O
and	O
a	O
significantly	O
negative	O
correlation	O
with	O
grain	O
yield	O
gyld	O
.	O
	
overall	O
,	O
heritability	O
h2	O
was	O
calculated	O
for	O
gyld	O
,	O
lm6	O
and	O
jim	O
and	O
resulted	O
to	O
be	O
0.42	O
,	O
0.32	O
and	O
0.20	O
,	O
respectively	O
.	O
	
a	O
total	O
of	O
4	O
snps	O
from	O
the	O
9k	O
iselect	O
array	O
were	O
used	O
in	O
the	O
study	O
for	O
the	O
analysis	O
of	O
population	O
structure	O
,	O
linkage	O
disequilibrium	O
ld	O
and	O
genome-wide	O
association	O
study	O
gwas	O
.	O
	
marker-trait	O
associations	O
mta	O
were	O
analyzed	O
for	O
grain	O
yield	O
and	O
cell	O
wall	O
determination	O
by	O
lm6	O
and	O
jim13	O
as	O
these	O
were	O
the	O
traits	O
showing	O
significant	O
correlations	O
between	O
the	O
years	O
.	O
	
a	O
single	O
qtl	O
for	O
gyld	O
containing	O
three	O
mtas	O
was	O
found	O
on	O
chromosome	O
3h	O
located	O
close	O
to	O
the	O
hv-eif4e	O
gene	O
,	O
which	O
is	O
known	O
to	O
regulate	O
resistance	O
to	O
baymv	O
.	O
	
subsequently	O
the	O
qtl	O
was	O
shown	O
to	O
be	O
tightly	O
linked	O
to	O
rym4	O
,	O
a	O
locus	O
for	O
resistance	O
to	O
the	O
virus	O
.	O
	
gwas	O
on	O
arabinans	O
quantified	O
by	O
lm6	O
resulted	O
in	O
the	O
identification	O
of	O
major	O
qtls	O
closely	O
located	O
on	O
3h	O
and	O
hypotheses	O
regarding	O
putative	O
candidate	O
genes	O
were	O
formulated	O
through	O
the	O
study	O
of	O
gene	O
expression	O
levels	O
based	O
on	O
bioinformatics	O
the	O
prevalence	B-T081
and	O
clinical	B-T080
relevance	B-T080
of	O
asa	B-T109
nonresponse	B-T033
after	O
cardiac	B-T061
surgery	I-T061
we	O
aimed	O
to	O
identify	O
the	O
prevalence	B-T081
of	O
acetylsalicylic	B-T109
acid	I-T109
asa	B-T109
nonresponse	B-T033
in	O
patients	O
after	O
coronary	B-T061
artery	I-T061
bypass	I-T061
graft	I-T061
cabg	I-T061
surgery	I-T061
and	O
the	O
possible	O
consequences	B-T169
for	O
the	O
rate	O
of	O
major	O
cardiovascular	B-T033
events	I-T033
.	O
	
this	O
prospective	O
,	O
observational	O
,	O
bicentric	B-T081
cohort	I-T081
study	I-T081
was	O
conducted	O
in	O
two	O
german	O
university	O
hospitals	O
.	O
	
a	O
total	O
of	O
400	O
patients	O
200	O
in	O
each	O
study	O
center	O
undergoing	O
elective	B-T061
cabg	B-T061
surgery	I-T061
were	O
enrolled	O
after	O
written	O
informed	O
consent	O
.	O
	
platelet	O
function	O
was	O
analyzed	O
on	O
day	O
3	O
d3	O
and	O
day	O
5	O
d5	O
postoperatively	B-T079
following	O
stimulation	O
with	O
arachidonic	B-T109
acid	I-T109
aspitest	O
and	O
with	O
thrombin	B-T116
receptor-activating	I-T116
peptide	I-T116
6	I-T116
traptest	O
using	O
multiple	O
electrode	O
aggregometry	O
multiplate	O
.	O
	
individuals	O
with	O
an	O
aspitest	O
40	O
au	O
were	O
categorized	O
as	O
asa	B-T109
nonresponders	B-T033
.	O
	
a	O
1-year	O
follow-up	O
recorded	O
the	O
combined	O
end	O
point	O
of	O
cardiovascular	B-T033
events	I-T033
,	O
hospital	O
admissions	O
,	O
or	O
deaths	B-T033
related	O
to	O
cardiovascular	B-T047
disease	I-T047
.	O
	
the	O
prevalence	B-T081
of	O
asa	B-T109
nonresponse	B-T033
was	O
51.5	O
on	O
d3	O
,	O
and	O
it	O
significantly	B-T078
increased	B-T081
to	O
71.3	O
on	O
d5	O
p	O
=	O
0049	O
.	O
	
the	O
area	O
under	O
the	O
aggregation	O
curve	O
in	O
the	O
traptest	O
p	O
<	O
0001	O
,	O
the	O
platelet	O
count	O
on	O
d5	O
p	O
=	O
009	O
,	O
and	O
the	O
cardiopulmonary	B-T033
bypass	I-T033
time	I-T033
p	O
=	O
01	O
were	O
identified	O
as	O
independent	O
predictors	O
of	O
an	O
asa	B-T109
nonresponse	B-T033
.	O
	
a	O
1-year	O
follow-up	O
recorded	O
54	O
events	O
fulfilling	O
criteria	O
for	O
the	O
combined	O
end	B-T080
point	I-T080
with	O
no	O
difference	O
between	O
asa	B-T109
responders	B-T033
and	O
nonresponders	B-T033
.	O
	
this	O
study	O
indicates	O
a	O
high	O
incidence	O
of	O
perioperative	B-T079
asa	B-T109
nonresponse	B-T033
in	O
patients	O
following	O
cabg	B-T061
.	O
	
no	O
effect	O
on	O
the	O
incidence	O
of	O
cardiovascular	B-T033
events	I-T033
was	O
recorded	O
in	O
the	O
1-year	O
follow-up	O
.	O
	
therefore	O
,	O
a	O
randomized	O
dosage	O
adjustment	O
trial	O
should	O
elucidate	O
whether	O
a	O
tailored	O
asa	B-T109
treatment	B-T061
after	O
cabg	B-T061
surgery	I-T061
genome	O
sequences	O
of	O
mycobacteriophages	O
jane	O
and	O
sneeze	O
,	O
new	O
members	O
of	O
cluster	O
g	O
jane	O
and	O
sneeze	O
are	O
newly	O
isolated	B-T169
phages	O
of	O
mycobacterium	O
smegmatis	O
mc	O
from	O
hillsborough	O
,	O
nj	O
,	O
and	O
palo	O
verde	O
,	O
costa	O
rica	O
,	O
respectively	O
.	O
	
both	O
are	O
cluster	O
g	O
,	O
subcluster	O
g1	O
mycobacteriophages	O
.	O
	
notable	O
nucleotide	O
differences	B-T080
exist	O
between	O
genomes	O
in	O
the	O
right	O
half	O
,	O
including	O
the	O
presence	O
of	O
mycobacteriophage	O
mobile	O
element	O
1	O
effect	B-T080
of	O
punica	O
granatum	O
fruit	O
peel	O
on	O
glucose-6-phosphate	B-T116
dehydrogenase	I-T116
and	O
malate	B-T116
dehydrogenase	I-T116
in	O
amphistome	O
gastrothylax	O
indicus	O
increasing	B-T169
anthelmintic	O
resistance	O
and	O
the	O
impact	B-T080
of	O
conventional	O
anthelmintics	O
on	O
the	O
environment	O
,	O
it	O
is	O
important	O
to	O
look	O
for	O
alternative	O
strategies	O
against	O
helminth	O
parasite	O
in	O
sheep	O
.	O
	
important	O
lipogenic	B-T116
enzymes	I-T116
like	O
glucose-6-phosphate	B-T116
dehydrogenase	I-T116
g-6-pdh	B-T116
and	O
malate	B-T116
dehydrogenase	I-T116
mdh	B-T116
show	O
subcellular	O
distribution	O
pattern	O
.	O
	
activity	O
of	O
g-6-pdh	B-T116
was	O
largely	O
restricted	O
to	O
cytosolic	O
fraction	O
while	O
mdh	B-T116
was	O
found	O
in	O
both	O
cytosolic	O
and	O
mitochondrial	O
fraction	O
in	O
gastrothylax	O
indicus	O
.	O
	
following	O
in	B-T080
vitro	I-T080
treatment	B-T169
with	O
ethanolic	B-T109
and	O
aqueous	O
extracts	O
of	O
punica	O
granatum	O
fruit	O
peel	O
and	O
commercial	O
anthelmintic	O
,	O
albendazole	B-T109
g-6-pdh	B-T116
activity	O
was	O
decreased	B-T080
by	O
19-32	O
%	O
,	O
whereas	O
mdh	B-T116
was	O
suppressed	B-T169
by	O
24-41	O
%	O
,	O
compared	O
to	O
the	O
respective	O
control	O
.	O
	
albendazole	B-T109
was	O
quite	O
effective	B-T080
when	O
compared	O
with	O
negative	O
control	O
and	O
both	O
the	O
extracts	O
.	O
	
the	O
results	B-T169
indicate	O
that	O
phytochemicals	B-T109
of	O
plant	O
may	O
act	O
as	O
potential	B-T080
vermifuge	O
or	O
remitting	B-T047
seronegative	I-T047
symmetrical	I-T047
synovitis	I-T047
with	I-T047
pitting	I-T047
edema	I-T047
appearance	O
on	O
fdg	O
pet/ct	O
remitting	B-T047
seronegative	I-T047
symmetrical	I-T047
synovitis	I-T047
with	I-T047
pitting	I-T047
edema	I-T047
rs3pe	B-T047
is	O
a	O
rare	B-T047
condition	I-T047
in	O
the	O
elderly	O
and	O
can	O
appear	O
as	O
a	O
first	O
presentation	O
of	O
various	O
types	B-T080
of	O
rheumatic	B-T047
and	O
malignant	B-T047
diseases	I-T047
.	O
	
we	O
presented	O
a	O
62-	O
year	B-T079
-old	O
man	O
with	O
the	O
diagnosis	B-T033
of	O
rs3pe	B-T047
based	O
on	O
the	O
clinical	O
sign	O
and	O
laboratory	B-T078
data	I-T078
.	O
	
because	O
of	O
the	O
possibility	O
of	O
associated	O
malignancies	O
in	O
rs3pe	B-T047
,	O
fdg	O
pet/ct	O
was	O
performed	O
to	O
exclude	O
occult	O
tumors	O
.	O
	
the	O
images	O
showed	O
multiple	B-T081
,	O
symmetrically	B-T033
,	O
diffusely	O
increased	B-T081
f-fdg	B-T109
uptake	O
in	O
the	O
soft	O
tissue	O
around	O
joints	O
and	O
bones	O
in	O
the	O
shoulders	O
,	O
hips	O
,	O
knees	O
,	O
and	O
parks	O
as	O
social	B-T169
and	O
cultural	B-T169
spaces	O
among	O
u.s	O
-	O
and	O
foreign	B-T080
-	O
born	O
latinas	O
parks	O
provide	O
opportunities	O
for	O
people	O
to	O
engage	O
in	O
activities	O
that	O
can	O
promote	O
physical	B-T169
and	O
emotional	B-T033
well-being	B-T078
.	O
	
using	O
focus	O
groups	O
and	O
personal	O
interviews	O
conducted	O
in	O
selected	O
neighborhoods	O
of	O
a	O
northeastern	O
city	O
with	O
a	O
high	B-T080
rate	B-T081
of	O
obesity	B-T047
,	O
we	O
examined	B-T033
perceptions	O
of	O
barriers	B-T078
and	O
facilitators	B-T080
regarding	O
the	O
use	B-T169
of	I-T169
parks	O
and	O
park	O
features	B-T080
that	O
would	O
promote	O
physical	O
activity	O
among	O
latina	O
women	O
n	O
=	O
39	O
.	O
	
foreign	B-T080
-	O
born	O
latinas	O
emphasized	O
the	O
environmental	O
characteristics	B-T080
of	O
parks	O
and	O
the	O
types	B-T080
of	O
amenities	O
that	O
can	O
support	O
preferred	O
cultural	O
and	O
social	O
activities	O
,	O
while	O
u.s	O
.	O
	
-	O
born	O
latinas	O
emphasized	O
the	O
use	O
of	O
parks	O
for	O
physical	O
activity	O
and	O
weight	O
management	O
.	O
	
most	O
striking	O
were	O
the	O
different	O
ways	O
in	O
which	O
foreign	B-T080
-	O
born	O
participants	O
conceptualized	O
parks	O
as	O
sociocultural	O
family	O
centers	O
,	O
extending	O
more	O
common	B-T081
conceptualizations	O
centered	O
on	O
exercise	O
or	O
individual	O
health	B-T078
gain	B-T081
.	O
	
these	O
findings	B-T169
suggest	O
the	O
need	O
for	O
new	B-T080
policies	O
that	O
incorporate	O
culturally	B-T169
specific	B-T080
park	O
programming	O
to	O
promote	O
national	O
goals	O
of	O
increasing	B-T169
levels	B-T080
of	O
physical	O
activity	O
for	O
the	O
impact	B-T080
of	O
childhood	O
maltreatment	O
on	O
the	O
differential	B-T080
efficacy	B-T080
of	O
cbasp	B-T061
versus	O
escitalopram	B-T109
in	O
patients	O
with	O
chronic	O
depression	O
a	O
secondary	O
analysis	O
childhood	O
maltreatment	O
cm	O
has	O
been	O
indicated	B-T033
as	O
a	O
predictor	B-T078
of	O
a	O
differential	B-T080
response	O
to	O
antidepressant	B-T061
treatment	I-T061
with	O
psychotherapy	B-T061
compared	O
to	O
medication	O
.	O
	
in	O
this	O
secondary	O
analysis	O
,	O
we	O
investigated	B-T169
whether	O
the	O
presence	B-T080
of	O
cm	O
results	B-T169
in	O
a	O
differential	B-T080
indication	B-T078
for	O
the	O
cognitive	B-T061
behavioral	I-T061
analysis	I-T061
system	I-T061
of	I-T061
psychotherapy	I-T061
cbasp	B-T061
or	O
escitalopram	B-T109
plus	O
clinical	O
management	O
esc	B-T109
.	O
	
sixty	O
patients	O
with	O
chronic	O
depression	O
were	O
randomized	O
to	O
either	O
22	O
sessions	O
of	O
cbasp	B-T061
or	O
esc	B-T109
over	O
the	O
course	B-T079
of	O
8	B-T079
weeks	I-T079
of	O
acute	B-T079
and	O
20	B-T079
weeks	I-T079
of	O
extended	B-T169
treatment	B-T061
at	O
2	O
german	O
treatment	O
sites	O
.	O
	
cm	O
was	O
assessed	O
using	O
the	O
childhood	B-T079
trauma	B-T080
questionnaire	O
and	O
the	O
clinician	O
rated	O
early	O
trauma	O
inventory	O
.	O
	
intention-to-treat	O
analyses	O
were	O
used	O
to	O
examine	O
the	O
impact	B-T080
of	O
cm	O
on	O
depression	O
,	O
global	O
functioning	O
,	O
and	O
quality	B-T078
of	I-T078
life	I-T078
.	O
	
the	O
presence	B-T080
of	O
cm	O
did	O
not	O
result	B-T169
in	O
significant	B-T078
differences	B-T080
in	O
treatment	O
response	O
to	O
cbasp	B-T061
or	O
esc	B-T109
on	O
any	O
outcome	B-T081
measure	I-T081
after	O
28	B-T079
weeks	I-T079
of	O
treatment	B-T061
independent	B-T169
of	I-T169
the	O
type	O
of	O
cm	O
assessment	O
.	O
	
after	O
8	B-T079
weeks	I-T079
,	O
a	O
significant	B-T078
cm	O
treatment	B-T061
interaction	B-T169
was	O
found	B-T033
for	O
scores	B-T081
on	O
the	O
montgomery-asberg	O
depression	O
rating	O
scale	O
.	O
	
patients	O
with	O
a	O
history	B-T033
of	O
cm	O
receiving	B-T080
cbasp	B-T061
had	O
a	O
significantly	B-T081
lower	I-T081
response	B-T079
rate	I-T079
compared	O
to	O
patients	O
without	O
cm	O
and	O
to	O
those	O
receiving	B-T080
esc	B-T109
after	O
8	B-T079
weeks	I-T079
.	O
	
conclusively	B-T080
,	O
cbasp	B-T061
and	O
esc	B-T109
are	O
equally	O
effective	B-T080
treatment	B-T061
options	O
for	O
the	O
difficult	B-T080
to	O
treat	B-T169
subgroup	O
of	O
patients	O
with	O
chronic	O
depression	O
and	O
a	O
history	B-T033
of	O
cm	O
.	O
	
cm	O
may	O
be	O
a	O
predictor	B-T078
of	O
a	O
longer	B-T080
latency	B-T079
of	O
treatment	O
response	O
in	O
the	O
case	B-T169
of	O
psychotherapy	B-T061
.	O
	
cbasp	B-T061
and	O
escitalopram	B-T109
are	O
equally	O
effective	B-T080
treatment	B-T061
options	O
for	O
chronic	O
depression	O
.	O
	
both	O
treatments	B-T061
are	O
also	O
equally	O
effective	B-T080
for	O
the	O
difficult	B-T080
to	O
treat	B-T169
subgroup	O
of	O
patients	O
with	O
chronic	O
depression	O
and	O
a	O
history	B-T033
of	O
childhood	O
maltreatment	O
.	O
	
childhood	O
maltreatment	O
may	O
result	B-T169
in	O
a	O
longer	B-T080
latency	B-T079
of	O
treatment	O
response	O
in	O
the	O
case	B-T169
of	O
a	O
role	O
for	O
the	O
locus	O
coeruleus	O
in	O
the	O
analgesic	B-T033
efficacy	I-T033
of	O
n-acetylaspartylglutamate	B-T116
peptidase	I-T116
gcpii	B-T116
inhibitors	O
zj43	B-T109
and	O
2-pmpa	B-T109
n-acetylaspartylglutamate	B-T116
naag	B-T116
is	O
the	O
third	O
most	O
prevalent	O
and	O
widely	O
distributed	O
neurotransmitter	O
in	O
the	O
mammalian	O
nervous	O
system	O
.	O
	
naag	B-T116
activates	O
a	O
group	B-T116
ii	I-T116
metabotropic	I-T116
glutamate	I-T116
receptor	I-T116
mglur3	B-T116
and	O
is	O
inactivated	O
by	O
an	O
extracellular	B-T116
enzyme	I-T116
,	O
glutamate	I-T116
carboxypeptidase	I-T116
ii	I-T116
gcpii	B-T116
in	O
vivo	O
.	O
	
inhibitors	O
of	O
this	O
enzyme	O
are	O
analgesic	B-T109
in	O
animal	O
models	O
of	O
inflammatory	O
,	O
neuropathic	B-T033
and	O
bone	O
cancer	O
pain	O
.	O
	
naag	B-T116
and	O
gcpii	B-T116
are	O
present	O
in	O
the	O
locus	O
coeruleus	O
,	O
a	O
center	O
for	O
the	O
descending	O
noradrenergic	O
inhibitory	O
pain	O
system	O
.	O
	
in	O
the	O
formalin	B-T109
footpad	O
model	O
,	O
systemic	B-T169
treatment	B-T169
with	O
gcpii	O
inhibitors	O
reduces	O
both	O
phases	O
of	O
the	O
inflammatory	O
pain	O
response	O
and	O
increases	O
release	O
of	O
spinal	O
noradrenaline	B-T109
.	O
	
this	O
analgesic	B-T033
efficacy	I-T033
is	O
blocked	B-T169
by	O
systemic	B-T169
injection	B-T061
of	O
a	O
group	B-T116
ii	I-T116
mglur	I-T116
antagonist	O
,	O
by	O
intrathecal	B-T061
spinal	I-T061
injection	I-T061
of	O
an	O
alpha	O
2	O
adrenergic	O
receptor	O
antagonist	O
and	O
by	O
microinjection	B-T061
of	O
an	O
α-amino-3-hydroxy-5-methylisoxazole-4-propionic	O
acid	O
ampa	O
receptor	O
antagonist	O
directly	O
into	O
the	O
contralateral	O
locus	O
coeruleus	O
.	O
	
footpad	O
inflammation	O
increases	O
release	O
of	O
glutamate	B-T116
in	O
the	O
contralateral	O
locus	O
coeruleu	O
s	O
and	O
systemic	B-T169
treatment	B-T169
with	O
a	O
gcpii	O
inhibitor	O
blocks	B-T169
this	O
increase	O
.	O
	
direct	B-T080
injection	B-T061
of	O
gcpii	O
inhibitors	O
into	O
the	O
contralateral	O
or	O
ipsilatera	O
l	O
locus	O
coeruleus	O
reduces	O
both	O
phases	O
of	O
the	O
inflammatory	O
pain	O
response	O
in	O
a	O
dose-dependent	B-T081
manner	O
and	O
the	O
contralateral	O
effect	B-T080
also	O
is	O
blocked	B-T169
by	O
intrathecal	B-T061
injection	I-T061
of	O
an	O
alpha	O
2	O
adrenergic	O
receptor	O
antagonist	O
.	O
	
these	O
data	O
support	O
the	O
hypothesis	B-T078
that	O
the	O
analgesic	B-T033
efficacy	I-T033
of	O
systemically	O
administered	O
gcpii	O
inhibitors	O
is	O
mediated	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
the	O
contralatera	O
l	O
locus	O
coeruleus	O
via	O
group	B-T116
ii	I-T116
mglur	I-T116
,	O
ampa	B-T116
and	O
alpha	B-T116
2	I-T116
adrenergic	I-T116
receptors	I-T116
.	O
	
association	B-T080
of	O
physical	O
activity	O
on	O
body	O
composition	O
,	O
cardiometabolic	B-T033
risk	I-T033
factors	I-T033
,	O
and	O
prevalence	B-T081
of	O
cardiovascular	B-T047
disease	I-T047
in	O
the	O
korean	O
population	O
from	O
the	O
fifth	O
korea	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
,	O
2008-2011	O
data	B-T078
regarding	O
associations	B-T080
among	O
physical	O
activity	O
pa	O
level	B-T080
,	O
body	O
composition	O
,	O
and	O
prevalence	B-T081
of	O
cardiovascular	B-T047
diseases	I-T047
in	O
asian	B-T081
populations	I-T081
are	O
rare	B-T080
.	O
	
the	O
international	O
physical	O
activity	O
questionnaire	O
ipaq	O
was	O
utilized	O
to	O
estimate	B-T081
pa	O
levels	B-T080
and	O
analyze	O
the	O
association	B-T080
of	O
pa	O
level	B-T080
with	O
various	O
body	O
composition	O
parameters	O
and	O
the	O
prevalence	B-T081
of	O
cardiovascular	B-T047
diseases	I-T047
by	O
using	O
data	B-T078
from	O
the	O
korean	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
from	O
2008	O
to	O
2011	O
.	O
	
moderate	B-T080
and	O
high	B-T080
pa	O
levels	B-T080
were	O
associated	B-T080
with	O
lower	B-T081
prevalence	I-T081
of	O
hypertension	B-T047
and	O
diabetes	B-T047
mellitus	I-T047
,	O
and	O
lower	B-T080
concentrations	B-T081
of	O
serum	B-T033
ferritin	I-T033
,	O
parathyroid	B-T033
hormone	I-T033
,	O
and	O
alkaline	B-T033
phosphatase	I-T033
.	O
	
sarcopenia	B-T047
low	B-T080
vs	O
.	O
	
moderate	B-T080
vs	O
.	O
	
high	B-T080
pa	O
group	B-T078
14.3	O
vs	O
.	O
	
10.5	O
vs	O
.	O
	
7.3	O
,	O
p	B-T081
=	O
0.001	O
,	O
underweight	B-T033
5.7	O
vs	O
.	O
	
4.9	O
vs	O
.	O
	
3.5	O
,	O
p	O
=	O
0.001	O
,	O
and	O
central	B-T033
obesity	I-T033
7.8	O
vs	O
.	O
	
6.9	O
vs	O
.	O
	
6.3	O
,	O
p	O
=	O
0.002	O
were	O
more	O
often	O
observed	B-T169
in	O
the	O
low	B-T080
pa	O
group	B-T078
.	O
	
the	O
prevalence	B-T081
rates	B-T081
of	O
cardiovascular	B-T047
diseases	I-T047
were	O
lower	B-T080
in	O
the	O
moderate	B-T080
odds	B-T081
ratio	I-T081
or	B-T081
,	O
0.822	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
,	O
0.737	O
p	B-T081
=	O
0.001	O
and	O
high	B-T080
activity	O
groups	B-T078
or	B-T081
,	O
0.663	O
95%	O
ci	B-T081
,	O
0.589	O
p	B-T081
=	O
0.001	O
than	O
in	O
the	O
low	B-T080
activity	O
group	B-T078
,	O
even	O
after	O
adjusting	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
,	O
underlying	B-T047
disease	I-T047
,	O
and	O
general	B-T047
or	O
abdominal	B-T033
obesity	I-T033
and	O
muscle	B-T033
mass	I-T033
.	O
	
regular	O
physical	O
activity	O
was	O
associated	B-T080
with	O
a	O
low	B-T081
prevalence	I-T081
of	O
cardiovascular	B-T047
diseases	I-T047
stroke	O
,	O
myocardial	B-T047
infarction	I-T047
,	O
stable	B-T047
angina	I-T047
,	O
and	O
chronic	B-T047
renal	I-T047
disease	I-T047
,	O
which	O
was	O
independent	B-T169
of	I-T169
body	O
composition	O
and	O
conventional	O
risk	B-T033
factors	I-T033
in	O
the	O
korean	O
population	O
,	O
with	O
a	O
positive	B-T033
dose-response	O
relationship	O
.	O
	
treated	B-T061
prevalence	B-T081
of	O
attention-deficit/hyperactivity	O
disorder	O
increased	B-T081
from	O
2009	O
to	O
2015	O
among	O
school-aged	O
children	O
and	O
adolescents	O
in	O
the	O
united	O
states	O
the	O
purpose	B-T169
of	O
this	O
brief	O
is	O
to	O
describe	B-T078
changes	B-T169
in	O
the	O
treated	B-T061
prevalence	B-T081
of	O
medically	B-T169
managed	O
attention-deficit/hyperactivity	O
disorder	O
adhd	O
among	O
insured	O
school-aged	O
children	O
and	O
adolescents	O
in	O
the	O
united	O
states	O
from	O
2009	O
to	O
2015	O
.	O
	
we	O
examine	B-T033
the	O
differences	B-T081
between	O
those	O
with	O
employer-sponsored	B-T081
insurance	I-T081
esi	B-T081
and	O
with	O
medicaid	O
insurance	O
.	O
	
we	O
utilized	O
two	O
large	O
longitudinal	O
administrative	O
datasets	O
containing	O
medical	B-T169
and	O
drug	O
claims	O
data	B-T078
on	O
individuals	O
with	O
esi	B-T081
and	O
medicaid	O
insurance	O
from	O
truven	O
health	O
marketscan	O
administrative	O
claims	O
databases	O
.	O
	
treated	B-T061
prevalence	B-T081
was	O
measured	B-T080
as	O
the	O
percentage	B-T081
of	O
school-aged	O
children	O
and	O
adolescents	O
enrolled	O
in	O
a	O
calendar	B-T079
year	I-T079
who	O
met	O
the	O
criteria	B-T078
for	O
medically	B-T169
managed	O
adhd	O
in	O
the	O
same	O
calendar	B-T079
year	I-T079
.	O
	
subjects	O
were	O
eligible	B-T080
for	O
inclusion	B-T080
if	O
they	O
were	O
aged	O
6-17	O
years	B-T079
and	O
were	O
continuously	B-T078
enrolled	O
during	O
a	O
calendar	B-T079
year	I-T079
.	O
	
the	O
annual	B-T079
prevalence	B-T081
of	O
treated	B-T061
adhd	O
among	O
school-aged	O
children	O
and	O
adolescents	O
with	O
esi	B-T081
increased	B-T081
from	O
4.5	O
in	O
2009	O
to	O
6.7	O
in	O
2015	O
.	O
	
among	O
those	O
with	O
medicaid	O
it	O
increased	B-T081
from	O
11.3	O
in	O
2009	O
to	O
13.3	O
in	O
2012	O
,	O
and	O
fell	O
after	O
2012	O
,	O
remaining	O
steady	B-T080
from	O
2013	O
through	O
2015	O
.	O
	
treated	B-T061
prevalence	B-T081
of	O
adhd	O
increased	B-T081
continuously	B-T078
over	O
time	B-T079
among	O
school-aged	O
children	O
and	O
adolescents	O
with	O
esi	B-T081
,	O
but	O
declined	B-T081
slightly	O
after	O
2012	O
among	O
those	O
in	O
the	O
medicaid	O
sample	O
.	O
	
acute	B-T079
macular	B-T047
edema	I-T047
and	O
peripapillary	O
soft	B-T080
exudate	O
after	O
pancreas	B-T061
transplantation	I-T061
with	O
accelerated	B-T169
progression	O
of	O
diabetic	B-T047
retinopathy	I-T047
the	O
effect	O
of	O
pancreas	B-T061
transplantation	I-T061
on	O
diabetic	B-T047
retinopathy	I-T047
remains	O
inconclusive	B-T080
.	O
	
herein	O
,	O
we	O
report	O
six	O
patients	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
mellitus	I-T047
dm	B-T047
who	O
underwent	O
pancreas	B-T061
transplantation	I-T061
and	O
developed	O
acute	B-T079
macular	B-T047
edema	I-T047
and	O
peripapillary	O
soft	B-T080
exudate	O
with	O
rapid	B-T080
progression	O
to	O
proliferative	B-T047
diabetic	I-T047
retinopathy	I-T047
.	O
	
in	O
this	O
retrospective	O
observational	O
study	O
,	O
diabetic	B-T047
patients	O
who	O
underwent	O
pancreas	B-T061
transplantation	I-T061
in	O
a	O
single	B-T081
medical	O
center	O
and	O
developed	O
symptomatic	B-T169
acute	B-T079
macular	B-T047
edema	I-T047
and	O
peripapillary	O
soft	B-T080
exudate	O
within	O
3	B-T079
months	I-T079
after	B-T079
the	O
operation	B-T061
were	O
enrolled	O
.	O
	
the	O
complete	B-T080
ophthalmic	B-T079
course	I-T079
and	O
medical	O
records	O
of	O
the	O
patients	O
were	O
retrospectively	B-T080
reviewed	B-T080
.	O
	
diabetic	B-T047
retinopathy	I-T047
and	O
progression	O
following	B-T079
treatment	B-T061
after	O
pancreas	B-T061
transplantation	I-T061
were	O
measured	B-T080
.	O
	
six	O
chinese	O
women	O
with	O
type	B-T047
1	I-T047
dm	I-T047
were	O
enrolled	O
in	O
this	O
study	O
.	O
	
mean	O
hemoglobin	B-T116
hb	I-T116
a1c	I-T116
was	O
13.4	O
prior	O
to	O
transplantation	B-T061
and	O
decreased	B-T081
rapidly	B-T080
to	O
6.5	O
within	O
2	B-T079
months	I-T079
postsurgery	B-T079
.	O
	
the	O
patients	O
had	O
no	B-T169
or	O
mild	B-T080
pretransplant	B-T169
diabetic	B-T047
retinopathy	I-T047
and	O
developed	O
acute	B-T079
symptomatic	B-T169
macular	B-T047
edema	I-T047
and	O
peripapillary	O
soft	B-T080
exudate	O
in	O
both	O
eyes	O
after	O
pancreas	B-T061
transplantation	I-T061
.	O
	
all	O
macular	B-T047
edema	I-T047
resolved	B-T033
either	O
with	O
or	O
without	B-T080
treatment	B-T061
.	O
	
five	O
cases	B-T169
progressed	O
to	O
proliferative	B-T047
diabetic	I-T047
retinopathy	I-T047
and	O
received	B-T080
panretinal	B-T061
photocoagulation	I-T061
.	O
	
diabetic	B-T047
retinopathy	I-T047
remained	O
stable	B-T080
in	O
all	B-T081
eyes	O
after	B-T079
treatment	B-T061
,	O
and	O
the	O
visual	B-T169
prognosis	B-T033
was	I-T033
good	I-T033
,	O
except	B-T169
in	O
one	B-T081
eye	O
that	O
had	O
macular	O
branch	B-T047
retinal	I-T047
artery	I-T047
occlusion	I-T047
with	O
foveal	O
involvement	B-T169
.	O
	
acute	B-T079
macular	B-T047
edema	I-T047
after	O
pancreas	B-T061
transplantation	I-T061
has	O
a	O
favorable	B-T080
treatment	B-T080
outcome	I-T080
despite	O
rapid	O
progression	O
to	O
proliferative	B-T047
diabetic	I-T047
retinopathy	I-T047
.	O
	
high	B-T080
pretransplant	B-T169
hba1c	B-T116
and	O
abrupt	B-T080
blood	B-T109
sugar	I-T109
normalization	B-T169
may	O
be	O
related	O
to	O
the	O
disease	O
course	O
.	O
	
anger	O
and	O
aggression	O
in	O
borderline	O
personality	O
disorder	O
and	O
attention	O
deficit	O
hyperactivity	O
disorder	O
-	O
does	O
stress	B-T033
matter	O
the	O
impact	B-T080
of	O
stress	B-T033
on	O
anger	O
and	O
aggression	O
in	O
borderline	O
personality	O
disorder	O
bpd	O
and	O
attention	O
deficit	O
hyperactivity	O
disorder	O
adhd	O
has	O
not	O
been	O
thoroughly	O
investigated	B-T169
.	O
	
the	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	B-T169
different	O
aspects	O
of	O
anger	O
and	O
aggression	O
in	O
patients	O
with	O
these	O
disorders	B-T047
.	O
	
twenty-nine	O
unmedicated	B-T033
female	O
bpd	O
patients	O
,	O
28	O
adhd	O
patients	O
and	O
30	O
healthy	B-T080
controls	I-T080
hc	B-T080
completed	O
self-reports	O
measuring	B-T080
trait	O
anger	O
,	O
aggression	O
and	O
emotion	O
regulation	O
capacities	O
.	O
	
a	O
modified	O
version	O
of	O
the	O
point	O
subtraction	O
aggression	O
paradigm	O
and	O
a	O
state	O
anger	O
measurement	O
were	O
applied	O
under	O
resting	B-T080
and	O
stress	B-T080
conditions	I-T080
.	O
	
stress	B-T033
was	O
induced	B-T169
by	O
the	O
mannheim	O
multicomponent	O
stress	O
test	O
mmst	O
.	O
	
both	O
patient	O
groups	O
scored	B-T081
significantly	O
higher	O
on	O
all	O
self-report	O
measures	B-T080
compared	O
to	O
hcs	B-T080
.	O
	
compared	O
to	O
adhd	O
patients	O
,	O
bpd	O
patients	O
reported	O
higher	O
trait	O
aggression	O
and	O
hostility	O
,	O
a	O
stronger	O
tendency	O
to	O
express	O
anger	O
when	O
provoked	O
and	O
to	O
direct	O
anger	O
inwardly	O
.	O
	
furthermore	O
,	O
bpd	O
patients	O
exhibited	O
higher	O
state	O
anger	O
than	O
hcs	B-T080
and	O
adhd	O
patients	O
under	O
both	O
conditions	O
and	O
showed	O
a	O
stress-dependent	B-T169
anger	O
increase	O
.	O
	
at	O
the	O
behavioral	O
level	O
,	O
no	O
significant	O
effects	O
were	O
found	O
.	O
	
in	O
bpd	O
patients	O
,	O
aggression	O
and	O
anger	O
were	O
positively	O
correlated	O
with	O
emotion	O
regulation	O
deficits	B-T080
.	O
	
our	O
findings	B-T033
suggest	O
a	O
significant	O
impact	B-T080
of	O
stress	B-T033
on	O
self-perceived	O
state	O
anger	O
in	O
bpd	O
patients	O
but	O
not	O
on	O
aggressive	O
behavior	O
towards	O
others	O
in	O
females	O
with	O
bpd	O
or	O
adhd	O
.	O
	
however	O
,	O
it	O
appears	O
to	O
be	O
pronounced	O
inwardly	O
directed	O
anger	O
which	O
is	O
of	O
clinical	B-T080
importance	B-T080
in	O
bpd	O
patients	O
.	O
	
interferon	O
gamma	O
and	O
interleukin	O
10	O
polymorphisms	O
in	O
chinese	O
children	O
with	O
hemophagocytic	B-T047
lymphohistiocytosis	I-T047
the	O
aim	O
of	O
the	O
study	O
is	O
to	O
investigate	B-T169
the	O
association	O
of	O
interferon	O
gamma	O
ifn-γ	O
and	O
interleukin-10	O
il-10	O
gene	O
single	O
nucleotide	O
polymorphisms	O
with	O
the	O
susceptibility	O
of	O
hemophagocytic	B-T047
lymphohistiocytosis	I-T047
hlh	B-T047
in	O
chinese	O
children	O
without	B-T033
known	I-T033
family	I-T033
history	I-T033
of	I-T033
hlh	B-T047
.	O
	
forty	O
children	O
with	O
hlh	B-T047
and	O
160	O
age	O
-	O
and	O
gender	O
-matched	O
healthy	B-T080
controls	I-T080
from	O
xuzhou	O
children's	O
hospital	O
were	O
enrolled	O
in	O
the	O
study	O
.	O
	
serum	O
ifn-γ	B-T116
and	O
il-10	B-T116
levels	O
were	O
measured	B-T080
by	O
enzyme	O
linked-immunosorbent	O
assay	O
.	O
	
polymorphisms	O
of	O
the	O
ifn-γ	O
gene	O
at	O
position	O
+874	O
and	O
+2109	O
,	O
and	O
il-10	O
at	O
position	O
-1082	O
were	O
analyzed	B-T033
by	O
allele	O
-	O
specific	B-T080
pcr	O
.	O
	
median	O
serum	O
concentrations	B-T081
of	O
ifn	B-T116
-γ	I-T116
and	O
il-10	B-T116
were	O
significantly	B-T081
higher	I-T081
in	O
children	O
with	O
hlh	B-T047
compared	O
to	O
healthy	B-T080
controls	I-T080
.	O
	
the	O
frequencies	B-T079
of	O
ifn-γ	O
+874	O
t/a	O
and	O
t/t	O
genotypes	O
,	O
as	O
well	O
as	O
t	O
allele	O
,	O
were	O
significantly	B-T081
higher	I-T081
in	O
the	O
hlh	B-T047
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
.	O
	
the	O
frequencies	B-T079
of	O
il-10	O
-1082	O
g/a	O
genotype	O
and	O
g	O
allele	O
were	O
significantly	B-T081
increased	I-T081
in	O
hlh	B-T047
patients	O
compared	O
with	O
healthy	B-T080
controls	I-T080
.	O
	
no	B-T033
significant	I-T033
difference	B-T033
was	O
found	O
in	O
the	O
distribution	B-T169
of	O
ifn-γ	O
+2109	O
g/a	O
genotypes	O
between	O
children	O
with	O
hlh	B-T047
and	O
controls	B-T080
.	O
	
this	O
study	O
presents	B-T033
preliminary	B-T079
evidence	B-T078
for	O
the	O
association	O
between	O
ifn	O
+874	O
t/a	O
,	O
t/t	O
,	O
il-10	O
-1082	O
a/g	O
genotypes	O
,	O
and	O
hlh	B-T047
susceptibility	O
in	O
chinese	O
children	O
with	O
data	B-T078
-driven	O
implementation	O
of	O
alarm	O
reduction	B-T080
interventions	B-T061
in	O
a	O
cardiovascular	O
surgical	O
icu	O
alarm	B-T033
fatigue	I-T033
in	O
the	O
icu	O
setting	O
has	O
been	O
well	O
documented	O
in	O
the	O
literature	O
.	O
	
the	O
icu's	O
high-intensity	O
environment	O
requires	O
staff's	O
vigilant	O
attention	O
,	O
and	O
distraction	O
from	O
false	B-T080
and	O
non-actionable	O
alarms	O
pulls	O
staff	O
away	O
from	O
important	O
tasks	O
,	O
creates	O
dissatisfaction	O
,	O
and	O
is	O
a	O
potential	O
patient	O
safety	O
risk	B-T078
if	O
alarms	O
are	O
missed	B-T080
or	O
ignored	B-T078
.	O
	
this	O
project	O
was	O
intended	O
to	O
improve	O
patient	O
safety	O
by	O
optimizing	O
alarm	O
systems	B-T169
in	O
a	O
cardiovascular	O
surgical	O
intensive	O
care	O
unit	O
cvsicu	O
.	O
	
specific	O
aims	O
were	O
to	O
examine	B-T033
nurses	O
'	O
attitudes	O
toward	O
clinical	B-T080
alarm	O
signals	O
,	O
assess	O
nurses	O
'	O
ability	O
to	O
discriminate	O
audible	O
alarm	O
signals	O
,	O
and	O
implement	O
a	O
bundled	O
set	O
of	O
best	B-T078
practices	I-T078
for	O
monitor	B-T033
alarm	I-T033
reduction	B-T080
without	O
undermining	O
patient	O
safety	O
.	O
	
cvsicu	O
nurses	O
completed	O
an	O
alarm	O
perception	O
survey	O
and	O
participated	O
in	O
alarm	O
discriminability	B-T169
testing	I-T169
.	O
	
nurse	O
survey	O
data	O
and	O
baseline	B-T081
monitor	O
alarm	O
data	B-T078
were	O
used	O
to	O
select	O
targeted	B-T169
alarm	O
reduction	B-T080
interventions	B-T061
,	O
which	O
were	O
progressively	O
phased	O
in	O
.	O
	
monitor	O
alarm	O
data	B-T078
and	O
cardiorespiratory	B-T033
event	I-T033
data	B-T078
were	O
trended	O
over	O
one	O
year	B-T079
.	O
	
five	O
of	O
the	O
most	O
frequent	O
cvsicu	O
monitor	B-T033
alarm	I-T033
types-	O
pulse	O
oximetry	O
,	O
heart	O
rate	O
,	O
systolic	B-T033
and	O
diastolic	B-T047
blood	I-T047
pressure	I-T047
,	O
pulse	O
oximetry	O
sensor	O
,	O
and	O
ventricular	B-T047
tachycardia	I-T047
>	O
2-were	O
targeted	B-T169
.	O
	
after	O
implementation	O
,	O
there	O
was	O
a	O
61%	O
reduction	B-T080
in	O
average	O
alarms	O
per	O
monitored	O
bed	O
and	O
a	O
downward	O
trend	O
in	O
cardiorespiratory	B-T033
events	I-T033
.	O
	
to	O
reduce	B-T080
alarm	B-T033
fatigue	I-T033
it	O
is	O
important	O
to	O
decrease	B-T081
alarm	O
burden	B-T078
through	O
targeted	B-T169
interventions	B-T061
.	O
	
methods	O
to	O
reduce	O
non-actionable	O
alarms	O
include	O
adding	O
short	O
delays	B-T079
to	O
allow	O
alarm	O
self-correction	B-T169
,	O
adjusting	O
default	O
alarm	O
threshold	B-T080
limits	B-T169
,	O
providing	O
alarm	O
notification	O
through	O
a	O
secondary	O
device	O
,	O
and	O
teaching	O
staff	O
to	O
optimize	O
alarm	O
settings	O
for	O
individual	O
patients	O
.	O
	
the	O
ncam1	O
gene	O
set	O
is	O
linked	O
to	O
depressive	O
symptoms	O
and	O
their	O
brain	O
structural	O
correlates	O
in	O
healthy	O
individuals	O
depressive	O
symptoms	O
exist	O
on	O
a	O
continuum	O
,	O
the	O
far	O
end	O
of	O
which	O
is	O
found	O
in	O
depressive	O
disorders	O
.	O
	
utilizing	O
the	O
continuous	O
spectrum	O
of	O
depressive	O
symptoms	O
may	O
therefore	O
contribute	O
to	O
the	O
understanding	O
of	O
the	O
biological	B-T033
underpinnings	I-T033
of	O
depression	O
.	O
	
gene	O
set	O
enrichment	O
analysis	O
gsea	O
is	O
an	O
important	O
tool	O
for	O
the	O
identification	O
of	O
gene	O
groups	O
linked	O
to	O
complex	O
traits	O
,	O
and	O
was	O
applied	O
in	O
the	O
present	O
study	O
on	O
genome-wide	O
association	O
study	O
gwas	O
data	B-T033
of	I-T033
depression	I-T033
scores	I-T033
and	O
their	O
brain-level	O
structural	O
correlates	O
in	O
healthy	O
young	O
individuals	O
.	O
	
on	O
symptom	B-T033
level	I-T033
i.e	O
.	O
	
depression	B-T033
scores	I-T033
,	O
robust	B-T080
enrichment	O
was	O
identified	O
for	O
two	O
gene	O
sets	O
ncam1	O
interactions	O
and	O
collagen	O
formation	O
.	O
	
depression	B-T033
scores	I-T033
were	O
also	O
associated	B-T080
with	I-T080
decreased	B-T081
fractional	O
anisotropy	O
fa	O
-	O
a	O
brain	O
white	O
matter	O
property	O
-	O
within	O
the	O
forceps	O
minor	O
and	O
the	O
left	O
superior	O
temporal	O
longitudinal	O
fasciculus	O
.	O
	
within	O
each	O
of	O
these	O
tracts	O
,	O
mean	O
fa	O
value	O
of	O
depression	B-T033
score	I-T033
-	O
associated	O
voxels	O
was	O
used	O
as	O
a	O
phenotype	O
in	O
a	O
subsequent	O
gsea	O
.	O
	
the	O
ncam1	O
interactions	O
gene	O
set	O
was	O
significantly	O
enriched	O
in	O
these	O
tracts	O
.	O
	
by	O
linking	O
the	O
ncam1	O
interactions	O
gene	O
set	O
to	O
depression	B-T033
scores	I-T033
and	O
their	O
structural	O
brain	O
correlates	O
in	O
healthy	O
participants	O
,	O
the	O
current	O
study	O
contributes	O
to	O
the	O
understanding	O
of	O
the	O
molecular	B-T033
underpinnings	I-T033
of	O
depressive	O
symptomatology	O
.	O
	
the	O
burden	O
of	O
hpv	O
-related	O
diseases	B-T047
in	O
italy	O
,	O
2001-12	O
human	B-T047
papillomavirus	I-T047
hpv	I-T047
infection	I-T047
is	O
the	O
main	O
cause	O
of	O
cervical	O
cancer	O
and	O
plays	O
a	O
relevant	O
role	O
in	O
the	O
development	B-T169
of	O
genital	B-T047
warts	I-T047
and	O
of	O
the	O
cancer	O
of	O
penis	O
and	O
anus	O
,	O
head	O
/	O
neck	O
,	O
oropharynx	O
and	O
genitourinary	O
system	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
is	O
the	O
evaluation	B-T169
of	O
hospitalizations	O
due	O
to	O
hpv-related	B-T047
pathologies	I-T047
in	O
2001-12	O
in	O
italy	O
.	O
	
the	O
national	O
hospital	O
discharge	O
forms	O
were	O
provided	O
by	O
the	O
ministry	O
of	O
health	O
.	O
	
the	O
hpv	O
-related	O
hospitalizations	O
were	O
identified	O
using	O
specific	O
diagnostic	B-T169
codes	O
,	O
accordingly	O
to	O
the	O
icd-9-cm	O
coding	O
system	O
.	O
	
the	O
proportion	O
of	O
hospitalizations	O
of	O
potentially	O
hpv-related	B-T047
pathologies	I-T047
,	O
obtained	O
from	O
the	O
literature	O
,	O
was	O
evaluated	B-T169
as	O
well	O
as	O
the	O
hospitalization	B-T081
rates	I-T081
hr	B-T081
and	O
their	O
trend	B-T079
over	O
time	B-T079
.	O
	
uterine	O
cervical	O
cancer	O
and	O
cin	O
iii	O
accounted	O
for	O
40%	O
of	O
hospitalizations	O
hr	B-T081
15.6	O
000	O
and	O
17.6	O
000	O
,	O
respectively	O
.	O
	
head	O
/	O
neck	O
and	O
oropharynx	O
pathologies	B-T169
accounted	O
for	O
24.5	O
of	O
cases	B-T169
hr	B-T081
16/100	O
000	O
and	O
3.9	O
000	O
,	O
in	O
males	O
and	O
females	O
,	O
respectively	O
,	O
followed	O
by	O
genital	B-T047
warts	I-T047
17.3	O
of	O
hospitalizations	O
hr	B-T081
7.5	O
000	O
in	O
males	O
and	O
8.52	O
000	O
in	O
females	O
,	O
anal	O
8.1	O
of	O
hospitalizations	O
,	O
genitourinary	O
7.7	O
and	O
penis	O
cancers	O
2.2	O
.	O
	
the	O
study	O
,	O
even	O
if	O
limited	O
to	O
the	O
evaluation	B-T169
of	O
hospitalizations	O
,	O
points	O
out	O
how	O
hpv-related	B-T047
pathologies	I-T047
continue	O
to	O
be	O
a	O
relevant	O
public	B-T078
health	I-T078
issue	B-T033
in	O
italy	O
with	O
a	O
high	O
impact	B-T080
on	O
the	O
discovery	O
of	O
potent	B-T080
and	O
selective	B-T080
kynurenine	B-T116
3-monooxygenase	I-T116
inhibitors	O
for	O
the	O
treatment	B-T061
of	O
acute	B-T047
pancreatitis	I-T047
a	O
series	B-T081
of	O
potent	B-T080
,	O
competitive	B-T080
and	O
highly	B-T080
selective	B-T080
kynurenine	B-T116
monooxygenase	I-T116
inhibitors	O
have	O
been	O
discovered	O
via	O
a	O
substrate	O
-based	O
approach	O
for	O
the	O
treatment	B-T061
of	O
acute	B-T047
pancreatitis	I-T047
.	O
	
the	O
lead	B-T169
compound	O
demonstrated	O
good	B-T080
cellular	O
potency	B-T080
and	O
clear	O
pharmacodynamic	O
activity	O
in	O
vivo	O
.	O
	
draft	O
genome	O
sequence	O
of	O
providencia	O
stuartii	O
ps71	O
,	O
a	O
multidrug-resistant	O
strain	O
associated	B-T080
with	I-T080
nosocomial	B-T047
infections	I-T047
in	O
greece	O
providencia	O
stuartii	O
is	O
frequently	B-T079
associated	B-T080
with	I-T080
nosocomial	B-T047
outbreaks	I-T047
and	O
displays	O
intrinsic	O
resistance	B-T169
to	O
many	O
commonly	B-T081
used	O
antimicrobials	O
.	O
	
we	O
report	O
here	O
the	O
draft	O
genome	O
sequence	O
of	O
a	O
p	O
.	O
	
stuartii	O
strain	O
carrying	O
acquired	B-T080
resistance	O
genes	O
conferring	O
panresistance	B-T169
to	O
cephalosporins	B-T109
blashv-5	O
and	O
blaveb-1	O
,	O
carbapenems	B-T109
blavim-1	O
,	O
and	O
aminoglycosides	B-T109
rmtb	O
involved	O
in	O
an	O
outbreak	O
in	O
greek	O
hospitals	O
.	O
	
impact	B-T080
of	O
diabetic	B-T047
ketoacidosis	I-T047
management	O
in	O
the	O
medical	O
intensive	O
care	O
unit	O
after	O
order	O
set	O
implementation	O
to	O
determine	O
the	O
rate	B-T081
of	O
compliance	O
to	O
the	O
2006	O
and	O
2009	O
ada	O
dka	O
guidelines	O
in	O
the	O
medical	O
intensive	O
care	O
unit	O
micu	O
at	O
a	O
large	O
academic	O
medical	O
centre	O
after	O
the	O
implementation	O
of	O
a	O
computerised	O
dka	O
order	O
set	O
and	O
protocol	B-T061
.	O
	
retrospective	B-T080
chart	O
review	O
of	O
adult	O
patients	O
with	O
dka	B-T047
admitted	O
to	O
the	O
micu	O
.	O
	
results	O
of	O
pre-order	O
set	O
pre	O
were	O
compared	O
to	O
those	O
of	O
data	O
post-order	O
set	O
post	O
.	O
	
the	O
primary	B-T169
outcome	I-T169
was	O
a	O
composite	O
administration	B-T061
of	O
intravenous	B-T061
fluid	I-T061
resuscitation	I-T061
in	O
the	O
first	O
24	O
h	O
,	O
insulin	B-T116
bolus	B-T061
and	O
initial	B-T079
insulin	B-T116
infusion	B-T079
rate	I-T079
.	O
	
twelve	O
of	O
60	O
patients	O
20%	O
in	O
the	O
pre	O
group	O
received	O
treatment	B-T061
compliant	B-T080
with	O
the	O
2006	O
guidelines	O
versus	O
14	O
of	O
55	O
patients	O
25.5	O
in	O
the	O
post	O
group	O
or	B-T081
1.22	O
95%	O
ci	B-T081
0.44	O
to	O
3.4	O
,	O
p	O
=	O
0.51	O
.	O
	
compliance	O
to	O
the	O
2009	O
guidelines	O
was	O
significantly	B-T081
higher	I-T081
in	O
the	O
post	O
group	O
31.7	O
versus	O
65.5	O
,	O
or	B-T081
4.44	O
95%	O
ci	B-T081
1.8	O
to	O
10.92	O
,	O
p	O
=	O
0.0004	O
.	O
	
compliance	O
for	O
individual	O
components	O
was	O
26.7	O
versus	O
70.9	O
for	O
fluid	B-T061
resuscitation	I-T061
p	O
=	O
0.0001	O
,	O
55%	O
versus	O
49.1	O
for	O
insulin	B-T116
bolus	B-T061
p	O
=	O
0.58	O
and	O
60%	O
versus	O
81.3	O
for	O
initial	B-T079
insulin	B-T116
infusion	B-T079
rate	I-T079
p	O
=	O
0.014	O
,	O
respectively	O
.	O
	
time	B-T079
to	O
dka	B-T047
resolution	O
was	O
decreased	B-T081
p	O
=	O
0.04	O
,	O
and	O
hypoglycaemia	B-T047
was	O
increased	B-T081
p	O
=	O
0.0022	O
.	O
	
implementation	O
of	O
a	O
computerised	O
dka	O
order	O
set	O
and	O
protocol	B-T061
was	O
associated	B-T080
with	I-T080
improved	B-T033
compliance	O
to	O
the	O
2009	O
ada	O
dka	O
guidelines	O
,	O
24-h	O
fluid	B-T061
resuscitation	I-T061
,	O
initial	B-T079
insulin	B-T116
infusion	B-T079
rate	I-T079
,	O
time	B-T079
to	O
dka	B-T047
resolution	O
and	O
appropriate	O
transition	O
to	O
subcutaneous	O
insulin	B-T116
.	O
	
however	O
,	O
patients	O
in	O
the	O
post	O
implementation	O
group	O
were	O
more	O
likely	O
to	O
exhibit	O
hypoglycaemia	B-T047
.	O
	
construction	O
of	O
an	O
acetylcholinesterase	B-T116
sensor	O
based	O
on	O
synthesized	O
paramagnetic	O
nanoparticles	O
,	O
a	O
simple	O
tool	O
for	O
neurotoxic	O
compounds	O
assay	O
magnetic	O
particles	O
mps	O
have	O
been	O
widely	O
used	O
in	O
biological	B-T169
applications	I-T169
in	O
recent	O
years	O
as	O
a	O
carrier	O
for	O
various	O
molecules	O
.	O
	
their	O
big	O
advantage	O
is	O
in	O
repeated	O
use	O
of	O
immobilized	O
molecules	O
including	O
enzymes	B-T116
.	O
	
acetylcholinesterase	B-T116
ache	B-T116
is	O
an	O
enzyme	B-T116
playing	O
crucial	O
role	O
in	O
neurotransmission	O
and	O
the	O
enzyme	B-T116
is	O
targeted	B-T169
by	O
various	O
molecules	O
like	O
alzheimer's	B-T047
drugs	O
,	O
pesticides	O
and	O
warfare	B-T109
agents	I-T109
.	O
	
in	O
this	O
work	O
,	O
an	O
electrochemical	O
biosensor	O
having	O
ache	B-T116
immobilized	B-T116
onto	O
mps	O
and	O
stabilized	B-T033
through	O
glutaraldehyde	B-T109
ga	I-T109
molecule	I-T109
was	O
proposed	O
for	O
assay	O
of	O
the	O
neurotoxic	O
compounds	O
.	O
	
the	O
prepared	O
nanoparticles	O
were	O
modified	B-T080
by	I-T080
pure	B-T116
ache	I-T116
and	O
they	O
were	O
used	O
for	O
the	O
measurement	B-T169
anti-alzheimer's	B-T033
drug	O
galantamine	B-T109
and	O
carbamate	B-T109
pesticide	I-T109
carbofuran	B-T109
with	O
limit	B-T078
of	O
detection	B-T033
1.5	O
µm	O
and	O
20	O
nm	O
,	O
respectively	O
.	O
	
all	O
measurements	B-T169
were	O
carried	O
out	O
using	O
screen-printed	O
sensor	O
with	O
carbon	O
working	O
,	O
silver	O
reference	O
,	O
and	O
carbon	O
auxiliary	O
electrode	O
.	O
	
standard	O
ellman's	O
assay	O
was	O
used	O
for	O
validation	O
measurement	B-T169
of	O
both	O
inhibitors	O
.	O
	
part	O
of	O
this	O
work	O
was	O
the	O
elimination	O
of	O
reversible	B-T169
inhibitors	O
represented	O
by	O
galantamine	B-T109
from	O
the	O
active	B-T169
site	I-T169
of	O
ache	B-T116
.	O
	
for	O
this	O
purpose	O
,	O
we	O
used	O
a	O
lower	O
ph	B-T081
to	O
get	O
the	O
original	B-T078
activity	O
of	O
ache	B-T116
after	O
inhibition	O
by	O
galantamine	B-T109
.	O
	
we	O
also	O
observed	B-T169
decarbamylation	O
of	O
the	O
ache	B-T116
-	O
carbofuran	B-T109
adduct	O
.	O
	
influence	O
of	O
organic	B-T109
solvents	I-T109
to	O
ache	B-T116
as	O
well	O
as	O
repeatability	O
of	O
measurement	B-T169
with	O
mps	O
with	O
ache	B-T116
alanine	B-T116
aminotransferase	I-T116
is	O
a	O
marker	O
of	O
lipotoxicity	B-T047
consequences	B-T169
and	O
hyperandrogenemia	B-T033
in	O
women	O
with	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
several	O
studies	O
have	O
reported	O
higher	O
levels	O
of	O
alanine	B-T116
aminotransferase	I-T116
alt	B-T116
in	O
women	O
with	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
pcos	B-T047
compared	O
with	O
control	O
subjects	O
.	O
	
plasma	O
alt	O
levels	O
are	O
considered	O
a	O
marker	O
of	O
hepatic	O
lipotoxicity	B-T047
because	O
of	O
their	O
significant	O
associations	O
with	O
different	O
hepatic	O
metabolic	O
dysfunctions	O
,	O
such	O
as	O
hepatic	B-T047
steatosis	I-T047
and	O
hepatic	O
insulin	O
resistance	O
.	O
	
retrospective	O
chart	O
review	O
aiming	O
to	O
assess	O
,	O
in	O
pcos	B-T047
women	O
,	O
the	O
relationship	O
between	O
alt	O
levels	O
and	O
measures	O
of	O
lipotoxicity	B-T047
consequences	B-T169
that	O
are	O
available	O
clinically	O
,	O
both	O
during	O
fasting	O
and	O
using	O
the	O
oral	O
glucose	O
tolerance	O
test	O
.	O
	
women	O
n	O
=	O
132	O
with	O
pcos	B-T047
,	O
were	O
in	O
average	O
27.9	O
years	B-T079
of	O
age	O
,	O
with	O
a	O
mean	O
body	O
mass	O
index	O
of	O
34.1	O
kg/m	O
and	O
49%	O
had	O
a	O
metabolic	B-T047
syndrome	I-T047
mets	B-T047
.	O
	
alt	O
levels	O
were	O
significantly	O
correlated	O
with	O
homeostatic	O
model	O
assessment	O
for	O
insulin	O
resistance	O
r	O
=	O
0.42	O
,	O
p	O
<	O
0.001	O
,	O
hdl-c	B-T109
r	O
=	O
-0	O
,	O
p	O
<	O
0.001	O
,	O
matsuda	O
index	O
-0	O
,	O
p	O
<	O
0.001	O
,	O
insulin	O
secretion-sensitivity	O
index-2	O
-0	O
,	O
p	O
=	O
0.043	O
,	O
and	O
free	B-T109
testosterone	I-T109
0.38	O
,	O
p	O
<	O
0.001	O
,	O
but	O
not	O
with	O
fasting	O
glucose	O
and	O
triglyceride	O
levels	O
.	O
	
alt	B-T116
cutoff	O
24	O
iu/l	O
was	O
associated	O
with	O
all	O
these	O
parameters	O
,	O
including	O
fasting	O
glucose	O
p	O
=	O
0.021	O
and	O
triglyceride	O
levels	O
p	O
=	O
0.041	O
,	O
and	O
detected	O
more	O
women	O
with	O
the	O
mets	B-T047
59.2	O
vs	O
.	O
	
36.1	O
,	O
p	O
=	O
0.008	O
and	O
whole-body	O
insulin	O
resistance	O
matsuda	O
index	O
<12	O
l	O
,	O
85.3	O
vs	O
.	O
	
51.9	O
,	O
p	O
=	O
0.004	O
.	O
	
plasma	O
alt	O
levels	O
seem	O
to	O
be	O
a	O
strong	O
predictor	B-T078
not	O
only	O
of	O
liver	O
lipotoxicity	B-T047
but	O
also	O
of	O
systemic	B-T047
lipotoxic	I-T047
consequences	B-T169
and	O
hyperandrogenemia	B-T033
in	O
women	O
with	O
pcos	B-T047
.	O
	
although	O
it	O
requires	O
validation	O
in	O
another	O
study	O
,	O
an	O
alt	B-T116
cutoff	O
of	O
24	O
iu/l	O
may	O
help	O
clinicians	O
identify	O
women	O
with	O
increased	O
metabolic	O
risks	O
.	O
	
opioid	B-T109
use	O
in	O
chronic	O
pain	O
patients	O
with	O
chronic	B-T047
kidney	I-T047
disease	I-T047
a	O
systematic	O
review	O
to	O
investigate	O
the	O
prevalence	B-T081
of	O
chronic	O
pain	O
and	O
opioid	B-T109
management	O
among	O
patients	O
with	O
chronic	B-T047
kidney	I-T047
disease	I-T047
ckd	B-T047
.	O
	
systematic	O
review	O
.	O
	
a	O
systematic	O
search	O
was	O
performed	O
,	O
including	O
citations	O
from	O
1960	O
to	O
may	O
2015	O
.	O
	
the	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	O
prevalence	B-T081
of	O
pain	O
type	B-T080
,	O
dose	B-T081
,	O
and	O
reason	O
for	O
opioid	B-T109
use	O
effectiveness	B-T080
of	O
pain	B-T061
control	I-T061
and	O
associated	O
adverse	O
effects	O
of	O
opioids	B-T109
in	O
ckd	B-T047
patients	O
.	O
	
twelve	O
of	O
131	O
articles	O
met	O
inclusion	B-T080
criteria	I-T080
.	O
	
there	O
were	O
no	O
randomized	O
controlled	O
trials	O
rct	O
evaluable	O
,	O
and	O
12	O
were	O
observational	O
studies	O
.	O
	
out	O
of	O
12	O
studies	O
,	O
four	O
were	O
of	O
high	B-T080
quality	B-T080
,	O
six	O
were	O
of	O
moderate	B-T081
quality	B-T080
,	O
and	O
the	O
remaining	O
two	O
were	O
low	B-T080
-	O
quality	B-T080
studies	O
.	O
	
the	O
studies	O
were	O
from	O
different	O
countries	O
with	O
sample	B-T081
size	I-T081
ranging	O
from	O
10	O
to	O
12	O
.	O
	
several	O
studies	O
showed	O
a	O
high	O
prevalence	B-T081
of	O
chronic	B-T079
uncontrolled	O
pain	O
.	O
	
the	O
effectiveness	O
of	O
different	O
categories	O
of	O
opioids	B-T109
,	O
dose	B-T081
,	O
duration	B-T081
,	O
and	O
commonly	O
prescribed	O
opioids	B-T109
varied	O
across	O
studies	O
.	O
	
based	O
on	O
a	O
systematic	O
review	O
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	B-T081
of	O
chronic	O
pain	O
among	O
patients	O
with	O
ckd	B-T047
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underprescription	O
of	O
analgesics	B-T109
or	O
opioids	B-T109
in	O
the	O
ckd	B-T047
population	B-T081
.	O
	
clinicians	O
are	O
in	O
need	O
of	O
additional	O
and	O
well-designed	O
randomized	O
control	O
trials	O
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	B-T109
therapy	B-T061
,	O
appropriate	O
opioid	B-T109
doses	B-T081
and	O
dosing	B-T081
intervals	B-T079
,	O
outcomes	O
with	O
adequacy	B-T080
of	O
symptom	B-T061
control	I-T061
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	O
side	O
effects	O
.	O
	
cognitive	O
impairment	O
in	O
first-episode	B-T079
drug-naïve	O
patients	O
with	O
schizophrenia	O
relationships	B-T080
with	O
serum	B-T081
concentrations	I-T081
of	O
brain-derived	B-T116
neurotrophic	I-T116
factor	I-T116
and	O
glial	B-T116
cell	I-T116
line-derived	I-T116
neurotrophic	I-T116
factor	I-T116
evidence	O
suggests	O
that	O
brain-derived	B-T116
neurotrophic	I-T116
factor	I-T116
bdnf	B-T116
and	O
glial	B-T116
cell	I-T116
line	I-T116
-derived	I-T116
neurotrophic	I-T116
factor	I-T116
gdnf	B-T116
are	O
important	O
in	O
the	O
regulation	O
of	O
synaptic	O
plasticity	O
,	O
which	O
plays	O
a	O
key	O
role	O
in	O
the	O
cognitive	O
processes	O
in	O
psychiatric	O
disorders	O
.	O
	
our	O
work	O
aimed	O
at	O
exploring	O
the	O
associations	B-T080
between	O
serum	O
bdnf	B-T116
and	O
gdnf	B-T116
levels	O
and	O
cognitive	O
functions	O
in	O
first-episode	O
drug-naïve	O
fedn	O
patients	O
with	O
schizophrenia	O
.	O
	
the	O
bdnf	B-T116
and	O
gdnf	B-T116
levels	O
of	O
58	O
fedn	O
patients	O
and	O
55	O
age	O
-	O
and	O
sex	O
-matched	O
healthy	B-T080
controls	I-T080
were	O
measured	O
and	O
test	O
subjects	O
were	O
examined	O
using	O
several	O
neurocognitive	O
tests	O
including	O
the	O
verbal	O
fluency	O
test	O
vft	O
,	O
the	O
trail	O
making	O
test	O
tmt	O
,	O
the	O
digit	O
span	O
test	O
dst	O
,	O
and	O
the	O
stroop	O
test	O
.	O
	
patients	O
performed	O
significantly	O
worse	O
than	O
controls	O
in	O
nearly	O
all	O
neurocognitive	O
performances	O
except	O
the	O
forward	O
subscale	O
part	O
of	O
the	O
dst	O
.	O
	
bdnf	B-T116
levels	B-T080
were	O
inversely	O
correlated	O
to	O
tmt-part	B-T080
b	I-T080
scores	I-T080
and	O
positively	O
correlated	O
to	O
vft-action	O
in	O
the	O
fedn	O
group	O
.	O
	
gdnf	B-T116
levels	B-T080
showed	O
a	O
positive	O
correlation	O
with	O
vft-action	B-T080
scores	I-T080
and	O
a	O
negative	O
correlation	O
with	O
tmt-part	B-T080
b	I-T080
scores	I-T080
of	O
these	O
patients	O
.	O
	
current	O
data	O
suggests	O
that	O
cognitive	O
dysfunction	O
widely	O
exists	O
in	O
the	O
early	B-T079
stages	I-T079
of	O
schizophrenia	O
.	O
	
bdnf	B-T116
and	O
gdnf	B-T116
may	O
be	O
jointly	O
contributed	O
to	O
the	O
pathological	B-T169
mechanisms	B-T169
involved	O
in	O
cognitive	O
impairment	O
in	O
fedn	O
patients	O
with	O
comprehensive	B-T080
functional	O
analysis	O
of	O
large	O
lists	O
of	O
genes	O
and	O
proteins	B-T116
the	O
interpretation	O
of	O
high	O
dimensional	O
datasets	O
resulting	O
from	O
genomic	O
and	O
proteomic	O
experiments	O
in	O
a	O
timely	O
and	O
efficient	O
manner	O
is	O
challenging	O
.	O
	
cluego	O
software	O
is	O
a	O
cytoscape	O
app	O
that	O
extracts	O
representative	O
functional	O
biological	B-T080
information	B-T078
for	O
large	O
lists	O
of	O
genes	O
or	O
proteins	B-T116
.	O
	
the	O
functional	O
enrichment	O
analysis	O
is	O
based	O
on	O
the	O
latest	O
publicly	O
available	O
data	B-T078
from	O
multiple	O
annotation	O
and	O
ontology	O
resources	B-T078
that	O
can	O
be	O
automatically	B-T169
accessed	O
through	O
cluego	O
.	O
	
predefined	O
settings	O
for	O
the	O
selection	O
of	O
the	O
terms	B-T078
are	O
provided	O
to	O
facilitate	O
the	O
analysis	O
.	O
	
results	B-T169
are	O
visualized	O
as	O
networks	B-T169
in	O
which	O
gene	O
ontology	O
go	O
terms	O
and	O
pathways	O
are	O
grouped	O
based	O
on	O
their	O
biological	O
role	O
.	O
	
many	O
species	O
are	O
now	O
supported	O
by	O
cluego	O
and	O
additional	O
organisms	O
are	O
added	O
on	O
demand	O
.	O
	
cluego	O
can	O
be	O
used	O
together	O
with	O
the	O
cluepedia	O
app	O
to	O
enable	O
the	O
visualization	O
of	O
protein-protein	O
interactions	O
within	O
or	O
between	O
management	B-T061
of	O
precipitated	O
opiate	O
withdrawal	O
syndrome	O
induced	B-T169
by	O
nalmefene	B-T109
mistakenly	O
prescribed	O
in	O
opiate	O
-	O
dependent	B-T169
patients	I-T169
a	O
review	O
for	O
clinicians	O
nalmefene	B-T109
,	O
a	O
long-acting	O
µ-opioid	O
antagonist	O
approved	B-T080
to	O
treat	B-T169
alcohol	O
use	O
disorder	O
,	O
is	O
occasionally	B-T079
mistakenly	O
prescribed	O
to	O
opiate	O
-	O
dependent	B-T169
or	O
opioid	B-T109
-	O
treated	B-T169
patients	O
.	O
	
we	O
review	B-T078
recent	O
literature	O
on	O
drug-drug	O
interactions	O
between	O
nalmefene	B-T109
and	O
opioids	B-T109
that	O
lead	O
to	O
precipitated	O
opioid	O
withdrawal	O
,	O
and	O
focus	O
on	O
its	O
management	B-T061
and	O
planning	B-T169
for	O
care	O
at	O
discharge	O
.	O
	
areas	O
covered	O
this	O
article	O
provides	O
a	O
brief	O
and	O
comprehensive	O
review	O
of	O
management	O
of	O
precipitated	O
opioid	O
withdrawal	O
syndrome	O
when	O
nalmefene	B-T109
is	O
associated	B-T080
with	I-T080
an	O
opioid	B-T109
,	O
whether	O
misused	B-T033
or	O
legally	B-T169
prescribed	O
.	O
	
expert	O
opinion	O
when	O
treating	B-T169
an	O
opiate	O
-	O
dependent	B-T169
patient	I-T169
with	O
co-occurring	O
alcohol	O
use	O
disorder	O
,	O
both	O
conditions	B-T080
need	O
to	O
be	O
a	O
focus	O
of	O
clinical	B-T080
attention	I-T080
.	O
	
new	B-T080
drugs	O
for	O
alcohol	O
use	O
disorder	O
have	O
been	O
approved	B-T080
,	O
but	O
must	O
be	O
given	O
cautiously	O
and	O
with	O
a	O
full	O
understanding	O
of	O
their	O
potential	B-T080
drug-drug	O
interactions	O
with	O
opioid	B-T109
medications	O
.	O
	
opiate	O
-	O
dependent	B-T169
patients	I-T169
should	O
be	O
intensively	O
monitored	O
for	O
risk	B-T033
factors	I-T033
of	O
alcohol	O
use	O
disorder	O
and	O
should	O
be	O
continuously	O
motivated	O
for	O
treatment	B-T061
maintenance	I-T061
.	O
	
when	O
nalmefene	B-T109
is	O
administered	O
to	O
opiate	O
-	O
dependent	B-T169
patients	I-T169
,	O
acute	B-T079
opioid	O
withdrawal	O
syndrome	O
may	O
occur	O
.	O
	
management	B-T061
of	O
precipitated	O
acute	B-T079
opioid	O
withdrawal	O
may	O
include	O
short	O
or	O
long-acting	O
µ-opioid	O
agonists	O
during	O
hospitalization	O
,	O
in	O
addition	O
to	O
supportive	B-T061
treatment	I-T061
.	O
	
the	O
best	O
management	O
of	O
polydrug	B-T033
abusers	I-T033
is	O
based	O
on	O
a	O
multidisciplinary	O
approach	O
,	O
which	O
should	O
be	O
pursued	O
and	O
improved	B-T033
through	B-T169
continuing	B-T078
medical	I-T078
education	I-T078
.	O
	
discovering	O
key	O
residues	O
of	O
dengue	O
virus	O
ns2b-ns3-protease	B-T116
new	O
binding	O
sites	O
for	O
antiviral	O
inhibitors	O
design	O
the	O
ns2b-ns3	B-T116
protease	I-T116
is	O
essential	O
for	O
the	O
dengue	O
virus	O
denv	O
replication	O
process	O
.	O
	
this	O
complex	O
constitutes	O
a	O
target	B-T169
for	O
efficient	O
antiviral	O
discovery	O
because	O
a	O
drug	O
could	O
inhibit	O
the	O
viral	O
polyprotein	O
processing	O
.	O
	
furthermore	O
,	O
since	O
the	O
protease	B-T116
is	O
highly	O
conserved	O
between	O
the	O
four	O
dengue	O
virus	O
serotypes	O
,	O
it	O
is	O
probable	O
that	O
a	O
drug	O
would	O
be	O
equally	O
effective	O
against	O
all	O
of	O
them	O
.	O
	
in	O
this	O
article	O
,	O
a	O
strategy	O
is	O
reported	O
that	O
allowed	O
us	O
to	O
identify	O
influential	B-T078
residues	O
on	O
the	O
function	O
of	O
the	O
dengue	O
ns2b-ns3	B-T116
protease	I-T116
.	O
	
moreover	O
,	O
this	O
is	O
a	O
strategy	O
that	O
could	O
be	O
applied	O
to	O
virtually	O
any	O
protein	B-T116
for	O
the	O
search	O
of	O
alternative	O
influential	B-T078
residues	O
,	O
and	O
for	O
non-competitive	O
inhibitor	O
development	B-T169
.	O
	
first	O
,	O
we	O
incorporated	O
several	O
features	O
derived	O
from	O
computational	O
alanine	B-T116
scanning	O
mutagenesis	O
,	O
sequence	O
,	O
structure	O
conservation	O
,	O
and	O
other	O
structure	O
-based	O
characteristics	B-T080
.	O
	
second	O
,	O
these	O
features	O
were	O
used	O
as	O
variables	O
to	O
obtain	O
a	O
multilayer	O
perceptron	O
model	O
to	O
identify	O
defined	O
groups	B-T078
clusters	O
of	O
key	O
residues	O
as	O
possible	O
candidate	O
pockets	O
for	O
binding	O
sites	O
of	O
new	O
leads	O
on	O
the	O
denv	O
protease	B-T116
.	O
	
the	O
identified	O
residues	O
included	O
i	O
amino	B-T116
acids	I-T116
close	O
to	O
the	O
beta	O
sheet	O
-loop-	O
beta	O
sheet	O
known	O
to	O
be	O
important	O
in	O
its	O
closed	O
conformation	O
for	O
ns2b	B-T116
ii	O
residues	O
close	O
to	O
the	O
active	B-T169
site	I-T169
,	O
iii	O
several	O
residues	O
evenly	O
spread	O
on	O
the	O
ns2b-ns3	B-T116
contact	O
surface	O
,	O
and	O
iv	O
some	O
inner	O
residues	O
most	O
likely	O
related	O
to	O
the	O
overall	O
stability	B-T080
of	O
the	O
protease	B-T116
.	O
	
in	O
addition	O
,	O
we	O
found	O
concordance	O
on	O
our	O
list	O
of	O
residues	O
with	O
previously	O
identified	O
amino	B-T116
acids	I-T116
part	O
of	O
a	O
highly	O
conserved	O
peptide	B-T116
studied	O
for	O
vaccine	O
development	O
.	O
	
association	B-T080
of	O
toll-like	B-T116
receptor	I-T116
4	I-T116
on	O
human	O
monocyte	O
subsets	O
and	O
vulnerability	B-T033
characteristics	B-T080
of	O
coronary	O
plaque	B-T033
as	O
assessed	O
by	O
64-slice	O
multidetector	O
computed	O
tomography	O
although	O
toll-like	B-T116
receptor	I-T116
4	I-T116
tlr-4	B-T116
is	O
involved	O
in	O
monocyte	O
activation	O
in	O
patients	O
with	O
accelerated	B-T169
forms	O
of	O
atherosclerosis	B-T047
,	O
the	O
relationship	B-T080
between	O
the	O
expression	O
of	O
tlr-4	B-T116
on	O
circulating	B-T169
monocyte	O
s	O
and	O
coronary	O
plaque	B-T033
vulnerability	B-T033
has	O
not	O
previously	O
been	O
evaluated	O
.	O
	
we	O
investigated	O
this	O
relationship	B-T080
using	O
64-slice	O
multidetector	O
computed	O
tomography	O
mdct	O
in	O
patients	O
with	O
stable	B-T047
angina	I-T047
pectoris	I-T047
sap	B-T047
and	O
results	O
enrolled	O
65	O
patients	O
with	O
sap	B-T047
who	O
underwent	O
mdct	O
.	O
	
three	O
monocyte	O
subsets	O
cd14	O
,	O
cd14	O
,	O
and	O
cd14	O
and	O
expression	O
of	O
tlr-4	B-T116
were	O
measured	O
by	O
flow	O
cytometry	O
.	O
	
intracoronary	O
plaques	B-T033
were	O
assessed	O
by	O
64-slice	O
mdct	O
.	O
	
we	O
defined	O
vulnerability	B-T033
of	O
intracoronary	O
plaques	B-T033
according	O
to	O
the	O
presence	O
of	O
positive	O
remodeling	O
remodeling	B-T033
index	I-T033
>1	O
and/or	O
low	O
ct	O
attenuation	B-T081
<35	O
hu	O
.	O
	
the	O
circulating	B-T169
cd14	O
more	O
frequently	O
expressed	O
tlr-4	B-T116
than	O
cd14	O
and	O
cd14	O
p<0	O
.	O
	
the	O
relative	O
proportion	O
of	O
the	O
expression	O
of	O
tlr-4	B-T116
on	O
cd14	O
was	O
significantly	O
greater	O
in	O
patients	O
with	O
vulnerable	B-T033
plaque	I-T033
compared	O
with	O
those	O
without	O
10.4	O
4.1	O
%	O
vs	O
.	O
	
4.5	O
2.8	O
%	O
,	O
p=0	O
.	O
	
in	O
addition	O
,	O
the	O
relative	O
proportion	O
of	O
tlr-4	B-T116
expression	O
on	O
cd14	O
positively	O
correlated	B-T080
with	O
the	O
remodeling	B-T033
index	I-T033
r=0	O
,	O
p=0	O
and	O
negatively	O
correlated	B-T080
with	O
ct	O
attenuation	B-T081
value	I-T081
r=-0	O
,	O
p=0	O
.	O
	
upregulation	O
of	O
tlr-4	B-T116
on	O
cd14	O
might	O
be	O
associated	B-T080
with	I-T080
coronary	O
plaque	B-T033
vulnerability	B-T033
in	O
patients	O
with	O
delta-frequency	B-T033
stimulation	O
of	O
cerebellar	O
projections	O
can	O
compensate	B-T080
for	O
schizophrenia	O
-related	O
medial	O
frontal	O
dysfunction	O
schizophrenia	O
involves	O
abnormalities	B-T033
in	O
the	O
medial	O
frontal	O
cortex	O
that	O
lead	O
to	O
cognitive	O
deficits	O
.	O
	
here	O
we	O
investigate	B-T169
a	O
novel	B-T080
strategy	O
to	O
normalize	O
medial	O
frontal	O
brain	O
activity	O
by	O
stimulating	O
cerebellar	O
projections	O
.	O
	
we	O
used	O
an	O
interval	B-T079
timing	I-T079
task	O
to	O
study	O
elementary	O
cognitive	O
processing	O
that	O
requires	O
both	O
frontal	O
and	O
cerebellar	O
networks	O
that	O
are	O
disrupted	B-T080
in	O
patients	O
with	O
schizophrenia	O
.	O
	
we	O
report	O
three	O
novel	B-T080
findings	B-T033
.	O
	
first	O
,	O
patients	O
with	O
schizophrenia	O
had	O
dysfunctional	O
delta	O
rhythms	O
between	O
1-4	O
hz	O
in	O
the	O
medial	O
frontal	O
cortex	O
.	O
	
we	O
explored	O
cerebellar	O
-	O
frontal	O
interactions	B-T169
in	O
animal	O
models	O
and	O
found	O
that	O
both	O
frontal	O
and	O
cerebellar	O
neurons	O
were	O
modulated	O
during	O
interval	B-T079
timing	I-T079
and	O
had	O
delta-frequency	B-T033
interactions	B-T169
.	O
	
finally	O
,	O
delta-frequency	B-T033
optogenetic	O
stimulation	O
of	O
thalamic	O
synaptic	O
terminals	O
of	O
lateral	O
cerebellar	O
projection	O
neurons	O
rescued	O
timing	O
performance	O
as	O
well	O
as	O
medial	O
frontal	O
activity	O
in	O
a	O
rodent	O
model	O
of	O
schizophrenia-related	O
frontal	O
dysfunction	O
.	O
	
these	O
data	B-T078
provide	O
insight	O
into	O
how	O
the	O
cerebellum	O
influences	O
medial	O
frontal	O
networks	O
and	O
the	O
role	O
of	O
the	O
cerebellum	O
in	O
cognitive	O
processing	O
.	O
	
variables	B-T080
associated	B-T080
with	I-T080
unplanned	B-T080
general	O
adult	O
icu	O
admission	O
in	O
hospitalised	O
patients	O
protocol	O
for	O
a	O
systematic	B-T169
review	B-T078
failure	B-T169
to	O
promptly	O
identify	B-T080
deterioration	O
in	O
hospitalised	O
patients	O
is	O
associated	B-T080
with	I-T080
delayed	B-T079
admission	O
to	O
intensive	O
care	O
units	O
icus	O
and	O
poor	B-T080
outcomes	B-T080
.	O
	
existing	O
vital	O
sign	O
-based	O
early	B-T081
warning	I-T081
score	I-T081
ews	B-T081
algorithms	O
do	O
not	O
have	O
a	O
sufficiently	B-T080
high	B-T080
positive	O
predictive	B-T080
value	I-T080
to	O
be	O
used	O
for	O
automated	B-T169
activation	O
of	O
an	O
icu	O
outreach	O
team	O
.	O
	
incorporating	B-T169
additional	O
patient	O
data	O
might	O
improve	B-T033
the	O
predictive	B-T080
power	B-T081
of	O
ews	B-T081
algorithms	O
however	O
,	O
it	O
is	O
currently	B-T079
not	O
known	O
which	O
patient	O
data	O
or	O
variables	B-T080
are	O
most	O
predictive	B-T080
of	O
icu	O
admission	O
.	O
	
we	O
describe	O
the	O
protocol	O
for	O
a	O
systematic	B-T169
review	B-T078
of	O
variables	B-T080
associated	B-T080
with	I-T080
icu	O
admission	O
.	O
	
medline	O
,	O
embase	O
,	O
cinahl	O
and	O
the	O
cochrane	O
library	O
,	O
including	B-T169
cochrane	O
database	O
of	O
systematic	O
reviews	O
and	O
the	O
cochrane	O
central	O
register	O
of	O
controlled	O
trials	O
central	O
will	O
be	O
searched	O
for	O
studies	O
that	O
assess	O
the	O
association	B-T080
of	O
routinely	B-T080
recorded	O
variables	B-T080
associated	B-T080
with	I-T080
subsequent	B-T079
unplanned	B-T080
icu	O
admission	O
.	O
	
only	O
studies	O
involving	B-T169
adult	O
patients	O
admitted	O
to	O
general	O
icus	O
will	O
be	O
included	B-T169
.	O
	
we	O
will	O
extract	B-T080
data	B-T078
relating	B-T080
to	I-T080
the	O
statistical	O
association	O
between	O
icu	O
admission	O
and	O
predictor	B-T078
variables	B-T080
,	O
the	O
quality	B-T080
of	O
the	O
studies	O
and	O
the	O
generalisability	O
of	O
the	O
findings	B-T033
.	O
	
the	O
results	B-T169
of	O
this	O
review	B-T078
will	O
aid	B-T080
the	O
development	B-T169
of	O
future	O
models	O
which	O
predict	B-T078
the	O
risk	B-T078
of	O
unplanned	B-T080
icu	O
admission	O
.	O
	
diagnosis	B-T033
of	O
retinal	O
health	B-T078
in	O
digital	O
fundus	O
images	O
using	O
continuous	O
wavelet	O
transform	O
cwt	O
and	O
entropies	O
vision	O
is	O
paramount	O
to	O
humans	O
to	O
lead	O
an	O
active	O
personal	O
and	O
professional	O
life	O
.	O
	
the	O
prevalence	B-T081
of	O
ocular	B-T047
diseases	I-T047
is	O
rising	O
,	O
and	O
diseases	B-T047
such	O
as	O
glaucoma	B-T047
,	O
diabetic	B-T047
retinopathy	I-T047
dr	B-T047
and	O
age-related	B-T047
macular	I-T047
degeneration	I-T047
amd	B-T047
are	O
the	O
leading	B-T169
causes	B-T169
of	O
blindness	B-T033
in	O
developed	B-T080
countries	I-T080
.	O
	
identifying	O
these	O
diseases	B-T047
in	O
mass	O
screening	O
programmes	O
is	O
time-consuming	B-T080
,	O
labor	O
-intensive	O
and	O
the	O
diagnosis	B-T033
can	O
be	O
subjective	B-T080
.	O
	
the	O
use	O
of	O
an	O
automated	O
computer	O
aided	O
diagnosis	O
system	O
will	O
reduce	O
the	O
time	O
taken	O
for	O
analysis	O
and	O
will	O
also	O
reduce	O
the	O
inter-observer	B-T081
subjective	I-T081
variabilities	I-T081
in	O
image	O
interpretation	O
.	O
	
in	O
this	O
work	O
,	O
we	O
propose	O
one	O
such	O
system	O
for	O
the	O
automatic	B-T169
classification	O
of	O
normal	B-T080
from	O
abnormal	B-T033
dr	B-T047
,	O
amd	B-T047
,	O
glaucoma	B-T047
images	O
.	O
	
we	O
had	O
a	O
total	O
of	O
404	O
normal	B-T080
and	O
1082	O
abnormal	B-T033
fundus	O
images	O
in	O
our	O
database	O
.	O
	
as	O
the	O
first	O
step	O
,	O
2d-continuous	O
wavelet	O
transform	O
cwt	O
decomposition	O
on	O
the	O
fundus	O
images	O
of	O
two	O
classes	O
was	O
performed	O
.	O
	
subsequently	O
,	O
energy	B-T081
features	O
and	O
various	O
entropies	O
namely	O
yager	O
,	O
renyi	O
,	O
kapoor	O
,	O
shannon	O
,	O
and	O
fuzzy	O
were	O
extracted	O
from	O
the	O
decomposed	O
images	O
.	O
	
then	O
,	O
adaptive	O
synthetic	O
sampling	O
approach	O
was	O
applied	O
to	O
balance	O
the	O
normal	B-T080
and	O
abnormal	B-T033
datasets	O
.	O
	
next	O
,	O
the	O
extracted	O
features	O
were	O
ranked	O
according	O
to	O
the	O
significances	O
using	O
particle	O
swarm	O
optimization	O
pso	O
.	O
	
thereupon	O
,	O
the	O
ranked	O
and	O
selected	O
features	O
were	O
used	O
to	O
train	O
the	O
random	O
forest	O
classifier	O
using	O
stratified	B-T080
10-fold	O
cross	O
validation	O
.	O
	
overall	O
,	O
the	O
proposed	O
system	O
presented	O
a	O
performance	B-T081
rate	I-T081
of	O
92.48	O
,	O
and	O
a	O
sensitivity	B-T081
and	O
specificity	B-T081
of	O
89.37	O
and	O
95.58	O
respectively	O
using	O
15	O
features	O
.	O
	
this	O
novel	O
system	O
shows	O
promise	O
in	O
detecting	O
abnormal	B-T033
fundus	O
images	O
,	O
and	O
hence	O
,	O
could	O
be	O
a	O
valuable	O
adjunct	O
eye	O
health	B-T078
screening	O
tool	O
that	O
could	O
be	O
employed	O
in	O
polyclinics	O
,	O
and	O
thereby	O
reduce	O
the	O
workload	B-T081
of	O
specialists	O
at	O
the	O
epigenetic	O
landscape	O
of	O
age	O
-	O
related	B-T169
diseases	B-T047
the	O
geroscience	O
perspective	B-T078
in	O
this	O
review	O
,	O
we	O
summarize	O
current	O
knowledge	O
regarding	O
the	O
epigenetics	O
of	O
age	O
-	O
related	B-T169
diseases	B-T047
,	O
focusing	O
on	O
those	O
studies	O
that	O
have	O
described	O
dna	O
methylation	O
landscape	O
in	O
cardio-vascular	B-T047
diseases	I-T047
,	O
musculoskeletal	O
function	O
and	O
frailty	B-T033
.	O
	
we	O
stress	O
the	O
importance	O
of	O
adopting	O
the	O
conceptual	O
framework	O
of	O
""""	O
geroscience	O
""""	O
,	O
which	O
starts	O
from	O
the	O
observation	O
that	O
advanced	O
age	O
is	O
the	O
major	O
risk	B-T033
factor	I-T033
for	O
several	O
of	O
these	O
pathologies	B-T169
and	O
aims	B-T078
at	O
identifying	O
the	O
mechanistic	B-T080
links	I-T080
between	O
aging	O
and	O
age	O
-	O
related	B-T169
diseases	B-T047
.	O
	
dna	O
methylation	O
undergoes	O
a	O
profound	O
remodeling	O
during	O
aging	O
,	O
which	O
includes	O
global	O
hypomethylation	O
of	O
the	O
genome	O
,	O
hypermethylation	O
at	O
specific	B-T080
loci	O
and	O
an	O
increase	B-T169
in	O
inter-individual	O
variation	O
and	O
in	O
stochastic	B-T081
changes	B-T169
of	O
dna	O
methylation	O
values	B-T080
.	O
	
these	O
epigenetic	O
modifications	B-T033
can	O
be	O
an	O
important	O
contributor	O
to	O
the	O
development	B-T169
of	O
age	O
-	O
related	B-T169
diseases	B-T047
,	O
but	O
our	O
understanding	O
on	O
the	O
complex	B-T080
relationship	B-T080
between	O
the	O
epigenetic	O
signatures	O
of	O
aging	O
and	O
age	O
-	O
related	B-T169
disease	B-T047
is	O
still	O
poor	O
.	O
	
the	O
most	O
relevant	B-T080
results	B-T033
in	O
this	O
field	O
come	O
from	O
the	O
use	O
of	O
the	O
so	O
called	O
""""	O
epigenetics	O
clocks	O
""""	O
in	O
cohorts	O
of	O
subjects	O
affected	B-T169
by	O
age	O
-	O
related	B-T169
diseases	B-T047
.	O
	
we	O
report	O
these	O
studies	O
in	O
final	O
section	O
of	O
this	O
beneficial	B-T080
effects	I-T080
of	O
phyllanthus	O
amarus	O
against	O
high	O
fructose	O
diet	O
induced	O
insulin	O
resistance	O
and	O
hepatic	O
oxidative	O
stress	O
in	O
male	O
wistar	O
rats	O
insulin	O
resistance	O
ir	O
is	O
a	O
characteristic	O
feature	O
of	O
obesity	B-T047
,	O
type	B-T047
2	I-T047
diabetes	I-T047
mellitus	I-T047
,	O
and	O
cardiovascular	B-T047
diseases	I-T047
.	O
	
emerging	O
evidence	O
suggests	O
that	O
the	O
high-fructose	B-T109
consumption	O
is	O
a	O
potential	B-T080
and	O
important	O
factor	B-T169
responsible	O
for	O
the	O
rising	B-T169
incidence	I-T169
of	O
ir	O
.	O
	
the	O
present	O
study	O
investigates	B-T169
the	O
beneficial	B-T080
effects	I-T080
of	O
aqueous	O
extract	O
of	O
phyllanthus	O
amaru	O
s	O
paae	O
on	O
ir	O
and	O
oxidative	O
stress	O
in	O
high-fructose	B-T109
hf	B-T109
fed	O
male	O
wistar	O
rats	O
.	O
	
hf	O
diet	O
66%	O
of	O
fructose	O
and	O
paae	O
200	O
mg/kg	O
body	O
weight/day	O
were	O
given	O
concurrently	B-T079
to	O
the	O
rats	O
for	O
a	O
period	O
of	O
60	O
days	O
.	O
	
fructose-fed	B-T080
rats	O
showed	O
weight	B-T033
gain	I-T033
,	O
hyperglycemia	B-T047
,	O
hyperinsulinemia	B-T047
,	O
impaired	B-T047
glucose	I-T047
tolerance	I-T047
,	O
impaired	O
insulin	O
sensitivity	O
,	O
dyslipidemia	B-T047
,	O
hyperleptinemia	B-T047
,	O
and	O
hypoadiponectinemia	B-T047
p	O
<	O
0.05	O
after	O
60	O
days	O
.	O
	
co-administration	B-T061
of	O
paae	O
along	O
with	O
hf	O
diet	O
significantly	O
ameliorated	O
all	O
these	O
alterations	B-T078
.	O
	
regarding	O
hepatic	O
antioxidant	O
status	O
,	O
higher	O
lipid	O
peroxidation	O
and	O
protein	O
oxidation	O
,	O
lower	O
reduced	O
glutathione	O
levels	O
and	O
lower	O
activities	O
of	O
enzymatic	O
antioxidants	O
,	O
and	O
the	O
histopathological	B-T169
changes	I-T169
like	O
mild	O
to	O
severe	O
distortion	B-T080
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	O
observed	O
in	O
the	O
hf	O
diet	O
-fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
paae	O
treatment	B-T061
.	O
	
these	O
findings	O
indicate	O
that	O
paae	O
is	O
beneficial	O
in	O
improving	O
insulin	O
sensitivity	O
and	O
attenuating	O
metabolic	B-T047
syndrome	I-T047
and	O
hepatic	O
oxidative	O
stress	O
in	O
fructose-fed	B-T080
rats	O
.	O
	
environmental	B-T169
factors	I-T169
and	O
hypertension	B-T047
environmental	B-T169
factors	I-T169
are	O
a	O
major	O
cause	O
of	O
poor	B-T033
health	I-T033
worldwide	O
.	O
	
the	O
most	O
solid	O
evidence	B-T078
is	O
for	O
air	O
pollution	O
,	O
leading	O
to	O
increased	O
disability-adjusted	O
life	O
years	O
.	O
	
outdoor	O
temperature	B-T081
and	O
other	O
seasonal	B-T079
climate	O
changes	O
may	O
also	O
influence	O
cardiovascular	O
health	B-T078
,	O
according	O
to	O
their	O
direct	O
modulation	O
of	O
air	O
pollution	O
.	O
	
moreover	O
,	O
an	O
increasing	O
body	O
of	O
evidence	B-T078
associates	O
environmental	O
exposure	O
to	O
noise	O
with	O
poor	B-T033
cardiovascular	I-T033
outcome	I-T033
,	O
and	O
in	O
particular	O
with	O
hypertension	B-T047
.	O
	
this	O
review	O
is	O
aimed	O
at	O
reviewing	O
current	O
evidence	B-T078
about	O
the	O
role	O
of	O
these	O
environmental	B-T169
factors	I-T169
in	O
cardiovascular	B-T047
disease	I-T047
and	O
specifically	O
hypertension	B-T047
.	O
	
in	O
particular	O
,	O
the	O
impact	B-T080
of	O
air	O
pollution	O
,	O
with	O
its	O
short-term	B-T079
and	O
long-term	O
effects	O
,	O
the	O
outdoor	O
temperature	B-T081
and	O
noise	O
pollution	O
will	O
be	O
investigated	O
.	O
	
people	O
belonging	O
to	O
low	B-T080
social	B-T080
classes	I-T080
,	O
as	O
well	O
as	O
children	O
,	O
women	O
,	O
older	O
people	O
and	O
those	O
with	O
established	O
cardiovascular	B-T047
diseases	I-T047
,	O
seem	O
to	O
have	O
a	O
greater	O
susceptibility	B-T169
to	O
the	O
effects	B-T080
of	O
environmental	B-T033
stressors	I-T033
,	O
recalling	O
the	O
concept	B-T078
of	O
""""	O
environmental	B-T078
justice	I-T078
""""	O
.	O
	
the	O
accumulating	O
strong	O
scientific	O
evidence	B-T078
may	O
thus	O
support	O
public	O
health	O
policies	O
aimed	O
at	O
reducing	O
social	B-T080
inequalities	I-T080
in	O
cardiovascular	O
health	B-T078
.	O
	
the	O
effects	B-T080
of	I-T080
probiotic	O
and	O
synbiotic	O
supplementation	B-T061
on	O
metabolic	B-T047
syndrome	I-T047
indices	B-T078
in	O
adults	O
at	O
risk	B-T078
of	O
type	B-T047
2	I-T047
diabetes	I-T047
study	O
protocol	O
for	O
a	O
randomized	O
controlled	O
trial	O
the	O
incidence	B-T081
of	O
type	B-T047
2	I-T047
diabetes	I-T047
,	O
cardiovascular	B-T047
diseases	I-T047
,	O
and	O
obesity	B-T047
has	O
been	O
rising	B-T169
dramatically	O
however	O
,	O
their	O
pathogenesis	O
is	O
particularly	O
intriguing	O
.	O
	
recently	O
,	O
dysbiosis	O
of	O
the	O
intestinal	O
microbiota	O
has	O
emerged	O
as	O
a	O
new	B-T080
candidate	B-T078
that	O
may	O
be	O
linked	O
to	O
metabolic	B-T047
diseases	I-T047
.	O
	
we	O
hypothesize	O
that	O
selective	O
modulation	O
of	O
the	O
intestinal	O
microbiota	O
by	O
probiotic	O
or	O
synbiotic	O
supplementation	B-T061
may	B-T080
improve	I-T080
metabolic	B-T047
dysfunction	I-T047
and	O
prevent	B-T080
diabetes	B-T047
in	O
prediabetics	B-T047
.	O
	
in	O
this	O
study	O
,	O
a	O
synthesis	O
and	O
study	O
of	O
synbiotics	O
will	O
be	O
carried	O
out	O
for	O
the	O
first	O
time	O
in	O
iran	O
.	O
	
in	O
a	O
randomized	O
triple-blind	O
controlled	O
clinical	O
trial	O
,	O
120	O
adults	O
with	O
impaired	B-T047
glucose	I-T047
tolerance	I-T047
based	O
on	O
the	O
inclusion	B-T080
criteria	I-T080
will	O
be	O
selected	O
by	O
a	O
simple	O
random	B-T080
sampling	O
method	O
and	O
will	O
be	O
randomly	B-T080
allocated	O
to	O
6	O
months	B-T079
of	O
6	O
g/d	O
probiotic	O
,	O
synbiotic	O
or	O
placebo	O
.	O
	
the	O
fecal	O
abundance	B-T080
of	O
bacteria	O
,	O
blood	O
pressure	O
,	O
height	O
,	O
weight	O
,	O
and	O
waist	O
and	O
hip	O
circumferences	O
will	O
be	O
measured	B-T080
at	O
baseline	B-T081
and	O
following	B-T079
treatment	B-T061
.	O
	
also	O
,	O
plasma	O
lipid	O
profiles	O
,	O
hba1c	B-T116
,	O
fasting	O
plasma	O
glucose	O
,	O
and	O
insulin	B-T116
levels	B-T080
,	O
will	O
be	O
measured	B-T080
and	O
insulin	O
resistance	O
homa-ir	O
and	O
beta-cell	O
function	O
homa-b	O
will	O
be	O
calculated	O
at	O
baseline	B-T081
and	O
will	O
be	O
repeated	B-T169
at	O
months	B-T079
3	O
,	O
6	O
,	O
12	O
,	O
and	O
18	O
.	O
	
the	O
data	B-T078
will	O
be	O
compared	O
within	O
and	O
between	O
groups	O
using	B-T169
statistical	O
methods	O
.	O
	
the	O
results	B-T169
of	O
this	O
trial	O
could	O
contribute	O
to	O
the	O
evidence-based	O
clinical	O
guidelines	O
that	O
address	O
gut	O
microbiota	O
manipulation	B-T061
to	O
maximize	B-T169
health	B-T081
benefits	I-T081
in	O
prevention	B-T061
and	O
management	O
of	O
metabolic	B-T047
syndrome	I-T047
in	O
prediabetes	B-T047
.	O
	
iranian	O
registry	O
of	O
clinical	O
trials	O
irct201511032321n2	O
.	O
	
evaluation	O
of	O
the	O
relationship	B-T080
between	O
the	O
static	B-T080
measurement	B-T169
of	O
transverse	O
arch	O
flexibility	B-T080
of	O
the	O
forefoot	O
and	O
gait	B-T033
parameters	O
in	O
healthy	O
subjects	O
purpose	O
to	O
investigate	B-T169
the	O
relationship	B-T080
between	O
the	O
static	B-T080
measurement	B-T169
of	O
the	O
transverse	O
arch	O
of	O
the	O
forefoot	O
,	O
using	O
a	O
3-dimensional	O
3d	O
foot	O
scanner	O
,	O
and	O
kinetics	O
and	O
kinematics	O
of	O
gait	B-T033
parameters	O
in	O
the	O
sagittal	O
plane	O
.	O
	
subjects	O
and	O
methods	O
twenty	O
healthy	O
subjects	O
participated	O
in	O
this	O
study	O
.	O
	
the	O
transverse	O
arch	O
of	O
the	O
forefoot	O
was	O
measured	B-T080
under	O
three	O
conditions	B-T080
as	O
follows	O
condition	B-T080
1	O
,	O
sitting	B-T033
condition	B-T080
2	O
,	O
standing	O
and	O
condition	B-T080
3	O
,	O
foot	O
forward	O
and	O
lower	O
leg	O
tilting	B-T080
anteriorly	O
to	O
the	O
maximum	B-T081
position	O
with	O
heel	O
contact	B-T169
.	O
	
gait	B-T033
parameters	O
were	O
recorded	B-T081
using	O
a	O
3d	O
motion	O
analysis	O
system	O
and	O
force	O
plate	O
.	O
	
correlation	B-T080
coefficients	B-T081
between	O
taf	B-T080
for	O
each	O
comparison	O
of	O
conditions	B-T080
and	O
gait	B-T033
parameters	O
were	O
calculated	O
using	O
the	O
spearman	O
correlation	O
analysis	O
.	O
	
results	B-T169
rates	B-T081
of	O
the	O
transverse	O
arch	O
of	O
the	O
forefoot	O
width	B-T081
and	O
height	O
between	O
condition	B-T080
2	O
and	O
condition	B-T080
3	O
were	O
significantly	B-T080
correlated	I-T080
with	O
the	O
anterior	O
and	O
posterior	O
component	O
of	O
ground	O
reaction	O
forces	O
,	O
the	O
hip	O
joint	O
extension	B-T169
angle	O
,	O
and	O
the	O
ankle	O
plantar	O
flexion	O
moment	O
.	O
	
conclusion	B-T078
our	O
study's	O
findings	B-T033
indicated	B-T033
that	O
increased	B-T081
stiffness	O
of	O
the	O
transverse	O
arch	O
of	O
the	O
forefoot	O
was	O
related	B-T080
to	O
the	O
increase	B-T169
in	O
ankle	O
plantar	O
moment	O
,	O
and	O
decreased	B-T081
stiffness	O
of	O
the	O
transverse	O
arch	O
of	O
the	O
forefoot	O
was	O
related	B-T080
to	O
the	O
increase	B-T169
in	O
hip	O
joint	O
extension	B-T169
angle	O
during	O
management	O
and	O
case	O
outcome	O
of	O
gastric	O
impaction	O
in	O
four	O
raptors	O
a	O
case	O
series	O
four	O
captive	O
raptors	O
,	O
an	O
american	O
kestrel	O
falco	O
sparverius	O
,	O
peregrine	O
falcon	O
falco	O
peregrinus	O
,	O
golden	O
eagle	O
aquila	O
chrysaetos	O
,	O
and	O
barn	O
owl	O
tyto	O
alba	O
,	O
were	O
diagnosed	B-T033
with	O
ventricular	O
and/or	O
proventricular	O
foreign	O
material	O
impactions	O
consisting	O
of	O
artificial	O
turf	O
substrate	O
,	O
paper	O
and	O
plastic	O
substrate	O
,	O
grass	O
,	O
and	O
newspaper	O
.	O
	
partial	B-T047
or	I-T047
total	I-T047
anorexia	I-T047
was	O
reported	O
in	O
all	O
birds	O
and	O
decreased	B-T081
casting	B-T061
in	O
2	O
birds	O
.	O
	
survey	O
radiographs	O
confirmed	O
presence	O
of	O
gastric	O
enlargement	B-T061
in	O
all	O
4	O
birds	O
.	O
	
the	O
kestrel	O
and	O
eagle	O
were	O
treated	B-T169
unsuccessfully	O
with	O
gastroscopy	O
and	O
gastric	B-T061
lavage	I-T061
,	O
respectively	O
,	O
followed	O
by	O
surgical	B-T033
intervention	I-T033
to	O
remove	O
the	O
ventricular	O
impactions	O
.	O
	
both	O
birds	O
died	B-T033
of	I-T033
undetermined	I-T033
causes	I-T033
after	B-T079
surgery	I-T079
.	O
	
the	O
peregrine	O
falcon	O
died	B-T033
before	B-T061
medical	I-T061
or	O
surgical	B-T033
intervention	I-T033
was	O
started	O
,	O
and	O
the	O
owl	O
was	O
managed	O
successfully	O
with	O
oral	O
mineral	O
oil	O
and	O
liquid	B-T061
diet	I-T061
to	O
facilitate	O
egestion	O
of	O
the	O
foreign	O
material	O
as	O
a	O
pellet	B-T081
.	O
	
lead	O
poisoning	O
was	O
suspected	O
as	O
the	O
predisposing	B-T079
cause	I-T079
for	O
foreign	O
body	O
ingestion	O
in	O
the	O
eagle	O
,	O
but	O
underlying	B-T169
causes	I-T169
for	O
pica	O
in	O
the	O
other	O
birds	O
were	O
not	B-T080
determined	I-T080
.	O
	
radiographs	O
can	O
provide	O
useful	O
diagnostic	O
information	O
in	O
sick	O
raptors	O
that	O
exhibit	O
vomiting	O
or	O
changes	B-T033
in	I-T033
appetite	I-T033
or	O
casting	B-T061
frequency	I-T061
,	O
and	O
may	O
help	O
guide	O
treatment	B-T061
decisions	I-T061
of	O
impacted	B-T169
birds	O
.	O
	
careful	O
consideration	B-T033
of	O
substrate	O
,	O
enrichment	O
items	O
,	O
and	O
access	O
to	O
potential	B-T080
foreign	O
material	O
that	O
could	O
be	O
ingested	O
may	O
be	O
the	O
best	O
pre-emptive	O
management	O
strategy	O
in	O
captive	O
anti-inflammatory	B-T033
activity	O
of	O
elaeagnus	O
angustifolia	O
fruit	B-T109
extract	I-T109
on	O
rat	O
paw	O
edema	O
the	O
elaeagnus	O
angustifolia	O
fruit	O
has	O
been	O
traditionally	O
used	O
in	O
iranian	O
herbal	O
medicine	O
to	O
treat	B-T169
diarrhea	O
and	O
rheumatoid	B-T047
arthritis	I-T047
.	O
	
in	O
the	O
present	O
study	O
,	O
the	O
effects	B-T080
of	O
e	O
.	O
	
angustifolia	O
fruit	B-T109
extract	I-T109
on	O
the	O
acute	B-T079
and	O
chronic	B-T079
phases	I-T079
of	O
formalin	B-T109
-	O
induced	B-T169
rat	O
paw	O
edema	O
were	O
examined	B-T033
.	O
	
the	O
acute	B-T079
and	O
chronic	B-T079
anti-inflammatory	B-T033
effects	I-T033
of	O
e	O
.	O
	
angustifolia	O
fruit	B-T109
extract	I-T109
were	O
investigated	B-T169
through	O
the	O
subcutaneous	B-T169
injection	I-T169
of	O
100	O
μl	O
of	O
formalin	B-T109
2.5	O
into	O
a	O
rat's	O
hind	O
paw	O
.	O
	
thirty	B-T079
minutes	I-T079
before	O
the	O
procedure	B-T169
,	O
the	O
experimental	B-T080
groups	B-T078
were	O
treated	B-T169
intraperitoneally	O
with	O
hydroalcoholic	B-T109
fruit	I-T109
extracts	I-T109
of	O
e	O
.	O
	
angustifolia	O
concentrations	B-T081
of	O
100	O
,	O
300	O
,	O
700	O
,	O
and	O
1000	O
mg/kg	O
sodium	B-T109
salicylate	I-T109
ss	B-T109
,	O
400	O
mg/kg	O
and	O
distilled	O
water	O
were	O
used	O
as	O
positive	B-T033
and	O
negative	B-T033
control	O
groups	O
,	O
respectively	O
.	O
	
treatment	B-T169
with	O
ss	B-T109
and	O
the	O
fruit	B-T109
extracts	I-T109
were	O
performed	B-T169
daily	B-T079
for	O
8	O
days	B-T079
,	O
and	O
the	O
degree	B-T081
of	O
edema	O
was	O
measured	B-T080
by	O
using	O
mercury	O
plethysmometer	O
and	O
digital	O
caliper	O
.	O
	
in	O
the	O
acute	B-T079
anti-inflammatory	B-T033
study	O
,	O
the	O
extract	O
showed	O
a	O
significant	O
anti-inflammatory	B-T080
effect	I-T080
in	O
a	O
dose-dependent	B-T081
manner	O
.	O
	
the	O
results	B-T169
of	O
1000	O
mg/kg	O
of	O
the	O
extract	O
was	O
significantly	O
different	B-T080
compared	O
with	O
the	O
negative	B-T033
control	O
group	O
p<0	O
and	O
was	O
comparable	O
to	O
sodium	B-T109
salicylate	I-T109
p<0	O
.	O
	
results	B-T169
from	O
the	O
chronic	B-T079
study	O
suggested	B-T078
that	O
e	O
.	O
	
angustifolia	O
extract	O
significantly	O
reduced	B-T080
paw	O
edema	O
and	O
inflammation	O
in	O
a	O
dose-dependent	B-T081
manner	O
.	O
	
the	O
results	B-T169
also	O
showed	O
that	O
the	O
measurement	B-T169
by	O
digital	O
caliper	O
and	O
mercury	O
plethysmometer	O
were	O
both	O
reliable	O
and	O
might	O
be	O
applied	O
interchangeably	O
p<0	O
.	O
	
phytochemical	O
tests	O
indicated	O
that	O
the	O
hydroalcoholic	B-T109
fruit	I-T109
extract	I-T109
of	O
e	O
.	O
	
angustifolia	O
was	O
positive	B-T033
for	O
cardiac	B-T109
glycosides	I-T109
,	O
flavonoids	B-T109
,	O
terpenoids	B-T109
,	O
and	O
saponins	B-T109
.	O
	
based	O
on	O
our	O
findings	B-T033
,	O
the	O
e	O
.	O
	
angustifolia	O
fruit	B-T109
extract	I-T109
probably	O
has	O
acute	B-T079
and	O
chronic	B-T079
anti-inflammatory	B-T033
activities	O
to	O
support	O
its	O
applications	O
in	O
folk	B-T061
medicine	I-T061
.	O
	
increased	B-T081
cerebral	O
blood	O
volume	O
pulsatility	B-T080
during	O
head-down	O
tilt	O
with	O
elevated	B-T033
carbon	I-T033
dioxide	I-T033
the	O
spacecot	O
study	O
astronauts	O
aboard	O
the	O
international	O
space	O
station	O
iss	O
have	O
exhibited	O
hyperopic	O
shifts	O
,	O
posterior	O
eye	O
globe	O
flattening	O
,	O
dilated	O
optic	O
nerve	O
sheaths	O
,	O
and	O
even	O
optic	O
disc	O
swelling	O
from	O
spaceflight	O
.	O
	
elevated	O
intracranial	O
pressure	O
icp	O
consequent	O
to	O
cephalad	O
fluid	O
shifts	O
is	O
commonly	O
hypothesized	O
as	O
contributing	O
to	O
these	O
ocular	O
changes	O
.	O
	
head-down	O
tilt	O
hdt	O
is	O
frequently	O
utilized	O
as	O
an	O
earth	O
-based	O
analog	O
to	O
study	O
similar	O
fluid	O
shifts	O
.	O
	
sealed	O
environments	O
like	O
the	O
iss	O
also	O
exhibit	O
elevated	B-T033
carbon	I-T033
dioxide	I-T033
co2	O
,	O
a	O
potent	O
arteriolar	O
vasodilator	O
that	O
could	O
further	O
affect	O
cerebral	O
blood	O
volume	O
and	O
flow	O
,	O
intracranial	O
compliance	O
,	O
and	O
icp	O
.	O
	
a	O
collaborative	O
pilot	O
study	O
between	O
the	O
national	O
space	O
biomedical	O
research	O
institute	O
and	O
the	O
german	O
aerospace	O
center	O
tested	O
the	O
hypotheses	O
that	O
1	O
hdt	O
and	O
elevated	O
co2	O
physiologically	O
interact	O
,	O
and	O
2	O
cerebrovascular	O
pulsatility	O
is	O
related	O
to	O
hdt	O
and/or	O
elevated	O
co2	O
in	O
a	O
double-blind	O
crossover	O
study	O
n=6	O
,	O
we	O
measured	O
cerebral	O
blood	O
volume	O
cbv	O
pulsatility	O
via	O
near-infrared	O
spectroscopy	O
,	O
alongside	O
non-invasive	O
icp	O
and	O
intraocular	O
pressure	O
iop	O
during	O
28-hr	O
-12	O
hdt	O
at	O
both	O
nominal	O
0.04	O
and	O
elevated	O
0.5	O
ambient	O
co2	O
in	O
our	O
cohort	O
,	O
cbv	O
pulsatility	O
increased	O
significantly	O
over	O
time	O
at	O
cardiac	O
frequencies	O
0.031	O
μm/hr	O
increase	O
in	O
hbt	O
pulsatility	O
amplitude	O
and	O
mayer	O
wave	O
frequencies	O
0.019	O
μm/hr	O
increase	O
.	O
	
the	O
hdt	O
-	O
co2	O
interaction	O
on	O
pulsatility	O
was	O
not	O
robust	O
,	O
but	O
rather	O
driven	O
by	O
an	O
individual	O
.	O
	
significant	O
differences	O
between	O
atmospheres	O
were	O
not	O
detected	O
in	O
icp	O
or	O
iop	O
.	O
	
further	O
work	O
is	O
needed	O
to	O
reproduce	O
these	O
findings	O
in	O
a	O
larger	O
cohort	O
,	O
to	O
determine	O
whether	O
a	O
"""water"	O
"hammer"""	O
effect	O
in	O
cerebral	O
pulsatility	O
is	O
also	O
present	O
during	O
spaceflight	O
,	O
and	O
whether	O
it	O
is	O
associated	O
with	O
ocular	O
changes	O
in	O
astronauts	O
shift	O
work	O
is	O
associated	B-T080
with	I-T080
metabolic	B-T047
syndrome	I-T047
in	O
young	B-T079
female	O
korean	O
workers	O
shift	O
work	O
is	O
associated	B-T080
with	I-T080
health	B-T078
problems	I-T078
,	O
including	O
metabolic	B-T047
syndrome	I-T047
.	O
	
this	O
study	O
investigated	O
the	O
association	B-T080
between	O
shift	O
work	O
and	O
metabolic	B-T047
syndrome	I-T047
in	O
young	B-T079
workers	O
.	O
	
a	O
total	O
of	O
3	O
subjects	O
aged	O
20-40	O
years	O
enrolled	O
in	O
the	O
2011-2012	O
korean	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
were	O
divided	O
into	O
shift	B-T033
and	O
day	B-T033
workers	I-T033
.	O
	
we	O
conducted	O
a	O
cross-sectional	O
study	O
and	O
calculated	B-T169
odds	B-T081
ratios	I-T081
using	O
multivariate	B-T081
logistic	O
regression	O
analysis	O
in	O
order	O
to	O
examine	B-T033
the	O
association	B-T080
between	O
shift	O
work	O
and	O
metabolic	B-T047
syndrome	I-T047
.	O
	
the	O
prevalence	B-T081
of	O
metabolic	B-T047
syndrome	I-T047
was	O
14.3	O
and	O
7.1	O
among	O
male	O
and	O
female	O
shift	B-T033
workers	I-T033
,	O
respectively	O
.	O
	
after	O
adjusting	O
for	O
confounding	B-T169
factors	I-T169
,	O
shift	O
work	O
was	O
associated	B-T080
with	I-T080
metabolic	B-T047
syndrome	I-T047
in	O
female	O
workers	O
odds	B-T081
ratio	I-T081
,	O
2.53	O
95%	O
confidence	B-T081
interval	I-T081
,	O
1.12	O
to	O
5.70	O
.	O
	
shift	O
work	O
was	O
associated	B-T080
with	I-T080
metabolic	B-T047
syndrome	I-T047
in	O
young	B-T079
women	O
.	O
	
timely	O
efforts	O
are	O
necessary	O
to	O
manage	O
metabolic	B-T047
syndrome	I-T047
in	O
the	O
in	B-T080
vitro	I-T080
differentiation	O
of	O
human	O
pluripotent	O
stem	O
cells	O
into	O
trophoblastic	O
cells	O
the	O
placenta	O
is	O
the	O
first	O
organ	O
to	O
develop	O
during	O
embryogenesis	O
and	O
is	O
required	O
for	O
the	O
survival	O
of	O
the	O
developing	O
embryo	O
.	O
	
the	O
placenta	O
is	O
comprised	O
of	O
various	O
trophoblastic	O
cells	O
that	O
differentiate	O
from	O
the	O
extra-embryonic	O
trophectoderm	O
cells	O
of	O
the	O
preimplantation	O
blastocyst	O
.	O
	
as	O
such	O
,	O
our	O
understanding	O
of	O
the	O
early	O
differentiation	O
events	O
of	O
the	O
human	O
placenta	O
is	O
limited	O
because	O
of	O
ethical	O
and	O
legal	O
restrictions	O
on	O
the	O
isolation	B-T061
and	O
manipulation	B-T061
of	O
human	O
embryogenesis	O
.	O
	
human	O
pluripotent	O
stem	O
cells	O
hpscs	O
are	O
a	O
robust	O
model	O
system	O
for	O
investigating	O
human	O
development	O
and	O
can	O
also	O
be	O
differentiated	O
in	B-T080
vitro	I-T080
into	O
trophoblastic	O
cells	O
that	O
express	O
markers	O
of	O
the	O
various	O
trophoblast	O
cell	O
types	O
.	O
	
here	O
,	O
we	O
present	O
a	O
detailed	O
protocol	O
for	O
differentiating	O
hpscs	O
into	O
trophoblastic	O
cells	O
using	O
bone	B-T116
morphogenic	I-T116
protein	I-T116
4	I-T116
and	O
inhibitors	B-T080
of	O
the	O
activin	B-T116
/	O
nodal	O
signaling	O
pathways	O
.	O
	
this	O
protocol	O
generates	O
various	O
trophoblast	O
cell	O
types	O
that	O
can	O
be	O
transfected	O
with	O
sirnas	O
for	O
investigating	O
loss-of-function	O
phenotypes	O
or	O
can	O
be	O
infected	B-T033
with	O
pathogens	O
.	O
	
additionally	O
,	O
hpscs	O
can	O
be	O
genetically	O
modified	O
and	O
then	O
differentiated	O
into	O
trophoblast	O
progenitors	O
for	O
gain-of-function	O
analyses	O
.	O
	
this	O
in	B-T080
vitro	I-T080
differentiation	O
method	O
for	O
generating	O
human	O
trophoblasts	O
starting	O
from	O
hpscs	O
overcomes	O
the	O
ethical	O
and	O
legal	O
restrictions	B-T169
of	O
working	O
with	O
early	O
human	O
embryos	O
,	O
and	O
this	O
system	O
can	O
be	O
used	O
for	O
a	O
variety	O
of	O
applications	O
,	O
including	O
drug	O
discovery	O
and	O
stem	O
cell	O
research	O
.	O
	
metabolomics	O
analysis	O
of	O
anaphylactoid	O
reaction	O
reveals	B-T080
its	O
mechanism	B-T169
in	O
a	O
rat	O
model	O
anaphylactoid	O
reactions	O
,	O
accounting	O
for	O
more	O
than	O
77%	O
of	O
all	O
immune-mediated	B-T047
immediate	I-T047
hypersensitivity	I-T047
reactions	I-T047
,	O
have	O
become	O
a	O
serious	B-T080
threat	B-T078
to	O
public	O
health	O
,	O
but	O
their	O
effect	B-T080
mechanism	B-T169
is	O
not	B-T033
clear	I-T033
and	O
diagnostic	O
tests	O
are	O
limited	B-T169
.	O
	
comprehensive	B-T080
metabolite	O
analysis	O
may	O
reveal	B-T080
the	O
anaphylactoid	B-T080
effect	B-T080
mechanism	B-T169
systematically	B-T169
and	O
provide	O
reference	B-T081
for	O
future	B-T079
diagnostic	B-T169
purposes	B-T169
.	O
	
plasma	O
from	O
brown	O
norway	O
rats	O
given	O
intravenous	B-T169
injection	I-T169
of	O
saline	O
,	O
compound	B-T109
48/80	I-T109
2.5	O
ml/kg	O
or	O
ovalbumin	B-T116
20	O
ml/kg	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	B-T169
to	O
study	O
the	O
effect	B-T080
mechanism	B-T169
of	O
anaphylactoid	O
reactions	O
through	O
metabolomics	O
uplc-qtof-ms/ms	O
.	O
	
metabolomics	O
integrated	O
with	O
proteomics	O
data	O
were	O
used	B-T169
to	O
analyze	O
the	O
anaphylactoid	B-T080
pathways	O
by	O
metaboanalyst	O
followed	B-T079
by	I-T079
integrated	O
pathway	O
analysis	O
.	O
	
thirty	O
metabolites	O
were	O
identified	B-T080
through	O
the	O
metlin	O
database	O
by	O
ms/ms	O
and	O
18	O
of	O
them	O
were	O
confirmed	B-T080
by	I-T080
authentic	B-T081
standards	I-T081
.	O
	
the	O
results	B-T169
showed	O
that	O
adenosine	O
,	O
histamine	B-T109
,	O
n-acetylhistamine	B-T109
,	O
n	B-T109
,	O
malate	B-T109
and	O
xanthine	O
are	O
important	B-T080
indices	O
for	O
anaphylactoid	O
reactions	O
.	O
	
it	O
could	O
be	O
concluded	O
that	O
the	O
effect	B-T080
mechanism	B-T169
is	O
mainly	O
composed	O
of	O
histidine	O
metabolism	O
,	O
arachidonic	O
acid	O
metabolism	O
,	O
energy	O
metabolism	O
,	O
purine	B-T169
metabolism	I-T169
and	O
other	B-T080
small	B-T081
molecules	O
through	B-T169
30	O
metabolites	O
.	O
	
multiple	O
linear	O
regression	O
analysis	O
indicated	B-T033
that	O
not	B-T169
only	B-T081
histamine	B-T109
but	O
also	O
n	B-T109
and	O
arachidonic	B-T109
acid	I-T109
could	O
be	O
used	B-T169
to	O
evaluate	O
anaphylactoid	B-T080
symptoms	O
of	O
animals	O
.	O
	
furthermore	O
,	O
the	O
citrate	O
cycle	O
,	O
histidine	O
metabolism	O
and	O
arachidonic	O
acid	O
metabolism	O
could	O
be	O
the	O
main	B-T080
pathways	O
of	O
anaphylactoid	O
reactions	O
as	O
determined	B-T080
by	I-T080
metaboanalyst	O
.	O
	
the	O
results	B-T169
may	O
provide	O
a	O
reference	O
to	O
improve	B-T033
diagnostic	B-T080
accuracy	I-T080
and	O
predict	B-T078
and	O
monitor	O
treatment	B-T080
efficacy	I-T080
in	O
anaphylactoid	O
reactions	O
in	O
the	O
clinical	O
setting	O
.	O
	
the	O
prevalence	B-T081
of	O
sleep	B-T047
apnea	I-T047
in	O
type	O
b	O
aortic	O
dissection	O
implications	O
for	O
false	B-T080
lumen	O
thrombosis	O
obstructive	B-T047
sleep	I-T047
apnea	I-T047
osa	B-T047
has	O
been	O
implicated	O
in	O
aortic	B-T047
dissection	I-T047
.	O
	
thrombosis	O
of	O
the	O
false	B-T080
lumen	O
is	O
associated	B-T080
with	I-T080
a	O
prognosis	O
of	O
type	O
b	O
aortic	O
dissection	O
aod	O
,	O
and	O
partial	O
thrombosis	O
has	O
been	O
reported	O
to	O
be	O
an	O
independent	O
predictor	O
of	O
mortality	B-T081
.	O
	
this	O
study	O
sought	O
to	O
explore	O
whether	O
the	O
severity	B-T080
of	O
osa	B-T047
is	O
associated	B-T080
with	I-T080
false	B-T080
lumen	O
thrombosis	O
.	O
	
in	O
this	O
observational	O
study	O
,	O
151	O
type	O
b	O
aod	O
patients	O
were	O
recruited	O
consecutively	O
from	O
2013	O
to	O
2015	O
.	O
	
the	O
status	O
of	O
the	O
false	B-T080
lumen	O
was	O
classified	O
as	O
patent	O
,	O
partially	B-T081
thrombosed	O
,	O
or	O
completely	O
thrombosed	O
based	O
on	O
a	O
computer	O
tomography	O
angiography	O
image	B-T078
.	O
	
patients	O
were	O
divided	O
into	O
non-osa	O
group	O
apnea-hypopnea	O
index	O
ahi	O
<	O
5	O
,	O
and	O
mild	O
5	O
ahi	O
15	O
,	O
moderate	O
15	O
<	O
ahi	O
30	O
,	O
and	O
severe	O
osa	O
groups	O
ahi	O
>	O
30	O
using	O
the	O
ahi	O
.	O
	
the	O
prevalence	B-T081
of	O
osa	B-T047
in	O
type	O
b	O
dissection	O
was	O
66.2	O
.	O
	
among	O
151	O
cases	O
,	O
51	O
patients	O
33.8	O
were	O
in	O
the	O
non-osa	O
group	O
,	O
56	O
37.1	O
were	O
in	O
the	O
mild	O
group	O
,	O
21	O
13.9	O
were	O
in	O
the	O
moderate	O
group	O
,	O
and	O
23	O
15.2	O
were	O
in	O
the	O
severe	O
group	O
.	O
	
additionally	O
,	O
a	O
partially	B-T081
thrombosed	O
false	B-T080
lumen	O
was	O
observed	O
in	O
88	O
patients	O
58.3	O
.	O
	
multivariable	B-T081
analysis	I-T081
revealed	O
that	O
osa	B-T047
severity	B-T080
was	O
positively	B-T033
associated	B-T080
with	I-T080
partial	B-T081
thrombosis	O
odds	B-T081
ratio	I-T081
,	O
1.784	O
,	O
95%	O
confidence	B-T081
interval	I-T081
1.182	O
,	O
p	O
=	O
006	O
after	O
adjusting	O
for	O
other	O
confounding	B-T169
factors	I-T169
.	O
	
osa	B-T047
was	O
present	O
in	O
two-thirds	O
of	O
patients	O
with	O
type	O
b	O
aod	O
.	O
	
the	O
severity	B-T080
of	O
osa	B-T047
was	O
significantly	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
of	O
partial	B-T081
false	B-T080
lumen	O
thrombosis	O
.	O
	
osa	B-T047
may	O
therefore	O
be	O
implicated	O
in	O
both	O
the	O
etiology	B-T169
and	O
prognosis	O
of	O
contextual	O
factors	O
for	O
stunting	O
among	O
children	O
of	O
age	O
6	O
to	O
24	O
months	B-T079
in	O
an	O
under-privileged	O
community	O
of	O
dhaka	O
,	O
bangladesh	O
to	O
determine	O
factors	B-T169
associated	B-T080
with	I-T080
stunting	O
among	O
children	O
aged	O
6	O
to	O
24	O
months	B-T079
in	O
a	O
slum	B-T080
of	O
dhaka	O
,	O
bangladesh	O
.	O
	
we	O
conducted	O
this	O
case	O
control	O
study	O
during	O
november	O
2009	O
to	O
december	O
2012	O
.	O
	
children	O
were	O
classified	O
as	O
case	O
if	O
length-for-age	B-T081
z-score	I-T081
laz	B-T081
was	O
<-2	O
and	O
as	O
control	O
if	O
laz	B-T081
was	O
>-1	O
sd	O
.	O
	
the	O
logistic	O
regression	O
model	O
was	O
used	O
to	O
find	O
the	O
factors	B-T169
associated	B-T080
with	I-T080
stunting	O
.	O
	
the	O
significant	O
risk	B-T033
factors	I-T033
for	O
stunting	O
were	O
child's	O
age	O
>12	O
months	B-T079
,	O
maternal	O
undernutrition	B-T047
,	O
mother's	B-T033
education	I-T033
<5	O
years	B-T079
,	O
consumption	O
of	O
untreated	O
drinking	O
water	O
and	O
monthly	B-T079
family	O
income	B-T081
<100	O
usd	B-T081
.	O
	
the	O
findings	B-T033
of	O
this	O
study	O
reiterated	O
the	O
role	O
of	O
maternal	O
undernutrition	B-T047
and	O
less	B-T033
education	I-T033
,	O
consumption	O
of	O
untreated	O
drinking	O
water	O
and	O
poor	O
family	O
income	B-T081
as	O
important	O
associated	B-T080
factors	B-T169
of	O
childhood	B-T079
stunting	O
most	O
americans	O
have	O
good	B-T080
health	I-T080
,	O
little	O
unmet	B-T033
need	I-T033
,	O
and	O
few	O
health	B-T081
care	I-T081
expenses	I-T081
the	O
distribution	O
of	O
health	B-T081
care	I-T081
expenditures	I-T081
remains	O
highly	O
concentrated	B-T081
,	O
but	O
most	O
americans	O
use	O
few	O
health	B-T078
care	I-T078
resources	I-T078
and	O
have	O
low	O
out-of-pocket	O
spending	O
.	O
	
more	O
than	O
93	O
percent	O
of	O
""""	O
low	O
spenders	O
""""	O
those	O
in	O
the	O
bottom	O
half	O
of	O
the	O
population	O
believe	O
they	O
have	O
received	B-T080
all	O
needed	O
care	O
in	O
a	O
timely	B-T080
manner	O
.	O
	
the	O
low	O
spending	O
by	O
the	O
majority	O
of	O
the	O
population	O
has	O
remained	O
almost	O
unchanged	O
during	O
the	O
thirty-seven-	O
year	B-T079
period	B-T079
examined	B-T033
.	O
	
penile	O
erosion	O
in	O
a	O
paraplegic	B-T047
man	O
with	O
indwelling	O
urinary	O
catheter	O
and	O
scrotal	B-T033
edema	I-T033
the	O
chronic	B-T079
use	B-T169
of	I-T169
urinary	O
indwelling	O
catheters	O
is	O
a	O
common	O
practice	O
in	O
the	O
setting	O
of	O
long-term	B-T079
patient	O
care	O
and	O
is	O
associated	O
with	O
numerous	O
complications	O
.	O
	
more	O
awareness	O
about	O
urogenital	O
trauma	O
from	O
urinary	B-T061
catheterization	I-T061
is	O
needed	O
,	O
as	O
it	O
is	O
as	O
common	O
as	O
symptomatic	B-T169
urinary	B-T047
tract	I-T047
infections	I-T047
.	O
	
there	O
are	O
a	O
number	O
of	O
preventable	B-T080
measures	I-T080
that	O
can	O
be	O
taken	O
to	O
decrease	B-T081
the	O
risk	B-T078
of	O
mechanical	O
trauma	O
to	O
the	O
urethra	O
and	O
glans	O
penis	O
caused	O
by	O
chronic	B-T079
catheterization	B-T061
.	O
	
we	O
present	O
a	O
case	O
of	O
a	O
27-	O
year	B-T079
old	B-T079
paraplegic	B-T047
male	O
needing	O
a	O
chronic	B-T079
indwelling	O
catheter	O
that	O
acquired	B-T080
ventral	O
penile	O
erosion	O
while	O
being	O
cared	O
for	O
in	O
the	O
icu	O
setting	O
.	O
	
modified	B-T169
anastomotic	B-T061
technique	I-T061
for	O
thoracolaparoscopic	B-T061
ivor-lewis	I-T061
esophagectomy	I-T061
early	B-T079
outcomes	B-T080
and	O
technical	B-T080
details	I-T080
thoracoscopic	B-T061
intrathoracic	I-T061
esophagogastrostomy	I-T061
is	O
a	O
technically	O
demanding	O
operation	O
these	O
technical	O
requirements	O
restrict	O
the	O
extensive	O
application	B-T169
of	I-T169
minimally	B-T080
invasive	B-T080
ivor-lewis	B-T061
esophagectomy	I-T061
.	O
	
in	O
an	O
attempt	O
to	O
reduce	B-T081
the	O
difficulty	O
of	O
this	O
surgical	B-T061
procedure	I-T061
,	O
this	O
study	O
developed	O
a	O
modified	B-T169
anastomotic	B-T061
technique	I-T061
for	O
thoracolaparoscopic	B-T061
ivor-lewis	I-T061
esophagectomy	I-T061
.	O
	
during	O
the	O
entirety	O
of	O
this	O
modified	B-T169
approach	B-T169
,	O
neither	O
technically	O
challenging	O
operations	B-T061
such	O
as	O
intrathoracic	B-T061
suturing	I-T061
or	O
knotting	B-T061
,	O
nor	O
special	O
instruments	O
such	O
as	O
an	O
orvil	O
system	O
or	O
a	O
reverse-puncture	O
head	O
are	O
required	O
.	O
	
between	O
october	O
2015	O
and	O
january	O
2016	O
,	O
15	O
consecutive	B-T080
patients	O
with	O
cancer	O
in	O
the	O
distal	O
third	O
of	O
the	O
esophagus	O
or	O
the	O
gastric	O
cardia	O
underwent	O
this	O
modified	B-T169
surgical	B-T061
procedure	I-T061
.	O
	
the	O
good	O
short-term	B-T079
outcomes	B-T080
that	O
were	O
achieved	O
suggest	O
that	O
the	O
modified	B-T169
anastomotic	B-T061
technique	I-T061
is	O
safe	O
and	O
feasible	O
for	O
thoracolaparoscopic	B-T061
ivor-lewis	I-T061
esophagectomy	I-T061
.	O
	
quantitative	O
analysis	O
of	O
cell	O
proliferation	O
by	O
a	O
dye	O
dilution	O
assay	O
application	B-T169
to	O
cell	O
lines	O
and	O
cocultures	O
cell	O
proliferation	O
represents	O
one	O
of	O
the	O
most	O
fundamental	O
processes	O
in	O
biological	O
systems	O
,	O
thus	O
the	O
quantitative	O
analysis	O
of	O
cell	O
proliferation	O
is	O
important	O
in	O
many	O
biological	O
applications	B-T169
such	O
as	O
drug	O
screening	O
,	O
production	O
of	O
biologics	O
,	O
and	O
assessment	O
of	O
cytotoxicity	O
.	O
	
conventional	B-T080
proliferation	O
assays	O
mainly	O
quantify	O
cell	O
number	O
based	O
on	O
a	O
calibration	B-T081
curve	I-T081
of	O
a	O
homogeneous	B-T080
cell	O
population	O
,	O
and	O
therefore	O
are	O
not	O
applicable	O
for	O
the	O
analysis	O
of	O
cocultured	O
cells	O
.	O
	
moreover	O
,	O
these	O
assays	O
measure	B-T169
cell	O
proliferation	O
indirectly	O
,	O
based	O
on	O
cellular	O
metabolic	O
activity	O
or	O
dna	B-T081
content	I-T081
.	O
	
to	O
overcome	O
these	O
shortcomings	O
,	O
a	O
dye	O
dilution	O
assay	O
employing	O
fluorescent	O
cell	O
tracking	O
dyes	O
that	O
are	O
retained	B-T169
within	O
cells	O
was	O
applied	O
and	O
was	O
diluted	B-T169
proportionally	B-T080
by	O
subsequent	O
cell	O
divisions	O
.	O
	
here	O
,	O
it	O
was	O
demonstrated	O
that	O
this	O
assay	O
could	O
be	O
implemented	O
to	O
quantitatively	O
analyze	O
the	O
cell	O
proliferation	O
of	O
different	O
types	O
of	O
cell	O
lines	O
,	O
and	O
to	O
concurrently	B-T079
analyze	O
the	O
proliferation	B-T169
of	O
two	O
types	O
of	O
cell	O
lines	O
in	O
coculture	O
by	O
utilizing	O
cell	O
tracking	O
dyes	O
with	O
different	O
spectral	B-T081
characteristics	B-T080
.	O
	
the	O
mean	B-T081
division	I-T081
time	I-T081
estimated	B-T081
by	O
the	O
dye	O
dilution	O
assay	O
is	O
compared	O
with	O
the	O
population	B-T079
doubling	I-T079
time	I-T079
obtained	O
from	O
conventional	B-T080
methods	O
and	O
values	O
from	O
literature	O
.	O
	
additionally	O
,	O
dye	O
transfer	O
between	O
cocultured	O
cells	O
was	O
investigated	B-T169
and	O
it	O
was	O
found	O
that	O
it	O
is	O
a	O
characteristic	B-T080
of	O
the	O
cells	O
rather	O
than	O
a	O
characteristic	B-T080
of	O
the	O
dye	O
.	O
	
it	O
was	O
suggested	O
that	O
this	O
method	O
can	O
be	O
easily	O
combined	O
with	O
other	O
flow	O
cytometric	O
analyses	O
of	O
cellular	O
properties	B-T080
,	O
providing	O
valuable	B-T080
information	B-T078
on	O
cell	B-T080
status	I-T080
under	O
diverse	B-T080
conditions	B-T080
.	O
	
engineering	O
and	O
in	O
vivo	O
applications	B-T169
of	O
riboswitches	O
riboswitches	O
are	O
common	B-T081
gene	O
regulatory	O
units	O
mostly	O
found	O
in	O
bacteria	O
that	O
are	O
capable	B-T080
of	O
altering	B-T078
gene	O
expression	O
in	O
response	O
to	O
a	O
small	B-T109
molecule	I-T109
.	O
	
these	O
structured	O
rna	O
elements	O
consist	O
of	O
two	O
modular	O
subunits	B-T081
an	O
aptamer	O
domain	O
that	O
binds	O
with	O
high	B-T080
specificity	B-T081
and	O
affinity	O
to	O
a	O
target	B-T169
ligand	O
and	O
an	O
expression	O
platform	O
that	O
transduces	O
ligand	O
binding	O
to	O
a	O
gene	O
expression	O
output	O
.	O
	
significant	B-T078
progress	B-T169
has	O
been	O
made	O
in	O
engineering	O
novel	B-T080
aptamer	O
domains	O
for	O
new	B-T080
small	B-T109
molecule	I-T109
inducers	O
of	O
gene	O
expression	O
.	O
	
modified	B-T169
expression	O
platforms	O
have	O
also	O
been	O
optimized	O
to	O
function	B-T169
when	O
fused	B-T169
with	O
both	O
natural	B-T169
and	O
synthetic	B-T080
aptamer	O
domains	O
.	O
	
as	O
this	O
field	O
expands	O
,	O
the	O
use	O
of	O
these	O
privileged	B-T078
scaffolds	O
has	O
permitted	O
the	O
development	B-T169
of	O
tools	O
such	O
as	O
rna	O
-based	O
fluorescent	O
biosensors	O
.	O
	
in	O
this	O
review	O
,	O
we	O
summarize	O
the	O
methods	O
that	O
have	O
been	O
developed	O
to	O
engineer	O
new	O
riboswitches	O
and	O
highlight	O
applications	B-T169
of	O
natural	B-T169
and	O
synthetic	B-T080
riboswitches	O
in	O
enzyme	O
and	O
strain	O
engineering	O
,	O
in	O
controlling	O
gene	O
expression	O
and	O
cellular	O
physiology	O
,	O
and	O
in	O
real-time	O
imaging	O
of	O
cellular	O
metabolites	O
and	O
signals	O
.	O
	
a	O
novel	B-T080
assay	O
to	O
measure	B-T081
tertiary	O
and	O
quaternary	B-T109
amines	I-T109
in	O
wastewater	O
an	O
indicator	B-T169
for	O
ndma	B-T109
wastewater	O
precursors	B-T078
this	O
study	O
examined	B-T033
the	O
potential	B-T080
of	O
using	O
a	O
novel	B-T080
bulk	O
amine	O
assay	O
as	O
an	O
approximation	B-T080
for	O
the	O
tertiary	O
and	O
quaternary	B-T109
amine	I-T109
load	O
in	O
wastewaters	O
and	O
surface	O
water	O
samples	O
,	O
and	O
this	O
approximation	B-T080
was	O
compared	O
to	O
n-nitrosodimethylamine	B-T109
ndma	B-T109
formation	B-T169
potential	B-T080
using	O
chloramines	B-T109
.	O
	
an	O
existing	O
colorimetric	O
method	O
was	O
examined	B-T033
and	O
optimized	O
for	O
the	O
detection	B-T033
of	O
amines	B-T109
in	O
environmental	O
water	O
samples	O
.	O
	
the	O
method	O
consists	O
of	O
liquid-liquid	O
extraction	O
followed	O
by	O
a	O
catalyzed	B-T169
reaction	O
to	O
form	O
a	O
yet-	O
undefined	B-T078
product	O
that	O
is	O
known	O
to	O
be	O
both	O
a	O
strong	B-T080
chromophore	O
and	O
fluorophore	O
.	O
	
previous	O
work	O
verified	O
that	O
this	O
reaction	O
was	O
effectively	O
catalyzed	B-T169
by	O
a	O
number	B-T081
of	O
compounds	B-T080
containing	O
tertiary	O
and	O
quaternary	B-T109
amine	I-T109
moieties	O
.	O
	
many	O
tertiary	O
and	O
quaternary	B-T109
compounds	I-T109
are	O
also	O
efficient	B-T080
producers	B-T169
of	O
ndma	B-T109
under	O
chloramination	O
conditions	B-T080
,	O
and	O
a	O
linear	B-T080
correlation	I-T080
was	O
consequently	B-T033
derived	O
from	O
the	O
bulk	O
amine	O
signals	O
vs	O
.	O
	
ndma	B-T109
formation	B-T169
potential	B-T080
in	O
various	O
wastewater	O
samples	O
r	O
=	O
0.74	O
n	O
=	O
24	O
p-value	O
<	O
0.05	O
.	O
	
the	O
results	O
provide	O
evidence	B-T078
that	O
approximately	B-T080
2%	O
of	O
the	O
tertiary	O
and	O
quaternary	O
amines	O
measured	B-T080
can	O
form	O
ndma	B-T109
and	O
an	O
estimated	B-T081
0.01	O
of	O
nitrogen	O
in	O
dissolved	B-T109
organic	I-T109
nitrogen	I-T109
originates	I-T109
from	O
these	O
bulk	B-T109
amines	I-T109
.	O
	
the	O
normalization	O
of	O
ndma	B-T109
concentration	B-T081
by	O
the	O
amine	B-T109
measurement	B-T169
revealed	O
that	O
ozone	O
effectively	B-T080
destroyed	O
those	O
tertiary	O
and	O
quaternary	B-T109
amine	I-T109
structures	O
more	O
likely	O
to	O
form	O
ndma	B-T109
in	O
treated	B-T169
wastewater	O
samples	O
.	O
	
this	O
bulk	O
amine	O
assay	O
illustrates	O
that	O
proxy	O
measurements	B-T169
of	O
tertiary	O
and	O
quaternary	B-T109
amines	I-T109
can	O
be	O
linked	O
to	O
the	O
ndma	B-T109
formation	B-T169
potential	B-T080
of	O
a	O
given	O
sample	O
,	O
and	O
this	O
approach	O
may	O
prove	O
useful	B-T080
as	O
a	O
characterizing	O
tool	B-T169
for	O
ndma	B-T109
precursors	B-T078
in	O
chlamydia	O
pneumoniae	O
infection	O
promotes	O
vascular	O
endothelial	O
cell	O
angiogenesis	O
through	O
an	O
iqgap1	B-T116
-related	O
signaling	O
pathway	O
chlamydia	O
pneumoniae	O
c	O
.	O
	
pneumoniae	O
infection	O
plays	O
a	O
potential	O
role	O
in	O
angiogenesis	O
.	O
	
however	O
,	O
it	O
is	O
still	O
an	O
enigma	O
how	O
c	O
.	O
	
pneumoniae	O
is	O
involved	B-T169
in	O
this	O
process	O
.	O
	
therefore	O
,	O
we	O
investigated	B-T169
the	O
effect	B-T080
of	O
c	O
.	O
	
pneumoniae	O
infection	O
on	O
angiogenesis	O
,	O
and	O
then	O
explored	O
the	O
roles	O
of	O
iqgap1	B-T116
-related	O
signaling	O
in	O
c	O
.	O
	
pneumoniae	O
infection	O
-	O
induced	B-T169
angiogenesis	O
.	O
	
c	O
.	O
	
pneumoniae	O
infection	O
significantly	O
enhanced	O
angiogenesis	O
as	O
assessed	O
by	O
the	O
tube	O
formation	O
assay	O
possibly	B-T033
by	O
inducing	B-T169
vascular	O
endothelial	O
cell	O
vec	O
migration	O
in	O
the	O
wound	O
healing	O
and	O
transwell	O
migration	O
assays	O
.	O
	
subsequently	B-T079
,	O
immunoprecipitation	O
,	O
western	O
blot	O
and	O
tube	O
formation	O
assay	O
results	O
showed	O
that	O
the	O
phosphorylation	O
of	O
both	O
iqgap1	B-T116
and	O
n-wasp	B-T116
was	O
required	B-T169
for	O
the	O
angiogenesis	O
induced	B-T169
by	O
c	O
.	O
	
pneumoniae	O
infection	O
.	O
	
our	O
co-immunoprecipitation	O
study	O
revealed	B-T080
that	O
iqgap1	B-T116
physically	O
associated	B-T080
with	I-T080
n-wasp	B-T116
after	O
c	O
.	O
	
pneumoniae	O
infection	O
of	O
vecs	O
.	O
	
actin	O
polymerization	O
assay	O
further	O
showed	O
that	O
in	O
c	O
.	O
	
pneumoniae	O
-	O
infected	B-T033
vecs	O
,	O
both	O
iqgap1	B-T116
and	O
n-wasp	B-T116
were	O
recruited	O
to	O
filamentous	B-T116
actin	I-T116
,	O
and	O
shared	O
some	O
common	B-T081
compartments	O
localized	O
at	O
the	O
leading	O
edge	O
of	O
lamellipodia	O
,	O
which	O
was	O
impaired	B-T169
after	O
the	O
depletion	B-T169
of	O
iqgap1	B-T116
by	O
using	O
the	O
small	O
interference	O
rna	O
.	O
	
moreover	O
,	O
the	O
knockdown	O
of	O
iqgap1	O
also	O
significantly	B-T081
decreased	I-T081
n-wasp	B-T116
phosphorylation	O
at	O
tyr256	B-T116
induced	B-T169
by	O
c	O
.	O
	
pneumoniae	O
infection	O
.	O
	
we	O
conclude	B-T078
that	O
c	O
.	O
	
pneumoniae	O
infection	O
promotes	O
vec	O
migration	O
and	O
angiogenesis	O
presumably	O
through	O
the	O
iqgap1	B-T116
-related	O
signaling	O
pathway	O
.	O
	
four-dimensional	O
graded	O
consciousness	O
both	O
the	O
multidimensional	O
phenomenon	O
and	O
the	O
polysemous	B-T080
notion	I-T080
of	O
consciousness	O
continue	O
to	O
prove	O
resistant	B-T169
to	O
consistent	B-T078
measurement	B-T169
and	O
unambiguous	O
definition	O
.	O
	
this	O
is	O
hardly	O
surprising	O
,	O
given	O
that	O
there	O
is	O
no	B-T033
agreement	I-T033
even	O
as	O
regards	O
the	O
most	O
fundamental	O
issues	B-T033
they	O
involve	O
.	O
	
one	O
of	O
the	O
basic	O
disagreements	O
present	O
in	O
the	O
continuing	O
debate	O
about	O
consciousness	O
pertains	O
to	O
its	O
gradational	O
nature	B-T078
.	O
	
the	O
general	O
aim	O
of	O
this	O
article	O
is	O
to	O
show	O
how	O
consciousness	O
might	O
be	O
graded	O
and	O
multidimensional	O
at	O
the	O
same	O
time	B-T079
.	O
	
we	O
therefore	O
focus	O
on	O
the	O
question	O
of	O
what	O
it	O
is	O
,	O
exactly	O
,	O
that	O
is	O
or	O
could	O
be	O
graded	O
in	O
cases	B-T169
of	O
consciousness	O
,	O
and	O
how	O
we	O
can	O
measure	B-T081
it	O
.	O
	
ultimately	O
,	O
four	O
different	O
gradable	O
aspects	B-T080
of	O
consciousness	O
will	O
be	O
described	O
quality	B-T080
,	O
abstractness	O
,	O
complexity	O
and	O
usefulness	B-T080
,	O
which	O
belong	O
to	O
four	O
different	O
dimensions	B-T081
,	O
these	O
being	O
understood	O
,	O
respectively	O
,	O
as	O
phenomenal	B-T080
,	O
semantic	B-T078
,	O
physiological	B-T169
,	O
and	O
functional	B-T169
.	O
	
consequently	O
,	O
consciousness	O
may	O
be	O
said	O
to	O
vary	O
with	O
respect	O
to	O
phenomenal	B-T080
quality	B-T080
,	O
semantic	B-T078
abstraction	O
,	O
physiological	B-T169
complexity	O
,	O
and	O
functional	B-T169
usefulness	B-T080
.	O
	
it	O
is	O
hoped	O
that	O
such	O
a	O
four-dimensional	O
approach	O
will	O
help	O
to	O
clarify	O
and	O
justify	O
claims	O
about	O
the	O
hierarchical	B-T078
nature	I-T078
of	O
consciousness	O
.	O
	
the	O
approach	O
also	O
proves	O
explanatorily	O
advantageous	B-T080
,	O
as	O
it	O
enables	O
us	O
not	O
only	O
to	O
draw	O
attention	O
to	O
certain	O
new	O
and	O
important	B-T080
differences	B-T080
in	O
respect	O
of	O
subjective	B-T080
measures	B-T081
of	O
awareness	O
and	O
to	O
justify	O
how	O
a	O
given	O
creature	O
may	O
be	O
ranked	O
higher	B-T080
in	O
one	O
dimension	O
of	O
consciousness	O
and	O
lower	O
in	O
terms	O
of	O
another	O
,	O
but	O
also	O
allows	O
for	O
innovative	O
explanations	O
of	O
a	O
variety	O
of	O
well-known	O
phenomena	O
amongst	O
these	O
,	O
the	O
interpretations	O
of	O
blindsight	B-T080
and	O
locked-in	B-T047
syndrome	I-T047
will	O
be	O
briefly	O
outlined	O
here	O
.	O
	
moreover	O
,	O
a	O
4d	O
framework	O
makes	O
possible	O
many	O
predictions	B-T078
and	O
hypotheses	B-T078
that	O
may	O
be	O
experimentally	O
tested	B-T169
we	O
point	O
out	O
a	O
few	O
such	O
possibilities	O
pertaining	O
to	O
interdimensional	B-T169
dependencies	I-T169
.	O
	
synthesis	O
of	O
some	O
unique	O
carbamate	B-T109
derivatives	O
bearing	O
2-furoyl-1-piperazine	O
as	O
a	O
valuable	O
therapeutic	O
agents	O
the	O
aim	B-T078
of	O
the	O
research	O
work	O
was	O
to	O
synthesize	O
different	O
biologically	O
active	O
carbamate	B-T109
derivatives	O
bearing	O
2-furoyl-1-piperazine	O
and	O
having	O
modest	O
toxicity	O
.	O
	
the	O
synthesis	O
was	O
completed	O
as	O
a	O
multiple	B-T169
sequence	I-T169
.	O
	
the	O
structural	O
confirmation	B-T033
of	O
all	O
the	O
synthesized	O
compounds	O
was	O
obtained	O
by	O
ei-ms	O
,	O
ir	O
and	O
1h-nmr	O
spectral	O
data	O
.	O
	
the	O
enzyme	O
inhibition	O
and	O
antibacterial	B-T033
potential	I-T033
of	O
the	O
synthesized	O
compounds	O
was	O
evaluated	O
.	O
	
to	O
find	O
the	O
utility	O
of	O
the	O
prepared	O
compounds	O
as	O
possible	O
therapeutic	O
agents	O
their	O
cytotoxicity	O
was	O
also	O
checked	O
.	O
	
all	O
the	O
compounds	O
were	O
active	B-T169
against	O
acetylcholinesterase	B-T116
enzyme	I-T116
,	O
especially	O
12	O
and	O
14	O
showed	O
very	O
good	B-T080
inhibitory	O
potential	O
relative	O
to	O
eserine	B-T109
,	O
a	O
reference	B-T081
standard	I-T081
.	O
	
almost	O
all	O
the	O
compounds	O
showed	O
good	O
activities	O
against	O
both	O
gram-positive	O
and	O
gram-negative	O
bacterial	O
strains	O
.	O
	
epidemiology	O
and	O
outcomes	O
of	O
injuries	O
in	O
kenya	O
a	O
multisite	O
surveillance	O
study	O
injury	O
is	O
a	O
leading	O
cause	O
of	O
disability	B-T033
and	O
death	B-T033
worldwide	O
,	O
accounting	O
for	O
over	O
5	O
million	O
deaths	B-T033
each	O
year	B-T079
.	O
	
the	O
injury	O
burden	B-T078
is	O
higher	O
in	O
low-	O
and	O
middle-income	O
countries	O
where	O
more	O
than	O
90%	O
of	O
injury	O
-related	O
deaths	O
occur	O
.	O
	
despite	O
this	O
burden	O
,	O
the	O
use	O
of	O
prospective	O
trauma	O
registries	O
to	O
describe	O
injury	B-T033
epidemiology	O
and	O
outcomes	O
is	O
limited	O
in	O
low-	O
and	O
middle-income	O
countries	O
.	O
	
kenya	O
lacks	O
robust	O
data	O
to	O
describe	O
injury	O
epidemiology	O
and	O
care	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
epidemiology	O
and	O
outcomes	O
of	O
injuries	O
at	O
4	O
referral	O
hospitals	O
in	O
kenya	O
using	O
hospital	O
-based	O
trauma	O
registries	O
.	O
	
from	O
january	O
2014	O
to	O
may	O
2015	O
,	O
all	O
injured	O
patients	O
presenting	O
to	O
the	O
casualty	O
departments	O
of	O
kenyatta	O
national	O
,	O
thika	O
level	O
5	O
,	O
machakos	O
level	O
5	O
,	O
and	O
meru	O
level	O
5	O
hospitals	O
were	O
enrolled	O
prospectively	O
.	O
	
data	O
collected	O
included	O
demographic	O
characteristics	O
,	O
type	O
of	O
prehospital	O
care	O
received	O
,	O
prehospital	O
time	O
,	O
injury	O
pattern	O
,	O
and	O
outcomes	O
.	O
	
a	O
total	O
of	O
14	O
patients	O
were	O
enrolled	O
in	O
our	O
study	O
.	O
	
patients	O
were	O
predominantly	O
male	O
76.1	O
and	O
young	O
mean	O
age	O
28	O
years	O
.	O
	
the	O
most	O
common	O
mechanisms	O
of	O
injury	O
were	O
road	O
traffic	O
injuries	O
36.8	O
,	O
falls	O
26.4	O
,	O
and	O
being	O
struck/hit	O
by	O
a	O
person	O
or	O
object	O
20.1	O
.	O
	
burn	O
was	O
the	O
most	O
common	O
mechanism	O
of	O
injury	O
in	O
the	O
age	O
category	O
under	O
5	O
years	O
.	O
	
body	O
regions	O
commonly	O
injured	O
were	O
lower	O
extremity	O
35.1	O
,	O
upper	O
extremity	O
33.4	O
,	O
and	O
head	O
26.0	O
.	O
	
the	O
overall	O
mortality	O
rate	O
was	O
2.4	O
.	O
	
significant	O
predictors	O
of	O
mortality	O
from	O
multivariate	O
analysis	O
were	O
glasgow	O
coma	O
scale	O
12	O
,	O
estimated	O
injury	O
severity	O
score	O
9	O
,	O
burns	O
,	O
and	O
gunshot	O
injuries	O
.	O
	
hospital	O
-based	O
trauma	O
registries	O
can	O
be	O
important	O
sources	O
of	O
data	O
to	O
study	O
the	O
epidemiology	O
of	O
injuries	O
in	O
low-	O
and	O
middle-income	O
countries	O
.	O
	
data	O
from	O
such	O
trauma	O
registries	O
can	O
highlight	O
key	O
needs	O
and	O
be	O
used	O
to	O
design	O
public	O
health	O
interventions	O
and	O
quality-of-care	O
improvement	O
programs	O
a	O
child	O
with	O
phenylketonuria	B-T047
and	O
focal	B-T047
segmental	I-T047
glomerulosclerosis	I-T047
,	O
the	O
bright	O
side	O
of	O
proteinuria	B-T033
phenylketonuria	B-T047
pku	B-T047
is	O
the	O
most	O
common	B-T081
inborn	B-T047
error	I-T047
of	I-T047
amino	I-T047
acid	I-T047
metabolism	I-T047
.	O
	
phenylalanine	B-T116
hydroxylase	I-T116
is	O
the	O
underlying	O
deficient	B-T169
enzyme	B-T116
.	O
	
if	O
left	O
untreated	B-T033
,	O
growth	B-T047
failure	I-T047
,	O
microcephaly	O
,	O
global	O
developmental	O
delay	O
,	O
seizures	O
and	O
severe	O
intellectual	O
impairment	O
would	O
characterize	O
the	O
clinical	O
picture	O
of	O
pku	B-T047
.	O
	
on	O
the	O
other	O
side	O
of	O
protein	B-T116
homeostasis	O
lies	O
nephrotic	B-T047
syndrome	I-T047
.	O
	
it	O
is	O
a	O
well-known	O
quantitative	B-T081
defect	B-T169
due	O
to	O
significant	B-T078
proteinuria	B-T033
.	O
	
focal	B-T047
segmental	I-T047
glomerulosclerosis	I-T047
fsgs	B-T047
is	O
a	O
special	B-T080
congenital	B-T080
variant	B-T080
affecting	B-T169
children	O
and	O
adults	O
.	O
	
hereby	O
,	O
we	O
describe	O
a	O
three-	O
year	O
old	O
male	O
child	O
who	O
presented	B-T033
with	O
generalized	B-T033
edema	I-T033
and	O
global	O
developmental	O
delay	O
.	O
	
investigations	O
revealed	B-T080
pku	B-T047
along	O
with	O
fsgs	B-T047
.	O
	
we	O
assume	O
that	O
congenital	B-T047
nephrosis	I-T047
ameliorated	B-T033
the	O
picture	O
of	O
pku	B-T047
,	O
and	O
had	O
a	O
salutary	B-T080
effect	I-T080
on	O
the	O
growth	O
and	O
development	O
.	O
	
such	O
coexistence	O
between	O
pku	B-T047
and	O
fsgs	B-T047
gastrointestinal	B-T047
disorders	I-T047
in	O
curry-jones	B-T047
syndrome	I-T047
clinical	B-T080
and	O
molecular	B-T080
insights	O
from	O
an	O
affected	B-T169
newborn	O
curry-jones	B-T047
syndrome	I-T047
cjs	B-T047
is	O
a	O
pattern	O
of	O
malformation	O
that	O
includes	O
craniosynostosis	B-T047
,	O
pre-axial	B-T033
polysyndactyly	I-T033
,	O
agenesis	O
of	O
the	O
corpus	O
callosum	O
,	O
cutaneous	B-T033
and	O
gastrointestinal	O
abnormalities	O
.	O
	
a	O
recurrent	O
,	O
mosaic	O
mutation	O
of	O
smo	O
c.1234	O
c>t	O
p.leu412phe	O
causes	O
cjs	O
.	O
	
this	O
report	O
describes	O
the	O
gastrointestinal	O
and	O
surgical	O
findings	O
in	O
a	O
baby	O
with	O
cjs	O
who	O
presented	O
with	O
abdominal	O
obstruction	O
and	O
reviews	O
the	O
spectrum	O
of	O
gastrointestinal	O
malformations	O
in	O
this	O
rare	O
disorder	O
.	O
	
a	O
41-	O
week	O
,	O
4	O
g	O
,	O
female	O
presented	O
with	O
craniosynostosis	O
,	O
pre-axial	O
polysyndactyly	O
,	O
and	O
cutaneous	O
findings	O
consistent	O
with	O
a	O
clinical	O
diagnosis	O
of	O
cjs	O
.	O
	
the	O
infant	O
developed	O
abdominal	O
distension	O
beginning	O
on	O
the	O
second	O
day	O
of	O
life	O
.	O
	
surgical	O
exploration	O
revealed	O
an	O
intestinal	O
malrotation	O
for	O
which	O
she	O
underwent	O
a	O
ladd	O
procedure	O
.	O
	
multiple	O
small	O
nodules	O
were	O
found	O
on	O
the	O
surface	O
of	O
the	O
small	O
and	O
large	O
bowel	O
in	O
addition	O
to	O
an	O
apparent	O
intestinal	O
duplication	O
that	O
seemed	O
to	O
originate	O
posterior	O
to	O
the	O
pancreas	O
.	O
	
histopathology	O
of	O
serosal	O
nodules	O
revealed	O
bundles	O
of	O
smooth	O
muscle	O
with	O
associated	O
ganglion	O
cells	O
.	O
	
molecular	O
analysis	O
demonstrated	O
the	O
smo	O
c.1234	O
c>t	O
mutation	O
in	O
varying	O
amounts	O
in	O
affected	O
skin	O
up	O
to	O
35%	O
and	O
intestinal	O
hamartoma	O
26%	O
.	O
	
gastrointestinal	O
features	O
including	O
structural	O
malformations	O
,	O
motility	O
disorders	O
,	O
and	O
upper	O
gi	O
bleeding	O
are	O
major	O
causes	O
of	O
morbidity	O
in	O
cjs	O
.	O
	
smooth	O
muscle	O
hamartomas	O
are	O
a	O
recognized	O
feature	O
of	O
children	O
with	O
cjs	O
typically	O
presenting	O
with	O
abdominal	O
obstruction	O
requiring	O
surgical	O
intervention	O
.	O
	
a	O
somatic	O
mutation	O
in	O
smo	O
likely	O
accounts	O
for	O
the	O
structural	O
malformations	O
and	O
predisposition	O
to	O
form	O
bowel	O
hamartomas	O
and	O
myofibromas	O
.	O
	
the	O
mutation	O
burden	O
in	O
the	O
involved	O
tissues	O
likely	O
accounts	O
for	O
the	O
variable	O
manifestations	I-T033
sella	O
turcica	O
bridging	O
and	O
dental	B-T033
anomalies	I-T033
is	O
there	O
an	O
association	B-T080
sella	O
turcica	O
bridging	O
stb	O
,	O
or	O
calcification	O
of	O
the	O
interclinoid	O
ligament	O
of	O
sella	O
turcica	O
,	O
has	O
been	O
reported	O
to	O
be	O
associated	B-T080
with	I-T080
some	O
dental	B-T033
anomalies	I-T033
palatal	B-T033
canine	I-T033
impaction	O
and	O
transposition	O
.	O
	
the	O
aim	O
of	O
the	O
study	O
was	O
to	O
find	O
any	O
association	B-T080
between	O
canine	B-T033
impaction	O
,	O
hyperdontia	B-T033
or	O
hypodontia	O
and	O
sellar	O
dimensions	B-T081
or	O
bridging	O
.	O
	
lateral	O
cephalometric	O
radiographs	O
from	O
78	O
patients	O
with	O
impacted	O
canines	B-T033
,	O
68	O
with	O
dental	O
agenesis	O
and	O
17	O
with	O
hyperdontia	B-T033
were	O
collected	O
.	O
	
linear	O
dimensions	B-T081
of	O
sella	O
turcica	O
were	O
calculated	O
and	O
compared	O
to	O
those	O
of	O
a	O
control	O
group	O
47	O
individuals	O
.	O
	
a	O
standardize	O
scoring	O
scale	O
was	O
used	O
to	O
quantify	O
the	O
extent	O
of	O
stb	O
from	O
each	O
radiographs	O
.	O
	
the	O
frequency	B-T079
of	O
partial	B-T081
and	O
complete	B-T080
calcifications	O
of	O
sella	O
in	O
patients	O
with	O
dental	B-T033
anomalies	I-T033
is	O
increased	B-T081
when	O
compared	O
to	O
controls	O
.	O
	
stb	O
can	O
influence	O
the	O
interclinoid	B-T081
distance	I-T081
but	O
does	O
not	O
affect	O
other	O
linear	O
dimensions	B-T081
of	O
sella	O
.	O
	
no	O
statistically	B-T081
significant	I-T081
difference	O
has	O
been	O
found	O
in	O
sellar	O
dimensions	B-T081
and	O
stb	O
expression	O
when	O
evaluating	O
radiographs	O
at	O
different	O
ages	O
.	O
	
stb	O
is	O
frequently	O
found	O
in	O
patients	O
with	O
dental	B-T033
abnormalities	I-T033
.	O
	
coxiella	O
burnetii	O
isolates	O
originating	O
from	O
infected	O
cattle	O
induce	B-T169
a	O
more	O
pronounced	O
proinflammatory	O
cytokine	O
response	O
compared	O
to	O
isolates	O
from	O
infected	O
goats	O
and	O
sheep	O
coxiella	O
burnetii	O
is	O
the	O
causative	B-T033
agent	I-T033
of	O
q	B-T047
fever	I-T047
.	O
	
although	O
the	O
prevalence	B-T081
of	O
c	O
.	O
	
burnetii	O
in	O
cattle	O
is	O
much	O
higher	O
than	O
in	O
goats	O
and	O
sheep	O
,	O
infected	O
cattle	O
are	O
rarely	O
associated	B-T080
with	I-T080
human	O
outbreaks	O
.	O
	
we	O
investigated	B-T169
whether	O
the	O
immune	O
response	O
of	O
humans	O
differs	O
after	O
contact	O
with	O
c	O
.	O
	
burnetii	O
isolates	O
from	O
different	O
host	O
origins	O
or	O
with	O
different	O
multilocus	O
variable	O
number	O
of	O
tandem	O
repeat	O
analysis	O
mlva	O
genotypes	O
.	O
	
cytokine	O
responses	O
were	O
measured	O
in	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
pbmcs	O
stimulated	O
with	O
16	O
c	O
.	O
	
burnetii	O
isolates	O
with	O
known	O
mlva	O
genotype	O
from	O
goats	O
,	O
sheep	O
,	O
cattle	O
,	O
acute	B-T047
and	O
chronic	B-T047
q	I-T047
fever	I-T047
patients	O
.	O
	
coxiella	O
burnetii	O
isolates	O
originating	O
from	O
cattle	O
induce	B-T169
significantly	O
more	O
il-1β	B-T116
,	O
tnf-α	B-T116
and	O
il-22	B-T116
than	O
the	O
isolates	O
from	O
goats	O
,	O
sheep	O
or	O
chronic	B-T047
q	I-T047
fever	I-T047
patients	O
.	O
	
comparing	O
the	O
cytokine	B-T116
induction	B-T169
of	O
the	O
isolates	O
based	O
on	O
their	O
mvla	O
genotype	O
did	O
not	O
reveal	O
differences	O
in	O
response	O
between	O
the	O
mlva	O
genotypes	O
.	O
	
the	O
proinflammatory	O
cytokine	O
response	O
induced	B-T169
in	O
human	O
pbmcs	O
by	O
c	O
.	O
	
burnetii	O
isolates	O
from	O
cattle	O
may	O
explain	O
the	O
low	O
incidence	B-T081
of	O
human	O
q	B-T047
fever	I-T047
outbreaks	O
caused	O
by	O
cattle	O
.	O
	
the	O
cytokine	B-T116
profile	O
of	O
pbmcs	O
stimulated	O
with	O
c	O
.	O
	
burnetii	O
isolates	O
from	O
chronic	O
q	O
fever	O
patients	O
resembles	O
isolates	O
from	O
goats	O
.	O
	
furthermore	O
,	O
cytokine	B-T081
responses	O
seem	O
to	O
be	O
depending	O
on	O
host	O
origin	O
than	O
on	O
mlva	O
genotype	O
a	O
novel	O
brca1-associated	B-T116
protein-1	I-T116
isoform	B-T116
affects	O
response	O
of	O
mesothelioma	O
cells	O
to	O
drugs	O
impairing	B-T169
brca1	B-T116
-mediated	O
dna	O
repair	O
brca1	B-T116
associated	I-T116
protein1	I-T116
bap1	B-T116
is	O
a	O
tumor	B-T116
suppressor	I-T116
involved	O
in	O
multiple	B-T081
cellular	O
processes	O
such	O
as	O
transcriptional	O
regulation	O
,	O
chromatin	O
modification	O
by	O
deubiquitinating	O
histone	B-T116
2a	I-T116
,	O
and	O
dna	O
repair	O
.	O
	
bap1	B-T116
mutations	O
are	O
frequent	B-T079
in	O
malignant	O
pleural	O
mesothelioma	O
mpm	O
.	O
	
our	O
aim	B-T078
was	O
to	O
functionally	B-T169
characterize	B-T080
a	O
newly	O
identified	B-T080
isoform	B-T116
of	B-T116
bap1	I-T116
and	O
investigate	B-T169
the	O
effects	B-T080
of	O
its	O
expression	O
on	O
drug	O
sensitivity	O
in	O
mpm	O
.	O
	
expression	O
of	O
bap1	B-T116
isoforms	O
was	O
detected	B-T033
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
in	O
mpm	O
and	O
normal	B-T080
mesothelium	O
cell	O
lines	O
and	O
tumor	O
and	O
nontumor	O
samples	O
.	O
	
histone	B-T116
h2a	I-T116
ubiquitination	O
levels	B-T080
were	O
analyzed	O
by	O
western	O
blot	O
after	O
acidic	O
extraction	O
of	O
core	B-T116
histones	I-T116
.	O
	
subcellular	O
localization	B-T169
of	O
bap1	B-T116
isoforms	B-T116
was	O
examined	B-T033
by	O
immunofluorescence	O
.	O
	
mpm	O
cell	O
survival	O
in	O
response	O
to	O
poly	B-T116
diphosphate-ribose	I-T116
polymerase	I-T116
parp	B-T116
and	O
dual	O
phosphoinositide	B-T116
3-kinase	I-T116
pi3k	B-T116
mammalian	B-T116
target	I-T116
of	I-T116
rapamycin	I-T116
mtor	B-T116
inhibitors	O
was	O
analyzed	O
by	O
in	O
vitro	O
assays	O
.	O
	
we	O
have	O
identified	B-T080
a	O
novel	O
alternative	B-T116
splice	I-T116
isoform	I-T116
of	O
bap1	B-T116
bap1δ	O
that	O
misses	O
part	O
of	O
the	O
catalytic	O
domain	O
.	O
	
cells	O
transfected	O
with	O
bap1δ	O
showed	O
reduced	B-T080
deubiquitinating	O
activity	O
compared	O
with	O
full-length	O
bap1	B-T116
.	O
	
the	O
expression	O
of	O
bap1δ	O
transcript	O
is	O
more	O
abundant	B-T080
in	O
nontumor	O
than	O
in	O
tumor	O
samples	O
.	O
	
mpm	O
cell	O
lines	O
expressing	O
more	O
than	O
20%	O
of	O
bap1δ	O
are	O
more	O
sensitive	B-T169
to	O
olaparib	B-T109
a	O
parp1	B-T116
inhibitor	O
cytotoxicity	O
,	O
and	O
this	O
sensitivity	B-T169
is	O
enhanced	O
when	O
olaparib	B-T109
treatment	O
is	O
combined	B-T080
with	O
gdc0980	O
a	O
dual	O
pi3k	B-T116
-	O
mtor	B-T116
inhibitor	O
,	O
which	O
induces	B-T169
downregulation	O
of	O
brca1	B-T116
.	O
	
these	O
observations	O
suggest	O
that	O
bap1δ	O
does	O
regulate	O
dna	O
damage	O
response	O
and	O
influences	O
drug	O
sensitivity	O
.	O
	
it	O
might	O
therefore	O
be	O
relevant	B-T080
to	O
investigate	B-T169
whether	O
patients	O
with	O
high	B-T080
expression	O
of	O
bap1δ	O
may	O
be	O
responsive	O
to	O
parp	B-T116
/	O
pi3k	B-T116
-	O
mtor	B-T116
inhibitors	O
.	O
	
cucurbitacin	B-T109
b	I-T109
protects	O
against	O
pressure	O
overload	O
induced	O
cardiac	O
hypertrophy	O
lack	O
of	O
effective	O
anti-cardiac	O
hypertrophy	O
drugs	O
creates	O
a	O
major	O
cause	B-T169
for	O
the	O
increasing	O
prevalence	B-T081
of	O
heart	B-T047
failure	I-T047
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
anti-hypertrophy	B-T033
and	O
anti-fibrosis	B-T033
potential	B-T080
of	O
a	O
natural	O
plant	O
triterpenoid	B-T109
,	O
cucurbitacin	B-T109
b	I-T109
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
	
aortic	B-T061
banding	I-T061
ab	B-T061
was	O
performed	O
to	O
induce	O
cardiac	O
hypertrophy	O
.	O
	
after	O
1	O
week	O
of	O
surgery	B-T061
,	O
mice	O
were	O
receive	O
cucurbitacin	B-T109
b	I-T109
treatment	B-T061
gavage	B-T169
,	O
0.2	O
mg/kg	O
body	O
weight	O
/2	O
day	O
.	O
	
after	O
4	O
weeks	O
of	O
ab	B-T061
,	O
cucurbitacin	B-T109
b	I-T109
demonstrated	O
a	O
strong	O
anti-hypertrophy	B-T033
and	O
-fibrosis	B-T033
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	B-T081
,	O
myocardial	O
cell	O
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	O
,	O
ameliorated	O
of	O
systolic	B-T079
and	O
diastolic	O
abnormalities	B-T033
,	O
normalized	O
in	O
gene	O
expression	O
of	O
hypertrophic	O
and	O
fibrotic	B-T169
markers	O
,	O
reserved	O
microvascular	B-T080
density	I-T080
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O
	
cucurbitacin	B-T109
b	I-T109
also	O
showed	O
significant	O
hypertrophy	O
inhibitory	B-T033
effect	I-T033
in	O
phenylephrine	B-T109
stimulated	O
cardiomyocytes	O
.	O
	
the	O
cucurbitacin	B-T109
b	I-T109
-mediated	O
mitigated	O
cardiac	O
hypertrophy	O
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	B-T080
with	I-T080
the	O
blockade	B-T169
of	O
akt	B-T116
/	O
mtor	B-T116
/	O
foxo3a	B-T116
signal	O
pathway	O
,	O
validated	O
by	O
sc79	B-T109
,	O
mk2206	B-T109
,	O
and	O
3-ma	O
,	O
the	O
akt	B-T116
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O
	
the	O
overexpression	O
of	O
constitutively	O
active	O
akt	B-T116
completely	O
abolished	O
the	O
cucurbitacin	B-T109
b	I-T109
-mediated	O
protection	O
of	O
cardiac	O
hypertrophy	O
in	O
human	O
cardiomyocytes	O
ac16	O
.	O
	
collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	B-T109
b	I-T109
protects	O
against	O
cardiac	O
hypertrophy	O
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	B-T080
with	I-T080
the	O
inhibition	O
of	O
akt	B-T116
/	O
mtor	B-T116
/	O
foxo3a	B-T116
signal	O
axis	O
.	O
	
inflammatory	B-T169
and	O
oxidative	O
stress	O
markers	O
in	O
experimental	B-T080
allergic	B-T047
asthma	I-T047
ovalbumin	B-T116
-	O
induced	B-T169
allergic	B-T047
lung	I-T047
inflammation	I-T047
ali	B-T047
is	O
a	O
condition	B-T080
believed	O
to	O
be	O
mediated	O
by	O
cytokines	B-T116
,	O
extracellular	O
matrix	O
remodeling	O
,	O
and	O
redox	O
imbalance	O
.	O
	
in	O
this	O
study	O
,	O
we	O
evaluated	O
pulmonary	O
function	O
together	O
with	O
inflammatory	B-T169
markers	O
as	O
interleukin-4	B-T116
il-4	B-T116
,	O
myeloperoxidase	B-T116
mpo	B-T116
,	O
eosinophil	O
cells	O
,	O
and	O
redox	O
markers	O
in	O
the	O
lungs	O
of	O
balb/c	O
mice	O
after	O
ovalbumin	B-T116
ova	B-T116
sensitization	O
and	O
challenge	O
.	O
	
our	O
results	B-T169
showed	O
an	O
increase	B-T169
in	O
bronchial	B-T047
hyperresponsiveness	I-T047
stimulated	O
by	O
methacholine	B-T109
mch	B-T109
,	O
inflammatory	B-T169
cell	O
influx	O
,	O
especially	O
eosinophils	O
together	O
with	O
an	O
increase	B-T169
of	O
high	B-T116
mobility	I-T116
group	I-T116
box	I-T116
1	I-T116
hmgb1	B-T116
and	O
altered	O
lipid	O
peroxidation	O
lp	O
and	O
antioxidant	O
defenses	O
in	O
the	O
ova	B-T116
group	O
compared	O
to	O
the	O
control	O
group	O
p	O
0.5	O
.	O
	
thus	O
,	O
we	O
demonstrated	O
that	O
ova	B-T116
-	O
induced	B-T169
ali	B-T047
altered	O
redox	O
status	O
concomitantly	B-T079
with	O
impaired	B-T169
lung	O
function	O
,	O
which	O
was	O
associated	B-T080
with	I-T080
hmgb1	B-T116
expression	O
and	O
proteolytic	O
remodeling	O
.	O
	
taken	O
together	O
all	O
results	B-T169
found	O
here	O
,	O
we	O
may	O
suggest	O
hmgb1	B-T116
is	O
an	O
important	B-T080
therapeutic	B-T169
target	B-T169
for	O
asthma	B-T047
,	O
once	O
orchestrates	B-T080
the	O
redox	O
signaling	O
,	O
inflammation	O
,	O
and	O
remodeling	O
that	O
contribute	O
to	O
the	O
disease	B-T047
development	B-T169
.	O
	
association	B-T080
among	O
prematurity	B-T047
<30	O
weeks'	O
gestational	O
age	O
,	O
blood	O
pressure	O
,	O
urinary	B-T080
albumin	B-T116
,	O
calcium	O
,	O
and	O
phosphate	O
in	O
early	B-T079
childhood	I-T079
there	O
is	O
a	O
paucity	O
of	O
data	B-T078
on	O
blood	O
pressures	O
bp	O
,	O
urinary	B-T080
albumin	B-T116
,	O
and	O
mineral	O
excretion	O
in	O
early	B-T079
childhood	I-T079
in	O
contemporary	B-T079
cohorts	O
of	O
extremely	B-T080
low	B-T080
gestational	O
age	O
ga	O
neonates	O
.	O
	
our	O
aim	O
was	O
to	O
compare	O
bps	O
and	O
the	O
urinary	B-T080
excretion	O
of	O
albumin	B-T116
,	O
calcium	O
,	O
and	O
phosphate	O
in	O
preterm	B-T079
and	O
term-born	O
cohorts	O
in	O
early	B-T079
childhood	I-T079
.	O
	
this	O
was	O
a	O
prospective	O
observational	O
study	O
conducted	O
at	O
a	O
single	B-T081
center	O
,	O
involving	B-T169
children	O
<5	O
years	O
age	O
,	O
born	B-T033
preterm	I-T033
ga	B-T033
<30	I-T033
weeks	I-T033
or	O
at	O
term	O
37	B-T033
weeks'	I-T033
ga	I-T033
.	O
	
urinary	O
albumin	O
mg/l	O
,	O
calcium	O
and	O
phosphate	O
levels	O
indexed	O
to	O
creatinine	B-T109
mg/dl	O
,	O
and	O
bp	O
were	O
measured	B-T080
.	O
	
the	O
median	O
iqr	B-T081
follow-up	O
age	O
of	O
our	O
cohort	O
n	O
=	O
106	O
was	O
30	O
16-48	O
months	B-T079
.	O
	
preterm-born	O
children	O
n	O
=	O
55	O
had	O
a	O
significantly	B-T081
lower	I-T081
mean	B-T081
ga	O
and	O
birth	O
weight	O
and	O
higher	B-T080
mean	B-T081
systolic	O
,	O
diastolic	O
,	O
and	O
mean	B-T033
bps	I-T033
,	O
compared	O
with	O
term	O
n	O
=	O
51	O
controls	O
.	O
	
a	O
significantly	B-T081
higher	I-T081
proportion	B-T081
of	O
preterm-born	O
children	O
weighed	O
<10th	B-T033
centile	I-T033
and	O
had	O
systolic	O
bp	O
>95th	B-T033
centile	I-T033
at	O
follow-up	O
.	O
	
albumin	B-T116
and	O
calcium	O
excretion	O
did	O
not	B-T033
differ	I-T033
between	O
the	O
groups	O
median	B-T081
urine-phosphate	O
creatinine	O
ratios	O
were	O
higher	B-T080
in	O
the	O
preterm	O
group	O
.	O
	
on	O
logistic	O
regression	O
,	O
lower	B-T080
ga	O
and	O
younger	B-T079
age	O
at	O
follow-up	O
were	O
significantly	B-T078
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
of	O
systolic	O
and	O
diastolic	O
bp	O
above	O
the	O
95th	B-T033
centile	I-T033
male	O
gender	O
was	O
associated	B-T080
with	I-T080
decreased	B-T081
risk	B-T078
of	O
diastolic	B-T047
hypertension	I-T047
.	O
	
even	O
in	O
early	B-T079
childhood	I-T079
,	O
children	O
born	O
preterm	O
had	O
significantly	B-T078
elevated	B-T080
bp	O
,	O
compared	O
with	O
their	O
term-born	O
counterparts	O
.	O
	
closer	O
monitoring	O
of	O
bps	O
in	O
this	O
population	O
recombinant	B-T116
protein	O
transduction	O
domain	O
-	O
cu/zn	B-T116
superoxide	I-T116
dismutase	I-T116
alleviates	B-T080
bone	O
cancer	O
pain	O
via	O
peroxiredoxin	B-T116
4	I-T116
modulation	O
and	O
antioxidation	O
bone	O
cancer	O
pain	O
bcp	O
is	O
a	O
serious	B-T080
chronic	B-T079
clinical	B-T080
condition	I-T080
and	O
reactive	O
oxygen	O
species	O
ros	O
were	O
considered	B-T078
to	O
be	O
involved	B-T169
in	O
its	O
development	B-T169
and	O
persistency	B-T079
.	O
	
normally	B-T080
,	O
superoxide	B-T116
dismutase	I-T116
sod	B-T116
converts	O
superoxide	O
anions	O
to	O
hydrogen	O
peroxide	O
h2o2	O
and	O
h2o2	O
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	B-T116
4	I-T116
.	O
	
we	O
reported	O
previously	O
that	O
recombinant	B-T116
protein	O
transduction	O
domain	O
ptd	O
cu/zn	B-T116
sod	I-T116
effectively	B-T080
scavenged	O
excessive	B-T080
ros	O
and	O
prevented	B-T169
cardiomyocytes	O
from	O
hypoxia-reoxygenation	B-T169
damage	B-T169
.	O
	
however	O
,	O
whether	O
ptd	O
-	O
cu/zn	B-T116
sod	I-T116
would	O
prevent	B-T169
bcp	O
development	B-T169
is	O
unknown	B-T080
.	O
	
in	O
the	O
current	B-T079
study	O
,	O
we	O
found	B-T033
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	B-T169
remarkable	O
hyperalgesia	O
,	O
increased	B-T081
h2o2	O
levels	B-T080
and	O
decreased	B-T081
sod	B-T116
and	O
peroxiredoxin	B-T116
4	I-T116
levels	B-T080
.	O
	
after	O
administration	B-T169
of	O
recombinant	B-T116
ptd	O
-	O
cu/zn	B-T116
sod	I-T116
to	O
these	O
tumor-burden	B-T081
rats	O
,	O
their	O
hyperalgesia	O
was	O
significantly	B-T078
attenuated	O
and	O
peroxiredoxin	B-T116
4	I-T116
expression	O
was	O
significantly	B-T081
increased	I-T081
.	O
	
in	B-T169
addition	I-T169
,	O
an	O
increased	B-T081
expression	O
of	O
n-methyl-d-aspartic	B-T116
acid	I-T116
nmda	I-T116
receptors	I-T116
and	O
a	O
decreased	B-T081
expression	O
of	O
γ-aminobutyric	B-T116
acid	I-T116
gaba	I-T116
receptors	I-T116
in	O
this	O
cancer	O
pain	O
were	O
prevented	B-T169
by	O
ptd	O
-	O
cu/zn	B-T116
sod	I-T116
administration	B-T169
or	O
peroxiredoxin	B-T116
4	I-T116
overexpression	O
.	O
	
our	O
data	B-T078
suggested	B-T078
that	O
reactive	O
oxygen	O
species	O
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	O
pain	O
development	B-T169
and	O
persistency	B-T079
which	O
can	O
be	O
attenuated	B-T080
by	I-T080
the	O
adminstration	B-T169
of	O
recombinant	B-T116
ptd	I-T116
-	O
cu/zn	B-T116
sod	I-T116
via	O
the	O
peroxiredoxin	B-T116
4	I-T116
modulation	O
from	O
oxidative	O
stress	O
.	O
	
immune	B-T033
dysregulation	I-T033
in	O
offspring	O
of	O
a	O
bipolar	O
parent	O
.	O
	
altered	O
serum	O
levels	B-T080
of	O
immune	B-T169
growth	B-T116
factors	I-T116
at	O
adolescent	O
age	O
immune	B-T033
dysregulation	I-T033
plays	O
a	O
role	O
in	O
the	O
vulnerability	B-T033
for	O
mood	O
disorders	O
.	O
	
immune	B-T169
growth	B-T116
factors	I-T116
,	O
such	O
as	O
stem	B-T116
cell	I-T116
factor	I-T116
scf	B-T116
,	O
insulin-like	B-T116
growth	I-T116
factor-binding	I-T116
protein-2	I-T116
igf-bp2	B-T116
,	O
epidermal	B-T116
growth	I-T116
factor	I-T116
egf	B-T116
,	O
il-7	B-T116
and	O
scd25	B-T116
have	O
repeatedly	O
been	O
reported	O
altered	B-T169
in	O
patients	O
with	O
mood	O
disorders	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	B-T169
levels	B-T080
of	O
these	O
factors	B-T116
in	O
serum	O
of	O
adolescent	O
bipolar	O
offspring	O
,	O
who	O
have	O
a	O
heightened	B-T080
risk	B-T078
for	O
mood	O
disorder	O
development	B-T169
and	O
to	O
also	O
analyze	O
the	O
data	B-T078
combined	O
with	O
previously	O
published	O
data	O
.	O
	
growth	B-T116
factors	I-T116
were	O
assessed	O
by	O
cba	O
/	O
elisa	O
in	O
adolescent	O
bipolar	O
offspring	O
n=96	O
,	O
mean	B-T081
age	O
=16	O
years	B-T079
and	O
in	O
age	O
-	O
and	O
gender	O
-	O
matched	B-T080
healthy	B-T080
controls	O
n=50	O
.	O
	
egf	B-T116
belonged	O
to	O
a	O
mutually	O
correlating	B-T080
cluster	B-T081
of	O
mainly	O
neurotrophic	B-T116
compounds	I-T116
including	O
s100b	B-T116
and	O
bdnf	B-T116
,	O
which	O
were	O
in	O
general	O
decreased	B-T081
in	O
serum	O
.	O
	
il-7	B-T116
,	O
scf	B-T116
,	O
igf-bp2	B-T116
and	O
scd25	B-T116
,	O
belonged	O
to	O
a	O
different	O
mutually	O
correlating	B-T080
cluster	B-T081
of	O
immune	B-T169
growth	B-T116
factors	I-T116
,	O
which	O
were	O
in	O
general	O
increased	B-T081
igf-bp2	B-T116
significantly	B-T078
in	O
serum	O
of	O
offspring	O
without	O
a	O
mood	O
disorder	O
,	O
il-7	B-T116
and	O
scf	B-T116
in	O
serum	O
of	O
offspring	O
who	O
had	O
expirienced	O
a	O
mood	O
episode	O
.	O
	
this	O
pattern	O
of	O
de	B-T081
-	O
and	O
increases	B-T169
was	O
not	O
different	O
between	O
bipolar	O
offspring	O
that	O
developed	O
or	O
did	O
not	O
develop	O
a	O
mood	O
disorder	O
over	O
time	B-T079
,	O
apart	O
from	O
the	O
igf-bp2	B-T116
level	B-T080
,	O
which	O
was	O
near	O
significantly	B-T078
higher	O
in	O
offspring	O
later	O
developing	O
a	O
mood	O
disorder	O
.	O
	
correlations	B-T080
with	O
the	O
previously	O
published	O
immune-cellular	O
abnormalities	O
were	O
not	O
found	O
.	O
	
in	O
conclusion	B-T078
non-affected	O
adolescents	O
at	O
familial	B-T169
mood	O
disorder	O
development	B-T169
risk	B-T078
were	O
characterized	O
by	O
a	O
distinct	O
pattern	O
of	O
a	O
series	O
of	O
compounds	B-T116
operating	O
in	O
a	O
network	B-T169
of	O
hematopoiesis	O
,	O
neurogenesis	O
and	O
enos	B-T116
s-nitrosylates	O
β-actin	B-T116
on	O
cys374	B-T116
and	O
regulates	O
pkc-θ	B-T116
at	O
the	O
immune	O
synapse	O
by	O
impairing	B-T169
actin	O
binding	O
to	O
profilin-1	B-T116
the	O
actin	O
cytoskeleton	O
coordinates	O
the	O
organization	O
of	O
signaling	O
microclusters	O
at	O
the	O
immune	O
synapse	O
is	O
however	O
,	O
the	O
mechanisms	O
involved	O
remain	O
poorly	O
understood	O
.	O
	
we	O
show	O
here	O
that	O
nitric	O
oxide	O
no	O
generated	O
by	O
endothelial	B-T116
nitric	I-T116
oxide	I-T116
synthase	I-T116
enos	B-T116
controls	O
the	O
coalescence	O
of	O
protein	B-T116
kinase	I-T116
c-θ	I-T116
pkc-θ	B-T116
at	O
the	O
central	O
supramolecular	O
activation	O
cluster	O
c-smac	O
of	O
the	O
is	O
.	O
	
enos	B-T116
translocated	O
with	O
the	O
golgi	O
to	O
the	O
is	O
and	O
partially	O
colocalized	O
with	O
f-actin	B-T116
around	O
the	O
c-smac	O
.	O
	
this	O
resulted	O
in	O
reduced	O
actin	O
polymerization	O
and	O
centripetal	O
retrograde	O
flow	O
of	O
β-actin	B-T116
and	O
pkc-θ	B-T116
from	O
the	O
lamellipodium-like	O
distal	O
d	O
,	O
promoting	O
pkc-θ	B-T116
activation	O
.	O
	
furthermore	O
,	O
enos	B-T116
-derived	O
no	O
s-nitrosylated	O
β-actin	B-T116
on	O
cys374	B-T116
and	O
impaired	B-T169
actin	O
binding	O
to	O
profilin-1	B-T116
pfn1	B-T116
,	O
as	O
confirmed	O
with	O
the	O
transnitrosylating	O
agent	O
s-nitroso-l-cysteine	B-T109
cys-no	B-T109
.	O
	
the	O
importance	O
of	O
no	O
and	O
the	O
formation	O
of	O
pfn1-actin	B-T116
complexes	I-T116
on	O
the	O
regulation	O
of	O
pkc-θ	B-T116
was	O
corroborated	O
by	O
overexpression	O
of	O
pfn1	O
-	O
and	O
actin-binding	O
defective	O
mutants	O
of	O
β-actin	O
c374s	O
and	O
pfn1	O
h119e	O
,	O
respectively	O
,	O
which	O
reduced	O
the	O
coalescence	O
of	O
pkc-θ	B-T116
at	O
the	O
c-smac	O
.	O
	
these	O
findings	O
unveil	O
a	O
novel	O
no	O
-dependent	O
mechanism	O
by	O
which	O
the	O
actin	O
cytoskeleton	O
controls	O
the	O
organization	O
and	O
activation	O
of	O
signaling	O
microclusters	O
at	O
the	O
dobutamine	O
stress	O
echocardiography	O
impact	B-T080
of	O
abnormal	B-T033
blood	O
potassium	O
levels	O
on	O
cardiac	B-T033
arrhythmias	I-T033
guidelines	O
suggest	O
that	O
an	O
abnormal	B-T033
blood	O
potassium	O
level	O
is	O
a	O
relative	O
contraindication	B-T080
to	O
performing	B-T169
dobutamine	O
stress	O
echocardiography	O
dse	O
.	O
	
however	O
,	O
this	O
has	O
not	O
been	O
previously	O
studied	O
.	O
	
we	O
reviewed	B-T080
a	O
consecutive	O
series	O
of	O
patients	O
who	O
had	O
potassium	O
testing	B-T169
within	O
48	O
hours	B-T079
of	O
undergoing	O
dse	O
for	O
the	O
evaluation	O
of	O
myocardial	B-T047
ischemia	I-T047
over	O
a	O
10-	O
year	B-T079
period	B-T079
n	O
=	O
13	O
.	O
	
normal	O
potassium	O
range	B-T081
in	O
our	O
laboratory	O
is	O
3.6	O
mmol/l	O
.	O
	
hemolyzed	B-T033
samples	I-T033
were	O
not	O
included	O
.	O
	
the	O
association	B-T080
of	O
potassium	B-T033
levels	I-T033
with	O
the	O
development	B-T169
of	O
supraventricular	O
and	O
ventricular	B-T047
arrhythmias	I-T047
was	O
assessed	O
.	O
	
the	O
incidence	O
of	O
clinically	O
significant	O
arrhythmias	B-T033
was	O
very	O
low	B-T080
supraventricular	B-T047
tachycardia	I-T047
/	O
atrial	B-T047
fibrillation	I-T047
,	O
4.9	O
nonsustained	O
ventricular	O
tachycardia	O
,	O
2.9	O
sustained	B-T047
ventricular	I-T047
tachycardia	I-T047
or	O
ventricular	B-T047
fibrillation	I-T047
,	O
0.1	O
,	O
confirming	O
the	O
overall	O
safety	O
of	O
dse	O
.	O
	
most	O
arrhythmias	B-T033
88%	O
occurred	O
in	O
patients	O
with	O
normal	O
potassium	B-T033
levels	I-T033
,	O
and	O
arrhythmia	B-T033
rates	B-T081
remained	O
low	B-T080
in	O
patients	O
with	O
potassium	O
abnormalities	B-T033
.	O
	
patients	O
with	O
hyperkalemia	B-T033
had	O
a	O
lower	O
risk	B-T078
of	O
developing	O
mild	B-T080
odds	B-T081
ratio	I-T081
or	B-T081
,	O
0.39	O
95%	O
ci	B-T081
,	O
0.22	O
and	O
severe	B-T080
or	B-T081
,	O
0.13	O
95%	O
ci	B-T081
,	O
0.01	O
supraventricular	O
arrhythmias	O
as	O
well	O
as	O
mild	B-T080
ventricular	B-T047
arrhythmias	I-T047
or	B-T081
,	O
0.58	O
95%	O
ci	B-T081
,	O
0.40	O
.	O
	
even	O
though	O
events	O
were	O
rare	B-T080
,	O
patients	O
with	O
severe	B-T080
hypokalemia	B-T033
potassium	B-T033
levels	I-T033
3.1	O
mmol/l	O
had	O
an	O
increased	B-T081
risk	B-T078
of	O
supraventricular	O
arrhythmia	O
and	O
ventricular	B-T047
ectopy	I-T047
.	O
	
dse	O
is	O
safe	O
even	O
in	O
the	O
setting	O
of	O
abnormalities	B-T033
in	O
blood	O
potassium	O
concentrations	O
,	O
and	O
hence	O
cancellation	O
of	O
dse	O
in	O
patients	O
with	O
potassium	O
abnormalities	B-T033
does	O
not	O
appear	O
warranted	O
.	O
	
elevated	B-T080
potassium	B-T033
levels	I-T033
are	O
associated	B-T080
with	I-T080
lower	O
rates	O
of	O
clinically	O
significant	O
supraventricular	O
and	O
ventricular	B-T047
arrhythmias	I-T047
.	O
	
while	O
remaining	O
at	O
relatively	O
low	B-T080
risk	B-T078
,	O
patients	O
with	O
very	O
low	B-T080
potassium	B-T033
levels	I-T033
3.1	O
mmol/l	O
at	O
the	O
time	O
of	O
dse	O
have	O
a	O
modestly	O
increased	B-T081
risk	B-T078
of	O
arrhythmia	B-T033
.	O
	
consideration	O
could	O
be	O
given	O
to	O
correcting	O
severe	B-T080
hypokalemia	B-T033
prior	B-T079
to	O
anatomical	B-T080
subgroup	O
analysis	O
of	O
the	O
meridian	O
cohort	O
posterior	B-T033
fossa	I-T033
abnormalities	I-T033
to	O
assess	O
the	O
diagnostic	B-T169
and	O
clinical	B-T080
contribution	O
of	O
in	O
utero	O
magnetic	O
resonance	O
iumr	O
imaging	O
in	O
fetuses	O
diagnosed	B-T033
with	O
abnormalities	B-T033
of	I-T033
the	I-T033
posterior	I-T033
fossa	I-T033
as	O
the	O
only	O
intracranial	B-T033
abnormality	I-T033
recognised	O
on	O
antenatal	O
ultrasonography	O
uss	O
.	O
	
we	O
report	O
a	O
sub-group	O
analysis	O
of	O
fetuses	O
with	O
abnormalities	B-T033
of	I-T033
the	I-T033
posterior	I-T033
fossa	I-T033
diagnosed	B-T033
on	O
antenatal	O
uss	O
with	O
or	O
without	O
ventriculomegaly	O
from	O
the	O
meridian	O
cohort	O
who	O
had	O
iumr	O
imaging	O
within	O
2	O
weeks	O
of	O
uss	O
and	O
outcome	B-T080
reference	B-T078
data	I-T078
were	O
available	B-T169
.	O
	
the	O
diagnostic	B-T080
accuracy	I-T080
of	O
uss	O
and	O
iumr	O
are	O
reported	O
as	O
well	O
as	O
indicators	O
of	O
diagnostic	B-T080
confidence	I-T080
and	O
effects	B-T080
on	O
prognosis	O
and	O
clinical	O
management	O
.	O
	
abnormalities	B-T033
confined	I-T033
to	I-T033
the	I-T033
posterior	I-T033
fossa	I-T033
according	O
to	O
uss	O
were	O
found	O
in	O
81	O
fetuses	O
67	O
with	O
parenchymal	O
and	O
14	O
with	O
csf	O
-containing	O
lesions	B-T033
.	O
	
the	O
overall	O
diagnostic	B-T080
accuracy	I-T080
for	O
detecting	B-T033
an	O
isolated	B-T169
posterior	B-T033
fossa	I-T033
abnormality	I-T033
was	O
65%	O
for	O
uss	O
and	O
88%	O
for	O
iumr	O
difference	B-T081
=	O
22%	O
,	O
95%	O
ci	O
14.0	O
to	O
30.5	O
,	O
p	O
<	O
0.0001	O
.	O
	
there	O
was	O
an	O
improvement	O
in	O
'	O
appropriate	B-T080
'	O
diagnostic	B-T080
confidence	I-T080
as	O
assessed	O
by	O
a	O
score	B-T081
-	O
based	B-T169
weighted	B-T081
average	B-T081
'	O
method	O
p	O
<	O
0.0001	O
and	O
a	O
three-fold	O
reduction	B-T061
in	O
'high	B-T080
confidence	O
but	O
incorrect	B-T080
diagnoses	B-T033
'	O
was	O
achieved	O
by	O
using	O
iumr	O
imaging	O
.	O
	
the	O
prognostic	O
information	O
given	O
to	O
the	O
women	O
after	O
iumr	O
imaging	O
changed	O
in	O
44%	O
of	O
cases	O
and	O
the	O
overall	B-T080
effect	B-T080
of	O
iumr	O
on	O
clinical	O
management	O
was	O
considered	O
to	O
be	O
'	O
significant	B-T078
'	O
,	O
'	O
major	B-T080
'	O
or	O
'	O
decisive	B-T033
'	O
in	O
35%	O
of	O
cases	O
.	O
	
our	O
data	B-T078
suggests	O
that	O
any	O
woman	O
whose	O
fetus	O
has	O
a	O
posterior	B-T033
fossa	I-T033
abnormality	I-T033
as	O
the	O
only	O
intracranial	B-T033
finding	I-T033
on	O
uss	O
should	O
have	O
iumr	O
imaging	O
for	O
further	O
evaluation	O
.	O
	
this	O
is	O
on	O
the	O
basis	B-T169
of	O
improved	B-T033
diagnostic	B-T080
accuracy	I-T080
and	O
confidence	B-T080
which	O
has	O
substantial	B-T080
effects	B-T080
on	O
the	O
prognostic	O
information	O
given	O
to	O
women	O
and	O
changes	O
in	O
clinical	O
management	O
.	O
	
design	O
,	O
synthesis	O
,	O
and	O
evaluation	O
of	O
curcumin	B-T109
derivatives	O
as	O
nrf2	B-T116
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	O
activation	O
of	O
nuclear	B-T116
factor	I-T116
erythroid-2-related	I-T116
factor	I-T116
2	I-T116
nrf2	B-T116
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	O
,	O
and	O
natural	O
curcumin	B-T109
stands	O
out	O
as	O
a	O
potent	O
nrf2	B-T116
activator	O
and	O
cancer	O
chemopreventive	O
agent	O
.	O
	
in	O
this	O
study	O
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	B-T109
analogs	O
by	O
introducing	O
the	O
geminal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nrf2	B-T116
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	O
.	O
	
the	O
geminally	O
dimethylated	O
and	O
catechol	B-T109
-type	O
curcumin	B-T109
analog	O
compound	O
3	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	O
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert-butyl	B-T109
hydroperoxide	I-T109
t-bhp	B-T109
death	O
of	O
hepg2	O
cells	O
.	O
	
mechanism	B-T169
studies	O
indicate	O
that	O
its	O
cytoprotective	O
effects	B-T080
are	O
mediated	O
by	O
activating	O
the	O
nrf2	B-T116
signaling	O
pathway	O
in	O
the	O
michael	O
acceptor	O
-	O
and	O
catechol	B-T109
-dependent	O
manners	O
.	O
	
additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-mediated	O
oxidations	O
of	O
compound	O
3	O
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	B-T109
,	O
contribute	O
significantly	O
to	O
its	O
nrf2	B-T116
-dependent	O
cytoprotection	O
.	O
	
this	O
work	O
provides	O
an	O
example	O
of	O
successfully	O
designing	O
natural	B-T169
curcumin	B-T109
-directed	O
nrf2	B-T116
activators	O
by	O
a	O
stability	O
-increasing	O
and	O
proelectrophilic	O
safe	O
with	O
self-injury	O
a	O
practical	O
guide	O
to	O
understanding	O
,	O
responding	O
and	O
harm-reduction	B-T061
inckle	O
kay	O
safe	O
with	O
self-injury	O
a	O
practical	O
guide	O
to	O
understanding	O
,	O
responding	O
and	O
harm-reduction	B-T061
274pp	O
23.99	O
pccs	O
books	O
9781910919163	O
1910919160	O
formula	O
see	O
text	O
the	O
author	O
begins	O
her	O
book	O
with	O
a	O
concise	B-T081
exploration	B-T169
of	O
the	O
stereotypes	O
and	O
truths	B-T080
of	O
self-harm	O
.	O
	
in	O
the	O
following	O
seven	O
chapters	O
,	O
she	O
sets	O
out	O
a	O
grounded	O
and	O
often	O
challenging	O
view	O
of	O
how	O
self-harm	O
is	O
understood	O
from	O
differing	O
pre-hospital	B-T079
policies	O
for	O
the	O
care	O
of	O
patients	O
with	O
acute	B-T047
coronary	I-T047
syndromes	I-T047
in	O
india	O
a	O
policy	O
document	O
analysis	O
ischemic	O
heart	O
disease	O
is	O
the	O
leading	B-T169
cause	B-T033
of	I-T033
death	I-T033
in	O
india	O
.	O
	
in	O
high-income	B-T033
countries	O
,	O
pre-hospital	O
systems	O
of	O
care	O
have	O
been	O
developed	O
to	O
manage	O
acute	B-T079
manifestations	B-T080
of	I-T080
ischemic	O
heart	O
disease	O
,	O
such	O
as	O
acute	B-T047
coronary	I-T047
syndrome	I-T047
acs	B-T047
.	O
	
however	O
,	O
it	O
is	O
unknown	B-T080
whether	O
guidelines	O
,	O
policies	O
,	O
regulations	O
,	O
or	O
laws	O
exist	O
to	O
guide	O
pre-hospital	B-T079
acs	B-T047
care	O
in	O
india	O
.	O
	
we	O
undertook	O
a	O
nation-wide	O
document	O
analysis	O
to	O
address	O
this	O
gap	O
in	O
knowledge	O
.	O
	
from	O
november	B-T079
2014	O
to	O
may	B-T079
2016	O
,	O
we	O
searched	O
for	O
publicly	B-T080
available	B-T169
emergency	B-T061
care	I-T061
guidelines	O
and	O
legislation	O
addressing	O
pre-hospital	B-T079
acs	B-T047
care	O
in	O
all	O
29	O
indian	O
states	O
and	O
7	O
union	O
territories	O
via	O
internet	O
search	O
and	O
direct	B-T080
correspondence	O
.	O
	
we	O
found	B-T033
two	O
documents	O
addressing	O
pre-hospital	B-T079
acs	B-T047
care	O
.	O
	
though	O
india	O
has	O
legislation	O
mandating	O
acute	O
care	O
for	O
emergencies	O
such	O
as	O
trauma	O
,	O
regulations	O
or	O
laws	O
to	O
guide	O
pre-hospital	B-T079
acs	B-T047
care	O
are	O
largely	O
absent	B-T169
.	O
	
policy	O
makers	O
urgently	B-T079
need	B-T080
to	O
develop	O
comprehensive	B-T080
,	O
multi-stakeholder	B-T080
policies	O
for	O
pre-hospital	B-T079
emergency	O
cardiovascular	O
care	O
in	O
lack	B-T080
of	O
antimicrobial	O
efficacy	B-T080
of	O
mecetronium	B-T109
etilsulfate	I-T109
in	O
propanol	B-T109
-based	O
hand	O
rubs	O
for	O
surgical	B-T061
hand	O
disinfection	O
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
mecetronium	B-T109
etilsulfate	I-T109
mes	B-T109
contributes	O
to	O
overall	O
efficacy	B-T080
in	O
surgical	B-T061
hand	O
disinfection	O
.	O
	
three	O
blinded	O
hand	O
rubs	O
45%	O
iso-propanol	B-T109
,	O
30%	O
n-propanol	B-T109
were	O
applied	B-T169
for	O
1.5	O
min	O
and	O
compared	O
with	O
the	O
en	O
12791	O
reference	O
procedure	B-T169
crossover	O
design	O
.	O
	
one	O
commercial	O
hand	O
rub	O
contained	O
0.2	O
mes	B-T109
,	O
and	O
the	O
two	O
other	O
hand	O
rubs	O
were	O
identical	B-T080
apart	O
from	O
0.2	O
mes	B-T109
.	O
	
none	O
of	O
the	O
formulations	O
had	O
a	O
log10	B-T081
reduction	B-T080
after	O
3	O
h	O
that	O
was	O
significantly	O
better	B-T080
compared	O
with	O
the	O
reference	O
procedure	B-T169
mean	B-T081
1.72	O
standard	B-T081
deviation	I-T081
1.15	O
.	O
	
the	O
antimicrobial	O
contribution	O
of	O
mes	B-T109
in	O
hand	O
rubs	O
skin	O
conductance	O
responses	O
and	O
neural	B-T169
activations	O
during	O
fear	O
conditioning	O
and	O
extinction	O
recall	O
across	O
anxiety	O
disorders	O
the	O
fear	O
conditioning	O
and	O
extinction	O
neurocircuitry	O
has	O
been	O
extensively	B-T080
studied	O
in	O
healthy	B-T080
and	O
clinical	B-T080
populations	O
,	O
with	O
a	O
particular	O
focus	O
on	O
posttraumatic	O
stress	O
disorder	O
.	O
	
despite	O
significant	B-T078
overlap	B-T079
of	O
symptoms	O
between	O
posttraumatic	O
stress	O
disorder	O
and	O
anxiety	O
disorders	O
,	O
the	O
latter	O
has	O
received	B-T080
less	B-T081
attention	O
.	O
	
given	O
that	O
dysregulated	O
fear	O
levels	B-T080
characterize	O
anxiety	O
disorders	O
,	O
examining	O
the	O
neural	B-T169
correlates	B-T080
of	O
fear	O
and	O
extinction	O
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	O
disorders	O
.	O
	
to	O
investigate	B-T169
the	O
psychophysiological	O
and	O
neural	B-T169
correlates	B-T080
of	O
fear	O
conditioning	O
and	O
extinction	O
recall	O
in	O
anxiety	O
disorders	O
and	O
to	O
document	O
how	O
these	O
features	B-T080
differ	O
as	O
a	O
function	B-T169
of	O
multiple	B-T081
diagnoses	B-T033
or	O
anxiety	B-T033
severity	B-T080
.	O
	
this	O
investigation	O
was	O
a	O
cross-sectional	O
,	O
case-control	O
,	O
functional	O
magnetic	O
resonance	O
imaging	O
study	O
at	O
an	O
academic	O
medical	O
center	O
.	O
	
participants	O
were	O
healthy	B-T080
controls	O
and	O
individuals	O
with	O
at	O
least	O
1	O
of	O
the	O
following	B-T079
anxiety	O
disorders	O
generalized	O
anxiety	O
disorder	O
,	O
social	O
anxiety	O
disorder	O
,	O
specific	O
phobia	O
,	O
and	O
panic	O
disorder	O
.	O
	
the	O
study	O
dates	B-T079
were	O
between	O
march	O
2013	O
and	O
may	O
2015	O
.	O
	
two-day	O
fear	O
conditioning	O
and	O
extinction	O
paradigm	O
.	O
	
skin	O
conductance	O
responses	O
,	O
blood	O
oxygenation	O
level-dependent	O
responses	O
,	O
trait	O
anxiety	B-T033
scores	I-T033
from	O
the	O
state	O
trait	O
anxiety	O
inventory	O
-	O
trait	O
form	B-T080
,	O
and	O
functiona	B-T169
l	O
connectivity	B-T169
.	O
	
this	O
study	O
included	O
21	O
healthy	B-T080
controls	O
10	O
women	O
and	O
61	O
individuals	O
with	O
anxiety	O
disorders	O
36	O
women	O
.	O
	
p	B-T081
values	I-T081
reported	O
for	O
the	O
neuroimaging	O
results	O
are	O
all	O
familywise	O
error	B-T080
corrected	B-T080
.	O
	
skin	O
conductance	O
responses	O
during	O
extinction	O
recall	O
did	O
not	O
differ	O
between	O
individuals	O
with	O
anxiety	O
disorders	O
and	O
healthy	B-T080
controls	O
ηp2	B-T081
=	O
0.001	O
,	O
p	O
=	O
79	O
,	O
where	O
ηp2	B-T081
is	O
partial	B-T081
eta	I-T081
squared	I-T081
.	O
	
the	O
anxiety	B-T033
group	O
had	O
lower	B-T080
activation	O
of	O
the	O
ventromedial	O
prefrontal	O
cortex	O
vmpfc	O
during	O
extinction	O
recall	O
ηp2	B-T081
=	O
0.178	O
,	O
p	O
=	O
02	O
.	O
	
a	O
similar	O
hypoactive	B-T033
pattern	O
was	O
found	O
during	O
early	B-T079
conditioning	O
ηp2	B-T081
=	O
0.106	O
,	O
p	O
=	O
009	O
.	O
	
the	O
vmpfc	O
hypoactivation	O
was	O
associated	B-T080
with	I-T080
anxiety	B-T033
symptom	I-T033
severity	B-T080
r	O
=	O
-0	O
,	O
p	O
=	O
01	O
for	O
conditioning	O
and	O
r	O
=	O
-0	O
,	O
p	O
=	O
004	O
for	O
extinction	O
recall	O
and	O
the	O
number	B-T081
of	O
co-occuring	O
anxiety	O
disorders	O
diagnosed	B-T033
ηp2	B-T081
=	O
0.137	O
,	O
p	O
=	O
009	O
for	O
conditioning	O
and	O
ηp2	B-T081
=	O
0.227	O
,	O
p	O
=	O
004	O
for	O
extinction	O
recall	O
.	O
	
psychophysiological	O
interaction	B-T081
analyses	I-T081
revealed	B-T080
that	O
the	O
fear	O
network	O
connectivity	O
differed	O
between	O
healthy	B-T080
controls	O
and	O
the	O
anxiety	B-T033
group	O
during	O
fear	O
learning	O
ηp2	B-T081
range	B-T081
between	O
0.088	O
and	O
0.176	O
and	O
p	B-T081
range	B-T081
between	O
0.02	O
and	O
0.003	O
and	O
extinction	O
recall	O
ηp2	B-T081
range	B-T081
between	O
0.111	O
and	O
0.235	O
and	O
p	B-T081
range	B-T081
between	O
0.02	O
and	O
0.002	O
.	O
	
despite	O
no	O
skin	O
conductance	O
response	O
group	O
differences	B-T081
during	O
extinction	O
recall	O
,	O
brain	O
activation	O
patterns	O
between	O
anxious	O
and	O
healthy	B-T080
individuals	O
differed	O
.	O
	
these	O
findings	B-T033
encourage	O
future	B-T079
studies	O
to	O
examine	O
the	O
conditions	B-T080
longitudinally	O
and	O
in	O
the	O
context	B-T078
of	O
treatment	O
trials	O
to	O
improve	B-T033
and	O
guide	B-T061
therapeutics	I-T061
via	O
advanced	B-T080
neurobiological	O
understanding	O
of	O
each	O
extracellular	O
vesicles	O
from	O
bone	O
marrow	O
derived	O
mesenchymal	O
stem	O
cells	O
protect	B-T033
against	O
murine	O
hepatic	O
ischemia	O
-	O
reperfusion	O
injury	O
hepatic	O
ischemia-reperfusion	O
injury	O
iri	O
and	O
associated	O
inflammation	O
contributes	O
to	O
liver	O
dysfunction	O
and	O
complications	O
after	O
liver	O
surgery	O
and	O
transplantation	O
.	O
	
mesenchymal	O
stem	O
cells	O
msc	O
have	O
been	O
reported	O
to	O
reduce	O
hepatic	O
iri	O
because	O
of	O
their	O
reparative	O
immunomodulatory	O
effects	O
in	O
injured	O
tissues	O
.	O
	
recent	O
studies	O
have	O
highlighted	O
beneficial	O
effects	O
of	O
extracellular	O
vesicles	O
from	O
mscs	O
msc	O
-	O
ev	O
on	O
tissue	O
injury	O
.	O
	
the	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	O
marrow	O
derived	O
msc	O
-	O
ev	O
were	O
evaluated	O
in	O
an	O
experimental	O
murine	O
model	O
of	O
hepatic	O
iri	O
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	O
and	O
portal	O
vein	O
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O
	
compared	O
with	O
controls	O
,	O
intravenous	O
administration	O
of	O
msc	O
-	O
ev	O
30	O
minutes	O
prior	O
to	O
iri	O
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	O
,	O
decreased	O
caspase-3	O
positive	O
and	O
apoptotic	O
cells	O
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O
	
msc	O
-	O
ev	O
increased	O
hepatic	O
mrna	O
expression	O
of	O
nacht	O
,	O
lrr	O
and	O
pyd	O
domains-containing	O
protein	O
12	O
nlrp12	O
,	O
and	O
the	O
chemokine	O
c-x-c	O
motif	O
ligand	O
1	O
cxcl1	O
,	O
and	O
reduced	O
mrna	O
expression	O
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
il-6	O
during	O
iri	O
.	O
	
msc	O
-	O
ev	O
increased	O
cell	O
viability	O
and	O
suppressed	O
both	O
oxidative	O
injury	O
and	O
nf-κb	O
activity	O
in	O
aml12	O
murine	O
hepatocytes	O
in	O
vitro	O
.	O
	
in	O
conclusion	O
,	O
the	O
administration	O
of	O
ev	O
derived	O
from	O
bone	O
marrow	O
derived	O
mscs	O
may	O
ameliorate	O
hepatic	O
iri	O
by	O
reducing	O
hepatic	O
injury	O
through	O
modulation	O
of	O
the	O
inflammatory	O
response	O
.	O
	
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
	
all	O
rights	O
nucleic	O
acid	O
detection	O
with	O
crispr	O
-	O
cas13a	B-T116
/	O
c2c2	B-T116
rapid	B-T080
,	O
inexpensive	O
,	O
and	O
sensitive	B-T169
nucleic	O
acid	O
detection	O
may	O
aid	B-T080
point-of-care	B-T078
pathogen	O
detection	B-T061
,	O
genotyping	O
,	O
and	O
disease	B-T047
monitoring	O
.	O
	
the	O
rna	O
-guided	O
,	O
rna	O
-	O
targeting	B-T169
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
crispr	O
effector	B-T116
cas13a	B-T116
previously	O
known	O
as	O
c2c2	B-T116
exhibits	O
a	O
""""	O
collateral	O
effect	B-T080
""""	O
of	O
promiscuous	O
ribonuclease	O
activity	O
upon	O
target	B-T169
recognition	O
.	O
	
we	O
combine	B-T080
the	O
collateral	O
effect	B-T080
of	O
cas13a	B-T116
with	O
isothermal	O
amplification	O
to	O
establish	B-T080
a	O
crispr	O
-based	O
diagnostic	B-T169
crispr	O
-	O
dx	B-T169
,	O
providing	O
rapid	B-T080
dna	O
or	O
rna	O
detection	B-T061
with	O
attomolar	B-T081
sensitivity	I-T081
and	O
single-base	O
mismatch	B-T080
specificity	B-T081
.	O
	
we	O
use	O
this	O
cas13a	B-T116
-based	O
molecular	B-T080
detection	B-T061
platform	O
,	O
termed	O
specific	O
high-sensitivity	O
enzymatic	O
reporter	O
unlocking	O
sherlock	O
,	O
to	O
detect	B-T033
specific	B-T080
strains	O
of	O
zika	O
and	O
dengue	O
virus	O
,	O
distinguish	O
pathogenic	O
bacteria	O
,	O
genotype	O
human	O
dna	O
,	O
and	O
identify	B-T080
mutations	O
in	O
cell-free	O
tumor	O
dna	O
.	O
	
furthermore	O
,	O
sherlock	O
reaction	B-T169
reagents	O
can	O
be	O
lyophilized	O
for	O
cold-chain	O
independence	O
and	O
long-term	B-T079
storage	B-T169
and	O
be	O
readily	O
reconstituted	O
on	O
paper	O
for	O
field	O
applications	O
.	O
	
a	O
plea	O
for	O
thoracoscopic	O
resection	B-T061
of	O
solitary	O
pulmonary	O
nodule	O
in	O
cancer	O
patients	O
solitary	O
pulmonary	O
nodules	O
spn	O
are	O
frequently	O
detected	B-T033
in	O
cancer	O
patients	O
.	O
	
these	O
lesions	B-T033
are	O
often	O
considered	O
as	O
pulmonary	O
metastases	O
and	O
increasingly	B-T169
treated	B-T169
by	O
non-surgical	B-T061
techniques	I-T061
without	O
histological	B-T169
confirmation	B-T033
.	O
	
the	O
aim	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
histological	B-T169
nature	B-T169
of	O
spn	O
resected	B-T080
by	O
thoracoscopy	O
and	O
to	O
identify	O
risk	B-T033
factors	I-T033
of	O
malignancy	O
.	O
	
single-institution	O
retrospective	O
analysis	O
of	O
all	O
consecutive	B-T080
patients	O
with	O
previously	O
known	O
malignancies	O
who	O
underwent	O
thoracoscopic	O
resection	B-T061
of	O
spn	O
with	O
unknown	B-T080
diagnosis	B-T033
between	O
2001	O
and	O
2014	O
.	O
	
one	O
hundred	O
and	O
forty	O
cancer	O
patients	O
underwent	O
thoracoscopic	O
resection	B-T061
of	O
a	O
spn	O
.	O
	
the	O
resected	B-T080
spn	O
was	O
benign	B-T080
in	O
34	O
patients	O
24.3	O
and	O
malignant	B-T080
in	O
106	O
patients	O
.	O
	
the	O
latter	O
were	O
metastasis	O
in	O
70	O
patients	O
50%	O
and	O
a	O
primary	B-T080
lung	O
cancer	O
in	O
36	O
patients	O
25.7	O
.	O
	
upon	O
univariate	O
analysis	O
,	O
malignancy	O
was	O
significantly	O
associated	B-T080
with	I-T080
age	O
>60	O
years	B-T079
,	O
disease	B-T047
-free	O
interval	B-T079
24	O
months	B-T079
,	O
spn	O
size	O
>8	O
mm	O
,	O
upper	O
lobe	O
localization	B-T169
and	O
suvmax	B-T081
>	O
2.5	O
on	O
pet-ct	O
.	O
	
upon	O
multivariate	B-T081
analysis	I-T081
,	O
upper	O
lobe	O
localization	B-T169
and	O
suvmax	B-T081
>	O
2.5	O
were	O
associated	B-T080
with	I-T080
malignancy	O
.	O
	
smoking	O
was	O
significantly	O
associated	B-T080
with	I-T080
spn	O
containing	O
primary	B-T080
lung	O
cancer	O
.	O
	
in	O
this	O
series	B-T081
,	O
only	O
50%	O
of	O
spn	O
in	O
patients	O
with	O
known	O
malignant	B-T047
disease	I-T047
were	O
pulmonary	O
metastases	O
and	O
25%	O
had	O
a	O
newly	B-T080
diagnosed	I-T080
nsclc	O
.	O
	
smoking	O
was	O
associated	B-T080
with	I-T080
primary	B-T080
lung	O
cancer	O
but	O
no	B-T033
other	O
predictor	B-T078
was	O
found	O
to	O
allow	O
the	O
distinction	O
between	O
pulmonary	O
metastasis	O
and	O
lung	O
cancer	O
.	O
	
these	O
results	O
endorse	O
the	O
need	O
of	O
histological	B-T169
confirmation	B-T033
of	O
spn	O
in	O
patients	O
with	O
previous	B-T079
malignancies	O
to	O
avoid	O
diagnostic	B-T169
uncertainty	B-T033
and	O
suboptimal	B-T080
treatments	B-T061
.	O
	
reliability	B-T080
of	O
fear	O
assessment	O
in	O
growing	B-T033
pigs	O
exposed	B-T080
to	I-T080
a	O
novel	B-T080
object	O
test	B-T169
in	O
commercial	O
conditions	B-T080
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
reliability	B-T080
and	O
feasibility	O
of	O
a	O
novel	B-T080
object	O
test	B-T169
assessing	O
fear	O
in	O
pigs	O
in	O
commercial	O
conditions	B-T080
.	O
	
a	O
total	O
of	O
18	O
commercial	O
farms	O
were	O
visited	O
,	O
and	O
321	O
pens	O
housing	O
4	O
growing	B-T033
pigs	O
were	O
assessed	O
.	O
	
three	O
balloons	O
were	O
used	O
as	O
a	O
novel	O
stimulus	O
.	O
	
measures	B-T081
were	O
a	O
the	O
time	B-T079
it	O
took	O
for	O
the	O
first	O
pig	O
to	O
contact	O
1	O
of	O
the	O
balloons	O
,	O
b	O
percentage	O
of	O
nonhuman	O
animals	O
watching	O
the	O
balloons	O
each	O
for	O
10	O
s	O
,	O
and	O
c	O
percentage	O
of	O
animals	O
touching	B-T169
the	O
balloons	O
during	O
periods	B-T079
of	O
5	O
s	O
.	O
	
the	O
time	B-T079
of	O
the	O
first	O
pig	O
to	O
contact	O
1	O
of	O
the	O
balloons	O
ranged	B-T081
from	O
0	O
s	O
to	O
362	O
s	O
.	O
	
an	O
effect	B-T080
of	O
the	O
farm	O
was	O
found	O
p	O
<	O
0001	O
for	O
contact	O
latency	B-T079
,	O
ranging	B-T081
from	O
6.8	O
s	O
to	O
73.3	O
s	O
,	O
but	O
little	O
difference	B-T080
was	O
found	O
in	O
terms	O
of	O
intrafarm	O
variability	O
.	O
	
interobserver	O
repeatability	O
was	O
also	O
high	B-T080
in	O
this	O
measure	B-T081
,	O
ranging	B-T081
from	O
r	O
=	O
74	O
to	O
r	O
=	O
96	O
.	O
	
as	O
a	O
result	O
,	O
it	O
is	O
concluded	O
that	O
contact	O
latency	B-T079
could	O
be	O
a	O
good	O
measure	B-T081
to	O
assess	O
fear	O
of	O
a	O
novel	O
stimulus	O
in	O
commercial	O
farms	O
.	O
	
precise	O
prediction	B-T078
of	O
activators	O
for	O
the	O
human	O
constitutive	B-T116
androstane	I-T116
receptor	I-T116
using	O
structure	O
-based	O
three-dimensional	B-T081
quantitative	I-T081
structure-activity	I-T081
relationship	I-T081
methods	O
the	O
constitutive	B-T116
androstane	I-T116
receptor	I-T116
car	B-T116
,	O
nr1i3	B-T116
regulates	O
the	O
expression	O
of	O
numerous	B-T081
drug-metabolizing	O
enzymes	B-T116
and	O
transporters	B-T116
.	O
	
the	O
upregulation	O
of	O
various	O
enzymes	B-T116
,	O
including	O
cyp2b6	B-T116
,	O
by	O
car	B-T116
activators	O
is	O
a	O
critical	O
problem	O
leading	O
to	O
clinically	O
severe	B-T080
drug-drug	O
interactions	O
ddis	O
.	O
	
to	O
date	O
,	O
however	O
,	O
few	O
effective	B-T080
computational	O
approaches	O
for	O
identifying	O
car	B-T116
activators	O
exist	O
.	O
	
in	O
this	O
study	O
,	O
we	O
aimed	O
to	O
develop	O
three-dimensional	B-T081
quantitative	I-T081
structure-activity	I-T081
relationship	I-T081
3d-qsar	B-T081
models	O
to	O
predict	O
the	O
car	B-T116
activating	O
potency	B-T080
of	O
compounds	O
emerging	O
in	O
the	O
drug-discovery	O
process	O
.	O
	
models	O
were	O
constructed	O
using	O
comparative	O
molecular	O
field	O
analysis	O
comfa	O
based	O
on	O
the	O
molecular	O
alignments	B-T081
of	O
ligands	O
binding	O
to	O
car	B-T116
,	O
which	O
were	O
obtained	O
from	O
ensemble	O
ligand-docking	O
using	O
28	O
compounds	O
as	O
a	O
training	O
set	O
.	O
	
the	O
comfa	O
model	O
,	O
modified	B-T080
by	I-T080
adding	O
a	O
lipophilic	B-T081
parameter	B-T081
with	O
calculated	O
logd7.4	O
s+logd7	O
,	O
demonstrated	O
statistically	O
good	O
predictive	B-T080
ability	I-T080
r	O
=	O
0.99	O
,	O
q	O
=	O
0.74	O
.	O
	
we	O
also	O
confirmed	O
the	O
excellent	O
predictability	B-T081
of	O
the	O
3d-qsar	B-T081
model	O
for	O
car	B-T116
activation	O
r	O
=	O
0.71	O
using	O
seven	O
compounds	O
as	O
a	O
test	O
set	O
for	O
external	O
validation	O
.	O
	
collectively	O
,	O
our	O
results	B-T169
indicate	O
that	O
the	O
3d-qsar	B-T081
model	O
developed	O
in	O
this	O
study	O
provides	O
precise	B-T080
prediction	B-T078
of	O
car	B-T116
activating	O
potency	B-T080
and	O
,	O
thus	O
,	O
should	O
be	O
useful	O
for	O
selecting	O
drug	O
candidates	O
with	O
minimized	B-T080
ddi	O
risk	B-T078
related	O
to	O
enzyme-induction	O
in	O
the	O
early	B-T079
drug-discovery	O
stage	B-T079
.	O
	
effects	B-T080
of	I-T080
sirna	O
-mediated	O
suppression	O
of	O
hpv-11	O
l1	O
expression	O
on	O
the	O
proliferation	O
and	O
apoptosis	O
of	O
vaginal	O
epithelial	O
cells	O
the	O
aim	B-T078
of	O
the	O
present	O
study	O
was	O
to	O
investigate	B-T169
the	O
effects	B-T080
of	I-T080
human	B-T047
papillomavirus	I-T047
hpv	I-T047
infection	I-T047
on	O
the	O
gynecological	B-T047
disease	I-T047
of	O
vaginitis	B-T047
and	O
to	O
demonstrate	O
how	O
the	O
small	O
interfering	O
rna	O
sirna	O
method	O
may	O
be	O
used	O
for	O
hpv	O
prevention	B-T061
in	O
the	O
clinic	O
.	O
	
human	O
vaginal	O
epithelial	O
cells	O
were	O
transfected	O
with	O
hpv-11	O
l1	O
expression	O
vector	O
and	O
sirna	O
-	O
hpv-11	O
l1	O
vectors	O
and	O
a	O
control	O
group	O
was	O
transfected	O
with	O
scrambled	O
sirna	O
.	O
	
cell	O
proliferation	O
in	O
each	O
group	O
was	O
analyzed	O
using	O
the	O
mtt	O
assay	O
and	O
the	O
expression	O
of	O
apoptosis	O
-associated	O
proteins	B-T116
was	O
measured	B-T080
by	O
western	O
blot	O
analysis	O
.	O
	
compared	O
with	O
the	O
control	O
group	O
,	O
hpv-11	O
l1	O
mrna	O
and	O
protein	O
levels	O
were	O
significantly	O
increased	B-T081
following	O
transfection	O
with	O
the	O
hpv-11	O
l1	O
expression	O
vector	O
in	O
cells	O
p<0	O
,	O
but	O
this	O
result	O
was	O
significantly	O
reversed	O
by	O
silencing	O
of	O
hpv-11	O
l1	O
p<0	O
.	O
	
in	O
addition	O
,	O
cell	O
proliferation	O
in	O
the	O
hpv-11	B-T078
group	I-T078
was	O
lower	B-T080
than	O
that	O
in	O
the	O
control	O
group	O
however	O
,	O
cell	O
proliferation	O
was	O
significantly	O
increased	B-T081
in	O
cells	O
transfected	O
with	O
silenced	O
l1	O
compared	O
with	O
that	O
in	O
the	O
control	O
group	O
p<0	O
.	O
	
furthermore	O
,	O
silencing	O
of	O
hpv-11	O
l1	O
significantly	O
decreased	B-T081
caspase-3	O
and	O
caspase-9	O
expressions	O
in	O
cells	O
,	O
whereas	O
the	O
expression	O
was	O
increased	B-T081
in	O
the	O
hpv-11	O
l1	O
group	O
p<0	O
.	O
	
the	O
present	O
study	O
suggested	O
that	O
sirna	O
-mediated	O
silencing	O
of	O
hpv-11	O
l1	O
may	O
have	O
potential	O
therapeutic	B-T061
applications	I-T061
for	O
treating	O
gynecological	B-T047
diseases	I-T047
associated	B-T080
with	I-T080
hpv-11	O
infection	O
.	O
	
an	O
evaluation	O
of	O
neuroendocrine	O
dysfunction	O
following	O
acute	B-T079
aneurysmal	O
subarachnoid	O
hemorrhage	O
a	O
prospective	O
study	O
the	O
aim	B-T078
was	O
to	O
investigate	B-T169
the	O
incidence	O
and	O
pattern	O
of	O
neuroendocrine	O
changes	O
in	O
cases	O
of	O
acute	B-T079
aneurysmal	O
subarachnoid	O
hemorrhage	O
sah	O
.	O
	
endocrine	O
assessment	O
was	O
performed	O
in	O
100	O
consecutive	O
cases	O
of	O
acute	B-T079
aneurysmal	O
sah	O
presenting	O
within	O
7	O
days	B-T079
of	O
ictus	B-T047
.	O
	
the	O
gonadotropic	B-T116
,	O
somatotrophic	B-T116
,	O
thyrotropic	B-T116
,	O
and	O
corticotrophic	B-T116
axes	O
were	O
evaluated	O
for	O
their	O
possible	O
dysfunction	O
.	O
	
a	O
total	O
of	O
100	O
cases	O
38	O
males	O
,	O
62	O
females	O
age	O
range	B-T081
-	O
17-76	O
years	B-T079
mean	B-T081
age	O
-	O
43.6	O
years	B-T079
of	O
acute	B-T079
sah	O
were	O
studied	O
.	O
	
the	O
aneurysms	B-T047
were	O
located	O
in	O
the	O
anterior	O
circulation	O
n	O
=	O
95	O
and	O
posterior	O
circulation	O
n	O
=	O
5	O
.	O
	
the	O
most	O
common	O
hormone	B-T047
deficiency	I-T047
was	O
of	O
growth	B-T116
hormone	I-T116
n	O
=	O
67	O
,	O
followed	O
by	O
gonadotrophin	B-T116
n	O
=	O
50	O
,	O
corticotrophin	B-T116
n	O
=	O
49	O
and	O
thyrotrophin	B-T116
n	O
=	O
35	O
.	O
	
hyperprolactinemia	B-T047
was	O
noted	O
in	O
10	O
cases	O
.	O
	
one-pituitary	B-T033
hormone	I-T033
axis	I-T033
deficiency	I-T033
was	O
noted	O
in	O
26	O
cases	O
while	O
67	O
cases	O
had	O
two	O
or	O
more	O
pituitary	B-T116
hormone	I-T116
axes	O
dysfunction	O
.	O
	
a	O
total	O
of	O
93	O
cases	O
had	O
hormonal	O
dysfunction	O
in	O
one	O
or	O
more	O
pituitary	B-T116
hormone	I-T116
axes	I-T116
,	O
and	O
seven	O
cases	O
had	O
no	O
hormonal	O
dysfunction	O
.	O
	
endocrine	B-T047
dysfunction	I-T047
occurs	O
in	O
93%	O
cases	O
of	O
acute	B-T079
sah	O
and	O
multiple	O
pituitary	B-T116
hormone	I-T116
axes	I-T116
dysfunction	O
occurs	O
in	O
67%	O
cases	O
.	O
	
it	O
is	O
suggested	O
that	O
hormonal	O
evaluation	O
should	O
be	O
considered	O
as	O
part	O
of	O
management	O
of	O
acute	B-T079
sah	O
.	O
	
validity	B-T081
and	O
reliability	B-T081
of	O
fluoroscopy	O
for	O
digital	O
radiography	O
a	O
new	O
way	O
to	O
evaluate	O
diaphragmatic	O
mobility	O
fluoroscopy	O
is	O
considered	O
the	O
most	O
accurate	O
method	O
to	O
evaluate	O
the	O
diaphragm	O
,	O
yet	O
most	O
existing	O
methods	O
for	O
measuring	O
diaphragmatic	O
mobility	O
using	O
fluoroscopy	O
are	O
complex	O
.	O
	
to	O
assess	O
the	O
validity	B-T081
and	O
reliability	B-T081
of	O
a	O
new	O
evaluation	O
method	O
of	O
diaphragmatic	O
motion	O
using	O
fluoroscopy	O
by	O
digital	O
radiography	O
of	O
healthy	B-T080
adults	O
.	O
	
twenty-six	O
adults	O
were	O
evaluated	O
,	O
according	O
to	O
the	O
parameters	O
anthropometry	O
and	O
pulmonary	O
function	O
test	O
.	O
	
the	O
evaluation	O
of	O
diaphragm	O
mobility	O
by	O
means	O
of	O
fluoroscopy	O
by	O
digital	O
radiography	O
method	O
was	O
randomly	O
conducted	O
by	O
two	O
raters	O
a	O
and	O
b	O
.	O
	
the	O
pearson	B-T081
correlation	I-T081
coefficient	I-T081
and	O
the	O
intraclass	B-T081
correlation	I-T081
coefficient	I-T081
icc	B-T081
were	O
used	O
to	O
assess	O
the	O
concurrent	O
validity	B-T081
.	O
	
the	O
inter-rater	O
and	O
intra-rater	O
reliability	B-T081
of	O
the	O
measurement	B-T169
of	O
diaphragmatic	O
motion	O
was	O
determined	O
using	O
icc	B-T081
and	O
a	O
confidence	O
interval	O
of	O
95%	O
.	O
	
there	O
was	O
a	O
relationship	B-T080
in	O
the	O
assessment	O
of	O
the	O
concurrent	O
validity	B-T081
.	O
	
there	O
was	O
good	O
inter-rater	O
reliability	B-T081
for	O
right	O
hemidiaphragm	O
mobility	O
and	O
moderate	O
reliability	B-T081
for	O
left	O
hemidiaphragm	O
in	O
the	O
first	O
assessment	O
.	O
	
in	O
the	O
second	O
assessment	O
,	O
there	O
was	O
good	O
reliability	B-T081
for	O
the	O
mobility	O
of	O
both	O
hemidiaphragms	O
.	O
	
there	O
was	O
good	O
intra-rater	O
reliability	B-T081
in	O
the	O
mobility	O
of	O
both	O
hemidiaphragms	O
for	O
raters	O
a	O
and	O
b	O
.	O
	
the	O
evaluation	O
of	O
diaphragmatic	O
motion	O
using	O
fluoroscopy	O
by	O
digital	O
radiography	O
proved	O
to	O
be	O
a	O
valid	B-T080
and	O
reliable	B-T080
method	O
of	O
healthy	B-T080
adults	O
.	O
	
loss	B-T080
of	I-T080
control	I-T080
over	O
alcohol	O
seeking	O
in	O
rats	O
depends	O
on	O
individual	O
vulnerability	B-T033
and	O
duration	O
of	O
alcohol	O
consumption	O
experience	O
alcohol	O
use	O
disorder	O
aud	O
is	O
characterized	O
by	O
excessive	B-T033
alcohol	I-T033
use	I-T033
and	O
persistent	B-T079
alcohol	O
seeking	O
despite	O
knowledge	O
of	O
its	O
negative	O
consequences	O
.	O
	
importantly	O
,	O
aud	O
typically	O
develops	O
after	O
chronic	B-T079
excessive	B-T033
alcohol	I-T033
use	I-T033
in	O
a	O
subgroup	O
of	O
individuals	O
who	O
drink	B-T033
alcohol	I-T033
,	O
suggesting	O
that	O
aud	O
results	O
from	O
an	O
interaction	B-T169
between	O
individual	O
vulnerability	B-T033
and	O
prolonged	O
alcohol	O
exposure	O
.	O
	
the	O
present	O
study	O
assessed	O
the	O
contribution	O
of	O
prolonged	O
exposure	O
to	O
alcohol	O
and	O
individual	O
levels	O
of	O
alcohol	O
intake	O
to	O
the	O
development	B-T169
of	O
loss	B-T080
of	I-T080
control	I-T080
over	O
alcohol	O
seeking	O
in	O
a	O
conditioned	O
suppression	O
model	O
.	O
	
to	O
investigate	B-T169
the	O
impact	O
of	O
prolonged	O
alcohol	O
exposure	O
,	O
conditioned	B-T169
suppression	I-T169
of	O
alcohol	O
seeking	O
was	O
assessed	O
after	O
2	O
and	O
4	O
months	O
of	O
intermittent	B-T079
alcohol	I-T079
access	I-T079
iaa	B-T079
in	O
a	O
subgroup	O
of	O
rats	O
drinking	O
moderate	O
amounts	O
of	O
alcohol	O
.	O
	
we	O
observed	O
that	O
suppression	B-T169
of	O
alcohol	O
seeking	O
was	O
reduced	O
after	O
4	O
months	O
compared	O
with	O
2	O
months	O
of	O
iaa	B-T079
.	O
	
the	O
influence	O
of	O
individual	O
levels	O
of	O
alcohol	O
intake	O
on	O
loss	B-T080
of	I-T080
control	I-T080
over	O
alcohol	O
seeking	O
was	O
subsequently	O
determined	B-T080
by	I-T080
assessing	O
conditioned	B-T169
suppression	I-T169
in	O
subgroups	O
of	O
low	B-T080
and	I-T080
high	I-T080
alcohol	I-T080
drinking	I-T080
rats	O
.	O
	
unlike	O
the	O
low	B-T080
alcohol	I-T080
drinking	I-T080
rats	O
,	O
the	O
high	B-T080
alcohol	I-T080
drinking	I-T080
rats	O
showed	O
aversion-resistant	B-T169
alcohol	O
seeking	O
after	O
2	O
months	O
of	O
iaa	B-T079
,	O
although	O
both	O
groups	B-T078
showed	O
comparable	O
levels	O
of	O
conditioned	O
freezing	O
.	O
	
these	O
findings	O
show	O
that	O
the	O
development	O
of	O
loss	B-T080
of	I-T080
control	I-T080
over	O
alcohol	O
seeking	O
,	O
a	O
key	O
characteristic	O
of	O
aud	O
in	O
humans	O
,	O
is	O
dependent	O
on	O
both	O
the	O
extent	O
of	O
alcohol	O
exposure	O
and	O
the	O
individual's	O
neural	B-T169
correlates	O
of	O
experimental	B-T080
trauma	O
memory	O
retrieval	O
traumatic	B-T169
memories	O
such	O
as	O
intrusions	O
and	O
flashbacks	B-T033
play	O
a	O
major	O
role	O
in	O
the	O
development	B-T169
and	O
maintenance	O
of	O
post-traumatic	O
stress	O
disorder	O
ptsd	O
.	O
	
a	O
thorough	O
understanding	O
of	O
the	O
neural	B-T169
mechanisms	B-T169
underlying	O
traumatic	B-T169
memories	O
is	O
indispensable	O
for	O
precise	O
diagnosis	B-T033
,	O
for	O
personalized	B-T080
treatment	B-T061
and	O
prevention	B-T061
.	O
	
in	O
particular	O
,	O
the	O
identification	B-T080
of	O
early	O
neural	B-T169
predictor	O
variables	O
for	O
intrusion	O
development	B-T169
shortly	O
after	O
trauma	O
exposure	B-T080
requires	O
detailed	O
investigation	O
.	O
	
here	O
,	O
we	O
examined	B-T033
the	O
neural	O
correlates	O
of	O
early	O
experimental	B-T080
trauma	O
memory	O
retrieval	O
in	O
a	O
traumatic	O
film	O
paradigm	O
in	O
42	O
young	O
healthy	B-T080
females	O
,	O
using	O
both	O
implicit	B-T033
and	O
explicit	O
retrieval	O
tasks	O
.	O
	
we	O
show	O
that	O
implicit	B-T033
experimental	B-T080
trauma	O
retrieval	O
specifically	O
involved	O
the	O
retrosplenial	O
cortex	O
and	O
the	O
anterior	O
cingulate	O
cortex	O
acc	O
,	O
while	O
both	O
retrieval	O
tasks	O
resulted	O
in	O
trauma-related	B-T033
activity	O
in	O
the	O
posterior	O
cingulate	O
cortex	O
pcc	O
and	O
the	O
precuneus	O
.	O
	
importantly	O
,	O
neural	B-T169
activity	O
early	O
after	O
experimental	B-T080
trauma	O
exposure	B-T080
predicted	B-T078
later	O
intrusion	O
development	B-T169
,	O
with	O
independent	B-T078
contributions	O
from	O
activity	O
in	O
the	O
retrosplenial	O
cortex	O
implicit	B-T033
retrieval	O
and	O
the	O
pcc	O
explicit	O
retrieval	O
.	O
	
additional	B-T169
analyses	O
revealed	B-T080
a	O
stronger	O
connectivity	B-T169
between	O
the	O
bilateral	O
amygdala	O
and	O
the	O
supplementary	O
motor	O
area	O
,	O
precentral	O
and	O
paracentral	O
lobule	O
for	O
the	O
control	O
group	O
compared	O
to	O
the	O
experimental	B-T080
trauma	O
group	B-T078
.	O
	
our	O
study	O
gives	O
new	O
insights	O
in	O
the	O
neural	B-T169
correlates	O
of	O
experimental	B-T080
trauma	O
memory	O
retrieval	O
and	O
their	O
predictive	B-T080
value	I-T080
for	O
subsequent	B-T079
symptom	O
development	B-T169
.	O
	
our	O
results	B-T169
could	O
provide	O
the	O
basis	O
for	O
personalized	B-T080
early	O
treatment	O
and	O
prevention	B-T080
of	O
ptsd	O
.	O
	
targeting	O
the	O
nrf2	B-T116
/	O
amyloid-beta	O
liaison	O
in	O
alzheimer's	B-T047
disease	I-T047
a	O
rational	B-T081
approach	I-T081
amyloid	B-T116
is	O
a	O
prominent	B-T080
feature	B-T080
of	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
.	O
	
yet	O
,	O
a	O
linear	O
linkage	B-T080
between	O
amyloid-β	B-T116
peptide	I-T116
aβ	B-T116
and	O
the	O
disease	B-T079
onset	I-T079
and	O
progression	O
has	O
recently	O
been	O
questioned	O
.	O
	
in	O
this	O
context	B-T078
,	O
the	O
crucial	O
partnership	B-T080
between	O
aβ	O
and	O
nrf2	O
pathways	O
is	O
acquiring	B-T080
paramount	B-T080
importance	B-T080
,	O
offering	O
prospects	O
for	O
deciphering	B-T169
the	O
aβ	B-T116
-centered	O
disease	B-T047
network	B-T169
.	O
	
here	O
,	O
we	O
report	O
on	O
a	O
new	B-T080
class	O
of	O
antiaggregating	O
agents	O
rationally	O
designed	O
to	O
simultaneously	B-T079
activate	O
transcription	O
-based	O
antioxidant	O
responses	O
,	O
whose	O
lead	O
1	O
showed	O
interesting	O
properties	B-T080
in	O
a	O
preliminary	B-T079
investigation	O
.	O
	
relying	O
on	O
the	O
requirements	B-T033
of	O
aβ	B-T116
recognition	O
,	O
we	O
identified	B-T080
the	O
catechol	O
derivative	O
12	O
.	O
	
in	O
sh-sy5y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	B-T080
remarkable	O
free	O
radical	O
scavenger	O
properties	B-T080
to	O
the	O
ability	O
to	O
trigger	B-T080
the	O
nrf2	O
pathway	O
and	O
induce	O
the	O
nrf2	B-T116
-	O
dependent	B-T169
defensive	B-T033
gene	O
nqo1	O
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	O
.	O
	
moreover	O
,	O
12	O
prevented	O
the	O
formation	B-T169
of	O
cytotoxic	B-T169
stable	B-T080
oligomeric	O
intermediates	O
,	O
being	O
significantly	B-T078
more	B-T081
effective	B-T080
,	O
and	O
per	O
se	O
less	O
toxic	O
,	O
than	O
prototype	O
1	O
.	O
	
more	O
importantly	O
,	O
as	O
different	B-T080
chemical	O
features	O
were	O
exploited	O
to	O
regulate	O
nrf2	O
and	O
aβ	B-T116
activities	O
,	O
the	O
two	O
pathways	O
could	O
be	O
tuned	O
independently	O
.	O
	
these	O
findings	O
point	O
to	O
compound	O
12	O
and	O
its	O
derivatives	O
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	B-T169
potential	B-T080
of	O
the	O
nrf2	B-T116
/	O
aβ	B-T116
cellular	O
network	B-T169
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	O
leads	O
to	O
confront	O
young	B-T079
people	O
,	O
mental	O
health	O
practitioners	O
and	O
researchers	O
co-produce	O
a	O
transition	O
preparation	O
programme	O
to	O
improve	O
outcomes	B-T169
and	O
experience	O
for	O
young	B-T079
people	O
leaving	O
child	O
and	O
adolescent	O
mental	O
health	O
services	O
camhs	O
in	O
the	O
uk	O
young	B-T079
people	O
attending	O
child	O
and	O
adolescent	O
mental	O
health	O
services	O
camhs	O
are	O
required	O
to	O
move	O
on	O
,	O
either	O
through	O
discharge	B-T079
or	O
referral	O
to	O
an	O
adult	O
service	O
,	O
at	O
age	O
17/18	O
,	O
a	O
period	B-T079
of	O
increased	B-T081
risk	B-T078
for	O
onset	B-T080
of	I-T080
mental	B-T033
health	I-T033
problems	I-T033
and	O
other	O
complex	B-T080
psychosocial	B-T169
and	O
physical	B-T169
changes	B-T169
.	O
	
camhs	O
transitions	O
are	O
often	O
poorly	O
managed	O
with	O
negative	B-T033
outcomes	B-T169
for	O
young	B-T079
people	O
.	O
	
better	O
preparation	O
may	O
improve	O
outcomes	B-T169
and	O
experience	O
.	O
	
this	O
study	O
aimed	O
to	O
co-produce	O
,	O
with	O
young	B-T079
people	O
who	O
had	O
transitioned	O
or	O
were	O
facing	O
transition	O
from	O
camhs	O
,	O
a	O
camhs	O
transition	O
preparation	O
programme	O
tpp	O
,	O
deliverable	O
in	O
routine	B-T080
nhs	O
settings	O
.	O
	
eighteen	O
young	B-T079
people	O
,	O
aged	O
17-22	O
,	O
from	O
three	O
uk	O
national	O
health	O
service	O
nhs	O
mental	O
health	O
foundation	O
trusts	O
participated	O
in	O
creative	O
,	O
participatory	O
research	O
workshops	O
.	O
	
seven	O
parents	O
completed	O
short	O
questionnaires	O
.	O
	
thirty	O
clinical	O
staff	O
from	O
two	O
trusts	O
took	O
part	O
in	O
workshops	O
to	O
ensure	O
deliverability	O
of	O
young	B-T079
people's	O
ideas	B-T078
.	O
	
young	B-T079
people	O
were	O
offered	O
co-research	O
opportunities	O
.	O
	
most	O
young	B-T079
people	O
felt	O
anxious	B-T033
,	O
fearful	O
and	O
uncertain	O
on	O
leaving	O
camhs	O
and	O
perceived	O
mental	O
health	O
services	O
as	O
uncaring	O
.	O
	
participants	O
outlined	O
transition	O
procedures	B-T169
and	O
drafted	O
a	O
range	O
of	O
preparation	O
activities	O
,	O
centred	O
around	O
dedicated	O
transition	O
peer	B-T061
support	I-T061
and	O
a	O
transition	O
booklet	O
,	O
which	O
should	O
be	O
offered	O
to	O
all	O
camhs	O
leavers	O
,	O
irrespective	O
of	O
discharge	B-T079
or	O
transfer	B-T078
to	O
an	O
adult	O
service	O
.	O
	
preparation	O
should	O
aim	O
to	O
build	O
confidence	O
to	O
help	O
young	B-T079
people	O
take	O
responsibility	O
for	O
themselves	O
and	O
flourish	O
in	O
the	O
adult	O
world	O
coping	O
or	O
getting	O
through	O
it	O
was	O
not	O
enough	O
.	O
	
some	O
clinicians	O
also	O
felt	O
anxious	B-T033
at	O
transition	O
and	O
recognised	O
the	O
potential	O
impact	B-T080
on	O
young	B-T079
people	O
of	O
poor	O
communication	O
and	O
lack	B-T080
of	O
understanding	O
between	O
services	O
.	O
	
parents	O
would	O
appreciate	O
help	O
to	O
support	O
their	O
offspring	O
during	O
the	O
transition	O
period	B-T079
.	O
	
clinicians	O
cited	O
lack	B-T080
of	O
funding	O
and	O
inflexible	O
nhs	O
procedures	B-T169
and	O
policies	O
as	O
potential	O
barriers	B-T080
to	O
the	O
implementation	O
of	O
young	B-T079
people's	O
ideas	B-T078
.	O
	
nine	O
young	B-T079
people	O
took	O
up	O
co-research	O
opportunities	O
.	O
	
mental	O
health	O
services	O
underestimate	O
the	O
anxiety	B-T033
of	O
camhs	O
leavers	O
.	O
	
young	B-T079
people	O
have	O
clear	O
ideas	B-T078
about	O
the	O
preparation	O
they	O
require	O
to	O
leave	O
camhs	O
with	O
the	O
confidence	O
to	O
take	O
responsibility	O
for	O
their	O
own	O
health	O
care	O
.	O
	
close	O
collaboration	O
of	O
nhs	O
staff	O
and	O
researchers	O
facilitates	O
the	O
implementation	O
of	O
research	O
findings	B-T169
.	O
	
the	O
histone	B-T116
acetyltransferase	I-T116
gcn5	I-T116
positively	O
regulates	O
t	O
cell	O
activation	O
histone	B-T116
acetyltransferases	I-T116
hats	B-T116
regulate	O
inducible	O
transcription	O
in	O
multiple	B-T081
cellular	O
processes	O
and	O
during	O
inflammatory	O
and	O
immune	O
response	O
.	O
	
however	O
,	O
the	O
functions	O
of	O
general	B-T116
control	I-T116
nonrepressed-protein	I-T116
5	I-T116
gcn5	B-T116
,	O
an	O
evolutionarily	O
conserved	O
hat	B-T116
from	O
yeast	O
to	O
human	O
,	O
in	O
immune	O
regulation	O
remain	O
unappreciated	O
.	O
	
in	O
this	O
study	O
,	O
we	O
conditionally	O
deleted	O
gcn5	B-T116
encoded	O
by	O
the	O
kat2a	O
gene	O
specifically	O
in	O
t	O
lymphocytes	O
by	O
crossing	O
floxed	O
gcn5	O
and	O
lck-cre	O
mice	O
,	O
and	O
demonstrated	O
that	O
gcn5	B-T116
plays	O
important	O
roles	O
in	O
multiple	O
stages	B-T079
of	O
t	O
cell	O
functions	O
including	O
development	O
,	O
clonal	O
expansion	O
,	O
and	O
differentiation	O
.	O
	
loss	B-T033
of	I-T033
gcn5	B-T116
functions	O
impaired	O
t	O
cell	O
proliferation	O
,	O
il-2	O
production	O
,	O
and	O
th1	O
/	O
th17	O
,	O
but	O
not	O
th2	O
and	O
regulatory	O
t	O
cell	O
differentiation	O
.	O
	
gcn5	B-T116
is	O
recruited	O
onto	O
the	O
il-2	O
promoter	O
by	O
interacting	B-T169
with	O
the	O
nfat	B-T116
in	O
t	O
cells	O
upon	O
tcr	B-T116
stimulation	O
.	O
	
interestingly	O
,	O
instead	O
of	O
directly	O
acetylating	O
nfat	O
,	O
gcn5	O
catalyzes	O
histone	O
h3	O
lysine	O
h9	O
acetylation	O
to	O
promote	O
il-2	O
production	O
.	O
	
t	O
cell	O
-specific	O
suppression	O
of	O
gcn5	O
partially	O
protected	O
mice	O
from	O
myelin	O
oligodendrocyte	O
glycoprotein	O
-	O
induced	O
experimental	O
autoimmune	O
encephalomyelitis	O
,	O
an	O
experimental	O
model	O
for	O
human	O
multiple	O
sclerosis	O
.	O
	
our	O
study	O
reveals	O
previously	O
unknown	O
physiological	O
functions	O
for	O
gcn5	O
and	O
a	O
molecular	O
mechanism	O
underlying	O
these	O
functions	O
in	O
regulating	O
t	O
cell	O
immunity	O
.	O
	
hence	O
gcn5	O
may	O
be	O
an	O
important	O
new	O
target	O
for	O
autoimmune	O
disease	O
therapy	B-T061
minor	O
physical	O
anomalies	O
and	O
dermatoglyphic	O
signs	O
in	O
affective	O
disorders	O
a	O
systematic	O
review	O
the	O
increased	B-T081
prevalence	B-T081
of	O
minor	O
physical	O
anomalies	O
mpas	O
and	O
the	O
abnormalities	O
of	O
dermatoglyphic	O
patterns	O
may	O
be	O
physical	B-T169
manifestations	B-T169
of	O
neurodevelopmental	O
disruption	O
in	O
affective	O
disorders	O
.	O
	
this	O
paper	O
aims	O
to	O
review	O
the	O
current	O
state	O
of	O
knowledge	O
on	O
the	O
frequency	B-T079
of	O
mpas	O
and	O
dermatoglyphic	O
abnormalities	O
in	O
mood	O
disorders	O
.	O
	
a	O
medline	O
,	O
psychinfo	O
and	O
web	O
of	O
science	O
search	O
was	O
carried	O
out	O
to	O
collect	O
all	O
publications	O
on	O
the	O
frequency	B-T079
of	O
mpas	O
and	O
on	O
dermatoglyphic	O
traits	O
in	O
bipolar	O
disorder	O
and	O
unipolar	O
depression	O
.	O
	
24	O
studies	O
on	O
mpas	O
,	O
19	O
on	O
dermatoglyphics	O
,	O
and	O
5	O
dealing	O
with	O
both	O
were	O
found	O
with	O
discrepant	B-T033
findings	B-T169
.	O
	
the	O
relative	B-T080
contribution	O
of	O
neurodevelopmental	O
retardation	O
to	O
the	O
aetiology	B-T169
of	O
affective	O
disorders	O
remains	O
undetermined	O
,	O
the	O
field	O
is	O
open	O
for	O
further	O
research	O
.	O
	
increased	B-T169
recognition	O
of	O
neurodevelopmental	O
processes	O
in	O
the	O
origin	B-T079
of	O
affective	O
disorders	O
may	O
allow	O
for	O
earlier	O
and	O
more	O
effective	B-T080
intervention	B-T061
and	O
novel	O
strategy	O
to	O
expand	O
super-charged	O
nk	O
cells	O
with	O
significant	B-T080
potential	I-T080
to	O
lyse	O
and	O
differentiate	B-T080
cancer	O
stem	O
cells	O
differences	B-T081
in	O
nk	O
expansion	O
and	O
function	B-T169
between	O
healthy	O
and	O
cancer	O
patients	O
natural	O
killer	O
nk	O
cells	O
are	O
known	O
to	O
target	O
cancer	O
stem	O
cells	O
and	O
undifferentiated	O
tumors	O
.	O
	
in	O
this	O
paper	O
,	O
we	O
provide	O
a	O
novel	O
strategy	O
for	O
expanding	O
large	O
numbers	O
of	O
super-charged	O
nk	O
cells	O
with	O
significant	B-T080
potential	I-T080
to	O
lyse	O
and	O
differentiate	B-T080
cancer	O
stem	O
cells	O
and	O
demonstrate	O
the	O
differences	B-T081
in	O
the	O
dynamics	O
of	O
nk	O
cell	O
expansion	O
between	O
healthy	O
donors	O
and	O
cancer	O
patients	O
.	O
	
decline	B-T033
in	I-T033
cytotoxicity	I-T033
and	O
lower	O
interferon	O
ifn	O
secretion	O
by	O
osteoclast	O
oc	O
nk	O
cells	O
from	O
cancer	O
patients	O
correlates	O
with	O
faster	B-T080
expansion	O
of	O
residual	O
contaminating	B-T169
t	O
cells	O
within	O
purified	B-T169
nk	O
cells	O
,	O
whereas	O
healthy	O
donors	O
'	O
ocs	O
continue	O
expanding	O
super-charged	O
nk	O
cells	O
while	O
limiting	O
t	O
cell	O
expansion	O
for	O
up	O
to	O
60	O
days	B-T079
.	O
	
similar	O
to	O
patient	O
nk	O
cells	O
,	O
nk	O
cells	O
from	O
tumor	O
-bearing	O
blt-humanized	O
mice	O
promote	O
faster	B-T080
expansion	O
of	O
residual	O
t	B-T033
cells	I-T033
resulting	I-T033
in	I-T033
decreased	I-T033
numbers	I-T033
and	O
function	B-T169
of	O
nk	O
cells	O
,	O
whereas	O
nk	O
cells	O
from	O
mice	O
with	O
no	B-T033
tumor	O
continue	O
expanding	O
nk	O
cells	O
and	O
retain	O
their	O
cytotoxicity	O
.	O
	
in	O
addition	O
,	O
dendritic	O
cells	O
dcs	O
in	O
contrast	O
to	O
ocs	O
are	O
found	O
to	O
promote	O
faster	B-T080
expansion	O
of	O
residual	O
t	O
cells	O
within	O
purified	B-T169
nk	O
cells	O
resulting	O
in	O
the	O
decline	B-T033
in	I-T033
nk	I-T033
cell	I-T033
numbers	I-T033
from	O
healthy	O
individuals	O
.	O
	
addition	O
of	O
anti-cd3	B-T116
mab	I-T116
inhibits	O
t	O
cell	O
proliferation	O
while	O
enhancing	O
nk	O
cell	O
expansion	O
however	O
,	O
expanding	O
nk	O
cells	O
have	O
lower	O
cytotoxicity	O
but	O
higher	B-T080
secretion	O
of	O
ifn-γ	O
.	O
	
expansion	O
and	O
functional	B-T169
activation	O
of	O
super-charged	O
nk	O
cells	O
by	O
ocs	O
is	O
dependent	B-T080
on	O
interleukin	B-T116
il	I-T116
and	O
il-15	B-T116
.	O
	
thus	O
,	O
in	O
this	O
report	O
,	O
we	O
not	O
only	O
provide	O
a	O
novel	O
strategy	O
to	O
expand	O
super-charged	O
nk	O
cells	O
,	O
but	O
also	O
demonstrate	O
that	O
rapid	O
and	O
sustained	O
expansion	O
of	O
residual	O
t	O
cells	O
within	O
the	O
purified	B-T169
nk	O
cells	O
during	O
expansion	O
with	O
dcs	O
or	O
ocs	O
could	O
be	O
a	O
potential	B-T080
mechanism	B-T169
by	O
which	O
the	O
numbers	B-T081
and	O
function	B-T169
of	O
nk	B-T033
cells	I-T033
decline	I-T033
in	O
cancer	O
patients	O
and	O
in	O
blt-humanized	O
mice	O
.	O
	
extremely	B-T080
giant	O
liver	O
hemangioma	O
50	O
cm	O
with	O
kasabach-merritt	B-T047
syndrome	I-T047
a	O
33-	O
year	B-T079
-	O
old	B-T079
male	O
has	O
been	O
found	B-T033
with	O
a	O
giant	O
liver	O
hemangioma	O
of	O
initial	B-T079
size	O
29	O
cm	O
for	O
5	O
years	B-T079
.	O
	
he	O
received	B-T080
arterial	B-T061
embolization	I-T061
twice	B-T081
in	O
order	O
to	O
shrink	O
the	O
tumor	O
however	O
,	O
no	B-T080
effect	I-T080
was	O
obtained	B-T169
.	O
	
the	O
tumor	O
had	O
rapidly	B-T080
grown	O
to	O
50	O
cm	O
and	O
caused	O
abnormalities	B-T033
in	O
the	O
hematological	O
and	O
coagulative	O
systems	B-T169
.	O
	
preoperative	B-T079
computed	O
tomography	O
revealed	B-T080
that	O
the	O
right	O
hepatic	O
vein	O
,	O
right	O
hepatic	O
artery	O
,	O
and	O
right	O
portal	O
vein	O
were	O
not	B-T033
involved	I-T033
by	O
the	O
hemangioma	O
.	O
	
resection	B-T061
of	O
the	O
giant	O
liver	O
hemangioma	O
was	O
successfully	B-T080
performed	B-T169
after	O
intraoperative	B-T079
intentional	B-T080
bloodletting	B-T061
with	O
concurrent	B-T079
blood	B-T061
salvage	I-T061
.	O
	
all	O
hematological	O
and	O
coagulative	O
abnormalities	B-T033
had	O
returned	B-T080
to	O
normal	B-T080
after	O
the	O
role	O
of	O
cysteine	B-T116
residues	O
in	O
regulation	B-T169
of	O
peptidyl-prolyl	O
cis-trans	O
isomerase	O
activity	O
of	O
wheat	O
cyclophilin	B-T116
tacypa-1	O
oxidative	B-T169
conditions	B-T080
result	O
in	O
inhibition	O
of	O
peptidyl-prolyl	O
cis-trans	O
isomerase	O
ppiase	O
activity	O
of	O
several	O
cyclophilins	B-T116
.	O
	
thiol	B-T109
groups	O
have	O
been	O
implicated	O
in	O
redox	O
regulation	B-T169
of	O
these	O
proteins	B-T116
.	O
	
in	O
our	O
previous	O
study	O
,	O
we	O
proposed	O
that	O
activity	O
of	O
wheat	O
cyclophilin	B-T116
,	O
tacypa-1	O
,	O
may	O
be	O
modulated	O
through	O
a	O
novel	O
dual	O
mechanism	B-T169
of	O
redox	O
regulation	B-T169
.	O
	
to	O
further	O
understand	O
the	O
regulation	B-T169
of	O
ppiase	O
activity	O
of	O
tacypa-1	O
,	O
we	O
generated	O
mutants	O
of	O
tacypa-1	O
by	O
substituting	O
cysteine	B-T116
residues	O
at	O
positions	O
-40	O
and	O
-122	O
with	O
serine	B-T116
,	O
and	O
at	O
-126	O
with	O
proline	B-T116
.	O
	
comparative	O
analysis	O
of	O
their	O
ppiase	O
activity	O
revealed	O
that	O
catalytic	O
efficiencies	B-T081
kcat/km	O
of	O
tacypa-1c40s	B-T116
0.37	O
x	O
106	O
m-1	O
s-1	O
and	O
tacypa-1c122s	B-T116
0.31	O
x	O
106	O
m-1	O
s-1	O
were	O
significantly	B-T081
lower	I-T081
as	O
compared	O
to	O
the	O
native	O
tacypa-1	B-T116
1.33	O
x	O
106	O
m-1	O
s-1	O
,	O
whereas	O
kcat/km	O
of	O
the	O
double	O
mutant	O
tacypa-1c40s/c122s	B-T116
was	O
significantly	B-T081
higher	I-T081
2.36	O
x	O
106	O
m-1	O
s-1	O
.	O
	
compared	O
to	O
wild-type	O
tacypa-1	O
,	O
the	O
different	O
mutants	O
also	O
showed	O
differential	B-T080
sensitivity	B-T169
to	O
cu2+	O
.	O
	
furthermore	O
,	O
the	O
results	B-T169
of	O
this	O
study	O
also	O
revealed	B-T080
that	O
despite	O
lacking	B-T080
ppiase	O
activity	O
,	O
the	O
mutant	O
tacypa-1c126p	O
was	O
able	O
to	O
confer	O
partial	B-T081
protection	B-T033
against	O
heat	O
stress	O
.	O
	
these	O
observations	O
suggest	O
that	O
the	O
mechanism	B-T169
of	O
tacypa-1	O
-induced	O
thermotolerance	O
may	O
also	O
involve	O
other	O
activities	O
besides	O
cis	O
to	O
trans	O
isomerisation	O
,	O
which	O
needs	O
to	O
be	O
identified	B-T080
association	B-T080
of	O
exclusive	O
breastfeeding	O
duration	B-T079
with	O
systemic	B-T047
inflammation	I-T047
markers	O
in	O
adolescents	O
a	O
cross-sectional	O
study	O
breastfeeding	B-T033
duration	I-T033
has	O
been	O
associated	B-T080
with	I-T080
less	B-T081
low-grade	B-T080
inflammation	O
in	O
healthy	B-T080
adolescents	O
,	O
but	O
there	O
is	O
scarce	B-T080
information	B-T078
regarding	O
obese	B-T047
subjects	O
.	O
	
this	O
study	O
aimed	O
to	O
evaluate	O
whether	O
exclusive	O
breastfeeding	O
is	O
related	O
to	O
serum	B-T081
concentrations	I-T081
of	O
inflammatory	B-T169
markers	O
in	O
a	O
population	O
of	O
spanish	O
adolescents	O
.	O
	
a	O
cross-sectional	O
study	O
was	O
performed	B-T169
on	O
1	O
adolescents	O
13.2	O
1.2	O
years	O
randomly	O
recruited	O
from	O
schools	O
in	O
southeast	O
spain	O
.	O
	
data	B-T078
on	O
breastfeeding	B-T033
duration	I-T033
were	O
collected	B-T169
via	O
a	O
parental	O
questionnaire	O
.	O
	
interleukin-6	B-T116
il-6	B-T116
and	O
tumor	B-T116
necrosis	I-T116
factor-alpha	I-T116
tnf-α	B-T116
were	O
determined	B-T080
by	I-T080
enzyme-linked	O
immunosorbent	O
assay	O
.	O
	
c-reactive	B-T116
protein	I-T116
crp	B-T116
was	O
determined	B-T080
by	I-T080
solid-phase	O
chemiluminescent	O
immunometric	O
assay	O
.	O
	
nonadjusted	O
and	O
adjusted	O
multivariate	B-T081
correlation	O
analyses	O
confirmed	B-T080
a	O
strong	B-T080
association	B-T080
p	O
<	O
001	O
,	O
95%	O
confidence	B-T081
interval	I-T081
between	O
the	O
three	O
markers	O
of	O
inflammation	O
and	O
exclusive	O
breastfeeding	O
duration	B-T079
.	O
	
no	B-T033
significant	I-T033
differences	B-T080
were	O
observed	B-T169
for	O
il-6	B-T116
,	O
tnf-α	B-T116
,	O
and	O
crp	B-T116
serum	B-T081
concentrations	I-T081
among	O
normal	O
weight	O
,	O
overweight	O
,	O
and	O
obese	B-T047
adolescents	O
,	O
except	B-T169
for	I-T169
il-6	B-T116
between	O
normal	O
weight	O
and	O
obese	B-T047
subjects	O
.	O
	
likewise	O
,	O
no	B-T033
significant	I-T033
association	B-T080
was	O
found	B-T033
between	O
these	O
markers	O
of	O
inflammation	O
and	O
body	O
mass	O
index	O
bmi	O
z-score	B-T081
.	O
	
we	O
found	B-T033
a	O
possible	B-T033
association	B-T080
between	O
inflammatory	B-T169
markers	O
and	O
exclusive	O
breastfeeding	O
duration	B-T079
in	O
adolescents	O
,	O
regardless	B-T080
of	O
their	O
bmi	O
.	O
	
this	O
finding	B-T033
suggests	B-T078
that	O
increased	B-T081
body	O
weight	O
or	O
obesity	B-T047
might	O
not	O
mediate	O
the	O
association	B-T080
between	O
breastfeeding	O
and	O
inflammation	O
.	O
	
these	O
results	B-T169
contribute	O
to	O
the	O
understanding	O
of	O
the	O
relationship	B-T080
between	O
breastfeeding	O
and	O
inflammatory	B-T169
markers	O
in	O
effect	B-T080
of	O
ultrasound	O
and	O
enzymatic	B-T116
pre-treatment	O
on	O
yield	B-T081
and	O
properties	B-T080
of	O
banana	O
juice	O
effect	B-T080
of	O
ultrasound	O
and	O
enzymatic	B-T116
pre-treatments	O
with	O
cellulase	B-T116
and	O
pectinase	B-T116
on	O
yield	B-T081
and	O
properties	B-T080
of	O
banana	O
juice	O
were	O
investigated	B-T169
.	O
	
a	O
two-level	O
full	O
factorial	O
design	O
was	O
employed	O
.	O
	
the	O
factors	O
selected	O
were	O
ultrasonication	B-T079
time	I-T079
0	O
and	O
30	O
min	B-T079
,	O
cellulase	B-T116
concentration	B-T081
0	O
and	O
0.2	O
and	O
pectinase	B-T116
concentration	B-T081
0	O
and	O
0.2	O
.	O
	
the	O
responses	O
studied	O
were	O
yield	B-T081
,	O
viscosity	O
,	O
clarity	O
,	O
total	B-T081
soluble	I-T081
solids	I-T081
tss	B-T081
and	O
ph	B-T081
.	O
	
it	O
was	O
observed	O
that	O
pectinase	B-T116
was	O
more	O
effective	B-T080
in	O
increasing	B-T169
the	O
yield	B-T081
of	O
juice	O
compared	O
to	O
cellulase	B-T116
.	O
	
ultrasonic	O
pre-treatment	O
alone	O
did	O
not	B-T033
significantly	B-T169
increase	I-T169
the	O
yield	B-T081
of	O
juice	O
.	O
	
when	O
ultrasound	O
was	O
combined	O
with	O
pre-treatment	O
with	O
both	O
the	O
enzymes	B-T116
maximum	B-T081
yield	I-T081
of	O
89.40	O
was	O
obtained	O
compared	O
to	O
47.30	O
in	O
the	O
control	O
.	O
	
the	O
viscosity	O
of	O
the	O
juice	O
decreased	B-T081
with	O
addition	O
of	O
enzymes	B-T116
and	O
with	O
application	O
of	O
ultrasound	O
.	O
	
the	O
clarity	B-T080
of	O
the	O
juice	O
was	O
not	O
affected	O
by	O
cellulase	B-T116
treatment	B-T169
,	O
but	O
improved	B-T033
with	O
pectinase	B-T116
treatment	B-T169
.	O
	
ultrasonication	O
alone	O
was	O
found	O
to	O
be	O
more	O
effective	B-T080
than	O
pectinase	B-T116
or	O
cellulase	B-T116
treatment	B-T169
in	O
improving	B-T080
the	O
clarity	O
of	O
the	O
juice	O
.	O
	
the	O
tss	B-T081
increased	B-T081
with	O
enzymatic	B-T116
treatment	B-T169
,	O
ultrasonication	O
and	O
their	O
combination	O
.	O
	
ph	B-T081
was	O
not	O
affected	O
by	O
treatment	B-T169
type	O
,	O
but	O
was	O
found	O
to	O
be	O
lower	O
for	O
the	O
treated	B-T169
juices	O
.	O
	
significant	B-T080
correlations	I-T080
electrocardiographic	O
appearance	O
of	O
aortic	B-T047
stenosis	I-T047
before	O
and	O
after	O
aortic	B-T061
valve	I-T061
replacement	I-T061
so	O
far	O
,	O
the	O
specific	O
appearance	O
of	O
qrs	B-T033
complex	I-T033
,	O
st-segment	B-T033
,	O
and	O
t	B-T033
wave	I-T033
was	O
observed	B-T169
in	O
aortic	B-T047
stenosis	I-T047
as	B-T047
.	O
	
s-wave	B-T033
dynamic	B-T169
change	B-T169
in	O
leads	O
v1	O
-	O
v3	O
was	O
not	O
reported	O
in	O
as	B-T047
.	O
	
in	O
a	O
single-center	O
,	O
prospective	O
study	O
,	O
we	O
included	O
a	O
total	O
number	O
of	O
1.175	O
patients	O
who	O
underwent	O
surgical	B-T061
aortic	B-T061
valve	I-T061
replacement	I-T061
avr	B-T061
.	O
	
we	O
conducted	O
3-year	O
gathering	O
of	O
patients	O
with	O
symptomatic	B-T169
and	O
asymptomatic	B-T033
severe	O
as	B-T047
,	O
and	O
separated	O
them	O
by	O
hemodynamic	O
stability	O
into	O
groups	O
a	O
and	O
b	O
,	O
through	O
eflv	O
of	O
more	O
or	O
less	O
than	O
50%	O
,	O
ava	O
of	O
more	O
or	O
less	O
than	O
0.9	O
cm	O
,	O
pg	O
between	O
55	O
and	O
75	O
mm	B-T081
hg	I-T081
or	O
over	O
75	O
mm	B-T081
hg	I-T081
,	O
and	O
end-diastolic	B-T033
lv	I-T033
dimension	I-T033
of	O
more	O
or	O
less	O
than	O
56	O
mm	O
.	O
	
we	O
evaluated	O
the	O
impact	B-T080
of	O
s-wave	B-T033
magnitude	B-T081
in	O
right	O
precordial	O
leads	O
before	O
and	O
after	O
avr	B-T061
in	O
all	O
patients	O
.	O
	
we	O
followed	O
s-wave	B-T033
changes	B-T169
in	O
electrocardiogram	B-T033
altogether	O
with	O
hemodynamic	B-T061
measurements	I-T061
derived	O
from	O
echocardiography	O
.	O
	
analysis	O
of	O
echocardiographic	O
parameters	B-T033
,	O
measured	B-T080
in	O
patients	O
before	O
surgery	B-T061
,	O
did	O
not	O
show	O
statistical	B-T081
significance	I-T081
between	O
asymptomatic	B-T033
and	O
symptomatic	B-T169
group	O
.	O
	
the	O
statistical	B-T081
significance	I-T081
was	O
observed	B-T169
in	O
the	O
change	B-T169
in	O
s-wave	B-T033
magnitude	B-T081
in	O
the	O
right	O
precordial	O
leads	O
in	O
both	O
subsets	O
of	O
patients	O
before	O
avr	B-T061
.	O
	
we	O
found	O
statistically	B-T081
significant	I-T081
predictive	B-T080
value	I-T080
of	O
s-wave	B-T033
magnitude	B-T081
in	O
leads	O
v2	O
-	O
v3	O
for	O
dependent	B-T169
variables	I-T169
pg	O
and	O
end-diastolic	B-T033
lv	I-T033
dimension	I-T033
.	O
	
s-wave	B-T033
changes	O
in	O
right	O
precordial	O
leads	O
can	O
predict	O
increase	B-T169
in	O
pg	O
and	O
critical	O
narrowing	O
of	O
ava	O
,	O
suggestive	B-T169
of	I-T169
timely	O
referral	O
for	O
avr	B-T061
.	O
	
anemia	B-T047
complicating	B-T169
type	B-T047
2	I-T047
diabetes	I-T047
prevalence	B-T081
,	O
risk	B-T033
factors	I-T033
and	O
prognosis	O
to	O
determine	O
the	O
prevalence	B-T081
,	O
risk	B-T033
factors	I-T033
and	O
prognosis	O
of	O
anemia	B-T047
in	O
representative	O
community-based	O
patients	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
.	O
	
data	O
from	O
the	O
fremantle	O
diabetes	O
study	O
phase	O
ii	O
fds2	O
n=1551	O
,	O
mean	O
age	O
65.7years	O
,	O
51.9	O
males	O
and	O
busselton	O
diabetes	O
study	O
bds	O
n=186	O
,	O
mean	O
age	O
70.2years	O
,	O
50.0	O
males	O
cohorts	O
,	O
and	O
from	O
186	O
matched	O
bds	O
participants	O
without	O
diabetes	B-T047
,	O
were	O
analyzed	O
.	O
	
the	O
prevalence	B-T081
of	O
anemia	B-T047
hemoglobin	B-T116
130g/l	O
males	O
,	O
120g/l	O
females	O
was	O
determined	B-T080
in	O
each	O
sample	O
.	O
	
in	O
fds2	O
,	O
associates	O
of	O
anemia	B-T047
were	O
assessed	O
using	O
multiple	O
logistic	O
regression	O
and	O
cox	B-T081
proportional	I-T081
hazards	I-T081
modeling	I-T081
identified	O
predictors	B-T033
of	O
death	O
during	O
4.3	O
post-recruitment	O
.	O
	
the	O
prevalence	B-T081
of	O
anemia	B-T047
at	O
baseline	O
was	O
11.5	O
in	O
fds2	O
participants	O
,	O
17.8	O
in	O
bds	O
type	O
2	O
patients	O
and	O
5.4	O
in	O
bds	O
participants	O
without	O
diabetes	B-T047
.	O
	
in	O
fds2	O
,	O
163	O
of	O
178	O
patients	O
with	O
anemia	B-T047
91.6	O
had	O
at	O
least	O
one	O
other	O
risk	B-T033
factor	I-T033
serum	O
vitamin	O
b12	O
<140pmol/l	O
,	O
serum	B-T033
ferritin	I-T033
<30μg/l	O
and/or	O
transferrin	O
saturation	O
<20%	O
,	O
serum	O
testosterone	O
<10nmol/l	O
males	O
,	O
glitazone	B-T109
therapy	B-T061
,	O
estimated	O
glomerular	O
filtration	O
rate	O
egfr	O
<60ml/min	O
1.73m	O
,	O
malignancy	O
,	O
hemoglobinopathy	B-T047
.	O
	
more	O
anemic	B-T033
than	O
non-anemic	B-T033
fds2	O
patients	O
died	O
28.7	O
versus	O
8.0	O
p<0	O
.	O
	
after	O
adjustment	O
for	O
other	O
independent	O
predictors	B-T033
age	O
as	O
time-scale	O
,	O
male	O
sex	O
,	O
aboriginality	B-T033
,	O
marital	O
status	O
,	O
smoking	O
,	O
egfr	O
,	O
anemia	B-T047
was	O
associated	B-T080
with	I-T080
a	O
57%	O
increase	B-T169
in	O
mortality	O
p=0	O
.	O
	
type	B-T047
2	I-T047
diabetes	I-T047
at	O
least	O
doubles	O
the	O
risk	O
of	O
anemia	B-T047
but	O
other	O
mostly	O
modifiable	O
risk	B-T033
factors	I-T033
are	O
usually	O
present	B-T033
.	O
	
anemia	B-T047
is	O
associated	B-T080
with	I-T080
an	O
increased	B-T033
risk	I-T033
of	I-T033
death	I-T033
after	O
adjustment	O
for	O
other	O
succinic	B-T109
acid	I-T109
production	O
by	O
immobilized	O
cultures	O
using	O
spent	O
sulphite	O
liquor	O
as	O
fermentation	O
medium	O
spent	O
sulphite	O
liquor	O
ssl	O
was	O
used	O
as	O
carbon	O
source	B-T033
for	O
the	O
production	O
of	O
succinic	B-T109
acid	I-T109
using	O
immobilized	O
cultures	O
of	O
actinobacillus	O
succinogenes	O
and	O
basfia	O
succiniciproducens	O
on	O
two	O
different	O
supports	O
,	O
delignified	O
cellulosic	O
material	O
dcm	O
and	O
alginate	B-T109
beads	O
.	O
	
fed-batch	O
immobilized	O
cultures	O
with	O
a	O
.	O
	
succinogenes	O
in	O
alginates	B-T109
resulted	O
in	O
higher	B-T080
sugar	B-T109
to	O
succinic	B-T109
acid	I-T109
conversion	B-T081
yield	I-T081
0.81g	O
than	O
the	O
respective	O
yield	B-T081
achieved	O
0.65g	O
when	O
dcm	O
immobilized	O
cultures	O
were	O
used	O
.	O
	
the	O
final	O
succinic	B-T109
acid	I-T109
concentration	B-T081
and	O
yield	B-T081
achieved	O
in	O
fed-batch	O
with	O
immobilized	O
cultures	O
of	O
b	O
.	O
	
succiniciproducens	O
in	O
alginates	B-T109
45g/l	O
and	O
0.66g	O
were	O
higher	B-T080
than	O
a	O
.	O
	
succinogenes	O
immobilized	O
cultures	O
35.4g	O
and	O
0.61g	O
using	O
nano	B-T081
-	O
filtrated	O
ssl	O
as	O
fermentation	O
medium	O
.	O
	
immobilized	O
cultures	O
of	O
b	O
.	O
	
succiniciproducens	O
in	O
alginate	B-T109
beads	O
were	O
reused	O
in	O
four	O
sequential	O
fed-batch	O
fermentations	O
of	O
nano	B-T081
-	O
filtrated	O
ssl	O
leading	O
to	O
the	O
production	O
of	O
64.7g	O
of	O
succinic	B-T109
acid	I-T109
with	O
a	O
yield	B-T081
range	O
of	O
0.42	O
and	O
productivity	B-T081
range	O
of	O
0.29	O
.	O
	
the	O
immobilized	O
cultures	O
improved	O
the	O
efficiency	B-T081
of	O
succinic	B-T109
acid	I-T109
production	O
as	O
compared	O
to	O
free	O
cell	O
cultures	O
.	O
	
interventions	O
to	O
improve	B-T033
grandparent	O
caregivers'	O
mental	O
and	O
physical	B-T033
health	I-T033
an	O
integrative	O
review	O
the	O
aim	B-T078
of	O
this	O
integrative	O
review	O
is	O
to	O
appraise	O
grandparent	O
caregiver	O
interventions	O
that	O
are	O
designed	O
to	O
improve	B-T033
their	O
physical	B-T033
and	O
mental	O
health	O
.	O
	
a	O
database	O
search	O
was	O
performed	O
to	O
identify	O
relevant	B-T080
studies	O
published	O
between	O
january	O
1	O
,	O
1980	O
,	O
and	O
december	O
31	O
,	O
2014	O
.	O
	
thirteen	O
publications	O
,	O
including	O
11	O
studies	O
,	O
met	O
all	O
inclusion	B-T080
and	O
exclusion	B-T169
criteria	I-T169
.	O
	
all	O
studies	O
included	O
grandparent	O
mental	O
health	O
outcomes	B-T169
with	O
fewer	O
focusing	O
on	O
physical	B-T033
health	I-T033
and	O
social	O
relations	O
.	O
	
improvements	O
were	O
found	O
in	O
all	O
three	O
areas	O
with	O
fewer	O
improvements	O
seen	O
in	O
physical	B-T033
health	I-T033
.	O
	
however	O
,	O
small	B-T081
effect	I-T081
sizes	I-T081
were	O
seen	O
with	O
most	O
measures	B-T169
of	O
these	O
outcomes	B-T169
.	O
	
although	O
the	O
interventions	O
led	O
to	O
positive	O
grandparent	O
caregiver	O
outcomes	O
,	O
the	O
studies	O
were	O
limited	B-T169
by	O
their	O
design	O
,	O
only	O
one	O
of	O
which	O
was	O
a	O
randomized	O
controlled	O
trial	O
.	O
	
also	O
,	O
interventions	O
did	O
not	O
consider	O
variations	B-T080
in	O
the	O
grandchild's	O
or	O
parent's	O
ages	O
or	O
if	O
the	O
grandparent	O
provided	O
primary	B-T080
or	O
shared	O
care	O
.	O
	
these	O
gaps	O
should	O
be	O
addressed	O
in	O
future	B-T079
research	O
.	O
	
an	O
attenuated	O
mycobacterium	O
tuberculosis	O
clinical	B-T080
strain	O
with	O
a	O
defect	B-T169
in	O
esx-1	B-T116
secretion	O
induces	O
minimal	B-T080
host	O
immune	O
responses	O
and	O
pathology	O
although	O
mycobacterium	O
tuberculosis	O
m.tb	O
dk9897	O
is	O
an	O
attenuated	O
strain	O
,	O
it	O
was	O
isolated	B-T169
from	O
a	O
patient	O
with	O
extrapulmonary	B-T047
tuberculosis	I-T047
and	O
vaccination	B-T061
with	O
a	O
subunit	O
vaccine	O
h56	O
induced	B-T169
poor	B-T080
protection	B-T033
against	O
it	O
.	O
	
both	O
attenuation	O
and	O
lack	B-T080
of	O
protection	B-T033
are	O
because	O
m.tb	O
dk9897	O
cannot	O
secrete	O
the	O
esxa	B-T116
virulence	B-T109
factor	I-T109
nor	O
induce	O
a	O
host	O
response	O
against	O
it	O
.	O
	
genome	O
sequencing	O
identified	O
a	O
frameshift	O
mutation	O
in	O
the	O
eccca1	O
gene	O
.	O
	
since	O
the	O
encoded	O
eccca1	B-T116
protein	I-T116
provides	O
energy	B-T081
for	O
esx-1	B-T116
secretion	O
,	O
it	O
suggested	O
a	O
defect	B-T169
in	O
the	O
esx-1	B-T116
type	O
vii	O
secretion	O
system	O
.	O
	
genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
m.tb	O
h37rv	O
sequence	O
of	O
eccca1-ecccb1-pe35	O
re-established	O
esxa	B-T116
secretion	O
,	O
host	O
specific	O
esxa	B-T116
t-cell	O
responses	O
,	O
and	O
increased	B-T081
strain	O
virulence	O
.	O
	
the	O
esx-1	B-T116
secretion	O
defect	B-T169
prevents	B-T169
several	O
virulence	B-T109
factors	I-T109
from	O
being	O
functional	O
during	O
infection	O
and	O
therefore	O
attenuates	O
m.tb	O
.	O
	
it	O
precludes	O
specific	O
t-cell	O
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	O
cytokine	O
production	O
,	O
gross	O
pathology	O
or	O
granuloma	O
formation	O
in	O
lungs	O
from	O
m.tb	O
dk9897	O
infected	B-T033
animals	I-T033
.	O
	
this	O
coincides	O
with	O
m.tb	O
dk9897	O
being	O
unable	O
to	O
disrupt	O
the	O
phagosome	O
membrane	O
and	O
make	O
contact	O
to	O
the	O
results	B-T033
for	O
patients	O
with	O
sarcoma	O
not	B-T080
otherwise	I-T080
specified	I-T080
and	O
other	O
diagnoses	B-T033
than	O
ewing	O
sarcoma	O
treated	B-T033
according	O
to	O
the	O
euro-ewing	O
99	O
trial	O
euro-ewing	O
99	O
trial	O
of	O
the	O
european	O
ewing	O
tumor	O
working	O
initiative	B-T033
of	O
national	O
groups	B-T078
ee99	O
was	O
an	O
international	B-T078
phase	O
iii	O
study	O
in	O
patients	O
with	O
ewing	O
sarcoma	O
.	O
	
the	O
german	O
society	O
of	O
pediatric	O
oncology	O
and	O
hematology	O
gpoh	O
data	O
center	O
registered	O
and	O
followed	O
patients	O
with	O
other	O
diagnoses	B-T033
than	O
ewing	O
sarcoma	O
who	O
were	O
treated	B-T033
according	O
to	O
the	O
ee99	O
protocol	O
in	O
an	O
additional	O
non-ewing	O
database	O
.	O
	
data	B-T078
of	O
27	O
patients	O
with	O
other	O
diagnoses	B-T033
than	O
ewing	O
sarcoma	O
treated	B-T033
according	O
to	O
the	O
ee99	O
protocol	O
were	O
analyzed	O
.	O
	
patients	O
had	O
miscellaneous	B-T080
histologic	B-T169
diagnoses	B-T033
,	O
the	O
majority	B-T081
were	O
diagnosed	B-T033
with	O
sarcoma	O
not	B-T080
otherwise	I-T080
specified	I-T080
nos	B-T080
arising	O
in	O
bone	O
and	O
soft	O
tissue	O
63%	O
.	O
	
the	O
median	B-T081
age	O
at	O
diagnosis	B-T033
was	O
16.9	O
years	O
range	O
4.5	O
.	O
	
localized	B-T047
disease	I-T047
was	O
diagnosed	B-T033
in	O
61.5	O
of	O
the	O
patients	O
and	O
38.5	O
had	O
distant	O
metastases	O
at	O
time	O
of	O
primary	B-T080
diagnosis	B-T033
.	O
	
the	O
median	B-T081
follow-up	O
time	B-T079
was	O
3.7	O
years	O
range	O
0.5	O
.	O
	
patients	O
with	O
localized	B-T047
disease	I-T047
showed	O
a	O
3-year	O
event-free	B-T081
survival	I-T081
efs	B-T081
of	O
68%	O
,	O
compared	O
to	O
3-year	O
efs	B-T081
of	O
20%	O
in	O
patients	O
with	O
metastases	O
p	O
=	O
0.042	O
.	O
	
three-year	O
efs	B-T081
for	O
patients	O
with	O
sarcoma	O
nos	B-T080
was	O
52%	O
,	O
patients	O
with	O
localized	B-T047
and	O
metastatic	O
disease	O
showed	O
3-year	O
efs	B-T081
of	O
66	O
and	O
20%	O
,	O
respectively	O
.	O
	
efs	B-T081
in	O
patients	O
with	O
other	O
diagnoses	B-T033
than	O
ewing	O
sarcoma	O
treated	B-T033
according	O
to	O
ee99	O
was	O
significantly	B-T078
higher	O
in	O
patients	O
with	O
localized	B-T047
than	O
metastatic	O
disease	O
.	O
	
sarcomas	O
of	O
soft	O
tissue	O
and	O
bone	O
that	O
cannot	O
be	O
classified	O
to	O
current	B-T079
diagnostic	O
categories	O
constitute	O
a	O
therapeutic	B-T169
challenge	O
.	O
	
capsular	B-T109
polysaccharide	I-T109
types	B-T080
and	O
virulence-related	O
traits	O
of	O
epidemic	O
kpc	B-T047
-	O
producing	B-T169
klebsiella	O
pneumoniae	O
isolates	O
in	O
a	O
chinese	O
university	O
hospital	O
klebsiella	O
pneumoniae	O
is	O
an	O
important	B-T080
human	O
pathogen	O
associated	B-T080
with	I-T080
a	O
variety	O
of	O
diseases	B-T047
and	O
the	O
prevalence	B-T081
of	O
blakpc	O
carrying	O
k	O
.	O
	
pneumoniae	O
kpc-kp	O
is	O
rapidly	B-T169
increasing	I-T169
.	O
	
capsule	B-T116
is	O
an	O
important	B-T080
virulence	B-T109
factor	I-T109
in	O
k	O
.	O
	
pneumoniae	O
.	O
	
in	O
this	O
study	O
,	O
we	O
determined	O
to	O
first	O
systematically	B-T169
characterize	O
capsular	B-T109
polysaccharide	I-T109
cps	B-T109
and	O
virulence	O
traits	O
in	O
kpc-kp	O
strains	O
.	O
	
a	O
total	O
of	O
56	O
kpc-kp	O
isolates	O
were	O
recovered	B-T080
from	O
clinical	O
samples	O
in	O
a	O
chinese	O
hospital	O
,	O
which	O
were	O
assigned	B-T169
to	O
clonal	B-T078
lineages	I-T078
by	O
multilocus	O
sequence	O
typing	O
mlst	O
.	O
	
capsule	B-T116
typing	O
wzi	O
sequencing	O
and	O
wzc	O
polymerase	O
chain	O
reaction	O
pcr	O
and	O
virulence	O
genes	O
were	O
characterized	O
by	O
molecular	O
approaches	O
.	O
	
the	O
virulence	O
of	O
these	O
strains	O
was	O
determined	O
by	O
biofilm	O
formation	O
,	O
serum	O
killing	O
resistance	B-T169
,	O
phagocytosis	O
,	O
and	O
infection	O
models	O
.	O
	
six	O
different	O
sts	B-T033
were	O
found	B-T033
among	O
56	O
kpc-kp	O
isolates	O
76.8	O
43	O
of	O
56	O
isolates	O
belonged	O
to	O
st11	B-T033
,	O
6	B-T033
isolates	O
belonged	O
to	O
st147	B-T033
,	O
4	O
isolates	O
belonged	O
to	O
st15	B-T033
,	O
1	O
isolate	O
belonged	O
to	O
st1456	B-T033
,	O
1	O
isolate	O
belonged	O
to	O
st65	B-T033
,	O
and	O
1	O
isolate	O
was	O
st23	B-T033
.	O
	
based	O
on	O
the	O
wzi	O
gene	O
dna	O
sequences	O
and	O
wzc	O
pcr	O
,	O
these	O
56	O
strains	O
were	O
classified	O
as	O
capsular	B-T116
type	B-T080
wzi47-k47	B-T116
n	O
=	O
37	O
,	O
wzi64-k64	B-T116
n	O
=	O
8	O
,	O
wzi8-k8	B-T116
n	O
=	O
4	O
,	O
wzi37-k37	B-T116
n	O
=	O
4	O
,	O
wzi53-k53	B-T116
n	O
=	O
1	O
,	O
wzi125-k2	B-T116
n	O
=	O
1	O
,	O
and	O
wzi1-k1	B-T116
n	O
=	O
1	O
.	O
	
heterogeneity	O
was	O
detected	B-T033
in	O
biofilm	O
formation	O
and	O
phagocytosis	O
among	O
different	O
cps	B-T109
types	B-T080
.	O
	
st11	B-T033
strains	O
were	O
less	O
virulent	B-T080
than	O
other	O
st	B-T033
strains	O
.	O
	
kpc-kp	O
strains	O
exhibit	O
variability	O
of	O
virulence-associated	O
traits	O
.	O
	
differences	O
were	O
associated	O
with	O
the	O
st	B-T033
types	B-T080
and	O
interaction-driven	B-T169
distinctive	O
electronic	O
states	O
of	O
artificial	O
atoms	O
at	O
the	O
zno	O
interface	B-T080
we	O
have	O
investigated	B-T169
the	O
electronic	O
states	O
of	O
planar	O
quantum	O
dots	O
at	O
the	O
zno	O
interface	B-T080
containing	O
a	O
few	O
interacting	B-T169
electrons	O
in	O
an	O
externally	B-T169
applied	I-T169
magnetic	O
field	O
.	O
	
the	O
electron-electron	O
interaction	B-T169
effects	B-T080
are	O
expected	O
to	O
be	O
much	B-T080
stronger	I-T080
in	O
this	O
case	B-T169
than	O
in	O
traditional	B-T169
semiconductor	I-T169
quantum	I-T169
systems	I-T169
,	O
such	O
as	O
in	O
gaas	O
or	O
inas	O
quantum	O
dots	O
.	O
	
in	O
order	O
to	O
highlight	O
that	O
stronger	B-T080
coulomb	B-T080
effects	I-T080
in	O
the	O
zno	O
quantum	O
dots	O
,	O
we	O
have	O
compared	O
the	O
energy	O
spectra	O
and	O
the	O
magnetization	O
in	O
this	O
system	B-T169
to	O
those	O
of	O
the	O
inas	O
quantum	O
dots	O
.	O
	
we	O
have	O
found	O
that	O
in	O
the	O
zno	O
quantum	O
dots	O
the	O
signatures	O
of	O
stronger	B-T080
coulomb	B-T169
interaction	I-T169
manifests	B-T169
in	O
an	O
unique	B-T080
ground	O
state	O
that	O
has	O
very	O
different	B-T080
properties	O
than	O
the	O
corresponding	O
ones	O
in	O
the	O
inas	O
dot	O
.	O
	
our	O
results	B-T169
for	O
the	O
magnetization	O
also	O
exhibits	B-T080
behaviors	I-T080
never	B-T079
before	B-T079
observed	B-T169
in	O
a	O
quantum	O
dot	O
for	O
a	O
realistic	B-T081
set	I-T081
of	I-T081
parameters	I-T081
.	O
	
we	O
have	O
found	O
a	O
stronger	B-T080
temperature	B-T081
dependence	B-T080
and	O
other	O
unexpected	B-T080
features	I-T080
,	O
such	O
as	O
paramagnetic-like	O
behavior	O
at	O
high	B-T081
temperatures	I-T081
for	O
a	O
quantum-dot	O
helium	O
.	O
	
evaluation	O
of	O
tobacco	O
control	O
policies	O
in	O
san	O
francisco	O
homeless	O
housing	O
programs	O
the	O
2014	O
surgeon	O
general's	O
report	O
noted	B-T080
that	O
high	B-T080
smoking	B-T033
rates	I-T033
in	O
vulnerable	O
populations	O
such	O
as	O
the	O
homeless	O
have	O
been	O
a	O
persistent	B-T079
public	O
health	B-T033
problem	I-T033
smoking	O
prevalence	B-T081
among	O
individuals	O
experiencing	O
homelessness	B-T033
exceeds	O
70%	O
.	O
	
historically	O
,	O
service	O
providers	O
for	O
the	O
homeless	O
have	O
not	O
enacted	O
comprehensive	B-T080
tobacco	O
control	O
policies	O
.	O
	
we	O
conducted	B-T169
a	O
qualitative	O
study	O
of	O
homeless	O
housing	O
programs	O
in	O
san	O
francisco	O
.	O
	
administrators	O
representing	O
9	O
of	O
the	O
city's	O
11	O
homeless	O
service	O
agencies	O
were	O
interviewed	O
to	O
assess	O
institutional	B-T078
smoking	O
-related	O
policies	O
and	O
cessation	O
programs	B-T169
and	O
perceived	O
barriers	B-T080
and	O
receptivity	B-T169
to	O
instituting	B-T078
tobacco	B-T109
control	B-T169
interventions	B-T061
.	O
	
respondents	O
indicated	B-T033
that	O
although	O
most	O
programs	B-T169
had	O
adopted	B-T080
smoke	O
-	O
free	B-T169
grounds	O
and	O
some	O
had	O
eliminated	B-T080
evidence	B-T078
of	O
staff	O
smoking	O
,	O
the	O
smoking	O
status	B-T080
of	O
clients	O
was	O
assessed	O
only	O
when	O
required	B-T169
by	O
funders	O
.	O
	
none	O
of	O
the	O
programs	B-T169
offered	B-T033
smoking	O
cessation	O
interventions	B-T061
.	O
	
most	O
administrators	O
were	O
receptive	B-T169
to	O
adopting	B-T080
policies	O
that	O
would	O
promote	O
a	O
tobacco	B-T109
-	O
free	B-T169
culture	O
however	O
,	O
they	O
noted	B-T080
that	O
their	O
clients	O
had	O
unique	B-T080
challenges	O
that	O
made	O
traditional	B-T169
smoking	O
cessation	O
programs	B-T169
unfeasible	O
.	O
	
homeless	O
housing	O
programs	O
in	O
san	O
francisco	O
have	O
not	O
yet	O
adopted	B-T080
a	O
tobacco	B-T109
-	O
free	B-T169
culture	O
.	O
	
existing	O
policies	O
were	O
created	O
in	O
response	O
to	O
external	O
mandates	O
,	O
and	O
smoking	O
cessation	O
programs	B-T169
may	O
need	O
to	O
be	O
modified	B-T169
in	O
order	O
to	O
effectively	B-T080
reach	O
identification	O
of	O
low	O
micromolar	B-T081
dual	O
inhibitors	O
for	O
aldose	B-T116
reductase	I-T116
alr2	B-T116
and	O
poly	B-T116
adp-ribose	I-T116
polymerase	I-T116
parp-1	B-T116
using	O
structure	O
based	O
design	O
approach	O
clinical	O
studies	O
have	O
revealed	O
that	O
diabetic	B-T047
retinopathy	I-T047
is	O
a	O
multifactorial	O
disorder	B-T047
.	O
	
moreover	O
,	O
studies	O
also	O
suggest	O
that	O
alr2	B-T116
and	O
parp-1	B-T116
co-occur	O
in	O
retinal	O
cells	O
,	O
making	O
them	O
appropriate	O
targets	B-T169
for	O
the	O
treatment	B-T061
of	O
diabetic	B-T047
retinopathy	I-T047
.	O
	
to	O
find	O
the	O
dual	O
inhibitors	O
of	O
alr2	B-T116
and	O
parp-1	B-T116
,	O
the	O
structure	O
based	O
design	O
was	O
carried	O
out	O
in	O
parallel	O
for	O
both	O
the	O
target	B-T169
proteins	B-T116
.	O
	
a	O
series	O
of	O
novel	O
thiazolidine-2	B-T109
tzd	B-T109
derivatives	B-T169
were	O
therefore	O
rationally	O
designed	O
,	O
synthesized	O
and	O
their	O
in	B-T080
vitro	I-T080
inhibitory	O
activities	O
against	O
alr2	B-T116
and	O
parp-1	B-T116
were	O
evaluated	O
.	O
	
the	O
experimental	B-T033
results	I-T033
showed	O
that	O
compounds	O
5b	O
and	O
5f	O
,	O
with	O
2-chloro	O
and	O
4-fluoro	O
substitutions	O
,	O
showed	O
biochemical	B-T169
activities	O
in	O
micromolar	B-T081
and	O
submicromolar	B-T081
range	B-T081
ic50	B-T081
1.34	O
against	O
both	O
the	O
targeted	B-T169
enzymes	B-T116
.	O
	
the	O
structure-activity	B-T080
relationship	I-T080
elucidated	O
for	O
these	O
novel	O
inhibitors	O
against	O
both	O
the	O
enzymes	B-T116
provide	O
new	O
insight	O
into	O
the	O
binding	O
mode	B-T169
of	O
the	O
inhibitors	O
to	O
the	O
active	B-T169
sites	I-T169
of	O
enzymes	B-T116
.	O
	
the	O
positive	B-T033
results	B-T033
of	O
the	O
biochemical	B-T169
assay	O
suggest	O
that	O
these	O
compounds	O
may	O
be	O
further	O
optimized	O
and	O
utilized	B-T169
for	O
the	O
treatment	B-T061
of	O
diabetic	B-T047
retinopathy	I-T047
.	O
	
microbiology	O
of	O
the	O
upper	O
and	O
lower	O
airways	O
in	O
pediatric	B-T080
cystic	B-T047
fibrosis	I-T047
patients	O
objective	O
to	O
evaluate	O
the	O
microbiology	O
of	O
the	O
upper	O
and	O
lower	O
airways	O
in	O
pediatric	B-T080
cystic	B-T047
fibrosis	I-T047
cf	B-T047
patients	O
who	O
underwent	O
sinus	B-T061
surgery	I-T061
.	O
	
study	O
design	O
retrospective	O
case	O
series	O
with	O
chart	O
review	O
.	O
	
setting	O
tertiary	O
care	O
children's	O
hospital	O
.	O
	
subjects	O
and	O
methods	O
a	O
total	O
of	O
201	O
paired	O
sinus	O
and	O
pulmonary	O
cultures	O
from	O
105	O
cf	B-T047
patients	O
were	O
identified	O
between	O
1996	O
and	O
2014	O
.	O
	
demographics	O
and	O
culture	O
results	B-T169
were	O
analyzed	O
.	O
	
results	B-T169
the	O
mean	O
age	O
of	O
patients	O
was	O
11.2	O
5.4	O
years	O
range	O
,	O
1-27	O
years	O
,	O
and	O
approximately	O
one-half	O
were	O
female	O
.	O
	
methicillin	B-T109
-	O
sensitive	B-T169
staphylococcus	O
aureus	O
was	O
the	O
most	O
common	O
pathogen	O
overall	O
.	O
	
a	O
significantly	O
higher	O
prevalence	B-T081
of	O
pseudomonas	O
aeruginosa	O
32%	O
for	O
pulmonary	O
and	O
37%	O
for	O
sinus	O
cultures	O
was	O
observed	O
in	O
older	O
patients	O
versus	O
younger	O
patients	O
p	B-T081
<	O
001	O
.	O
	
there	O
was	O
low	O
to	O
moderate	B-T080
agreement	B-T080
between	O
sinus	O
and	O
pulmonary	O
cultures	O
kappa	O
statistic	B-T081
range	I-T081
,	O
0.03	O
.	O
	
the	O
prevalence	B-T081
of	O
methicillin-resistant	O
s	O
aureus	O
mrsa	O
increased	O
significantly	B-T081
for	O
lower	O
respiratory	O
tract	O
culture	O
from	O
5%	O
to	O
16%	O
and	O
sinus	O
culture	O
from	O
5%	O
to	O
27%	O
between	O
1996-2004	O
and	O
2010-2014	O
p	B-T081
=	O
016	O
and	O
p	B-T081
<	O
001	O
,	O
respectively	O
.	O
	
the	O
prevalence	B-T081
of	O
positive	B-T033
sinus	O
cultures	O
increased	O
from	O
40%	O
to	O
85%	O
between	O
1996-2004	O
and	O
2010-2014	O
p	B-T081
=	O
018	O
.	O
	
patients	O
with	O
pulmonary	B-T080
mrsa	O
were	O
more	O
likely	O
to	O
be	O
coinfected	B-T047
with	O
pulmonary	B-T080
p	O
aeruginosa	O
risk	B-T081
ratio	I-T081
,	O
2.4	O
95%	O
ci	B-T081
,	O
1.2	O
p	O
=	O
015	O
or	O
aspergillus	O
fumigatus	O
risk	B-T081
ratio	I-T081
,	O
2.2	O
95%	O
ci	B-T081
,	O
1.2	O
p	O
=	O
035	O
.	O
	
conclusions	O
there	O
is	O
low	O
to	O
moderate	B-T080
correlation	B-T080
between	O
pulmonary	B-T080
and	O
sinus	O
pathogens	O
in	O
cf	B-T047
patients	O
.	O
	
this	O
is	O
important	O
to	O
consider	O
when	O
treating	B-T061
infections	O
.	O
	
the	O
prevalence	B-T081
of	O
mrsa	O
in	O
sinus	O
cultures	O
has	O
increased	O
over	O
time	O
and	O
warrants	O
further	O
the	O
role	O
of	O
mir-451	O
in	O
the	O
switching	O
between	O
proliferation	B-T169
and	O
migration	O
in	O
malignant	O
glioma	O
cells	O
ampk	B-T116
signaling	O
,	O
mtor	B-T116
modulation	O
and	O
rac1	B-T116
activation	O
required	O
glioblastoma	O
multiforme	O
gbm	O
,	O
who	O
grade	O
iv	O
astrocytoma	O
,	O
is	O
the	O
most	O
common	O
primary	O
neoplasm	O
of	O
the	O
central	O
nervous	O
system	O
cns	O
and	O
has	O
the	O
highest	O
malignancy	O
and	O
mortality	B-T081
rates	I-T081
.	O
	
the	O
invasive	B-T080
nature	I-T080
of	O
gbm	O
complicates	O
surgical	B-T061
resection	I-T061
and	O
restricts	O
chemotherapeutic	B-T061
access	I-T061
,	O
contributing	O
to	O
poor	O
patient	O
prognosis	O
.	O
	
the	O
migration	O
of	O
tumor	O
cells	O
is	O
closely	O
related	O
to	O
the	O
tumor	O
cell	O
proliferation	B-T169
.	O
	
the	O
acquisition	O
of	O
migratory	B-T169
capability	B-T080
,	O
in	O
addition	O
to	O
intracellular	O
factors	B-T169
,	O
is	O
proposed	O
to	O
be	O
a	O
crucial	B-T169
mechanism	I-T169
during	O
the	O
progression	B-T169
of	O
invasion	B-T033
.	O
	
using	O
qrt-pcr	O
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
mir-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	O
tissue	O
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O
	
in	O
glioma	O
cell	O
lines	O
,	O
we	O
found	O
that	O
decreased	B-T081
mir-451	O
expression	O
suppressed	B-T169
tumor	O
cell	O
proliferation	B-T169
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	B-T079
low	O
level	O
of	O
cab39	B-T116
/	O
ampk	B-T116
/	O
mtor	B-T116
pathway	B-T169
activation	I-T169
and	O
high	O
level	O
of	O
rac1	B-T116
/	O
cofilin	B-T116
pathway	B-T169
activation	I-T169
,	O
respectively	O
.	O
	
notably	O
,	O
the	O
effect	O
of	O
mir-451	O
on	O
cytological	B-T169
behavior	I-T169
and	O
on	O
the	O
activation	O
of	O
mtor	B-T116
and	O
rac1	B-T116
was	O
limited	O
when	O
ampkα1	B-T116
expression	O
was	O
knocked-down	O
with	O
a	O
synthetic	O
shrna	O
.	O
	
we	O
suggest	O
that	O
the	O
glioma	O
microenvironment	O
results	O
in	O
heterogeneity	B-T080
of	O
mir-451	O
expression	O
.	O
	
our	O
data	O
indicated	O
that	O
mir-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
ampk	B-T116
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mtor	B-T116
and	O
rac1	B-T116
/	O
cofilin	B-T116
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	B-T169
and	O
migration	O
,	O
respectively	O
.	O
	
our	O
results	O
highlight	O
the	O
need	O
to	O
consider	O
opposing	O
roles	O
of	O
a	O
therapeutic	B-T169
target	O
which	O
,	O
while	O
suppressing	B-T169
tumor	O
cell	O
proliferation	B-T169
,	O
could	O
also	O
promote	O
cell	O
infiltration	O
.	O
	
comparison	O
of	O
gasoline	O
direct-injection	O
gdi	O
and	O
port	O
fuel	O
injection	O
pfi	O
vehicle	O
emissions	O
emission	O
certification	O
standards	O
,	O
cold-start	B-T033
,	O
secondary	O
organic	B-T080
aerosol	O
formation	B-T169
potential	B-T080
,	O
and	O
potential	B-T080
climate	O
impacts	B-T080
recent	O
increases	B-T081
in	O
the	O
corporate	B-T080
average	B-T081
fuel	I-T081
economy	I-T081
standards	O
have	O
led	O
to	O
widespread	O
adoption	O
of	O
vehicles	O
equipped	O
with	O
gasoline	O
direct-injection	O
gdi	O
engines	O
.	O
	
changes	O
in	O
engine	O
technologies	O
can	O
alter	O
emissions	O
.	O
	
to	O
quantify	B-T081
these	O
effects	B-T080
,	O
we	O
measured	B-T080
gas-	O
and	O
particle-phase	O
emissions	O
from	O
82	O
light-duty	B-T080
gasoline	O
vehicles	O
recruited	O
from	O
the	O
california	O
in-use	O
fleet	O
tested	O
on	O
a	O
chassis	O
dynamometer	O
using	O
the	O
cold-start	B-T033
unified	O
cycle	O
.	O
	
the	O
fleet	O
included	O
15	O
gdi	O
vehicles	O
,	O
including	O
8	O
gdis	O
certified	O
to	O
the	O
most-stringent	O
emissions	O
standard	O
,	O
superultra-low-emission	O
vehicles	O
sulev	O
.	O
	
we	O
quantified	B-T081
the	O
effects	B-T080
of	I-T080
engine	O
technology	O
,	O
emission	O
certification	O
standards	O
,	O
and	O
cold-start	B-T033
on	O
emissions	O
.	O
	
for	O
vehicles	O
certified	O
to	O
the	O
same	O
emissions	O
standard	O
,	O
there	O
is	O
no	O
statistical	O
difference	B-T081
of	O
regulated	O
gas-phase	O
pollutant	O
emissions	O
between	O
pfis	O
and	O
gdis	O
.	O
	
however	O
,	O
gdis	O
had	O
,	O
on	O
average	B-T081
,	O
a	O
factor	B-T169
of	O
2	O
higher	O
particulate	O
matter	O
pm	O
mass	O
emissions	O
than	O
pfis	O
due	O
to	O
higher	O
elemental	O
carbon	O
ec	O
emissions	O
.	O
	
sulev	O
certified	O
gdis	O
have	O
a	O
factor	B-T169
of	O
2	O
lower	O
pm	O
mass	O
emissions	O
than	O
gdis	O
certified	O
as	O
ultralow-emission	O
vehicles	O
3.0	O
1.1	O
versus	O
6.3	O
1.1	O
mg/mi	O
,	O
suggesting	O
improvements	O
in	O
engine	O
design	O
and	O
calibration	B-T081
.	O
	
comprehensive	B-T080
organic	B-T080
speciation	O
revealed	B-T080
no	O
statistically	B-T081
significant	I-T081
differences	B-T081
in	O
the	O
composition	O
of	O
the	O
volatile	B-T080
organic	B-T109
compounds	I-T109
emissions	O
between	O
pfi	O
and	O
gdis	O
,	O
including	O
benzene	B-T109
,	O
toluene	B-T109
,	O
ethylbenzene	B-T109
,	O
and	O
xylenes	B-T109
btex	B-T109
.	O
	
therefore	O
,	O
the	O
secondary	O
organic	B-T080
aerosol	O
and	O
ozone	O
formation	B-T169
potential	B-T080
of	O
the	O
exhaust	O
does	O
not	O
depend	O
on	O
engine	O
technology	O
.	O
	
cold-start	B-T033
contributes	O
a	O
larger	B-T081
fraction	B-T081
of	I-T081
the	O
total	O
unified	O
cycle	O
emissions	O
for	O
vehicles	O
meeting	O
more-stringent	O
emission	O
standards	O
.	O
	
organic	B-T080
gas	O
emissions	O
were	O
the	O
most	O
sensitive	B-T169
to	O
cold-start	B-T033
compared	O
to	O
the	O
other	O
pollutants	O
tested	O
here	O
.	O
	
there	O
were	O
no	O
statistically	B-T081
significant	I-T081
differences	B-T081
in	O
the	O
effects	B-T080
of	I-T080
cold-start	B-T033
on	O
gdis	O
and	O
pfis	O
.	O
	
for	O
our	O
test	O
fleet	O
,	O
the	O
measured	B-T080
14.5	O
decrease	B-T081
in	O
co2	O
emissions	O
from	O
gdis	O
was	O
much	O
greater	B-T081
than	O
the	O
potential	B-T080
climate	O
forcing	O
associated	B-T080
with	I-T080
higher	O
black	O
carbon	O
emissions	O
.	O
	
thus	O
,	O
switching	O
from	O
pfi	O
to	O
gdi	O
vehicles	O
will	O
likely	O
lead	O
to	O
a	O
reduction	B-T080
in	O
net	O
global	O
warming	O
.	O
	
trib3	B-T116
downregulation	O
enhances	O
doxorubicin	B-T109
-	O
induced	B-T169
cytotoxicity	O
in	O
gastric	O
cancer	O
cells	O
trib3	B-T116
,	O
which	O
is	O
a	O
pseudokinase	B-T116
known	O
to	O
regulate	O
multiple	O
pro-survival	O
pathways	O
,	O
appears	O
to	O
be	O
a	O
potential	O
therapeutic	B-T061
target	B-T169
for	O
the	O
treatment	B-T061
of	O
human	O
tumors	O
.	O
	
however	O
,	O
its	O
precise	O
role	O
in	O
cancer	O
is	O
controversial	O
,	O
as	O
trib3	B-T116
protein	O
levels	O
have	O
been	O
associated	O
with	O
both	O
good	B-T033
and	O
poor	B-T033
prognosis	I-T033
in	O
cancer	O
patients	O
.	O
	
here	O
,	O
we	O
investigated	O
the	O
significance	O
of	O
trib3	B-T116
expression	O
in	O
the	O
survival	O
of	O
gastric	O
cancer	O
cells	O
exposed	O
to	O
anticancer	B-T109
drugs	I-T109
.	O
	
we	O
found	O
that	O
the	O
tested	B-T169
anticancer	B-T109
drug	I-T109
,	O
doxorubicin	B-T109
,	O
induced	B-T169
cytotoxicity	O
by	O
decreasing	O
trib3	O
transcription	O
,	O
which	O
was	O
followed	O
by	O
apoptotic	O
cell	O
death	O
.	O
	
moreover	O
,	O
trib3	O
sirna	O
knockdown	O
appeared	O
to	O
enhance	O
doxorubicin	B-T109
-	O
induced	B-T169
apoptosis	O
in	O
gastric	O
cancer	O
cells	O
,	O
concurrently	O
with	O
altering	O
the	O
expression	O
of	O
downstream	O
apoptotic	B-T116
factors	I-T116
.	O
	
conversely	O
,	O
overexpression	O
of	O
trib3	B-T116
significantly	O
protected	O
cells	O
against	O
doxorubicin	B-T109
-	O
induced	B-T169
apoptosis	O
.	O
	
our	O
results	O
indicate	O
that	O
downregulation	O
of	O
trib3	B-T116
appears	O
to	O
promote	O
cell	O
death	O
and	O
enhance	O
doxorubicin	B-T109
-	O
induced	B-T169
apoptosis	O
,	O
supporting	O
the	O
anti-apoptotic	O
role	O
of	O
trib3	B-T116
.	O
	
the	O
inductions	O
of	O
three	O
classes	O
of	O
mapks	B-T116
failed	O
to	O
affect	O
doxorubicin	B-T109
-mediated	O
trib3	B-T116
downregulation	O
,	O
while	O
trib3	B-T116
overexpression	O
did	O
not	O
affect	O
doxorubicin	B-T109
-	O
induced	B-T169
mapk	O
activation	O
.	O
	
in	O
sum	O
,	O
our	O
findings	B-T033
indicate	O
that	O
trib3	B-T116
plays	O
an	O
anti-apoptotic	O
role	O
in	O
doxorubicin	B-T109
-treated	O
gastric	O
cancer	O
cell	O
lines	O
,	O
perhaps	O
indicating	O
that	O
the	O
status	O
of	O
trib3	B-T116
expression	O
in	O
response	O
to	O
anticancer	B-T109
drugs	I-T109
,	O
such	O
as	O
doxorubicin	B-T109
,	O
irinotecan	B-T109
or	O
oxaliplatin	B-T109
,	O
may	O
reflect	O
the	O
efficiency	O
for	O
cancer	B-T061
therapy	I-T061
.	O
	
digital	O
myopericytoma	O
a	O
case	O
report	O
and	O
systematic	O
literature	O
review	O
a	O
myopericytoma	O
mp	O
is	O
an	O
exceedingly	O
rare	O
perivascular	O
tumor	O
of	O
unknown	B-T033
etiology	I-T033
.	O
	
given	O
their	O
potential	B-T080
for	O
mimicry	O
and	O
malignancy	O
,	O
mp	O
tumors	O
pose	O
a	O
unique	O
challenge	O
for	O
surgeons	O
and	O
may	O
be	O
overlooked	O
on	O
differential	O
diagnosis	O
.	O
	
we	O
present	O
a	O
case	O
report	O
of	O
an	O
otherwise	O
healthy	B-T080
33-year-old	O
right-hand	O
dominant	O
male	O
who	O
presented	O
to	O
our	O
outpatient	O
clinic	O
with	O
a	O
2-month	O
history	O
of	O
painless	B-T169
swelling	B-T033
and	O
erythema	B-T033
of	I-T033
the	I-T033
pulp	I-T033
of	I-T033
his	I-T033
left	I-T033
index	I-T033
finger	I-T033
.	O
	
subsequent	O
plain	O
film	O
x-ray	O
showed	O
near-complete	B-T080
bony	B-T033
destruction	I-T033
of	O
his	O
distal	O
phalanx	O
.	O
	
pathological	O
evaluation	O
of	O
an	O
incisional	O
biopsy	O
showed	O
a	O
benign	O
variant	O
of	O
mp	O
.	O
	
the	O
lesion	B-T033
was	O
treated	O
by	O
excision	B-T061
with	O
tumor	O
shelling	B-T061
,	O
and	O
there	O
was	O
no	B-T080
evidence	I-T080
of	I-T080
recurrence	O
81	O
days	O
postoperatively	B-T079
.	O
	
a	O
systematic	O
literature	O
review	O
of	O
the	O
management	O
and	O
outcome	B-T080
of	O
all	O
known	O
cases	O
of	O
hand	O
and	O
wrist	O
mp	O
gene	O
expression	O
reveals	O
evidence	B-T078
for	O
egfr	B-T116
-dependent	O
proximal-distal	O
limb	O
patterning	O
in	O
a	O
myriapod	O
evolution	O
of	O
segmented	O
limbs	O
is	O
one	O
of	O
the	O
key	O
innovations	O
of	O
arthropoda	O
,	O
allowing	O
development	O
of	O
functionally	O
specific	O
specialized	O
head	O
and	O
trunk	O
appendages	O
,	O
a	O
major	O
factor	O
behind	O
their	O
unmatched	O
evolutionary	O
success	O
.	O
	
proximodistal	O
limb	O
patterning	O
is	O
controlled	O
by	O
two	O
regulatory	O
networks	O
in	O
the	O
vinegar	O
fly	O
drosophila	O
melanogaster	O
,	O
and	O
other	O
insects	O
.	O
	
the	O
first	O
is	O
represented	O
by	O
the	O
function	O
of	O
the	O
morphogens	O
wingless	B-T116
wg	B-T116
and	O
decapentaplegic	B-T116
dpp	B-T116
the	O
second	O
by	O
the	O
egfr-signaling	O
cascade	O
.	O
	
while	O
the	O
role	O
of	O
wg	B-T116
and	O
dpp	B-T116
has	O
been	O
studied	O
in	O
a	O
wide	O
range	O
of	O
arthropods	O
representing	O
all	O
main	O
branches	O
,	O
that	O
is	O
,	O
pancrustacea	O
=	O
hexapoda	O
+	O
crustacea	O
,	O
myriapoda	O
and	O
chelicerata	O
,	O
investigation	B-T169
of	O
the	O
potential	O
role	O
of	O
egfr-signaling	O
is	O
restricted	O
to	O
insects	O
hexapoda	O
.	O
	
gene	O
expression	O
analysis	O
of	O
egfr	B-T116
,	O
its	O
potential	B-T080
ligands	O
,	O
and	O
putative	B-T116
downstream	I-T116
factors	I-T116
in	O
the	O
pill	O
millipede	O
glomeris	O
marginata	O
myriapoda	O
diplopoda	O
,	O
reveals	O
that-in	O
at	O
least	O
mandibulate	O
arthropods	O
-	O
egfr-signaling	O
is	O
likely	O
a	O
conserved	O
regulatory	B-T033
mechanism	I-T033
in	O
proximodistal	O
limb	O
patterning	O
.	O
	
pirfenidone	B-T109
normalizes	B-T169
the	O
tumor	O
microenvironment	O
to	O
improve	O
chemotherapy	B-T061
normalization	B-T061
of	O
the	O
tumor	O
microenvironment	O
by	O
selectively	O
targeting	B-T169
components	O
of	O
the	O
tumor	O
extracellular	O
matrix	O
has	O
been	O
recently	O
proposed	O
to	O
have	O
the	O
potential	B-T080
to	O
decompress	B-T169
tumor	O
blood	O
vessels	O
,	O
increase	B-T169
vessel	O
perfusion	O
and	O
thus	O
,	O
improve	O
drug	B-T061
delivery	I-T061
and	O
the	O
efficacy	B-T080
of	O
cancer	B-T061
therapy	I-T061
.	O
	
therefore	O
,	O
we	O
now	O
need	O
to	O
identify	B-T080
safe	O
and	O
well	O
tolerated	B-T033
pharmaceutical	O
agents	O
that	O
are	O
able	O
to	O
remodel	O
the	O
microenvironment	O
of	O
solid	O
tumors	O
and	O
enhance	O
chemotherapy	B-T061
.	O
	
in	O
this	O
study	O
,	O
we	O
repurposed	O
pirfenidone	B-T109
,	O
a	O
clinically	B-T080
approved	B-T080
anti-fibrotic	O
drug	O
for	O
the	O
treatment	B-T061
of	O
idiopathic	B-T047
pulmonary	I-T047
fibrosis	I-T047
,	O
to	O
investigate	B-T169
its	O
possible	O
role	O
on	O
tumor	O
microenvironment	O
normalization	B-T061
.	O
	
using	O
two	O
orthotopic	O
mammary	O
tumor	O
models	O
we	O
demonstrate	O
that	O
pirfenidone	B-T109
reduces	B-T081
collagen	B-T116
and	O
hyaluronan	B-T109
levels	B-T080
and	O
,	O
as	O
a	O
result	B-T169
,	O
significantly	B-T078
increases	B-T169
blood	O
vessel	O
functionality	B-T169
and	O
perfusion	O
and	O
improves	O
the	O
anti-tumor	B-T080
efficacy	I-T080
of	O
doxorubicin	B-T109
.	O
	
reduction	B-T080
of	O
extracellular	O
matrix	O
components	O
were	O
mediated	O
via	O
tgfβ	B-T169
signaling	I-T169
pathway	I-T169
inhibition	O
due	O
to	O
downregulation	O
of	O
tgfβ1	O
,	O
col1a1	O
,	O
col3a1	O
,	O
has2	O
,	O
has3	O
expression	O
levels	B-T080
.	O
	
our	O
findings	B-T033
provide	O
evidence	B-T078
that	O
repurposing	O
pirfenidone	B-T109
could	O
be	O
used	O
as	O
a	O
promising	O
strategy	O
to	O
enhance	O
drug	B-T061
delivery	I-T061
to	O
solid	O
tumors	O
by	O
normalizing	B-T061
the	O
tumor	O
microenvironment	O
.	O
	
serum	O
vascular	B-T116
endothelial	I-T116
growth	I-T116
factor	I-T116
receptor-3	I-T116
levels	B-T081
in	O
patients	O
with	O
esophageal	O
squamous	O
cell	O
cancer	O
esophageal	O
cancer	O
is	O
one	O
of	O
the	O
most	O
aggressive	O
tumors	O
of	O
the	O
gastrointestinal	O
tract	O
.	O
	
in	O
this	O
study	O
,	O
we	O
quantified	O
the	O
serum	O
vascular	B-T116
endothelial	I-T116
growth	I-T116
factor-3	I-T116
vegfr-3	B-T116
expression	O
in	O
patients	O
with	O
esophageal	O
squamous	O
cell	O
carcinoma	O
escc	O
to	O
evaluate	O
the	O
role	O
of	O
vegfr-3	B-T116
in	O
escc	O
.	O
	
ninety	O
five	O
patients	O
with	O
escc	O
were	O
studied	O
.	O
	
pre-therapy	B-T079
and	O
preoperative	B-T079
samples	O
were	O
stored	O
and	O
elisa	O
was	O
used	O
to	O
designate	O
the	O
concentrations	O
of	O
vegfr-3	B-T116
.	O
	
the	O
serum	B-T081
values	I-T081
of	O
vegfr-3	B-T116
were	O
significantly	O
higher	O
in	O
patients	O
with	O
escc	O
than	O
in	O
healthy	B-T080
donors	O
p<0	O
.	O
	
the	O
results	O
imply	O
a	O
very	O
good	O
sensitivity	B-T081
of	O
vegfr-3	B-T116
in	O
escc	O
.	O
	
vegfr-3	B-T116
may	O
be	O
a	O
good	O
diagnostic	B-T169
biomarker	O
for	O
escc	O
.	O
	
biomarker	O
,	O
escc	O
,	O
vegfr-3	B-T116
.	O
	
zinc	O
and	O
wound	O
healing	O
a	O
review	B-T169
of	I-T169
zinc	O
physiology	O
and	O
clinical	B-T169
applications	I-T169
our	O
understanding	O
of	O
the	O
role	O
of	O
zinc	O
in	O
normal	O
human	O
physiology	O
is	O
constantly	B-T080
expanding	O
,	O
yet	O
there	O
are	O
major	O
gaps	O
in	O
our	O
knowledge	O
with	O
regard	O
to	O
the	O
function	B-T169
of	O
zinc	O
in	O
wound	O
healing	O
.	O
	
this	O
review	O
aims	B-T078
to	O
provide	O
the	O
clinician	O
with	O
sufficient	B-T080
understanding	O
of	O
zinc	O
biology	O
and	O
an	O
up-to-date	O
perspective	O
on	O
the	O
role	O
of	O
zinc	O
in	O
wound	O
healing	O
.	O
	
zinc	O
is	O
an	O
essential	O
ion	O
that	O
is	O
crucial	O
for	O
maintenance	O
of	O
normal	O
physiology	O
,	O
and	O
zinc	B-T047
deficiency	I-T047
has	O
many	O
manifestations	B-T169
ranging	O
from	O
delayed	B-T079
wound	O
healing	O
to	O
immune	B-T047
dysfunction	I-T047
and	O
impairment	B-T169
of	O
multiple	B-T081
sensory	O
systems	O
.	O
	
while	O
consensus	O
has	O
been	O
reached	O
regarding	O
the	O
detrimental	B-T080
effects	I-T080
of	O
zinc	B-T047
deficiency	I-T047
on	O
wound	O
healing	O
,	O
there	O
is	O
considerable	O
discord	O
in	O
the	O
literature	O
on	O
the	O
optimal	O
methods	O
and	O
true	B-T081
benefits	I-T081
of	O
zinc	O
receipt	O
of	O
thyroid	B-T047
hormone	I-T047
deficiency	I-T047
treatment	B-T061
and	O
risk	B-T078
of	O
herpes	B-T047
zoster	I-T047
thyroid	B-T116
hormone	I-T116
th	B-T116
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	O
gene	O
expression	O
and	O
replication	O
in	O
neurons	O
via	O
epigenetics	O
through	O
its	O
nuclear	B-T116
receptors	I-T116
.	O
	
it	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	B-T047
are	O
predisposed	O
to	O
herpes	B-T047
zoster	I-T047
hz	B-T047
,	O
suggesting	O
that	O
the	O
th	B-T047
deficiency	I-T047
may	O
be	O
a	O
risk	B-T033
factor	I-T033
for	O
varicella	O
zoster	O
virus	O
vzv	O
reactivation	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
test	O
the	O
hypothesis	B-T078
that	O
th	B-T061
treatment	I-T061
will	O
ameliorate	O
the	O
complication	O
of	O
hz	B-T047
.	O
	
this	O
study	O
investigated	B-T169
the	O
hypothesis	B-T078
by	O
enquiring	O
into	O
a	O
comprehensive	O
medical	O
database	O
at	O
kaiser	O
permanente	O
southern	O
california	O
kpsc	O
to	O
verify	O
whether	O
patients	O
taking	O
th	B-T116
medication	O
experience	O
a	O
reduction	O
in	O
hz	B-T047
occurrence	O
.	O
	
it	O
was	O
shown	O
by	O
kaplan-meier	B-T081
analysis	I-T081
that	O
hypothyroidism	B-T047
patients	O
taking	O
th	B-T116
medicines	O
had	O
a	O
lower	O
risk	B-T078
of	O
hz	B-T047
.	O
	
the	O
fully	O
adjusted	O
analysis	O
indicated	O
that	O
patients	O
receiving	O
medication	O
for	O
the	O
treatment	B-T061
of	O
th	B-T047
deficiency	I-T047
exhibited	O
a	O
reduced	O
risk	B-T078
of	O
hz	B-T047
hazard	B-T081
ratio	I-T081
0.60	O
,	O
95%	O
confidence	B-T081
interval	I-T081
0.51	O
.	O
	
this	O
lower	O
risk	B-T078
of	O
hz	B-T047
was	O
significant	O
in	O
all	O
age	O
groups	O
except	O
the	O
18-39	O
years	B-T079
cohort	O
.	O
	
in	O
addition	O
,	O
female	O
patients	O
taking	O
th	B-T061
treatment	I-T061
exhibited	O
a	O
lower	O
risk	B-T078
than	O
their	O
male	O
counterparts	O
.	O
	
together	O
these	O
findings	B-T033
support	O
the	O
hypothesis	B-T078
that	O
a	O
constant	O
level	O
of	O
th	B-T116
will	O
provide	O
a	O
degree	O
of	O
protection	O
from	O
contracting	O
hz	B-T047
.	O
	
more	O
studies	O
are	O
underway	O
to	O
evaluate	O
the	O
laboratory	O
data	O
for	O
an	O
analysis	O
of	O
hormonal	B-T080
effects	B-T080
on	O
peer	O
exclusion	O
during	O
the	O
pubertal	B-T033
transition	O
the	O
role	O
of	O
social	O
competence	O
for	O
some	O
youth	O
,	O
early	B-T047
puberty	I-T047
is	O
accompanied	O
by	O
peer	O
exclusion	O
.	O
	
yet	O
early	B-T079
developers	O
may	O
experience	O
less	O
peer	O
exclusion	O
if	O
they	O
have	O
social	O
competence	O
,	O
which	O
would	O
bolster	B-T169
their	O
ability	O
to	O
develop	B-T169
and	O
maintain	O
positive	B-T033
relationships	B-T080
with	O
their	O
peers	O
.	O
	
accordingly	O
,	O
the	O
present	B-T033
study	O
tests	O
whether	O
pubertal	B-T033
timing	B-T079
and	O
tempo	B-T079
predicts	B-T078
decrements	B-T080
in	O
children's	O
social	O
competence	O
and	O
whether	O
decrements	B-T080
in	O
social	O
competence	O
account	O
for	O
associations	B-T080
between	O
puberty	O
timing	B-T079
and	O
tempo	B-T079
and	O
peer	O
exclusion	O
over	O
time	B-T079
.	O
	
longitudinal	O
data	B-T078
were	O
drawn	O
from	O
1364	O
families	O
48%	O
female	O
76%	O
white	O
m	O
=	O
9.32	O
years	B-T079
,	O
sd	O
=	O
48	O
,	O
at	O
wave	O
3	O
who	O
participated	B-T169
in	O
waves	O
3-5	O
i.e	O
,	O
grades	O
4-6	O
of	O
phase	O
iii	O
of	O
the	O
nichd	O
-	O
seccyd	O
.	O
	
the	O
results	B-T169
from	O
latent	O
growth	O
curve	O
models	O
indicated	O
that	O
earlier	B-T079
pubertal	B-T033
timing	B-T079
and	O
more	O
rapid	B-T080
pubertal	B-T033
tempo	B-T079
among	O
girls	O
were	O
associated	B-T080
with	I-T080
high	B-T080
initial	B-T079
levels	B-T080
of	O
peer	O
exclusion	O
.	O
	
moreover	O
,	O
mediation	O
analyses	O
revealed	O
that	O
early	B-T079
developers'	O
susceptibility	B-T169
to	O
peer	O
exclusion	O
was	O
associated	B-T080
with	I-T080
their	O
initial	B-T079
level	B-T080
of	O
social	O
competence	O
.	O
	
in	O
boys	O
,	O
pubertal	B-T033
timing	B-T079
and	O
tempo	B-T079
were	O
not	O
directly	O
associated	B-T080
with	I-T080
peer	O
exclusion	O
instead	O
,	O
indirect	O
effects	B-T080
of	I-T080
pubertal	B-T033
timing	B-T079
on	O
peer	O
exclusion	O
intercept	B-T081
,	O
slope	B-T081
occurred	O
through	O
initial	B-T079
levels	B-T080
of	O
social	O
competence	O
.	O
	
on	O
average	B-T081
,	O
early	B-T079
developers'	O
who	O
had	O
low	B-T080
levels	B-T080
of	O
social	O
competence	O
also	O
had	O
high	B-T080
initial	B-T079
levels	B-T080
of	O
peer	O
exclusion	O
but	O
experienced	O
decrements	B-T080
in	O
peer	O
exclusion	O
over	O
time	O
.	O
	
the	O
association	B-T080
between	O
the	O
intercepts	B-T081
for	O
puberty	O
and	O
peer	O
exclusion	O
and	O
the	O
slopes	B-T081
for	O
social	O
competence	O
and	O
peer	O
exclusion	O
were	O
stronger	B-T080
for	O
boys	O
than	O
girls	O
.	O
	
overall	O
,	O
our	O
findings	B-T033
suggest	O
that	O
early	B-T079
developers'	O
susceptibility	B-T169
to	O
and	O
experiences	O
of	O
peer	O
exclusion	O
are	O
associated	B-T080
with	I-T080
their	O
development	B-T169
of	O
social	O
competence	O
.	O
	
air	O
pollution	O
characteristics	B-T080
and	O
health	B-T061
risks	I-T061
in	O
henan	O
province	O
,	O
china	O
events	O
of	O
severe	B-T080
air	O
pollution	O
occurred	O
frequently	O
in	O
china	O
recently	O
,	O
thus	O
understanding	O
of	O
the	O
air	O
pollution	O
characteristics	B-T080
and	O
its	O
health	B-T078
risks	B-T078
is	O
very	O
important	O
.	O
	
in	O
this	O
work	O
,	O
we	O
analyzed	O
a	O
two-year	O
dataset	O
march	O
2014	O
-	O
february	O
2016	O
including	O
daily	B-T079
concentrations	B-T081
of	O
six	O
criteria	O
pollutants	O
pm2.5	O
,	O
pm10	O
,	O
co	O
,	O
so2	O
,	O
no2	O
,	O
and	O
o3	O
from	O
18	O
cities	O
in	O
henan	O
province	O
.	O
	
results	O
reveal	O
the	O
serious	O
air	O
pollution	O
status	B-T080
in	O
henan	O
province	O
,	O
especially	O
the	O
northern	O
part	O
,	O
and	O
zhengzhou	O
is	O
the	O
city	O
with	O
the	O
worst	B-T080
air	B-T080
quality	I-T080
.	O
	
annual	O
average	O
pm2.5	O
concentrations	B-T081
exceed	O
the	O
second	O
grade	O
of	O
chinese	B-T081
ambient	I-T081
air	I-T081
quality	I-T081
standard	I-T081
75μg/m	O
at	O
both	O
2014	O
and	O
2015	O
.	O
	
pm2.5	O
is	O
typically	O
the	O
major	O
pollutant	O
,	O
but	O
ozone	O
pollution	O
can	O
be	O
significant	O
during	O
summer	B-T079
.	O
	
furthermore	O
,	O
as	O
the	O
commonly	O
used	O
air	O
quality	O
index	O
aqi	O
neglects	O
the	O
mutual	O
health	B-T078
effects	O
from	O
multiple	O
pollutants	O
,	O
we	O
introduced	O
the	O
aggregate	O
air	O
quality	O
index	O
aaqi	O
and	O
health-risk	O
based	O
air	O
quality	O
index	O
haqi	O
to	O
evaluate	B-T061
the	I-T061
health	I-T061
risks	I-T061
.	O
	
results	O
show	O
that	O
based	O
on	O
haqi	O
,	O
the	O
current	O
aqi	O
system	O
likely	O
significantly	O
underestimate	O
the	O
health	B-T078
risks	B-T078
of	O
air	O
pollution	O
,	O
highlighting	O
that	O
the	O
general	O
public	O
may	O
need	O
stricter	O
health	O
protection	O
measures	O
.	O
	
the	O
population	B-T081
-weighted	O
two-year	O
average	O
haqi	O
data	O
further	O
demonstrates	O
that	O
all	O
population	B-T081
in	O
the	O
studied	O
cities	O
in	O
henan	O
province	O
live	O
with	O
polluted	O
air	O
-	O
72%	O
of	O
the	O
population	B-T081
is	O
exposed	B-T080
to	I-T080
air	O
that	O
is	O
unhealthy	B-T033
for	O
sensitive	B-T169
people	O
,	O
while	O
28%	O
of	O
people	O
is	O
exposed	B-T080
to	I-T080
air	O
that	O
can	O
be	O
harmful	O
to	O
healthy	B-T080
people	O
and	O
the	O
health	B-T078
risks	B-T078
are	O
much	O
greater	O
during	O
winter	B-T079
than	O
during	O
other	O
seasons	B-T079
.	O
	
future	O
works	O
should	O
further	O
improve	O
the	O
haqi	O
algorithm	O
,	O
and	O
validate	O
the	O
links	O
between	O
the	O
clinical	O
/	O
epidemiologic	B-T169
data	O
and	O
the	O
haqi	O
increased	B-T081
risk	B-T078
of	O
ptld	O
in	O
lung	B-T033
transplant	I-T033
recipients	I-T033
with	O
cystic	B-T047
fibrosis	I-T047
post-transplant	O
lymphoproliferative	O
disease	O
ptld	O
is	O
an	O
important	O
cause	O
of	O
morbidity	B-T081
and	O
mortality	B-T081
following	O
lung	B-T061
transplantation	I-T061
.	O
	
recipients	O
with	O
cystic	B-T047
fibrosis	I-T047
cf	B-T047
may	O
have	O
an	O
increased	B-T081
risk	B-T078
of	O
ptld	O
although	O
the	O
literature	O
is	O
limited	O
to	O
single	O
center	O
cohorts	O
.	O
	
our	O
primary	O
aim	O
is	O
to	O
examine	O
ptld	O
in	O
an	O
adult	O
lung	B-T061
transplant	I-T061
population	O
by	O
utilizing	O
the	O
international	O
society	O
for	O
heart	O
and	O
lung	O
transplantation	O
registry	O
.	O
	
we	O
studied	O
30	O
adult	O
recipients	O
of	O
lung	B-T061
transplants	I-T061
performed	O
between	O
1999	O
and	O
2011	O
.	O
	
the	O
primary	O
outcome	B-T169
was	O
development	B-T169
of	O
and	O
time	B-T079
to	O
ptld	O
.	O
	
in	O
addition	O
to	O
indication	O
for	O
transplant	B-T061
,	O
other	O
predictors	B-T078
examined	O
included	O
epstein-barr	O
virus	O
ebv	O
and	O
cytomegalovirus	O
cmv	O
serostatus	O
,	O
gender	O
,	O
and	O
age	O
.	O
	
outcomes	B-T169
were	O
assessed	O
with	O
univariable	O
and	O
multivariable	B-T081
cox	I-T081
proportional	I-T081
hazard	I-T081
models	I-T081
to	O
obtain	O
hazard	B-T081
ratios	I-T081
hr	B-T081
.	O
	
17%	O
of	O
the	O
cohort	O
had	O
a	O
diagnosis	B-T033
of	O
cf	B-T047
.	O
	
ptld	O
developed	O
in	O
2%	O
of	O
cf	B-T047
recipients	O
compared	O
to	O
1%	O
for	O
non-cf	B-T033
recipients	I-T033
p<0	O
.	O
	
compared	O
to	O
non-cf	B-T033
recipients	I-T033
,	O
cf	B-T047
recipients	O
had	O
higher	B-T081
prevalence	I-T081
of	O
ebv	O
and	O
cmv	O
seronegativity	O
and	O
higher	B-T081
prevalences	I-T081
of	O
high	B-T078
risk	I-T078
ebv	O
and	O
cmv	O
mismatch	O
d+/r-	O
.	O
	
there	O
is	O
a	O
significant	O
association	O
between	O
cf	B-T047
and	O
the	O
development	B-T169
of	O
ptld	O
hr	B-T081
1.66	O
95%	O
ci	O
1.30	O
.	O
	
stratified	B-T081
multivariable	I-T081
analysis	I-T081
controlling	O
for	O
age	O
revealed	O
ebv	O
negative	B-T033
non-cf	B-T033
recipients	I-T033
have	O
an	O
almost	O
2	O
fold	O
increased	B-T081
risk	B-T078
of	O
developing	O
ptld	O
,	O
whereas	O
ebv	O
negative	O
cf	B-T047
recipients	O
had	O
an	O
almost	O
6.5	O
fold	O
increased	B-T081
risk	B-T078
.	O
	
cf	B-T047
recipients	O
have	O
a	O
higher	O
risk	B-T078
for	O
ptld	O
compared	O
to	O
non-cf	B-T033
recipients	I-T033
.	O
	
further	O
studies	O
are	O
needed	O
to	O
account	O
for	O
additional	O
risk	B-T033
factors	I-T033
and	O
management	O
in	O
this	O
population	B-T033
post-transplant	I-T033
.	O
	
methods	O
,	O
tools	O
and	O
current	B-T079
perspectives	B-T078
in	O
proteogenomics	O
with	O
combined	O
technological	O
advancements	O
in	O
high-throughput	O
next-generation	O
sequencing	O
and	O
deep	O
mass	O
spectrometry	O
-based	O
proteomics	O
,	O
proteogenomics	O
,	O
i.e	O
,	O
the	O
integrative	O
analysis	O
of	O
proteomic	B-T078
and	I-T078
genomic	I-T078
data	I-T078
,	O
has	O
emerged	O
as	O
a	O
new	O
research	O
field	O
.	O
	
early	O
efforts	O
in	O
the	O
field	O
were	O
focused	O
on	O
improving	O
protein	B-T116
identification	B-T080
using	O
sample-specific	O
genomic	O
and	O
transcriptomic	O
sequencing	O
data	O
.	O
	
more	O
recently	O
,	O
integrative	O
analysis	O
of	O
quantitative	B-T081
measurements	B-T169
from	O
genomic	O
and	O
proteomic	O
studies	O
have	O
identified	B-T080
novel	O
insights	O
into	O
gene	O
expression	O
regulation	O
,	O
cell	O
signaling	O
,	O
and	O
disease	B-T047
.	O
	
many	O
methods	O
and	O
tools	O
have	O
been	O
developed	O
or	O
adapted	O
to	O
enable	O
an	O
array	O
of	O
integrative	B-T169
proteogenomic	I-T169
approaches	I-T169
and	O
in	O
this	O
article	O
,	O
we	O
systematically	B-T169
classify	O
published	O
methods	O
and	O
tools	O
into	O
four	O
major	O
categories	O
,	O
1	O
sequence	O
-centric	O
proteogenomics	O
2	O
analysis	O
of	O
proteogenomic	O
relationships	O
3	O
integrative	O
modeling	O
of	O
proteogenomic	O
data	O
and	O
4	O
data	O
sharing	O
and	O
visualization	O
.	O
	
we	O
provide	O
a	O
comprehensive	O
review	O
of	O
methods	O
and	O
available	O
tools	O
in	O
each	O
category	O
and	O
highlight	O
their	O
typical	O
applications	B-T169
plasma	O
dna	O
and	O
rna	O
differentially	B-T080
impact	B-T080
coagulation	O
during	O
abdominal	B-T047
sepsis	I-T047
-an	O
explorative	O
study	O
cell-free	O
dna	O
cfdna	O
and	O
extracellular	O
rna	O
exrna	O
are	O
both	O
suspected	B-T078
to	O
activate	B-T169
coagulation	B-T047
cascades	I-T047
in	O
sepsis	B-T047
.	O
	
therefore	O
,	O
our	O
study	O
investigated	B-T169
the	O
influence	O
of	O
plasmatic	O
nucleic	O
acids	O
on	O
coagulation	O
in	O
septic	B-T169
patients	O
in	O
comparison	O
to	O
patients	O
after	O
major	O
abdominal	B-T061
surgery	I-T061
.	O
	
a	O
total	O
of	O
15	O
patients	O
with	O
sepsis	B-T047
,	O
10	O
postoperative	B-T079
patients	O
,	O
and	O
10	O
healthy	O
volunteers	O
were	O
included	B-T169
in	O
this	O
longitudinal	O
study	O
.	O
	
blood	O
was	O
collected	B-T078
at	O
sepsis	B-T047
onset	B-T079
and	O
after	O
surgery	B-T061
respectively	O
,	O
as	O
well	O
as	O
after	O
24	O
,	O
72	O
and	O
168	O
h	O
.	O
	
levels	B-T080
of	O
cfdna	O
and	O
exrna	O
were	O
measured	B-T080
by	O
quantitative	B-T081
probe-based	O
polymerase	O
chain	O
reaction	O
.	O
	
in	O
addition	O
,	O
thromboelastography	O
for	O
coagulation	O
as	O
well	O
as	O
thromboaggregometry	O
for	O
platelet	O
function	O
was	O
conducted	O
.	O
	
both	O
cfdna	O
and	O
exrna	O
were	O
elevated	B-T080
in	O
patients	O
with	O
sepsis	B-T047
compared	O
with	O
postoperative	B-T079
patients	O
and	O
healthy	O
volunteers	O
.	O
	
while	O
higher	B-T080
exrna	O
levels	B-T080
correlated	B-T080
with	O
a	O
faster	O
clotting	O
time	O
and	O
more	O
stable	O
clots	O
,	O
cfdna	O
correlated	B-T080
with	O
a	O
shorter	O
clotting	O
time	O
but	O
also	O
less	O
fibrinolysis	O
.	O
	
in	O
addition	O
,	O
higher	B-T080
cfdna	O
seems	O
to	O
be	O
associated	B-T080
with	I-T080
kidney	O
dysfunction	O
as	O
well	O
as	O
with	O
general	O
markers	O
of	O
cell	O
damage	O
lactate	B-T116
dehydrogenase	I-T116
and	O
lactate	B-T109
.	O
	
both	O
nucleic	O
acid	O
species	O
might	O
be	O
associated	B-T080
with	I-T080
different	B-T080
effects	B-T080
on	O
coagulation	O
during	O
sepsis	B-T047
,	O
with	O
an	O
overall	B-T080
procoagulatory	O
influence	O
.	O
	
for	O
this	O
reason	O
,	O
individualized	B-T080
therapeutic	B-T061
approaches	I-T061
in	O
patients	O
suffering	O
from	O
coagulation	O
-	O
associated	B-T033
organ	B-T047
dysfunction	I-T047
association	B-T080
of	O
fat	O
mass	O
and	O
obesity	B-T047
-	O
associated	B-T080
gene	O
variant	O
with	O
lifestyle	O
factors	B-T169
and	O
body	O
fat	O
in	O
indian	O
children	O
common	O
intronic	O
variants	O
of	O
the	O
fat	O
mass	O
and	O
obesity	B-T047
-	O
associated	B-T080
fto	O
gene	O
have	O
been	O
associated	B-T080
with	I-T080
obesity	B-T047
-related	O
traits	O
in	O
humans	O
.	O
	
1	O
the	O
aim	O
of	O
this	O
study	O
is	O
to	O
study	O
the	O
distribution	O
of	O
fto	O
gene	O
variants	O
across	O
different	O
body	O
mass	O
index	O
bmi	O
categories	O
and	O
2	O
to	O
explore	O
the	O
association	B-T080
between	O
fto	O
gene	O
variants	O
and	O
lifestyle	O
factors	B-T169
in	O
obese	B-T047
and	O
normal	B-T033
weight	I-T033
indian	O
children	O
.	O
	
fifty-six	O
children	O
26	O
boys	O
,	O
mean	O
age	O
10.3	O
2.2	O
years	B-T079
were	O
studied	O
.	O
	
height	O
,	O
weight	O
,	O
and	O
waist	O
and	O
hip	O
circumference	O
were	O
measured	B-T080
.	O
	
physical	O
activity	O
questionnaire	O
and	O
food	O
intake	B-T169
food	O
frequency	O
questionnaire	O
were	O
assessed	O
.	O
	
body	O
fat	O
percentage	O
%bf	O
was	O
measured	O
by	O
dual-energy	O
x-ray	O
absorptiometry	O
.	O
	
fto	O
allelic	O
variants	O
at	O
rs9939609	O
site	O
were	O
detected	O
by	O
sybr	O
green	O
amplification	O
refractory	O
mutation	O
system	O
real-time	O
polymerase	O
chain	O
reaction	O
using	O
allele	O
-	O
specific	B-T080
primers	O
.	O
	
generalized	B-T081
linear	I-T081
model	I-T081
was	O
used	O
to	O
investigate	B-T169
the	O
simultaneous	B-T079
influence	O
of	O
genetic	B-T169
and	O
lifestyle	O
factors	B-T169
on	O
%bf	O
.	O
	
mean	O
height	O
,	O
weight	O
,	O
and	O
bmi	O
of	O
normal	B-T080
and	O
obese	B-T047
children	O
were	O
130.6	O
7.1	O
versus	O
143.2	O
15.6	O
,	O
24.0	O
5.2	O
versus	O
53.1	O
15.8	O
,	O
and	O
13.9	O
2.1	O
versus	O
25.3	O
3.2	O
,	O
respectively	O
.	O
	
the	O
frequency	O
of	O
aa	O
allele	O
was	O
57%	O
among	O
obese	B-T047
children	O
and	O
35%	O
in	O
normal	B-T033
weight	I-T033
children	O
.	O
	
children	O
with	O
the	O
aa	O
allele	O
who	O
were	O
obese	B-T047
had	O
least	O
physical	O
activity	O
,	O
whereas	O
children	O
with	O
at	O
allele	O
and	O
obesity	B-T047
had	O
the	O
highest	B-T080
intake	B-T081
of	I-T081
calories	I-T081
when	O
compared	O
to	O
children	O
who	O
had	O
at	O
allele	O
and	O
were	O
normal	B-T080
.	O
	
%bf	O
was	O
positively	O
associated	B-T080
with	I-T080
aa	O
alleles	O
and	O
junk	O
food	O
intake	B-T169
and	O
negatively	O
with	O
healthy	B-T080
food	O
intake	B-T169
and	O
moderate	O
physical	O
activity	O
.	O
	
healthy	O
lifestyle	O
with	O
high	O
physical	O
activity	O
and	O
diet	O
low	B-T080
in	O
calories	B-T081
and	O
fat	B-T109
may	O
help	O
in	O
modifying	B-T169
the	O
risk	B-T078
imposed	O
by	O
fto	O
variants	O
in	O
museum	O
specimen	O
data	B-T078
reveal	O
emergence	O
of	O
a	O
plant	B-T047
disease	I-T047
may	O
be	O
linked	O
to	O
increases	B-T169
in	O
the	O
insect	O
vector	O
population	O
the	O
emergence	O
rate	O
of	O
new	O
plant	O
diseases	O
is	O
increasing	O
due	O
to	O
novel	O
introductions	O
,	O
climate	O
change	O
,	O
and	O
changes	O
in	O
vector	O
populations	O
,	O
posing	O
risks	O
to	O
agricultural	O
sustainability	O
.	O
	
assessing	O
and	O
managing	O
future	O
disease	O
risks	O
depends	O
on	O
understanding	O
the	O
causes	O
of	O
contemporary	O
and	O
historical	O
emergence	O
events	O
.	O
	
since	O
the	O
mid-1990s	O
,	O
potato	O
growers	O
in	O
the	O
western	O
united	O
states	O
,	O
mexico	O
,	O
and	O
central	O
america	O
have	O
experienced	O
severe	O
yield	O
loss	O
from	O
zebra	O
chip	O
disease	O
and	O
have	O
responded	O
by	O
increasing	O
insecticide	O
use	O
to	O
suppress	O
populations	O
of	O
the	O
insect	O
vector	O
,	O
the	O
potato	O
psyllid	O
,	O
bactericera	O
cockerelli	O
hemiptera	O
triozidae	O
.	O
	
despite	O
the	O
severe	O
nature	O
of	O
zebra	O
chip	O
outbreaks	O
,	O
the	O
causes	O
of	O
emergence	O
remain	O
unknown	O
.	O
	
we	O
tested	O
the	O
hypotheses	O
that	O
1	O
b	O
.	O
	
cockerelli	O
occupancy	O
has	O
increased	O
over	O
the	O
last	O
century	O
in	O
california	O
and	O
2	O
such	O
increases	O
are	O
related	O
to	O
climate	O
change	O
,	O
specifically	O
warmer	O
winters	O
.	O
	
we	O
compiled	O
a	O
dataset	O
of	O
87	O
museum	O
specimen	O
occurrence	O
records	O
across	O
the	O
order	O
hemiptera	O
collected	O
between	O
1900	O
and	O
2014	O
.	O
	
we	O
then	O
analyzed	O
changes	O
in	O
b	O
.	O
	
cockerelli	O
distribution	O
using	O
a	O
hierarchical	O
occupancy	O
model	O
using	O
changes	O
in	O
background	O
species	O
lists	O
to	O
correct	O
for	O
collecting	O
effort	O
.	O
	
we	O
found	O
evidence	O
that	O
b	O
.	O
	
cockerelli	O
occupancy	O
has	O
increased	O
over	O
the	O
last	O
century	O
.	O
	
however	O
,	O
these	O
changes	O
appear	O
to	O
be	O
unrelated	O
to	O
climate	O
changes	O
,	O
at	O
least	O
at	O
the	O
scale	O
of	O
our	O
analysis	O
.	O
	
to	O
the	O
extent	O
that	O
species	O
occupancy	O
is	O
related	O
to	O
abundance	O
,	O
our	O
analysis	O
provides	O
the	O
first	O
quantitative	O
support	O
for	O
the	O
hypothesis	O
that	O
b	O
.	O
	
cockerelli	O
population	O
abundance	O
has	O
increased	O
,	O
but	O
further	O
work	O
is	O
needed	O
to	O
link	O
b	O
.	O
	
cockerelli	O
population	O
dynamics	O
to	O
zebra	O
chip	O
epidemics	O
.	O
	
finally	O
,	O
we	O
demonstrate	O
how	O
this	O
historical	O
macro-ecological	O
approach	O
provides	O
a	O
general	O
framework	O
for	O
comparative	O
risk	O
assessment	O
of	O
future	O
pest	O
and	O
insect	O
vector	O
outbreaks	O
.	O
	
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
	
all	O
rights	O
effect	B-T080
of	O
halotolerant	O
rhizobacteria	O
isolated	B-T169
from	O
halophytes	O
on	O
the	O
growth	O
of	O
sugar	O
beet	O
beta	O
vulgaris	O
l	O
under	O
salt	O
stress	O
utilization	B-T169
of	O
rhizobacteria	O
that	O
have	O
associated	B-T080
with	I-T080
plant	O
roots	O
in	O
harsh	B-T033
environments	O
could	O
be	O
a	O
feasible	O
strategy	O
to	O
deal	O
with	O
limits	O
to	O
agricultural	O
production	O
caused	O
by	O
soil	O
salinity	O
.	O
	
halophytes	O
occur	O
naturally	O
in	O
high	B-T080
-	O
salt	O
environments	O
,	O
and	O
their	O
roots	O
may	O
be	O
associated	B-T080
with	I-T080
promising	O
microbial	O
candidates	O
for	O
promoting	O
growth	O
and	O
salt	O
tolerance	O
in	O
crops	O
.	O
	
this	O
study	O
aimed	O
to	O
isolate	B-T169
efficient	O
halotolerant	O
plant	O
-	O
growth	O
-	O
promoting	O
rhizobacterial	B-T080
strains	O
from	O
halophytes	O
and	O
evaluate	O
their	O
activity	O
and	O
effects	B-T080
on	O
sugar	O
beet	O
beta	O
vulgaris	O
l	O
growth	O
under	O
salinity	O
stress	O
.	O
	
a	O
total	O
of	O
23	O
isolates	O
were	O
initially	O
screened	O
for	O
their	O
ability	O
to	O
secrete	O
1-aminocyclopropane-1-carboxylate	B-T116
deaminase	I-T116
acd	B-T116
as	O
well	O
as	O
other	O
plant-growth	O
-	O
promoting	O
characteristics	B-T080
and	O
subsequently	O
identified	B-T080
by	O
sequencing	B-T169
the	O
16s	O
rrna	O
gene	O
.	O
	
three	O
isolates	O
,	O
identified	O
as	O
micrococcus	O
yunnanensis	O
,	O
planococcus	O
rifietoensis	O
and	O
variovorax	O
paradoxus	O
,	O
enhanced	O
salt	O
stress	O
tolerance	B-T080
remarkably	O
in	O
sugar	O
beet	O
,	O
resulting	B-T169
in	I-T169
greater	B-T081
seed	O
germination	O
and	O
plant	O
biomass	B-T081
,	O
higher	B-T080
photosynthetic	O
capacity	B-T081
and	O
lower	B-T080
stress	B-T033
-	O
induced	B-T169
ethylene	B-T109
production	B-T169
at	O
different	B-T080
nacl	O
concentrations	B-T081
50-125	O
mm	O
.	O
	
these	O
results	B-T169
demonstrate	O
that	O
salinity	O
-	O
adapted	O
,	O
acd	B-T116
-producing	O
bacteria	O
isolated	B-T169
from	O
halophytes	O
could	O
promote	O
sugar	O
beet	O
growth	O
under	O
saline	O
stress	O
conditions	O
.	O
	
potential	B-T080
sunitinib	B-T109
-	O
induced	B-T169
coronary	O
artery	O
and	O
aortic	B-T047
dissections	I-T047
small-molecule	B-T061
multitargeted	I-T061
tyrosine	I-T061
kinase	I-T061
inhibitor	I-T061
tki	I-T061
therapy	I-T061
is	O
used	O
in	O
different	O
types	O
of	O
cancer	O
.	O
	
these	O
drugs	O
have	O
been	O
associated	B-T080
with	I-T080
cardiovascular	O
toxicity	O
,	O
including	O
aortic	B-T047
dissection	I-T047
.	O
	
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	B-T079
time	I-T079
that	O
a	O
coronary	B-T047
dissection	I-T047
potentially	B-T080
associated	B-T080
with	I-T080
a	O
tki	B-T061
treatment	I-T061
recovery	O
of	O
orthographic	O
processing	O
after	O
stroke	B-T047
a	O
longitudinal	O
fmri	O
study	O
an	O
intact	O
orthographic	O
processing	O
system	O
is	O
critical	O
for	O
normal	O
reading	O
and	O
spelling	O
.	O
	
here	O
we	O
investigate	O
the	O
neural	B-T169
changes	I-T169
associated	O
with	O
impairment	B-T169
and	O
subsequent	O
recovery	O
of	O
the	O
orthographic	O
lexical	O
processing	O
system	O
in	O
an	O
individual	O
with	O
an	O
ischemic	O
left	B-T047
posterior	I-T047
cerebral	I-T047
artery	I-T047
pca	I-T047
stroke	I-T047
.	O
	
this	O
work	O
describes	O
a	O
longitudinal	O
case	O
study	O
of	O
a	O
patient	O
,	O
whose	O
initials	O
are	O
mmy	O
,	O
with	O
impairments	B-T169
in	O
orthographic	O
lexical	O
processing	O
for	O
reading	O
and	O
spelling	O
at	O
stroke	B-T047
onset	B-T079
,	O
and	O
who	O
recovered	O
these	O
skills	O
within	O
1	O
year	O
post	O
stroke	B-T047
.	O
	
we	O
tested	O
the	O
hypothesis	B-T078
that	O
this	O
acute	B-T079
impairment	B-T169
to	O
reading	O
and	O
spelling	O
would	O
be	O
associated	O
with	O
a	O
selective	O
loss	B-T081
of	I-T081
neural	B-T169
activation	I-T169
in	O
the	O
left	O
fusiform	O
gyrus	O
fg	O
,	O
and	O
that	O
subsequent	O
recovery	O
would	O
be	O
associated	O
with	O
a	O
gain	B-T081
of	I-T081
neural	B-T169
activation	I-T169
in	O
this	O
region	O
.	O
	
mmy's	O
case	O
provided	O
a	O
unique	O
opportunity	O
to	O
assess	O
the	O
selectivity	O
of	O
neural	B-T169
changes	I-T169
because	O
she	O
demonstrated	O
a	O
behavioral	O
recovery	O
of	O
naming	O
as	O
well	O
i.e	O
,	O
if	O
there	O
is	O
neural	B-T169
recovery	I-T169
for	O
reading	O
and	O
spelling	O
,	O
but	O
not	O
naming	O
,	O
then	O
these	O
neural	B-T169
changes	I-T169
are	O
selective	O
to	O
the	O
recovery	O
of	O
orthographic	O
processing	O
.	O
	
to	O
test	O
our	O
hypothesis	O
,	O
we	O
examined	O
longitudinal	O
behavioral	O
and	O
functional	O
magnetic	O
resonance	O
imaging	O
fmri	O
data	O
of	O
reading	O
,	O
spelling	O
,	O
and	O
visual	O
object	O
naming	O
acquired	O
acutely	O
,	O
3	O
weeks	O
,	O
5	O
months	O
,	O
and	O
one	O
year	O
post	O
stroke	B-T047
.	O
	
in	O
confirmation	O
of	O
our	O
hypothesis	B-T078
,	O
the	O
loss	O
and	O
subsequent	O
gain	O
of	O
orthographic	O
lexical	O
processing	O
was	O
associated	O
with	O
up-regulation	O
of	O
neural	B-T169
activation	I-T169
in	O
areas	O
previously	O
associated	O
with	O
orthographic	O
lexical	O
processing	O
i.e	O
,	O
the	O
left	O
mid-fg	O
and	O
inferior	O
frontal	O
junction	O
ifj	O
.	O
	
furthermore	O
,	O
these	O
neural	B-T169
changes	I-T169
were	O
found	O
to	O
be	O
selective	O
to	O
orthographic	O
processing	O
,	O
as	O
they	O
were	O
observed	O
for	O
reading	O
and	O
spelling	O
,	O
but	O
not	O
for	O
visual	O
object	O
naming	O
within	O
the	O
left	O
mid-fg	O
.	O
	
this	O
work	O
shows	O
that	O
left	B-T047
pca	I-T047
stroke	I-T047
can	O
temporarily	O
and	O
selectively	O
disrupt	O
the	O
orthographic	O
lexical	O
processing	O
system	O
,	O
not	O
only	O
in	O
the	O
posterior	O
region	O
adjacent	O
to	O
the	O
stroke	B-T047
,	O
but	O
also	O
in	O
relatively	O
distant	O
frontal	O
orthographic	O
processing	O
nodal	O
skip	B-T033
metastasis	O
in	O
thoracic	O
esophageal	O
squamous	O
cell	O
carcinoma	O
a	O
cohort	B-T081
study	I-T081
nodal	O
skip	B-T033
metastasis	O
is	O
a	O
prognostic	O
factor	O
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	O
is	O
still	O
unclear	B-T033
.	O
	
the	O
present	O
study	O
aimed	O
to	O
investigate	B-T169
occurrence	O
and	O
effect	B-T080
of	O
nodal	O
skip	B-T033
metastases	O
in	O
thoracic	O
esophageal	O
squamous	O
cell	O
carcinoma	O
.	O
	
all	O
578	O
patients	O
undergoing	O
esophagectomy	B-T061
for	O
thoracic	O
esophageal	O
squamous	O
cell	O
carcinoma	O
at	O
the	O
center	O
for	O
esophageal	O
diseases	O
located	O
in	O
padova	O
between	O
january	B-T080
1992	O
and	O
december	B-T080
2010	O
were	O
retrospectively	O
evaluated	O
.	O
	
selection	B-T080
criteria	I-T080
were	O
r0	B-T033
resection	I-T033
,	O
pathological	B-T169
m0	B-T033
stage	I-T033
and	O
pathological	B-T169
lymph	B-T033
node	I-T033
involvement	I-T033
.	O
	
patients	O
receiving	O
neoadjuvant	B-T061
therapy	I-T061
were	O
excluded	O
.	O
	
the	O
selection	O
identified	O
88	O
patients	O
with	O
lymph	B-T033
node	I-T033
involvement	I-T033
confirmed	O
by	O
pathological	B-T169
evaluation	O
.	O
	
sixteen	O
patients	O
18.2	O
had	O
nodal	O
skip	B-T033
metastasis	O
.	O
	
adjusting	O
for	O
the	O
number	O
of	O
lymph	O
node	O
metastases	O
,	O
patient	O
with	O
nodal	O
skip	B-T033
metastasis	O
had	O
similar	O
5-year	O
overall	B-T081
survival	I-T081
14%	O
vs	O
.	O
	
13%	O
,	O
p	O
=	O
0.93	O
and	O
5-year	O
disease	B-T081
free	I-T081
survival	I-T081
14%	O
vs	O
.	O
	
9%	O
,	O
p	O
=	O
0.48	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	O
and	O
distant	O
lymph	O
node	O
metastases	O
.	O
	
the	O
risk	O
difference	O
of	O
nodal	O
skip	B-T033
metastasis	O
was	O
-24	O
95%	O
c.i	B-T081
.	O
	
-43	O
to	O
-5	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	O
metastasis	O
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	O
metastasis	O
-2	O
95%	O
c.i	B-T081
.	O
	
-29	O
to	O
25.2	O
in	O
middle	O
thoracic	O
esophagus	O
and	O
-23	O
95%	O
c.i	B-T081
.	O
	
-47	O
to	O
1.8	O
in	O
lower	O
thoracic	O
esophagus	O
compared	O
to	O
upper	O
thoracic	O
esophagus	O
18.1	O
95%	O
c.i	B-T081
.	O
	
3.2	O
to	O
33.0	O
in	O
clinical	B-T080
n0	B-T033
stage	I-T033
vs	O
.	O
	
clinical	B-T080
n+	B-T033
stage	I-T033
.	O
	
nodal	O
skip	B-T033
metastasis	O
is	O
a	O
common	O
pattern	O
of	O
metastatic	B-T033
lymph	I-T033
involvement	I-T033
in	O
thoracic	O
esophageal	O
squamous	O
cell	O
carcinoma	O
.	O
	
however	O
,	O
neither	B-T080
overall	B-T081
survival	I-T081
nor	O
disease	B-T081
free	I-T081
survival	I-T081
are	O
associated	B-T080
with	I-T080
nodal	O
skip	B-T033
metastasis	O
association	B-T080
of	O
leukemia	O
inhibitory	O
factor	O
gene	O
polymorphism	O
and	O
in	B-T080
vitro	I-T080
fertilization	O
outcome	B-T169
in	O
a	O
population	O
in	O
northern	O
iran	O
several	O
studies	O
have	O
been	O
demonstrated	O
that	O
endometrial	O
leukemia	B-T116
inhibitory	I-T116
factor	I-T116
lif	B-T116
is	O
important	O
in	O
embryo	O
implantation	O
.	O
	
lif	B-T116
is	O
a	O
secreted	O
glycoprotein	B-T116
with	O
a	O
variety	O
of	O
biological	O
functions	O
including	O
stimulation	O
of	O
cell	O
proliferation	O
,	O
differentiation	O
and	O
survival	O
that	O
are	O
all	O
essential	B-T080
for	O
blastocyete	O
development	B-T169
and	O
implantation	O
.	O
	
the	O
lif	B-T116
receptor	I-T116
activates	O
several	O
signaling	O
pathways	O
in	O
diverse	O
cell	O
types	O
,	O
including	O
jak/stat	B-T169
,	O
mapk	B-T116
and	O
pi3-kinase	B-T116
pathways	O
in	O
the	O
endometrium	O
of	O
fertile	O
woman	O
.	O
	
it	O
has	O
been	O
suggested	O
that	O
the	O
initial	O
lower	O
expression	O
of	O
lif	B-T116
in	O
proliferative	O
phase	B-T079
may	O
be	O
one	O
of	O
the	O
causes	O
for	O
multiple	O
failure	B-T169
of	O
implantation	B-T061
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
association	B-T080
between	O
maternal	B-T033
genotype	O
of	O
snp	O
3951c/t	O
lif	B-T116
and	O
in	B-T061
vitro	I-T061
fertilization	I-T061
and	O
embryo	B-T061
transfer	I-T061
ivf	B-T061
-	O
et	B-T061
outcome	B-T080
in	O
infertile	O
women	O
.	O
	
this	O
case-control	O
study	O
was	O
comprised	O
of	O
infertile	O
patients	O
n=70	O
and	O
women	O
having	O
one	O
healthy	B-T033
child	I-T033
as	O
controls	O
n=73	O
.	O
	
genotyping	O
for	O
snp-3951c/t	O
was	O
performed	O
by	O
pcr/rflp	O
.	O
	
allele	O
and	O
genotype	O
distribution	B-T169
did	O
not	O
differ	O
significantly	O
between	O
patients	O
and	O
controls	O
p>0	O
.	O
	
the	O
lif	B-T116
genotype	O
frequencies	B-T081
amongst	O
the	O
70	O
cases	B-T169
were	O
c/c	O
=40%	O
,	O
c/t	O
=52	O
and	O
t/t	O
=7	O
the	O
c	O
and	O
t	O
allele	O
frequencies	B-T081
were	O
66%	O
and	O
34%	O
,	O
respectively	O
.	O
	
the	O
lif	B-T116
genotype	O
frequencies	B-T081
amongst	O
the	O
73	O
controls	O
were	O
c/c	O
=45	O
,	O
c/t	O
=50	O
and	O
t/t	O
=4	O
the	O
c	O
and	O
t	O
allele	O
frequencies	B-T081
were	O
70%	O
and	O
30%	O
,	O
respectively	O
.	O
	
in	O
conclusion	O
,	O
the	O
results	B-T169
of	O
this	O
study	O
indicate	O
that	O
snp	O
3951c/t	O
of	O
lif	B-T116
may	O
not	O
be	O
associated	B-T080
with	I-T080
ivf	B-T061
-	O
et	B-T061
outcome	B-T080
in	O
this	O
population	O
.	O
	
although	O
more	O
studies	O
should	O
be	O
considered	O
with	O
larger	O
number	O
of	O
patients	O
and	O
control	O
subjects	O
to	O
confirm	B-T080
our	O
anti	B-T033
angiogenic	I-T033
effect	I-T033
of	O
chebulagic	B-T109
acid	I-T109
involves	O
inhibition	O
of	O
vegfr2	O
and	O
gsk3β	O
dependent	O
signaling	O
pathways	O
inhibition	O
of	O
angiogenesis	O
is	O
a	O
useful	O
strategy	O
to	O
prevent	B-T080
cancer	O
growth	O
,	O
which	O
targets	B-T169
new	O
vessels	O
that	O
grow	O
to	O
nourish	O
actively	O
proliferating	B-T169
tumor	O
cells	O
.	O
	
endothelial	O
cells	O
can	O
use	O
a	O
number	O
of	O
different	O
pathways	O
to	O
cause	O
angiogenesis	O
and	O
each	O
step	O
in	O
these	O
pathways	O
can	O
be	O
targeted	B-T169
.	O
	
the	O
use	O
of	O
multi	O
targeted	O
drugs	O
is	O
gaining	O
much	O
importance	O
in	O
this	O
scenario	O
.	O
	
our	O
previous	O
results	O
have	O
shown	O
the	O
anti	B-T033
angiogenic	I-T033
effect	I-T033
of	O
chebulagic	B-T109
acid	I-T109
-	O
a	O
benzopyran	B-T109
tannin	B-T109
present	O
in	O
the	O
fruits	O
of	O
terminalia	O
chebula	O
.	O
	
the	O
present	O
study	O
was	O
designed	O
to	O
examine	O
the	O
molecular	O
mechanism	O
of	O
the	O
anti	B-T033
angiogenic	I-T033
effect	I-T033
of	O
chebulagic	B-T109
acid	I-T109
.	O
	
results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	O
studies	O
and	O
huvecs	O
in	O
culture	O
suggested	O
that	O
chebulagic	B-T109
acid	I-T109
inhibited	O
gsk-3β	B-T116
dependent	B-T169
β-catenin	B-T116
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
ve-cadherin	B-T116
/	O
β-catenin	B-T116
signaling	O
and	O
vegfr2	B-T116
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
vegf	O
signaling	O
.	O
	
chebulagic	B-T109
acid	I-T109
inhibits	O
angiogenesis	O
by	O
blocking	B-T169
both	O
vegf	B-T116
/	O
vegfr2	B-T116
and	O
cell-cell	O
contact	O
dependent	O
downstream	O
signaling	O
pathway	O
.	O
	
identification	O
of	O
protective	O
b-cell	O
epitopes	O
within	O
the	O
novel	O
malaria	O
vaccine	O
candidate	O
p	B-T116
.	O
	
falciparum	I-T116
schizont	I-T116
egress	I-T116
antigen-1	I-T116
naturally	B-T169
-acquired	O
antibodies	B-T116
to	O
pfsea-1a	B-T116
are	O
associated	O
with	O
protection	O
against	O
severe	O
malaria	B-T047
in	O
children	O
.	O
	
vaccination	B-T061
of	O
mice	O
with	O
pbsea-1a	O
decreases	O
parasitemia	B-T047
and	O
prolongs	O
survival	O
following	O
plasmodium	O
berghei	O
anka	O
challenge	O
.	O
	
to	O
enhance	O
the	O
immunogenicity	O
of	O
pfsea-1a	B-T116
,	O
we	O
identified	O
five	O
linear	O
,	O
b-cell	O
epitopes	O
using	O
peptide	B-T116
microarrays	O
probed	O
with	O
anti-sera	B-T116
from	O
rpfsea-1a	B-T116
-	O
vaccinated	B-T033
non-human	O
primates	O
.	O
	
we	O
evaluated	O
the	O
relationship	O
between	O
epitope	O
-specific	O
antibody	B-T116
levels	O
and	O
protection	O
from	O
parasitemia	B-T047
in	O
a	O
longitudinal	O
treatment	B-T061
-	O
reinfection	B-T169
cohort	O
in	O
western	O
kenya	O
.	O
	
antibodies	B-T116
to	O
three	O
epitopes	O
were	O
associated	O
with	O
16-17%	O
decreased	O
parasitemia	B-T047
over	O
an	O
18-	O
week	B-T079
high	O
transmission	O
season	O
.	O
	
we	O
are	O
currently	O
designing	O
immunogens	B-T116
to	O
enhance	O
antibody	O
responses	O
to	O
these	O
three	O
estrogen	B-T109
deficiency	B-T169
accelerates	B-T169
lumbar	O
facet	O
joints	O
arthritis	B-T047
dramatic	O
increase	B-T169
in	O
the	O
prevalence	B-T081
of	O
lumbar	O
facet	O
joint	O
lfj	O
arthritis	B-T047
in	O
women	O
around	O
the	O
age	O
of	O
menopause	O
indicates	O
a	O
protective	B-T078
role	I-T078
for	O
estrogen	B-T109
in	O
lfj	O
arthritis	B-T047
.	O
	
to	O
date	O
,	O
there	O
is	O
no	B-T080
evidence	I-T080
for	O
this	O
indication	B-T078
and	O
the	O
mechanism	B-T169
of	O
such	O
an	O
effect	B-T080
remains	O
poorly	O
understood	O
.	O
	
in	O
this	O
study	O
,	O
ovariectomized	O
ovx	O
mice	O
were	O
used	O
to	O
mimic	O
the	O
estrogen	B-T109
-	O
deficient	B-T169
status	B-T080
of	O
post-menopausal	O
women	O
.	O
	
micro-ct	O
and	O
immunohistochemistry	O
was	O
employed	O
to	O
assess	O
the	O
morphological	O
and	O
molecular	B-T080
changes	B-T169
in	O
ovariectomy	B-T061
-	O
induced	B-T169
lfj	O
arthritis	B-T047
.	O
	
the	O
results	B-T169
show	O
that	O
the	O
lfj	O
subchondral	O
bone	O
mass	O
was	O
significantly	O
decreased	B-T081
in	O
ovx	O
mice	O
,	O
with	O
increased	B-T081
cavities	O
on	O
the	O
interface	O
of	O
the	O
subchondral	O
bone	O
.	O
	
severe	B-T080
cartilage	O
degradation	B-T169
was	O
observed	O
in	O
ovariectomy	B-T061
-	O
induced	B-T169
lfj	O
arthritis	B-T047
.	O
	
increased	B-T081
blood	O
vessels	O
and	O
innervations	B-T080
were	O
also	O
found	O
in	O
degenerated	O
lfj	O
,	O
particularly	O
in	O
the	O
subchondral	O
bone	O
area	O
.	O
	
17β-estradiol	B-T109
treatment	B-T061
efficiently	O
suppressed	B-T169
lfj	O
subchondral	B-T033
bone	I-T033
turnover	I-T033
,	O
markedly	O
inhibited	B-T080
cartilage	O
degradation	B-T169
,	O
and	O
increased	B-T081
blood	O
vessel	O
and	O
nerve	O
ending	O
growth	O
in	O
degenerated	O
lfj	O
in	O
ovx	O
mice	O
.	O
	
our	O
study	O
reveals	O
that	O
estrogen	B-T109
is	O
a	O
key	O
factor	B-T169
in	O
regulating	B-T169
lfj	I-T169
metabolism	I-T169
.	O
	
severe	B-T080
lfj	O
degeneration	O
occurs	O
when	O
estrogen	B-T109
is	O
absent	B-T169
in	O
vivo	O
.	O
	
collapsed	B-T169
subchondral	O
bone	O
may	O
be	O
the	O
initiation	B-T169
of	O
this	O
process	O
,	O
and	O
estrogen	B-T061
replacement	I-T061
therapy	I-T061
can	O
effectively	O
prevent	O
degeneration	O
of	O
lfj	O
under	O
estrogen	B-T109
-	O
deficient	B-T169
conditions	B-T080
.	O
	
dexmedetomidine	B-T109
effect	B-T080
on	O
emergence	O
agitation	O
and	O
delirium	O
in	O
children	O
undergoing	O
laparoscopic	B-T061
hernia	I-T061
repair	I-T061
a	O
preliminary	B-T079
study	O
objective	O
to	O
evaluate	O
the	O
safety	B-T080
and	O
efficacy	B-T080
of	O
dexmedetomidine	B-T109
dex	B-T109
to	O
prevent	O
emergence	O
agitation	O
ea	O
and	O
delirium	O
ed	O
in	O
children	O
undergoing	O
laparoscopic	B-T061
hernia	I-T061
repair	I-T061
under	O
general	B-T061
anesthesia	I-T061
.	O
	
methods	O
100	O
children	O
1-5	O
years	B-T079
,	O
10-25	O
kg	O
were	O
randomized	O
into	O
four	O
groups	B-T078
controls	O
saline	O
and	O
intravenous	O
dex	B-T109
at	O
0.25	O
,	O
0.5	O
,	O
and	O
1.0	O
µg/kg	O
d1	B-T081
,	O
d2	B-T081
,	O
d3	B-T081
,	O
respectively	O
.	O
	
dex	B-T109
/	O
saline	O
infusion	B-T061
was	O
started	O
following	O
anesthesia	O
.	O
	
ea	O
and	O
ed	O
were	O
evaluated	O
on	O
a	O
5-point	O
scale	O
.	O
	
results	O
for	O
the	O
c	O
,	O
d1	B-T081
,	O
d2	B-T081
,	O
and	O
d3	B-T081
groups	B-T078
,	O
respectively	O
,	O
ea	O
frequencies	B-T079
were	O
45.8	O
,	O
30.4	O
,	O
12%	O
,	O
4%	O
ed	O
frequencies	B-T079
29.1	O
,	O
13%	O
,	O
4%	O
,	O
4%	O
chipps	O
scores	B-T081
8	O
,	O
6	O
,	O
3	O
,	O
3	O
sevoflurane	B-T109
doses	B-T081
from	O
13.2	O
3.4	O
controls	O
to	O
9.4	O
3.5	O
ml	O
d3	B-T081
.	O
	
intervals	B-T079
until	O
mask	O
removal	O
/	O
spontaneous	O
eye	O
opening	O
were	O
significantly	O
longer	B-T080
for	O
d2	B-T081
and	O
d3	B-T081
than	O
controls	O
.	O
	
pacu	O
stay	B-T079
was	O
longer	B-T080
for	O
d3	B-T081
.	O
	
conclusions	O
there	O
was	O
significantly	O
less	O
postoperative	B-T079
ea	O
and	O
pain	O
,	O
with	O
less	O
sevoflurane	B-T109
required	O
,	O
using	O
farnesylthiosalicylic	B-T109
acid	I-T109
-loaded	O
lipid-polyethylene	O
glycol-polymer	O
hybrid	O
nanoparticles	O
for	O
treatment	B-T061
of	O
glioblastoma	O
we	O
aimed	O
to	O
develop	O
lipid-polyethylene	O
glycol	O
peg	O
hybrid	O
nanoparticles	O
,	O
which	O
have	O
high	O
affinity	O
to	O
tumour	O
tissue	O
with	O
active	O
ingredient	O
,	O
a	O
new	O
generation	B-T079
antineoplastic	B-T109
drug	I-T109
,	O
farnesylthiosalicylic	B-T109
acid	I-T109
fta	B-T109
for	O
treatment	B-T061
of	O
glioblastoma	O
.	O
	
farnesylthiosalicylic	B-T109
acid	I-T109
-loaded	O
poly	O
acid	O
distearoyl-glycerol-3-phospho-ethanolamine-n	O
methoxy	O
peg	O
ammonium	O
salt	O
plga-dspe-peg	O
with	O
or	O
without	O
1	O
dotap	O
hybrid	O
nanoparticles	O
has	O
been	O
prepared	B-T033
and	O
evaluated	O
for	O
in-vitro	O
characterization	O
.	O
	
cytotoxicity	O
of	O
fta-loaded	B-T109
nanoparticles	I-T109
along	O
with	O
its	O
efficacy	B-T081
on	O
rat	O
glioma-2	O
rg2	O
cells	O
was	O
also	O
evaluated	O
both	O
in	O
vitro	O
in	O
comparison	O
with	O
non-malignant	O
cell	O
line	O
,	O
l929	O
and	O
in	O
vivo	O
.	O
	
scanning	O
electron	O
microscopy	O
studies	O
showed	O
that	O
all	O
formulations	O
prepared	O
had	O
smooth	O
surface	O
and	O
spherical	O
in	O
shape	O
.	O
	
fta	B-T109
and	O
fta-loaded	B-T109
nanoparticles	I-T109
have	O
cytotoxic	O
activity	O
against	O
rg2	O
glioma	O
cell	O
lines	O
in	O
cell	O
culture	O
studies	O
,	O
which	O
further	O
increases	O
with	O
addition	O
of	O
dotap	O
.	O
	
magnetic	O
resonance	O
imaging	O
and	O
histopathologic	O
evaluation	O
on	O
rg2	O
tumour	O
cells	O
in	O
rat	O
glioma	O
model	O
49	O
female	O
wistar	O
rats	O
,	O
250-300	O
g	O
comparing	O
intravenous	B-T169
and	O
intratumoral	B-T169
injections	I-T169
of	O
the	O
drug	O
have	O
been	O
performed	O
and	O
fta-loaded	B-T109
nanoparticles	I-T109
reduced	O
tumour	O
size	O
significantly	O
in	O
in-vivo	O
studies	O
,	O
with	O
higher	O
efficiency	B-T081
of	O
intratumoral	B-T169
administration	I-T169
than	O
intravenous	B-T169
route	I-T169
.	O
	
farnesylthiosalicylic	B-T109
acid	I-T109
-loaded	O
plga-dspe-peg-dotap	O
hybrid	O
nanoparticles	O
are	O
proven	O
to	O
be	O
effective	B-T080
against	O
glioblastoma	O
in	O
both	O
in-vitro	O
and	O
in-vivo	O
experiments	O
.	O
	
map	O
learning	O
and	O
working	O
memory	O
multimodal	O
learning	O
strategies	O
the	O
current	O
research	O
investigated	O
whether	O
learning	O
spatial	O
information	B-T078
from	O
a	O
map	O
involves	O
different	B-T169
modalities	I-T169
,	O
which	O
are	O
managed	O
by	O
discrete	O
components	O
in	O
working	O
memory	O
.	O
	
in	O
four	O
experiments	O
,	O
participants	O
studied	O
a	O
map	O
either	O
while	O
performing	O
a	O
simultaneous	B-T079
interference	O
task	O
high	O
cognitive	B-T081
load	I-T081
or	O
without	O
interference	O
low	O
cognitive	B-T081
load	I-T081
.	O
	
the	O
modality	B-T078
of	O
interference	O
varied	O
between	O
experiments	O
.	O
	
experiment	O
1	O
used	O
a	O
tapping	O
task	O
visuospatial	O
,	O
experiment	O
2	O
a	O
backwards	O
counting	O
task	O
verbal	B-T080
,	O
experiment	O
3	O
an	O
articulatory	O
suppression	O
task	O
verbal	B-T080
and	O
experiment	O
4	O
an	O
n-back	O
task	O
central	O
executive	O
.	O
	
spatial	B-T033
recall	I-T033
was	O
assessed	O
in	O
two	O
tests	O
,	O
directional	O
judgements	O
and	O
map	O
drawing	O
.	O
	
cognitive	B-T081
load	I-T081
was	O
found	O
to	O
affect	O
spatial	B-T033
recall	I-T033
detrimentally	O
regardless	B-T080
of	O
interference	O
modality	B-T078
.	O
	
the	O
findings	O
suggest	O
that	O
when	O
learning	O
maps	O
people	O
use	O
a	O
multimodal	O
learning	O
strategy	O
,	O
utilising	O
resources	B-T078
from	O
all	O
components	O
of	O
working	O
memory	O
.	O
	
4-anilino-2-pyridylquinazolines	B-T109
and	O
-	O
pyrimidines	O
as	O
highly	O
potent	B-T080
and	O
nontoxic	B-T080
inhibitors	O
of	O
breast	B-T116
cancer	I-T116
resistance	I-T116
protein	I-T116
abcg2	B-T116
multidrug	O
resistance	O
mdr	O
mediated	O
by	O
atp-binding	B-T116
cassette	I-T116
abc	I-T116
transport	I-T116
proteins	I-T116
remains	O
a	O
major	O
problem	O
in	O
the	O
chemotherapeutic	B-T061
treatment	I-T061
of	O
cancer	O
and	O
might	O
be	O
overcome	O
by	O
inhibition	O
of	O
the	O
transporter	B-T116
.	O
	
because	O
of	O
the	O
lack	O
of	O
understanding	O
,	O
the	O
complex	O
mechanisms	B-T169
involved	O
in	O
the	O
transport	O
process	O
,	O
in	O
particular	O
for	O
breast	B-T116
cancer	I-T116
resistance	I-T116
protein	I-T116
bcrp	B-T116
/	O
abcg2	B-T116
,	O
there	O
is	O
a	O
persistent	O
need	O
for	O
studies	O
of	O
inhibitors	O
of	O
abcg2	B-T116
.	O
	
in	O
this	O
study	O
,	O
we	O
investigated	B-T169
a	O
systematic	O
series	O
of	O
4-substituted-2-pyridylquinazolines	B-T109
in	O
terms	O
of	O
their	O
inhibitory	O
potency	B-T080
as	O
well	O
as	O
selectivity	B-T081
toward	O
abcg2	B-T116
.	O
	
for	O
comparison	O
,	O
the	O
quinazoline	B-T109
scaffold	I-T109
was	O
reduced	O
to	O
the	O
significantly	O
smaller	O
4-methylpyrimidine	O
basic	O
structure	O
.	O
	
furthermore	O
,	O
the	O
cytotoxicity	O
and	O
the	O
ability	O
to	O
reverse	B-T169
mdr	O
was	O
tested	O
with	O
the	O
chemotherapeutic	O
agents	O
sn-38	B-T109
and	O
mitoxantrone	B-T109
mx	B-T109
.	O
	
interaction	B-T169
of	O
the	O
compounds	O
with	O
abcg2	B-T116
was	O
investigated	B-T169
by	O
a	O
colorimetric	O
atpase	B-T116
assay	O
.	O
	
enzyme	O
kinetic	O
studies	O
were	O
carried	O
out	O
with	O
hoechst	O
33342	O
as	O
fluorescent	O
dye	O
and	O
substrate	O
of	O
abcg2	B-T116
to	O
elucidate	O
the	O
compounds	O
binding	O
modes	O
.	O
	
the	O
value	O
of	O
biosamples	O
in	O
smoking	O
cessation	O
trials	O
a	O
review	O
of	O
genetic	O
,	O
metabolomic	O
,	O
and	O
epigenetic	O
findings	B-T033
evidence	O
is	O
emerging	O
that	O
certain	O
genotypes	O
and	O
biomarkers	O
are	O
associated	O
with	O
smoking	O
cessation	O
success	O
and	O
efficacy	O
of	O
smoking	B-T061
cessation	I-T061
treatments	I-T061
.	O
	
we	O
review	O
key	O
findings	O
that	O
open	O
potential	O
avenues	O
for	O
personalizing	O
smoking	B-T061
cessation	I-T061
treatment	I-T061
according	O
to	O
an	O
individual's	O
genetic	O
or	O
metabolic	O
profile	O
.	O
	
these	O
results	O
provide	O
important	O
incentive	B-T080
for	O
smoking	O
cessation	O
researchers	O
to	O
collect	O
biosamples	O
and	O
perform	O
genotyping	O
in	O
research	O
studies	O
and	O
clinical	O
trials	O
.	O
	
acr	O
appropriateness	B-T078
criteria	I-T078
radiologic	B-T169
management	O
of	O
mesenteric	B-T047
ischemia	I-T047
mesenteric	B-T047
vascular	I-T047
insufficiency	I-T047
is	O
a	O
serious	O
medical	B-T033
condition	I-T033
that	O
may	O
lead	O
to	O
bowel	B-T047
infarction	I-T047
,	O
morbidity	B-T081
,	O
and	O
mortality	B-T081
that	O
may	O
approach	O
50%	O
.	O
	
recommended	O
therapy	B-T061
for	O
acute	B-T047
mesenteric	I-T047
ischemia	I-T047
includes	O
aspiration	B-T061
embolectomy	B-T061
,	O
transcatheter	B-T061
thrombolysis	B-T061
,	O
and	O
angioplasty	B-T061
with	O
or	O
without	O
stenting	B-T061
for	O
the	O
treatment	B-T061
of	O
underlying	O
arterial	O
stenosis	O
.	O
	
nonocclusive	B-T047
mesenteric	I-T047
ischemia	I-T047
may	O
respond	O
to	O
transarterial	B-T061
infusion	I-T061
of	O
vasodilators	O
such	O
as	O
nitroglycerin	B-T109
,	O
papaverine	B-T109
,	O
glucagon	B-T116
,	O
and	O
prostaglandin	B-T109
e1	I-T109
.	O
	
recommended	O
therapy	B-T061
for	O
chronic	B-T047
mesenteric	I-T047
ischemia	I-T047
includes	O
angioplasty	B-T061
with	O
or	O
without	O
stent	B-T061
placement	I-T061
and	O
,	O
if	O
an	O
endovascular	B-T061
approach	I-T061
is	O
not	O
possible	O
,	O
surgical	B-T061
bypass	I-T061
or	O
endarterectomy	B-T061
.	O
	
the	O
diagnosis	B-T033
of	O
median	B-T047
arcuate	I-T047
ligament	I-T047
syndrome	I-T047
is	O
controversial	O
,	O
but	O
surgical	B-T061
release	O
may	O
be	O
appropriate	O
depending	O
on	O
the	O
clinical	B-T080
situation	I-T080
.	O
	
venous	O
mesenteric	B-T047
ischemia	I-T047
may	O
respond	O
to	O
systemic	B-T169
anticoagulation	B-T061
alone	O
.	O
	
transhepatic	O
or	O
transjugular	O
superior	O
mesenteric	O
vein	O
catheterization	O
and	O
thrombolytic	O
infusion	O
can	O
be	O
offered	O
depending	O
on	O
the	O
severity	O
of	O
symptoms	O
,	O
condition	B-T033
of	I-T033
the	I-T033
patient	I-T033
,	O
and	O
response	O
to	O
systemic	B-T169
anticoagulation	B-T061
.	O
	
adjunct	B-T169
transjugular	B-T061
intrahepatic	I-T061
portosystemic	I-T061
shunt	I-T061
creation	I-T061
can	O
be	O
considered	O
for	O
outflow	O
improvement	O
.	O
	
the	O
american	O
college	O
of	O
radiology	O
appropriateness	B-T078
criteria	I-T078
are	O
evidence-based	B-T169
guidelines	O
for	O
specific	O
clinical	B-T033
conditions	I-T033
that	O
are	O
reviewed	B-T080
annually	B-T079
by	O
a	O
multidisciplinary	O
expert	O
panel	O
.	O
	
the	O
guideline	O
development	B-T169
and	O
revision	B-T079
include	O
an	O
extensive	O
analysis	O
of	O
current	O
medical	B-T078
literature	I-T078
from	O
peer-reviewed	O
journals	O
and	O
the	O
application	O
of	O
well-established	O
methodologies	O
rand	O
/	O
ucla	O
appropriateness	B-T080
method	O
and	O
grading	O
of	O
recommendations	O
assessment	O
,	O
development	O
,	O
and	O
evaluation	O
or	O
grade	O
to	O
rate	O
the	O
appropriateness	B-T080
of	O
imaging	O
and	O
treatment	B-T061
procedures	I-T061
for	O
specific	O
clinical	B-T080
scenarios	B-T169
.	O
	
in	O
those	O
instances	B-T078
where	O
evidence	B-T078
is	O
lacking	B-T080
or	O
equivocal	B-T080
,	O
expert	O
opinion	O
may	O
supplement	B-T169
the	O
available	O
evidence	B-T078
to	O
recommend	O
imaging	O
or	O
blur	B-T080
perception	O
throughout	O
the	O
visual	O
field	O
in	O
myopia	B-T047
and	O
emmetropia	B-T033
we	O
evaluated	O
the	O
ability	O
of	O
emmetropic	B-T033
and	O
myopic	B-T047
observers	O
to	O
detect	B-T033
and	O
discriminate	B-T080
blur	B-T080
across	O
the	O
retina	O
under	O
monocular	O
or	O
binocular	O
viewing	O
conditions	B-T080
.	O
	
we	O
recruited	O
39	O
young	B-T079
23-30	O
years	O
healthy	B-T033
adults	I-T033
n	O
=	O
19	O
myopes	B-T047
with	O
best-corrected	B-T080
visual	O
acuity	O
0.0	O
logmar	O
20/20	O
or	O
better	B-T080
in	O
each	O
eye	O
and	O
no	B-T033
binocular	I-T033
or	O
accommodative	B-T033
dysfunction	I-T033
.	O
	
monocular	O
and	O
binocular	O
blur	B-T080
discrimination	B-T080
thresholds	B-T080
were	O
measured	B-T080
as	O
a	O
function	O
of	O
pedestal	B-T080
blur	I-T080
using	O
naturalistic	B-T169
stimuli	O
with	O
an	O
adaptive	O
4afc	O
procedure	O
.	O
	
stimuli	O
were	O
presented	B-T078
in	O
a	O
46	O
diameter	B-T081
window	O
at	O
40	O
cm	O
.	O
	
gaussian	B-T080
blur	I-T080
pedestals	I-T080
were	O
confined	B-T169
to	O
an	O
annulus	O
at	O
either	O
0	O
,	O
4	O
,	O
8	O
,	O
or	O
12	O
eccentricity	O
,	O
with	O
a	O
blur	B-T080
increment	B-T081
applied	B-T169
to	O
only	O
one	O
quadrant	O
of	O
the	O
image	O
.	O
	
the	O
adaptive	O
procedure	O
efficiently	B-T080
estimated	B-T081
a	O
dipper	B-T033
shaped	I-T033
blur	B-T080
discrimination	B-T080
threshold	B-T080
function	O
with	O
two	B-T081
parameters	O
intrinsic	O
blur	B-T080
and	O
blur	B-T080
sensitivity	B-T169
.	O
	
the	O
amount	B-T081
of	O
intrinsic	O
blur	B-T080
increased	B-T081
for	O
retinal	O
eccentricities	O
beyond	O
4	O
p	O
<	O
0.001	O
and	O
was	O
lower	O
in	O
binocular	O
than	O
monocular	O
conditions	B-T080
p	O
<	O
0.001	O
,	O
but	O
was	O
similar	B-T080
across	O
refractive	O
groups	B-T078
p	O
=	O
0.47	O
.	O
	
blur	B-T080
sensitivity	B-T169
decreased	B-T081
with	O
retinal	O
eccentricity	O
p	O
<	O
0.001	O
and	O
was	O
highest	B-T080
for	O
binocular	O
viewing	O
,	O
but	O
only	O
for	O
central	O
vision	O
p	O
<	O
0.05	O
.	O
	
myopes	B-T047
showed	O
worse	B-T033
blur	B-T080
sensitivity	B-T169
than	O
emmetropes	B-T033
monocularly	O
p	O
<	O
0.05	O
but	O
not	O
binocularly	O
p	O
=	O
0.66	O
.	O
	
as	O
expected	O
,	O
blur	B-T080
perception	O
worsens	B-T033
in	O
the	O
visual	O
periphery	O
and	O
binocular	O
summation	O
is	O
most	O
evident	B-T078
in	O
central	O
vision	O
.	O
	
furthermore	O
,	O
myopes	B-T047
exhibit	O
a	O
monocular	O
impairment	B-T169
in	O
blur	B-T080
sensitivity	B-T169
that	O
improves	B-T033
under	O
binocular	O
conditions	B-T080
.	O
	
implications	O
for	O
the	O
development	B-T169
of	O
myopia	B-T047
risk	B-T033
factors	I-T033
of	O
neurological	O
deterioration	O
in	O
patients	O
with	O
cerebral	B-T047
infarction	I-T047
due	O
to	O
large-artery	B-T047
atherosclerosis	I-T047
in	O
some	O
patients	O
with	O
acute	B-T079
ischemic	B-T047
stroke	I-T047
,	O
neurological	O
deterioration	O
nd	O
is	O
observed	B-T169
,	O
and	O
it	O
is	O
difficult	B-T080
to	O
predict	B-T078
at	O
the	O
time	B-T079
of	I-T079
admission	I-T079
.	O
	
especially	O
in	O
some	O
patients	O
with	O
large-artery	B-T047
atherosclerosis	I-T047
laa	B-T047
,	O
aggressive	B-T079
medical	O
treatments	O
and	O
surgical	O
interventions	O
might	O
be	O
helpful	B-T080
to	O
prevent	O
nd	O
.	O
	
therefore	O
,	O
we	O
investigated	B-T169
factors	B-T169
associated	B-T080
with	I-T080
nd	O
in	O
patients	O
with	O
laa	B-T047
.	O
	
we	O
studied	O
patients	O
with	O
laa	B-T047
who	O
were	O
admitted	O
to	O
our	O
hospital	O
.	O
	
we	O
divided	B-T169
them	O
into	O
2	O
groups	B-T078
with	O
group	B-T078
1	O
and	O
without	O
deterioration	O
group	B-T078
2	O
,	O
and	O
evaluated	O
their	O
medical	O
records	O
,	O
risk	B-T033
factors	I-T033
,	O
and	O
radiological	O
findings	B-T033
,	O
such	O
as	O
number	O
of	O
diffusion	O
-	O
positive	B-T033
lesion	B-T033
and	O
degree	O
of	O
stenosis	O
.	O
	
our	O
study	O
population	O
consisted	O
of	O
171	O
patients	O
71	O
41.5	O
did	O
and	O
100	O
58.5	O
did	O
not	O
suffer	O
deterioration	O
.	O
	
by	O
univariate	O
analysis	O
,	O
blood	O
pressure	O
bp	O
,	O
heart	O
rate	O
,	O
national	B-T033
institutes	I-T033
of	I-T033
health	I-T033
stroke	I-T033
scale	I-T033
nihss	I-T033
score	I-T033
,	O
number	O
of	O
diffusion	O
-	O
positive	B-T033
lesion	B-T033
,	O
count	O
of	O
red	O
blood	O
cell	O
,	O
high-density	B-T116
lipoprotein	I-T116
,	O
and	O
degree	O
of	O
stenosis	O
differed	O
significantly	B-T078
between	O
the	O
2	O
groups	B-T078
.	O
	
by	O
multivariate	B-T081
analysis	I-T081
,	O
systolic	O
bp	O
170	O
mm	O
hg	O
,	O
odds	B-T081
ratio	I-T081
7.20	O
,	O
p	O
<	O
was	O
associated	B-T080
with	I-T080
nd	O
.	O
	
furthermore	O
,	O
number	O
of	O
diffusion-weighted	O
image	O
dwi	O
positive	B-T033
lesion	B-T033
8	O
,	O
degree	O
of	O
stenosis	O
>80	O
,	O
and	O
nihss	B-T033
score	I-T033
4	O
were	O
also	O
independent	B-T078
factors	B-T169
associated	B-T080
with	I-T080
nd	O
.	O
	
high	B-T047
bp	I-T047
,	O
severity	B-T080
of	O
neurological	B-T033
deficit	I-T033
at	O
the	O
time	B-T079
of	I-T079
admission	I-T079
,	O
and	O
radiological	O
findings	B-T033
,	O
such	O
as	O
degree	O
of	O
stenosis	O
and	O
number	O
of	O
dwi	O
-	O
positive	B-T033
lesion	B-T033
,	O
are	O
independently	B-T033
associated	B-T080
with	I-T080
nd	O
in	O
patients	O
with	O
development	B-T169
and	O
validation	O
of	O
an	O
easy-to-use	O
risk	O
assessment	O
tool	O
for	O
cumulative	O
low	O
back	O
loading	O
the	O
lifting	O
fatigue	O
failure	O
tool	O
lifft	O
recent	O
evidence	O
suggests	O
that	O
musculoskeletal	B-T047
disorders	I-T047
msds	B-T047
may	O
be	O
the	O
result	O
of	O
a	O
fatigue	O
failure	B-T169
process	I-T169
in	O
affected	B-T169
tissues	O
.	O
	
this	O
paper	O
describes	O
a	O
new	O
low	O
back	O
exposure	O
assessment	O
tool	O
the	O
lifting	O
fatigue	O
failure	O
tool	O
lifft	O
,	O
which	O
estimates	O
a	O
""""	O
daily	B-T081
dose	I-T081
""""	O
of	O
cumulative	B-T080
loading	O
on	O
the	O
low	O
back	O
using	O
fatigue	O
failure	B-T169
principles	B-T078
.	O
	
only	O
three	O
variables	B-T080
are	O
necessary	O
to	O
derive	O
the	O
cumulative	B-T080
load	O
associated	B-T080
with	I-T080
a	O
lifting	O
task	O
the	O
weight	B-T081
of	I-T081
the	I-T081
load	I-T081
,	O
the	O
maximum	O
horizontal	B-T081
distance	I-T081
from	O
the	O
spine	O
to	O
the	O
load	O
,	O
and	O
the	O
number	O
of	O
repetitions	B-T169
for	O
tasks	B-T061
performed	I-T061
during	O
the	O
workday	B-T079
.	O
	
the	O
new	O
tool	O
was	O
validated	O
using	O
two	O
existing	O
epidemiological	B-T169
databases	O
the	O
lumbar	B-T033
motion	I-T033
monitor	O
lmm	O
database	O
,	O
and	O
a	O
database	O
from	O
a	O
u.s	O
.	O
	
automotive	O
manufacturer	O
.	O
	
the	O
lifft	O
cumulative	O
damage	O
metric	O
explained	O
92%	O
of	O
the	O
deviance	O
in	O
low	O
back	O
disorders	O
lbds	O
in	O
the	O
lmm	O
database	O
and	O
72-95%	O
of	O
the	O
deviance	O
in	O
low	O
back	O
outcomes	O
in	O
the	O
automotive	O
database	O
depending	O
on	O
the	O
outcome	O
measure	O
.	O
	
thus	O
,	O
lifft	O
is	O
practitioner	O
friendly	O
and	O
its	O
cumulative	O
damage	O
metric	O
highly	O
related	O
to	O
low	O
back	O
outcomes	I-T080
genetic	O
diversity	O
in	O
various	O
accessions	O
of	O
pineapple	O
ananas	O
comosus	O
l	O
merr	O
using	O
issr	O
and	O
ssr	O
markers	O
inter	O
simple	O
sequence	O
repeat	O
issr	O
and	O
simple	O
sequence	O
repeat	O
ssr	O
markers	O
were	O
used	O
to	O
assess	O
the	O
genetic	O
diversity	O
of	O
36	O
pineapple	O
accessions	O
that	O
were	O
introduced	O
from	O
10	O
countries	O
/	O
regions	O
.	O
	
thirteen	O
issr	O
primers	O
amplified	O
96	O
bands	O
,	O
of	O
which	O
91	O
93.65	O
were	O
polymorphic	B-T080
,	O
whereas	O
20	O
ssr	O
primers	O
amplified	O
73	O
bands	O
,	O
of	O
which	O
70	O
96.50	O
were	O
polymorphic	B-T080
.	O
	
nei's	O
gene	O
diversity	O
h	O
=	O
0.28	O
,	O
shannon's	O
information	O
index	O
i	O
=	O
0.43	O
,	O
and	O
polymorphism	O
information	O
content	O
pic	O
=	O
0.29	O
generated	O
using	O
the	O
ssr	O
primers	O
were	O
higher	O
than	O
that	O
with	O
issr	O
primers	O
h	O
=	O
0.23	O
,	O
i	O
=	O
0.37	O
,	O
pic	O
=	O
0.24	O
,	O
thereby	O
suggesting	O
that	O
the	O
ssr	O
system	O
is	O
more	O
efficient	O
than	O
the	O
issr	O
system	O
in	O
assessing	O
genetic	O
diversity	O
in	O
various	O
pineapple	O
accessions	O
.	O
	
mean	O
genetic	B-T169
similarities	B-T080
were	O
0.74	O
,	O
0.61	O
,	O
and	O
0.69	O
,	O
as	O
determined	O
using	O
issr	O
,	O
ssr	O
,	O
and	O
combined	O
issr	O
/	O
ssr	O
,	O
respectively	O
.	O
	
these	O
results	O
suggest	O
that	O
the	O
genetic	O
diversity	O
among	O
pineapple	O
accessions	O
is	O
very	O
high	O
.	O
	
we	O
clustered	O
the	O
36	O
pineapple	O
accessions	O
into	O
three	O
or	O
five	O
groups	O
on	O
the	O
basis	O
of	O
the	O
phylogenetic	B-T080
trees	I-T080
constructed	O
based	O
on	O
the	O
results	O
of	O
issr	O
,	O
ssr	O
,	O
and	O
combined	O
issr	O
/	O
ssr	O
analyses	O
using	O
the	O
unweighted	O
pair-group	O
with	O
arithmetic	O
averaging	O
upgma	O
method	O
.	O
	
the	O
results	O
of	O
principal	B-T081
components	I-T081
analysis	I-T081
pca	B-T081
also	O
supported	O
the	O
upgma	O
clustering	O
.	O
	
these	O
results	O
will	O
be	O
useful	O
not	O
only	O
for	O
the	O
scientific	O
conservation	O
and	O
management	O
of	O
pineapple	O
germplasm	O
but	O
also	O
for	O
the	O
improvement	O
of	O
the	O
current	O
pineapple	O
breeding	O
strategies	O
.	O
	
advanced	O
age	O
is	O
not	O
a	O
barrier	B-T169
to	O
creating	O
a	O
functional	B-T169
arteriovenous	O
fistula	O
a	O
retrospective	O
study	O
arteriovenous	O
fistulas	O
avfs	O
are	O
the	O
recommended	O
form	O
of	O
vascular	O
access	O
for	O
hemodialysis	B-T061
.	O
	
however	O
,	O
controversy	O
exists	O
regarding	O
whether	O
avfs	O
are	O
suitable	O
for	O
elderly	O
patients	O
.	O
	
single-center	O
retrospective	O
review	O
to	O
investigate	B-T169
the	O
impact	B-T080
of	O
age	O
on	O
avf	O
outcomes	B-T169
.	O
	
five	O
hundred	O
and	O
twenty-five	O
patients	O
with	O
avf	O
creation	O
were	O
stratified	B-T080
based	O
on	O
age	O
<65	O
,	O
65-75	O
,	O
and	O
>75	O
years	B-T079
.	O
	
avf	O
outcomes	B-T169
including	O
primary	B-T080
failure	B-T169
,	O
avf	O
patency	O
primary	B-T080
,	O
secondary	B-T080
,	O
and	O
functional	B-T169
,	O
and	O
avf	O
complications	O
were	O
studied	O
for	O
3	O
years	B-T079
following	O
avf	O
creation	O
.	O
	
the	O
cohort	O
was	O
63%	O
male	O
,	O
44%	O
caucasian	O
,	O
and	O
55%	O
had	O
diabetes	B-T047
or	O
cardiovascular	B-T047
disease	I-T047
.	O
	
39%	O
were	O
aged	O
<65	O
years	B-T079
,	O
33%	O
65-75	O
years	B-T079
,	O
and	O
28%	O
were	O
aged	O
>75	O
years	B-T079
.	O
	
no	O
differences	O
in	O
rates	O
of	O
primary	B-T080
failure	B-T169
,	O
loss	O
of	O
primary	B-T080
patency	O
,	O
complications	O
,	O
or	O
need	O
for	O
intervention	B-T061
were	O
observed	O
between	O
age	O
groups	O
.	O
	
there	O
was	O
a	O
significant	O
association	B-T080
of	O
age	O
with	O
secondary	B-T080
patency	O
and	O
functional	B-T169
patency	O
,	O
with	O
age	O
>75	O
being	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
shortened	B-T080
lifespan	B-T079
of	O
the	O
fistula	O
.	O
	
for	O
patients	O
aged	O
>75	O
years	B-T079
,	O
secondary	B-T080
patency	O
at	O
3	O
years	B-T079
was	O
64%	O
compared	O
to	O
75%-78%	O
for	O
younger	B-T079
patients	O
.	O
	
functional	B-T169
patency	O
at	O
2	O
years	B-T079
was	O
69%	O
for	O
those	O
aged	O
>75	O
years	B-T079
compared	O
to	O
78%-81%	O
for	O
younger	B-T079
patients	O
.	O
	
we	O
found	O
no	O
difference	O
in	O
avf	O
maturation	O
,	O
primary	B-T080
patency	O
,	O
complications	O
,	O
or	O
interventions	B-T061
in	O
those	O
over	O
the	O
age	O
of	O
75	O
compared	O
to	O
younger	B-T079
counterparts	O
.	O
	
while	O
secondary	B-T080
and	O
functional	B-T169
patency	O
rates	B-T081
were	O
significantly	O
lower	O
in	O
those	O
aged	O
>75	O
years	B-T079
,	O
the	O
magnitude	O
of	O
difference	O
is	O
likely	O
not	O
clinically	O
relevant	O
.	O
	
therefore	O
,	O
we	O
recommend	O
that	O
advanced	O
age	O
alone	O
should	O
not	O
preclude	O
patients	O
from	O
avf	O
creation	O
.	O
	
a	O
modified	B-T169
esbl	B-T116
nordmann/dortet/poirel-based	O
protocol	O
to	O
optimize	O
early	O
sepsis	O
management	O
we	O
evaluated	O
a	O
modification	O
of	O
a	O
colorimetric	O
test	O
recently	O
described	O
by	O
dortet	O
et	O
al	O
.	O
	
2015	O
for	O
the	O
rapid	O
detection	O
of	O
esbl	O
-producing	O
enterobacteriaceae	O
directly	O
from	O
positive	O
blood	O
cultures	O
that	O
requires	O
less	O
manipulation	O
,	O
materials	O
and	O
hands-on	O
time	O
.	O
	
the	O
simplified	O
protocol	O
showed	O
a	O
sensitivity	O
and	O
specificity	O
of	O
100%	O
and	O
95.7	O
the	O
use	O
of	O
informativity	O
in	O
the	O
development	B-T169
of	O
robust	O
viromics	O
-based	O
examinations	O
metagenomics	O
-based	O
studies	O
have	O
provided	O
insight	O
into	O
many	O
of	O
the	O
complex	O
microbial	O
communities	O
responsible	O
for	O
maintaining	O
life	O
on	O
this	O
planet	O
.	O
	
sequencing	O
efforts	O
often	O
uncover	O
novel	O
genetic	O
content	O
this	O
is	O
most	O
evident	O
for	O
phage	O
communities	O
,	O
in	O
which	O
upwards	O
of	O
90%	O
of	O
all	O
sequences	O
exhibit	O
no	O
similarity	O
to	O
any	O
sequence	O
in	O
current	O
data	O
repositories	O
.	O
	
for	O
the	O
small	B-T081
fraction	I-T081
that	O
can	O
be	O
identified	O
,	O
the	O
top	O
blast	O
hit	O
is	O
generally	O
posited	O
as	O
being	O
representative	O
of	O
a	O
viral	O
taxon	O
present	O
in	O
the	O
sample	O
of	O
origin	O
.	O
	
homology	B-T080
-based	O
classification	O
,	O
however	O
,	O
can	O
be	O
misleading	O
as	O
sequence	O
repositories	O
capture	O
but	O
a	O
small	B-T081
fraction	I-T081
of	O
phage	O
diversity	O
.	O
	
furthermore	O
,	O
lateral	O
gene	O
transfer	O
is	O
pervasive	O
within	O
phage	O
communities	O
.	O
	
as	O
such	O
,	O
the	O
presence	O
of	O
a	O
particular	O
gene	O
may	O
not	O
be	O
indicative	O
of	O
the	O
presence	O
of	O
a	O
particular	O
viral	O
species	O
.	O
	
rather	O
,	O
it	O
is	O
just	O
that	O
an	O
indication	B-T078
of	O
the	O
presence	O
of	O
a	O
specific	O
gene	O
.	O
	
to	O
circumvent	O
this	O
limitation	B-T169
,	O
we	O
have	O
developed	O
a	O
new	O
method	O
for	O
the	O
analysis	O
of	O
viral	O
metagenomic	O
datasets	O
.	O
	
blast	O
hits	O
are	O
weighted	O
,	O
integrating	O
the	O
sequence	O
identity	O
and	O
length	O
of	O
alignments	O
as	O
well	O
as	O
a	O
taxonomic	B-T169
signal	I-T169
,	O
such	O
that	O
each	O
gene	O
is	O
evaluated	O
with	O
respect	O
to	O
its	O
information	B-T078
content	I-T078
.	O
	
through	O
this	O
quantifiable	B-T081
metric	I-T081
,	O
predictions	B-T078
of	O
viral	O
community	O
structure	O
can	O
be	O
made	O
with	O
confidence	O
.	O
	
as	O
a	O
proof-of-concept	B-T078
,	O
the	O
approach	O
presented	O
here	O
was	O
implemented	O
and	O
applied	O
to	O
seven	O
freshwater	O
viral	O
metagenomes	O
.	O
	
while	O
providing	O
a	O
robust	B-T080
method	I-T080
for	O
evaluating	O
viral	O
metagenomic	O
data	O
,	O
the	O
tool	O
is	O
versatile	B-T080
and	O
can	O
easily	O
be	O
customized	O
to	O
investigations	O
of	O
any	O
environment	O
or	O
presence	B-T033
of	I-T033
citrinin	B-T109
in	O
grains	O
and	O
its	O
possible	B-T033
health	B-T078
effects	B-T080
citrinin	B-T109
is	O
a	O
mycotoxin	B-T109
produced	B-T169
by	O
several	O
species	O
of	O
the	O
genera	O
aspergillus	O
,	O
penicillium	O
and	O
monascus	O
and	O
it	O
occurs	O
mainly	O
in	O
stored	O
grain	O
.	O
	
citrinin	B-T109
is	O
generally	O
formed	B-T169
after	O
harvest	B-T169
and	O
occurs	O
mainly	O
in	O
stored	O
grains	O
,	O
it	O
also	O
occurs	O
in	O
other	O
plant	O
products	O
.	O
	
often	O
,	O
the	O
co-occurrence	B-T079
with	O
other	O
mycotoxins	B-T109
is	O
observed	B-T169
,	O
especially	O
ochratoxin	B-T109
a	I-T109
,	O
which	O
is	O
usually	O
associated	B-T080
with	I-T080
endemic	B-T047
nephropathy	I-T047
.	O
	
at	O
the	O
european	O
union	O
level	B-T080
,	O
systematic	B-T169
monitoring	O
of	O
citrinin	B-T109
in	O
grains	O
began	O
with	O
the	O
aim	B-T078
of	O
determining	B-T080
its	O
highest	O
permissible	B-T081
amount	I-T081
in	O
food	O
.	O
	
thus	O
,	O
far	O
the	O
systematic	B-T169
monitoring	O
of	O
the	O
above	B-T109
mentioned	I-T109
mycotoxin	I-T109
in	O
croatia	O
is	O
yet	O
to	O
begin	B-T079
.	O
	
the	O
main	O
goal	O
of	O
this	O
study	O
was	O
to	O
determine	B-T080
the	O
presence	B-T033
of	I-T033
citrinin	B-T109
in	O
grains	O
sampled	B-T078
in	O
the	O
area	O
of	O
međimurje	O
,	O
osijek-baranja	O
,	O
vukovar-srijem	O
and	O
brod-posavina	O
county	O
.	O
	
for	O
the	O
purpose	B-T169
of	O
identification	B-T080
and	O
quantification	B-T081
of	O
citrinin	B-T109
,	O
high	O
performance	O
liquid	O
chromatograph	O
hplc	O
with	O
fluorescence	O
was	O
used	B-T033
calibration	B-T081
curve	I-T081
k	O
>	O
0.999	O
intra	O
assay	O
cv	O
=	O
2.1	O
inter	O
assay	O
cv	O
=	O
4.3	O
loq	B-T081
<	O
1	O
μg/kg	O
.	O
	
from	O
the	O
area	O
of	O
međimurje	O
county	O
,	O
10	O
samples	O
of	O
corn	O
and	O
10	O
samples	O
of	O
wheat	O
were	O
analyzed	O
.	O
	
none	O
of	O
the	O
samples	O
contained	O
citrinin	B-T109
<1	O
μg/kg	O
.	O
	
from	O
the	O
area	O
of	O
osijek-baranja	O
and	O
vukovar-srijem	O
county	O
,	O
15	O
samples	O
from	O
each	O
county	O
were	O
analyzed	O
.	O
	
the	O
mean	B-T081
value	I-T081
for	O
the	O
samples	O
of	O
osijek-baranja	O
county	O
was	O
19.63	O
μg/kg	O
median	B-T081
=15	O
μg/kg	O
,	O
while	O
for	O
vukovar-srijem	O
county	O
the	O
mean	B-T081
value	I-T081
of	O
citrinin	B-T109
was	O
14	O
μg/kg	O
median	B-T081
=1	O
μg/kg	O
.	O
	
from	O
5	O
analyzed	O
samples	O
from	O
brod-posavina	O
county	O
,	O
one	O
of	O
the	O
samples	O
contained	O
citrinin	B-T109
in	O
the	O
amount	B-T081
of	O
23.8	O
μg/kg	O
,	O
while	O
the	O
registered	O
amount	B-T081
s	O
in	O
the	O
other	O
samples	O
were	O
<1	O
μg/kg	O
.	O
	
the	O
results	B-T169
show	O
that	O
grains	O
from	O
several	B-T081
counties	O
contain	O
certain	O
amounts	B-T081
of	O
citrinin	B-T109
possibly	O
indicating	B-T033
a	O
significant	B-T078
intake	B-T169
of	O
citrinin	B-T109
in	O
humans	O
.	O
	
it	O
must	O
be	O
stated	O
that	O
grains	O
and	O
grain-based	O
products	O
are	O
the	O
basis	O
of	O
everyday	B-T079
diet	O
of	O
all	O
age	O
groups	O
,	O
especially	O
small	O
children	O
,	O
where	O
higher	B-T080
intake	B-T169
of	O
citrinin	B-T109
can	O
occur	O
.	O
	
consequently	O
,	O
we	O
emphasize	B-T080
the	O
need	O
for	O
systematic	B-T169
analysis	O
of	O
larger	B-T081
amount	I-T081
of	O
samples	O
,	O
from	O
both	O
large	O
grains	O
and	O
small	O
grains	O
,	O
especially	O
in	O
the	O
area	O
of	O
brod-posavina	O
county	O
,	O
in	O
order	O
to	O
obtain	O
more	O
realistic	O
notion	O
of	O
citrinin	B-T109
contamination	B-T078
of	O
grains	O
and	O
to	O
asses	O
the	O
health	B-T078
risk	B-T078
in	O
recurrent	O
noncoding	O
regulatory	O
mutations	O
in	O
pancreatic	O
ductal	O
adenocarcinoma	O
the	O
contributions	O
of	O
coding	O
mutations	O
to	O
tumorigenesis	O
are	O
relatively	O
well	O
known	O
however	O
,	O
little	O
is	O
known	O
about	O
somatic	O
alterations	O
in	O
noncoding	O
dna	O
.	O
	
here	O
we	O
describe	O
gecco	O
genomic	O
enrichment	O
computational	O
clustering	O
operation	O
to	O
analyze	O
somatic	O
noncoding	O
alterations	O
in	O
308	O
pancreatic	O
ductal	O
adenocarcinomas	O
pdas	O
and	O
identify	O
commonly	O
mutated	O
regulatory	O
regions	O
.	O
	
we	O
find	O
recurrent	O
noncoding	O
mutations	O
to	O
be	O
enriched	O
in	O
pda	O
pathways	O
,	O
including	O
axon	O
guidance	O
and	O
cell	O
adhesion	O
,	O
and	O
newly	O
identified	B-T080
processes	O
,	O
including	O
transcription	O
and	O
homeobox	O
genes	O
.	O
	
we	O
identified	B-T080
mutations	O
in	O
protein	O
binding	O
sites	O
correlating	O
with	O
differential	B-T080
expression	O
of	O
proximal	O
genes	O
and	O
experimentally	O
validated	O
effects	B-T080
of	I-T080
mutations	O
on	O
expression	O
.	O
	
we	O
developed	O
an	O
expression	B-T081
modulation	I-T081
score	I-T081
that	O
quantifies	B-T081
the	O
strength	B-T078
of	O
gene	O
regulation	O
imposed	O
by	O
each	O
class	O
of	O
regulatory	O
elements	O
,	O
and	O
found	O
the	O
strongest	O
elements	O
were	O
most	O
frequently	O
mutated	O
,	O
suggesting	O
a	O
selective	O
advantage	O
.	O
	
our	O
detailed	O
single-cancer	O
analysis	O
of	O
noncoding	O
alterations	O
identifies	O
regulatory	O
mutations	O
as	O
candidates	B-T080
for	O
diagnostic	O
and	O
prognostic	B-T080
markers	I-T080
,	O
and	O
suggests	O
new	O
mechanisms	B-T169
for	O
tumor	O
evolution	O
.	O
	
distal	O
posterior	O
cerebral	O
artery	O
revascularization	B-T061
for	O
a	O
fusiform	O
pca	O
aneurysm	B-T047
a	O
lesson	O
learned	O
the	O
need	O
for	O
revascularization	B-T061
with	O
proximal	O
posterior	O
cerebral	O
artery	O
occlusion	O
in	O
the	O
treatment	B-T169
of	O
giant	B-T047
and	O
fusiform	O
aneurysms	O
is	O
unclear	O
.	O
	
while	O
early	O
series	O
demonstrated	O
only	O
about	O
a	O
10%	O
chance	O
of	O
infarction	O
following	O
posterior	O
cerebral	O
artery	O
occlusion	O
,	O
recently	O
several	O
authors	O
have	O
advocated	O
a	O
bypass	B-T061
prior	O
to	O
parent	O
vessel	O
sacrifice	O
in	O
all	O
cases	O
.	O
	
we	O
present	O
the	O
case	O
of	O
an	O
adult	O
man	O
with	O
a	O
fusiform	O
aneurysm	O
of	O
the	O
right	O
posterior	O
cerebral	O
artery	O
at	O
the	O
p2-p3	O
junction	O
.	O
	
he	O
clinically	B-T033
failed	I-T033
a	O
balloon	O
test	O
occlusion	O
preoperatively	B-T079
and	O
therefore	O
underwent	O
an	O
occipital	O
artery	O
to	O
distal	O
posterior	O
cerebral	O
artery	O
bypass	B-T061
with	O
subsequent	O
endovascular	B-T061
occlusion	I-T061
of	I-T061
the	I-T061
parent	I-T061
vessel	I-T061
and	O
aneurysm	B-T047
.	O
	
despite	O
the	O
fact	O
that	O
the	O
immediate	O
and	O
6	O
month	O
follow	O
up	O
cerebral	O
angiography	O
confirmed	O
a	O
patent	O
bypass	B-T061
,	O
the	O
patient	O
still	O
developed	O
a	O
posterior	O
cerebral	O
artery	O
territory	B-T047
stroke	I-T047
.	O
	
we	O
believe	O
this	O
case	O
demonstrates	O
that	O
successful	O
distal	O
revascularization	B-T061
in	O
the	O
setting	O
of	O
proximal	O
posterior	O
cerebral	O
artery	O
occlusion	O
does	O
not	O
guarantee	O
against	O
cerebral	B-T047
ischemia	I-T047
and	O
infarction	O
even	O
in	O
those	O
patients	O
that	O
fail	O
a	O
test	O
occlusion	O
.	O
	
when	O
is	O
a	O
test	B-T080
score	I-T080
fair	B-T080
for	O
the	O
individual	O
who	O
is	O
being	O
tested	O
effects	B-T080
of	I-T080
different	O
scoring	O
procedures	O
across	O
multiple	B-T081
attempts	O
when	O
testing	B-T169
a	O
motor	O
skill	O
task	O
tests	O
or	O
test	O
batteries	O
used	O
for	O
assessing	O
motor	O
skills	O
,	O
either	O
in	O
research	O
studies	O
or	O
in	O
clinical	O
settings	O
,	O
apply	O
a	O
variety	O
of	O
procedures	B-T169
for	O
scoring	O
performances	O
,	O
including	O
everything	O
from	O
one	O
to	O
ten	O
attempts	O
,	O
of	O
which	O
the	O
best	O
is	O
scored	B-T081
or	O
an	O
average	B-T081
is	O
computed	O
.	O
	
the	O
rationale	O
behind	O
scoring	O
procedures	B-T169
is	O
rarely	O
stated	O
,	O
and	O
it	O
seems	O
that	O
the	O
number	O
of	O
attempts	O
allowed	O
is	O
decided	O
without	O
much	O
qualification	O
from	O
research	O
.	O
	
it	O
is	O
uncertain	O
whether	O
procedures	B-T169
fairly	O
capture	O
an	O
individual's	O
skill	O
level	B-T080
.	O
	
thus	O
,	O
the	O
validity	O
of	O
the	O
tests	O
may	O
be	O
compromised	O
.	O
	
the	O
present	O
study	O
tested	O
24	O
young	O
female	O
soccer	O
players	O
on	O
the	O
juggling	O
of	O
a	O
soccer	O
ball	O
.	O
	
they	O
were	O
given	O
10	O
attempts	O
,	O
and	O
trials	O
were	O
scored	B-T081
according	O
to	O
nine	O
different	O
procedures	B-T169
including	O
the	O
'	O
best	B-T080
of	I-T080
'	O
or	O
'	O
mean	B-T081
of	I-T081
'	O
either	O
one	O
,	O
two	O
,	O
three	O
,	O
five	O
,	O
or	O
ten	O
attempts	O
.	O
	
individual	O
raw	B-T081
scores	I-T081
differed	O
widely	O
across	O
trials	O
,	O
but	O
no	B-T080
general	I-T080
effect	I-T080
of	O
trials	O
was	O
found	O
.	O
	
the	O
mean	B-T081
sd	I-T081
percentage	I-T081
difference	I-T081
between	O
the	O
lowest	B-T080
and	O
highest	B-T080
scores	B-T081
was	O
27.7	O
,	O
with	O
17	O
players	O
71%	O
demonstrating	O
a	O
significant	B-T078
change	O
from	O
lowest	B-T080
to	O
highest	B-T080
score	B-T081
.	O
	
correlations	B-T080
between	O
raw	B-T081
scores	I-T081
were	O
low	B-T080
across	O
trials	O
,	O
while	O
they	O
were	O
generally	O
higher	B-T080
across	O
scoring	O
procedures	B-T169
.	O
	
the	O
first	O
trial	O
was	O
significantly	B-T078
different	B-T080
from	O
the	O
remaining	O
both	O
as	O
a	O
raw	B-T081
score	I-T081
and	O
as	O
scoring	O
procedure	B-T169
.	O
	
the	O
mean	B-T081
percentage	I-T081
difference	I-T081
between	O
best-of-two	B-T081
and	O
best-of-ten	B-T081
scores	I-T081
was	O
95%	O
,	O
with	O
50	O
%	O
of	O
the	O
players	O
demonstrating	O
a	O
significant	B-T078
difference	B-T080
between	O
the	O
two	O
scoring	O
procedures	B-T169
.	O
	
no	B-T033
significant	I-T033
differences	I-T033
were	O
found	O
across	O
mean-of-rule	B-T081
scorings	I-T081
.	O
	
best-of-rule	B-T081
and	O
mean-of-rule	B-T081
scorings	I-T081
were	O
significantly	B-T078
different	B-T080
except	O
for	O
the	O
best-of-two	B-T081
vs	O
.	O
	
mean-of-two	B-T081
.	O
	
the	O
mean	B-T081
difference	I-T081
between	O
highest	B-T080
and	O
lowest	B-T080
rank	O
across	O
players	O
was	O
6.7	O
3.6	O
,	O
with	O
individual	O
rankings	O
within	O
the	O
group	O
varying	O
33%	O
on	O
average	O
across	O
procedures	B-T169
.	O
	
one	O
player	O
moved	O
from	O
3rd	O
to	O
23rd	O
place	O
because	O
of	O
procedural	B-T169
differences	B-T080
.	O
	
therefore	O
,	O
it	O
is	O
concluded	O
that	O
scoring	O
procedures	B-T169
affect	O
results	O
and	O
may	O
have	O
an	O
impact	O
on	O
test	O
outcomes	O
.	O
	
this	O
may	O
present	O
consequences	O
for	O
decision-making	O
from	O
test	O
results	O
,	O
such	O
as	O
diagnosing	B-T033
and	O
selection	O
of	O
intervention	B-T061
groups	B-T078
.	O
	
we	O
hope	O
that	O
our	O
results	O
would	O
inspire	O
further	O
research	O
into	O
the	O
scoring	O
procedures	B-T169
of	O
the	O
vast	O
amount	O
of	O
tests	O
a	O
fast	O
peak-searching	O
algorithm	O
for	O
ultrasonic	O
elastography	O
tissue	O
axial	O
strain	O
estimation	O
with	O
ultrasound	O
elastography	O
has	O
become	O
a	O
hot	O
field	O
in	O
recent	O
years	O
.	O
	
however	O
,	O
for	O
keypoints	O
tracking-based	O
elastography	O
algorithms	O
,	O
locating	B-T033
extrema	B-T080
in	O
multimodal	O
ultrasonic	B-T169
radiofrequency	O
signals	O
is	O
still	O
a	O
challenging	O
problem	B-T033
.	O
	
in	O
this	O
paper	O
,	O
a	O
new	O
method	O
is	O
proposed	B-T080
to	O
locate	B-T033
the	O
local	O
maxima	B-T081
and	O
minima	B-T080
of	O
the	O
rf	O
signals	O
directly	O
without	O
derivation	B-T080
operation	O
.	O
	
this	O
algorithm	O
can	O
accurately	O
locate	B-T033
extrema	B-T080
even	O
if	O
disturbed	O
peaks	B-T080
resulting	O
from	O
different	O
noise	O
exist	O
.	O
	
furthermore	O
,	O
the	O
new	O
algorithm	O
can	O
speed	O
up	O
approximately	O
79%	O
of	O
the	O
implementation	O
process	O
as	O
compared	O
with	O
the	O
standard	O
cross-correlation	O
method	O
on	O
the	O
same	O
computing	O
platform	O
.	O
	
in	O
addition	O
,	O
the	O
elastographic	O
signal-to-noise	B-T081
ratio	I-T081
and	O
the	O
contrast-to-noise	B-T081
ratio	I-T081
audiovisual	O
integration	O
supports	O
face	O
-	O
name	O
associative	O
memory	O
formation	O
prior	O
multisensory	B-T080
experience	O
influences	O
how	O
we	O
perceive	O
our	O
environment	O
,	O
and	O
hence	O
how	O
memories	O
are	O
encoded	O
for	O
subsequent	O
retrieval	O
.	O
	
this	O
study	O
investigated	O
if	O
audiovisual	O
av	O
integration	O
and	O
associative	O
memory	O
formation	O
rely	O
on	O
overlapping	O
or	O
distinct	O
processes	O
.	O
	
our	O
functional	O
magnetic	O
resonance	O
imaging	O
results	O
demonstrate	O
that	O
the	O
neural	O
mechanisms	B-T169
underlying	O
av	O
integration	O
and	O
associative	O
memory	O
overlap	B-T079
substantially	O
.	O
	
in	O
particular	O
,	O
activity	O
in	O
anterior	O
superior	O
temporal	O
sulcus	O
sts	O
is	O
increased	O
during	O
av	O
integration	O
and	O
also	O
determines	O
the	O
success	O
of	O
novel	O
av	O
face	O
-	O
name	O
association	O
formation	O
.	O
	
dynamic	O
causal	O
modeling	O
results	O
further	O
demonstrate	O
how	O
the	O
anterior	O
sts	O
interacts	O
with	O
the	O
associative	O
memory	O
system	O
to	O
facilitate	O
successful	O
memory	O
formation	O
for	O
av	O
face	O
-	O
name	O
associations	O
.	O
	
specifically	O
,	O
the	O
connection	O
of	O
fusiform	O
gyrus	O
to	O
anterior	O
sts	O
is	O
enhanced	O
while	O
the	O
reverse	O
connection	O
is	O
reduced	O
when	O
participants	O
subsequently	O
remembered	O
both	O
face	O
and	O
name	O
.	O
	
collectively	O
,	O
our	O
results	O
demonstrate	O
how	O
multisensory	B-T080
associative	O
memories	O
can	O
be	O
formed	O
for	O
subsequent	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
quantification	B-T081
of	O
acetamiprid	B-T109
and	O
thiacloprid	B-T109
residues	O
in	O
butterbur	O
grown	O
under	O
regulated	O
conditions	O
an	O
analytical	O
method	O
was	O
developed	O
to	O
quantify	B-T081
the	O
residual	O
levels	B-T080
of	O
the	O
neonicotinoid	O
insecticides	O
,	O
acetamiprid	B-T109
and	O
thiacloprid	B-T109
,	O
in	O
field-incurred	B-T169
butterbur	O
samples	O
using	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
lc-ms/ms	O
.	O
	
samples	O
were	O
extracted	O
with	O
acetonitrile	B-T109
and	O
partitioned	O
with	O
dichloromethane	B-T109
.	O
	
after	O
partitioning	O
,	O
purification	B-T169
was	O
conducted	O
using	O
a	O
florisil	O
cartridge	O
.	O
	
linearity	O
of	O
a	O
matrix-matched	B-T081
calibration	I-T081
curve	I-T081
of	O
the	O
two	O
compounds	O
over	O
a	O
concentration	B-T081
range	B-T081
of	O
0.004	O
was	O
excellent	O
,	O
with	O
determination	B-T081
coefficients	I-T081
r	B-T081
.	O
	
the	O
limits	B-T081
of	I-T081
detection	I-T081
lod	B-T081
and	O
quantitation	B-T081
loq	B-T081
for	O
both	O
acetamiprid	B-T109
and	O
thiacloprid	B-T109
were	O
0.0006	O
and	O
0.002mg	O
,	O
respectively	O
.	O
	
the	O
average	O
recoveries	O
for	O
acetamiprid	B-T109
and	O
thiacloprid	B-T109
at	O
two	O
spiking	B-T080
levels	I-T080
0.02	O
and	O
0.1mg	O
,	O
i.e	O
,	O
10	O
loq	B-T081
and	O
50	O
loq	B-T081
were	O
between	O
78.23	O
to	O
82.17	O
,	O
with	O
relative	B-T081
standard	I-T081
deviations	I-T081
rsds	B-T081
.	O
	
the	O
method	O
was	O
successfully	O
applied	O
to	O
field-incurred	B-T169
samples	O
treated	B-T169
with	O
a	O
commercial	O
pesticide	O
product	O
,	O
either	O
once	O
zero	O
or	O
7	O
days	B-T079
before	O
harvest	B-T169
or	O
twice	O
0	O
and	O
7	O
,	O
7	O
and	O
14	O
,	O
or	O
14	O
and	O
21	O
days	B-T079
before	O
harvest	B-T169
.	O
	
the	O
highest	O
and	O
lowest	O
residues	O
were	O
obtained	O
for	O
the	O
7	O
and	O
0	O
days	B-T079
'	O
treatment	B-T169
and	O
the	O
21	O
and	O
14	O
days	B-T079
'	O
treatment	B-T169
,	O
respectively	O
.	O
	
the	O
developed	O
method	O
is	O
simple	O
and	O
accurate	B-T080
and	O
can	O
be	O
extrapolated	O
to	O
other	O
leafy	O
vegetables	O
.	O
	
percentile	B-T081
categorization	O
of	O
qt	B-T033
interval	I-T033
as	O
an	O
approach	O
for	O
identifying	O
adult	O
patients	O
at	O
risk	B-T078
for	O
cardiovascular	O
death	O
the	O
results	O
from	O
studies	O
of	O
the	O
association	O
of	O
qt	B-T033
prolongation	I-T033
with	O
cardiovascular	O
death	O
cvd	O
have	O
been	O
inconsistent	B-T080
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
major	O
correction	B-T081
formulas	I-T081
to	O
percentile	B-T081
values	I-T081
of	O
qt	B-T081
for	O
heart	O
rate	O
ranges	B-T081
as	O
to	O
their	O
ability	O
to	O
remove	O
the	O
relationship	B-T080
of	O
qt	B-T081
to	O
heart	O
rate	O
and	O
to	O
predict	O
cvd	O
.	O
	
participants	O
were	O
16	O
veterans	O
who	O
had	O
an	O
initial	O
ecg	B-T033
at	O
the	O
veterans	O
affairs	O
medical	O
center	O
,	O
palo	O
alto	O
,	O
between	O
march	B-T079
31	O
,	O
1987	O
,	O
and	O
december	B-T080
20	O
,	O
1999	O
,	O
and	O
were	O
followed	O
for	O
cvd	O
.	O
	
the	O
4	O
major	O
correction	B-T081
formulas	I-T081
bazett	B-T081
,	O
fridericia	B-T081
,	O
framingham	B-T081
,	O
and	O
hodges	B-T081
were	O
used	O
to	O
correct	O
qt	B-T033
interval	I-T033
.	O
	
in	O
addition	O
,	O
the	O
percentiles	B-T081
for	O
heart	O
rate	O
ranges	B-T081
as	O
proposed	O
by	O
schwartz	O
were	O
calculated	O
.	O
	
during	O
median	O
follow-up	O
of	O
17.8	O
years	B-T079
,	O
455	O
cvd	O
events	O
occurred	O
.	O
	
when	O
compared	O
to	O
the	O
other	O
equations	O
,	O
qtc	O
bazett	O
had	O
the	O
greatest	O
dependence	O
on	O
heart	O
rate	O
r	O
=	O
0.18	O
.	O
	
the	O
hazard	B-T081
ratio	I-T081
95%	O
confidence	B-T081
interval	I-T081
for	O
cvd	O
was	O
2.08	O
1.28	O
for	O
the	O
98th	O
percentile	B-T081
of	O
qt	B-T033
interval	I-T033
by	O
heart	O
rate	O
ranges	B-T081
,	O
2.05	O
1.27	O
for	O
qtc	B-T081
bazett	I-T081
,	O
1.39	O
0.44	O
for	O
qtc	B-T081
fridericia	O
,	O
1.05	O
0.26	O
for	O
qtc	O
hodges	I-T081
,	O
and	O
1.12	O
0.28	O
for	O
qtc	B-T081
framingham	I-T081
.	O
	
the	O
hazard	O
ratio	O
of	O
qtc	B-T081
bazett	I-T081
was	O
significantly	B-T081
higher	I-T081
than	O
the	O
other	O
formulas	O
except	O
for	O
the	O
98th	O
percentile	B-T081
method	O
.	O
	
the	O
framingham	B-T081
,	O
hodges	B-T081
,	O
and	O
fridericia	B-T081
equations	I-T081
remove	O
the	O
effect	B-T080
of	O
heart	O
rate	O
on	O
qt	B-T033
interval	I-T033
significantly	O
better	O
than	O
the	O
bazett	B-T081
equation	I-T081
.	O
	
using	O
qt-interval	B-T033
percentiles	B-T081
based	O
on	O
heart	O
rate	O
provides	O
a	O
consistent	O
approach	O
both	O
for	O
identifying	O
those	O
whose	O
qt	B-T033
intervals	I-T033
prolong	O
due	O
to	O
drugs	B-T061
or	O
other	O
stressors	B-T078
and	O
for	O
assessing	O
cvd	O
risk	B-T078
.	O
	
how	O
should	O
i	O
study	O
for	O
the	O
exam	O
self-regulated	O
learning	O
strategies	O
and	O
achievement	O
in	O
introductory	O
biology	O
in	O
college	O
introductory	O
science	O
courses	O
,	O
students	O
are	O
challenged	O
with	O
mastering	O
large	O
amounts	O
of	O
disciplinary	B-T080
content	I-T080
while	O
developing	O
as	O
autonomous	O
and	O
effective	B-T080
learners	O
.	O
	
self-regulated	O
learning	O
srl	O
is	O
the	O
process	O
of	O
setting	O
learning	B-T078
goals	I-T078
,	O
monitoring	O
progress	B-T169
toward	O
them	O
,	O
and	O
applying	O
appropriate	O
study	O
strategies	O
.	O
	
srl	O
characterizes	O
successful	O
,	O
"""expert"""	O
learners	O
,	O
and	O
develops	O
with	O
time	O
and	O
practice	O
.	O
	
in	O
a	O
large	O
,	O
undergraduate	O
introductory	O
biology	O
course	O
,	O
we	O
investigated	O
1	O
what	O
srl	O
strategies	O
students	O
reported	O
using	O
the	O
most	O
when	O
studying	O
for	O
exams	O
,	O
2	O
which	O
strategies	O
were	O
associated	O
with	O
higher	O
achievement	O
and	O
with	O
grade	O
improvement	B-T033
on	O
exams	O
,	O
and	O
3	O
what	O
study	O
approaches	O
students	O
proposed	O
to	O
use	O
for	O
future	O
exams	O
.	O
	
higher	B-T080
-	O
achieving	O
students	O
,	O
and	O
students	O
whose	O
exam	O
grades	O
improved	B-T033
in	O
the	O
first	B-T033
half	I-T033
of	O
the	O
semester	B-T079
,	O
reported	O
using	O
specific	O
cognitive	O
and	O
metacognitive	O
strategies	O
significantly	O
more	O
frequently	B-T079
than	O
their	O
lower	O
-	O
achieving	O
peers	O
.	O
	
lower	O
-	O
achieving	O
students	O
more	O
frequently	B-T079
reported	O
that	O
they	O
did	O
not	O
implement	O
their	O
planned	O
strategies	O
or	O
,	O
if	O
they	O
did	O
,	O
still	O
did	O
not	O
improve	O
their	O
outcomes	B-T169
.	O
	
these	O
results	O
suggest	O
that	O
many	O
students	O
entering	O
introductory	O
biology	O
have	O
limited	B-T169
knowledge	O
of	O
srl	O
strategies	O
and/or	O
limited	B-T169
ability	O
to	O
implement	O
them	O
,	O
which	O
can	O
impact	B-T080
their	O
achievement	O
.	O
	
course	O
-specific	O
interventions	O
that	O
promote	O
srl	O
development	O
should	O
be	O
considered	O
as	O
integral	O
pedagogical	O
tools	O
,	O
aimed	O
at	O
fostering	O
development	O
of	O
students	O
'	O
lifelong	B-T079
learning	O
skills	O
.	O
	
characterising	O
bias	B-T078
in	O
regulatory	B-T078
risk	I-T078
and	O
decision	O
analysis	O
an	O
analysis	O
of	O
heuristics	O
applied	O
in	O
health	O
technology	O
appraisal	O
,	O
chemicals	O
regulation	O
,	O
and	O
climate	O
change	O
governance	O
in	O
many	O
environmental	O
and	O
public	O
health	O
domains	O
,	O
heuristic	O
methods	O
of	O
risk	B-T078
and	O
decision	O
analysis	O
must	O
be	O
relied	O
upon	O
,	O
either	O
because	O
problem	B-T033
structures	I-T033
are	O
ambiguous	O
,	O
reliable	O
data	B-T078
is	O
lacking	B-T080
,	O
or	O
decisions	O
are	O
urgent	O
.	O
	
this	O
introduces	O
an	O
additional	O
source	B-T033
of	O
uncertainty	B-T033
beyond	O
model	O
and	O
measurement	B-T081
error	I-T081
-	O
uncertainty	B-T033
stemming	O
from	O
relying	O
on	O
inexact	O
inference	O
rules	O
.	O
	
here	O
we	O
identify	B-T169
and	O
analyse	B-T169
heuristics	O
used	O
to	O
prioritise	O
risk	B-T078
objects	O
,	O
to	O
discriminate	B-T080
between	O
signal	O
and	O
noise	O
,	O
to	O
weight	B-T081
evidence	B-T078
,	O
to	O
construct	O
models	O
,	O
to	O
extrapolate	O
beyond	O
datasets	O
,	O
and	O
to	O
make	O
policy	O
.	O
	
some	O
of	O
these	O
heuristics	O
are	O
based	O
on	O
causal	O
generalisations	B-T080
,	O
yet	O
can	O
misfire	O
when	O
these	O
relationships	B-T080
are	O
presumed	O
rather	O
than	O
tested	O
e.g	O
.	O
	
surrogates	O
in	O
clinical	O
trials	O
.	O
	
others	O
are	O
conventions	B-T080
designed	O
to	O
confer	O
stability	B-T080
to	O
decision	O
analysis	O
,	O
yet	O
which	O
may	O
introduce	O
serious	O
error	B-T080
when	O
applied	O
ritualistically	O
e.g	O
.	O
	
significance	B-T169
testing	I-T169
.	O
	
some	O
heuristics	O
can	O
be	O
traced	O
back	O
to	O
formal	O
justifications	B-T078
,	O
but	O
only	O
subject	O
to	O
strong	O
assumptions	B-T078
that	O
are	O
often	O
violated	O
in	O
practical	B-T169
applications	I-T169
.	O
	
heuristic	O
decision	O
rules	O
e.g	O
.	O
	
feasibility	O
rules	O
in	O
principle	O
act	O
as	O
surrogates	O
for	O
utility	B-T080
maximisation	I-T080
or	O
distributional	B-T169
concerns	B-T078
,	O
yet	O
in	O
practice	O
may	O
neglect	O
costs	B-T081
and	I-T081
benefits	I-T081
,	O
be	O
based	O
on	O
arbitrary	B-T080
thresholds	B-T080
,	O
and	O
be	O
prone	O
to	O
gaming	O
.	O
	
we	O
highlight	O
the	O
problem	B-T033
of	O
rule-entrenchment	O
,	O
where	O
analytical	O
choices	O
that	O
are	O
in	O
principle	O
contestable	O
are	O
arbitrarily	O
fixed	O
in	O
practice	O
,	O
masking	O
uncertainty	B-T033
and	O
potentially	O
introducing	O
bias	B-T078
.	O
	
strategies	O
for	O
making	O
risk	B-T078
and	O
decision	O
analysis	O
more	O
rigorous	O
include	O
formalising	O
the	O
assumptions	B-T078
and	O
scope	O
conditions	B-T078
under	O
which	O
heuristics	O
should	O
be	O
applied	O
testing	B-T169
rather	O
than	O
presuming	O
their	O
underlying	O
empirical	B-T078
or	O
theoretical	B-T078
justifications	I-T078
using	O
sensitivity	B-T081
analysis	O
,	O
simulations	O
,	O
multiple	O
bias	O
analysis	O
,	O
and	O
deductive	O
systems	O
of	O
inference	O
e.g	O
.	O
	
directed	O
acyclic	O
graphs	O
to	O
characterise	O
rule	O
uncertainty	B-T033
and	O
refine	O
heuristics	O
adopting	O
""""	O
recovery	O
schemes	O
""""	O
to	O
correct	O
for	O
known	O
biases	B-T078
and	O
basing	O
decision	O
rules	O
on	O
clearly	O
articulated	O
values	B-T080
and	O
evidence	B-T078
,	O
rather	O
than	O
multicentric	O
castleman	O
disease	O
of	O
hyaline	O
vascular	O
variant	B-T080
presenting	O
with	O
unusual	B-T080
systemic	B-T169
manifestations	B-T080
a	O
case	O
report	O
castleman	O
disease	O
is	O
a	O
rare	B-T080
lymphoproliferative	O
disorder	O
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	B-T047
and	O
systemic	B-T169
manifestations	B-T080
.	O
	
it	O
can	O
be	O
categorized	O
in	O
numerous	B-T081
ways	O
,	O
such	O
as	O
unicentric	B-T047
versus	O
multicentric	O
,	O
histopathological	B-T169
variants	B-T080
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	O
,	O
and	O
mixed	B-T080
,	O
or	O
subtypes	O
based	O
on	O
causative	B-T033
viral	B-T047
infections	I-T047
human	O
immunodeficiency	O
virus	O
,	O
human	O
herpesvirus-8	O
,	O
or	O
kaposi	O
sarcoma	O
herpesvirus	O
.	O
	
presentation	O
ranges	O
from	O
asymptomatic	B-T033
to	O
symptoms	O
involving	O
multiple	B-T081
organs	O
.	O
	
even	O
though	O
the	O
exact	O
mechanism	B-T169
of	O
pathogenesis	O
is	O
unknown	O
,	O
treatment	B-T169
is	O
directed	B-T080
toward	O
possible	O
etiologies	B-T169
such	O
as	O
interleukin-6	B-T116
,	O
cluster	B-T116
of	I-T116
differentiation	I-T116
20	I-T116
,	O
and	O
viral	B-T169
agents	I-T169
.	O
	
a	O
36-	O
year	B-T079
-old	O
sri	O
lankan	O
woman	O
presented	O
with	O
generalized	O
body	O
swelling	O
and	O
foamy	O
urine	O
of	O
2	O
weeks	B-T079
'	O
duration	B-T079
.	O
	
examination	O
revealed	O
pallor	B-T033
generalized	B-T033
edema	I-T033
axillary	O
,	O
cervical	O
,	O
and	O
inguinal	B-T047
lymphadenopathy	I-T047
hypertension	B-T047
and	O
hepatomegaly	B-T033
.	O
	
investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	B-T033
range	I-T033
proteinuria	I-T033
with	O
hypoalbuminemia	B-T047
,	O
hypogammaglobulinemia	B-T047
,	O
and	O
features	B-T080
of	O
hyaline	O
-	O
vascular	O
type	B-T080
castleman	O
disease	O
in	O
a	O
lymph	O
node	O
biopsy	O
.	O
	
she	O
was	O
managed	O
with	O
rituximab	B-T116
and	O
had	O
good	O
clinical	B-T080
improvement	O
.	O
	
castleman	O
disease	O
has	O
a	O
broad	O
spectrum	O
of	O
clinical	B-T080
manifestations	B-T080
,	O
disease	B-T047
pathogeneses	O
,	O
and	O
associations	B-T080
and/or	O
complications	O
.	O
	
medical	B-T169
professionals	O
need	O
to	O
be	O
familiar	O
with	O
this	O
spectrum	O
because	O
timely	O
diagnosis	B-T033
and	O
aggressive	B-T061
targeted	I-T061
therapy	I-T061
are	O
the	O
cornerstones	O
of	O
managing	O
these	O
the	O
ages-reykjavik	O
study	O
atlases	O
non-linear	O
multi-spectral	B-T078
template	I-T078
and	O
atlases	O
for	O
studies	O
of	O
the	O
ageing	O
brain	O
quantitative	B-T081
analyses	I-T081
of	O
brain	O
structures	O
from	O
magnetic	O
resonance	O
mr	O
image	O
data	B-T078
are	O
often	O
performed	O
using	O
automatic	B-T169
segmentation	O
algorithms	O
.	O
	
many	O
of	O
these	O
algorithms	O
rely	O
on	O
templates	B-T078
and	O
atlases	O
in	O
a	O
common	O
coordinate	O
space	O
.	O
	
most	O
freely	B-T080
available	B-T169
brain	O
atlases	O
are	O
generated	O
from	O
relatively	O
young	B-T079
individuals	O
and	O
not	O
always	O
derived	O
from	O
well-defined	O
cohort	B-T081
studies	I-T081
.	O
	
in	O
this	O
paper	O
,	O
we	O
introduce	O
a	O
publicly	O
available	B-T169
multi-spectral	B-T078
template	I-T078
with	O
corresponding	O
tissue	O
probability	B-T081
atlases	O
and	O
regional	O
atlases	O
,	O
optimised	O
to	O
use	O
in	O
studies	O
of	O
ageing	O
cohorts	O
mean	O
age	O
75	O
5	O
years	O
.	O
	
furthermore	O
,	O
we	O
provide	O
validation	O
data	B-T078
from	O
a	O
regional	O
segmentation	O
pipeline	O
to	O
assure	O
the	O
integrity	B-T080
of	O
the	O
comparative	O
and	O
evolutionary	O
analysis	O
of	O
an	O
adapter	O
molecule	O
myd88	O
in	O
invertebrate	O
metazoans	O
the	O
myeloid	O
differentiation	O
factor	O
88	O
myd88	O
is	O
an	O
essential	O
adapter	O
in	O
toll-like	B-T116
receptor	I-T116
tlr	B-T116
signalling	O
pathways	O
,	O
with	O
tlr	B-T116
the	O
first	O
pattern-recognition	B-T116
receptor	I-T116
prr	B-T116
that	O
was	O
discovered	O
in	O
drosophila	O
.	O
	
in	O
the	O
present	O
study	O
,	O
a	O
myd88	O
gene	O
was	O
identified	B-T080
and	O
characterized	O
from	O
a	O
commercially	O
important	O
shellfish	O
,	O
scapharca	O
subcrenata	O
,	O
including	O
a	O
death	O
domain	O
and	O
tir	O
domain	O
conserved	O
within	O
other	O
molluscs	O
.	O
	
furthermore	O
,	O
comparative	O
genomic	O
evidence	O
revealed	O
that	O
myd88	O
was	O
of	O
different	B-T080
lengths	B-T081
and	O
contained	O
quantitative	B-T081
exon	O
and	O
intron	O
regions	O
,	O
which	O
might	O
be	O
involved	O
in	O
specific	B-T169
mechanisms	I-T169
.	O
	
to	O
further	O
explore	O
the	O
phylogenetic	O
relationships	O
of	O
invertebrate	O
metazoan	O
myd88	O
,	O
we	O
applied	O
mrbayes	O
and	O
phyml	O
software	O
to	O
construct	O
phylogenetic	B-T080
trees	I-T080
using	O
bayesian	B-T081
and	O
maximum	B-T081
likelihood	I-T081
approaches	I-T081
,	O
respectively	O
,	O
which	O
suggested	O
that	O
the	O
myd88	O
of	O
arthropoda	O
was	O
closely	O
related	O
to	O
lower	B-T080
invertebrates	O
,	O
in	O
contrast	B-T080
to	O
morphological	O
taxonomy	O
.	O
	
finally	O
,	O
we	O
investigated	B-T169
the	O
evolutionary	O
patterns	O
and	O
location	O
of	O
positive	O
selection	O
sites	O
psss	O
in	O
the	O
myd88	O
gene	O
from	O
arthropoda	O
,	O
mollusca	O
and	O
insecta	O
using	O
paml	O
software	O
with	O
the	O
maximum	O
likelihood	O
method	O
.	O
	
the	O
data	B-T078
showed	O
that	O
positive	O
selection	O
sites	O
were	O
detected	B-T033
in	O
these	O
groups	O
,	O
and	O
partial	O
sites	O
were	O
located	O
in	O
the	O
tir	O
domain	O
but	O
were	O
not	B-T033
found	I-T033
in	O
the	O
death	O
domain	O
.	O
	
to	O
summarize	O
,	O
in	O
this	O
study	O
,	O
we	O
report	O
on	O
the	O
diversification	O
of	O
myd88	O
in	O
invertebrate	O
metazoans	O
,	O
the	O
specific	B-T080
evolutionary	O
position	O
of	O
arthropoda	O
myd88	O
,	O
and	O
the	O
positive	B-T033
selection	O
pressures	O
on	O
myd88	O
of	O
arthropoda	O
,	O
mollusca	O
and	O
insecta	O
.	O
	
these	O
results	B-T169
are	O
a	O
valuable	O
contribution	O
to	O
understand	O
and	O
clarify	O
the	O
evolutionary	O
pattern	O
of	O
tlr	B-T116
/	O
myd88	O
signalling	O
pathways	O
in	O
invertebrate	O
and	O
vertebrate	O
taxa	O
.	O
	
rubinstein-taybi	B-T047
syndrome	I-T047
associated	B-T080
with	I-T080
pituitary	O
macroadenoma	O
a	O
case	O
report	O
rubinstein-taybi	B-T047
syndrome	I-T047
rsts	B-T047
is	O
an	O
autosomal	B-T047
dominant	I-T047
disorder	I-T047
that	O
is	O
classically	O
characterized	O
by	O
prenatal	B-T079
and	O
postnatal	B-T079
growth	O
restriction	O
,	O
microcephaly	O
,	O
dysmorphic	O
craniofacial	O
features	O
,	O
broad	B-T033
thumbs	I-T033
and	O
toes	B-T033
,	O
and	O
intellectual	O
disability	O
.	O
	
we	O
describe	O
the	O
first	O
reported	O
case	O
of	O
a	O
pituitary	O
macroadenoma	O
associated	B-T080
with	I-T080
rsts	B-T047
.	O
	
a	O
39-year-old	O
caucasian	O
female	O
with	O
a	O
past	B-T033
medical	I-T033
history	I-T033
of	O
rsts	B-T047
diagnosed	B-T033
at	O
age	O
two	O
was	O
found	O
to	O
have	O
a	O
gadolinium	O
-enhancing	O
pituitary	O
mass	O
on	O
magnetic	O
resonance	O
imaging	O
mri	O
of	O
the	O
brain	O
three	O
years	B-T079
ago	O
during	O
workup	O
for	O
migraine-like	O
headaches	O
.	O
	
subsequent	O
serial	O
imaging	O
showed	O
radiographic	B-T078
evidence	I-T078
of	O
growth	O
up	O
to	O
11.5	O
x	O
14.0	O
x	O
10.0	O
mm	O
in	O
size	O
.	O
	
the	O
pituitary	O
sellar	B-T033
lesion	I-T033
was	O
resected	B-T061
through	O
an	O
endoscopic	O
transnasal	O
transsphenoidal	O
approach	O
and	O
was	O
found	O
to	O
be	O
a	O
thyrotroph	O
adenoma	O
.	O
	
rsts	B-T047
is	O
a	O
rare	B-T080
,	O
neurodevelopmental	O
genetic	B-T047
disease	I-T047
where	O
most	O
patients	O
with	O
disabilities	O
survive	O
into	O
adulthood	B-T079
.	O
	
the	O
disorder	B-T047
is	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
predisposition	O
for	O
development	B-T169
of	O
nervous	O
system	O
tumors	O
,	O
including	O
pituitary	O
adenomas	O
.	O
	
the	O
clinico-	O
radiological	O
paradox	B-T033
of	O
cognitive	O
function	O
and	O
mri	O
burden	B-T078
of	O
white	O
matter	O
lesions	B-T033
in	O
people	O
with	O
multiple	B-T047
sclerosis	I-T047
a	O
systematic	O
review	O
and	O
meta-analysis	O
moderate	B-T080
correlation	B-T080
exists	O
between	O
the	O
imaging	O
quantification	O
of	O
brain	O
white	O
matter	O
lesions	B-T033
and	O
cognitive	B-T169
performance	O
in	O
people	O
with	O
multiple	B-T047
sclerosis	I-T047
ms	B-T047
.	O
	
this	O
may	O
reflect	O
the	O
greater	O
importance	O
of	O
other	O
features	B-T080
,	O
including	O
subvisible	O
pathology	O
,	O
or	O
methodological	B-T078
limitations	B-T169
of	O
the	O
primary	B-T080
literature	O
.	O
	
to	O
summarise	O
the	O
cognitive	B-T169
clinico-	O
radiological	O
paradox	B-T033
and	O
explore	O
the	O
potential	B-T080
methodological	B-T078
factors	B-T169
that	O
could	O
influence	O
the	O
assessment	O
of	O
this	O
relationship	B-T080
.	O
	
systematic	O
review	O
and	O
meta-analysis	O
of	O
primary	B-T080
research	O
relating	O
cognitive	O
function	O
to	O
white	O
matter	O
lesion	B-T033
burden	B-T078
.	O
	
fifty	O
papers	O
met	O
eligibility	B-T080
criteria	I-T080
for	O
review	O
,	O
and	O
meta-analysis	O
of	O
overall	O
results	B-T169
was	O
possible	O
in	O
thirty-two	O
2050	O
participants	O
.	O
	
aggregate	B-T080
correlation	B-T080
between	O
cognition	O
and	O
t2	B-T033
lesion	B-T033
burden	B-T078
was	O
r	O
=	O
-0	O
95%	O
confidence	B-T081
interval	I-T081
-0	O
,	O
-0	O
.	O
	
wide	O
methodological	B-T078
variability	O
was	O
seen	O
,	O
particularly	O
related	O
to	O
key	O
factors	B-T169
in	O
the	O
cognitive	B-T169
data	B-T078
capture	O
and	O
image	O
analysis	O
techniques	O
.	O
	
resolving	O
the	O
persistent	O
clinico-	O
radiological	O
paradox	B-T033
will	O
likely	O
require	O
simultaneous	O
evaluation	O
of	O
multiple	B-T081
components	O
of	O
the	O
complex	B-T080
pathology	O
using	O
optimum	B-T080
measurement	B-T169
techniques	B-T169
for	O
both	O
cognitive	B-T169
and	O
mri	O
feature	B-T080
quantification	B-T081
.	O
	
we	O
recommend	O
a	O
consensus	O
initiative	O
to	O
support	O
common	O
standards	B-T080
for	O
image	O
analysis	O
in	O
ms	B-T047
,	O
enabling	O
benchmarking	B-T081
while	O
also	O
supporting	O
ongoing	O
long	O
non-coding	O
rna	O
snhg6	O
as	O
a	O
potential	O
biomarker	O
for	O
hepatocellular	O
carcinoma	O
long	O
non-coding	O
rnas	O
lncrnas	O
refer	O
to	O
all	O
non-protein	O
coding	O
transcripts	O
longer	O
than	O
200	O
nucleotides	O
.	O
	
their	O
critical	O
roles	O
in	O
different	O
biological	B-T080
pathways	O
have	O
been	O
already	O
well	O
established	O
.	O
	
altered	O
expression	O
of	O
lncrnas	O
can	O
be	O
involved	O
in	O
the	O
cancer	O
initiation	O
and/or	O
progression	O
.	O
	
since	O
patients	O
with	O
hepatocellular	O
carcinoma	O
hcc	O
are	O
usually	O
diagnosed	B-T033
in	O
late	B-T079
stages	I-T079
,	O
developing	O
diagnostic	O
methods	O
seems	O
to	O
be	O
essential	O
.	O
	
in	O
this	O
study	O
,	O
the	O
expression	O
levels	O
of	O
different	O
lncrnas	O
were	O
systematically	O
analysed	O
in	O
different	O
genomic	O
and	O
transcriptome	O
datasets	O
.	O
	
the	O
analyses	O
showed	O
that	O
snhg6	O
is	O
among	O
the	O
lncrnas	O
with	O
distinctive	O
dysregulation	O
of	O
expression	O
and	O
copy	O
number	O
variation	O
in	O
hcc	O
tumors	O
compared	O
with	O
normal	O
tissues	O
.	O
	
the	O
results	O
also	O
suggest	O
that	O
the	O
dysregulation	O
of	O
snhg6	O
is	O
highly	O
cancer	O
type	O
specific	O
.	O
	
through	O
co-occurrence	O
analyses	O
,	O
we	O
found	O
that	O
snhg6	O
and	O
its	O
related	O
co-expressed	O
genes	O
on	O
8q	O
are	O
involved	O
in	O
the	O
structural	O
integrity	B-T080
of	O
ribosome	O
and	O
translation	O
.	O
	
this	O
comprehensive	B-T080
in	O
silico	O
analysis	O
,	O
provides	O
a	O
resource	O
for	O
investigating	B-T169
snhg6	O
in	O
hepatocellular	O
carcinoma	O
and	O
lays	O
the	O
groundwork	O
for	O
design	O
of	O
next	O
expressional	O
divergence	O
of	O
insect	O
gox	O
genes	O
from	O
specialist	O
to	O
generalist	O
glucose	B-T116
oxidase	I-T116
insect	O
herbivores	O
often	O
secrete	O
glucose	B-T116
oxidase	I-T116
gox	B-T116
onto	O
plants	O
to	O
counteract	O
plant	O
defenses	O
and	O
potential	B-T080
pathogens	O
.	O
	
whether	O
generalist	O
herbivores	O
always	O
have	O
significantly	B-T081
higher	I-T081
gox	B-T116
activities	O
than	O
their	O
specialist	O
counterparts	O
at	O
any	O
comparable	O
stage	O
or	O
conditions	O
and	O
how	O
this	O
is	O
realized	O
remain	O
unknown	O
.	O
	
to	O
address	O
these	O
two	O
general	O
questions	O
,	O
we	O
subjected	O
larvae	O
of	O
a	O
pair	O
of	O
sister	O
species	O
differed	O
mainly	O
in	O
host	O
range	O
,	O
the	O
generalist	O
helicoverpa	O
armigera	O
and	O
its	O
specialist	O
counterpart	O
helicoverpa	O
assulta	O
,	O
to	O
the	O
same	O
sets	O
of	O
stage	O
,	O
protein	B-T116
to	O
digestible	O
carbohydrate	O
p	O
ratio	O
,	O
allelochemical	O
or	O
host	O
plant	O
treatments	B-T169
for	O
simultaneous	O
analyses	O
of	O
gox	O
transcripts	O
and	O
activities	O
in	O
their	O
labial	O
glands	O
.	O
	
gox	O
activity	O
and	O
transcripts	O
are	O
upregulated	O
concurrently	O
with	O
food	O
ingestion	O
and	O
body	O
growth	O
,	O
downregulated	O
with	O
stopping	O
ingestion	O
and	O
wandering	O
for	O
pupation	O
in	O
both	O
species	O
.	O
	
the	O
three	O
tested	O
host	O
plants	O
upregulated	O
gox	O
transcripts	O
,	O
and	O
to	O
a	O
lesser	O
extent	O
,	O
gox	O
activity	O
in	O
both	O
species	O
.	O
	
there	O
were	O
significant	O
differences	O
in	O
both	O
gox	O
transcripts	O
and	O
activity	O
elicited	O
by	O
allelochemicals	O
,	O
but	O
only	O
in	O
gox	O
transcripts	O
by	O
p	O
ratios	O
in	O
both	O
species	O
.	O
	
gox	B-T116
activities	O
were	O
higher	O
in	O
h	O
.	O
	
armigera	O
than	O
h	O
.	O
	
assulta	O
in	O
all	O
the	O
comparable	O
treatments	O
,	O
but	O
gox	O
transcripts	O
were	O
significantly	B-T081
higher	I-T081
either	O
in	O
generalists	O
or	O
in	O
specialists	O
,	O
depending	O
on	O
the	O
developmental	B-T079
stages	I-T079
,	O
host	O
plants	O
,	O
p	O
ratio	O
and	O
allelochemicals	O
they	O
encounter	O
.	O
	
these	O
data	B-T078
indicate	O
that	O
the	O
greater	B-T081
gox	B-T116
activity	O
in	O
generalist	O
herbivores	O
is	O
not	O
achieved	O
by	O
greater	B-T081
transcription	O
rate	O
,	O
but	O
by	O
greater	O
transcript	O
stability	O
,	O
greater	O
translation	O
rate	O
,	O
better	O
enzyme	O
stability	O
propranolol	B-T109
effects	O
on	O
decompression	B-T047
sickness	I-T047
in	O
a	O
simulated	O
dissub	O
rescue	O
in	O
swine	O
disabled	O
submarine	O
dissub	O
survivors	O
may	O
face	O
elevated	B-T033
co2	I-T033
levels	I-T033
and	O
inert	O
gas	O
saturation	O
,	O
putting	O
them	O
at	O
risk	O
for	O
co2	O
toxicity	B-T080
and	O
decompression	B-T047
sickness	I-T047
dcs	B-T047
.	O
	
propranolol	B-T109
was	O
shown	O
to	O
reduce	O
co2	O
production	O
in	O
an	O
experimental	O
dissub	O
model	O
in	O
humans	O
but	O
its	O
effects	O
on	O
dcs	B-T047
in	O
a	O
dissub	O
rescue	O
scenario	O
are	O
unknown	O
.	O
	
a	O
100%	O
oxygen	O
prebreathe	O
opb	O
reduces	O
dcs	B-T047
incidence	O
and	O
severity	O
and	O
is	O
incorporated	O
into	O
some	O
dissub	O
rescue	O
protocols	O
.	O
	
we	O
used	O
a	O
swine	O
model	O
of	O
dissub	O
rescue	O
to	O
study	O
the	O
effect	O
of	O
propranolol	B-T109
on	O
dcs	B-T047
incidence	O
and	O
mortality	B-T081
with	O
and	O
without	O
an	O
opb	O
.	O
	
in	O
experiment	O
1	O
,	O
male	O
yorkshire	O
swine	O
70	O
kg	O
were	O
pressurized	O
to	O
2.8	O
ata	O
for	O
22	O
h	O
.	O
	
propranolol	B-T109
1.0	O
mg	O
kg-1	O
iv	O
was	O
administered	B-T169
at	I-T169
21.25	O
h	O
.	O
	
at	O
22	O
h	O
,	O
the	O
animal	O
was	O
rapidly	B-T169
decompressed	I-T169
and	O
observed	O
for	O
dcs	B-T047
type	O
,	O
onset	B-T079
time	I-T079
,	O
and	O
mortality	B-T081
.	O
	
experimental	O
animals	O
n	O
=	O
21	O
69	O
4.1	O
kg	O
,	O
prop1.0	B-T109
,	O
were	O
compared	O
to	O
prop1.0	B-T109
-	O
opb45	O
n	O
=	O
8	O
69	O
2.8	O
kg	O
with	O
the	O
same	O
dive	O
profile	O
,	O
except	O
for	O
a	O
45	O
min	O
opb	O
prior	O
to	O
decompression	B-T169
.	O
	
in	O
experiment	O
2	O
,	O
the	O
same	O
methodology	B-T078
was	O
used	O
with	O
the	O
following	O
changes	O
swine	O
pressurized	O
to	O
2.8	O
ata	O
for	O
28	O
h	O
experimental	O
group	O
n	O
=	O
25	O
67	O
3.3	O
kg	O
,	O
prop0.5	B-T109
bis	O
,	O
propranolol	B-T109
0.5	O
mg	O
kg-1	O
bis	O
twice	O
iv	O
was	O
administered	B-T169
at	I-T169
22	O
h	O
and	O
26	O
h	O
.	O
	
control	O
animals	O
n	O
=	O
25	O
67	O
3.9	O
kg	O
received	O
normal	O
saline	O
.	O
	
opb	O
reduced	B-T081
mortality	I-T081
in	O
prop1.0	B-T109
-	O
obp45	O
compared	O
to	O
prop1.0	B-T109
0%	O
vs	O
.	O
	
71%	O
.	O
	
prop0.5	B-T109
bis	O
had	O
increased	B-T081
mortality	I-T081
compared	O
to	O
control	O
60-%	O
vs	O
.	O
	
4%	O
.	O
	
administration	O
of	O
beta	O
blockers	O
prior	O
to	O
saturation	B-T169
decompression	I-T169
appears	O
to	O
increase	O
dcs	B-T047
and	O
worsen	B-T081
mortality	I-T081
in	O
a	O
swine	O
model	O
however	O
,	O
their	O
effects	O
in	O
bounce	O
diving	O
gut	O
microbiota	O
-mediated	O
protection	B-T033
against	O
diarrheal	O
infections	O
the	O
mammalian	O
gut	O
microbiota	O
is	O
a	O
highly	O
abundant	O
and	O
diverse	O
microbial	O
community	O
that	O
resides	O
in	O
the	O
gastrointestinal	O
tract	O
.	O
	
one	O
major	O
benefit	O
that	O
the	O
gut	O
microbiota	O
provides	O
to	O
its	O
host	O
is	O
colonization	B-T033
resistance	B-T169
-the	O
ability	O
to	O
prevent	B-T169
colonization	B-T033
by	O
foreign	O
microbes	O
,	O
including	O
diarrheal	O
pathogens	O
such	O
as	O
clostridium	O
difficile	O
,	O
salmonella	O
enterica	O
serovar	O
typhimurium	O
and	O
diarrheagenic	O
escherichia	O
coli	O
.	O
	
we	O
conducted	O
a	O
literature	O
review	O
of	O
the	O
effects	B-T080
of	I-T080
the	O
gut	O
microbiota	O
on	O
infection	O
by	O
diarrheal	O
pathogens	O
.	O
	
we	O
used	O
pubmed	O
to	O
search	O
for	O
relevant	O
articles	O
published	O
before	O
july	O
2016	O
,	O
as	O
well	O
as	O
incorporated	O
data	B-T078
from	O
our	O
laboratory	O
.	O
	
the	O
gut	O
microbiota	O
provides	O
protection	B-T033
from	O
diarrheal	O
infections	O
both	O
by	O
direct	B-T080
inhibition	O
of	O
pathogens	O
and	O
by	O
indirect	B-T080
effects	B-T080
on	O
host	O
functions	B-T169
.	O
	
direct	B-T080
effects	B-T080
of	I-T080
the	O
microbiota	O
on	O
diarrheal	O
pathogens	O
include	O
competing	O
for	O
nutrients	O
and	O
producing	O
metabolites	O
that	O
inhibit	B-T169
pathogen	O
growth	O
or	O
virulence	O
.	O
	
indirect	B-T080
effects	B-T080
of	I-T080
the	O
gut	O
microbiota	O
include	O
promoting	O
maintenance	O
of	O
the	O
gut	O
mucosal	O
barrier	O
and	O
stimulating	O
innate	O
and	O
adaptive	O
immunity	O
.	O
	
human	O
epidemiological	O
studies	O
and	O
experimental	B-T080
infections	O
of	O
laboratory	O
animals	O
both	O
demonstrate	O
that	O
antibiotic	B-T061
treatment	I-T061
can	O
alter	O
the	O
gut	O
microbial	O
community	O
and	O
thereby	O
reduce	O
colonization	B-T033
resistance	B-T169
against	O
diarrheal	O
pathogens	O
.	O
	
further	O
research	O
might	O
lead	O
to	O
the	O
development	B-T169
of	O
next-generation	O
probiotics	O
that	O
could	O
be	O
used	O
to	O
bolster	O
colonization	B-T033
resistance	B-T169
and	O
thus	O
prevent	B-T169
travellers'	B-T047
diarrheal	I-T047
.	O
	
ecotoxicity	O
testing	B-T169
and	O
environmental	O
risk	O
assessment	O
of	O
iron	O
nanomaterials	O
for	O
sub-surface	O
remediation	O
-	O
recommendations	B-T078
from	O
the	O
fp7	O
project	O
nanorem	O
nanoremediation	O
with	O
iron	O
fe	O
nanomaterials	O
opens	O
new	O
doors	O
for	O
treating	B-T169
contaminated	B-T169
soil	O
and	O
groundwater	O
,	O
but	O
is	O
also	O
accompanied	O
by	O
new	O
potential	B-T078
risks	I-T078
as	O
large	O
quantities	O
of	O
engineered	O
nanomaterials	O
are	O
introduced	O
into	O
the	O
environment	O
.	O
	
in	O
this	O
study	O
,	O
we	O
have	O
assessed	O
the	O
ecotoxicity	O
of	O
four	O
engineered	O
fe	O
nanomaterials	O
,	O
specifically	O
,	O
nano-goethite	O
,	O
trap-ox	O
fe-zeolites	O
,	O
carbo-iron	O
and	O
fermeg12	O
,	O
developed	O
within	O
the	O
european	O
fp7	O
project	O
nanorem	O
for	O
sub-surface	O
remediation	O
towards	O
a	O
test	O
battery	O
consisting	O
of	O
eight	O
ecotoxicity	O
tests	O
on	O
bacteria	O
v	O
.	O
	
fisheri	O
,	O
e	O
.	O
	
coli	O
,	O
algae	O
p	O
.	O
	
subcapitata	O
,	O
chlamydomonas	O
sp	O
,	O
crustaceans	O
d	O
.	O
	
magna	O
,	O
worms	O
e	O
.	O
	
fetida	O
,	O
l	O
.	O
	
variegatus	O
and	O
plants	O
r	O
.	O
	
sativus	O
,	O
l	O
.	O
	
multiflorum	O
.	O
	
the	O
tested	O
materials	O
are	O
commercially	O
available	O
and	O
include	O
fe	O
oxide	O
and	O
nanoscale	O
zero	O
valent	O
iron	O
nzvi	O
,	O
but	O
also	O
hybrid	O
products	O
with	O
fe	O
loaded	O
into	O
a	O
matrix	O
.	O
	
all	O
but	O
one	O
material	O
,	O
a	O
ball	O
milled	O
nzvi	O
fermeg12	O
,	O
showed	O
no	B-T033
toxicity	I-T033
in	O
the	O
test	O
battery	O
when	O
tested	O
in	O
concentrations	B-T081
up	O
to	O
100	O
mg/l	O
,	O
which	O
is	O
the	O
cutoff	B-T169
for	O
hazard	B-T080
labeling	O
in	O
chemicals	O
regulation	O
in	O
europe	O
.	O
	
however	O
it	O
should	O
be	O
noted	O
that	O
fe	O
nanomaterials	O
proved	O
challenging	O
to	O
test	O
adequately	O
due	O
to	O
their	O
turbidity	B-T080
,	O
aggregation	B-T169
and	O
sedimentation	O
behavior	O
in	O
aqueous	B-T080
media	O
.	O
	
this	O
paper	O
provides	O
a	O
number	O
of	O
recommendations	B-T078
concerning	O
future	B-T169
testing	I-T169
of	O
fe	O
nanomaterials	O
and	O
discusses	O
environmental	O
risk	O
assessment	O
grade	O
group	O
underestimation	B-T033
in	O
prostate	O
biopsy	O
predictive	O
factors	O
and	O
outcomes	B-T033
in	O
candidates	O
for	O
active	O
surveillance	O
we	O
intended	O
to	O
analyze	O
the	O
outcomes	B-T033
and	O
predictive	O
factors	O
for	O
underestimating	O
the	O
prostate	O
cancer	O
pca	O
grade	O
group	O
gg	O
from	O
prostate	O
biopsies	O
in	O
a	O
large	O
monocentric	O
cohort	O
of	O
patients	O
treated	B-T169
by	O
minimally	B-T061
invasive	I-T061
radical	I-T061
prostatectomy	I-T061
rp	B-T061
.	O
	
using	O
a	O
monocentric	O
prospectively	O
maintained	O
database	O
,	O
we	O
included	O
3062	O
patients	O
who	O
underwent	O
minimally	B-T061
invasive	I-T061
rp	I-T061
between	O
2006	O
and	O
2013	O
.	O
	
we	O
explored	O
clinicopathologic	O
features	O
and	O
outcomes	B-T033
associated	B-T080
with	I-T080
a	O
gg	O
upgrade	O
from	O
biopsy	O
to	O
rp	B-T061
.	O
	
multivariate	O
logistic	O
regression	O
was	O
used	O
to	O
develop	O
and	O
validate	O
a	O
nomogram	O
to	O
predict	O
upgrading	O
for	O
gg1	O
.	O
	
biopsy	O
gg	O
was	O
upgraded	O
after	O
rp	B-T061
in	O
51.5	O
of	O
cases	O
.	O
	
patients	O
upgraded	O
from	O
gg1	O
to	O
gg2	O
or	O
gg3	O
after	O
rp	B-T061
had	O
a	O
longer	B-T079
time	I-T079
to	O
biochemical	B-T033
recurrence	I-T033
than	O
those	O
with	O
gg2	O
or	O
gg3	O
respectively	O
,	O
on	O
both	O
biopsy	O
and	O
rp	B-T061
,	O
but	O
a	O
shorter	B-T079
time	I-T079
to	O
biochemical	B-T033
recurrence	I-T033
than	O
those	O
who	O
remained	O
gg1	O
after	O
rp	O
p	O
<	O
0001	O
.	O
	
in	O
multivariate	B-T081
analyses	I-T081
,	O
variables	B-T081
predicting	O
upgrading	O
for	O
gg1	O
pca	O
were	O
age	O
p	O
=	O
0014	O
,	O
abnormal	O
digital	O
rectal	O
examination	O
p	O
<	O
0001	O
,	O
prostate	O
-specific	O
antigen	O
density	O
p	O
<	O
0001	O
,	O
percentage	O
of	O
positive	O
cores	O
p	O
<	O
0001	O
,	O
and	O
body	O
mass	O
index	O
p	O
=	O
037	O
.	O
	
a	O
nomogram	O
was	O
generated	O
and	O
validated	O
internally	O
.	O
	
biopsy	O
grading	O
system	O
is	O
misleading	O
in	O
approximately	O
50%	O
of	O
cases	O
.	O
	
upgrading	O
gg	O
from	O
biopsy	O
to	O
rp	O
may	O
have	O
consequences	O
on	O
clinical	O
outcomes	O
.	O
	
a	O
nomogram	O
using	O
clinicopathologic	O
features	O
could	O
aid	O
the	O
probability	O
of	O
needing	O
to	O
upgrade	O
gg1	O
patients	O
at	O
their	O
initial	O
evaluation	O
characterization	O
of	O
electrocorticogram	O
high	B-T080
-	O
gamma	O
signal	O
in	O
response	O
to	O
varying	B-T080
upper	O
extremity	O
movement	O
velocity	B-T081
the	O
mechanism	B-T169
by	O
which	O
the	O
human	O
primary	O
motor	O
cortex	O
m1	O
encodes	O
upper	O
extremity	O
movement	O
kinematics	O
is	O
not	O
fully	O
understood	O
.	O
	
for	O
example	O
,	O
human	O
electrocorticogram	O
ecog	O
signals	O
have	O
been	O
shown	O
to	O
modulate	O
with	O
upper	O
extremity	O
movement	O
s	O
however	O
,	O
this	O
relationship	B-T080
has	O
not	O
been	O
explicitly	B-T080
characterized	O
.	O
	
to	O
address	O
this	O
issue	B-T033
,	O
we	O
recorded	B-T081
high	B-T080
-	O
density	B-T081
ecog	O
signals	O
from	O
patients	O
undergoing	O
epilepsy	B-T047
surgery	B-T061
evaluation	O
as	O
they	O
performed	B-T169
elementary	O
upper	O
extremity	O
movements	O
while	O
systematically	B-T169
varying	B-T080
movement	O
speed	B-T081
and	O
duration	B-T079
.	O
	
specifically	B-T080
,	O
subjects	O
performed	B-T169
intermittent	B-T079
pincer	B-T033
grasp	I-T033
/	O
release	B-T169
,	O
elbow	B-T033
flexion	I-T033
/	O
extension	B-T169
,	O
and	O
shoulder	B-T033
flexion	I-T033
/	O
extension	B-T169
at	O
slow	B-T080
,	O
moderate	B-T080
,	O
and	O
fast	B-T080
speeds	B-T081
.	O
	
in	O
all	O
movements	O
,	O
bursts	B-T081
of	O
power	B-T081
in	O
the	O
high	B-T080
-	O
see	O
text	O
band	O
80-160	O
hz	O
were	O
observed	B-T169
in	O
m1	O
.	O
	
in	O
addition	B-T169
,	O
the	O
amplitude	O
of	O
these	O
power	B-T081
bursts	B-T081
and	O
the	O
area	O
of	O
m1	O
with	O
elevated	B-T080
high	B-T080
-	O
see	O
text	O
activity	O
were	O
directly	B-T080
proportional	B-T080
to	O
the	O
movement	O
speed	B-T081
.	O
	
likewise	O
,	O
the	O
duration	B-T079
of	O
elevated	B-T080
high	B-T080
-	O
see	O
text	O
activity	O
increased	B-T081
with	O
movement	O
duration	B-T079
.	O
	
based	B-T169
on	O
linear	B-T081
regression	I-T081
,	O
m1	O
high	B-T080
-	O
see	O
text	O
power	B-T081
amplitude	O
and	O
duration	B-T079
covaried	B-T080
with	O
movement	O
speed	B-T081
and	O
duration	B-T079
,	O
respectively	O
,	O
with	O
an	O
average	B-T081
formula	O
see	O
text	O
of	O
formula	O
see	O
text	O
and	O
formula	O
see	O
text	O
.	O
	
these	O
findings	B-T033
indicate	B-T078
that	O
the	O
encoding	O
of	O
upper	O
extremity	O
movement	O
speed	B-T081
by	O
m1	O
high	B-T080
-	O
see	O
text	O
activity	O
is	O
primarily	B-T080
linear	O
.	O
	
also	O
,	O
the	O
fact	O
that	O
this	O
activity	O
remained	O
elevated	B-T080
throughout	O
a	O
movement	O
suggests	O
that	O
m1	O
does	O
not	O
merely	O
generate	O
transient	B-T079
instructions	O
for	O
a	O
specific	B-T080
movement	O
duration	B-T079
,	O
but	O
instead	O
is	O
responsible	O
for	O
the	O
entirety	B-T081
of	O
the	O
movement	O
.	O
	
finally	O
,	O
the	O
spatial	O
distribution	O
of	O
high	B-T080
-	O
see	O
text	O
activity	O
suggests	O
the	O
presence	B-T033
of	O
a	O
recruitment	O
phenomenon	O
in	O
which	O
higher	B-T080
speeds	B-T081
or	O
increased	B-T081
muscle	O
activity	O
involve	O
activation	O
of	O
larger	O
m1	O
area	O
fatty	B-T109
acids	I-T109
have	O
different	B-T080
adipogenic	O
differentiation	O
potentials	B-T080
in	O
stromal	O
vascular	O
cells	O
isolated	B-T169
from	O
abdominal	O
fat	O
in	O
laying	O
hens	O
this	O
study	O
was	O
conducted	O
to	O
examine	O
the	O
effects	B-T080
of	I-T080
fatty	B-T109
acids	I-T109
fa	B-T109
with/without	O
chicken	O
serum	O
cs	O
on	O
the	O
expression	O
of	O
adipogenic	O
transcripts	O
and	O
adipogenesis	O
in	O
chicken	O
stromal	O
vascular	O
cells	O
svc	O
.	O
	
in	O
experiment	O
1	O
,	O
svc	O
were	O
grown	O
in	O
dmem	O
containing	O
10%	O
fbs	O
control	O
and	O
treated	B-T169
with	O
300	O
µm	O
oleic	B-T109
acid	I-T109
ola	B-T109
+	O
fbs	O
,	O
linoleic	B-T109
acid	I-T109
lna	B-T109
+	O
fbs	O
,	O
palmitic	B-T109
acid	I-T109
pam	B-T109
+	O
fbs	O
,	O
or	O
stearic	B-T109
acid	I-T109
sta	B-T109
+	O
fbs	O
for	O
48	O
h	O
.	O
	
in	O
experiment	O
2	O
,	O
cells	O
were	O
grown	O
in	O
dmem	O
containing	O
5%	O
cs	O
and	O
treated	B-T169
with	O
300	O
µm	O
ola	B-T109
cs	O
+	O
ola	B-T109
,	O
pam	B-T109
cs	O
+	O
pam	B-T109
,	O
sta	B-T109
cs	O
+	O
sta	B-T109
or	O
200	O
µm	O
lna	B-T109
cs	O
+	O
lna	B-T109
for	O
48	O
h	O
.	O
	
adipogenesis	O
was	O
determined	O
using	O
oil	O
red	O
o	O
staining	O
and	O
glycerol-3-phosphate	O
dehydrogenase	O
gpdh	O
activity	O
.	O
	
the	O
proportion	O
of	O
ola	B-T109
,	O
pam	B-T109
,	O
or	O
sta	B-T109
was	O
increased	B-T081
p	O
<	O
0.05	O
in	O
svc	O
grown	O
in	O
either	O
fbs	O
or	O
cs	O
with	O
ola	B-T109
,	O
pam	B-T109
or	O
sta	B-T109
.	O
	
adipogenesis	O
was	O
induced	B-T169
in	O
fbs	O
+	O
ola	B-T109
,	O
fbs	O
+	O
lna	B-T109
,	O
fbs	O
+	O
pam	B-T109
,	O
fbs	O
+	O
sta	B-T109
,	O
cs	O
+	O
ola	B-T109
,	O
cs	O
+	O
lna	B-T109
,	O
cs	O
+	O
pam	B-T109
,	O
or	O
cs	O
+	O
sta	B-T109
compared	O
to	O
fbs	O
.	O
	
gpdh	O
activity	O
was	O
significantly	B-T081
higher	I-T081
in	O
fbs	O
+	O
ola	B-T109
and	O
fbs	O
+	O
lna	B-T109
than	O
one	O
in	O
fbs	O
.	O
	
compared	O
to	O
fbs	O
,	O
the	O
expression	O
of	O
fabp4	O
mrna	O
increased	B-T081
p	O
<	O
0.05	O
in	O
fbs	O
+	O
ola	B-T109
,	O
fbs	O
+	O
lna	B-T109
,	O
or	O
fbs	O
+	O
pam	B-T109
,	O
whereas	O
that	O
of	O
c/ebpα	O
,	O
c/ebpβ	O
,	O
and	O
atgl	O
increased	B-T081
p	O
<	O
0.05	O
in	O
fbs	O
+	O
ola	B-T109
or	O
fbs	O
+	O
lna	B-T109
cells	O
.	O
	
expression	O
of	O
fabp4	O
and	O
c/ebpβ	O
mrna	O
was	O
higher	B-T080
in	O
cs	O
,	O
cs	O
+	O
ola	B-T109
,	O
cs	O
+	O
lna	B-T109
,	O
cs	O
+	O
pam	B-T109
,	O
or	O
cs	O
+	O
sta	B-T109
compared	O
with	O
fbs	O
,	O
whereas	O
the	O
expression	O
of	O
atgl	O
and	O
c/ebpα	O
was	O
higher	B-T080
in	O
cs	O
,	O
cs	O
+	O
ola	B-T109
,	O
or	O
cs	O
+	O
lna	B-T109
than	O
fbs	O
cells	O
.	O
	
in	O
conclusion	O
,	O
these	O
results	B-T033
showed	O
that	O
fa	B-T109
have	O
different	B-T080
potentials	B-T080
to	O
induce	B-T169
adipogenesis	O
,	O
lna	B-T109
is	O
the	O
most	O
potent	B-T080
among	O
the	O
tested	O
fa	B-T109
,	O
and	O
these	O
potentials	B-T080
can	O
be	O
improved	O
in	O
the	O
presence	B-T033
of	O
a	O
novel	B-T080
rapid	B-T080
analysis	O
using	O
mass	O
spectrometry	O
to	O
evaluate	O
downstream	O
refolding	O
of	O
recombinant	B-T116
human	I-T116
insulin-like	I-T116
growth	I-T116
factor-1	I-T116
mecasermin	B-T116
mecasermin	B-T116
is	O
used	O
to	O
treat	O
elevated	B-T047
blood	I-T047
sugar	I-T047
as	O
well	O
as	O
growth	B-T116
hormone	I-T116
-	O
resistant	B-T169
laron-type	B-T047
dwarfism	I-T047
.	O
	
mecasermin	B-T116
isolated	O
from	O
inclusion	O
bodies	O
in	O
extracts	O
of	O
e.coli	O
must	O
be	O
refolded	O
to	O
acquire	O
sufficient	O
activity	O
.	O
	
however	O
,	O
there	O
is	O
no	O
rapid	B-T080
analytical	O
method	O
for	O
monitoring	O
refolding	O
during	O
the	O
purification	O
process	O
.	O
	
we	O
prepared	O
mecasermin	B-T116
drug	O
product	O
,	O
in-process	O
samples	O
during	O
the	O
oxidation	O
of	O
mecasermin	B-T116
,	O
forced-reduced	O
mecasermin	B-T116
,	O
and	O
aerially	O
oxidized	O
mecasermin	B-T116
after	O
forced	O
reduction	O
.	O
	
desalted	O
mecasermin	B-T116
samples	O
were	O
analyzed	O
using	O
maldi-isd	O
.	O
	
the	O
peak	B-T081
intensity	I-T081
ratio	I-T081
of	O
product	O
to	O
precursor	O
ion	O
was	O
determined	O
.	O
	
the	O
charge	B-T080
state	I-T080
distribution	I-T080
csd	B-T080
of	O
mecasermin	B-T116
ions	O
was	O
evaluated	O
using	O
esi-ms	O
coupled	O
with	O
sec-mode	O
hplc	O
.	O
	
the	O
drift	B-T081
time	I-T081
and	O
collision	B-T081
cross-sectional	I-T081
areas	I-T081
ccs	B-T081
of	O
mecasermin	B-T116
ions	O
were	O
evaluated	O
using	O
esi-ims-ms	O
coupled	B-T169
with	O
sec-mode	O
hplc	O
.	O
	
maldi-isd	O
data	O
,	O
csd	B-T081
values	I-T081
determined	O
using	O
esi-ms	O
,	O
and	O
the	O
ccs	B-T081
acquired	O
using	O
esi-ims-ms	O
revealed	O
the	O
relationship	B-T080
between	O
the	O
folded	O
and	O
unfolded	O
proteoforms	B-T116
of	O
forced-reduced	O
mecasermin	B-T116
and	O
aerially	O
oxidized	O
mecasermin	B-T116
with	O
the	O
free-sh	B-T081
protein	I-T081
ratio	I-T081
of	O
mecasermin	B-T116
drug	O
product	O
.	O
	
the	O
collision	B-T081
cross-sectional	I-T081
area	I-T081
,	O
which	O
is	O
determined	O
using	O
esi-ims-ms	O
,	O
provided	O
proteoform	B-T116
information	O
through	O
rapid	B-T080
monitoring	O
<2	O
min	O
of	O
in-process	O
samples	O
during	O
the	O
manufacture	O
of	O
mecasermin	B-T116
.	O
	
esi-ims-ms	O
coupled	O
with	O
sec-mode	O
hplc	O
is	O
a	O
rapid	B-T080
and	O
robust	B-T080
method	O
for	O
analyzing	O
the	O
free-sh	B-T081
protein	I-T081
ratio	I-T081
of	O
mecasermin	B-T116
that	O
allows	O
evaluating	O
and	O
monitoring	O
proteoform	B-T116
changes	O
during	O
the	O
oxidation	O
of	O
mecasermin	B-T116
.	O
	
esi-ims-ms	O
is	O
applicable	O
as	O
a	O
process	O
analytical	O
technology	O
tool	O
for	O
identifying	O
the	O
""""	O
critical	B-T080
quality	B-T080
attributes	B-T080
""""	O
and	O
implementing	O
""""	O
quality	B-T080
by	O
design	O
""""	O
for	O
manufacturing	O
regulated	O
intron	O
removal	O
integrates	O
motivational	O
state	O
and	O
experience	O
myriad	O
experiences	O
produce	O
transient	O
memory	O
,	O
yet	O
,	O
contingent	O
on	O
the	O
internal	O
state	O
of	O
the	O
organism	O
and	O
the	O
saliency	O
of	O
the	O
experience	O
,	O
only	O
some	O
memories	O
persist	O
over	O
time	B-T079
.	O
	
how	O
experience	O
and	O
internal	O
state	O
influence	O
the	O
duration	B-T079
of	O
memory	O
at	O
the	O
molecular	O
level	O
remains	O
unknown	O
.	O
	
a	O
self-assembled	B-T080
aggregated	I-T080
state	O
of	O
drosophila	B-T116
orb2a	I-T116
protein	I-T116
is	O
required	O
specifically	O
for	O
long-lasting	O
memory	O
.	O
	
we	O
report	O
that	O
in	O
the	O
adult	O
fly	O
brain	O
the	O
mrna	O
encoding	O
orb2a	B-T116
protein	I-T116
exists	O
in	O
an	O
unspliced	O
non-protein-coding	O
form	O
.	O
	
the	O
convergence	O
of	O
experience	O
and	O
internal	O
drive	O
transiently	O
increases	B-T169
the	O
spliced	O
protein-coding	O
orb2a	O
mrna	O
.	O
	
a	O
screen	O
identified	O
pasilla	B-T116
,	O
the	O
fly	O
ortholog	O
of	O
mammalian	O
nova-1	B-T116
/	O
2	B-T116
,	O
as	O
a	O
mediator	B-T116
of	O
orb2a	O
mrna	O
processing	O
.	O
	
a	O
single-nucleotide	O
substitution	O
in	O
the	O
intronic	O
region	O
that	O
reduces	B-T080
pasilla	B-T116
binding	O
and	O
intron	O
removal	O
selectively	O
impairs	B-T169
long-term	O
memory	O
.	O
	
we	O
posit	O
that	O
pasilla	B-T116
-mediated	O
processing	O
of	O
unspliced	O
orb2a	O
mrna	O
integrates	O
experience	O
and	O
internal	O
state	O
to	O
control	O
orb2a	B-T116
protein	I-T116
abundance	B-T080
and	O
long-term	O
memory	O
formation	B-T169
.	O
	
the	O
flashe	O
study	O
survey	O
development	B-T169
,	O
dyadic	O
perspectives	O
,	O
and	O
participant	O
characteristics	B-T080
the	O
national	O
cancer	O
institute	O
developed	O
the	O
family	O
life	O
,	O
activity	O
,	O
sun	O
,	O
health	B-T078
,	O
and	O
eating	O
flashe	O
study	O
to	O
examine	O
multiple	O
cancer	B-T061
preventive	I-T061
behaviors	O
within	O
parent	O
-	O
adolescent	O
dyads	O
.	O
	
the	O
purpose	O
of	O
creating	O
flashe	O
was	O
to	O
enable	O
the	O
examination	O
of	O
physical	O
activity	O
,	O
diet	O
,	O
and	O
other	O
cancer	B-T061
preventive	I-T061
behaviors	I-T061
and	O
potential	O
correlates	O
among	O
parent	O
-	O
adolescent	O
dyads	O
.	O
	
flashe	O
surveys	O
were	O
developed	O
from	O
a	O
process	O
involving	O
literature	O
reviews	O
,	O
scientific	O
input	O
from	O
experts	O
in	O
the	O
field	O
,	O
cognitive	O
testing	O
,	O
and	O
usability	O
testing	O
.	O
	
this	O
cross-sectional	O
,	O
web-based	O
study	O
of	O
parents	O
and	O
their	O
adolescent	O
children	O
aged	O
12-17	O
years	O
was	O
administered	B-T169
between	O
april	B-T079
and	O
october	B-T079
2014	O
.	O
	
the	O
nationwide	O
sample	O
consisted	O
of	O
1	O
parent	O
-	O
adolescent	O
dyads	O
1	O
parents	O
and	O
1	O
adolescents	O
who	O
returned	O
all	O
flashe	O
surveys	O
.	O
	
flashe	O
assessed	O
parent	O
and	O
adolescent	O
reports	O
of	O
several	O
intrapersonal	O
and	O
interpersonal	B-T080
domains	O
including	O
psychosocial	B-T080
variables	I-T080
,	O
parenting	O
,	O
and	O
the	O
community	B-T080
and	O
home	O
environments	O
.	O
	
on	O
a	O
subset	O
of	O
example	O
flashe	O
items	O
across	O
these	O
domains	O
,	O
responses	B-T078
of	O
parents	O
and	O
adolescents	O
within	O
the	O
same	O
dyads	O
were	O
positively	O
and	O
significantly	O
correlated	B-T081
r	O
=0	O
.	O
	
analyses	O
were	O
run	O
in	O
2015-2016	O
.	O
	
flashe	O
data	O
present	O
multiple	O
opportunities	O
for	O
studying	O
research	B-T078
questions	I-T078
among	O
individuals	O
or	O
dyads	O
,	O
including	O
the	O
ability	O
to	O
examine	O
similarity	B-T080
between	O
parents	O
and	O
adolescents	O
on	O
many	O
constructs	O
relevant	O
to	O
cancer	B-T061
preventive	I-T061
behaviors	I-T061
.	O
	
flashe	O
data	O
are	O
publicly	O
available	O
for	O
researchers	O
and	O
practitioners	O
to	O
help	O
advance	O
research	O
on	O
cancer	B-T061
preventive	I-T061
health	O
behaviors	O
.	O
	
sex	O
differences	O
in	O
the	O
effect	B-T080
of	I-T080
chronic	O
mild	O
stress	O
on	O
mouse	O
prefrontal	O
cortical	O
bdnf	B-T116
levels	O
a	O
role	O
of	O
major	O
ovarian	B-T109
hormones	I-T109
depression	O
induced	B-T169
by	O
stress	B-T033
is	O
affected	O
by	O
sex	O
,	O
age	O
and	O
hormonal	B-T080
status	O
of	O
the	O
animal	O
and	O
also	O
by	O
duration	B-T079
and	O
type	O
of	O
the	O
stressors	B-T078
.	O
	
moreover	O
,	O
higher	O
prevalence	O
of	O
depression	O
and	O
comorbidities	B-T078
in	O
women	O
than	O
men	O
implies	O
the	O
need	O
to	O
include	O
the	O
sex	O
variable	O
in	O
studies	O
on	O
animal	O
models	O
of	O
depression	O
.	O
	
the	O
present	O
study	O
was	O
therefore	O
initiated	O
to	O
evaluate	O
the	O
effect	B-T080
of	I-T080
sex	O
and	O
ovarian	B-T109
hormones	I-T109
on	O
depression	O
-like	O
phenotypes	O
in	O
mice	O
exposed	O
to	O
a	O
21-day	O
chronic	O
variable	O
mild	O
stress	O
cvms	O
paradigm	O
.	O
	
adult	O
male	O
,	O
intact	B-T033
female	I-T033
and	O
,	O
ovariectomized	B-T033
ovx	I-T033
female	I-T033
mice	O
exposed	O
to	O
cvms	O
displayed	O
despair	O
behavior	O
,	O
a	O
depression	O
-like	O
phenotype	O
,	O
in	O
all	O
the	O
groups	O
.	O
	
however	O
,	O
intact	B-T033
females	I-T033
alone	O
,	O
but	O
not	O
males	O
and	O
ovx	B-T033
females	I-T033
,	O
showed	O
anhedonia	O
,	O
another	O
depression	O
-like	O
phenotype	O
.	O
	
at	O
the	O
molecular	B-T081
level	I-T081
,	O
the	O
expression	O
of	O
brain-derived	B-T116
neurotrophic	I-T116
factor	I-T116
bdnf	B-T116
,	O
a	O
neuropeptide	B-T116
associated	B-T080
with	I-T080
depression	O
,	O
and	O
few	O
other	O
stress	B-T033
-specific	O
genes	O
crh	O
,	O
nr3c1	O
,	O
cart	O
,	O
and	O
npy	O
were	O
measured	O
in	O
the	O
prefrontal	O
cortex	O
pfc	O
region	O
of	O
the	O
reward	O
circuitry	O
.	O
	
there	O
was	O
a	O
significant	O
decrease	O
in	O
the	O
bdnf	B-T116
protein	O
expression	O
along	O
with	O
an	O
increase	O
in	O
the	O
mrna	O
expression	O
of	O
crh	O
,	O
nr3c1	O
,	O
cart	O
,	O
and	O
npy	O
in	O
intact	B-T033
females	I-T033
,	O
but	O
not	O
in	O
the	O
other	O
two	O
groups	O
of	O
mice	O
.	O
	
ovx	B-T033
females	I-T033
resembled	O
males	O
in	O
behavioral	B-T033
and	O
molecular	B-T033
responses	I-T033
to	O
cvms	O
.	O
	
17β-estradiol	B-T109
e2	B-T109
administration	B-T061
,	O
not	O
progesterone	B-T109
p4	B-T109
,	O
to	O
ovx	B-T033
female	I-T033
stress	B-T033
mice	O
,	O
mitigated	O
despair	O
and	O
enhanced	O
hedonic	O
capacity	O
with	O
an	O
increased	O
expression	O
of	O
bdnf	B-T116
in	O
pfc	O
.	O
	
this	O
study	O
strengthens	O
the	O
evidence	O
for	O
the	O
beneficial	O
effects	B-T080
of	I-T080
e2	B-T109
administration	B-T061
in	O
stress	B-T033
development	B-T169
and	O
evaluation	O
of	O
the	O
adhd	O
cognitions	O
scale	O
for	O
adults	O
the	O
clinical	O
literature	O
on	O
adhd	O
in	O
adults	O
suggests	O
that	O
""""	O
overly	O
positive	O
""""	O
or	O
optimistic	O
cognitions	O
may	O
contribute	O
to	O
impairment	O
and	O
failure	O
to	O
use	O
self-regulation	O
skills	O
in	O
this	O
population	O
,	O
yet	O
the	O
research	O
literature	O
on	O
this	O
topic	O
is	O
limited	O
.	O
	
we	O
developed	O
the	O
adhd	O
cognitions	O
scale	O
acs	O
,	O
a	O
brief	O
self-report	O
measure	O
of	O
adhd	O
-related	O
thoughts	O
,	O
and	O
evaluated	O
its	O
psychometric	O
properties	O
.	O
	
we	O
collected	O
self-report	O
measures	O
,	O
inculding	O
the	O
acs	O
,	O
from	O
two	O
large	O
community	O
samples	O
ns	O
=	O
262	O
,	O
304	O
.	O
	
the	O
measure	O
demonstrated	O
a	O
one-factor	O
solution	O
that	O
replicated	O
in	O
the	O
second	O
sample	O
.	O
	
evidence	O
of	O
good	O
internal	O
consistency	O
and	O
also	O
convergent	O
and	O
divergent	O
validity	O
was	O
obtained	O
for	O
both	O
samples	O
.	O
	
scores	O
on	O
the	O
acs	O
correlated	O
with	O
functional	O
impairment	O
,	O
time	O
management	O
problems	O
,	O
and	O
avoidant	O
coping	O
strategies	O
.	O
	
with	O
additional	O
study	O
,	O
the	O
acs	O
may	O
be	O
useful	O
to	O
identify	O
and	O
track	O
maladaptive	O
adhd	O
-related	O
cognitions	O
during	O
cognitive-behavioral	O
treatment	O
,	O
and	O
to	O
further	O
study	O
the	O
role	O
of	O
these	O
thoughts	O
in	O
adhd	O
-related	O
impairment	B-T169
visual	B-T169
confidence	O
visual	B-T169
confidence	O
refers	O
to	O
an	O
observer's	O
ability	O
to	O
judge	O
the	O
accuracy	B-T080
of	O
her	O
perceptual	O
decisions	O
.	O
	
even	O
though	O
confidence	O
judgments	O
have	O
been	O
recorded	O
since	O
the	O
early	O
days	O
of	O
psychophysics	O
,	O
only	O
recently	O
have	O
they	O
been	O
recognized	O
as	O
essential	O
for	O
a	O
deeper	O
understanding	O
of	O
visual	O
perception	O
.	O
	
the	O
reluctance	O
to	O
study	O
visual	B-T169
confidence	O
may	O
have	O
come	O
in	O
part	O
from	O
obtaining	O
convincing	O
experimental	B-T078
evidence	I-T078
in	O
favor	O
of	O
metacognitive	O
abilities	O
rather	O
than	O
just	O
perceptual	O
sensitivity	O
.	O
	
some	O
effort	O
has	O
thus	O
been	O
dedicated	O
to	O
offer	O
different	O
experimental	O
paradigms	O
to	O
study	O
visual	B-T169
confidence	O
in	O
humans	O
and	O
nonhuman	O
animals	O
.	O
	
to	O
understand	O
the	O
origins	B-T079
of	O
confidence	O
judgments	O
,	O
investigators	O
have	O
developed	O
two	O
competing	O
frameworks	O
.	O
	
the	O
approach	O
based	O
on	O
signal	O
decision	O
theory	O
is	O
popular	O
but	O
fails	B-T169
to	O
account	O
for	O
response	B-T079
times	I-T079
.	O
	
in	O
contrast	O
,	O
the	O
approach	O
based	O
on	O
accumulation	O
of	O
evidence	B-T078
models	O
naturally	O
includes	O
the	O
dynamics	O
of	O
perceptual	O
decisions	O
.	O
	
these	O
models	O
can	O
explain	O
a	O
range	O
of	O
results	B-T169
,	O
including	O
the	O
apparently	O
paradoxical	B-T080
dissociation	O
between	O
performance	O
and	O
confidence	O
grapevine	O
subtilase	B-T116
family	I-T116
update	O
on	O
new	O
sequences	O
and	O
nomenclature	O
proposal	O
in	O
grapevine	O
,	O
serine	B-T116
peptidases	I-T116
from	O
the	O
subtilase	B-T116
family	I-T116
were	O
recently	O
associated	O
to	O
plasmopara	O
viticola	O
resistance	B-T169
.	O
	
this	O
family	O
in	O
grapevine	O
,	O
first	O
characterized	O
in	O
2014	O
,	O
was	O
re-analyzed	O
last	O
year	O
and	O
82	O
subtilase	B-T116
genes	O
were	O
identified	O
.	O
	
however	O
,	O
in	O
november	O
of	O
2016	O
,	O
the	O
national	O
center	O
for	O
biotechnology	O
information	O
database	O
ncbi	O
made	O
a	O
new	O
public	O
release	O
of	O
the	O
grapevine	O
genome	O
annotation	O
based	O
on	O
new	O
sequencing	O
data	O
and	O
better	O
prediction	B-T078
algorithms	O
.	O
	
as	O
a	O
consequence	B-T169
,	O
some	O
gene	O
annotations	O
and	O
lengths	O
changed	O
.	O
	
here	O
we	O
present	O
an	O
update	O
to	O
the	O
grapevine	O
subtilase	B-T116
gene	O
family	O
sequences	O
sbt	B-T116
,	O
namely	O
sequence	O
identifiers	O
,	O
bioinformatic	O
predictions	B-T078
and	O
recommend	O
a	O
nomenclature	O
for	O
the	O
grapevine	O
sbt	B-T116
genes	O
.	O
	
our	O
results	O
show	O
that	O
grapevine	O
subtilase	B-T116
gene	O
family	O
is	O
now	O
constituted	O
by	O
87	O
subtilase	B-T116
genes	O
encoding	O
for	O
109	O
subtilase	B-T116
proteins	I-T116
and	O
,	O
despite	O
the	O
reported	O
alterations	O
,	O
expression	O
data	B-T078
on	O
subtilases	B-T116
associated	O
to	O
grapevine	O
resistance	B-T169
to	O
p	O
.	O
	
viticola	O
pathosystem	O
did	O
not	O
suffer	O
any	O
shared	O
decision	O
making	O
and	O
the	O
promise	B-T078
of	O
a	O
respectful	O
and	O
equitable	O
healthcare	O
system	O
in	O
peru	O
peru	O
has	O
achieved	O
sustained	O
development	O
in	O
the	O
last	O
two	O
decades	B-T081
.	O
	
however	O
,	O
despite	O
this	O
achievement	O
,	O
it	O
has	O
not	O
been	O
matched	O
with	O
improvements	O
in	O
the	O
quality	B-T080
of	I-T080
education	I-T080
and	O
health	O
investment	O
in	O
both	O
sectors	B-T078
is	O
among	O
the	O
lowest	O
in	O
the	O
region	O
.	O
	
this	O
situation	O
perpetuates	O
huge	O
gaps	B-T033
in	O
infrastructure	O
and	O
also	O
conditions	O
a	O
poor	B-T033
literacy	I-T033
level	I-T033
of	O
the	O
population	O
specifically	O
in	O
health	B-T078
.	O
	
currently	O
,	O
there	O
is	O
a	O
fragmented	O
model	O
of	O
patient	O
care	O
,	O
in	O
which	O
the	O
systems	O
are	O
exclusive	O
of	O
each	O
other	O
.	O
	
they	O
do	O
not	O
cooperate	O
or	O
communicate	O
with	O
each	O
other	O
and	O
if	O
there	O
is	O
no	O
vertical	O
communication	O
within	O
the	O
system	O
,	O
preventing	O
referral	O
of	O
patients	O
directly	O
from	O
the	O
basic	B-T033
level	I-T033
to	O
the	O
complex	B-T033
level	I-T033
of	O
care	O
when	O
needed	O
.	O
	
in	O
addition	O
,	O
there	O
has	O
been	O
no	O
progress	O
in	O
the	O
development	B-T169
of	O
an	O
empathetic	O
,	O
respectful	O
or	O
person-centered	O
clinical	O
practice	O
instead	O
,	O
economic	B-T169
,	O
social	B-T169
and	O
educational	O
differences	O
perpetuate	O
a	O
paternalistic	O
clinical	O
practice	O
.	O
	
the	O
task	O
of	O
orienting	O
medical	O
training	O
towards	O
the	O
development	B-T169
of	O
humanism	B-T078
is	O
pending	O
.	O
	
the	O
patient	O
is	O
the	O
center	O
of	O
the	O
medical	O
act	O
and	O
the	O
main	O
objective	O
of	O
doctors'	O
actions	O
.	O
	
a	O
humanistic	O
care	O
approach	O
will	O
not	O
only	O
empower	O
the	O
person	O
in	O
the	O
clinical	O
encounter	O
-	O
to	O
participate	O
and	O
make	O
decisions	O
related	O
to	O
his/her	O
health	O
care	O
-	O
but	O
it	O
will	O
allow	O
us	O
to	O
move	O
towards	O
an	O
empathetic	O
,	O
caring	O
,	O
respectful	O
and	O
kind	O
model	O
of	O
clinical	O
practice	O
.	O
	
identification	O
of	O
markers	O
for	O
quiescent	B-T080
pancreatic	O
stellate	O
cells	O
in	O
the	O
normal	B-T080
human	O
pancreas	O
pancreatic	O
stellate	O
cells	O
pscs	O
play	O
a	O
central	O
role	O
as	O
source	O
of	O
fibrogenic	O
cells	O
in	O
pancreatic	O
cancer	O
and	O
chronic	B-T047
pancreatitis	I-T047
.	O
	
in	O
contrast	O
to	O
quiescent	B-T080
hepatic	O
stellate	O
cells	O
qhscs	O
,	O
a	O
specific	O
marker	O
for	O
quiescent	B-T080
pscs	O
qpscs	O
that	O
can	O
be	O
used	O
in	O
formalin-fixed	O
and	O
paraffin	O
embedded	O
ffpe	O
normal	O
human	O
pancreatic	O
tissue	O
has	O
not	O
been	O
identified	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
a	O
marker	O
enabling	O
the	O
identification	O
of	O
qpscs	O
in	O
normal	B-T080
human	O
ffpe	O
pancreatic	O
tissue	O
.	O
	
immunohistochemical	O
ihc	O
,	O
double-ihc	O
,	O
immunofluorescence	O
if	O
and	O
double-if	O
analyses	O
were	O
carried	O
out	O
using	O
a	O
tissue	O
microarray	O
consisting	O
of	O
cores	O
with	O
normal	B-T080
human	O
pancreatic	O
tissue	O
.	O
	
cores	O
with	O
normal	B-T080
human	O
liver	O
served	O
as	O
control	O
.	O
	
antibodies	B-T116
directed	O
against	O
adipophilin	B-T116
,	O
α-sma	B-T116
,	O
cd146	B-T116
,	O
crbp-1	B-T116
,	O
cytoglobin	B-T116
,	O
desmin	B-T116
,	O
gfap	B-T116
,	O
nestin	B-T116
,	O
s100a4	B-T116
and	O
vinculin	B-T116
were	O
examined	O
,	O
with	O
special	O
emphasis	O
on	O
their	O
expression	O
in	O
periacinar	O
cells	O
in	O
the	O
normal	B-T080
human	O
pancreas	O
and	O
perisinusoidal	O
cells	O
in	O
the	O
normal	B-T080
human	O
liver	O
.	O
	
the	O
immunolabelling	O
capacity	B-T081
was	O
evaluated	O
according	O
to	O
a	O
semiquantitative	O
scoring	O
system	O
.	O
	
double-if	O
of	O
the	O
markers	O
of	O
interest	O
together	O
with	O
markers	O
for	O
other	O
periacinar	O
cells	O
was	O
performed	O
.	O
	
moreover	O
,	O
the	O
utility	O
of	O
histochemical	O
stains	O
for	O
the	O
identification	O
of	O
human	O
qpscs	O
was	O
examined	O
,	O
and	O
their	O
ultrastructure	B-T078
was	O
revisited	O
by	O
electron	O
microscopy	O
.	O
	
adipophilin	B-T116
,	O
crbp-1	B-T116
,	O
cytoglobin	B-T116
and	O
vinculin	B-T116
were	O
expressed	O
in	O
qhscs	O
in	O
the	O
liver	O
,	O
whereas	O
cytoglobin	B-T116
and	O
adipophilin	B-T116
were	O
expressed	O
in	O
qpscs	O
in	O
the	O
pancreas	O
.	O
	
adipophilin	B-T116
immunohistochemistry	O
was	O
highly	O
dependent	O
on	O
the	O
preanalytical	B-T079
time	I-T079
interval	I-T079
pati	B-T079
from	O
removal	O
of	O
the	O
tissue	O
to	O
formalin	O
fixation	O
.	O
	
cytoglobin	B-T116
,	O
s100a4	B-T116
and	O
vinculin	B-T116
were	O
expressed	O
in	O
periacinar	O
fibroblasts	O
fbs	O
.	O
	
the	O
other	O
examined	O
markers	O
were	O
negative	O
in	O
human	O
qpscs	O
.	O
	
our	O
data	O
indicate	O
that	O
cytoglobin	B-T116
and	O
adipophilin	B-T116
are	O
markers	O
of	O
qpscs	O
in	O
the	O
normal	B-T080
human	O
pancreas	O
.	O
	
however	O
,	O
the	O
use	O
of	O
adipophilin	B-T116
as	O
a	O
qpsc	O
marker	O
may	O
be	O
limited	O
due	O
to	O
its	O
high	O
dependence	O
on	O
optimal	O
pati	B-T079
.	O
	
cytoglobin	B-T116
,	O
on	O
the	O
other	O
hand	O
,	O
is	O
a	O
sensitive	O
marker	O
for	O
qpscs	O
but	O
is	O
expressed	O
in	O
fbs	O
biomagnetic	O
monitoring	O
of	O
atmospheric	O
pollution	O
a	O
review	B-T169
of	I-T169
magnetic	O
signatures	O
from	O
biological	O
sensors	O
biomagnetic	O
monitoring	O
of	O
atmospheric	O
pollution	O
is	O
a	O
growing	O
application	O
in	O
the	O
field	O
of	O
environmental	O
magnetism	O
.	O
	
particulate	O
matter	O
pm	O
in	O
atmospheric	O
pollution	O
contains	O
readily-	O
measurable	B-T169
concentrations	O
of	O
magnetic	O
minerals	O
.	O
	
biological	B-T080
surfaces	O
,	O
exposed	O
to	O
atmospheric	O
pollution	O
,	O
accumulate	O
magnetic	O
particles	O
over	O
time	O
,	O
providing	O
a	O
record	O
of	O
location	O
-	O
specific	B-T080
,	O
time-integrated	B-T033
air	B-T080
quality	I-T080
information	B-T078
.	O
	
this	O
review	O
summarizes	O
current	O
knowledge	O
of	O
biological	O
material	O
'	O
sensors	O
'	O
used	O
for	O
biomagnetic	O
monitoring	O
purposes	O
.	O
	
our	O
work	O
addresses	O
the	O
range	O
of	O
magnetic	O
properties	O
reported	O
for	O
lichens	O
,	O
mosses	O
,	O
leaves	O
,	O
bark	O
,	O
trunk	O
wood	O
,	O
insects	O
,	O
crustaceans	O
,	O
mammal	O
and	O
human	O
tissues	O
their	O
associations	O
with	O
atmospheric	O
pollutant	O
species	O
pm	O
,	O
nox	O
,	O
trace	O
elements	O
,	O
pahs	B-T109
the	O
pros	B-T033
and	I-T033
cons	I-T033
of	O
biomagnetic	O
monitoring	O
of	O
atmospheric	O
pollution	O
current	O
challenges	O
for	O
large-scale	O
implementation	O
of	O
biomagnetic	O
monitoring	O
and	O
future	B-T079
perspectives	O
.	O
	
a	O
summary	O
table	O
is	O
presented	O
,	O
with	O
the	O
aim	O
of	O
aiding	O
researchers	O
and	O
policy	O
makers	O
in	O
selecting	O
the	O
most	O
suitable	O
biological	O
sensor	O
for	O
their	O
intended	O
biomagnetic	O
monitoring	O
role	O
of	O
infrared	O
spectroscopy	O
and	O
imaging	O
in	O
cancer	O
diagnosis	B-T033
ftir	O
imaging	O
has	O
been	O
used	O
to	O
diagnose	B-T033
and	O
differentiate	B-T080
the	O
molecular	B-T080
differences	B-T080
between	O
normal	O
and	O
diseased	B-T047
tissues	O
.	O
	
the	O
differences	B-T080
correspond	O
to	O
the	O
distribution	B-T169
and	O
structure	O
of	O
lipids	B-T109
,	O
proteins	B-T116
,	O
nucleic	O
acids	O
as	O
well	O
as	O
other	O
metabolites	O
.	O
	
these	O
differences	B-T080
depended	O
on	O
the	O
type	B-T033
and	O
the	O
grade	O
of	O
cancer	O
.	O
	
the	O
sensitivity	B-T169
of	O
chemotherapy	B-T061
drugs	O
on	O
individual	O
specific	O
was	O
also	O
discussed	O
.	O
	
here	O
,	O
we	O
emphasize	O
that	O
ftir	O
spectroscopy	O
and	O
imaging	O
can	O
be	O
considered	O
as	O
a	O
promising	O
technique	B-T169
and	O
will	O
find	O
its	O
place	O
on	O
the	O
detection	B-T061
of	O
this	O
dreadful	B-T047
disease	I-T047
because	O
of	O
high	O
sensitivity	O
,	O
accuracy	B-T080
and	O
inexpensive	O
technique	B-T169
.	O
	
now	O
the	O
medical	O
community	O
started	O
using	O
and	O
accepting	O
this	O
technique	B-T169
for	O
early	B-T079
stage	I-T079
cancer	O
detection	B-T061
.	O
	
but	O
,	O
this	O
technique	B-T169
endures	O
several	O
challenges	O
on	O
its	O
application	O
into	O
the	O
diagnosis	B-T033
of	O
cancer	O
in	O
regards	O
of	O
sample	O
preparations	O
,	O
data	O
interpretation	O
,	O
and	O
data	O
analysis	O
.	O
	
in	O
general	O
,	O
more	O
research	O
is	O
needed	O
in	O
this	O
field	O
and	O
it	O
is	O
necessary	O
to	O
understand	O
the	O
morphology	B-T080
and	O
biology	O
of	O
the	O
sample	O
before	O
using	O
the	O
spectroscopy	O
and	O
imaging	O
because	O
invaluable	B-T080
information	B-T078
the	O
clasp2	B-T116
protein	B-T169
interaction	I-T169
network	I-T169
in	O
adipocytes	O
links	O
clip2	B-T116
to	O
agap3	B-T116
,	O
clasp2	B-T116
to	O
g2l1	B-T116
,	O
mark2	B-T116
,	O
and	O
soga1	B-T116
,	O
and	O
identifies	O
soga1	B-T116
as	O
a	O
microtubule-associated	B-T116
protein	I-T116
clasp2	B-T116
is	O
a	O
microtubule-associated	B-T116
protein	I-T116
that	O
undergoes	O
insulin	B-T116
-	O
stimulated	O
phosphorylation	O
and	O
co-localization	B-T169
with	O
reorganized	B-T078
actin	B-T116
and	O
glut4	B-T116
at	O
the	O
plasma	O
membrane	O
.	O
	
to	O
gain	B-T081
insight	O
to	O
the	O
role	O
of	O
clasp2	B-T116
in	O
this	O
system	O
,	O
we	O
developed	B-T169
and	O
successfully	B-T080
executed	O
a	O
streamlined	B-T080
interactome	O
approach	O
and	O
built	O
a	O
clasp2	B-T116
protein	B-T169
network	I-T169
in	O
3t3-l1	O
adipocytes	O
.	O
	
using	O
two	O
different	B-T080
commercially	O
available	B-T169
antibodies	B-T116
for	O
clasp2	B-T116
and	O
an	O
antibody	B-T116
for	O
epitope	O
-tagged	O
,	O
overexpressed	O
clasp2	B-T116
,	O
we	O
performed	B-T169
multiple	B-T081
affinity	O
purification	O
coupled	B-T169
with	O
mass	O
spectrometry	O
ap	O
-	O
ms	O
experiments	O
in	O
combination	B-T080
with	O
label-free	B-T033
quantitative	B-T081
proteomics	O
and	O
analyzed	O
the	O
data	B-T078
with	O
the	O
bioinformatics	O
tool	O
significance	O
analysis	O
of	O
interactome	O
saint	O
.	O
	
we	O
discovered	O
that	O
clasp2	B-T116
co-immunoprecipitates	O
co-ips	O
the	O
novel	O
protein	B-T116
soga1	B-T116
,	O
the	O
microtubule-associated	B-T116
protein	I-T116
kinase	I-T116
mark2	B-T116
,	O
and	O
the	O
microtubule	O
/	O
actin	B-T116
-	O
regulating	O
protein	B-T116
g2l1	B-T116
.	O
	
the	O
gtpase-activating	B-T116
proteins	I-T116
agap1	B-T116
and	O
agap3	B-T116
were	O
also	O
enriched	O
in	O
the	O
clasp2	B-T116
interactome	O
,	O
although	O
subsequent	B-T079
agap3	B-T116
and	O
clip2	B-T116
interactome	O
analysis	O
suggests	O
a	O
preference	B-T078
of	O
agap3	B-T116
for	O
clip2	B-T116
.	O
	
follow-up	O
mark2	B-T116
interactome	O
analysis	O
confirmed	B-T033
reciprocal	B-T080
co-ip	O
of	O
clasp2	B-T116
and	O
also	O
revealed	O
mark2	B-T116
can	O
co-ip	O
soga1	B-T116
,	O
glycogen	B-T116
synthase	I-T116
,	O
and	O
glycogenin	B-T116
.	O
	
investigating	B-T169
the	O
soga1	B-T116
interactome	O
confirmed	B-T033
soga1	B-T116
can	O
reciprocal	B-T080
co-ip	O
both	O
clasp2	B-T116
and	O
mark2	B-T116
as	O
well	O
as	O
glycogen	B-T116
synthase	I-T116
and	O
glycogenin	B-T116
.	O
	
soga1	B-T116
was	O
confirmed	B-T033
to	O
colocalize	O
with	O
clasp2	B-T116
and	O
also	O
with	O
tubulin	B-T116
,	O
which	O
identifies	O
soga1	B-T116
as	O
a	O
new	O
microtubule-associated	B-T116
protein	I-T116
.	O
	
these	O
results	B-T033
introduce	O
the	O
metabolic	O
function	O
of	O
these	O
proposed	B-T080
novel	O
protein	B-T169
networks	I-T169
and	O
their	O
relationship	B-T080
with	O
microtubules	O
as	O
new	O
fields	O
of	O
cytoskeleton	O
-	O
associated	B-T080
protein	O
biology	O
.	O
	
